PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Li, WY; Fu, XM; Wang, ZD; Li, ZG; Ma, D; Sun, P; Liu, GB; Zhu, XF; Wang, Y				Li, Wen-Yuan; Fu, Xiu-Mei; Wang, Zhen-Dong; Li, Zhi-Gang; Ma, Duo; Sun, Ping; Liu, Gui-Bo; Zhu, Xiao-Feng; Wang, Ying			Kruppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							SPINAL-CORD-INJURY; IN-VITRO; AXON REGENERATION; NERVE REGENERATION; POTENTIAL ROLE; ACTIVATION; EXPRESSION; KNOCKDOWN; DELETION; PATHWAY	Our previous study has shown that the transcription factor Kruppel-like factor 7 (KLF7) promotes peripheral nerve regeneration and motor function recovery after spinal cord injury. KLF7 also participates in traumatic brain injury, but its regulatory mechanisms remain poorly understood. In the present study, an HT22 cell model of traumatic brain injury was established by stretch injury and oxygen-glucose deprivation. These cells were then transfected with an adeno-associated virus carrying KLF7 (AAV-KLF7). The results revealed that, after stretch injury and oxygen-glucose deprivation, KLF7 greatly reduced apoptosis, activated caspase-3 and lactate dehydrogenase, downregulated the expression of the apoptotic markers B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax) and cleaved caspase-3, and increased the expression of beta III-tubulin and the antiapoptotic marker Bcl-2. Furthermore, KLF7 overexpression upregulated Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) phosphorylation in HT22 cells treated by stretch injury and oxygen-glucose deprivation. Immunoprecipitation assays revealed that KLF7 directly participated in the phosphorylation of STAT3. In addition, treatment with AG490, a selective inhibitor of JAK2/STAT3, weakened the protective effects of KLF7. A mouse controlled cortical impact model of traumatic brain injury was then established. At 30 minutes before modeling, AAV-KLF7 was injected into the ipsilateral lateral ventricle. The protein and mRNA levels of KLF7 in the hippocampus were increased at 1 day after injury and recovered to normal levels at 3 days after injury. KLF7 reduced ipsilateral hippocampal atrophy, decreased the injured cortex volume, downregulated Bax and cleaved caspase-3 expression, and increased the number of 5-bromo-2 ' -deoxyuridine-positive neurons and Bcl-2 protein expression. Moreover, KLF7 transfection greatly enhanced the phosphorylation of JAK2 and STAT3 in the ipsilateral hippocampus. These results suggest that KLF7 may protect hippocampal neurons after traumatic brain injury through activation of the JAK2/STAT3 signaling pathway. The study was approved by the Institutional Review Board of Mudanjiang Medical University, China (approval No. mdjyxy-2018-0012) on March 6, 2018.	[Li, Wen-Yuan; Ma, Duo; Sun, Ping; Liu, Gui-Bo; Zhu, Xiao-Feng; Wang, Ying] Mudanjiang Med Univ, Inst Neural Tissue Engn, Mudanjiang, Heilongjiang, Peoples R China; [Fu, Xiu-Mei] Chengde Med Univ, Coll Basic Med Sci, Dept Anat, Chengde, Hebei, Peoples R China; [Fu, Xiu-Mei] Chengde Med Univ, Hebei Key Lab Nerve Injury & Repair, Chengde, Hebei, Peoples R China; [Wang, Zhen-Dong] Mudanjiang City Second Peoples Hosp, Dept Otorhinolaryngol, Mudanjiang, Heilongjiang, Peoples R China; [Li, Zhi-Gang] Mudanjiang Med Univ, Hongqi Hosp, Dept Gen Surg 1, Mudanjiang, Heilongjiang, Peoples R China		Zhu, XF; Wang, Y (corresponding author), Mudanjiang Med Univ, Inst Neural Tissue Engn, Mudanjiang, Heilongjiang, Peoples R China.	sjkx@sohu.com; yingwang2016@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870977]; Natural Science Foundation of Heilongjiang of ChinaNatural Science Foundation of Heilongjiang Province [H2018068]; Basic Research Operating Expenses Program of Heilongjiang Provincial Universities of China [2019-KYYWFMY-0018]; Graduate Innovative Research Projects of Mudanjiang Medical College of China [YJSCX-MY22]; Key projects of Education Department of Hebei Province of China [ZD2020178]; Hebei Key Laboratory of Nerve Injury and Repair of China	This study was supported by the National Natural Science Foundation of China, No. 81870977 (to YW); the Natural Science Foundation of Heilongjiang of China, No. H2018068 (to WYL); the Basic Research Operating Expenses Program of Heilongjiang Provincial Universities of China, No. 2019-KYYWFMY-0018 (to WYL); the Graduate Innovative Research Projects of Mudanjiang Medical College of China, No. YJSCX-MY22 (to DM); Key projects of Education Department of Hebei Province of China, No. ZD2020178 (to XMF); and Hebei Key Laboratory of Nerve Injury and Repair of China (to XMF).	Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Falnikar A, 2018, J NEUROTRAUM, V35, P2195, DOI 10.1089/neu.2017.5497; Fang XY, 2019, EXP NEUROL, V318, P258, DOI 10.1016/j.expneurol.2019.05.011; Gao ST, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/139085; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Laub F, 2001, DEV BIOL, V233, P305, DOI 10.1006/dbio.2001.0243; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li D, 2019, MED SCI MONITOR, V25, P1871, DOI 10.12659/MSM.915727; Li WY, 2020, J TISSUE ENG, V11, DOI 10.1177/2041731420980136; Li WY, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab3188; Li WY, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1621629; Li Y, 2017, APOPTOSIS, V22, P510, DOI 10.1007/s10495-016-1327-1; Li Z, 2008, EXP NEUROL, V214, P47, DOI 10.1016/j.expneurol.2008.07.007; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Lv JX, 2019, MOL MED REP, V19, P271, DOI 10.3892/mmr.2018.9644; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nagata K, 2014, NEUROSCIENCE, V256, P426, DOI 10.1016/j.neuroscience.2013.10.055; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Qu WR, 2020, CEREB CORTEX, V30, P3859, DOI 10.1093/cercor/bhaa002; Rizk M, 2021, NEURAL REGEN RES, V16, P926, DOI 10.4103/1673-5374.297057; Salvador E, 2018, METHODS MOL BIOL, V1717, P219, DOI 10.1007/978-1-4939-7526-6_17; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sirbulescu RF, 2010, NEUROSCIENCE, V171, P599, DOI 10.1016/j.neuroscience.2010.09.002; Song Y, 2019, CHEM-BIOL INTERACT, V304, P173, DOI 10.1016/j.cbi.2019.03.013; Sun TJ, 2021, ZHONGGUO ZUZHI GONGC, V25, P123; Tao JH, 2018, BIOMED PHARMACOTHER, V106, P1003, DOI 10.1016/j.biopha.2018.07.026; Tetreault MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038338; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Volkening B, 2017, GLIA, V65, P817, DOI 10.1002/glia.23128; Wang Y, 2017, NEUROSCIENCE, V340, P319, DOI 10.1016/j.neuroscience.2016.10.069; Wang ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31101-5; Xu JH, 2021, NEURAL REGEN RES, V16, P166, DOI 10.4103/1673-5374.286978; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Zhang QS, 2016, EXP THER MED, V12, P4107, DOI 10.3892/etm.2016.3889; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zheng JZ, 2010, J NEUROSCI RES, V88, P3376, DOI 10.1002/jnr.22488	46	0	0	18	18	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2022	17	3					661	672		10.4103/1673-5374.320991			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	US8QL	WOS:000697690900034	34380908	Green Published, gold			2022-02-06	
J	Ravula, AR; Rodriguez, J; Younger, D; Perumal, V; Shao, NN; Rao, KVR; Pfister, B; Chandra, N				Ravula, Arun Reddy; Rodriguez, Jose; Younger, Daniel; Perumal, Venkatesan; Shao, Ningning; Rao, Kakulavarapu V. Rama; Pfister, Bryan; Chandra, Namas			Animal model of repeated low-level blast traumatic brain injury displays acute and chronic neurobehavioral and neuropathological changes	EXPERIMENTAL NEUROLOGY			English	Article						Anxiety; Astrocytes; Blast traumatic brain injury; Behavioral changes; Depression; Motor incoordination; Microglia; Neuroinflammation; Oxidative stress; Occupational low level blast	DISORDER-RELATED TRAITS; MOUSE MODEL; RAT MODEL; EXPOSURE; SINGLE; CONSEQUENCES; DEFICITS	Blast-induced neurotrauma (BINT) is not only a signature injury to soldiers in combat field and training facilities but may also a growing concern in civilian population due to recent increases in the use of improvised explosives by insurgent groups. Unlike moderate or severe BINT, repeated low-level blast (rLLB) is different in its etiology as well as pathology. Due to the constant use of heavy weaponry as part of combat readiness, rLLB usually occurs in service members undergoing training as part of combat readiness. rLLB does not display overt pathological symptoms; however, earlier studies report chronic neurocognitive changes such as altered mood, irritability, and aggressive behavior, all of which may be caused by subtle neuropathological manifestations. Current animal models of rLLB for investigation of neurobehavioral and neuropathological alterations have not been adequate and do not sufficiently represent rLLB conditions. Here, we developed a rat model of rLLB by applying controlled low-level blast pressures (<10 psi) repeated successively five times to mimic the pressures experienced by service members. Using this model, we assessed anxiety-like symptoms, motor coordination, and short-term memory as a function of time. We also examined levels of superoxide-producing enzyme NADPH oxidase, microglial activa-tion, and reactive astrocytosis as factors likely contributing to these neurobehavioral changes. Animals exposed to rLLB displayed acute and chronic anxiety-like symptoms, motor and short-term memory impairments. These changes were paralleled by increased microglial activation and reactive astrocytosis. Conversely, animals exposed to a single low-level blast did not display significant changes. Collectively, this study demonstrates that, unlike a single low-level blast, rLLB exerts a cumulative impact on different brain regions and produces chronic neuropathological changes in so doing, may be responsible for neurobehavioral alterations.	[Ravula, Arun Reddy; Rodriguez, Jose; Younger, Daniel; Perumal, Venkatesan; Shao, Ningning; Rao, Kakulavarapu V. Rama; Pfister, Bryan; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Newark, NJ 07102 USA; [Rao, Kakulavarapu V. Rama] New Jersey Inst Technol, Ctr Injury Biomech, Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Rao, Kakulavarapu V. Rama] Walter Reed Army Inst Res, Blast Induced Neurotrauma Grp, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Rao, KVR (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07102 USA.	kakulavarapuvenkata41@gmail.com; namas.chandra@njit.edu			Congressionally Directed Medical Research Programs (CDMRP)United States Department of Defense [14059001, W81XWH-15-1-0303, 12744758 (RH180040)]	This work was carried out from funding provided by grant no. 14059001, W81XWH-15-1-0303, entitled "Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tubes" (NC) and Grant12744758 (RH180040) from Congressionally Directed Medi-cal Research Programs (CDMRP) (NC co-PI) . We gratefully acknowledge Dr. Maciej Skotak for finely fabricating the blast surfboard with con-nectors for anesthesia supply directly to the animal in the blast chamber. We also acknowledge Dr. Kevin Pang, Ph.D. for providing valuable suggestions in behavioral studies numerous occations.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Aravind A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00990; Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Ashafaq M, 2017, MOL NEUROBIOL, V54, P5941, DOI 10.1007/s12035-016-0096-8; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Biswas SK, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5698931; Boutte AM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6445; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Ganpule S., 2016, INT J EXP COMPUT BIO, V4, P13; Habtemariam S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8512048; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Jimenez JC, 2018, NEURON, V97, P670, DOI 10.1016/j.neuron.2018.01.016; Kamnaksh A, 2014, J NEUROTRAUM, V31, pA44; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kerr MSD, 2017, FRONT NEURAL CIRCUIT, V11, DOI [10.3389/fncir:2017.00026, 10.3389/fncir.2017.00026]; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Murugan M, 2020, BRAIN BEHAV IMMUN, V88, P340, DOI 10.1016/j.bbi.2020.03.029; Papesh MA, 2019, J NEUROTRAUM, V36, P702, DOI 10.1089/neu.2018.5801; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01015; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00797; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Zhu SH, 2017, CNS NEUROSCI THER, V23, P310, DOI 10.1111/cns.12677	58	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2022	349								113938	10.1016/j.expneurol.2021.113938			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XX8WF	WOS:000736567800001	34863680				2022-02-06	
J	Stanley, SP; Truong, EI; DeMario, BS; Ladhani, HA; Tseng, ES; Ho, VP; Kelly, ML				Stanley, Samuel P.; Truong, Evelyn I.; DeMario, Belinda S.; Ladhani, Husayn A.; Tseng, Esther S.; Ho, Vanessa P.; Kelly, Michael L.			Variations in Discharge Destination Following Severe TBI across the United States	JOURNAL OF SURGICAL RESEARCH			English	Article						Discharge destination; Practice variation; TBI; Trauma center	TRAUMATIC BRAIN-INJURY; SKILLED NURSING FACILITIES; INPATIENT REHABILITATION; REGIONAL-VARIATION; HEART-FAILURE; MEDICAID; REIMBURSEMENTS	Background: Discharge destination after traumatic brain injury (TBI) may be influenced by non-patient factors such as regional or institutional practice patterns. We hypothesized that non-patient factors would be associated with discharge destination in severe TBI patients. Methods: All patients in the ACS Trauma Quality Improvement Program 2016 data set with severe TBI, defined as head Abbreviated Injury Scale >= 3, were categorized by discharge destination. Logistic regression was used to assess factors associated with each destination; odds ratios and 95% confidence level are reported. Regressions were adjusted for age, gender, race, insurance, GCS, ISS, polytrauma, mechanism, neurosurgical procedure, geographic region, teaching status, trauma center level, hospital size, and neurosurgeon group size. Results: 75,690 patients met inclusion criteria. 51% were discharged to home, 16% to rehab, 14% to SNF, and 11% deceased. Mortality was similar across geographic region, teaching status, and hospital size. Southern patients were more likely to be discharged to home while Northeastern patients were more likely to be discharged to rehab. Treatment by groups of 3 or more neurosurgeons was associated with SNF discharge as was treatment at community or non-teaching hospitals. Patients treated at larger hospitals were less likely to be discharged to rehab and more likely to go to SNF. Conclusions: Geographic region, neurosurgeon group size, teaching status, and hospital size are significantly associated with variation in discharge destination following severe TBI. Regional and institutional variation in practice patterns may play important roles in recovery for some patients with severe TBI. (C) 2021 Elsevier Inc. All rights reserved.	[Stanley, Samuel P.; Truong, Evelyn I.; DeMario, Belinda S.; Ladhani, Husayn A.; Tseng, Esther S.; Ho, Vanessa P.] MetroHlth Med Ctr, Dept Surg, Cleveland, OH USA; [Ho, Vanessa P.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Kelly, Michael L.] MetroHlth Med Ctr, Dept Neurol Surg, 2500 MetroHlth Dr, Cleveland, OH 44109 USA		Kelly, ML (corresponding author), MetroHlth Med Ctr, Dept Neurol Surg, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	mkelly4@metrohealth.org		Tseng, Esther/0000-0003-2515-7744; Truong, Evelyn/0000-0001-8852-1887; Stanley, Samuel/0000-0002-7455-7085	National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research [KL2TR002547]	This publication was made possible by the Clinical and Translational Science Collaborative of Cleveland, KL2TR002547 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The authors wish to thank Wyatt P. Bensken BS, Case Western Reserve University Department of Population and Quantitative Health Sciences, for his assistance with data collection. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. VPH is supported by the Clinical and Translational Science Collaborative of Cleveland (KL2TR002547) from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. VPH spouse is a consultant for Zimmer Biomet, Medtronic, Sig Medical, and Atricure.	Agrawal M, 2014, BRAIN INJURY, V28, P292, DOI 10.3109/02699052.2013.865266; Akintoye E, 2017, AM J CARDIOL, V120, P817, DOI 10.1016/j.amjcard.2017.05.058; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Briasoulis A, 2018, AM J CARDIOL, V121, P1575, DOI 10.1016/j.amjcard.2018.02.047; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Casper DS, 2019, SPINE, V44, P1585, DOI 10.1097/BRS.0000000000003241; Census.gov, 2021, POP POP CHANG EST CO; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US, DOI [10.3171/2011.3.jns102010, DOI 10.3171/2011.3.JNS102010]; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Hussey PS, 2015, JAMA INTERN MED, V175, P1056, DOI 10.1001/jamainternmed.2015.0674; Ifejika NL, 2021, AM J PHYS MED REHAB, V100, P675, DOI 10.1097/PHM.0000000000001605; Kaura AS, 2018, PLAST RECONSTR SURG, V142, P1653, DOI 10.1097/PRS.0000000000005013; Lalezari RM, 2018, J BONE JOINT SURG AM, V100, P236, DOI 10.2106/JBJS.17.00279; Lee SY, 2019, BRAIN INJURY, V33, P1263, DOI 10.1080/02699052.2019.1641747; Newhouse JP, 2013, JAMA-J AM MED ASSOC, V310, P1227, DOI 10.1001/jama.2013.278139; Oyesanya TO, 2020, BRAIN INJURY, V34, P1222, DOI 10.1080/02699052.2020.1797172; Peck MD, 2010, J BURN CARE RES, V31, P603, DOI 10.1097/BCR.0b013e3181e4d6dd; Rahman M, 2017, HEALTH SERV RES, V52, P656, DOI 10.1111/1475-6773.12507; Rogers S, 2015, ARCH PHYS MED REHAB, V96, P276, DOI 10.1016/j.apmr.2014.09.018; Rosenbaum AM, 2018, BRAIN INJURY, V32, P907, DOI 10.1080/02699052.2018.1469040; Santiago CC, 2020, CLIN IMAG, V66, P67, DOI 10.1016/j.clinimag.2020.04.032; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SNFDATA, 2021, SNF STAT STAT; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; Truong EI, 2021, J TRAUMA ACUTE CARE, V91, P114, DOI 10.1097/TA.0000000000003114; Weerahandi H, 2019, J AM MED DIR ASSOC, V20, P432, DOI 10.1016/j.jamda.2019.01.135; Werner RM, 2019, HEALTH SERV RES, V54, P1184, DOI 10.1111/1475-6773.13227; Werner RM, 2019, JAMA INTERN MED, V179, P617, DOI 10.1001/jamainternmed.2018.7998; Xian Y, 2017, STROKE, V48, P2836, DOI 10.1161/STROKEAHA.117.016904; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403; Zhu Y, 2020, J AM GERIATR SOC, V68, P847, DOI 10.1111/jgs.16308	33	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2022	271						98	105		10.1016/j.jss.2021.10.023			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	XQ3UV	WOS:000731474000004	34875550				2022-02-06	
J	Tang, W; Guo, ZD; Chai, WN; Du, DL; Yang, XM; Cao, L; Chen, H; Zhou, C; Cheng, CJ; Sun, XC; Huang, ZJ; Zhong, JJ				Tang, Wei; Guo, Zong-Duo; Chai, Wei-Na; Du, Dong-Lin; Yang, Xiao-Min; Cao, Lang; Chen, Hong; Zhou, Chao; Cheng, Chong-Jie; Sun, Xiao-Chuan; Huang, Zhi-Jian; Zhong, Jian-Jun			Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							LONG NONCODING RNA; OXIDATIVE STRESS; METALLOTHIONEIN; ANGIOGENESIS; EXPRESSION; CONTRIBUTES; ACTIVATION	MicroRNA-491-5p (miR-491-5p) plays an important role in regulating cell proliferation and migration; however, the effect of miR-491-5p on neovascularization after traumatic brain injury remains poorly understood. In this study, a controlled cortical injury model in C57BL/6 mice and an oxygen-glucose deprivation model in microvascular endothelial cells derived from mouse brain were established to simulate traumatic brain injury in vivo and in vitro, respectively. In the in vivo model, quantitative real-time-polymerase chain reaction results showed that the expression of miR-491-5p increased or decreased following the intracerebroventricular injection of an miR-491-5p agomir or antagomir, respectively, and the expression of miR-491-5p decreased slightly after traumatic brain injury. To detect the neuroprotective effects of miR-491-p, neurological severity scores, Morris water maze test, laser speckle techniques, and immunofluorescence staining were assessed, and the results revealed that miR-491-5p downregulation alleviated neurological dysfunction, promoted the recovery of regional cerebral blood flow, increased the number of lectin-stained microvessels, and increased the survival of neurons after traumatic brain injury. During the in vitro experiments, the potential mechanism of miR-491-5p on neovascularization was explored through quantitative real-time-polymerase chain reaction, which showed that miR-491-5p expression increased or decreased in brain microvascular endothelial cells after transfection with an miR-491-5p mimic or inhibitor, respectively. Dual-luciferase reporter and western blot assays verified that metallothionein-2 was a target gene for miR-491-5p. Cell counting kit 8 (CCK-8) assay, flow cytometry, and 2?,7?-dichlorofluorescein diacetate (DCFH-DA) assay results confirmed that the downregulation of miR-491-5p increased brain microvascular endothelial cell viability, reduced cell apoptosis, and alleviated oxidative stress under oxygen-glucose deprivation conditions. Cell scratch assay, Transwell assay, tube formation assay, and western blot assay results demonstrated that miR-491-5p downregulation promoted the migration, proliferation, and tube formation of brain microvascular endothelial cells through a metallothionein-2-dependent hypoxia-inducible factor-1 alpha /vascular endothelial growth factor pathway. These findings confirmed that miR-491-5p downregulation promotes neovascularization, restores cerebral blood flow, and improves the recovery of neurological function after traumatic brain injury. The mechanism may be mediated through a metallothionein-2-dependent hypoxia-inducible factor-1 alpha /vascular endothelial growth factor signaling pathway and the alleviation of oxidative stress. All procedures were approved by Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, China (approval No. 2020-304) on June 22, 2020.	[Tang, Wei; Guo, Zong-Duo; Chai, Wei-Na; Du, Dong-Lin; Yang, Xiao-Min; Chen, Hong; Zhou, Chao; Cheng, Chong-Jie; Sun, Xiao-Chuan; Huang, Zhi-Jian; Zhong, Jian-Jun] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Cao, Lang] Chongqing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Chongqing, Peoples R China		Huang, ZJ; Zhong, JJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	zhijian@cqmu.eau.cn; jianjun@hospital.camu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82071397, 82071332]; Youth Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801230]; Excellent Scientific Research Talents Fund of the First Affiliated Hospital of Chongqing Medical University, China	This work was supported by the National Natural Science Foundation of China, Nos. 82071397 (to XCS), 82071332 (to ZDG); the Youth Fund of the National Natural Science Foundation of China, No. 81801230 (to JJZ); and the Excellent Scientific Research Talents Fund of the First Affiliated Hospital of Chongqing Medical University, China (to JJZ). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Bai XY, 2018, ANTIOXID REDOX SIGN, V29, P355, DOI 10.1089/ars.2017.7278; Chang YY, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.263; Chen T, 2018, ONCOL LETT, V16, P6472, DOI 10.3892/ol.2018.9451; Chin HK, 2018, ONCOL REP, V39, P2351, DOI 10.3892/or.2018.6312; Daverey A, 2016, NEUROSCIENCE, V333, P92, DOI 10.1016/j.neuroscience.2016.07.012; Fukai T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081849; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; He JC, 2018, NEUROBIOL DIS, V117, P114, DOI 10.1016/j.nbd.2018.06.003; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Jiang F, 2014, TOXICOL LETT, V231, P55, DOI 10.1016/j.toxlet.2014.08.024; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JH, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153031; Kim H, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0344-x; Kim JH, 2016, ECOTOX ENVIRON SAFE, V125, P78, DOI 10.1016/j.ecoenv.2015.12.001; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee SH, 2009, AM J PHYSIOL-CELL PH, V297, pC207, DOI 10.1152/ajpcell.00579.2008; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liu H, 2018, BRAIN RES, V1700, P118, DOI 10.1016/j.brainres.2018.07.006; Lu L, 2019, CANCER MANAG RES, V11, P1805, DOI 10.2147/CMAR.S183085; Lynes MA, 2014, CELL STRESS CHAPERON, V19, P605, DOI 10.1007/s12192-014-0501-z; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Nakajima K, 2019, NEUROTOX RES, V35, P668, DOI 10.1007/s12640-018-9981-4; Nielsen AE, 2006, BIOMARK INSIGHTS, V1, P99; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Schuermann A, 2015, ANGIOGENESIS, V18, P463, DOI 10.1007/s10456-015-9473-6; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Sun W, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0490-4; Sun Y, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108576; Takahashi S, 2015, MOL MED REP, V12, P795, DOI 10.3892/mmr.2015.3459; Tian XC, 2016, J NEUROCHEM, V139, P757, DOI 10.1111/jnc.13833; Tiwari A, 2018, CURR CANCER DRUG TAR, V18, P266, DOI 10.2174/1568009617666170630142725; Ved R, 2018, J NEUROL, V265, P1241, DOI 10.1007/s00415-018-8855-2; Wang C, 2019, INT J BIOL MACROMOL, V135, P212, DOI 10.1016/j.ijbiomac.2019.05.101; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Wang K, 2020, DIABETES, V69, P1779, DOI 10.2337/db19-0829; Watari K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0829-0; Wu G, 2020, EUR REV MED PHARMACO, V24, P12836, DOI 10.26355/eurrev_202012_24185; Wu JC, 2020, NEUROSCIENCE, V440, P160, DOI 10.1016/j.neuroscience.2020.05.045; Xue WL, 2012, AM J PHYSIOL-HEART C, V302, pH2528, DOI 10.1152/ajpheart.00850.2011; Yan CC, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110656; Yu T, 2018, CANCER SCI, V109, P1393, DOI 10.1111/cas.13583; Zhang B, 2019, BRAIN RES, V1725, DOI 10.1016/j.brainres.2019.146469; Zhang DQ, 2021, AGING-US, V13, P4079, DOI 10.18632/aging.202373; Zhang L, 2020, NEUROMOL MED, V22, P484, DOI 10.1007/s12017-020-08599-y; Zhang L, 2018, J CELL BIOCHEM, V119, P5460, DOI 10.1002/jcb.26705; Zhao BM, 2019, ONCOL LETT, V17, P5005, DOI 10.3892/ol.2019.10177; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou C, 2020, NEURAL REGEN RES, V15, P2318, DOI 10.4103/1673-5374.285001; Zhou F, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110724; Zhou GH, 2008, J AM COLL CARDIOL, V52, P655, DOI 10.1016/j.jacc.2008.05.019; Zhou YX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00581	58	0	0	38	38	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2022	17	3					577	+		10.4103/1673-5374.314326			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	US8QL	WOS:000697690900025	34380897	Green Published			2022-02-06	
J	Zhao, JJ; Wang, ZH; Zhang, YJ; Wang, WJ; Cheng, AF; Rong, PJ; Shan, CL				Zhao, Jing-Jun; Wang, Zheng-Hui; Zhang, Ying-Jie; Wang, Wen-Jing; Cheng, Ai-Fang; Rong, Pei-Jing; Shan, Chun-Lei			The mechanisms through which auricular vagus nerve stimulation protects against cerebral ischemia/reperfusion injury	NEURAL REGENERATION RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; GAP-JUNCTIONS; INFLAMMATION; ASTROCYTES; CONNEXIN43; ISCHEMIA; STROKE; PHOSPHORYLATION; COMMUNICATION; INHIBITION	Previous studies have shown that vagus nerve stimulation can improve patients' locomotor function. The stimulation of the auricular vagus nerve, which is the only superficial branch of the vagus nerve, may have similar effects to vagus nerve stimulation. However, the precise mechanisms remain poorly understood. In this study, rat models of cerebral ischemia/reperfusion injury were established by modified Longa ligation. Twenty-four hours later, 7-day auricular vagus nerve stimulation was performed. The results showed that auricular vagus nerve stimulation promoted the secretion of acetylcholine, inhibited the secretion of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha, and reduced connexin 43 phosphorylation in the ischemic penumbra and motor cortex, promoting locomotor function recovery in rats with cerebral ischemia/reperfusion injury. These findings suggested that auricular vagus nerve stimulation promotes the recovery of locomotor function in rats with cerebral ischemia/reperfusion injury by altering the secretion of acetylcholine and inflammatory factors and the phosphorylation of connexin 43. This study was approved by the Animal Use and Management Committee of Shanghai University of Traditional Chinese Medicine on November 8, 2019 (approval No. PZSHUTCM191108014).	[Zhao, Jing-Jun; Wang, Wen-Jing; Shan, Chun-Lei] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Ctr Rehabil Med, Shanghai, Peoples R China; [Zhao, Jing-Jun; Wang, Wen-Jing; Shan, Chun-Lei] Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China; [Zhao, Jing-Jun; Shan, Chun-Lei] Engn Res Ctr Tradit Chinese Med Intelligent Rehab, Minist Educ, Shanghai, Peoples R China; [Wang, Zheng-Hui] Xinxiang Med Univ, Affiliated Hosp 1, Ctr Rehabil Med, Xinxiang, Henan, Peoples R China; [Zhang, Ying-Jie; Cheng, Ai-Fang] Shanghai Res Inst Acupuncture & Meridian, Shanghai, Peoples R China; [Rong, Pei-Jing] Chinese Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China		Shan, CL (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Ctr Rehabil Med, Shanghai, Peoples R China.; Shan, CL (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China.; Shan, CL (corresponding author), Engn Res Ctr Tradit Chinese Med Intelligent Rehab, Minist Educ, Shanghai, Peoples R China.	shanclhappy@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81704163, 81874035]; National Key R&D Program of China [2018YFC2001600]; Shanghai Health Commission Accelerated the Development of Traditional Chinese Medicine Three-Year Action Plan Project of China [ZY(2018-2020)-CCCX-2001-06/2004-05]; Program of Shanghai Academic Research Leader of China [19XD1403600]	This study was supported by the National Natural Science Foundation of China, Nos. 81704163 (to JJZ), 81874035 (to CLS); the National Key R&D Program of China, No. 2018YFC2001600 (to CLS); the Shanghai Health Commission Accelerated the Development of Traditional Chinese Medicine Three-Year Action Plan Project of China, No. ZY(2018-2020)-CCCX-2001-06/2004-05 (to CLS); and the Program of Shanghai Academic Research Leader of China, No. 19XD1403600 (to CLS). The funding bodies played no role in the study design, collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Avila-Munoz E, 2014, AGEING RES REV, V18, P29, DOI 10.1016/j.arr.2014.07.004; Ay I, 2016, BRAIN STIMUL, V9, P166, DOI 10.1016/j.brs.2015.11.008; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Castellano P, 2016, J NEUROCHEM, V137, P561, DOI 10.1111/jnc.13603; Chen CC, 2016, INT J MED SCI, V13, P754, DOI 10.7150/ijms.15847; Chen W, 2018, J NEUROPHYSIOL, V119, P305, DOI 10.1152/jn.00654.2017; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Dabrowski J, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/9708905; Du Yihong S.Y., 2021, CHIN J TISSUE ENG RE, V25, P4743; Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Goebel U, 2021, NEURAL REGEN RES, V16, P192, DOI 10.4103/1673-5374.290098; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hsu CCT, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917690166; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102342; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Li WEI, 2000, EUR J NEUROSCI, V12, P2644, DOI 10.1046/j.1460-9568.2000.00162.x; Liang Z, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00703; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma JX, 2019, NEUROCHEM INT, V131, DOI 10.1016/j.neuint.2019.104539; Mioni C, 2005, CRIT CARE MED, V33, P2621, DOI 10.1097/01.CCM.0000186762.05301.13; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Mravec B, 2010, AUTON NEUROSCI-BASIC, V158, P8, DOI 10.1016/j.autneu.2010.08.009; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Paxinos G., 2013, MOUSE BRAIN STEREOTA, VFourth; Reifler ANN, 2015, CURR BIOL, V25, P2763, DOI 10.1016/j.cub.2015.09.018; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Solan JL, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121596; Sutor B, 2005, BBA-BIOMEMBRANES, V1719, P59, DOI 10.1016/j.bbamem.2005.09.005; Wong CHY, 2008, CURR MED CHEM, V15, P1; Xu AL, 2020, NEURAL REGEN RES, V15, P78, DOI 10.4103/1673-5374.264465; Yuan DD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1998-y	39	0	0	26	26	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAR	2022	17	3					594	600		10.4103/1673-5374.320992			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	US8QL	WOS:000697690900027	34380899	Green Published			2022-02-06	
J	Hsieh, MT; Lu, HJ; Chen, LF; Liu, CY; Hsu, SC; Cheng, CH				Hsieh, Meng-Tien; Lu, Hsinjie; Chen, Li-Fen; Liu, Chia-Yih; Hsu, Shih-Chieh; Cheng, Chia-Hsiung			Cancellation but not restraint ability is modulated by trait anxiety: An event-related potential and oscillation study using Go-Nogo and stop-signal tasks	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Inhibitory function; N2; P3; Brain oscillation; Cognitive Failures Questionnaire (CFQ)	TRAUMATIC BRAIN-INJURY; RESPONSE-INHIBITION; ALPHA-OSCILLATIONS; COGNITIVE FAILURES; ERP COMPONENTS; PERFORMANCE; CONFLICT; GO/NOGO; ATTENTION; DEFICITS	Background: Trait anxiety has a detrimental effect on attention, which further leads to dysfunction of inhibitory control. However, there is no study examining how trait anxiety modulates inhibitory abilities on restraint and cancellation in the same subjects. Therefore, we aimed to use electrophysiological recordings to interrogate whether and to what extent trait anxiety modulated these two kinds of inhibitory functions. The Cognitive Failures Questionnaire (CFQ), a self-reported assessment of daily absentmindedness, was also used to examine its association with inhibition-related electrophysiological indicators. Methods: Forty subjects were recruited from the top 10% (Higher Trait Anxiety [HTA], n= 20) and last 10% (Lower Trait Anxiety [LTA], n= 20) of the trait anxiety score distribution from 400 college students. During electrophysiological recordings, the Go-Nogo and stop-signal tasks were performed, which evaluated the abilities of restraint and cancellation, respectively. Results: The HTA and LTA groups showed a comparable behavioral performance of restraint and cancellation abilities. However, the results of time-frequency analysis revealed that those with HTA demonstrated a stronger power of alpha oscillations (600-1000 ms) in response to Stop trials in the stop-signal task, compared with individuals with LTA. Such oscillatory activity was positively correlated with the CFQ score. There was no significant between-group difference of the brain activation in the Go-Nogo task. Limitations: Future studies can recruit both individuals with trait anxiety and anxiety disorders to clarify the boundaries between healthy and pathological worries in terms of cancellation ability. Conclusions: cancellation, but not restraint, is modulated by trait anxiety.	[Hsieh, Meng-Tien] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Hsieh, Meng-Tien; Lu, Hsinjie; Cheng, Chia-Hsiung] Chang Gung Univ, Lab Brain Imaging & Neural Dynam BIND Lab, Taoyuan, Taiwan; [Lu, Hsinjie; Cheng, Chia-Hsiung] Chang Gung Univ, Dept Occupat Therapy, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan; [Lu, Hsinjie; Cheng, Chia-Hsiung] Chang Gung Univ, Grad Inst Behav Sci, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan; [Chen, Li-Fen] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan; [Liu, Chia-Yih; Cheng, Chia-Hsiung] Chang Gung Mem Hosp, Dept Psychiat, Linkou, Taiwan; [Hsu, Shih-Chieh] New Taipei Municipal TuCheng Hosp, Dept Psychiat, Chang Gung Med Fdn, New Taipei, Taiwan; [Cheng, Chia-Hsiung] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan		Cheng, CH (corresponding author), Chang Gung Univ, Dept Occupat Therapy, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan.; Cheng, CH (corresponding author), Chang Gung Univ, Grad Inst Behav Sci, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan.	ch.cheng@mail.cgu.edu.tw			Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPD1K0061, CMRPD1K0581]; Chang Gung University [BMRPE25]; Healthy Aging Research Center, Chang Gung University from the Featured Areas Research Center Program [EMRPD1K0431]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST-105-2628-B-182-004-MY3, MOST-108-2628-B-182-002, MOST-109-2628-B-182-012, MOST-110-2628-B-182-010]	This work was supported by Chang Gung Memorial Hospital (CMRPD1K0061, CMRPD1K0581), Chang Gung University (BMRPE25), YHealthy Aging Research Center, Chang Gung University from the Featured Areas Research Center Program within the Framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (EMRPD1K0431), Ministry of Science and Technology (MOST-105-2628-B-182-004-MY3, MOST-108-2628-B-182-002, MOST-109-2628-B-182-012, MOST-110-2628-B-182-010), Taiwan.	Barbas H, 2018, J NEUROPHYSIOL, V120, P2659, DOI 10.1152/jn.00936.2017; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carrillo-de-la-Pena MT, 2019, BIOL PSYCHOL, V143, P85, DOI 10.1016/j.biopsycho.2019.01.010; Chen GL, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01187-2; Cheng CH, 2019, BRAIN COGNITION, V135, DOI 10.1016/j.bandc.2019.05.012; Covey TJ, 2013, INT J PSYCHOPHYSIOL, V87, P363, DOI 10.1016/j.ijpsycho.2013.03.009; Cunillera T, 2016, NEUROIMAGE, V140, P66, DOI 10.1016/j.neuroimage.2015.11.044; De Loof E, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13417; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dikker S, 2020, SOC COGN AFFECT NEUR, V15, P1193, DOI 10.1093/scan/nsaa142; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Freunberger R, 2011, BRAIN RES, V1375, P93, DOI 10.1016/j.brainres.2010.12.048; Frey JN, 2015, BRAIN RES, V1626, P183, DOI 10.1016/j.brainres.2015.02.017; Gonzalez-Villar AJ, 2019, PSYCHOSOM MED, V81, P380, DOI 10.1097/PSY.0000000000000677; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Kamarajan C, 2006, BIOL PSYCHIAT, V59, P625, DOI 10.1016/j.biopsych.2005.08.017; Keskin-Ergen Y, 2014, DEPRESS ANXIETY, V31, P997, DOI 10.1002/da.22212; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Knyazev G G, 2010, Neurosci Behav Physiol, V40, P29, DOI 10.1007/s11055-009-9227-2; Knyazev GG, 2008, CLIN NEUROPHYSIOL, V119, P556, DOI 10.1016/j.clinph.2007.11.041; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazev GG, 2004, INT J PSYCHOPHYSIOL, V53, P147, DOI 10.1016/j.ijpsycho.2004.03.001; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Lavelle CF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00994; Littman R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186774; Liu SN, 2021, CLIN NEUROPHYSIOL, V132, P554, DOI 10.1016/j.clinph.2020.11.034; Logan GD, 2014, PSYCHOL REV, V121, P66, DOI 10.1037/a0035230; Mahoney AM, 1998, PSYCHOL REP, V82, P1432, DOI 10.2466/PR0.82.3.1432-1434; Min D, 2020, BRAIN TOPOGR, V33, P208, DOI 10.1007/s10548-020-00754-9; Neo PSH, 2011, COGN AFFECT BEHAV NE, V11, P485, DOI 10.3758/s13415-011-0046-x; Pandey AK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.002; Porta-Casteras D, 2020, J AFFECT DISORDERS, V267, P211, DOI 10.1016/j.jad.2020.02.029; Raud L, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116582; Righi S, 2009, J ANXIETY DISORD, V23, P1132, DOI 10.1016/j.janxdis.2009.07.018; Roche RAP, 2005, EXP BRAIN RES, V160, P60, DOI 10.1007/s00221-004-1985-z; Savostyanov AN, 2009, NEUROSCI LETT, V449, P112, DOI 10.1016/j.neulet.2008.10.084; Schall JD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0193; Sehlmeyer C, 2010, NEUROPSYCHOLOGIA, V48, P2488, DOI 10.1016/j.neuropsychologia.2010.04.022; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; SPIELBERGER CD, 1984, J PERS ASSESS, V48, P95; Thomas SJ, 2014, CLIN NEUROPHYSIOL, V125, P463, DOI 10.1016/j.clinph.2013.08.018; Tiego J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01339; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Wei H, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13643; Weinreich A, 2016, INT J PSYCHOPHYSIOL, V110, P200, DOI 10.1016/j.ijpsycho.2016.07.517; Wiegand I, 2019, NEUROBIOL AGING, V79, P93, DOI 10.1016/j.neurobiolaging.2019.03.017; Xia LS, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00028; Yu YJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00120	53	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 15	2022	299						188	195		10.1016/j.jad.2021.11.066			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	XY6BD	WOS:000737054400025	34863714				2022-02-06	
J	Jaiswal, S; Brabazon, F; Von Leden, R; Acs, D; Collier, S; Allison, N; Dardzinski, B; Byrnes, KR				Jaiswal, Shalini; Brabazon, Fiona; von Leden, Ramona; Acs, Deanna; Collier, Sean; Allison, Nathanael; Dardzinski, Bernard; Byrnes, Kimberly R.			Spinal cord injury chronically depresses glucose uptake in the rodent model	NEUROSCIENCE LETTERS			English	Article						Spinal Cord Injury; Fluorodeoxyglucose; PET; CT	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; RATS	The pathophysiology following spinal cord injury (SCI) progresses from its lesion epicenter resulting in cellular and systemic changes acutely, sub-acutely and chronically. The symptoms of the SCI depend upon the severity of the injury and its location in the spinal cord. However, there is lack of studies that have longitudinally assessed acute through chronic in vivo changes following SCI. In this combinatorial study we fill this gap by evaluating acute to chronic effects of moderate SCI in rats. We have used fluorodeoxyglucose (FDG) imaging with positron emission tomography (PET) as a marker to assess glucose metabolism, motor function, and immunohistochemistry to examine changes following moderate SCI. Our results demonstrate decreased FDG uptake at the injury site chronically at days 28 and 90 post injury compared to baseline. This alteration in glucose uptake was not restricted to the lesion site, showing depressed FDG uptake in non-injured areas (cervical spinal cord and cerebellum). The alteration in glucose uptake was correlated with reductions in neuronal cell viability and increases in glial cell activation at 90 days at the lesion site, as well as chronic impairments in motor function. These data demonstrate the chronic effects of SCI on glucose metabolism both within the lesion and distally within the spinal cord and brain.	[Jaiswal, Shalini; Dardzinski, Bernard] Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Jaiswal, Shalini] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Jaiswal, Shalini; Allison, Nathanael; Dardzinski, Bernard] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Brabazon, Fiona; von Leden, Ramona; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Acs, Deanna; Collier, Sean; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room C2115, Bethesda, MD 20814 USA		Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd,Room C2115, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu			Defense Health Program, Congressionally Directed Medical Research Programs through the Spinal Cord Injury Research Program [SC170244]	This work was supported by the Defense Health Program, Congressionally Directed Medical Research Programs through the Spinal Cord Injury Research Program under Award No. SC170244.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; de la Cueva-Barrao L, 2009, REV NEUROLOGIA, V49, P58, DOI 10.33588/rn.4902.2008676; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Floeth FW, 2010, EUR RADIOL, V20, P2925, DOI 10.1007/s00330-010-1877-5; Franz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102896; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hattori N, 2004, J NUCL MED, V45, P775; HORNER PJ, 1995, EXP NEUROL, V133, P231, DOI 10.1006/exnr.1995.1026; Ito K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3794029; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shen J, 2019, PAIN PHYSICIAN, V22, pE215; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; Tewarie RDSN, 2010, MOL IMAGING, V9, P108, DOI 10.2310/7290.2010.00011; Tseng GF, 1996, ACTA ANAT, V155, P184; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Visavadiya NP, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8181393; von Leden RE, 2019, NEUROSCI LETT, V690, P23, DOI 10.1016/j.neulet.2018.10.004; von Leden RE, 2016, NEUROSCI LETT, V621, P126, DOI 10.1016/j.neulet.2016.04.027; West NR, 2001, NEUROPATHOLOGY, V21, P188, DOI 10.1046/j.1440-1789.2001.00398.x; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zhang L, NEUROIMAGE-CLIN, V31	32	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 6	2022	771								136416	10.1016/j.neulet.2021.136416			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XZ2CC	WOS:000737465100001	34954116				2022-02-06	
J	Kahriman, A; Bouley, J; Bosco, DA; Shazeeb, MS; Henninger, N				Kahriman, Aydan; Bouley, James; Bosco, Daryl A.; Shazeeb, Mohammed Salman; Henninger, Nils			Differential association of baseline body weight and body-weight loss with neurological deficits, histology, and death after repetitive closed head traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Animal model; Behavior; Body weight; Histology; Seizures; Traumatic brain injury	MODEL; OBESITY; MICE; NEURODEGENERATION	Clinical observations indicate that body weight (BW) extremes are associated with worse outcome after traumatic brain injury (TBI); yet, it is uncertain whether the baseline BW (bBW) may affect outcome after mouse TBI. We retrospectively analyzed 129 similarly aged (9-12 weeks) male C57BL6/J mice that were subjected to repetitive closed head TBI (rTBI) using an established weight drop paradigm as well as 55 sham injured mice. We sought to determine whether the bBW as well as the post-TBI weight relative to baseline (%BW) were associated with a variety of post-rTBI outcomes, including acute model complications (skull fractures and macroscopic hemorrhage), impact seizures, return of the righting reflex (RR), the neurological severity score (NSS), post-rTBI BW-change, and 28-day mortality. In a subset of rTBI mice, we also assessed for potential associations between the bBW and %BW and performance in the novel object recognition (NOR) task and various histological outcomes at 28 days. We found no association between the bBW with acute model complications, impact seizure burden, RR, NSS, and NOR performance at 28 days, as well as cerebral microbleed burden, presence of hyperphosphorylated tau, and TDP-43 pathology after rTBI. However, a higher bBW was associated with a longer time to first impact seizure, a greater microglial activation, astrocytosis, and neuronal loss in the injured cerebral cortex at 28 days. A greater %BW-loss was associated with a shorter impact seizure-free survival, longer time to return of the righting reflex, greater neurological deficit severity as assessed by the NSS and NOR, and worse mortality. On multiple linear regression there was no independent association of the %BW-loss with neuronal loss and neuroinflammation after adjustment for the bBW. These observations indicate that the bBW and %BWloss may be important biological variables in certain experimental mouse TBI investigations, depending on the outcome measures of interest.	[Kahriman, Aydan; Bouley, James; Bosco, Daryl A.; Henninger, Nils] Univ Massachusetts, Dept Neurol, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA; [Shazeeb, Mohammed Salman] Univ Massachusetts, Dept Radiol, Med Sch, Worcester, MA 01655 USA; [Shazeeb, Mohammed Salman] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Henninger, Nils] Univ Massachusetts, Dept Psychiat, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA		Henninger, N (corresponding author), Univ Massachusetts, Dept Neurol, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA.; Henninger, N (corresponding author), Univ Massachusetts, Dept Psychiat, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA.	nils.henninger@umassmed.edu					Alford S, 2018, OBES REV, V19, P269, DOI 10.1111/obr.12629; Angoa-Perez M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65972-4; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bieniek KF, 2021, J NEUROPATH EXP NEUR, V80, P210, DOI 10.1093/jnen/nlab001; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Cone JT, 2021, J NEUROSURG, V134, P1667, DOI 10.3171/2020.3.JNS193458; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dibello V, 2021, NEURAL REGEN RES, V16, P2149, DOI 10.4103/1673-5374.310672; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Kahriman A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01220-8; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; LaPlaca MC, 2021, J NEUROTRAUM, V38, P1399, DOI 10.1089/neu.2020.7328; Lee YM, 2016, PHYSICIAN SPORTSMED, V44, P217, DOI 10.1080/00913847.2016.1216718; Lloret A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00508; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wu LM, 2021, J CEREBR BLOOD F MET, V41, P3260, DOI 10.1177/0271678X211021771; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zimering Mark B, 1800, J Endocrinol Diabetes, V6, DOI 10.15226/2374-6890/6/3/001137	35	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 6	2022	771								136430	10.1016/j.neulet.2021.136430			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD4FL	WOS:000740370200004	34973374				2022-02-06	
J	Mirzaeva, L; Lobzin, S; Gilhus, NE; Rekand, T				Mirzaeva, Liudmila; Lobzin, Sergey; Gilhus, Nils Erik; Rekand, Tiina			Influence of age on acute traumatic spinal cord injury in Saint Petersburg, Russia	SPINAL CORD SERIES AND CASES			English	Article							MORTALITY; REHABILITATION; EPIDEMIOLOGY; OUTCOMES; PEOPLE; TRENDS; OLDER	Study design Retrospective cohort study. Objectives To evaluate influence of age after traumatic spinal cord injury (TSCI). Setting 13 specialized hospitals with neurosurgical departments of Saint Petersburg, Russia. Methods Charts of all patients admitted with TSCI to the city hospitals 2012-2016. Demographic and clinical characteristics, surgical interventions, complications, mortality rate, and hospital stays were recorded. Results 311 patients with TSCI were included. TSCI was more common in younger age. Mean age (SD) was 42.4 (16.8) years. Patients were divided into four age groups: 18-29, 30-44, 45-59 and >= 60 years. The group >= 60 years had the lowest percentage of concomitant traumatic brain injury (TBI), 25%, versus 43% in TSCI < 60 years, p < 0.05. Low falls were the most frequent cause in patients aged 60 years and older, and led to less severe neurological deficits (p < 0.05). Complications were most frequent in motor complete TSCI (AIS A and AIS B) and in persons with combined TSCI and TBI at older age. Total complication rate was 67% at the age of >= 60 years versus 38% <60 years in TSCI with TBI (p < 0.05). Respiratory complications occurred in 67% >= 45 years versus 45% <45 years, p < 0.05. In-hospital mortality rate after TSCI was higher in the oldest age group. Conclusions Respiratory complications are common and the in-hospital mortality is higher among elderly people. Older patients with TSCI and TBI are at high risk for complications.	[Mirzaeva, Liudmila; Lobzin, Sergey] North Western State Med Univ, Dept Neurol, St Petersburg, Russia; [Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Gilhus, Nils Erik; Rekand, Tiina] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Rekand, Tiina] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden		Rekand, T (corresponding author), Haukeland Hosp, Dept Neurol, Bergen, Norway.; Rekand, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci & Physiol, Gothenburg, Sweden.	tiina.rekand@helse-bergen.no			Norwegian Centre for International Cooperation in Education	The study was supported by a grant from the Norwegian Centre for International Cooperation in Education.	Ahn H, 2015, CAN MED ASSOC J, V187, P873, DOI 10.1503/cmaj.150085; Bank M, 2018, GERIATR ORTHOP SURG, V9, DOI 10.1177/2151459318770882; Biering-Sorensen F, 2017, SPINAL CORD, V55, P759, DOI 10.1038/sc.2017.59; Bombardier CH, 2016, ARCH PHYS MED REHAB, V97, P1628, DOI 10.1016/j.apmr.2016.03.008; Chan LW, 2018, WORLD J UROL, V36, P1603, DOI 10.1007/s00345-018-2326-3; Derrett S, 2012, INJURY PREV, V18, P343, DOI 10.1136/injuryprev-2011-040266; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DEVIVO MJ, 1992, PARAPLEGIA, V30, P820, DOI 10.1038/sc.1992.158; Fassett DR, 2007, J NEUROSURG-SPINE, V7, P277, DOI 10.3171/SPI-07/09/277; Ferro S, 2017, SPINAL CORD, V55, P1103, DOI 10.1038/sc.2017.88; Furlan JC, 2009, J NEUROTRAUM, V26, P1361, DOI [10.1089/neu.2008.0764, 10.1089/neu.2008-0764]; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Haldrup M, 2019, ACTA NEUROCHIR, V161, P2223, DOI 10.1007/s00701-019-04031-y; Halvorsen A, 2019, SPINAL CORD, V57, P331, DOI 10.1038/s41393-018-0225-5; Hsieh CH, 2013, ARCH PHYS MED REHAB, V94, pS175, DOI 10.1016/j.apmr.2012.10.038; Martin ND, 2011, J TRAUMA, V71, P380, DOI 10.1097/TA.0b013e318228221f; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; Mirzaeva L, 2020, SPINAL CORD, V58, P970, DOI 10.1038/s41393-020-0458-y; Mirzaeva L, 2019, SPINAL CORD, V57, P692, DOI 10.1038/s41393-019-0266-4; Nulle Anda, 2017, Spinal Cord Ser Cases, V3, P17088, DOI 10.1038/s41394-017-0002-2; PENROD LE, 1990, ARCH PHYS MED REHAB, V71, P963; Scivoletto G, 2017, ACTA NEUROCHIR SUPPL, V124, P203, DOI 10.1007/978-3-319-39546-3_31; Bellucci CHS, 2015, NEUROEPIDEMIOLOGY, V44, P85, DOI 10.1159/000371519; Wilson JR, 2014, SPINE J, V14, P1192, DOI 10.1016/j.spinee.2013.08.005	24	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2058-6124			SPINAL CORD SER CASE	Spinal Cord Ser. Cases	FEB 2	2022	8	1							16	10.1038/s41394-022-00484-z			5	Clinical Neurology; Rehabilitation	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Rehabilitation	YR9AW	WOS:000750282200001	35110530				2022-02-06	
J	Bambakidis, T; Dekker, SE; Williams, AM; Biesterveld, B; Bhatti, UF; Liu, BL; Li, YQ; Pickell, Z; Buller, B; Alam, HB				Bambakidis, Ted; Dekker, Simone E.; Williams, Aaron M.; Biesterveld, Ben E.; Bhatti, Umar F.; Liu, Baoling; Li, Yongqing; Pickell, Zachary; Buller, Benjamin; Alam, Hasan B.			Early Treatment With a Single Dose of Mesenchymal Stem Cell Derived Extracellular Vesicles Modulates the Brain Transcriptome to Create Neuroprotective Changes in a Porcine Model of Traumatic Brain Injury and Hemorrhagic Shock	SHOCK			English	Article						Exosomes; extracellular vesicles; neuronal plasticity; neuroprotection; shock; traumatic brain injury	GROWTH-FACTOR-BETA; EXPRESSION; BDNF; MECHANISMS; PLASTICITY; INDUCTION; SUBUNITS; NEURONS	Background: Cell-based therapies using mesenchymal stem cell derived extracellular vesicles (EVs) improve neurologic outcomes in animal models of traumatic brain injury (TBI), stroke, and hemorrhage. Using a porcine 7-day survival model of TBI and hemorrhagic shock (HS), we previously demonstrated that EV-treatment was associated with reduced brain lesion size, neurologic severity score, and cerebral inflammation. However, the underlying cellular and genomic mechanisms remain poorly defined. We hypothesize that EV treatment modulates the brain transcriptome to enhance neuroprotection and neurorestoration following TBI + HS. Methods: Swine were subjected to severe TBI (8-mm cortical impact) and HS (40% blood volume). After 1 h of shock, animals were randomized (n = 4/group) to treatment with either lactated Ringer's (LR) or LR + EV. Both groups received fluid resuscitation after 2 h of shock, and autologous packed red blood cells 5 h later. After 7-days, brains were harvested and RNA-sequencing was performed. The transcriptomic data were imported into the iPathway pipeline for bioinformatics analyses. Results: 5,273 genes were differentially expressed in the LR + EV group versus LR alone (total 9,588 measured genes). Genes with the greatest upregulation were involved in synaptic transmission and neuronal development and differentiation, while downregulated genes were involved in inflammation. GO-terms experiencing the greatest modulation were involved in inflammation, brain development, and cell adhesion. Pathway analysis revealed significant modulation in the glutamatergic and GABAergic systems. Network analysis revealed downregulation of inflammation, and upregulation of neurogenesis, and neuron survival and differentiation. Conclusions: In a porcine model of TBI + HS, EV treatment was associated with an attenuation of cerebral inflammatory networks and a promotion of neurogenesis and neuroplasticity. These transcriptomic changes could explain the observed neuroprotective and neurorestorative properties associated with EV treatment.	[Bambakidis, Ted; Dekker, Simone E.; Williams, Aaron M.; Biesterveld, Ben E.; Bhatti, Umar F.; Liu, Baoling; Li, Yongqing; Pickell, Zachary; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Bambakidis, Ted] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Dekker, Simone E.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Buller, Benjamin] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Alam, HB (corresponding author), Northwestern Univ, Feinberg Sch Med, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA.; Alam, HB (corresponding author), Northwestern Univ, Northwestern Mem Hosp, 676 N St Clair St,Suite 2320, Chicago, IL 60611 USA.	Hasan.Alam@nm.org			Massey Foundation TBI Research Grant; U.S. Army Medical Research Materiel Command Grant [W81XWH-09-1-0520]	This study was supported by the Massey Foundation TBI Research Grant (to A.M.W. and H.B.A.) and the U.S. Army Medical Research Materiel Command Grant W81XWH-09-1-0520 (to H.B.A.).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choo AM, 2012, NEUROCHEM INT, V60, P506, DOI 10.1016/j.neuint.2012.02.007; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Giacobbo BL, 2019, MOL NEUROBIOL, V56, P3295, DOI 10.1007/s12035-018-1283-6; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07394-3; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Liu Y, 2019, J CELL PHYSIOL, V234, P9525, DOI 10.1002/jcp.27641; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Notaras M, 2019, NEUROSCIENTIST, V25, P434, DOI 10.1177/1073858418810142; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; Senatorov VV, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8283; Sharma A, 2019, P NATL ACAD SCI USA, V116, P21800, DOI 10.1073/pnas.1903566116; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Uittenbogaard M, 2005, J NEUROCHEM, V92, P585, DOI 10.1111/j.1471-4159.2004.02886.x; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Williams AM, 2020, J TRAUMA ACUTE CARE, V89, P536, DOI 10.1097/TA.0000000000002815; Williams AM, 2020, J TRAUMA ACUTE CARE, V89, P388, DOI 10.1097/TA.0000000000002698; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang Y, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022145; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zheng F, 2009, NEUROCHEM INT, V54, P385, DOI 10.1016/j.neuint.2009.01.006; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	49	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2022	57	2					281	290		10.1097/SHK.0000000000001889			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	YG0DX	WOS:000742170000017	34798633				2022-02-06	
J	Campbell, B; Budreau, D; Williams-Perez, S; Chakravarty, S; Galet, C; McGonagill, P				Campbell, Brady; Budreau, Daniel; Williams-Perez, Sophia; Chakravarty, Subhashish; Galet, Colette; McGonagill, Patrick			Admission Lymphopenia Predicts Infectious Complications and Mortality in Traumatic Brain Injury Victims	SHOCK			English	Article						Infectious complications; lymphocyte count; lymphopenia; mortality; traumatic brain injury	SEPSIS; IMMUNOSUPPRESSION; DIAGNOSIS; DEATH	Background: Traumatic brain injury (TBI) is a major cause of mortality and disability associated with increased risk of secondary infections. Identifying a readily available biomarker may help direct TBI patient care. Herein, we evaluated whether admission lymphopenia could predict outcomes of TBI patients. Methods: This is a 10-year retrospective review of TBI patients with a head Abbreviated Injury Score 2 to 6 and absolute lymphocyte counts (ALC) collected within 24 h of admission. Exclusion criteria were death within 24 h of admission and presence of bowel perforation on admission. Demographics, admission data, injury severity score, mechanism of injury, and outcomes were collected. Association between baseline variables and outcomes was analyzed. Results: We included 2,570 patients; 946 (36.8%) presented an ALC <= 1,000 on admission (lymphopenic group). Lymphopenic patients were significantly older, less likely to smoke, and more likely to have heart failure, hypertension, or chronic kidney disease. Lymphopenia was associated with increased risks of mortality (OR = 1.903 [1.389-2.608]; P < 0.001) and pneumonia (OR = 1.510 [1.081-2.111]; P = 0.016), increased LOS (OR = 1.337 [1.217-1.469]; P < 0.001), and likelihood of requiring additional healthcare resources at discharge (OR = 1.669 [1.344-2.073], P < 0.001). Additionally, lymphopenia increased the risk of early in-hospital death (OR = 1.459 [1.097-1.941]; P = 0.009). Subgroup analysis showed that lymphopenia was associated with mortality in polytrauma patients and those who presented with two or more concurrent types of TBI. In all subgroup analyses, lymphopenia was associated with longer length of stay and discharge requiring higher level of care. Conclusion: A routine complete blood count with differential for all TBI patients may help predict patient outcomes and direct care accordingly.	[Campbell, Brady; Williams-Perez, Sophia] Carver Coll Med, Iowa City, IA USA; [Budreau, Daniel; Galet, Colette; McGonagill, Patrick] Univ Iowa, Dept Surg, Acute Care Surg Div, Iowa City, IA 52242 USA; [Budreau, Daniel] Aurora BayCare Med Ctr, Green Bay, WI USA; [Chakravarty, Subhashish] Collins Aerosp, Cedar Rapids, IA USA		McGonagill, P (corresponding author), Univ Iowa, Dept Surg, Acute Care Surg Div, Iowa City, IA 52242 USA.	patrick-mcgonagill@uiowa.edu					Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Center for disease control, 2020, FASTSTATS LEAD CAUS; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Chung KP, 2015, SHOCK, V43, P569, DOI 10.1097/SHK.0000000000000347; Cohen SB, 2012, STAT BRIEF MED EXPEN; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Division of Acute Care Rehabilitation Research and Disability Prevention, 2020, REP C TRAUM BRAIN IN; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Girardot T, 2017, APOPTOSIS, V22, P295, DOI 10.1007/s10495-016-1325-3; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; HOYT DB, 1990, J TRAUMA, V30, P759, DOI 10.1097/00005373-199007000-00001; Jogia T, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.272; LEWIS RT, 1979, J SURG RES, V26, P365, DOI 10.1016/0022-4804(79)90021-0; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morotti A, 2017, NEUROCRIT CARE, V26, P160, DOI 10.1007/s12028-016-0367-2; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; NIH National Heart Lung and Blood Institute, LYMPH; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sorensen M, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-019-0227-z; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Vulliamy PE, 2016, EUR J TRAUMA EMERG S, V42, P755, DOI 10.1007/s00068-015-0585-x	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	FEB	2022	57	2					189	198		10.1097/SHK.0000000000001872			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	YG0DX	WOS:000742170000006	34618726				2022-02-06	
J	Chen, D; Sun, YY; Zhou, LY; Yang, S; Hong, FY; Liu, XD; Sun, ZL; Huang, J; Feng, DF				Chen, Di; Sun, Yi-Yu; Zhou, Lai-Yang; Yang, Shuo; Hong, Fei-Yang; Liu, Xian-Dong; Sun, Zhao-Liang; Huang, Ju; Feng, Dong-Fu			Maf1 regulates axonal regeneration of retinal ganglion cells after injury	EXPERIMENTAL NEUROLOGY			English	Article						Maf1; Retinal ganglion cells; Survival; Regeneration; PTEN; mTOR	RNA-POLYMERASE-III; OPTIC-NERVE; MTOR; MICE; CNS	Retinal ganglion cells (RGCs) are the sole output neurons that carry visual information from the eye to the brain. Due to various retinal and optic nerve diseases, RGC somas and axons are vulnerable to damage and lose their regenerative capacity. A basic question is whether the manipulation of a key regulator of RGC survival can protect RGCs from retinal and optic nerve diseases. Here, we found that Maf1, a general transcriptional regulator, was upregulated in RGCs from embryonic stage to adulthood. We determined that the knockdown of Maf1 promoted the survival of RGCs and their axon regeneration through altering the activity of the PTEN/mTOR pathway, which could be blocked by rapamycin. We further observed that the inhibition of Maf1 prevented the retinal ganglion cell complex from thinning after optic nerve crush. These findings reveal a neuroprotective effect of knocking down Maf1 on RGC survival after injury and provide a potential therapeutic strategy for traumatic optic neuropathy.	[Chen, Di; Sun, Zhao-Liang; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai 201999, Peoples R China; [Sun, Yi-Yu; Zhou, Lai-Yang; Feng, Dong-Fu] Southern Med Univ, Affiliated Fengxian Hosp, Shanghai 201499, Peoples R China; [Yang, Shuo; Hong, Fei-Yang; Huang, Ju] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Liu, Xian-Dong] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Sch Med, Shanghai 200020, Peoples R China		Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai 201999, Peoples R China.; Huang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China.	juhuang@shsmu.edu.cn; drneuro@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772059]; Shanghai Science and Technology CommissionShanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM) [19411968200]; Shanghai Ninth People's Hospital [JYJC 202001]	This work was supported by National Natural Science Foundation of China (81772059) , Shanghai Science and Technology Commission (19411968200) and Shanghai Ninth People's Hospital (JYJC 202001) .	Apara A, 2017, J NEUROSCI, V37, P9632, DOI 10.1523/JNEUROSCI.0643-16.2017; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Bonhoure N, 2015, GENE DEV, V29, P934, DOI 10.1101/gad.258350.115; Cai Y, 2016, ONCOTARGET, V7, P10812, DOI 10.18632/oncotarget.7769; Chen K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02809-y; Galvao J, 2018, INVEST OPHTH VIS SCI, V59, P2736, DOI 10.1167/iovs.17-23319; Guo XZ, 2021, CELL, V184, P4299, DOI 10.1016/j.cell.2021.06.031; Guo XZ, 2016, ELIFE, V5, DOI 10.7554/eLife.11903; Hu Y, 2012, NEURON, V73, P445, DOI 10.1016/j.neuron.2011.11.026; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Kole C, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.31; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Li HJ, 2019, EXP CELL RES, V375, P10, DOI 10.1016/j.yexcr.2019.01.009; Li Y, 2016, HEPATOLOGY, V63, P1928, DOI 10.1002/hep.28507; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4; McCown TJ, 2011, CURR GENE THER, V11, P181; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nathan FM, 2020, MOL THER, V28, P1902, DOI 10.1016/j.ymthe.2020.04.010; Norsworthy MW, 2017, NEURON, V94, P1112, DOI 10.1016/j.neuron.2017.05.035; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Palian BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004789; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Smith KR, 2010, MOL CELL NEUROSCI, V44, P330, DOI 10.1016/j.mcn.2010.04.004; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun Y, 2019, THERANOSTICS, V9, P7268, DOI 10.7150/thno.33006; Trapani I, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040287; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wang XW, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107537; Wang XW, 2018, CELL REP, V24, P2540, DOI 10.1016/j.celrep.2018.07.105; Weng YL, 2017, NEURON, V94, P337, DOI 10.1016/j.neuron.2017.03.034; Williams PR, 2020, ANNU REV VIS SCI, V6, P195, DOI 10.1146/annurev-vision-022720-094953; Wolfgang PT, 2019, EXP NEUROL, V317, P271, DOI 10.1016/j.expneurol.2019.03.011; Zhang SS, 2018, BBA-GENE REGUL MECH, V1861, P338, DOI 10.1016/j.bbagrm.2018.01.019	35	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2022	348								113948	10.1016/j.expneurol.2021.113948			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XX9GU	WOS:000736595400005	34902358				2022-02-06	
J	Macruz, FBD; Feltrin, FS; Zaninotto, A; Guirado, VMD; Otaduy, MCG; Tsunemi, MH; Nucci, MP; Rimkus, C; Andrade, CS; Leite, CD				de Carvalho Macruz, Fabiola Bezerra; Feltrin, Fabricio Stewan; Zaninotto, Ana; de Paula Guirado, Vinicius Monteiro; Garcia Otaduy, Maria Concepcion; Tsunemi, Miriam Harumi; Nucci, Mariana Penteado; Rimkus, Carolina; Andrade, Celi Santos; Leite, Claudia da Costa			Longitudinal assessment of magnetization transfer ratio, brain volume, and cognitive functions in diffuse axonal injury	BRAIN AND BEHAVIOR			English	Article; Early Access						axonal; myelinic damage; brain atrophy; diffuse axonal injury; magnetization transfer imaging; traumatic brain injury	HEAD-INJURY; GRAY-MATTER; MEMORY; ATROPHY; MODERATE; TENSOR; AGE; DIAGNOSIS; DEFICITS; MODEL	Background Diffuse axonal injury (DAI) is a frequent mechanism of traumatic brain injury (TBI) that triggers a sequence of parenchymal changes that progresses from focal axonal shear injuries up to inflammatory response and delayed axonal disconnection. Objective The main purpose of this study is to evaluate changes in the axonal/myelinic content and the brain volume up to 12 months after TBI and to correlate these changes with neuropsychological results. Methods Patients with DAI (n = 25) were scanned at three time points after trauma (2, 6, and 12 months), and the total brain volume (TBV), gray matter volume, and white matter volume (WMV) were calculated in each time point. The magnetization transfer ratio (MTR) for the total brain (TB MTR), gray matter (GM MTR), and white matter (WM MTR) was also quantified. In addition, Hopkins verbal learning test (HVLT), Trail Making Test (TMT), and Rey-Osterrieth Complex Figure test were performed at 6 and 12 months after the trauma. Results There was a significant reduction in the mean TBV, WMV, TB MTR, GM MTR, and WM MTR between time points 1 and 3 (p < .05). There was also a significant difference in HVLT-immediate, TMT-A, and TMT-B scores between time points 2 and 3. The MTR decline correlated more with the cognitive dysfunction than the volume reduction. Conclusion A progressive axonal/myelinic rarefaction and volume loss were characterized, especially in the white matter (WM) up to 1 year after the trauma. Despite that, specific neuropsychological tests revealed that patients' episodic verbal memory, attention, and executive function improved during the study. The current findings may be valuable in developing long-term TBI rehabilitation management programs.	[de Carvalho Macruz, Fabiola Bezerra; Feltrin, Fabricio Stewan; Garcia Otaduy, Maria Concepcion; Nucci, Mariana Penteado; Rimkus, Carolina; Andrade, Celi Santos; Leite, Claudia da Costa] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Radiol & Oncol, Sao Paulo, Brazil; [Zaninotto, Ana] Univ Sao Paulo, Neuropsychol Div, Dept Neurol, Hosp Clin,Fac Med, Sao Paulo, Brazil; [de Paula Guirado, Vinicius Monteiro] Univ Sao Paulo, Neurosurg Div, Dept Neurol, Hosp Clin,Fac Med, Sao Paulo, Brazil; [Tsunemi, Miriam Harumi] Univ Estadual Paulista, Dept Biostat, Botucatu, SP, Brazil		Macruz, FBD (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Dept Radiol & Oncol, Sao Paulo, Brazil.	fabiolamacruz@hotmail.com			FAPESP-Cinapce project	We are thankful to the patients who agreed to join this study. Finally, a special thanks is extended to FAPESP-Cinapce project.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akin F., 2020, AM SPEECH LANGUAGE H; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fjaer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084162; Foss MP, 2013, CLINICS, V68, P1197, DOI 10.6061/clinics/2013(09)04; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kumar R, 2003, MAGN RESON IMAGING, V21, P893, DOI 10.1016/S0730-725X(03)00189-9; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pagani E, 2008, NEUROL SCI, V29, pS290, DOI 10.1007/s10072-008-1001-7; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pomeroy IM, 2008, NEUROSCI LETT, V437, P121, DOI 10.1016/j.neulet.2008.03.069; Reid-Arndt SA, 2011, APPL NEUROPSYCHOL, V18, P291, DOI 10.1080/09084282.2011.595456; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Seiler S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00263; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tange O, 2011, MAGASINE, V36, P42; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29	51	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.											e2490	10.1002/brb3.2490		FEB 2022	13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	YP9LJ	WOS:000748940000001	35103410	gold			2022-02-06	
J	Dhillon, NK; Adjamian, N; Fierro, NM; Conde, G; Barmparas, G; Ley, EJ				Dhillon, Navpreet K.; Adjamian, Norair; Fierro, Nicole M.; Conde, Geena; Barmparas, Galinos; Ley, Eric J.			Early Antibiotic Administration is Independently Associated with Improved Survival in Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Antibiotics; Infection; Sepsis; Trauma; Traumatic brain injury	EARLY POSITIVE CULTURES; IMMUNE; AGE; CEFTRIAXONE; MORTALITY; RISK	Background: Central and systemic immune dysfunction after traumatic brain injury (TBI) can lead to infectious-related complications, which may result in delayed mortality. The role of early empiric antibiotics after TBI has not been characterized to date, but is recommended in select cases to decrease complications. We aimed to determine the relationship between early antibiotic use and in-hospital mortality in TBI patients. Methods: A retrospective review was conducted of TBI patients requiring ICU admission at an urban, academic, Level I trauma center from 01/2014 to 08/2016. Data collection included demographics, injury characteristics, details regarding antibiotic use, and outcomes. Early antibiotic administration was defined as any antibiotic given within 48 hs from admission. Patients given early antibiotics (EARLY) were compared to those who received their first dose later or did not receive any antibiotics (non-EARLY). Results: Of the 488 TBI patients meeting inclusion criteria, 189 (38.7%) received early antibiotics. EARLY patients were younger (EARLY 54.2 versus non-EARLY 61.5 ys, P < 0.01) and more likely to be male (71.4% versus 60.9%, P = 0.02). Injury severity scores (23.6 versus 17.2, P < 0.01) and regional head abbreviated injury scale scores (3.9 versus 3.7, P < 0.01) were significantly higher in patients who received early antibiotics. Unadjusted in-hospital mortality rates were similar, however EARLY was associated with a lower mortality rate (AOR 0.17, 95% CI: 0.07 - 0.43, adjusted P < 0.01) after adjusting for confounders. Conclusions: Despite presenting with a higher injury burden, TBI patients who received early antibiotics had a lower associated mortality rate compared to their counterparts. Future investigations are necessary to understand the underlying mechanisms that result in this potential survival benefit. (C) 2021 Elsevier Inc. All rights reserved.	[Dhillon, Navpreet K.; Fierro, Nicole M.; Conde, Geena; Barmparas, Galinos; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA; [Adjamian, Norair] Community Mem Hlth Syst, Dept Surg, Ventura, CA USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org		Adjamian, Norair/0000-0001-6819-1518			Adediran T, 2019, J SURG RES, V243, P427, DOI 10.1016/j.jss.2019.05.053; Asano K, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/692352; Barmparas G, 2018, SURG INFECT, V19, P410, DOI 10.1089/sur.2017.268; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Caplan HW, 2019, CURR SURG REP, V7, DOI 10.1007/s40137-019-0237-x; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dhillon NK, 2018, J SURG RES, V224, P140, DOI 10.1016/j.jss.2017.11.031; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Diaz MF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67723-x; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kempuraj D, 2021, NEUROTOX RES, V39, P359, DOI 10.1007/s12640-020-00288-9; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Li YT, 2020, NEUROCRIT CARE, V32, P272, DOI 10.1007/s12028-019-00773-w; Marut D, 2020, CLIN NEUROL NEUROSUR, V193, DOI 10.1016/j.clineuro.2020.105777; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Orsucci D, 2009, CNS NEUROL DISORD-DR, V8, P222; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Tikka T, 2001, J NEUROCHEM, V78, P1409, DOI 10.1046/j.1471-4159.2001.00543.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; VanVlem B, 1996, INFECTION, V24, P275, DOI 10.1007/BF01743360; Wirtz MR, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00359-3; Yang YX, 2019, NEUROIMMUNOMODULAT, V26, P43, DOI 10.1159/000495465; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766; Zhu L, 2007, ANN CLIN LAB SCI, V37, P356	36	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2022	270						495	502		10.1016/j.jss.2021.10.015			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XF6FD	WOS:000724163900001	34808469				2022-02-06	
J	Driessen, MLS; Sturms, LM; Bloemers, FW; ten Duis, HJ; Edwards, MJR; den Hartog, D; Kuipers, EJ; Leenhouts, PA; Poeze, M; Schipper, IB; Spanjersberg, RW; Wendt, KW; de Wit, RJ; van Zutphen, SWAM; de Jongh, MAC; Leenen, LPH				Driessen, Mitchell L. S.; Sturms, Leontien M.; Bloemers, Frank W.; ten Duis, Henk Jan; Edwards, Michael J. R.; den Hartog, Dennis; Kuipers, E. J.; Leenhouts, Peter A.; Poeze, Martijn; Schipper, Inger B.; Spanjersberg, Richard W.; Wendt, Klaus W.; de Wit, Ralph J.; van Zutphen, Stefan W. A. M.; de Jongh, Mariska A. C.; Leenen, Luke P. H.			The Detrimental Impact of the COVID-19 Pandemic on Major Trauma Outcomes in the Netherlands A Comprehensive Nationwide Study	ANNALS OF SURGERY			English	Article						COVID-19; impact; major trauma patient; resource utilization; trauma care	EPIDEMIOLOGY; INJURY	Objective: To evaluate the impact of the COVID-19 pandemic on the outcome of major trauma patients in the Netherlands. Summary Background Data: Major trauma patients highly rely on immediate access to specialized services, including ICUs, shortages caused by the impact of the COVID-19 pandemic may influence their outcome. Methods: A multi-center observational cohort study, based on the Dutch National Trauma Registry was performed. Characteristics, resource usage, and outcome of major trauma patients (injury severity score >= 16) treated at all trauma-receiving hospitals during the first COVID-19 peak (March 23 through May 10) were compared with those treated from the same period in 2018 and 2019 (reference period). Results: During the peak period, 520 major trauma patients were admitted, versus 570 on average in the pre-COVID-19 years. Significantly fewer patients were admitted to ICU facilities during the peak than during the reference period (49.6% vs 55.8%; P=0.016). Patients with less severe traumatic brain injuries in particular were less often admitted to the ICU during the peak (40.5% vs 52.5%; P=0.005). Moreover, this subgroup showed an increased mortality compared to the reference period (13.5% vs 7.7%; P=0.044). These results were confirmed using multivariable logistic regression analyses. In addition, a significant increase in observed versus predicted mortality was recorded for patients who had a priori predicted mortality of 50% to 75% (P=0.012). Conclusions: The COVID-19 peak had an adverse effect on trauma care as major trauma patients were less often admitted to ICU and specifically those with minor through moderate brain injury had higher mortality rates.	[Driessen, Mitchell L. S.; Sturms, Leontien M.; Kuipers, E. J.] Dutch Network Emergency Care LNAZ, Utrecht, Netherlands; [Bloemers, Frank W.; Leenhouts, Peter A.] Univ Amsterdam, Dept Surg, Med Ctr, Amsterdam, Netherlands; [Edwards, Michael J. R.] Radboud Univ Nijmegen, Dept Trauma Surg, Med Ctr, Nijmegen, Netherlands; [den Hartog, Dennis] Univ Med Ctr Rotterdam, Trauma Res Unit, Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Poeze, Martijn] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands; [Schipper, Inger B.] Leiden Univ, Dept Trauma Surg, Med Ctr, Leiden, Netherlands; [Spanjersberg, Richard W.] Isala Hosp, Dept Trauma Surg, Zwolle, Netherlands; [Wendt, Klaus W.] Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [de Wit, Ralph J.] Med Spectrum Twente, Dept Trauma Surg, Enschede, Netherlands; [van Zutphen, Stefan W. A. M.] Elisabeth Two Cities Hosp, Dept Surg, Tilburg, Netherlands; [de Jongh, Mariska A. C.] Network Emergency Care Brabant, Tilburg, Netherlands; [Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands		Driessen, MLS (corresponding author), Dutch Network Emergency Care LNAZ, Utrecht, Netherlands.	mls.driessen@lnaz.nl					Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Crenn V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-80309-x; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Driessen MLS, 2020, INJURY, V51, P2553, DOI 10.1016/j.injury.2020.08.013; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Ghafil C, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1320; Halvachizadeh S, 2020, INT ORTHOP, V44, P1621, DOI 10.1007/s00264-020-04740-5; IBM Corp. Released, 2017, IBM SPSS STAT VERS 2; Jacob S, 2020, ANZ J SURG, V90, P2227, DOI 10.1111/ans.16307; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leichtle SW, 2020, INJURY, V51, P2437, DOI 10.1016/j.injury.2020.08.014; Maringe C, 2020, LANCET ONCOL, V21, P1023, DOI 10.1016/S1470-2045(20)30388-0; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mitra AR, 2020, CAN MED ASSOC J, V192, pE694, DOI 10.1503/cmaj.200794; Plate Joost D J, 2018, Trauma Surg Acute Care Open, V3, pe000178, DOI 10.1136/tsaco-2018-000178; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Rinkel LA, 2021, J NEUROL, V268, P403, DOI 10.1007/s00415-020-10069-1; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; The Dutch National Intensive Care Evaluation, 2021, COVID 19 DUTCH INT C; van Aert GJJ, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045015; Verweij M, 2020, PUBLIC HEALTH ETH-UK, V13, P157, DOI 10.1093/phe/phaa027; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; Waseem S, 2021, J Clin Orthop Trauma, V12, P200, DOI 10.1016/j.jcot.2020.11.005; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhao J, 2020, STROKE, V51, P1996, DOI 10.1161/STROKEAHA.120.030225	27	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	FEB	2022	275	2					252	258		10.1097/SLA.0000000000005300			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YE0LP	WOS:000740824400012	35007227	Green Published, hybrid			2022-02-06	
J	Fouda, AY; Eldahshan, W; Xu, ZM; Lemtalsi, T; Shosha, E; Zaidi, SAH; Abdelrahman, AA; Cheng, PNM; Narayanan, SP; Caldwell, RW; Caldwell, RB				Fouda, Abdelrahman Y.; Eldahshan, Wael; Xu, Zhimin; Lemtalsi, Tahira; Shosha, Esraa; Zaidi, Syed A. H.; Abdelrahman, Ammar A.; Cheng, Paul Ning-Man; Narayanan, S. Priya; Caldwell, R. William; Caldwell, Ruth B.			Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Retinal ischemia; Stroke; Ischemia-reperfusion injury; Neuroprotection; Neurodegeneration; Arginase	IN-VITRO; ARGININE; SURVIVAL; NEURODEGENERATION; NEUROPROTECTION; CULTURES; NEURONS; BDNF	Arginase 1 (A1) is the enzyme that hydrolyzes the amino acid, L-arginine, to ornithine and urea. We have previously shown that A1 deletion worsens retinal ischemic injury, suggesting a protective role of A1. In this translational study, we aimed to study the utility of systemic pegylated A1 (PEG-A1, recombinant human arginase linked to polyethylene glycol) treatment in mouse models of acute retinal and brain injury. Cohorts of WT mice were subjected to retinal ischemia-reperfusion (IR) injury, traumatic optic neuropathy (TON) or brain cerebral ischemia via middle cerebral artery occlusion (MCAO) and treated with intraperitoneal injections of PEG-A1 or vehicle (PEG only). Drug penetration into retina and brain tissues was measured by western blotting and immunolabeling for PEG. Neuroprotection was measured in a blinded fashion by quantitation of NeuN (neuronal marker) immunolabeling of retina flat-mounts and brain infarct area using triphenyl tetrazolium chloride (TTC) staining. Furthermore, ex vivo retina explants and in vitro retina neuron cultures were subjected to oxygen-glucose deprivation (OGD) followed by reoxygenation (R) and treated with PEG-A1. PEG-A1 given systemically did not cross the intact blood-retina/brain barriers in sham controls but reached the retina and brain after injury. PEG-A1 provided neuroprotection after retinal IR injury, TON and cerebral ischemia. PEG-A1 treatment was also neuroprotective in retina explants subjected to OGD/R but did not improve survival in retinal neuronal cultures exposed to OGD/R. In summary, systemic PEG-A1 administration is neuroprotective and provides an excellent route to deliver the drug to the retina and the brain after acute injury.	[Fouda, Abdelrahman Y.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, 4301 West Markham St, Little Rock, AR 72205 USA; [Fouda, Abdelrahman Y.; Shosha, Esraa; Abdelrahman, Ammar A.] Cairo Univ, Fac Pharm, Dept Clin Pharm, Cairo, Egypt; [Eldahshan, Wael; Xu, Zhimin; Lemtalsi, Tahira; Shosha, Esraa; Zaidi, Syed A. H.; Narayanan, S. Priya; Caldwell, Ruth B.] Augusta Univ, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA; [Xu, Zhimin; Lemtalsi, Tahira; Zaidi, Syed A. H.; Abdelrahman, Ammar A.; Narayanan, S. Priya; Caldwell, R. William; Caldwell, Ruth B.] Augusta Univ, Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Abdelrahman, Ammar A.; Caldwell, R. William] Augusta Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Narayanan, S. Priya; Caldwell, Ruth B.] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Narayanan, S. Priya; Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Cheng, Paul Ning-Man] Biocanc Treatment Int, Tai Po, 511-513 Bioinformat Bldg,Hong Kong Sci Pk, Hong Kong, Peoples R China; [Narayanan, S. Priya] Univ Georgia, Dept Clin & Adm Pharm, Augusta, GA USA		Fouda, AY (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, 4301 West Markham St, Little Rock, AR 72205 USA.; Caldwell, RB (corresponding author), Augusta Univ, Vasc Biol Ctr, 1460 Laney Walker Blvd, Augusta, GA 30912 USA.	afouda@uams.edu; rcaldwel@augusta.edu		Zaidi, Syed Adeel/0000-0002-9177-0881	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EY11766, P30EY031631]; Department of Veterans Affairs, Veterans Health Administration (RBC), Office of Research and Development, Biomedical Laboratory Research and DevelopmentUS Department of Veterans Affairs [BX001233]; K99 award [1K99EY029373-01A1]; Culver Vision Discovery Institute at Augusta University	This work was supported by grants from the National Institute of Health (NIH grant R01-EY11766 to RBC, RWC), the Department of Veterans Affairs, Veterans Health Administration (RBC), Office of Research and Development, Biomedical Laboratory Research and Development (BX001233 to RBC), K99 award (1K99EY029373-01A1 to AYF) and the Culver Vision Discovery Institute at Augusta University. The research reported in this publication was also supported by the NIH core grant number P30EY031631. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. R. B. Caldwell is the recipient of a Research Career Scientist Award from the Department of Veterans Affairs. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Dr. Tauheed Ishrat at the University of Tennessee Health Science Center (UTHSC) for his help with standardizing the mouse MCAO model.	Alarautalahti V, 2019, INVEST OPHTH VIS SCI, V60, P1914, DOI 10.1167/iovs.18-25156; Barakat W, 2018, N-S ARCH PHARMACOL, V391, P603, DOI 10.1007/s00210-018-1489-1; Bieber M, 2019, STROKE, V50, P2875, DOI 10.1161/STROKEAHA.119.026652; Brunner JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14285-1; Cai W, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131355; Caldwell RW, 2018, PHYSIOL REV, V98, P641, DOI 10.1152/physrev.00037.2016; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; De Santo C, 2018, INT J CANCER, V142, P1490, DOI 10.1002/ijc.31170; del Amo EM, 2017, PROG RETIN EYE RES, V57, P134, DOI 10.1016/j.preteyeres.2016.12.001; Eldahshan W, 2019, AM J PHYSIOL-HEART C, V316, pH1192, DOI 10.1152/ajpheart.00446.2018; Estevez AG, 2006, J NEUROSCI, V26, P8512, DOI 10.1523/JNEUROSCI.0728-06.2006; Feun LG, 2015, CURR OPIN CLIN NUTR, V18, P78, DOI 10.1097/MCO.0000000000000122; Fouda AY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00277; Fouda AY, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.51; Fouda AY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1051-6; GILAD GM, 1989, LIFE SCI, V44, P1963, DOI 10.1016/0024-3205(89)90409-8; Han G, 2014, INVEST OPHTH VIS SCI, V55, P5616, DOI 10.1167/iovs.14-14371; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jindal V, 2015, MOL NEUROBIOL, V51, P878, DOI 10.1007/s12035-014-8732-7; Jittiporn K, 2014, MICROVASC RES, V93, P72, DOI 10.1016/j.mvr.2014.03.005; Johnson TV, 2008, INVEST OPHTH VIS SCI, V49, P3503, DOI 10.1167/iovs.07-1601; Kelley WJ, 2018, ACTA BIOMATER, V79, P283, DOI 10.1016/j.actbio.2018.09.001; Kong D, 2016, EXP EYE RES, V151, P82, DOI 10.1016/j.exer.2016.08.002; Lam SK, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0128-0; Lee JH, 2009, BIOCHEM BIOPH RES CO, V384, P524, DOI 10.1016/j.bbrc.2009.05.015; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Madan S, 2018, MOL GENET METAB, V125, P112, DOI 10.1016/j.ymgme.2018.07.007; Mathew B, 2019, BIOMATERIALS, V197, P146, DOI 10.1016/j.biomaterials.2019.01.016; McLaughlin T, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00267; MORGAN JF, 1958, J BIOL CHEM, V233, P664; Morrow K, 2013, LEUKEMIA, V27, P569, DOI 10.1038/leu.2012.247; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Noro T, 2015, INVEST OPHTH VIS SCI, V56, P5012, DOI 10.1167/iovs.15-17142; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Osborne A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1041-8; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Perigolo-Vicente R, 2014, BIOCHEM BIOPH RES CO, V449, P477, DOI 10.1016/j.bbrc.2014.05.036; Shosha E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.295; Taj SH, 2016, BIOMATERIALS, V91, P151, DOI 10.1016/j.biomaterials.2016.03.025; Xu ZM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00970; Yau T, 2015, INVEST NEW DRUG, V33, P496, DOI 10.1007/s10637-014-0200-8; Yu Deshan, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P149; Zarruk JG, 2018, EXP NEUROL, V301, P120, DOI 10.1016/j.expneurol.2017.08.011	46	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2022	348								113923	10.1016/j.expneurol.2021.113923			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XE9OZ	WOS:000723712400004	34780773				2022-02-06	
J	Galea, O; O'Leary, S; Treleaven, J				Galea, O.; O'Leary, S.; Treleaven, J.			Cervical musculoskeletal and sensorimotor impairments 4 weeks to 6 months following mild traumatic brain injury: An observational cohort study	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						mTBI; Concussion; Cervical musculoskeletal; Cervical sensorimotor; Neck pain	WHIPLASH-ASSOCIATED DISORDERS; NECK TORSION TEST; VISUAL DISTURBANCES; STANDING BALANCE; CLINICAL-TESTS; DIZZINESS; RELIABILITY; CONCUSSION; UNSTEADINESS; DISABILITY	Background: Clinically relevant scores of neck disability have been observed in adults post mild traumatic brain injury (mTBI), even in those who initially report to be recovered. Potentially cervical musculoskeletal and/or cervical sensorimotor impairments may underlie these persistent symptoms post mTBI. Objective: To determine whether cervical impairments exist beyond expected recovery times following concussion compared to healthy controls (HC). Study design: Observational cohort study. Methods: Participants aged 18-60 years consisting of 39 HC, and 72 individuals, 4 weeks to 6 months post mTBI of which 35 considered themselves asymptomatic (Asymp), and 37 symptomatic (Symp). Cervical outcome measures included range and velocity of motion, flexor muscle endurance, presence of at least one dysfunctional cervical joint, joint position error-neutral and torsion, movement accuracy, smooth pursuit neck torsion test (SPNT) and balance. Results: Individuals in the Symp mTBI group demonstrated significantly reduced: flexion and rotation range, rotation velocity, flexor endurance and movement accuracy as well as increased postural sway and a higher percentage had positive cervical joint dysfunction (p < 0.01]. The mTBI group who considered themselves recovered (Asymp)demonstrated significantly lower rotation range, flexor endurance, and a higher percentage had positive cervical joint dysfunction and positive SPNT (p < 0.05) compared to HCs. Conclusion: Individuals reporting symptoms post mTBI demonstrated cervical spine musculoskeletal and sensorimotor impairments beyond expected recovery times. Those not reporting symptoms had fewer but some cervical impairments. The need for a comprehensive neck assessment should be considered, perhaps even in those not reporting symptoms.	[Galea, O.; O'Leary, S.; Treleaven, J.] Univ QLD, Neck & Head Res Unit, SHRS, Brisbane, Qld, Australia; [O'Leary, S.] 2 Royal Brisbane & Womens Hosp, Physiotherapy Dept, Brisbane, Qld, Australia		Treleaven, J (corresponding author), Univ QLD, Neck & Head Res Unit, SHRS, Brisbane, Qld, Australia.	j.treleaven@uq.edu.au		GALEA, Olivia/0000-0001-5013-7580	Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	This research was supported by an Australian Government Research Training Program Scholarship.	Audette I, 2010, J ORTHOP SPORT PHYS, V40, P318, DOI 10.2519/jospt.2010.3180; Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; Bahat HS, 2015, MANUAL THER, V20, P295, DOI 10.1016/j.math.2014.10.002; Baker M, 2019, MUSCULOSKEL SCI PRAC, V42, P193, DOI 10.1016/j.msksp.2019.04.002; Bogduk N, 2004, CEPHALALGIA, V24, P819, DOI 10.1111/j.1468-2982.2004.00774.x; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daly L, 2018, MUSCULOSKEL SCI PRAC, V33, P18, DOI 10.1016/j.msksp.2017.10.007; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Galea OA, 2019, MUSCULOSKEL SCI PRAC, V41, P15, DOI 10.1016/j.msksp.2019.02.002; Goncalves C, 2019, MUSCULOSKEL SCI PRAC, V43, P103, DOI 10.1016/j.msksp.2019.07.010; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; JULL G, 1988, MED J AUSTRALIA, V148, P233, DOI 10.5694/j.1326-5377.1988.tb99431.x; Jull G, 2018, MUSCULOSKEL SCI PRAC, V38, P148, DOI 10.1016/j.msksp.2018.09.012; Kasch H., 2017, SCAND J PAIN, V3, P197; Kennedy Ewan, 2019, J Orthop Sports Phys Ther, V49, P845, DOI 10.2519/jospt.2019.8547; Liang ZQ, 2021, HEADACHE, V61, P882, DOI 10.1111/head.14136; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schneider GM, 2013, ARCH PHYS MED REHAB, V94, P1628, DOI 10.1016/j.apmr.2013.02.015; Schneider K, 2014, BRAIN INJURY, V28, P796; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; SPITZER WO, 1995, SPINE, V20, pS1; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Thomas L., 2017, CLIN GUIDE SAFE MANU; Tjell C, 1998, AM J OTOL, V19, P76; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2005, J REHABIL MED, V37, P224, DOI 10.1080/16501970510027989; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Williams K, 2017, MUSCULOSKEL SCI PRAC, V29, P115, DOI 10.1016/j.msksp.2017.03.012; Yu LJ, 2011, MANUAL THER, V16, P339, DOI 10.1016/j.math.2010.12.006; Zito G, 2006, MANUAL THER, V11, P118, DOI 10.1016/j.math.2005.04.007	50	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	FEB	2022	57								102490	10.1016/j.msksp.2021.102490			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XK4NG	WOS:000727443900001	34847469				2022-02-06	
J	Germine, LT; Joormann, J; Passell, E; Rutter, LA; Scheuer, L; Martini, P; Hwang, I; Lee, S; Sampson, N; Barch, DM; House, SL; Beaudoin, FL; An, XM; Stevens, JS; Zeng, DL; Linnstaedt, SD; Jovanovic, T; Clifford, GD; Neylan, TC; Rauch, SL; Lewandowski, C; Hendry, PL; Sheikh, S; Storrow, AB; Musey, PI; Jones, CW; Punches, BE; McGrath, ME; Pascual, JL; Mohiuddin, K; Pearson, C; Peak, DA; Domeier, RM; Bruce, SE; Rathlev, NK; Sanchez, LD; Pietrzak, RH; Pizzagalli, DA; Harte, SE; Elliott, JM; Koenen, KC; Ressler, KJ; McLean, SA; Kessler, RC				Germine, Laura T.; Joormann, Jutta; Passell, Eliza; Rutter, Lauren A.; Scheuer, Luke; Martini, Paolo; Hwang, Irving; Lee, Sue; Sampson, Nancy; Barch, Deanna M.; House, Stacey L.; Beaudoin, Francesca L.; An, Xinming; Stevens, Jennifer S.; Zeng, Donglin; Linnstaedt, Sarah D.; Jovanovic, Tanja; Clifford, Gari D.; Neylan, Thomas C.; Rauch, Scott L.; Lewandowski, Christopher; Hendry, Phyllis L.; Sheikh, Sophia; Storrow, Alan B.; Musey, Paul I.; Jones, Christopher W.; Punches, Brittney E.; McGrath, Meghan E.; Pascual, Jose L.; Mohiuddin, Kamran; Pearson, Claire; Peak, David A.; Domeier, Robert M.; Bruce, Steven E.; Rathlev, Niels K.; Sanchez, Leon D.; Pietrzak, Robert H.; Pizzagalli, Diego A.; Harte, Steven E.; Elliott, James M.; Koenen, Karesten C.; Ressler, Kerry J.; McLean, Samuel A.; Kessler, Ronald C.			Neurocognition after motor vehicle collision and adverse post-traumatic neuropsychiatric sequelae within 8 weeks: Initial findings from the AURORA study	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Trauma; Longitudinal; Cognition; Neuropsychology; Digital neuropsychology; Digital cognitive assessment	STRESS-DISORDER; PTSD SYMPTOMS; COGNITIVE IMPAIRMENT; CONCUSSION SYMPTOMS; WIDESPREAD PAIN; HEAD-INJURY; HEALTH; RISK; PERFORMANCE; OUTCOMES	Background: Previous work has indicated that differences in neurocognitive functioning may predict the development of adverse post-traumatic neuropsychiatric sequelae (APNS). Such differences may be vulnerability factors or simply correlates of APNS-related symptoms. Longitudinal studies that measure neurocognitive functioning at the time of trauma are needed to determine whether such differences precede the development of APNS. Methods: Here, we present findings from a subsample of 666 ambulatory patients from the AURORA (Advancing Understanding of RecOvery afteR trumA) study. All patients presented to EDs after a motor vehicle collision (MVC). We examined associations of neurocognitive test performance shortly after MVC with peritraumatic symptoms in the ED and APNS (depression, post-traumatic stress, post-concussive symptoms, and pain) 2 weeks and 8 weeks later. Neurocognitive tests assessed processing speed, attention, verbal reasoning, memory, and social perception. Results: Distress in the ED was associated with poorer processing speed and short-term memory. Poorer shortterm memory was also associated with depression at 2 weeks post-MVC, even after controlling for peritraumatic distress. Finally, higher vocabulary scores were associated with pain 2 weeks post-MVC. Limitations: Self-selection biases among those who present to the ED and enroll in the study limit generalizability. Also, it is not clear whether observed neurocognitive differences predate MVC exposure or arise in the immediate aftermath of MVC exposure. Conclusions: Our results suggest that processing speed and short-term memory may be useful predictors of trauma-related characteristics and the development of some APNS, making such measures clinically-relevant for identifying at-risk individuals.	[Germine, Laura T.; Passell, Eliza; Rutter, Lauren A.; Scheuer, Luke] McLean Hosp, Inst Technol Psychiat, 1010 Pleasant St, Belmont, MA 02478 USA; [Germine, Laura T.; Rutter, Lauren A.; Pizzagalli, Diego A.; Ressler, Kerry J.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Germine, Laura T.; Martini, Paolo] Many Brains Project, Belmont, MA USA; [Joormann, Jutta] Yale Univ, Dept Psychol, New Haven, CT USA; [Hwang, Irving; Lee, Sue; Sampson, Nancy; Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Barch, Deanna M.] Washington Univ, Coll Arts & Sci, Dept Psychol & Brain Sci, St Louis, MO 63110 USA; [House, Stacey L.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Beaudoin, Francesca L.] Brown Univ, Alpert Med Sch, Dept Emergency Med & Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Beaudoin, Francesca L.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Beaudoin, Francesca L.] Miriam Hosp, Dept Emergency Med, Providence, RI 02906 USA; [An, Xinming; Linnstaedt, Sarah D.; McLean, Samuel A.] Univ N Carolina, Dept Anesthesiol, Inst Trauma Recovery, Chapel Hill, NC 27515 USA; [Stevens, Jennifer S.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Zeng, Donglin] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Jovanovic, Tanja] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Clifford, Gari D.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA; [Clifford, Gari D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Neylan, Thomas C.] San Francisco VA Healthcare Syst, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rauch, Scott L.; Pizzagalli, Diego A.] McLean Hosp, 115 Mill St, Belmont, MA 02178 USA; [Lewandowski, Christopher] Henry Ford Hlth Syst, Dept Emergency Med, Detroit, MI USA; [Hendry, Phyllis L.; Sheikh, Sophia] Univ Florida, Coll Med, Dept Emergency Med, Jacksonville, FL USA; [Storrow, Alan B.] Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN USA; [Musey, Paul I.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Jones, Christopher W.] Rowan Univ, Cooper Med Sch, Dept Emergency Med, Camden, NJ USA; [Punches, Brittney E.] Univ Cincinnati, Coll Nursing, Coll Med, Dept Emergency Med, Cincinnati, OH USA; [McGrath, Meghan E.] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Pascual, Jose L.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pascual, Jose L.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mohiuddin, Kamran] Einstein Med Ctr, Dept Emergency Med Internal Med, Philadelphia, PA USA; [Pearson, Claire] Wayne State Univ, Dept Emergency Med, Ascens St John Hosp, Detroit, MI USA; [Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Bruce, Steven E.] Univ Missouri, Dept Psychol Sci, St Louis, MO USA; [Rathlev, Niels K.] Univ Massachusetts, Dept Emergency Med, Med Sch Baystate, Springfield, MA USA; [Sanchez, Leon D.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Sanchez, Leon D.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Pietrzak, Robert H.] US Dept Vet Affairs, Natl Ctr Posttraumat Stress Disorder, VA Connecticut Healthcare Syst, West Haven, CT USA; [Pietrzak, Robert H.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Harte, Steven E.] Univ Michigan, Sch Med, Dept Anesthesiol, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI USA; [Harte, Steven E.] Univ Michigan, Sch Med, Internal Med Rheumatol, Ann Arbor, MI USA; [Elliott, James M.] Univ Sydney, Kolling Inst Med Res, Northern Clin Sch, St Leonards, NSW, Australia; [Elliott, James M.] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Koenen, Karesten C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ressler, Kerry J.] McLean Hosp, Div Depress & Anxiety Disorders, 115 Mill St, Belmont, MA 02178 USA; [McLean, Samuel A.] Univ N Carolina, Dept Emergency Med, Chapel Hill, NC 27515 USA		Germine, LT (corresponding author), McLean Hosp, Inst Technol Psychiat, 1010 Pleasant St, Belmont, MA 02478 USA.	lgermine@mclean.harvard.edu		Clifford, Gari/0000-0002-5709-201X			Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Auvergne L, 2016, PSYCHOSOM MED, V78, P68, DOI 10.1097/PSY.0000000000000253; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Beard C, 2009, COGNITIVE THER RES, V33, P406, DOI 10.1007/s10608-009-9235-0; Ben-Zion Z, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00477; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Bomyea J, 2012, CLIN PSYCHOL REV, V32, P630, DOI 10.1016/j.cpr.2012.06.008; Bortsov AV, 2013, EUR J PAIN, V17, P1243, DOI 10.1002/j.1532-2149.2013.00285.x; Bosaipo NB, 2017, NEUROSCI BIOBEHAV R, V73, P309, DOI 10.1016/j.neubiorev.2016.12.014; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; CDC, 2011, NATL HOSP AMBULATORY; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chaytor NS, 2021, CLIN NEUROPSYCHOL, V35, P148, DOI 10.1080/13854046.2020.1811893; Cor MK, 2012, SOC SCI RES, V41, P1003, DOI 10.1016/j.ssresearch.2012.05.007; Coster JE, 2017, ACAD EMERG MED, V24, P1137, DOI 10.1111/acem.13220; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Dodell-Feder D, 2020, PSYCHOL MED, V50, P133, DOI 10.1017/S003329171800404X; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fortenbaugh FC, 2018, NEUROIMAGE, V171, P148, DOI 10.1016/j.neuroimage.2018.01.002; Fox, 2019, ADV METHODS PRACTICE, V2, P378, DOI [10.1177/2515245919879695, DOI 10.1177/2515245919879695]; Gale CR, 2016, J EPIDEMIOL COMMUN H, V70, P813, DOI 10.1136/jech-2015-206479; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Germine L, 2012, PSYCHON B REV, V19, P847, DOI 10.3758/s13423-012-0296-9; Golier JA, 2006, ANN NY ACAD SCI, V1071, P54, DOI 10.1196/annals.1364.006; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Iverson G.L., 2008, FDN CLIN FORENSIC PR, P243; Joormann J., 2020, PSYCHOL MED, P1; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2021, MOL PSYCHIATR, V26, P3108, DOI 10.1038/s41380-020-00911-3; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Lempert KM, 2019, PSYCHOL MED, V49, P190, DOI 10.1017/S0033291718001770; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lindgren KP, 2013, J BEHAV THER EXP PSY, V44, P368, DOI 10.1016/j.jbtep.2013.03.003; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McLean SA, 2020, MOL PSYCHIATR, V25, P283, DOI 10.1038/s41380-019-0581-3; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Passell E., 2019, DIGITAL COGNITIVE AS; Passell E, 2021, BEHAV RES METHODS, V53, P2544, DOI 10.3758/s13428-021-01597-3; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Platts-Mills TF, 2012, ACAD EMERG MED, V19, P821, DOI 10.1111/j.1553-2712.2012.01383.x; PROMIS Cooperative Group, 2021, PROM INT SCOR; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Rutter LA, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00062; Rutter LA, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1282; Rutter LA, 2019, J EXP PSYCHOL GEN, V148, P1993, DOI 10.1037/xge0000559; Santiago PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059236; Schafer J, 2018, BEHAV RES THER, V102, P60, DOI 10.1016/j.brat.2018.01.004; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Shalev A.Y, 2003, P 19 ANN M ISTSS; Stein DJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0957-8; Sterling M, 2011, PAIN, V152, P1272, DOI 10.1016/j.pain.2011.01.056; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Suliman S, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000113; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Ulirsch JC, 2014, EUR J PAIN, V18, P559, DOI 10.1002/j.1532-2149.2013.00395.x; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Vogel SC, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00691; Wadley VG, 2009, J GERIATR PSYCH NEUR, V22, P87, DOI 10.1177/0891988708328215; Wilmer JB, 2012, COGN NEUROPSYCHOL, V29, P360, DOI 10.1080/02643294.2012.753433; Zalewski, 1994, Assessment, V1, P133, DOI 10.1177/1073191194001002003	84	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	FEB 1	2022	298		B				57	67		10.1016/j.jad.2021.10.104			11	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	YC7ZJ	WOS:000739905500004	34800569				2022-02-06	
J	Golub, VM; Reddy, DS				Golub, Victoria M.; Reddy, Doodipala Samba			Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities	EXPERIMENTAL NEUROLOGY			English	Article						Brain injury; Seizure; Post-traumatic epilepsy; CCI; Hippocampus; HFOs; Microgliosis	CONTROLLED CORTICAL IMPACT; HIGH-FREQUENCY OSCILLATIONS; STATUS EPILEPTICUS; DENTATE GYRUS; MOUSE MODEL; HEAD-INJURY; PLUS-MAZE; EPILEPTOGENESIS; NEUROGENESIS; RATS	Traumatic brain injury (TBI) is a leading cause of acquired epilepsy referred to as post-traumatic epilepsy (PTE), characterized by spontaneous recurrent seizures (SRS) that start in the months or years following TBI. There is a critical need to develop small animal models for advancing the neurotherapeutics of PTE, which accounts for 20% of all acquired epilepsy cases. Despite many previous attempts, there are few PTE models with demonstrated consistency or longitudinal incidence of SRS, a critical feature for creating models for investigation of novel therapeutics for preventing PTE. Over the past few years, we have made in-depth updates and several advances to our mouse model of TBI in which SRS consistently occurs upon 24/7 monitoring for 4 months. Here, we show that an advanced cortical contusion damage in mice elicits a chronic state of PTE with SRS and robust epileptiform activity, along with cognitive comorbidities. We observed SRS in 33% and 87% of moderate and severe injury cohorts, respectively. Though incidence was higher in the severe cohort, moderate injury elicited a robust epileptogenesis. Progressive neuronal damage, neurodegeneration, and inflammation signals were evident in many brain regions; comorbid behavior and cognitive deficits were observed for up to 4-months. SRS onset was correlated with the inception of interneuron loss after TBI. Contralateral hippocampal sclerosis was unique and well correlated with SRS, confirming a potential network basis for epileptogenesis. Collectively, this mouse model exhibits a number of hallmark TBI sequelae reminiscent of human PTE. This model provides a vital tool for probing molecular pathological mechanisms and therapeutic interventions for post-traumatic epileptogenesis. Significance statement: TBI is a leading cause of post-traumatic epilepsy (PTE). Despite many attempts to create PTE in animals, success has been limited due to a lack of consistent spontaneous "epileptic" seizures after TBI. We present a comprehensive phenotype of PTE after contusion brain injury in mice, which exhibits robust spontaneous seizures along with neuronal loss, inflammation, and cognitive dysfunction. Our broad profiling of a TBI mouse reveals features of progressive, long-lasting epileptic activity, unique contralateral hippocampal sclerosis, and comorbid mood and memory deficits. The PTE mouse shows a striking consistency in recapitulating major pathological sequelae of human PTE. This mouse model will be helpful in assessing mechanisms and interventions for TBI-induced epilepsy and mood dysfunction.	[Golub, Victoria M.; Reddy, Doodipala Samba] Texas A&M Univ, Coll Med, Dept Neurosci & Expt Therapeut, Hlth Sci Ctr, Bryan, TX 77807 USA		Reddy, DS (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Neurosci & Expt Therapeut Inst Pharmacol & Neurot, 8447 State Highway 47, Bryan, TX 77807 USA.	sambareddy@tamu.edu			Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-1-0660]; Texas A&M Presi-dential X-Grant award	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the FY 2015 Epilepsy Research Pro-gram under Award #W81XWH-16-1-0660. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Department of Defense. Furthermore, this study was made possible by funding from the Texas A&M Presi-dential X-Grant award (to D.S.R) . The authors thank Dr. Xin Wu for technical help with stereology, Dr. Bryan Clossen for his expertise with TBI surgeries, Dr. Sreevidhya Ramakrishnan and Revanth Dusi for their help coding the MatLab scripts for seizure and discharge detection andHFO analysis, Dr. Karienn Montgomery for help with Water-maze studies, and Deepthi Perumal, Sarah Elmer, and Tina Reddy for their help with histology-stereology counts. Finally, we gratefully acknowl-edge again the exceptional technical assistance of Dr. Sreevidhya Ramakrishnan with EEG seizure detection algorithms and seizure veri-fication analysis.	Amrein I, 2011, EUR J NEUROSCI, V34, P978, DOI 10.1111/j.1460-9568.2011.07804.x; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Behr C, 2015, EPILEPSY RES, V115, P8, DOI 10.1016/j.eplepsyres.2015.05.006; Benar CG, 2010, CLIN NEUROPHYSIOL, V121, P301, DOI 10.1016/j.clinph.2009.10.019; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Clossen BL, 2017, BBA-MOL BASIS DIS, V1863, P1519, DOI 10.1016/j.bbadis.2017.02.003; Coan AC, 2009, NEUROLOGY, V73, P834, DOI 10.1212/WNL.0b013e3181b783dd; Danzer SC, 2019, EPILEPSY CURR, V19, P316, DOI 10.1177/1535759719868186; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Dieter JN, 2019, NEUROSCI INSIGHTS, V14, DOI 10.1177/1179069519892933; Dinocourt C, 2003, J COMP NEUROL, V459, P407, DOI 10.1002/cne.10622; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Ewell LA, 2019, ELIFE, V8, DOI 10.7554/eLife.42148; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Golub V.M., 2018, P SOC NEUR ANN C NOV; Golub V.M., 2016, P AM EP SOC ANN C DE; Golub V.M., 2020, P AM EP SOC ANN C DE; Golub V.M., 2019, P AM EP SOC ANN C DE; Golub V.M., 2017, P AM EP SOC ANN C DE; Golub V.M., 2017, P MIL HLTH SYST ANN; Golub V.M., 2022, PHARMACOL REV, V74; Golub V, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.04587; Golub VM, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00196, 10.3389/fnagi.2015.00196]; Gulyas AI, 2015, CURR OPIN NEUROBIOL, V31, P26, DOI 10.1016/j.conb.2014.07.020; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kappock TJ, 1996, CHEM REV, V96, P2659, DOI 10.1021/cr9402034; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Khurgel M, 1996, EPILEPSY RES, V26, P163, DOI 10.1016/S0920-1211(96)00051-4; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Konduru SS, 2021, EPILEPSIA OPEN, V6, P181, DOI 10.1002/epi4.12462; Kulkarni SK, 1996, METHOD FIND EXP CLIN, V18, P219; Kuruba R., 2016, AM EP SOC ANN M DEC; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lapinlampi N, 2020, EPILEPSIA, V61, P2035, DOI 10.1111/epi.16632; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Marion D W, 1999, Clin Neurosurg, V45, P184; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Ngwenya LB, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01014; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Okie S, 2016, NEW ENGL J MED, V375, P180, DOI 10.1056/NEJMms1604272; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pijet B, 2018, MOL NEUROBIOL, V55, P9294, DOI 10.1007/s12035-018-1061-5; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Reddy D.S, 2017, P MIL HLTH SYST ANN; Reddy Doodipala Samba, 2018, Curr Protoc Pharmacol, V81, pe41, DOI 10.1002/cpph.41; Reddy SD, 2015, J PHARMACOL EXP THER, V353, P517, DOI 10.1124/jpet.114.222075; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schaefer SY, 2012, CEREB CORTEX, V22, P1407, DOI 10.1093/cercor/bhr237; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; SCHEIBEL ME, 1974, EPILEPSIA, V15, P55, DOI 10.1111/j.1528-1157.1974.tb03997.x; Schonberger J, 2019, ANN CLIN TRANSL NEUR, DOI 10.1002/acn3.50941; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Shandra O, 2020, JOVE-J VIS EXP, DOI 10.3791/60360; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Singh T, 2020, EPILEPSIA, V61, P2811, DOI 10.1111/epi.16715; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Sun ZP, 2018, EPILEPSY BEHAV, V87, P188, DOI 10.1016/j.yebeh.2018.08.002; Szu JI, 2020, NEUROSCIENCE, V428, P140, DOI 10.1016/j.neuroscience.2019.12.006; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang X, 2016, BRAIN RES, V1646, P174, DOI 10.1016/j.brainres.2016.05.055; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; West S, 2016, EPILEPTIC DISORD, V18, P113, DOI 10.1684/epd.2016.0825; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WYLER AR, 1995, NEUROSURGERY, V37, P982, DOI 10.1227/00006123-199511000-00019; Xu SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01149; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhu BY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13170-w; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548	118	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2022	348								113946	10.1016/j.expneurol.2021.113946			28	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XX8UY	WOS:000736564400001	34896334	hybrid			2022-02-06	
J	Goodlin, GT; Steinbeck, L; Bergfeld, D; Haselhorst, A				Goodlin, Gabrielle T.; Steinbeck, Lindsey; Bergfeld, Deborah; Haselhorst, Alexandria			Adaptive Cycling	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Para-cycling; Paralympics; Injury; Sports-related concussion	BONE-MINERAL DENSITY; SPINAL-CORD-INJURY; SUMMER PARALYMPIC GAMES; ENERGY-EXPENDITURE; PROSPECTIVE COHORT; AUTONOMIC FUNCTION; CEREBRAL-PALSY; INTERNATIONAL STANDARDS; UNITED-STATES; RISK-FACTORS		[Goodlin, Gabrielle T.; Steinbeck, Lindsey; Bergfeld, Deborah; Haselhorst, Alexandria] Univ Texas Austin, Phys Med & Rehabil, Dept Neurol, Dell Med Sch, 1400 North IH 35,Suite 2-230, Austin, TX 78701 USA		Haselhorst, A (corresponding author), Univ Texas Austin, Phys Med & Rehabil, Dept Neurol, Dell Med Sch, 1400 North IH 35,Suite 2-230, Austin, TX 78701 USA.	ajhaselhorst@ascension.org					Armstrong EL, 2020, DEV MED CHILD NEUROL, V62, P1406, DOI 10.1111/dmcn.14648; Athanasopoulos S, 2009, OPEN SPORTS MED J, V3, P1, DOI [10.2174/1874387000903010001, DOI 10.2174/1874387000903010001]; Bhambhani Y, 2010, DISABIL REHABIL, V32, P2172, DOI 10.3109/09638288.2010.505678; Blauwet C, 2016, PM&R, V8, P798, DOI 10.1016/j.pmrj.2016.07.004; Blauwet CA, 2017, SPORTS MED, V47, P1697, DOI 10.1007/s40279-017-0696-0; Blauwet CA, 2013, BRIT J SPORT MED, V47, P832, DOI 10.1136/bjsports-2012-092103; Boyd C., 2021, SPORTS NUTR PARALYMP, P91; Bratland-Sanda S, 2013, EUR J SPORT SCI, V13, P499, DOI 10.1080/17461391.2012.740504; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Brook EM, 2019, SCAND J MED SCI SPOR, V29, P678, DOI 10.1111/sms.13385; Burke LM, 2010, J PEDIATR ADOL GYNEC, V23, P11, DOI 10.1016/j.jpag.2009.04.005; Childers WL, 2014, J BIOMECH, V47, P2306, DOI 10.1016/j.jbiomech.2014.04.037; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; de Bruin AP, 2017, CURR OPIN PSYCHOL, V16, P148, DOI 10.1016/j.copsyc.2017.05.009; Declerck L, 2019, CURR SPORT MED REP, V18, P458, DOI 10.1249/JSR.0000000000000662; Decock M, 2016, BRIT J SPORT MED, V50, P669, DOI 10.1136/bjsports-2015-095612; Derman W, 2016, BRIT J SPORT MED, V50, P1064, DOI 10.1136/bjsports-2016-096215; Derman W, 2018, BRIT J SPORT MED, V52, P24, DOI 10.1136/bjsports-2017-098039; Derman W, 2018, BRIT J SPORT MED, V52, P17, DOI 10.1136/bjsports-2017-097962; Derman W, 2014, PM&R, V6, pS23, DOI 10.1016/j.pmrj.2014.05.016; Derman W, 2013, BRIT J SPORT MED, V47, P420, DOI 10.1136/bjsports-2013-092375; Duffy CM, 2000, J PEDIATR ORTHOPED, V20, P356, DOI 10.1097/00004694-200005000-00016; Emond SD, 1999, ANN EMERG MED, V33, P56, DOI 10.1016/S0196-0644(99)70417-8; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; EVANS EP, 1981, Z KINDERCHIR, V34, P425; Fagher K, 2020, PM&R, V12, P271, DOI 10.1002/pmrj.12211; Frotzler A, 2015, SPINAL CORD, V53, P701, DOI 10.1038/sc.2015.74; Gerrish Heather R, 2017, Int J Exerc Sci, V10, P1018; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Goktepe AS, 2004, AM J PHYS MED REHAB, V83, P279, DOI 10.1097/01.PHM.0000118036.20170.6C; GONZALEZ EG, 1974, ARCH PHYS MED REHAB, V55, P111; Goosey-Tolfrey VL, 2010, ADAPT PHYS ACT Q, V27, P47, DOI 10.1123/apaq.27.1.47; Grams L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157931; Griggs Katy E, 2020, Temperature (Austin), V7, P37, DOI 10.1080/23328940.2019.1617030; Griggs KE, 2015, SPORTS MED, V45, P9, DOI 10.1007/s40279-014-0241-3; Grossberg R, 2015, DEV MED CHILD NEUROL, V57, P1064, DOI 10.1111/dmcn.12790; GRUNDILL WL, 1986, S AFR MED J, V70, P413; Hanief YN, 2020, ADV REHABIL, V34, P37; Hirschmuller A, 2021, AM J PHYS MED REHAB, V100, P173, DOI 10.1097/PHM.0000000000001501; Huang TS, 1996, METABOLISM, V45, P718, DOI 10.1016/S0026-0495(96)90137-7; Hunter AGW, 1996, AM J MED GENET, V62, P255, DOI 10.1002/(SICI)1096-8628(19960329)62:3<255::AID-AJMG10>3.0.CO;2-J; Jiang SD, 2006, OSTEOPOROSIS INT, V17, P180, DOI 10.1007/s00198-005-2028-8; Karrer Y, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000801; Katz-Leurer M, 2006, CLIN REHABIL, V20, P398, DOI 10.1191/0269215505cr960oa; Kim W, 2015, BONE, V71, P89, DOI 10.1016/j.bone.2014.10.003; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krassioukov A, 2014, PM&R, V6, pS58, DOI 10.1016/j.pmrj.2014.05.023; Krassioukov A, 2012, J SPINAL CORD MED, V35, P201, DOI 10.1179/1079026812Z.00000000053; Krempien JL, 2011, INT J SPORT NUTR EXE, V21, P417, DOI 10.1123/ijsnem.21.5.417; Kromer P, 2011, SPORTVERLETZ SPORTSC, V25, P167, DOI 10.1055/s-0031-1273308; Leet AI, 2006, J PEDIATR ORTHOPED, V26, P624, DOI 10.1097/01.bpo.0000235228.45539.c7; Ljungqvist A, 2009, CLIN J SPORT MED, V19, P347, DOI 10.1097/JSM.0b013e3181b7332c; Maltais D, 2004, MED SCI SPORT EXER, V36, P1674, DOI 10.1249/01.MSS.0000142312.43629.D8; Marreiros HF, 2012, J SPINAL CORD MED, V35, P9, DOI 10.1179/2045772311Y.0000000042; Martinelli V, 2015, CHILD NERV SYST, V31, P1361, DOI 10.1007/s00381-015-2726-2; Mazzeo F, 2015, FUNCT NEUROL, V30, P91; McKibben MJ, 2015, UROL CLIN N AM, V42, P527, DOI 10.1016/j.ucl.2015.05.006; Mergler S, 2009, DEV MED CHILD NEUROL, V51, P773, DOI 10.1111/j.1469-8749.2009.03384.x; Miyahara K, 2008, J BONE MINER METAB, V26, P101, DOI 10.1007/s00774-007-0789-1; Moran RN, 2020, J ATHL TRAINING, V55, P856, DOI 10.4085/1062-6050-294-19; Mountjoy M, 2018, INT J SPORT NUTR EXE, V28, P316, DOI 10.1123/ijsnem.2018-0136; Mountjoy M, 2015, BRIT J SPORT MED, V49, P1354, DOI 10.1136/bjsports-2015-094873; Patatoukas Dimitrios, 2011, Folia Med (Plovdiv), V53, P40; Pediatrics AAo, 2010, PREPARTICIPATION PHY; Presedo A, 2007, J PEDIATR ORTHOPED, V27, P147, DOI 10.1097/BPO.0b013e3180317403; Previnaire J. G., 2010, Annals of Physical and Rehabilitation Medicine, V53, P520, DOI 10.1016/j.rehab.2010.06.006; Price M, 2010, SPORTS MED, V40, P681, DOI 10.2165/11531960-000000000-00000; Price MJ, 2018, HAND CLINIC, V157, P799, DOI 10.1016/B978-0-444-64074-1.00050-1; Price MJ, 2003, MED SCI SPORT EXER, V35, P1100, DOI 10.1249/01.MSS.0000074655.76321.D7; Rimmer JH, 2008, JAMA-J AM MED ASSOC, V299, P1255; Ringenbach SDR, 2020, J DEV PHYS DISABIL, V32, P535, DOI 10.1007/s10882-019-09706-z; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Roi GS, 2014, ACCIDENT ANAL PREV, V73, P170, DOI 10.1016/j.aap.2014.08.010; Schwellnus M, 2013, BRIT J SPORT MED, V47, P433, DOI 10.1136/bjsports-2013-092371; Sherk V, 2008, J BONE MINER RES, V23, P1449, DOI 10.1359/JBMR.080402; Slade JM, 2004, EUR J APPL PHYSIOL, V92, P363, DOI 10.1007/s00421-004-1103-8; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Statuta SM, 2017, BRIT J SPORT MED, V51, P1570, DOI 10.1136/bjsports-2017-097700; Stephenson B, 2021, SCAND J MED SCI SPOR, V31, P4, DOI 10.1111/sms.13835; Stephenson B, 2020, INT J SPORT PHYSIOL, V15, P231, DOI 10.1123/ijspp.2019-0116; Szalay EA, 2011, CLIN ORTHOP RELAT R, V469, P1253, DOI 10.1007/s11999-010-1634-8; Szollar SM, 1998, AM J PHYS MED REHAB, V77, P28, DOI 10.1097/00002060-199801000-00005; Tanabe K, 2019, ARCH OSTEOPOROS, V14, DOI 10.1007/s11657-019-0627-9; Trbovich M, 2021, J SPINAL CORD MED, V44, P902, DOI 10.1080/10790268.2020.1751489; Vestergaard P, 1998, SPINAL CORD, V36, P790, DOI 10.1038/sj.sc.3100648; WEAVER DS, 1977, POSTGRAD MED, V62, P93, DOI 10.1080/00325481.1977.11714703; Webborn N, 2012, LANCET, V380, P65, DOI 10.1016/S0140-6736(12)60831-9; Weiler R, 2018, CLIN J SPORT MED, V28, P43, DOI 10.1097/JSM.0000000000000407; West CR, 2015, SCAND J MED SCI SPOR, V25, P476, DOI 10.1111/sms.12308; Willick SE, 2013, BRIT J SPORT MED, V47, P426, DOI 10.1136/bjsports-2013-092374; Woodlee MT, 2006, CURR DIR PSYCHOL SCI, V15, P203, DOI 10.1111/j.1467-8721.2006.00436.x; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	92	0	0	8	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	FEB	2022	33	1			SI		45	60		10.1016/j.pmr.2021.08.004			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XA6IE	WOS:000720747100006	34799002				2022-02-06	
J	Goss, AL; Creutzfeldt, CJ				Goss, Adeline L.; Creutzfeldt, Claire J.			Prognostication, Ethical Issues, and Palliative Care in Disorders of Consciousness	NEUROLOGIC CLINICS			English	Article						Consciousness; Palliative care; Ethics; Traumatic brain injury; Neurocritical care	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; VEGETATIVE STATE; DETECTING AWARENESS; RECOVERY; REHABILITATION; DISABILITY; MORTALITY; END; MULTICENTER		[Goss, Adeline L.] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA; [Creutzfeldt, Claire J.] Univ Washington, Dept Neurol, 325 Ninth Ave, Seattle, WA 98104 USA		Goss, AL (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.	adeline.goss@ucsf.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS099421-01A1]	Dr Creutzfeldt is funded through a NINDS career development award (K23 NS099421-01A1) .	Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Anderson WG, 2015, ANN AM THORAC SOC, V12, P142, DOI 10.1513/AnnalsATS.201407-325OC; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANNAS GJ, 1990, NEW ENGL J MED, V323, P670, DOI 10.1056/NEJM199009063231010; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Aubinet C, 2020, NEUROREHAB NEURAL RE, V34, P172, DOI 10.1177/1545968319899914; Aubinet C, 2018, HUM BRAIN MAPP, V39, P4519, DOI 10.1002/hbm.24303; Azabou E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2104-z; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bernat JL, 2020, ANN NEUROL, V87, P19, DOI 10.1002/ana.25636; Bernat JL, 2017, ANN NEUROL, V82, P863, DOI 10.1002/ana.25089; Bernat JL, 2009, ANN NY ACAD SCI, V1157, P117, DOI 10.1111/j.1749-6632.2008.04124.x; Bodien YG, 2020, NEUROREHABILITATION, V46, P65, DOI 10.3233/NRE-192860; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; de la Morena MJE, 2013, ACTA NEUROL SCAND, V127, P413, DOI 10.1111/ane.12061; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Farah MJ, 2008, NEUROETHICS-NETH, V1, P9, DOI 10.1007/s12152-008-9006-8; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Fins JJ, 2013, ARCH PHYS MED REHAB, V94, P1934, DOI 10.1016/j.apmr.2012.12.028; Formisano R, 2019, CAN J NEUROL SCI, V46, P607, DOI 10.1017/cjn.2019.227; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gipson J, 2014, NEUROETHICS-NETH, V7, P1, DOI 10.1007/s12152-012-9174-4; Gonzalez-Lara LE, 2021, BRAIN INJURY, V35, P200, DOI 10.1080/02699052.2020.1865565; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Graham M, 2015, AJOB NEUROSCIENCE, V6, P31, DOI DOI 10.1080/21507740.2015.1014072; Graham M, 2020, CAMB Q HEALTHC ETHIC, V29, P511, DOI 10.1017/S0963180120000286; Graham M, 2019, NEUROETHICS-NETH, V12, P153, DOI 10.1007/s12152-018-9361-z; Graham Mackenzie, 2018, AJOB Neurosci, V9, P128, DOI 10.1080/21507740.2018.1460415; Graham M, 2017, ETHICAL THEORY MORAL, V20, P1005, DOI 10.1007/s10677-017-9836-8; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Johnson LSM, 2013, CAN THEY SUFFER ETHI, V6, P8; Kahane G, 2009, J MED PHILOS, V34, P6, DOI 10.1093/jmp/jhn038; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Kowalski RG, 2021, JAMA NEUROL, V78, P548, DOI 10.1001/jamaneurol.2021.0084; Laureys S, 2005, NAT REV NEUROSCI, V6, P899, DOI 10.1038/nrn1789; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; LeClaire MM, 2005, CHEST, V128, P1728, DOI 10.1378/chest.128.3.1728; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Martens G, 2020, ANN PHYS REHABIL MED, V63, P263, DOI 10.1016/j.rehab.2019.10.004; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Peterson A, 2020, BIOETHICS, V34, P295, DOI 10.1111/bioe.12678; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Rubin EB, 2011, NEUROL CLIN, V29, P1055, DOI 10.1016/j.ncl.2011.07.007; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schwartz CE, 2006, QUAL LIFE RES, V15, P1533, DOI 10.1007/s11136-006-0025-9; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Simpkin AL, 2019, J GEN INTERN MED, V34, P2586, DOI 10.1007/s11606-019-04860-8; Smith LGF, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19652; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Sun YX, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1040-5; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Tran LN, 2016, NEUROCRIT CARE, V25, P266, DOI 10.1007/s12028-016-0283-5; TRESCH DD, 1991, J AM GERIATR SOC, V39, P17, DOI 10.1111/j.1532-5415.1991.tb05900.x; Tung J, 2020, QUAL LIFE RES, V29, P1217, DOI 10.1007/s11136-019-02390-8; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Erp WS, 2020, ANN NEUROL, V87, P12, DOI 10.1002/ana.25624; Wade DT, 2018, EUR J NEUROL, V25, P619, DOI 10.1111/ene.13572; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wittenberg E, 2015, TXB PALLIATIVE CARE; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zaksh Y, 2019, CLIN REHABIL, V33, P345, DOI 10.1177/0269215518802339; Zurasky JA, 2005, NEUROLOGY, V64, P725, DOI 10.1212/01.WNL.0000152045.56837.58	92	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2022	40	1			SI		59	75		10.1016/j.ncl.2021.08.005			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XA7ZD	WOS:000720859700006	34798975				2022-02-06	
J	Greve, M				Greve, Mark			Acute Cycling Injuries	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Sports injuries; Bicycling injuries; Traumatic brain injury; Sports medicine; Blunt chest trauma; Burn management; Wound management	HEAD-INJURY; CONCUSSION; MANAGEMENT		[Greve, Mark] Brown Univ, Warren Alpert Sch Med, Dept Emergency Med, Div Sports Med, 55 Claverick St,2nd Floor, Providence, RI 02903 USA		Greve, M (corresponding author), Brown Univ, Warren Alpert Sch Med, Dept Emergency Med, Div Sports Med, 55 Claverick St,2nd Floor, Providence, RI 02903 USA.	mark.greve@brownphysicians.org					Alarhayem AQ, 2019, J VASC SURG, V69, P1519, DOI 10.1016/j.jvs.2018.07.075; Alfrey EJ, 2021, J SURG RES, V257, P593, DOI 10.1016/j.jss.2020.08.009; Awad MA, 2018, J UROLOGY, V199, P798, DOI 10.1016/j.juro.2017.10.017; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Bergaminelli C, 2019, INT J SURG CASE REP, V61, P123, DOI 10.1016/j.ijscr.2019.07.043; Bjurlin MA, 2011, UROLOGY, V78, P1187, DOI 10.1016/j.urology.2011.07.1386; Elliott J, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000525; Gaines RJ, 2012, ORTHOPEDICS, V35, pE1276, DOI 10.3928/01477447-20120725-34; Gaither TW, 2018, J SEX MED, V15, P510, DOI 10.1016/j.jsxm.2018.02.004; Galvagno Samuel M Jr, 2019, Anesthesiol Clin, V37, P13, DOI 10.1016/j.anclin.2018.09.009; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Greve M, 2014, INT SPORTMED J, V15, P265; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Haeberle HS, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118793392; Heron N, 2020, BRIT J SPORT MED, V54, P127, DOI 10.1136/bjsports-2019-101455; Jackson WT, 2019, MED CLIN N AM, V103, P251, DOI 10.1016/j.mcna.2018.10.005; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; LeBlanc KE, 2014, AM FAM PHYSICIAN, V89, P945; Martinez John M, 2006, Curr Sports Med Rep, V5, P125; NOAKES TD, 1995, SPORTS MED, V20, P348, DOI 10.2165/00007256-199520050-00006; Porter Daniel, 2020, Clin Pract Cases Emerg Med, V4, P642, DOI 10.5811/cpcem.2020.7.48358; Quinn RH, 2006, WILD ENVIRON MED, V17, P41, DOI 10.1580/PR09-05.1; Reichman EF, 2013, EMERGENCY MED PROCED, P526; Ropars M, 2017, ORTHOP TRAUMATOL-SUR, V103, pS53, DOI 10.1016/j.otsr.2016.11.007; Sanchez Anthony R 2nd, 2005, Curr Sports Med Rep, V4, P50; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stigson H., 2019, C INT C BIOM INJ FLO; Tagliapietra J, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10100788; Wedmore I, 2015, EMERG MED CLIN N AM, V33, P363, DOI 10.1016/j.emc.2014.12.008; Winston FK, 1998, PEDIATRICS, V102, P596, DOI 10.1542/peds.102.3.596; Wood Stephen P, 2003, Prehosp Emerg Care, V7, P241, DOI 10.1080/10903120390936860; Yao KH, 2012, AUST FAM PHYSICIAN, V41, P223	32	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	FEB	2022	33	1			SI		135	158		10.1016/j.pmr.2021.08.010			24	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XA6IE	WOS:000720747100012	34798995				2022-02-06	
J	Gurney, JM; Staudt, AM; Del Junco, DJ; Shackelford, SA; Mann-Salinas, EA; Cap, AP; Spinella, PC; Martin, MJ				Gurney, Jennifer M.; Staudt, Amanda M.; Del Junco, Deborah J.; Shackelford, Stacy A.; Mann-Salinas, Elizabeth A.; Cap, Andrew P.; Spinella, Philip C.; Martin, Matthew J.			Whole blood at the tip of the spear: A retrospective cohort analysis of warm fresh whole blood resuscitation versus component therapy in severely injured combat casualties	SURGERY			English	Article							DAMAGE CONTROL RESUSCITATION; TRAUMATIC BRAIN-INJURY; TRANSFUSION; HEMORRHAGE; SURVIVAL; PLASMA; TIME; BIAS; ASSOCIATION; AFGHANISTAN	Background: Death from uncontrolled hemorrhage occurs rapidly, particularly among combat casualties. The US military has used warm fresh whole blood during combat operations owing to clinical and operational exigencies, but published outcomes data are limited. We compared early mortality between casualties who received warm fresh whole blood versus no warm fresh whole blood. Methods: Casualties injured in Afghanistan from 2008 to 2014 who received >2 red blood cell containing units were reviewed using records from the Joint Trauma System Role 2 Database. The primary outcome was 6-hour mortality. Patients who received red blood cells solely from component therapy were categorized as the non-warm fresh whole blood group. Non- warm fresh whole blood patients were frequency-matched to warm fresh whole blood patients on identical strata by injury type, patient affiliation, tourniquet use, prehospital transfusion, and average hourly unit red blood cell transfusion rates, creating clinically unique strata. Multilevel mixed effects logistic regression adjusted for the matching, immortal time bias, and other covariates. Results: The 1,105 study patients (221 warm fresh whole blood, 884 non-warm fresh whole blood) were classified into 29 unique clinical strata. The adjusted odds ratio of 6-hour mortality was 0.27 (95% confidence interval 0.13-0.58) for the warm fresh whole blood versus non-warm fresh whole blood group. The reduction in mortality increased in magnitude (odds ratio = 0.15, P = .024) among the subgroup of 422 patients with complete data allowing adjustment for seven additional covariates. There was a dose-dependent effect of warm fresh whole blood, with patients receiving higher warm fresh whole blood dose (>33% of red blood cell-containing units) having significantly lower mortality versus the non-warm fresh whole blood group. Conclusion: Warm fresh whole blood resuscitation was associated with a significant reduction in 6-hour mortality versus non-warm fresh whole blood in combat casualties, with a dose-dependent effect. These findings support warm fresh whole blood use for hemorrhage control as well as expanded study in military and civilian trauma settings. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).	[Gurney, Jennifer M.; Mann-Salinas, Elizabeth A.; Cap, Andrew P.] US Army Inst Surg Res, San Antonio, TX USA; [Gurney, Jennifer M.; Del Junco, Deborah J.; Shackelford, Stacy A.; Mann-Salinas, Elizabeth A.] Joint Trauma Syst, San Antonio, TX USA; [Gurney, Jennifer M.; Shackelford, Stacy A.; Cap, Andrew P.; Martin, Matthew J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Staudt, Amanda M.] Geneva Fdn, San Antonio, TX USA; [Spinella, Philip C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Martin, Matthew J.] Scripps Mercy Hosp, Dept Surg, San Diego, CA USA		Gurney, JM (corresponding author), JBSA Ft Sam, 3698 Chambers Pass, Houston, TX 78234 USA.	jennifer.m.gurney.mil@mail.mil			Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program [W81XWH-15-2-0 085]	This work was partially supported by the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program under Award No. W81XWH-15-2-0 085. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Armed Services Blood Program, 2016, ADV US WHOL BLOOD CO; Bernard AC, 2011, J TRAUMA, V70, pS34, DOI 10.1097/TA.0b013e31821a586e; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; del Junco DJ, 2015, INJURY, V46, P775, DOI 10.1016/j.injury.2015.01.043; del Junco DJ, 2013, J TRAUMA ACUTE CARE, V75, pS97, DOI 10.1097/TA.0b013e318298b0a4; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Fox EE, 2017, SHOCK, V47, P567, DOI 10.1097/SHK.0000000000000788; Freedman J, 2014, TRANSFUS APHER SCI, V50, P5, DOI 10.1016/j.transci.2013.12.003; Gurney J, 2020, TRANSFUSION, V60, pS180, DOI 10.1111/trf.15767; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Hess JR, 2003, TRANSFUSION, V43, P1622, DOI 10.1046/j.1537-2995.2003.00576.x; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2021, ANN SURG, V273, P395, DOI 10.1097/SLA.0000000000004563; Holcomb JB, 2018, TRANSFUSION, V58, P1821, DOI 10.1111/trf.14818; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Howard JT, 2018, J TRAUMA ACUTE CARE, V84, P11, DOI 10.1097/TA.0000000000001727; JTS, 2012, JOINT THEAT TRAUM SY; Kahlert J, 2017, CLIN EPIDEMIOL, V9, P195, DOI 10.2147/CLEP.S129886; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; Mann-Salinas EA, 2016, J TRAUMA ACUTE CARE, V81, pS121, DOI 10.1097/TA.0000000000001092; McGinity AC, 2018, J TRAUMA ACUTE CARE, V84, pS115, DOI 10.1097/TA.0000000000001905; Moore HB, 2018, LANCET, V392, P283, DOI 10.1016/S0140-6736(18)31553-8; NAS, NAT TRAUM CAR SYST I; Neal MD, 2012, J TRAUMA ACUTE CARE, V72, P892, DOI 10.1097/TA.0b013e31823d84a7; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Nuttall GA, 2008, ANESTHESIOLOGY, V108, P3, DOI 10.1097/01.anes.0000296718.35703.20; Palm K, 2012, J TRAUMA ACUTE CARE, V73, pS459, DOI 10.1097/TA.0b013e3182754887; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Seheult JN, 2018, TRANSFUSION, V58, P1838, DOI 10.1111/trf.14779; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Sharpe JP, 2012, J TRAUMA ACUTE CARE, V73, P1553, DOI 10.1097/TA.0b013e3182660119; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Spinella PC, 2016, CURR OPIN HEMATOL, V23, P536, DOI 10.1097/MOH.0000000000000284; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Starr D., 2012, BLOOD EPIC HIST MED; Stolla M, 2019, TRANSFUSION, V59, P1522, DOI 10.1111/trf.15169; Tchetgen EJT, 2015, EPIDEMIOLOGY, V26, P473, DOI 10.1097/EDE.0000000000000317; Vanderspurt CK, 2019, TRANSFUSION, V59, P965, DOI 10.1111/trf.15086	44	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2022	171	2					518	525		10.1016/j.surg.2021.05.051			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YO4BF	WOS:000747886000032	34253322	hybrid			2022-02-06	
J	Hannah, TC; Jumreornvong, O; Marayati, NF; Spiera, Z; Ali, M; Li, AY; Durbin, JR; Dreher, N; Gometz, A; Lovell, M; Choudhri, T				Hannah, Theodore C.; Jumreornvong, Oranicha; Marayati, Naoum F.; Spiera, Zachary; Ali, Muhammad; Li, Adam Y.; Durbin, John R.; Dreher, Nick; Gometz, Alex; Lovell, Mark; Choudhri, Tanvir			A Multivariable Analysis to Evaluate the Presence or Absence of Gender Differences in Baseline ImPACT Composite Scores and Symptom Severity Ratings in Student-Athletes Ages 12-18 Years	PEDIATRIC EXERCISE SCIENCE			English	Article						adolescent athletes; baseline neurocognition; sports-related concussion	SEX-DIFFERENCES; NEUROPSYCHOLOGICAL FUNCTION; NEUROCOGNITIVE PERFORMANCE; CONCUSSION SYMPTOMS; RESPONSE-INHIBITION; SOCCER PLAYERS; REACTION-TIME; HIGH-SCHOOL; HISTORY; IMPULSIVITY	Introduction: Gender differences in neurocognitive function have been reported over the past few decades. However, multiple studies that report gender differences in Immediate Post-Concussion Assessment and Cognitive Tests composite scores ignore potential confounders which may lead to inaccurate results. Methods: A total of 4829 male and 2477 female baseline Immediate PostConcussion Assessment and Cognitive Tests from 2009 to 2019 of subjects ages 12-18 years were used to evaluate gender differences in baseline neurocognitive scores and symptom severity ratings. Regression analyses were used to assess the effects of gender on neurocognitive performance at baseline while controlling for a number of potential confounders including symptom burden at the time of testing. Results: Differences in 3 of 5 composite scores as well as severity rating scores were maintained in multivariate analysis. Females had increased Post-Concussion Symptom Scale (beta = 3.54, 95% confidence interval, 2.91 to 4.16, P < .0001) along with higher verbal memory (beta = 1.82, 95% confidence interval, 1.15 to 2.50, P < .0001) and visual motor (beta = 1.29, 95% confidence interval, 0.85-1.72, P < .0001) scores. Conclusions: Statistically significant gender differences were found in baseline neurocognitive function. This study clarifies for the first time that gender differences in these neurocognitive domains are not simply an artifact of differences in symptom burden. However, the small effect sizes call into question the clinical relevance of these differences.	[Hannah, Theodore C.; Jumreornvong, Oranicha; Marayati, Naoum F.; Spiera, Zachary; Ali, Muhammad; Li, Adam Y.; Durbin, John R.; Dreher, Nick; Choudhri, Tanvir] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Gometz, Alex] Concuss Management New York, Phys Med & Rehabil, New York, NY USA; [Lovell, Mark] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA		Hannah, TC (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA.	theodore.hannah@icahn.mssm.edu		Hannah, Theodore/0000-0001-6527-9725			Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; BLEECKER ML, 1988, J CLIN PSYCHOL, V44, P403, DOI 10.1002/1097-4679(198805)44:3<403::AID-JCLP2270440315>3.0.CO;2-0; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Burris K, 2020, J SPORT SCI, V38, P320, DOI 10.1080/02640414.2019.1698090; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Crosbie J, 2013, J ABNORM CHILD PSYCH, V41, P497, DOI 10.1007/s10802-012-9693-9; Fernie G, 2010, DRUG ALCOHOL DEPEN, V112, P54, DOI 10.1016/j.drugalcdep.2010.05.011; French J, 2019, AM J SPORT MED, V47, P3263, DOI 10.1177/0363546519875137; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kimura D, 2002, PSYCHOL REP, V91, P1137, DOI 10.2466/PR0.91.7.1137-1142; KIMURA D, 1984, PROG BRAIN RES, V61, P423; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; LEWIS RS, 1987, BRAIN COGNITION, V6, P142, DOI 10.1016/0278-2626(87)90115-1; Liu TR, 2013, NEUROREPORT, V24, P126, DOI 10.1097/WNR.0b013e32835d846b; Liutsko L, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10010036; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Morgan JE, 2011, PERS INDIV DIFFER, V51, P429, DOI 10.1016/j.paid.2011.03.043; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Murray SO, 2018, CURR BIOL, V28, P2794, DOI 10.1016/j.cub.2018.06.014; Ragland JD, 2000, NEUROPSYCHOLOGIA, V38, P451, DOI 10.1016/S0028-3932(99)00086-X; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Saunders B, 2008, ALCOHOL CLIN EXP RES, V32, P888, DOI 10.1111/j.1530-0277.2008.00648.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Weafer J, 2014, ADDICT BEHAV, V39, P1573, DOI 10.1016/j.addbeh.2013.10.033; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	35	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0899-8493	1543-2920		PEDIATR EXERC SCI	Pediatr. Exerc. Sci.	FEB	2022	34	1					36	43		10.1123/pes.2021-0010			8	Pediatrics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Physiology; Sport Sciences	YN1LI	WOS:000747026500006	34517341				2022-02-06	
J	Hu, Y; Feng, XY; Chen, JH; Wu, Y; Shen, LY				Hu, Yun; Feng, Xiaoyan; Chen, Junhui; Wu, Yan; Shen, Liuyan			Hydrogen-rich saline alleviates early brain injury through inhibition of necroptosis and neuroinflammation via the ROS/HO-1 signaling pathway after traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						hydrogen-rich saline; traumatic brain injury; early brain injury; necroptosis; neuroinflammation	OXIDATIVE STRESS; MICE; ERYTHROPOIETIN; DYSFUNCTION; HEMORRHAGE; INHALATION	Traumatic brain injury (TBI) has been recognized as a serious public health issue and a key contributor to disability and death, with a huge economic burden worldwide. Hydrogen, which is a slight and specific cytotoxic oxygen radical scavenger, has been demonstrated to ameliorate early brain injury (EBI) through reactive oxygen species (ROS), oxidative stress injury, apoptosis and necroptosis. Necroptosis refers to a type of programmed cell death process that has a vital function in neuronal cell death following TBI. The specific function of necroptosis in hydrogen-mediated neuroprotection after TBI, however, has yet to be determined. The present study aimed to examine the neuroprotective effects and possible molecular basis that underly hydrogen-rich saline in TBI-stimulated EBI by examining neural necroptosis in the C57BL/6 mouse model. The brain water content, neurological score, neuroinflammatory cytokines (NF-kappa Beta, TNF-alpha, IL-6 and IL-1 beta) and ROS were evaluated using flow cytometry. Malondialdehyde, superoxide dismutase (SOD) and glutathione (GSH) levels were evaluated using a biochemical kit. Receptor-interacting protein kinase (RIP)1, RIP3, Nrf2 and Heme oxygenase-1 (HO-1) were evaluated using western blotting. mRNA of Nrf2 and HO-1 were evaluated using quantitative PCR. Neuronal death was evaluated by TUNEL staining. The outcomes illustrated that hydrogen-rich saline treatment considerably enhanced the neurological score, increased neuronal survival, decreased the levels of serum MDA and brain ROS, increased the levels of serum GSH and SOD. In addition the protein expression levels of RIP1 and RIP3 and the cytokines NF-kappa B, TNF-alpha, IL-1 beta and IL-6 were downregulated compared with the TBI group, which demonstrated that hydrogen-rich saline-induced inhibition of necroptosis and neuroinflammation ameliorated neuronal death following TBI. The neuroprotective capacity of hydrogen-rich saline was demonstrated to be partly dependent on the ROS/heme oxygenase-1 signaling pathway. Taken together, the findings of the present study indicated that hydrogen-rich saline enhanced neurological outcomes in mice and minimized neuronal death by inducing protective effects against neural necroptosis as well as neuroinflammation.	[Hu, Yun; Feng, Xiaoyan; Chen, Junhui; Wu, Yan; Shen, Liuyan] Anhui Med Univ, Dept Neurosurg, Wuxi Clin Coll, Hosp 904,Joint Logist Support Force PLA, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China		Chen, JH (corresponding author), Anhui Med Univ, Dept Neurosurg, Wuxi Clin Coll, Hosp 904,Joint Logist Support Force PLA, 101 Xing Yuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	chenjunhui101@163.com					Afonso MB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.280; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Chen HG, 2015, INT IMMUNOPHARMACOL, V28, P643, DOI 10.1016/j.intimp.2015.07.034; Chen JH, 2020, NEURAL REGEN RES, V15, P1947, DOI 10.4103/1673-5374.280326; Chen JH, 2018, WORLD NEUROSURG, V113, pE690, DOI 10.1016/j.wneu.2018.02.122; Chen JH, 2021, J CELL PHYSIOL, V236, P6920, DOI 10.1002/jcp.30351; Chen JH, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00110; Chen JH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00107; Chen JH, 2019, J CELL MOL MED, V23, P2256, DOI 10.1111/jcmm.14105; Chen T, 2021, CNS NEUROL DISORD-DR, V20, P266, DOI 10.2174/1871527319666201001110937; Chen T, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2198-5; Choi KS, 2018, BRAIN RES BULL, V142, P122, DOI 10.1016/j.brainresbull.2018.07.006; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Das S, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.166050; Dohi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108034; Dong XH, 2019, AM J TRANSL RES, V11, P499; Fei WJ, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12464; Feng XY, 2021, MOL MED REP, V24, DOI 10.3892/mmr.2021.12300; Feng YQ, 2013, CURR EYE RES, V38, P396, DOI 10.3109/02713683.2012.748919; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hollingshead JRF, 2016, POSTGRAD MED J, V92, P4, DOI 10.1136/postgradmedj-2015-133328; Huang GR, 2021, CRIT REV EUKAR GENE, V31, DOI 10.1615/CritRevEukaryotGeneExpr.2021037390; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jia RH, 2019, CELL MOL NEUROBIOL, V39, P857, DOI 10.1007/s10571-019-00685-5; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kaiser S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100496; Kumagai K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69028-5; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Li FY, 2019, ANN CLIN TRANSL NEUR, V6, P1825, DOI 10.1002/acn3.50878; Li HC, 2020, AGING-US, V12, P21687, DOI 10.18632/aging.103975; Li YC, 2021, CELL MOL NEUROBIOL, V41, P263, DOI 10.1007/s10571-020-00850-1; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu C, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.13108; Liu LL, 2014, BRAIN RES, V1589, P78, DOI 10.1016/j.brainres.2014.09.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; National Research Counci, 2011, GUIDE CARE USE LAB A, V8, DOI 10.17226/12910; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Ning K, 2018, MED GAS RES, V8, P154, DOI 10.4103/2045-9912.248266; Ohno K, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/353152; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Shen HT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.58; Takeuchi S, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0176-1; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Tian J, 2020, NEUROCHEM RES, V45, P2926, DOI 10.1007/s11064-020-03141-9; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang MM, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111305; Wang PP, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6978784; Wang YF, 2020, NEUROL RES, V42, P487, DOI 10.1080/01616412.2020.1747717; Wang Y, 2020, INT J NEUROSCI, V130, P621, DOI 10.1080/00207454.2019.1702535; Wehn AC, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01236-0; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu YJ, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.696362; Yang TY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00790; Yu Y, 2019, INT IMMUNOPHARMACOL, V69, P11, DOI 10.1016/j.intimp.2019.01.022; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zhang Y, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02770-w; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Zou R, 2019, SHOCK, V52, P134, DOI 10.1097/SHK.0000000000001194	62	0	0	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	FEB	2022	23	2							126	10.3892/etm.2021.11049			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XX0LG	WOS:000735998300001	34970349	Green Published, gold			2022-02-06	
J	Jang, KB; You, MJ; Yang, B; Rim, C; Kim, HJ; Kwon, MS				Jang, Kyu-Beom; You, Min-Jung; Yang, Bohyun; Rim, Chan; Kim, Hui-Ju; Kwon, Min-Soo			Persistent Acidic Environment Induces Impaired Phagocytosis via ERK in Microglia	NEUROCHEMICAL RESEARCH			English	Article; Early Access						Microglia; Acidic environment; Cytokine; Phagocytosis; ERK; Neurological disorders	EXTRACELLULAR ACIDIFICATION; PH; TDAG8; FRACTALKINE; INHIBITION; ACIDOSIS; DISEASE; BRAIN	Acidic environment evoked by stroke, traumatic brain injury, and Alzheimer's disease may change the functional properties of microglia. Nevertheless, the underlying mechanisms of functional changes in microglia remain unclear. In this study, we found that acidic stimuli (pH 6.8) increased rapidly interleukin (IL)-1 beta and IL-6 mRNA levels and subsequently reduced IL-10, transforming growth factor (TGF)-beta 1, Cx3cr1, and P2ry12 as the exposure time to acidic environment increase in BV2 cells. In addition, persistent acidic environment (pH 6.8 for 6 h) induced impaired phagocytic function in BV2 cells. Short-term acidic exposure (pH 6.8 for 30 min) increased cyclic AMP (cAMP) and phospho-protein kinase A (PKA) but inhibited phospho-extracellular signal-regulated kinase (p-ERK). However, under persistent acidic environment (pH 6.8 for 6 h), cyclic AMP and PKA were normalized and p-ERK was increased with TDAG8 (T cell death associated gene 8; GPR65) reduction. FR 180,204, an ERK inhibitor, rescued the persistent acidic environment-induced functional changes in BV2 cells and its effect was recapitulated in primary neonatal microglia. Thus, we propose that ERK targeting may be an alternative strategy to restore microglial dysfunction in the central nervous system (CNS) acidic environment in various neurological disorders.	[Jang, Kyu-Beom; You, Min-Jung; Yang, Bohyun; Rim, Chan; Kim, Hui-Ju; Kwon, Min-Soo] CHA Univ, Dept Pharmacol, Res Inst Basic Med Sci, Sch Med, Cha Bio Complex,335 Pangyo, Gyeonggi Do 13488, Seongnam Si, South Korea		Kwon, MS (corresponding author), CHA Univ, Dept Pharmacol, Res Inst Basic Med Sci, Sch Med, Cha Bio Complex,335 Pangyo, Gyeonggi Do 13488, Seongnam Si, South Korea.	minsoo100@cha.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MIST) [2019M3C7A1032561, 2021M3E5D9025027]	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MIST) (2019M3C7A1032561 and 2021M3E5D9025027).	Baik SH, 2019, CELL METAB, V30, P493, DOI 10.1016/j.cmet.2019.06.005; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen B, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.81; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; de Ceglia R, 2015, BRAIN BEHAV IMMUN, V45, P263, DOI 10.1016/j.bbi.2014.12.003; Decker Y, 2021, NEUROBIOL AGING, V101, P40, DOI 10.1016/j.neurobiolaging.2020.12.007; Deczkowska A, 2018, NAT NEUROSCI, V21, P779, DOI 10.1038/s41593-018-0145-x; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Diaz FE, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1218297; Fang BY, 2010, INT J NEUROSCI, V120, P591, DOI 10.3109/00207454.2010.505353; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Galloway DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00790; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jin Y, 2014, J NEUROCHEM, V129, P683, DOI 10.1111/jnc.12661; Langfelder A, 2015, CELL CALCIUM, V57, P247, DOI 10.1016/j.ceca.2015.01.004; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Luo LX, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104925; Masuda T, 2020, CELL REP, V30, P1271, DOI 10.1016/j.celrep.2020.01.010; Menyhart A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01284-4; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Michl J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0393-7; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Napoli I, 2009, GLIA, V57, P1660, DOI 10.1002/glia.20878; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Re DB, 2006, NAT NEUROSCI, V9, P859; Recasens M, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02063-1; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Ritzel RM, 2021, GLIA, V69, P746, DOI 10.1002/glia.23926; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; Sinning A, 2013, FEBS LETT, V587, P1923, DOI 10.1016/j.febslet.2013.04.045; Tan YL, 2020, MOL PSYCHIATR, V25, P351, DOI 10.1038/s41380-019-0609-8; Thews O, 2019, CANCER METAST REV, V38, P113, DOI 10.1007/s10555-018-09777-y; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; You MJ, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02351-4	42	0	0	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.												10.1007/s11064-022-03533-z		FEB 2022	13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	YQ6UV	WOS:000749443400001	35103911				2022-02-06	
J	Jha, KA; Rasiah, PK; Gentry, J; Del Mar, NA; Kumar, R; Adebiyi, A; Reiner, A; Gangaraju, R				Jha, Kumar Abhiram; Rasiah, Pratheepa Kumari; Gentry, Jordy; Del Mar, Nobel A.; Kumar, Ravi; Adebiyi, Adebowale; Reiner, Anton; Gangaraju, Rajashekhar			Mesenchymal stem cell secretome protects against oxidative stress-induced ocular blast visual pathologies	EXPERIMENTAL EYE RESEARCH			English	Article						Explosive blast; Neurodegeneration; Muller; Inflammation; Retina; Confocal; Catalase	TRAUMATIC BRAIN-INJURY; MOUSE MODEL; CATALASE; OVERPRESSURE; DAMAGE; PREVENTION; MECHANISM; ANTERIOR; GLOBE	Visual deficits are a common concern among subjects with head trauma. Stem cell therapies have gained recent attention in treating visual deficits following head trauma. Previously, we have shown that adipose-derived stem cell (ASC) concentrated conditioned medium (ASC-CCM), when delivered via an intravitreal route, yielded a significant improvement in vision accompanied by a decrease in retinal neuroinflammation in a focal cranial blast model that indirectly injures the retina. The purpose of the current study is to extend our previous studies to a direct ocular blast injury model to further establish the preclinical efficacy of ASC-CCM. Adult C57BL/6J mice were subjected to repetitive ocular blast injury (rOBI) of 25 psi to the left eye, followed by intravitreal delivery of ASC-CCM (similar to 200 ng protein/2 mu l) or saline within 2-3 h. Visual function and histological changes were measured 4 weeks after injury and treatment. In vitro, Muller cells were used to evaluate the antioxidant effect of ASC-CCM. Visual acuity, contrast sensitivity, and b-wave amplitudes in rOBI mice receiving saline were significantly decreased compared with age-matched sham blast mice. Immunohistological analyses demonstrated a significant increase in glial fibrillary acidic protein (a retinal injury marker) in Muller cell processes, DNA/RNA damage, and nitrotyrosine (indicative of oxidative stress) in the retina, while qPCR analysis revealed a >2-fold increase in proinflammatory cytokines (TNF-alpha, ICAM1, and Ccl2) in the retina, as well as markers for microglia/macrophage activation (IL-1 beta and CD86). Remarkably, rOBI mice that received ASC-CCM demonstrated a significant improvement in visual function compared to saline-treated rOBI mice, with visual acuity, contrast sensitivity, and b-wave amplitudes that were not different from those in sham mice. This improvement in visual function also was associated with a significant reduction in retinal GFAP, neuroinflammation markers, and oxidative stress compared to saline-treated rOBI mice. In vitro, Muller cells exposed to oxidative stress via increasing doses of hydrogen peroxide demonstrated decreased viability, increased GFAP mRNA expression, and reduced activity for the antioxidant catalase. On the other hand, oxidatively stressed Muller cells pre-incubated with ASC-CCM showed normalized GFAP, viability, and catalase activity. In conclusion, our study demonstrates that a single intravitreal injection of ASC-CCM in the rOBI can significantly rescue retinal injury and provide significant restoration of visual function. Our in vitro studies suggest that the antioxidant catalase may play a major role in the protective effects of ASC-CCM, uncovering yet another aspect of the multifaceted benefits of ASC secretome therapies in neurotrauma.	[Jha, Kumar Abhiram; Rasiah, Pratheepa Kumari; Gentry, Jordy] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, 930 Madison Ave,Suite 769, Memphis, TN 38163 USA; [Del Mar, Nobel A.] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 317 Wittenborg Bldg,875 Monroe Ave, Memphis, TN 38163 USA; [Kumar, Ravi; Adebiyi, Adebowale] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 956 Court Ave,Coleman Bldg,Suite C211, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 522 Wittenborg Bldg,875 Monroe Ave, Memphis, TN 38163 USA; [Gangaraju, Rajashekhar] Univ Tennessee, Dept Ophthalmol Anat & Neurobiol, Neurosci Inst, Hlth Sci Ctr, 930 Madison Ave,Suite 768, Memphis, TN 38163 USA; [Jha, Kumar Abhiram] GIOSTAR Res Inc Pvt Ltd, Mohali, Punjab, India		Gangaraju, R (corresponding author), Univ Tennessee, Dept Ophthalmol Anat & Neurobiol, Neurosci Inst, Hlth Sci Ctr, 930 Madison Ave,Suite 768, Memphis, TN 38163 USA.	jha82a@gmail.com; prasiah@uthsc.edu; jgentr21@uthsc.edu; ndelmar@uthsc.edu; fravikum@uthsc.edu; aadebiyi@uthsc.edu; areiner@uthsc.edu; sgangara@uthsc.edu		Adebiyi, Adebowale/0000-0002-7033-1871	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0778, W81XWH-16-1-0076]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY023427]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Neuroscience Institute, UTHSC	This study was funded by grants from the Department of Defense (W81XWH-16-1-0778), National Eye Institute (EY023427), and unrestricted funds from Research to Prevent Blindness to RG and Department of Defense (W81XWH-16-1-0076) to AR. KAJ and PR are the recipients of a postdoc fellowship award from the Neuroscience Institute, UTHSC. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Abouhish H, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070599; Allen RS, 2018, J NEUROTRAUM, V35, P2104, DOI 10.1089/neu.2017.5394; Alvarez-Barrios A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010089; ATALLA L, 1987, CURR EYE RES, V6, P1181, DOI 10.3109/02713688709025227; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Bodart-Santos V, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1432-5; Bricker-Anthony C, 2016, J OCUL PHARMACOL TH, V32, P286, DOI 10.1089/jop.2015.0104; Carley SD, 1997, J ACCID EMERG MED, V14, P76; Chen BH, 2011, EXP EYE RES, V93, P599, DOI 10.1016/j.exer.2011.07.007; Chen Y, 2009, OCUL SURF, V7, P176, DOI 10.1016/S1542-0124(12)70185-4; Court AC, 2020, EMBO REP, V21, DOI 10.15252/embr.201948052; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Das M, 2019, REV NEUROSCIENCE, V30, P305, DOI 10.1515/revneuro-2018-0015; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Giordano CR, 2015, INVEST OPHTH VIS SCI, V56, P3095, DOI 10.1167/iovs.14-16194; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P4159, DOI 10.1167/iovs.19-27565; He JL, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.641157; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoch E, 2019, P FIND EXP REC 7 DEP; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Jezierska-Wozniak K, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030683; Jha KA, 2021, J NEUROTRAUM, V38, P1702, DOI 10.1089/neu.2020.7309; Jha KA, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1436-1; Jha KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072016; Jiang H, 2019, J OPHTHALMOL, V2019, DOI 10.1155/2019/1360805; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kim SY, 2021, EXP EYE RES, V203, DOI 10.1016/j.exer.2020.108391; Liangsupree T, 2021, J CHROMATOGR A, V1636, DOI 10.1016/j.chroma.2020.461773; Liu YY, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01448-3; Lorente L, 2020, NEUROCRIT CARE, V32, P790, DOI 10.1007/s12028-019-00800-w; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; McMaster D, 2021, EYE, V35, P3451, DOI 10.1038/s41433-020-01359-z; Mehhase J, 2006, BBA-MOL CELL RES, V1763, P854, DOI 10.1016/j.bbamcr.2006.04.012; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naguib S, 2021, REDOX BIOL, V42, DOI 10.1016/j.redox.2021.101883; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nunomura A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/200682323; Odhiambo WA, 2002, INT J ORAL MAX SURG, V31, P374, DOI 10.1054/ijom.2001.0199; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Potter DR, 2018, J TRAUMA ACUTE CARE, V84, P245, DOI 10.1097/TA.0000000000001744; Prevention C. f.D.C.a, 2001, MMWR MORB MORTAL WKL, V51, P1; Rasiah Pratheepa Kumari, 1800, Histol Histopathol, V36, P711, DOI 10.14670/HH-18-315; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; SCOTT MD, 1993, BIOCHIM BIOPHYS ACTA, V1181, P163, DOI 10.1016/0925-4439(93)90106-B; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Shimouchi A, 2016, JPN J OPHTHALMOL, V60, P51, DOI 10.1007/s10384-015-0415-z; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Smith DH, 2021, J NEUROTRAUM, V38, P3204, DOI 10.1089/neu.2021.0094; Vasquez-Vivar J, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101407; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yonekawa Y, 2014, OPHTHALMOLOGY, V121, P1670, DOI 10.1016/j.ophtha.2014.04.004	60	0	0	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	FEB	2022	215								108930	10.1016/j.exer.2022.108930			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	YL8ZM	WOS:000746175600004	35016886				2022-02-06	
J	Josef, AP; Garcia, NM				Josef, Abigail P.; Garcia, Nicole M.			Systemic Anticoagulation and Reversal	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Anticoagulant reversal; Warfarin; Heparin; Direct-acting oral anticoagulants; Prothrombin complex concentrate	TRAUMATIC BRAIN-INJURY; ORAL ANTICOAGULANTS; INTRACRANIAL HEMORRHAGE; FROZEN PLASMA; DABIGATRAN; GUIDANCE; HEPARIN; AGENTS		[Josef, Abigail P.; Garcia, Nicole M.] East Carolina Univ, Brody Sch Med, Dept Surg, Trauma Surg Crit Care Acute Care Surg, 600 Moye Blvd, Greenville, NC 27858 USA		Garcia, NM (corresponding author), East Carolina Univ, Brody Sch Med, Dept Surg, Trauma Surg Crit Care Acute Care Surg, 600 Moye Blvd, Greenville, NC 27858 USA.	Garcian16@ecu.edu					Baskaran J, PROTHROMBIN COMPLEX, P2021; Boer C, 2018, BRIT J ANAESTH, V120, P914, DOI 10.1016/j.bja.2018.01.023; Bower MM, 2019, STROKE, V50, P529, DOI 10.1161/STROKEAHA.118.023840; Burnett AE, 2016, J THROMB THROMBOLYS, V41, P206, DOI 10.1007/s11239-015-1310-7; Caldeira D, 2015, J NEUROL, V262, P516, DOI 10.1007/s00415-014-7462-0; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Chenoweth JA, 2017, WEST J EMERG MED, V18, P794, DOI 10.5811/westjem.2017.5.33092; Cheung ZB, 2021, ARCH ORTHOP TRAUM SU, DOI 10.1007/s00402-020-03701-2; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Cuker A, 2019, AM J HEMATOL, V94, P697, DOI 10.1002/ajh.25475; Dhakal P, 2017, CLIN APPL THROMB-HEM, V23, P410, DOI 10.1177/1076029616675970; Faine BA, 2018, AM J HEALTH-SYST PH, V75, P72, DOI 10.2146/ajhp160520; Fakhry SM, 2021, J TRAUMA ACUTE CARE, V90, P215, DOI 10.1097/TA.0000000000002985; Franchini M, 2010, BLOOD TRANSFUS-ITALY, V8, P149, DOI [10.2450/2010.0149-09, 10.2450/2010-0149-09]; Galanaud JP, 2013, J THROMB HAEMOST, V11, P402, DOI 10.1111/jth.12127; Ganetsky M, 2011, J MED TOXICOL, V7, P281, DOI 10.1007/s13181-011-0178-y; Giangrande PLF, 2002, INT J CLIN PRACT, V56, P615; Gosselin RC, 2019, INT J LAB HEMATOL, V41, P33, DOI 10.1111/ijlh.12992; Greinacher A, 2015, THROMB HAEMOSTASIS, V113, P931, DOI 10.1160/TH14-11-0982; Hariharan S, 2012, J CLIN PHARMACOL, V52, p119S, DOI 10.1177/0091270011415527; Hasan SS, 2020, J THROMB THROMBOLYS, V50, P814, DOI 10.1007/s11239-020-02235-z; Hickey M, 2013, CIRCULATION, V128, P360, DOI 10.1161/CIRCULATIONAHA.113.001875; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Kopytek M, 2020, J PHYSIOL PHARMACOL, V71, P47, DOI 10.26402/jpp.2020.1.03; Kuramatsu JB, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2492-8; McBane RD, 2020, MAYO CLIN PROC, V95, P2467, DOI 10.1016/j.mayocp.2020.08.030; McKeage K, 2001, DRUGS, V61, P515, DOI 10.2165/00003495-200161040-00005; Milling TJ, 2020, AM J EMERG MED, V38, P1890, DOI 10.1016/j.ajem.2020.05.086; Milling TJ, 2020, TRENDS CARDIOVAS MED, V30, P86, DOI 10.1016/j.tcm.2019.03.004; Moia M, 2019, INTERN EMERG MED, V14, P1233, DOI 10.1007/s11739-019-02177-2; Mujer Mark Terence P, 2020, Adv Hematol, V2020, P7636104, DOI 10.1155/2020/7636104; Nederpelt CJ, 2020, J TRAUMA ACUTE CARE, V88, P186, DOI 10.1097/TA.0000000000002518; Owens RE, 2017, CLIN CARDIOL, V40, P407, DOI 10.1002/clc.22659; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Pollack CV, 2017, NEW ENGL J MED, V377, P431, DOI 10.1056/NEJMoa1707278; Rawal A, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.07.101; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Seyve L, IMPACT 4 DIRECT ORAL; Simon EM, 2018, EMERG MED CLIN N AM, V36, P585, DOI 10.1016/j.emc.2018.04.014; Strein M, 2020, CURR OPIN CRIT CARE, V26, P122, DOI 10.1097/MCC.0000000000000706; US Food and Drug Administration (FDA), HIGHL PRESCR INF KCE; US National Library of Medicine, PROT SULF INJ SOL; van Ryn J, 2009, BLOOD, V114, P440, DOI 10.1182/blood.V114.22.1065.1065; Wardrop D, 2008, BRIT J HAEMATOL, V141, P757, DOI 10.1111/j.1365-2141.2008.07119.x; Wienen W, 2007, THROMB HAEMOSTASIS, V98, P155, DOI 10.1160/TH07-03-0183; Yee J, 2019, WEST J EMERG MED, V20, P770, DOI 10.5811/westjem.2018.5.38235; Young AM, 2018, J CLIN ONCOL, V36, P2017, DOI 10.1200/JCO.2018.78.8034	48	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	FEB	2022	102	1					53	63		10.1016/j.suc.2021.09.011			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XJ4WJ	WOS:000726789900006	34800389				2022-02-06	
J	Key, VH; Noland, JB				Key, Vincent H.; Noland, Joseph B.			Concussion in Head Trauma	FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA			English	Article						Concussion; Traumatic brain injury; Sport concussion assessment tool (SCAT); Modified balance error scoring system (mBESS)			[Key, Vincent H.] Univ Kansas Hlth Syst, Orthopaed Surg Sports Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Noland, Joseph B.] Univ Kansas Hlth Syst, Family Med, Kansas City, KS USA; [Noland, Joseph B.] 7405 Renner Rd, Shawnee, KS 66217 USA		Key, VH (corresponding author), Univ Kansas Hlth Syst, Orthopaed Surg Sports Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	vkey@kumc.edu					Davis GA, 2020, NEUROSURGERY, V87, P418, DOI 10.1093/neuros/nyaa057; Gregory A, 2021, CLIN SPORT MED, V40, P53, DOI 10.1016/j.csm.2020.08.011; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179	5	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-7406	1558-1926		FACIAL PLAST SURG CL	Facial Plast. Surg. Clin. N. Am.	FEB	2022	30	1			SI		11	14		10.1016/j.fsc.2021.08.013			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XB2BN	WOS:000721137800002	34809881				2022-02-06	
J	Kotler, DH; Iaccarino, MA; Rice, S; Herman, S				Kotler, Dana H.; Iaccarino, Mary Alexis; Rice, Sarah; Herman, Seth			Return to Cycling Following Brain Injury A Proposed Multidisciplinary Approach	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Cycling; Traumatic brain injury; Concussion; Crash	DRIVING ASSESSMENT; CONCUSSION; NETHERLANDS; IMPAIRMENT; SYMPTOMS; CRASHES; LESSONS; VISION; HEALTH		[Kotler, Dana H.; Iaccarino, Mary Alexis] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Rice, Sarah] Athlet Phys Therapy, Chicago, IL USA; [Herman, Seth] Calif Rehabil Inst, Los Angeles, CA USA		Kotler, DH (corresponding author), Spaulding Outpatient Ctr Wellesley, 65 Walnut St,Suite 250, Wellesley, MA 02481 USA.	dkotler@mgh.narvard.edu					Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abramson AK, 2012, MED CYCL 2012; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bini RR, 2016, J SCI CYCLING, V5, P1; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Fonda B, 2014, J SCI CYCLING, V3, P18; Fonda B, 2016, THESIS U BIRMINGHAM; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamel RN, 2019, SPORTS MED, V49, P1183, DOI 10.1007/s40279-019-01122-9; Hymas R, BICYCLE ACCIDENTS RO; Jacobsen PL, 2015, INJURY PREV, V21, P271, DOI 10.1136/ip.9.3.205rep; League of American Bicyclists, 2014, BIC SAF MUST PRIOR F; Lowrey KM., 2019, TRAUMATIC BRAIN INJU; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; National Center for Statistics and Analysis, 2019, BIC OTH CYCL 2017 DA; National Highway Traffic Safety Administration, 2019, BIC PED SAF; National Highway Traffic Safety Administration, 2018, 2016 BIC OTH CYCL TR; National Highway Traffic Safety Administration, BIC SAF; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; Owsley C, 2015, SURV OPHTHALMOL, V60, P250, DOI 10.1016/j.survophthal.2015.01.005; Parkin J, 2010, ACCIDENT ANAL PREV, V42, P159, DOI 10.1016/j.aap.2009.07.018; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Perrin Adam E, 2012, Conn Med, V76, P461; Peveler WW, 2007, J STRENGTH COND RES, V21, P1023; Quesada JIP, 2019, EUR J SPORT SCI, V19, P842, DOI 10.1080/17461391.2018.1556738; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; Rice S, 2020, J ATHL TRAINING, V55, P11, DOI 10.4085/1062-6050-91-19; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Robinson Dorothy L, 2005, Health Promot J Austr, V16, P47; Salai M, 1999, BRIT J SPORT MED, V33, P398, DOI 10.1136/bjsm.33.6.398; Saviola D, 2018, EUR J PHYS REHAB MED, V54, P717, DOI 10.23736/S1973-9087.17.04905-X; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schwab AL, 2013, VEHICLE SYST DYN, V51, P1059, DOI 10.1080/00423114.2013.793365; Sergio LE, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.541630; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Sun HY, 2017, FOREN SCI RES, V2, P174, DOI 10.1080/20961790.2017.1390836; Swart J, 2019, CURR SPORT MED REP, V18, P490, DOI 10.1249/JSR.0000000000000665; Teschke K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1205; Tin ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087633; Tin ST, 2013, PREV MED, V57, P152, DOI 10.1016/j.ypmed.2013.05.001; WIERDA M, 1991, APPL COGNITIVE PSYCH, V5, P113, DOI 10.1002/acp.2350050205; Wilson DG, 2004, BICYCLING SCI	48	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	FEB	2022	33	1			SI		91	105		10.1016/j.pmr.2021.08.007			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XA6IE	WOS:000720747100009	34799005				2022-02-06	
J	Kotler, DH; Cushman, DM; Rice, S; Gilbert, C; Bhatnagar, S; Robidoux, CG; Iaccarino, MA				Kotler, Dana H.; Cushman, Daniel M.; Rice, Sarah; Gilbert, Christopher; Bhatnagar, Saurabha; Robidoux, C. Greg; Iaccarino, Mary Alexis			Fear, Anxiety, and Return to Sport After Cycling Crashes A Survey of Cyclists	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Bicycle; Trauma; Injury; Psychological; Concussion	PSYCHOLOGICAL-FACTORS; HEALTH-BENEFITS; SOCIAL SUPPORT; INJURY; RISK; REHABILITATION; CONCUSSION; DEPRESSION; TRANSPORT; SYMPTOMS		[Kotler, Dana H.; Bhatnagar, Saurabha; Iaccarino, Mary Alexis] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Kotler, Dana H.; Bhatnagar, Saurabha; Iaccarino, Mary Alexis] Spaulding Rehabil Hosp, Boston, MA USA; [Kotler, Dana H.; Robidoux, C. Greg] Spaulding Outpatient Ctr Wellesley, 65 Walnut St,Suite 250, Wellesley, MA 02481 USA; [Kotler, Dana H.] Newton Wellesley Hosp, Newton, MA USA; [Cushman, Daniel M.] Univ Utah, Div Phys Med & Rehabil, 590 Wakara Way, Salt Lake City, UT 84108 USA; [Rice, Sarah] Athlet Phys Therapy, Chicago, IL USA; [Gilbert, Christopher] Harvard Univ Extens, 51 Brattle St, Cambridge, MA 02138 USA; [Bhatnagar, Saurabha] US Dept Vet Affairs, 1722 I St NW, Washington, DC USA; [Iaccarino, Mary Alexis] Massachusetts Gen Hosp, Boston, MA 02114 USA		Kotler, DH (corresponding author), Spaulding Outpatient Ctr Wellesley, 65 Walnut St,Suite 250, Wellesley, MA 02481 USA.	dkotler@mgh.narvard.edu					[Anonymous], 2006, MED SCI SPORT EXER, V38, P2030, DOI 10.1249/MSS.0b013e31802b37a6; [Anonymous], 2019, US CYCLING ACTIVE ME; Ardern CL, 2013, BRIT J SPORT MED, V47, P1120, DOI 10.1136/bjsports-2012-091203; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Clement D, 2015, J ATHL TRAINING, V50, P95, DOI 10.4085/1062-6050-49.3.52; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Craig A, 2017, TRAFFIC INJ PREV, V18, P273, DOI 10.1080/15389588.2016.1248760; Czuppon S, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091786; De Bernardo N, 2012, J SPORT SCI, V30, P1047, DOI 10.1080/02640414.2012.687112; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Garcia GH, 2016, AM J SPORT MED, V44, P572, DOI 10.1177/0363546515612466; Gossling S, 2015, ECOL ECON, V113, P106, DOI 10.1016/j.ecolecon.2015.03.006; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsu CJ, 2017, SPORTS HEALTH, V9, P162, DOI 10.1177/1941738116666813; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kotler DH, 2016, CURR SPORT MED REP, V15, P199, DOI 10.1249/JSR.0000000000000262; Kvist J, 2005, KNEE SURG SPORT TR A, V13, P393, DOI 10.1007/s00167-004-0591-8; League of American Bicyclists, 2016, WE RID AN BICYCL AM; Maibach E, 2009, PREV MED, V49, P326, DOI 10.1016/j.ypmed.2009.06.028; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Padaki AS, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118787159; Palmer-Green D, 2014, BRIT J SPORT MED, V48, P650; Perrin Adam E, 2012, Conn Med, V76, P461; Poulos RG, 2015, ACCIDENT ANAL PREV, V78, P29, DOI 10.1016/j.aap.2015.02.009; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; Rice S, 2020, J ATHL TRAINING, V55, P11, DOI 10.4085/1062-6050-91-19; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; SMITH AM, 1994, J ATHL TRAINING, V29, P337; Sonesson S, 2017, KNEE SURG SPORT TR A, V25, P1375, DOI 10.1007/s00167-016-4294-8; Stoyanova M, 2012, J ANXIETY DISORD, V26, P206, DOI 10.1016/j.janxdis.2011.11.006; United States Census Bureau, 2016, AM COMMUNITY SURVEY; USA Cycling, ACT MEMB DEM, V2018; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Yang JZ, 2014, J ATHL TRAINING, V49, P773, DOI 10.4085/1062-6050-49.3.65	41	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	FEB	2022	33	1			SI		107	122		10.1016/j.pmr.2021.08.008			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XA6IE	WOS:000720747100010	34798993				2022-02-06	
J	Lannon, MM; Duda, T; Martyniuk, A; Engels, PT; Sharma, SV				Lannon, Melissa M.; Duda, Taylor; Martyniuk, Amanda; Engels, Paul T.; Sharma, Sunjay, V			Pediatric craniocerebral gunshot injuries: A National Trauma Database study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Neurotrauma; gunshot wound; craniocerebral gunshot injury; intracranial; National Trauma Database	BRAIN-INJURY; WOUNDS; SURVIVAL; CHILDREN; UPDATE	BACKGROUND We aimed to determine the outcomes and prognostic factors in pediatric craniocerebral gunshot injury (CGI) patients. Pediatric patients may have significantly different physiology, neuroplasticity, and clinical outcomes in CGI than adults. There is limited literature on this topic, mainly case reports and small case series. METHODS We queried the National Trauma Data Bank for all pediatric CGI between 2014 and 2017. Patients were identified using International Classification of Diseases, Ninth Revision, codes. Demographic, emergency department, and clinical data were analyzed. Subgroup analysis was attempted for groups with Glasgow Coma Scale (GCS) scores of 9 to 15 and ages 0 to 8 years. RESULTS In a 3-year period, there were 209 pediatric patients (aged 0-18 years) presenting to American hospitals with signs of life. The overall mortality rate was 53.11%. A linear relationship was demonstrated showing a mortality rate of 79% by initial GCS in GCS score of 3, 56% in GCS scores of 4 to 8, 22% in GCS scores of 9 to 12, and 5% in GCS scores of 13 to 15. The youngest patients, aged 0 to 8 years, had dramatically better initial GCS and subsequently lower mortality rates. Regression analysis showed mortality benefit in the total population for intracranial pressure monitoring (odds ratio, 0.267) and craniotomy (odds ratio, 0.232). CONCLUSION This study uses the National Trauma Data Bank to quantify the prevalence of pediatric intracranial gunshot wounds, with the goal to determine risk factors for prognosis in this patient population. Significant effects on mortality for invasive interventions including intracranial pressure monitoring and craniotomy for all patients suggest low threshold for use of these procedures if there is any clinical concern. The presence of a 79% mortality rate in patients with GCS score of 3 on presentation suggests that as long as there is not a declared neurologic death, intracranial pressure monitoring and treatment measures including craniotomy should be considered by the consulting clinician.	[Lannon, Melissa M.; Duda, Taylor; Martyniuk, Amanda; Engels, Paul T.; Sharma, Sunjay, V] McMaster Univ, Div Neurosurg, HSC 2P7D,1200 Main St W, Hamilton, ON L8N 3Z5, Canada		Duda, T (corresponding author), McMaster Univ, Div Neurosurg, HSC 2P7D,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	taylor.duda@medportal.ca					Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; Canadian Paediatric Society, MAN PAED PAT AC HEAD; Centers for Disease Control and Prevention NC for IP and C, 2020, WEB BAS INJ STAT QUE; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; Davis JS, 2013, J SURG RES, V184, P556, DOI 10.1016/j.jss.2012.12.047; Duda T, 2020, J TRAUMA ACUTE CARE, V89, P1239, DOI 10.1097/TA.0000000000002900; Frosen J, 2019, ACTA NEUROCHIR, V161, P1285, DOI 10.1007/s00701-019-03952-y; Gordon AS, 2014, CHILD NERV SYST, V30, P1589, DOI 10.1007/s00381-014-2429-0; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; McFadyen J Grant, 2012, Int J Crit Illn Inj Sci, V2, P121, DOI 10.4103/2229-5151.100888; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Murphy S, 2016, CURR TRAUMA REP, V2, P222, DOI 10.1007/s40719-016-0065-8; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Parikh Kavita, 2017, Hosp Pediatr, V7, P303, DOI 10.1542/hpeds.2016-0146; The Committee on Trauma American College of Surgeons, 2018, ADV TRAUM LIF SUPP S, V10th	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2022	92	2					428	435		10.1097/TA.0000000000003385			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	YM9ZV	WOS:000746928900028	34407004				2022-02-06	
J	Martineau-Lessard, C; Arbour, C; Germelus, NE; Williamson, D; De Beaumont, L; Bernard, F				Martineau-Lessard, Chloe; Arbour, Caroline; Germelus, Naicha-Eveline; Williamson, David; De Beaumont, Louis; Bernard, Francis			Pupil Light Reflex for the Assessment of Analgesia in Critically Ill Sedated Patients With Traumatic Brain Injury: A Preliminary Study	JOURNAL OF NEUROSCIENCE NURSING			English	Article						analgesia; pain; pupil; pupillometry; sedation; traumatic brain injury; pupil dilation; dilation velocity	NOXIOUS-STIMULATION; PAIN; PUPILLOMETRY; ISOFLURANE; MANAGEMENT; ANESTHESIA; DILATION	BACKGROUND: Analgesia monitoring is essential to preserve comfort in critically ill sedated patients with traumatic brain injury (TBI). Although pupil dilation (PD) and pain behaviors can be used to assess analgesia, these indicators require application of noxious stimulations for elicitation. Recently, the pupillary light reflex (PLR) has emerged as a nonnoxious parameter that may be used to predict analgesia requirements in non-brain-injured patients. Here, we explored whether PLR can be used for the purpose of analgesia monitoring in critically ill sedated TBI patients. METHODS: Fifteen mechanically ventilated TBI patients (11 men; 54 +/- 20 years) under continuous analgesia and sedation infusions were assessed at predefined time within 72 hours of intensive care unit admission. Data collection was performed using video-pupillometry and the Behavioral Pain Scale. At each assessment, pupil size and PLR at rest were recorded followed immediately by the documentation of PD and pain behaviors elicited by a calibrated noxious stimulus. Blood concentrations of analgesics/sedatives were monitored. RESULTS: One hundred three assessments were completed. PLR resulted in an average decrease of 19% in pupil diameter, and PD resulted in an average increase of 10% in pupil diameter. Variations in PLR and PD were more pronounced in subjects who showed a Behavioral Pain Scale score greater than 3 (a recognized sign of subanalgesia) compared with those with no behavioral reaction. Multiple regression analyses suggest a significant overlap between fluctuations in pupillary reflexes and blood levels of fentanyl, not propofol. CONCLUSION: In our sample, percentages of variation in PLR and PD were found to be directly representative of TBI patients' fentanyl blood concentration. Considering information about blood drug concentration is generally not available at bedside, PLR could be used as a proxy to assess analgesia requirements before a nociceptive procedure in critically ill sedated TBI patients who are vulnerable to stress.	[Martineau-Lessard, Chloe; Arbour, Caroline; Germelus, Naicha-Eveline; Williamson, David; De Beaumont, Louis] Hop Sacre Coeur Montreal, CIUSSS Nord Iile Montreal, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Martineau-Lessard, Chloe; De Beaumont, Louis; Bernard, Francis] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Williamson, David] Univ Montreal, Fac Pharm, Montreal, PQ, Canada		Arbour, C (corresponding author), Hop Sacre Coeur Montreal, CIUSSS Nord Iile Montreal, Montreal, PQ, Canada.; Arbour, C (corresponding author), Univ Montreal, Fac Nursing, Montreal, PQ, Canada.	caroline.arbour@umontreal.ca			Traumatology Research Consortium from the Fonds de la Recherche du Quebec - Sante	This work was supported by the Traumatology Research Consortium from the Fonds de la Recherche du Quebec - Sante.	Arbour C, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/175794; Barros JKA., 2018, HOS PAL MED INT JNL, V2, P378, DOI [10.15406/hpmij.2018.02.00129, DOI 10.15406/HPMIJ.2018.02.00129]; Barvais L, 2003, BRIT J ANAESTH, V91, P347, DOI 10.1093/bja/aeg178; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Brooks JCW, 2017, J NEUROSCI, V37, P2279, DOI 10.1523/JNEUROSCI.2193-16.2016; Chapman CR, 1999, PSYCHOPHYSIOLOGY, V36, P44, DOI 10.1017/S0048577299970373; Coelho AC, 2021, NURS CRIT CARE, DOI 10.1111/nicc.12641; Connelly MA, 2014, ARCH DIS CHILD, V99, P1125, DOI 10.1136/archdischild-2014-306286; Deldar K, 2018, BMC NURS, V17, DOI 10.1186/s12912-018-0281-3; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Guglielminotti J, 2013, ANESTH ANALG, V116, P1057, DOI 10.1213/ANE.0b013e31828a7218; Haddock JH, 2017, OCHSNER J, V17, P250; Jutras M, 2020, J PHARMACEUT BIOMED, V190, DOI 10.1016/j.jpba.2020.113521; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; LARSON MD, 1993, ANESTH ANALG, V76, P1072; Larson MD, 2000, REGION ANESTH PAIN M, V25, P60, DOI 10.1016/S1098-7339(00)80012-7; Leslie K, 1996, ANESTHESIOLOGY, V84, P52, DOI 10.1097/00000542-199601000-00006; Lukaszewicz AC, 2015, ANESTH ANALG, V120, P1297, DOI 10.1213/ANE.0000000000000609; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marshall M, 2019, J NEUROSCI NURS, V51, P84, DOI 10.1097/JNN.0000000000000416; Martyn JAJ, 2019, NEW ENGL J MED, V380, P365, DOI 10.1056/NEJMra1800222; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Sessler CN, 2001, SEMIN RESP CRIT CARE, V22, P211, DOI 10.1055/s-2001-13834; Shirozu K, 2017, J CLIN MONIT COMPUT, V31, P291, DOI 10.1007/s10877-016-9839-3; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tipton MJ, 2017, J PHYSIOL-LONDON, V595, P5729, DOI 10.1113/JP274596; Vinclair M, 2019, ANESTH ANALG, V129, P1540, DOI 10.1213/ANE.0000000000004173; Wildemeersch D, 2018, ACTA ANAESTH SCAND, V62, P1050, DOI 10.1111/aas.13129; Zengin N, 2020, NURS CRIT CARE, V25, P109, DOI 10.1111/nicc.12465	31	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	FEB	2022	54	1					6	12		10.1097/JNN.0000000000000627			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	YE0CP	WOS:000740800200004	35007259				2022-02-06	
J	Meier, TB; Guedes, VA; Smith, EG; Sass, D; Mithani, S; Vorn, R; Savitz, J; Teague, TK; McCrea, MA; Gill, JM				Meier, Timothy B.; Guedes, Vivian A.; Smith, Ethan G.; Sass, Dilorom; Mithani, Sara; Vorn, Rany; Savitz, Jonathan; Teague, T. Kent; McCrea, Michael A.; Gill, Jessica M.			Extracellular vesicle-associated cytokines in sport-related concussion	BRAIN BEHAVIOR AND IMMUNITY			English	Article						mTBI; Inflammation; Blood-based biomarkers; Exosomes	BRAIN-INJURY; SYMPTOMS; TRAUMA	Growing evidence suggests that sport-related concussion results in a robust inflammatory response that can be measured in serum or plasma and is predictive of symptom recovery. Recently, extracellular vesicles (EV) derived from serum or plasma have emerged as a promising source of biomarkers for neurological disorders like concussion because they may better reflect central immunological activity. However, the association of acute concussion with EV-associated cytokines has not yet been systematically studied in humans. We tested the hypothesis that EV-associated cytokines are elevated acutely and predictive of symptom duration following concussion in a cohort of high-school and collegiate football players. Players were enrolled and provided serum samples at a preseason baseline visit (N = 857). An additional blood draw was obtained in players that subsequently suffered a concussion (N = 23) within 6-hours post-injury and in matched, uninjured players (N = 44). Concentrations of Interleukin-6 (IL-6), IL-1 beta, IL-1 receptor antagonist (IL-1RA), IL-10, and tumor necrosis factor were measured in EV and EV-depleted serum samples. EV-associated IL-6 was significantly elevated post-injury relative to baseline levels and controls (ps < 0.01). In EV-depleted samples, IL-1RA was significantly elevated post-injury relative to baseline levels and controls (ps < 0.01). Time-to-event analyses showed that post-injury EV-associated IL-6 levels were positively associated with the number of days that injured athletes reported symptoms (p < 0.05). These results highlight the potential of EV-associated cytokines as biomarkers of concussion.	[Meier, Timothy B.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Guedes, Vivian A.; Smith, Ethan G.; Mithani, Sara; Vorn, Rany; Gill, Jessica M.] NINR, NIH, Bethesda, MD 20892 USA; [Savitz, Jonathan] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Oklahoma, Sch Community Med, Dept Surg & Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Teague, T. Kent] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Vorn, Rany/0000-0002-9158-9302; de Alvarenga Guedes, Vivian/0000-0001-8478-2465	Defense Health Program under the Department of Defense (DOD) Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Institute of Neurological Disorders And Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099789]; National Institute of Nursing Research Intramural Research Program; National Center for Advancing Translational Sciences, NIH [UL1TR001436]	The authors thank Ashlee Taylor and Brenda Davis from University of Oklahoma Integrative Immunology Center; Ashley LaRoche, Alexa Wild, and Daniel Huber at the Medical College of Wisconsin. This work was supported by the Defense Health Program under the Department of Defense (DOD) Broad Agency Announcement for Extra-mural Medical Research through Award No. W81XWH-14-1-0561. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the DOD. Support for this work was also provided by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health (NIH) under Award Number R21NS099789. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Additional support provided by the National Institute of Nursing Research Intramural Research Program. The REDCap electronic data-base and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, NIH, Award Number UL1TR001436.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Banks WA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124407; Beard K, 2020, J NEUROTRAUM, V37, P2045, DOI 10.1089/neu.2020.6990; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Chan L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030604; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Dolcetti E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197336; Fitzgerald W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27190-x; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Giloteaux L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02560-0; Guedes VA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00663; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Hosseinkhani B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01789; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shetty T, 2019, J HEAD TRAUMA REHAB, V34, pE28, DOI 10.1097/HTR.0000000000000450; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu LB, 2021, J NEUROTRAUM, V38, P918, DOI 10.1089/neu.2020.7177; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331	25	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2022	100						83	87		10.1016/j.bbi.2021.11.015			5	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	YI7UX	WOS:000744050900009	34848337				2022-02-06	
J	Pechacek, KM; Reck, AM; Frankot, MA; Vonder Haar, C				Pechacek, K. M.; Reck, A. M.; Frankot, M. A.; Vonder Haar, C.			Minocycline fails to treat chronic traumatic brain injury-induced impulsivity and attention deficits	EXPERIMENTAL NEUROLOGY			English	Article						Controlled cortical impact; Executive function; Microglia; Five choice serial reaction time task	MICROGLIAL ACTIVATION; UNITED-STATES; HEAD-INJURY; RATS; NEUROINFLAMMATION; NEURODEGENERATION; INFLAMMATION; RECOVERY; MODERATE	Traumatic brain injury (TBI) impacts millions worldwide and can cause lasting psychiatric symptoms. Chronic neuroinflammation is a characteristic of post-injury pathology and is also associated with psychiatric conditions such as ADHD and bipolar disorder. Therefore, the current study sought to determine whether TBI-induced impulsivity and inattention could be treated using minocycline, an antibiotic with anti-inflammatory properties. Rats were trained on the five-choice serial reaction time task (5CSRT), a measure of motor impulsivity and attention. After behavior was stable on the 5CSRT, rats received either a bilateral frontal TBI or sham procedure. Minocycline was given at either an early (1 h post-injury) or chronic (9 weeks post-injury) timepoint. Minocycline was delivered every 12 h for 5 days (45 mg/kg, i.p.). Behavioral testing on the 5CSRT began again after one week of recovery and continued for 12 more weeks, then rats were transcardially perfused. Impulsivity and inattention were both substantially increased following TBI. Minocycline had no therapeutic effects at either the early or late time points. TBI rats had increased lesion volume, but minocycline did not attenuate lesion size. Additionally, microglia count measured by IBA-1(+) cells was only increased acutely after TBI, and minocycline did not differentially change the number of microglia in TBI rats. Despite this, minocycline had clear effects on the gut microbiome. Based on the results of this study, minocycline may have limited efficacy for post-injury psychiatric-like symptoms.	[Pechacek, K. M.; Reck, A. M.; Frankot, M. A.; Vonder Haar, C.] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26506 USA; [Vonder Haar, C.] West Virginia Univ, Dept Neurosci, Morgantown, WV 26506 USA; [Pechacek, K. M.; Vonder Haar, C.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Vonder Haar, C (corresponding author), Ohio State Univ, Dept Neurosci, Wexner Med Ctr, 688 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Cole.VonderHaar@osumc.edu		Reck, Antonio/0000-0002-2113-6519	National Institutes for HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS110905, P20-GM109098, T32 AG052375]	We would like to thank Virginia Milleson, Jeff Adkins, Lauren Giesler, and other members of the Injury and Recovery Lab for their assistance in performing behavioral and histological analyses. This research was funded by the National Institutes for Health (R01-NS110905, P20-GM109098, T32 AG052375) . The authors have no competing interests.	Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Benedetti F, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00071; Brenner LA, 2020, J HEAD TRAUMA REHAB, V35, P332, DOI 10.1097/HTR.0000000000000615; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Cheng C, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12208; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Haber M, 2018, J CEREBR BLOOD F MET, V38, P1312, DOI 10.1177/0271678X17718106; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hasebe K, 2019, BRAIN BEHAV IMMUN, V82, P309, DOI 10.1016/j.bbi.2019.09.001; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kumar A, 2014, INFLAMMOPHARMACOLOGY, V22, P155, DOI 10.1007/s10787-013-0187-3; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Martens KM, 2019, J NEUROTRAUM, V36, P2827, DOI 10.1089/neu.2019.6470; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mitchell RHB, 2014, J AM ACAD CHILD PSY, V53, P274, DOI 10.1016/j.jaac.2013.11.013; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Oades RD, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-32; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Schmidtner AK, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0556-9; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Yegla B, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00296; Zhao XH, 2015, BRAIN RES BULL, V111, P97, DOI 10.1016/j.brainresbull.2015.01.002	49	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2022	348								113924	10.1016/j.expneurol.2021.113924			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XE9OZ	WOS:000723712400001	34774860				2022-02-06	
J	Plassman, BL; Chanti-Ketterl, M; Pieper, CF; Yaffe, K				Plassman, Brenda L.; Chanti-Ketterl, Marianne; Pieper, Carl F.; Yaffe, Kristine			Traumatic brain injury and dementia risk in male veteran older twins-Controlling for genetic and early life non-genetic factors	ALZHEIMERS & DEMENTIA			English	Article; Early Access						Alzheimer's disease; dementia; traumatic brain injury; twin studies	ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; HEAD-INJURY; DIAGNOSIS; ASSOCIATION; IMPAIRMENT; PREVALENCE; CRITERIA; AGE	Introduction This study leveraged the twin study design, which controls for shared genetic and early life exposures, to investigate the association between traumatic brain injury (TBI) and dementia. Methods Members of the National Academy of Sciences-National Research Council's Twins Registry of World War II male veterans were assigned a cognitive outcome based on a multi-step assessment protocol. History of TBI was obtained via interviews. Results Among 8302 individuals, risk of non-Alzheimer's disease (non-AD) dementia was higher in those with TBI (hazard ratio [HR] = 2.00, 95% confidence interval [CI], 0.97-4.12), than for AD (HR = 1.23, 95% CI, 0.76-2.00). To add more control of genetic and shared environmental factors, we analyzed 100 twin pairs discordant for both TBI and dementia onset, and found TBI-associated risk for non-AD dementia increased further (McNemar odds ratio = 2.70; 95% CI, 1.27-6.25). Discussion These findings suggest that non-AD mechanisms may underlie the association between TBI and dementia, potentially providing insight into inconsistent results from prior studies.	[Plassman, Brenda L.; Chanti-Ketterl, Marianne] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, 2200 West Main St,Suite A200, Durham, NC 27705 USA; [Plassman, Brenda L.] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27705 USA; [Plassman, Brenda L.; Chanti-Ketterl, Marianne; Pieper, Carl F.] Duke Univ, Ctr Aging & Human Dev, Med Ctr, Durham, NC 27705 USA; [Pieper, Carl F.] Duke Univ, Dept Biostat & Bioinformat, Med Ctr, Durham, NC 27705 USA; [Yaffe, Kristine] Dept Psychiat & Behav Sci, San Francisco, CA USA; [Yaffe, Kristine] Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Dept Epidemiol & Biostat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA		Plassman, BL (corresponding author), Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, 2200 West Main St,Suite A200, Durham, NC 27705 USA.	brenda.plassman@duke.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; US Department of DefenseUnited States Department of Defense	the National Institutes of Health; theUS Department of Defense	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hrubec Z, 1978, Prog Clin Biol Res, V24 Pt B, P153; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; JABLON S, 1967, AM J HUM GENET, V19, P133; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kleinbaum D., 2005, SURVIVAL ANAL SELF L, V2nd; Kornblith E, 2020, NEUROLOGY, V95, pE1768, DOI 10.1212/WNL.0000000000010617; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman BL, 2006, TWIN RES HUM GENET, V9, P950, DOI 10.1375/183242706779462381; Plassman Brenda L, 2006, Alzheimers Dement, V2, P2, DOI 10.1016/j.jalz.2005.11.001; Reed T, 2005, TWIN RES HUM GENET, V8, P362, DOI 10.1375/twin.8.4.362; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Seifan A, 2015, NEUROEPIDEMIOLOGY, V45, P237, DOI 10.1159/000439568; SILVERMAN J M, 1989, Alzheimer Disease and Associated Disorders, V3, P218, DOI 10.1097/00002093-198903040-00004; Tani Y, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20740; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.												10.1002/alz.12571		FEB 2022	9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP8JX	WOS:000748867200001	35102695				2022-02-06	
J	Rivas, L; Vella, M; Ju, T; Fernandez-Moure, JS; Sparks, A; Seamon, MJ; Sarani, B				Rivas, Lisbi; Vella, Michael; Ju, Tammy; Fernandez-Moure, Joseph S.; Sparks, Andrew; Seamon, Mark J.; Sarani, Babak			Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury	AMERICAN SURGEON			English	Article						deep venous thrombosis; pulmonary embolus; traumatic brain injury; brain injury	PHARMACOLOGICAL THROMBOPROPHYLAXIS; ENOXAPARIN PROPHYLAXIS; HEMORRHAGE PROGRESSION; SAFETY; ANTICOAGULATION; EFFICACY	Introduction Timing to start of chemoprophylaxis for venous thromboembolism (VTE) in patients with traumatic brain injury (TBI) remains controversial. We hypothesize that early administration is not associated with increased intracranial hemorrhage. Methods A retrospective study of adult patients with TBI following blunt injury was performed. Patients with penetrating brain injury, any moderate/severe organ injury other than the brain, need for craniotomy/craniectomy, death within 24 hours of admission, or progression of bleed on 6 hour follow-up head computed tomography scan were excluded. Patients were divided into early (<= 24 hours) and late (>24 hours) cohorts based on time to initiation of chemoprophylaxis. Progression of bleed was the primary outcome. Results 264 patients were enrolled, 40% of whom were in the early cohort. The average time to VTE prophylaxis initiation was 17 hours and 47 hours in the early and late groups, respectively (P < .0001). There was no difference in progression of bleed (5.6% vs. 7%, P = .67), craniectomy/-craniotomy rate (1.9% vs. 2.5%, P = .81), or VTE rate (0% vs. 2.5%, P = .1). Conclusion Early chemoprophylaxis is not associated with progression of hemorrhage or need for neurosurgical intervention in patients with TBI and a stable head CT 7 hours following injury.	[Rivas, Lisbi; Ju, Tammy; Sparks, Andrew; Sarani, Babak] George Washington Univ, Ctr Trauma & Crit Care, Dept Surg, Washington, DC 20037 USA; [Vella, Michael; Fernandez-Moure, Joseph S.; Seamon, Mark J.] Univ Penn, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Vella, Michael] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Fernandez-Moure, Joseph S.] Univ Penn, Dept Surg, Perelman Sch Med, Duke Med Ctr, Durham, NC USA		Sarani, B (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, 2150 Penn Ave NW,Suite 6B, Washington, DC 20037 USA.	bsarani@mfa.zwu.edu		Sparks, Andrew/0000-0001-8668-4105; Ju, Tammy/0000-0001-6089-6599			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Depew AJ, 2008, AM SURGEON, V74, P906; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012	19	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2022	88	2					187	193		10.1177/0003134820983171			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YD5PL	WOS:000740488700006	33502231				2022-02-06	
J	Sharma, R; Casillas-Espinosa, PM; Dill, LK; Rewell, SSJ; Hudson, MR; O'Brien, TJ; Shultz, SR; Semple, BD				Sharma, Rishabh; Casillas-Espinosa, Pablo M.; Dill, Larissa K.; Rewell, Sarah S. J.; Hudson, Matthew R.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.			Pediatric traumatic brain injury and a subsequent transient immune challenge independently influenced chronic outcomes in male mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Lipopolysaccharide; Neurotrauma; Inflammation; Seizures; Epilepsy; Behavior	PTZ-INDUCED SEIZURES; ELEVATED PLUS-MAZE; POSTTRAUMATIC EPILEPSY; SICKNESS BEHAVIOR; AGED MICE; NOGO-A; LIPOPOLYSACCHARIDE; RECEPTOR; YOUNG; EXPRESSION	Traumatic brain injury (TBI) is a major contributor to death and disability worldwide. Children are at particularly high risk of both sustaining a TBI and experiencing serious long-term consequences, such as cognitive deficits, mental health problems and post-traumatic epilepsy. Severe TBI patients are highly susceptible to nosocomial infections, which are mostly acquired within the first week of hospitalization post-TBI. Yet the potential chronic impact of such acute infections following pediatric TBI remains unclear. In this study, we hypothesized that a peripheral immune challenge, such as lipopolysaccharide (LPS)-mimicking a hospital-acquired infection-would worsen inflammatory, neurobehavioral, and seizure outcomes after experimental pediatric TBI. To test this, three-week old male C57B1/6J mice received a moderate controlled cortical impact or sham surgery, followed by 1 mg/kg i.p. LPS (or 0.9% saline vehicle) at 4 days TBI. Mice were randomized to four groups; sham-saline, sham-LPS, TBI-saline or TBI-LPS (n = 15/group). Reduced general activity and increased anxiety-like behavior were observed within 24 h in LPS-treated mice, indicating a transient sickness response. LPS-treated mice also exhibited a reduction in body weights, which persisted chronically. From 2 months post-injury, mice underwent a battery of tests for sensorimotor, cognitive, and psychosocial behaviors. TBI resulted in hyperactivity and spatial memory deficits, independent of LPS; whereas LPS resulted in subtle deficits in spatial memory retention. At 5 months post-injury, video-electroencephalographic recordings were obtained to evaluate both spontaneous seizure activity as well as the evoked seizure response to pentylenetetrazol (PTZ). TBI increased susceptibility to PTZ-evoked seizures; whereas LPS appeared to increase the incidence of spontaneous seizures. Post-mortem analyses found that TBI, but not LPS, resulted in robust glial reactivity and loss of cortical volume. A TBI x LPS interaction in hippocampal volume suggested that TBI-LPS mice had a subtle increase in ipsilateral hippocampus tissue loss; however, this was not reflected in neuronal cell counts. Both TBI and LPS independently had modest effects on chronic hippocampal gene expression. Together, contrary to our hypothesis, we observed minimal synergy between TBI and LPS. Instead, pediatric TBI and a subsequent transient immune challenge independently influenced chronic outcomes. These findings have implications for future preclinical modeling as well as acute post-injury patient management.	[Sharma, Rishabh; Casillas-Espinosa, Pablo M.; Dill, Larissa K.; Rewell, Sarah S. J.; Hudson, Matthew R.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Casillas-Espinosa, Pablo M.; Dill, Larissa K.; Rewell, Sarah S. J.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Alfred Hlth, Dept Neurol, Prahran, Vic, Australia; [Casillas-Espinosa, Pablo M.; O'Brien, Terence J.; Shultz, Sandy R.; Semple, Bridgette D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia		Semple, BD (corresponding author), Monash Univ, Alfred Ctr, Dept Neurosci, Level 6,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Bridgette.Semple@monash.edu		Hudson, Matthew/0000-0001-5016-735X	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1141347, APP1176426, APP1087172]; Co-Funded Monash Graduate Scholarship; Monash University Central Clinical School; US Department of DefenseUnited States Department of Defense [W81XWH2010848]	The authors are supported by grants from the National Health and Medical Research Council of Australia [APP1141347 to BDS; APP1176426 to TOB; APP1087172 to PCE] , a Co-Funded Monash Graduate Scholarship [RS] , Monash University Central Clinical School [BDS and SS] , and the US Department of Defense [W81XWH2010848; BDS] .	Aarabi B, 2000, Neurosurg Focus, V8, pe1; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Ahlers FS, 2019, EPILEPSIA, V60, P275, DOI 10.1111/epi.14626; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Antshel KM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-72; Arai K, 2001, JPN J PHARMACOL, V87, P195, DOI 10.1254/jjp.87.195; Aria F, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10090620; Arif H, 2021, J NEUROTRAUM, V38, P1515, DOI 10.1089/neu.2020.7238; Aungst S, 2013, J NEUROPHYSIOL, V109, P813, DOI 10.1152/jn.00869.2012; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Berg BM, 2004, BRAIN BEHAV IMMUN, V18, P149, DOI 10.1016/S0889-1591(03)00113-2; Bian YQ, 2013, BEHAV BRAIN RES, V253, P253, DOI 10.1016/j.bbr.2013.07.028; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Broer S, 2016, EXP NEUROL, V279, P57, DOI 10.1016/j.expneurol.2016.02.011; Bubalo N, 2014, FASEB J, V28; Casillas-Espinosa PM, 2019, PROG NEUROBIOL, V182, DOI 10.1016/j.pneurobio.2019.101677; Casillas-Espinosa PM, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.04.011; Casillas-Espinosa PM, 2019, EPILEPSIA, V60, P783, DOI 10.1111/epi.14691; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Chang HK, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11857; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Coulter IC, 2019, CURR OPIN PEDIATR, V31, P769, DOI 10.1097/MOP.0000000000000820; Cusick MF, 2017, J NEUROVIROL, V23, P696, DOI 10.1007/s13365-017-0554-8; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; DePaula-Silva A, 2018, J NEUROVIROL, V24, P464, DOI 10.1007/s13365-018-0636-2; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Elsamadicy AA, 2021, CLIN NEUROL NEUROSUR, V203, DOI 10.1016/j.clineuro.2021.106556; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fraklin K., 2007, MOUSE BRAIN STEREOTA; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goh MSL, 2021, J NEUROL NEUROSUR PS, V92, P847, DOI 10.1136/jnnp-2020-325066; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guo J, 2014, NEUROSCIENCE, V263, P1, DOI 10.1016/j.neuroscience.2014.01.008; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Hartman ME, 2021, J PEDIAT INF DIS SOC, V10, P1044, DOI 10.1093/jpids/piab087; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hwang SY, 2019, BRAIN INJURY, V33, P1420, DOI 10.1080/02699052.2019.1641625; Jacovides CL, 2019, J TRAUMA ACUTE CARE, V87, P552, DOI 10.1097/TA.0000000000002403; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kang JB, 2019, LAB ANIM RES, V35, DOI 10.1186/s42826-019-0018-9; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keith KA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10010004; Keret A, 2018, SEIZURE-EUR J EPILEP, V58, P29, DOI 10.1016/j.seizure.2018.03.018; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Kim KK, 2013, ENDOCRINOL METAB, V28, P214, DOI 10.3803/EnM.2013.28.3.214; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kovacs Z, 2014, BRAIN RES BULL, V104, P7, DOI 10.1016/j.brainresbull.2014.03.003; Lengel D, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113329; Lin WJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040589; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Lossin C, 2003, J NEUROSCI, V23, P11289; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Magni DV, 2011, EPILEPSY RES, V93, P138, DOI 10.1016/j.eplepsyres.2010.11.007; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Maroso M, 2011, NEUROTHERAPEUTICS, V8, P304, DOI 10.1007/s13311-011-0039-z; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Meneses G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201375; Mikkonen ED, 2020, EPILEPSIA, V61, P693, DOI 10.1111/epi.16483; Ming Z, 2015, NEUROSCI LETT, V590, P96, DOI 10.1016/j.neulet.2015.01.081; Nelson LD, 2021, J ABNORM PSYCHOL, V130, P423, DOI 10.1037/abn0000672; Nemes AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17377-z; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; O'Brien TJ, 2013, EPILEPSIA, V54, P70, DOI 10.1111/epi.12300; Pandya A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28189-0; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peng LF, 2019, NEUROSCIENCE, V398, P76, DOI 10.1016/j.neuroscience.2018.12.001; Pitkanen A, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.01.007; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Qian F, 2021, BIOMATERIALS, V270, DOI 10.1016/j.biomaterials.2021.120675; Queen AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152289; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Salley J, 2020, SEMIN SPEECH LANG, V41, P125, DOI 10.1055/s-0040-1701682; Salvi SS, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00249; Sanz P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114096; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Semple BD, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00002; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sharma R, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02114-1; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shimada T, 2018, JOVE-J VIS EXP, DOI 10.3791/56573; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Sparkman NL, 2005, PHYSIOL BEHAV, V86, P244, DOI 10.1016/j.physbeh.2005.07.016; SQUIRES RF, 1984, LIFE SCI, V35, P1439, DOI 10.1016/0024-3205(84)90159-0; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; Valero J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00083; Van Erum J, 2019, EPILEPSY BEHAV, V95, P51, DOI 10.1016/j.yebeh.2019.02.029; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Y, 2017, J NEUROL SCI, V381, P82, DOI 10.1016/j.jns.2017.08.279; Webster KM, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112979; Wu C, 2015, METAB BRAIN DIS, V30, P367, DOI 10.1007/s11011-014-9560-1; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yeo V, 2021, SLEEP MED, V81, P387, DOI 10.1016/j.sleep.2021.03.013; Young JC, 2019, EPILEPSY BEHAV, V97, P229, DOI 10.1016/j.yebeh.2019.05.032; Yu ZQ, 2012, ANN CLIN LAB SCI, V42, P26; Zamani A, 2020, BRAIN RES BULL, V156, P43, DOI 10.1016/j.brainresbull.2019.12.015; Zhai XL, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.146945; Zhang F, 2019, PEDIATR INT, V61, P904, DOI 10.1111/ped.13946; Zhou XY, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/8191079; Zubareva OE, 2020, BRAIN BEHAV IMMUN, V90, P3, DOI 10.1016/j.bbi.2020.07.034	129	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2022	100						29	47		10.1016/j.bbi.2021.11.013			19	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	YI7UX	WOS:000744050900005	34808288				2022-02-06	
J	Snyder, N; Cinelli, M; Rapos, V; Cretual, A; Olivier, AH				Snyder, Natalie; Cinelli, Michael; Rapos, Victoria; Cretual, Armel; Olivier, Anne-Helene			Collision avoidance strategies between two athlete walkers: Understanding impaired avoidance behaviours in athletes with a previous concussion*	GAIT & POSTURE			English	Article						Mutual adaptation; Adaptive locomotion; Visuomotor integration; Person-person interactions; Concussion; Contact sport	RECOVERY; BALANCE	Background: Individuals who have sustained a concussion often display associated balance control deficits and visuomotor impairments despite being cleared by a physician to return to sport. Such visuomotor impairments can be highlighted in collision avoidance tasks that involves a mutual adaptation between two walkers. However, studies have yet to challenged athletes with a previous concussion during an everyday collision avoidance task, following return to sport. Research Question: Do athletes with a previous concussion display associated behavioural changes during a 90 degrees collision avoidance task with an approaching pedestrian? Methods: Thirteen athletes (ATH; 9 females, 23 +/- 4years) and 13 athletes with a previous concussion (CONC; 9 females, 22 +/- 3 years, concussion 6 months) walked at a comfortable walking speed along a 12.6 m pathway while avoiding another athlete on a 90o-collision course. Each participant randomly interacted with individuals from the same group 20 times and interacted with individuals from the opposite group 21 times. Minimum predicted distance (mpd) was used to examine collision avoidance behaviours between ATH and CONC groups. Results: The overall progression of mpd(t) did not differ between groups (p .05). During the collision avoidance task, previously concussed athletes contributed less when passing second compared to their peers(p < .001). When two previously concussed athletes were on a collision course, there was a greater amount of variability resulting in inappropriate adaptive behaviours. Significance: Although successful at avoiding a collision with an approaching athlete, previously concussed athletes exhibit behavioural changes manifesting in riskier behaviours. The current findings suggest that previously concussed athletes possess behavioural changes even after being cleared to returned to sport, which may increase their risk of a subsequent injury when playing.	[Snyder, Natalie; Cinelli, Michael; Rapos, Victoria] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave,W Rm 501, Waterloo, ON, Canada; [Cretual, Armel; Olivier, Anne-Helene] Univ Rennes, M2S, IRISA, CNRS,Inria, Rennes, France		Cinelli, M (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave,W Rm 501, Waterloo, ON, Canada.	mcinelli@wlu.ca			Natural Science and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [2019-05894]; Mitacs Globalink Research Award [IT10798]; Inria-Rennes-Bretagne Atlantique, France Associate Team Grant [EQA-031901-BEAR]	Natural Science and Engineering Research Council of Canada (NSERC) awarded to Michael Cinelli (2019-05894) . Mitacs Globalink Research Award was awarded to Michael Cinelli and Natalie Snyder (IT10798) . Inria-Rennes-Bretagne Atlantique, France Associate Team Grant was awarded to Anne-Helene Olivier (EQA-031901-BEAR) . We would also like to acknowledge the doctors (Pierrick Guillemot and Patrice Ngassa) who treated and helped recruit the athletes.	Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Berton F, 2019, 2019 26TH IEEE CONFERENCE ON VIRTUAL REALITY AND 3D USER INTERFACES (VR), P717, DOI 10.1109/VR.2019.8798204; Caccese JB, 2021, SPORTS MED, V51, P2209, DOI 10.1007/s40279-021-01472-3; Chmielewski TL, 2021, J SPORT HEALTH SCI, V10, P154, DOI 10.1016/j.jshs.2020.11.005; Croft J.L., 2017, J MOTOR BEHAV, P1; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Knorr AG, 2016, J EXP PSYCHOL HUMAN, V42, P1332, DOI 10.1037/xhp0000223; Locklin J, 2010, SPORTS MED, V40, P183, DOI 10.2165/11319440-000000000-00000; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Olivier AH, 2013, GAIT POSTURE, V38, P751, DOI 10.1016/j.gaitpost.2013.03.017; Olivier AH, 2012, GAIT POSTURE, V36, P399, DOI 10.1016/j.gaitpost.2012.03.021; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rapos V, 2021, GAIT POSTURE, V88, P210, DOI 10.1016/j.gaitpost.2021.05.033; Rapos V, 2019, GAIT POSTURE, V72, P16, DOI 10.1016/j.gaitpost.2019.05.016; Reilly N, 2020, EXP BRAIN RES, V238, P2783, DOI 10.1007/s00221-020-05934-4; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152	25	0	0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2022	92						24	29		10.1016/j.gaitpost.2021.11.003			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	XO4AL	WOS:000730129200005	34801953				2022-02-06	
J	Stauch, CM; Fanburg-Smith, JC; Walley, KC; King, JL; Murie, B; Kim, M; Koroneos, Z; Waning, D; Elfar, JC; Aynardi, MC				Stauch, Christopher M.; Fanburg-Smith, Julie C.; Walley, Kempland C.; King, Jesse L.; Murie, Benjamin; Kim, Morgan; Koroneos, Zachary; Waning, David; Elfar, John C.; Aynardi, Michael C.			Animal model detects early pathologic changes of Charcot neuropathic arthropathy	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Charcot-neuropathic-arthropathy; Neuropathy; Vasculopathy; Mouse model; Human; early	BONE-MINERAL DENSITY; DIABETIC FOOT; OSTEOARTHROPATHY; NEUROARTHROPATHY; MORTALITY; OBESITY; ULCER; DIET	Charcot neuropathic arthropathy is a degenerative, debilitating disease that affects the foot and ankle in patients with diabetes and peripheral neuropathy, often resulting in destruction, amputation. Proposed etiologies include neurotraumatic, inflammatory, and neurovascular. There has been no previous animal model for Charcot. This study proposes a novel rodent model of induced neuropathic arthropathy to understand the earliest progressive pathologic changes of human Charcot. High-fat-diet-induced obese (DIO) Wild-type C57BL/6J mice (n = 8, diabetic) and age-matched low-fat-diet controls (n = 6) were run on an inclined high-intensity treadmill protocol four times per week for 7 weeks to induce mechanical neurotrauma to the hind-paw, creating Charcot neuropathic arthropathy. Sensory function and radiologic correlation were assessed; animals were sacrificed to evaluate hindpaw soft tissue and joint pathology. With this model, Charcot-DIO mice reveals early pathologic features of Charcot neuropathic arthropathy, a distinctive subchondral microfracture callus, perichondral/subchondral osseous hypertrophy/osteosclerosis, that precedes fragmentation/destruction observed in human surgical pathology specimens. There is intraneural vacuolar-myxoid change and arteriolosclerosis. The DIO mice demonstrated significant hot plate sensory neuropathy compared (P < 0.01), radiographic collapse of the longitudinal arch in DIO mice (P < 0.001), and diminished bone density in DIO, compared with normal controls. Despite exercise, high-fat-DIO mice increased body weight and percentage of body fat (P < 0.001). This murine model of diet-induced obesity and peripheral neuropathy, combined with repetitive mechanical trauma, simulates the earliest changes observed in human Charcot neuropathic arthropathy, of vasculopathicneuropathic etiology. An understanding of early pathophysiology may assist early diagnosis and intervention and reduce patient morbidity and mortality in Charcot neuropathic arthropathy.	[Stauch, Christopher M.; Fanburg-Smith, Julie C.; King, Jesse L.; Elfar, John C.; Aynardi, Michael C.] Penn State Coll Med, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Stauch, Christopher M.; Fanburg-Smith, Julie C.; Walley, Kempland C.; King, Jesse L.; Kim, Morgan; Koroneos, Zachary; Waning, David; Elfar, John C.; Aynardi, Michael C.] Milton S Hershey Med Ctr, Dept Orthoped, Hershey, PA USA; [Fanburg-Smith, Julie C.; Murie, Benjamin] Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA USA; [Fanburg-Smith, Julie C.] Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA USA		Fanburg-Smith, JC (corresponding author), Penn State Coll Med, Penn State Milton S Hershey Med Ctr, 500 Univ Dr, Hershey, PA 17033 USA.; Fanburg-Smith, JC (corresponding author), CORTS, Dept Pathol, 500 Univ Dr, Hershey, PA 17033 USA.; Fanburg-Smith, JC (corresponding author), CORTS, Dept Pediat, 500 Univ Dr, Hershey, PA 17033 USA.; Fanburg-Smith, JC (corresponding author), CORTS, Dept Orthoped, 500 Univ Dr, Hershey, PA 17033 USA.	jcfsmd@gmail.com					Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P390, DOI 10.7547/87507315-92-7-390; Bevan WPC, 2008, FOOT ANKLE INT, V29, P568, DOI 10.3113/FAI.2008.0568; Biessels GJ, 2014, J PERIPHER NERV SYST, V19, P77, DOI 10.1111/jns5.12072; Boulton AJM, 2004, DIABETOLOGIA, V47, P1343, DOI 10.1007/s00125-004-1463-y; Eichenholtz SN, 1966, CHARCOT JOINTS; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; Gazis A, 2004, DIABETIC MED, V21, P1243, DOI 10.1111/j.1464-5491.2004.01215.x; Glazebrook MA, 2008, J ORTHOP RES, V26, P840, DOI 10.1002/jor.20546; Guyton GP, 2001, J BONE JOINT SURG AM, V83A, P1084, DOI 10.2106/00004623-200107000-00017; Jolivalt Corinne G, 2016, Curr Protoc Mouse Biol, V6, P223, DOI 10.1002/cpmo.11; Kambiz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126892; Kang Yun-Seok, 2017, J Exerc Nutrition Biochem, V21, P48, DOI 10.20463/jenb.2016.0063; Kaynak G, 2013, DIABET FOOT ANKLE, V4, P1; King J, 2020, ANN DIAGN PATHOL, V47, DOI 10.1016/j.anndiagpath.2020.151509; Konarzewska A, 2018, J ULTRASON, V18, P42, DOI 10.15557/JoU.2018.0007; La Fontaine Javier, 2016, Foot (Edinb), V26, P7, DOI 10.1016/j.foot.2015.11.001; Margolis DJ, 2011, DATA POINTS PUBL SER; Mayfield JA, 1998, DIABETES CARE, V21, P2161, DOI 10.2337/diacare.21.12.2161; McCabe LR, 2019, BONE, V118, P20, DOI 10.1016/j.bone.2018.03.024; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Ok DP, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0852-z; Papanas N, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.20872; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; Petrova NL, 2010, DIABETES CARE, V33, P2254, DOI 10.2337/dc10-0636; Petrova NL, 2005, DIABETIC MED, V22, P756, DOI 10.1111/j.1464-5491.2005.01510.x; Rajbhandari SM, 2002, DIABETOLOGIA, V45, P1085, DOI 10.1007/s00125-002-0885-7; Rogers LC, 2011, DIABETES CARE, V34, P2123, DOI 10.2337/dc11-0844; Schon LC, 2002, FOOT ANKLE INT, V23, P30, DOI 10.1177/107110070202300106; Smith AG, 2012, J PERIPHER NERV SYST, V17, P15, DOI 10.1111/j.1529-8027.2012.00390.x; Sohn MW, 2010, DIABETES CARE, V33, P98, DOI 10.2337/dc09-1497; Sohn MW, 2009, DIABETES CARE, V32, P816, DOI 10.2337/dc08-1695; Vincent AM, 2009, ROLE OXLDL LOX, P58; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wukich DK, 2014, FOOT ANKLE INT, V35, P1108, DOI 10.1177/1071100714547218; Xu LL, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/305205; YOUNG MJ, 1995, DIABETES CARE, V18, P34, DOI 10.2337/diacare.18.1.34	37	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	FEB	2022	56								151878	10.1016/j.anndiagpath.2021.151878			8	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	YL7MN	WOS:000746072600003	34953234				2022-02-06	
J	Sullivan, JE; Panjwani, S; Cahan, MA				Sullivan, Jennifer E.; Panjwani, Suraj; Cahan, Mitchell A.			Influence of Insurance Status on Subdural Hematoma Management- An NTDB Analysis	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Insurance; Subdural hematoma; Disparity	MORTALITY; RACE	Background: Traumatic brain injury is a major public health concern with a rising inci-dence in the United States. Prior studies have looked at associations between insurance status and traumatic brain injury, but none have focused specifically on traumatic subdural hematomas (SDH). It is important to evaluate whether insurance and/or other social deter-minants of health play a role in treatment and outcomes of traumatic SDH. Methods: A retrospective analysis of the National Trauma Data Bank was conducted from 2012 to 2016 to look at associations between insurance status and management of SDH with surgery versus intracranial pressure (ICP)/EVD monitoring. Secondary outcomes of interest were emergency department (ED) length of stay (LOS), hospital LOS, ICU admission, ICU LOS, and mortality. Results: We identified 68,687 adult patients with a single diagnosis of subdural hematoma. Overall, self-pay patients with SDH were younger, predominately male, and more likely to be non-white compared to patients with public or private health insurance. More specifically, Black/African American SDH patients made up a large percentage of the self-pay category (15.5%; P < 0.001) compared to publicly and privately insured (7.5% and 8.0%, respectively). After adjusting for age, sex, injury severity score (ISS), Glasgow Coma Scale, alcohol intoxica-tion, and trauma center level, publicly insured patients were 1.86 (95% CI 1.36-2.55, P < 0.001) times more likely to undergo a craniotomy or craniectomy compared to self-pay patients. However, insurance status did not appear to impact whether a patient received ICP/EVD monitoring (OR 0.52; 95% CI 0.24-1.18, P = 0.118). There was no statistically significant dif-ference in ED LOS, Hospital LOS, and ICU LOS between insurance categories. Conclusions: Publicly insured patients have higher odds of undergoing surgical management for traumatic SDH compared to self-pay patients. Further studies evaluating this association are warranted. (c) 2021 Elsevier Inc. All rights reserved.	[Sullivan, Jennifer E.; Panjwani, Suraj; Cahan, Mitchell A.] Univ Massachusetts, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA; [Panjwani, Suraj] St Marys Hosp Trinity Hlth New England, Dept Surg, Hartford, CT USA; [Cahan, Mitchell A.] Mt Auburn Hosp, Dept Surg, Cambridge, MA USA; [Cahan, Mitchell A.] Beth Israel Deaconess Med Ctr, Roberta & Stephen R Weiner Dept Surg, Boston, MA 02215 USA		Cahan, MA (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.	Mitchell.Cahan@mah.org		Panjwani, Suraj/0000-0002-4695-8148; Sullivan, Jennifer/0000-0002-6842-5932			Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Conway D., ADULTS AGE 26 HAD HI; Englum BR, 2016, AM SURGEON, V82, P281; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Follow M.G., EFFECTS MEDICAID EXP; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; Hagerty V, 2020, WORLD NEUROSURG, V141, pE484, DOI 10.1016/j.wneu.2020.05.214; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Kaiser Family Foundation, STAT STAT MED EXP DE; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Marion DW, 2006, NEUROSURGERY, V58, P655; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Mikhail JN, 2016, J TRAUMA NURS, V23, P347, DOI 10.1097/JTN.0000000000000246; Nayebaghayee Hossein, 2016, Asian J Neurosurg, V11, P46, DOI 10.4103/1793-5482.165780; Porter A, 2020, CRIT CARE MED, V48, pE584, DOI 10.1097/CCM.0000000000004398; Reid LD, 2020, INPATIENT STAYS EMER; Short SS, 2013, J SURG RES, V184, P383, DOI 10.1016/j.jss.2013.03.042	19	0	0	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2022	270						139	144		10.1016/j.jss.2021.08.018			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WI2XE	WOS:000708229000018	34656891				2022-02-06	
J	Sun, L; Liu, R; Yang, HJ; Yu, TT; Wu, JP; Wang, Q				Sun, Lei; Liu, Ru; Yang, Huajun; Yu, Tingting; Wu, Jianping; Wang, Qun			Characteristics of Epileptiform Spike-wave Discharges and Chronic Histopathology in Controlled Cortical Impact Model of Sprague-Dawley Rats	NEUROCHEMICAL RESEARCH			English	Article; Early Access						Traumatic brain injury; Nonconvulsive seizure; Spike-wave discharges; Chronic histopathology; Reactive gliosis	PERCUSSION BRAIN-INJURY; POSTTRAUMATIC EPILEPSY; ABSENCE EPILEPSY; RETIGABINE; SEIZURES; CONSCIOUSNESS; INHIBITION; MECHANISMS; MOUSE	Post-traumatic epilepsy (PTE) is a serious complication that can occur following traumatic brain injury (TBI). Sustained secondary changes after TBI promote the process of PTE. Here, we aim to evaluate changes in behavior, electrocorticogram, and histomorphology in rats following chronic TBI models. We observed intensive 7-8 Hz spike-wave-discharges (SWDs) at frontal recording sites and quantified them in SD rats with different degrees of TBI and compared them with age-matched sham rats to evaluate the association between SWDs and injury severity. Notably, although SWDs were even presented in the sham group, the number and duration of events were much lower than those in the TBI groups. SWDs have numerous similarities to absence seizures, such as abrupt onset, termination, and lack of postictal suppression, which may be the nonconvulsive characteristics of PTE. Retigabine, a novel antiepileptic drug, is ineffective in reducing SWDs. In addition, we examined chronic histopathological changes in TBI rats. Rats subjected to moderate and severe TBI exhibited significantly impaired neurological function, which was accompanied by marked cortical injury, hippocampus deformation, reactive gliosis, and mossy fiber sprouting. Long-term progressive structural changes in the brain are one of the characteristics of epileptogenesis after TBI. Our study provided the potential value of epileptiform SWDs in reflecting the nonconvulsive characteristic of PTE and highlighted the vital role of chronic pathological changes, such as reactive gliosis, in promoting the epileptogenesis following TBI.	[Sun, Lei; Liu, Ru; Yu, Tingting; Wu, Jianping; Wang, Qun] Capital Med Univ, Beijing Tiantan Hosp, Beijing 100070, Peoples R China; [Sun, Lei; Liu, Ru; Yang, Huajun; Yu, Tingting; Wu, Jianping] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100070, Peoples R China; [Sun, Lei; Liu, Ru; Yu, Tingting; Wu, Jianping; Wang, Qun] China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China; [Wu, Jianping] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China; [Wang, Qun] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China; [Yang, Huajun] Capital Med Univ, Beijing Friendship Hosp, Beijing 100050, Peoples R China		Wu, JP; Wang, Q (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing 100070, Peoples R China.; Wu, JP (corresponding author), Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100070, Peoples R China.; Wu, JP; Wang, Q (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing 100070, Peoples R China.; Wu, JP (corresponding author), Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China.; Wang, Q (corresponding author), Beijing Inst Brain Disorders, Beijing 100069, Peoples R China.	biojpwu@ccmu.edu.cn; wangq@ccmu.edu.cn			Capital Medical University Advanced Innovation Center for Human Brain Protection [20181101]; National Key R&D Program of China [2017YFC1307501]; Beijing-Tianjin-Hebei Cooperative Basic Research Program [H2018206435]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870935]	This work was mainly supported by the startup fund from Capital Medical University Advanced Innovation Center for Human Brain Protection (20181101, JW), and partially by grants from National Key R&D Program of China (2017YFC1307501, QW), Beijing-Tianjin-Hebei Cooperative Basic Research Program (H2018206435, QW), the National Natural Science Foundation of China (81870935, JW).	ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; COENEN AML, 1992, EPILEPSY RES, V12, P75, DOI 10.1016/0920-1211(92)90029-S; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Jones AL, 2018, NEUROLOGY, V90, pE474, DOI 10.1212/WNL.0000000000004927; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Komoltsev IG, 2021, NEUROSCI RES, V166, P42, DOI 10.1016/j.neures.2020.05.005; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Luttjohann A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00016; Mazarati A, 2008, EPILEPSIA, V49, P1777, DOI 10.1111/j.1528-1167.2008.01674.x; McCafferty C, 2018, NAT NEUROSCI, V21, P744, DOI 10.1038/s41593-018-0130-4; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Sick T, 2017, J NEUROTRAUM, V34, P2467, DOI 10.1089/neu.2016.4826; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; Sofroniew MV, 2020, TRENDS IMMUNOL, V41, P758, DOI 10.1016/j.it.2020.07.004; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Taylor JA, 2019, J NEUROSCI, V39, P4829, DOI 10.1523/JNEUROSCI.1167-18.2019; Tenney JR, 2013, EPILEPSY CURR, V13, P135, DOI 10.5698/1535-7511-13.3.135; Treven M, 2015, EPILEPSIA, V56, P647, DOI 10.1111/epi.12950; Walker MC., 2012, JASPERS BASIC MECH E; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107	44	0	0	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.												10.1007/s11064-022-03542-y		FEB 2022	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	YQ6UV	WOS:000749443400002	35103912				2022-02-06	
J	Teel, EF; Caron, JG; Gagnon, IJ				Teel, Elizabeth F.; Caron, Jeffrey G.; Gagnon, Isabelle J.			Higher parental stress is significantly related to longer clinical recovery times in concussed children: A mixed-methods study	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Pediatric; Traumatic brain injury; Anxiety; Symptoms; Qualitative; Quantitative	TRAUMATIC BRAIN INJURY; HIGH-SCHOOL; SYMPTOMS; OUTCOMES; PREDICTORS; ANXIETY; SPORT	Objectives: Parental stress and anxiety negatively influences a child's recovery following traumatic brain injury, but these relationships are largely unexplored in a concussion-specific sample. We hypothesized that children with parents experiencing high stress or with pre-existing anxiety would take significantly longer to recover from concussion. Design: Mixed-methods. Methods: Forty-nine concussed children (13.8 +/- 2.3 years, nfemales = 27) and their parents were recruited. Quantitative data were collected using the Perceived Stress Scale (10-item). Qualitative data (n = 12) were collected through a semi-structured interview with the parent. Kaplan-Meier curves and Cox proportional hazard models analyzed the effect of parental stress and anxiety on time in clinic (days between clinic presentation and discharge) and recovery time (days between concussion and clinic discharge). Thematic analysis was used to analyze interview data. Results: Parental anxiety was not significantly related to either the child's time in clinic (P = 0.27) or recovery time (P = 0.41). Conversely, higher perceived parental stress was related to longer recovery time (Hazard Ratio: 2.162, 95% CI: 1.075, 4.348; p = 0.03) for the injured child, with similar results for time in clinic (Hazard Ratio: 1.883, 95% CI: 0.966, 3.668, p = 0.06). During the interview, parents expressed their stress was directly tied to their child's symptoms and overall functioning and varied throughout recovery. Conclusions: Recovery time is significantly longer in concussed children whose parents are experiencing higher levels of stress, but not pre-existing anxiety, following injury. Parental stress varies throughout recovery, with stress generally higher in the acute post-injury period. Clinicians should monitor parental stress post-concussion when possible. (C) 2021 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Teel, Elizabeth F.; Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Caron, Jeffrey G.] Univ Montreal, Sch Kinesiol & Phys Act Sci, Montreal, PQ, Canada; [Caron, Jeffrey G.] Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada; [Gagnon, Isabelle J.] McGill Univ, Hlth Ctr, Trauma Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Teel, Elizabeth F.] 5252 Boul Masionneuve,Off 3E17, Montreal, PQ H4A 3S5, Canada; [Caron, Jeffrey G.] Ctr Educ Phys & Sports CEPSUM, Local 7229, Montreal, PQ H3T 1J4, Canada; [Gagnon, Isabelle J.] 5252 Boul Masionneuve,Off 3E45, Montreal, PQ H4A 3S5, Canada		Teel, EF (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.; Teel, EF (corresponding author), 5252 Boul Masionneuve,Off 3E17, Montreal, PQ H4A 3S5, Canada.	elizabeth.teel@mail.mcgill.ca; jeffrey.caron@umontreal.ca; isabelle.gagnon8@mcgill.ca			Toronto Dominion Bank Post-Doctoral Fellowship in Child Health Research Excellence through the Research Institute at the McGill University Health Centre; Fonds de Recherche du Quebec - Sante (FRQ-S); Reseau Provincial de Recherche en Adaptation-Readaptation	This study is funded by the Toronto Dominion Bank Post-Doctoral Fellowship in Child Health Research Excellence through the Research Institute at the McGill University Health Centre, Fonds de Recherche du Quebec - Sante (FRQ-S), and the Reseau Provincial de Recherche en Adaptation-Readaptation.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; Driscoll K., 2011, J EARLY CHILD INFANT, V7, P1; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gagnon I, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2019-2317; Greene JC, 1989, EEPA, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Lazarus R., 1966, PSYCHOL STRESS COPIN; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Legarreta AD, 2018, J NEUROSURG-PEDIATR, V22, P238, DOI 10.3171/2018.3.PEDS1850; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Moran AP, 2011, QUAL RES SPORT EXERC, V3, P362, DOI 10.1080/2159676X.2011.607843; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Teel EF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00672; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Williamson V, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012944; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220	31	0	0	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2022	25	2					108	114		10.1016/j.jsams.2021.08.014			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YJ6HR	WOS:000744633200003	34518082				2022-02-06	
J	Wang, G; Wu, HL; Liu, YP; Yan, DQ; Yuan, ZL; Chen, L; Yang, Q; Gao, YS; Diao, B				Wang, Gang; Wu, Hua-Ling; Liu, Yue-Ping; Yan, De-Qi; Yuan, Zi-Lin; Chen, Li; Yang, Qian; Gao, Yu-Song; Diao, Bo			Pre-clinical study of human umbilical cord mesenchymal stem cell transplantation for the treatment of traumatic brain injury: safety evaluation from immunogenic and oncogenic perspectives	NEURAL REGENERATION RESEARCH			English	Article							CYTOKINES; EXPRESSION; CHEMOKINES	Stem cell therapy is a promising strategy for the treatment of traumatic brain injury (TBI). However, animal experiments are needed to evaluate safety; in particular, to examine the immunogenicity and tumorigenicity of human umbilical cord mesenchymal stem cells (huMSCs) before clinical application. In this study, huMSCs were harvested from human amniotic membrane and umbilical cord vascular tissue. A rat model of TBI was established using the controlled cortical impact method. Starting from the third day after injury, the rats were injected with 10 mu L of 5 x 106/mL huMSCs by cerebral stereotaxis or with 500 mu L of 1 x 106/mL huMSCs via the tail vein for 3 successive days. huMSC transplantation decreased the serum levels of proinflammatory cytokines in rats with TBI and increased the serum levels of anti-inflammatory cytokines, thereby exhibiting good immunoregulatory function. The transplanted huMSCs were distributed in the liver, lung and brain injury sites. No abnormal proliferation or tumorigenesis was found in these organs up to 12 months after transplantation. The transplanted huMSCs negligibly proliferated in vivo, and apoptosis was gradually observed at later stages. These findings suggest that huMSC transplantation for the treatment of traumatic brain injury displays good safety. In addition, huMSCs exhibit good immunoregulatory function, which can help prevent and reduce secondary brain injury caused by the rapid release of inflammatory factors after TBI. This study was approved by the Ethics Committee of Wuhan General Hospital of PLA (approval No. 20160054) on November 1, 2016.	[Wang, Gang; Liu, Yue-Ping; Yuan, Zi-Lin; Chen, Li; Yang, Qian; Diao, Bo] Gen Hosp Cent Theater Command, Basic Med Lab, Wuhan, Hubei, Peoples R China; [Wang, Gang; Liu, Yue-Ping; Yuan, Zi-Lin; Chen, Li; Yang, Qian; Diao, Bo] Hubei Key Lab Cent Nervous Syst Tumor & Intervent, Wuhan, Hubei, Peoples R China; [Wu, Hua-Ling] Third Peoples Hosp Yongzhou, Dept Clin Lab, Yongzhou, Hunan, Peoples R China; [Yan, De-Qi; Gao, Yu-Song] 990th Hosp Joint Logist Support Troops PLA, Dept Neurosurg, Zhumadian, Henan, Peoples R China		Diao, B (corresponding author), Gen Hosp Cent Theater Command, Basic Med Lab, Wuhan, Hubei, Peoples R China.; Diao, B (corresponding author), Hubei Key Lab Cent Nervous Syst Tumor & Intervent, Wuhan, Hubei, Peoples R China.	dpitao@163.com			General Project of Hubei Health Committee of China [WJ2019M263]	The work was supported by the General Project of Hubei Health Committee of China, No. WJ2019M263 (to GW).	Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Bonsack B, 2020, CNS NEUROSCI THER, V26, P603, DOI 10.1111/cns.13378; Cassado AD, 2017, RESULTS PROBL CELL D, V62, P161, DOI 10.1007/978-3-319-54090-0_7; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Dehghanian F, 2020, J MOL NEUROSCI, V70, P677, DOI 10.1007/s12031-019-01475-w; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Garitaonandia I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34478; Gong HB, 2014, CANCER BIOL THER, V15, P185, DOI 10.4161/cbt.26719; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Kim HM, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12965; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Lam PK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01772-7; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LEONARDI E, 1992, J CLIN PATHOL, V45, P416, DOI 10.1136/jcp.45.5.416; Liu S, 2021, NEURAL REGEN RES, V16, DOI 10.4103/1673-5374.310698; Lo Sicco C, 2017, STEM CELL TRANSL MED, V6, P1018, DOI 10.1002/sctm.16-0363; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schepici G, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56030137; Schonenberger F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0618-9; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Sun C, 2021, NEURAL REGEN RES, V16, P2324, DOI 10.4103/1673-5374.310942; Svensson A, 2017, J NEURO-ONCOL, V131, P245, DOI 10.1007/s11060-016-2302-y; Tan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178624; Tyagi Vineet, 2016, Surg Neurol Int, V7, P78, DOI 10.4103/2152-7806.189296; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Xu LY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0087-0; Yuan CH., 2021, ZHONGGUO ZUZHI GONGC, V25, P5018; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou YX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00301; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	42	0	0	26	30	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2022	17	2					354	361		10.4103/1673-5374.317985			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	TQ2OU	WOS:000678125500031	34269210	gold, Green Published			2022-02-06	
J	Xu, XJ; Yang, MS; Zhang, B; Ge, QQ; Niu, F; Dong, JQ; Zhuang, Y; Liu, BY				Xu, Xiao-Jian; Yang, Meng-Shi; Zhang, Bin; Ge, Qian-Qian; Niu, Fei; Dong, Jin-Qian; Zhuang, Yuan; Liu, Bai-Yun			Genome-wide interrogation of transfer RNA-derived small RNAs in a mouse model of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article							OXIDATIVE STRESS; FRAGMENTS; CLP1; BIOGENESIS; METHYLATION; METABOLISM; MATURATION; TSRNAS; RAT	Transfer RNA (tRNA)-derived small RNAs (tsRNAs) are a recently established family of regulatory small non-coding RNAs that modulate diverse biological processes. Growing evidence indicates that tsRNAs are involved in neurological disorders and play a role in the pathogenesis of neurodegenerative disease. However, whether tsRNAs are involved in traumatic brain injury-induced secondary injury remains poorly understood. In this study, a mouse controlled cortical impact model of traumatic brain injury was established, and integrated tsRNA and messenger RNA (mRNA) transcriptome sequencing were used. The results revealed that 103 tsRNAs were differentially expressed in the mouse model of traumatic brain injury at 72 hours, of which 56 tsRNAs were upregulated and 47 tsRNAs were downregulated. Based on microRNA-like seed matching and Pearson correlation analysis, 57 differentially expressed tsRNA-mRNA interaction pairs were identified, including 29 tsRNAs and 26 mRNAs. Moreover, Gene Ontology annotation of target genes revealed that the significantly enriched terms were primarily associated with inflammation and synaptic function. Collectively, our findings suggest that tsRNAs may be associated with traumatic brain injury-induced secondary brain injury, and are thus a potential therapeutic target for traumatic brain injury. The study was approved by the Beijing Neurosurgical Institute Animal Care and Use Committee (approval No. 20190411) on April 11, 2019.	[Xu, Xiao-Jian; Yang, Meng-Shi; Zhang, Bin; Ge, Qian-Qian; Niu, Fei; Dong, Jin-Qian; Zhuang, Yuan; Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Yang, Meng-Shi; Zhang, Bin; Ge, Qian-Qian; Dong, Jin-Qian; Zhuang, Yuan; Liu, Bai-Yun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Yang, Meng-Shi; Zhang, Bin; Ge, Qian-Qian; Dong, Jin-Qian; Zhuang, Yuan; Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Liu, Bai-Yun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Bai-Yun] China Natl Clin Res, Ctr Neurol Dis, Beijing, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res, Ctr Neurol Dis, Beijing, Peoples R China.	liubaiyun1212@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471238, 81771327]; Beijing Municipal Health Commission [PXM2020_026280_000002]	This work was supported by grants from the National Natural Science Foundation of China, Nos. 81471238, 81771327; and Construction of Central Nervous System Injury Basic Science and Clinical Translational Research Platform, Budget of Beijing Municipal Health Commission 2020, No. PXM2020_026280_000002 (all to BYL).	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001; Assefa AT, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6721-y; Bae YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1180-y; Balatti V, 2017, P NATL ACAD SCI USA, V114, P8071, DOI 10.1073/pnas.1706908114; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/nmeth.3508, 10.1038/NMETH.3508]; Dhahbi JM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00074; Elkordy A, 2019, BRAIN RES, V1714, P8, DOI 10.1016/j.brainres.2019.02.019; Elkordy A, 2018, J NEUROCHEM, V146, P560, DOI 10.1111/jnc.14321; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Fujikawa DG, 2015, COMPUT STRUCT BIOTEC, V13, P212, DOI 10.1016/j.csbj.2015.03.004; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Geslain R, 2011, P NATL ACAD SCI USA, V108, P16489, DOI 10.1073/pnas.1113715108; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Hayne CK, 2020, NUCLEIC ACIDS RES, V48, P7609, DOI 10.1093/nar/gkaa438; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hogg MC, 2019, J CLIN INVEST, V129, P2946, DOI 10.1172/JCI126346; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Hu B, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0207-x; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jehn J, 2020, RNA, V26, P694, DOI 10.1261/rna.073395.119; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Karaiskos S, 2016, F1000RES 5ISCB COMM, V5; Kim HK, 2017, NATURE, V552, P57, DOI 10.1038/nature25005; Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li SQ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050246; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Martin A, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418774267; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Qin C, 2020, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00326; Qin C, 2020, NEURAL REGEN RES, V15, P212, DOI 10.4103/1673-5374.265560; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rudinger-Thirion J, 2011, P NATL ACAD SCI USA, V108, pE794, DOI 10.1073/pnas.1103698108; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Shan NY, 2020, CANCERS, V12, DOI 10.3390/cancers12082230; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Shi JC, 2019, TRENDS BIOCHEM SCI, V44, P185, DOI 10.1016/j.tibs.2018.09.007; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Su ZL, 2020, RNA BIOL, V17, P1183, DOI 10.1080/15476286.2020.1721047; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun TJ, 2021, ZHONGGUO ZUZHI GONGC, V25, P123; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Wang CJ, 2019, MOL MED REP, V19, P3564, DOI 10.3892/mmr.2019.10024; Weitzer S, 2015, WIRES RNA, V6, P47, DOI 10.1002/wrna.1255; Winek K, 2020, P NATL ACAD SCI USA, V117, P32606, DOI 10.1073/pnas.2013542117; Xie YY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00217-4; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yang MS, 2021, NEURAL REGEN RES, V16, P1235, DOI 10.4103/1673-5374.301028; Yu MQ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00955-6; Zhang B, 2020, J NEUROTRAUM, V37, P262, DOI 10.1089/neu.2019.6556; Zhang S, 2019, AGING-US, V11, P10485, DOI 10.18632/aging.102471; Zhang YF, 2019, NAT REV ENDOCRINOL, V15, P489, DOI 10.1038/s41574-019-0226-2; Zhang YF, 2017, CELL RES, V27, P1307, DOI 10.1038/cr.2017.109; Zhong FD, 2019, CELL RES, V29, P548, DOI 10.1038/s41422-019-0175-2; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhu CS, 2020, ACTA PHYSIOL, V228, DOI 10.1111/apha.13391; Zhu L, 2018, CANCER LETT, V419, P1, DOI 10.1016/j.canlet.2018.01.015	80	0	0	18	23	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2022	17	2					386	394		10.4103/1673-5374.314315			9	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	TQ2OU	WOS:000678125500035	34269214	Green Published, gold			2022-02-06	
J	Yoo, RE; Choi, SH; Youn, SW; Hwang, M; Kim, E; Oh, BM; Lee, JY; Hwang, I; Kang, KM; Yun, TJ; Kim, JH; Sohn, CH				Yoo, Roh-Eul; Choi, Seung Hong; Youn, Sung-Won; Hwang, Moonjung; Kim, Eunkyung; Oh, Byung-Mo; Lee, Ji Ye; Hwang, Inpyeong; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho			Myelin Content in Mild Traumatic Brain Injury Patients with Post-Concussion Syndrome: Quantitative Assessment with a Multidynamic Multiecho Sequence	KOREAN JOURNAL OF RADIOLOGY			English	Article						Mild traumatic brain injury; Multidynamic multiecho; Myelin volume; Post-concussion syndrome	TENSOR IMAGING DETECTS; DIFFUSION-TENSOR; WHITE-MATTER; MULTIPLE-SCLEROSIS; DEMYELINATION; DEGENERATION; INTEGRITY; SUPPORT	Objective: This study aimed to explore the myelin volume change in patients with mild traumatic brain injury (mTBI) with post-concussion syndrome (PCS) using a multidynamic multiecho (MDME) sequence and automatic whole-brain segmentation. Materials and Methods: Forty-one consecutive mTBI patients with PCS and 29 controls, who had undergone MRI including the MDME sequence between October 2016 and April 2018, were included. Myelin volume fraction (MVF) maps were derived from the MDME sequence. After three dimensional T1-based brain segmentation, the average MVF was analyzed at the bilateral cerebral white matter (WM), bilateral cerebral gray matter (GM), corpus callosum, and brainstem. The Mann-Whitney U-test was performed to compare MVF and myelin volume between patients with mTBI and controls. Myelin volume was correlated with neuropsychological test scores using the Spearman rank correlation test. Results: The average MVF at the bilateral cerebral WM was lower in mTBI patients with PCS (median [interquartile range], 25.2% [22.6%-26.4%]) than that in controls (26.8% [25.6%-27.8%]) (p = 0.004). The region-of-interest myelin volume was lower in mTBI patients with PCS than that in controls at the corpus callosum (1.87 cm(3) [1.70-2.05 cm(3)] vs. 2.21 cm(3) [1.86- 3.46 cm(3)]; p = 0.003) and brainstem (9.98 cm(3) [9.45-11.00 cm(3)] vs. 11.05 cm(3) [10.10-11.53 cm(3)]; p = 0.015). The total myelin volume was lower in mTBI patients with PCS than that in controls at the corpus callosum (0.45 cm(3) [0.39-0.48 cm(3)] vs. 0.48 cm(3) [0.45-0.54 cm(3)]; p = 0.004) and brainstem (1.45 cm(3) [1.28-1.59 cm(3)] vs. 1.54 cm(3) [1.42-1.67 cm(3)]; p = 0.042). No significant correlation was observed between myelin volume parameters and neuropsychological test scores, except for the total myelin volume at the bilateral cerebral WM and verbal learning test (delayed recall) (r = 0.425; p = 0.048). Conclusion: MVF quantified from the MDME sequence was decreased at the bilateral cerebral WM in mTBI patients with PCS. The total myelin volumes at the corpus callosum and brainstem were decreased in mTBI patients with PCS due to atrophic changes.	[Yoo, Roh-Eul; Choi, Seung Hong; Lee, Ji Ye; Hwang, Inpyeong; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chul-Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea; [Kim, Eunkyung; Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Rehabil Med, Coll Med, Seoul, South Korea; [Choi, Seung Hong] Inst Basic Sci IBS, Ctr Nanoparticle Res, Seoul, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Youn, Sung-Won] Daegu Catholic Univ, Dept Radiol, Med Ctr, Daegu, South Korea; [Hwang, Moonjung] GE Healthcare Korea, Seoul, South Korea; [Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea		Choi, SH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, 101 Daehak Ro, Seoul 03080, South Korea.	verocay1@snu.ac.kr		Oh, Byung-Mo/0000-0001-9353-7541; Hwang, Inpyeong/0000-0002-1291-8973; Choi, Seung Hong/0000-0002-0412-2270; Lee, Ji Ye/0000-0002-3929-6254; Yun, Tae Jin/0000-0001-8441-4574; Kim, Eunkyung/0000-0001-6264-722X	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science ICT and Future Planning [NRF-2020R1A2C2008949, NRF-2020R1A4A1018714]; Creative Pioneering Researchers Program through Seoul National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2017R1D1A1B04034838]; Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT, South Korea); Ministry of Trade, Industry and Energy; Ministry of Health and Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea; Ministry of Food and Drug SafetyMinistry of Food & Drug Safety (MFDS) [9991007218, KMDF_PR_20200901_0086]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2021R1A4A1028713]; Institute for Basic Science [IBS-R006-A1]	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science ICT and Future Planning (NRF-2020R1A2C2008949, NRF-2020R1A4A1018714) ; Creative Pioneering Researchers Program through Seoul National University; Institute for Basic Science (IBS-R006-A1) ; the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2017R1D1A1B04034838) ; and the Korea Medical Device Development Fund grant funded by the Korea government (the Ministry of Science and ICT, South Korea; the Ministry of Trade, Industry and Energy; the Ministry of Health and Welfare, Republic of Korea; and the Ministry of Food and Drug Safety) (project no. 9991007218, KMDF_PR_20200901_0086) . This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2021R1A4A1028713) .	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alves W., 1992, PHYS MED REHABIL STA, V6, P21; Andica C, 2018, J NEURORADIOLOGY, V45, P164, DOI 10.1016/j.neurad.2017.10.002; Bai LJ, 2020, HUM BRAIN MAPP, V41, P4431, DOI 10.1002/hbm.25135; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Hagiwara A, 2019, AM J NEURORADIOL, V40, P1642, DOI 10.3174/ajnr.A6209; Hagiwara A, 2017, AM J NEURORADIOL, V38, P237, DOI 10.3174/ajnr.A4977; Hagiwara A, 2019, INVEST RADIOL, V54, P39, DOI 10.1097/RLI.0000000000000510; Hagiwara A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28852-6; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kwon JS, 2002, J KOREAN NEUROPSYCHI, V41, P347; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mohammadian M, 2020, J NEUROTRAUM, V37, P2616, DOI 10.1089/neu.2020.7081; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spader HS, 2019, J NEUROSURG, V130, P1321, DOI 10.3171/2017.12.JNS171597; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Warntjes JBM, 2017, AM J NEURORADIOL, V38, P1096, DOI 10.3174/ajnr.A5168; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	42	0	0	0	0	KOREAN SOCIETY OF RADIOLOGY	SEOUL	71, YANGJAECHEON-RO, SEOCHO-GU, SEOUL, SOUTH KOREA	1229-6929	2005-8330		KOREAN J RADIOL	Korean J. Radiol.	FEB	2022	23	2					226	236		10.3348/kjr.2021.0253			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	YP3AL	WOS:000748497500009	35029073				2022-02-06	
J	Zhang, CM; Lee, VKH; Yu, JML; Cheung, JPY; Koljonen, PA; Shea, GKH				Zhang, Changmeng; Lee, Victor Kam Ho; Yu, Jeremy Man Leung; Cheung, Jason Pui Yin; Koljonen, Paul Aarne; Shea, Graham Ka Hon			Length of Cervical Stenosis, Admission ASIA Motor Scores, and BASIC Scores Are Predictors of Recovery Rate Following Central Cord Syndrome	SPINE			English	Article						central cord syndrome; prognostic factors; spinal cord injury; surgical decompression; trauma	INJURY; DECOMPRESSION; SURGERY; SPINE	Study Design. A retrospective cohort study. Objective. This study aims to determine whether quantitative magnetic resonance imaging (MRI) parameters and radiological scoring systems could be used as a reliable assessment tool for predicting neurological recovery trajectory following acute traumatic central cord injury syndrome (CCS). Summary of Background Data. Controversy remains in whether CCS should be managed conservatively or by early surgical decompression. It is essential to understand how clinical and radiological parameters correlate with neurological deficits and how they predict recovery trajectories. Methods. We identified patients with CCS admitted between 2011 and 2018 with a minimum of 1-year follow-up. Cervical MRIs were analyzed for cord/canal dimensions, Brain and Spinal Injury Center (BASIC) scores and sagittal grading as ordinal scales of intraparenchymal cord injury. Japanese Orthopaedic Association (JOA) recovery rates (>= 50% as good, < 50% as poor) were analyzed against these variables by logistic regression and receiver operator characteristic (ROC) curves. Additionally, we evaluated American Spinal Injury Association motor scale (AMS) scores/recovery rates. Results. Sixty patients were included, of which 30 were managed conservatively and 30 via surgical decompression. The average follow-up duration for the entire cohort was (51.1 +/- 25.7) months. Upon admission, sagittal grading correlated with AMS and JOA scores (P < 0.01, beta = 0.48). Volume of the C2 to C7 canal and axial cord area over the site of maximal compression correlated with AMS and JOA scores respectively (P = 0.04, beta = 0.26; P = 0.01, beta = 0.28). We determined admission AMS more than 61 to be a clinical cutoff for good recovery (area under the receiver operating curve [AUC] = 0.74, 95% confidence interval [CI]: 0.61-0.85, sensitivity 80.9%, specificity 69.2%, P < 0.01). Radiological cutoffs to identify patients with poor recovery rates were length of cervical spinal stenosis more than 3.9 cm (AUC = 0.76, 95% CI: 0.63-0.87, specificity 91.7%, sensitivity 52.2%, P < 0.01), BASIC score of more than 1 (AUC = 0.69, 95% CI: 0.56-0.81, specificity 80.5%, sensitivity 51.1%, P = 0.02). Surgical decompression performed as a salvage procedure upon plateau of recovery did not improve neurological outcomes. Conclusion. Clinical and radiological parameters upon presentation were prognosticative of neurological recovery rates in CCS. Surgery performed beyond the acute post-injury period failed to improve outcomes.	[Zhang, Changmeng; Cheung, Jason Pui Yin; Koljonen, Paul Aarne; Shea, Graham Ka Hon] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Lee, Victor Kam Ho; Yu, Jeremy Man Leung] Queen Mary Hosp, Dept Radiol, Hong Kong, Peoples R China		Shea, GKH (corresponding author), Queen Mary Hosp, Dept Orthopaed & Traumatol, Gen Off, Pokfulam, 5th Floor,Professorial Block, Hong Kong, Peoples R China.	hkgshea@gmail.com	Cheung, Jason Pui Yin/AAJ-2016-2020	Cheung, Jason Pui Yin/0000-0002-7052-0875; Lee, Kam Ho/0000-0002-1641-7180	University of Hong KongUniversity of Hong Kong	This work was funded in part by Basic Science Seed Funding from the University of Hong Kong.	Aarabi B, 2011, J NEUROSURG-SPINE, V14, P122, DOI 10.3171/2010.9.SPINE09922; Aito S, 2007, SPINAL CORD, V45, P292, DOI 10.1038/sj.sc.3101944; Al-Habib AF, 2011, J NEUROTRAUM, V28, P1431, DOI 10.1089/neu.2009.1157; Badhiwala JH., 2019, NEUROSURGERY, V66, DOI [10.1093/neuros/nyz310_447, DOI 10.1093/NEUROS/NYZ310_447]; Brodell DW, 2015, SPINE J, V15, P435, DOI 10.1016/j.spinee.2014.09.015; Brooks NP, 2017, NEUROSURG CLIN N AM, V28, P41, DOI 10.1016/j.nec.2016.08.002; Chen TY, 1998, SPINE, V23, P2398, DOI 10.1097/00007632-199811150-00007; Dvorak MF, 2005, SPINE, V30, P2303, DOI 10.1097/01.brs.0000182304.35949.11; Farhadi HF, 2018, J NEUROTRAUM, V35, P1398, DOI 10.1089/neu.2017.5510; Furlan JC, 2011, SPINE, V36, P784, DOI 10.1097/BRS.0b013e3181e7be3a; Guest J, 2002, J NEUROSURG, V97, P25, DOI 10.3171/spi.2002.97.1.0025; Hur JW, 2016, J SPINAL CORD MED, V39, P655, DOI 10.1179/2045772315Y.0000000048; Krappinger D, 2019, EUR SPINE J, V28, P434, DOI 10.1007/s00586-018-5796-5; Lenehan B, 2009, EUR SPINE J, V18, P1458, DOI 10.1007/s00586-009-1107-5; Nowak DD, 2009, J AM ACAD ORTHOP SUR, V17, P756, DOI 10.5435/00124635-200912000-00004; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; SCHNEIDER RC, 1954, J NEUROSURG, V11, P546, DOI 10.3171/jns.1954.11.6.0546; Song J, 2005, J CLIN NEUROSCI, V12, P438, DOI 10.1016/j.jocn.2004.04.008; Stevenson CM, 2016, SPINAL CORD, V54, P1010, DOI 10.1038/sc.2016.34; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Tench CR, 2005, J MAGN RESON IMAGING, V21, P197, DOI 10.1002/jmri.20253; Thompson C, 2015, EUR SPINE J, V24, P195, DOI 10.1007/s00586-014-3432-6; Uribe J, 2005, SURG NEUROL, V63, P505, DOI 10.1016/j.surneu.2004.09.037; Wei LX, 2019, CLIN NEUROL NEUROSUR, V178, P1, DOI 10.1016/j.clineuro.2019.01.006; Wilson JR, 2020, GLOB SPINE J, V10, p84S, DOI 10.1177/2192568219877860; Yamazaki T, 2005, SURG NEUROL, V63, P95, DOI 10.1016/j.surneu.2004.03.020	26	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	FEB 1	2022	47	3					212	219		10.1097/BRS.0000000000004178			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	YC3CG	WOS:000739571700009	34310538				2022-02-06	
J	Brown, HK; Saha, S; Chan, TCY; Cheung, AM; Fralick, M; Ghassemi, M; Herridge, M; Kwan, J; Rawal, S; Rosella, L; Tang, T; Weinerman, A; Lunsky, Y; Razak, F; Verma, AA				Brown, Hilary K.; Saha, Sudipta; Chan, Timothy C. Y.; Cheung, Angela M.; Fralick, Michael; Ghassemi, Marzyeh; Herridge, Margaret; Kwan, Janice; Rawal, Shail; Rosella, Laura; Tang, Terence; Weinerman, Adina; Lunsky, Yona; Razak, Fahad; Verma, Amol A.			Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							DEVELOPMENTAL-DISABILITIES; ASSOCIATION; DISCHARGE; PEOPLE; HEALTH; BENEFICIARIES; ADULTS; WOMEN; RISK	Background: Disability-related considerations have largely been absent from the COVID-19 response, despite evidence that people with disabilities are at elevated risk for acquiring COVID-19. We evaluated clinical outcomes in patients who were admitted to hospital with COVID-19 with a disability compared with patients without a disability. Methods: We conducted a retrospective cohort study that included adults with COVID-19 who were admitted to hospital and discharged between Jan. 1, 2020, and Nov. 30, 2020, at 7 hospitals in Ontario, Canada. We compared in-hospital death, admission to the intensive care unit (ICU), hospital length of stay and unplanned 30-day readmission among patients with and without a physical disability, hearing or vision impairment, traumatic brain injury, or intellectual or developmental disability, overall and stratified by age (<= 64 and >= 65 yr) using multivariable regression, controlling for sex, residence in a long-term care facility and comorbidity. Results: Among 1279 admissions to hospital for COVID-19, 22.3% had a disability. We found that patients with a disability were more likely to die than those without a disability (28.1% v. 17.6%), had longer hospital stays (median 13.9 v. 7.8 d) and more readmissions (17.6% v. 7.9%), but had lower ICU admission rates (22.5% v. 28.3%). After adjustment, there were no statistically significant differences between those with and without disabilities for in-hospital death or admission to ICU. After adjustment, patients with a disability had longer hospital stays (rate ratio 1.36, 95% confidence interval [CI] 1.19-1.56) and greater risk of readmission (relative risk 1.77, 95% CI 1.14-2.75). In age-stratified analyses, we observed longer hospital stays among patients with a disability than in those without, in both younger and older subgroups; readmission risk was driven by younger patients with a disability. Interpretation: Patients with a disability who were admitted to hospital with COVID-19 had longer stays and elevated readmission risk than those without disabilities. Disability-related needs should be addressed to support these patients in hospital and after discharge.	[Brown, Hilary K.] Univ Toronto Scarborough, Dept Hlth & Soc, Scarborough, ON, Canada; [Saha, Sudipta; Chan, Timothy C. Y.; Razak, Fahad; Verma, Amol A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Brown, Hilary K.; Rosella, Laura] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chan, Timothy C. Y.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Cheung, Angela M.; Fralick, Michael; Herridge, Margaret; Kwan, Janice; Rawal, Shail; Tang, Terence; Weinerman, Adina; Lunsky, Yona; Verma, Amol A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ghassemi, Marzyeh] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Lunsky, Yona] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Cheung, Angela M.; Fralick, Michael; Rawal, Shail] Sinai Hlth Syst, Dept Med, Toronto, ON, Canada; [Ghassemi, Marzyeh] Toronto Gen Hosp, Vector Inst, Toronto, ON, Canada; [Cheung, Angela M.; Herridge, Margaret] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Weinerman, Adina] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Lunsky, Yona] Ctr Addict & Mental Hlth, Azrieli Adult Neurodev Ctr, Toronto, ON, Canada; [Razak, Fahad; Verma, Amol A.] Unity Hlth Toronto, Dept Med, Toronto, ON, Canada; [Rosella, Laura; Tang, Terence] Trillium Hlth Partners, Inst Better Hlth, Mississauga, ON, Canada		Verma, AA (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Verma, AA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Verma, AA (corresponding author), Unity Hlth Toronto, Dept Med, Toronto, ON, Canada.	amol.verma@mail.utoronto.ca					[Anonymous], 2011, LANCET, V377, P1977, DOI 10.1016/S0140-6736(11)60844-1; [Anonymous], 2001, INT CLASS FUNCT DIS; [Anonymous], 2000, DIS SEC COND; [Anonymous], 2016, DIS CAN INIT FIND CA; [Anonymous], 2021, CAN COD STAND VERS 2; [Anonymous], 2018, MEAS HLTH INEQ TOOLK; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE257, DOI 10.1016/S2468-2667(20)30076-1; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Baksh RA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-052482; Bosworth ML, 2021, LANCET PUBLIC HEALTH, V6, pE817, DOI 10.1016/S2468-2667(21)00206-1; Bourke J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019113; Boyle CA, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100943; Brown HK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34993; Brown HK, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100909; Christensen DM, 2020, J GEN INTERN MED, V35, P2801, DOI 10.1007/s11606-020-05991-z; Darney BG, 2017, WOMEN HEALTH ISS, V27, P336, DOI 10.1016/j.whi.2016.12.007; Dessie ZG, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06536-3; Dixon-Ibarra A, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130251; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Embregts PJCM, 2021, J APPL RES INTELLECT, V34, P480, DOI 10.1111/jar.12812; Fortis S, 2018, J CRIT CARE, V48, P237, DOI 10.1016/j.jcrc.2018.09.005; Galea MD, 2021, J SPINAL CORD MED, DOI 10.1080/10790268.2020.1871254; Garcia-Azorin D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00781; Hariyanto TI, 2021, EUR ARCH PSY CLIN N, V271, P393, DOI 10.1007/s00406-020-01205-z; Healthcare Cost and Utilization Project (HCUP), 2020, CLIN CLASSIFICATIONS; Hippisley-Cox J, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n2244; Hirose N, 2021, J INTELLECT DEV DIS, DOI 10.3109/13668250.2021.1877644; Howard-Anderson J, 2016, J HOSP MED, V11, P407, DOI 10.1002/jhm.2560; Huls A, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100769; Javitt JC, 2007, OPHTHALMOLOGY, V114, P238, DOI 10.1016/j.ophtha.2006.07.054; Jesus TS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126178; Joy M, 2020, BRIT J GEN PRACT, V70, pE890, DOI 10.3399/bjgp20X713393; Kadri SS, 2020, JAMA-J AM MED ASSOC, V324, P2553, DOI 10.1001/jama.2020.20323; Karmakar M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.36462; Khoury AJ, 2013, DISABIL HEALTH J, V6, P141, DOI 10.1016/j.dhjo.2012.11.006; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Korupolu R, 2020, SPINAL CORD SER CASE, V6, DOI 10.1038/s41394-020-0284-7; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Kuper Hannah, 2020, Wellcome Open Res, V5, P79, DOI 10.12688/wellcomeopenres.15833.1; Landes SD, 2021, DISABIL HEALTH J, V14, DOI 10.1016/j.dhjo.2020.101051; Landes SD, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100969; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Li LM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.23282; Lin E, 2013, J INTELL DISABIL RES, V57, P462, DOI 10.1111/jir.12002; Mann JR, 2007, ANN FAM MED, V5, P528, DOI 10.1370/afm.740; McCoy JO, 2020, J ACUTE CARE PHYS TH, V11, P191, DOI 10.1097/JAT.0000000000000136; Mitchell JP, 2015, J HEALTHC QUAL, V37, P33, DOI 10.1097/01.JHQ.0000460126.88382.13; Morciano M, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01945-2; National Center on Birth Defects and Developmental Disabilities Division of Human Development and Disability, 2019, DIS HLTH DATA SYST D; Negrini S, 2020, ARCH PHYS MED REHAB, V101, P2027, DOI 10.1016/j.apmr.2020.08.001; Olulana Oluwaseyi, 2020, medRxiv, DOI 10.1101/2020.06.24.20139212; Parish SL, 2009, SOC SERV REV, V83, P33, DOI 10.1086/598755; Pawelka E, 2020, INFECTION, V48, P51, DOI 10.1007/s15010-019-01335-0; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Reed NS, 2020, LANCET PUBLIC HEALTH, V5, pE423, DOI 10.1016/S2468-2667(20)30161-4; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rotenberg S, 2021, COVID 19 VACCINATION; Staples John A, 2014, CMAJ Open, V2, pE77, DOI 10.9778/cmajo.20130053; Steptoe A, 2021, LANCET PUBLIC HEALTH, V6, pE365, DOI 10.1016/S2468-2667(21)00069-4; Strydom A, 2013, RES DEV DISABIL, V34, P1881, DOI 10.1016/j.ridd.2013.02.021; Taylor DM., 2018, AM DISABILITIES 2014; Turk MA, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100942; Verma AA, 2021, J AM MED INFORM ASSN, V28, P578, DOI 10.1093/jamia/ocaa225; Verma AA, 2021, CAN MED ASSOC J, V193, pE410, DOI 10.1503/cmaj.202795; Verma Amol A, 2017, CMAJ Open, V5, pE842, DOI 10.9778/cmajo.20170097; Williamson EJ, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1592; Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	68	0	0	0	0	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	JAN 31	2022	194	4					E112	E121		10.1503/cmaj.211277			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YP5VZ	WOS:000748692100001	35101870	gold			2022-02-06	
J	Chen, PY; Hsieh, SH; Lin, CK; Wei, L; Su, YK; Tsai, PS; Chiu, HY				Pin-Yuan Chen; Shu-Hua Hsieh; Che-Kuang Lin; Wei, Li; Yu-Kai Su; Pei-Shan Tsai; Hsiao-Yean Chiu			Mental fatigue mediates the relationship between cognitive functions and return to productive activity following traumatic brain injury: a mediation analysis	BRAIN INJURY			English	Article; Early Access						Cognitive functions; mental fatigue; return to productive activity; traumatic brain injury	DISABILITY RATING-SCALE; NORMATIVE DATA; MILD; VALIDITY; WORK; RELIABILITY; FREQUENCY; TESTS	Purpose We performed a mediation analysis to investigate how mental fatigue mediates the relationship between cognitive functions and the return to productive activity following TBI. Methods One hundred and one people (>= 20 years) with first-time TBI more than 3 months who completed a series of cognitive tasks followed by Chinese versions of the Mental Fatigue Scale and Community Integration Questionnaire-Revised. Mediation analysis was used to test our hypotheses. Results Recognition memory and information processing speed were the only cognitive functions correlated with mental fatigue (B = -0.56 and -0.37, P = .04 and < 0.001) and the return to productive activity (B = 0.69 and 0.19, both P < .001) after controlling for confounders. Mental fatigue partially mediated the associations of recognition memory and information processing speed with the return to productive activity (B = 0.15 and 0.08, P = .001 and < 0.001, proportion of mediation = 22% and 46%) after the adjustment of confounders. Conclusions The findings suggest that mental fatigue can partially mediate the relationship between cognitive deficits and return to productive activity. Mental fatigue can be considered a crucial, treatable mediator of the adverse effects of cognitive impairment upon return to productive activity following TBI.	[Pin-Yuan Chen] Chang Gung Mem Hosp, Dept Neurosurg, Keelung, Taiwan; [Pin-Yuan Chen] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Pin-Yuan Chen] Chang Gung Mem Hosp, Keelung Branch, Community Med Res Ctr, Keelung, Taiwan; [Shu-Hua Hsieh; Pei-Shan Tsai; Hsiao-Yean Chiu] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Shu-Hua Hsieh; Che-Kuang Lin] Far Eastern Mem Hosp, Dept Nursing, New Taipei, Taiwan; [Wei, Li] Taipei Med Univ, Dept Neurosurg, Wan Fang Hosp, Taipei, Taiwan; [Wei, Li] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Yu-Kai Su] Taipei Med Univ, Dept Neurosurg, Shuang Ho Hosp, New Taipei, Taiwan; [Hsiao-Yean Chiu] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Hsiao-Yean Chiu] Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan		Chiu, HY (corresponding author), 250 Wuxing St, Taipei 110, Taiwan.	hychiu0315@tmu.edu.tw		Tsai, Pei-Shan/0000-0003-1274-574X	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 110-2628-B-038-017]; Chang Gung Memorial HospitalChang Gung Memorial Hospital [CRRPG2K0041]	This study was supported by a grant to H.Y. Chiu from the Ministry of Science and Technology, Taiwan (MOST 110-2628-B-038-017) and to P. Y. Chen from the Chang Gung Memorial Hospital (CRRPG2K0041).	Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bowler R., 1992, CLIN NEUROPSYCHOL, V6, P103, DOI [10.1080/13854049208404123, DOI 10.1080/13854049208404123]; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Chiu HY, 2018, BRAIN INJURY, V32, P652, DOI 10.1080/02699052.2018.1432893; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Deepika A, 2017, NEUROL INDIA, V65, P83, DOI 10.4103/0028-3886.198228; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Materne M, 2019, J OCCUP REHABIL, V29, P728, DOI 10.1007/s10926-019-09833-6; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Messinis L, 2007, ARCH CLIN NEUROPSYCH, V22, P773, DOI 10.1016/j.acn.2007.06.005; Meyers JE., 1995, REY COMPLEX FIGURES; Milani Sadaf Arefi, 2018, Alzheimers Dement (Amst), V10, P773, DOI 10.1016/j.dadm.2018.09.003; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Tay MRJ, 2019, AM J PHYS MED REHAB, V98, P971, DOI 10.1097/PHM.0000000000001227; van Zomeren AH., 1994, CLIN NEUROPSYCOLOGY; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Watson PA, 2020, NEUROPSYCHOL REV, V30, P194, DOI 10.1007/s11065-020-09433-9; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003	42	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2022.2034044		JAN 2022	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP8BW	WOS:000748846000001	35099340				2022-02-06	
J	Yue, JK; Chang, D; Han, KJ; Wang, AS; Oh, T; Sun, PP				Yue, John K.; Chang, Diana; Han, Kasey J.; Wang, Albert S.; Oh, Taemin; Sun, Peter P.			Management of migrating intracranial bullet fragments in a 13-year-old female after firearm brain injury: technical and surgical nuances	BRAIN INJURY			English	Article; Early Access						Firearm injury; migrating bullet fragments; pediatric neurosurgery; penetrating brain injury; traumatic brain injury	GUNSHOT WOUNDS; HEAD; RATES	Introduction We present the challenges and nuances of management in a rare case of multiple migrating intracranial fragments after pediatric gunshot wound to the head (GSWH). Case Presentation A 13-year-old girl suffered left parietal GSWH, with new neurologic decline 3 days after initial debridement. Serial imaging showed the largest intracranial fragments had migrated into the left trigone, and descended further with head of bed (HOB) elevation. HOB was iteratively decreased, with concurrent intracranial pressure monitoring. After extubation, with an alert and stable neurologic exam, HOB was decreased to -15 degrees, allowing gravity-assisted migration of the fragments to an anatomically favorable position within the left occipital horn. The patient underwent occipital craniotomy for fragment retrieval on hospital day 27. Two large and >20 smaller fragments were retrieved using neuronavigation and intraoperative ultrasound. Forensics showed these to be .45 caliber handgun bullet fragments. The patient recovered well after 2-months of intensive inpatient rehabilitation. Discussion During new neurologic decline after GSWH, bullet migration must be considered and serial cranial imaging is requisite. Surgical retrieval of deep fragments requires judicious planning to minimize further injury. Tightly controlled HOB adjustments with gravity assistance for repositioning of fragments may have utility in optimizing anatomic favorability prior to surgery.	[Yue, John K.; Chang, Diana; Han, Kasey J.; Wang, Albert S.; Oh, Taemin; Sun, Peter P.] Univ Calif San Francisco, Dept Neurosurg, 1001 Potrero Ave,Bldg 1,Rm 101, San Francisco, CA 94143 USA; [Yue, John K.; Chang, Diana; Han, Kasey J.; Wang, Albert S.; Oh, Taemin; Sun, Peter P.] Univ Calif San Francisco, Dept Neurosurg, Div Pediat Neurosurg, San Francisco, CA 94143 USA		Yue, JK (corresponding author), Univ Calif San Francisco, Dept Neurosurg, 1001 Potrero Ave,Bldg 1,Rm 101, San Francisco, CA 94143 USA.	john.yue@ucsf.edu					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; BAKAY L, 1982, NEW YORK STATE J MED, V82, P313; Bedell Gary M, 2002, Pediatr Rehabil, V5, P107, DOI 10.1080/1363849021000013540; Bizhan Aarabi, 2015, Handb Clin Neurol, V127, P181, DOI 10.1016/B978-0-444-52892-6.00012-X; Castillo-Rangel C, 2010, NEUROCIRUGIA, V21, P326; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Deng HS, 2019, J NEUROSURG-PEDIATR, V24, P498, DOI 10.3171/2019.5.PEDS19119; Deng HS, 2019, J NEUROTRAUM, V36, P322, DOI 10.1089/neu.2017.5591; Duddleston PJ, 2020, J NEUROSURG-PEDIATR, V26, P445, DOI 10.3171/2020.4.PEDS19606; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; Fujimoto Y, 2001, NEUROL MED-CHIR, V41, P499, DOI 10.2176/nmc.41.499; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Grinshteyn E, 2019, PREV MED, V123, P20, DOI 10.1016/j.ypmed.2019.02.026; Hazama A, 2018, WORLD NEUROSURG, V117, P309, DOI 10.1016/j.wneu.2018.06.132; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Hughes BD, 2006, J NEUROSURG, V105, P233, DOI 10.3171/ped.2006.105.3.233; Hussain M, 2011, JCPSP-J COLL PHYSICI, V21, P182, DOI 03.2011/JCPSP.182183; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Karabagli H, 2005, PEDIATR NEUROSURG, V41, P148, DOI 10.1159/000085873; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Moores LE, 2012, WORLD NEUROSURG, V77, P481, DOI 10.1016/j.wneu.2011.07.029; Rammo RA, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.06.015; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Zafonte RD, 1998, ARCH PHYS MED REHAB, V79, P1469, DOI 10.1016/S0003-9993(98)90246-5	33	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2022.2034185		JAN 2022	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP7WB	WOS:000748830800001	35099341				2022-02-06	
J	Kornblith, E; Bahorik, A; Li, YX; Peltz, CB; Barnes, DE; Yaffe, K				Kornblith, Erica; Bahorik, Amber; Li, Yixia; Peltz, Carrie B.; Barnes, Deborah E.; Yaffe, Kristine			Traumatic brain injury, cardiovascular disease, and risk of dementia among older US Veterans	BRAIN INJURY			English	Article; Early Access						Veterans; traumatic brain injury; dementia; cardiovascular disease	ALZHEIMERS-DISEASE; HEAD-INJURY; EPIDEMIOLOGY; ASSOCIATION; DISABILITY; OUTCOMES; ADULTS	Objective: Traumatic brain injury (TBI) is associated with elevated rates of cardiovascular disease (CVD), and both CVD and TBI are risk factors for dementia. We investigated whether CVD and its risk factors underlie the association between TBI and dementia. Materials and Methods: Cox proportional hazards models among 195,416 Veterans Health Administration patients age 55+ with TBI and a non-TBI, age/sex/race-matched comparison sample. Results: Veterans +TBI were more likely to have any CVD diagnosis (24% vs 36% p = <0.001) or risk factor (83 vs. 90% p < .001) compared to -TBI. During follow-up (mean similar to 7 years), 12.0% of Veterans with TBI only (HR: 2.17 95% CI 2.09-2.25), and 10.3% with CVD only developed dementia (HR 1.21 95% CI 1.15-1.28), compared to 6.5% with neither. There was an additive association between TBI and CVD on dementia risk (HR 2.51, 95% CI 2.41-2.61). Among those +TBI (+/- CVD), risk was minimally attenuated by adjustment for CVD/CVD risk factors (unadjusted HR: 2.38, 95% CI: 2.31-2.45; adjusted HR: 2.17, 95% CI 2.10-2.23). Conclusions: Older veterans TBI have increased prevalence of CVD/CVD risk factors. TBI and CVD had an additive statistical association, with dementia risk increased by similar to 2.5-fold. However, CVD accounted for little of the association between TBI and dementia. More research is needed to understand mechanisms of TBI-dementia and inform clinical guidelines post-TBI.	[Kornblith, Erica; Li, Yixia; Peltz, Carrie B.; Barnes, Deborah E.; Yaffe, Kristine] San Francisco Vet Affairs Hlth Care Syst, 4150 Clement St, San Francisco, CA 94121 USA; [Kornblith, Erica; Bahorik, Amber; Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94143 USA; [Bahorik, Amber; Li, Yixia; Peltz, Carrie B.; Yaffe, Kristine] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Kornblith, E (corresponding author), San Francisco Vet Affairs Hlth Care Syst, 4150 Clement St, San Francisco, CA 94121 USA.	erica.kornblith@va.gov			Assistant Secretary of Defense for Health Affairs by the Department of Defense, through the Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award [W81XWH-18-PH/TBIRP-LIMBIC, W81XWH1920067, W81XWH-13-2-0095]; U.S. Department of Veterans Affairs Awards [I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, I01 RX 002170]; U.S. Army Medical Research Acquisition Activity, Fort Detrick MD	This work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Psychological Health/Traumatic Brain Injury Research Program Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award/W81XWH-18-PH/TBIRP-LIMBIC under Awards No. W81XWH1920067 and W81XWH-13-2-0095, and by the U.S. Department of Veterans Affairs Awards No. I01 CX002097, I01 CX002096, I01 HX003155, I01 RX003444, I01 RX003443, I01 RX003442, I01 CX001135, I01 CX001246, I01 RX001774, I01 RX 001135, I01 RX 002076, I01 RX 001880, I01 RX 002172, I01 RX 002173, I01 RX 002171, I01 RX 002174, and I01 RX 002170. The U.S. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.Dr. Yaffe was	Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Eriksson UK, 2010, ALZ DIS ASSOC DIS, V24, P213, DOI 10.1097/WAD.0b013e3181d1b99b; Fletcher-Sandersjoo A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051596; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nyam TTE, 2019, WORLD NEUROSURG, V122, pE740, DOI 10.1016/j.wneu.2018.10.130; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Peterson K., 2019, EVIDENCE BRIEF TRAUM; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stampfer MJ, 2006, J INTERN MED, V260, P211, DOI 10.1111/j.1365-2796.2006.01687.x; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; US Department of Veterans Affiars (VA) Veterans Health Administration (VHA) Dementia Steering Committee (DSC), 2016, VHA DEM STEER COMM R; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2	29	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2022.2033842		JAN 2022	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP7VN	WOS:000748829400001	35099335				2022-02-06	
J	Mollayeva, T; Tran, A; Chan, V; Colantonio, A; Escobar, MD				Mollayeva, Tatyana; Tran, Andrew; Chan, Vincy; Colantonio, Angela; Escobar, Michael D.			Sex-specific analysis of traumatic brain injury events: applying computational and data visualization techniques to inform prevention and management	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Data-driven research; Environment; Health analytics; Human factors; Physical force agent; The Haddon matrix; Sex	ALCOHOL-INTOXICATION; HEALTH; INTERVENTION; EPIDEMIOLOGY; STRATEGIES; ASSAULT; ADULTS; FALLS; CITY	Background The interplay of host, agent, and environment implicated in traumatic brain injury (TBI) events is difficult to account for in hypothesis-driven research. Data-driven analysis of injury data can enable insight into injury events in novel ways. This research dissected complex and multidimensional data at the time of the TBI event by exploiting data mining and information visualization methods. Methods We drew upon population-based decade-long health administrative data collected through the routine operation of the publicly funded health system in Ontario, Canada. We applied a computational approach to categorize health records of 235,003 patients with TBI versus the same number of reference patients without TBI, individually matched based on sex, age, place of residence, and neighbourhood income quantile. We adopted the basic concepts of the Haddon Matrix (host, agent, environment) to organize emerging factors significantly related to TBI versus non-TBI events. To explore sex differences, the data of male and female patients with TBI were plotted on heatmaps and clustered using hierarchical clustering algorithms. Results Based on detected similarities, the computational technique yielded 34 factors on which individual TBI-event codes were loaded, allowing observation of a set of definable patterns within the host, the agent, and the environment. Differences in the patterns of host, agent and environment were found between male and female patients with TBI, which are currently not identified based on data from injury surveillance databases. The results were internally validated. Conclusions The study outlines novel areas for research relevant to TBI and offers insight into how computational and visual techniques can be applied to advance the understanding of TBI event. Results highlight unique aspects of sex differences of the host and agent at the injury event, as well as differences in exposure to adverse social and environmental circumstances, which can be a function of gender, aiding in future studies of injury prevention and gender-transformative care.	[Mollayeva, Tatyana; Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Kite Toronto Rehabil Inst, Toronto, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Mollayeva, Tatyana; Chan, Vincy; Colantonio, Angela] Univ Toronto, Temerty Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Mollayeva, Tatyana; Tran, Andrew; Chan, Vincy] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Mollayeva, Tatyana; Tran, Andrew; Colantonio, Angela; Escobar, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mollayeva, Tatyana] Trinity Coll Dublin, Global Brain Hlth Inst, Inst Neurosci, Dublin, Ireland; [Chan, Vincy] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Hlth Network, Kite Toronto Rehabil Inst, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Toronto, Temerty Fac Med, Rehabil Sci Inst, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Mollayeva, T (corresponding author), Trinity Coll Dublin, Global Brain Hlth Inst, Inst Neurosci, Dublin, Ireland.	tatyana.mollayeva@utoronto.ca			Canada's Strategy for Patient-Oriented Research (SPOR); Ontario SPOR Support Unit; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Government of Ontario	This study utilized ICES Data & Analytic Services (DAS) and used de-identified data from the ICES Data Repository, which is managed by ICES with support from its funders and partners: Canada's Strategy for Patient-Oriented Research (SPOR), the Ontario SPOR Support Unit, the Canadian Institutes of Health Research and the Government of Ontario. The opinions, results, and conclusions reported are those of the authors. No endorsement by ICES or any of its funders or partners is intended or should be inferred. Parts of this material are based on data and information compiled and provided by CIHI. However, the analyses, conclusions, opinions, and statements expressed herein are those of the author and not necessarily those of CIHI.	Ahmadian L, 2021, BMC MED INFORM DECIS, V21, DOI 10.1186/s12911-021-01515-9; Al-Qurain AA, 2020, DRUG AGING, V37, P291, DOI 10.1007/s40266-019-00742-0; Asgari S, 2019, CRIT CARE MED, V47, pE880, DOI 10.1097/CCM.0000000000003966; Asuero AG, 2006, CRIT REV ANAL CHEM, V36, P41, DOI 10.1080/10408340500526766; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baru A, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-018-0206-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Bosch F, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0182-5; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Budd KM, 2019, SEX ABUSE-J RES TR, V31, P296, DOI 10.1177/1079063217706708; Buchele G, 2020, AGING CLIN EXP RES, V32, P441, DOI 10.1007/s40520-019-01215-5; Canadian Institutes of Health Research, SEX GEND HLTH RES; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chan V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240208; Chan V, 2020, ARCH PHYS MED REHAB, V101, P1523, DOI 10.1016/j.apmr.2020.05.017; Chell J, 2019, ACCIDENT ANAL PREV, V133, DOI 10.1016/j.aap.2019.07.015; Chishtie JA, 2020, J MED INTERNET RES, V22, DOI 10.2196/17892; Connell M, 2015, INT J LAW PSYCHIAT, V42-43, P98, DOI 10.1016/j.ijlp.2015.08.013; Coronado V.G, SURVEILLANCE TRAUMAT, P1; Coronado VG, 2012, CHAPTER TRAUMATIC BR, V2nd, P72; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; DiGiorgio AM, 2020, WORLD NEUROSURG, V135, DOI 10.1016/j.wneu.2019.12.095; Fijalkowski RJ, 2009, STAPP CAR CRASH JO, V53, P193; Fitzgerald K, 2020, HEALTH COMMUN, V35, P356, DOI 10.1080/10410236.2018.1563032; Folweiler KA, 2020, J NEUROTRAUM, V37, P1431, DOI 10.1089/neu.2019.6705; Freeman J, 2011, ACCIDENT ANAL PREV, V43, P34, DOI 10.1016/j.aap.2010.06.004; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Garza N, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00112; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Government of Canada, CAN HLTH CAR SYST; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; HADDON W, 1968, AM J PUBLIC HEALTH N, V58, P1431, DOI 10.2105/AJPH.58.8.1431; HADDON W, 1980, PUBLIC HEALTH REP, V95, P411; Haines KL, 2019, J SURG RES, V235, P131, DOI 10.1016/j.jss.2018.09.072; Ham LS, 2019, J STUD ALCOHOL DRUGS, V80, P252; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hearst MA, 2020, IEEE T VIS COMPUT GR, V26, P2748, DOI 10.1109/TVCG.2019.2904683; Ishiguro Lisa, 2016, Healthc Q, V19, P7; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jamoulle M., 2015, REV BRAS MED FAM COM, V10, P1; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kundu B, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18168; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Larsen ML, 2016, J FORENSIC LEG MED, V43, P8, DOI 10.1016/j.jflm.2016.06.007; Leo P, 2016, TRANSLATIONAL RES TR; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Loder RT, 2020, J FORENSIC LEG MED, V69, DOI 10.1016/j.jflm.2019.101887; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; MATZSCH T, 1986, J TRAUMA, V26, P538; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; McCreary DR, 2020, HEALTH PROMOT INT, V35, P535, DOI 10.1093/heapro/daz049; McKenzie K, 2012, EPIDEMIOL REV, V34, P4, DOI 10.1093/epirev/mxr014; McLean IA, 2013, BEST PRACT RES CL OB, V27, P39, DOI 10.1016/j.bpobgyn.2012.08.006; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.678971; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Navas JF, 2019, ACCIDENT ANAL PREV, V124, P174, DOI 10.1016/j.aap.2018.12.024; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oxley J, 2018, ACCIDENT ANAL PREV, V114, P77, DOI 10.1016/j.aap.2017.01.010; Pattanayak SK, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0130; Pena EA, 2011, ANN STAT, V39, P556, DOI 10.1214/10-AOS844; Peterson AB, 2019, J SAFETY RES, V71, P315, DOI 10.1016/j.jsr.2019.09.017; Puts MTE, 2017, AGE AGEING, V46, P383, DOI 10.1093/ageing/afw247; Pyper Evelyn, 2018, Healthc Q, V20, P6, DOI 10.12927/hcq.2018.25431; Rafanelli Martina, 2021, Minerva Med, DOI 10.23736/S0026-4806.21.07749-1; RAMSEYER GC, 1979, J EXP EDUC, V47, P307, DOI 10.1080/00220973.1979.11011698; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Rocha TAH, 2020, J NEUROSURG, V132, P1961, DOI 10.3171/2019.2.JNS182098; Schull M J, 2020, Int J Popul Data Sci, V4, P1135, DOI 10.23889/ijpds.v4i2.1135; Servia L, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01151-3; Shaffer VA, 2018, ANN BEHAV MED, V52, P429, DOI 10.1093/abm/kax008; Statistics Canada, 2017, ONT PROV CAN COUNTR; Sullman MJM, 2017, ACCIDENT ANAL PREV, V106, P23, DOI 10.1016/j.aap.2017.05.016; Tannenbaum C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0247-7; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; Vriend I, 2017, SPORTS MED, V47, P2027, DOI 10.1007/s40279-017-0718-y; World Health Organization, NEUROTRAUMA; World Health Organization, INT STAT CLASS DIS R; World Health Organization, PREV NONC DIS; Xiong LL, 2016, AIMS PUBLIC HEALTH, V3, P907, DOI 10.3934/publichealth.2016.4.907; Yamagami K, 2019, WORLD NEUROSURG, V130, pE26, DOI 10.1016/j.wneu.2019.05.140; Youkhana B, 2019, INJURY, V50, P1433, DOI 10.1016/j.injury.2019.06.023; Yu WY, 2013, ACCIDENT ANAL PREV, V50, P887, DOI 10.1016/j.aap.2012.07.015; Zetterqvist J, 2019, STAT MED, V38, P4749, DOI 10.1002/sim.8332; Zhang YH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020572; Zhao HQ, 2018, STAT APPL GENET MOL, V17, DOI 10.1515/sagmb-2017-0054	94	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	JAN 30	2022	22	1							30	10.1186/s12874-021-01493-6			17	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	YP1YZ	WOS:000748424900003	35094688	gold			2022-02-06	
J	Kesavan, C; Rundle, C; Mohan, S				Kesavan, Chandrasekhar; Rundle, Charles; Mohan, Subburaman			Repeated mild traumatic brain injury impairs fracture healing in male mice	BMC RESEARCH NOTES			English	Article						r-mTBI; Bone fracture; Mice; Three-point bending; Micro-CT	MODEL	Objectives The goal of this study was to evaluate the long-term impact of repeated (r) mild traumatic brain injury (mTBI) on the healing of fractures in a mouse model. Ten week-old male mice were subjected to r-mTBI once per day for 4 days followed by closed femoral fracture using a three-point bending technique, 1 week post impact and fracture healing phenotype evaluated at 20 weeks of age. Results Micro-CT analysis of the fracture callus region at nine weeks post fracture revealed reduced bone volume (30%, p < 0.05) in the r-mTBI fracture group compared to the control-fracture group. The connectivity density of the fracture callus bone was reduced by 40% (p < 0.01) in the r-mTBI fracture group. Finite element analysis of the fracture callus region showed reduced failure load (p = 0.08) in the r-mTBI group compared to control group. There was no residual cartilage in the fracture callus region of either the r-mTBI or control fracture group. The reduced fracture callus bone volume and mechanical strength of fracture callus in r-mTBI mice 9 weeks post fracture are consistent with negative effects of r-mTBI on fracture healing over a long-term resulting in decreased mechanical strength of the fracture callus.	[Kesavan, Chandrasekhar; Rundle, Charles; Mohan, Subburaman] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, 11201 Benton St, Loma Linda, CA 92357 USA; [Kesavan, Chandrasekhar; Rundle, Charles; Mohan, Subburaman] Loma Linda Univ, Dept Med, 11234 Anderson St, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Orthoped Surg, 11234 Anderson St, Loma Linda, CA 92354 USA		Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, 11201 Benton St, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Loma Linda Univ, Dept Med, 11234 Anderson St, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Orthoped Surg, 11234 Anderson St, Loma Linda, CA 92354 USA.	Subburaman.Mohan@va.gov			BLR&D merit review grant from Veterans Administration [1-101-BX-002717]; Veterans AdministrationUS Department of Veterans Affairs	This study was supported by a BLR&D merit review grant, 1-101-BX-002717, awarded to Subburaman Mohan from Veterans Administration. Subburaman Mohan is a recipient of Senior Research Career Scientist Award from Veterans Administration. The supporting Agencies did not participate in the design of the study, data collection and analysis, and interpretation of data nor in writing and reviewing the manuscript.	Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; de Bakker CMJ, 2017, CURR OSTEOPOROS REP, V15, P32, DOI 10.1007/s11914-017-0346-3; Ek O, 2013, LANCET, V381, P874, DOI 10.1016/S0140-6736(12)62173-4; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P772; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Ibrahim M, 2016, FOLIA BIOL-PRAGUE, V62, P175; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Kaur A, 2019, HISTOCHEM CELL BIOL, V151, P43, DOI 10.1007/s00418-018-1712-7; Kesavan C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55258-9; Kesavan C, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.42; Kgosidialwa O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133323; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Laskowitz D., 2016, TRANSLATIONAL RES TR; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Morioka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48126-z; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Ritter K, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/8835730; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sav A, 2019, PITUITARY, V22, P201, DOI 10.1007/s11102-019-00958-8; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Whittier DE, 2020, OSTEOPOROSIS INT, V31, P1607, DOI 10.1007/s00198-020-05438-5	33	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		1756-0500		BMC RES NOTES	BMC Res. Notes	JAN 29	2022	15	1							25	10.1186/s13104-022-05906-7			6	Biology; Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	YQ3LQ	WOS:000749214200001	35093144	gold			2022-02-06	
J	Brightwell, BD; Stone, A; Li, XJ; Hardy, P; Thompson, K; Noehren, B; Jacobs, C				Brightwell, Benjamin D.; Stone, Austin; Li, Xiaojuan; Hardy, Peter; Thompson, Katherine; Noehren, Brian; Jacobs, Cale			Blood flow Restriction training After patellar INStability (BRAINS Trial)	TRIALS			English	Article						Patellar instability; Blood-flow restriction training; Rehabilitation; Randomized controlled trial	RESISTANCE EXERCISE; METABOLIC STRESS; MUSCLE; DISLOCATIONS; MECHANISMS; STRENGTH; RISK; PAIN	Background: Patellar instability is a common and understudied condition that disproportionally affects athletes and military personnel. The rate of post-traumatic osteoarthritis that develops following a patellar dislocation can be up to 50% of individuals 5-15 years after injury. Conservative treatment is the standard of care for patellar instability however, there are no evidence-informed rehabilitation guidelines in the scientific literature. The purpose of this study is to assess the effectiveness of blood-flow restriction training (BFRT) for patellar instability. Our hypotheses are that this strategy will improve patient-reported outcomes and accelerate restoration of symmetric strength and knee biomechanics necessary to safely return to activity. Methods/design: This is a parallel-group, superiority, randomized, double-blinded, placebo-controlled clinical trial at the University of Kentucky, sports medicine clinic that aims to recruit 78 patients with acute patellar dislocations randomly allocated into two groups: (1) sham BFRT and (2) BFRT. Both groups will receive the current standard of care physical therapy 3 times per week for up to 9 weeks. Physical therapy sessions will consist of typical standard of care treatment followed by BFRT or sham BFRT. Primary outcomes include the Norwich Patellar Instability Scale, quadriceps strength, and imaging and biochemical biomarkers of cartilage degradation. Discussion: The current standard of care for non-operative treatment of patellar instability is highly variable does not adequately address the mechanisms necessary to restore lower extremity function and protect the long-term health of articular cartilage following injury. This proposed novel intervention strategy uses an easily implementable therapy to evaluate if BFRT significantly improves patient-reported outcomes, function, and joint health over the first year of recovery.	[Brightwell, Benjamin D.; Stone, Austin; Hardy, Peter; Thompson, Katherine; Noehren, Brian; Jacobs, Cale] Univ Kentucky, 740 S Limestone,Suite K401, Lexington, KY 40536 USA; [Li, Xiaojuan] Cleveland Clin, Cleveland, OH 44106 USA		Jacobs, C (corresponding author), Univ Kentucky, 740 S Limestone,Suite K401, Lexington, KY 40536 USA.	cale.jacobs@uky.edu			Department of DefenseUnited States Department of Defense [W81XWH2010449]; NIH National Center for Advancing Translational Sciences [UL1TR001998]	The project is funded by the Department of Defense (Award number: W81XWH2010449) with additional support by the NIH National Center for Advancing Translational Sciences through grant number UL1TR001998. The Department of Defense contact person for this trial is Robin Walker, PhD, Science Officer, Peer Review Medical Research Program (PRMRP), The Congressionally Directed Medical Research Programs (CDMRP), USAMRDC, Phone: 301.619.7177, Email:robin.k.walker5.ctr@mail.mil.The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Defense or NIH. The Department of Defense and the NIH did not have a role in the design of the study, collection, analysis, or interpretation of data, or writing the manuscript.	Amin S, 2009, ARTHRITIS RHEUM-US, V60, P189, DOI 10.1002/art.24182; Bowman EN, 2019, SPORTS HEALTH, V11, P149, DOI 10.1177/1941738118821929; Conchie H, 2016, KNEE, V23, P708, DOI 10.1016/j.knee.2016.04.009; Erickson LN, 2019, PHYS THER, V99, P1010, DOI 10.1093/ptj/pzz062; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; HAWKINS RJ, 1986, AM J SPORT MED, V14, P117, DOI 10.1177/036354658601400204; Kacin A, 2011, SCAND J MED SCI SPOR, V21, pE231, DOI 10.1111/j.1600-0838.2010.01260.x; Kuikka PI, 2013, SCAND J MED SCI SPOR, V23, P281, DOI 10.1111/j.1600-0838.2011.01397.x; Lucas KCH, 2020, KNEE, V27, P1285, DOI 10.1016/j.knee.2020.05.008; Moiz M, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118766275; Nielsen JL, 2012, J PHYSIOL-LONDON, V590, P4351, DOI 10.1113/jphysiol.2012.237008; NOYES FR, 1991, AM J SPORT MED, V19, P178, DOI 10.1177/036354659101900214; Pearson SJ, 2015, SPORTS MED, V45, P187, DOI 10.1007/s40279-014-0264-9; Powers CM, 1998, J ORTHOP SPORT PHYS, V28, P345, DOI 10.2519/jospt.1998.28.5.345; Salonen EE, 2017, AM J SPORT MED, V45, P1376, DOI 10.1177/0363546516687549; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Scott BR, 2014, SPORTS MED, V44, P1037, DOI 10.1007/s40279-014-0177-7; Slysz J, 2016, J SCI MED SPORT, V19, P669, DOI 10.1016/j.jsams.2015.09.005; Smith TO, 2019, KNEE, V26, P1192, DOI 10.1016/j.knee.2019.10.021; Suga T, 2012, EUR J APPL PHYSIOL, V112, P3915, DOI 10.1007/s00421-012-2377-x; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Thiebaud RS, 2013, INTERV MED APPL SCI, V5, P53, DOI 10.1556/IMAS.5.2013.2.1; Yasuda T, 2014, SCAND J MED SCI SPOR, V24, P799, DOI 10.1111/sms.12087	23	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JAN 28	2022	23	1							88	10.1186/s13063-022-06017-1			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	YP6AX	WOS:000748705300001	35090543	gold, Green Published			2022-02-06	
J	Celorrio, M; Shumilov, K; Payne, C; Vadivelu, S; Friess, SH				Celorrio, Marta; Shumilov, Kirill; Payne, Camryn; Vadivelu, Sangeetha; Friess, Stuart H.			Acute minocycline administration reduces brain injury and improves long-term functional outcomes after delayed hypoxemia following traumatic brain injury	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Hypoxemia; Minocycline; Neuroprotection; Secondary injury; Pre-clinical trial	CONTROLLED CORTICAL IMPACT; WHITE-MATTER INJURY; MICROGLIAL ACTIVATION; N-ACETYLCYSTEINE; CLINICAL-TRIAL; HEAD-INJURY; T-CELLS; NEUROPROTECTION; NEURODEGENERATION; PROGESTERONE	Clinical trials of therapeutics for traumatic brain injury (TBI) demonstrating preclinical efficacy for TBI have failed to replicate these results in humans, in part due to the absence of clinically feasible therapeutic windows for administration. Minocycline, an inhibitor of microglial activation, has been shown to be neuroprotective when administered early after experimental TBI but detrimental when administered chronically to human TBI survivors. Rather than focusing on the rescue of primary injury with early administration of therapeutics which may not be clinically feasible, we hypothesized that minocycline administered at a clinically feasible time point (24 h after injury) would be neuroprotective in a model of TBI plus delayed hypoxemia. We first explored several different regimens of minocycline dosing with the initial dose 24 h after injury and 2 h prior to hypoxemia, utilizing short-term neuropathology to select the most promising candidate. We found that a short course of minocycline reduced acute microglial activation, monocyte infiltration and hippocampal neuronal loss at 1 week post injury. We then conducted a preclinical trial to assess the long-term efficacy of a short course of minocycline finding reductions in hippocampal neurodegeneration and synapse loss, preservation of white matter myelination, and improvements in fear memory performance at 6 months after injury. Timing in relation to injury and duration of minocycline treatment and its impact on neuroinflammatory response may be responsible for extensive neuroprotection observed in our studies.	[Celorrio, Marta; Shumilov, Kirill; Payne, Camryn; Vadivelu, Sangeetha; Friess, Stuart H.] Washington Univ, St Louis Sch Med, Dept Pediat, Div Crit Care Med, 660 South Euclid Ave, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, St Louis Sch Med, Dept Pediat, Div Crit Care Med, 660 South Euclid Ave, St Louis, MO 63110 USA.	friess@wustl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097721]; Children's Discovery Institute of Washington University; St. Louis Children's Hospital [CDI-CORE-2015-505, CDI-CORE-2019-813]; Foundation for Barnes-Jewish Hospital [3770, 4642]; Office of Research Infrastructure Programs (ORIP), a part of the NIH Office of the Director [OD021629]; Washington University School of Medicine	This work was supported by the National Institutes of Health (R01NS097721). Fluorescent imaging was performed on a Zeiss Axio Imager Z2 Fluorescence Microscope with ApoTome 2 optical sectioning grid imager through the use of Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine, The Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CDI-CORE-2015-505 and CDI-CORE-2019-813) and the Foundation for Barnes-Jewish Hospital (3770 and 4642). Confocal imaging was generated on a Zeiss LSM 880 Airyscan Confocal Microscope which was purchased with support from the Office of Research Infrastructure Programs (ORIP), a part of the NIH Office of the Director under grant OD021629.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Bae S, 2020, BRAIN IMAGING BEHAV, V14, P1850, DOI 10.1007/s11682-019-00127-2; Becher B, 2000, GLIA, V29, P293; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Celorrio M, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01137-2; Celorrio M, 2021, EXP NEUROL, V335, DOI 10.1016/j.expneurol.2020.113507; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; Cornell Jessica, 2022, Neural Regen Res, V17, P705, DOI 10.4103/1673-5374.322423; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Duhaime AC, 2007, PEDIATR CRIT CARE ME, V8, P71, DOI 10.1097/01.PCC.0000253552.60687.AC; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fattoretti P, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00141; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hei MF, 2019, BEHAV BRAIN RES, V365, P26, DOI 10.1016/j.bbr.2019.02.044; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Parikh U, 2016, J NEUROPATH EXP NEUR, V75, P731, DOI 10.1093/jnen/nlw045; Pernici CD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64783-x; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sauerbeck AD, 2020, NEURON, V107, P257, DOI 10.1016/j.neuron.2020.04.012; Scheff SW, 1996, DEMENTIA, V7, P226, DOI 10.1159/000106884; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Sharma R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23458; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Strahan JA, 2017, DEV NEUROBIOL, V77, P753, DOI 10.1002/dneu.22457; Strickland BA, 2021, J CLIN NEUROSCI, V86, P50, DOI 10.1016/j.jocn.2021.01.005; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; WILLIAMS DN, 1974, LANCET, V2, P744; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Witcher KG, 2021, J NEUROSCI, V41, P1597, DOI 10.1523/JNEUROSCI.2469-20.2020; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	54	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JAN 28	2022	10	1							10	10.1186/s40478-022-01310-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YO9YO	WOS:000748288500001	35090569	gold			2022-02-06	
J	Hume, PA; Quarrie, KL; Lewis, GN; Theadom, A				Hume, Patria A.; Quarrie, Kenneth L.; Lewis, Gwyn N.; Theadom, Alice			NZ-RugbyHealth Study: Self-reported Injury Experience and Current Health of Former Rugby Union and Non-contact Sport Players	SPORTS MEDICINE			English	Article; Early Access							CHRONIC TRAUMATIC ENCEPHALOPATHY; IDENTIFICATION TEST AUDIT; ALCOHOL-USE DISORDERS; PERFORMANCE PROJECT; RECURRENT CONCUSSION; LEAGUE PLAYERS; GLOBAL BURDEN; FOOTBALL; RISK; CONSUMPTION	Background There is limited research on associations between playing rugby union and player health post-retirement. Objective This study investigated differences in self-reported sport injury history and current self-reported health characteristics between former New Zealand rugby and non-contact sport players with a view to identifying issues to be further investigated with stronger epidemiological research designs. Methods Using a cross-sectional design, the NZ-RugbyHealth study surveyed 470 former rugby and non-contact sport players (43.8 +/- 8.1 years; 127 elite rugby, 271 community rugby, 72 non-contact sport) recruited from October 2012 to April 2014. Demographic information, engagement in sport, sport injuries, medical conditions, mood, alcohol and substance use and ratings of current health status were obtained from a self-report 58-item general health e-questionnaire. We highlighted standardised differences in means of > 0.6 and differences in relative percentages of > 1.43 for variables between groups as representing at least moderate effect sizes, and of being worthy of follow-up studies. Results Higher percentages of the elite rugby player group had sustained injuries of a given body-site type (e.g. neck sprain/strain, thigh bruising, hamstring strain) combination than the non-contact sports players. Higher percentages of the rugby groups reported having sustained concussion (94% for elite, 82% for community, 26% for non-contact), injuries requiring hospitalisation (73%, 46%, 25%), injuries that stopped participation in sport permanently (28%, 28%, 11%) and sport-related surgery (72%, 46%, 32%) during their playing career. Both rugby groups had a higher prevalence of osteoarthritis (37%, 18%, 6%) than non-contact athletes and community rugby players had higher levels of hazardous alcohol consumption (38%, 40%, 25%) in retirement than non-contact athletes. There was little difference between rugby players and non-contact sports athletes in self-reported mood, substance use and current physical or psychological health ratings. Conclusions Former rugby player groups were at higher risk than the non-contact player group for most injuries during their playing careers, and in retirement had greater prevalence of osteoarthritis and hazardous alcohol consumption. The relative youth of the groups (43.8 years on average) means that health issues that typically do not emerge until later life may not have yet manifested.	[Hume, Patria A.; Quarrie, Kenneth L.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sport Performance Res Inst New Zealand, Private Bag 92006, Auckland 1142, New Zealand; [Hume, Patria A.; Theadom, Alice] Auckland Univ Technol, Traumat Brain Injury Network TBIN, Auckland, New Zealand; [Lewis, Gwyn N.] Auckland Univ Technol, Hlth & Rehabil Res Inst HRRI, Auckland, New Zealand; [Quarrie, Kenneth L.] New Zealand Rugby, Wellington, New Zealand		Hume, PA (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sport Performance Res Inst New Zealand, Private Bag 92006, Auckland 1142, New Zealand.; Hume, PA (corresponding author), Auckland Univ Technol, Traumat Brain Injury Network TBIN, Auckland, New Zealand.	patria.hume@aut.ac.nz					Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2021, WHANGANUI CHRONICLE; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brown K, 2016, ALCOHOL ALCOHOLISM, V51, P747, DOI 10.1093/alcalc/agw006; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Carson A, 2017, J NEUROL NEUROSUR PS, V88, P462, DOI 10.1136/jnnp-2016-315510; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Cunningham J, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000356; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Du Preez EJ, 2017, CLIN J SPORT MED, V27, P530, DOI 10.1097/JSM.0000000000000411; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gee S., 2020, INT J SOCIOL LEISURE, DOI [10.1007/s41978-020-00071-2, DOI 10.1007/S41978-020-00071-2]; GERRARD DF, 1994, BRIT J SPORT MED, V28, P229, DOI 10.1136/bjsm.28.4.229; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hind K, 2020, SPORTS MED, V50, P2051, DOI 10.1007/s40279-020-01310-y; Hopkins WG, 2002, SCALE MAGNITUDES EFF; Hume P., 1999, SPORTSMART 10 POINT; Hume PA, 2015, PLAYER FACT SHEET WO; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Jernigan D, 2017, ADDICTION, V112, P7, DOI 10.1111/add.13591; Jones ME, 2019, J SCI MED SPORT, V22, P871, DOI 10.1016/j.jsams.2019.03.004; Kahu-Kauika PS., 2011, EXPLORING PLAYERS PE; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kilic O, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2019-000693; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King DA., 2021, JSM PHYS MED REHABIL, V5, P9; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; KNIGHT RG, 1988, BRIT J CLIN PSYCHOL, V27, P279, DOI 10.1111/j.2044-8260.1988.tb00792.x; Lewis GN, 2017, NEW ZEAL MED J, V130, P34; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Ministerial Forum on Alcohol Advertising and Sponsorship, 2014, MIN FOR ALC ADV SPON; Ministry of Health, 2012, HLTH NZ AD 2011 12 K; Ministry of Health, 2014, TOB US 2012 13 NZ HL; Ministry of Health, 2013, HAZ DRINK 2011 12 FI; Ministry of Health, 2010, DRUG US NZ KEY RES 2; Muthuri SG, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0534-4; New Zealand Rugby, 2017, RESP RESP REV; O'Brien KS, 2008, ADDICTION, V103, P1961, DOI 10.1111/j.1360-0443.2008.02371.x; O'Brien KS, 2017, NEW ZEAL MED J, V130, P6; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Phillips J., 1987, MANS COUNTRY IMAGE P; Quarrie K, 2020, SPORTS MED, V50, P415, DOI 10.1007/s40279-019-01176-9; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; Quarrie KL, 1996, ADDICTION, V91, P1865, DOI 10.1111/j.1360-0443.1996.tb03815.x; Radio New Zealand, 2017, ALCOHOL RUGBY ED DOE; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; RugbyPass, 2018, CONC CLAIMS AN RUGBY; Rumgay H, 2021, LANCET ONCOL, V22, P1071, DOI 10.1016/S1470-2045(21)00279-5; RW Staff, 2020, WORLD RUGB FAC CONC; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schuring N, 2017, KNEE SURG SPORT TR A, V25, P3179, DOI 10.1007/s00167-016-4255-2; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simpson J., 1994, TACKLING RUGBY INJUR; Szabo A, 2021, J GERONTOL B-PSYCHOL, V76, P496, DOI 10.1093/geronb/gbz143; Tennant R, 2007, QUAL LIFE RES, V16, P687, DOI 10.1007/s11136-006-9145-5; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; UK parliament, 2021, HOUS COMM DIG C MED, P42; VanderVeen JD, 2021, ARCH PHYS MED REHAB, V102, P1198, DOI 10.1016/j.apmr.2020.10.112; WALLER AE, 1994, BRIT J SPORT MED, V28, P223, DOI 10.1136/bjsm.28.4.223; West S, 2011, NEUROREHABILIT NEURA, V25, P3, DOI [10.1177/1545968310392352, DOI 10.1177/1545968310392352]; Yeomans C, 2018, SPORTS MED, V48, P837, DOI 10.1007/s40279-017-0838-4; Zhou J, 2014, INT REV SOCIOL SPORT, V49, P278, DOI 10.1177/1012690213493105	77	0	0	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.												10.1007/s40279-021-01630-7		JAN 2022	13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YQ0LE	WOS:000749010100001	35088235	hybrid			2022-02-06	
J	Alexiou, GA; Tzima, A; Lianos, GD; Lampros, M; Sotiropoulos, A; Rizos, D; Ygropoulou, O; Zika, J; Alexiou, ES; Voulgaris, S				Alexiou, George A.; Tzima, Aggeliki; Lianos, Georgios D.; Lampros, Marios; Sotiropoulos, Athanasios; Rizos, Dimitrios; Ygropoulou, Olga; Zika, Jiolanda; Alexiou, Eleutherios-Spyridon; Voulgaris, Spyridon			Neutrophil to lymphocyte ratio in the prediction of coagulopathy in traumatic brain injury	BIOMARKERS IN MEDICINE			English	Article; Early Access						coagulopathy; neutrophil-to-lymphocyte ratio; traumatic brain injury	BIOMARKER	Lay abstract Traumatic brain injury (TBI) is a public health issue of increasing incidence. Coagulopathy after TBI is a frequent event, associated with a poor prognosis and biomarkers that could predict coagulopathy occurrence are needed. The neutrophil-to-lymphocyte ratio (NLR) is useful as a cost-effective biomarker to assess prognosis and the need for cranial computed tomography in patients with mild TBI. We found that NLR could additionally predict which TBI patients might develop coagulopathy with a 87.5% sensitivity and 52.9% specificity. Combination of NLR with other low-cost biomarkers and the clinical findings might further increase accuracy in the prediction of coagulopathy. Aim: Traumatic brain injury (TBI) is a public health issue of increasing incidence. Coagulopathy after TBI is a frequent event, associated with a poor prognosis, and biomarkers that could predict coagulopathy occurrence are needed. The neutrophil-to-lymphocyte ratio (NLR) is useful as a cost-effective biomarker to assess prognosis and the need for cranial computed tomography in patients with mild TBI. As no study has yet evaluated the association of NLR with coagulopathy, we investigated whether the NLR at presentation could predict coagulopathy occurrence after TBI. Materials & methods: A retrospective study was conducted of patients aged >18 years who attended the emergency department (ED) with TBI, over a 3-year period. We included all patients for whom the NLR at presentation was available, and who underwent a brain CT scan. Results: The study included 173 patients (mean age 57.4 +/- 21.1 years) with TBI, the most frequent cause of which was a fall. According to the Glasgow Coma Scale, 37 patients had severe TBI, 19 moderate and 117 mild TBI and 40 patients (23.1%) developed coagulopathy. Their mean NLR was 7.5 +/- 6.7. Using receiver operating characteristic curve analysis, a cut-off value of 4.2 for NLR had 87.5% sensitivity and 52.9% specificity for predicting coagulopathy occurrence. Conclusion: Coagulopathy occurs frequently after TBI. This study investigated the value of NLR as a biomarker to predict coagulopathy occurrence, and concluded that NLR might be a novel and inexpensive biomarker for decision making in the management of TBI. Combination of NLR with other low-cost biomarkers and the clinical findings might further increase accuracy in the prediction of coagulopathy.	[Alexiou, George A.; Tzima, Aggeliki; Lampros, Marios; Sotiropoulos, Athanasios; Zika, Jiolanda; Alexiou, Eleutherios-Spyridon; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece; [Lianos, Georgios D.] Univ Hosp Ioannina, Dept Surg, Ioannina, Greece; [Rizos, Dimitrios; Ygropoulou, Olga] G Hatzikosta Gen Hosp, Dept Intens Care Unit, Ioannina, Greece		Lianos, GD (corresponding author), Univ Hosp Ioannina, Dept Surg, Ioannina, Greece.	georgiolianos@yahoo.gr		Alexiou, George/0000-0003-0257-4481			Alexiou GA., 2014, NEUROIMMUNOL NEUROIN, V1, P131, DOI DOI 10.4103/2347-8659.143666; Alexiou GA, 2020, BIOMARK MED, V14, P1085, DOI 10.2217/bmm-2020-0150; Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Bohm JK, 2021, NEUROCRIT CARE, V35, P184, DOI 10.1007/s12028-020-01151-7; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dong CH, 2018, CLIN BIOCHEM, V52, P131, DOI 10.1016/j.clinbiochem.2017.11.008; Du Q, 2018, CLIN CHIM ACTA, V487, P145, DOI 10.1016/j.cca.2018.09.035; Feng MJ, 2018, CLIN CHIM ACTA, V480, P84, DOI 10.1016/j.cca.2018.01.044; Lattanzi S, 2018, J NEUROL SCI, V387, P98, DOI 10.1016/j.jns.2018.01.038; Lianos GD, 2020, BIOMARK MED, V14, P169, DOI 10.2217/bmm-2019-0497; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Maegele Marc, 1800, Neurosurgery, V89, P954, DOI 10.1093/neuros/nyab358; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Shen YF, 2016, CLIN CHIM ACTA, V456, P75, DOI 10.1016/j.cca.2016.02.029; Sun SY, 2020, BIOMARK MED, V14, P1341, DOI 10.2217/bmm-2019-0583; Switonska M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110771; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wu GQ, 2016, CLIN CHIM ACTA, V458, P124, DOI 10.1016/j.cca.2016.05.001; Xie QJ., 2021, WORLD NEUROSURG, V22, pS1878; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Zhang ZY, 2019, CLIN CHIM ACTA, V497, P6, DOI 10.1016/j.cca.2019.07.008; Zhao J-L., 2019, WORLD NEUROSURG, V3, P32930; Zhuang DZ, 2021, ANN CLIN TRANSL NEUR, V8, P1601, DOI 10.1002/acn3.51409	28	0	0	0	0	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.												10.2217/bmm-2021-0582		JAN 2022	6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	YN3UY	WOS:000747187500001	35081739				2022-02-06	
J	Byard, RW				Byard, Roger W.			Acute alcohol intoxication and lethal neck flexion	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article; Early Access						Neck hyperflexion; Positional asphyxia; Alcohol; Intoxication	POSITIONAL ASPHYXIA; DEATH; CIRCUMSTANCES; ADULTS	Positional asphyxia occurs when the mechanics of normal respiratory processes are impaired by the position of the body, not by external crushing forces. It is a well-known complication of drug and alcohol intoxication. However, less well appreciated is the potential role of neck hyperflexion as a specific cause of death in individuals with acute alcohol intoxication. Two cases are reported to demonstrate the usefulness of meticulous scene descriptions and documentation in cases of alcohol toxicity. Case 1: An intoxicated 51-year-old woman was found deceased with neck hyperflexion due to pressure on her head from a vehicle bumper bar (blood alcohol 0.24%). Case 2: An intoxicated 46-year-old man was found lying on his back with his neck acutely flexed and his chin pressed firmly into his shoulder (blood alcohol 0.4%). In both cases the deaths were attributed to positional asphyxia due to hyperflexion of the neck associated with alcohol intoxication, with potential exacerbation from concussion and alcohol/drug effects. Careful review of the scene findings and statements from those who are first to find a body in cases of acute alcohol intoxication may be necessary to determine the incidence of marked neck hyperflexion and its possible role in these deaths.	[Byard, Roger W.] Forens Sci SA, Adelaide, SA, Australia; [Byard, Roger W.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia		Byard, RW (corresponding author), Forens Sci SA, Adelaide, SA, Australia.; Byard, RW (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.	roger.byard@sa.gov.au					Austin A, 2011, J FORENSIC SCI, V56, P649, DOI 10.1111/j.1556-4029.2011.01723.x; BELL MD, 1992, AM J FOREN MED PATH, V13, P101, DOI 10.1097/00000433-199206000-00004; Birkenhead, 2008, FAMOUS TRIALS, P507; Bugelli V, 2020, AM J FOREN MED PATH, V41, P217, DOI 10.1097/PAF.0000000000000559; Byard R W, 1996, J Clin Forensic Med, V3, P115, DOI 10.1016/S1353-1131(96)90000-0; Byard RW, 2020, LEGAL MED-TOKYO, V43, DOI 10.1016/j.legalmed.2020.101678; Byard RW, 2013, FORENSIC SCI MED PAT, V9, P568, DOI 10.1007/s12024-013-9462-2; Byard Roger W, 2005, J Clin Forensic Med, V12, P316; Byard RW, 2008, J FORENSIC LEG MED, V15, P415, DOI 10.1016/j.jflm.2008.01.001; Byard RW, 2006, FORENSIC SCI INT, V159, P200, DOI 10.1016/j.forsciint.2005.08.003; Chan TC, 1998, AM J FOREN MED PATH, V19, P201, DOI 10.1097/00000433-199809000-00001; deJong JL, 2020, J FORENSIC SCI, V65, P2008, DOI 10.1111/1556-4029.14524; Malik A, AM J PSYCHIAT, V205, P125; Padosch SA, 2005, FORENSIC SCI INT, V149, P67, DOI 10.1016/j.forsciint.2004.05.016; SKLAR DP, 1988, AM J EMERG MED, V6, P219; Steinberg A, 2021, MED SCI LAW, V61, P215, DOI 10.1177/0025802420988370; Vilke GM, 2020, J FORENSIC LEG MED, V75, DOI 10.1016/j.jflm.2020.102056; Vilke GM, 2012, J EMERG MED, V43, P897, DOI 10.1016/j.jemermed.2011.02.017	18	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.												10.1007/s12024-021-00443-4		JAN 2022	3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	YQ0XD	WOS:000749041300001	35083701				2022-02-06	
J	Cifu, DX				Cifu, David X.			Clinical research findings from the long-term impact of military-relevant brain injury consortium-Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC) 2013-2021	BRAIN INJURY			English	Article; Early Access						Concussion; military; veteran; consortium; long-term effects	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN VETERANS; INTERIM ANALYSIS; COMBAT VETERANS; MILD TBI; ASSOCIATION; SYMPTOMS; PTSD; IRAQ; DIAGNOSES	This is a summary of the published research from the 14 observational, longitudinal and big-data, epidemiological studies supported by the LIMBIC-CENC program from 2013-2021 examining the long-term effects of combat-related traumatic brain injury (TBI). Findings from these 43 primary and secondary analyses include: 1) unique fluid, advanced neuroimaging and electrophysiologic biomarkers associated with mild traumatic brain injury (mTBI), number of mTBIs and related dysfunction, 2) increases in a range of chronic difficulties, including neurosensory, sleep, pain, cognitive deficits, behavioral disorders, overall symptom burden, healthcare costs and service-connected disability, associated with mTBI, all-severity traumatic brain injury (TBI), blast exposure, and number of mTBIs, and 3) increases in the risk for suicide and neurodegeneration, including dementia and Parkinson's disease, associated with mTBI and all-severity TBI. Ongoing LIMBIC-CENC longitudinal and epidemiologic research will clarify, confirm and expand upon these findings.	[Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Cifu, David X.] Dept Vet Affairs, Washington, DC USA		Cifu, DX (corresponding author), Virginia Commonwealth Univ, 1223 East Marshall St, Richmond, VA 23298 USA.	dcifu@vcu.edu			Department of Biotechnology, Ministry of Science and Technology [W81XWH-18-PH/TBIRP-LIMBIC]	This work was supported by the Department of Biotechnology, Ministry of Science and Technology [W81XWH-18-PH/TBIRP-LIMBIC].	Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Bouldin ED, 2021, J HEAD TRAUMA REHAB, V36, P10, DOI 10.1097/HTR.0000000000000574; Byers AL, 2020, BRAIN INJURY, V34, P328, DOI 10.1080/02699052.2019.1701708; Carlson KF, 2019, AM J AUDIOL, V28, P181, DOI 10.1044/2018_AJA-TTR17-18-0042; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Davenport ND, 2018, BRAIN INJURY, V32, P1245, DOI 10.1080/02699052.2018.1494854; Davenport ND, 2016, BRAIN INJURY, V30, P1491, DOI 10.1080/02699052.2016.1219057; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Dismuke-Greer C, 2020, ARCH PHYS MED REHAB, V101, P1720, DOI 10.1016/j.apmr.2020.06.008; Dismuke-Greer CE, 2018, HEALTH EQUITY, V2, P304, DOI 10.1089/heq.2018.0047; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; Garcia A, 2020, J NEUROTRAUM, V37, P2517, DOI 10.1089/neu.2019.6916; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gilmore CS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30824; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Hoot MR, 2018, BRAIN INJURY, V32, P1169, DOI 10.1080/02699052.2018.1482427; Jak AJ, 2020, CLIN NEUROPSYCHOL, V34, P1070, DOI 10.1080/13854046.2020.1730975; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Khokhar BR, 2021, MIL MED, V186, pE293, DOI 10.1093/milmed/usaa249; Kornblith E, 2020, NEUROLOGY, V95, pE1768, DOI 10.1212/WNL.0000000000010617; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Martindale SL, 2021, J AFFECT DISORDERS, V282, P236, DOI 10.1016/j.jad.2020.12.161; Martindale SL, 2020, NEUROPSYCHOLOGY, V34, P735, DOI 10.1037/neu0000672; Martinson SJ, 2019, B ENTOMOL RES, V109, P141, DOI [10.1017/S0007485318000184, 10.1080/02699052.2018.1492741]; Merritt VC, 2020, ARCH CLIN NEUROPSYCH, V35, P491, DOI 10.1093/arclin/acaa006; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Newsome MR, 2018, BRAIN INJURY, V32, P1236, DOI 10.1080/02699052.2018.1494853; O'Neil ME, 2021, J HEAD TRAUMA REHAB, V36, pE363, DOI 10.1097/HTR.0000000000000665; Obama B., 2012, EXECUTIVE ORDER IMPR; Ord AS, 2021, REHABIL PSYCHOL, V66, P31, DOI 10.1037/rep0000333; Pugh MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222674; Rowland JA, 2018, BRAIN CONNECT, V8, P205, DOI 10.1089/brain.2017.0556; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Swan AA, 2017, HEARING RES, V349, P4, DOI 10.1016/j.heares.2017.01.013; Swan AA, 2020, J HEAD TRAUMA REHAB, V35, pE253, DOI 10.1097/HTR.0000000000000513; Swan AA, 2018, BRAIN INJURY, V32, P1637, DOI 10.1080/02699052.2018.1518539; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Walker WC, 2018, BRAIN INJURY, V32, P1156, DOI 10.1080/02699052.2018.1483529; Walker WC, 2018, BRAIN INJURY, V32, P1079, DOI 10.1080/02699052.2018.1479041; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Werner JK, 2021, SLEEP, V44, DOI 10.1093/sleep/zsaa272	45	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.												10.1080/02699052.2022.2033843		JAN 2022	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YN5TF	WOS:000747320100001	35080997				2022-02-06	
J	Kinney, AR; Gerber, HR; Hostetter, TA; Brenner, LA; Forster, JE; Stephenson, RO				Kinney, Adam R.; Gerber, Holly R.; Hostetter, Trisha A.; Brenner, Lisa A.; Forster, Jeri E.; Stephenson, Ryan O.			Morally Injurious Combat Events as an Indirect Risk Factor for Postconcussive Symptoms Among Veterans: The Mediating Role of Posttraumatic Stress	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article; Early Access						morally injurious events; moral injury; veterans; mild traumatic brain injury; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; MILITARY SERVICE MEMBERS; MENTAL-HEALTH; MILD TBI; EXPOSURE; PERSISTENT; DISORDER; SOLDIERS; PTSD; AFGHANISTAN	Clinical Impact Statement This study indicates that responses to morally injurious events (MIEs) may serve as a risk factor for postconcussive symptoms in veterans with mild traumatic brain injury (mTBI), through its association with posttraumatic stress disorder (PTSD). Upon replication of findings, researchers and clinicians should systematically develop and test interventions that mitigate this risk by reducing maladaptive emotions and beliefs associated with MIEs. Further, clinicians serving veterans with comorbid mTBI and MIE-related PTSD should implement evidence-based approaches for PTSD while tailoring such treatment to the distinct features of moral injury. Objective: Psychosocial factors, including combat-related distress (e.g., posttraumatic stress disorder [PTSD]), contribute to postconcussive symptoms (PCS) among veterans with mild traumatic brain injury (mTBI). However, research on risk factors for PCS has focused solely on life-threatening combat experiences, neglecting the morally injurious dimension of combat-related trauma and associated implications for treatment. Morally injurious events (MIEs) are associated with PTSD symptoms among veterans, a robust risk factor of PCS. Nonetheless, the interplay between MIEs, PTSD symptoms, and PCS remains poorly understood. We sought to investigate MIEs as an indirect risk factor for PCS among Veterans with mTBI. Method: This cross-sectional study of 145 veterans with mTBI used path analysis to investigate whether PTSD symptoms mediated the relationship between MIEs (transgressions and betrayals) and PCS (mood-behavioral, vestibular-sensory, and cognitive domains) among 145 veterans with mTBI. We used the Moral Injury Event Scale, PTSD Checklist-Civilian Version, and Neurobehavioral Symptom Inventory to measure MIEs, PTSD, and PCS, respectively. Results: Perceived transgressions were indirectly associated with mood-behavioral (beta = .21, p = .005), vestibular-sensory (beta = .17, p = .005), and cognitive PCS (beta = .20, p = .005), as mediated by PTSD. Greater transgressions were associated with more severe PTSD (beta = .27, p = .003), and greater PTSD was associated with more severe mood-behavioral (beta = .79, p < .001), vestibular-sensory (beta = .64, p < .001), and cognitive PCS (beta = .73, p < .001). Betrayals were not indirectly associated with PCS. Conclusions: Findings offer preliminary support for responses to MIEs being a modifiable risk factor for PCS among veterans. Interventions designed to foster veterans' recovery by targeting the unique emotions and beliefs associated with MIEs may be indicated.	[Kinney, Adam R.; Gerber, Holly R.; Hostetter, Trisha A.; Brenner, Lisa A.; Forster, Jeri E.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Aurora, CO USA; [Kinney, Adam R.; Brenner, Lisa A.; Forster, Jeri E.; Stephenson, Ryan O.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Gerber, Holly R.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Kinney, Adam R.; Gerber, Holly R.; Hostetter, Trisha A.; Brenner, Lisa A.; Forster, Jeri E.; Stephenson, Ryan O.] Eastern Colorado Hlth Care Syst, Denver Vet Affairs Med Ctr, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA		Kinney, AR (corresponding author), Rocky Mt Reg VAMC RMR VAMC, Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, 1700 North Wheeling St,G-3-116M, Aurora, CO 80045 USA.	adam.kinney@va.gov			Veterans Health AdministrationUS Department of Veterans Affairs; Rocky Mountain Mental Illness Research Education and Clinical Center	This manuscript is based on work supported by the Veterans Health Administration, and the Rocky Mountain Mental Illness Research Education and Clinical Center, but does not necessarily represent the views of the Department of Veterans Affairs or the United States Government.	Amara JH, 2019, J HEAD TRAUMA REHAB, V34, P11, DOI 10.1097/HTR.0000000000000404; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Bahraini NH, 2018, PSYCHOL ASSESSMENT, V30, P1013, DOI 10.1037/pas0000555; Bahraini NH, 2018, J HEAD TRAUMA REHAB, V33, pE7, DOI 10.1097/HTR.0000000000000307; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Borges LM, 2019, J CONTEXT BEHAV SCI, V13, P134, DOI 10.1016/j.jcbs.2019.08.002; Brenner LA, 2015, REHABIL PSYCHOL, V60, P277, DOI 10.1037/rep0000048; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dedert EA, 2019, BEHAV SLEEP MED, V17, P595, DOI 10.1080/15402002.2018.1435544; Ferdosi H, 2019, AM J EPIDEMIOL, V188, P77, DOI 10.1093/aje/kwy199; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Frankfurt SB, 2017, MIL MED, V182, pE1950, DOI 10.7205/MILMED-D-17-00062; Gray MJ, 2012, BEHAV THER, V43, P407, DOI 10.1016/j.beth.2011.09.001; Griffin BJ, 2019, J TRAUMA STRESS, V32, P350, DOI 10.1002/jts.22362; Group T. M. O C-M T. B. I. W, 2016, VA DOD CLIN PRACTICE; Haarbauer-Krupa J, 2021, J NEUROTRAUM, V38, P3235, DOI 10.1089/neu.2021.0062; Held Philip, 2017, Focus (Am Psychiatr Publ), V15, P399, DOI 10.1176/appi.focus.20170023; Held P, 2018, COGN BEHAV PRACT, V25, P377, DOI 10.1016/j.cbpra.2017.09.003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jackson DL, 2003, STRUCT EQU MODELING, V10, P128, DOI 10.1207/S15328007SEM1001_6; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jordan AH, 2017, PSYCHOL TRAUMA-US, V9, P627, DOI 10.1037/tra0000249; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kline RB., 2011, PRINCIPLES PRACTICE, V3; Koenig HG, 2018, J RELIG HEALTH, V57, P249, DOI 10.1007/s10943-017-0531-9; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Litz B.T., 2017, ADAPTIVE DISCLOSURE; Litz BT, 2018, J TRAUMA STRESS, V31, P286, DOI 10.1002/jts.22276; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; MacKinnon DP., 2008, ERLBAUM, DOI [DOI 10.1007/978-1-4842-0043-8_5, DOI 10.4324/9780203809556]; Magruder KM, 2004, J TRAUMA STRESS, V17, P293, DOI 10.1023/B:JOTS.0000038477.47249.c8; Marx BP, 2010, DEPRESS ANXIETY, V27, P287, DOI 10.1002/da.20659; Merritt VC, 2020, REHABIL PSYCHOL, V65, P279, DOI 10.1037/rep0000323; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Muthen LK, 1998, MPLUS USERS GUIDE, V8th; Nash WP, 2013, MIL MED, V178, P646, DOI 10.7205/MILMED-D-13-00017; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shay J, 2014, PSYCHOANAL PSYCHOL, V31, P182, DOI 10.1037/a0036090; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Weathers F.W., 1993, ANN CONV INT SOC TRA; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wisco BE, 2017, DEPRESS ANXIETY, V34, P340, DOI 10.1002/da.22614; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270	74	0	0	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma												10.1037/tra0001213		JAN 2022	10	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	YN0EW	WOS:000746942000001	35084915				2022-02-06	
J	Radvansky, GA; Doolen, AC; Pettijohn, KA; Ritchey, M				Radvansky, Gabriel A.; Doolen, Abigail C.; Pettijohn, Kyle A.; Ritchey, Maureen			A New Look at Memory Retention and Forgetting	JOURNAL OF EXPERIMENTAL PSYCHOLOGY-LEARNING MEMORY AND COGNITION			English	Article; Early Access						consolidation; forgetting; memory; retention	LONG-TERM-MEMORY; TEMPORAL-LOBE EPILEPSY; FOCAL RETROGRADE-AMNESIA; CLOSED-HEAD-INJURY; REMOTE MEMORY; WORKING-MEMORY; AUTOBIOGRAPHICAL MEMORY; MENTAL MODELS; DISTRIBUTED PRACTICE; ANTEROGRADE AMNESIA	The forgetting curve is one of the most well known and established findings in memory research. Knowing the pattern of memory change over time can provide insight into underlying cognitive mechanisms. The default understanding is that forgetting follows a continuous, negatively accelerating function, such as a power function. We show that this understanding is incorrect. We first consider whether forgetting rates vary across different intervals of time reported in the literature. We found that there were different patterns of forgetting across different time periods. Next, we consider evidence that complex memories, such as those derived from event cognition, show different patterns, such as linear forgetting. Based on these findings, we argue that forgetting cannot be adequately explained by a single continuous function. As an alternative, we propose a Memory Phases Framework, through which the progress of memory can be divided into phases that parallel changes associated with neurological memory consolidation. These phases include (a) Working Memory (WM) during the first minute of retention, (b) Early Long-Term Memory (e-LTM) during the 12 hr following encoding, (c) a period of Transitional Long-Term Memory (t-LTM) during the following week or so, and (d) Long-Lasting Memory (LLM) memory beyond this. These findings are of significance for any field of study where being able to predict retention and forgetting is important, such as training, eyewitness memory, or clinical treatment. They are also important for evaluating behavioral or neuroscientific manipulations targeting memories over longer periods of time when different processes may be involved.	[Radvansky, Gabriel A.; Doolen, Abigail C.; Pettijohn, Kyle A.] Univ Notre Dame, Dept Psychol, 390 Corbett Family Hall, Notre Dame, IN 46556 USA; [Pettijohn, Kyle A.] Naval Med Res Unit Dayton NAMRU D, Dayton, OH USA; [Ritchey, Maureen] Boston Coll, Dept Psychol & Neurosci, Chestnut Hill, MA 02167 USA		Radvansky, GA (corresponding author), Univ Notre Dame, Dept Psychol, 390 Corbett Family Hall, Notre Dame, IN 46556 USA.	gradvans@nd.edu					Abel M, 2019, J EXP PSYCHOL LEARN, V45, P272, DOI 10.1037/xlm0000576; Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; Abraham WC, 2002, J NEUROSCI, V22, P9626; ALBERT M S, 1981, Journal of Clinical Neuropsychology, V3, P1, DOI 10.1080/01688638108403109; ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Altmann EM, 2012, PSYCHOL SCI, V23, P1435, DOI 10.1177/0956797612446027; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Anderson M.C., 1996, MEMORY, P237, DOI [10.1016/B978-012102570-0/50010-0, DOI 10.1016/B978-012102570-0/50010-0]; Anderson RB, 1997, MEM COGNITION, V25, P724, DOI 10.3758/BF03211315; Antony JW, 2017, TRENDS COGN SCI, V21, P573, DOI 10.1016/j.tics.2017.05.001; Austin SDM, 1921, AM J PSYCHOL, V32, P370, DOI 10.2307/1414001; Averell L, 2011, J MATH PSYCHOL, V55, P25, DOI 10.1016/j.jmp.2010.08.009; Bahrick HP, 2008, EMOTION, V8, P13, DOI 10.1037/1528-3542.8.1.13; BAHRICK HP, 1984, J EXP PSYCHOL GEN, V113, P1, DOI 10.1037/0096-3445.113.1.1; BAHRICK HP, 1975, J EXP PSYCHOL GEN, V104, P54, DOI 10.1037/0096-3445.104.1.54; BAHRICK HP, 1983, PSYCHOL LEARN MOTIV, V17, P125, DOI 10.1016/S0079-7421(08)60098-5; BARR WB, 1990, NEUROPSYCHOLOGIA, V28, P243, DOI 10.1016/0028-3932(90)90018-J; Barry DN, 2019, TRENDS COGN SCI, V23, P128, DOI 10.1016/j.tics.2018.11.005; Barry DN, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005479; Bauer PJ, 2017, MEMORY, V25, P1089, DOI 10.1080/09658211.2016.1265130; Bauer PJ, 2016, MEMORY, V24, P1345, DOI 10.1080/09658211.2015.1110595; Bayliss DM, 2015, J MEM LANG, V81, P34, DOI 10.1016/j.jml.2014.12.004; Bean C.H., 1912, CURVE FORGETTING; BEATTY WW, 1988, NEUROBIOL AGING, V9, P181, DOI 10.1016/S0197-4580(88)80048-4; BEATTY WW, 1987, PSYCHOL MED, V17, P657, DOI 10.1017/S0033291700025897; BEATTY WW, 1989, INT J CLIN NEUROPSYC, V11, P55; BEATTY WW, 1988, ARCH NEUROL-CHICAGO, V45, P611, DOI 10.1001/archneur.1988.00520300029013; BEGG I, 1974, MEM COGNITION, V2, P353, DOI 10.3758/BF03209009; Bell BD, 2005, PSYCHOL ASSESSMENT, V17, P103, DOI 10.1037/1040-3590.17.1.103; Bell BD, 2006, J CLIN EXP NEUROPSYC, V28, P1435, DOI 10.1080/13803390500434367; Berens SC, 2020, NAT HUM BEHAV, V4, P866, DOI 10.1038/s41562-020-0888-8; Berntsen D, 2004, MEM COGNITION, V32, P427, DOI 10.3758/BF03195836; Berntsen D, 2008, MEM COGNITION, V36, P449, DOI 10.3758/MC.36.2.449; Blake RV, 2000, BRAIN, V123, P472, DOI 10.1093/brain/123.3.472; BOGARTZ RS, 1990, J EXP PSYCHOL LEARN, V16, P936, DOI 10.1037/0278-7393.16.5.936; BOGARTZ RS, 1990, J EXP PSYCHOL LEARN, V16, P138, DOI 10.1037/0278-7393.16.1.138; Bonnici HM, 2013, HIPPOCAMPUS, V23, P849, DOI 10.1002/hipo.22155; Bousfield WA, 1953, J GEN PSYCHOL, V49, P229, DOI 10.1080/00221309.1953.9710088; BREGMAN AS, 1968, J EXP PSYCHOL, V78, P539, DOI 10.1037/h0026635; BRIGGS GE, 1954, J EXP PSYCHOL, V47, P285, DOI 10.1037/h0060251; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; BURT CDB, 1992, APPL COGNITIVE PSYCH, V6, P389, DOI 10.1002/acp.2350060504; Burtt HE, 1925, J APPL PSYCHOL, V9, P5, DOI 10.1037/h0073966; Butler C, 2012, NEUROPSYCHOLOGIA, V50, P2973, DOI 10.1016/j.neuropsychologia.2012.07.027; Butler CR, 2007, ANN NEUROL, V61, P587, DOI 10.1002/ana.21111; BUTTER MJ, 1970, J EXP PSYCHOL, V84, P252, DOI 10.1037/h0029094; BUTTERS N, 1977, ALCOHOL CLIN EXP RES, V1, P73, DOI 10.1111/j.1530-0277.1977.tb05771.x; BUTTERS N, 1984, SEMIN NEUROL, V4, P226, DOI 10.1055/s-2008-1041554; Butters N., 1982, HUMAN MEMORY AMNESIA, P257; CARLESIMO GA, 1995, CORTEX, V31, P285, DOI 10.1016/S0010-9452(13)80363-2; Carpenter SK, 2008, MEM COGNITION, V36, P438, DOI 10.3758/MC.36.2.438; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Catal LL, 2004, MEM COGNITION, V32, P311, DOI 10.3758/BF03196861; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Chan JCK, 2010, MEMORY, V18, P49, DOI 10.1080/09658210903405737; CHANCE JE, 1987, B PSYCHONOMIC SOC, V25, P415; COHEN NJ, 1981, NEUROPSYCHOLOGIA, V19, P337, DOI 10.1016/0028-3932(81)90064-6; CONWAY MA, 1991, J EXP PSYCHOL GEN, V120, P395; Cooper RA, 2019, PSYCHOL SCI, V30, P657, DOI 10.1177/0956797619836093; COURTOIS MR, 1981, J APPL PSYCHOL, V66, P639, DOI 10.1037/0021-9010.66.5.639; CRAIG CS, 1972, J GEN PSYCHOL, V87, P85; Cronel-Ohayon S, 2006, NEUROPEDIATRICS, V37, P317, DOI 10.1055/s-2007-964997; D'Esposito M, 1996, J Int Neuropsychol Soc, V2, P565; DAVIDSON D, 1994, J MEM LANG, V33, P757, DOI 10.1006/jmla.1994.1036; Dewar M, 2012, PSYCHOL SCI, V23, P955, DOI 10.1177/0956797612441220; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doolen AC, 2021, MEMORY, V29, P963, DOI 10.1080/09658211.2021.1953079; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Dudai Y, 2015, NEURON, V88, P20, DOI 10.1016/j.neuron.2015.09.004; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Ebbinghaus H, 2013, ANN NEUROSCI, V20, P155, DOI 10.5214/ans.0972.7531.200408; Eichenlaub JB, 2017, STUD NEUROSCI, P161, DOI 10.1007/978-3-319-45066-7_10; Ellis JA, 1998, CONTEMP EDUC PSYCHOL, V23, P419, DOI 10.1006/ceps.1997.0976; EPSTEIN ML, 1976, J GEN PSYCHOL, V95, P127, DOI 10.1080/00221309.1976.9710872; ERDELYI MH, 1974, COGNITIVE PSYCHOL, V6, P159, DOI 10.1016/0010-0285(74)90008-5; Evans SJ, 2014, NEUROPSYCHOLOGIA, V53, P64, DOI 10.1016/j.neuropsychologia.2013.11.007; Finkenbinder EO, 1913, AM J PSYCHOL, V24, P8, DOI 10.2307/1413271; FIORAVANTI M, 1992, BRAIN COGNITION, V18, P116, DOI 10.1016/0278-2626(92)90073-U; Fisher J.S., 2020, THESIS U NOTRE DAME; Fisher JS, 2019, J MEM LANG, V108, DOI 10.1016/j.jml.2019.104035; Fisher JS, 2018, J MEM LANG, V102, P130, DOI 10.1016/j.jml.2018.05.008; Fitzgerald Z, 2013, EPILEPSIA, V54, P819, DOI 10.1111/epi.12090; Flores S, 2017, J EXP PSYCHOL LEARN, V43, P1183, DOI 10.1037/xlm0000367; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; FREEDMAN M, 1984, CAN J NEUROL SCI, V11, P297, DOI 10.1017/S031716710004556X; GADE A, 1990, NEUROPSYCHOLOGIA, V28, P985, DOI 10.1016/0028-3932(90)90113-3; GARNHAM A, 1981, MEM COGNITION, V9, P560, DOI 10.3758/BF03202350; Gaudino EA, 2001, NEUROPSY NEUROPSY BE, V14, P32; GEHRING RE, 1976, MEM COGNITION, V4, P256, DOI 10.3758/BF03213172; GILBERT TF, 1957, J GEN PSYCHOL, V56, P281, DOI 10.1080/00221309.1957.9920339; GILLILAND A R, 1948, J Educ Psychol, V39, P19, DOI 10.1037/h0061032; GIOVAGNOLI AR, 1995, EPILEPSIA, V36, P704, DOI 10.1111/j.1528-1157.1995.tb01050.x; GLASNAPP DR, 1978, PSYCHOL SCHOOLS, V15, P595, DOI 10.1002/1520-6807(197810)15:4<595::AID-PITS2310150426>3.0.CO;2-4; Goetschalckx L, 2018, MEMORY, V26, P581, DOI 10.1080/09658211.2017.1383435; Goldsmith M, 2005, J MEM LANG, V52, P505, DOI 10.1016/j.jml.2005.01.010; GRAF P, 1984, J VERB LEARN VERB BE, V23, P553, DOI 10.1016/S0022-5371(84)90346-3; Graves EA, 1936, J EXP PSYCHOL, V19, P316, DOI 10.1037/h0057827; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; HASHER L, 1978, J EXP PSYCHOL-HUM L, V4, P318; HASHTROUDI S, 1988, J EXP PSYCHOL LEARN, V14, P749, DOI 10.1037/0278-7393.14.4.749; Healy AF, 2000, J MEM LANG, V42, P147, DOI 10.1006/jmla.1999.2671; Hebscher M, 2019, TRENDS COGN SCI, V23, P989, DOI 10.1016/j.tics.2019.09.009; HELLYER S, 1962, J EXP PSYCHOL, V64, P650, DOI 10.1037/h0043117; Hirst W, 2015, J EXP PSYCHOL GEN, V144, P604, DOI 10.1037/xge0000055; Horner AJ, 2013, J EXP PSYCHOL GEN, V142, P1370, DOI 10.1037/a0033626; HOWARTH E, 1968, Journal of Experimental Research in Personality, V3, P114; HUBER SJ, 1986, ARCH NEUROL-CHICAGO, V43, P987, DOI 10.1001/archneur.1986.00520100009006; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; Isaac CL, 1999, J EXP PSYCHOL LEARN, V25, P942, DOI 10.1037/0278-7393.25.4.942; Jackson HF, 1991, NEUROPSYCHOLOGY, V5, P89; Jansari AS, 2010, NEUROPSYCHOLOGIA, V48, P1707, DOI 10.1016/j.neuropsychologia.2010.02.018; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Jeunehomme O, 2018, MEMORY, V26, P759, DOI 10.1080/09658211.2017.1406120; Joensen BH, 2020, J EXP PSYCHOL GEN, V149, P230, DOI 10.1037/xge0000648; Jones H.E., 1923, ARCH PSYCHOLOGIE, V68; Kane M.J., 2007, VARIATION WORKING ME, V1, P21; KAPLAN R, 1969, PSYCHON SCI, V15, P84, DOI 10.3758/BF03336212; KAPUR N, 1986, NEUROPSYCHOLOGIA, V24, P215, DOI 10.1016/0028-3932(86)90054-0; Kapur N, 1997, BRAIN COGNITION, V35, P58, DOI 10.1006/brcg.1997.0927; KAPUR N, 1989, CORTEX, V25, P387, DOI 10.1016/S0010-9452(89)80053-X; Kapur N, 1996, J COGNITIVE NEUROSCI, V8, P416, DOI 10.1162/jocn.1996.8.5.416; Kemp S, 2012, EPILEPSY BEHAV, V24, P382, DOI 10.1016/j.yebeh.2012.04.119; KEPPEL G, 1962, J VERB LEARN VERB BE, V1, P153, DOI 10.1016/S0022-5371(62)80023-1; Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808; KLEINSMITH LJ, 1964, J EXP PSYCHOL, V67, P124, DOI 10.1037/h0045203; KLEINSMITH LJ, 1963, J EXP PSYCHOL, V65, P190, DOI 10.1037/h0040288; KOMATSU S, 1984, JPN PSYCHOL RES, V26, P194, DOI 10.4992/psycholres1954.26.194; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; KOPPENAAL RJ, 1963, J VERB LEARN VERB BE, V2, P310, DOI 10.1016/S0022-5371(63)80099-7; Kristo G, 2009, MEMORY, V17, P816, DOI 10.1080/09658210903143841; Krueger WCF, 1929, J EXP PSYCHOL, V12, P71, DOI 10.1037/h0072036; Lavach J.F., 1971, EFFECTS EMOTIONAL AR; LAWLESS HT, 1978, PERCEPT PSYCHOPHYS, V24, P493, DOI 10.3758/BF03198772; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; LePort AKR, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02017; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; Linton M., 1982, MEMORY OBSERVED REME, P77; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; LOFTUS GR, 1985, J EXP PSYCHOL LEARN, V11, P397, DOI 10.1037/0278-7393.11.2.397; LOFTUS GR, 1990, J EXP PSYCHOL LEARN, V16, P916, DOI 10.1037/0278-7393.16.5.916; LOFTUS GR, 1985, J EXP PSYCHOL LEARN, V11, P817, DOI 10.1037/0278-7393.11.1-4.817; Lucchelli F, 1998, NEUROCASE, V4, P447, DOI 10.1093/neucas/4.6.447; Luh C.W., 1922, PSYCHOL MONOGR, V31, pi, DOI [10.1037/h0093177, DOI 10.1037/H0093177]; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P195, DOI 10.1037/0278-7393.14.2.195; Mameniskiene R, 2006, EPILEPSY BEHAV, V8, P278, DOI 10.1016/j.yebeh.2005.11.003; Mammarella N, 2007, Q J EXP PSYCHOL, V60, P551, DOI 10.1080/17470210600760227; Manes F, 2005, J NEUROL NEUROSUR PS, V76, P1387, DOI 10.1136/jnnp.2004.036582; Markowitsch HJ, 1997, EUR J NEUROL, V4, P178, DOI 10.1111/j.1468-1331.1997.tb00324.x; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; Martin R.C., 1991, NEUROPSYCHOLOGY, V5, P3, DOI [10.1037/0894-4105.5.1.3, DOI 10.1037/0894-4105.5.1.3]; Martini M, 2018, J COGN PSYCHOL, V30, P558, DOI 10.1080/20445911.2018.1506457; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; Mayes AR, 2003, CORTEX, V39, P567, DOI 10.1016/S0010-9452(08)70855-4; MAYES AR, 1988, CORTEX, V24, P367, DOI 10.1016/S0010-9452(88)80001-7; McBride DM, 1999, J EXP PSYCHOL LEARN, V25, P583, DOI 10.1037/0278-7393.25.3.583; McBride DM, 1997, J EXP PSYCHOL GEN, V126, P371, DOI 10.1037/0096-3445.126.4.371; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCormick C, 2020, CEREB CORTEX, V30, P5972, DOI 10.1093/cercor/bhaa172; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGeoch JA, 1932, PSYCHOL REV, V39, P352, DOI 10.1037/h0069819; McGibbon T, 2013, NEUROPSYCHOLOGIA, V51, P114, DOI 10.1016/j.neuropsychologia.2012.11.004; MCKEE RD, 1992, J NEUROSCI, V12, P3765; Meeter M, 2005, MEM COGNITION, V33, P793, DOI 10.3758/BF03193075; Meeter M, 2004, PSYCHOL BULL, V130, P843, DOI 10.1037/0033-2909.130.6.843; MEUDELL PR, 1980, NEUROPSYCHOLOGIA, V18, P133, DOI 10.1016/0028-3932(80)90059-7; Montaldi D., 1989, DEV CLIN EXPT NEUROP, P213, DOI [10.1007/978-1-4757-9996-5_17, DOI 10.1007/978-1-4757-9996-5_17]; Moscovitch M, 2019, TRENDS COGN SCI, V23, P634, DOI 10.1016/j.tics.2019.05.001; Muhlert N, 2011, NEUROPSYCHOLOGIA, V49, P2417, DOI 10.1016/j.neuropsychologia.2011.04.018; Muhlert N, 2010, NEUROPSYCHOLOGIA, V48, P3235, DOI 10.1016/j.neuropsychologia.2010.07.001; MURDOCK BB, 1961, J EXP PSYCHOL, V62, P618, DOI 10.1037/h0043657; Murre JMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120644; Murre JMJ, 2011, PSYCHON B REV, V18, P592, DOI 10.3758/s13423-011-0076-y; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NELSON TO, 1980, BEHAV RES METH INSTR, V12, P42, DOI 10.3758/BF03208322; Nunoi M, 2016, J COGN PSYCHOL, V28, P756, DOI 10.1080/20445911.2016.1189917; O'Rear A.E., 2020, DIARY STUDY UNPUB; OConnor M, 1997, BRAIN COGNITION, V35, P71, DOI 10.1006/brcg.1997.0928; PARKIN AJ, 1990, Q J EXP PSYCHOL-A, V42, P585, DOI 10.1080/14640749008401238; PARKIN AJ, 1991, BRIT J CLIN PSYCHOL, V30, P349, DOI 10.1111/j.2044-8260.1991.tb00955.x; PAYNE DG, 1987, PSYCHOL BULL, V101, P5, DOI 10.1037/0033-2909.101.1.5; Pertzov Y, 2013, J EXP PSYCHOL HUMAN, V39, P1224, DOI 10.1037/a0030947; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; Pettijohn K.A., 2018, THESIS U NORTE DAME; POSTMAN L, 1965, Q J EXP PSYCHOL, V17, P132, DOI 10.1080/17470216508416422; POSTMAN L, 1968, J VERB LEARN VERB BE, V7, P672, DOI 10.1016/S0022-5371(68)80124-0; Radosavljevich P.R., 1907, BEHALTEN VERGESSEN B, V1; Radvansky GA, 2017, MEM COGNITION, V45, P1028, DOI 10.3758/s13421-017-0713-4; Radvansky G.A., 2014, EVENT COGNITION, DOI [10.1093/acprof:oso/9780199898138.001.0001, DOI 10.1093/ACPROF:OSO/9780199898138.001.0001]; Radvansky G.A., 1997, COGNITIVE MODELS MEM, P173; Radvansky GA, 1999, J EXP PSYCHOL GEN, V128, P198, DOI 10.1037/0096-3445.128.2.198; RADVANSKY GA, 1991, J EXP PSYCHOL LEARN, V17, P940, DOI 10.1037/0278-7393.17.5.940; RADVANSKY GA, 1990, PSYCHOL AGING, V5, P209, DOI 10.1037/0882-7974.5.2.209; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Raymaekers LHC, 2014, MEMORY, V22, P19, DOI 10.1080/09658211.2013.791321; Reed JM, 1998, J NEUROSCI, V18, P3943; Reinvang I, 1998, NEUROPSYCHOLOGIA, V36, P1335, DOI 10.1016/S0028-3932(98)00021-9; Ribot T., 1882, DIS MEMORY ESSAY POS, DOI [10.1037/12818-000, DOI 10.1037/12818-000]; Riccio DC, 2003, CURR DIR PSYCHOL SCI, V12, P41, DOI 10.1111/1467-8721.01222; Ricker TJ, 2020, J EXP PSYCHOL LEARN, V46, P60, DOI 10.1037/xlm0000719; Ricker TJ, 2014, J EXP PSYCHOL LEARN, V40, P1510, DOI 10.1037/xlm0000018; Ricker TJ, 2014, J EXP PSYCHOL LEARN, V40, P417, DOI 10.1037/a0034301; Ricker TJ, 2010, J EXP PSYCHOL LEARN, V36, P1355, DOI 10.1037/a0020356; Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262; ROEDIGER HL, 1992, J EXP PSYCHOL LEARN, V18, P1251, DOI 10.1037/0278-7393.18.6.1251; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; ROEDIGER HL, 1978, MEM COGNITION, V6, P296; ROEDIGER HL, 1982, J VERB LEARN VERB BE, V21, P635, DOI 10.1016/S0022-5371(82)90810-6; Rohrer D, 2005, APPL COGNITIVE PSYCH, V19, P361, DOI 10.1002/acp.1083; Rohrer D, 2006, APPL COGNITIVE PSYCH, V20, P1209, DOI 10.1002/acp.1266; Rowland CA, 2015, MEMORY, V23, P403, DOI 10.1080/09658211.2014.889710; Rubin DC, 1999, J EXP PSYCHOL LEARN, V25, P1161, DOI 10.1037/0278-7393.25.5.1161; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Rubin DC, 1998, MEM COGNITION, V26, P3, DOI 10.3758/BF03211366; RUBIN DC, 1978, J VERB LEARN VERB BE, V17, P599, DOI 10.1016/S0022-5371(78)90370-5; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; RUNQUIST WN, 1983, MEM COGNITION, V11, P641, DOI 10.3758/BF03198289; RYBACK RS, 1970, PSYCHON SCI, V20, P353, DOI 10.3758/BF03335686; Sadeh T, 2020, J COGNITIVE NEUROSCI, V32, P386, DOI 10.1162/jocn_a_01491; Sadeh T, 2014, TRENDS COGN SCI, V18, P26, DOI 10.1016/j.tics.2013.10.008; SAGAR HJ, 1988, BRAIN, V111, P185, DOI 10.1093/brain/111.1.185; SALMON DP, 1988, BRAIN COGNITION, V7, P201, DOI 10.1016/0278-2626(88)90030-9; Schrauf RW, 1998, J MEM LANG, V39, P437, DOI 10.1006/jmla.1998.2585; Seamon JG, 2002, MEM COGNITION, V30, P1054, DOI 10.3758/BF03194323; SEHULSTER JR, 1989, MEM COGNITION, V17, P590, DOI 10.3758/BF03197082; Sekeres MJ, 2016, LEARN MEMORY, V23, P72, DOI 10.1101/lm.039057.115; Shapiro LR, 2006, MEMORY, V14, P129, DOI 10.1080/09658210544000006; Shepherd J.W., 1982, IDENTIFICATION EVIDE; SHEPHERD JW, 1973, AM J PSYCHOL, V86, P627, DOI 10.2307/1421948; Shiffrin R., 1968, PSYCHOL LEARNING MOT, P90, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; Siler J, 2020, MEM COGNITION, V48, P645, DOI 10.3758/s13421-019-00997-3; SLAMECKA NJ, 1983, J EXP PSYCHOL LEARN, V9, P384, DOI 10.1037/0278-7393.9.3.384; SLOMAN SA, 1988, J EXP PSYCHOL LEARN, V14, P223, DOI 10.1037/0278-7393.14.2.223; SMITH DA, 1981, MEM COGNITION, V9, P550, DOI 10.3758/BF03202349; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; Squire L.R., 1982, HUMAN MEMORY AMNESIA, P275; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1978, NEUROPSYCHOLOGIA, V16, P313, DOI 10.1016/0028-3932(78)90025-8; SQUIRE LR, 1989, J NEUROSCI, V9, P828; SQUIRE LR, 1975, J EXP PSYCHOL-HUM L, V104, P50; SQUIRE LR, 1989, J EXP PSYCHOL LEARN, V15, P241, DOI 10.1037/0278-7393.15.2.241; SQUIRE LR, 1990, COLD SH Q B, V55, P1007; SQUIRE LR, 1987, NEUROPSYCHOLOGIA, V25, P195, DOI 10.1016/0028-3932(87)90131-X; Staats A.W., 1970, LONG TERM RETENTION; STANHOPE N, 1993, APPL COGNITIVE PSYCH, V7, P239, DOI 10.1002/acp.2350070308; Staresina BP, 2009, NEURON, V63, P267, DOI 10.1016/j.neuron.2009.06.024; Staugaard SR, 2019, MEM COGNITION, V47, P893, DOI 10.3758/s13421-019-00904-w; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Strong EK, 1913, PSYCHOL REV, V20, P339, DOI 10.1037/h0072087; STUSS DT, 1988, BRAIN COGNITION, V8, P348, DOI 10.1016/0278-2626(88)90059-0; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Talamini LM, 2012, LEARN MEMORY, V19, P239, DOI 10.1101/lm.024281.111; Tanaka Y, 1999, NEUROLOGY, V53, P344, DOI 10.1212/WNL.53.2.344; Thapar A, 2001, MEM COGNITION, V29, P424, DOI 10.3758/BF03196393; Thompson C.P., 1996, AUTOBIOGRAPHICAL MEM; Thomsen DK, 2008, MEMORY, V16, P420, DOI 10.1080/09658210802010497; Tramoni E, 2011, BRAIN, V134, P816, DOI 10.1093/brain/awr002; TULVING E, 1966, J VERB LEARN VERB BE, V5, P381, DOI 10.1016/S0022-5371(66)80048-8; Tunney RJ, 2007, ACTA PSYCHOL, V125, P37, DOI 10.1016/j.actpsy.2006.06.002; TURVEY MT, 1975, Q J EXP PSYCHOL, V27, P47, DOI 10.1080/14640747508400463; VALLAR G, 1982, Q J EXP PSYCHOL-A, V34, P53, DOI 10.1080/14640748208400857; van der Werf SP, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00605; Van Ormer E.B., 1932, ARCH PSYCHOLOGIE, V137, P49; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; VONCRAMON DY, 1993, NEUROPSYCHOLOGIA, V31, P1159, DOI 10.1016/0028-3932(93)90065-8; WAGENAAR WA, 1986, COGNITIVE PSYCHOL, V18, P225, DOI 10.1016/0010-0285(86)90013-7; WALKER EL, 1963, J VERB LEARN VERB BE, V2, P113, DOI 10.1016/S0022-5371(63)80075-4; Wallner L, 2018, MEM COGNITION, V46, P878, DOI 10.3758/s13421-018-0809-5; Warrington E.K., 1982, HUMAN MEMORY AMNESIA, P61; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; Weaver CA, 2004, AM J PSYCHOL, V117, P517; White KG, 2012, J EXP PSYCHOL LEARN, V38, P255, DOI 10.1037/a0025197; Wickelgren W.A., 1977, LEARN MEMORY; WICKELGREN WA, 1974, MEM COGNITION, V2, P775, DOI 10.3758/BF03198154; WICKELGREN WA, 1975, MEM COGNITION, V3, P385, DOI 10.3758/BF03212929; WICKELGREN WA, 1972, J MATH PSYCHOL, V9, P418, DOI 10.1016/0022-2496(72)90015-6; Wilkinson H, 2012, CORTEX, V48, P317, DOI 10.1016/j.cortex.2011.01.002; WILSON RS, 1981, CORTEX, V17, P41, DOI 10.1016/S0010-9452(81)80005-6; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683; Wixted J.T., 2013, OXFORD HDB COGNITIVE, V1, P436, DOI [10.1093/oxfordhb/9780199988693.013.0021, DOI 10.1093/OXFORDHB/9780199988693.013.0021]; Wixted JT, 2007, PSYCHOL SCI, V18, P133, DOI 10.1111/j.1467-9280.2007.01862.x; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; WIXTED JT, 1990, J EXP PSYCHOL LEARN, V16, P927, DOI 10.1037/0278-7393.16.5.927; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; WIXTED JT, 1991, PSYCHOL SCI, V2, P409, DOI 10.1111/j.1467-9280.1991.tb00175.x; Wylie M, 1926, AM J PSYCHOL, V37, P224, DOI 10.2307/1413689; Yarmey AD, 1996, LAW HUMAN BEHAV, V20, P459, DOI 10.1007/BF01498981; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030; Youtz AC, 1941, PSYCHOL MONOGR, V53, P1; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	303	0	0	2	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-7393	1939-1285		J EXP PSYCHOL LEARN	J. Exp. Psychol.-Learn. Mem. Cogn.												10.1037/xlm0001110		JAN 2022	27	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	YN0DC	WOS:000746937400001	35084927				2022-02-06	
J	Ruhl, L; Kuramatsu, JB; Sembill, JA; Kallmunzer, B; Madzar, D; Gerner, ST; Giede-Jeppe, A; Balk, S; Mueller, T; Jager, J; Schwab, S; Huttner, HB; Sprugel, MI				Ruehl, Lena; Kuramatsu, Joji B.; Sembill, Jochen A.; Kallmuenzer, Bernd; Madzar, Dominik; Gerner, Stefan T.; Giede-Jeppe, Antje; Balk, Stefanie; Mueller, Tamara; Jaeger, Jakob; Schwab, Stefan; Huttner, Hagen B.; Spruegel, Maximilian, I			Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article; Early Access						stroke; consciousness; acquired brain injury; subarachnoid haemorrhage; epilepsy	CARE; GUIDELINES; MANAGEMENT; RECOVERY; HEMATOMA; SEIZURES	Objective This study determined the effect of amantadine treatment on consciousness in patients with non-traumatic brain injury. Methods We pooled individual patient data of five single-centre observational studies to determine the effect of amantadine treatment among patients with ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, community-acquired bacterial meningitis and status epilepticus, admitted between January 2012 and December 2015 and ventilated >= 7 days. Patient selection and multivariable regression modelling were used to adjust for differences in intergroup comparison and for parameters associated with consciousness. Improvement of consciousness 5 days after treatment initiation was defined as primary outcome. Secondary outcomes included Glasgow Coma Scale (GCS) at day 5 and GCS at day 10, rate of ICU delirium, epileptic seizures and all-cause mortality at 90 days. Results Overall, 84 of 294 (28.6%) eligible patients received amantadine. Amantadine treatment was associated with improvement of consciousness at day 5 (amantadine: 86.9% vs control: 54.0%; absolute difference: 32.9 (20.0-44.2); adjusted OR (aOR): 5.71 (2.50-13.05), p<0.001). Secondary outcomes showed differences in GCS 5 days (9 (8-11) vs 6 (3-9), p<0.001) and GCS 10 days (10(8-11) vs 9(6-11),p=0.003) after treatment initiation. There were no significant differences regarding all-cause mortality (aOR: 0.89 (0.44-1.82), p=0.758) and ICU delirium (aOR: 1.39 (0.58-3.31), p=0.462). Rate of epileptic seizures after initiation of amantadine treatment was numerically higher in the amantadine group (amantadine: 10.7% vs control: 3.0%; absolute difference: 7.7 (0.3-16.4); aOR: 3.68 (0.86-15.71), p=0.079). Conclusions Amantadine treatment is associated with improved consciousness among patients with different types of non-traumatic brain injury in this observational cohort analysis. Epileptic seizures should be considered as potential side effects and randomised controlled trials are needed to confirm these findings.	[Ruehl, Lena; Kuramatsu, Joji B.; Sembill, Jochen A.; Kallmuenzer, Bernd; Madzar, Dominik; Gerner, Stefan T.; Giede-Jeppe, Antje; Balk, Stefanie; Mueller, Tamara; Jaeger, Jakob; Schwab, Stefan; Huttner, Hagen B.; Spruegel, Maximilian, I] Friedrich Alexander Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Bayern, Germany		Sprugel, MI (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Bayern, Germany.	spruegel@uk-erlangen.de		Kuramatsu, Joji B./0000-0002-7630-7880	Johannes and Frieda Marohn Foundation, University of Erlangen, Germany [Alz/Iko-Spru/2020]	Supported by a research grant (Alz/Iko-Spru/2020) from the Johannes and Frieda Marohn Foundation, University of Erlangen, Germany. The funding had no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Akcil EF, 2018, TURK J ANAESTHESIOL, V46, P100, DOI 10.5152/TJAR.2018.20280; Biffi A, 2016, BRAIN, V139, P2694, DOI 10.1093/brain/aww199; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Gagnon DJ, 2020, NEUROCRIT CARE, V33, P283, DOI 10.1007/s12028-020-00977-5; Gao Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021822; Gerner ST, 2020, CEREBROVASC DIS, V49, P307, DOI 10.1159/000508577; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giede-Jeppe A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90816-0; Haupenthal D, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15859; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kuramatsu JB, 2019, JAMA-J AM MED ASSOC, V322, P1392, DOI 10.1001/jama.2019.13014; Leclerc AM, 2021, NEUROCRIT CARE, V34, P102, DOI 10.1007/s12028-020-00986-4; Madzar D, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2235-2; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Peoples J., 2020, EC NEUROLOGY, V12, P01; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Sembill JA, 2021, ANN NEUROL, V89, P474, DOI 10.1002/ana.25969; Sembill JA, 2017, NEUROLOGY, V89, P423, DOI 10.1212/WNL.0000000000004174; Siedler G, 2019, STROKE, V50, P3051, DOI 10.1161/STROKEAHA.119.026139; Sprugel MI, 2021, STROKE, V52, P975, DOI 10.1161/STROKEAHA.120.029345; Sprugel MI, 2021, INT J STROKE, V16, P83, DOI 10.1177/1747493019895662; Sprugel MI, 2019, NEUROLOGY, V93, pE1159, DOI 10.1212/WNL.0000000000008129; Sprugel MI, 2019, J NEUROL NEUROSUR PS, V90, P783, DOI 10.1136/jnnp-2018-319786; Sprugel MI, 2018, STROKE, V49, P2621, DOI 10.1161/STROKEAHA.118.021614; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	32	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry												10.1136/jnnp-2021-327408		JAN 2022	6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	YP9CA	WOS:000748915200001	35086939	hybrid			2022-02-06	
J	Jadaun, KS; Mehan, S; Sharma, A; Siddiqui, EM; Kumar, S; Alsuhaymi, N				Jadaun, Kuldeep Singh; Mehan, Sidharth; Sharma, Aarti; Siddiqui, Ehraz Mehmood; Kumar, Sumit; Alsuhaymi, Naif			Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage	CURRENT MEDICAL SCIENCE			English	Article; Early Access						intracerebral hemorrhage; autologous blood; PI3K; AKT; mTOR; hematoma; chrysophanol; apoptosis; neurotransmitter; neuroinflammation	EARLY BRAIN-INJURY; MOLECULAR-MECHANISMS; CELL-DEATH; INFLAMMATION; RAT; SOLANESOL; PATHWAY; TARGET; PATHOPHYSIOLOGY; ACTIVATION	Objective Intracerebral hemorrhage (ICH) refers to predominant, sporadic, and non-traumatic bleeding in the brain parenchyma. The PI3K/AKT/mTOR signaling pathway is an important signal transduction pathway regulated by enzyme-linked receptors and has many biological functions in mammals. It plays a key role in neuronal metabolism, gene expression regulation, and tissue homeostasis in the healthy and diseased brain. Methods In the present study, the role of the PI3K/AKT/mTOR pathway inhibitor chrysophanol (CPH) (10 mg/kg and 20 mg/kg, orally) in the improvement of ICH-associated neurological defects in rats was investigated. Autologous blood (20 mu L/5 min/unilateral/intracerebroventricular) mimics ICH-like defects involving cellular and molecular dysfunction and neurotransmitter imbalance. The current study also included various behavioral assessments to examine cognition, memory, and motor and neuromuscular coordination. The protein expression levels of PI3K, AKT, and mTOR as well as myelin basic protein and apoptotic markers, such as Bax, Bcl-2, and caspase-3, were examined using ELISA kits. Furthermore, the levels of various neuroinflammatory cytokines and oxidative stress markers were assessed. Additionally, the neurological severity score, brain water content, gross brain pathology, and hematoma size were used to indicate neurological function and brain edema. Results CPH was found to be neuroprotective by restoring neurobehavioral alterations and significantly reducing the elevated PI3K, AKT, and mTOR protein levels, and modulating the apoptotic markers such as Bax, Bcl-2, and caspase-3 in rat brain homogenate. CPH substantially reduced the inflammatory cytokines like interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha. CPH administration restored the neurotransmitters GABA, glutamate, acetylcholine, dopamine, and various oxidative stress markers. Conclusion Our results show that CPH may be a promising therapeutic approach for overcoming neuronal damage caused by the overexpression of the PI3K/AKT/mTOR signaling pathway in ICH-induced neurological dysfunctions in rats.	[Jadaun, Kuldeep Singh; Mehan, Sidharth; Sharma, Aarti; Siddiqui, Ehraz Mehmood; Kumar, Sumit] ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India; [Alsuhaymi, Naif] Umm Al Qura Univ, Fac Hlth Sci AlQunfudah, Dept Emergency Med Serv, Mecca, Saudi Arabia		Mehan, S (corresponding author), ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India.	kuldecpsj19@gmail.com; sidh.mehan@gmail.com		Mehan, Sidharth/0000-0003-0034-835X			Abd-Elrahman KS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0456-1; Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Aladag MA, 2017, BRIT J NEUROSURG, V31, P439, DOI 10.1080/02688697.2017.1297367; Alam Mohmmad Mamtaj, 2021, Current Bioactive Compounds, V17, pe010621184055, DOI 10.2174/1573407216999200723113054; Ali T, 2018, MOL NEUROBIOL, V55, P6076, DOI 10.1007/s12035-017-0798-6; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Bala R, 2015, RSC ADV, V5, P72881, DOI 10.1039/c5ra13160j; Brandt C, 2018, NEUROPHARMACOLOGY, V140, P107, DOI 10.1016/j.neuropharm.2018.08.002; Brivio P, 2020, CELL MOL NEUROBIOL, V40, P1037, DOI 10.1007/s10571-020-00793-7; Buitendag JJP, 2017, SAMJ S AFR MED J, V107, P777, DOI [10.7196/SAMJ.2017.v107i9.12394, 10.7196/samj.2017.v107i9.12394]; Buss L., 2016, F1000RES, V5, pF1000; Chae U, 2017, PHARMACOLOGY, V100, P153, DOI 10.1159/000477814; Chaudhry BZ., 2016, MANAGEMENT BLEEDING, P171; Chen A, 2013, MOL MED REP, V8, P1011, DOI 10.3892/mmr.2013.1628; Chen BL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.12.35; Chen Y, 2019, EXP THER MED, V17, P1771, DOI 10.3892/etm.2018.7120; Chen-Roetling J, 2017, NEUROBIOL DIS, V102, P140, DOI 10.1016/j.nbd.2017.03.008; Chiang MF, 2006, ACTA NEUROCHIR, V148, P615, DOI 10.1007/s00701-006-0771-z; Chu X, 2018, NEUROCHEM RES, V43, P972, DOI 10.1007/s11064-018-2503-1; Copotoiu R, 2016, TRANSFUS CLIN BIOL, V23, P222, DOI 10.1016/j.tracli.2016.07.004; Cui JZ, 2017, CELL PHYSIOL BIOCHEM, V42, P137, DOI 10.1159/000477122; Daniel PM, 2018, NEURO-ONCOLOGY, V20, P1344, DOI 10.1093/neuonc/noy068; Deinsberger W, 1996, NEUROL RES, V18, P475; Duan XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1203285; Dudi R., 2018, PHARMASPIRE, V10, P68; Duggal P, 2020, CURR ALZHEIMER RES, V17, P601, DOI 10.2174/1567205017666201007120112; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fathimoghadam H, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01213; FISHER JC, 1971, TECHNOL FORECAST SOC, V3, P75, DOI 10.1016/S0040-1625(71)80005-7; Galho AR, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/17/175101; Giacoppo S, 2017, FITOTERAPIA, V116, P77, DOI 10.1016/j.fitote.2016.11.010; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hao ZL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000091.pub2; Hodges SL, 2018, NEUROREPORT, V29, P1109, DOI 10.1097/WNR.0000000000001081; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Jamwal S, 2016, PHYSIOL BEHAV, V155, P180, DOI 10.1016/j.physbeh.2015.12.015; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jeong HJ, 2018, INT IMMUNOPHARMACOL, V54, P238, DOI 10.1016/j.intimp.2017.11.019; Jiang WJ, 2016, RSC ADV, V6, P38192, DOI 10.1039/c5ra19841k; Kale A, 2018, J RADIAT RES, V59, P404, DOI 10.1093/jrr/rry032; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Krafft PR, 2012, JOVE-J VIS EXP, DOI 10.3791/4289; Kumar N, 2021, METAB BRAIN DIS, V36, P911, DOI 10.1007/s11011-021-00691-x; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Lee KY, 2004, AM J NEURORADIOL, V25, P1470; Lee MJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00192; Li MX, 2020, TRANSL RES, V217, P61, DOI 10.1016/j.trsl.2019.12.006; Lim W, 2017, J CELL PHYSIOL, V232, P331, DOI 10.1002/jcp.25423; Liu H, 2017, COMPLEMENT THER MED, V32, P85, DOI 10.1016/j.ctim.2017.03.014; Liu L, 2015, NEUROL RES, V37, P874, DOI 10.1179/1743132815Y.0000000067; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Lu Q., 2015, BIO-PROTOCOL, V5, pe1541; Magistris F., 2013, MUMJ, V10, P15; Mamik MK., 2017, NEUROIMMUNE PHARM, P93; Mammana S., 2018, ONCOTARGET, V9, P8263; Mehan S, 2018, INDIAN J PHARMACOL, V50, P309, DOI 10.4103/ijp.IJP_11_18; Mehan S, 2017, NEURAL REGEN RES, V12, P290, DOI 10.4103/1673-5374.200812; Minj E, 2021, NEUROCHEM RES, V46, P2867, DOI 10.1007/s11064-021-03366-2; Mishra V., 2016, NAT PROD INDIAN J, V12, P1; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Neri LM, 2002, BBA-MOL CELL BIOL L, V1584, P73, DOI 10.1016/S1388-1981(02)00300-1; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Park S, 2018, TOXICOL APPL PHARM, V360, P201, DOI 10.1016/j.taap.2018.10.010; Prateeksha, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020068; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Rahi S, 2021, HUM EXP TOXICOL, V40, P1880, DOI 10.1177/09603271211013456; Rajdev K, 2020, IBRO REP, V8, P101, DOI 10.1016/j.ibror.2020.03.001; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Schlunk F, 2015, TRANSL STROKE RES, V6, P257, DOI 10.1007/s12975-015-0410-1; Sharma A, 2021, NEUROCHEM INT, V147, DOI 10.1016/j.neuint.2021.105067; Sharma N., 2021, PHYTOMED PLUS, V1, DOI [10.1016/j.phyplu.2021.100051, DOI 10.1016/J.PHYPLU.2021.100051]; Sharma R, 2019, TOXICOL REP, V6, P1164, DOI 10.1016/j.toxrep.2019.10.019; Shi KB, 2019, LANCET NEUROL, V18, P1058, DOI 10.1016/S1474-4422(19)30078-X; Siddiqui EM, 2021, SAUDI J BIOL SCI, V28, P6417, DOI 10.1016/j.sjbs.2021.07.010; Singh A., 2021, PHYTOMED PLUS, V1; Singh D, 2013, J THERM ANAL CALORIM, V111, P2069, DOI 10.1007/s10973-012-2448-6; Singh N, 2017, PHARMACOLOGY, V100, P172, DOI 10.1159/000453580; Su SY, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.110002; Tao CY, 2020, TRANSL STROKE RES, V11, P541, DOI 10.1007/s12975-019-00745-4; Terai K, 2003, NEUROCHEM RES, V28, P779, DOI 10.1023/A:1022826220469; Tiwari A, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11030288; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Verma L., 2010, INT J PHARM PROF RES, V1, P127; Wang HB, 2020, ACS OMEGA, V5, P15385, DOI 10.1021/acsomega.0c01472; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang T, 2020, METAB BRAIN DIS, V35, P959, DOI 10.1007/s11011-020-00571-w; Wen Q, 2018, INT IMMUNOPHARMACOL, V56, P90, DOI 10.1016/j.intimp.2018.01.023; Wu YN, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00682; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Ye T, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-2103-z; Yudushkin I, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020067; Zeng QH, 2017, INT J CLIN EXP MED, V10, P14761; Zhang CY, 2019, EUR REV MED PHARMACO, V23, P4890, DOI 10.26355/eurrev_201906_18077; Zhang HB, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104375; Zhang J, 2014, NEURAL REGEN RES, V9, P924, DOI 10.4103/1673-5374.133141; Zhang J, 2018, PHARMAZIE, V73, P228, DOI 10.1691/ph.2018.7980; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang WG, 2012, EXP NEUROL, V233, P799, DOI 10.1016/j.expneurol.2011.11.046; Zhao HL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0940-4; Zhao YM, 2018, J PHARMACOL SCI, V138, P16, DOI 10.1016/j.jphs.2018.08.002; Zhao YM, 2016, NEUROSCI LETT, V630, P16, DOI 10.1016/j.neulet.2016.07.036; Zipfel GJ, 2009, STROKE, V40, pS16, DOI 10.1161/STROKEAHA.108.533174	109	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2096-5230	2523-899X		CURR MED SCI	Curr. Med. Sci.												10.1007/s11596-022-2496-x		JAN 2022	18	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	YM7TP	WOS:000746773600001	35079960				2022-02-06	
J	Liddell, BJ; Das, P; Malhi, GS; Felmingham, KL; Outhred, T; Cheung, J; Den, M; Nickerson, A; Askovic, M; Aroche, J; Coello, M; Bryant, RA				Liddell, Belinda J.; Das, Pritha; Malhi, Gin S.; Felmingham, Kim L.; Outhred, Tim; Cheung, Jessica; Den, Miriam; Nickerson, Angela; Askovic, Mirjana; Aroche, Jorge; Coello, Mariano; Bryant, Richard A.			Torture exposure and the functional brain: investigating disruptions to intrinsic network connectivity using resting state fMRI	TRANSLATIONAL PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; TRAUMA; SYMPTOMS; DISSOCIATION; MECHANISMS; SURVIVORS; CONFLICT; REFUGEES; INJURY	Torture has profound psychological and physiological consequences for survivors. While some brain structures and functions appear altered in torture survivors, it is unclear how torture exposure influences functional connectivity within and between core intrinsic brain networks. In this study, 37 torture survivors (TS) and 62 non-torture survivors (NTS) participated in a resting-state fMRI scan. Data-driven independent components analysis identified active intrinsic networks. Group differences in functional connectivity in the default mode network (DMN), salience network (SN) and central executive network (CEN) of the triple network model, as well any prefrontal network, were examined while controlling for PTSD symptoms and exposure to other potentially traumatic events. The analysis identified 25 networks; eight comprised our networks of interest. Within-network group differences were observed in the left CEN (lCEN), where the TS group showed less spectral power in the low-frequency band. Differential internetwork dynamic connectivity patterns were observed, where the TS group showed stronger positive coupling between the lCEN and anterior dorsomedial and ventromedial DMN, and stronger negative coupling between a lateral frontal network and the lCEN and anterior dorsomedial DMN (when contrasted with the NTS group). Group differences were not attributed to torture severity or dissociative symptoms. Torture survivors showed disrupted dynamic functional connectivity between a laterally-aligned lCEN that serves top-down control functions over external processes and the midline DMN that underpins internal self-referential processes, which may be an adaptive response to mitigate the worst effects of the torture experience. This study provides a critical step in mapping the neural signature of torture exposure to guide treatment development and selection.	[Liddell, Belinda J.; Cheung, Jessica; Den, Miriam; Nickerson, Angela; Bryant, Richard A.] UNSW Sydney, Sch Psychol, Sydney, NSW 2052, Australia; [Das, Pritha; Malhi, Gin S.; Outhred, Tim] Univ Sydney, Fac Med & Hlth, Northern Clin Sch, Dept Psychiat, Sydney, NSW, Australia; [Das, Pritha; Malhi, Gin S.; Outhred, Tim] Royal North Shore Hosp, Acad Dept Psychiat, Northern Sydney Local Hlth Dist, Sydney, NSW 2065, Australia; [Das, Pritha; Malhi, Gin S.; Outhred, Tim] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, CADE Clin, Sydney, NSW 2065, Australia; [Felmingham, Kim L.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3010, Australia; [Askovic, Mirjana; Aroche, Jorge; Coello, Mariano] NSW Serv Treatment & Rehabil Torture & Trauma Sur, Carramar, NSW 2163, Australia		Liddell, BJ (corresponding author), UNSW Sydney, Sch Psychol, Sydney, NSW 2052, Australia.	b.liddell@unsw.edu.au			Australian Research CouncilAustralian Research Council [LP120200284]	The authors gratefully acknowledge the contribution and courage of the participants in this study. We thank the staff of the NSW Service for the Treatment and Rehabilitation of Torture and Trauma Survivors (STARTTS) for their input to this project. We acknowledge the efforts of members of the Refugee Trauma and Recovery Program team, including Daniela Peiris, Emma Doolan and Alice Kim, for their contributions. This study was funded by the Australian Research Council (grant number LP120200284).	Abrol A, 2017, NEUROIMAGE, V163, P160, DOI 10.1016/j.neuroimage.2017.09.020; Adenauer H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-127; Adenauer H, 2010, BIOL PSYCHIAT, V68, P451, DOI 10.1016/j.biopsych.2010.05.015; Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amensty International, 2014, TORT 2014 30 YEARS B; [Anonymous], 1984, CONV TORT OTH CRUEL; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; Basoglu M, 2009, AM J ORTHOPSYCHIAT, V79, P135, DOI 10.1037/a0015681; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Carlson EB., 1993, DISSOCIATION, V6, P16; Catani C, 2009, EUR ARCH PSY CLIN N, V259, P340, DOI 10.1007/s00406-009-0006-4; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Davey CG, 2016, NEUROIMAGE, V132, P390, DOI 10.1016/j.neuroimage.2016.02.022; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Gjini K, 2013, J PSYCHIATR RES, V47, P1492, DOI 10.1016/j.jpsychires.2013.06.007; Jeong H, 2019, BRIT J PSYCHIAT, V214, P347, DOI 10.1192/bjp.2018.260; Kirmayer L J, 2017, Torture, V27, P84; Lanius RA, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27905; Leach J, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0048-y; Lebois LAM, 2021, AM J PSYCHIAT, V178, P165, DOI 10.1176/appi.ajp.2020.19060647; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Liddell B, 2021, AUST NZ J PSYCHIAT, V55, P153, DOI 10.1177/0004867420950819; Liddell BJ, 2019, CLIN PSYCHOL SCI, V7, P811, DOI 10.1177/2167702619841047; Liddell BJ, 2018, LANCET PSYCHIAT, V5, P101, DOI 10.1016/S2215-0366(17)30332-2; Liddell BJ, 2018, MENTAL HLTH REFUGEE, P135; Malhi GS, 2019, BRIT J PSYCHIAT, V215, P545, DOI 10.1192/bjp.2019.10; McDonnell M, 2013, CURR OPIN PSYCHIATR, V26, P1, DOI 10.1097/YCO.0b013e32835aea9d; McLaughlin KA, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01561-6; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Neria Y, 2021, AM J PSYCHIAT, V178, P128, DOI 10.1176/appi.ajp.2020.20121727; Nicholson AA, 2020, NEUROIMAGE-CLIN, V27, DOI 10.1016/j.nicl.2020.102262; Nickerson A, 2016, PSYCHIAT RES, V242, P233, DOI 10.1016/j.psychres.2016.05.048; Nickerson A, 2014, CLIN PSYCHOL-SCI PR, V21, P172, DOI 10.1111/cpsp.12064; Pistoia F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01038; Quide Y, 2021, BRAIN IMAGING BEHAV, V15, P2356, DOI 10.1007/s11682-020-00431-2; Quiroga J., 2005, TORTURE, V16, P1; Rasmussen A, 2011, Z PSYCHOL, V219, P143, DOI 10.1027/2151-2604/a000061; Schauer M, 2010, Z PSYCHOL, V218, P109, DOI 10.1027/0044-3409/a000018; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Silove D, 2002, COMPR PSYCHIAT, V43, P49, DOI 10.1053/comp.2002.29843; Silove D, 2013, INTERVENTION, V11, P237; Stark EA, 2015, NEUROSCI BIOBEHAV R, V56, P207, DOI 10.1016/j.neubiorev.2015.07.007; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; United Nations Committee Against Torture (UNCAT), 2012, UN CONV TORT OTH CRU; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vrca A, 1997, COLLEGIUM ANTROPOL, V21, P229; Waller NG, 1997, J ABNORM PSYCHOL, V106, P499, DOI 10.1037/0021-843X.106.4.499; Weiss William M, 2016, Torture, V26, P17; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Williams ACD, 2013, BRIT J PAIN, V7, P101, DOI 10.1177/2049463713483596; Yuen NH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00900; Zandieh S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003387	62	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	JAN 26	2022	12	1							37	10.1038/s41398-022-01795-3			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	YQ3PG	WOS:000749223600003	35082270	gold			2022-02-06	
J	Roine, T; Mohammadian, M; Hirvonen, J; Kurki, T; Posti, JP; Takala, RSK; Newcombe, VF; Tallus, J; Katila, AJ; Maanpaeae, HR; Frantzen, J; Menon, D; Tenovuo, O				Roine, Timo; Mohammadian, Mehrbod; Hirvonen, Jussi; Kurki, Timo; Posti, Jussi P.; Takala, Riikka S. K.; Newcombe, Virginia F.; Tallus, Jussi; Katila, Ari J.; Maanpaeae, Henna-Riikka; Frantzen, Janek; Menon, David; Tenovuo, Olli			Structural Brain Connectivity Correlates with Outcome in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						connectome; diffusion MRI; Glasgow Outcome Scale; tractography; traumatic brain injury	CONSTRAINED SPHERICAL DECONVOLUTION; DIFFUSION MRI; TRACTOGRAPHY; DISTORTIONS; CONNECTOME; IMAGES; MODEL; SCALE; SIFT; TBI	We investigated the topology of structural brain connectivity networks and its association with outcome after mild traumatic brain injury, a major cause of permanent disability. Eighty-five patients with mild traumatic brain injury underwent magnetic resonance imaging (MRI) twice, about three weeks and eight months after injury, and 30 age-matched orthopedic trauma control subjects were scanned. Outcome was assessed with Extended Glasgow Outcome Scale on average eight months after injury. We performed constrained spherical deconvolution-based probabilistic streamlines tractography on diffusion MRI data and parcellated cortical and subcortical gray matter into 84 regions based on T1-weighted data to reconstruct structural brain connectivity networks weighted by the number of streamlines. Graph theoretical methods were employed to measure network properties in both patients and controls, and correlations between these properties and outcome were calculated. We found no global differences in the network properties between patients with mild traumatic brain injury and orthopedic control subjects at either stage. We found significantly increased betweenness centrality of the right pars opercularis in the chronic stage compared with control subjects, however. Further, both global and local network properties correlated significantly with outcome. Higher normalized global efficiency, degree, and strength as well as lower small-worldness were associated with better outcome. Correlations between the outcome and the local network properties were the most prominent in the left putamen and the left postcentral gyrus. Our results indicate that both global and local network properties provide valuable information about the outcome already in the acute/subacute stage and, therefore, are promising biomarkers for prognostic purposes in mild traumatic brain injury.	[Roine, Timo] Univ Turku, Turku Brain & Mind Ctr, Turku, Finland; [Mohammadian, Mehrbod; Kurki, Timo; Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Takala, Riikka S. K.] Univ Turku, Anaesthesiol Intens Care Emergency Care & Pain M, Turku, Finland; [Roine, Timo] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Rakentajanaukio 2 C, Espoo 02150, Finland; [Mohammadian, Mehrbod; Kurki, Timo; Posti, Jussi P.; Tallus, Jussi; Maanpaeae, Henna-Riikka; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland; [Hirvonen, Jussi; Kurki, Timo] Turku Univ Hosp, Dept Radiol, Turku, Finland; [Posti, Jussi P.; Maanpaeae, Henna-Riikka; Frantzen, Janek] Turku Univ Hosp, Neuroctr, Dept Neurosurg, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Menon, David] Addenbrookes Hosp, Div Anaesthesia, Cambridge, England		Roine, T (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Rakentajanaukio 2 C, Espoo 02150, Finland.	timo.roine@iki.fi		Posti, Jussi/0000-0002-5925-5193	TBIcare FP7 project; University of Turku; Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Maire Taponen Foundation; Academy of Medical Sciences/The Health Foundation Fellowship; Health Sciences (Finland)	This study was partly funded by the TBIcare FP7 project. M.M received funding from University of Turku. T.R. received support from the Emil Aaltonen Foundation, the Maud Kuistila Memorial Foundation, and the Finnish Cultural Foundation. J.P.P. received funding from the Academy of Finland (Grant #17379), Government's Special Financial Transfer tied to academic research in Health Sciences (Finland), and Maire Taponen Foundation. V.N. is supported by an Academy of Medical Sciences/The Health Foundation Fellowship.	Ala-Seppala H, 2016, BRAIN INJURY, V30, P1062, DOI 10.3109/02699052.2016.1170880; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Calamante F, 2015, NEUROIMAGE, V117, P284, DOI 10.1016/j.neuroimage.2015.05.070; Carney N.A., 2007, J NEUROTRAUM, V24, P1; Civier O, 2019, NEUROIMAGE, V194, P68, DOI 10.1016/j.neuroimage.2019.02.039; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hartwigsen G, 2010, NEUROPSYCHOLOGIA, V48, P3155, DOI 10.1016/j.neuropsychologia.2010.06.032; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lipp I, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2019.116471; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Mohammadian M, 2020, J NEUROTRAUM, V37, P2616, DOI 10.1089/neu.2020.7081; Mohammadian M, 2017, NEUROIMAGE-CLIN, V13, P174, DOI 10.1016/j.nicl.2016.11.016; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Qiu L, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.18; Roine T, 2019, AM J NEURORADIOL, V40, P2146, DOI 10.3174/ajnr.A6306; Roine T, 2019, MED IMAGE ANAL, V52, P56, DOI 10.1016/j.media.2018.10.009; Roine T, 2015, MED IMAGE ANAL, V24, P269, DOI 10.1016/j.media.2015.01.001; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Roine U, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0058-4; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Schiavi S, 2020, HUM BRAIN MAPP, V41, P2951, DOI 10.1002/hbm.24989; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith RE, 2015, NEUROIMAGE, V119, P338, DOI 10.1016/j.neuroimage.2015.06.092; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Solmaz B, 2017, HUM BRAIN MAPP, V38, P2913, DOI 10.1002/hbm.23561; Spielberg JM, 2015, P NATL ACAD SCI USA, V112, P10020, DOI 10.1073/pnas.1500048112; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; van der Horn HJ, 2017, J NEUROTRAUM, V34, P1035, DOI 10.1089/neu.2016.4659; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	69	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0093		JAN 2022	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YO7NG	WOS:000748122700001	35018829				2022-02-06	
J	Kim, H; Kim, MJ; Kwon, YW; Jeon, S; Lee, SY; Kim, CS; Choi, BT; Shin, YI; Hong, SW; Shin, HK				Kim, Hyunha; Kim, Min Jae; Kwon, Young Woo; Jeon, Sangheon; Lee, Seo-Yeon; Kim, Chang-Seok; Choi, Byung Tae; Shin, Yong-Il; Hong, Suck Won; Shin, Hwa Kyoung			Benefits of a Skull-Interfaced Flexible and Implantable Multilight Emitting Diode Array for Photobiomodulation in Ischemic Stroke	ADVANCED SCIENCE			English	Article; Early Access						light-emitting diodes; photobiomodulation; poststroke cognitive impairments; stroke	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; LED THERAPY; LIGHT; SAFETY; MECHANISMS; SINGLE; MAZE; MICE	Photobiomodulation (PBM) has received attention due to its potential for improving tissue function and enhancing regeneration in stroke. A lightweight, compact, and simple system of miniaturized electronic devices consisting of packaged light-emitting diodes (LEDs) that incorporates a flexible substrate for in vivo brain PBM in a mouse model is developed. Using this device platform, the preventive and therapeutic effects of PBM affixed to the exposed skull of mice in the photothrombosis and middle cerebral artery occlusion stroke model are evaluated. Among the wavelength range of 630, 850, and 940 nm LED array, the PBM with 630-nm LED array is proved to be the most effective for reducing the infarction volume and neurological impairment after ischemic stroke. Moreover, the PBM with 630 nm LED array remarkably improves the capability of spatial learning and memory in the chronic poststroke phase, attenuates AIM2 inflammasome activation and inflammasome-mediated pyroptosis, and modulates microglial polarization in the hippocampus and cortex 7 days following ischemic stroke. Thus, PBM may prevent tissue and functional damage in acute ischemic injury, thereby attenuating the development of cognitive impairment after stroke.	[Kim, Hyunha; Kim, Min Jae; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Grad Training Program Korean Med Therapeut Hlth A, Yangsan 50612, South Korea; [Kim, Hyunha] Creighton Univ, Dept Pharmacol & Neurosci, Sch Med, Omaha, NE 68178 USA; [Kwon, Young Woo] Pusan Natl Univ, Coll Nanosci & Nanotechnol, Dept Nanofus Technol, Busan 46241, South Korea; [Jeon, Sangheon; Kim, Chang-Seok; Hong, Suck Won] Pusan Natl Univ, Coll Nanosci & Nanotechnol, Dept Congo Mechatron Engn, Dept Opt & Mechatron Engn, Busan 46241, South Korea; [Lee, Seo-Yeon] Wonkwang Univ, Dept Pharmacol, Sch Med, Iksan 54538, South Korea; [Shin, Yong-Il] Pusan Natl Univ, Sch Med, Dept Rehabil Med, Yangsan 50612, South Korea		Hong, SW (corresponding author), Pusan Natl Univ, Coll Nanosci & Nanotechnol, Dept Congo Mechatron Engn, Dept Opt & Mechatron Engn, Busan 46241, South Korea.	swhong@pusan.ac.kr; julie@pusan.ac.kr		Hong, Suck Won/0000-0001-7291-1020; Kim, MinJae/0000-0003-2883-3189	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2019R1A2C1088796, NRF2021M3A9E4081781, NRF-2021R1A5A1032937]	H.K. andM.J.K. contributed equally to this work. This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (Grant Nos. NRF-2019R1A2C1088796, NRF2021M3A9E4081781, and NRF-2021R1A5A1032937).	Banqueri M, 2019, BRAIN RES, V1720, DOI 10.1016/j.brainres.2019.146300; Biswas S, 2016, NPG ASIA MATER, V8, DOI 10.1038/am.2016.186; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Cho GM, 2020, J GERONTOL A-BIOL, V75, P631, DOI 10.1093/gerona/gly240; Cho Y, 2021, ADV MATER, V33, DOI 10.1002/adma.202005786; Eltchechem CD, 2017, LASER MED SCI, V32, P749, DOI 10.1007/s10103-017-2156-3; Gold AB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-17; Gutruf P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13637-w; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Jang TM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc9675; Jeong GS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1980; Jeong S, 2018, NAT PHOTONICS, V12, P277, DOI 10.1038/s41566-018-0120-9; Jeong YC, 2020, ADV MATER, V32, DOI 10.1002/adma.201907522; Ji BW, 2018, MICROSYST NANOENG, V4, DOI 10.1038/s41378-018-0027-0; Kim H, 2020, BRAIN BEHAV IMMUN, V87, P765, DOI 10.1016/j.bbi.2020.03.011; Kim MJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2479602; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Klein E, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00659; Koo J, 2018, NAT MED, V24, P1830, DOI 10.1038/s41591-018-0196-2; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lee HI, 2017, J BIOPHOTONICS, V10, P1761, DOI 10.1002/jbio.201700038; Lee HI, 2017, J BIOPHOTONICS, V10, P1502, DOI 10.1002/jbio.201600244; Lee HI, 2017, BIOCHEM BIOPH RES CO, V486, P945, DOI 10.1016/j.bbrc.2017.03.131; Lee HI, 2016, RESTOR NEUROL NEUROS, V34, P201, DOI 10.3233/RNN-150559; Li HB, 2021, MATER HORIZ, V8, P383, DOI 10.1039/d0mh00483a; Mardinly AR, 2018, NAT NEUROSCI, V21, P881, DOI 10.1038/s41593-018-0139-8; Markvicka EJ, 2018, NAT MATER, V17, P618, DOI 10.1038/s41563-018-0084-7; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; McColl BW, 2007, BIOCHEM SOC T, V35, P1163, DOI 10.1042/BST0351163; Meyer DM, 2016, NEUROSCI LETT, V630, P254, DOI 10.1016/j.neulet.2016.06.038; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Naeser MA, 2020, PHOTOBIOMOD PHOTOMED, V38, P115, DOI 10.1089/photob.2019.4630; Pisanello F, 2017, NAT NEUROSCI, V20, P1180, DOI 10.1038/nn.4591; Salehpour F., 2018, J VISUALIZED EXP, P59076; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Samineni VK, 2017, PAIN, V158, P2108, DOI 10.1097/j.pain.0000000000000968; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Song EM, 2020, NAT MATER, V19, P590, DOI 10.1038/s41563-020-0679-7; Svilainis L, 2008, MEASUREMENT, V41, P647, DOI 10.1016/j.measurement.2007.09.003; Swardfager W, 2013, NEUROSCI BIOBEHAV R, V37, P436, DOI 10.1016/j.neubiorev.2013.01.021; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Yamagishi K, 2019, NAT BIOMED ENG, V3, P27, DOI 10.1038/s41551-018-0261-7; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Zhang H, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202100576; Zhao J, 2019, TRENDS CHEM, V1, P559, DOI 10.1016/j.trechm.2019.07.001; Zheng H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10418-3; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	58	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2198-3844		ADV SCI	Adv. Sci.											2104629	10.1002/advs.202104629		JAN 2022	16	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	YM4KO	WOS:000746545400001	35076161	gold			2022-02-06	
J	Lange, RT; French, LM; Bailie, JM; Merritt, VC; Pattinson, CL; Hungerford, LD; Lippa, SM; Brickell, TA				Lange, Rael T.; French, Louis M.; Bailie, Jason M.; Merritt, Victoria C.; Pattinson, Cassandra L.; Hungerford, Lars D.; Lippa, Sara M.; Brickell, Tracey A.			Clinical utility of PTSD, resilience, sleep, and blast as risk factors to predict poor neurobehavioral functioning following traumatic brain injury: A longitudinal study in US military service members	QUALITY OF LIFE RESEARCH			English	Article; Early Access						Traumatic brain injury; Posttraumatic stress; Sleep disturbance; Resilience; Military	POSTTRAUMATIC-STRESS-DISORDER; DETECT SYMPTOM EXAGGERATION; QUALITY-OF-LIFE; VALIDITY-10 SCALE; HEALTH; DISTURBANCES; VETERANS; TBI; AFGHANISTAN; POPULATION	Purpose This study examined the clinical utility of post-traumatic stress disorder (PTSD), low resilience, poor sleep, and lifetime blast exposure as risk factors for predicting future neurobehavioral outcome following traumatic brain injury (TBI). Methods Participants were 591 U.S. military service members and veterans who had sustained a TBI (n = 419) or orthopedic injury without TBI (n = 172). Participants completed the Neurobehavioral Symptom Inventory, PTSD Checklist, and the TBI-Quality of Life (TBI-QOL) scale at baseline and follow-up. Results Using the four risk factors at baseline, 15 risk factor combinations were examined by calculating odds ratios to predict poor neurobehavioral outcome at follow-up (i.e., number of abnormal scores across five TBI-QOL scales [e.g., Fatigue, Depression]). The vast majority of risk factor combinations resulted in odds ratios that were considered to be clinically meaningful (i.e., >= 2.5) for predicting poor outcome. The risk factor combinations with the highest odds ratios included PTSD singularly, or in combination with poor sleep and/or low resilience (odds ratios = 4.3-72.4). However, poor sleep and low resilience were also strong predictors in the absence of PTSD (odds ratios = 3.1-29.8). Conclusion PTSD, poor sleep, and low resilience, singularly or in combination, may be valuable risk factors that can be used clinically for targeted early interventions.	[Lange, Rael T.; French, Louis M.; Bailie, Jason M.; Hungerford, Lars D.; Brickell, Tracey A.] Traumat Brain Injury Ctr Excellence, Silver Spring, MD 20910 USA; [Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Lange, Rael T.; French, Louis M.; Lippa, Sara M.; Brickell, Tracey A.] Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [French, Louis M.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Oceanside, CA USA; [Merritt, Victoria C.] VA San Diego Healthcare Syst, San Diego, CA USA; [Merritt, Victoria C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Pattinson, Cassandra L.] Univ Queensland, Brisbane, Qld, Australia; [Hungerford, Lars D.] Naval Med Ctr San Diego, San Diego, CA USA; [Lange, Rael T.; Bailie, Jason M.; Hungerford, Lars D.; Brickell, Tracey A.] Gen Dynam Informat Technol, Falls Church, VA 22042 USA		Lange, RT (corresponding author), Traumat Brain Injury Ctr Excellence, Silver Spring, MD 20910 USA.; Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA.; Lange, RT (corresponding author), Natl Intrepid Ctr Excellence, Bethesda, MD 20814 USA.; Lange, RT (corresponding author), Univ British Columbia, Vancouver, BC, Canada.; Lange, RT (corresponding author), Gen Dynam Informat Technol, Falls Church, VA 22042 USA.	rael.lange@gmail.com			DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]; VA Clinical Science Research & Development Service [IK2 CX001952]	This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. 101. Additionally, Victoria Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service.	Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Bailie J, 2020, ARCH CLIN NEUROPSYCH, V35, P931, DOI 10.1093/arclin/acaa068.138; Bailie J., HIGH LEVELS BLAST EX; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Bilmes L., 2006, EC COSTS IRAQ WAR AP; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Kalisch R, 2017, NAT HUM BEHAV, V1, P784, DOI 10.1038/s41562-017-0200-8; Lange R. T., 2019, POOR SLEEP RISK FACT; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Merritt V. C., 2022, BRAIN INJURY; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Modica LCM, 2021, J NEUROTRAUM, V38, P1654, DOI 10.1089/neu.2020.7405; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Pattinson CL, 2021, J CLIN SLEEP MED, V17, P2425, DOI 10.5664/jcsm.9454; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rowland JA, 2020, BRAIN INJURY, V34, P642, DOI 10.1080/02699052.2020.1729418; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor MK, 2014, MIL MED, V179, P744, DOI 10.7205/MILMED-D-13-00551; Traumatic Brain Injury Center of Excellence, 2021, DOD WORLDW NUMB TRAU; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Yehuda R, 2007, J TRAUMA STRESS, V20, P435, DOI 10.1002/jts.20260	62	0	0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.												10.1007/s11136-022-03092-4		JAN 2022	12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	YM8AV	WOS:000746792400002	35076825				2022-02-06	
J	Li, GQ; Duan, L; Yang, FBA; Yang, L; Deng, YJ; Yu, Y; Xu, YL; Zhang, YN				Li, Guoqiang; Duan, Lei; Yang, Fengbiao; Yang, Liang; Deng, Yajun; Yu, Yue; Xu, Yanlong; Zhang, Yinian			Curcumin suppress inflammatory response in traumatic brain injury via p38/MAPK signaling pathway	PHYTOTHERAPY RESEARCH			English	Article; Early Access						curcumin; inflammation; neurological function; p38; MAPK	NF-KAPPA-B; P38 MAPK; NEUROPROTECTIVE ROLE; ACTIVATION; MANAGEMENT; MICROGLIA; CYTOKINES; RATS	Traumatic brain injury (TBI) is a common disease worldwide with a high mortality and disability rate and is closely related to the inflammatory response. However, the molecular mechanisms during the pathophysiological responses are not completely understood. This study was conducted to investigate the protective effect of curcumin on TBI and the molecular mechanisms of the p38/MAPK signal pathway. We found that curcumin remarkably ameliorated secondary brain injury after TBI, including effects on the neurological severity score and inflammation. After injection of curcumin, the neurological function score of mice decreased significantly. Curcumin exhibited antiinflammatory pharmacological effects, as reflected by inhibition of inflammatory factors (e.g., interleukin [IL]-1 beta, IL-6, and tumor necrosis factor [TNF]-alpha). Additionally, curcumin notably reduced the expression of p-p38 according to western blotting and immunohistochemical analyses. In conclusion, curcumin remarkably alleviated posttraumatic inflammation and thus shows potential for treating inflammation associated with TBI.	[Li, Guoqiang; Duan, Lei; Yang, Fengbiao; Yu, Yue; Xu, Yanlong; Zhang, Yinian] Lanzhou Univ, Dept Neurosurg, Hosp 2, Lanzhou 730030, Gansu, Peoples R China; [Li, Guoqiang; Duan, Lei; Yang, Fengbiao; Yu, Yue; Xu, Yanlong; Zhang, Yinian] Lanzhou Univ, Key Lab Neurol Gansu Prov, Hosp 2, Lanzhou, Peoples R China; [Yang, Liang; Deng, Yajun] Lanzhou Univ, Dept Orthopaed, Hosp 2, Lanzhou, Peoples R China; [Yang, Liang; Deng, Yajun] Lanzhou Univ, Key Lab Orthopaed Dis Gansu Prov, Hosp 2, Lanzhou, Peoples R China		Zhang, YN (corresponding author), Lanzhou Univ, Dept Neurosurg, Hosp 2, Lanzhou 730030, Gansu, Peoples R China.	ery_zhangyinian@lzu.edu.cn			Gansu Province Health Industry Research Project [GSWSKY2018-01]; Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital [CY2017-BJ15, CY2021-MS-B11]; Cuiying Scientific and Special fund project for doctoral training program of Lanzhou University Second Hospital [YJS-BD-31]; Natural Science Foundation of Gansu Province [21JR1RA128]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771297]	Gansu Province Health Industry Research Project, Grant/Award Number: GSWSKY2018-01; Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital, Grant/Award Numbers: CY2017-BJ15, CY2021-MS-B11; Cuiying Scientific and Special fund project for doctoral training program of Lanzhou University Second Hospital, Grant/Award Number: YJS-BD-31; Natural Science Foundation of Gansu Province, Grant/Award Number: 21JR1RA128; National Natural Science Foundation of China, Grant/Award Number: 81771297	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Akaishi T, 2020, BIOL PHARM BULL, V43, P138, DOI 10.1248/bpb.b19-00699; Akomolafe SF, 2020, NEUROTOX RES, V38, P199, DOI 10.1007/s12640-020-00205-0; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Brilha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16250-3; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chiang YM, 2005, BRIT J PHARMACOL, V146, P352, DOI 10.1038/sj.bjp.0706343; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; de Freitas ML, 2018, EPILEPSY RES, V146, P137, DOI 10.1016/j.eplepsyres.2018.08.003; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hay E, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.108729; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Heinrich M, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112230; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Izzo AA, 2020, BRIT J PHARMACOL, V177, P2169, DOI 10.1111/bph.15054; Jayaraj RL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1516-2; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kim DS, 2015, AM J CHINESE MED, V43, P731, DOI 10.1142/S0192415X15500457; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kostenko Sergiy, 2011, World J Biol Chem, V2, P73, DOI 10.4331/wjbc.v2.i5.73; Liang FQ, 1999, J CLIN INVEST, V104, P1603, DOI 10.1172/JCI7362; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mohammed HS, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165665; Page HRA, 2019, BRIT J PHARMACOL, V176, P1635, DOI 10.1111/bph.14598; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qi R, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106091; Razavi BM, 2021, PHYTOTHER RES, V35, P6489, DOI 10.1002/ptr.7224; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Scuto MC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102417; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Su LP, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1061-4; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tu XK, 2014, INFLAMMATION, V37, P1544, DOI 10.1007/s10753-014-9881-6; Wang JL, 2020, BIOMED PHARMACOTHER, V123, DOI 10.1016/j.biopha.2019.109752; Wang QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034122; Wang Y, 2019, ACS APPL MATER INTER, V11, P3763, DOI 10.1021/acsami.8b20594; Wei TH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134693; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yavarpour-Bali H, 2019, INT J NANOMED, V14, P4449, DOI 10.2147/IJN.S208332; Yun DH, 2009, EXP MOL MED, V41, P17, DOI 10.3858/emm.2009.41.1.003; Zhou RX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1651-9; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	54	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.												10.1002/ptr.7391		JAN 2022	12	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YM8NN	WOS:000746825700001	35080289				2022-02-06	
J	Mojahed, A; Abderezaei, J; Ozkaya, E; Bergman, L; Vakakis, A; Kurt, M				Mojahed, Alireza; Abderezaei, Javid; Ozkaya, Efe; Bergman, Lawrence; Vakakis, Alexander; Kurt, Mehmet			Predictive Helmet Optimization Framework Based on Reduced-Order Modeling of the Brain Dynamics	ANNALS OF BIOMEDICAL ENGINEERING			English	Article; Early Access						Reduced-order brain model; Helmet design; mTBI; Nonlinear corpus callosum model; Experimental impact tests	HEAD ACCELERATION; HYBRID III; INJURY; IMPACT; CONCUSSION; MILD; SYSTEM; KINEMATICS; STANDARDS; WHIPLASH	Sports-related traumatic brain injuries (TBIs) are among the leading causes of head injuries in the world. Use of helmets is the main protective measure against this epidemic. The design criteria for the majority of the helmets often only consider the kinematics of the head. This approach neglects the importance of regional deformations of the brain especially near the deep white matter structures such as the corpus callosum (CC) which have been implicated in mTBI studies. In this work, we develop a dynamical reduced-order model of the skull-brain-helmet system to analyze the effect of various helmet parameters on the dynamics of the head and CC. Here, we show that the optimal head-helmet coupling values that minimize the CC dynamics are different from the ones that minimize the skull and brain dynamics (at some kinematics, up to two times stiffer for the head motion mitigation). By comparing our results with experimental impact tests performed on seven different helmets for five different sports, we found that the football helmets with an absorption of about 65-75% of the impact energy had the best performance in mitigating the head motion. Here, we found that none of the helmets are effective in protecting the CC from harmful impact energies. Our computational results reveal that the origin of the difference between the properties of a helmet mitigating the CC motion vs. the head motion is nonlinear vs. linear dynamics. Unlike the globally linear behavior of the head dynamics, we demonstrate that the CC exhibits nonlinear mechanical response similar to an energy sink. This means that there are scenarios where, at the instant of impact, the CC does not undergo extreme motions, but these may occur with a time delay as it absorbs shock energy from other parts of the brain. These findings hint at the importance of considering tissue level dynamics in designing new helmets.	[Mojahed, Alireza; Vakakis, Alexander] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Abderezaei, Javid; Ozkaya, Efe] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Bergman, Lawrence] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA; [Kurt, Mehmet] Icahn Sch Med Mt Sinai, Biomed Engn & Imaging Inst Imaging Inst, New York, NY 10029 USA; [Mojahed, Alireza] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Abderezaei, Javid; Kurt, Mehmet] Univ Washington, Dept Mech Engn, Seattle, WA 98115 USA		Mojahed, A (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	amojahed@mit.edu			National Science FoundationNational Science Foundation (NSF) [CMMI-17-1727761, CMMI-17-1728186]	This work was supported in part by National Science Foundation Grant No. CMMI-17-1727761 and CMMI-17-1728186. Any opinions, findings, and conclusions or recommendations expressed in this work are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Andena L, 2016, PROCEDIA ENGINEER, V147, P478, DOI 10.1016/j.proeng.2016.06.224; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailly N, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10228286; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Caccese V, 2016, EXP TECHNIQUES, V40, P413, DOI [10.1111/ext.12079, 10.1007/s40799-016-0046-4]; Clark JM, 2020, ANN BIOMED ENG, V48, P2247, DOI 10.1007/s10439-020-02531-y; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Eppinger R., 1998, DEV IMPROVED INJURY; Fernandes FAO, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040735; Funk JR, 2020, ANN BIOMED ENG, V48, P2652, DOI 10.1007/s10439-020-02632-8; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Ghazi K, 2021, J NEUROTRAUM, V38, P1023, DOI 10.1089/neu.2020.7281; Giudice JS, 2020, ANN BIOMED ENG, V48, P1524, DOI 10.1007/s10439-020-02472-6; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Holbourn AHS, 1943, LANCET, V2, P438; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KrzeminskI DE., 2011, SPORTS TECHNOL, V4, P65; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YS., 2008, NONLINEAR TARGETED E; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2013, J AUSTRALAS COLL ROA, V24, P11; Mojahed A, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046503; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ouckama R., 2014, P IRCOBI C; Ramirez BJ, 2018, MATER DESIGN, V137, P298, DOI 10.1016/j.matdes.2017.10.037; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shafiee A., 2015, MODARES MECH ENG, V15, P248; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Sproule DW, 2017, P I MECH ENG P-J SPO, V231, P317, DOI 10.1177/1754337117703019; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Ward C., 1980, SAE T, V89, P3867; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	57	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.												10.1007/s10439-022-02908-1		JAN 2022	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	YM7NT	WOS:000746758400001	35076786				2022-02-06	
J	Oezen, I; Arkan, S; Clausen, F; Ruscher, K; Marklund, N				oezen, Ilknur; Arkan, Sertan; Clausen, Fredrik; Ruscher, Karsten; Marklund, Niklas			Diffuse Traumatic Injury in the Mouse Disrupts Axon-Myelin Integrity in the Cerebellum	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						cerebellum; CNPase; fluid percussion; myelin; myelin basic protein (MBP); neurofilament; traumatic brain injury	EXPERIMENTAL BRAIN-INJURY; CELL-ADHESION MOLECULES; FLUID PERCUSSION MODEL; NEUROFASCIN; NODE; PROTEOLYSIS; PROTEINS; SPECTRIN; DAMAGE; CYTOSKELETONS	Cerebellar dysfunction after traumatic brain injury (TBI) is commonly suspected based on clinical symptoms, although cerebellar pathology has rarely been investigated. To address the hypothesis that the cerebellar axon-myelin unit is altered by diffuse TBI, we used the central fluid percussion injury (cFPI) model in adult mice to create widespread axonal injury by delivering the impact to the forebrain. We specifically focused on changes in myelin components (myelin basic protein [MBP], 2 ',3 '-cyclic nucleotide 3 '-phosphodiesterase [CNPase], nodal/paranodal domains [neurofascin (Nfasc), ankyrin-G], and phosphorylated neurofilaments [SMI-31, SMI-312]) in the cerebellum, remote from the impact, at two, seven, and 30 days post-injury (dpi). When compared with sham-injured controls, cerebellar MBP and CNPase protein levels were decreased at 2 dpi that remained reduced up to 30 dpi. Diffuse TBI induced different effects on neuronal (Nfasc 186, Nfasc 140) and glial (Nfasc 155) neurofascin isoforms that play a key role in the assembly of the nodes of Ranvier. Expression of Nfasc 140 in the cerebellum increased at 7 dpi, in contrast to Nfasc 155 levels, which were decreased. Although neurofascin binding partner ankyrin-G protein levels decreased acutely after cFPI, its expression levels increased at 7 dpi and remained unchanged up to 30 dpi. The TBI-induced reduction in neurofilament phosphorylation (SMI-31) observed in the cerebellum was closely associated with decreased levels of the myelin proteins MBP and CNPase. This is the first evidence of temporal and spatial structural changes in the axon-myelin unit in the cerebellum, remote from the location of the impact site, in a diffuse TBI model in mice.	[oezen, Ilknur; Arkan, Sertan; Ruscher, Karsten; Marklund, Niklas] Lund Univ, Lund Brain Injury Lab Neurosurg Res, Lund, Sweden; [Clausen, Fredrik] Lund Univ, Dept Clin Sci, Expt Brain Res Lab, Lund, Sweden; [Ruscher, Karsten; Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg Lund, Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Dept Clin Sci, Neurosurg, S-22220 Lund, Sweden.	niklas.marklund@med.lu.se					Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2018, J NEUROTRAUM, V35, P2837, DOI 10.1089/neu.2018.5660; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Graham NSN, 2020, BRAIN, V143, P3685, DOI 10.1093/brain/awaa316; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Henschke JU, 2020, ELIFE, V9, DOI 10.7554/eLife.59148; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008749; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kononenko O, 2019, RESTOR NEUROL NEUROS, V37, P87, DOI 10.3233/RNN-180882; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mao HJ, 2018, J BIOMECH, V77, P228, DOI 10.1016/j.jbiomech.2018.07.004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Posmantur RM, 1998, NEUROCHEM RES, V23, P1265, DOI 10.1023/A:1020792132629; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Sloane JA, 2003, J NEUROCHEM, V84, P157, DOI 10.1046/j.1471-4159.2003.01541.x; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Susuki K, 2008, EXP BIOL MED, V233, P394, DOI 10.3181/0709-MR-243; Susuki K, 2016, EXP NEUROL, V283, P446, DOI 10.1016/j.expneurol.2015.11.012; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang MS, 2000, J NEUROPATH EXP NEUR, V59, P599, DOI 10.1093/jnen/59.7.599; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wyatt KD, 2005, EUR J NEUROSCI, V21, P2285, DOI 10.1111/j.1460-9568.2005.04053.x; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhang A, 2015, J NEUROSCI, V35, P2246, DOI 10.1523/JNEUROSCI.3552-14.2015	58	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0321		JAN 2022	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YO6VM	WOS:000748076500001	35018831				2022-02-06	
J	Blass, BE; Bhandare, RR; Canney, DJ				Blass, Benjamin E.; Bhandare, Richie Rashmin; Canney, Daniel J.			Discovery of oxazolidinone-based heterocycles as subtype selective sigma-2 ligands	MEDICINAL CHEMISTRY RESEARCH			English	Article; Early Access						Sigma-2; Sigma-1; Sigma receptor; Oxazolidin-2-one	RECEPTOR; IDENTIFICATION; AFFINITY; BINDING; DESIGN	The sigma-2 (sigma(2)) receptor, also known as the Transmembrane Protein 97 (TMEM97, and MAC30 (Meningioma-associated protein), has been linked to a number of conditions are disease states such as schizophrenia, cancer, Alzheimer's disease, traumatic brain injury, and neuropathic pain. As part or our on-going effort identify novel sigma(2) ligands, we have identified a series of novel, functionalized oxazolidin-2-one sigma-2 ligands (4). Our lead compound (4h) demonstrated high affinity (K-i = 36 nM) and excellent sigma(1)/sigma(2) selectivity (79-fold). Evaluation of its affinity at key CNS targets via the Psychoactive Drug Screening Program (PDSP) also indicated a high degree of selectivity for sigma(2) over other receptors. [GRAPHICS] .	[Blass, Benjamin E.; Canney, Daniel J.] Temple Univ, Sch Pharm, 3307 North Broad St, Philadelphia, PA 19122 USA; [Bhandare, Richie Rashmin] Ajman Univ, Coll Pharm, Dept Pharmaceut Sci, POB 346, Ajman, U Arab Emirates		Blass, BE (corresponding author), Temple Univ, Sch Pharm, 3307 North Broad St, Philadelphia, PA 19122 USA.	Benjamin.Blass@Temple.edu			National Institute of Mental Health's Psychoactive Drug Screening ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [HHSN-271-2013-00017-C]	Ki determinations were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2013-00017-C (NIMH PDSP) [28]. The NIMH PDSP is directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. For experimental details please refer to the PDSP web site https://pdsp.unc.edu/ims/investigator/web/.The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. TPSA and cLogP values were generated using the Dotmatics software suite (Dotmatics LLC The Old Monastery, Windhill Bishops, Stortford Herts, CW23 2ND UK).	Alon A, 2021, NATURE, V600, P759, DOI 10.1038/s41586-021-04175-x; Alon A, 2017, P NATL ACAD SCI USA, V114, P7160, DOI 10.1073/pnas.1705154114; Asong G, 2019, BIOORGAN MED CHEM, V27, P2629, DOI 10.1016/j.bmc.2019.04.012; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bhandare RR, 2014, MED CHEM, V10, P361, DOI 10.2174/15734064113096660043; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; BOWEN WD, 1995, EUR J PHARMACOL, V278, P257, DOI 10.1016/0014-2999(95)00176-L; Ebrahimi-Fakhari D, 2016, HUM MOL GENET, V25, P3588, DOI 10.1093/hmg/ddw204; GREGORY WA, 1989, J MED CHEM, V32, P1673, DOI 10.1021/jm00128a003; Guo L, 2015, CURR MED CHEM, V22, P989, DOI 10.2174/0929867322666150114163607; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Iyamu ID, 2019, CHEMMEDCHEM, V14, P1248, DOI 10.1002/cmdc.201900203; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; KHAZAN N, 1984, NEUROPHARMACOLOGY, V23, P983, DOI 10.1016/0028-3908(84)90015-7; Laurini E, 2010, BIOORG MED CHEM LETT, V20, P2954, DOI 10.1016/j.bmcl.2010.03.009; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; McDonald ES, 2020, J NUCL MED, V61, P665, DOI 10.2967/jnumed.119.232363; PERREGAARD J, 1995, J MED CHEM, V38, P1998, DOI 10.1021/jm00011a019; Rishton GM, 2021, ACS MED CHEM LETT, V12, P1389, DOI 10.1021/acsmedchemlett.1c00048; Sahn JJ, 2017, ACS CHEM NEUROSCI, V8, P1801, DOI 10.1021/acschemneuro.7b00200; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; VILNER BJ, 1995, CANCER RES, V55, P408; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917	27	0	0	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.												10.1007/s00044-022-02848-4		JAN 2022	10	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YM2RS	WOS:000746426900002		Green Submitted			2022-02-06	
J	Bruno, J; Ragozzino, S; Quitt, J; Siegemund, M; Labhardt, N				Bruno, Jowita; Ragozzino, Silvio; Quitt, Jonas; Siegemund, Martin; Labhardt, Niklaus			Severe acute respiratory syndrome coronavirus 2, primary varicella zoster virus coinfection, and a polymicrobial ventilator-associated tracheobronchitis in an adult immunocompetent male: a case report	JOURNAL OF MEDICAL CASE REPORTS			English	Article						SARS-CoV-2; COVID-19; COVID-19-related skin lesions; Varicella zoster virus; Chickenpox; Coinfection	COVID-19	Background The spectrum of clinical manifestations and differential diagnosis associated with coronavirus disease 2019 is broad, ranging from fever and cutaneous eruptions to respiratory distress or even neurological disorders. Coexisting multipathogen infections significantly increase the complexity of the proper diagnostic and therapeutic approach and correlate with the rate of intensive care unit admissions and in-hospital mortality. Case presentation We present a case of multipathogen respiratory infection with severe acute respiratory syndrome coronavirus 2, varicella zoster virus, and polymicrobial tracheobronchitis in a 48-year-old Caucasian male hospitalized after traumatic brain injury. The patient tested positive for severe acute respiratory syndrome coronavirus 2 infection upon admission. During his stay in the intensive care unit, the patient developed a vesicular exanthema along with respiratory failure and signs of septic shock. Conclusion This case of an adult presenting with severe acute respiratory syndrome coronavirus 2 infection and simultaneous primary varicella zoster virus infection illustrates the importance of considering coinfections in patients with coronavirus disease 2019 with unusual clinical manifestations.	[Bruno, Jowita; Quitt, Jonas; Siegemund, Martin] Univ Hosp Basel, Dept Intens Care, Petersgraben 4, CH-4031 Basel, Switzerland; [Ragozzino, Silvio; Labhardt, Niklaus] Univ Hosp Basel, Dept Infect Dis, Spitalstr 21, CH-4031 Basel, Switzerland; [Labhardt, Niklaus] Swiss Trop & Publ Hlth Inst, Dept Med, Basel, Switzerland; [Labhardt, Niklaus] Univ Basel, Basel, Switzerland		Quitt, J (corresponding author), Univ Hosp Basel, Dept Intens Care, Petersgraben 4, CH-4031 Basel, Switzerland.	jonas.quitt@usb.ch		Quitt, Jonas/0000-0003-1915-0837; Ragozzino, Silvio/0000-0002-8100-2096			Acharya D, 2020, NAT REV IMMUNOL, V20, P397, DOI 10.1038/s41577-020-0346-x; Contou D, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00736-x; Casas CG, 2020, BRIT J DERMATOL, V183, P71, DOI 10.1111/bjd.19163; Garcia-Vidal C, 2021, CLIN MICROBIOL INFEC, V27, P83, DOI 10.1016/j.cmi.2020.07.041; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Huang W, 2020, CYTOM PART A, V97, P772, DOI 10.1002/cyto.a.24172; Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046; Marzano AV, 2020, J AM ACAD DERMATOL, V83, P280, DOI 10.1016/j.jaad.2020.04.044; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; Mohsen AH, 2003, EUR RESPIR J, V21, P886, DOI 10.1183/09031936.03.00103202; Patel P, 2021, NEUROL-CLIN PRACT, V11, pE219, DOI 10.1212/CPJ.0000000000000902; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387; Tunbridge AJ, 2008, J INFECTION, V57, P95, DOI 10.1016/j.jinf.2008.03.004; Xu R, 2020, BRIT J DERMATOL, V183, P1145, DOI 10.1111/bjd.19484; Zheng MJ, 2020, CELL MOL IMMUNOL, V17, P533, DOI 10.1038/s41423-020-0402-2	15	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1752-1947		J MED CASE REP	J. Med. Case Rep.	JAN 24	2022	16	1							45	10.1186/s13256-022-03253-6			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	YM5BZ	WOS:000746591100001	35073976	Green Accepted, gold			2022-02-06	
J	Choi, S; Won, J; Park, K; Kim, S				Choi, Sola; Won, Jongim; Park, Kyuenam; Kim, Sujin			Hemispheric Differences in Self-evaluation Errors of Upper Extremity Movement in Patients with Chronic Stroke	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Early Access						Arms; Hemispheric specialization; Performance; Self-evaluation; Strokes; Upper extremity paresis; Video recording	TRAUMATIC BRAIN-INJURY; MOTOR IMPAIRMENT; ANOSOGNOSIA; AWARENESS; HEMIPLEGIA; UNAWARENESS; ANATOMY; REHABILITATION; LIMITATIONS; EXTENSION	Objective: There is growing evidence that the side of brain lesions results in distinct upper extremity deficits in motor control, movement behavior, and emotional and cognitive function poststroke. We investigated self-evaluation errors, which are the differences in scores between patient self-evaluation and clinician evaluations, and compared patients with left hemisphere damage (LHD) and right hemisphere damage (RHD) poststroke. Method: Twenty-eight patients with chronic stroke (LHD = 16) performed the actual amount of the test twice with a one-week interval. We videotaped the participants' movements, and participants with stroke and evaluators graded the quality of movement scores by watching video recordings. Results: Self-evaluation errors were significantly lower in patients with LHD than in those with RHD (t = 2.350, p = .019). Interestingly, this error did not change after the clinician provided the correct score as feedback. Chi-squared analysis revealed that more patients with LHD underestimated their movements (chi(2) = 9.049, p = .002), while more patients with RHD overestimated (chi(2) = 7.429, p = .006) in the send evaluation. Furthermore, there were no correlations between self-evaluation error and age, cognitive function, physical impairment, ability to control emotions, or onset months poststroke. Conclusions: Patients with stroke and therapists evaluated the same movements differently, and this can be dependent on hemispheric damage. Therapists might need to encourage patients with LHD who underestimate their movement to ensure continuous use of their more-affected arm. Patients with RHD who overestimate their movement might need treatment to overcome impaired self-awareness, such as video recordings, to protect from unexpected dangerous situations.	[Choi, Sola; Won, Jongim; Park, Kyuenam; Kim, Sujin] Jeonju Univ, Dept Phys Therapy, Jeonju, South Korea; [Choi, Sola] Samsung Hosp, Dept Phys & Rehabil Med, Seoul, South Korea		Kim, S (corresponding author), Jeonju Univ, Dept Phys Therapy, 303 Cheonjam Ro, Jeonju Si, Jeollabuk Do, South Korea.	sujink@jj.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIT) [2017R1C1B5076731]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2017R1C1B5076731).	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Besharati S, 2015, NEUROPSYCHOL REHABIL, V25, P319, DOI 10.1080/09602011.2014.923319; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; Cocchini G, 2018, J INT NEUROPSYCH SOC, V24, P45, DOI 10.1017/S1355617717000662; Cocchini G, 2010, NEUROPSYCHOLOGIA, V48, P1489, DOI 10.1016/j.neuropsychologia.2010.01.019; Cocchini G, 2009, NEUROPSYCHOLOGY, V23, P223, DOI 10.1037/a0014266; D'Imperio D, 2017, CORTEX, V92, P187, DOI 10.1016/j.cortex.2017.04.009; Della Sala S, 2009, CLIN NEUROPSYCHOL, V23, P406, DOI 10.1080/13854040802251393; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fotopoulou A, 2010, BRAIN, V133, P3564, DOI 10.1093/brain/awq233; Fotopoulou A, 2009, NEUROPSYCHOLOGIA, V47, P1256, DOI 10.1016/j.neuropsychologia.2009.01.018; Fowler EA, 2018, NEUROPSYCHOLOGIA, V119, P191, DOI 10.1016/j.neuropsychologia.2018.08.007; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Haaland KY, 2012, ARCH PHYS MED REHAB, V93, P1957, DOI 10.1016/j.apmr.2012.05.011; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Han CE, 2013, NEUROREHAB NEURAL RE, V27, P439, DOI 10.1177/1545968312471904; Hartman-Maeir A, 2001, NEUROREHAB NEURAL RE, V15, P213, DOI 10.1177/154596830101500309; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; Hidaka Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002343; Jehkonen M, 2006, ACTA NEUROL SCAND, V114, P293, DOI 10.1111/j.1600-0404.2006.00723.x; Jenkinson PM, 2011, J CLIN EXP NEUROPSYC, V33, P1079, DOI 10.1080/13803395.2011.596822; 김경현, 2019, [Physical Therapy Korea, 한국전문물리치료학회지], V26, P24; Kim S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00883; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Lee Kang Soo, 2009, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V48, P61; Mahmood K, 2016, COMMUN INF LIT, V10, P199, DOI 10.15760/comminfolit.2016.10.2.24; Mani S, 2014, NEUROREHAB NEURAL RE, V28, P584, DOI 10.1177/1545968314520720; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MIZUNO M, 1991, Keio Journal of Medicine, V40, P221; Nakase T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-39; Nurmi ME, 2014, CORTEX, V61, P43, DOI 10.1016/j.cortex.2014.04.008; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Pia L, 2013, CORTEX, V49, P1694, DOI 10.1016/j.cortex.2012.08.017; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; R Core Team, 2020, R LANG ENV STAT COMP; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schlosser T, 2013, J ECON PSYCHOL, V39, P85, DOI 10.1016/j.joep.2013.07.004; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Spalletta G, 2006, AM J GERIAT PSYCHIAT, V14, P220, DOI 10.1097/01.JGP.0000194647.72654.a1; Spinazzola L, 2008, NEUROPSYCHOLOGIA, V46, P915, DOI 10.1016/j.neuropsychologia.2007.12.015; Starkstein SE, 2010, CAN J PSYCHIAT, V55, P355, DOI 10.1177/070674371005500604; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1726, DOI 10.1053/apmr.2002.35660; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Taub E, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P475, DOI 10.1037/10361-022; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Uswatte G., 1999, COGN NEUROREHABILIT, P215; Varghese R, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01340; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8	54	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.											PII S1355617721001430	10.1017/S1355617721001430		JAN 2022	9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	YM0FI	WOS:000746258800001	35067270	hybrid			2022-02-06	
J	Kaneko, H; Namihira, M; Yamamoto, S; Numata, N; Hyodo, K				Kaneko, Hidekazu; Namihira, Masakazu; Yamamoto, Shoko; Numata, Noriaki; Hyodo, Koji			Oral administration of cyclic glycyl-proline facilitates task learning in a rat stroke model	BEHAVIOURAL BRAIN RESEARCH			English	Article						Dipeptide; Learning; Rehabilitation; Adult neurogenesis; Choice reaction time task; Focal ischemic lesion	TRAUMATIC BRAIN-INJURY; REACTION-TIME-TASK; NEURAL STEM-CELLS; NEUROPEPTIDE CYCLOPROLYLGLYCINE; NEUROTROPHIC FACTOR; MOTOR RECOVERY; PLASTICITY; DIKETOPIPERAZINE; NEUROGENESIS; DIPEPTIDE	Cyclic glycyl-proline (cGP) exerts neuroprotective effects against ischemic stroke and may promote neural plasticity or network remodeling. We sought to determine to what extent oral administration of cGP could facilitate task learning in rats with ischemic lesions. We trained rats to perform a choice reaction time task using their forepaws. One week after changing the food to pellets containing cGP (no cGP: 0 mg/kg; low cGP: 25 mg/ kg; and high cGP: 75 mg/kg), we made a focal ischemic lesion on the left or right forepaw area of the sensorimotor cortex. After recovery of task performance, we altered the correct-response side of the task, and then analyzed the number of training days required for the rat to reach a learning criterion (error rate < 15%) and the regulation of adult neurogenesis in the subventricular zones (SVZs), taking lesion size into account. The low-cGP group required fewer training days for task learning than the no-cGP group. Unexpectedly, rats with larger lesions required fewer training days in the no-cGP and low-cGP groups, but more training days in the high-cGP group. The number of Ki67-immunopositive cells (indicating proliferative cells) in ipsilesional SVZ increased more rapidly in the low-cGP and high-cGP groups than in the no-cGP group. However, lesion size had only a small effect on required training days and the number of Ki67-immunopositive cells. We conclude that oral administration of cGP can facilitate task learning in rats with focal ischemic infarction through neural plasticity and network remodeling, even with minimal neuroprotective effects.	[Kaneko, Hidekazu; Namihira, Masakazu; Hyodo, Koji] Natl Inst Adv Ind Sci & Technol, Ibaraki, Japan; [Yamamoto, Shoko; Numata, Noriaki] Jellice Co Ltd, Tech Ctr, Sendai, Miyagi, Japan		Kaneko, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Higashi Ku, AIST Tsukuba Cent 6, Tsukuba, Ibaraki 3058566, Japan.	kaneko.h@aist.go.jp			AIST; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP18K10808]; Jellice	This paper is based on results obtained from a project commissioned by the New Energy and Industrial Technology Development Organiza-tion (NEDO) . This work was partially supported by grants from AIST (HK) , collaborative research funds of Jellice and AIST (HK, MN, and KH) , and JSPS KAKENHI Grant Number JP18K10808 (HK) .	Anderson MF, 2002, DEV BRAIN RES, V134, P115; Aswendt M, 2021, TRANSL STROKE RES, V12, P87, DOI 10.1007/s12975-020-00802-3; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Brewer A, 2005, NEUROPEPTIDES, V39, P117, DOI 10.1016/j.npep.2005.01.006; Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008; Capilla-Gonzalez V, 2015, ADV EXP MED BIOL, V853, P1, DOI 10.1007/978-3-319-16537-0_1; Chen CL, 2000, ARCH PHYS MED REHAB, V81, P447, DOI 10.1053/mr.2000.3837; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; Deak F, 2012, J GERONTOL A-BIOL, V67, P611, DOI 10.1093/gerona/gls118; Decimo I, 2012, CURR PHARM DESIGN, V18, P1755, DOI 10.2174/138161212799859611; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P184, DOI 10.1038/jcbfm.1986.31; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fox J, 2019, COMPANION APPL REGRE, Vsecond; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Guan J, 2007, NEUROPHARMACOLOGY, V53, P749, DOI 10.1016/j.neuropharm.2007.08.010; Guan J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04388; Guan J, 2010, BEHAV BRAIN RES, V210, P221, DOI 10.1016/j.bbr.2010.02.039; Gudasheva TA, 2020, DOKL BIOCHEM BIOPHYS, V493, P190, DOI 10.1134/S1607672920040067; Gudasheva TA, 2016, DOKL BIOCHEM BIOPHYS, V471, P387, DOI 10.1134/S160767291606003X; Gudasheva TA, 2016, DOKL BIOCHEM BIOPHYS, V469, P273, DOI 10.1134/S1607672916040104; Gudasheva TA, 1996, FEBS LETT, V391, P149, DOI 10.1016/0014-5793(96)00722-3; Gudasheva TA, 1997, EUR J DRUG METAB PH, V22, P245, DOI 10.1007/BF03189814; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hara Y, 2015, J NIPPON MED SCH, V82, P7; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huat TJ, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-91; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaneko H, 2006, BEHAV BRAIN RES, V174, P151, DOI 10.1016/j.bbr.2006.07.020; Kaneko H, 2017, LEARN BEHAV, V45, P191, DOI 10.3758/s13420-016-0255-9; Kaneko N, 2017, J NEUROCHEM, V141, P835, DOI 10.1111/jnc.14002; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Krishnamurthi RVM, 2009, BRIT J PHARMACOL, V156, P662, DOI 10.1111/j.1476-5381.2008.00064.x; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lenth Russell V, 2020, CRAN; Mansouri H, 2004, COMMUN STAT-THEOR M, V33, P2217, DOI 10.1081/STA-200026599; Mulder AB, 2005, EXP BRAIN RES, V163, P32, DOI 10.1007/s00221-004-2135-3; Nemirovich-Danchenko NM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00588; Noguchi H., 2016, NEUROGENESIS, V3, DOI [10.1080/23262133.2016.1232679, DOI 10.1080/23262133.2016.1232679]; Nudo RJ, 1999, REV NEUROL, V155, P713; Ostrovskaya RU, 1999, BEHAV PHARMACOL, V10, P549, DOI 10.1097/00008877-199909000-00013; Ottoboni L, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00052; POSSAMAI CA, 1974, BEHAV RES METH INSTR, V6, P53, DOI 10.3758/BF03200289; Samonina G, 2002, Pathophysiology, V8, P229, DOI 10.1016/S0928-4680(02)00018-4; Sano H, 2013, ADV BIOMED ENG, V2, P72, DOI 10.14326/abe.2.72; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schreiner A.E., 2013, ISRN NEUROL, V2013; Singh-Mallah G, 2016, ENDOCRINOLOGY, V157, P3130, DOI 10.1210/en.2016-1189; Therneau T.M., 2000, STAT BIOL HEALTH; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Yuan HH, 2015, MOL NEUROBIOL, V51, P512, DOI 10.1007/s12035-014-8717-6; Zhang Bo, 2006, Chinese Medical Sciences Journal, V21, P184	61	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 24	2022	417								113561	10.1016/j.bbr.2021.113561			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	WB7EO	WOS:000703732600013	34509530				2022-02-06	
J	Kersey, J; Baum, CM; Hammel, J; Terhorst, L; McCue, M; Skidmore, ER				Kersey, Jessica; Baum, Carolyn M.; Hammel, Joy; Terhorst, Lauren; McCue, Michael; Skidmore, Elizabeth R.			Cut points and sensitivity to change of the Enfranchisement scale of the Community Participation Indicators in adults with traumatic brain injury	PM&R			English	Article; Early Access							QUALITY-OF-LIFE; MEASUREMENT INSTRUMENTS; MULTIDIMENSIONAL SCALE; DIAGNOSTIC-TESTS; PEOPLE	Background Community participation is an important outcome of rehabilitation following traumatic brain injury. Yet, few measures assess inclusion and belonging (enfranchisement) as a dimension of community participation. The Enfranchisement scale of the Community Participation Indicators addresses this need. However, research on its psychometric properties is lacking. Objective To examine cut points and sensitivity to change of the Enfranchisement scale of the Community Participation Indicators in adults with traumatic brain injury. Design This was a repeated measures study with assessments administered twice (3 months apart). Setting Assessments were administered either over the phone, virtually (Zoom), or in person at the participant's home. Participants A total of 44 participants from community settings who had either experienced a traumatic brain injury within the previous year or were receiving rehabilitation interventions were recruited. Main Outcome Measure The Enfranchisement scale has two subscales: the Control subscale (range: 13-65) and the Importance subscale (range: 14-70). On both subscales, lower scores indicate better enfranchisement. Methods The software SAS PROC Logistic and the macro %ROCPlot were used to examine cut points at varying levels of sensitivity and specificity. The area under the receiver operating characteristics curve was calculated to determine overall classification accuracy. Minimum detectable change and minimal clinically important difference were also calculated. Results For the Control subscale, a cut point of 44 (area under the curve = .75), a minimum detectable change of 8, and a minimal clinically important difference of 5 were found. For the Importance subscale, a cut point of 39 (area under the curve = .81), a minimum detectable change of 8, and a minimal clinically important difference of 5 were found. Conclusions The cut points resulted in good classification accuracy, providing support for their reliability. The results provided evidence that both subscales are sensitive to change in adults with brain injury.	[Kersey, Jessica; Skidmore, Elizabeth R.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, OTR L, Pittsburgh, PA 15260 USA; [Baum, Carolyn M.] Washington Univ, Program Occupat Therapy, OTR L, St Louis, MO 63110 USA; [Hammel, Joy] Univ Illinois, Dept Occupat Therapy, OTR L, Chicago, IL USA; [Terhorst, Lauren] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA USA; [McCue, Michael] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Rehabil Sci & Technol, Pittsburgh, PA USA		Kersey, J (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, OTR L, Pittsburgh, PA 15260 USA.	jmk286@pitt.edu		Kersey, Jessica/0000-0001-9082-6962	University of Pittsburgh School of Health and Rehabilitation Sciences Dissertation Fund	University of Pittsburgh School of Health and Rehabilitation Sciences Dissertation Fund	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Becker Heather, 2014, Int J MS Care, V16, P1, DOI 10.7224/1537-2073.2012-047; Bland JM, 2009, PHYS THER SPORT, V10, P39, DOI 10.1016/j.ptsp.2008.10.002; Bluvol A, 2004, J ADV NURS, V48, P322, DOI 10.1111/j.1365-2648.2004.03004.x; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Dontje ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195424; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fritz JM, 2001, PHYS THER, V81, P1546, DOI 10.1093/ptj/81.9.1546; Gonen M., 2007, ANAL RECEIVER OPERAT; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Kersey J, 2022, CLIN REHABIL, V36, P251, DOI 10.1177/02692155211052188; Kersey J, 2022, CLIN REHABIL, V36, P263, DOI 10.1177/02692155211040930; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Magasi S., 2015, ARCH PHYS MED REHAB, V96, P6; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6; SAS, PLOT ROC CURV CUTP L; Vaingankar JA, 2012, COMPR PSYCHIAT, V53, P286, DOI 10.1016/j.comppsych.2011.04.005; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Wyrwich KW, 2000, J EVAL CLIN PRACT, V6, P39, DOI 10.1046/j.1365-2753.2000.00238.x; Yasui NY, 2009, DISABIL REHABIL, V31, P761, DOI 10.1080/09638280802306638; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	37	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12743		JAN 2022	8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	YL5MT	WOS:000745935600001	34865309				2022-02-06	
J	Marin, C; Fuentes, M; Alobid, I; Tubita, V; Rojas-Lechuga, MJ; Mullol, J				Marin, Concepcio; Fuentes, Mireya; Alobid, Isam; Tubita, Valeria; Jesus Rojas-Lechuga, Maria; Mullol, Joaquim			Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson's Disease-Like Pathology	NEUROCHEMICAL RESEARCH			English	Article; Early Access						Excitotoxicity; Traumatic brain injury; Secondary neuronal degeneration; Parkinson's disease; Neurodegeneration; Olfaction; Dopamine; Substantia nigra	ERK5 MAP KINASE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; HEAD-INJURY; NORADRENERGIC MODULATION; DISCRIMINATION; RISK; VULNERABILITY; DYSFUNCTION; EXPRESSION	There is increasing preclinical and clinical data supporting a potential association between Traumatic Brain Injury (TBI) and Parkinson's disease (PD). It has been suggested that the glutamate-induced excitotoxicity underlying TBI secondary neuronal degeneration (SND) might be associated with further development of PD. Interestingly, an accumulation of extracellular glutamate and olfactory dysfunction are both sharing pathological conditions in TBI and PD. The possible involvement of glutamate excitotoxicity in olfactory dysfunction has been recently described, however, the role of olfactory bulbs (OB) glutamate excitotoxicity as a possible mechanism involved in the association between TBI and PD-related neurodegeneration has not been investigated yet. We examined the number of nigral dopaminergic neurons (TH +), nigral alpha-synuclein expression, the striatal dopamine transporter (DAT) expression, and motor performance after bilateral OB N-Methyl-D-Aspartate (NMDA)-induced excitotoxic lesions in rodents. Bulbar NMDA administration induced a decrease in the number of correct choices in the discrimination tests one week after lesions (p < 0.01) and a significant decrease in the number of nigral DAergic neurons (p < 0.01) associated with an increase in alpha-synuclein expression (p < 0.01). No significant striatal changes in DAT expression or motor alterations were observed. Our results show an association between TBI-induced SND and PD-related neurodegeneration suggesting that the OB excitotoxicity occurring in TBI SND may be a filling gap mechanism underlying the link between TBI and PD-like pathology.	[Marin, Concepcio; Fuentes, Mireya; Alobid, Isam; Tubita, Valeria; Jesus Rojas-Lechuga, Maria; Mullol, Joaquim] Inst Invest Biomed August Pi & Sunyer IDIBAP, INGENIO, IRCE, IDIBAPS CELLEX,Dept 2B, Rossello 149-153, Barcelona 08036, Spain; [Marin, Concepcio; Fuentes, Mireya; Alobid, Isam; Jesus Rojas-Lechuga, Maria; Mullol, Joaquim] Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain; [Alobid, Isam; Jesus Rojas-Lechuga, Maria; Mullol, Joaquim] Hosp Clin Barcelona, Rhinol Unit, ENT Dept, Villarroel 170, Barcelona 08036, Catalonia, Spain; [Alobid, Isam; Jesus Rojas-Lechuga, Maria; Mullol, Joaquim] Hosp Clin Barcelona, Smell Clin, ENT Dept, Villarroel 170, Barcelona 08036, Catalonia, Spain; [Tubita, Valeria] Univ Barcelona, Barcelona, Catalonia, Spain		Marin, C; Mullol, J (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAP, INGENIO, IRCE, IDIBAPS CELLEX,Dept 2B, Rossello 149-153, Barcelona 08036, Spain.; Marin, C; Mullol, J (corresponding author), Ctr Biomed Invest Resp Dis CIBERES, Barcelona, Spain.; Mullol, J (corresponding author), Hosp Clin Barcelona, Rhinol Unit, ENT Dept, Villarroel 170, Barcelona 08036, Catalonia, Spain.; Mullol, J (corresponding author), Hosp Clin Barcelona, Smell Clin, ENT Dept, Villarroel 170, Barcelona 08036, Catalonia, Spain.	cmarin@clinic.cat; jmullol@clinic.cat			Fundacio La Marato TV3 [110610];  [PI19/00806]	This work was partially supported by a research grant (110610) from Fundacio La Marato TV3 and a grant from the Spanish Ministerio de Ciencia, Innovacion y Universidades (PI19/00806).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Acosta G, 2019, MOL CELL NEUROSCI, V98, P140, DOI 10.1016/j.mcn.2019.06.004; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Ardiles Y, 2007, EXP NEUROL, V207, P275, DOI 10.1016/j.expneurol.2007.06.022; Aydin MD, 2021, INT J NEUROSCI, V131, P220, DOI 10.1080/00207454.2020.1737049; Bae YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1180-y; Bertogliat MJ, 2020, NEUROCHEM INT, V133, DOI 10.1016/j.neuint.2019.104642; Bloem BR, 2021, LANCET, V397, P2284, DOI 10.1016/S0140-6736(21)00218-X; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brushfield AM, 2008, BEHAV NEUROSCI, V122, P54, DOI 10.1037/0735-7044.122.1.54; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Ciofalo A, 2018, BRAIN INJURY, V32, P550, DOI 10.1080/02699052.2018.1432074; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Escanilla O, 2009, BEHAV NEUROSCI, V123, P828, DOI 10.1037/a0015855; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Haugen J, 2016, J NEURAL TRANSM, V123, P421, DOI 10.1007/s00702-016-1524-7; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hoglinger GU, 2015, ACTA NEUROPATHOL, V130, P333, DOI 10.1007/s00401-015-1451-y; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Iovino L, 2020, J PHARMACOL SCI, V144, P151, DOI 10.1016/j.jphs.2020.07.011; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2020, J NEUROL NEUROSUR PS, V91, P631, DOI 10.1136/jnnp-2019-321759; Khanlou N, 2009, J NEUROVIROL, V15, P131, DOI 10.1080/13550280802578075; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lan YL, 2019, AM J TRANSL RES, V11, P2616; Langdon C, 2019, RHINOLOGY, V57, P460, DOI 10.4193/Rhin18.295; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Lee JH, 2016, BRAIN STRUCT FUNCT, V221, P3259, DOI 10.1007/s00429-015-1099-3; Lethbridge R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035024; Litim N, 2017, NEUROPHARMACOLOGY, V115, P166, DOI 10.1016/j.neuropharm.2016.03.036; Liu HA, 2011, EXP NEUROL, V228, P270, DOI 10.1016/j.expneurol.2011.01.021; Mallah K, 2019, MOL CELL PROTEOMICS, V18, P1669, DOI 10.1074/mcp.RA119.001604; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Marin C, 2014, NEUROBIOL DIS, V64, P36, DOI 10.1016/j.nbd.2013.12.009; Marin C, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00949-x; Marin C, 2019, MOL NEUROBIOL, V56, P8063, DOI 10.1007/s12035-019-1639-6; Marin C, 2019, MOL NEUROBIOL, V56, P5643, DOI 10.1007/s12035-019-1472-y; Marin C, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0796-4; Marin C, 2017, NEUROSCIENCE, V364, P28, DOI 10.1016/j.neuroscience.2017.09.008; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pajarillo E, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.03.002; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049622; Pavlis M, 2006, PHYSIOL BEHAV, V87, P109, DOI 10.1016/j.physbeh.2005.09.011; Rao VLR, 2001, BRAIN RES, V911, P96; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Rudow G, 2008, ACTA NEUROPATHOL, V115, P461, DOI 10.1007/s00401-008-0352-8; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Selvakumar GP, 2020, EXP NEUROBIOL, V29, P230, DOI 10.5607/en20017; Sheng LF, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00983-w; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tatti R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4791; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Thapa K, 2021, J MOL NEUROSCI, V71, P1725, DOI 10.1007/s12031-021-01841-7; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Vilas D, 2020, J PARKINSON DIS, V10, P951, DOI 10.3233/JPD-201972; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wang J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.585584; Wang WB, 2015, J NEUROSCI, V35, P7833, DOI 10.1523/JNEUROSCI.3745-14.2015; Womack KB, 2020, J NEUROTRAUM, V37, P2113, DOI 10.1089/neu.2019.6892; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Wu XJ, 2019, ACS CHEM NEUROSCI, V10, P1791, DOI 10.1021/acschemneuro.8b00683; Zhang YL, 2020, ACS CHEM NEUROSCI, V11, P406, DOI 10.1021/acschemneuro.9b00609; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	89	0	0	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.												10.1007/s11064-021-03503-x		JAN 2022	12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	YL2XY	WOS:000745760800001	35067829				2022-02-06	
J	Riccardi, JS; Vogel, S; Ciccia, AH				Riccardi, Jessica Salley; Vogel, Samantha; Ciccia, Angela H.			Preliminary findings on TBI knowledge of professionals working with justice-involved youth	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Brain injury; knowledge; youth; juvenile; professionals; pre-sentence investigations	TRAUMATIC BRAIN-INJURY; JUVENILE-OFFENDERS; CRIMINAL BEHAVIOR; YOUNG OFFENDERS; MISCONCEPTIONS; PREVALENCE; VIOLENT; HEALTH; CRIME; DYSFUNCTION	Professionals working with justice-involved youth (JIYs) play a critical role in identifying and providing supports and services related to traumatic brain injury (TBI). The aim of this study was to better understand the knowledge of TBI of professionals working with JIYs, a research priority identified by the National Conference of State Legislatures. Fifty employees of an urban juvenile court system completed an online survey about their TBI knowledge. Respondents scored an average of 77.31% correct, yet patterns emerged in item responses and based on participant characteristics that indicate opportunities for training and education on TBI. The results of this preliminary study provide foundational evidence on TBI knowledge of professionals working with JIYs, inform future TBI-related trainings and education provided to professionals working with JIYs, and inform other practices and policies related to JIYs with TBI.	[Riccardi, Jessica Salley; Vogel, Samantha; Ciccia, Angela H.] Case Western Reserve Univ, Dept Psychol Sci, Commun Sci, Cleveland, OH USA		Riccardi, JS (corresponding author), 11635 Euclid Ave,Room 308, Cleveland, OH 44106 USA.	jxs1654@case.edu		Riccardi, Jessica S./0000-0002-3102-3358; Ciccia, Angela/0000-0003-2189-4827			Bobbio A, 2020, INT J LAW CRIME JUST, V62, DOI 10.1016/j.ijlcj.2020.100388; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Christle C, 2005, EXCEPTIONALITY, V13, P69, DOI DOI 10.1207/S15327035EX1302_2; Cohen M, 2010, NEUROPSYCHOL REHABIL, V20, P355, DOI 10.1080/09602010903309401; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Durand E, 2017, ANN PHYS REHABIL MED, V60, P95, DOI 10.1016/j.rehab.2017.02.003; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Esthappan S, 2020, YOUTH VIOLENCE JUV J, V18, P274, DOI 10.1177/1541204020901761; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Gordon WA, 2017, J HEAD TRAUMA REHAB, V32, P393, DOI 10.1097/HTR.0000000000000274; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Graif C, 2015, CRIMINOLOGY, V53, P366, DOI 10.1111/1745-9125.12078; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoffmann JP, 2018, AM BEHAV SCI, V62, P1525, DOI 10.1177/0002764218787020; Hoffmann JP, 2013, CRIMINOLOGY, V51, P629, DOI 10.1111/1745-9125.12014; Hughes N, 2020, LANCET CHILD ADOLESC, V4, P163, DOI 10.1016/S2352-4642(19)30401-8; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; JASP Team, 2020, JASP VERSION 0141 CO; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; King NS, 2019, BRAIN INJURY, V33, P1556, DOI 10.1080/02699052.2019.1655794; Kvarfordt C.L., 2005, CHILD YOUTH CARE FOR, V34, P27, DOI [https://doi.org/10.1007/s10566-004-0880-x, DOI 10.1007/S10566-004-0880-X]; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lowry R, 2021, AM J PREV MED, V60, P352, DOI 10.1016/j.amepre.2020.10.018; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; Mckinlay A., 2013, INT NEUROTRAMA LETT, V33, P1; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Nagele D, 2018, J OFFENDER REHABIL, V57, P562, DOI 10.1080/10509674.2018.1549178; Nkoana W, 2020, INT J EDUC DEV, V78, DOI 10.1016/j.ijedudev.2020.102261; O'Rourke C, 2018, DISABIL REHABIL, V40, P1119, DOI 10.1080/09638288.2017.1288274; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Sarri R., 2001, DECISION MAKING JUVE, DOI [https://doi.org/10.1037/e512512006-001, DOI 10.1037/E512512006-001]; Savage J, 2017, AGGRESS VIOLENT BEH, V37, P91, DOI 10.1016/j.avb.2017.08.002; Sciandra M, 2013, J EXP CRIMINOL, V9, P451, DOI 10.1007/s11292-013-9189-9; Snow PC, 2018, INT J SPEECH-LANG PA, V20, P458, DOI 10.1080/17549507.2017.1297484; Swain NR, 2020, INT J LANG COMM DIS, V55, P458, DOI 10.1111/1460-6984.12529; Teigen A., 2019, STATE APPROACHES ADD; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Van Hazebroek BCM, 2019, CRIM JUSTICE BEHAV, V46, P1542, DOI 10.1177/0093854819876306; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Williams P.H., 2012, BARROW CADBURY TRUST, V36, P1; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wszalek JA, 2015, J HEAD TRAUMA REHAB, V30, P86, DOI 10.1097/HTR.0000000000000130; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	55	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2022.2027771		JAN 2022	11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YM7GX	WOS:000746740600001	35077241				2022-02-06	
J	Schneider, BS; Arciniegas, DB; Harenski, C; Clarke, GJB; Kiehl, KA; Koenigs, M				Schneider, Brett S.; Arciniegas, David B.; Harenski, Carla; Clarke, Gerard Janez Brett; Kiehl, Kent A.; Koenigs, Michael			The prevalence, characteristics, and psychiatric correlates of traumatic brain injury in incarcerated individuals: an examination in two independent samples	BRAIN INJURY			English	Article						Traumatic brain injury; TBI; forensic; head injury; prison	ALCOHOL-USE DISORDER; SUBSTANCE USE; PRISON POPULATIONS; FRONTAL LOBES; HEAD-INJURY; DSM-IV; OUTCOMES; RELIABILITY; VALIDITY; HISTORY	Primary Objective Identify the prevalence, characteristics, and psychological correlates of traumatic brain injury (TBI) among incarcerated individuals. Research Design Three aims: (1) Determine the prevalence and characteristics of TBI in 1469 adults incarcerated in Wisconsin state prisons (1064 men, 405 women); (2) Characterize the relationship between mild TBI and mental illness in a sub-sample of men and women; (3) Reproduce the findings from Aim 1 and Aim 2 in an independent sample of 1015 adults incarcerated in New Mexico state prisons (600 men, 415 women). Methods and Procedures Standardized TBI assessment with structured clinical interviews and self-report questionnaires. Main Outcomes and Results Rates of TBI were approximately five times greater than the general population, with a substantially higher rate of TBI caused by assault. In the Wisconsin sample, mild TBI was associated with greater levels of post-traumatic stress disorder (PTSD) among women (but not among men). In the New Mexico sample, TBI of any severity was associated with greater levels of major depressive disorder (MDD) among women (but not among men). Conclusions This study thus provides novel data on TBI and its correlates among individuals incarcerated in state prisons, and highlights a specific treatment need within the prison population.	[Schneider, Brett S.; Koenigs, Michael] Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA; [Schneider, Brett S.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Arciniegas, David B.] Univ Colorado, Marcus Inst Brain Hlth, Anschutz Med Campus, Aurora, CO USA; [Arciniegas, David B.] Univ New Mexico, Dept Psychiat & Behav Sci, Sch Med, Albuquerque, NM USA; [Harenski, Carla; Clarke, Gerard Janez Brett; Kiehl, Kent A.] MIND Res Network, Albuquerque, NM USA; [Kiehl, Kent A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Kiehl, Kent A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM USA; [Kiehl, Kent A.] Univ New Mexico, Dept Law, Albuquerque, NM USA		Koenigs, M (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	mrkoenigs@wisc.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070539, R01MH071896, R01MH109329]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA020870, R01DA026505, R01DA026964]	This work was supported by the National Institute of Mental Health [R01MH070539, R01MH071896, R01MH109329]; National Institute on Drug Abuse [R01DA020870,R01DA026505,R01DA026964].	Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Association AP, DSM 4 DIAGN STAT MAN; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bartoli F, 2015, ADDICT BEHAV, V41, P46, DOI 10.1016/j.addbeh.2014.09.029; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bown D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211684; Brooke J, 2020, DEMENTIA-LONDON, V19, P1509, DOI 10.1177/1471301218801715; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Crocker LD, 2018, BEHAV RES THER, V108, P68, DOI 10.1016/j.brat.2018.07.004; Deb S, 1999, AM J PSYCHIAT, V156, P374; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Durand E, 2017, ANN PHYS REHABIL MED, V60, P95, DOI 10.1016/j.rehab.2017.02.003; Durand E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.535; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; First M., 2015, STRUCTURED CLIN INTE; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Herrold AA., 2015, CURR ADDICT REP, V2, P273, DOI [10.1007/S40429-015-0078-3, DOI 10.1007/S40429-015-0078-3, 10.1007/s40429-015-0078-3, DOI 10.1007/s40429-015-0078-3]; HOLM S, 1979, SCAND J STAT, V6, P65; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Maschi T, 2012, GERONTOLOGIST, V52, P441, DOI 10.1093/geront/gnr131; Mathias JL, 2014, J NEUROTRAUM, V31, P658, DOI 10.1089/neu.2013.3160; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; O'Rourke C, 2018, DISABIL REHABIL, V40, P1119, DOI 10.1080/09638288.2017.1288274; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Peterson A., 2019, CTR DIS CONTROL PREV, P24; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schneider ALC, 2018, NEW ENGL J MED, V379, P1176, DOI 10.1056/NEJMc1808550; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silverberg ND, 2016, J INT NEUROPSYCH SOC, V22, P816, DOI 10.1017/S1355617716000692; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Turner KA, 2018, COGN BEHAV PRACT, V25, P261; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wall K, 2018, CRIM JUSTICE BEHAV, V45, P1588, DOI 10.1177/0093854818778082; Watson HR, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0699-9; Weathers FW., PTSD CHECKLIST CIVIL; Weidner RR, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100466; Weil ZM, 2018, ALCOHOL RES-CURR REV, V39, P171; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wildeman C, 2017, LANCET, V389, P1464, DOI 10.1016/S0140-6736(17)30259-3; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Witzel JG, 2016, EUR ARCH PSY CLIN N, V266, P533, DOI 10.1007/s00406-015-0620-2; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zust Barbara L, 2009, Issues Ment Health Nurs, V30, P246, DOI 10.1080/01612840802701265	86	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2021	35	14					1690	1701		10.1080/02699052.2021.2013534		JAN 2022	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP1JQ	WOS:000745905300001	35067151				2022-02-06	
J	Sun, C; Qi, L; Cheng, Y; Zhao, Y; Gu, C				Sun, Chao; Qi, Lin; Cheng, Yang; Zhao, Yi; Gu, Chen			Immediate induction of varicosities by transverse compression but not uniaxial stretch in axon mechanosensation	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Axonal varicosity; Mild traumatic brain injury (mTBI); Diffuse axonal injury (DAI); Transverse compression; Uniaxial stretch; Concussion; Neural plasticity; Microtubule	TRAUMATIC BRAIN-INJURY; CHANNELS; THRESHOLD; TRANSPORT; MODEL	Uniaxial stretch is believed to drive diffuse axonal injury (DAI) in mild traumatic brain injury (mTBI). Axonal varicosities are enlarged structures along axonal shafts and represent a hallmark feature of DAI. Here we report that axonal varicosities initiate in vivo immediately after head impact and are mainly induced by transverse compression but not uniaxial stretch. Vertical and lateral impacts to the mouse head induced axonal varicosities in distinct brain regions before any changes of microglial markers. Varicosities preferentially formed along axons perpendicular to impact direction. In cultured neurons, whereas 50% uniaxial strain was needed to rapidly induce axonal varicosities in a nanowrinkled stretch assay, physiologically-relevant transverse compression effectively induced axonal varicosities in a fluid puffing assay and can generate large but nonuniform deformation simulated by finite element analysis. Therefore, impact strength and direction may determine the threshold and spatial pattern of axonal varicosity initiation, respectively, partially resulting from intrinsic properties of axon mechanosensation.	[Sun, Chao; Gu, Chen] Ohio State Univ, Dept Biol Chem & Pharmacol, 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA; [Qi, Lin; Cheng, Yang; Zhao, Yi] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Sun, Chao; Gu, Chen] Ohio State Univ, MCDB Grad Program, Columbus, OH 43210 USA; [Qi, Lin] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Cheng, Yang] Beijing Inst Technol, Sch Opt & Photon, 5 Yard,Zhong Guan Cun South St, Beijing 100081, Peoples R China		Gu, C (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, 182 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.; Zhao, Y (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Gu, C (corresponding author), Ohio State Univ, MCDB Grad Program, Columbus, OH 43210 USA.	zhao.178@osu.edu; gu.49@osu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS093073, R21AA024873]	We thank Campus Microscopy & Imaging facility at OSU for technical assistance in transmission electron microscopy, Drs. David L. Brody and Thomas Esparza for rcTBI mouse brains, Drs. Sheryl L. Wellington and Wai Hang Cheng for helping to set up the CHIMERA system in our laboratory, and Dr. David L. Brody for comments on several versions of the manuscript. This work was supported, in part, by grants from NIH (R01NS093073 and R21AA024873) to CG. All animal experiments have been conducted in accordance with the NIH Animal Use Guidelines. The authors declare no competing financial interests.	Alisafaei F, 2020, BIOPHYS J, V119, P1290, DOI 10.1016/j.bpj.2020.08.024; Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Barry J, 2013, J CELL SCI, V126, P2027, DOI 10.1242/jcs.122234; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Chuckowree JA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00223; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cross DJ, 2019, J ALZHEIMERS DIS, V67, P859, DOI 10.3233/JAD-180871; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Fallqvist B, 2016, J MECH BEHAV BIOMED, V59, P168, DOI 10.1016/j.jmbbm.2015.11.039; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Gabrieli D., 2010, J BIOMECH ENG-T ASME; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gu C, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.610857; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Gu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011931; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jukkola P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00344; Jukkola P, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-70; Jukkola PI, 2012, NEUROBIOL DIS, V47, P280, DOI 10.1016/j.nbd.2012.04.012; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nickel M, 2019, J NEUROIMMUNOL, V334, DOI 10.1016/j.jneuroim.2019.576998; Nogueira ML, 2016, ALZHEIMERS DEMENT, V12, P11, DOI 10.1016/j.jalz.2015.03.005; Pernici CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44174-7; Rice J, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0829-9; Servello D, 2018, JOVE-J VIS EXP, DOI 10.3791/57202; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Weber MT, 2019, BRAIN PATHOL, V29, P437, DOI 10.1111/bpa.12677; Wu YH, 2021, J NEUROTRAUM, V38, P2336, DOI 10.1089/neu.2020.7402; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	46	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	JAN 24	2022	10	1							7	10.1186/s40478-022-01309-8			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YM5QJ	WOS:000746628900001	35074017	gold, Green Accepted			2022-02-06	
J	Sun, GZ; Zhao, ZM; Lang, JD; Sun, BY; Zhao, QT				Sun, Guozhu; Zhao, Zongmao; Lang, Jiadong; Sun, Boyu; Zhao, Qitao			Nrf2 loss of function exacerbates endoplasmic reticulum stress-induced apoptosis in TBI mice	NEUROSCIENCE LETTERS			English	Article						Nrf2; Endoplasmic reticulum stress; Apoptosis; Neuroprotection; Traumatic brain injury	OXIDATIVE STRESS; BRAIN-INJURY; ER STRESS; INHIBITION; PATHWAY; DAMAGE; DEATH	Nuclear factor erythroid 2-related factor 2 (Nrf2) plays an important role in neuroprotection and recover. Our studies have showed that endoplasmic reticulum (ER) stress-induced apoptosis aggravates secondary damage following traumatic brain injury (TBI). Whether Nrf2 involved in ER stress and ER stress-mediated apoptosis is not clearly investigated. This present study explored the effect of Nrf2 knockout on ER stress and ER stressinduced apoptosis in TBI mice. A lateral fluid percussion injury (FPI) model of TBI was built based on Nrf2 knockout (Nrf2(-/- )) mice and wild-type (Nrf2(+/+)) mice, and the expressions of marker proteins of ER stress and ER stress-induced apoptosis were checked at 24 h following TBI. We found that Nrf2(-/-) mice presented more severe neurological deficit, brain edema and neuronal cell apoptosis compared with Nrf2(+/+) mice. And, the TBI Nrf2(-/- ) mice were significantly increased expression of marker proteins of ER stress and ER stressinduced apoptotic pathway including glucose regulated protein (GRP78), protein kinase RNA-like ER kinase (PERK), inositol requiring enzyme (IRE1), activating transcription factor 6 (ATF6), C/EBP homologous protein (CHOP), caspase-12 and caspase-3, compared with that in WT mice. These results suggest that Nrf2 could ameliorate TBI-induced second brain injury partly through ER stress signal pathway.	[Sun, Guozhu; Zhao, Zongmao; Lang, Jiadong; Sun, Boyu; Zhao, Qitao] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China		Sun, GZ (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China.	sungzh705@163.com			Natural Science Foundation of Hebei Province of ChinaNatural Science Foundation of Hebei Province [H2020206437, H2014206303]; Key Medical Scientific Research Project of HeBei Province of China [20170088]	This research was supported by the Natural Science Foundation of Hebei Province of China (No. H2020206437 and No. H2014206303) and Key Medical Scientific Research Project of HeBei Province of China (No. 20170088).	Bahar E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091558; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Chen X, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146566; Chuang WL, 2016, MOLECULES, V21, DOI 10.3390/molecules21040460; Dandekar A, 2015, METHODS MOL BIOL, V1292, P205, DOI 10.1007/978-1-4939-2522-3_15; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; He YX, 2019, NEUROREPORT, V30, P344, DOI 10.1097/WNR.0000000000001205; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Krajka-Kuzniak V, 2017, PHARMACOL REP, V69, P393, DOI 10.1016/j.pharep.2016.12.011; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lee JY, 2014, J NEUROTRAUM, V31, P582, DOI 10.1089/neu.2013.3146; Li L, 2019, NEURAL REGEN RES, V14, P1573, DOI 10.4103/1673-5374.255972; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Prentice H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964518; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Sun DD, 2020, BRAIN RES, V1732, DOI 10.1016/j.brainres.2020.146682; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Thangameeran SIM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030750; Wang CF, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1248; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Wu FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00406; Xiang CC, 2017, APOPTOSIS, V22, P1, DOI 10.1007/s10495-016-1296-4; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Zhang H., 2017, AM J TRANSL RES, V9; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z	40	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 23	2022	770								136400	10.1016/j.neulet.2021.136400			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XU2TA	WOS:000734122900001	34923041				2022-02-06	
J	Ashendorf, L; Withrow, S; Ward, SH; Sullivan, SK; Sugarman, MA				Ashendorf, Lee; Withrow, Susanne; Ward, Sarah H.; Sullivan, Sara K.; Sugarman, Michael A.			Decision rules for an abbreviated administration of the Test of Memory Malingering	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						ADHD; assessment; forensic neuropsychology; head injury; performance validity	TOMM TRIAL 1; PERFORMANCE VALIDITY; CLASSIFICATION ACCURACY; COGNITIVELY INTACT; SCREENING MEASURE; EMBEDDED MEASURES; NORMATIVE DATA; SYMPTOM; ERRORS; RATES	The present study investigated abbreviation methods for the Test of Memory Malingering (TOMM) in relation to traditional manual-based test cutoffs and independently derived more stringent cutoffs suggested by recent research (<= 48 on Trial 2 or 3). Consecutively referred outpatient U.S. military veterans (n = 260) were seen for neuropsychological evaluation for mild traumatic brain injury or possible attention-deficit/hyperactivity disorder. Performance on TOMM Trial 1 was evaluated, including the total score and errors on the first 10 items (TOMMe10), to determine correspondence and redundancy with Trials 2 and 3. Using the traditional cutoff, valid performance on Trials 2 and 3 was predicted by zero errors on TOMMe10 and by Trial 1 scores greater than 41. Invalid performance was predicted by commission of more than three errors on TOMMe10 and by Trial 1 scores less than 34. For revised TOMM cutoffs, a Trial 1 score above 46 was predictive of a valid score, and a TOMMe10 score of three or more errors or a Trial 1 score below 36 was associated with invalid TOMM performance. Conditional abbreviation of the TOMM is feasible in a vast majority of cases without sacrificing information regarding performance validity. Decision trees are provided to facilitate administration of the three trials.	[Ashendorf, Lee; Ward, Sarah H.] VA Cent Western Massachusetts, Mental Hlth Serv Line, Worcester, MA USA; [Ashendorf, Lee; Ward, Sarah H.] Univ Massachusetts, Med Sch, Dept Psychiat, Worcester, MA 01605 USA; [Withrow, Susanne] VA Pittsburgh Healthcare Syst, Behav Hlth Serv Line, Pittsburgh, PA USA; [Sullivan, Sara K.] VA Bedford Healthcare Syst, Psychol Serv, Bedford, MA USA; [Sugarman, Michael A.] Med Univ South Carolina, Dept Neurol, Charleston, SC 29425 USA		Ashendorf, L (corresponding author), Worcester VA Hlth Clin, 403 Belmont St, Worcester, MA 01604 USA.	Lee.Ashendorf@va.gov					American Psychiatric Association (APA) DSM-5 Task Force, 2013, DSM 5 DIAGN STAT MAN, V5th ed.; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Ashendorf L, 2019, CLIN NEUROPSYCHOL, V33, P1388, DOI 10.1080/13854046.2018.1543454; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Assistant Secretary of Defense, 2015, TRAUMATIC BRAIN INJU; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Beck A.T., 1996, MANUAL BECK DEPRESSI, DOI DOI 10.1037/T00742-000; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brand BL, 2019, PSYCHOL TRAUMA-US, V11, P513, DOI 10.1037/tra0000405; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cohen CD, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1908596; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; Denning JH, 2021, APPL NEUROPSYCH-ADUL, V28, P35, DOI 10.1080/23279095.2019.1588122; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Donders J, 2020, APPL NEUROPSYCH-CHIL, V9, P355, DOI 10.1080/21622965.2020.1750109; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Gavett BE, 2005, APPL NEUROPSYCHOL, V12, P1, DOI 10.1207/s15324826an1201_1; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Grabyan JM, 2018, CLIN NEUROPSYCHOL, V32, P468, DOI 10.1080/13854046.2017.1368715; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kraemer LDR, 2020, PSYCHOL ASSESSMENT, V32, P442, DOI 10.1037/pas0000802; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCaul C, 2018, CLIN NEUROPSYCHOL, V32, P1054, DOI 10.1080/13854046.2018.1425481; Meyers JE., 1995, REY COMPLEX FIGURE T; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Schmidt M., 1996, REY AUDITORY VERBAL; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P7, DOI 10.1080/13854046.2020.1849803; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webber TA, 2018, PSYCHOL INJ LAW, V11, P325, DOI 10.1007/s12207-018-9335-9; Wechsler, 1997, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Weiss RA, 2017, PSYCHOL ASSESSMENT, V29, P881, DOI 10.1037/pas0000381; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634; Williamson KD, 2014, CLIN NEUROPSYCHOL, V28, P1182, DOI 10.1080/13854046.2014.956674; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	67	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2022.2026948		JAN 2022	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YM2AL	WOS:000746381900001	35068279				2022-02-06	
J	Yang, W; Han, YH; Wang, HC; Lu, CT; Yu, XC; Zhao, YZ				Yang, Wei; Han, Yong-Hui; Wang, Heng-Cai; Lu, Cui-Tao; Yu, Xi-Chong; Zhao, Ying-Zheng			Intradermal injection of icariin-HP-beta-cyclodextrin improved traumatic brain injury via the trigeminal epineurium-brain dura pathway	JOURNAL OF DRUG TARGETING			English	Article; Early Access						Icariin; inclusion complex; intradermal injection; traumatic brain injury; drug delivery	CORTICOSTERONE-INDUCED APOPTOSIS; DELIVERY; MODEL; INFLAMMATION; INVOLVEMENT; MEK/ERK	The lower bioavailability after oral administration limited icariin applications in central nervous system. Icariin/HP-beta-cyclodextrin (HP-beta-CD) inclusion complex was prepared for acute severe opening traumatic brain injury (TBI) via facial intradermal (i.d.) in the mystacial pad. After fluid percussion-induced TBI, icariin/HP-beta-CD at 0.4 mg/kg i.d. preserved more neurons and oligodendrocytes than intranasal injection (i.n.) or intravenous injection via tail vein (i.v.) and decreased microglia and astrocyte activation. Icariin/HP-beta-CD i.d. reduced apoptosis in cortical penumbra while i.n. and i.v. showed weak or no effects. Icariin/HP-beta-CD i.d. reduced Evans blue leakage and altered CD34, ZO-1, Claudin-5, and beta-catenin expression after TBI. Moreover, icariin/HP-beta-CD promoted human umbilical vein endothelial cells proliferation. Thus, Icariin/HP-beta-CD i.d. improved TBI, including blood-brain barrier opening. Fluorescein 5-isothiocyanate (FITC) and 3,3'-Dioctadecyloxacarbocyanine perchlorate (DiOC18(3)) mimic HP-beta-CD and icariin respectively. FITC and DiOC18(3) were similarly delivered to trigeminal epineurium, perineurium and perivascular spaces or tissues, caudal dura mater, and scattered in trigeminal fasciculus, indicating that icariin/HP-beta-CD was delivered to the brain via trigeminal nerve-dura mater-brain pathways. In sum, intradermal injection in mystacial pad might deliver icariin/HP-beta-CD to the brain and icariin/HP-beta-CD improved acute severe opening TBI.	[Yang, Wei; Han, Yong-Hui; Wang, Heng-Cai; Lu, Cui-Tao; Yu, Xi-Chong; Zhao, Ying-Zheng] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China		Yu, XC; Zhao, YZ (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China.	wenzhyu2004@163.com; pharmtds@163.com			Zhejiang Provincal Natural science foundation of China [LY17H170001, LY19H180001]; Wenzhou scientific and technological innovation project [ZY2021019]; Zhejiang Province Science and Technology Plan Research and Xinmiao Talent Program [2020R413085]	This research was supported by Zhejiang Provincal Natural science foundation of China under Grant No. LY17H170001, LY19H180001, Wenzhou scientific and technological innovation project [Grant No. ZY2021019]. This research was supported by Zhejiang Province Science and Technology Plan Research and Xinmiao Talent Program [Grant No. 2020R413085].	Anderson W R, 1988, Drug Des Deliv, V2, P287; Cao LH, 2019, MOLECULES, V24, DOI 10.3390/molecules24203700; Chen WF, 2017, PHYTOMEDICINE, V25, P93, DOI 10.1016/j.phymed.2016.12.017; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Cong HR, 2020, EUR J PHARMACOL, V885, DOI 10.1016/j.ejphar.2020.173523; Dai MM, 2021, METAB BRAIN DIS, V36, P1779, DOI 10.1007/s11011-021-00731-6; Guo Y, 2020, FOLIA NEUROPATHOL, V58, P245, DOI 10.5114/fn.2020.100067; Joo H, 2019, PLANTA MED, V85, P231, DOI 10.1055/a-0753-0400; Kong L, 2019, CLIN EXP DERMATOL, V44, P144, DOI 10.1111/ced.13735; Li F, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116739; Li M, 2017, MAT SCI ENG C-MATER, V71, P260, DOI 10.1016/j.msec.2016.10.016; Lin HM, 2020, INT J NANOMED, V15, P3251, DOI 10.2147/IJN.S233747; Lin HM, 2018, CURR DRUG DELIV, V15, P1009, DOI 10.2174/1567201815666171221125411; Liu BJ, 2011, BRAIN RES, V1375, P59, DOI 10.1016/j.brainres.2010.12.053; Liu LM, 2019, INT IMMUNOPHARMACOL, V68, P95, DOI 10.1016/j.intimp.2018.12.055; Lu CC, 2015, EUR J PHARM SCI, V77, P24, DOI 10.1016/j.ejps.2015.05.014; Ma DL, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/9974625; MACARAK EJ, 1991, BIOCHEM PHARMACOL, V42, P1502, DOI 10.1016/0006-2952(91)90467-J; Sun S, 2019, PLANTA MED, V85, P473, DOI 10.1055/a-0837-0975; Wang GQ, 2018, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00441; Wang PZ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20203107; Wang YK, 2005, PHARMACOL RES, V52, P174, DOI 10.1016/j.phrs.2005.02.023; Xu D, 2020, INT J PHARMACEUT, V586, DOI 10.1016/j.ijpharm.2020.119550; Xu SJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4684962; Yang W, 2019, DRUG DELIV, V26, P393, DOI 10.1080/10717544.2019.1587044; Yang W, 2012, J PHARM PHARMACOL, V64, P190, DOI 10.1111/j.2042-7158.2011.01388.x; Yu XC, 2017, J CONTROL RELEASE, V258, P22, DOI 10.1016/j.jconrel.2017.05.001; Zhang HY, 2012, MOL MED REP, V6, P967, DOI 10.3892/mmr.2012.1041; Zhang XX, 2017, BRAIN DEV-JPN, V39, P593, DOI 10.1016/j.braindev.2017.03.021; Zhang Y, 2012, INT J NANOMED, V7, P4239, DOI 10.2147/IJN.S33014; Zhang YF, 2017, BRAIN RES BULL, V130, P180, DOI 10.1016/j.brainresbull.2017.01.025; Zhang ZG, 2018, CHIN J INTEGR MED, V24, P366, DOI 10.1007/s11655-018-2823-z; Zheng J, 2021, PHARM BIOL, V59, P183, DOI 10.1080/13880209.2021.1878238; Zhong RL, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3745051	34	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1061-186X	1029-2330		J DRUG TARGET	J. Drug Target.												10.1080/1061186X.2021.2023159		JAN 2022	10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YM2BA	WOS:000746383400001	35023434				2022-02-06	
J	Choi, K; Kim, MS; Keum, MA; Choi, S; Kyoung, KH; Kim, JT; Kim, S; Noh, M				Choi, Kyunghak; Kim, Min Soo; Keum, Min Ae; Choi, Seongho; Kyoung, Kyu-Hyouck; Kim, Jihoon T.; Kim, Sungjeep; Noh, Minsu			Risk factors for end-stage renal disease in patients with trauma and stage 3 acute kidney injury	MEDICINE			English	Article						end-stage renal disease; renal replacement therapy; traumatic brain injury		Research on long-term renal outcomes in patients with acute kidney injury (AKI) and trauma, especially those with traumatic brain injury (TBI), has been limited. In this study, we enrolled patients with stage 3 AKI as per the Kidney Disease Improving Global Outcomes guidelines, who initiated renal replacement therapy (RRT). These patients were divided into 2 groups depending on the presence of TBI. Comparing the baseline characteristics and management strategies of each group, we analyzed whether TBI affects the progression of kidney disease. Between January 1, 2014 and June 30, 2020, 51 patients who initiated RRT due to AKI after trauma were enrolled in this study. TBI was identified in 20 patients, and the clinical conditions were not related to TBI in the remaining 31. The study endpoint was set to determine whether the patients of each group needed RRT persistently at discharge and at the time of recent outpatient clinic. Six (30.0%) out of 20 patients with TBI and 2 (6.5%) out of 31 patients without TBI required conventional hemodialysis, as per the most recent data. No significant within-group differences were found in terms of the baseline characteristics and management strategies. In the logistic regression analysis, TBI was independently associated with disease progression to end-stage renal disease. TBI is a risk factor for end-stage renal disease in patients with trauma and stage 3 AKI who initiate RRT.	[Choi, Kyunghak; Keum, Min Ae; Choi, Seongho; Kyoung, Kyu-Hyouck; Kim, Jihoon T.; Kim, Sungjeep; Noh, Minsu] Univ Ulsan, Ulsan Univ Hosp, Dept Surg, Coll Med, Ulsan, South Korea; [Kim, Min Soo] Univ Ulsan, Ulsan Univ Hosp, Dept Neurosurg, Coll Med, Ulsan, South Korea		Noh, M (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Dept Surg, Coll Med, Ulsan, South Korea.	leominsunoh@uuh.ulsan.kr					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Civiletti F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42147-4; Elterman Joel, 2015, J Trauma Acute Care Surg, V79, pS171, DOI 10.1097/TA.0000000000000572; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Haines RW, 2019, J TRAUMA ACUTE CARE, V86, P141, DOI 10.1097/TA.0000000000002085; Harrois A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2265-9; Harrois A, 2017, CURR OPIN CRIT CARE, V23, P447, DOI 10.1097/MCC.0000000000000463; Kurzhagen JT, 2020, J NEPHROL, V33, P1171, DOI 10.1007/s40620-020-00793-2; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Podoll AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077376; Shashaty MGS, 2012, J CRIT CARE, V27, P496, DOI 10.1016/j.jcrc.2012.02.002; Skinner DL, 2014, INJURY, V45, P259, DOI 10.1016/j.injury.2013.07.013; Wu CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171999	15	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 21	2022	101	3							e28581	10.1097/MD.0000000000028581			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YK3HY	WOS:000745109600045	35060520	gold, Green Accepted			2022-02-06	
J	Howell, DR; Seehusen, CN; Carry, PM; Walker, GA; Reinking, SE; Wilson, JC				Howell, David R.; Seehusen, Corrine N.; Carry, Patrick M.; Walker, Gregory A.; Reinking, Sarah E.; Wilson, Julie C.			An 8-Week Neuromuscular Training Program After Concussion Reduces 1-Year Subsequent Injury Risk: A Randomized Clinical Trial	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						mild traumatic brain injury; adolescent; injury prevention; rehabilitation; treatment; therapy; exercise	SPORT-RELATED CONCUSSION; LOWER-EXTREMITY INJURY; MUSCULOSKELETAL INJURY; AEROBIC EXERCISE; TASK; INTERVENTION; ASSOCIATION; FEASIBILITY; PREVENTION; MANAGEMENT	Background: Existing data suggest that after concussion, athletes experience an increased risk of subsequent injury. Exploring methods that may reduce injury risk after successful postconcussion return to play may lead to new treatment approaches. Purpose: To examine the efficacy of a neuromuscular training (NMT) intervention on acute sports-related time-loss injury over the subsequent year relative to standard of care. Study Design: Randomized clinical trial; Level of evidence, 1. Methods: A total of 27 youth athletes were assessed initially postconcussion (median, 7 days postconcussion; interquartile range [IQR], 5-10) and after return-to-play clearance (median, 40 days postconcussion; IQR, 15-52). After return-to-play clearance, they were randomly assigned to NMT intervention (n = 11; mean +/- SD age, 14.7 +/- 1.7 years; 36% female) or standard of care (n = 16; mean +/- SD age, 15.3 +/- 1.8 years; 44% female). The intervention (duration, 8 weeks; frequency, 2 times per week) included guided strength exercises with landing stabilization focus. Standard of care received no recommendations. For the subsequent year, athletes prospectively completed a monthly log of sports-related injuries and organized sports competitions. Results: During the first year after postconcussion return-to-play clearance, sports-related time-loss injuries were more common among standard of care relative to NMT intervention (75% [95% CI, 48%-93%] vs 36% [95% CI, 11%-69%]). After adjusting for age and sex, the hazard of subsequent injury in the standard-of-care group was 3.56 times (95% CI, 1.11-11.49; P = .0334) that of the NMT intervention group. Sports participation was similar between NMT intervention and standard of care during the year-long monitoring period (hours of organized sports per month; median, 12 [IQR, 2.6-32.1] vs 15.6 [IQR, 3.5-105.9]; P = .55). The age- and sex-adjusted incidence of injuries was 10.2 per 1000 competitive exposures (95% CI, 3.7-28.4) in the standard-of-care group as opposed to 3.4 per 1000 (95% CI, 0.9-13.4) in the NMT intervention group. After adjusting for age and sex, incidence of injuries was higher for standard of care vs NMT intervention (rate ratio, 2.96 [95% CI, 0.89-9.85]; P = .076). Conclusion: Although preliminary, our findings suggest that an NMT intervention initiated after return-to-play clearance may significantly reduce sports-related time-loss injuries over the subsequent year. Registration: NCT03917290 (ClinicalTrials.gov identifier).	[Howell, David R.; Seehusen, Corrine N.; Walker, Gregory A.; Reinking, Sarah E.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.; Carry, Patrick M.; Walker, Gregory A.; Wilson, Julie C.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Carry, Patrick M.] Childrens Hosp Colorado, Musculoskeletal Res Ctr, Aurora, CO USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sports Med Ctr, Dept Orthoped,Sch Med, 13123 E 16th Ave, Aurora, CO 80045 USA.	david.howell@cuanschutz.edu		Howell, David/0000-0002-2955-0191			Aydogdu YT, 2018, DEMENT GER COGN D EX, V8, P328, DOI 10.1159/000492964; Biese KM, 2021, PHYS THER SPORT, V48, P76, DOI 10.1016/j.ptsp.2020.12.018; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Chmielewski TL, 2021, J SPORT HEALTH SCI, V10, P154, DOI 10.1016/j.jshs.2020.11.005; Churchill NW, 2021, J NEUROTRAUM, V38, P3097, DOI 10.1089/neu.2021.0123; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Foss KDB, 2018, J ATHL TRAINING, V53, P20, DOI 10.4085/1062-6050-173-16; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Howell DR, 2021, PHYS THER SPORT, V52, P132, DOI 10.1016/j.ptsp.2021.05.014; Howell DR, 2021, AM J SPORT MED, V49, P1912, DOI 10.1177/03635465211005761; Howell DR, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20216297; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Hunzinger KJ, 2021, J SCI MED SPORT, V24, P368, DOI 10.1016/j.jsams.2020.10.013; Ingriselli JM, 2014, J SCI MED SPORT, V17, P580, DOI 10.1016/j.jsams.2013.11.006; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jildeh Toufic R, 2021, Arthrosc Sports Med Rehabil, V3, pe219, DOI 10.1016/j.asmr.2020.09.014; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Lee Bobby Jean, 1800, J Athl Train, DOI 10.4085/533-20; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Myer GD, 2008, CLIN SPORT MED, V27, P425, DOI 10.1016/j.csm.2008.02.006; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Pomares-Noguera C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00040; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Root JM, 2019, CLIN PEDIATR, V58, P731, DOI 10.1177/0009922819839230; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Steib S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00920; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Sugimoto D, 2014, SPORTS MED, V44, P551, DOI 10.1007/s40279-013-0135-9; Sugimoto D, 2012, J ATHL TRAINING, V47, P714, DOI 10.4085/1062-6050-47.6.10; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Wittrup EM, 2020, OPEN ACCESS J SPORTS, V11, P169, DOI 10.2147/OAJSM.S280841; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	51	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.											03635465211069372	10.1177/03635465211069372		JAN 2022	10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	YQ0AD	WOS:000748979900001	35060759				2022-02-06	
J	Vike, NL; Bari, S; Stetsiv, K; Walter, A; Newman, S; Kawata, K; Bazarian, JJ; Martinovich, Z; Nauman, EA; Talavage, TM; Papa, L; Slobounov, SM; Breiter, HC				Vike, Nicole L.; Bari, Sumra; Stetsiv, Khrystyna; Walter, Alexa; Newman, Sharlene; Kawata, Keisuke; Bazarian, Jeffrey J.; Martinovich, Zoran; Nauman, Eric A.; Talavage, Thomas M.; Papa, Linda; Slobounov, Semyon M.; Breiter, Hans C.			A preliminary model of football-related neural stress that integrates metabolomics with transcriptomics and virtual reality	ISCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; ACID BETA-OXIDATION; CHAIN ACYL-COENZYME; MITOCHONDRIAL DYSFUNCTION; CIRCULATING MICRORNA; BALANCE MODULE; SOCCER PLAYERS; HEAD IMPACTS; CONCUSSION; METABOLISM	Research suggests contact sports affect neurological health. This study used permutation-based mediation statistics to integrate measures of metabolomics, neuroinflammatory miRNAs, and virtual reality (VR)-based motor control to investigate multi-scale relationships across a season of collegiate American football. Fourteen significant mediations (six pre-season, eight across-season) were observed where metabolites always mediated the statistical relationship between miRNAs and VR-based motor control (p(Sobel)(perm) <= 0.05; total effect > 50%),suggesting a hypothesis that metabolites sit in the statistical pathway between transcriptome and behavior. Three results further supported a model of chronic neuroinflammation, consistent with mitochondrial dysfunction: (1) Mediating metabolites were consistently medium-to-long chain fatty acids, (2) tricarboxylic acid cycle metabolites decreased across-season, and (3) accumulated head acceleration events statistically moderated pre-season metabolite levels to directionally model post-season metabolite levels. These preliminary findings implicate potential mitochondrial dysfunction and highlight probable peripheral blood biomarkers underlying repetitive head impacts in otherwise healthy collegiate foot-ball athletes.	[Vike, Nicole L.; Bari, Sumra; Stetsiv, Khrystyna; Martinovich, Zoran; Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA; [Walter, Alexa; Slobounov, Semyon M.] Penn State Univ, Dept Kinesiol, University Pk, PA 16801 USA; [Newman, Sharlene] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Kawata, Keisuke] Indiana Univ, Sch Publ Hlth, Dept Kinesiol, Bloomington, IN 47405 USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA; [Bazarian, Jeffrey J.] Univ Rochester, Dept Emergency Med, Rochester, NY 14627 USA; [Nauman, Eric A.; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL 32806 USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Boston, MA 02114 USA; [Breiter, Hans C.] Harvard Sch Med, Boston, MA 02114 USA		Breiter, HC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Warren Wright Adolescent Ctr, Chicago, IL 60611 USA.; Slobounov, SM (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16801 USA.; Breiter, HC (corresponding author), Harvard Sch Med, Boston, MA 02114 USA.	sms18@psu.edu; h-breiter@northwestern.edu			NIH (United States)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NSF (United States)National Science Foundation (NSF); DoD (United States)United States Department of Defense; SS's lab; LP's lab; HB's lab (Warren Wright Adolescent Center)	All work in this paper was funded by the listed academic institutions, and without specific NIH (United States), NSF (United States), or DoD (United States) support. Data collection was funded by SS's lab. MiRNA analysis was funded by LP's lab. Funding for metabolomic analysis, data integration, and manuscript preparation was funded by HB's lab (Warren Wright Adolescent Center). We thank the Pennsylvania State University football athletes for their participation in this study, along with Katie Finelli, Madeleine Scaramuzzo, and Peter H. Seidenberg, MD for their assistance with participant recruitment, clinical assessment, and data collection. We further thank John Csernansky, MD for his helpful comments and editing. Given the substantial guidance provided by the Reviewers of this work, we must note that all Reviewers met criteria to be considered authors of this work.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Al-Khelaifi F, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0114-z; Alosco ML, 2020, BRAIN IMAGING BEHAV, V14, P1419, DOI 10.1007/s11682-019-00060-4; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; Altman N, 2016, NAT METHODS, V13, P281, DOI 10.1038/nmeth.3812; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Badaam K.M., 2013, IOSR J DENT MED SCI, V4, P24, DOI [10.9790/0853-0452427, DOI 10.9790/0853-0452427]; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Basak I, 2016, CELL MOL LIFE SCI, V73, P811, DOI 10.1007/s00018-015-2093-x; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2020, NEUROLOGY, V94, pE232, DOI 10.1212/WNL.0000000000008817; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Binkley TL, 2015, J STRENGTH COND RES, V29, P2503, DOI 10.1519/JSC.0000000000000886; Bodman M, 2001, ARCH NEUROL-CHICAGO, V58, P811, DOI 10.1001/archneur.58.5.811; Boison D., 2012, SURVIVAL INJURY OUTC; BONATI M, 1982, CLIN PHARMACOL THER, V32, P98, DOI 10.1038/clpt.1982.132; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bult CJ, 2019, NUCLEIC ACIDS RES, V47, pD801, DOI 10.1093/nar/gky1056; Camargo A, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-15; Cao F., 2017, ADV BIOL MED, V2, P43; Chang L, 2020, NUCLEIC ACIDS RES, V48, pW244, DOI 10.1093/nar/gkaa467; Chang LS, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00150-w; Che J, 2019, MOL CARCINOGEN, V58, P1234, DOI 10.1002/mc.23006; Chen Y., 2020, CEREB CORTEX COMMUN, V1; Chu SH, 2019, METABOLITES, V9, DOI 10.3390/metabo9060117; CLASSEN JB, 1989, J CELL PHYSIOL, V141, P53, DOI 10.1002/jcp.1041410109; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Cole CR, 2005, J STRENGTH COND RES, V19, P490; Cole DA, 2003, J ABNORM PSYCHOL, V112, P558, DOI 10.1037/0021-843X.112.4.558; COOK RD, 1979, J AM STAT ASSOC, V74, P169, DOI 10.2307/2286747; Cui M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057065; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Denk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126423; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Di Pietro V, 2021, BRIT J SPORT MED, V55, P1395, DOI 10.1136/bjsports-2020-103274; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Farias FHG, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-124; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fisher RA., 1935, DESIGN EXPT; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Gao Y, 2019, NEUROPHYSIOLOGY+, V51, P400, DOI 10.1007/s11062-020-09835-8; Gayen M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072312; GOLLOB HF, 1987, CHILD DEV, V58, P80, DOI 10.1111/j.1467-8624.1987.tb03492.x; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Harland M, 2020, J NEUROSCI, V40, P1756, DOI 10.1523/JNEUROSCI.2324-19.2020; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hernandez-Aguilera A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/135698; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hinton PS, 2004, INT J SPORT NUTR EXE, V14, P389, DOI 10.1123/ijsnem.14.4.389; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Hsu KW, 2016, ONCOTARGET, V7, P38036, DOI 10.18632/oncotarget.9342; Hu YG, 2019, J INTEGR NEUROSCI, V18, P57, DOI 10.31083/j.jin.2019.01.12; Huang DH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4907-3; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Jee MK, 2012, HUM GENE THER, V23, P508, DOI 10.1089/hum.2011.121; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Jiang M, 2018, CELL PHYSIOL BIOCHEM, V47, P864, DOI [10.1159/000490078and, 10.1159/000490078]; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kelly RS, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165936; Kenny D.A., 2021, MEDIATION; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kobayashi N, 2012, ONCOTARGET, V3, P1455; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kohram F, 2018, J CELL BIOCHEM, V119, P5798, DOI 10.1002/jcb.26765; Kolahdouzan M, 2017, CNS NEUROSCI THER, V23, P272, DOI 10.1111/cns.12684; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Kraemer HC, 2008, HEALTH PSYCHOL, V27, pS101, DOI 10.1037/0278-6133.27.2(Suppl.).S101; Kroehl ME, 2020, PEERJ, V8, DOI 10.7717/peerj.8246; Kumar D, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2019.134347; Laketa D, 2015, J MED BIOCHEM, V34, P215, DOI 10.2478/jomb-2014-0025; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latini A, 2003, EUR J NEUROSCI, V17, P2017, DOI 10.1046/j.1460-9568.2003.02639.x; Lee PJ, 2005, J INHERIT METAB DIS, V28, P141, DOI 10.1007/s10545-005-5262-5; Lee TA, 2021, CLIN J SPORT MED, V31, pE245, DOI 10.1097/JSM.0000000000000778; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li XH, 2016, APOPTOSIS, V21, P708, DOI 10.1007/s10495-016-1238-1; Ling XH, 2019, ONCOL REP, V42, P991, DOI 10.3892/or.2019.7231; Liu H, 2017, EUR REV MED PHARMACO, V21, P2734; Lockhart G, 2011, PSYCHOSOM MED, V73, P29, DOI 10.1097/PSY.0b013e318200a54b; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Logue D, 2018, SPORTS MED, V48, P73, DOI 10.1007/s40279-017-0790-3; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luria A.R, 1973, FDN NEUROPSYCHOLOGY; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; Lv JL, 2018, CHEM-BIOL INTERACT, V296, P89, DOI 10.1016/j.cbi.2018.09.010; Ma XT, 2014, INT J MED SCI, V11, P810, DOI 10.7150/ijms.8647; MacKinnon D.P., 2012, APA HDB RES METHODS, P313, DOI DOI 10.1037/13620-018; Mackinnon D.P, 2008, INTRO STAT MEDIATION, VFirst, P1; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Magalhaes RC, 2019, RES DEV DISABIL, V95, DOI 10.1016/j.ridd.2019.103508; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mao XJ, 2018, J BIOMATER TISS ENG, V8, P1622, DOI 10.1166/jbt.2018.1915; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marin-Valencia I, 2013, J CEREBR BLOOD F MET, V33, P175, DOI 10.1038/jcbfm.2012.151; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Merritt J.L., 1993, MEDIUM CHAIN ACYL CO; Merritt JL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.57; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Naqvi Afsar Raza, 2016, J Microb Biochem Technol, V8, P136; Nauman EA, 2020, ANNU REV BIOMED ENG, V22, P387, DOI 10.1146/annurev-bioeng-091219-053447; Navaderi M, 2020, MULT SCLER RELAT DIS, V39, DOI 10.1016/j.msard.2019.101446; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Pearl J, 2014, PSYCHOL METHODS, V19, P459, DOI 10.1037/a0036434; Pearl J, 2012, PREV SCI, V13, P426, DOI 10.1007/s11121-011-0270-1; Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057; Peng Z, 2014, J BUON, V19, P733; Porter Craig, 2017, JBMR Plus, V1, P59, DOI 10.1002/jbm4.10011; R Development Core Team, 2012, R LANG ENV STAT COMP; Reddycherla AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125311; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Romberg M.H, 1853, MANUAL NERVOUS DIS M, V2nd; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Shi H, 2018, INT J CLIN EXP PATHO, V11, P4405; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; SIEKEVITZ P, 1957, SCI AM, V197, P131, DOI 10.1038/scientificamerican0757-131; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Sinha M, 2012, NEUROMOL MED, V14, P221, DOI 10.1007/s12017-012-8183-0; Slobounov S.M., 2014, CONCUSSION ATHLETICS, P60; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Solaroglu I, 2005, J CLIN NEUROSCI, V12, P273, DOI 10.1016/j.jocn.2004.12.002; Spencer SJ, 2005, J PERS SOC PSYCHOL, V89, P845, DOI 10.1037/0022-3514.89.6.845; StataCorp, 2021, STATA STAT SOFTWARE; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Thangaraj A, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2020.101843; Tommasi S, 2016, ONCOTARGET, V7, P80363, DOI 10.18632/oncotarget.10345; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Wajner M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150240; Wanders RJA, 2011, FEBS J, V278, P182, DOI 10.1111/j.1742-4658.2010.07947.x; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang Q., 2021, ALTERN MED, V2021, DOI [10.1155/2021/6621206, DOI 10.1155/2021/6621206]; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Xie P, 2020, MOL BIOL REP, V47, P4199, DOI 10.1007/s11033-020-05543-y; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang G, 2019, J NEUROSURG, V131, P1445, DOI 10.3171/2018.5.JNS173061; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005; Yoo SM, 2020, BMB REP, V53, P35, DOI 10.5483/BMBRep.2020.53.1.274; Zhao FY, 2017, J NEUROPATH EXP NEUR, V76, P709, DOI 10.1093/jnen/nlx052; Zheng D, 2015, DIABETOLOGIA, V58, P1949, DOI 10.1007/s00125-015-3622-8; Zhong LJ, 2021, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.544285; Zhou JH, 2021, NEUROCHEM RES, V46, P945, DOI 10.1007/s11064-020-03224-7; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	179	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2589-0042		ISCIENCE	iScience	JAN 21	2022	25	1							103483	10.1016/j.isci.2021.103483			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YN2DF	WOS:000747073100006	35106455	gold			2022-02-06	
J	Jiang, XF; Zhu, YH; Zhen, S; Wang, L				Jiang, Xiaofeng; Zhu, Yanhong; Zhen, Shuai; Wang, Lei			Mechanical power of ventilation is associated with mortality in neurocritical patients: a cohort study	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article; Early Access						Mechanical ventilation; Mechanical power; Mortality; Neurocritical care	TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; LUNG INJURY; VOLUME	This study aimed to determine the predictive relevance of mechanical power in the clinical outcomes (such as ICU mortality, hospital mortality, 90-day mortality, length of ICU stay, and number of ventilator-free days at day 28) of neurocritical patients. This is a retrospective cohort analysis of an open-access clinical database known as MIMIC-III. The study included patients who had sustained an acute brain injury and required invasive ventilation for at least 24 h. Demographic parameters, disease severity scores (Glasgow coma scale), comorbidities, vital signs, laboratory parameters and ventilator parameters were collected within the first 24 h of ICU admission. The main outcome was the relationship between MP and ICU mortality. A total of 529 patients were selected for the study. The critical value of MP was 12.16 J/min, with the area under the curve (AUC) of the MP was 0.678 (95% CI 0.637-0.718), and compared to the GCS scores, the MP performed significantly better in discrimination (DeLong's test: p < 0.001). Among these patients elevated MP was associated to higher ICU mortality (OR 1.11; 95% CI 1.06-1.17; p < 0.001), enhanced the risk of hospital mortality, prolonged ICU stay, and decreased the number of ventilator-free days. In the subgroup analysis, high MP was associated with ICU mortality regardless of ARDS (OR 1.01, 95% CI 1.00-1.02, p = 0.009; OR 1.01, 95% CI 1.00-1.02, p = 0.018, respectively) or obesity (OR 1.01, 95% CI 1.00-1.02, p = 0.012; OR 1.01, 95% CI 1.01-1.02, p < 0.001, respectively). In neurocritical care patients undergoing invasive ventilation, elevated MP is linked to higher ICU mortality and a variety of other clinical outcomes.	[Jiang, Xiaofeng; Zhen, Shuai] Jinhua Municipal Cent Hosp, Dept Anesthesiol, Jinhua, Zhejiang, Peoples R China; [Zhu, Yanhong; Wang, Lei] First Peoples Hosp Pinghu, Dept Anesthesiol, 500 Sangang Rd,Danghu St, Pinghu 314200, Zhejiang, Peoples R China		Wang, L (corresponding author), First Peoples Hosp Pinghu, Dept Anesthesiol, 500 Sangang Rd,Danghu St, Pinghu 314200, Zhejiang, Peoples R China.	13615739338@163.com					Abujaber A, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01363-z; Asehnoune K, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1994-0; Beitler JR, 2016, CLIN CHEST MED, V37, P633, DOI 10.1016/j.ccm.2016.07.004; Bilotta F, 2016, ULTRASOUND MED BIOL, V42, P2708, DOI 10.1016/j.ultrasmedbio.2016.06.007; Borsellino B, 2016, EXPERT REV RESP MED, V10, P1123, DOI 10.1080/17476348.2017.1235976; Coppola S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02963-x; De Jong A, 2018, INTENS CARE MED, V44, P1106, DOI 10.1007/s00134-018-5241-6; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907; Gattinoni L, 2016, INTENS CARE MED, V42, P1567, DOI 10.1007/s00134-016-4505-2; GATTINONI L, 1995, AM J RESP CRIT CARE, V151, P1807, DOI 10.1164/ajrccm.151.6.7767524; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hardcastle TC, 2017, WORLD J SURG, V41, P1153, DOI 10.1007/s00268-016-3530-1; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Manzano F, 2008, CRIT CARE MED, V36, P2225, DOI 10.1097/CCM.0b013e31817b8a92; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Picetti E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02875-w; Rached MAKB, 2019, INJURY, V50, P65, DOI 10.1016/j.injury.2018.08.022; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Sadowitz Benjamin, 2016, World J Crit Care Med, V5, P74, DOI 10.5492/wjccm.v5.i1.74; Neto AS, 2018, INTENS CARE MED, V44, P1914, DOI 10.1007/s00134-018-5375-6; TEASDALE G, 1974, LANCET, V2, P81; Treschan TA, 2015, BEST PRACT RES-CLIN, V29, P341, DOI 10.1016/j.bpa.2015.08.002; van Meenen DMP, 2020, INTENS CARE MED EXP, V8, DOI 10.1186/s40635-020-00346-8; Zhang ZH, 2019, INTENS CARE MED, V45, P856, DOI 10.1007/s00134-019-05627-9	27	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.												10.1007/s10877-022-00805-5		JAN 2022	8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	YK0RP	WOS:000744931300002	35059914	hybrid			2022-02-06	
J	Stitt, D; Kabaliuk, N; Alexander, K; Draper, N				Stitt, Danyon; Kabaliuk, Natalia; Alexander, Keith; Draper, Nick			Potential of Soft-Shell Rugby Headgear to Mitigate Linear and Rotational Peak Accelerations	ANNALS OF BIOMEDICAL ENGINEERING			English	Article; Early Access						Linear acceleration; Rotational acceleration; Rugby; Concussion; Headgear; Impact testing	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; AXONAL INJURY; UNION PLAYERS; IMPACT; FOAMS; BEHAVIOR; SEASON	Rugby union is a popular sport played across the world. The physical contact inherent in the game means that players are at increased risk of concussive injury. In 2019, World Rugby created a new category of permitted headgear under Law 4 as a medical device. This established a pathway for headgear designed to reduce peak accelerations to be worn in matches. Investigations of the potential of soft-shelled protective headgear to reduce head impact accelerations have been mostly limited to the analysis of linear kinematics. However rotational head impact accelerations have long been implicated as far more injurious. The aim of this study, therefore, was to assess the linear and rotational acceleration reduction brought about by soft-shelled rugby headgear. A Hybrid III headform and neck were dropped onto a modular elastomer programmer impact surface, impacting at four different velocities (1.7-3.4 m/s) in five different impact orientations. Impact surface angles were 0 degrees, 30 degrees, and 45 degrees. Peak linear and rotational accelerations, PLA and PRA respectively, were recorded. All headgear significantly reduced PLAs and PRAs when compared to a no headgear scenario. The new generation, headgear reduced all measures significantly more than the older generation of headgear. Impact locations offset from the center of mass of the headform resulted in the highest PRAs measured. As the impact surface angle increased, both PLAs and PRAs decreased. The study demonstrated that headgear tested lowered PLAs by up to 50%, and PRAs by up to 60% compared to the bare headform. Our data suggest that new generation headgear could make a difference on the field in reducing injurious impact accelerations in a collision.	[Stitt, Danyon; Kabaliuk, Natalia; Alexander, Keith] Univ Canterbury, Dept Mech Engn, Private Bag 4800, Christchurch 8140, New Zealand; [Draper, Nick] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand		Kabaliuk, N (corresponding author), Univ Canterbury, Dept Mech Engn, Private Bag 4800, Christchurch 8140, New Zealand.	natalia.kabaliuk@canterbury.ac.nz		Stitt, Danyon/0000-0002-7139-3660			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; [Anonymous], 2019, SKULL N SOFT SHELL H; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Bland M.L., 2018, P IRCOBI C ATH GREEC; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Bottlang M, 2020, ANN BIOMED ENG, V48, P68, DOI 10.1007/s10439-019-02328-8; CCC, 2017, CUST MAD VENT RUGB H; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Davies OL, 1999, CELL POLYM, V18, P117; Denny-Brown D E, 1941, Proc R Soc Med, V34, P691; Draper N, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/5567625; Fuller CW, 2017, BRIT J SPORT MED, V51, P1272, DOI 10.1136/bjsports-2016-097301; Gamebreaker, 2020, D30; Gamebreaker, 2019, SOFT PROT RUGB SCRUM; Ganly M, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000464; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; Graham R, 2014, YOUTH IMPROVING SCI; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hecimovich MD, 2017, J PAEDIATR CHILD H, V53, P246, DOI 10.1111/jpc.13405; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Holbourn AHS, 1943, LANCET, V2, P438; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King D, 2019, J SCI MED SPORT, V22, P532, DOI 10.1016/j.jsams.2018.10.015; King D, 2017, ARC J RES SPORTS MED, V2, P9; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Knouse CL, 2003, J ATHL TRAINING, V38, P330; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindholm US., 1974, J CELL PLAST, V10, P127, DOI DOI 10.1177/0021955X7401000306; Lyn G., 2001, SPORTS ENG, V4, P153; Ma R, 2016, MED SCI SPORT EXER, V48, P1957, DOI 10.1249/MSS.0000000000000997; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mihalik JP, 2020, ANN BIOMED ENG, V48, P2555, DOI 10.1007/s10439-020-02658-y; Mills NJ, 2003, COMPOS SCI TECHNOL, V63, P2389, DOI 10.1016/S0266-3538(03)00272-0; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Ramsteiner F, 2001, POLYM TEST, V20, P661, DOI 10.1016/S0142-9418(00)00090-8; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rowson S, 2020, ANN BIOMED ENG, V48, P2626, DOI 10.1007/s10439-020-02675-x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rugby W., 2017, GLOBAL RUGBY PARTICI; Rugby W, 2019, WORLD RUGBY LAW 4 HE; Rugby W., 2019, HEADGEAR PERFORMANCE, V6; Saint-Michel F, 2006, COMPOS SCI TECHNOL, V66, P2700, DOI 10.1016/j.compscitech.2006.03.009; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; Silver D, 2018, J NEUROL SCI, V388, P40, DOI 10.1016/j.jns.2018.02.046; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Walsh E, 2009, ISBS C P ARCH; Walsh ES, 2010, PROCEDIA ENGINEER, V2, P3487, DOI 10.1016/j.proeng.2010.04.202; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9	64	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.												10.1007/s10439-022-02912-5		JAN 2022	19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	YJ8WN	WOS:000744808500002	35059915	hybrid			2022-02-06	
J	Li, YP; Zhang, J; Wang, HL; Zhu, L; Zhang, HZ; Ma, Q; Liu, XG; Dong, L; Lu, GY				Li, Yuping; Zhang, Jun; Wang, Haili; Zhu, Lei; Zhang, Hengzhu; Ma, Qiang; Liu, Xiaoguang; Dong, Lun; Lu, Guangyu			Does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled-analysis	NEUROLOGICAL SCIENCES			English	Article; Early Access						Erythropoietin; Traumatic brain injury; Mortality; Good functional outcome; Meta-analysis	RECOMBINANT-HUMAN-ERYTHROPOIETIN; SUBARACHNOID HEMORRHAGE; NEUROLOGICAL RECOVERY; CEREBRAL-ISCHEMIA; DOUBLE-BLIND; EPO-TBI; RECEPTOR; NEUROPROTECTION; DARBEPOETIN; EXPRESSION	Objective The aim of this meta-analysis was to review the scientific literature published until April 18, 2021, to summarize existing knowledge on the efficacy and safety of erythropoietin (EPO) for traumatic brain injury (TBI). Methods This systematic review followed PRISMA guidelines. Randomized controlled trials (RCTs) reporting on the efficacy and safety of EPO in the treatment of TBI were systematically searched in relevant electronic databases according to a pre-designed search strategy. The primary outcomes are the mortality; and secondary outcomes are the good functional outcome (GFO) and adverse events (AEs). Results A total of 10 RCTs involving 2,402 participants fulfilled the inclusion criteria. The results showed that there is a significant difference in terms of the mortality (RR = 0.67, 95% CI = 0.54-0.84, P = 0.0003) and seizure rate (RR = 0.52, 95% CI = 0.29-0.96, P = 0.04) between the EPO groups compared to those in the control groups. However, compared with the control groups, the GFO in the EPO groups was not statistically significant (RR = 1.18, 95% CI = 0.93-1.48, P = 0.17). Conclusions Findings of the present meta-analysis suggest that the use of EPO could reduce mortality rate in patients with TBI, without increasing the incidence of AEs. EPO has potential research and application value in the treatment of TBI.	[Li, Yuping; Zhu, Lei; Ma, Qiang; Liu, Xiaoguang; Dong, Lun] Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Neuro Intens Care Unit, Yangzhou, Jiangsu, Peoples R China; [Li, Yuping; Zhang, Hengzhu; Dong, Lun] Xuzhou Med Univ, Dept Neurosurg, Yangzhou Clin Med Coll, Xuzhou, Jiangsu, Peoples R China; [Zhang, Jun] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Wang, Haili] Dalian Med Univ, Dept Clin Med, Dalian, Liaoning, Peoples R China; [Lu, Guangyu] Yangzhou Univ, Med Coll, Inst Publ Hlth, Yangzhou, Jiangsu, Peoples R China		Lu, GY (corresponding author), Yangzhou Univ, Med Coll, Inst Publ Hlth, Yangzhou, Jiangsu, Peoples R China.	Guangyu.lu@yzu.edu.cn			China Natural Science FoundationNational Natural Science Foundation of China (NSFC) [82172603]; Jiangsu Province Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20190241]; Jiangsu Provincial Key Medical Talents Program [QNRC2016326]; Jiangsu Province Key Experiments of Basic and Clinical Translation of Non-coding RNA [201902]; Hospital Level Support Projects [Fcjs202050]	This study was supported by the program of study on the China Natural Science Foundation (82172603);Jiangsu Province Natural Science Foundation (BK20190241); Jiangsu Provincial Key Medical Talents Program (QNRC2016326); Jiangsu Province Key Experiments of Basic and Clinical Translation of Non-coding RNA (201902); and Hospital Level Support Projects (Fcjs202050).	Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Bai XF, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009532; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Campana WM, 1998, INT J MOL MED, V1, P235; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; FDA, 2015, SAF AL HUM MED PROD; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Kertmen H, 2014, ACTA NEUROCHIR, V156, P951, DOI 10.1007/s00701-014-2008-x; Kim SS, 2008, J KOREAN MED SCI, V23, P484, DOI 10.3346/jkms.2008.23.3.484; Knott RJ, 2019, J NEUROTRAUM, V36, P2541, DOI 10.1089/neu.2018.6229; Lee J, 2019, AM J EMERG MED, V37, P1101, DOI 10.1016/j.ajem.2018.08.072; Li YP, 2016, LANCET, V388, P92; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080599; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; Liu SW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030230; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu GY, 2020, WORLD NEUROSURG, V133, pE135, DOI 10.1016/j.wneu.2019.08.184; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; MASUDA S, 1994, J BIOL CHEM, V269, P19488; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Ozturk Erdogan, 2005, Prog Neuropsychopharmacol Biol Psychiatry, V29, P922, DOI 10.1016/j.pnpbp.2005.04.028; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pellegrini L, 2013, NEUROL RES, V35, P937, DOI 10.1179/1743132813Y.0000000235; Ratilal BO, 2014, J NEUROSURG, V121, P55, DOI 10.3171/2014.2.JNS132197; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Romanova GA, 2015, B EXP BIOL MED+, V158, P318, DOI 10.1007/s10517-015-2751-x; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Sims B, 2010, BRAIN RES, V1321, P88, DOI 10.1016/j.brainres.2010.01.040; Skrifvars M, 2017, J NEUROTRAUM, P1; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; Steensma DP, 2015, AM J HEMATOL, V90, P877, DOI 10.1002/ajh.24110; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; The Nordic Cochrane Centre, COCHRANE COLLABORATI; Turner RJ, 2004, J AM COLL NUTR, V23, p541S, DOI 10.1080/07315724.2004.10719399; Wang B, 2016, NEUROTHERAPEUTICS, V13, P418, DOI 10.1007/s13311-015-0418-y; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Zhang HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113093; Zhang J, 2020, CLIN NEUROL NEUROSUR, V198, DOI 10.1016/j.clineuro.2020.106131	56	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.												10.1007/s10072-022-05877-4		JAN 2022	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YJ2ZL	WOS:000744403500003	35044560				2022-02-06	
J	Zhang, L; Tian, M; Wang, HD; Mao, L				Zhang, Li; Tian, Mi; Wang, Handong; Mao, Lei			Expression characteristics of long noncoding RNA and messenger RNA in human traumatic brain injury	NEUROREPORT			English	Article						biological processes; human traumatic brain injury; long noncoding RNA; nuclear factor E2-related factor 2	CLASSIFICATION; TARGET; LNCRNA	Objectives The role of long noncoding RNAs has attracted significant attention in diseases. However, their expression characteristics in human traumatic brain injury are unclear. Methods The brain contusion tissues and tissues adjacent to the brain contusion from 6 server traumatic brain injury patients were used to analyze differential expression signatures of long noncoding RNAs and mRNAs via full-length transcriptome sequencing, Gene Ontology analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and establishment of a long noncoding RNA/mRNA coexpression network. Results We identified 1720 long noncoding RNAs and 1632 mRNAs differential expression. Microarray analysis showed that 874 long noncoding RNAs and 1405 mRNAs were upregulated, 846 long noncoding RNAs and 227 mRNAs were downregulated. Subsequently, we used Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses to reveal signaling pathways that were associated with target genes. Then, a long noncoding RNA/mRNA coexpression network was generated, which showed an absolute correlation coefficient value >0.99 for 559 long noncoding RNA-mRNA pairs. Finally, we comprehensive analyzed long noncoding RNA/mRNA coexpression network and Kyoto Encyclopedia of Genes and Genomes pathway and found the top five pairs of long noncoding RNA/mRNA. Accordingly, we identified that long noncoding RNA tubulin beta 6 class V/nuclear factor E2-related factor 2 was most closely related to the pathological process after traumatic brain injury. Conclusions Our results indicated that the expression profiles of long noncoding RNAs and mRNAs were different after traumatic brain injury, providing new insight regarding long noncoding RNAs in human traumatic brain injury.	[Zhang, Li; Wang, Handong; Mao, Lei] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Tian, Mi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China		Mao, L (corresponding author), Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	leiching2021@126.com			construction of Key Medical Subjects of Jiangsu Province [ZDXKB2016023]	This work was supported by Grants from the construction of Key Medical Subjects of Jiangsu Province (no. ZDXKB2016023) from H.W.	Asalone KC, 2021, GENOME BIOL EVOL, V13, DOI 10.1093/gbe/evab088; Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010; Dashti S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76024-2; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Fazeli W, 2017, HUM MOL GENET, V26, P4055, DOI 10.1093/hmg/ddx296; Fu C, 2018, NEUROTHERAPEUTICS, V15, P1139, DOI 10.1007/s13311-018-0649-9; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1; Jiang L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.566579; Kgosidialwa O, 2019, IRISH J MED SCI, V188, P1201, DOI 10.1007/s11845-019-02007-6; Klimiankou M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00116; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kumar MM, 2017, CURR TOP MED CHEM, V17, P1750, DOI 10.2174/1568026617666161116144744; Li K, 2018, ANN RHEUM DIS, V77, P935, DOI 10.1136/annrheumdis-2017-212658; Li ZX, 2019, NEUROPSYCH DIS TREAT, V15, P1671, DOI 10.2147/NDT.S206624; Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Ren DB, 2020, MOL THER-NUCL ACIDS, V22, P99, DOI 10.1016/j.omtn.2020.08.012; Ren JC, 2020, ENVIRON MOL MUTAGEN, V61, P786, DOI 10.1002/em.22382; Roach NP, 2020, GENOME RES, V30, P299, DOI 10.1101/gr.251314.119; Wang F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3546-4; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang SC, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00425; Wu ZM, 2017, MOL NEUROBIOL, V54, P7670, DOI 10.1007/s12035-016-0246-z; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Yi M, 2019, CELL CYCLE, V18, P2332, DOI 10.1080/15384101.2019.1647024; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang L, 2019, MOL THER-NUCL ACIDS, V17, P754, DOI 10.1016/j.omtn.2019.07.013; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang Y, 2020, NEUROCHEM RES, V45, P1700, DOI 10.1007/s11064-020-03035-w; Zheng XH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01112	34	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JAN 19	2022	33	2					90	99		10.1097/WNR.0000000000001756			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE0FN	WOS:000740808500007	34954770				2022-02-06	
J	Dorociak, KE; Soble, JR; Rupert, PA; Fink, JW; Lee, RC; Anitescu, M; Weiss, D; Cooke, G; Resch, ZJ; Pliskin, NH				Dorociak, Katherine E.; Soble, Jason R.; Rupert, Patricia A.; Fink, Joseph W.; Lee, Raphael C.; Anitescu, Magdalena; Weiss, David; Cooke, Gerald; Resch, Zachary J.; Pliskin, Neil H.			Pain Influences Neuropsychological Performance Following Electrical Injury: A Cross-Sectional Study	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Early Access						Electrical injury; Nerves; Chronic pain; Assessment; Traumatic injury; Cognition; Psychopathology; Mediation	LOW-VOLTAGE; POSTTRAUMATIC-STRESS; RHEUMATOID-ARTHRITIS; DEPRESSION; MECHANISMS; FIBROMYALGIA; PREDICTORS; QUALITY; MEMORY; RETURN	Objective: Electrical injury (EI) is a significant, multifaceted trauma often with multi-domain cognitive sequelae, even when the expected current path does not pass through the brain. Chronic pain (CP) research suggests pain may affect cognition directly and indirectly by influencing emotional distress which then impacts cognitive functioning. As chronic pain may be critical to understanding EI-related cognitive difficulties, the aims of the current study were: examine the direct and indirect effects of pain on cognition following EI and compare the relationship between pain and cognition in EI and CP populations. Method: This cross-sectional study used data from a clinical sample of 50 patients with EI (84.0% male; M (age) = 43.7 years) administered standardized measures of pain (Pain Patient Profile), depression, and neurocognitive functioning. A CP comparison sample of 93 patients was also included. Results: Higher pain levels were associated with poorer attention/processing speed and executive functioning performance among patients with EI. Depression was significantly correlated with pain and mediated the relationship between pain and attention/processing speed in patients with EI. When comparing the patients with EI and CP, the relationship between pain and cognition was similar for both clinical groups. Conclusions: Findings indicate that pain impacts mood and cognition in patients with EI, and the influence of pain and its effect on cognition should be considered in the assessment and treatment of patients who have experienced an electrical injury.	[Dorociak, Katherine E.] VA Palo Alto Hlth Care Syst, Dept Psychol, 3801 Miranda Ave, Palo Alto, CA 94304 USA; [Soble, Jason R.; Resch, Zachary J.; Pliskin, Neil H.] Univ Illinois, Dept Psychiat, Coll Med, Chicago, IL 60612 USA; [Soble, Jason R.; Pliskin, Neil H.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL USA; [Rupert, Patricia A.] Loyola Univ Chicago, Dept Psychol, Chicago, IL USA; [Fink, Joseph W.; Lee, Raphael C.; Anitescu, Magdalena; Weiss, David; Cooke, Gerald; Pliskin, Neil H.] Chicago Elect Trauma Rehabil Inst, Chicago, IL USA; [Fink, Joseph W.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Lee, Raphael C.; Weiss, David] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Lee, Raphael C.] Univ Chicago, Dept Surg Med Anat & Organismal Biol, Chicago, IL 60637 USA; [Anitescu, Magdalena] Univ Chicago Med, Dept Anesthesia & Crit Care, Chicago, IL USA; [Cooke, Gerald] US Physiatry LLC, Dept Rehabil Med, Riverforest, IL USA		Dorociak, KE (corresponding author), VA Palo Alto Hlth Care Syst, Dept Psychol, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	katiedorociak@gmail.com		Resch, Zachary/0000-0002-3199-6168; Soble, Jason/0000-0003-3348-8762			Aase DM, 2014, ARCH CLIN NEUROPSYCH, V29, P125, DOI 10.1093/arclin/act117; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barrash J, 1996, Appl Neuropsychol, V3, P75, DOI 10.1207/s15324826an0302_5; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Bernstein MT, 2021, NEUROPSYCHOL REV, V31, P349, DOI 10.1007/s11065-020-09468-y; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Brandt J., 1997, HOPKINS VERBAL LEARN; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Bryan BC, 2009, J NEUROPSYCH CLIN N, V21, pIV, DOI [10.1176/appi.neuropsych.21.4.iv, 10.1176/appi.neuropsych.21.3.iv]; Crews WD, 1997, APPL NEUROPSYCHOL, V4, P208, DOI 10.1207/s15324826an0404_2; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis D.C., 2017, CALIFORNIA VERBAL LE, V3rd; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Ghavami Y, 2014, TRAUMA MON, V19, P29, DOI 10.5812/traumamon.18748; Golden CJ., 2002, STROOP COLOR WORD TE; Grace GM, 1999, J CLIN EXP NEUROPSYC, V21, P477, DOI 10.1076/jcen.21.4.477.876; Green P., 2003, GREENS WORD MEMORY T; Grigorovich A, 2013, J BURN CARE RES, V34, P659, DOI 10.1097/BCR.0b013e31827e5062; Grossman A. Richard, 1993, Journal of Burn Care and Rehabilitation, V14, P169, DOI 10.1097/00004630-199303000-00008; Hahn-Ketter AE, 2016, CLIN NEUROPSYCHOL, V30, P216, DOI 10.1080/13854046.2016.1155647; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; He B, 2013, IEEE T BIO-MED ENG, V60, P589, DOI 10.1109/TBME.2013.2244886; Heaton R., 1993, WISCONSIN CARD SORTI; Iezzi T, 2004, INT J BEHAV MED, V11, P56, DOI 10.1207/s15327558ijbm1101_7; JAMISON RN, 1989, PAIN, V37, P289, DOI 10.1016/0304-3959(89)90193-0; Jennette KJ, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1900398; Ji RR, 2018, ANESTHESIOLOGY, V129, P343, DOI 10.1097/ALN.0000000000002130; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; Kim CT, 2001, ARCH PHYS MED REHAB, V82, P993, DOI 10.1053/apmr.2001.23955; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lee R.C., 1992, ELECT TRAUMA PATHOPH; LEE RC, 1987, PLAST RECONSTR SURG, V80, P672, DOI 10.1097/00006534-198711000-00002; Lee RC, 2000, ANNU REV BIOMED ENG, V2, P477, DOI 10.1146/annurev.bioeng.2.1.477; Lee RC, 1997, CURR PROB SURG, V34, P682, DOI 10.1016/S0011-3840(97)80007-X; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; National Safety Council, 2016, INJ FACTS; Nicholas M, 2019, PAIN, V160, P28, DOI 10.1097/j.pain.0000000000001390; Noble J, 2006, BURNS, V32, P159, DOI 10.1016/j.burns.2005.08.022; Oosterman JM, 2013, EUR J PAIN, V17, P735, DOI 10.1002/j.1532-2149.2012.00235.x; Pliskin NH, 2006, J INT NEUROPSYCH SOC, V12, P17, DOI 10.1017/S1355617706060061; Pliskin NH, 1998, J TRAUMA, V44, P709, DOI 10.1097/00005373-199804000-00027; Pliskin NH, 1999, ANN NY ACAD SCI, V888, P140, DOI 10.1111/j.1749-6632.1999.tb07952.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Primeau M, 2005, NEUROREHABILITATION, V20, P25; Ramati A, 2009, J NEUROTRAUM, V26, P1815, DOI [10.1089/neu.2008.0867, 10.1089/neu.2008-0867]; Ramati A, 2009, GEN HOSP PSYCHIAT, V31, P360, DOI 10.1016/j.genhosppsych.2009.03.010; Resch ZJ, 2021, NEUROPSYCHOL REV, V31, P331, DOI 10.1007/s11065-021-09477-5; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Rey A., 1964, LEXAMEN CLINIQUE PSY; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shih JG, 2017, J BURN CARE RES, V38, pE293, DOI 10.1097/BCR.0000000000000373; Shura RD, 2018, NEUROPSYCHOL REV, V28, P269, DOI 10.1007/s11065-018-9377-5; Singerman J, 2008, J BURN CARE RES, V29, P773, DOI 10.1097/BCR.0b013e318184815d; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Soble JR, 2019, CLIN NEUROPSYCHOL, V33, P1501, DOI 10.1080/13854046.2019.1616114; Theman K, 2008, J BURN CARE RES, V29, P959, DOI 10.1097/BCR.0b013e31818b9eb6; Tollison D.C., 1995, PAIN PATIENT PROFILE; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Vernon-Wilkinson R., 1993, ARCH CLIN NEUROPSYCH, V9, P2; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Wechsler, 2008, WAIS 4 ADM SCORING M; Willoughby SG, 1999, ARCH PHYS MED REHAB, V80, P1300, DOI 10.1016/S0003-9993(99)90033-3; Wolfson, 1993, HALSTEAD REITAN NEUR	78	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.											PII S1355617721001478	10.1017/S1355617721001478		JAN 2022	11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	YJ7BF	WOS:000744685000001	35039108				2022-02-06	
J	Fischer, D; Snider, SB; Barra, ME; Sanders, WR; Rapalino, O; Schaefer, P; Foulkes, AS; Bodien, YG; Edlow, BL				Fischer, David; Snider, Samuel B.; Barra, Megan E.; Sanders, William R.; Rapalino, Otto; Schaefer, Pamela; Foulkes, Andrea S.; Bodien, Yelena G.; Edlow, Brian L.			Disorders of Consciousness Associated With COVID-19 A Prospective Multimodal Study of Recovery and Brain Connectivity	NEUROLOGY			English	Article							AGE-RELATED-CHANGES; SCALE; DEFINITION	Background and Objectives In patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (DoC) have emerged as a serious complication. The prognosis and pathophysiology of COVID-DoC remain unclear, complicating decisions about continuing life-sustaining treatment. We describe the natural history of COVID-DoC and investigate its associated brain connectivity profile. Methods In a prospective longitudinal study, we screened consecutive patients with COVID-19 at our institution. We enrolled critically ill adult patients with a DoC unexplained by sedation or structural brain injury and who were planned to undergo a brain MRI. We performed resting-state fMRI and diffusion MRI to evaluate functional and structural connectivity compared to healthy controls and patients with DoC resulting from severe traumatic brain injury (TBI). We assessed the recovery of consciousness (command following) and functional outcomes (Glasgow Outcome Scale Extended [GOSE] and the Disability Rating Scale [DRS]) at hospital discharge and 3 and 6 months after discharge. We also explored whether clinical variables were associated with recovery from COVID-DoC. Results After screening 1,105 patients with COVID-19, we enrolled 12 with COVID-DoC. The median age was 63.5 years (interquartile range 55-76.3 years). After the exclusion of 1 patient who died shortly after enrollment, all of the remaining 11 patients recovered consciousness 0 to 25 days (median 7 [5-14.5] days) after the cessation of continuous IV sedation. At discharge, all surviving patients remained dependent: median GOSE score 3 (1-3) and median DRS score 23 (16-30). Ultimately, however, except for 2 patients with severe polyneuropathy, all returned home with normal cognition and minimal disability: at 3 months, median GOSE score 3 (3-3) and median DRS score 7 (5-13); at 6 months, median GOSE score 4 (4-5), median DRS score 3 (3-5). Ten patients with COVID-DoC underwent advanced neuroimaging; functional and structural brain connectivity in those with COVID-DoC was diminished compared to healthy controls, and structural connectivity was comparable to that in patients with severe TBI. Discussion Patients who survived invariably recovered consciousness after COVID-DoC. Although disability was common after hospitalization, functional status improved over the ensuing months. While future research is necessary, these prospective findings inform the prognosis and pathophysiology of COVID-DoC.	[Fischer, David; Barra, Megan E.; Sanders, William R.; Bodien, Yelena G.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Barra, Megan E.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Pharm, Boston, MA 02114 USA; [Rapalino, Otto; Schaefer, Pamela] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Foulkes, Andrea S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Foulkes, Andrea S.] Harvard Med Sch, Boston, MA 02115 USA; [Fischer, David; Snider, Samuel B.] Brigham & Womens Hosp, Div Neurocrit Care, Dept Neurol, Boston, MA 02115 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA		Fischer, D (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Fischer, D (corresponding author), Brigham & Womens Hosp, Div Neurocrit Care, Dept Neurol, Boston, MA 02115 USA.	d.b.fisch@gmail.com		Rapalino, Otto/0000-0002-5038-4183; Sanders, William/0000-0003-4536-9357; Fischer, David/0000-0001-8181-0643	NIH National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS06574309, R21NS109627]; James S. McDonnell Foundation COVID-19 Recovery of Consciousness Consortium; NIH Director's Office [DP2HD101400]; Tiny Blue Dot Foundation	This study was supported by the NIH National Institute of Neurologic Disorders and Stroke (R25NS06574309, R21NS109627), the James S. McDonnell Foundation COVID-19 Recovery of Consciousness Consortium, the NIH Director's Office (DP2HD101400), and the Tiny Blue Dot Foundation.	Abdo WF, 2021, NEUROLOGY, V96, pE1437, DOI 10.1212/WNL.0000000000011355; Agarwal S, 2020, STROKE, V51, P2649, DOI 10.1161/STROKEAHA.120.030940; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Boehme AK., NEUROCRIT CARE; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Edlow BL, 2021, NEUROCRIT CARE, V34, P365, DOI 10.1007/s12028-021-01192-6; Edlow BL, 2020, NEUROCRIT CARE, V33, P627, DOI 10.1007/s12028-020-01133-9; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Fischer D, 2020, ANN NEUROL, V88, P851, DOI 10.1002/ana.25838; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Huberman Barrie J, 2020, J Clin Ethics, V31, P219; Jain V, 2020, INT J PUBLIC HEALTH, V65, P533, DOI 10.1007/s00038-020-01390-7; Jolly AE, 2021, BRAIN, V144, P92, DOI 10.1093/brain/awaa372; Karaca-Mandic P, 2021, JAMA INTERN MED, V181, P131, DOI 10.1001/jamainternmed.2020.3857; Kondziella D, 2020, EUR J NEUROL, V27, P741, DOI 10.1111/ene.14151; Lambrecq V, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1489; Liang WH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00562-2020; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Newcombe VFJ, 2021, INTENS CARE MED, V47, P116, DOI 10.1007/s00134-020-06241-w; Pinzon RT, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00565; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raza A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8429; Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937; Sair HI, 2018, RADIOLOGY, V287, P247, DOI 10.1148/radiol.2017162161; Sangare A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110845; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Snider SB, 2020, NEUROIMAGE-CLIN, V28, DOI 10.1016/j.nicl.2020.102503; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Song M, 2018, ELIFE, V7, DOI 10.7554/eLife.36173; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Velly L, 2018, LANCET NEUROL, V17, P317, DOI 10.1016/S1474-4422(18)30027-9; Waldman GJ, 2020, ANN NEUROL, V88, P653, DOI 10.1002/ana.25830; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yong SJ, 2021, ACS CHEM NEUROSCI, V12, P573, DOI 10.1021/acschemneuro.0c00793; Yu YM, 2021, BRAIN IMAGING BEHAV, V15, P1966, DOI 10.1007/s11682-020-00390-8; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370	43	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 18	2022	98	3					E315	E325		10.1212/WNL.0000000000013067			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI1XM	WOS:000743649100013	34862317	hybrid, Green Accepted			2022-02-06	
J	Kenny, R; Elez, M; Clansey, A; Virji-Babul, N; Wu, LC				Kenny, Rebecca; Elez, Marko; Clansey, Adam; Virji-Babul, Naznin; Wu, Lyndia C.			Head Impact Exposure and Biomechanics in University Varsity Women's Soccer	ANNALS OF BIOMEDICAL ENGINEERING			English	Article; Early Access						Head impact exposure; Repetitive head impacts; Soccer heading; Female athletes; Mouthpiece sensor; Video verification; Head impact kinematics	INSTRUMENTED MOUTHGUARD; LABORATORY EVALUATION; ACCELERATION; VALIDATION; CONCUSSION; KINEMATICS; FREQUENCY; SYSTEM; REDUCE; INJURY	Soccer is a unique sport where players purposefully and voluntarily use their unprotected heads to manipulate the direction of the ball. There are limited soccer head impact exposure data to further study brain injury risks. The objective of the current study was to combine validated mouthpiece sensors with comprehensive video analysis methods to characterize head impact exposure and biomechanics in university varsity women's soccer. Thirteen female soccer athletes were instrumented with mouthpiece sensors to record on-field head impacts during practices, scrimmages, and games. Multi-angle video was obtained and reviewed for all on-field activity to verify mouthpiece impacts and identify contact scenarios. We recorded 1307 video-identified intentional heading impacts and 1011 video-verified sensor impacts. On average, athletes experienced 1.83 impacts per athlete-exposure, with higher exposure in practices than games/scrimmages. Median and 95th percentile peak linear and peak angular accelerations were 10.0, 22.2 g, and 765, 2296 rad/s(2), respectively. Long kicks, top of the head impacts and jumping headers resulted in the highest impact kinematics. Our results demonstrate the importance of investigating and monitoring head impact exposure during soccer practices, as well as the opportunity to limit high-kinematics impact exposure through heading technique training and reducing certain contact scenarios.	[Kenny, Rebecca] Univ British Columbia, Dept Rehabil Sci, 2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Elez, Marko] Univ British Columbia, Dept Integrated Sci, 6356 Agr Rd Room 464, Vancouver, BC V6T 1Z2, Canada; [Clansey, Adam; Wu, Lyndia C.] Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Ln 2054, Vancouver, BC V6T 1Z4, Canada; [Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, 2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada		Wu, LC (corresponding author), Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Ln 2054, Vancouver, BC V6T 1Z4, Canada.	lwu@mech.ubc.ca		Wu, Lyndia/0000-0002-8236-032X	UBC Women's Soccer team; Li Tze Fong Memorial Fellowship; UBC Four Year Fellowship program; Canadian New Frontiers in Research Fund [NFRFE-2018-00141]	The authors would like to thank UBC Women's Soccer team and the team coach Jesse Symons, whose support made this study possible. We thank Sandra Wong, Britney Ha, Ava Katz, Tyler Proctor, Annika Szarka, Ian Hunter and Joyce Kao for their invaluable help in field data collection and video analyses. Special thanks to the Wake Forest Center for Injury Biomechanics researchers Logan Miller, Konstantina Strates and Joel Stitzel for their collaboration and assistance in mouthpiece sensor deployment. We would also like to thank Susan Schmidt and Kaitlyn Spicer for assistance in dental molding. This study was supported by the Li Tze Fong Memorial Fellowship, the UBC FourYear Fellowship program, and the Canadian New Frontiers in Research Fund (Grant Number NFRFE-2018-00141).	Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bartsch A, 2012, SPORTS ENG, V15, P93, DOI 10.1007/s12283-012-0089-4; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beaudouin F, 2020, SCAND J MED SCI SPOR, V30, P1506, DOI 10.1111/sms.13694; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; FIFA, 2018, FIFA WORLD CUP TM ME; Filben TM, 2021, J BIOMECH, V126, DOI 10.1016/j.jbiomech.2021.110619; Gabler LF, 2020, ANN BIOMED ENG, V48, P2599, DOI 10.1007/s10439-020-02654-2; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A, 2019, SCI MED FOOTBALL, V3, P109, DOI 10.1080/24733938.2018.1506591; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Higgins M, 2007, J ATHL TRAINING, V42, P5; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kunz M., 2007, FIFA BIG COUNT 2006; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Levendusky T., 2021, SCI FOOTB ROUTLEDGE, P407; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McCunn R, 2021, SPORTS MED, V51, P2147, DOI 10.1007/s40279-021-01492-z; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patton DA, 2020, ANN BIOMED ENG, V48, P2497, DOI 10.1007/s10439-020-02642-6; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Sharratt A. U.K, 2020, HEALTHING CA; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Tomblin BT, 2021, J APPL BIOMECH, V37, P36, DOI 10.1123/jab.2020-0071; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; U.S. Soccer Federation, 2018, CONC HEAD INJ; Wang T, 2021, ANN BIOMED ENG, V49, P3189, DOI 10.1007/s10439-021-02868-y; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	55	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.												10.1007/s10439-022-02914-3		JAN 2022	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	YI4QD	WOS:000743833100002	35041117				2022-02-06	
J	Sood, NT; Godfrey, C; Arana, CC; Anderson, V; Catroppa, C				Sood, Nikita Tuli; Godfrey, Celia; Arana, Clara Chavez; Anderson, Vicki; Catroppa, Cathy			Paediatric traumatic brain injury and the dysregulation profile: The mediating role of decision-making	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; Mediation; Decision-making; Dysregulation profile; Paediatric	BEHAVIORAL OUTCOMES; EXECUTIVE FUNCTIONS; PREFRONTAL CORTEX; SELF-REGULATION; CHILDREN; CHILDHOOD; EPIDEMIOLOGY; DISORDER; DEFICIT; DAMAGE	Decision-making is often impacted by paediatric traumatic brain injury (TBI). However, there are few tools available to assess these skills in children, with even less research on the consequences of decision-making deficits on dysregulation following TBI. This prospective preliminary study investigated whether decision-making mediated the effect of TBI on dysregulation in children. The performance of school-aged children aged between 7 and 15 years with TBI (n = 49) and that of typically developing controls (n = 22) was compared on The Decision-making Task, and on parent ratings of the dysregulation profile as characterized by the Child Behaviour Checklist-Dysregulation Profile. Relative to the Control group, the TBI group performed more poorly on the decision-making task, and parents of the TBI group rated their children to be more poorly on the dysregulation profile. Mediation analyses indicated that decision-making mediated the relationship between TBI and the dysregulation profile. Our preliminary findings suggest the need for further research in the area of decision-making, and its impact on dysregulated behaviours in children following TBI.	[Sood, Nikita Tuli; Godfrey, Celia; Anderson, Vicki; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Sood, Nikita Tuli; Godfrey, Celia; Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Melbourne, Vic, Australia; [Sood, Nikita Tuli; Godfrey, Celia; Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Arana, Clara Chavez] Erasmus Sch Social & Behav Sci, Dept Psychol Educ & Child Studies, Rotterdam, Netherlands		Sood, NT (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	nikita.tuli@mcri.edu.au			University of MelbourneUniversity of Melbourne	This research received no specific grant from any funding agency, commercial or not-forprofit sectors. The first author was supported by the PhD scholarships provided by the University of Melbourne.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aitken M, 2019, J AFFECT DISORDERS, V253, P87, DOI 10.1016/j.jad.2019.04.034; Althoff RR, 2010, PSYCHIAT RES, V178, P550, DOI 10.1016/j.psychres.2010.05.002; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Ayer L, 2009, J CHILD PSYCHOL PSYC, V50, P1291, DOI 10.1111/j.1469-7610.2009.02089.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bellani M, 2012, EPIDEMIOL PSYCH SCI, V21, P155, DOI 10.1017/S2045796011000849; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Chavez-Arana C, 2019, CHILD NEUROPSYCHOL, V25, P1125, DOI 10.1080/09297049.2019.1589442; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Cohen J., 2013, STAT POWER ANAL BEHA; Deutz MHF, 2016, EUR CHILD ADOLES PSY, V25, P431, DOI 10.1007/s00787-015-0745-x; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fairchild AJ, 2017, AM J CLIN NUTR, V105, P1259, DOI 10.3945/ajcn.117.152546; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Glockner A, 2008, J EXP PSYCHOL LEARN, V34, P1055, DOI 10.1037/0278-7393.34.5.1055; Guerra N., 2014, WORLD BANK POLICY RE; Hanten G, 2006, NEUROCASE, V12, P247, DOI 10.1080/13554790600910490; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; IBM Corp, 2016, IBM SPSS STAT WINDOW; Kim J, 2012, J CHILD PSYCHOL PSYC, V53, P918, DOI 10.1111/j.1469-7610.2012.02546.x; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kuhberger A, 2002, ORGAN BEHAV HUM DEC, V89, P1162, DOI 10.1016/S0749-5978(02)00021-3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Masi G, 2015, J AFFECT DISORDERS, V186, P249, DOI 10.1016/j.jad.2015.05.069; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Miyapuram KP, 2013, PROG BRAIN RES, V202, P239, DOI 10.1016/B978-0-444-62604-2.00014-9; Modecki KL, 2017, CHILD DEV, V88, P417, DOI 10.1111/cdev.12734; Montoya AK, 2017, PSYCHOL METHODS, V22, P6, DOI 10.1037/met0000086; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; PAYNE JW, 1976, ORGAN BEHAV HUM PERF, V16, P366, DOI 10.1016/0030-5073(76)90022-2; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rochat L, 2019, NEUROPSYCHOL REV, V29, P27, DOI 10.1007/s11065-018-9387-3; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Sonuga-Barke EJS, 2016, J CHILD PSYCHOL PSYC, V57, P321, DOI 10.1111/jcpp.12496; Sood N, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1338-x; TEASDALE G, 1974, LANCET, V2, P81; Vaidya AR, 2017, DECISION NEUROSCIENCE: AN INTEGRATIVE PERSPECTIVE, P277, DOI 10.1016/B978-0-12-805308-9.00022-1; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th	52	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2022.2025861		JAN 2022	14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YI4HB	WOS:000743809300001	35040743				2022-02-06	
J	Boltzmann, M; Schmidt, SB; Gutenbrunner, C; Krauss, JK; Hoglinger, GU; Rollnik, JD				Boltzmann, Melanie; Schmidt, Simone B.; Gutenbrunner, Christoph; Krauss, Joachim K.; Hoeglinger, Guenter U.; Rollnik, Jens D.			One-year outcome of brain injured patients undergoing early neurological rehabilitation: a prospective observational study	BMC NEUROLOGY			English	Article						Neurological rehabilitation; Brain injured patients; Long-term prognosis; Glasgow outcome scale-extended; Coma recovery scale-revised	MINIMALLY CONSCIOUS STATE; DISORDERS; RECOVERY; PREDICTORS; DISABILITY; SCALE	Background The present study intended to analyze the outcome of patients with severe brain injury one-year after discharge from early rehabilitation. Methods Early neurological rehabilitation patients admitted to intensive or intermediate care units and discharged between June 2018 and May 2020 were screened for eligibility. The level of consciousness was evaluated using the Coma Recovery Scale-Revised (CRS-R) upon admission and at discharge. At one-year follow-up, the outcome was assessed with the Glasgow Outcome Scale-extended (GOSE). Demographical and clinical data collected during inpatient rehabilitation were used to predict the outcome 1 year after discharge. Results Two hundred sixty-four patients (174 males, 90 females) with a median age of 62 years (IQR = 51-75) and a median duration of their disease of 18 days (IQR = 12-28) were included in the study. At follow-up, the mortality rate was 27% (n = 71). Age and discharge CRS-R total score were independent predictors in a Cox proportional hazards model with death (yes/no) as the dependent variable. According to the GOSE interviews, most patients were either dead (n = 71; 27%), in a vegetative state (n = 28; 11%) or had a severe disability (n = 124; 47%), whereas only a few patients showed a moderate disability (n = 18; 7%) or a good recovery (n = 23; 9%) 1 year after discharge. Age, non-traumatic etiology, discharge CRS-R total score and length of stay independently predicted whether the outcome was good or poor at follow-up. Conclusion Age was an important predictor for outcome at one-year follow-up, which might be due to altered brain plasticity and more comorbidities in elderly subjects. In addition, the present study demonstrated that the CRS-R total score at discharge might be more important for the prediction of one-year outcome than the initial assessment upon admission.	[Boltzmann, Melanie; Schmidt, Simone B.; Rollnik, Jens D.] Hannover Med Sch, Associated Inst, BDH Clin Hess Oldendorf, Inst Neurorehabil Res, Hessisch Oldendorf, Germany; [Gutenbrunner, Christoph] Hannover Med Sch, Dept Rehabil Med, Hannover, Germany; [Krauss, Joachim K.] Hannover Med Sch, Dept Neurosurg, Hannover, Germany; [Hoeglinger, Guenter U.] Hannover Med Sch, Dept Neurol, Hannover, Germany		Boltzmann, M (corresponding author), Hannover Med Sch, Associated Inst, BDH Clin Hess Oldendorf, Inst Neurorehabil Res, Hessisch Oldendorf, Germany.	m.boltzmann@bdh-klinik-hessisch-oldendorf.de					Boltzmann M, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02063-5; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2020, NEUROLOGY, V95, pE1488, DOI 10.1212/WNL.0000000000010254; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Hamilton JA, 2020, NEUROPSYCHOL REHABIL, V30, P266, DOI 10.1080/09602011.2018.1461656; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee HY, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01758-5; Lucca LF, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1293-7; MAHONEY F I, 1965, Md State Med J, V14, P61; Maurer-Karattup P., 2010, NEUROL REHABIL, V16, P232; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Pohl M, 2016, NERVENARZT, V87, P634, DOI 10.1007/s00115-016-0093-1; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; Rollnik JD, 2017, NERVENARZT, V88, P652, DOI 10.1007/s00115-017-0332-0; Schmidt SB, 2018, EUR J PHYS REHAB MED, V54, P939, DOI 10.23736/S1973-9087.18.05100-6; Schonle PW., 2000, INT HDB NEUROPSYCHOL, P327, DOI [10.1007/978-1-4757-5569-5_22, DOI 10.1007/978-1-4757-5569-5_22]; Seminog OO, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1778; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	27	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 17	2022	22	1							30	10.1186/s12883-022-02549-w			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI0AQ	WOS:000743520600001	35039012	Green Published, gold			2022-02-06	
J	Leveille, E; Aljassar, M; Beland, B; Saeedi, RJ; Marcoux, J				Leveille, Etienne; Aljassar, Meshal; Beland, Benjamin; Saeedi, Rothaina Jamal; Marcoux, Judith			Determinants of hyponatremia following a traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article; Early Access						Traumatic brain injury; Hyponatremia; Head trauma; Cerebral salt wasting; SIADH	HEAD-INJURY; PREVALENCE; DIAGNOSIS; ETIOLOGY; MODERATE; DISEASE; LEVEL; SIADH; SCORE	Background Hyponatremia is common in patients with central nervous system disease. It may prolong hospitalization and increase morbidity and mortality. However, the incidence and risks factors remain largely unknown in traumatic brain injury (TBI). The objectives of this study are to characterize hyponatremia in TBI patients and find its main risk factors. Methods All patients admitted with a diagnosis of acute TBI over a 1-year period were included, except patients with known chronic hyponatremia, those who died within 72 h, and those receiving hyperosmolar therapy to treat their intracranial hypertension. Sodium levels throughout hospitalization were collected. Post-traumatic hyponatremia was defined as follows: borderline (1-2 points below normal and 1-2 days duration) and significant (more than 2 points below normal and/or more than 2 days duration). Demographic data, GCS, mechanism of injury, and CT findings were collected. These factors were correlated to the incidence of hyponatremia. Results Hyponatremia was found in 29% of the 283 included patients and was significant in 2/3 of the cases. Significant hyponatremia had a narrower peak, between 7 and 11 days, while borderline hyponatremia started earlier and was more distributed in time. Factors associated with hyponatremia were greater age (p = 0.004), worse ISS (p = 0.017), worse Marshall Grade on CT (p = 0.007), and a diffuse pattern of injury on CT (p < 0.001). Significant hyponatremia was associated with: a diffuse pattern of injury on CT (p = 0.032), the presence of intracerebral hemorrhage (p = 0.027), and multiple lesions on CT (p = 0.043). Conclusions Post-traumatic hyponatremia is common and can lead to serious consequences in TBI patients. Adequate monitoring and treatment are therefore important. Older patients and those with more significant injury on CT are more at risk.	[Leveille, Etienne; Marcoux, Judith] McGill Univ, Dept Neurol & Neurosurg, Hlth Ctr, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada; [Aljassar, Meshal] Ibn Sina Hosp, Dept Neurosurg & Neurosci, Sabah Med Reg, Kuwait, Kuwait; [Beland, Benjamin] Univ Calgary, Foothills Med Ctr, Calgary, AB, Canada; [Saeedi, Rothaina Jamal] King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia		Marcoux, J (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Hlth Ctr, 1650 Cedar Ave,Room L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca		Marcoux, Judith/0000-0002-7000-642X			Ackerman GL, 1990, CLIN METHODS HIST PH, V3rd; Afzal A, 2018, TRACE ELEM ELECTROLY, V35, P61, DOI 10.5414/TEX01504; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BETHUNE JE, 1965, NEW ENGL J MED, V272, P771, DOI 10.1056/NEJM196504152721504; CLARK BA, 1994, J AM SOC NEPHROL, V5, P1106; Coenraad Minneke J., 2003, Eur J Intern Med, V14, P302, DOI 10.1016/S0953-6205(03)00100-6; Cuesta M, 2016, ENDOCRINOL NUTR, V63, P230, DOI 10.1016/j.endonu.2015.12.007; Deveduthras N, 2019, S AFR J SURG, V57, P62, DOI 10.17159/2078-5151/2019/v57n2a2823; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Escamilla-Ocanas CE, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104789; Hoffman H, 2018, WORLD NEUROSURG, V110, pE621, DOI 10.1016/j.wneu.2017.11.058; Human T, 2017, NEUROCRIT CARE, V27, P242, DOI 10.1007/s12028-016-0343-x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kopp UC, 2015, AM J PHYSIOL-REG I, V308, pR79, DOI 10.1152/ajpregu.00351.2014; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; Patel S, 2009, SAUDI J KIDNEY DIS T, V20, P560; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Rabinstein AA, 2003, NEUROLOGIST, V9, P290, DOI 10.1097/01.nrl.0000095258.07720.89; Rajagopal R, 2017, WORLD NEUROSURG, V108, P529, DOI 10.1016/j.wneu.2017.09.013; Ridwan S, 2019, WORLD NEUROSURG, V129, pE538, DOI 10.1016/j.wneu.2019.05.210; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Sayama T, 2000, NEUROL RES, V22, P151, DOI 10.1080/01616412.2000.11741052; Shanavas C, 2016, INDIAN J NEUROTRAUM, V13, P94, DOI 10.1055/s-0036-1592186; Shapiro DS, 2010, INTERN MED J, V40, P574, DOI 10.1111/j.1445-5994.2010.02217.x; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Smith M, 2017, AM SURGEON, V83, pE126; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Uozumi Y, 2017, J CLIN NEUROSCI, V46, P118, DOI 10.1016/j.jocn.2017.08.037; Upadhyay A, 2009, SEMIN NEPHROL, V29, P227, DOI 10.1016/j.semnephrol.2009.03.004; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213	36	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.												10.1007/s10072-022-05894-3		JAN 2022	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH2RY	WOS:000743020400001	35037099				2022-02-06	
J	Ling, DSF; Yang, L; Goodman, JH				Ling, Douglas S. F.; Yang, Lie; Goodman, Jeffrey H.			Brivaracetam prevents the development of epileptiform activity when administered early after cortical neurotrauma in rats	EPILEPSIA			English	Article; Early Access						antiepileptogenesis; brivaracetam; early intervention; posttraumatic epilepsy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; POSTTRAUMATIC SEIZURES; GLUTAMATE; HYPEREXCITABILITY; EPILEPTOGENESIS; INHIBITION; NEOCORTEX; EPILEPSY; LIGAND	Objectives There is no effective therapy to prevent the development of posttraumatic epilepsy (PTE). Recently, we reported that administration of the antiseizure medication (ASM) levetiracetam (LEV) shortly after trauma prevented the development of epileptiform activity in two experimental models of neurotrauma. However, the time window for effective intervention with LEV may be too narrow for most clinical settings. Using the controlled cortical impact (CCI) injury model, the current study tested whether early administration of brivaracetam (BRV), an ASM with 20 times the affinity of LEV for the SV2A synaptic vesicle protein, could improve upon the antiepileptogenic action observed with LEV. Methods Rats (postnatal day [P] 24-32) subjected to CCI injury were given a single dose of BRV (21 or 100 mg/kg, i.p.) at one of three post-injury time points: immediately (0-2 minutes), 30 minutes, or 60 minutes. Control animals received only vehicle (0.9% saline). Posttraumatic electrographic epileptiform activity was assayed ex vivo from coronal neocortical slices collected proximal to the injury (four per rat) 3-4 weeks after injury. In this model, ictal-like burst discharges occur spontaneously or can be evoked in an "all or none" manner with applied electrical stimulation within the first 2 weeks after injury. Results A single dose of BRV administered to rats up to 60 minutes after traumatic brain injury (TBI) significantly reduced the development of posttraumatic epileptiform activity by (1) inhibiting the development of both evoked and spontaneous epileptiform activity, (2) raising the threshold for stimulus-evoked epileptiform discharges, and (3) reducing the intensity of epileptiform bursts that arise after cortical neurotrauma. Significance Clinically there has been little success preventing the development of posttraumatic epilepsy. The results of this study support the hypothesis that early intervention with BRV has the potential to prevent or reduce posttraumatic epileptogenesis, and that there may be a limited time window for successful prophylactic intervention.	[Ling, Douglas S. F.; Yang, Lie; Goodman, Jeffrey H.] SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, 450 Clarkson Ave,MSC 29, Brooklyn, NY 11203 USA; [Ling, Douglas S. F.; Goodman, Jeffrey H.] SUNY Downstate Hlth Sci Univ, Robert F Furchgott Ctr Behav & Neural Sci, Brooklyn, NY 11203 USA; [Goodman, Jeffrey H.] SUNY Downstate Hlth Sci Univ, Dept Neurol, Brooklyn, NY 11203 USA; [Goodman, Jeffrey H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA		Ling, DSF (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Physiol & Pharmacol, 450 Clarkson Ave,MSC 29, Brooklyn, NY 11203 USA.	douglas.ling@downstate.edu		Ling, Douglas/0000-0003-2466-164X; Yang, Lie/0000-0003-4329-0282; Goodman, Jeffrey/0000-0001-6001-8040	UCB Biopharma SA	UCB Biopharma SA	AYALA GF, 1973, BRAIN RES, V52, P1, DOI 10.1016/0006-8993(73)90647-1; Brochot A, 2010, BASIC CLIN PHARMACOL, V106, P256, DOI 10.1111/j.1742-7843.2009.00536.x; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dupuis N, 2015, EPILEPSIA, V56, P800, DOI 10.1111/epi.12973; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gillard M, 2011, EUR J PHARMACOL, V664, P36, DOI 10.1016/j.ejphar.2011.04.064; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Kenda BM, 2004, J MED CHEM, V47, P530, DOI 10.1021/jm030913e; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Klein P, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2019.107762; Ling DSF, 1995, J NEUROPHYSIOL, V74, P2329, DOI 10.1152/jn.1995.74.6.2329; Ling DSF., 2019, AES 2019 ANN M DAT A; Loscher W, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.04.011; Matagne A, 2008, BRIT J PHARMACOL, V154, P1662, DOI 10.1038/bjp.2008.198; MATSUMOTO H, 1964, EXP NEUROL, V9, P286, DOI 10.1016/0014-4886(64)90025-1; Meehan AL, 2011, J NEUROPHYSIOL, V106, P1227, DOI 10.1152/jn.00279.2011; Nicolo JP, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102069; Niespodziany I, 2017, EPILEPSIA, V58, pE157, DOI 10.1111/epi.13890; Niquet J, 2017, EPILEPSIA, V58, P1199, DOI 10.1111/epi.13787; Ooba S, 2008, NEUROSCI RES, V62, P195, DOI 10.1016/j.neures.2008.08.005; PARAMESWARAN R, 1979, J MARKETING RES, V16, P291, DOI 10.2307/3150696; PRINCE DA, 1968, EXP NEUROL, V21, P467, DOI 10.1016/0014-4886(68)90066-6; Saletti PG, 2019, NEUROBIOL DIS, V123, P86, DOI 10.1016/j.nbd.2018.06.017; Sanz-Blasco S, 2016, NEUROREPORT, V27, P705, DOI 10.1097/WNR.0000000000000601; Schmidt D, 2014, NEUROTHERAPEUTICS, V11, P401, DOI 10.1007/s13311-013-0252-z; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Sun DA, 2001, STROKE, V32, P2344, DOI 10.1161/hs1001.097242; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Villasana LE, 2019, J NEUROTRAUM, V36, P2454, DOI 10.1089/neu.2018.6162; Wood MD, 2018, EPILEPSIA, V59, pE147, DOI 10.1111/epi.14532; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; Yang L, 2000, EPILEPSIA, V41, P1507; Yang L, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2020.113571; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yang XF, 2007, EPILEPSIA, V48, P1861, DOI 10.1111/j.1528-1167.2006.01132.x; Yang XF, 2009, SEIZURE-EUR J EPILEP, V18, P615, DOI 10.1016/j.seizure.2009.07.004; Zona C, 2010, EPILEPSY RES, V88, P46, DOI 10.1016/j.eplepsyres.2009.09.024	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia												10.1111/epi.17167		JAN 2022	11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH4AC	WOS:000743110000001	35037242				2022-02-06	
J	Sekine, Y; Kamada, K; Koyama, T; Hoshikawa, S; Uchino, S; Komatsu, T				Sekine, Yuta; Kamada, Kotaro; Koyama, Takeshi; Hoshikawa, Seigo; Uchino, Sayuri; Komatsu, Takayuki			Descriptive epidemiology of injuries in Japanese collegiate men's basketball: 2013/2014 to 2019/2020	INJURY EPIDEMIOLOGY			English	Article						Basketball; Collegiate; Injury surveillance	SURVEILLANCE SYSTEM; ASSOCIATION; SPORTS; PREVENTION; PLAYERS; PROGRAM; CONCUSSION; RATES; RISK	Background Basketball is one of the most played sports in the world. However, only a few studies have examined the epidemiology of Japanese collegiate men's basketball injuries. This study investigated the incidence of injury among Japanese collegiate men's basketball from the 2013/2014 to the 2019/2020 seasons and identified unique patterns by comparing our data with the National Collegiate Athletic Association (NCAA) men's basketball data. Methods Data from Japanese collegiate basketball teams of the Kanto Collegiate Basketball Federation Division I League during the 2013/2014 to 2019/2020 academic years (23 team-seasons) were used in this study. Injury rates per 1000 athlete exposures (AEs), injury proportions, and the injury rate ratio (IRR) were calculated according to the events, injury types, body parts, and common injury mechanisms. Injury rates were then compared with that from the time-loss injury data of the NCAA's previous reports. Results In total, 480 injuries during 97,515 AEs were reported, leading to an injury rate of 4.92 per 1000 AEs (95% CI = 4.48-5.36). The overall injury rate was higher in Japan than in the NCAA ([2009/2010-2014/2015] IRR = 1.55, 95% CI = 1.39-1.73; [2014/2015-2018/2019] IRR = 1.64, 95% CI = 1.48-1.82). Lower extremity injuries occurred most frequently (73.5%). Ankle sprain was the most common injury in Japan, with higher injury rates than in the NCAA (IRR = 2.10; 95% CI = 1.72-2.57). The injury rate of concussion was lower in Japan than in the NCAA (IRR = 0.28; 95% CI = 0.14-0.55). Conclusions The rates of overall injury and ankle sprain were higher and that of concussion was lower in Japan than in the NCAA. These results suggested the existence of international differences in the pattern or features of injuries in basketball players.	[Sekine, Yuta] Teikyo Heisei Univ, Fac Modern Life, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan; [Sekine, Yuta] Daito Bunka Univ, Fac Sports & Hlth Sci, 560 Iwadono, Higashimatsuyama, Saitama 3558501, Japan; [Kamada, Kotaro] Waseda Univ, Grad Sch Sport Sci, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan; [Koyama, Takeshi] Tokai Univ, Sports Med Sci Res Inst, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 2591292, Japan; [Hoshikawa, Seigo] Aoyama Gakuin Univ, Sch Social Informat, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan; [Uchino, Sayuri] Juntendo Univ, Fac Med, Dept Orthopaed, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Komatsu, Takayuki] Juntendo Univ, Dept Emergency & Crit Care Med, Nerima Hosp, Nerima Ku, 3-1-10 Takanodai, Tokyo 1778521, Japan; [Sekine, Yuta; Koyama, Takeshi; Hoshikawa, Seigo; Komatsu, Takayuki] Kanto Collegiate Basketball Federat, Dept Med & Sci, Shibuya Ku, 27-2 Sakuragaoka Cho, Tokyo 1500031, Japan		Sekine, Y (corresponding author), Teikyo Heisei Univ, Fac Modern Life, Nakano Ku, 4-21-2 Nakano, Tokyo 1648530, Japan.; Sekine, Y (corresponding author), Daito Bunka Univ, Fac Sports & Hlth Sci, 560 Iwadono, Higashimatsuyama, Saitama 3558501, Japan.; Sekine, Y (corresponding author), Kanto Collegiate Basketball Federat, Dept Med & Sci, Shibuya Ku, 27-2 Sakuragaoka Cho, Tokyo 1500031, Japan.	y.sekine@thu.ac.jp		SEKINE, YUTA/0000-0002-3327-920X	Japan Society for the Promotion of Science, KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP20K19514]	This study was supported by a grant from the Japan Society for the Promotion of Science, KAKENHI (JP20K19514).	Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Ben Abdelkrim N, 2007, BRIT J SPORT MED, V41, P69, DOI 10.1136/bjsm.2006.032318; Chandran A, 2020, J QUANT ANAL SPORTS, V16, P221, DOI 10.1515/jqas-2019-0030; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; Curtis CK, 2008, J ATHL TRAINING, V43, P230, DOI 10.4085/1062-6050-43.3.230; Dick R, 2007, J ATHL TRAINING, V42, P194; Dick R, 2007, J ATHL TRAINING, V42, P173; Heishman AD, 2020, J STRENGTH COND RES, V34, P546, DOI 10.1519/JSC.0000000000002812; Hertel J, 2019, J ATHL TRAINING, V54, P572, DOI 10.4085/1062-6050-344-18; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hosokawa Y, 2021, INJURY EPIDEMIOL, V8, DOI 10.1186/s40621-021-00326-w; Japan Association for University Athletics and Sport, GUID INV SAF; Japan Basketball Association, NUMB REG; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Koyama T, 2020, J STRENGTH COND RES; Kuzuhara K, 2016, J ATHL TRAINING, V51, P1022, DOI 10.4085/1062-6050-51.12.22; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Luig P, 2020, BRIT J SPORT MED, V54, P984, DOI 10.1136/bjsports-2018-100250; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; McInnes S. E., 1995, Journal of Sports Sciences, V13, P387, DOI 10.1080/02640419508732254; McKay GD, 2001, BRIT J SPORT MED, V35, P103, DOI 10.1136/bjsm.35.2.103; Morris SN, 2021, J ATHL TRAINING, V56, P681, DOI 10.4085/1062-6050-436-20; Nilstad A, 2015, J ORTHOP SPORT PHYS, V45, P998, DOI 10.2519/jospt.2015.5612; Omi Y, 2018, AM J SPORT MED, V46, P852, DOI 10.1177/0363546517749474; Riva D, 2016, J STRENGTH COND RES, V30, P461, DOI 10.1519/JSC.0000000000001097; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Tummala SV, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118805400; Zuckerman SL, 2018, BRIT J SPORT MED, V52, P261, DOI 10.1136/bjsports-2016-096005; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	31	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	JAN 17	2022	9	1							4	10.1186/s40621-022-00368-8			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YH9ZM	WOS:000743517600002	35039081	Green Submitted, Green Published, gold			2022-02-06	
J	Shi, YW; Wu, X; Zhou, JP; Cui, WX; Wang, J; Hu, Q; Zhang, SH; Han, LY; Zhou, MX; Luo, JN; Wang, Q; Liu, HX; Feng, DY; Ge, SN; Qu, Y				Shi, Yingwu; Wu, Xun; Zhou, Jinpeng; Cui, Wenxing; Wang, Jin; Hu, Qing; Zhang, Shenghao; Han, Liying; Zhou, Meixuan; Luo, Jianing; Wang, Qiang; Liu, Haixiao; Feng, Dayun; Ge, Shunnan; Qu, Yan			Single-Nucleus RNA Sequencing Reveals that Decorin Expression in the Amygdala Regulates Perineuronal Nets Expression and Fear Conditioning Response after Traumatic Brain Injury	ADVANCED SCIENCE			English	Article; Early Access						amygdala; decorin; fear conditioning; perineuronal nets; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; ANXIETY; GROWTH; MEMORY	Traumatic brain injury (TBI) is a risk factor for posttraumatic stress disorder (PTSD). Augmented fear is a defining characteristic of PTSD, and the amygdala is considered the main brain region to process fear. The mechanism by which the amygdala is involved in fear conditioning after TBI is still unclear. Using single-nucleus RNA sequencing (snRNA-seq), transcriptional changes in cells in the amygdala after TBI are investigated. In total, 72 328 nuclei are obtained from the sham and TBI groups. 7 cell types, and analysis of differentially expressed genes (DEGs) reveals widespread transcriptional changes in each cell type after TBI are identified. In in vivo experiments, it is demonstrated that Decorin (Dcn) expression in the excitatory neurons of the amygdala significantly increased after TBI, and Dcn knockout in the amygdala mitigates TBI-associated fear conditioning. Of note, this effect is caused by a Dcn-mediated decrease in the expression of perineuronal nets (PNNs), which affect the glutamate-gamma-aminobutyric acid balance in the amygdala. Finally, the results suggest that Dcn functions by interacting with collagen VI alpha 3 (Col6a3). Consequently, the findings reveal transcriptional changes in different cell types of the amygdala after TBI and provide direct evidence that Dcn relieves fear conditioning by regulating PNNs.	[Shi, Yingwu; Wu, Xun; Zhou, Jinpeng; Cui, Wenxing; Wang, Jin; Hu, Qing; Zhang, Shenghao; Han, Liying; Wang, Qiang; Liu, Haixiao; Feng, Dayun; Ge, Shunnan; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Shaanxi, Peoples R China; [Zhou, Meixuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China; [Luo, Jianing] West Theater Gen Hosp, Dept Neurosurg, Chengdu 610083, Sichuan, Peoples R China		Ge, SN; Qu, Y (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Shaanxi, Peoples R China.	gesn8561@fmmu.edu.cn; yanqu0123@fmmu.edu.cn			State Key Program of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81630027, 82130038]	Y.S., X.W., and J.Z. contributed equally to this work. The authors thank Prof. Yulin Dong (School of Basic Medicine, FourthMilitaryMedical University) for technical consulting in behavior test. This work received support from grants from the State Key Program of the National Natural Science Foundation of China (Nos. 81630027 and 82130038, to Y.Q.).	Banerjee SB, 2017, NEURON, V95, P169, DOI 10.1016/j.neuron.2017.06.007; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Cui WX, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12964; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Daquinag AC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122646; Feng DY, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101721; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hartley ND, 2019, NAT NEUROSCI, V22, P2000, DOI 10.1038/s41593-019-0528-7; Hirono M, 2018, J NEUROSCI, V38, P6130, DOI 10.1523/JNEUROSCI.3238-17.2018; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Kim B, 2018, P NATL ACAD SCI USA, V115, pE10730, DOI 10.1073/pnas.1811664115; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; Lamande SR, 2018, MATRIX BIOL, V71-72, P348, DOI 10.1016/j.matbio.2017.12.008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Minor K, 2008, NEUROBIOL DIS, V32, P88, DOI 10.1016/j.nbd.2008.06.009; Minor KH, 2011, BRAIN, V134, P1140, DOI 10.1093/brain/awq304; Morikawa S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46024; Murthy S, 2019, BIOL PSYCHIAT, V85, P1011, DOI 10.1016/j.biopsych.2019.02.021; Ohira K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-43; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Reicheft AC, 2019, TRENDS NEUROSCI, V42, P458, DOI 10.1016/j.tins.2019.04.003; Reznikov R, 2016, NEUROPSYCHOPHARMACOL, V41, P2810, DOI 10.1038/npp.2016.34; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Sah P, 2017, NEURON, V96, P1, DOI 10.1016/j.neuron.2017.09.013; Sanchez CM, 2021, J NEUROTRAUM, V38, P555, DOI 10.1089/neu.2020.7267; Shi W, 2019, P NATL ACAD SCI USA, V116, P27063, DOI 10.1073/pnas.1902680116; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stevens SR, 2021, ELIFE, V10, DOI 10.7554/eLife.66491; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Sydnor VJ, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102190; Thompson EH, 2018, P NATL ACAD SCI USA, V115, P607, DOI 10.1073/pnas.1713530115; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; UCHIZONO K, 1965, NATURE, V207, P642, DOI 10.1038/207642a0; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Yang S, 2021, MOL PSYCHIATR, V26, P5658, DOI 10.1038/s41380-021-01208-9; Yang WZ, 2016, NEURON, V92, P1352, DOI 10.1016/j.neuron.2016.11.018; Yu K, 2017, NAT NEUROSCI, V20, P1680, DOI 10.1038/s41593-017-0009-9; Zech M, 2015, AM J HUM GENET, V96, P883, DOI 10.1016/j.ajhg.2015.04.010; Zhang XY, 2020, NEURON, V105, P1077, DOI 10.1016/j.neuron.2019.12.025	54	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2198-3844		ADV SCI	Adv. Sci.											2104112	10.1002/advs.202104112		JAN 2022	14	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	YH5FH	WOS:000743192900001	35038242	gold			2022-02-06	
J	Takamori, S; Hamlin, MJ; King, D; Hume, PA; Tachikawa, K; Koyanagi, R; Yoshida, T				Takamori, Sohei; Hamlin, Michael John; King, Doug; Hume, Patria A.; Tachikawa, Kosuke; Koyanagi, Ryuta; Yoshida, Toru			Profiling the tackle and its injury characteristics in premier New Zealand club rugby union players over a complete season	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						sporting injuries; rugby; preventive medicine; brain concussion; male	PERFORMANCE; PREVENTION; EVENTS; RISK	Objectives RugbySmart is a safe tackle technique education programme. Our objective was to identify whether the RugbySmart-recommended safe tackle technique was exhibited by club rugby players and whether tackle-related injuries showed poor tackle technique characteristics. Methods The prospective cohort design enabled 28 senior club based amateur male rugby union players from New Zealand to be followed over 18 matches in the 2017 rugby season. Game video analysis by three analysts provided categorisation of tackle technique into type, approach, foot contact, leading foot and rear foot position, face and head position. Injuries were diagnosed by the same sports medicine physician. Results In the 18 matches, 28 players completed a combined total of 3006 tackles, with only six tackle-related injuries sustained. Notable findings included: (1) forwards complete more tackles than backs; (2) shoulder tackles were the most prevalent tackle; (3) good tackle technique as promoted by RugbySmart was demonstrated in 57.9% of all tackles and (4) of the six tackle-related injuries, two occurred despite RugbySmart desired tackle techniques. Conclusion This is the first study to investigate whether players were performing the recommended 'safe tackle technique' proposed by New Zealand Rugby's RugbySmart programme. As two of six tackle-related injuries occurred despite the RugbySmart preferred technique being performed, further technique analysis and a larger sample are needed to determine what techniques reduce risk of injury during tackles. As only 57.9% of tackles were performed with RugbySmart head and foot positions, further research and education regarding tackle technique recommendations are needed.	[Takamori, Sohei; Hamlin, Michael John] Lincoln Univ, Fac Environm Soc & Design, Dept Tourism Sport & Soc, Lincoln 7647, Canterbury, New Zealand; [Takamori, Sohei] Yokohama Minami Kyousai Hosp, Sports Med Ctr, Yokohama, Kanagawa, Japan; [Hamlin, Michael John; King, Doug; Hume, Patria A.] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Hume, Patria A.] Auckland Univ Technol, Traumat Brain Injury Network, Auckland, New Zealand; [Tachikawa, Kosuke] Cannon Eagles Rugby Club, Machida, Tokyo, Japan; [Koyanagi, Ryuta] Aichi Gakuin Univ, Div Liberal Arts & Sci, Nisshin, Aichi, Japan; [Yoshida, Toru] NTT Docomo Red Hurricanes Rugby Club, Osaka, Japan		Hamlin, MJ (corresponding author), Lincoln Univ, Fac Environm Soc & Design, Dept Tourism Sport & Soc, Lincoln 7647, Canterbury, New Zealand.	mike.hamlin@lincoln.ac.nz	Hume, Patria/P-1084-2017	Hume, Patria/0000-0003-1847-8128	Lincoln University; New Zealand Rugby; Yokohama Minami Kyousai Hospital Sports Centre	Funding was received from Lincoln University, New Zealand Rugby and the Yokohama Minami Kyousai Hospital Sports Centre.	Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabbett T, 2007, INT J SPORTS SCI COA, V2, P467, DOI [10.1260/174795407783359731, DOI 10.1260/174795407783359731]; Gabbett T, 2009, INT J SPORTS SCI COA, V4, P521, DOI 10.1260/174795409790291402; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hume PA., 2019, NZ J SPORTS MED, V45, P64; King D, 2020, ORGAN ACTIV, P1; Marcelino R, 2011, J SPORT SCI, V29, P733, DOI 10.1080/02640414.2011.552516; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; New Zealand Rugby Union, 2018, TACKL TECHN SEC TACK; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Quarrie KL., 2008, RUGBYSMART DEV DELIV; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; Sobue S., 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-098135, DOI 10.1136/BJSPORTS-2017-098135]; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; van Rooyen M, 2014, EUR J SPORT SCI, V14, P123, DOI 10.1080/17461391.2012.738710; van Rooyen MK, 2012, INT J PERF ANAL SPOR, V12, P517; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	28	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.												10.1136/bjsports-2021-104868		JAN 2022	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YL3RL	WOS:000745811500001	35042680				2022-02-06	
J	Hennessy, M; Sullivan, KA				Hennessy, Maria; Sullivan, Karen A.			Quality of life, community integration, service needs and clinical outcomes of people with traumatic brain injury in urban, regional and remote areas of Queensland, Australia	AUSTRALIAN JOURNAL OF RURAL HEALTH			English	Article; Early Access						community integration; head injury; mental health; quality of life; rehabilitation; traumatic brain injury	FAMILY INTERVENTION IMPACT; NEW-SOUTH-WALES; QUESTIONNAIRE; SCALE; REHABILITATION; INDIVIDUALS; SUPPORTS; VALIDITY; TBI	Objective To understand and explore the traumatic brain injury (TBI) outcomes for people returning to urban versus rural communities post-injury, and if geographical location plays a role in those outcomes. Design Cross-sectional mail-out survey of TBI patients, using standardised, quantitative measures. Setting Data were drawn from three Accessibility Remoteness Index of Australia (ARIA) areas in Queensland to model the contribution of these areas and other factors to TBI outcomes. Participants Using hospital records, 662 people with mild to severe TBI were identified. These people were sent a survey, postdischarge. Usable surveys were returned by 91 individuals, 6- to 18-months post-injury. Location was coded using the ARIA (urban n = 22, rural n = 43, remote n = 26). Main Outcome Measures TBI-related symptoms, quality of life, service obstacles, unmet needs, mental health and community integration. Results No group differences in TBI outcomes due to location were found. While the participant's gender, age, and injury severity were significant independent predictors of five of the six outcomes, location did not play a role. Conclusion Consistent with previous findings, geographical remoteness did not affect self-reported TBI outcomes. Older people, women and those with severe TBI had worse outcomes and required additional supports, and men require community integration assistance. An Australia-wide study with regular follow-ups is strongly recommended to support direct regional comparisons and improve service planning.	[Hennessy, Maria] James Cook Univ Singapore, Sch Psychol, Singapore, Singapore; [Sullivan, Karen A.] Queensland Univ Technol QUT, Sch Psychol & Counselling Queensland, Brisbane, Qld, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, Kelvin Grove Campus, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au					Access Economics , 2009, EC COST SPIN CORD IN; Acosta JD., 2014, RAND ONLINE MEASURE; Anderson S., 2004, J COGNITIVE REHABILI, V22, P6; Australian Bureau of Statistics, 2018, 2071 0 CENS POP HOUS; Australian Government DoH , 2019, 2 3 ACC REM IND AUST; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Curtin M, 2011, BRAIN INJURY, V25, P266, DOI 10.3109/02699052.2010.542793; Dijkers M., 2000, COMMUNITY INTEGRATIO; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Helps Y., 2008, HOSP SEPARATIONS DUE; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lehmkuhl D ., 1988, I REHABILITATION RES; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Murphy J., 2004, TOPICS EMERG MED, V26, P231; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schootman M, 1999, BRAIN INJURY, V13, P995; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; van der Krieke L, 2011, PSYCHIAT RES, V188, P456, DOI 10.1016/j.psychres.2011.05.013; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Yue JK, 2020, J NEUROSCI RURAL PRA, V11, P23, DOI 10.1055/s-0039-3402581	44	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-5282	1440-1584		AUST J RURAL HEALTH	Aust. J. Rural Health												10.1111/ajr.12823		JAN 2022	11	Public, Environmental & Occupational Health; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing	YH0JU	WOS:000742863900001	35034392				2022-02-06	
J	Chen, C; Hu, N; Wang, J; Xu, L; Jia, XL; Fan, X; Shi, JX; Chen, F; Tu, Y; Wang, YW; Li, XH				Chen, Chong; Hu, Nan; Wang, Jing; Xu, Lin; Jia, Xiao-Li; Fan, Xiu; Shi, Jian-Xin; Chen, Feng; Tu, Yue; Wang, You-Wei; Li, Xiao-Hong			Umbilical cord mesenchymal stem cells promote neurological repair after traumatic brain injury through regulating Treg/Th17 balance	BRAIN RESEARCH			English	Article						Trans-differentiation; Umbilical cord mesenchymal stem cells; Th17 cells; Treg cells; Traumatic brain injury	GROWTH-FACTOR-BETA; SIGNALING PATHWAY; MILD HYPOTHERMIA; DENTATE GYRUS; NEUROGENESIS; DIFFERENTIATION; INFLAMMATION; ACTIVATION; TH17/TREG; SURVIVAL	Traumatic brain injury (TBI) is a brain injury resulting from blunt mechanical external forces, which is a crucial public health and socioeconomic problem worldwide. TBI is one of the leading causes of death or disability. The primary injury of TBI is generally irreversible. Secondary injury caused by neuroinflammation could result in exacerbation of patients, which indicated that anti-inflammation and immunomodulatory were necessary for the treatment of TBI. Accumulated evidence reveals that the transplantation of umbilical cord mesenchymal stem cells (UCMSCs) could regulate the microenvironment in vivo and keep a balance of helper T 17(Th17)/ regulatory T cell (Treg). Therefore, it is reasonable to hypothesize that the UCMSCs could repair neurological impairment by maintaining the balance of Th17/Treg after TBI. In the study, we observed the phenomenon of transdifferentiation of T lymphocytes into Th17 cells after TBI. Rats were divided into Sham, TBI, and TBI + UCMSCs groups to explore the effects of the UCMSCs. The results manifested that trans-differentiation of Th17 into Treg was facilitated by UCMSCs, which was followed by promotion of neurological recovery and improvement of learning and memory in TBI rats. Furthermore, UCMSCs decreased the phosphorylation of nuclear factor-kappa B (NF-kappa B) and increased the expression of mothers against decapentaplegic homolog 3 (Smad3) in vivo and vitro experiments. In conclusion, UCMSCs maintained Th17/Treg balance via the transforming growth factor-I3 (TGF-I3)/ Smad3/ NF-kappa B signaling pathway.	[Chen, Chong; Hu, Nan; Jia, Xiao-Li; Fan, Xiu; Shi, Jian-Xin; Wang, You-Wei; Li, Xiao-Hong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China; [Chen, Chong; Hu, Nan; Jia, Xiao-Li; Fan, Xiu; Shi, Jian-Xin; Wang, You-Wei; Li, Xiao-Hong] Tianjin Univ, Tianjin Key Lab Brain Sci & Neural Engn, Tianjin 300072, Peoples R China; [Chen, Chong; Wang, Jing; Chen, Feng; Tu, Yue] Pingjin Hosp, Characterist Med Ctr PAPF, Tianjin Key Lab Neurotrauma Repair, Brain Ctr, Tianjin 300162, Peoples R China; [Xu, Lin] Hubei Gen Hosp Armed Police Force, Med Psychol Sect, Wuhan 430071, Peoples R China; [Wang, Jing] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan 030032, Peoples R China		Wang, YW; Li, XH (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China.	Youwei.wang@tju.edu.cn; xhli18@tju.edu.cn			National Nature Scientific Fund of China [81771352, 81971782, 81771350, 81772018]; Nature Scientific Fund of Tianjin [18JCJQJC48500, 19JCYBJC27900]	This work was supported by the National Nature Scientific Fund of China (81771352, 81971782, 81771350, 81772018) and the Nature Scientific Fund of Tianjin (18JCJQJC48500, 19JCYBJC27900).	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Cawley M J, 1998, J Neurosci Nurs, V30, P369; Chang DH, 2020, IMMUNITY, V53, P614, DOI 10.1016/j.immuni.2020.07.012; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi MC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070734; Chung C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37033; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Cui C, 2021, INT J MOL MED, V48, DOI 10.3892/ijmm.2021.4968; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hendrix S, 2007, J NEUROIMMUNOL, V184, P100, DOI 10.1016/j.jneuroim.2006.11.019; Higaki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191708; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.348; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Li SN, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1552-y; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Liu XY, 2020, J NEUROCHEM, V153, P230, DOI 10.1111/jnc.14859; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Nunez Joseph, 2008, J Vis Exp, DOI 10.3791/897; Obermajer N, 2014, J IMMUNOL, V193, P4988, DOI 10.4049/jimmunol.1401776; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Ran QS, 2015, NEURAL REGEN RES, V10, P1258, DOI 10.4103/1673-5374.162758; Roberts I, 1800, Cochrane Database Syst Rev, pCD001527; Sansone V, 2018, MED HYPOTHESES, V111, P4, DOI 10.1016/j.mehy.2017.12.013; Sart S, 2014, TISSUE ENG PT A, V20, P2666, DOI [10.1089/ten.TEA.2013.0437, 10.1089/ten.tea.2013.0437]; Shen Y, 2011, SCAND J IMMUNOL, V74, P176, DOI 10.1111/j.1365-3083.2011.02546.x; Shinozaki Y, 2019, J NEUROCHEM, V151, P64, DOI 10.1111/jnc.14817; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; TEASDALE G, 1974, LANCET, V2, P81; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Vitha S, 2011, METHODS MOL BIOL, V774, P33, DOI 10.1007/978-1-61779-234-2_3; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wang SS, 2018, J ALZHEIMERS DIS, V61, P1005, DOI 10.3233/JAD-170848; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Weng JY, 2012, MOL THER, V20, P2347, DOI 10.1038/mt.2012.208; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yang Jin-na, 2013, Chinese Pharmacological Bulletin, V29, P1045, DOI 10.3969/j.issn.1001-1978.2013.08.003; Zhang L, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117405	65	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2022	1775								147711	10.1016/j.brainres.2021.147711			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN3LA	WOS:000729408600004	34793756				2022-02-06	
J	Liu, H; Wei, ZS; Sun, XC; Wang, ZG				Liu, Han; Wei, Zhaosheng; Sun, Xiaochuan; Wang, Zhigang			MALAT1 improves functional recovery after traumatic brain injury through promoting angiogenesis in experimental mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Metastasis associated lung adenocarcinoma; transcript 1; Angiogenesis; Ang1 (Angiopoietin-1)	LONG NONCODING RNAS; ENDOTHELIAL GROWTH-FACTOR; NEUROGENESIS; ANGIOPOIETIN-1; ACTIVATION; PROTECTION; ISCHEMIA; PEPTIDE; PROTEIN	As a highly evolutionary conserved lncRNA, MALAT1 was first demonstrated to associate with metastasis of lung tumor by promoting angiogenesis. Activated vasculature was recently indicated to assist neurogenesis by secreting neurotrophic factor Ang1 (Angiopoietin-1). The purpose of this study is to investigate the potential role of MALAT1 in angiogenesis following traumatic brain injury (TBI). Adult male mice were subjected to controlled cortical impact (CCI) and brain microvascular endothelial cells were exposed to oxygen-glucose deprivation (OGD). MALAT1 RNA levels were quantified by qRT-PCR in different cells of CNS and located by RNA-FISH. Angiogenesis were measured by cell viability, migration assay, tube formation assay in vitro, and immunohistochemistry in vivo. Expression of Angiopoietin-1 was assessed by Western blot. Neurological functions were performed by NSS, Wire grip and MWM tests. Our results indicated that 1) MALAT1 RNA was localized in cerebral endothelium, enhanced by OGD stimuli. 2) Inhibition of MALAT1 by siRNA suppressed angiogenesis, as indicated by endothelial viability, tube formation, migration, and functional vessel density. 3) MALAT1 inhibition further decreased Ang1 expression in the endothelium. 4) Mice with MALAT1 inhibition exhibited worse behavioral performances (NSS, wire grip, Morris water maze), as compared to control. MALAT1 could promote angiogenesis, subsequently contributing to the Ang1 synthesis from active vasculature. It may eventually benefit to functional recovery following TBI.	[Liu, Han; Wei, Zhaosheng; Wang, Zhigang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Qingdao Campus, Qingdao, Shandong, Peoples R China; [Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China		Wang, ZG (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, Qingdao Campus, Qingdao, Shandong, Peoples R China.	wangzhigang201@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072, 81701226]; National Construction Project for Clinical Key Specialty [(2011)170]	This work was supported by the National Natural Science Foundation of China (No. 81571159), National Natural Science Foundation for Youth of China (No. 81601072 and No. 81701226), and National Construction Project for Clinical Key Specialty (No. (2011)170). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology and Experimental Research Center, the First Affiliated Hospital of Chongqing Medical University.	Aprea J, 2015, EMBO J, V34, P2865, DOI 10.15252/embj.201592655; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bhat SA, 2016, MOL NEUROBIOL, V53, P6950, DOI 10.1007/s12035-015-9584-5; Boon RA, 2016, J AM COLL CARDIOL, V68, P2589, DOI 10.1016/j.jacc.2016.09.949; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Fiedler J, 2015, J AM COLL CARDIOL, V66, P2005, DOI 10.1016/j.jacc.2015.07.081; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jae N, 2015, CIRC RES, V116, P1104, DOI 10.1161/CIRCRESAHA.115.306051; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Kim DH, 2015, BIOMATERIALS, V61, P115, DOI 10.1016/j.biomaterials.2015.05.025; Meng Z, 2014, NEUROSCIENCE, V267, P135, DOI 10.1016/j.neuroscience.2014.02.036; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; O'Donnell LA, 2015, J NEUROCHEM, V135, P309, DOI 10.1111/jnc.13250; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rosa AI, 2010, J NEUROSCI, V30, P4573, DOI 10.1523/JNEUROSCI.5597-09.2010; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sawada M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00053; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Tee AE, 2016, ONCOTARGET, V7, P8663, DOI 10.18632/oncotarget.6675; Thum T, 2014, CIRC RES, V114, P1366, DOI 10.1161/CIRCRESAHA.114.303896; Wang CP, 2017, MOL NEUROBIOL, V54, P2126, DOI 10.1007/s12035-016-9806-5; Wang D, 2013, CELL MOL LIFE SCI, V70, P2919, DOI 10.1007/s00018-012-1201-4; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yin KJ, 2013, BRAIN, V136, P1274, DOI 10.1093/brain/awt002; Zhang Q, 2016, MOL NEUROBIOL, V53, P662, DOI 10.1007/s12035-014-9035-8; Zhang XJ, 2017, J NEUROSCI, V37, P1797, DOI 10.1523/JNEUROSCI.3389-16.2017; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e	41	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2022	1775								147731	10.1016/j.brainres.2021.147731			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN3LA	WOS:000729408600003	34808123				2022-02-06	
J	Sundaresh, SN; Finan, JD; Elkin, BS; Basilio, AV; McKhann, GM; Morrison, B				Sundaresh, Sowmya N.; Finan, John D.; Elkin, Benjamin S.; Basilio, Andrew, V; McKhann, Guy M.; Morrison, Barclay, III			Region-Dependent Viscoelastic Properties of Human Brain Tissue Under Large Deformations	ANNALS OF BIOMEDICAL ENGINEERING			English	Article; Early Access						Biomechanics; Indentation; Quasilinear theory of viscoelasticity; Constitutive model	WHITE-MATTER INJURY; STATES HIGH-SCHOOL; SEX-DIFFERENCES; MECHANICAL-PROPERTIES; GRAY-MATTER; BEHAVIOR; STRAIN; CONCUSSIONS; EXTRACTION	This study characterizes the mechanical properties of human brain tissue resected during the course of surgery under multistep indentation loading up to 30% strain. The experimental characterization using fresh, post-operative, human brain tissue is highly advantageous since postmortem times can affect its biomechanical behavior. Although the quasilinear theory of viscoelasticity (QLV) approach has been widely used to model brain tissue mechanical properties, our analysis concluded that the linear viscoelastic approach provided a better fit to the experimental data overall. The only statistically significant regional difference in observed stiffness was between the cortex gray and dentate gyrus. There were no statistically significant age or sex dependent differences, although the data suggested that the cortex white matter in males was stiffer than that in females. Our results can help improve the accuracy of finite element models of brain tissue deformation to predict its response to traumatic brain injury.	[Sundaresh, Sowmya N.; Finan, John D.; Elkin, Benjamin S.; Basilio, Andrew, V; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA; [McKhann, Guy M.] Columbia Univ, New York Presbyterian Hosp, Dept Neurol Surg, Med Ctr, 710 West 168th St, New York, NY 10032 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1G20RR030893-01]; New York State Empire State Development, Division of Science Technology and Innovation (NYSTAR) [C090171]; National Highway Traffic Safety Administration (NHTSA) [DTNH22-08C-00088]; Paul Allen Family Foundation; Honda Motor Co., Ltd.	The authors thank Dr. A.A. Sosunov at the Columbia University Medical Center and the patients for providing the human brain tissue samples. The authors acknowledge the computing resources from Columbia University's Shared Research Computing Facility project, which is supported by NIH Research Facility Improvement Grant 1G20RR030893-01, and associated funds from the New York State Empire State Development, Division of Science Technology and Innovation (NYSTAR) Contract C090171, both awarded on April 15, 2010. This study was supported in part by the National Highway Traffic Safety Administration (NHTSA) (Project No. DTNH22-08C-00088), a grant from the Paul Allen Family Foundation, and funding from Honda Motor Co., Ltd.	Abba MT, 2020, MECH TIME-DEPEND MAT, DOI 10.1007/s11043-020-09472-y; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Bayly PV, 2014, J MECH BEHAV BIOMED, V29, P568, DOI 10.1016/j.jmbbm.2013.02.018; Bentil SA, 2014, J MECH BEHAV BIOMED, V30, P83, DOI 10.1016/j.jmbbm.2013.10.020; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Donohue BR, 2012, ACTA MATER, V60, P3943, DOI 10.1016/j.actamat.2012.03.034; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Garo A, 2007, BIORHEOLOGY, V44, P51; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Gur RC, 1999, J NEUROSCI, V19, P4065; Gur RC, 2017, J NEUROSCI RES, V95, P189, DOI 10.1002/jnr.23830; HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16, DOI 10.1017/S0305004100022325; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kalidindi SR, 2008, ACTA MATER, V56, P3523, DOI 10.1016/j.actamat.2008.03.036; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; MacManus DB, 2018, J MECH BEHAV BIOMED, V87, P256, DOI 10.1016/j.jmbbm.2018.07.025; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Macmanus DB., 2020, BRAIN MULTIPHYS, V1, P100018, DOI [10.1016/j.brain.2020.100018, DOI 10.1016/J.BRAIN.2020.100018]; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Pathak S, 2008, J EUR CERAM SOC, V28, P2213, DOI 10.1016/j.jeurceramsoc.2008.02.009; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001	44	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.												10.1007/s10439-022-02910-7		JAN 2022	9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	YG9QA	WOS:000742812400002	35034227				2022-02-06	
J	Yuan, T; He, HY; Liu, YP; Wang, JW; Kang, X; Fu, GH; Xie, FF; Li, AM; Chen, J; Wang, WX				Yuan, Tao; He, Hongyu; Liu, Yuepeng; Wang, Jianwei; Kang, Xin; Fu, Guanghui; Xie, Fangfang; Li, Aimin; Chen, Jun; Wang, Wenxue			Association between blood glucose levels and Glasgow Outcome Score in patients with traumatic brain injury: secondary analysis of a randomized trial	TRIALS			English	Article						Traumatic brain injury; Glasgow Outcome Score; Blood glucose; Hyperglycemia; Insulin therapy	GLYCEMIC CONTROL; HYPERGLYCEMIA; IMPACT; METABOLISM; BENEFITS; THERAPY	Background: Blood glucose levels that are too high or too low after traumatic brain injury (TBI) negatively affect patient prognosis. This study aimed to demonstrate the relationship between blood glucose levels and the Glasgow Outcome Score (GOS) in TBI patients. Methods: This study was based on a randomized, dual-center, open-label clinical trial. A total of 208 patients who participated in the randomized controlled trial were followed up for 5 years. Information on the disease, laboratory examination, insulin therapy, and surgery for patients with TBI was collected as candidate variables according to clinical importance. Additionally, data on 5-year and 6-month GOS were collected as primary and secondary outcomes, respectively. For multivariate analysis, a generalized additive model (GAM) was used to investigate relationships between blood glucose levels and GOS. The results are presented as odds ratios (ORs) with 95% confidence intervals (95% CIs). We further applied a two- piecewise linear regression model to examine the threshold effect of blood glucose level and GOS. Results: A total of 182 patients were included in the final analysis. Multivariate GAM analysis revealed that a bell-shaped relationship existed between average blood glucose level and 5-year GOS score or 6-month GOS score. The inflection points of the average blood glucose level were 8.81 (95% CI: 7.43-9.48) mmol/L considering 5-year GOS as the outcome and were 8.88 (95% CI 7.43-9.74) mmol/L considering 6-month GOS score as the outcome. The same analysis revealed that there was also a bell relationship between average blood glucose levels and the favorable outcome group (GOS score >= 4) at 5 years or 6 months. Conclusion: In a population of patients with traumatic brain injury, blood glucose levels were associated with the GOS. There was also a threshold effect between blood glucose levels and the GOS. A blood glucose level that is either too high or too low conveys a poor prognosis.	[Yuan, Tao; He, Hongyu; Wang, Jianwei; Kang, Xin; Fu, Guanghui; Xie, Fangfang; Wang, Wenxue] Xuzhou Med Univ, Dept Neurosurg, Affiliated Lianyungang Oriental Hosp, Lianyungang 222042, Jiangsu, Peoples R China; [Liu, Yuepeng] Xuzhou Med Univ, Ctr Clin Res & Translat Med, Affiliated Lianyungang Oriental Hosp, Lianyungang 222042, Jiangsu, Peoples R China; [Li, Aimin; Chen, Jun] Lianyungang 1 Peoples Hosp, Dept Neurosurg, Lianyungang 222042, Jiangsu, Peoples R China		Wang, WX (corresponding author), Xuzhou Med Univ, Dept Neurosurg, Affiliated Lianyungang Oriental Hosp, Lianyungang 222042, Jiangsu, Peoples R China.	760020210075@xzhmu.edu.cn		Wang, Wen-xue/0000-0002-9865-6811	GENERAL PROJECTS for the Department of Public Health of Jiangsu Province, China [H201462]	This study was supported by a grant (H201462) from GENERAL PROJECTS for the Department of Public Health of Jiangsu Province, China.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Baker L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67864-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; de Azevedo JRA, 2007, ARQ NEURO-PSIQUIAT, V65, P733, DOI 10.1590/S0004-282X2007000500001; De Block CEM, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0214-9; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Graffagnino C, 2010, NEUROCRIT CARE, V13, P307, DOI 10.1007/s12028-010-9469-4; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Matovu P, 2021, PEERJ, V9, DOI 10.7717/peerj.10589; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pakhetra R, 2011, Med J Armed Forces India, V67, P53, DOI 10.1016/S0377-1237(11)80015-8; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P93, DOI 10.17116/neiro201680293-101; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; [王文学 Wang Wenxue], 2018, [中华神经医学杂志, Chinese Journal of Neuromedicine], V17, P240; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; Yu XD, 2013, ENVIRON RES, V121, P79, DOI 10.1016/j.envres.2012.11.002; Yu XC, 2018, ENVIRON INT, V118, P116, DOI 10.1016/j.envint.2018.05.042; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhu CR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011671	23	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JAN 15	2022	23	1							38	10.1186/s13063-022-06005-5			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	YH1DT	WOS:000742915900002	35033158	gold, Green Published			2022-02-06	
J	Harper, KL; Moshier, S; Ellickson-Larew, S; Andersen, MS; Wisco, BE; Mahoney, CT; Keane, TM; Marx, BP				Harper, Kelly L.; Moshier, Samantha; Ellickson-Larew, Stephanie; Andersen, Martin S.; Wisco, Blair E.; Mahoney, Colin T.; Keane, Terence M.; Marx, Brian P.			A prospective examination of health care costs associated with posttraumatic stress disorder diagnostic status and symptom severity among veterans	JOURNAL OF TRAUMATIC STRESS			English	Article; Early Access							TRAUMATIC BRAIN-INJURY; FUNCTIONAL IMPAIRMENT; SERVICE UTILIZATION; SUICIDAL IDEATION; PHYSICAL HEALTH; PTSD SYMPTOMS; AFGHANISTAN; IRAQ; PREVALENCE; BURDEN	Posttraumatic stress disorder (PTSD) is associated with increased health care costs; however, most studies exploring this association use PTSD diagnostic data in administrative records, which can contain inaccurate diagnostic information and be confounded by the quantity of service use. We used a diagnostic interview to determine PTSD diagnostic status and examined associations between PTSD symptom severity and health care costs and utilization, extracted from Veteran Health Administration (VHA) administrative databases. Using a nationwide longitudinal sample of U.S. veterans with and without PTSD (N = 1,377) enrolled in VHA health care, we determined the costs and utilization of mental health and non-mental health outpatient, pharmacy, and inpatient services for 1 year following cohort enrollment. Relative to veterans without PTSD, those with PTSD had higher total health care, B = 0.47; mental health clinic care, B = 0.72; non-mental health clinic care, B = 0.30; and pharmacy costs, B = 0.72, ps < .001. More severe PTSD symptoms were associated with mental health clinic care costs, B = 0.12; non-mental health clinic care costs, B = 0.27; and higher odds of inpatient, B = 0.63, and emergency service use, B = 0.39, p < .001-p = .012. These findings indicate that veterans' PTSD status, determined by a clinician-administered semistructured diagnostic interview, was associated with higher health care costs and increased use of mental health and non-mental health clinic services. The findings also suggest that more severe PTSD is associated with increased costs and utilization, including costly emergency and inpatient utilization.	[Harper, Kelly L.; Ellickson-Larew, Stephanie; Keane, Terence M.; Marx, Brian P.] VA Boston Hlth Care Syst, Natl Ctr PTSD, Boston, MA USA; [Moshier, Samantha] Emmanuel Coll, Dept Psychol, Boston, MA USA; [Ellickson-Larew, Stephanie; Keane, Terence M.; Marx, Brian P.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Andersen, Martin S.] Univ N Carolina, Dept Econ, Greensboro, NC USA; [Wisco, Blair E.] Univ N Carolina, Dept Psychol, Greensboro, NC USA; [Mahoney, Colin T.] Western New England Univ, Dept Psychol, Springfield, MA USA		Harper, KL (corresponding author), Vet Affairs Boston Hlth Care Syst, Behav Sci Div, Natl Ctr PTSD, 150 S Huntington Ave, Boston, MA 02130 USA.	kelly.harper@va.gov			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0102, W81XWH-08-2-0100]; Department ofVeterans AffairsUS Department of Veterans Affairs; Government	The studywas funded by theU.S. Department of Defense (W81XWH-08-2-0102, W81XWH-08-2-0100). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of theU.S. Department ofVeterans Affairs or theU.S. Government. The authors report no conflicts of interest.	ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bergman HE, 2017, MIL PSYCHOL, V29, P117, DOI 10.1037/mil0000154; Bhatnagar V, 2015, J REHABIL RES DEV, V52, P827, DOI 10.1682/JRRD.2014.11.0288; Blais RK, 2014, J TRAUMA STRESS, V27, P168, DOI 10.1002/jts.21898; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Blonigen DM, 2017, PSYCHIAT QUART, V88, P721, DOI 10.1007/s11126-017-9490-2; Bourassa KJ, 2021, J TRAUMA STRESS, V34, P384, DOI 10.1002/jts.22637; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Calhoun PS, 2002, AM J PSYCHIAT, V159, P2081, DOI 10.1176/appi.ajp.159.12.2081; Chan D, 2009, PSYCHIAT SERV, V60, P1612, DOI 10.1176/ps.2009.60.12.1612; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Doran KM, 2013, ANN EMERG MED, V62, P151, DOI 10.1016/j.annemergmed.2013.02.016; First M., 2015, STRUCTURED CLIN INTE; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gillock KL, 2005, GEN HOSP PSYCHIAT, V27, P392, DOI 10.1016/j.genhosppsych.2005.06.004; Greysen SR, 2017, J AM GERIATR SOC, V65, P1996, DOI 10.1111/jgs.14955; Harpaz-Rotem I, 2016, BJPSYCH OPEN, V2, P286, DOI 10.1192/bjpo.bp.115.002451; Holowka DW, 2014, J CONSULT CLIN PSYCH, V82, P569, DOI 10.1037/a0036347; Ivanova JI, 2011, AM J MANAG CARE, V17, pE314; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kaier E., 2014, TRAUMATOLOGY, V20, P142, DOI [10.1037/h0099399, DOI 10.1037/H0099399]; Kartha A, 2008, MED CARE, V46, P388, DOI 10.1097/MLR.0b013e31815dc5d2; Keane TM, 2014, PSYCHOL ASSESSMENT, V26, P1138, DOI 10.1037/a0037133; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; Kendall-Tackett K, 2009, PSYCHOL TRAUMA-US, V1, P35, DOI 10.1037/a0015128; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lamoureux-Lamarche C, 2016, INT PSYCHOGERIATR, V28, P903, DOI 10.1017/S1041610215001775; Lee DJ, 2018, DEPRESS ANXIETY, V35, P609, DOI 10.1002/da.22736; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Morgan MA, 2019, GEN HOSP PSYCHIAT, V58, P33, DOI 10.1016/j.genhosppsych.2019.02.006; National Center for Veterans Analysis and Statistics, 2020, VA UT PROF FY 2017; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Panagioti M, 2012, COMPR PSYCHIAT, V53, P915, DOI 10.1016/j.comppsych.2012.02.009; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Powell MA, 2015, J TRAUMA STRESS, V28, P322, DOI 10.1002/jts.22027; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROSENHECK R, 1992, HOSP COMMUNITY PSYCH, V43, P145; Schnurr, 2013, PTSD CHECKLIST DSM 5; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; Sripada RK, 2014, GEN HOSP PSYCHIAT, V36, P589, DOI 10.1016/j.genhosppsych.2014.09.007; Stanley IH, 2021, J PSYCHIATR RES, V133, P60, DOI 10.1016/j.jpsychires.2020.12.001; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vujanovic AA, 2017, J NERV MENT DIS, V205, P531, DOI 10.1097/NMD.0000000000000690; Walker EA, 2003, ARCH GEN PSYCHIAT, V60, P369, DOI 10.1001/archpsyc.60.4.369; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900	49	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress												10.1002/jts.22785		JAN 2022	11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	YG3RZ	WOS:000742411100001	35030271				2022-02-06	
J	Iverson, GL; Berkner, PD; Zafonte, R; Maxwell, B; Terry, DP				Iverson, Grant L.; Berkner, Paul D.; Zafonte, Ross; Maxwell, Bruce; Terry, Douglas P.			Preseason Symptom Reporting and Cognition in Middle School Athletes with Past Concussions	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						concussion; cognition; sports; symptom reporting	NEUROPSYCHOLOGICAL PERFORMANCE; FOOTBALL PLAYERS; HISTORY; PREVALENCE; PREDICTORS; SCORES	This study examined the association between past concussions and current preseason symptom reporting and cognitive performance in 9,257 youth ages 11-13. Participants completed neurocognitive testing prior to participating in a school sports between 2009 and 2019. We stratified the sample by gender and number of prior concussions and assessed group differences on the Post-Concussion Symptom Scale total score and the ImPACT cognitive composite scores. Those with >= 2 prior concussions reported more symptoms than those with 0 concussions (d=0.43-0.46). Multiple regressions examining the contribution of concussion history and developmental/health history to symptom reporting showed the most significant predictors of symptoms scores were (in descending order): treatment for a psychiatric condition, treatment for headaches, history of learning disability (in boys only), history of attention-deficit/hyperactivity disorder, and age. Concussion history was the weakest statistically significant predictor in boys and not significant in girls. Cognitively, boys with 1 prior concussion had worse speed those with 0 concussions (d=0.11), and girls with >= 2 prior concussions had worse verbal/visual memory than girls with 0 concussions (ds=0.38-0.39). In summary, youth with >= 2 prior concussions reported more symptoms than those with no concussions. Boys with multiple concussions performed similarly on cognitive testing, while girls had worse memory scores.	[Iverson, Grant L.; Zafonte, Ross; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.; Zafonte, Ross] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp, Children Sports Concuss Program, Boston, MA USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Biddeford, ME USA; [Zafonte, Ross] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.	giverson@mgh.harvard.edu			Goldfarb Center for Public Policy and Civic Engagement at Colby College; Bill and Joan Alfond Foundation	This work was funded in part by the Goldfarb Center for Public Policy and Civic Engagement at Colby College, and the Bill and Joan Alfond Foundation (PI: Berkner). Dr. Grant Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Boston Bolts, ImPACT Applications, Inc., National Rugby League, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cohen J., 2013, STAT POWER ANAL BEHA; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner AJ, 2020, BRAIN INJURY, V34, P224, DOI 10.1080/02699052.2019.1683894; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Karr JE, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1850867; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Maietta JE, 2021, J INT NEUROPSYCH SOC, V27, P461, DOI 10.1017/S1355617720001149; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Moser RS, 2017, DEV NEUROPSYCHOL, V42, P276, DOI 10.1080/87565641.2017.1334785; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044	33	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.												10.1055/a-1538-0075		JAN 2022	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	YG4BE	WOS:000742435500001	35030638				2022-02-06	
J	Kamal, SR; Potukutchi, S; Gelovani, DJ; Bonomi, RE; Kallakuri, S; Cavanaugh, JM; Mangner, T; Conti, A; Liu, RS; Pasqualini, R; Arap, W; Sidman, RL; Perrine, SA; Gelovani, JG				Kamal, Swatabdi R.; Potukutchi, Shreya; Gelovani, David J.; Bonomi, Robin E.; Kallakuri, Srinivasu; Cavanaugh, John M.; Mangner, Thomas; Conti, Alana; Liu, Ren-Shyan; Pasqualini, Renata; Arap, Wadih; Sidman, Richard L.; Perrine, Shane A.; Gelovani, Juri G.			Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats	MOLECULAR PSYCHIATRY			English	Article; Early Access							HISTONE DEACETYLASE INHIBITORS; AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; NUCLEAR EXPORT; SYNAPTIC PLASTICITY; MICROGLIA ACTIVATION; GRAPHICAL ANALYSIS; CORPUS-CALLOSUM; CELLULAR EDEMA; NEW-MODEL	The fundamental role of epigenetic regulatory mechanisms involved in neuroplasticity and adaptive responses to traumatic brain injury (TBI) is gaining increased recognition. TBI-induced neurodegeneration is associated with several changes in the expression-activity of various epigenetic regulatory enzymes, including histone deacetylases (HDACs). In this study, PET/CT with 6-([F-18]trifluoroacetamido)-1- hexanoicanilide ([F-18]TFAHA) to image spatial and temporal dynamics of HDACs class IIa expression-activity in brains of adult rats subjected to a weight drop model of diffuse, non-penetrating, mild traumatic brain injury (mTBI). The mTBI model was validated by histopathological and immunohistochemical analyses of brain tissue sections for localization and magnitude of expression of heat-shock protein-70 kDa (HSP70), amyloid precursor protein (APP), cannabinoid receptor-2 (CB2), ionized calcium-binding adapter protein-1 (IBA1), histone deacetylase-4 and -5 (HDAC4 and HDAC5). In comparison to baseline, the expression-activities of HDAC4 and HDAC5 were downregulated in the hippocampus, nucleus accumbens, peri-3rd ventricular part of the thalamus, and substantia nigra at 1-3 days post mTBI, and remained low at 7-8 days post mTBI. Reduced levels of HDAC4 and HDAC5 expression observed in neurons of these brain regions post mTBI were associated with the reduced nuclear and neuropil levels of HDAC4 and HDAC5 with the shift to perinuclear localization of these enzymes. These results support the rationale for the development of therapeutic strategies to upregulate expression-activity of HDACs class IIa post-TBI. PET/CT (MRI) with [F-18]TFAHA can facilitate the development and clinical translation of unique therapeutic approaches to upregulate the expression and activity of HDACs class IIa enzymes in the brain after TBI.	[Kamal, Swatabdi R.; Potukutchi, Shreya; Cavanaugh, John M.; Gelovani, Juri G.] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI 48201 USA; [Kamal, Swatabdi R.; Potukutchi, Shreya; Gelovani, David J.; Bonomi, Robin E.; Cavanaugh, John M.; Gelovani, Juri G.] Wayne State Univ, Sch Med, Detroit, MI 48201 USA; [Kallakuri, Srinivasu; Conti, Alana; Perrine, Shane A.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Mangner, Thomas] Wayne State Univ, Karmanos Canc Inst, Cyclotron Radiochem Facil, Detroit, MI 48201 USA; [Mangner, Thomas; Pasqualini, Renata] Rutgers New Jersey Med Sch, Dept Radiat Oncol, Div Canc Biol, Newark, NJ 07103 USA; [Conti, Alana] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Conti, Alana] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; [Liu, Ren-Shyan] Natl Yang Ming Chiao Tung Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Liu, Ren-Shyan] Cheng Hsin Gen Hosp, Dept Nucl Med, Taipei 112, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei 112, Taiwan; [Pasqualini, Renata; Arap, Wadih] Rutgers Canc Inst New Jersey, Newark, NJ 07103 USA; [Arap, Wadih] Rutgers New Jersey Med Sch, Dept Med, Div Hematol Oncol, Newark, NJ 07103 USA; [Sidman, Richard L.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Gelovani, Juri G.] Wayne State Univ, Karmanos Canc Inst, Mol Imaging Program, Detroit, MI 48201 USA; [Gelovani, Juri G.] United Arab Emirates Univ, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates		Gelovani, JG (corresponding author), Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI 48201 USA.; Gelovani, JG (corresponding author), Wayne State Univ, Sch Med, Detroit, MI 48201 USA.; Gelovani, JG (corresponding author), Wayne State Univ, Karmanos Canc Inst, Mol Imaging Program, Detroit, MI 48201 USA.; Gelovani, JG (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.	jgelovani@uaeu.ac.ae			NIDA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01DA042057, RX002900]; Cancer Center Support Grant [P30 CA022453]; Levy-Logenbaugh Donor-Advised Fund	These studies were supported in part by the grants: R01DA042057 (NIDA/NIH) to SP and JGG; and RX002900 (VA) to AC and JGG. The Microscopy, Imaging, and Cytometry Resources Core are supported, in part, by the Cancer Center Support Grant (P30 CA022453, NCI/NIH) to Karmanos Cancer Institute, Wayne State University, Detroit, MI; RP and WA received awards from the Levy-Logenbaugh Donor-Advised Fund.	Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; Beaumont A, 2000, NEUROL RES, V22, P665; Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P171; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bonomi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133512; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernotta N, 2011, MOL BIOL CELL, V22, P278, DOI 10.1091/mbc.E10-07-0616; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chen XR, 2019, J MAGN RESON IMAGING, V49, P1069, DOI 10.1002/jmri.26258; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fitzsimons HL, 2015, NEUROBIOL LEARN MEM, V123, P149, DOI 10.1016/j.nlm.2015.06.006; Fleming CL, 2014, J MED CHEM, V57, P1132, DOI 10.1021/jm401945k; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gibson CL, 2010, J NEUROCHEM, V115, P806, DOI 10.1111/j.1471-4159.2010.06993.x; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Golay J, 2007, LEUKEMIA, V21, P1892, DOI 10.1038/sj.leu.2404860; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guo H, 2007, NUCL MED BIOL, V34, P483, DOI 10.1016/j.nucmedbio.2007.03.008; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hidaka H, 1996, Adv Pharmacol, V36, P193, DOI 10.1016/S1054-3589(08)60583-9; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holzer KJ, 2019, J PSYCHIATR RES, V114, P149, DOI 10.1016/j.jpsychires.2019.05.002; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Isaacs JT, 2013, CANCER RES, V73, P1386, DOI 10.1158/0008-5472.CAN-12-2730; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin KL, 2001, J MOL NEUROSCI, V16, P49, DOI 10.1385/JMN:16:1:49; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; Laws MT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40054-2; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; Mazzocchi M, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00191; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Nikodemova M, 2006, J NEUROCHEM, V96, P314, DOI 10.1111/j.1471-4159.2005.03520.x; Nikolian VC, 2019, J TRAUMA ACUTE CARE, V86, P232, DOI 10.1097/TA.0000000000002119; Paxinos G., 2006, RAT BRAIN STEREOTAXI, Vsixth; Peterson AB, 2019, SURVEILLANCE REPORT; Qureshi IA, 2013, JAMA NEUROL, V70, P703, DOI 10.1001/jamaneurol.2013.1443; Raymond E, 2014, CANCER CHEMOTH PHARM, V73, P1, DOI 10.1007/s00280-013-2321-8; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sagarkar S, 2019, BRAIN RES, V1711, P183, DOI 10.1016/j.brainres.2019.01.022; Saha P, 2019, J NEUROTRAUM, V36, P3284, DOI 10.1089/neu.2019.6373; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Song B, 2010, J BIOL CHEM, V285, P41122, DOI 10.1074/jbc.M110.130351; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vargas-Lopez V, 2016, NEUROBIOL LEARN MEM, V134, P328, DOI 10.1016/j.nlm.2016.08.009; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walz A, 2017, CLIN CANCER RES, V23, P1891, DOI 10.1158/1078-0432.CCR-15-2240; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2; Xu K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/143269; Yang H, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6583267; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang MH, 2018, MOL MED REP, V17, P8079, DOI 10.3892/mmr.2018.8898	128	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.												10.1038/s41380-021-01369-7		JAN 2022	11	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	YG1TT	WOS:000742278800001	35027678				2022-02-06	
J	Suominen, EN; Sajanti, AJ; Silver, EA; Koivunen, V; Bondfolk, AS; Koskimaki, J; Saarinen, AJ				Suominen, Eetu N.; Sajanti, Antti J.; Silver, Eero A.; Koivunen, Veerakaisa; Bondfolk, Anton S.; Koskimaki, Janne; Saarinen, Antti J.			Alcohol intoxication and lack of helmet use are common in electric scooter-related traumatic brain injuries: a consecutive patient series from a tertiary university hospital	ACTA NEUROCHIRURGICA			English	Article; Early Access						Traumatic brain injury; TBI; Electric scooter; Brain trauma; Traffic accident	CRANIOMAXILLOFACIAL INJURIES; EPIDEMIOLOGY; ACCIDENTS; PATTERNS	Purpose Clinicians have increasingly encountered traumatic brain injuries (TBI) related to electric scooter (ES) accidents. In this study, we aim to identify the modifiable risk factors for ES-related TBIs. Methods A retrospective cohort of consecutive patients treated for ES-related traumatic brain injuries in a tertiary university hospital between May 2019 and September 2021 was identified and employed for the study. The characteristics of the accidents along with the clinical and imaging findings of the injuries were collected from the patient charts. Results During the study period, 104 TBIs related to ES accidents were identified. There was a high occurrence of accidents late at night and on Saturdays. In four cases, the patient's helmet use was mentioned (3.8%). Seventy-four patients (71%) were intoxicated. At the scene of the accident, seventy-seven (74%) of the patients had a Glasgow Coma Scale score of 13-15, three patients (3%) had a score of 9-12, and two patients (2%) had a score of 3-8. The majority (83%) of TBIs were diagnosed as concussions. Eighteen patients had evidence of intracranial injuries in the imagining. Two patients required neurosurgical procedures. The estimated population standardized incidence increased from 7.0/100,000 (95% CI 3.5-11/100,000) in 2019 to 27/100,000 (95% CI 20-34/100,000) in 2021. Conclusions Alcohol intoxication and the lack of a helmet were common in TBIs caused by ES accidents. Most of the accidents occurred late at night. Targeting these modifiable factors could decrease the incidence of ES-related TBIs.	[Koivunen, Veerakaisa; Bondfolk, Anton S.] Univ Turku, Dept Clin Med, Turku, Finland; [Sajanti, Antti J.; Koskimaki, Janne] Turku Univ Hosp, Dept Neurosurg, Neuroctr, Turku, Finland; [Sajanti, Antti J.; Koskimaki, Janne] Univ Turku, Turku, Finland; [Silver, Eero A.] Univ Turku, Dept Anaesthesia & Intens Care, Turku, Finland; [Suominen, Eetu N.; Silver, Eero A.; Saarinen, Antti J.] Turku Univ Hosp, Kiinamyllynkatu 4-8, Turku 20521, Finland; [Suominen, Eetu N.; Saarinen, Antti J.] Univ Turku, Dept Paediat Orthopaed Surg, Kiinamyllynkatu 4-8, Turku 20521, Finland; [Saarinen, Antti J.] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland; [Saarinen, Antti J.] Helsinki Univ Hosp, Helsinki, Finland		Saarinen, AJ (corresponding author), Turku Univ Hosp, Kiinamyllynkatu 4-8, Turku 20521, Finland.; Saarinen, AJ (corresponding author), Univ Turku, Dept Paediat Orthopaed Surg, Kiinamyllynkatu 4-8, Turku 20521, Finland.; Saarinen, AJ (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	antti.j.saarinen@utu.fi		Koskimaki, Janne/0000-0002-2311-6327; Saarinen, Antti/0000-0002-2742-8491	University of Turku (UTU); Turku University Central Hospital; Paivikki and Sakari Sohlberg Foundation; Vappu Uuspaa Foundation	Open Access funding provided by University of Turku (UTU) including Turku University Central Hospital. Dr. Saarinen has received research funding from NuVasive Inc. not related to the present study. Funding was received from The Paivikki and Sakari Sohlberg Foundation and Vappu Uuspaa Foundation for this study.	Blomberg Stig Nikolaj Fasmer, 2019, BMJ Open, V9, pe033988, DOI 10.1136/bmjopen-2019-033988; Brownson ABS, 2019, NEW ZEAL MED J, V132, P62; Cicchino JB, 2021, TRAFFIC INJ PREV, V22, P401, DOI 10.1080/15389588.2021.1913280; Coronado VG, 1997, SURVEILLANCE TRAUMAT; Doser K, 2018, BRAIN INJURY, V32, P64, DOI 10.1080/02699052.2017.1363408; Eurostat, REV EUR STAND POP RE; Farley KX, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14500; Ishmael CR, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.19.00390; Kappagantu A, LARYNGOSCOPE; Kleinertz H, 2021, DTSCH ARZTEBL INT, V118, P117, DOI 10.3238/arztebl.m2021.0019; Kosola S, 2009, SCAND J SURG, V98, P175, DOI 10.1177/145749690909800309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mayhew LJ, 2019, J MED IMAG RADIAT ON, V63, P461, DOI 10.1111/1754-9485.12889; Mitchell G, 2019, EMERG MED AUSTRALAS, V31, P930, DOI 10.1111/1742-6723.13356; Moftakhar T, 2021, ARCH ORTHOP TRAUM SU, V141, P1207, DOI 10.1007/s00402-020-03589-y; Namiri NK, 2020, JAMA SURG, V155, P357, DOI 10.1001/jamasurg.2019.5423; Official Statistics of Finland (OSF), POPULATION STRUCTURE; Oksanen E, 2020, J ORAL MAXIL SURG, V78, P2273, DOI 10.1016/j.joms.2020.05.038; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Puzio TJ, 2020, TRAFFIC INJ PREV, V21, P175, DOI 10.1080/15389588.2019.1709176; Schlaff CD, 2019, WORLD NEUROSURG, V132, P202, DOI 10.1016/j.wneu.2019.08.237; Shichman I, 2021, J BONE JOINT SURG AM, V103, P1125, DOI 10.2106/JBJS.20.01746; Shiffler K, 2021, J ORAL MAXIL SURG, V79, P1084, DOI 10.1016/j.joms.2020.09.026; Stormann P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051569; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Tischler Eric H, 2021, J Clin Orthop Trauma, V23, P101607, DOI 10.1016/j.jcot.2021.101607; Toofany M, 2021, INJURY PREV, V27, P490, DOI 10.1136/injuryprev-2020-044085; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; Uluk D, 2021, EMERG MED J, DOI 10.1136/emermed-2020-210268	32	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.												10.1007/s00701-021-05098-2		JAN 2022	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YG7BM	WOS:000742639100001	35029763	Green Published, hybrid			2022-02-06	
J	Cruz-Mendez, JS; Herrera-Sanchez, MP; Cespedes-Rubio, AE; Rondon-Barragan, IS				Cruz-Mendez, Juan Sebastian; Herrera-Sanchez, Maria Paula; Cespedes-Rubio, Angel Enrique; Rondon-Barragan, Iang Schroniltgen			Molecular characterization of myelin basic protein a (mbpa) gene from red-bellied pacu (Piaractus brachypomus)	JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY			English	Article						Bioinformatics; Fish biomodel; Gene expression; Myelin basic protein; Phylogeny; Protein isoform	TRAUMATIC BRAIN-INJURY; DEVELOPMENTAL NEUROTOXICITY; IN-VIVO; FISH; CHLORPYRIFOS; CELL; EXPRESSION; EVOLUTION; DOMAINS; ANESTHETICS	Background Myelin basic protein (MBP) is one of the most important structural components of the myelin sheaths in both central and peripheral nervous systems. MBP has several functions including organization of the myelin membranes, reorganization of the cytoskeleton during the myelination process, and interaction with the SH3 domain in signaling pathways. Likewise, MBP has been proposed as a marker of demyelination in traumatic brain injury and chemical exposure. Methods The aim of this study was to molecularly characterize the myelin basic protein a (mbpa) gene from the Colombian native fish, red-bellied pacu, Piaractus brachypomus. Bioinformatic tools were used to identify the phylogenetic relationships, physicochemical characteristics, exons, intrinsically disordered regions, and conserved domains of the protein. Gene expression was assessed by qPCR in three models corresponding to sublethal chlorpyrifos exposure, acute brain injury, and anesthesia experiments. Results mbpa complete open reading frame was identified with 414 nucleotides distributed in 7 exons that encode 137 amino acids. MBPa was recognized as belonging to the myelin basic protein family, closely related with orthologous proteins, and two intrinsically disordered regions were established within the sequence. Gene expression of mbpa was upregulated in the optic chiasm of the chlorpyrifos exposed fish in contrast to the control group. Conclusions The physicochemical computed features agree with the biological functions of MBP, and basal gene expression was according to the anatomical distribution in the tissues analyzed. This study is the first molecular characterization of mbpa from the native species Piaractus brachypomus.	[Cruz-Mendez, Juan Sebastian; Herrera-Sanchez, Maria Paula; Rondon-Barragan, Iang Schroniltgen] Univ Tolima, Santa Helena Highs, Res Grp Immunobiol & Pathogenesis, Lab Immunol & Mol Biol,Fac Vet Med & Zootech, Ibague 730006299, Tolima, Colombia; [Rondon-Barragan, Iang Schroniltgen] Univ Tolima, Santa Helena Highs, Res Grp Neurodegenerat Dis, Fac Vet Med & Zootech, Ibague 730006299, Tolima, Colombia; [Rondon-Barragan, Iang Schroniltgen] Univ Tolima, Fac Vet Med & Zootech, Dept Anim Hlth, Lab Immunol & Mol Biol, Ibague 730006299, Colombia		Rondon-Barragan, IS (corresponding author), Univ Tolima, Santa Helena Highs, Res Grp Neurodegenerat Dis, Fac Vet Med & Zootech, Ibague 730006299, Tolima, Colombia.	isrondon@ut.edu.co		Herrera Sanchez, Maria Paula/0000-0002-1138-1625; Cruz Mendez, Juan Sebastian/0000-0002-1048-012X	Laboratory of Immunology and Molecular Biology (LIBM) in Ibague, Colombia	The research was funded by the Laboratory of Immunology and Molecular Biology (LIBM) in Ibague, Colombia.	Zapata-Guerra NA, 2020, AQUAC RES, V51, P4421, DOI 10.1111/are.14784; Appel R.D., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571, DOI 10.1385/1592598900]; Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Baraban M, 2016, BRAIN RES, V1641, P149, DOI 10.1016/j.brainres.2015.10.026; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Betancourt AM, 2006, TOXICOL SCI, V92, P500, DOI 10.1093/toxsci/kfl004; Blum M, 2021, NUCLEIC ACIDS RES, V49, pD344, DOI 10.1093/nar/gkaa977; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Brattelid T, 2000, LAB ANIM, V34, P430, DOI 10.1258/002367700780387660; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; Cacialli P, 2018, J COMP NEUROL, V526, P569, DOI 10.1002/cne.24352; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CCAC, 2010, CCAC GUID EUTH AN US, P36; Cho SJ, 2020, EPILEPSIA, V61, P1774, DOI 10.1111/epi.16589; d'Amora M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00976; El-Hossary G. G., 2009, Journal of Applied Sciences Research, P1218; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Garcia SJ, 2003, ENVIRON HEALTH PERSP, V111, P297, DOI 10.1289/ehp.5791; Garcia-Gonzalez D, 2013, ANAT REC, V296, P1424, DOI 10.1002/ar.22736; Glushakova OY, 2018, HDB NEUROEMERGENCY C, P139, DOI [10.1016/B978-0-12-804064-5.00008, DOI 10.1016/B978-0-12-804064-5.00008]; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Haines DE., 2018, FUNDAMENTAL NEUROSCI, DOI [10.1016/b978-0-323-39632-5.00016-5, DOI 10.1016/B978-0-323-39632-5.00016-5]; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Hanafy KA, 2011, FEBS LETT, V585, P3821, DOI 10.1016/j.febslet.2011.03.048; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Harauz G, 2009, CURR PROTEIN PEPT SC, V10, P196, DOI 10.2174/138920309788452218; Hirschberg D, 2003, J PROTEIN CHEM, V22, P177, DOI 10.1023/A:1023479131488; Holguin Cespedes GK, 2019, REV INT CONTAM AMBIE, V35, P815, DOI 10.20937/RICA.2019.35.04.04; Jenkins JA., 2014, GUIDELINES USE FISHE, DOI [10.47886/9781934874394, DOI 10.47886/9781934874394]; JUKES T H, 1969, P21; Kalwy S, 1998, J NEUROCHEM, V70, P435; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kirschner DA, 2008, NEURON GLIA BIOL, V4, P59, DOI 10.1017/S1740925X09990196; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kumar S, 2018, HANDB FOOD BIOENG, V8, P51, DOI 10.1016/B978-0-12-811517-6.00003-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu HB, 2001, J NEUROIMMUNOL, V116, P83, DOI 10.1016/S0165-5728(01)00284-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lust K, 2019, DEV NEUROBIOL, V79, P424, DOI 10.1002/dneu.22665; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; Marin-Mendez G. A., 2012, Orinoquia, V16, P62; Martins T, 2019, LAB ANIM-UK, V53, P325, DOI 10.1177/0023677218815199; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Mateu L, 1997, BIOPHYS J, V72, P2581, DOI 10.1016/S0006-3495(97)78901-X; McNeill RS, 2014, JOVE-J VIS EXP, DOI [10.3791/51753, 10.3791/51763]; Mehta Tejas, 2020, Open Access J Neurol Neurosurg, V12, P86; Mesa-Granda Martha N, 2007, Rev Colom Cienc Pecua, V20, P79; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Millet V, 2012, EXP NEUROL, V233, P490, DOI 10.1016/j.expneurol.2011.11.028; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Naranjo-Gómez Juan S., 2013, Actu Biol, V35, P85; Nawaz S, 2013, GLIA, V61, P1364, DOI 10.1002/glia.22520; Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009; Necci M, 2017, BIOINFORMATICS, V33, P1402, DOI 10.1093/bioinformatics/btx015; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; OBRIEN JS, 1965, SCIENCE, V147, P1099, DOI 10.1126/science.147.3662.1099; Poitelon Y, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040812; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Pott F, 2009, BRAIN RES, V1305, P137, DOI 10.1016/j.brainres.2009.09.084; Priborsky J, 2018, REV FISH SCI AQUAC, V26, P417, DOI 10.1080/23308249.2018.1442812; Rahman HUU, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142649; Ridsdale RA, 1997, J BIOL CHEM, V272, P4269, DOI 10.1074/jbc.272.7.4269; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Steshenko O, 2016, BIOPHYS J, V110, P2441, DOI 10.1016/j.bpj.2016.04.047; STONER GL, 1990, J NEUROCHEM, V55, P1404, DOI 10.1111/j.1471-4159.1990.tb03153.x; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; TAPIERO HERNÁNDEZ YACSON, 2013, Acta biol.Colomb., V18, P479; Tarulli A., 2021, NEUROLOGY, P107, DOI [10.1007/978-3-030-55598-6_7, DOI 10.1007/978-3-030-55598-6_7]; THRASHER JD, 1993, ARCH ENVIRON HEALTH, V48, P89, DOI 10.1080/00039896.1993.9938400; Torvund-Jensen J, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00185; Valdivia AO, 2020, ACS OMEGA, V5, P15454, DOI 10.1021/acsomega.0c01590; Vargas-Vargas Rafael Antonio, 2017, Anest. Méx., V29, P86; Watanabe T, 2018, BIOPHYSICAL BASIS OF PHYSIOLOGY AND CALCIUM SIGNALING MECHANISM IN CARDIAC AND SMOOTH MUSCLE, P99, DOI 10.1016/B978-0-12-814950-8.00004-4; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Yergert KM, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001053; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108646; Zhou L, 2007, J CHEM NEUROANAT, V34, P47, DOI 10.1016/j.jchemneu.2007.03.011; Zuchero JB, 2015, DEV CELL, V34, P152, DOI 10.1016/j.devcel.2015.06.011	85	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2090-5920			J GENET ENG BIOTECHN	J Genet. Eng. Biotechnol.	JAN 13	2022	20	1							8	10.1186/s43141-022-00296-6			13	Biotechnology & Applied Microbiology; Environmental Sciences; Toxicology	Emerging Sources Citation Index (ESCI)	Biotechnology & Applied Microbiology; Environmental Sciences & Ecology; Toxicology	YG2ZV	WOS:000742362900002	35024999	Green Accepted, gold			2022-02-06	
J	de Borja, C; Chang, CJ; Watkins, R; Senter, C				de Borja, Celina; Chang, Cindy J.; Watkins, Rhonda; Senter, Carlin			Optimizing Health and Athletic Performance for Women	CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE			English	Article						Female athlete; Team physician; Women in sports medicine	PHYSICAL-ACTIVITY; POSITION STATEMENT; BREAST SUPPORT; PREGNANCY; GENDER; SPORT; EXERCISE; STRENGTH; COMMUNICATION; BIOMECHANICS	Purpose of Review The exponential growth of women participating in competitive sports throughout the years was made possible through several initiatives by the International Olympic Committee and the passage and implementation of Title IX as a federal law in the United States. However, this positive trend towards gender equity in sports has not transpired for women in medicine, especially in fields that care for elite athletes. This current review will discuss specific areas that can be tailored to help female athletes prevent injuries and optimize their athletic performance. We will also highlight how increased female team physician representation in sports may help optimize care for female athletes. Recent Findings Female athletes are considered high risk for certain conditions such as ACL tears, patellofemoral pain syndrome, bone stress injuries, sport-related concussions, and sexual violence in sport. Addressing factors specific to female athletes has been found to be valuable in preventing injuries. Strength and conditioning can optimize athletic performance but remains underutilized among female athletes. Although diversity in healthcare workforce has been found to be beneficial for multiple reasons, women remain underrepresented in sports medicine. Increasing female team physician representation may positively impact care for female athletes. Team physicians must understand the physiologic, biomechanical, and anatomic factors that are unique to female athletes in order to tailor injury prevention programs and optimize their athletic performance. Advocating for gender equity in sports medicine to advance representation of women in the field will increase workforce diversity and promote excellence in sports medicine care.	[de Borja, Celina; Watkins, Rhonda] Univ Calif San Francisco, Div Pediat Orthopaed, Dept Orthopaed Surg, 1825 4th St,5th Floor, San Francisco, CA 94158 USA; [Chang, Cindy J.; Senter, Carlin] Univ Calif San Francisco, Primary Care Sports Med, Dept Orthopaed Surg, San Francisco, CA 94158 USA		de Borja, C (corresponding author), Univ Calif San Francisco, Div Pediat Orthopaed, Dept Orthopaed Surg, 1825 4th St,5th Floor, San Francisco, CA 94158 USA.	celina.deborja@ucsf.edu		de Borja, Celina/0000-0002-4262-5901			Academy USS, 2008, SPORT J, V22, P1543; Allen R.H., COMBINED ESTROGEN PR; Alsan M, 2019, AM ECON REV, V109, P4071, DOI 10.1257/aer.20181446; American Medical Society for Sports Medicine, 2019 2020 ANN REP AM; American Medical Women's Association, GEND EQ TASK FORC; [Anonymous], 2020, Obstet Gynecol, V135, pe178, DOI 10.1097/AOG.0000000000003772; [Anonymous], 2018, CURR SPORT MED REP, V17, P163, DOI 10.1249/JSR.0000000000000482; [Anonymous], 2016, MED SCI SPORT EXER, V48, P159, DOI 10.1249/MSS.0000000000000827; Ardern CL, 2011, AM J SPORT MED, V39, P538, DOI 10.1177/0363546510384798; Association of American Medical Colleges, 2020, AAMC STAT GEND EQ; Association of American Medical Colleges, 2019, MAJ US MED STUD AR W; Bekker S, 2018, BRIT J SPORT MED, V52, P1287, DOI 10.1136/bjsports-2018-099084; Bo K, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.220; Bohl CH, 2002, CRIT REV FOOD SCI, V42, P533, DOI 10.1080/20024091054247; Burnett E, 2015, J PHYS ACT HEALTH, V12, P588, DOI 10.1123/jpah.2013-0236; Carpenter R.V, 2014, WOMEN INTERCOLLEGIAT, V2014, P1; Centers for Disease Control and Prevention Division of Nutrition Physical Activity and Obesity, NUTR PHYS ACT OB DAT; Chang C, 2020, BRIT J SPORT MED, V54, P216, DOI 10.1136/bjsports-2019-101583; Coltman CE, 2019, J SCI MED SPORT, V22, P324, DOI 10.1016/j.jsams.2018.09.226; Corso Melissa, 2018, J Can Chiropr Assoc, V62, P150; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cox R, 2020, CLIN J SPORT MED, V30, P210, DOI 10.1097/JSM.0000000000000838; Lourenco TRD, 2018, INT UROGYNECOL J, V29, P1757, DOI 10.1007/s00192-018-3629-z; Deelen I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5919-2; DiPietro L, 2019, MED SCI SPORT EXER, V51, P1292, DOI 10.1249/MSS.0000000000001941; Eime R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5609-0; Elliott-Sale KJ, 2020, SPORTS MED, V50, P1785, DOI 10.1007/s40279-020-01317-5; Fokkema T, 2019, J SCI MED SPORT, V22, P106, DOI 10.1016/j.jsams.2018.06.003; Forsdyke D, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094850; Franks P, 2003, J WOMEN HEALTH GEN-B, V12, P73, DOI 10.1089/154099903321154167; Gregg EA, 2017, CLIN SPORT MED, V36, P603, DOI 10.1016/j.csm.2017.05.001; Haakstad LAH, 2011, EUR J CONTRACEP REPR, V16, P116, DOI 10.3109/13625187.2011.560307; Hilibrand MJ, 2015, PHYSICIAN SPORTSMED, V43, P403, DOI 10.1080/00913847.2015.1092856; Hinkle AJ, 2021, PHYSICIAN SPORTSMED, V49, P219, DOI 10.1080/00913847.2020.1811065; Howie EK, 2019, J SCI MED SPORT, V22, P456, DOI 10.1016/j.jsams.2018.11.006; Hurvitz Michal, 2009, Pediatr Endocrinol Rev, V7, P43; Indridadottir MH, 2015, LAEKNABLADID, V101, P451, DOI 10.17992/lbl.2015.10.45; International Olympic Committee, 2019, KEY DAT HIST WOM OL; International Olympic Committee, 2016, OST SER DIS, P1; International Olympic Committee, 2019, PROM WOM SPORTS TIM; Kaplan S, 2016, MED SCI MONITOR, V22, P1297, DOI 10.12659/MSM.898353; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Kolomanska-Bogucka D, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55090560; Koontz JS, 2020, BRIT J SPORT MED, V12, P352, DOI [10.1177/1941738120929946, DOI 10.1177/1941738120929946]; Lewis C, 2020, JAMA INTERN MED, V180, P324, DOI 10.1001/jamainternmed.2019.5092; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1491, DOI 10.1519/JSC.0000000000001387; Lowe DA, 2010, EXERC SPORT SCI REV, V38, P61, DOI 10.1097/JES.0b013e3181d496bc; Lynoe N, 2010, MED HEALTH CARE PHIL, V13, P59, DOI 10.1007/s11019-009-9218-7; Magro-Malosso ER, 2017, ACTA OBSTET GYN SCAN, V96, P921, DOI 10.1111/aogs.13151; Marks S, 2012, BRIT J SPORT MED, V46, P905, DOI 10.1136/bjsports-2011-090345; Master CL, 2021, BRIT J SPORT MED, V55, P1387, DOI 10.1136/bjsports-2020-103316; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGhee DE, 2020, EXERC SPORT SCI REV, V48, P99, DOI 10.1249/JES.0000000000000221; McGhee DE, 2020, PHYSIOLOGY, V35, P144, DOI 10.1152/physiol.00024.2019; McGhee DE, 2010, J SCI MED SPORT, V13, P568, DOI 10.1016/j.jsams.2010.03.003; McNulty KL, 2020, SPORTS MED, V50, P1813, DOI 10.1007/s40279-020-01319-3; Menees SB, 2005, GASTROINTEST ENDOSC, V62, P219, DOI 10.1016/S0016-5107(05)00540-7; Miller MJ, 2017, MIL MED, V182, pE1859, DOI 10.7205/MILMED-D-17-00093; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Monzani D, 2020, APPL PSYCHOL-HLTH WE, V12, P471, DOI 10.1111/aphw.12193; Morgan AM, 2020, CUREUS, V12, DOI 10.7759/cureus.9689; Mountjoy M, 2016, BRIT J SPORT MED, V50, P1019, DOI 10.1136/bjsports-2016-096121; Nakamura A, 2019, J AFFECT DISORDERS, V246, P29, DOI 10.1016/j.jad.2018.12.009; Nelson D. M, 2009, MED SCI SPORT EXER, V41, P51; Noon ML, 2012, CURR SPORT MED REP, V11, P43, DOI 10.1249/JSR.0b013e31824330b6; O'Reilly OC, 2020, AM J SPORT MED, V48, P739, DOI 10.1177/0363546519897039; Oosthuyse T, 2010, SPORTS MED, V40, P207, DOI 10.2165/11317090-000000000-00000; Parent S, 2016, J INTERPERS VIOLENCE, V31, P2666, DOI 10.1177/0886260515580366; da Silva DRP, 2019, SAO PAULO MED J, V137, P329, DOI 10.1590/1516-3180.2018.0333050719; Reynolds ML, 2012, J STRENGTH COND RES, V26, P174, DOI 10.1519/JSC.0b013e31821852b7; Richter KP, 2020, NEW ENGL J MED, V383, P2148, DOI 10.1056/NEJMsa1916935; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Shen MJ, 2018, J RACIAL ETHN HEALTH, V5, P117, DOI 10.1007/s40615-017-0350-4; Singal BM., 2006, CLIN J SPORT MED, V16, P440, DOI [10.1097/01.jsm.0000244600.23472.88, DOI 10.1097/01.JSM.0000244600.23472.88]; Sommi C, 2018, PHYSICIAN SPORTSMED, V46, P420, DOI 10.1080/00913847.2018.1486677; Spencer L, 2020, WOMENS HEALTH, V16, DOI 10.1177/1745506520918335; Statuta SM, 2020, PRIMARY CARE, V47, P65, DOI 10.1016/j.pop.2019.11.002; Thom DH, 2004, HEALTH AFFAIR, V23, P124, DOI 10.1377/hlthaff.23.4.124; Thorborg K, 2020, BRIT J SPORT MED, V54, P1380, DOI 10.1136/bjsports-2020-102966; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Tulloh L, 2019, BRIT J SPORT MED, V53, P1392, DOI 10.1136/bjsports-2019-101619; Uccella S, 2019, AM J PERINAT, V36, pS83, DOI 10.1055/s-0039-1691816; Verrilli LE, 2017, FERTIL STERIL, V108, pE122, DOI 10.1016/j.fertnstert.2017.07.374; Wesner ML, 2007, CLIN J SPORT MED, V17, P143, DOI 10.1097/JSM.0b013e31802b4fa6; Wowdzia JB, 2021, MED SCI SPORT EXER, V53, P534, DOI 10.1249/MSS.0000000000002510; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zebis MK, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094776	88	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1935-973X	1935-9748		CURR REV MUSCULOSKE	Curr. Rev. Musculoskelet. Med.	FEB	2022	15	1					10	20		10.1007/s12178-021-09735-2		JAN 2022	11	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	YS2GJ	WOS:000741894500001	35023069	hybrid			2022-02-06	
J	Dong, Y; Chen, SL; Liu, TL; Li, JH				Dong, Yan; Chen, Shulin; Liu, Tzu-Li; Li, Jinghua			Materials and Interface Designs of Waterproof Field-Effect Transistor Arrays for Detection of Neurological Biomarkers	SMALL			English	Article; Early Access						amperometry; field-effect transistors; flexible electronics; multiplexed sensing; potentiometry	AMINO-ACID RELEASE; SPREADING DEPOLARIZATION; SELECTIVE ELECTRODES; SILICON DIOXIDE; DETECTION LIMIT; BIOSENSORS; DEPRESSION; POTASSIUM; MEMBRANES; ULTRATHIN	The continuous, real-time, and concurrent detection of multiple biomarkers in bodily fluids is of high significance for advanced healthcare. While active, semiconductor-based biochemical sensing platforms provide levels of functionality exceeding those of their conventional passive counterparts, the stability of the active biosensors in the liquid environment for continuous operation remains a challenging topic. This work reports the development of a class of flexible and waterproof field-effect transistor arrays for multiplexed biochemical sensing. In this design, monolithic, ultrathin, dense, and low defect nanomembranes consisting of monocrystalline Si and thermally grown SiO2 simultaneously serve as high-performance backplane electronics for signal transduction and stable biofluid barriers with high structural integrity due to the high formation temperature. Coupling the waterproof transistors with various ion-selective membranes through the gate electrode allows for sensitive and selective detection of multiple ions as biomarkers for traumatic brain injury. The study also demonstrates a similar encapsulation structure which enables the design of waterproof amperometric sensors based on this materials strategy and integration scheme. Overall, key advantages in flexibility, stability, and multifunctionality highlight the potential of using such electronic sensing platforms for concurrent, continuous detection of various neurological biomarkers, proving a promising approach for early diagnosis and intervention of chronic diseases.	[Dong, Yan; Chen, Shulin; Liu, Tzu-Li] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA; [Li, Jinghua] Ohio State Univ, Chron Brain Injury Program, Dept Mat Sci & Engn, Columbus, OH 43210 USA		Li, JH (corresponding author), Ohio State Univ, Chron Brain Injury Program, Dept Mat Sci & Engn, Columbus, OH 43210 USA.	li.11017@osu.edu			Ohio State University start-up funds; Chronic Brain Injury Pilot Award Program; National Center For Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002733]; Ohio State University Materials Research Seed Grant Program - Center for Emergent Materials, an NSF-MRSEC [DMR-2011876]; Center for Exploration of Novel Complex Materials; Institute for Materials Research	This work was supported by The Ohio State University start-up funds, the Chronic Brain Injury Pilot Award Program, and the National Center For Advancing Translational Sciences (Award Number: UL1TR002733). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. This work was also supported in part by The Ohio State University Materials Research Seed Grant Program, funded by the Center for Emergent Materials, an NSF-MRSEC, grant DMR-2011876, the Center for Exploration of Novel Complex Materials, and the Institute for Materials Research.	Abbas AN, 2015, ACS NANO, V9, P5618, DOI 10.1021/acsnano.5b01961; Bakker E, 1997, CHEM REV, V97, P3083, DOI 10.1021/cr940394a; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; Bratov A, 2004, TALANTA, V62, P91, DOI 10.1016/S0039-9140(03)00402-8; Brown K., 2011, P INT WORKSH MIN SCA, P25; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chang ML, 2015, APPL SURF SCI, V359, P533, DOI 10.1016/j.apsusc.2015.10.144; Chen SL, 2022, BIOSENS BIOELECTRON, V195, DOI 10.1016/j.bios.2021.113683; Cockerill I, 2020, NANO LETT, V20, P4594, DOI 10.1021/acs.nanolett.0c01448; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; EGOROV VV, 1990, TALANTA, V37, P461, DOI 10.1016/0039-9140(90)80071-M; Elgrishi N, 2018, J CHEM EDUC, V95, P197, DOI 10.1021/acs.jchemed.7b00361; Estrela P, 2010, ANAL CHEM, V82, P3531, DOI 10.1021/ac902554v; EUGSTER R, 1994, ANAL CHIM ACTA, V289, P1, DOI 10.1016/0003-2670(94)80001-4; Fakih I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16979-y; Fang H, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0038; Fang H, 2016, P NATL ACAD SCI USA, V113, P11682, DOI 10.1073/pnas.1605269113; Goncales VR, 2020, ANNU REV ANAL CHEM, V13, P135, DOI 10.1146/annurev-anchem-091619-092506; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; Phan HP, 2019, ACS NANO, V13, P11572, DOI 10.1021/acsnano.9b05168; IVANOV VT, 1969, BIOCHEM BIOPH RES CO, V34, P803, DOI 10.1016/0006-291X(69)90251-4; Kaisti M, 2017, BIOSENS BIOELECTRON, V98, P437, DOI 10.1016/j.bios.2017.07.010; Kang SK, 2018, ACCOUNTS CHEM RES, V51, P988, DOI 10.1021/acs.accounts.7b00548; Kim J, 2015, ACS NANO, V9, P4572, DOI 10.1021/acsnano.5b01211; Kisiel A, 2020, ANALYST, V145, P2966, DOI 10.1039/c9an02621e; Knopfmacher O, 2010, NANO LETT, V10, P2268, DOI 10.1021/nl100892y; Koura SS, 1998, ACT NEUR S, V71, P244; Kuo WC, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071484; Lee D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24122-8; Li BR, 2013, J AM CHEM SOC, V135, P16034, DOI 10.1021/ja408485m; Li HM, 2017, SENSOR ACTUAT B-CHEM, V253, P759, DOI 10.1016/j.snb.2017.06.129; Li JH, 2018, P NATL ACAD SCI USA, V115, pE9542, DOI 10.1073/pnas.1813187115; Li S, 2020, PHYSICA B, V584, DOI 10.1016/j.physb.2020.412065; Liang YQ, 2020, ACS NANO, V14, P8866, DOI 10.1021/acsnano.0c03523; Libertino S, 2013, SENSOR ACTUAT B-CHEM, V179, P240, DOI 10.1016/j.snb.2012.09.108; Liu BL, 2014, ACS NANO, V8, P5304, DOI 10.1021/nn5015215; Liu QZ, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101469; Liu QZ, 2018, ACS NANO, V12, P1170, DOI 10.1021/acsnano.7b06823; Moser N, 2020, ANAL CHEM, V92, P5276, DOI 10.1021/acs.analchem.9b05836; Nakata S, 2018, NAT ELECTRON, V1, P596, DOI 10.1038/s41928-018-0162-5; Nakatsuka N, 2018, SCIENCE, V362, P319, DOI 10.1126/science.aao6750; OESCH U, 1980, ANAL CHEM, V52, P692, DOI 10.1021/ac50054a024; Pham TA, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.202004655; Rogers ML, 2017, J CEREBR BLOOD F MET, V37, P1883, DOI 10.1177/0271678X16674486; ROSE MC, 1974, BIOCHIM BIOPHYS ACTA, V372, P426, DOI 10.1016/0304-4165(74)90204-9; Sarangadharan I, 2018, BIOSENS BIOELECTRON, V107, P259, DOI 10.1016/j.bios.2018.02.036; Schwerdt HN, 2017, P NATL ACAD SCI USA, V114, P13260, DOI 10.1073/pnas.1713756114; Sheibani S, 2021, COMMUN MATER, V2, DOI 10.1038/s43246-020-00114-x; SHEMYAKIN MM, 1969, J MEMBRANE BIOL, V1, P402, DOI 10.1007/BF01869790; Telting-Diaz M, 2001, ANAL CHEM, V73, P5582, DOI 10.1021/ac010526h; TOPKAR A, 1993, THIN SOLID FILMS, V232, P265, DOI 10.1016/0040-6090(93)90020-P; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Walsh KB, 2014, BIOSENS BIOELECTRON, V54, P448, DOI 10.1016/j.bios.2013.11.038; White SP, 2016, ACS SENSORS, V1, P1213, DOI 10.1021/acssensors.6b00481; Zhao CZ, 2021, ACS NANO, V15, P904, DOI 10.1021/acsnano.0c07503; Zhu DH, 2019, ADV SCI, V6, DOI 10.1002/advs.201901166; Zhu YJ, 2016, ACTA HORTIC, V1111, P1, DOI [10.1109/ICPADS.2016.0010, 10.17660/ActaHortic.2016.1111.1, 10.1109/ICPADS.2016.8]	58	0	0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1613-6810	1613-6829		SMALL	Small											2106866	10.1002/smll.202106866		JAN 2022	14	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	YF8UD	WOS:000742076000001	35023615				2022-02-06	
J	Fei, X; Zhang, Y; Cheng, Y; Zhang, Y; Guo, J				Fei, Xiao; Zhang, Yi; Cheng, Yun; Zhang, Yu; Guo, Jing			Exploration of the application of Picture-Based Memory Impairment Screen in stroke patients in a preliminary study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Picture-based memory impairment screen; reliability; stroke; validity	MINI-MENTAL-STATE; MONTREAL COGNITIVE ASSESSMENT; TRAUMATIC BRAIN-INJURY; DEMENTIA; CHINESE; MOCA	Objective The objective was to explore the validity and reliability of the Picture-Based Memory Impairment Screen (PMIS) assessment tool in stroke patients and to provide an objective basis for its application in China. Methods: A total of 30 stroke patients in the Department of Rehabilitation Medicine were assessed using the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the PMIS. The results were evaluated by content validity, simultaneous validity, consistency test of instruments of assessment, inter-scorer reliability, and retest reliability. Results: The correlation coefficient between each item score and total score of PMIS was between 0.422 and 0.778 (p < 0.05), showing good content validity. The total score of PMIS was moderately positively correlated with the MMSE short-term memory score (p < 0.001), highly positively correlated with the MMSE long-term memory score and retrospective memory score (p < 0.001), and highly positively correlated with the MoCA long-term memory score, memory index and total score (p < 0.001), indicating good criterion validity. The consistency test of the two instruments of assessment showed that a PMIS <= 5 was used as the demarcation score for dementia, and it was tested for consistency with the MMSE dementia score of stroke patients, and the Kappa value was 0.81 (p < 0.001). The inter-scorer reliability and retest reliability were good (inter-scorer reliability intra-group correlation coefficient (ICC) >0.95; retest reliability ICC 0.904). Conclusion: The PMIS was a reliable and valid assessment tool, which can be used as memory impairment screening tool for stroke patients in China.	[Fei, Xiao; Zhang, Yi; Cheng, Yun; Zhang, Yu; Guo, Jing] First Peoples Hosp Changzhou, Dept Rehabil Med, 185 Jugian St, Changzhou 213003, Peoples R China		Zhang, Y (corresponding author), First Peoples Hosp Changzhou, Dept Rehabil Med, 185 Jugian St, Changzhou 213003, Peoples R China.	zhangyizhe1975@aliyun.com					Buschke H, 1999, NEUROLOGY, V52, P231, DOI 10.1212/WNL.52.2.231; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaynor E, 2018, J STROKE CEREBROVASC, V27, P2466, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.002; Hill NL, 2017, INT PSYCHOGERIATR, V29, P1965, DOI 10.1017/S1041610217001636; Irfani Fitri Fasihah, 2020, Med Glas (Zenica), V17, P433, DOI 10.17392/1135-20; Julayanont P, 2014, J AM GERIATR SOC, V62, P679, DOI 10.1111/jgs.12742; Kuiper JS, 2017, INT J GERIATR PSYCH, V32, P1059, DOI 10.1002/gps.4567; Li HZ, 2016, J ALZHEIMERS DIS, V53, P487, DOI 10.3233/JAD-160119; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Malik R, 2018, J AM GERIATR SOC, V66, P1598, DOI 10.1111/jgs.15422; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Tsai JC, 2016, ARCH PSYCHIAT NURS, V30, P486, DOI 10.1016/j.apnu.2016.01.015; Verghese J, 2012, J AM GERIATR SOC, V60, P2116, DOI 10.1111/j.1532-5415.2012.04191.x; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007; Zhang Z., 1999, CHIN J NEUROL, V32, P149, DOI DOI 10.3760/J.ISSN:1006-7876.1999.03.006; Zortea Maxciel, 2019, Dement. neuropsychol., V13, P44, DOI 10.1590/1980-57642018dn13-010005	22	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2021411		JAN 2022	4	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YH8AY	WOS:000743385200001	35037544				2022-02-06	
J	Nalder, E; King, G; Hunt, AW; Hartman, LR; Szigeti, Z; Drake, E; Shah, R; Sharzad, M; Resnick, M; Pereira, G; Lenton, E				Nalder, Emily; King, Gillian; Hunt, Anne W.; Hartman, Laura R.; Szigeti, Zara; Drake, Emma; Shah, Riya; Sharzad, Maryam; Resnick, Myles; Pereira, Giles; Lenton, Erica			Indicators of life success from the perspective of individuals with traumatic brain injury: a scoping review	DISABILITY AND REHABILITATION			English	Article; Early Access						Resiliency; adaptation; participation; identity; social; hope; review	QUALITY-OF-LIFE; OCCUPATIONAL ADAPTATION; COMMUNITY INTEGRATION; LIVED EXPERIENCE; SOCIAL IDENTITY; HEAD-INJURY; PEOPLE; RESILIENCE; PARTICIPATION; RECOVERY	Purpose The purpose was to synthesize qualitative literature and identify indicators of life success (positive life outcomes and experiences) that can help in understanding resiliency in the context of traumatic brain injury (TBI). Methods This scoping review involved searching nine online databases for population (TBI) and context (qualitative literature). Searches retrieved 42 852 articles and, after two-stage screening, 76 articles met the inclusion criteria of reporting indicators of life success from the perspective of individuals with TBI. Results Most studies were conducted in North America, Australia, or Europe. Participants were people living with TBI (mild to severe), of all age ranges. Positive life experiences were organized within four domains: understanding of oneself and one's life, social relationships and interaction, doing (engagement in activities, sense of control and accomplishment), and hope for the future. Conclusions The positive life experiences reflect both processes and outcomes (indicators of success) and highlight the need for a multidimensional approach when seeking to understand resiliency following TBI. The transactional framework of life experiences can be applied in future TBI resiliency research to understand how individuals negotiate adversity through experiences promoting understanding of oneself and the world, social relationships, engagement in activity and hope.	[Nalder, Emily; King, Gillian; Hunt, Anne W.; Drake, Emma; Shah, Riya; Sharzad, Maryam; Resnick, Myles; Pereira, Giles] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Nalder, Emily; King, Gillian; Hunt, Anne W.; Szigeti, Zara] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Nalder, Emily] March Dimes Canada, East York, ON, Canada; [King, Gillian; Hartman, Laura R.; Szigeti, Zara] Bloorview Res Inst, Toronto, ON, Canada; [King, Gillian; Hartman, Laura R.; Szigeti, Zara] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Lenton, Erica] Univ Toronto, Gerstein Sci Informat Ctr, Toronto, ON, Canada		Nalder, E (corresponding author), 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	emily.nalder@utoronto.ca		Nalder, Emily/0000-0001-9612-9420; Hartman, Laura/0000-0001-7246-7863	Canadian Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); March of Dimes CanadaMarch of Dimes	This work was supported by a Partnership Development Grant from the Canadian Social Sciences and Humanities Research Council. Dr. Nalder holds the Canada Research Chair (Tier 2) in Resiliency and Rehabilitation funded by the Canadian Institutes of Health Research, and a March of Dimes Canada, Paul J.J. Martin Early Career Professorship. Dr. King holds a Canada Research Chair (Tier 1) in Optimal Care for Children with Disabilities funded by the Canadian Institutes of Health Research.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Allen N, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1867654; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Arbour C, 2017, J ADV NURS, V73, P3133, DOI 10.1111/jan.13376; Arksey H., 2005, INT J SOC RES METHOD, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Bogan AM, 1997, BRAIN INJURY, V11, P431; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Bryson-Campbell M, 2016, J OCCUP SCI, V23, P208, DOI 10.1080/14427591.2015.1131188; Cahill SM, 2014, CAN J OCCUP THER, V81, P93, DOI 10.1177/0008417414533185; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Caron JG, 2021, PSYCHOL SPORT EXERC, V52, DOI 10.1016/j.psychsport.2020.101824; Carulli LA, 2018, J REHABIL, V84, P29; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chhuom TW, 2021, J NEUROSCI NURS, V53, P57, DOI 10.1097/JNN.0000000000000569; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Dmytro A, 2021, UKRAIN SCI MED YOUTH, V124, P15; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Downing M, 2021, NEUROPSYCHOL REHABIL, V31, P889, DOI 10.1080/09602011.2020.1744453; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Eakin JM, 2016, QUAL INQ, V22, P107, DOI 10.1177/1077800415617207; Fabricius AM, 2020, QUAL HEALTH RES, V30, P1033, DOI 10.1177/1049732319900163; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Glover A, 2003, DISABIL REHABIL, V25, P750, DOI 10.1080/0963828021000058503; Gould KR, 2015, BRAIN INJURY, V29, P283, DOI 10.3109/02699052.2014.974671; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Hartman LR, 2011, J OCCUP SCI, V18, P292, DOI 10.1080/14427591.2011.610776; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Infurna FJ, 2018, CLIN PSYCHOL REV, V65, P43, DOI 10.1016/j.cpr.2018.07.003; Jager A., 2016, FORUM QUALITATIVE SO, V17, P22, DOI DOI 10.17169/FQS-17.2.2526; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Jones JA, 2011, DISABIL REHABIL, V33, P1568, DOI 10.3109/09638288.2010.537803; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kent J., 2014, NZ J PHYSIOTHER, V42, P148; King G, 2003, QUAL HEALTH RES, V13, P184, DOI 10.1177/1049732302239598; King G, 2019, PHYS OCCUP THER PEDI, V39, P16, DOI 10.1080/01942638.2017.1379457; King G, 2020, DISABIL REHABIL, V42, P1031, DOI [10.1080/09638288.2018.1515266, 10.1080/17518423.2018.1497722]; King GA, 2010, NEW HORIZ MANAG, P361; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Knox L, 2017, DISABIL REHABIL, V39, P2250, DOI 10.1080/09638288.2016.1219925; Krenz U, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246514; Lawson S, 2008, THER RECREAT J, V42, P236; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lefkovits AM, 2021, NEUROPSYCHOL REHABIL, V31, P1582, DOI 10.1080/09602011.2020.1787849; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Libin AV, 2017, AM J ORTHOPSYCHIAT, V87, P129, DOI 10.1037/ort0000253; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th, P97; MacQueen R, 2020, NEUROPSYCHOL REHABIL, V30, P298, DOI 10.1080/09602011.2018.1466714; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Masten AS, 2006, ANN NY ACAD SCI, V1094, P13, DOI 10.1196/annals.1376.003; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Mealings M, 2021, BRAIN INJURY, V35, P315, DOI 10.1080/02699052.2020.1863466; Mealings M, 2020, NEUROPSYCHOL REHABIL, V30, P1255, DOI 10.1080/09602011.2019.1574231; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Muldoon OT, 2019, EUR J SOC PSYCHOL, V49, P1272, DOI 10.1002/ejsp.2564; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pappadis MR, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1836045; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Raphael D, 1996, SOC INDIC RES, V39, P65, DOI 10.1007/BF00300833; Rapport LJ, 2020, DISABIL REHABIL, V42, P2049, DOI 10.1080/09638288.2018.1552327; Rennie BJ, 2020, RURAL SPEC EDUC Q, V39, P91, DOI 10.1177/8756870519892886; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Sabat Ayesha, 2006, S Afr J Commun Disord, V53, P17; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Sandelowski M, 1991, Image J Nurs Sch, V23, P161, DOI 10.1111/j.1547-5069.1991.tb00662.x; Sandera AM, 2021, NEUROPSYCHOL REHABIL, V31, P1105, DOI 10.1080/09602011.2020.1762670; Schutz LE, 2007, J HEAD TRAUMA REHAB, V22, P48, DOI 10.1097/00001199-200701000-00006; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Tasker SL., 2003, ILLN CRISES LOSS, V11, P337, DOI DOI 10.1177/1054137303256585; Thoren C, 2019, WORK, V64, P415, DOI 10.3233/WOR-193003; Ungar M, 2011, AM J ORTHOPSYCHIAT, V81, P1, DOI 10.1111/j.1939-0025.2010.01067.x; Vos L, 2019, BRAIN INJURY, V33, P1615, DOI 10.1080/02699052.2019.1658132; Walsh RS, 2020, NEUROREHABILITATION, V47, P11, DOI 10.3233/NRE-203079; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	118	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.2025274		JAN 2022	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	YJ3HR	WOS:000744425300001	35037526				2022-02-06	
J	Young, MJ; Sanders, WR; Marujo, R; Bodien, YG; Edlow, BL				Young, Michael J.; Sanders, William R.; Marujo, Rose; Bodien, Yelena G.; Edlow, Brian L.			Return to Work Within Four Months of Grade 3 Diffuse Axonal Injury	NEUROHOSPITALIST			English	Article; Early Access						traumatic brain injury; prognosis; consciousness; diffuse axonal injury; microbleed	TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; HEAD-INJURY; CONSCIOUSNESS; MODERATE; MRI	Neuroprognostication following diffuse axonal injury (DAI) has historically relied on neuroimaging techniques with lower spatial resolution and contrast than techniques currently available in clinical practice. Since the initial studies of DAI classification and prognosis in the 1980s and 1990s, advances in neuroimaging have improved detection of brainstem microbleeds, a hallmark feature of Grade 3 DAI that has traditionally been associated with poor neurologic outcome. Here, we report clinical and radiologic data from two patients with severe traumatic brain injury and grade 3 DAI who recovered functional independence and returned to work within 4 months of injury. Importantly, both patients were scanned using 3 Tesla MRI protocols that included susceptibility-weighted imaging (SWI), a technique that provides enhanced sensitivity for detecting brainstem microbleeds. These observations highlight the importance of developing approaches to DAI classification and prognosis that better align with contemporary neuroimaging capabilities.	[Young, Michael J.; Sanders, William R.; Marujo, Rose; Bodien, Yelena G.; Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, Boston, MA 02114 USA; [Young, Michael J.; Sanders, William R.; Marujo, Rose; Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Boston, MA 02115 USA; [Young, Michael J.] Harvard Univ, Safra Ctr Eth, Cambridge, MA 02138 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02114 USA		Young, MJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 101 Merrimac St,Suite 300, Boston, MA 02114 USA.	michael.young@mgh.harvard.edu			NIH BRAIN Initiative [F32MH123001]; NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS109627, RF1NS115268]; NIH Director's Office [DP2HD101400]; Henry and AllisonMcCance Center for Brain Health/Mass General Neuroscience SPARC Award; AAN Palatucci Advocacy Leadership Grant; James S. McDonnell Foundation; Tiny Blue Dot Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported by the NIH BRAIN Initiative (F32MH123001), NIH National Institute of Neurological Disorders and Stroke (R21NS109627, RF1NS115268), NIH Director's Office (DP2HD101400), Henry and AllisonMcCance Center for Brain Health/Mass General Neuroscience SPARC Award, AAN Palatucci Advocacy Leadership Grant, James S. McDonnell Foundation, and Tiny Blue Dot Foundation. The funders had no role in the design, analysis, preparation, review, approval, or decision to submit this manuscript for publication.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bianciardi M, 2021, NEUROLOGY, V97, pE113, DOI 10.1212/WNL.0000000000012192; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Edlow BL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01077; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Jones K, 2021, NEUROCRIT CARE, V35, P311, DOI 10.1007/s12028-021-01230-3; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TEASDALE G, 1974, LANCET, V2, P81; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; van Eijck M, 2018, J NEUROTRAUM, V35, P2357, DOI 10.1089/neu.2018.5650	16	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1941-8744	1941-8752		NEUROHOSPITALIST	Neurohospitalist												10.1177/19418744211051459		JAN 2022	5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YQ7MY	WOS:000749491200001					2022-02-06	
J	Zhang, MQ; Zhang, Q; Yuan, W; Wu, JY; Liang, Y; Qin, HJ; Li, CS				Zhang Ming-qing; Zhang Qiang; Yuan Wei; Wu Jun-yuan; Liang Yong; Qin Hong-jie; Li Chun-sheng			Protective Effect of Shenfu Injection on Vascular Endothelial Damage in a Porcine Model of Hemorrhagic Shock	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article; Early Access						hemorrhagic shock; Shenfu Injection; vascular endothelial damage; Chinese medicine	TRAUMATIC BRAIN-INJURY; FU INJECTION; GINSENOSIDE RB1; HYPERTONIC SALINE; ANIMAL-MODEL; DYSFUNCTION; MICROCIRCULATION; COAGULATION; PULMONARY	Objective: To investigate the effects of Shenfu Injection (SFI) on endothelial damage in a porcine model of hemorrhagic shock (HS). Methods: After being bled to a mean arterial pressure of 40 +/- 3 mm Hg and held for 60 min, 32 pigs were treated with a venous injection of either shed blood (transfusion group), shed blood and saline (saline group), shed blood and SFI (SFI group) or without resuscitation (sham group). Venous blood samples were collected and analyzed at baseline and 0, 1, 2, 4, and 6 h after HS. Tumor necrosis factor-alpha (TNF-alpha), serum interleuking (IL)-6, and IL-10 levels were measured by enzyme-linked immunosorbent assay (ELISA); expressions of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule 1 (ICAM -1), von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1) and Bcl-2, Bax, and caspase-3 proteins were determined by Western blot. Results: The serum level of TNF-alpha in the SFI group was significantly lower than in the other groups at 0, 1, and 2 h after HS, while the level of IL-6 was lower at 4 and 6 h compared with the saline group (PP<0.05). The concentration of serum IL-10 was significantly higher in the SFI group than in the other groups at 0, 1, 4, and 6 h after HS (P<0.01). Western blot and immunohisto chemistry of vascular tissue showed that the expression of caspase-3 was downregulated, and that of Bcl-2 and Bax was upregulated in the SFI group compared to other groups (P<0.05). Conclusion: SFI attenuated endothelial injury in the porcine model of HS by inhibiting cell apoptosis, suppressing the formation of proinflammatory cytokines, and reducing endothelial activation.	[Zhang Ming-qing; Li Chun-sheng] Capital Med Univ, Beijing Friendship Hosp, Dept Emergency Med, Beijing 100050, Peoples R China; [Zhang Qiang] Peking Univ, Dept Crit Care Med, Hosp 3, Beijing 100191, Peoples R China; [Yuan Wei; Wu Jun-yuan; Liang Yong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency Med, Beijing 100020, Peoples R China; [Qin Hong-jie] Capital Med Univ, Beijing Luhe Hosp, Dept Emergency Med, Beijing 101199, Peoples R China		Li, CS (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Emergency Med, Beijing 100050, Peoples R China.	lcscyyy@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372025]; Annual Special Cultivation and Development Project for the Technology Innovation of Beijing [Z151100001615056]	Supported by the National Natural Science Foundation of China (No. 81372025) and the 2015 Annual Special Cultivation and Development Project for the Technology Innovation of Beijing (No. Z151100001615056)	Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Causey MW, 2011, J SURG RES, V170, P120, DOI 10.1016/j.jss.2011.01.014; Chen LM., 2001, CHINESE PHARMACOL B, V18, P695; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; Gao XQ, 2010, J ETHNOPHARMACOL, V132, P393, DOI 10.1016/j.jep.2010.07.033; Gu W, 2012, SHOCK, V38, P301, DOI 10.1097/SHK.0b013e31825f6632; Gurfinkel V, 2003, J TRAUMA, V54, P1137, DOI 10.1097/01.TA.0000064452.37534.29; Huang L, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/248786; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Li XD, 2017, J PHARMACOL SCI, V133, P115, DOI 10.1016/j.jphs.2017.01.007; Lu JM, 2012, CURR PHARM DESIGN, V18, P6339, DOI 10.2174/138161212803832254; Luo YK, 2016, TUMOR BIOL, V37, P10187, DOI 10.1007/s13277-016-4889-1; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Naumann DN, 2016, SHOCK, V46, P609, DOI 10.1097/SHK.0000000000000687; Roesner JP, 2009, CRIT CARE MED, V37, P598, DOI 10.1097/CCM.0b013e3181959a12; Schneider CP, 2004, BBA-MOL BASIS DIS, V1689, P22, DOI 10.1016/j.bbadis.2004.01.003; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Shao F, 2020, RESUSCITATION, V150, P139, DOI 10.1016/j.resuscitation.2019.11.010; Tong YM, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4929107; Tuma M, 2016, SHOCK, V46, P352, DOI 10.1097/SHK.0000000000000635; Urbano J, 2012, RESUSCITATION, V83, P1159, DOI 10.1016/j.resuscitation.2012.02.003; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Wang TA, 2010, EUR J PHARMACOL, V636, P121, DOI 10.1016/j.ejphar.2010.03.035; White NJ, 2017, J TRAUMA ACUTE CARE, V82, pS41, DOI 10.1097/TA.0000000000001436; Wu JY, 2016, J ETHNOPHARMACOL, V180, P97, DOI 10.1016/j.jep.2016.01.027; Yin Q, 2016, AM J EMERG MED, V34, P469, DOI 10.1016/j.ajem.2015.12.010; Zhang MY, 2012, RESUSCITATION, V83, P1152, DOI 10.1016/j.resuscitation.2012.01.041; Zhang Q, 2016, CHIN J INTEGR MED, V22, P101, DOI 10.1007/s11655-014-1857-8; Zhou GH, 2015, J ETHNOPHARMACOL, V160, P173, DOI 10.1016/j.jep.2014.11.043	32	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.												10.1007/s11655-021-2876-x		JAN 2022	8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	YF7EP	WOS:000741965500003	35023060				2022-02-06	
J	Fatima, N; Mowafi, H; Hariri, M; Alnahhas, H; Al-Kassem, A; Saqqur, M				Fatima, Nida; Mowafi, Hani; Hariri, Mahmoud; Alnahhas, Houssam; Al-Kassem, Anas; Saqqur, Maher			Neurotrauma in the Syrian War: analysis of 41,143 cases from July 2013-July 2015	NEUROLOGICAL SCIENCES			English	Article; Early Access						Neurotrauma; Traumatic brain injury; Spinal injury; War; Conflict; Humanitarian	ATTACKS	Introduction Despite nearly a decade of conflict, little is known about trauma and injuries resulting from the Syrian war. Methods Secondary analysis was conducted of an administrative dataset of patient presentations to a network of 95 waraffected hospitals in Syria from July 2013-July 2015. Logistic regression was performed to identify factors associated with mortality of neurotrauma patients. Results Of 193,618 overall trauma presentations, 41,143 were for neurotrauma (37,410 head trauma, 1407 spinal trauma, and 3133 peripheral nervous system). There were 31,359 males (76.2%) and 9784 females (23.8%). Males aged 19-30 years (10,113; 24.6%) were the largest single demographic group. Presumed non-combatants including females, elders, and children under 13 years (16,214; 39.4%) were the largest group of patients overall. There were 16,881 (41.0%) presentations with blunt injuries (blunt/crush injuries) and 21,307 (51.8%) patients with penetrating injuries (shrapnel, cut, gunshot). A total of 36,589 patients (89.6%) were treated and discharged from the hospital, 2100 (5.1%) were transferred to another facility, 2050 patients (5.0%) died in-hospital, 26 remained in the hospital (0.1%), and 108 (0.3%) had unknown disposition. The median length of hospital stay was 1 day. There were 4034 (9.7%) neurosurgical procedures documented. Patients with combined neurotrauma and general trauma suffered 30 times higher mortality than neurotrauma alone (aOR: 30.4; 95% CI: 20.8-44.2, p < 0.0001). Conclusion The Syrian War resulted in large volumes of neurotrauma patients. Presumed non-combatants comprised 39.4% of patients who survived to treatment at a facility. Further study is needed on long-term needs of neurotrauma victims of the Syrian war.	[Fatima, Nida] Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St, Boston, MA 02114 USA; [Mowafi, Hani] Yale Univ, Dept Emergency Med, New Haven, CT USA; [Hariri, Mahmoud] Idleb Hlth Directorate, Hlth Informat Syst Unit, Idleb, Syria; [Hariri, Mahmoud] Union Med Care & Relief Org UOSSM, Gaziantep, Turkey; [Alnahhas, Houssam] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Al-Kassem, Anas] Union Med Care & Relief Org Canada UOSSM Canada, Mississauga, ON, Canada; [Saqqur, Maher] Univ Alberta, Dept Neurol, Edmonton, AB, Canada; [Saqqur, Maher] Univ Toronto Mississauga, Dept Neurosci, MSK Trillium Hosp, Inst Better Hlth, Mississauga, ON, Canada		Fatima, N (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St, Boston, MA 02114 USA.	Fnida99@yahoo.com		Fatima, Nida/0000-0002-0976-888X	Union of Medical Care and Relief Organizations (UOSSM)	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The funding of data collection for the underlying administrative dataset was supplied by the Union of Medical Care and Relief Organizations (UOSSM). UOSSM had no role in the design, analysis or interpretation of the data, the writing of this manuscript, nor in the decision to publish.	Abdallah YEH, 2019, NEUROL-CLIN PRACT, V9, P9, DOI 10.1212/CPJ.0000000000000556; Alahdab Fares, 2014, Avicenna J Med, V4, P51, DOI 10.4103/2231-0770.133329; Elamein M, 2017, LANCET, V390, P2278, DOI 10.1016/S0140-6736(17)31328-4; Guha-Sapir D, 2018, LANCET GLOB HEALTH, V6, pE103, DOI [10.1016/s2214-109x(17)30469-2, 10.1016/S2214-109X(17)30469-2]; Guha-Sapir D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4736; Jamous MA, 2019, J NEUROL SURG PART A, V80, P345, DOI 10.1055/s-0039-1683878; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mowafi H, 2016, JAMA SURG, V151, P815, DOI 10.1001/jamasurg.2016.1297; Nasser R, 2016, SYRIA CONFRONTING FR; Patel P, 2017, B WORLD HEALTH ORGAN, V95, P79, DOI 10.2471/BLT.15.168328; Ri S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217905; Safeguarding Health in Conflict Coalition, 2017, IMPUNITY MUST END AT, P84; UNHCR, 2020, SYR REG REF RESP	13	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.												10.1007/s10072-022-05878-3		JAN 2022	6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE6FK	WOS:000741218900001	35018549	Green Submitted			2022-02-06	
J	Huang, YT; Zhang, HFZ; Yang, EW; Yue, KY; Gao, XY; Dai, SH; Wei, JL; Yang, YF; Luo, P; Li, X; Jiang, XF				Huang, Yutao; Zhang, Haofuzi; Yang, Erwan; Yue, Kangyi; Gao, Xiangyu; Dai, Shuhui; Wei, Jialiang; Yang, Yuefan; Luo, Peng; Li, Xin; Jiang, Xiaofan			Integrated Proteome and Phosphoproteome Analyses Reveal Early- and Late-Stage Protein Networks of Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article; Early Access						Traumatic brain injury; Proteome; Phosphoproteome; Protein-protein interaction; Cross-talk pathway and process	CLOSED-HEAD-INJURY; MODEL; RATS	Traumatic brain injury (TBI) is a major public health concern all around the world. Accumulating evidence suggests that pathological processes after brain injury continuously evolve. Here, we identified the differentially expressed proteins (DEPs) and differentially expressed phosphoproteins (DEPPs) in the early and late stages of TBI in mice using TMT labeling, enrichment of Phos affinity followed, and high-resolution LC-MS/MS analysis. Subsequently, integrative analyses, including functional enrichment-based clustering analysis, motif analysis, cross-talk pathway/process enrichment analysis, and protein-protein interaction enrichment analysis were performed to further identify the different and similar pathophysiologic mechanisms in the early and late stage. Our work reveals a map of early and late-stage protein networks in TBI, which shed light on useful biomarkers and the underlying mechanisms in TBI and its sequelae.	[Huang, Yutao; Zhang, Haofuzi; Yang, Erwan; Yue, Kangyi; Gao, Xiangyu; Dai, Shuhui; Wei, Jialiang; Yang, Yuefan; Luo, Peng; Jiang, Xiaofan] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Yang, Yuefan] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Li, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China		Luo, P; Jiang, XF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.; Li, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	pengluo@fmmu.edu.cn; li_xin_mail@126.com; jiangxf@fmmu.edu.cn		Huang, Yutao/0000-0002-2433-8183	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771322, 82171363, 82171321, 81871023]; Youth Talent Lifting Project [17-JCJQQT-037]; Youth Nova Program of Shanxi [2021KJXX-19]	This research was funded by the National Natural Science Foundation of China (Grant No. 81771322, 82171363, 82171321, 81871023), the Youth Talent Lifting Project (Grant No. 17-JCJQQT-037), and the Youth Nova Program of Shanxi (Grant No. 2021KJXX-19).	Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Feeney C, 2017, ANN NEUROL, V82, P30, DOI 10.1002/ana.24971; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Graham NSN, 2020, BRAIN, V143, P3685, DOI 10.1093/brain/awaa316; Green REA, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00615; Huang D, 2020, AGING, V12; Jamjoom AAB, 2020, BRAIN J NEUROL; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Li L, 2020, NEUROSCI BIOBEHAV R; Littlejohn EL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00925-6; Luo P, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1731-x; Luo P, 2015, NEUROLOGY, V84, P1909, DOI 10.1212/WNL.0000000000001544; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mulherkar S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010245; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Sawant-Pokam PA, 2020, J CLIN INVEST, V130, P6005, DOI 10.1172/JCI134793; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Vadhan JD, 2021, PHARMACOL THERAPEUT, V218, DOI 10.1016/j.pharmthera.2020.107684; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HX, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111547; Yuen KCJ, 2020, J CLIN ENDOCR METAB, V105, pE3054, DOI 10.1210/clinem/dgaa398; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	42	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.												10.1007/s12031-021-01949-w		JAN 2022	13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	YF7GT	WOS:000741971200001	35023002				2022-02-06	
J	Samuel, IBH; Pollin, KU; Breneman, CB				Samuel, Immanuel Babu Henry; Pollin, Kamila U.; Breneman, Charity B.			Lower cortical volume is associated with poor sleep quality after traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article; Early Access						Traumatic brain injury (TBI); Pittsburgh sleep quality index (PSQI); Voxel based morphometry (VBM); Sleep quality	DEFAULT MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; FUNCTIONAL CONNECTIVITY; INSOMNIA; DISTURBANCES; CONSEQUENCES; SCHIZOPHRENIA; OSCILLATIONS; IMPAIRMENTS	Traumatic brain injury (TBI) is known to be associated with poor sleep. In this report, we aimed to identify associations between differences in cortical volume and sleep quality post-TBI. MRI anatomical scans from 88 cases with TBI were analyzed in this report. Subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Voxel Based Morphometry (VBM), was used to obtain statistical maps of the association between PSQI and cortical volume in gray matter and white matter voxels. Higher PSQI total scores (poor sleep quality) were strongly associated with smaller gray matter volume in the cerebellum. White matter volume was not associated with total PSQI. The sleep disturbance subcomponent showed a significant association with gray and white matter volumes in the cerebellum. Although not significant, cortical areas such as the cingulate and medial frontal regions were associated with sleep quality. The cerebellum with higher contribution to motor and autonomic systems was associated strongly with poor sleep quality. Additionally, regions that play critical roles in inhibitory brain function and suppress mind wandering (i.e., default mode network including medial frontal and cingulate regions) were associated (although to a lesser extent) with sleep. Our findings suggest that poor sleep quality following TBI is significantly associated with lower cerebellar volume, with trending relationships in regions associated with inhibitory function.	[Samuel, Immanuel Babu Henry; Pollin, Kamila U.; Breneman, Charity B.] Vet Affairs Med Ctr, War Related Illness Sr Injury Study Ctr, 50 Irving St NW, Washington, DC 20422 USA; [Samuel, Immanuel Babu Henry; Breneman, Charity B.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA		Samuel, IBH (corresponding author), Vet Affairs Med Ctr, War Related Illness Sr Injury Study Ctr, 50 Irving St NW, Washington, DC 20422 USA.; Samuel, IBH (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	Immanuel.samuel@va.gov			Federal Interagency Traumatic Brain Injury Research (FITBIR) Informatics Systems	Data and/or research tools used in the preparation of this manuscript were obtained and analyzed from the controlled access datasets distributed from the Department of Defense (DOD) - and National Institutes of Health (NIH) -supported by the Federal Interagency Traumatic Brain Injury Research (FITBIR) Informatics Systems. FITBIR is a collaborative biomedical informatics system created by the DOD and the NIH to provide a national resource to support and accelerate research in TBI.	AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Babu Henry Samuel Immanuel, 2021, Mil Med, DOI 10.1093/milmed/usab377; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowring A, 2019, HUM BRAIN MAPP, V40, P3362, DOI 10.1002/hbm.24603; Burke SE., 2017, J CLIN TRANSL SCI, V1, P59, DOI [10.1017/cts.2017.210, DOI 10.1017/CTS.2017.210]; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Canto CB, 2017, TRENDS NEUROSCI, V40, P309, DOI 10.1016/j.tins.2017.03.001; Castellazzi G, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00331; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; DelRosso LM, 2014, NEUROL CLIN, V32, P893, DOI 10.1016/j.ncl.2014.07.003; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Ferguson BR, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00037; Galindo L, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00298; Gao ZY, 2018, NATURE, V563, P113, DOI 10.1038/s41586-018-0633-x; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Helfer B, 2019, EUR PSYCHIAT, V55, P45, DOI 10.1016/j.eurpsy.2018.09.006; Hill MN, 2018, NEUROPSYCHOPHARMACOL, V43, P80, DOI 10.1038/npp.2017.162; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huysmans D, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092133; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Janssens C, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13011; Joo EY, 2013, SLEEP, V36, P999, DOI 10.5665/sleep.2796; Joormann J, 2007, APPL PREV PSYCHOL, V12, P128, DOI 10.1016/j.appsy.2007.09.002; Kajimura S, 2016, NEUROIMAGE, V133, P21, DOI 10.1016/j.neuroimage.2016.03.009; Killgore WDS, 2013, NEUROREPORT, V24, P233, DOI 10.1097/WNR.0b013e32835edbdd; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Klumpp H, 2017, DEPRESS ANXIETY, V34, P651, DOI 10.1002/da.22622; Korenic SA, 2020, J PSYCHIATR RES, V120, P14, DOI 10.1016/j.jpsychires.2019.10.006; Lopez-Jornet P, 2015, J EUR ACAD DERMATOL, V29, P1285, DOI 10.1111/jdv.12795; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Macey PM, 2008, SLEEP, V31, P967; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCormick C, 2018, J NEUROSCI, V38, P2745, DOI 10.1523/JNEUROSCI.1812-17.2018; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meles SK, 2018, J NUCL MED, V59, P1437, DOI 10.2967/jnumed.117.202242; Mendlewicz J, 2009, WORLD J BIOL PSYCHIA, V10, P269, DOI 10.3109/15622970802503086; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Murphy C, 2018, NEUROIMAGE, V171, P393, DOI 10.1016/j.neuroimage.2018.01.017; Mysliwiec V, 2018, SLEEP MED REV, V37, P94, DOI 10.1016/j.smrv.2017.01.004; NASRALLAH HA, 1981, PSYCHOSOMATICS, V22, P359; Neumann N, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa035; Norman LJ, 2019, BIOL PSYCHIAT, V85, P713, DOI 10.1016/j.biopsych.2018.11.010; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Paik SH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00516; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Park YK, 2019, J CLIN NEUROL, V15, P438, DOI 10.3988/jcn.2019.15.4.438; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Payne L, 2013, J COGNITIVE NEUROSCI, V25, P1463, DOI 10.1162/jocn_a_00395; Philip NS, 2018, BIOL PSYCHIAT, V83, P263, DOI 10.1016/j.biopsych.2017.07.021; Samuel IBH, 2018, NEUROIMAGE, V183, P897, DOI 10.1016/j.neuroimage.2018.08.063; Santarnecchi E, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/3678534; Scheeringa R, 2012, BRAIN CONNECT, V2, P254, DOI 10.1089/brain.2012.0088; Schnakers C, 2019, J NEUROL NEUROSUR PS, V90, P617, DOI 10.1136/jnnp-2017-317829; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Sexton CE, 2017, HUM BRAIN MAPP, V38, P5465, DOI 10.1002/hbm.23739; Sexton CE, 2014, NEUROLOGY, V83, P967, DOI 10.1212/WNL.0000000000000774; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sours C, 2017, J NEUROTRAUM, V34, P1473, DOI 10.1089/neu.2016.4570; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Terpou Braeden A, 2019, Chronic Stress (Thousand Oaks), V3, p2470547018821496, DOI 10.1177/2470547018821496; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Wang L, 2014, SCHIZOPHR RES, V160, P67, DOI 10.1016/j.schres.2014.09.034; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yang C, 2006, SCHIZOPHR RES, V82, P251, DOI 10.1016/j.schres.2005.10.021; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zhou FQ, 2017, NEUROIMAGE-CLIN, V15, P458, DOI 10.1016/j.nicl.2016.05.011	83	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.												10.1007/s11682-021-00615-4		JAN 2022	10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE6IE	WOS:000741226100001	35018551				2022-02-06	
J	Timilsina, SS; Durr, N; Yafia, M; Sallum, H; Jolly, P; Ingber, DE				Timilsina, Sanjay S.; Durr, Nolan; Yafia, Mohamed; Sallum, Hani; Jolly, Pawan; Ingber, Donald E.			Ultrarapid Method for Coating Electrochemical Sensors with Antifouling Conductive Nanomaterials Enables Highly Sensitive Multiplexed Detection in Whole Blood	ADVANCED HEALTHCARE MATERIALS			English	Article; Early Access						antifouling; biomarkers; electrochemical biosensors; multiplexing; myocardial infarction; surface chemistry; traumatic brain injury	SURFACE-CHEMISTRY; PROTEINS; GLUTARALDEHYDE; DIAGNOSIS; GRAPHENE	The commercialization of electrochemical (EC)-sensors for medical diagnostics is currently limited by their rapid fouling in biological fluids, and use of potential antifouling coatings is hindered by the complexity and cost of application methods. Here, a simple ultrafast (< 1 min) method is described for coating EC-sensors with cross-linked bovine serum albumin infused with conductive, pentaamine-functionalized, graphene particles that can be stored at room temperature for at least 20-weeks, which provides unprecedented sensitivity and selectivity for diagnostic applications. The antifouling coating is applied directly on-chip using rapid heating via simple dip-coating, which provides unprecedented high levels of electrode conductivity for up to 9-weeks in unprocessed biological samples. This method is leveraged to develop a multiplexed platform for detecting clinically relevant biomarkers including myocardial infarction and traumatic brain injury using only 15 mu L of blood. Single-digit pg mL(-1) sensitivity is obtained within minutes in unprocessed human plasma and whole blood, which is faster and at least 50 times more sensitive than traditional enzyme-linked immunosorbent assays, and the signal generated is stable enough to be measured after 1 week of storage. The multiplexed EC-sensor platform is validated by analyzing 22 patient samples and demonstrating excellent correlation with reported clinical values.	[Timilsina, Sanjay S.; Durr, Nolan; Yafia, Mohamed; Sallum, Hani; Jolly, Pawan; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Med Sch, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Boston, MA 02115 USA		Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu		Sharma Timilsina, Sanjay/0000-0001-7550-2724; Jolly, Pawan/0000-0003-4076-2328; Ingber, Donald/0000-0002-4319-6520	Wyss Institute for Biologically Inspired Engineering at Harvard University and Biomedical Advanced Research and Development Authority (BARDA) [75A50121C00075]; Fonds de recherche du Quebec nature et technologie (FRQNT) [260284]	The authors thank Eurofins Scientific for optical characterization. They also acknowledge research funding from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Biomedical Advanced Research and Development Authority (BARDA; contract #75A50121C00075). M.Y. acknowledges Fonds de recherche du Quebec nature et technologie (FRQNT) postdoctoral fellowship #260284. S.S.T., N.D., P.J., and D.E.I. conceived this study. Experiments were carried out by S.S.T., N.D., M.Y., and P.J. under the guidance of D.E.I. Data analysis was carried out by S.S.T., N.D., and P.J., M.Y. developed the microfluidic chip cartridge and assisted with the microfluidic detection assay. H.S. developed the automated peristaltic pump system to perform microfluidics. P.J. conceptualized the idea, coordinated the experiments, and managed the project progress. All authors discussed the results and contributed to writing the manuscript.	Bhattacharyya S, 1998, J APPL PHYS, V83, P4491, DOI 10.1063/1.367211; Campuzano S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020423; Cevik S, 2019, CLIN NEUROL NEUROSUR, V183, DOI 10.1016/j.clineuro.2019.105380; CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418; Christensen P., 2007, TECHNIQUES MECH ELEC; Cui M, 2017, SENSOR ACTUAT B-CHEM, V244, P742, DOI 10.1016/j.snb.2017.01.060; del Rio JS, 2019, NAT NANOTECHNOL, V14, P1143, DOI 10.1038/s41565-019-0566-z; Dou MW, 2017, BIOSENS BIOELECTRON, V87, P865, DOI 10.1016/j.bios.2016.09.033; Eggers KM, 2009, CLIN CHEM, V55, P85, DOI 10.1373/clinchem.2007.101683; Elgrishi N, 2018, J CHEM EDUC, V95, P197, DOI 10.1021/acs.jchemed.7b00361; Gooding JJ, 2014, J BRAZIL CHEM SOC, V25, P418, DOI 10.5935/0103-5053.20130306; Hanssen BL, 2016, REV ANAL CHEM, V35, P1, DOI 10.1515/revac-2015-0008; Hosseini S, 2014, APPL SURF SCI, V317, P630, DOI 10.1016/j.apsusc.2014.08.167; Hu YC, 2016, LANGMUIR, V32, P11763, DOI 10.1021/acs.langmuir.6b03016; Hui N, 2017, ACS APPL MATER INTER, V9, P2914, DOI 10.1021/acsami.6b11682; Jiang C, 2020, CHEM REV, V120, P3852, DOI 10.1021/acs.chemrev.9b00739; Jolly P, 2015, SENSOR ACTUAT B-CHEM, V209, P306, DOI 10.1016/j.snb.2014.11.083; Libertino S, 2007, APPL SURF SCI, V253, P9116, DOI 10.1016/j.apsusc.2007.05.039; Lin PH, 2020, ANALYST, V145, P1110, DOI 10.1039/c9an02017a; Lipinska W, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/ab4fab; Lv SL, 2018, BIOSENS BIOELECTRON, V117, P138, DOI 10.1016/j.bios.2018.06.010; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Mueller T, 2018, CLIN CHIM ACTA, V487, P66, DOI 10.1016/j.cca.2018.09.026; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Montiel VRV, 2018, J AM CHEM SOC, V140, P14050, DOI 10.1021/jacs.8b08894; Russo MJ, 2021, ACS SENSORS, V6, P1482, DOI 10.1021/acssensors.1c00390; Sanjay ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep30474; Sanjay ST, 2015, ANALYST, V140, P7062, DOI 10.1039/c5an00780a; Saravanan N, 2014, J REINF PLAST COMP, V33, P1158, DOI 10.1177/0731684414524847; Taneja I, 2021, CTS-CLIN TRANSL SCI, V14, P1578, DOI 10.1111/cts.13030; Tyler BJ, 2011, BIOINTERPHASES, V6, P135, DOI 10.1116/1.3622347; Wilhelmi M, 2011, ANAL BIOANAL CHEM, V400, P697, DOI 10.1007/s00216-011-4833-6; Xie WJ, 2021, APPL SURF SCI, V544, DOI 10.1016/j.apsusc.2021.148950; Yang D, 2009, CARBON, V47, P145, DOI 10.1016/j.carbon.2008.09.045; Yang LL, 2020, ANAL CHIM ACTA, V1124, P104, DOI 10.1016/j.aca.2020.05.025; Zanello P., 2019, R SOC CHEM, V2019, P825; Zupancic U, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202010638	38	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.											2102244	10.1002/adhm.202102244		JAN 2022	13	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	YE8BJ	WOS:000741344200001	34965031				2022-02-06	
J	Kozin, ED; Knoll, RM; Bhattacharyya, N				Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil			Association of Pediatric Hearing Quality and Sports Participation: A Population-Based Study	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article; Early Access						traumatic brain injury; hearing loss; head injury; sport-related concussion	HIGH-SCHOOL; CONCUSSION; EPIDEMIOLOGY; IMPACT	Sports-related injuries, such as concussion, during childhood may result in considerable morbidity, including a range of negative developmental consequences. Auditory dysfunction is generally recognized to be a possible sequela of sports-related concussion; however, few epidemiologic studies have quantified the association between hearing quality and sports-related activity in the pediatric population. The National Health and Nutrition Examination Survey for the 2015-2016 cycle was utilized to determine the association of sports activities and hearing quality. Subjective abnormal hearing quality was more frequent among children who played football than those that did not (36.5% vs 26.8%; odds ratio, 1.56 [95% CI, 1.23-2.00]; P = .001). Other sports, such as basketball and soccer, did not have this association with hearing quality (P = .496 and P = .852, respectively). Our findings suggest a notable association between practice of a potentially high concussion sport and hearing quality. Children practicing football are 1.56 times more likely to report abnormal hearing quality. Level of Evidence: 4.	[Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil] Massachusetts Eye & Ear, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Kozin, Elliott D.; Knoll, Renata M.; Bhattacharyya, Neil] Harvard Med Sch, Dept Otolaryngol, Boston, MA 02115 USA		Kozin, ED (corresponding author), Massachusetts Eye & Ear, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.	Elliott_Kozin@meei.harvard.edu					Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Osetinsky LM, 2017, CLIN SPORT MED, V36, P315, DOI 10.1016/j.csm.2016.11.005; Thompson EC, 2018, BRAIN INJURY, V32, P763, DOI 10.1080/02699052.2018.1447686	11	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.											01945998211064578	10.1177/01945998211064578		JAN 2022	3	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	YP3LN	WOS:000748526400001	35015576				2022-02-06	
J	Ladang, A; Kovacs, S; Lengele, L; Locquet, M; Reginster, JY; Bruyere, O; Cavalier, E				Ladang, Aurelie; Kovacs, Stephanie; Lengele, Laetitia; Locquet, Medea; Reginster, Jean-Yves; Bruyere, Olivier; Cavalier, Etienne			Neurofilament light chain concentration in an aging population	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article; Early Access						Neurology; Blood-based biomarkers; NF-L; Reference ranges; Aging	REFERENCE INTERVALS; BLOOD; CREATININE; PROTEIN	Background Neurofilament light chain (NF-L) concentration is recognized to be modified in neurological diseases and traumatic brain injuries, but studies in the normal aging population are lacking. It is, therefore, urgent to identify influencing factors of NF-L concentration in the aging population. Method We assessed NF-L concentration in sera of a large cohort of 409 community-dwelling adults aged over 65 years. We studied the association between NF-L and various physiological factors but also with self-reported comorbidities or life-style habits. Results We showed that NF-L concentration in serum was tightly associated with cystatin C concentration (r = 0.501, p < 0.0001) and consequently, to the estimated glomerular filtration rate (eGFR) (r = - 0.492; p < 0.0001). Additionally, NF-L concentration was dependent on age and body mass index (BMI) but not sex. Among the self-reported comorbidities, subjects who reported neurological disorders, cardiovascular diseases or history of fracture had higher NF-L concentration in univariate analysis, whereas it was only the case for subjects who reported neurological disorders in the multivariate analysis. NF-L concentration was also increased when Mini-Mental State Examination (MMSE) was decreased (<= 25 points) but not when geriatric depression score (GDS) was increased (> 5 points) in both univariate and multivariate analysis. Finally, we are providing reference ranges by age categories for subjects with or without altered renal function. Conclusion NF-L concentration in the aging population is not driven by the increasing number of comorbidities or depression. Yet, NF-L blood concentration is dependent on kidney function and NF-L interpretation in patients suffering from renal failure should be taken with caution.	[Ladang, Aurelie; Kovacs, Stephanie; Cavalier, Etienne] Univ Liege, Clin Chem Dept, CHU Liege, Ave Hop 1, B-4000 Liege, Belgium; [Lengele, Laetitia; Locquet, Medea; Reginster, Jean-Yves; Bruyere, Olivier] Univ Liege, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Div Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium; [Bruyere, Olivier] Univ Liege, CHU Liege, SportS2, Phys Rehabil Med & Sports Traumatol, Liege, Belgium		Ladang, A (corresponding author), Univ Liege, Clin Chem Dept, CHU Liege, Ave Hop 1, B-4000 Liege, Belgium.	aladang@chuliege.be		Ladang, Aurelie/0000-0002-5316-3108	University of LiegeUniversity of Liege; clinical chemistry department	This study was supported by clinical chemistry department and University of Liege.	Akamine S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76990-7; Al Shweiki MHDR, 2019, J PSYCHIATR RES, V113, P137, DOI 10.1016/j.jpsychires.2019.03.019; Altman D.G., 1990, PRACTICAL STAT MED R; Andersson E, 2020, NEUROBIOL AGING, V95, P143, DOI 10.1016/j.neurobiolaging.2020.07.018; Arseneau E, 2016, CLIN CHEM LAB MED, V54, P377, DOI 10.1515/cclm-2015-0420; Ashton Nicholas J, 2021, Nat Commun, V12, P3400, DOI 10.1038/s41467-021-23620-z; Barro C, 2020, ANN CLIN TRANSL NEUR, V7, P2508, DOI 10.1002/acn3.51234; Beaudart C, 2015, EXP GERONTOL, V69, P103, DOI 10.1016/j.exger.2015.05.003; Chung CC, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420975917; Constantinescu R, 2010, PARKINSONISM RELAT D, V16, P142, DOI 10.1016/j.parkreldis.2009.07.007; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Ferreira-Atuesta C, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.642384; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Hou YC, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.657794; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kalm M, 2017, BRAIN RES, V1668, P12, DOI 10.1016/j.brainres.2017.05.011; Katisko K, 2020, J NEUROL, V267, P162, DOI 10.1007/s00415-019-09567-8; Khalil M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14612-6; Korley FK, 2019, STROKE, V50, P1669, DOI 10.1161/STROKEAHA.119.024941; Kuhle J, 2019, NEUROLOGY, V92, pE1007, DOI 10.1212/WNL.0000000000007032; Lambertsen KL, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10010056; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li DN, 2019, NEUROL THER, V8, pS73, DOI 10.1007/s40120-019-00164-5; Musso G, 2019, CLIN CHEM LAB MED, V57, P1433, DOI 10.1515/cclm-2019-0680; O'Bryant SE, 2019, JAMA NEUROL, V76, P1009, DOI 10.1001/jamaneurol.2019.0845; Rosen H, 2004, J NEUROL SCI, V221, P19, DOI 10.1016/j.jns.2004.03.003; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Tiedt S, 2018, NEUROLOGY, V91, pE1338, DOI 10.1212/WNL.0000000000006282; Uher T, 2021, MULT SCLER J, V27, P220, DOI 10.1177/1352458520912379; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Zou LX, 2020, EUR J INTERN MED, V80, P29, DOI 10.1016/j.ejim.2020.04.044	34	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.												10.1007/s40520-021-02054-z		JAN 2022	9	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	YE6KL	WOS:000741232000001	35018623	hybrid			2022-02-06	
J	Blass, BE; Gao, R; Blattner, KM; Gordon, JC; Pippin, DA; Canney, DJ				Blass, Benjamin E.; Gao, Rong; Blattner, Kevin M.; Gordon, John C.; Pippin, Douglas A.; Canney, Daniel J.			Synthesis and evaluation of novel, selective, functionalized gamma-butyrolactones as sigma-2 ligands	MEDICINAL CHEMISTRY RESEARCH			English	Article						Sigma-2; Sigma-1; gamma-butyrolactone; Sigma receptor	RECEPTOR; IDENTIFICATION	The sigma-2 (sigma(2)) receptor was discovered nearly 40 years ago and was recently identified as the Transmembrane Protein 97 (TMEM97, also known as MAC30 (Meningioma-associated protein)). Aberrant sigma(2) activity has been linked to diseases and conditions such as schizophrenia, Alzheimer's disease, neuropathic pain, traumatic brain injury, and cancer. The utility of sigma(2) as a therapeutic target is currently under investigation in numerous laboratories. Herein, we report on the synthesis and evaluation of a series of novel, functionalized gamma-butyrolactones that are potent sigma(2) receptor ligands.	[Blass, Benjamin E.; Gao, Rong; Gordon, John C.; Canney, Daniel J.] Temple Sch Pharm, Moulder Ctr Drug Discovery Res, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA; [Blattner, Kevin M.; Pippin, Douglas A.] Praeventix Inc, 665 Stockton Dr,Suite 200H, Exton, PA 19341 USA		Blass, BE (corresponding author), Temple Sch Pharm, Moulder Ctr Drug Discovery Res, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA.	Benjamin.Blass@Temple.edu		Blass, Benjamin/0000-0003-2449-4503	National Institute of Mental Health's Psychoactive Drug Screening ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [HHSN-271-2013-00017-C]	Ki determinations for compound binding to Sigma-1, and Sigma-2 were generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. For experimental details please refer to the PDSP web site https://pdsp.unc.edu/ims/investigator/web/.The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. TPSA and cLogP values were generated using the Dotmatics software suite (Dotmatics LLC The Old Monastery, Windhill Bishops, Stortford Herts, CW23 2ND UK).	Alon A, 2017, P NATL ACAD SCI USA, V114, P7160, DOI 10.1073/pnas.1705154114; Asong G, 2019, BIOORGAN MED CHEM, V27, P2629, DOI 10.1016/j.bmc.2019.04.012; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Blass BE, 2021, MED CHEM RES, V30, P1713, DOI 10.1007/s00044-021-02771-0; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; Ebrahimi-Fakhari D, 2016, HUM MOL GENET, V25, P3588, DOI 10.1093/hmg/ddw204; Guo L, 2015, CURR MED CHEM, V22, P989, DOI 10.2174/0929867322666150114163607; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; KHAZAN N, 1984, NEUROPHARMACOLOGY, V23, P983, DOI 10.1016/0028-3908(84)90015-7; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Sahn JJ, 2017, ACS CHEM NEUROSCI, V8, P1801, DOI 10.1021/acschemneuro.7b00200; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Vazquez-Rosa E, 2019, ACS CHEM NEUROSCI, V10, P1595, DOI 10.1021/acschemneuro.8b00543; VILNER BJ, 1995, CANCER RES, V55, P408; Yang JS, 2007, DRUG METAB DISPOS, V35, P501, DOI 10.1124/dmd.106.013359; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917	20	0	0	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1054-2523	1554-8120		MED CHEM RES	Med. Chem. Res.	FEB	2022	31	2					337	349		10.1007/s00044-021-02831-5		JAN 2022	13	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YK1YQ	WOS:000740594700001					2022-02-06	
J	Clark, AT; Abrahamson, EE; Harper, MM; Ikonomovic, MD				Clark, Alexander T.; Abrahamson, Eric E.; Harper, Matthew M.; Ikonomovic, Milos D.			Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer's disease related A beta amyloidosis	FLUIDS AND BARRIERS OF THE CNS			English	Article						Alzheimer's disease; Amyloid; Astrocyte; Blast injury; Blood-brain barrier; NVU; Neurovascular unit; Pericyte; Traumatic brain injury	BLOOD-BRAIN-BARRIER; EXPERIMENTAL RODENT MODEL; GANGLION-CELL DAMAGE; HIPPOCAMPAL MICROVASCULATURE; NEUROVASCULAR DYSFUNCTION; CAPILLARY PERICYTES; SENILE PLAQUES; FLOW; AGE; DISRUPTION	Background: Altered cerebrovascular function and accumulation of amyloid-beta (A beta) after traumatic brain injury (TBI) can contribute to chronic neuropathology and increase the risk for Alzheimer's disease (AD). TBI due to a blast-induced shock wave (bTBI) adversely affects the neurovascular unit (NVU) during the acute period after injury. However, the chronic effects of bTBI and A beta on cellular components of the NVU and capillary network are not well understood. Methods: We exposed young adult (age range: 76-106 days) female transgenic (Tg) APP/PS1 mice, a model of AD-like A beta amyloidosis, and wild type (Wt) mice to a single bTBI (similar to 138 kPa or similar to 20 psi) or to a Sham procedure. At 3-months or 12-months survival after exposure, we quantified neocortical A beta load in Tg mice, and percent contact area between aquaporin-4 (AQP4)-immunoreactive astrocytic end-feet and brain capillaries, numbers of PDGFR beta-immunoreactive pericytes, and capillary densities in both genotypes. Results: The astroglia AQP4-capillary contact area in the Tg-bTBI group was significantly lower than in the Tg-Sham group at 3-months survival. No significant changes in the AQP4-capillary contact area were observed in the Tg-bTBI group at 12-months survival or in the Wt groups. Capillary density in the Tg-bTBI group at 12-months survival was significantly higher compared to the Tg-Sham control and to the Tg-bTBI 3-months survival group. The Wt-bTBI group had significantly lower capillary density and pericyte numbers at 12-months survival compared to 3-months survival. When pericytes were quantified relative to capillary density, no significant differences were detected among the experimental groups, for both genotypes. Conclusion: In conditions of high brain concentrations of human A beta, bTBI exposure results in reduced AQP4 expression at the astroglia-microvascular interface, and in chronic capillary proliferation like what has been reported in AD. Long term microvascular changes after bTBI may contribute to the risk for developing chronic neurodegenerative disease later in life.	[Abrahamson, Eric E.; Ikonomovic, Milos D.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Univ Dr C, Pittsburgh, PA 15240 USA; [Clark, Alexander T.; Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol, Sch Med, 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Dept Psychiat, Sch Med, Thomas Detre Hall WPH,Room 1421,3811 Ohara St, Pittsburgh, PA 15213 USA; [Harper, Matthew M.] Iowa City VA Ctr Prevent & Treatment Visual Loss, 601 Hwy 6 West, Iowa City, IA 52246 USA; [Harper, Matthew M.] Univ Iowa, Dept Ophthalmol & Visual Sci & Biol, 200 Hawkins Dr, Iowa City, IA 52242 USA		Ikonomovic, MD (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Univ Dr C, Pittsburgh, PA 15240 USA.; Ikonomovic, MD (corresponding author), Univ Pittsburgh, Dept Neurol, Sch Med, 3471 Fifth Ave, Pittsburgh, PA 15213 USA.; Ikonomovic, MD (corresponding author), Univ Pittsburgh, Dept Psychiat, Sch Med, Thomas Detre Hall WPH,Room 1421,3811 Ohara St, Pittsburgh, PA 15213 USA.	ikonomovicmd@upmc.edu			Department of Veterans AffairsUS Department of Veterans Affairs [RX000952]; University of Pittsburgh Scholarly Research Project for Medical Students; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG052528, T32 MH019986]	Supported by Department of Veterans Affairs Grant RX000952 (MDI, MMH), NIH R01 AG052528 (MDI), T32 MH019986 (ATC), and the University of Pittsburgh Scholarly Research Project for Medical Students (ATC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the United States Government.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Abrahamson EE, 2013, J CEREBR BLOOD F MET, V33, P826, DOI 10.1038/jcbfm.2013.24; Abutarboush R, 2019, J NEUROTRAUM, V36, P3138, DOI 10.1089/neu.2019.6423; Acioglu C, 2021, BRAIN RES, V1758, DOI 10.1016/j.brainres.2021.147291; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051490; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Barretto TA, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0158; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bennett HC, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.627291; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Berthiaume AA, 2018, CELL REP, V22, P8, DOI 10.1016/j.celrep.2017.12.016; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burke MJC, 2014, NEUROPATH APPL NEURO, V40, P284, DOI 10.1111/nan.12085; Cheng JP, 2018, ACTA NEUROPATHOL, V136, P507, DOI 10.1007/s00401-018-1893-0; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; DeGracia DJ, 2007, NEUROL RES, V29, P356, DOI 10.1179/016164107X204666; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Farkas E, 2000, ACTA NEUROPATHOL, V100, P395, DOI 10.1007/s004010000195; Fernandez-Klett F, 2020, BRAIN PATHOL, V30, P1071, DOI 10.1111/bpa.12897; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Garcia GP, 2021, J NEUROTRAUM, V38, P3146, DOI 10.1089/neu.2021.0184; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Ghai V, 2020, J NEUROTRAUM, V37, P1418, DOI 10.1089/neu.2019.6826; Giuliani A, 2019, J NEUROPATH EXP NEUR, V78, P101, DOI 10.1093/jnen/nly125; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Harper MM, 2019, INVEST OPHTH VIS SCI, V60, P2716, DOI 10.1167/iovs.18-26353; Harper MM, 2014, INVEST OPHTH VIS SCI, V55, P1350, DOI 10.1167/iovs.13-13692; Hartmann DA, 2021, NAT NEUROSCI, V24, P633, DOI 10.1038/s41593-020-00793-2; Hawkes CA, 2013, EXP NEUROL, V250, P270, DOI 10.1016/j.expneurol.2013.09.020; Heyburn L, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.636707; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ikonomovic MD, 2020, ACTA NEUROPATHOL, V140, P463, DOI 10.1007/s00401-020-02175-1; Ikonomovic MD, 2019, NEUROPHARMACOLOGY, V145, P160, DOI 10.1016/j.neuropharm.2018.06.021; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kawoos U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84730-8; Kawoos U, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00650; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kisler K, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00027; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Korte N, 2020, ACTA NEUROPATHOL, V140, P793, DOI 10.1007/s00401-020-02215-w; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Logsdon AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29341-6; Lokkegaard A, 2001, HIPPOCAMPUS, V11, P726, DOI 10.1002/hipo.1088; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Ma QY, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0286-0; Meabon JS, 2020, J NEUROL SCI, V417, DOI 10.1016/j.jns.2020.117049; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MEIERRUGE W, 1985, ARCH GERONTOL GERIAT, V4, P219, DOI 10.1016/0167-4943(85)90004-4; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miners JS, 2018, J CEREBR BLOOD F MET, V38, P103, DOI 10.1177/0271678X17690761; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nelson AR, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00108; Nelson AR, 2016, BBA-MOL BASIS DIS, V1862, P887, DOI 10.1016/j.bbadis.2015.12.016; Nielsen S, 1997, J NEUROSCI, V17, P171; Nikolajsen GN, 2015, NEUROBIOL AGING, V36, P2954, DOI 10.1016/j.neurobiolaging.2015.08.004; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; NYENGAARD JR, 1988, APMIS, V96, P92; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; PERLMUTTER LS, 1990, BRAIN RES, V508, P13, DOI 10.1016/0006-8993(90)91111-S; Pogue AI, 2004, NEUROREPORT, V15, P1507, DOI 10.1097/01.wnr.0000130539.39937.1d; PORTER GA, 1990, EUR J CELL BIOL, V51, P85; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Richard E, 2010, J ALZHEIMERS DIS, V22, P811, DOI 10.3233/JAD-2010-100849; Ries M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00160; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Schager B, 2020, J CEREBR BLOOD F MET, V40, P2475, DOI 10.1177/0271678X19895245; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Soto-Rojas LO, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042022; STEWART PA, 1992, LAB INVEST, V67, P734; Sullivan DR, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000449; Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tachibana M, 2018, EXP NEUROL, V300, P13, DOI 10.1016/j.expneurol.2017.10.023; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Uzunalli G, 2021, FLUIDS BARRIERS CNS, V18, DOI 10.1186/s12987-020-00231-2; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152; Wu YX, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01178-7; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	136	0	0	5	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	JAN 10	2022	19	1							5	10.1186/s12987-021-00301-z			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE3MW	WOS:000741033200001	35012589	Green Published, gold			2022-02-06	
J	Tamez-Pena, J; Rosella, P; Totterman, S; Schreyer, E; Gonzalez, P; Venkataraman, A; Meyers, SP				Tamez-Pena, Jose; Rosella, Peter; Totterman, Saara; Schreyer, Edward; Gonzalez, Patricia; Venkataraman, Arun; Meyers, Steven P.			Post-concussive mTBI in Student Athletes: MRI Features and Machine Learning	FRONTIERS IN NEUROLOGY			English	Article						mTBI; post-concussion syndrome; quantitative MRI; diffusion imaging; radiomics	TRAUMATIC BRAIN-INJURY; RECOVERY; LEVEL; SPORT; TBI	Purpose: To determine and characterize the radiomics features from structural MRI (MPRAGE) and Diffusion Tensor Imaging (DTI) associated with the presence of mild traumatic brain injuries on student athletes with post-concussive syndrome (PCS).Material and Methods: 122 student athletes (65 M, 57 F), median (IQR) age 18.8 (15-20) years, with a mixed level of play and sports activities, with a known history of concussion and clinical PCS, and 27 (15 M, 12 F), median (IQR) age 20 (19, 21) years, concussion free athlete subjects were MRI imaged in a clinical MR machine. MPRAGE and DTI-FA and DTI-ADC images were used to extract radiomic features from white and gray matter regions within the entire brain (2 ROI) and the eight main lobes of the brain (16 ROI) for a total of 18 analyzed regions. Radiomic features were divided into five different data sets used to train and cross-validate five different filter-based Support Vector Machines. The top selected features of the top model were described. Furthermore, the test predictions of the top four models were ensembled into a single average prediction. The average prediction was evaluated for the association to the number of concussions and time from injury.Results: Ninety-one PCS subjects passed inclusion criteria (91 Cases, 27 controls). The average prediction of the top four models had a sensitivity of 0.80, 95% CI: [0.71, 0.88] and specificity of 0.74 95%CI [0.54, 0.89] for distinguishing subjects from controls. The white matter features were strongly associated with mTBI, while the whole-brain analysis of gray matter showed the worst association. The predictive index was significantly associated with the number of concussions (p < 0.0001) and associated with the time from injury (p < 0.01).Conclusion: MRI Radiomic features are associated with a history of mTBI and they were successfully used to build a predictive machine learning model for mTBI for subjects with PCS associated with a history of one or more concussions.	[Tamez-Pena, Jose] Tecnol Monterrey, Escuela Med, Monterrey, Mexico; [Tamez-Pena, Jose; Totterman, Saara; Schreyer, Edward; Gonzalez, Patricia] Qmetr Technol, Rochester, NY 14618 USA; [Rosella, Peter; Venkataraman, Arun; Meyers, Steven P.] Univ Rochester, Med Ctr, UR Imaging UMI, Rochester, NY 14642 USA		Tamez-Pena, J (corresponding author), Tecnol Monterrey, Escuela Med, Monterrey, Mexico.; Tamez-Pena, J (corresponding author), Qmetr Technol, Rochester, NY 14618 USA.	jose.tamezpena@tec.mx					Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; BARALDI A, 1995, IEEE T GEOSCI REMOTE, V33, P293, DOI 10.1109/36.377929; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CALDWELL CB, 1990, PHYS MED BIOL, V35, P235, DOI 10.1088/0031-9155/35/2/004; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; CLARKE KC, 1986, COMPUT GEOSCI, V12, P713, DOI 10.1016/0098-3004(86)90047-6; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Curry AE, 2019, J PEDIATR-US, V210, P13, DOI 10.1016/j.jpeds.2019.04.001; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Faqih MU, 2017, ADV HLTH SCI RES, V3, P130; Gioia G, 2006, TRAUMA, V4, P8; Hellewell SC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00350; Hellewell SC, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102253; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hier DB, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-021-00325-5; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; Holli KK, 2010, IFMBE PROC, V25, P37; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; Karr JE, 2021, BRAIN INJURY, V35, P1607, DOI 10.1080/02699052.2021.1976419; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Michoux N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145497; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; Scheifier C, 2017, PEDIATR RES, V81, P825, DOI 10.1038/pr.2017.3; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Siman R, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00249; Sorensen L, 2017, NEUROIMAGE-CLIN, V13, P470, DOI 10.1016/j.nicl.2016.11.025; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Unser M, 1996, P IEEE, V84, P626, DOI 10.1109/5.488704; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wilber CG, 2021, SEMIN NEUROL, V41, P124, DOI 10.1055/s-0041-1725134; Zhang S, 2019, EUR RADIOL, V29, P2751, DOI 10.1007/s00330-018-5921-1	44	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 10	2022	12								734329	10.3389/fneur.2021.734329			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YO6ZI	WOS:000748086500001	35082743	gold, Green Accepted			2022-02-06	
J	Bonn, MM; Dickey, JP; Moran, B; McGuire, S; Graham, L				Bonn, Marquise M.; Dickey, James P.; Moran, Becky; McGuire, Shannon; Graham, Laura			Completing an interdisciplinary outpatient intervention improves patient rehabilitation goals following a mild traumatic brain injury	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Mild traumatic brain injury; mTBI; interdisciplinary; rehabilitation; Canadian Occupational Performance Measure; COPM	OCCUPATIONAL PERFORMANCE-MEASURE; RESPONSE SHIFT; WORK	Background Individualized and interdisciplinary rehabilitation programs are recommended following a mild traumatic brain injury (mTBI), but often have long waitlists. Accordingly, innovative evidence-based programs are needed. Objectives The first objective of this study was to determine the number and types of rehabilitation goals chosen by individuals completing an interdisciplinary outpatient rehabilitation intervention (BrainEx90) for persisting symptoms following an mTBI. The second objective was to investigate whether completing BrainEx90 or choosing specific types of goals influenced performance and satisfaction ratings of these goals. Methods 217 individuals (44.4 +/- 13.5 years old) with persisting symptoms following an mTBI completed BrainEx90, a 16-session interdisciplinary group outpatient rehabilitation intervention at Parkwood Institute between November 2013 and September 2019. Performance and satisfaction ratings of self-identified goals before and after BrainEx90 were assessed using the Canadian Occupational Performance Measure, and changes in ratings were analyzed using a linear mixed effects model. Results 1008 goals were identified and categorized as: productivity (45%); leisure (37%); and self-care (18%). Satisfaction ratings were significantly higher for all goal types following BrainEx90. Satisfaction with self-care goals improved significantly more than leisure [t(151) = 3.24, p < .01] and productivity [t(144) = 2.97, p < .01] goals. Performance ratings were also significantly greater following BrainEx90 [2.4, 95% CI [2.27, 2.53], p < .01)]. Conclusion Performance and satisfaction of self-identified rehabilitation goals significantly improved following BrainEx90. Satisfaction with self-care goals demonstrated the greatest improvements, yet the most identified goal type was productivity.	[Bonn, Marquise M.] Western Univ, Fac Hlth Sci, Hlth & Rehabil Sci, London, ON, Canada; [Bonn, Marquise M.; Graham, Laura] Lawson Hlth Res Inst, London, ON, Canada; [Dickey, James P.] Western Univ, Fac Hlth Sci, Sch Kinesiol, London, ON, Canada; [Moran, Becky; McGuire, Shannon] Parkwood Inst, Reg Acquired Brain Injury Outpatient Program, London, ON, Canada; [Graham, Laura] Western Univ, Fac Hlth Sci, Sch Phys Therapy, London, ON, Canada		Graham, L (corresponding author), Western Univ, 1151 Richmond St, London, ON N6A 3K7, Canada.	lgraha29@uwo.ca	Dickey, James P/K-6776-2013	Dickey, James P/0000-0002-4101-835X			Acquired Brain Injury Knowledge Uptake and Guideline Development Group Strategy, 2007, ABIKUS EVIDENCE BASE; American Occupational Therapy Association-AOTA, 2014, AM J OCCUP THER, V68, ps01, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJOT.2014.682006]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Booth Julie, 2002, J Interprof Care, V16, P31, DOI 10.1080/13561820220104140; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cook Lysandra, 2005, Work, V25, P279; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Eyssen ICJM, 2011, J REHABIL RES DEV, V48, P517, DOI 10.1682/JRRD.2010.06.0110; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gordon KE, 2018, BRAIN INJURY, V32, P843, DOI 10.1080/02699052.2018.1463105; Hunt C., 2016, IDENTIFICATION HIDDE; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kendrick D, 2012, BRAIN INJURY, V26, P1243, DOI 10.3109/02699052.2012.672787; Lamontagne ME., 2016, INESSS ONF CLIN PRAC; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langer L., 2013, ARCH PHYS MED REHABI, V94, pe38, DOI [10.1016/j.apmr.2013.08.202, DOI 10.1016/J.APMR.2013.08.202]; Law Mary, 1998, Physical and Occupational Therapy in Pediatrics, V18, P83, DOI 10.1300/J006v18n01_06; Law MC., 2019, CANADIAN OCCUPATIONA, V5th Edition, P47; Lenth R., 2021, EMMEANS ESTIMATED MA; Macedo AM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1522, DOI 10.1002/art.24563; Marcoux J, 2017, CAN J NEUROL SCI, V44, P311, DOI 10.1017/cjn.2016.241; Momsen AM, 2012, J REHABIL MED, V44, P901, DOI 10.2340/16501977-1040; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Popescu C, 2015, J Med Life, V8, P272; R Core Team, 2021, R LANG ENV STAT COMP; Schwartz CE, 1999, SOC SCI MED, V48, P1531, DOI 10.1016/S0277-9536(99)00047-7; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Simmons CD, 2015, INT J PHYS MED REHAB, V3, P267, DOI [10.4172/2329-9096.1000267, DOI 10.4172/2329-9096.1000267]; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Statistic Canada, 2020, LAB FORC CHAR SEX DE, DOI [10.25318/1410001701-eng, DOI 10.25318/1410001701-ENG]; Stevens A, 2013, CLIN REHABIL, V27, P1005, DOI 10.1177/0269215513490178; Toomey M, 1995, Can J Occup Ther, V62, P242; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Walsh DA, 2004, SPINE, V29, P87, DOI 10.1097/01.BRS.0000105533.09601.4F	42	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2021.2022046		JAN 2022	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	YD6MG	WOS:000740553600001	35001810				2022-02-06	
J	Gao, C; Chen, XS; Xu, H; Guo, HM; Zheng, LX; Yan, YN; Ren, ZY; Luo, CL; Gao, Y; Wang, ZF; Tao, LY; Wang, T				Gao, Cheng; Chen, Xueshi; Xu, Heng; Guo, Hanmu; Zheng, Lexin; Yan, Ya'nan; Ren, Zhiyang; Luo, Chengliang; Gao, Yuan; Wang, Zufeng; Tao, Luyang; Wang, Tao			Restraint Stress Delays the Recovery of Neurological Impairments and Exacerbates Brain Damages through Activating Endoplasmic Reticulum Stress-mediated Neurodegeneration/Autophagy/Apopotosis post Moderate Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Moderate traumatic brain injury; Restraint stress; Endoplasmic reticulum stress; Neurodegeneration; Neurological impairments	SECONDARY NEURODEGENERATION; TAU PATHOLOGY; ASSOCIATION; STROKE; CORTEX	Based on accumulating evidence, patients recovering from mild and moderate traumatic brain injury (TBI) often experience increased sensitivity to stressful events. However, few studies have assessed on the effects and pathophysiological mechanisms of stress on TBI. In the current study, using a mouse model of moderate TBI, we investigated whether restraint stress (RS) regulates secondary neurodegeneration and neuronal cell death, which are commonly associated with neurological dysfunctions. Our data showed that RS significantly reduced body weight recovery, delayed the recovery of neurological functions (motor function, cognitive function and anxiety-like behavior) and exacerbated the brain lesion volume after moderate TBI. Immunofluorescence results indicated that moderate TBI-induced cell insults and blood-brain barrier leakage were aggravated by RS. Further Western blotting experiments showed that RS activated endoplasmic reticulum (ER) stress excessively after moderate TBI and decreased the number of NeuN-positive cells, but increased the number of CHOP/NeuN-co-positive cells by performing immunostaining in the injured cortex after moderate TBI. Moreover, RS increased the ratios of CHOP/A beta and CHOP/p-Tau co-positive cells in the injured cortex after moderate TBI. However, blocking ER stress with the classic ER stress inhibitor salubrinal remarkably decreased apoptosis and the levels of autophagy-related proteins in the mouse model of moderate TBI plus RS. Collectively, RS delays the recovery of neurological function and deteriorates morphological damage by excessively activating ER stress-mediated neurodegeneration, apoptosis and autophagy after moderate TBI. Thus, monitoring stress levels in patients recovering from non-severe TBI may merit consideration in the future.	[Gao, Cheng; Chen, Xueshi; Xu, Heng; Guo, Hanmu; Zheng, Lexin; Yan, Ya'nan; Ren, Zhiyang; Luo, Chengliang; Gao, Yuan; Wang, Zufeng; Tao, Luyang; Wang, Tao] Soochow Univ, Affiliated Guangji Hosp, Sch Basic Med & Biol Sci, Dept Forens Med, Suzhou 215123, Peoples R China		Tao, LY; Wang, T (corresponding author), Soochow Univ, Affiliated Guangji Hosp, Sch Basic Med & Biol Sci, Dept Forens Med, Suzhou 215123, Peoples R China.	taoluyang@suda.edu.cn; taowang@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82072110, 81971800, 81971163, 81601643]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants 82072110, 81971800, 81971163 and 81601643 from the National Natural Science Foundation of China and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Balkaya M, 2011, STROKE, V42, P3258, DOI 10.1161/STROKEAHA.110.607705; Broekaart DWM, 2018, EPILEPSIA, V59, P1931, DOI 10.1111/epi.14550; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Cui X, 2015, STROKE, V46, P827, DOI 10.1161/STROKEAHA.114.007145; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Gao C, 2020, STRESS, V23, P338, DOI 10.1080/10253890.2019.1678023; Gao JY, 2018, BEHAV BRAIN RES, V353, P114, DOI 10.1016/j.bbr.2018.07.007; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Huang RR, 2015, INT J MOL MED, V35, P553, DOI 10.3892/ijmm.2014.2026; Jones KA, 2015, BRAIN BEHAV IMMUN, V48, P57, DOI 10.1016/j.bbi.2015.02.014; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Li FZ, 2019, J NEUROCHEM, V148, P97, DOI 10.1111/jnc.14626; Li HH, 2015, INT J MOL SCI, V16, P10426, DOI 10.3390/ijms160510426; Li LP, 2021, NEUROSCI BIOBEHAV R, V120, P372, DOI 10.1016/j.neubiorev.2020.10.020; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Munoz-Mayorga D, 2020, NEUROBIOL STRESS, V13, DOI 10.1016/j.ynstr.2020.100241; Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Ong LK, 2017, J CEREBR BLOOD F MET, V37, P1338, DOI 10.1177/0271678X16654920; Rui TY, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12704; Santha P, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00088; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Su WJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00412; Toccalino D, 2021, OCCUP ENVIRON MED, V78, P769, DOI 10.1136/oemed-2020-107005; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Zhang JX, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7301615; Zhang Y, 2014, PHYSIOL BEHAV, V131, P41, DOI 10.1016/j.physbeh.2014.04.014; Zhao ZD, 2017, J CEREBR BLOOD F MET, V37, P3709, DOI 10.1177/0271678X17696100; Zhu XJ, 2017, NEUROCHEM INT, V110, P25, DOI 10.1016/j.neuint.2017.09.002	33	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-022-02735-4		JAN 2022	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD7LU	WOS:000740620100002	35001355				2022-02-06	
J	Raukola-Lindblom, M; Ljungqvist, L; Kurki, T; Tenovuo, O; Laasonen, M				Raukola-Lindblom, Marjaana; Ljungqvist, Linda; Kurki, Timo; Tenovuo, Olli; Laasonen, Marja			Cognitive-Linguistic outcome in moderate to severe diffuse axonal injury and association with fatigue	BRAIN INJURY			English	Article						Traumatic brain injury; diffuse axonal injury; cognitive-linguistic; fatigue	TRAUMATIC BRAIN-INJURY; MENTAL FATIGUE; ADULTS; MILD; INTERVENTIONS; PREDICTION; DISORDERS	Purpose Individuals with traumatic brain injury (TBI) often have persistent cognitive-linguistic deficits that negatively influence their life. Our objective was to examine the cognitive-linguistic outcome in individuals with moderate to severe diffuse axonal injury (DAI) with a novel test battery. As fatigue is a common symptom affecting the lives of individuals with DAI, we also wanted to assess whether the self-reported fatigue was associated with cognitive-linguistic abilities. Methods Selected cognitive-linguistic subtests of the Finnish KAT test and The Mental Fatigue Scale (MFS) were applied to 48 adults with moderate to severe DAI and 27 healthy controls. The majority of the participants with DAI were in the chronic stage. The groups were compared using ANCOVA. Linear regressions were used to analyze the association between MFS and cognitive-linguistic outcomes. Results The participants with DAI had significantly poorer scores than the controls in most cognitive-linguistic variables and reported significantly more fatigue. Two of the four cognitive-linguistic composite variables were associated with the degree of self-reported fatigue. Conclusions Cognitive-linguistic deficits are common in individuals with moderate to severe DAI, and The Finnish KAT test is a valuable tool to detect those. Fatigue was associated with linguistic working memory and language production.	[Raukola-Lindblom, Marjaana] Univ Turku, Dept Psychol & Speech Language Pathol, Dept Social Sci, Turku, Finland; [Ljungqvist, Linda] Psychosocial Serv, Welf Div, Turku, Finland; [Kurki, Timo] Univ Turku, Dept Radiol, Turku, Finland; [Kurki, Timo] Terveystalo Med Ctr, Turku, Finland; [Tenovuo, Olli] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland; [Laasonen, Marja] Univ Eastern Finland, Philosoph Fac, Sch Humanities, Logoped, Joensuu, Finland; [Laasonen, Marja] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Laasonen, Marja] Helsinki Univ Hosp, Dept Phoniatr, Helsinki, Finland; [Laasonen, Marja] Univ Helsinki, Helsinki, Finland		Raukola-Lindblom, M (corresponding author), Univ Turku, Fac Social Sci, Dept Psychol & Speech Language Pathol, Turku 20114, Finland.	marjaana.raukola-lindblom@utu.fi		Raukola-Lindblom, Marjaana/0000-0002-7662-8959	Oskar Oflund Foundation; Finnish Concordia Fund's grant	This study was supported financially by the Oskar Oflund Foundation's and the Finnish Concordia Fund's grant.	Andelic N, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051035; Avramovic P, 2017, BRAIN INJURY, V31, P502, DOI 10.1080/02699052.2017.1280854; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Berginstrom N, 2020, BRAIN INJURY, V34, P415, DOI 10.1080/02699052.2020.1725124; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Hicks EJ, 2011, INT J SPEECH-LANG PA, V13, P145, DOI 10.3109/17549507.2011.485329; Isaki E, 2000, BRAIN INJURY, V14, P441; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson JE, 2012, BRAIN INJURY, V26, P1118, DOI 10.3109/02699052.2012.666370; Kansagara D., 2013, COMPLICATIONS MILD T; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Laitinen V., 2015, KAT TESTI KIELELLISE; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; LeBlanc J, 2020, BRAIN INJURY, V34, P1472, DOI 10.1080/02699052.2020.1802669; Lee MS, 2016, APPL NEUROPSYCH-ADUL, V23, P436, DOI 10.1080/23279095.2016.1178644; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norman RS, 2019, BRAIN INJURY, V33, P1173, DOI 10.1080/02699052.2019.1632487; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Stolwyk RJ, 2021, NEUROPSYCHOL REHABIL, V31, P316, DOI 10.1080/09602011.2019.1692672; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	37	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2021	35	14					1674	1681		10.1080/02699052.2021.2012824		JAN 2022	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP1JQ	WOS:000741209800001	35015614				2022-02-06	
J	Weber, C; Andreassen, JS; Behbahani, M; Thorsen, K; Soreide, K				Weber, Clemens; Andreassen, Joakim Stray; Behbahani, Maziar; Thorsen, Kenneth; Soreide, Kjetil			Characteristics, image findings and clinical outcome of moderate and severe traumatic brain injury among severely injured children: a population-based cohort study	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Paediatric trauma; Traumatic brain injury; Glasgow Coma Scale; Mortality; Glasgow Outcome Scale	HEAD-INJURY; EPIDEMIOLOGY; SCORE; PRIORITY; COMA	Purpose The aim of this study was to explore patient and injury characteristics, image findings, short-term clinical outcome and time trends of moderate and severe traumatic brain injury in severely injured children. Methods This study is an observational cohort study based on prospectively collected data from an institutional trauma registry database covering all trauma patients in South West Norway. All paediatric patients registered in the database between 01.01.2004 and 31.12.2019 were included. Results During the 16 years-study periods, 82 paediatric patients with moderate (n = 42) and severe (n = 40) traumatic brain injury were identified. Median age was 13.0 years, 45% were female and median Glasgow Coma Scale score at admission was 9.0. Cranial fractures were common image findings in both groups. Cerebral contusions (32%) and epidural hematomas (29%) were more commonly found in moderate traumatic brain injury; cerebral contusions (49%), diffuse axonal injury (31%) and cerebral oedema (46%) were more prominent in severe traumatic brain injury. All children with moderate traumatic brain injury survived and favourable outcome was registered in 98%. Overall mortality in the severe traumatic brain injury cohort was 38% (thereof 25% due to TBI) and only 38% had a favourable short-term outcome. Conclusions In this population-based study on paediatric trauma patients over a period of 16 years severe traumatic brain injury in children still had a considerably high mortality and a higher proportion of patients experienced an unfavourable clinical short-term outcome. Moderate traumatic brain injury resulted in favourable clinical outcome.	[Weber, Clemens; Behbahani, Maziar] Stavanger Univ Hosp, Dept Neurosurg, Postboks 8100, N-4068 Stavanger, Norway; [Weber, Clemens] Univ Stavanger, Fac Hlth Sci, Dept Qual & Hlth Technol, Stavanger, Norway; [Andreassen, Joakim Stray; Thorsen, Kenneth; Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway; [Thorsen, Kenneth; Soreide, Kjetil] Univ Bergen, Fac Med, Dept Clin Med, Bergen, Norway; [Thorsen, Kenneth] Stavanger Univ Hosp, Sect Traumatol, Surg Clin, Stavanger, Norway		Weber, C (corresponding author), Stavanger Univ Hosp, Dept Neurosurg, Postboks 8100, N-4068 Stavanger, Norway.; Weber, C (corresponding author), Univ Stavanger, Fac Hlth Sci, Dept Qual & Hlth Technol, Stavanger, Norway.	clemens.weber@uis.no		Weber, Clemens/0000-0001-7007-5719			Alao T., 2021, PENETRATING HEAD TRA; [Anonymous], 2018, LANCET, V391, P813, DOI 10.1016/S0140-6736(18)30547-6; Armenia S, 2018, SURG J-NY, V4, pe136, DOI 10.1055/s-0038-1667315; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bean JR, 2016, WORLD NEUROSURG, V91, P618, DOI 10.1016/j.wneu.2016.03.069; CHAMPION HR, 1983, WORLD J SURG, V7, P4, DOI 10.1007/BF01655906; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; Coulter IC, 2019, CURR OPIN PEDIATR, V31, P769, DOI 10.1097/MOP.0000000000000820; Curtis K, 2020, INJURY, V51, P2053, DOI 10.1016/j.injury.2020.07.033; Dahl HM, 2021, EUR J PAEDIATR NEURO, V31, P70, DOI 10.1016/j.ejpn.2021.02.002; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Hankinson TC, 2016, WORLD NEUROSURG, V92, P540, DOI 10.1016/j.wneu.2016.06.012; Henry MK, 2021, PEDIATR EMERG CARE, V37, pE1, DOI 10.1097/PEC.0000000000001455; Hoang TN, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2019-000393; JENNETT B, 1975, LANCET, V1, P480; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Meshkinfamfard M, 2021, WORLD J SURG, V45, P1340, DOI 10.1007/s00268-021-05980-1; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Soreide K, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-3; Soreide K, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-19; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; TEASDALE G, 1974, LANCET, V2, P81; Thorsen K, 2021, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-021-01696-y; Valen A, 2019, TRAFFIC INJ PREV, V20, P460, DOI 10.1080/15389588.2019.1616700; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	31	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01820-y		JAN 2022	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YD4WI	WOS:000740414100001	34999903				2022-02-06	
J	Zheng, YK; Zeng, LH; Dong, XQ; Du, Q; Gao, Y				Zheng, Yongke; Zeng, Longhuan; Dong, Xiaoqiao; Du, Quan; Gao, Yue			Periostin aggravates the early phase of traumatic brain injury via the MAPK/ERK pathway	NEUROLOGICAL RESEARCH			English	Article; Early Access						Traumatic brain injury (TBI); periostin; ERK; U0126	SUBARACHNOID HEMORRHAGE; BARRIER DISRUPTION; RECOVERY; OUTCOMES; CELLS; RATS	Objectives Periostin is found associated with trauma severity and mortality following head injury. In this study, the role and mechanism of periostin in the traumatic brain injury were investigated. Methods Male Sprague-Dawley adult rats underwent sham or TBI modeling. Vehicle or recombinant periostin was administered intracerebroventricularly at 30 minutes post-TBI, and U0126, a specific MEK1/2 inhibitor, was administered intravenously at 30 minutes pre-TBI. Garcia neuroscore, limb function and brain water content assessments, as well as TUNEL and Western blotting assays were performed to evaluate the status of the above rats at 24 hours post-TBI. Finally, the motor test and Morris water maze test were performed to measure the effects of periostin and U0126 in the late phase of TBI. Results Periostin expression significantly increased 24 hours post-TBI. Treatment with R-periostin aggravated post-TBI neurobehavioral impairment, brain edema, induced apoptosis and raised the quantity of phospho-p38, phospho-JNK, phospho-ERK and MMP-9, and lowered the expression of ZO-1. However, U0126, a kind of inhibitor of MEK, lowered the quantities of phospho-ERK and MMP-9, raised the expression of ZO-1, and suppressed apoptosis. U0126 also ameliorated the neurobehavioral impairments and brain edema induced by R-periostin. Additionally, U0126 didn't inhibit the expression of periostin in the early phase of TBI model. IU0126 was also able to ameliorate the pathological conditions in the late phase of TBI. Discussion Periostin could aggravate neurobehavioral impairments and brain edema following TBI, and was involved in the early phase of TBI via the MAPK/ERK pathway.	[Zheng, Yongke; Zeng, Longhuan] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Intens Care Unit, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Dong, Xiaoqiao; Du, Quan] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Neurosurg, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Gao, Yue] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Dept Gerontol, Sch Med, Hangzhou, Zhejiang, Peoples R China		Zheng, YK (corresponding author), 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	zyk97091@163.com			Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LGD19H150002]	This work was supported by the Natural Science Foundation of Zhejiang Province (Grant Number: LGD19H150002).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Altay O, 2012, STROKE, V43, P2513, DOI 10.1161/STROKEAHA.112.661728; Chen P, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.922009; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Dong XQ, 2017, CLIN CHIM ACTA, V471, P298, DOI 10.1016/j.cca.2017.06.020; Du J, 2019, ADV EXP MED BIOL, V1132, P63, DOI 10.1007/978-981-13-6657-4_7; Gonzalez-Gonzalez L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00225; Guo XF, 2016, ONCOTARGET, V7, P80521, DOI 10.18632/oncotarget.11825; Hara M, 2018, J BONE JOINT SURG AM, V100, DOI 10.2106/JBJS.17.01230; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Ji WJ, 2017, CLIN CHIM ACTA, V474, P23, DOI 10.1016/j.cca.2017.09.002; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Liu L, 2017, STROKE, V48, P1108, DOI 10.1161/STROKEAHA.117.016629; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Minicucci MF, 2013, CLINICS, V68, P1344, DOI 10.6061/clinics/2013(10)09; Qin H, 2019, CELL REPROGRAM, V21, P122, DOI 10.1089/cell.2018.0051; Qin WW, 2019, AGING-US, V11, P11391, DOI 10.18632/aging.102537; Qiu F, 2013, J BIOCHEM MOL TOXIC, V27, P364, DOI 10.1002/jbt.21498; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shimamura M, 2012, STROKE, V43, P1108, DOI 10.1161/STROKEAHA.111.636662; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Yao XF, 2018, J MOL NEUROSCI, V65, P43, DOI 10.1007/s12031-018-1067-5; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhou ZW, 2020, NEUROSCIENCE, V438, P60, DOI 10.1016/j.neuroscience.2020.04.042	25	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.												10.1080/01616412.2021.2024728		JAN 2022	10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YE1TZ	WOS:000740914000001	35001858				2022-02-06	
J	Degeneffe, CE; Tucker, M; Ross, M; Umucu, E				Degeneffe, Charles Edmund; Tucker, Mark; Ross, Meredith; Umucu, Emre			The Influence of State-Level Contextual Factors on State/Federal System Vocational Rehabilitation Employment Outcomes for Persons With Traumatic Brain Injury	REHABILITATION COUNSELING BULLETIN			English	Article; Early Access						brain injury; counseling; career; vocational; public policy; rehabilitation counseling process or strategies	UNITED-STATES; SERVICES; INDIVIDUALS; UNEMPLOYMENT; PREVALENCE; CLIENTS	The purpose of this exploratory study was to develop a preliminary understanding of the influence of state-level contextual factors predictive of employment outcomes for State/Federal Vocational Rehabilitation System (State VR) participants with traumatic brain injury (TBI). Participants were 5,213 individuals with TBI with Individualized Plans for Employment closed during Federal Fiscal Year 2016. A four-step hierarchical logistic regression model (5.6% explained variance) containing five demographic, three state-level economic, six state TBI service climate, and nine State VR service variable expenditures correctly classified 57.0% of cases as attaining or not attaining an employment outcome at closure. Significant predictors associated with an employment closure were (a) education, veteran status, and presence of a secondary area of disability impairment; (b) state-level per-capita income; (c) State VR specialized acquired brain injury (ABI)/TBI service and state TBI Implementation Partnership grant funding; and (d) State VR service expenditures on diagnosis and treatment, occupational or vocational training, on-the-job training, job readiness training, transportation, maintenance support, and benefits counseling. The practice, policy, and research implications of these findings are presented.	[Degeneffe, Charles Edmund; Tucker, Mark; Ross, Meredith] San Diego State Univ, San Diego, CA 92182 USA; [Umucu, Emre] Univ Texas El Paso, El Paso, TX 79968 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Coll Educ, Dept Adm Rehabil & Postsecondary Educ, 5500 Campanile Dr, San Diego, CA 92182 USA.	cdegenef@sdsu.edu	Umucu, Emre/AAH-9101-2021				Administration for Community Living, 2020, TRAUMATIC BRAIN INJU; Ahonle ZJ, 2020, REHABIL COUNS BULL, V63, P143, DOI 10.1177/0034355219864684; [Anonymous], 2019, FED REGISTER; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bauer L, 2018, WORK PAYS DOES LIVE; Brain Injury Association of America, 2021, FIND BIA YOUR STAT; Brain Injury Association of America, 2017, STAT AFF; Brain Injury Association of America Texas Division, 2019, TEX BRAIN INJ RES DI; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Center for Large Data Research Data Sharing in Rehabilitation, 2018, RSA911 CORN U CTR LA; Chan F, 2016, J VOCAT REHABIL, V45, P5, DOI 10.3233/JVR-160806; Chan JY, 2014, REHABIL COUNS BULL, V57, P209, DOI 10.1177/0034355213509855; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Degeneffe C.E., 2014, MILITARY DEPLOYMENT, P293; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe C.E., 2019, J APPL REHABIL COUS, V50, P252; Degeneffe C.E., 2018, J APPL REHABIL COUS, V49, P11; Degeneffe CE, 2020, AUST J REHABIL COUNS, V26, P136, DOI 10.1017/jrc.2020.18; Ditchman N., 2014, CAREER DEV EMPLOYMEN, P343; Fidell, 2001, USING MULTIVARIATE S; Friedman C, 2018, REHABIL RES POL EDUC, V32, P123, DOI 10.1891/2168-6653.32.2.123; Gamble D, 2003, J REHABIL, V69, P31; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Human Resources and Services Administration, 2021, TRAUMATIC BRAIN INJU; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Lee, 2015, FAMILIES REHABILITAT, P153; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Mayo Clinic,, 2021, TRAUMATIC BRAIN INJU; Mertler C, 2005, ADV MULTIVARIATE STA; Musca SC, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00074; National Association of State Head Injury Administrators, 2014, TBIABI TRUST FUND PR; National Data and Statistical Center, 2016, NAT DAT 2016 PROF PE; Olney MF, 2011, REHABIL COUNS BULL, V54, P197, DOI 10.1177/0034355211400209; Payne L, 2018, BRAIN INJURY, V32, P980, DOI 10.1080/02699052.2018.1468573; Peterson EWF, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017736094; Rehabilitation Services Administration, REG; Rehabilitation Services Administration, 2016, RSA911 US DEP ED REH; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Spearman R., 2017, TRAUMATIC BRAIN INJU; SPSS Statistics, 2021, CRITERIA SUBC LOGIST; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Tucker MS, 2017, REHABIL COUNS BULL, V60, P215, DOI 10.1177/0034355216660279; U.S. Bureau of Labor Statistics, 2020, LOC AR UN STAT UN RA; U.S. Bureau of Labor Statistics, 2015, GOV MEAS MEAS UN; U.S. Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; United States Census Bureau, 2019, NSTEST201901 US CENS; United States Census Bureau, MED HOUS INC 2018 DO	53	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.											00343552211067576	10.1177/00343552211067576		JAN 2022	17	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	YD8WN	WOS:000740715800001					2022-02-06	
J	Kawabata, K; Nakajima, Y; Makino, T; Kobayashi, Y				Kawabata, Kaori; Nakajima, Yuya; Makino, Takehiro; Kobayashi, Yasutaka			Support for Returning to Work for a Patient of Social Behavior Disorder with Impaired Self-awareness	JOURNAL OF CONTEMPORARY PSYCHOTHERAPY			English	Article; Early Access						Higher brain dysfunction; Social behavior disorders; Self-awareness; Cognitive behavior therapy; Positive behavior support; Return to work	TRAUMATIC BRAIN-INJURY; INTERVENTIONS; PSYCHOTHERAPY; MANAGEMENT	Social behavioral disorders and impaired self-awareness, which are sequelae of brain injuries, have negative effects on interpersonal relationships and employment. In this study, we performed a long-term client-centered approach to help the patient diagnosed with a social behavior disorder and impaired self-awareness return to work. Cognitive rehabilitation, cognitive-behavioral treatment, and positive behavioral support were provided while assessing the self-awareness using the Japanese version of the Self-Regulation Skills Interview. This patient exemplifies the importance of establishing methods for self-monitoring and rebuilding a positive self-identity while considering the complexities of self-awareness when helping patients with impaired self-awareness. The patient took the initiative in managing problematic behaviors due to social behavior disorder, and as a result, was able to achieve stable self-awareness. The strategies described in this patient can be used in the future to treat patients with social behavior disorder due to inadequate self-awareness. In order to practice a client-centered approach while assessing the patient's level of self-awareness, it is important to build a trusting relationship over a long period. To assess the level of self-awareness, existing interviews, questionnaires, and work to express one's mental and physical state as seen by the patient may be effective.	[Kawabata, Kaori; Kobayashi, Yasutaka] Fukui Hlth Sci Univ, Fac Hlth Sci, Dept Rehabil, 55 Egami Cho 13-1, Fukui, Fukui 9103190, Japan; [Nakajima, Yuya] Fukui Gen Clin, Dept Rehabil, Fukui, Japan; [Makino, Takehiro] Fukui Gen Hosp, Dept Rehabil, Fukui, Japan; [Kawabata, Kaori; Nakajima, Yuya; Kobayashi, Yasutaka] Fukui Higher Brain Dysfunct Support Ctr, Fukui, Japan		Kawabata, K (corresponding author), Fukui Hlth Sci Univ, Fac Hlth Sci, Dept Rehabil, 55 Egami Cho 13-1, Fukui, Fukui 9103190, Japan.; Kawabata, K (corresponding author), Fukui Higher Brain Dysfunct Support Ctr, Fukui, Japan.	kawabata-ot@fukui-hsu.ac.jp					Amanzio M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01697; Amanzio M, 2018, INT PSYCHOGERIATR, V30, P1871, DOI 10.1017/S1041610218000455; Bach LJ, 2014, NEUROREHABILITATION, V35, P863, DOI 10.3233/NRE-141176; Brown L, 2021, NEUROPSYCHOL REHABIL, V31, P154, DOI 10.1080/09602011.2019.1680393; Cook JA, 2010, PSYCHIATR REHABIL J, V34, P113, DOI 10.2975/34.2.2010.113.120; Copeland M. E, 2002, WELLNESS RECOVERY AC; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cullen B, 2018, NEUROPSYCHOL REHABIL, V28, P17, DOI 10.1080/09602011.2015.1131722; Doig E, 2014, AM J OCCUP THER, V68, P578, DOI 10.5014/ajot.2014.010785; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Hart T, 2020, J INT NEUROPSYCH SOC, V26, P119, DOI 10.1017/S1355617719000833; Jack C, 2020, WALDEN DISSERTATIONS, V8463, P1; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; Little A, 2021, NEUROREHABILITATION, V48, P67, DOI 10.3233/NRE-201544; Minami S, 2019, OCCUPATIONAL THERAPY, V38, P103, DOI [10.32178/jotr.38.1_103, DOI 10.32178/JOTR.38.1_103]; Miyahara T., 2012, DEV SELF REGULATION, V40, P1117, DOI [10.11477/mf.1552102632, DOI 10.11477/MF.1552102632]; Monnet FP, 2003, EUR PSYCHIAT, V18, P269, DOI 10.1016/j.eurpsy.2003.09.001; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; Orfei MD, 2010, AM J GERIAT PSYCHIAT, V18, P1133, DOI 10.1097/JGP.0b013e3181dd1c50; Ownsworth T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P340; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Robertson J, 2010, PSYCHOL NEEDS FOLLOW; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	30	0	0	0	0	SPRINGER INT PUBL AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0022-0116	1573-3564		J CONTEMP PSYCHOTHER	J. Contemp. Psychother.												10.1007/s10879-021-09529-0		JAN 2022	7	Psychology, Clinical; Psychology, Psychoanalysis	Emerging Sources Citation Index (ESCI)	Psychology	YD1LB	WOS:000740139600001					2022-02-06	
J	Srinivasaiah, B; Muthuchellappan, R; Sesha, URG				Srinivasaiah, Bharath; Muthuchellappan, Radhakrishnan; Sesha, Umamaheswara Rao Ganne			A prospective observational study of electrocardiographic and echocardiographic changes in traumatic brain injury - effect of surgical decompression	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Traumatic brain injury; cardiac dysfunction; craniotomy	CARDIAC DYSFUNCTION; ABNORMALITIES; HEMORRHAGE	Background Traumatic brain injury (TBI) causes significant changes in myocardial function, which is represented by ECG and echocardiographic changes. We intended to study the effect of surgical decompression on these changes. Materials and methods We recruited adult TBI patients undergoing surgery within 48 h of injury. Preoperatively, the patient's demographic and clinical details were recorded. ECG and TTE were performed before surgery and 24 h later (first postoperative day [POD1]). ECG was analyzed for heart rate, PR, QRS, and QTc intervals, morphologic end-repolarization abnormalities (MERA), and ST-segment and T wave changes. TTE data included left ventricular ejection fraction (LVEF) and regional wall motion abnormalities (RWMA). Glasgow coma scale (GCS) at discharge was recorded. ECG and TTE changes before and after surgery were compared, and its association with discharge GCS was analyzed. Preoperative predictors of LV dysfunction were analyzed. Results Of the 110 patients recruited, common ECG changes were prolonged QTc interval (42%) and MERA (47%). TTE showed poor LVEF (<50%) in 10% and RWMA in 10.8% of patients. Following surgery, both ECG and TTE changes improved. Preoperative LVEF Conclusions Poor LV function was associated with poor admission GCS and prolonged QTc interval. Patients with reduced LV function had lower GCS at discharge.	[Srinivasaiah, Bharath; Muthuchellappan, Radhakrishnan; Sesha, Umamaheswara Rao Ganne] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, Bangalore, Karnataka, India		Srinivasaiah, B (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroanaesthesia & Neurocrit Care, 3rd Floor,Fac Block,Hosur Rd, Bangalore 560029, Karnataka, India.	bharathvinay@gmail.com					Agrawal A, 2008, CLIN NEUROL NEUROSUR, V110, P321, DOI 10.1016/j.clineuro.2008.01.013; Chin PS, 2005, NEUROLOGY, V64, P1977, DOI 10.1212/01.WNL.0000163858.77494.7A; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; ERBEL R, 1982, DEUT MED WOCHENSCHR, V107, P1872, DOI 10.1055/s-2008-1070223; Fan X, 2012, CHINESE MED J-PEKING, V125, P3430, DOI 10.3760/cma.j.issn.0366-6999.2012.19.013; Gudmundsson P, 2005, INT J CARDIOL, V101, P209, DOI 10.1016/j.ijcard.2004.03.027; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Katsanos AH, 2013, INT J CARDIOL, V167, P328, DOI 10.1016/j.ijcard.2012.06.107; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Krishnamoorthy Vijay, 2013, Case Rep Anesthesiol, V2013, P482596, DOI 10.1155/2013/482596; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Marion DW, 2006, NEUROSURGERY, V58, P655; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Palac Robert T, 2003, Prog Transplant, V13, P42; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727, DOI 10.1016/S0735-1097(88)80065-2; Tamaki T, 2004, BRIT J NEUROSURG, V18, P158, DOI 10.1080/02688690410001681019; Venkata C, 2018, CLIN MED RES, V16, P57, DOI 10.3121/cmr.2018.1437; Wang TD, 1997, INT J CARDIOL, V58, P308, DOI 10.1016/S0167-5273(96)02879-3	21	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2021.2024497		JAN 2022	6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YE1IS	WOS:000740884600001	35001787				2022-02-06	
J	Bishop, R; Won, SJ; Irvine, KA; Basu, J; Rome, ES; Swanson, RA				Bishop, Robin; Won, Seok Joon; Irvine, Karen-Amanda; Basu, Jayinee; Rome, Eric S.; Swanson, Raymond A.			Blast-induced axonal degeneration in the rat cerebellum in the absence of head movement	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; MOUSE MODEL; BARRIER; NEURODEGENERATION; INFLAMMATION; EXPOSURE; TBI	Blast exposure can injure brain by multiple mechanisms, and injury attributable to direct effects of the blast wave itself have been difficult to distinguish from that caused by rapid head displacement and other secondary processes. To resolve this issue, we used a rat model of blast exposure in which head movement was either strictly prevented or permitted in the lateral plane. Blast was found to produce axonal injury even with strict prevention of head movement. This axonal injury was restricted to the cerebellum, with the exception of injury in visual tracts secondary to ocular trauma. The cerebellar axonal injury was increased in rats in which blast-induced head movement was permitted, but the pattern of injury was unchanged. These findings support the contentions that blast per se, independent of head movement, is sufficient to induce axonal injury, and that axons in cerebellar white matter are particularly vulnerable to direct blast-induced injury.	[Bishop, Robin; Won, Seok Joon; Irvine, Karen-Amanda; Basu, Jayinee; Rome, Eric S.; Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Bishop, Robin; Won, Seok Joon; Irvine, Karen-Amanda; Basu, Jayinee; Rome, Eric S.; Swanson, Raymond A.] San Francisco VA Med Ctr, Neurol 127, San Francisco, CA 94121 USA; [Irvine, Karen-Amanda] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave,E4-220, Palo Alto, CA 94304 USA; [Irvine, Karen-Amanda] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA		Won, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Won, SJ (corresponding author), San Francisco VA Med Ctr, Neurol 127, San Francisco, CA 94121 USA.	Seokjoon.won@va.gov			U.S. Dept. of DefenseUnited States Department of Defense [W81XWH-13-2-0091]; Department of Veterans AffairsUS Department of Veterans Affairs	This work was supported by a Grant from the U.S. Dept. of Defense (W81XWH-13-2-0091) and by the Department of Veterans Affairs. We thank Mr. Harry Borg for assistance in fabricating the rat head fixation holster.	Beltramino C A, 1993, NIDA Res Monogr, V136, P101; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00128; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Davidsson J., 2009, INT IRCOBI C BIOM IN, P42; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Frank D, 2020, JOVE-J VIS EXP, DOI 10.3791/61198; GALLYAS F, 1980, STAIN TECHNOL, V55, P291, DOI 10.3109/10520298009067257; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Irvine KA, 2018, J NEUROTRAUM, V35, P918, DOI 10.1089/neu.2017.5044; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KASHALIKAR SJ, 1988, MED HYPOTHESES, V26, P1, DOI 10.1016/0306-9877(88)90103-X; Kawa L, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00479; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Kumar R, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00090; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ordek G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31728-4; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; du Sert NP, 2020, J PHYSIOL-LONDON, V598, P3793, DOI 10.1113/JP280389; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rabellino D, 2018, HUM BRAIN MAPP, V39, P3354, DOI 10.1002/hbm.24081; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Vazquez-Rosa E, 2020, P NATL ACAD SCI USA, V117, P27667, DOI 10.1073/pnas.2010430117; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Won SJ, 2010, J NEUROSCI, V30, P15409, DOI 10.1523/JNEUROSCI.2084-10.2010; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	64	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 7	2022	12	1							143	10.1038/s41598-021-03744-4			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD5VU	WOS:000740510500048	34996954	gold, Green Published			2022-02-06	
J	Chen, TG; Chen, SM; Wu, Y; Chen, YL; Wang, L; Liu, JF				Chen, Tiange; Chen, Siming; Wu, Yun; Chen, Yilei; Wang, Lei; Liu, Jinfang			A predictive model for postoperative progressive haemorrhagic injury in traumatic brain injuries	BMC NEUROLOGY			English	Article						Nomogram; Progressive haemorrhagic injury; Traumatic brain injury	HEAD TRAUMA; THROMBELASTOGRAPHY; VALIDATION	Background Progressive haemorrhagic injury after surgery in patients with traumatic brain injury often results in poor patient outcomes. This study aimed to develop and validate a practical predictive tool that can reliably estimate the risk of postoperative progressive haemorrhagic injury (PHI) in patients with traumatic brain injury (TBI). Methods Data from 645 patients who underwent surgery for TBI between March 2018 and December 2020 were collected. The outcome was postoperative intracranial PHI, which was assessed on postoperative computed tomography. The least absolute shrinkage and selection operator (LASSO) regression model, univariate analysis, and Delphi method were applied to select the most relevant prognostic predictors. We combined conventional coagulation test (CCT) data, thromboelastography (TEG) variables, and several predictors to develop a predictive model using binary logistic regression and then presented the results as a nomogram. The predictive performance of the model was assessed with calibration and discrimination. Internal validation was assessed. Results The signature, which consisted of 11 selected features, was significantly associated with intracranial PHI (p < 0.05, for both primary and validation cohorts). Predictors in the prediction nomogram included age, S-pressure, D-pressure, pulse, temperature, reaction time, PLT, prothrombin time, activated partial thromboplastin time, FIB, and kinetics values. The model showed good discrimination, with an area under the curve of 0.8694 (95% CI, 0.8083-0.9304), and good calibration. Conclusion This model is based on a nomogram incorporating CCT and TEG variables, which can be conveniently derived at hospital admission. It allows determination of this individual risk for postoperative intracranial PHI and will facilitate a timely intervention to improve outcomes.	[Chen, Tiange; Chen, Siming; Wu, Yun; Chen, Yilei; Liu, Jinfang] Cent South Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Wang, Lei] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China		Liu, JF (corresponding author), Cent South Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	jinfang_liu@csu.edu.cn			Xiangya Medical Big Data Foundation; Natural Science Foundation of Hunan Province of ChinaNatural Science Foundation of Hunan Province [2018JJ2649]; Health and Family Planning Commission of Hunan Province [B2019191]	This project was supported by the Xiangya Medical Big Data Foundation, the Natural Science Foundation of Hunan Province of China (Grant No.2018JJ2649), and Health and Family Planning Commission of Hunan Province (Grant No. B2019191).	Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anderson TN, 2020, J TRAUMA ACUTE CARE, V89, P80, DOI 10.1097/TA.0000000000002706; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Haas T, 2015, BRIT J ANAESTH, V114, P217, DOI 10.1093/bja/aeu303; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Shrestha Ajit, 2017, Asian J Neurosurg, V12, P648, DOI 10.4103/ajns.AJNS_192_14; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Webb AJ, 2021, NEUROCRIT CARE, V35, P738, DOI 10.1007/s12028-021-01217-0; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zhang LM, 2019, WORLD NEUROSURG, V132, pE21, DOI 10.1016/j.wneu.2019.09.024	27	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 7	2022	22	1							16	10.1186/s12883-021-02541-w			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YD3BV	WOS:000740250800005	34996389	Green Published, gold, Green Submitted			2022-02-06	
J	Jang, SH; Kim, SH; Kwon, HG				Jang, Sung Ho; Kim, Seong Ho; Kwon, Hyeok Gyu			Diagnostic sensitivity of traumatic axonal injury of the spinothalamic tract in patients with mild traumatic brain injury	MEDICINE			English	Article						diffusion tensor tractography; mild traumatic brain injury; sensitivity; spinothalamic tract	CENTRAL PAIN; CORTICORETICULAR PATHWAY; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; MECHANISMS; CORTEX	Diffusion tensor tractography (DTT) can detect traumatic axonal injury (TAI) in patients whose conventional brain magnetic resonance imaging results are negative. This study investigated the diagnostic sensitivity of TAI of the spinothalamic tract (STT) in patients with a mild traumatic brain injury (TBI) suffering from central pain symptoms, using DTT. Thirty-five patients with central pain following mild TBI and 30 healthy control subjects were recruited for this study. After DTT-based reconstruction of the STT, we analyzed the STT in terms of configuration (narrowing and/or tearing) and the DTT parameters (fractional anisotropy and tract volume). Thirty-three (94.3%) patients had at least 1 DTT parameter value at 1 standard deviation below the control group value, and 20 (57.1%) patients had values at 2 standard deviations, below the control group value. All 35 patients showed STT abnormalities (tearing, narrowing, or both) on DTT. A high diagnostic sensitivity of TAI of the STT in patients with mild TBI was achieved. However, the small number of subjects who visited the university hospital and the limitations of DTT should be considered when generalizing the results of this study.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Gyongsan, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Gyongsan, South Korea; [Kwon, Hyeok Gyu] Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sansungdaero 533, Sungnam Si 13135, Gyeonggi, South Korea		Kwon, HG (corresponding author), Eulji Univ, Coll Hlth Sci, Dept Phys Therapy, Sansungdaero 533, Sungnam Si 13135, Gyeonggi, South Korea.	khg0715@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; APKARIAN AV, 1989, J COMP NEUROL, V288, P493, DOI 10.1002/cne.902880309; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barad M., 2009, CONTINUUM MINNEAP MI, V15, P30, DOI 10.1212/01.con.0000348853.20265.b7; Brandstack N, 2016, CLIN NEURORADIOL, V26, P199, DOI 10.1007/s00062-014-0349-8; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chou XL, 2020, ELIFE, V9, DOI 10.7554/eLife.54157; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Fang Q, 2020, NEURON, V105, P355, DOI 10.1016/j.neuron.2019.10.027; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2016, ANN REHABIL MED-ARM, V40, P1149, DOI 10.5535/arm.2016.40.6.1149; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE42, DOI 10.1097/PHM.0000000000000414; Jang SH, 2013, SOMATOSENS MOT RES, V30, P206, DOI 10.3109/08990220.2013.796923; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kishi M, 2009, J NEUROL SCI, V281, P104, DOI 10.1016/j.jns.2009.03.012; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Krause T, 2012, J NEUROL NEUROSUR PS, V83, P776, DOI 10.1136/jnnp-2011-301936; Lee HD, 2015, BRAIN INJURY, V29, P1219, DOI 10.3109/02699052.2015.1045028; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller M D, 1993, Fam Pract Res J, V13, P15; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tenovuo O, 2007, PAIN, V131, P241, DOI 10.1016/j.pain.2007.07.003; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	46	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN 7	2022	101	1							e28536	10.1097/MD.0000000000028536			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YC8IH	WOS:000739929100019	35029922	gold, Green Published			2022-02-06	
J	Lee, YJ; Lee, SC; Wy, SY; Lee, HY; Lee, HL; Lee, WH; Oh, BM; Jeoung, JW				Lee, Yun Jeong; Lee, Seung Chan; Wy, Seo Young; Lee, Hoo Young; Lee, Hyang Lim; Lee, Woo Hyung; Oh, Byung-Mo; Jeoung, Jin Wook			Ocular Manifestations, Visual Field Pattern, and Visual Field Test Performance in Traumatic Brain Injury and Stroke	JOURNAL OF OPHTHALMOLOGY			English	Article							NEUROOPHTHALMIC MANIFESTATIONS; AUTOMATED PERIMETRY; UNITED-STATES; DISEASE; PREVENTION; IMPAIRMENT; BURDEN; BLAST	Purpose. To analyze ocular manifestations, visual field (VF) pattern, and VF test performance in traumatic brain injury (TBI) and stroke patients. Methods. This retrospective, cross-sectional study included 118 patients (236 eyes) with TBI and stroke who had undergone VF testing by standard automated perimetry with the central 24-2 threshold test. Clinical features including best-corrected visual acuity (BCVA), intraocular pressure (IOP), ocular manifestations, and VF test results including VF defect pattern, reliability, and global indices were analyzed and compared between the TBI and stroke patients. Results. In TBI patients, ocular manifestations included strabismus (11.1%), cataract (4.2%), and glaucoma suspect (2.8%), whereas in stroke patients, cataract (15.2%), strabismus (8.5%), diabetic retinopathy (4.9%), extraocular movement (EOM) limitation (3.0%), glaucoma suspect (3.0%), nystagmus (2.4%), drusen (1.2%), and vitreous hemorrhage (1.2%) were found. The VF test results showed that 47 eyes (85.5%) in TBI and 86 (65.2%) in stroke had VF defect; in TBI, the scattered pattern was the most common (56.4%), followed by homonymous hemianopsia (14.5%), homonymous quadrantanopia (10.9%), and total defect (3.6%), whereas in stroke, homonymous hemianopsia was the most common (31.8%), followed by scattered pattern (16.7%), homonymous quadrantanopia (12.1%), and total defect (4.5%). Only 15 eyes (27.3%) in TBI and 32 (24.2%) in stroke showed reliable VF indices. The mean deviation (MD) was -10.5 +/- 7.1 dB in TBI and -9.5 +/- 6.8 dB in stroke, and the pattern standard deviation (PSD) was 4.9 +/- 3.3 dB in TBI and 6.1 +/- 3.9 dB in stroke, without statistically significant differences between the two groups. Conclusion. Various ocular manifestations were found, and a considerable proportion of patients were experiencing VF defects and showed unreliable VF test performance. Our findings suggest that accurate evaluation and rehabilitation of visual function should be a matter of greater concern and emphasis in the management of TBI and stroke patients, besides systemic diseases.	[Lee, Yun Jeong; Lee, Seung Chan; Wy, Seo Young; Jeoung, Jin Wook] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lee, Hoo Young; Lee, Hyang Lim; Oh, Byung-Mo] Natl Traff Injury Rehabil Hosp, Yangpyeong, South Korea; [Lee, Hoo Young; Lee, Hyang Lim; Lee, Woo Hyung; Oh, Byung-Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Rehabil Med, Seoul, South Korea		Jeoung, JW (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	lyj0603@naver.com; tmdcks87@naver.com; wsy445@gmail.com; raphaellapmr@gmail.com; leehyanglim@gmail.com; whlee909@gmail.com; byungmo.oh.md22@gmail.com; neuroprotect@gmail.com			MOLIT Research Fund [0720205042, NTRH-20007]	This study was supported by the MOLIT Research Fund (grant no. 0720205042 (NTRH-20007)).	Alawieh A, 2018, BEHAV BRAIN RES, V340, P94, DOI 10.1016/j.bbr.2016.08.029; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Asbell PA, 2005, LANCET, V365, P599; Chesnut R.M., 1999, REHABILITATION TRAUM, P1; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; Ghannam ASB, 2017, CURR OPIN OPHTHALMOL, V28, P564, DOI 10.1097/ICU.0000000000000414; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KATZ J, 1988, ARCH OPHTHALMOL-CHIC, V106, P1252; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P750, DOI 10.1001/archophthalmol.2010.92; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Lemke S, 2016, OPHTHALMOLOGY, V123, P415, DOI 10.1016/j.ophtha.2015.10.003; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackay J., 2004, ATLAS HEART DIS STRO; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Mukesh BN, 2006, ARCH OPHTHALMOL-CHIC, V124, P79, DOI 10.1001/archopht.124.1.79; Naghavi M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l94; Pandian JD, 2018, LANCET, V392, P1269, DOI 10.1016/S0140-6736(18)31269-8; Pineles SL, 2006, ARCH OPHTHALMOL-CHIC, V124, P363, DOI 10.1001/archopht.124.3.363; Rajsic S, 2019, EUR J HEALTH ECON, V20, P107, DOI 10.1007/s10198-018-0984-0; Rowe F, 2013, STRABISMUS, V21, P150, DOI 10.3109/09273972.2013.786742; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Sand KM, 2013, ACTA NEUROL SCAND, V127, P52, DOI 10.1111/ane.12050; SCHINDLER S, 1981, ANN OPHTHALMOL, V13, P691; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Szatmary G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1162; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Walsh DV, 2015, MIL MED, V180, P178, DOI 10.7205/MILMED-D-14-00230; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	34	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-004X	2090-0058		J OPHTHALMOL	J. Ophthalmol.	JAN 7	2022	2022								1703806	10.1155/2022/1703806			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	YM3US	WOS:000746503600001	35036002	gold, Green Published			2022-02-06	
J	Ranjan, R; Amitabh; Prasad, DN; Kohli, E				Ranjan, Rahul; Amitabh; Prasad, Dipti N.; Kohli, Ekta			Hypothermic preconditioning attenuates hypobaric hypoxia induced spatial memory impairment in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Hypobaric hypoxia; Hypothermia; Neurodegeneration; Oxidative stress; Spatial memory	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; LEARNING DEFICITS; MILD HYPOTHERMIA; CARDIAC-ARREST; HIPPOCAMPUS; GLUTATHIONE; PLASTICITY; APOPTOSIS	Hypobaric Hypoxia (HH) is known to cause oxidative stress in the brain that leads to spatial memory deficit and neurodegeneration. For decades therapeutic hypothermia is used to treat global and focal ischemia in preserving brain functions that proved to be beneficial in humans and rodents. Considering these previous reports, the present study was designed to establish the therapeutic potential of hypothermia preconditioning on HH induced spatial memory, biochemical and morphological changes in adult rats. Male Sprague Dawley rats were exposed to HH (7620 m, similar to 282 mmHg) for 1, 3 and 7 days with and without hypothermic preconditioning. Spatial learning memory was assessed by Morris water maze (MWM) test along with evaluation of hippocampal pyramidal neuron damage by histological study. Oxidative stress was measured by studying the levels of nitric oxide (NO), reactive oxygen species (ROS), lipid peroxidation (LPO), oxidized and reduced glutathione (GSSG and GSH). Results of MWM test indicated prolonged path length and latency to reach the platform in HH groups that regained to normal in cold pre-treated groups. A likely neurodegeneration was evident in HH groups that lessen in the cold pre-treated groups. Hypothermic preconditioning prevented spatial memory impairment and neurodegeneration in animals subjected to HH via decreasing the NO, ROS and LPO compared to control animals. The GSH level and GSH/GSSG ratio was found to be higher in preconditioned animals as compared to respective HH exposed animals, indicative of redox scavenging and restoration of hippocampal neuronal structure as well as spatial memory. Therefore, hypothermic preconditioning improves spatial memory deficit by reducing HH induced oxidative stress and hippocampal neurodegeneration, hence can be used as a multi-target prophylactic measure to combat HH induced neurodegeneration.	[Ranjan, Rahul; Amitabh; Prasad, Dipti N.; Kohli, Ekta] Def Inst Physiol & Allied Sci, Div Neurobiol, Delhi 110054, India		Kohli, E (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Div Neurobiol, Minist Def, Lucknow Rd, Timarpur 3914790, India.	ektakohli@hotmail.com		Ranjan, Rahul/0000-0001-7457-0362	Defence Research and Development Organisation. Ministry of Defence, Govt. of India [DIP:263]; Defence Research and Development Organization, Govt. of IndiaDefence Research & Development Organisation (DRDO)	Ranjan R. is thankful to Defence Research and Development Organisation. Ministry of Defence, Govt. of India (Grant ID; DIP:263) for providing fellowship for the study. Authors are thankful to Defence Research and Development Organization, Govt. of India for funding the study.	ADAMS JH, 1975, BRIT J ANAESTH, V47, P121, DOI 10.1093/bja/47.2.121; Alva N, 2013, EXP PHYSIOL, V98, P1115, DOI 10.1113/expphysiol.2012.071365; Bailey DM, 2004, WILD ENVIRON MED, V15, P231; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Barhwal K, 2007, EUR J PHARMACOL, V570, P97, DOI 10.1016/j.ejphar.2007.05.063; Baumann E, 2009, BRAIN RES, V1269, P185, DOI 10.1016/j.brainres.2009.02.062; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard S, 2009, CRIT CARE MED, V37, pS227, DOI 10.1097/CCM.0b013e3181aa5d0c; Bossenmeyer C, 1998, BRAIN RES, V787, P107, DOI 10.1016/S0006-8993(97)01527-8; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Coimbra-Costa D, 2017, REDOX BIOL, V12, P216, DOI 10.1016/j.redox.2017.02.014; Colbourne F, 1999, NEUROSCIENCE, V90, P87, DOI 10.1016/S0306-4522(98)00375-3; DELLANNA ME, 1991, BEHAV BRAIN RES, V45, P125, DOI 10.1016/S0166-4328(05)80078-6; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Gonzalez-Barrios JA, 2002, BRAIN RES, V945, P114, DOI 10.1016/S0006-8993(02)02746-4; Hackenhaar FS, 2019, THER HYPOTHERMIA TEM, V9, P63, DOI 10.1089/ther.2018.0012; Hackenhaar FS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8704352; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hota SK, 2008, J NEUROSCI RES, V86, P1142, DOI 10.1002/jnr.21554; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Ilavazhagan G, 2001, AVIAT SPACE ENVIR MD, V72, P899; Jain K, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/742059; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; Kreisman NR, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146517; Kumar G, 2016, EBIOMEDICINE, V6, P171, DOI 10.1016/j.ebiom.2016.03.002; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174596; LIEBERMAN P, 1994, NATURE, V372, P325, DOI 10.1038/372325a0; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Maiti P, 2008, BEHAV BRAIN RES, V189, P233, DOI 10.1016/j.bbr.2008.01.007; Maiti P, 2006, NEUROCHEM INT, V49, P709, DOI 10.1016/j.neuint.2006.06.002; Maiti P, 2010, ACTA HISTOCHEM, V112, P222, DOI 10.1016/j.acthis.2008.10.005; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; McManus T, 2004, J NEUROCHEM, V91, P327, DOI 10.1111/j.1471-4159.2004.02711.x; Mishra S, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165769; Muthuraju S, 2011, EUR J PHARMACOL, V672, P96, DOI 10.1016/j.ejphar.2011.08.023; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Nishio S, 1999, ANN NY ACAD SCI, V890, P26, DOI 10.1111/j.1749-6632.1999.tb07978.x; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304, DOI 10.1002/jlb.43.4.304; Rodway GW, 2003, HEART LUNG, V32, P353, DOI 10.1016/j.hrtlng.2003.08.002; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; ShukittHale B, 1996, HUM EXP TOXICOL, V15, P312, DOI 10.1177/096032719601500407; Singh SN, 2001, EUR J APPL PHYSIOL, V84, P233, DOI 10.1007/s004210170010; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21711; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhao H, 2015, IRAN J BASIC MED SCI, V18, P194	61	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 7	2022	416								113568	10.1016/j.bbr.2021.113568			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	UU1HV	WOS:000698555100009	34499936				2022-02-06	
J	Rysakova, MP; Pavlova, IV; Vinogradova, LV				Rysakova, Maria P.; V. Pavlova, Irina; V. Vinogradova, Lyudmila			Spreading depolarization induced by amygdala micro-injury prevents disruption of fear memory extinction in rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Spreading depolarization; Acute brain injury; Fear conditioning; Extinction; Amygdala	BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; DEPRESSION; RECONSOLIDATION; MECHANISMS; STORAGE; LESIONS; CORTEX	Spreading depolarization (SD), a self-propagating wave of near-complete breakdown of the transmembrane ion gradients with water influx, regularly occurs in traumatized human brain. Here, we investigated long-term neurobehavioral consequences of injury-triggered SDs. Recently, we revealed that SD is reliably triggered by micro-injury of the amygdala, a key brain structure involved in fear processing. Using the classical Pavlovian fear conditioning paradigm, we investigated effects of the post-retrieval amygdala micro-injury and associated SD on fear memory in rats. We found that neither SD nor micro-injury alone affect fear response 24 h later but profoundly change it in subsequent extinction phase. If bilateral injury of the amygdala did not induce SD, fear extinction was severely impaired, while conditioned fear in rats with the identical amygdala injury triggering SD was successfully extinguished similarly to naive rats. Our study provides first experimental evidence for involvement of injury-induced SD in extinction of traumatic fear memory.	[Rysakova, Maria P.; V. Pavlova, Irina; V. Vinogradova, Lyudmila] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia		Rysakova, MP (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Dept Conditioned Reflexes & Physiol Emot, Butlerova St 5A, Moscow 17485, Russia.; Vinogradova, LV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Dept Mol Neurobiol, Butlerova St 5A, Moscow 17485, Russia.	rymarik@gmail.com; lvinogradova@gmail.com	Smirnova (Rysakova), Maria Pavlovna/K-6561-2016; Pavlova, Irina/AAC-3173-2022	Pavlova, Irina/0000-0001-8898-6676; Smirnova, Mariia/0000-0002-6668-958X	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [RFBR 18-015-00418]	This work was supported by Russian Foundation for Basic Research [RFBR 18-015-00418].	Barhorst KA, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-01000-3; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FREEDMAN NL, 1972, J COMP PHYSIOL PSYCH, V78, P433, DOI 10.1037/h0032286; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Harriott AM, 2021, ANN NEUROL, V89, P99, DOI 10.1002/ana.25926; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Kawahara N, 1997, NEUROSCI RES, V29, P37, DOI 10.1016/S0168-0102(97)00069-2; Kawahara N, 1999, EXP NEUROL, V158, P27, DOI 10.1006/exnr.1999.7091; Kida S, 2019, PSYCHOPHARMACOLOGY, V236, P49, DOI 10.1007/s00213-018-5086-2; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; Maren S, 1999, J NEUROSCI, V19, P8696; MEGIRIAN D, 1970, EXP NEUROL, V27, P34, DOI 10.1016/0014-4886(70)90199-8; MIES G, 1993, J NEUROCHEM, V60, P360, DOI 10.1111/j.1471-4159.1993.tb05860.x; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pacheco JM, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0070-19.2019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEARLMAN CA, 1966, J COMP PHYSIOL PSYCH, V61, P306, DOI 10.1037/h0023142; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Tzeng WY, 2012, NEUROBIOL LEARN MEM, V97, P241, DOI 10.1016/j.nlm.2012.01.001; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; Urbach A, 2017, J CEREBR BLOOD F MET, V37, P1776, DOI 10.1177/0271678X16643736; Vinogradova LV, 2020, NEUROL RES, V42, P76, DOI 10.1080/01616412.2019.1709745; Vinogradova LV, 2015, CEPHALALGIA, V35, P979, DOI 10.1177/0333102414565672	28	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 7	2022	416								113559	10.1016/j.bbr.2021.113559			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	UU1HV	WOS:000698555100005	34453972				2022-02-06	
J	Sheth, KN; Yuen, MM; Mazurek, MH; Cahn, BA; Prabhat, AM; Salehi, S; Shah, JT; By, S; Welch, EB; Sofka, M; Sacolick, LI; Kim, JA; Payabvash, S; Falcone, GJ; Gilmore, EJ; Hwang, DY; Matouk, C; Gordon-Kundu, B; Rn, AW; Petersen, N; Schindler, J; Gobeske, KT; Sansing, LH; Sze, G; Rosen, MS; Kimberly, WT; Kundu, P				Sheth, Kevin N.; Yuen, Matthew M.; Mazurek, Mercy H.; Cahn, Bradley A.; Prabhat, Anjali M.; Salehi, Sadegh; Shah, Jill T.; By, Samantha; Welch, E. Brian; Sofka, Michal; Sacolick, Laura, I; Kim, Jennifer A.; Payabvash, Seyedmehdi; Falcone, Guido J.; Gilmore, Emily J.; Hwang, David Y.; Matouk, Charles; Gordon-Kundu, Barbara; Rn, Adrienne Ward; Petersen, Nils; Schindler, Joseph; Gobeske, Kevin T.; Sansing, Lauren H.; Sze, Gordon; Rosen, Matthew S.; Kimberly, W. Taylor; Kundu, Prantik			Bedside detection of intracranial midline shift using portable magnetic resonance imaging	SCIENTIFIC REPORTS			English	Article							MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRAHOSPITAL TRANSPORT; COMPUTED-TOMOGRAPHY; SECONDARY INSULTS; STROKE; INFARCTION; SAFETY; CT	Neuroimaging is crucial for assessing mass effect in brain-injured patients. Transport to an imaging suite, however, is challenging for critically ill patients. We evaluated the use of a low magnetic field, portable MRI (pMRI) for assessing midline shift (MLS). In this observational study, 0.064 T pMRI exams were performed on stroke patients admitted to the neuroscience intensive care unit at Yale New Haven Hospital. Dichotomous (present or absent) and continuous MLS measurements were obtained on pMRI exams and locally available and accessible standard-of-care imaging exams (CT or MRI). We evaluated the agreement between pMRI and standard-of-care measurements. Additionally, we assessed the relationship between pMRI-based MLS and functional outcome (modified Rankin Scale). A total of 102 patients were included in the final study (48 ischemic stroke; 54 intracranial hemorrhage). There was significant concordance between pMRI and standard-of-care measurements (dichotomous, kappa =0.87; continuous, ICC=0.94). Low-field pMRI identified MLS with a sensitivity of 0.93 and specificity of 0.96. Moreover, pMRI MLS assessments predicted poor clinical outcome at discharge (dichotomous: adjusted OR 7.98, 95% CI 2.07-40.04, p=0.005; continuous: adjusted OR 1.59, 95% CI 1.11-2.49, p=0.021). Low-field pMRI may serve as a valuable bedside tool for detecting mass effect.	[Sheth, Kevin N.; Yuen, Matthew M.; Mazurek, Mercy H.; Cahn, Bradley A.; Prabhat, Anjali M.; Shah, Jill T.; Kim, Jennifer A.; Falcone, Guido J.; Gilmore, Emily J.; Hwang, David Y.; Gordon-Kundu, Barbara; Petersen, Nils; Schindler, Joseph; Gobeske, Kevin T.; Sansing, Lauren H.] Yale Sch Med, Dept Neurol, 15 York St,LLCI Room 1003C,POB 208018, New Haven, CT 06520 USA; [Salehi, Sadegh; By, Samantha; Welch, E. Brian; Sofka, Michal; Sacolick, Laura, I; Kundu, Prantik] Hyperfine Inc, Guilford, CT USA; [Payabvash, Seyedmehdi; Sze, Gordon] Yale Sch Med, Dept Neuroradiol, New Haven, CT USA; [Matouk, Charles] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Rn, Adrienne Ward] Yale New Haven Med Ctr, Neurosci Intens Care Unit, New Haven, CT USA; [Rosen, Matthew S.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Kimberly, W. Taylor] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Sheth, KN (corresponding author), Yale Sch Med, Dept Neurol, 15 York St,LLCI Room 1003C,POB 208018, New Haven, CT 06520 USA.	kevin.sheth@yale.edu			American Heart AssociationAmerican Heart Association [17CSA3355004]; Hyperfine Inc.	American Heart Association (Grant No. 17CSA3355004). Hyperfine Inc.	ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Barber PA, 2003, CEREBROVASC DIS, V16, P230, DOI 10.1159/000071121; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bhat SS, 2021, J MAGN RESON IMAGING, V54, P372, DOI 10.1002/jmri.27324; Bowry R, 2017, SEMIN RESP CRIT CARE, V38, P713, DOI 10.1055/s-0037-1607994; Brenner DJ, 2010, JAMA-J AM MED ASSOC, V304, P208, DOI 10.1001/jama.2010.973; Broocks G, 2018, STROKE, V49, P1906, DOI 10.1161/STROKEAHA.118.020507; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Casolla B, 2020, J NEUROL NEUROSUR PS, V91, P469, DOI 10.1136/jnnp-2019-322280; Curry WT, 2005, NEUROSURGERY, V56, P681, DOI 10.1227/01.NEU.0000156604.41886.62; Dandamudi S, 2016, ACAD RADIOL, V23, P1498, DOI 10.1016/j.acra.2016.08.016; Dittrich R, 2008, J NEUROL, V255, P896, DOI 10.1007/s00415-008-0802-1; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fan JS, 2012, ACAD EMERG MED, V19, P133, DOI 10.1111/j.1553-2712.2011.01285.x; Grunwald IQ, 2016, CEREBROVASC DIS, V42, P332, DOI 10.1159/000446861; Helwig SA, 2019, JAMA NEUROL, V76, P1484, DOI 10.1001/jamaneurol.2019.2829; Hricak H, 2011, RADIOLOGY, V258, P889, DOI 10.1148/radiol.10101157; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jeon SB, 2016, J STROKE, V18, P328, DOI 10.5853/jos.2016.00262; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kimberly WT, 2018, JAMA NEUROL, V75, P453, DOI 10.1001/jamaneurol.2017.5162; Kowalski RG, 2015, ANN NEUROL, V77, P804, DOI 10.1002/ana.24381; Liao CC, 2018, INT J BIOMED IMAGING, V2018, DOI 10.1155/2018/4303161; Marion DW, 2006, NEUROSURGERY, V58, P655; Martin ET, 2004, J AM COLL CARDIOL, V43, P1315, DOI 10.1016/j.jacc.2003.12.016; Martin M, 2017, NEUROCRIT CARE, V26, P87, DOI 10.1007/s12028-016-0291-5; Mazurek MH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25441-6; McKeown ME, 2021, NEUROCRIT CARE, DOI 10.1007/s12028-021-01341-x; Motuel J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0676-9; Nazarian S, 2017, NEW ENGL J MED, V377, P2555, DOI 10.1056/NEJMoa1604267; Ostwaldt AC, 2018, J NEUROIMAGING, V28, P530, DOI 10.1111/jon.12525; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pullicino PM, 1997, NEUROLOGY, V49, P1090, DOI 10.1212/WNL.49.4.1090; Rangaraju S, 2017, INTERV NEUROL, V6, P36, DOI 10.1159/000452634; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; Sarracanie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15177; Sheth KN, 2021, JAMA NEUROL, V78, P41, DOI 10.1001/jamaneurol.2020.3263; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Sommer T, 2017, ROFO-FORTSCHR RONTG, V189, P204, DOI 10.1055/s-0043-102029; Sun WP, 2013, NEUROCRIT CARE, V19, P299, DOI 10.1007/s12028-013-9894-2; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Tu PH, 2012, J CLIN NEUROSCI, V19, P661, DOI 10.1016/j.jocn.2011.07.045; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; Venook RD, 2006, MAGN RESON MED, V56, P177, DOI 10.1002/mrm.20927; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Wira CR, 2020, CURR EMERG HOSP ME R, V8, P9, DOI 10.1007/s40138-020-00207-4; Wu SM, 2018, STROKE, V49, P2918, DOI 10.1161/STROKEAHA.118.022001; Xie ZC, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5656480; Yang WS, 2018, NEUROCRIT CARE, V28, P314, DOI 10.1007/s12028-017-0483-7; Yoo AJ, 2013, J STROKE CEREBROVASC, V22, P742, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.002; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zhang HT, 2019, MED SCI MONITOR, V25, P10095, DOI 10.12659/MSM.918815	59	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JAN 7	2022	12	1							67	10.1038/s41598-021-03892-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YD5VU	WOS:000740510500088	34996970	Green Published, gold			2022-02-06	
J	Sivakumar, S; Tsetsou, S; Patel, AB; Stapleton, CJ; Grannan, BL; Schweitzer, JS; Chung, DY; Rosenthal, ES				Sivakumar, Shravan; Tsetsou, Spyridoula; Patel, Aman B.; Stapleton, Christopher J.; Grannan, Benjamin L.; Schweitzer, Jeffrey S.; Chung, David Y.; Rosenthal, Eric S.			Cortical Spreading Depolarizations and Clinically Measured Scalp EEG Activity After Aneurysmal Subarachnoid Hemorrhage and Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article; Early Access						Cortical spreading depolarization; Continuous electroencephalography; Delayed cerebral ischemia; Subarachnoid hemorrhage; Traumatic brain injury; Seizures; Ictal-interictal continuum	DELAYED CEREBRAL-ISCHEMIA	Background Spreading depolarizations (SDs) are associated with worse outcome following subarachnoid hemorrhage (SAH) and traumatic brain injury (TBI), but gold standard detection requires electrocorticography with a subdural strip electrode. Electroencephalography (EEG) ictal-interictal continuum abnormalities are associated with poor outcomes after TBI and with both delayed cerebral ischemia (DCI) and poor outcomes after SAH. We examined rates of SD detection in patients with SAH and TBI with intraparenchymal and subdural strip electrodes and assessed which continuous EEG (cEEG) measures were associated with intracranially quantified SDs. Methods In this single-center cohort, we included patients with SAH and TBI undergoing >= 24 h of interpretable intracranial monitoring via eight-contact intraparenchymal or six-contact subdural strip platinum electrodes or both. SDs were rated according to established consensus criteria and compared with cEEG findings rated according to the American Clinical Neurophysiology Society critical care EEG monitoring consensus criteria: lateralized rhythmic delta activity, generalized rhythmic delta activity, lateralized periodic discharges, generalized periodic discharges, any ictal-interictal continuum, or a composite scalp EEG tool for seizure risk estimation: the 2HELPS2B score. Among patients with SAH, cEEG was assessed for validated DCI biomarkers: new or worsening epileptiform abnormalities and new background deterioration. Results Over 6 years, SDs were recorded in 5 (18%) of 28 patients recorded with intraparenchymal electrodes and 4 (40%) of 10 patients recorded with subdural strip electrodes. There was no significant association between occurrence of SDs and day 1 cEEG findings (American Clinical Neurophysiology Society main terms lateralized periodic discharges, generalized periodic discharges, lateralized rhythmic delta activity, or seizures, individually or in combination). After SAH, established cEEG DCI predictors were not associated with SDs. Conclusions Intraparenchymal recordings yielded low rates of SD, and documented SDs were not associated with ictal-interictal continuum abnormalities or other cEEG DCI predictors. Identifying scalp EEG correlates of SD may require training computational EEG analytics and use of gold standard subdural strip electrocorticography recordings.	[Sivakumar, Shravan; Tsetsou, Spyridoula; Chung, David Y.; Rosenthal, Eric S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Patel, Aman B.; Stapleton, Christopher J.; Grannan, Benjamin L.; Schweitzer, Jeffrey S.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA		Rosenthal, ES (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	erosenthal@mgh.harvard.edu	Rosenthal, Eric/A-2085-2017	Rosenthal, Eric/0000-0003-3900-356X	National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23NS105950, KL2TR002542, K08NS112601]; United States ArmyUnited States Department of Defense [W81XWH-BAA-15-1]; American Heart AssociationAmerican Heart Association [18POST34030369]; Andrew David Heitman Foundation; Aneurysm and AVM Foundation; Brain Aneurysm Foundation; Andrew David Heitman Foundation Chairs of Research	This work was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke Grants 1K23NS105950 (ESR), KL2TR002542 (DYC), and K08NS112601 (DYC); United States Army Grant W81XWH-BAA-15-1 (ESR); the American Heart Association (18POST34030369; DYC); the Andrew David Heitman Foundation (ESR, ABP, DYC); the Aneurysm and AVM Foundation (DYC); and the Brain Aneurysm Foundation's Timothy P. Susco and Andrew David Heitman Foundation Chairs of Research (DYC).	Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Brinjikji W, 2013, AM J NEURORADIOL, V34, P1022, DOI 10.3174/ajnr.A3321; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Chamanzar A, 2019, IEEE T BIO-MED ENG, V66, P1115, DOI 10.1109/TBME.2018.2867112; Chung DY, 2016, J CLIN NEUROPHYSIOL, V33, P196, DOI 10.1097/WNP.0000000000000275; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2013, NEUROSCIENTIST, V19, P25, DOI 10.1177/1073858412453340; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Eickhoff M, 2014, EXP NEUROL, V253, P1, DOI 10.1016/j.expneurol.2013.12.008; Hartings J.A., 2019, JAMA NEUROL; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hirsch LJ, 2021, J CLIN NEUROPHYSIOL, V38, P1, DOI 10.1097/WNP.0000000000000806; Jeffcote T., 2013, DETECTION SPREADING; Kim JA, 2017, CLIN NEUROPHYSIOL, V128, P1091, DOI 10.1016/j.clinph.2017.01.016; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Maher M, 2020, STROKE, V51, P1326, DOI 10.1161/STROKEAHA.119.025997; Moffet EW, 2020, NEUROCRIT CARE, V33, P701, DOI 10.1007/s12028-020-00939-x; Muniz CF, 2016, J CLIN NEUROPHYSIOL, V33, P217, DOI 10.1097/WNP.0000000000000281; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Rosenthal ES, 2018, ANN NEUROL, V83, P958, DOI 10.1002/ana.25232; Sanchez-Porras R, 2013, EUR J NEUROL, V20, P1121, DOI 10.1111/ene.12139; Sinha S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17449; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2016, NEUROCRIT CARE, V24, P324, DOI 10.1007/s12028-016-0245-y; Sugimoto K, 2020, NEUROTHERAPEUTICS, V17, P497, DOI 10.1007/s13311-020-00850-5; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	31	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01418-7		JAN 2022	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YD1JY	WOS:000740136700001	34997536				2022-02-06	
J	Brett, BL; Bryant, AM; Espana, LY; Mayer, AR; Meier, TB				Brett, Benjamin L.; Bryant, Andrew M.; Espana, Lezlie Y.; Mayer, Andrew R.; Meier, Timothy B.			Investigating the overlapping associations of prior concussion, default mode connectivity, and executive function-based symptoms	BRAIN IMAGING AND BEHAVIOR			English	Article; Early Access						Executive function; Concussion; mTBI; Resting-state fMRI; Default mode network; Subjective cognitive function	COGNITIVE COMPLAINTS; RETROSPLENIAL CORTEX; SALIENCE NETWORK; HISTORY; INDIVIDUALS; BIOMARKERS; INJURY	Growing evidence suggests that younger athletes with greater concussion history are more likely to endorse greater subjective cognitive (e.g., executive function) symptoms, but not perform worse on objective cognitive testing. We sought to identify biological correlates of elevated cognitive symptoms in 100 healthy, collegiate-aged athletes with varying degrees of concussion history. Associations between concussion history with subjectively-rated executive function were assessed with generalized linear models. Using resting state fMRI, we examined associations between concussion history and between-and within-network connectivity across three networks integral to executive function; default mode network (DMN), frontoparietal network (FPN), and ventral attention network (VAN). Relationships of between-and within-network connectivity with subjective executive function were assessed. Although the large majority of participants did not report clinically relevant levels of executive difficulties, there was a significant association between concussion history and higher behavioral regulation-related symptoms; B = .04[.01, .07], p = .011. A significant elevation in total within-network connectivity was observed among those with a greater concussion history, B = .02[.002, .03], p = .028, which was primarily driven by a positive association between concussion history and within DMN connectivity, B = .02[.004, .04], p = .014. Higher behavioral regulation-related symptoms were associated with greater total within-network connectivity, B = 0.57[0.18, 0.96], p = .005, and increased within-network connectivity for the DMN, B = .49[.12, .86], p = .010). The current study identified a distinct biological correlate, increased within-DMN connectivity, which was associated with both a greater history of concussion and greater behavioral regulation symptoms. Future studies are required to determine the degree to which these changes associated with concussion history may evolve toward objective cognitive decline over the lifespan.	[Brett, Benjamin L.; Espana, Lezlie Y.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Bryant, Andrew M.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Neurol Dept,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Psychiat Dept,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Meier, TB (corresponding author), Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA.; Meier, TB (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Brett, Benjamin/0000-0003-2849-4658	National Institute Of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [L30NS113158]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23 AG073528]	Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R01NS102225. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. BLB acknowledges support from the National Institute of Neurological Disorders and Stroke (Award Number L30NS113158) and National Institute on Aging (Award Number K23 AG073528).This research was completed in part with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2021, SPORTS MED, V51, P1087, DOI 10.1007/s40279-020-01415-4; Chen HF, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00201-6; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2021, J NEUROTRAUM, V38, P3097, DOI 10.1089/neu.2021.0123; D'Souza MM, 2020, NEURORADIOL J, V33, P186, DOI 10.1177/1971400920901706; Dillen KNH, 2016, NEUROBIOL AGING, V44, P114, DOI 10.1016/j.neurobiolaging.2016.04.010; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Hafkemeijer A, 2013, BRAIN CONNECT, V3, P353, DOI 10.1089/brain.2013.0144; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Iyer KK, 2019, ANN CLIN TRANSL NEUR, DOI 10.1002/acn3.50951; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones DT, 2016, BRAIN, V139, P547, DOI 10.1093/brain/awv338; Jorm AF, 1997, PSYCHOL MED, V27, P91, DOI 10.1017/S0033291796003923; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Meier TB, 2021, J NEUROTRAUM, V38, P1358, DOI 10.1089/neu.2020.7143; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Numbers K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232961; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Rabin LA, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12103; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Terpstra AR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00712; Tooley UA, 2020, CEREB CORTEX, V30, P1, DOI 10.1093/cercor/bhz066; Verfaillie SCJ, 2018, BIOL PSYCHIAT-COGN N, V3, P463, DOI 10.1016/j.bpsc.2017.11.012; Viviano RP, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00591-9; Wang Y, 2013, J ALZHEIMERS DIS, V35, P751, DOI 10.3233/JAD-130080; Yasuno F, 2015, NEUROBIOL AGING, V36, P2145, DOI 10.1016/j.neurobiolaging.2015.03.006; Zanchi Davide, 2017, Neurosignals, V25, P127, DOI 10.1159/000486152; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	41	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.												10.1007/s11682-021-00617-2		JAN 2022	9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YC6FY	WOS:000739786300001	34989980				2022-02-06	
J	Fletcher-Sandersjoo, A; Tatter, C; Tjerkaski, J; Bartek, J; Svensson, M; Thelin, EP; Bellander, BM				Fletcher-Sandersjoo, Alexander; Tatter, Charles; Tjerkaski, Jonathan; Bartek Jr, Jiri; Svensson, Mikael; Thelin, Eric Peter; Bellander, Bo-Michael			Clinical Significance of Vascular Occlusive Events following Moderate-to-Severe Traumatic Brain Injury: An Observational Cohort Study	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article; Early Access						traumatic brain injury; head injury; neurotrauma; vascular occlusive event; pulmonary embolism; deep vein thrombosis; cerebral venous thrombosis	DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM	Preventing hemorrhage progression is a potential therapeutic opportunity in traumatic brain injury (TBI) management, but its use has been limited by fear of provoking vascular occlusive events (VOEs). However, it is currently unclear whether VOE actually affects outcome in these patients. The aim of this study was to determine incidence, risk factors, and clinical significance of VOE in patients with moderate-to-severe TBI. A retrospective observational cohort study of adults (>= 15 years) with moderate-to-severe TBI was performed. The presence of a VOE during hospitalization was noted from hospital charts and radiological reports. Functional outcome, using the Glasgow Outcome Scale (GOS), was assessed at 12 months posttrauma. Univariate and multivariate logistic regressions were used for endpoint assessment. In total, 848 patients were included, with a median admission Glasgow Coma Scale of 7. A VOE was detected in 54 (6.4%) patients, of which cerebral venous thrombosis was the most common (3.2%), followed by pulmonary embolism (1.7%) and deep vein thrombosis (1.3%). Length of ICU stay ( p < 0.001), body weight ( p = 0.002), and skull fracture ( p = 0.004) were independent predictors of VOE. VOE development did not significantly impact 12-month GOS, even after adjusting for potential confounders using propensity score matching. In conclusion, VOE in moderate-to-severe TBI patients was relatively uncommon, and did not affect 12-month GOS. This suggests that the potential benefit of treating bleeding progression might outweigh the risks of VOE.	[Fletcher-Sandersjoo, Alexander; Tatter, Charles; Bartek Jr, Jiri; Svensson, Mikael; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Fletcher-Sandersjoo, Alexander; Tatter, Charles; Tjerkaski, Jonathan; Bartek Jr, Jiri; Svensson, Mikael; Thelin, Eric Peter; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bartek Jr, Jiri] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Thelin, Eric Peter] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden		Fletcher-Sandersjoo, A (corresponding author), Karolinska Inst, Bioclinicum J5-20, S-17164 Solna, Sweden.	alexander.fletcher-sandersjoo@ki.se	Thelin, Eric/K-2144-2012	Thelin, Eric/0000-0002-2338-4364	Region Stockholm (Research Internship); StratNeuro (Karolinska Institutet); Erling-Persson Family Foundation; Region Stockholm (Clinical Research Appointment); Swedish Brain Foundation [FO2019-0006]	A.F.-S. acknowledges funding from Region Stockholm (Research Internship). E.P.T. acknowledges funding support from StratNeuro (Karolinska Institutet), he ErlingPersson Family Foundation, Region Stockholm (Clinical Research Appointment), and the Swedish Brain Foundation (#FO2019-0006). The funders had no role in the design or conduct of this research..	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bahloul M, 2017, INTENS CARE MED, V43, P1433, DOI 10.1007/s00134-017-4815-z; Blokhin IO, 2013, CURR OPIN HEMATOL, V20, P437, DOI 10.1097/MOH.0b013e3283634443; Braithwaite I, 2017, POSTGRAD MED J, V93, P354, DOI 10.1136/postgradmedj-2016-134365; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dietch ZC, 2015, J TRAUMA ACUTE CARE, V79, P970, DOI 10.1097/TA.0000000000000855; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Fletcher-Sandersjoo A., 2021, CLIN IMPACT HEMORRHA, DOI [10.21203/rs.3.rs-570495/v1, DOI 10.21203/RS.3.RS-570495/V1]; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Harrel F., 2021, RMS REGRESSION MODEL; Ho DE, 2011, J STAT SOFTW, V42; Hotoleanu Cristina, 2020, Med Pharm Rep, V93, P162, DOI 10.15386/mpr-1372; Lawati KA, 2021, INTENS CARE MED, V47, P14, DOI 10.1007/s00134-020-06279-w; Lu VM, 2020, NEUROSURG REV, V43, P861, DOI 10.1007/s10143-018-1045-y; Netteland DF, 2021, J NEUROSURG, V134, P1912, DOI 10.3171/2020.4.JNS20511; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; Seifi A, 2018, J CLIN NEUROSCI, V57, P46, DOI 10.1016/j.jocn.2018.08.042; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu X, 2021, BLOOD, V137, P544, DOI 10.1182/blood.2020007364	28	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.												10.1055/s-0041-1740567		JAN 2022	8	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	YC3ZY	WOS:000739634100001	34991168				2022-02-06	
J	Kawadkar, M; Mandloi, AS; Singh, N; Mukharjee, R; Dhote, VV				Kawadkar, Manisha; Mandloi, Avinash S.; Singh, Nidhi; Mukharjee, Rajesh; Dhote, Vipin V.			Combination therapy for cerebral ischemia: do progesterone and noscapine provide better neuroprotection than either alone in the treatment?	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						Stroke; BCCAO; HPLC; AUC; Half-life; Inflammation	TRAUMATIC BRAIN-INJURY; BRADYKININ B-2 RECEPTOR; COMMON CAROTID OCCLUSION; REPERFUSION INJURY; ARTERY OCCLUSION; P-GLYCOPROTEIN; BARRIER PERMEABILITY; FUNCTIONAL OUTCOMES; DRUG TRANSPORT; INFARCT VOLUME	Ischemic stroke presents multifaceted pathological outcomes with overlapping mechanisms of cerebral injury. High mortality and disability with stroke warrant a novel multi-targeted therapeutic approach. The neuroprotection with progesterone (PG) and noscapine (NOS) on cerebral ischemia-reperfusion (I-R) injury was demonstrated individually, but the outcome of combination treatment to alleviate cerebral damage is still unexplored. Randomly divided groups of rats (n = 6) were Sham-operated, I-R, PG (8 mg/kg), NOS (10 mg/kg), and PG + NOS (8 mg/kg + 10 mg/kg). The rats were exposed to bilateral common carotid artery occlusion, except Sham-operated, to investigate the therapeutic outcome of PG and NOS alone and in combination on I-R injury. Besides the alterations in cognitive and motor abilities, we estimated infarct area, oxidative stress, blood-brain barrier (BBB) permeability, and histology after treatment. Pharmacokinetic parameters like Cmax, Tmax, half-life, and AUC(0-t) were estimated in biological samples to substantiate the therapeutic outcomes of the combination treatment. We report PG and NOS prevent loss of motor ability and improve spatial memory after cerebral I-R injury. Combination treatment significantly reduced inflammation and restricted infarction; it attenuated oxidative stress and BBB damage and improved grip strength. Histopathological analysis demonstrated a significant reduction in leukocyte infiltration with the most profound effect in the combination group. Simultaneous analysis of PG and NOS in plasma revealed enhanced peak drug concentration, improved AUC, and prolonged half-life; the drug levels in the brain have increased significantly for both. We conclude that PG and NOS have beneficial effects against brain damage and the co-administration further reinforced neuroprotection in the cerebral ischemia-reperfusion injury.	[Kawadkar, Manisha; Mandloi, Avinash S.; Singh, Nidhi; Mukharjee, Rajesh; Dhote, Vipin V.] VNS Grp Inst, Fac Pharm, Dept Pharmacol, Bhopal 462044, Madhya Pradesh, India		Dhote, VV (corresponding author), VNS Grp Inst, Fac Pharm, Dept Pharmacol, Bhopal 462044, Madhya Pradesh, India.	vvdhote@yahoo.com		Dhote, Vipin/0000-0003-3880-5616			Agarwal S, 2011, CURR PHARM DESIGN, V17, P2793, DOI 10.2174/138161211797440186; Ali-Ahmed F, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.119.005609; Almahozi A, 2019, BEHAV SCI-BASEL, V9, DOI 10.3390/bs9030024; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Arakawa K, 2005, DIGEST DIS SCI, V50, P27, DOI 10.1007/s10620-005-1273-1; Auvity S, 2018, J NUCL MED, V59, P1609, DOI 10.2967/jnumed.118.210104; Boot E, 2020, J NEUROL NEUROSUR PS, V91, P411, DOI 10.1136/jnnp-2019-322424; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Bruschi F., 2002, MED SCI S SERIES, V17, DOI [10.1007/978-1-4615-1061-1-20, DOI 10.1007/978-1-4615-1061-1-20]; Gonzalez-Orozco JC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00503; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coomber B, 2010, BRAIN RES, V1361, P124, DOI 10.1016/j.brainres.2010.09.037; Cornford EM, 1999, ADV DRUG DELIVER REV, V36, P145, DOI 10.1016/S0169-409X(98)00082-9; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Danhof M, 2008, TRENDS PHARMACOL SCI, V29, P186, DOI 10.1016/j.tips.2008.01.007; Derendorf H, 2000, J CLIN PHARMACOL, V40, P1399; Dey S, 2020, J CHROMATOGR SCI, V58, P309, DOI 10.1093/chromsci/bmz116; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Elali A, 2011, STROKE, V42, P3238, DOI 10.1161/STROKEAHA.111.615559; Feng QR, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/7194075; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; Gaignard P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00406; Gallo JM, 2010, MT SINAI J MED, V77, P381, DOI 10.1002/msj.20193; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Guennoun R, 2019, CELL MOL NEUROBIOL, V39, P551, DOI 10.1007/s10571-018-0627-0; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Hashimoto N, 2004, J HEART LUNG TRANSPL, V23, P606, DOI 10.1016/S1053-2498(03)00297-3; Hedayatpour A, 2018, J MOL NEUROSCI, V66, P251, DOI 10.1007/s12031-018-1163-6; Hirota T, 2013, DRUG METAB PHARMACOK, V28, P28, DOI 10.2133/dmpk.DMPK-12-RV-085; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; IWASAKI Y, 1989, J NEUROL SCI, V90, P155, DOI 10.1016/0022-510X(89)90098-1; JETTE L, 1993, BIOCHIM BIOPHYS ACTA, V1150, P147, DOI 10.1016/0005-2736(93)90083-C; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036; Kawadkar M, 2021, N-S ARCH PHARMACOL, V394, P669, DOI 10.1007/s00210-020-02005-x; Khanmoradi M, 2014, IRAN J BASIC MED SCI, V17, P244; Kim TH, 2015, CNS NEUROSCI THER, V21, P327, DOI 10.1111/cns.12346; Krzyzanski W, 1998, J PHARM SCI, V87, P67, DOI 10.1021/js970168r; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Li DZ, 2003, BRIT J PHARMACOL, V139, P1539, DOI 10.1038/sj.bjp.0705385; Li HG, 2016, J STROKE CEREBROVASC, V25, P122, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.004; Liang LJ, 2016, MED GAS RES, V6, P33, DOI 10.4103/2045-9912.179343; Liao WG, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4210; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Liu YF, 2008, BIOMED CHROMATOGR, V22, P1194, DOI 10.1002/bmc.1042; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Mahmoudian M., 2003, Acta Physiologica Hungarica, V90, P313, DOI 10.1556/APhysiol.90.2003.4.4; Mahmoudian M, 2015, IRAN J NEUROL, V14, P12; Margaritescu O, 2009, ROM J MORPHOL EMBRYO, V50, P327; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muthiah D, 2019, DRUG METAB DISPOS, V47, P164, DOI 10.1124/dmd.118.083188; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; O'Collins VE, 2011, J CEREBR BLOOD F MET, V31, P962, DOI 10.1038/jcbfm.2010.184; Pai RS., 2013, INT SCH RES NOTICES, DOI 10.1155/2013/329072; Pan ZY, 2019, DRUG DES DEV THER, V13, P265, DOI 10.2147/DDDT.S192633; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Patil S, 2015, PHARMACOL BIOCHEM BE, V136, P13, DOI 10.1016/j.pbb.2015.07.001; Qin AP, 2019, RESTOR NEUROL NEUROS, V37, P1, DOI 10.3233/RNN-180837; Moscote-Salazar LR, 2018, J ACUTE DIS, V7, P20, DOI 10.4103/2221-6189.228874; Rajsic S, 2019, EUR J HEALTH ECON, V20, P107, DOI 10.1007/s10198-018-0984-0; Rida PCG, 2015, MED RES REV, V35, P1072, DOI 10.1002/med.21357; Ritter JM, 2008, BRIT J CLIN PHARMACO, V65, P299, DOI 10.1111/j.1365-2125.2008.03152.x; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Rosenborg S, 2010, CLIN PHARMACOL THER, V88, P343, DOI 10.1038/clpt.2010.107; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schwab M, 1997, BRAIN RES, V749, P82, DOI 10.1016/S0006-8993(96)01165-1; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805; Souza DG, 2003, BRIT J PHARMACOL, V139, P129, DOI 10.1038/sj.bjp.0705200; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Thompson Brandon J, 2014, Adv Pharmacol, V71, P165, DOI 10.1016/bs.apha.2014.06.013; Tiwari V, 2009, BEHAV BRAIN RES, V203, P296, DOI 10.1016/j.bbr.2009.05.016; Tuzcu M, 2006, EUR J PHARMACOL, V537, P106, DOI 10.1016/j.ejphar.2006.03.024; Uhr M, 2002, J NEUROENDOCRINOL, V14, P753, DOI 10.1046/j.1365-2826.2002.00836.x; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Vahabzadeh G, 2015, PHARMACOL REP, V67, P281, DOI 10.1016/j.pharep.2014.10.011; Wang TL, 2011, J CHROMATOGR B, V879, P3812, DOI 10.1016/j.jchromb.2011.10.025; Wang WZ, 2017, NEUROSCI LETT, V636, P233, DOI 10.1016/j.neulet.2016.11.026; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wong R, 2012, J PHARM PHARMACOL, V64, P1614, DOI 10.1111/j.2042-7158.2012.01537.x; Xiao GX, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00735; Xu P, 2014, J ZHEJIANG UNIV-SC B, V15, P84, DOI 10.1631/jzus.B1300141; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V346, P161, DOI 10.1006/abbi.1997.0302; Yan LL, 2014, MOLECULES, V19, P18923, DOI 10.3390/molecules191118923; Yang W, 2017, J CEREBR BLOOD F MET, V37, P3318, DOI 10.1177/0271678X17723783; Yanpallewar SU, 2004, PHARMACOL RES, V49, P143, DOI 10.1016/j.phrs.2003.08.005; Yousuf S, 2014, J CEREBR BLOOD F MET, V34, P297, DOI 10.1038/jcbfm.2013.198; Zhang HX, 2019, NEUROCHEM INT, V127, P2, DOI 10.1016/j.neuint.2018.10.005; Zhang L, 2012, TRENDS PHARMACOL SCI, V33, P415, DOI 10.1016/j.tips.2012.04.006; Zhang Li-wen, 2004, Yaoxue Xuebao, V39, P613; Zhang N, 2013, DRUG METAB DISPOS, V41, P2114, DOI 10.1124/dmd.113.053330; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zhu XY, 2019, J STEROID BIOCHEM, V185, P90, DOI 10.1016/j.jsbmb.2018.07.014; Zhu XY, 2017, J NEUROSCI, V37, P10998, DOI 10.1523/JNEUROSCI.3874-16.2017	111	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	FEB	2022	395	2					167	185		10.1007/s00210-021-02187-y		JAN 2022	19	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YG3CQ	WOS:000739247000001	34988596	Green Submitted			2022-02-06	
J	Thota, B; Marinica, A; Oh, MW; Cripps, MW; Moon, TS				Thota, Bhavana; Marinica, Alexander; Oh, Matthew W.; Cripps, Michael W.; Moon, Tiffany Sun			The Use of Tranexamic Acid in Trauma	CURRENT ANESTHESIOLOGY REPORTS			English	Article; Early Access						TXA; Tranexamic acid; Hemorrhage; Trauma; Coagulopathy; Fibrinolysis; Traumatic brain injury	FIBRINOLYSIS SHUTDOWN; HEMORRHAGE; MORTALITY; INJURY; ANTIFIBRINOLYTICS; METAANALYSIS; SAFETY	Purpose of Review The role of tranexamic acid (TXA) in hemorrhage control has been extensively studied in non-trauma patients and has been shown to decrease bleeding and improve outcomes. This review aims to discuss the known mechanisms of TXA, previous studies of its use in the surgical setting, and the proposed benefits and drawbacks of its use in trauma patients. Recent Findings The universal use of TXA in trauma patients at risk for hemorrhage is controversial. Recent studies have shown that TXA may be beneficial and reduces mortality in trauma patients, including for those with traumatic brain injury. However, there is still some uncertainty on the administration and dosing of TXA, as well as its effect on the incidence of thromboembolic events. This study reviews the role of TXA in trauma patients and the potential risks and benefits TXA administration may have in this patient population.	[Thota, Bhavana; Marinica, Alexander; Oh, Matthew W.; Moon, Tiffany Sun] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Cripps, Michael W.] Univ Colorado, Sch Med, Denver, CO USA		Moon, TS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.	Bhavana.Thota@students.jefferson.edu; Alexander.Marinica@UTSouthwestern.edu; Matthew.Oh@UTSouthwestern.edu; Michael.Cripps@Cuanschutz.edu; Tiffany.Moon@UTSouthwestern.edu		Moon, Tiffany/0000-0001-7052-5169			Briggs GD, 2020, ANZ J SURG, V90, P426, DOI 10.1111/ans.15755; Cai J, 2020, EUR J HAEMATOL, V104, P79, DOI 10.1111/ejh.13348; Callcut RA, 2019, J TRAUMA ACUTE CARE, V86, P864, DOI 10.1097/TA.0000000000002205; Chapman MP, 2013, J TRAUMA ACUTE CARE, V75, P961, DOI 10.1097/TA.0b013e3182aa9c9f; Coats TJ, 2019, EMERG MED J, V36, P78, DOI 10.1136/emermed-2018-207693; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Hanley C, 2021, BRIT J ANAESTH, V126, P12, DOI 10.1016/j.bja.2020.09.014; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Hu M, 2019, EUR REV MED PHARMACO, V23, P11025, DOI 10.26355/eurrev_201912_19810; Huebner BR, 2017, WILD ENVIRON MED, V28, pS50, DOI 10.1016/j.wem.2016.12.006; Hunt BJ, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12910; Inaba K, 2012, ARCH SURG-CHICAGO, V147, P119, DOI 10.1001/archsurg.2011.286; Jennings JD, 2016, ORTHOP CLIN N AM, V47, P137, DOI 10.1016/j.ocl.2015.08.014; Johnston LR, 2018, JAMA SURG, V153, P169, DOI 10.1001/jamasurg.2017.3821; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Lier H, 2019, ANESTH ANALG, V129, P1574, DOI 10.1213/ANE.0000000000004389; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore HB, 2019, ANESTH ANALG, V129, P762, DOI 10.1213/ANE.0000000000004234; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Morte D, 2019, J TRAUMA ACUTE CARE, V87, P125, DOI 10.1097/TA.0000000000002269; Myers SP, 2019, J TRAUMA ACUTE CARE, V86, P20, DOI 10.1097/TA.0000000000002061; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Neeki MM, 2018, WEST J EMERG MED, V19, P977, DOI 10.5811/westjem.2018.8.39336; Pabinger I, 2017, WIEN KLIN WOCHENSCHR, V129, P303, DOI 10.1007/s00508-017-1194-y; Paudyal P, 2017, EUR J EMERG MED, V24, P44, DOI 10.1097/MEJ.0000000000000323; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Ramirez RJ, 2017, CRIT CARE CLIN, V33, P85, DOI 10.1016/j.ccc.2016.08.004; Roberts I, 2015, J THROMB HAEMOST, V13, pS195, DOI 10.1111/jth.12878; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Valle EJ, 2014, J TRAUMA ACUTE CARE, V76, P1373, DOI 10.1097/TA.0000000000000242; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	46	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-6275		CURR ANESTHESIOL REP	Curr. Anesthesiol. Rep.												10.1007/s40140-021-00509-7		JAN 2022	8	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	YB7YV	WOS:000739223700001					2022-02-06	
J	Tverdal, C; Aarhus, M; Ronning, P; Skaansar, O; Skogen, K; Andelic, N; Helseth, E				Tverdal, Cathrine; Aarhus, Mads; Ronning, Pal; Skaansar, Ola; Skogen, Karoline; Andelic, Nada; Helseth, Eirik			Incidence of emergency neurosurgical TBI procedures: a population-based study	BMC EMERGENCY MEDICINE			English	Article						Emergency; Neurosurgery; Traumatic brain injury; Trauma center; Incidence	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; CARE; GUIDELINES; EPIDEMIOLOGY; MULTICENTER; MENINGITIS; MORTALITY	Background The rates of emergency neurosurgery in traumatic brain injury (TBI) patients vary between populations and trauma centers. In planning acute TBI treatment, knowledge about rates and incidence of emergency neurosurgery at the population level is of importance for organization and planning of specialized health care services. This study aimed to present incidence rates and patient characteristics for the most common TBI-related emergency neurosurgical procedures. Methods Oslo University Hospital is the only trauma center with neurosurgical services in Southeast Norway, which has a population of 3 million. We extracted prospectively collected registry data from the Oslo TBI Registry - Neurosurgery over a five-year period (2015-2019). Incidence was calculated in person-pears (crude) and age-adjusted for standard population. We conducted multivariate multivariable logistic regression models to assess variables associated with emergency neurosurgical procedures. Results A total of 2151 patients with pathological head CT scans were included. One or more emergency neurosurgical procedure was performed in 27% of patients. The crude incidence was 3.9/100,000 person-years. The age-adjusted incidences in the standard population for Europe and the world were 4.0/100,000 and 3.3/100,000, respectively. The most frequent emergency neurosurgical procedure was the insertion of an intracranial pressure monitor, followed by evacuation of the mass lesion. Male sex, road traffic accidents, severe injury (low Glasgow coma score) and CT characteristics such as midline shift and compressed/absent basal cisterns were significantly associated with an increased probability of emergency neurosurgery, while older age was associated with a decreased probability. Conclusions The incidence of emergency neurosurgery in the general population is low and reflects neurosurgery procedures performed in patients with severe injuries. Hence, emergency neurosurgery for TBIs should be centralized to major trauma centers.	[Tverdal, Cathrine; Aarhus, Mads; Ronning, Pal; Skaansar, Ola; Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway; [Tverdal, Cathrine; Skaansar, Ola; Helseth, Eirik] Univ Oslo, Inst Clin Med, Fac Med, Boks 1072 Blindern, N-0316 Oslo, Norway; [Skogen, Karoline] Oslo Univ Hosp, Dept Neuroradiol, POB 4956 Nydalen, N-0424 Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4956 Nydalen, N-0424 Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Boks 1072 Blindern, N-0316 Oslo, Norway		Tverdal, C (corresponding author), Oslo Univ Hosp, Dept Neurosurg, POB 4956 Nydalen, N-0424 Oslo, Norway.; Tverdal, C (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Boks 1072 Blindern, N-0316 Oslo, Norway.	uxtvec@ous-hf.no					Aarhus M, 2016, TRAUMEMANUALEN HODES; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; American Society of Anesthesiologists, ASA PHYS STAT CLASS; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; ATLS, 2018, ADV TRAUM LIF SUPP S, V10; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castillo-Angeles M, 2021, JAMA SURG, V156, P68, DOI 10.1001/jamasurg.2020.5397; Centers for Disease Control and Prevention, 2019, CTR DIS CONTR PREV; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; George EL, 2021, JAMA SURG, V156, DOI 10.1001/jamasurg.2020.5152; Gomez PA, 2017, NEUROCIRUGIA, V28, P1, DOI 10.1016/j.neucir.2016.11.002; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Hoffman H, 2020, WORLD NEUROSURG, V142, pE385, DOI 10.1016/j.wneu.2020.07.022; Hoffman H, 2019, NEUROCRIT CARE, V30, P666, DOI 10.1007/s12028-018-0656-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lecky FE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016355; Lilley EJ, 2016, J TRAUMA ACUTE CARE, V80, P998, DOI 10.1097/TA.0000000000001028; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Posti JP, 2020, AGE AGEING, V49, P779, DOI 10.1093/ageing/afaa037; Regional Committees for Medical and Health Research Ethics (REC), EX AVT NOT REQ APPR; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rossi-Mossuti F, 2016, J NEUROL SURG PART A, V77, P36, DOI 10.1055/s-0035-1563556; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Skaansar O, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01943-6; Sollid S, 2009, EMERG MED J, V26, P769, DOI 10.1136/emj.2008.061630; Sorinola A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00226; Statistics Norway, STATB POP; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Sundstrom T., 2020, MANAGEMENT SEVERE TR, DOI [10.1007/978-3-030-39383-0, DOI 10.1007/978-3-030-39383-0]; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Tverdal C, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00269-8; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Younsi A, 2021, EUR J TRAUMA EMERG S, V47, P1499, DOI 10.1007/s00068-020-01419-9	58	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	JAN 6	2022	22	1							1	10.1186/s12873-021-00561-w			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	YC8XZ	WOS:000739970300001	34991477	Green Published, gold, Green Submitted			2022-02-06	
J	Urhan, E; Karaca, Z; Unuvar, GK; Gundogan, K; Unluhizarci, K				Urhan, Emre; Karaca, Zuleyha; Unuvar, Gamze Kalin; Gundogan, Kursat; Unluhizarci, Kursad			Investigation of pituitary functions after acute coronavirus disease 2019	ENDOCRINE JOURNAL			English	Article; Early Access						COVID-19 (Coronavirus disease 2019); SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2); Pituitary; Growth hormone; Cortisol	ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; TRAUMATIC BRAIN-INJURY; SARS CORONAVIRUS; STIMULATION TEST; DYSFUNCTION; ACE2; GLUCOCORTICOIDS; PATHOGENESIS; INFECTION	Although coronavirus disease 2019 (COVID-19) mainly involves the lungs, it also affects many systems. The hypothalamic/pituitary axis is vulnerable to hypoxia, hypercoagulation, endothelial dysfunction and autoimmune changes induced by COVID-19 infection. Given that there is no extensive investigation on this issue, we investigated the pituitary functions three to seven months after acute COVID-19 infection. Forty-three patients after diagnosis of COVID-19 infection and 11 healthy volunteers were included in the study. In addition to the basal pituitary hormone levels, growth hormone (GH) and hypothalamo-pituitary adrenal (HPA) axes were evaluated by glucagon stimulation test (GST) and low-dose adrenocorticotropic hormone (ACTH) stimulation test, respectively. The peak cortisol responses to low-dose ACTH test were insufficient in seven (16.2%) patients. Twenty (46.5%) and four (9.3%) patients had inadequate GH and cortisol responses to GST, respectively. Serum insulin-like growth factor-1 (IGF-1) values were also lower than age and sex-matched references in four (9.3%) patients. The peak GH responses to GST were lower in the patient group when compared to the control group. Other abnormalities were mild thyroid-stimulating hormone elevation in four (9.3%) patients, mild prolactin elevation in two (4.6%) patients and central hypogonadism in four (9.3%) patients. Mean total testosterone values were lower in male patients when compared to male controls; however, the difference was not significant. These findings suggest that COVID-19 infection may affect pituitary functions, particularly the HPA and GH axes. These insufficiencies should be kept in mind in post-COVID follow-up. Long-term data are needed to determine whether these deficiencies are permanent or not.	[Urhan, Emre; Karaca, Zuleyha; Unluhizarci, Kursad] Erciyes Univ, Dept Endocrinol, Med Sch, TR-38039 Kayseri, Turkey; [Unuvar, Gamze Kalin] Erciyes Univ, Dept Infect Dis & Clin Microbiol, Med Sch, TR-38039 Kayseri, Turkey; [Gundogan, Kursat] Erciyes Univ, Dept Intens Care, Med Sch, TR-38039 Kayseri, Turkey		Unluhizarci, K (corresponding author), Erciyes Univ, Dept Endocrinol, Med Sch, TR-38039 Kayseri, Turkey.	kursad@erciyes.edu.tr			Council of Scientific Investigations of Erciyes University [TSA-202010491]	The Council of Scientific Investigations of Erciyes University supported this study (Project No: TSA-202010491) .	Adamko DJ, 1999, J EXP MED, V190, P1465, DOI 10.1084/jem.190.10.1465; [Anonymous], COVID-19 Diagnosis and Treatment Guideline in China, V7th; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Diri H, 2015, PITUITARY, V18, P884, DOI 10.1007/s11102-015-0666-1; Dokmetas HS, 2000, J CLIN ENDOCR METAB, V85, P3713, DOI 10.1210/jc.85.10.3713; Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031; Elbuken G, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-015-0125-0; Gavriatopoulou M, 2020, CLIN EXP MED, V20, P493, DOI 10.1007/s10238-020-00648-x; Goldberg MF, 2020, AM J NEURORADIOL, V41, P1170, DOI 10.3174/ajnr.A6588; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; Han T, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4281; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hayashi N, 2010, HYPERTENS RES, V33, P1182, DOI 10.1038/hr.2010.147; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Iqbal A, 2021, CUREUS, V13, DOI 10.7759/cureus.13080; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Karaca Z, 2021, REV ENDOCR METAB DIS, V22, P179, DOI 10.1007/s11154-020-09611-3; Karaca Z, 2019, PITUITARY, V22, P305, DOI 10.1007/s11102-018-00932-w; Karaca Z, 2011, PITUITARY, V14, P134, DOI 10.1007/s11102-010-0270-3; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; La Marca A, 2020, REPROD BIOMED ONLINE, V41, P903, DOI 10.1016/j.rbmo.2020.07.017; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Leow MKS, 2005, CLIN ENDOCRINOL, V63, P197, DOI 10.1111/j.1365-2265.2005.02325.x; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li T, 2020, EUR J CLIN MICROBIOL, V39, P2447, DOI 10.1007/s10096-020-03967-9; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Ma L, 2020, EFFECTS SARS COV 2 I, DOI [10.1101/2020.03.21.200326, DOI 10.1101/2020.03.21.200326]; Mahmud R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249644; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; Pal R, 2020, J ENDOCRINOL INVEST, V43, P1027, DOI 10.1007/s40618-020-01276-8; Pal R, 2020, ENDOCRINE, V68, P251, DOI 10.1007/s12020-020-02325-1; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Simsek Y, 2014, J ENDOCRINOL INVEST, V37, P1057, DOI 10.1007/s40618-014-0142-1; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Soliman Ashraf T, 2020, Acta Biomed, V91, pprint, DOI 10.23750/abm.v91i3.10074; Tanriverdi F, 2008, J ENDOCRINOL INVEST, V31, P489, DOI 10.1007/BF03346395; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Turner A. J., 2015, PROTECTIVE ARM RENIN, P185, DOI DOI 10.1016/B978-0-12-801364-9.00025-0; Vakili H, 2012, MOL CELL ENDOCRINOL, V363, P1, DOI 10.1016/j.mce.2012.08.001; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; Wang W, 2003, J CHIN ANTITUBERCULO, V25, P232, DOI DOI 10.1371/JOURNAL.PONE.0249421; Wei L, 2007, HUM PATHOL, V38, P95, DOI 10.1016/j.humpath.2006.06.011; Wei L, 2010, BIOCHEM CELL BIOL, V88, P723, DOI 10.1139/O10-022; Wheatland R, 2004, MED HYPOTHESES, V63, P855, DOI 10.1016/j.mehy.2004.04.009; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Xu J, 2006, BIOL REPROD, V74, P410, DOI 10.1095/biolreprod.105.044776; Yuen KCJ, 2019, ENDOCR PRACT, V25, P1191, DOI 10.4158/GL-2019-0405; Yuen Kevin C J, 2011, ISRN Endocrinol, V2011, P608056, DOI 10.5402/2011/608056; Zhou LY, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101642	55	0	0	1	1	JAPAN ENDOCRINE SOC	KYOTO	75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO, 604-8111, JAPAN	0918-8959	1348-4540		ENDOCR J	Endocr. J.												10.1507/endocrj.EJ21-0531		JAN 2022	10	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	YH0PM	WOS:000742878700001	34987144	gold			2022-02-06	
J	Xu, JM; Zhou, XY; Wang, CY; Hu, JL				Xu, Jinmei; Zhou, Xueying; Wang, Chunying; Hu, Jianli			The Value of Emergency Nursing Mode in the Treatment of Patients with Traumatic Shock	JOURNAL OF HEALTHCARE ENGINEERING			English	Article							HEMORRHAGIC-SHOCK; BRAIN-INJURY; RESUSCITATION; CARE	Objective. To study the value of emergency nursing mode in patients with traumatic shock. Methods. 76 patients with traumatic shock in our hospital from March 2019 to February 2021 were selected and divided into study group and control group according to different rescue modes, 38 cases in each group. The study group adopted emergency nursing mode for rescue, while the control group adopted routine nursing mode for rescue. The rescue intervention, emergency stay and preoperative preparation time, rescue success rate, emergency rescue effect, complications, and satisfaction rate of patients and their families for rescue were compared between the two groups. Results. The rescue intervention, emergency stay and preoperative preparation time of the study group were significantly shorter than those of the control group, and the difference was statistically significant (P < 0.05). The rescue success rate of the study group was 97.37%, which was significantly higher than 84.21% of the control group, and the difference was statistically significant (P < 0.05). The improvement rate of the study group was significantly higher than that of the control group, the disability rate was significantly lower than that of the control group, the overall emergency rescue effect was better than that of the control group, and the difference was statistically significant (P < 0.05). The incidence of complications in the study group was 2.63%, which was significantly lower than 23.68% in the control group (P < 0.05). The satisfaction rate of patients and their families in the study group was 97.37%, which was significantly higher than 84.21% in the control group (P < 0.05). Conclusion. Emergency nursing mode in patients with traumatic shock owns higher rescue value, can buy time for the operation, improve the success rate and effect of rescue, make safety and satisfaction higher. Overall, for patients with traumatic shock, emergency nursing mode is better than conventional rescue nursing.	[Xu, Jinmei] Ningbo Coll Hlth Sci, Ningbo 315104, Peoples R China; [Zhou, Xueying] Ningbo Mingzhou Hosp, Ningbo 315104, Peoples R China; [Wang, Chunying] Univ Chinese Acad Sci, Hwa Mei Hosp, Dept Nursing, Ningbo 315104, Peoples R China; [Hu, Jianli] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315104, Peoples R China		Xu, JM (corresponding author), Ningbo Coll Hlth Sci, Ningbo 315104, Peoples R China.	jinmeixu@ningbocollege.cn; 174550363@qq.com; hlb87366901@163.com; nbdxfyhujianli@126.com			Zhejiang Province Educational Science Planning Project [2020SCG106]; Zhejiang Vocational College Industry-Education Integration Project [60]; Zhejiang provincial department of education [47];  [2021]	This study was funded by Zhejiang Province Educational Science Planning Project (2020SCG106), 2021 Zhejiang Vocational College Industry-Education Integration Project (Zhejiaobanzhicheng [2021]; no. 60), and first batch of provincial level curriculum ideological and political teaching projects of Zhejiang provincial department of education, (Zhejiaohan [2021]; no. 47).	Caldwell NW, 2020, AM J NURS, V120, P36, DOI 10.1097/01.NAJ.0000697640.04470.21; Soto-Darias IC, 2020, GASTROENT HEPAT-BARC, V43, P519, DOI [10.1016/j.gastrohep.2020.02.0160210, 10.1016/j.gastrohep.2020.02.016]; Chandrasekaran S, 2021, IEEE T ULTRASON FERR, V68, P201, DOI 10.1109/TUFFC.2020.3022567; Chang Xiaowan, 2020, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V32, P1511, DOI 10.3760/cma.j.cn121430-20200408-00260; Chen FF, 2021, NURS EDUC TODAY, V102, DOI 10.1016/j.nedt.2021.104891; Cirocchi R, 2021, SURG-J R COLL SURG E, V19, pE485, DOI 10.1016/j.surge.2020.11.012; Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001; Diaz A, 2020, AM J SURG, V220, P509, DOI 10.1016/j.amjsurg.2020.05.002; Douma MJ, 2020, RESUSCITATION, V155, P103, DOI 10.1016/j.resuscitation.2020.07.010; Fan J, 2020, AGING-US, V12, P12479, DOI 10.18632/aging.103533; Zuo F, 2021, HUM CELL, V34, P177, DOI 10.1007/s13577-020-00431-w; George TP, 2020, JACEP OPEN, V1, P432, DOI 10.1002/emp2.12090; Giordano V, 2020, INJURY, V51, P1945, DOI 10.1016/j.injury.2020.08.008; Godoy DA, 2020, MED INTENSIVA, V44, P500, DOI 10.1016/j.medin.2020.01.014; Graf AC, 2020, J CLIN NURS, V29, P3097, DOI 10.1111/jocn.15234; Helling TS, 2020, J TRAUMA ACUTE CARE, V89, pE41, DOI 10.1097/TA.0000000000002826; Jain M, 2020, J FAM MED PRIM CARE, V9, P4974, DOI 10.4103/jfmpc.jfmpc_621_20; Jang H, 2021, PEDIATR EMERG CARE, V37, pE42, DOI 10.1097/PEC.0000000000001609; Johnston AN, 2021, EMERG MED AUSTRALAS, V33, P270, DOI 10.1111/1742-6723.13609; Jones T, 2020, AUSTRALAS EMERG CARE, V23, P173, DOI 10.1016/j.auec.2020.02.003; Kempsell-Smith Mark, 2020, Nurs Child Young People, V32, P13, DOI 10.7748/ncyp.2020.e1340; Mario C.F., 2020, AM SURGEON, V87, P370; Mohanty CR, 2020, CHIN J TRAUMATOL, V23, P243, DOI 10.1016/j.cjtee.2020.04.002; Mohr NM, 2020, CRIT CARE MED, V48, P1180, DOI 10.1097/CCM.0000000000004385; Newnham EC, 2021, WOMEN BIRTH, V34, pE435, DOI 10.1016/j.wombi.2020.09.001; Pitotti Christopher, 2020, Emerg Med Pract, V22, P1; Russo R, 2021, J BURN CARE RES, V42, P236, DOI 10.1093/jbcr/iraa172; Schochl H, 2020, J TRAUMA ACUTE CARE, V89, pE154, DOI 10.1097/TA.0000000000002887; Shih Ming-Chuan, 2020, Hu Li Za Zhi, V67, P70, DOI 10.6224/JN.202012_67(6).10; Shriki J, 2021, EMERG MED CLIN N AM, V39, P203, DOI 10.1016/j.emc.2020.09.012; Taniguchi T, 2021, CEN CASE REP, V10, P178, DOI 10.1007/s13730-020-00540-3; Williams AM, 2020, J TRAUMA ACUTE CARE, V89, P536, DOI 10.1097/TA.0000000000002815; Zhang P, 2021, CLIN NUTR, V40, P534, DOI 10.1016/j.clnu.2020.05.051; Zhou M, 2019, ELECT J MODERN MED H, V3, P100; Zhou M, 2020, NURS OPEN, V7, P1902, DOI 10.1002/nop2.580; Zhou W., 2020, PANMINERVA MED, V9, P31	36	0	0	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2040-2295	2040-2309		J HEALTHC ENG	J. Healthc. Eng.	JAN 6	2022	2022								6887236	10.1155/2022/6887236			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	YO0AD	WOS:000747610400005	35035851	Green Published			2022-02-06	
J	Bakaeva, Z; Lizunova, N; Tarzhanov, I; Boyarkin, D; Petrichuk, S; Pinelis, V; Fisenko, A; Tuzikov, A; Sharipov, R; Surin, A				Bakaeva, Zanda; Lizunova, Natalia; Tarzhanov, Ivan; Boyarkin, Dmitrii; Petrichuk, Svetlana; Pinelis, Vsevolod; Fisenko, Andrey; Tuzikov, Alexander; Sharipov, Rinat; Surin, Alexander			Lipopolysaccharide From E. coli Increases Glutamate-Induced Disturbances of Calcium Homeostasis, the Functional State of Mitochondria, and the Death of Cultured Cortical Neurons	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						lipopolysaccharide E. coli (LPS); glutamate excitotoxicity; intracellular free Ca2+ concentration ([Ca2+](i)); mitochondrial potential (??m); oxygen consumption rates (OCR); primary neuronal cultures; cell survival	TOLL-LIKE RECEPTORS; SPARE RESPIRATORY CAPACITY; RAPID COLORIMETRIC ASSAY; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; OXIDATIVE STRESS; NMDA RECEPTORS; APOPTOSIS; EXCITOTOXICITY; INHIBITION	Lipopolysaccharide (LPS), a fragment of the bacterial cell wall, specifically interacting with protein complexes on the cell surface, can induce the production of pro-inflammatory and apoptotic signaling molecules, leading to the damage and death of brain cells. Similar effects have been noted in stroke and traumatic brain injury, when the leading factor of death is glutamate (Glu) excitotoxicity too. But being an amphiphilic molecule with a significant hydrophobic moiety and a large hydrophilic region, LPS can also non-specifically bind to the plasma membrane, altering its properties. In the present work, we studied the effect of LPS from Escherichia coli alone and in combination with the hyperstimulation of Glu-receptors on the functional state of mitochondria and Ca2+ homeostasis, oxygen consumption and the cell survival in primary cultures from the rats brain cerebellum and cortex. In both types of cultures, LPS (0.1-10 mu g/ml) did not change the intracellular free Ca2+ concentration ([Ca2+](i)) in resting neurons but slowed down the median of the decrease in [Ca2+](i) on 14% and recovery of the mitochondrial potential (& UDelta;psi m) after Glu removal. LPS did not affect the basal oxygen consumption rate (OCR) of cortical neurons; however, it did decrease the acute OCR during Glu and LPS coapplication. Evaluation of the cell culture survival using vital dyes and the MTT assay showed that LPS (10 mu g/ml) and Glu (33 mu M) reduced jointly and separately the proportion of live cortical neurons, but there was no synergism or additive action. LPS-effects was dependent on the type of culture, that may be related to both the properties of neurons and the different ratio between neurons and glial cells in cultures. The rapid manifestation of these effects may be the consequence of the direct effect of LPS on the rheological properties of the cell membrane.	[Bakaeva, Zanda; Lizunova, Natalia; Tarzhanov, Ivan; Boyarkin, Dmitrii; Petrichuk, Svetlana; Pinelis, Vsevolod; Fisenko, Andrey; Surin, Alexander] Russian Minist Hlth, Natl Med Res Ctr Childrens Hlth, Lab Neurobiol, Moscow, Russia; [Bakaeva, Zanda] Kalmyk State Univ, Dept Gen Biol & Physiol, Elista, Russia; [Lizunova, Natalia] MN Lomonosov Moscow State Univ, Dept Biol, Moscow, Russia; [Tarzhanov, Ivan] Sechenov First Moscow State Med Univ, Inst Pharm, Minist Hlth Russian Federat, Moscow, Russia; [Tuzikov, Alexander] Russian Acad Sci, MM Shemyakin & YuA Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Sharipov, Rinat; Surin, Alexander] Inst Gen Pathol & Pathophysiol, Lab Fundamental & Appl Problems Pain, Moscow, Russia		Bakaeva, Z (corresponding author), Russian Minist Hlth, Natl Med Res Ctr Childrens Hlth, Lab Neurobiol, Moscow, Russia.; Bakaeva, Z (corresponding author), Kalmyk State Univ, Dept Gen Biol & Physiol, Elista, Russia.	bakaeva@nczd.ru			Russian Science FoundationRussian Science Foundation (RSF) [16-04-00792a, 17-00-00106]; Ministry of Science and Higher Education of the Russian Federation [0520-2019-0029]; Russian Ministry of Health [AAAAA19-119012590191-3]	This research was funded by the grants 16-04-00792a and 17-00-00106 of the Russian Science Foundation and grant 0520-2019-0029 from the Ministry of Science and Higher Education of the Russian Federation. The ionic homeostasis study was supported by the projects AAAAA19-119012590191-3 of the Russian Ministry of Health.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Aizawa F, 2016, BIOL PHARM BULL, V39, P1100, DOI 10.1248/bpb.b15-01037; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Ali T, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00096; Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; de Almeida MMA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040562; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bakaeva ZV, 2020, DOKL BIOCHEM BIOPHYS, V491, P62, DOI 10.1134/S1607672920020040; Bakaeva ZV, 2015, DOKL BIOCHEM BIOPHYS, V465, P406, DOI 10.1134/S1607672915060162; Barichello T, 2013, J MED MICROBIOL, V62, P1781, DOI 10.1099/jmm.0.059840-0; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Bermpohl D, 2005, J CLIN INVEST, V115, P1607, DOI 10.1172/JCI23223; Braun JS, 2002, J CLIN INVEST, V109, P19; Brown R, 2019, J NEUROL, V266, P268, DOI 10.1007/s00415-018-9110-6; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; CARR C, 1984, INFECT IMMUN, V43, P600, DOI 10.1128/IAI.43.2.600-606.1984; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Castilho RF, 1998, J NEUROSCI, V18, P10277; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chu JS, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030363; Ciesielski F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038677; Connolly NMC, 2018, CELL DEATH DIFFER, V25, P542, DOI 10.1038/s41418-017-0020-4; Cordoba J, 2010, METAB BRAIN DIS, V25, P73, DOI 10.1007/s11011-010-9172-3; Cui JS, 2018, CELL STRESS CHAPERON, V23, P281, DOI 10.1007/s12192-017-0841-6; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Djukic M, 2014, DEUT MED WOCHENSCHR, V139, P1987, DOI 10.1055/s-0034-1370283; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Efremov YM, 2020, BIOPHYS J, V119, P1712, DOI 10.1016/j.bpj.2020.09.022; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Giovan RA, 2018, PRIMARY CARE, V45, P505, DOI 10.1016/j.pop.2018.05.007; GUERRAROMERO L, 1993, PEDIATR RES, V33, P510, DOI 10.1203/00006450-199305000-00018; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; Hou LF, 2001, J NEUROSCI RES, V66, P592, DOI 10.1002/jnr.1249; Johnson LR, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00533; Khodorov B, 2004, PROG BIOPHYS MOL BIO, V86, P279, DOI 10.1016/j.pbiomolbio.2003.10.002; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Klockner U, 2014, J PHYSIOL-LONDON, V592, P1199, DOI 10.1113/jphysiol.2013.268540; Kolarova A, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-21; Korinek M, 2015, J PHYSIOL-LONDON, V593, P2279, DOI 10.1113/jphysiol.2014.288209; Kovacs Z, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00045; Kozlov AV, 2009, BBA-MOL BASIS DIS, V1792, P521, DOI 10.1016/j.bbadis.2009.03.004; Kumagai A, 2019, SYNAPSE, V73, DOI 10.1002/syn.22067; Lall H, 2008, MOL IMMUNOL, V45, P3045, DOI 10.1016/j.molimm.2008.03.014; LIMBRICK DD, 1995, BRAIN RES, V690, P145, DOI 10.1016/0006-8993(95)00552-2; Ma J, 2018, MED SCI MONITOR, V24, P2045, DOI 10.12659/MSM.905703; Ma William, 2003, Pediatr Crit Care Med, V4, P170, DOI 10.1097/01.PCC.0000059735.08694.8F; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Mangoni ML, 2008, J BIOL CHEM, V283, P22907, DOI 10.1074/jbc.M800495200; Mantani Y, 2011, HISTOL HISTOPATHOL, V26, P1295, DOI 10.14670/HH-26.1295; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagel M, 2015, BBA-BIOMEMBRANES, V1848, P2271, DOI 10.1016/j.bbamem.2015.06.008; Nakaguchi K, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/898012; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; O'Brien JA, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080381; Orlov SN, 2013, AM J PHYSIOL-CELL PH, V305, pC361, DOI 10.1152/ajpcell.00040.2013; Pardon MC, 2015, ROM J MORPHOL EMBRYO, V56, P903; Parthasarathy G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00306; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Rueda CB, 2016, BBA-BIOENERGETICS, V1857, P1158, DOI 10.1016/j.bbabio.2016.04.003; Salomao R, 2002, J ENDOTOXIN RES, V8, P371, DOI 10.1179/096805102125000704; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz DP, 2013, CURR PAIN HEADACHE R, V17, P340, DOI 10.1007/s11916-013-0340-0; Sharipov RR, 2018, BIOCHEM MOSC SUPPL S, V12, P369, DOI 10.1134/S1990747818050057; Shi H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-104; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shin HJ, 2007, MOL CELLS, V24, P119; Shuttleworth CW, 2010, NEUROCHEM INT, V56, P379, DOI 10.1016/j.neuint.2009.12.015; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Sriram CS, 2015, PHARMACOL BIOCHEM BE, V133, P83, DOI 10.1016/j.pbb.2015.03.022; Stevens SL, 2008, J CEREBR BLOOD F MET, V28, P1040, DOI 10.1038/sj.jcbfm.9600606; Surin AM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P864, DOI 10.1134/S0006297906080074; Surin AM, 2017, BIOCHEMISTRY-MOSCOW+, V82, P737, DOI 10.1134/S0006297917060104; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tumani H, 2000, GLIA, V30, P11, DOI 10.1002/(SICI)1098-1136(200003)30:1<11::AID-GLIA2>3.0.CO;2-E; TYMIANSKI M, 1993, NEURON, V11, P221, DOI 10.1016/0896-6273(93)90180-Y; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Vijay K, 2018, INT IMMUNOPHARMACOL, V59, P391, DOI 10.1016/j.intimp.2018.03.002; VOLTERRA A, 1992, ADV EXP MED BIOL, V318, P147; Weinberger JM, 2006, J NEUROL SCI, V249, P101, DOI 10.1016/j.jns.2006.06.010; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	100	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JAN 5	2022	14								811171	10.3389/fnmol.2021.811171			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YN8YX	WOS:000747539100001	35069113	Green Published, gold			2022-02-06	
J	La Rocca, M; Barisano, G; Bennett, A; Garner, R; Engel, J; Gilmore, EJ; McArthur, DL; Rosenthal, E; Stanis, J; Vespa, P; Willyerd, F; Zimmermann, LL; Toga, AW; Duncan, D				La Rocca, Marianna; Barisano, Giuseppe; Bennett, Alexis; Garner, Rachael; Engel, Jerome; Gilmore, Emily J.; McArthur, David L.; Rosenthal, Eric; Stanis, James; Vespa, Paul; Willyerd, Frederick; Zimmermann, Lara L.; Toga, Arthur W.; Duncan, Dominique		EpiBios4Rx Study Grp	Distribution and volume analysis of early hemorrhagic contusions by MRI after traumatic brain injury: a preliminary report of the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Lesion segmentation; Posttraumatic late seizures; Lesion volume analysis	TEMPORAL-LOBE EPILEPSY; POSTTRAUMATIC EPILEPSY; RISK-FACTORS	Traumatic brain injury (TBI) can produce heterogeneous injury patterns including a variety of hemorrhagic and non-hemorrhagic lesions. The impact of lesion size, location, and interaction between total number and location of contusions may influence the occurrence of seizures after TBI. We report our methodologic approach to this question in this preliminary report of the Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx). We describe lesion identification and segmentation of hemorrhagic contusions by early posttraumatic magnetic resonance imaging (MRI). We describe the preliminary methods of manual lesion segmentation in an initial cohort of 32 TBI patients from the EpiBioS4Rx cohort and the preliminary association of hemorrhagic contusion and edema location and volume to seizure incidence.	[La Rocca, Marianna; Barisano, Giuseppe; Bennett, Alexis; Garner, Rachael; Stanis, James; Toga, Arthur W.; Duncan, Dominique] Univ Southern Calif, Keck Sch Med USC, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA; [Engel, Jerome; McArthur, David L.; Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gilmore, Emily J.] Yale Univ, Dept Neurol, Comprehens Epilepsy Ctr, New Haven, CT USA; [Rosenthal, Eric] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Willyerd, Frederick] Phoenix Childrens Hosp, Phoenix, AZ USA; [Zimmermann, Lara L.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA		La Rocca, M (corresponding author), Univ Southern Calif, Keck Sch Med USC, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA.	marianna.larocca@loni.usc.edu			National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54 NS100064]	This study was conducted with the support of the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award number U54 NS100064 (EpiBioS4Rx).	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRA INJ; Chan CH, 2006, EPILEPSIA, V47, P399, DOI 10.1111/j.1528-1167.2006.00435.x; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Ding K., 2016, EPILEPSY TRAUMATIC B; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Garner R, 2019, EPILEPSIA, V60, P2151, DOI 10.1111/epi.16357; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Herrick JA, 2018, ANN CLIN TRANSL NEUR, V5, P630, DOI 10.1002/acn3.562; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kendirli MT, 2014, EPILEPSIA, V55, P1969, DOI 10.1111/epi.12854; Kim H, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00060; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; Ottman R, 2010, EPILEPSIA, V51, P191, DOI 10.1111/j.1528-1167.2009.02274.x; Pell GS, 2008, NEUROIMAGE, V39, P1151, DOI 10.1016/j.neuroimage.2007.09.061; Peng SJ, 2017, NEUROIMAGE-CLIN, V13, P55, DOI 10.1016/j.nicl.2016.11.010; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Riazi A. H., 2012, 2012 19th Iranian Conference of Biomedical Engineering (ICBME 2012). Proceedings, P209, DOI 10.1109/ICBME.2012.6519682; Rodriguez-Cruces R, 2015, QUANT IMAGING MED SU, V5, P264, DOI 10.3978/j.issn.2223-4292.2015.02.06; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Talairach J, 1988, COPLANAR STEREOTAXIC; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vespa PM, 2019, NEUROBIOL DIS, V123, P110, DOI 10.1016/j.nbd.2018.07.025; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	33	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2021	15	6			SI		2804	2812		10.1007/s11682-021-00603-8		JAN 2022	9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH2SZ	WOS:000739435800001	34985618				2022-02-06	
J	Qian, Y; Li, X; Fan, RF; Li, QF; Zhang, Y; He, XN; Yang, W; Sun, W; Lv, SK				Qian, Yan; Li, Xin; Fan, Raofei; Li, Qiaofen; Zhang, Yang; He, Xiaona; Yang, Wei; Sun, Wei; Lv, Shaokun			MicroRNA-31 inhibits traumatic brain injury-triggered neuronal cell apoptosis by regulating hypoxia-inducible factor-1A/vascular endothelial growth factor A axis	NEUROREPORT			English	Article						hypoxia-inducible factor; microRNA-31; traumatic brain injury; vascular endothelial growth factor	EXPRESSION; PI3K/AKT; PATHWAY; SYSTEM; VEGFA; MODEL	MicroRNAs are dysregulated in traumatic brain injury and are involved in neuronal cell behaviors. Previous studies identified miR-31 as a spinal cord injury-related microRNA, while its role in traumatic brain injury remains indistinct. Herein, we explored the participation of miR-31 in traumatic brain injury. Traumatic brain injury model was established after traumatic neuron injury. Neurocytes were transfected with miR-31 mimic or inhibitor. Cell counting kit-8, lactate dehydrogenase assay, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling, and western blot were applied to examine cell viability, lactate dehydrogenase releasing, apoptosis, and apoptosis-related protein. The binding between miR-31 and hypoxia-inducible factor-1A was verified by luciferase assay. Quantitative reverse transcription-PCR was used to detect the regulation of traumatic neuron injury or hypoxia-inducible factor-1A overexpression on vascular endothelial growth factor A level. The effects of hypoxia-inducible factor-1A or vascular endothelial growth factor A on neuronal cell injury were examined. Additionally, phosphatidylinositol 3kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway was also examined using western blot. Downregulation of miR-31 promoted traumatic neuron injury-induced neuronal cell injury, and its overexpression did the opposite. Hypoxia-inducible factor-1A acted as a downstream mRNA of miR-31 and its downregulation was involved in miR-31-regulated neuronal cell injury. Vascular endothelial growth factor A level was elevated by traumatic neuron injury or hypoxia-inducible factor-1A overexpression. Hypoxia-inducible factor-1A enhanced neuronal cell injury via promoting vascular endothelial growth factor A expression. Furthermore, miR-31/hypoxia-inducible factor-1A/vascular endothelial growth factor A regulated PI3K/AKT/mTOR pathway in neuronal cells. Our study demonstrated miR-31 inhibited neuronal cell apoptosis via regulating hypoxia-inducible factor-1A/vascular endothelial growth factor A axis.	[Qian, Yan; Li, Xin; Fan, Raofei; Li, Qiaofen; Zhang, Yang; He, Xiaona; Yang, Wei; Lv, Shaokun] Qujing 1 Hosp, Dept Rehabil Med, Qujing, Yunnan, Peoples R China; [Sun, Wei] Qujing 1 Hosp, Dept Neurosurg, Yuanlin 1 Rd, Qujing 655000, Yunnan, Peoples R China		Sun, W (corresponding author), Qujing 1 Hosp, Dept Neurosurg, Yuanlin 1 Rd, Qujing 655000, Yunnan, Peoples R China.	swzero5sunwei@163.com			Yunnan Key Clinical Specialty Construction Project [2018-04]	Yunnan Key Clinical Specialty Construction Project (No. 2018-04).; This research was supported by Yunnan Key Clinical Specialty Construction Project (No. 2018-04).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki M, 2017, CURR TOP MICROBIOL, V407, P153, DOI 10.1007/82_2017_6; Bae YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1180-y; Barros-Viegas AT, 2020, MOL THER-NUCL ACIDS, V19, P1219, DOI 10.1016/j.omtn.2020.01.010; Bohuslavova R, 2019, P NATL ACAD SCI USA, V116, P13414, DOI 10.1073/pnas.1903510116; Cai P, 2018, J CELL BIOCHEM, V119, P8195, DOI 10.1002/jcb.26830; Cho Y, 2015, NEURON, V88, P720, DOI 10.1016/j.neuron.2015.09.050; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Corti F, 2019, CANCER TREAT REV, V72, P45, DOI 10.1016/j.ctrv.2018.11.001; Davidson JO, 2018, FRONT BIOSCI-LANDMRK, V23, P2204, DOI 10.2741/4700; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huang JJ, 2019, ONCOL REP, V42, P1677, DOI 10.3892/or.2019.7307; Huang R, 2017, HAEMATOLOGICA, V102, P1956, DOI 10.3324/haematol.2017.174979; Ito M., 2019, OBM NEUROBIOL, V3, P19; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Kurogi R, 2019, J NEUROSURG, V130, P44, DOI 10.3171/2017.8.JNS1788; Li J, 2020, J CELL PHYSIOL, V235, P2414, DOI 10.1002/jcp.29146; Liang Z, 2018, EUR REV MED PHARMACO, V22, P3485, DOI 10.26355/eurrev_201806_15175; Liu X., 2019, SPINE PHILA PA 1976, V45, P364; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lopez BM., 2019, OBM NEUROBIOL, V3, P14; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Pearce AJ, 2019, OBM NEUROBIOL, V3, P20; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shi L, 2017, CHEM-BIOL INTERACT, V273, P228, DOI 10.1016/j.cbi.2017.06.024; Shibuya M, 2015, ENDOCR METAB IMMUNE, V15, P135, DOI 10.2174/1871530315666150316121956; Sole C, 2019, J INVEST DERMATOL, V139, P51, DOI 10.1016/j.jid.2018.07.026; Wang K, 2020, J SURG RES, V246, P419, DOI 10.1016/j.jss.2019.09.023; Wang YL, 2019, BRAIN DEV-JPN, V41, P649, DOI 10.1016/j.braindev.2019.04.010; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Yun Y, 2018, GENE THER, V25, P27, DOI 10.1038/gt.2017.92; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	41	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JAN 5	2022	33	1					1	12		10.1097/WNR.0000000000001741			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XK5EG	WOS:000727488100001	34874324				2022-02-06	
J	Ravi, P; Nageswaran, J; Ramanujam, M; Suriyakumar, S; Nambi, EA				Ravi, Praveen; Nageswaran, Jambu; Ramanujam, Muthumanickam; Suriyakumar, Sundar; Nambi, Elancheral Ayanambakkam			Correlation Between Traumatic Brain Injuries and Callus Formation in Long bone Fractures	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article; Early Access						Traumatic brain injury; Excess callus; Interleukin-6; Prolactin; Growth hormone	HEAD-INJURY; ENHANCED OSTEOGENESIS; FEMORAL FRACTURES; INTERLEUKIN-6; IL-6; OSTEOBLAST; RECEPTOR	Introduction Orthopaedic aphorism teaches that fractures of long bones when associated with head injuries frequently heal with excessive callus and at a faster rate than normal. However, the evidence on this subject is flimsy and the aphorism remains unsubstantiated. Numerous studies have been conducted evaluating the possible humoral and other factors involved leading to excess callus formation in patients with a head injury. This study was designed to evaluate the effects of a traumatic head injury on bone healing in adults with a diaphyseal fracture of the lower limb. Methods Fiveteen patients with a closed fracture of tibia or femur and associated head injury (cases) and 15 patients with a closed fracture of tibia or femur without an associated head injury (controls) were included in the study. All patients were evaluated in terms of various serum parameters, including IL-6, growth hormone, PTH, LDH, prolactin levels, and ALP. Head injuries were graded as mild, moderate, or severe. Ventilatory support if required was noted. Serum prolactin was repeated at 5 weeks. Patients were followed up with serial radiographs, and the volume of callus formed was calculated and compared. Results The mean value of growth hormone, interleukin-6 levels, and prolactin levels at 5 weeks were found to be higher in patients with head injuries, and the difference was highly significant (p = 0.001). The severity of head injury also correlated proportionately with the spike in IL-6 levels. There was more pronounced callus formation in patients with head injury group when compared to the controls. This difference was significant at all intervals. Discussion There was higher volume of callus noted at the end of 6 months in patients with severe head injury (GCS < 7) when compared to patients with moderate head injury (GCS > 7). The patients with severe head injury were naturally under ventilator support for a prolonged period compared to those with moderate head injury. It was thus indiscernible if the excess callus observed is due to the humoral cascade or as an effect of prolonged ventilation. Patients with head injuries show elevated parathyroid hormone levels, growth hormone levels at the time of injury, and elevated prolactin levels 5 weeks after the trauma-all of which might contribute to enhanced osteogenesis. Interleukin-6 levels are also elevated and the levels correlate to severity of head injury. Conclusion Head injury triggers a humoral cascade invloving interleukin-6, parathyroid hormoe, growth hormone, and prolactin that contributes to enhanced fracture healing.	[Ravi, Praveen; Nageswaran, Jambu; Ramanujam, Muthumanickam; Nambi, Elancheral Ayanambakkam] SRM Med Coll & Res Inst, Dept Orthopaed, Chengalpattu 603203, Tamil Nadu, India; [Suriyakumar, Sundar] Sri Ramachandra Inst Higher Educ & Res, Dept Orthopaed, SRMC, Chennai 600116, Tamil Nadu, India		Ravi, P (corresponding author), SRM Med Coll & Res Inst, Dept Orthopaed, Chengalpattu 603203, Tamil Nadu, India.	praveenravi2010@gmail.com; jambusrmc@gmail.com; muthumanickam9@gmail.com; drssundhar@gmail.com; praveenravi20101993200@gmail.com					Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Khallaf FG, 2016, J ORTHOP, V13, P69, DOI 10.1016/j.jor.2016.02.001; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Kurer MHJ., 1991, J BONE JOINT SURG BR, V73, P59; Lee JS, 2009, ARCH ORTHOP TRAUM SU, V129, P711, DOI 10.1007/s00402-008-0632-8; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Mustafa KH., 2008, TIKRIT MED J, V14, P127; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Oni OOA., 1996, ORTHOPAEDICS, V4, P269; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Sang XG, 2017, ANN CLIN BIOCHEM, V54, P584, DOI 10.1177/0004563216673087; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Wang YH, 2007, AM J PHYSIOL-ENDOC M, V292, pE594, DOI 10.1152/ajpendo.00216.2006; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	30	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.												10.1007/s43465-021-00594-0		JAN 2022	10	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	YB8DS	WOS:000739236400001					2022-02-06	
J	Sisakht, AM; Karamzade-Ziarati, N; Jahanbakhshi, A; Shahpasand, K; Aghababaei, S; Ahmadvand, O; Azar, M; Fattahi, A; Zamanzadeh, S				Sisakht, Alireza Mohsenian; Karamzade-Ziarati, Najme; Jahanbakhshi, Amin; Shahpasand, Koorosh; Aghababaei, Samareh; Ahmadvand, Omid; Azar, Maziar; Fattahi, Arash; Zamanzadeh, Selva			Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article; Early Access						Traumatic brain injury; cis p-tau; beta-amyloid; cerebrospinal fluid; Glasgow Coma Scale	PHOSPHORYLATED-TAU; ALZHEIMER-DISEASE; NEURODEGENERATION; RISK; DEMENTIA; ANTIBODY	Traumatic brain injury (TBI) is the main cause of death and disability among young people. Following TBI, immune system activation and cytokine release induce kinase activity and hyperphosphorylation of tau protein, a structural molecule in axonal microtubules. The cis configuration of phosphorylated tau at Th231 is extremely neurotoxic and is having a prion nature, spreads to brain areas as well as CSF. We examined the cerebrospinal fluid (CSF) cis p-tau levels in 32 TBI patients and 5 non-TBI controls to find out the correlation with TBI severity. CSF samples were drained 5-7 days after TBI and subjected for ELISA analysis with anti cis p-tau and beta-amyloid antibodies. We had no patients with mild TBI, two patients with moderate (6.2%), 23 patients with severe (71.9%), and 7 patients with critical TBI (21.9%). While mean CSF beta-amyloid in TBI and control groups did not show a statistically significant difference, the mean CSF cis p-tau level was significantly higher in the TBI group than the control samples. Also, intergroup analysis demonstrated that CSF cis p-tau levels were statistically different according to the head injury severity. Although CSF cis p-tau increased in the TBI patients, beta-amyloid did not show a significant difference between patients and controls. Also, we observed an obvious negative correlation between CSF cis p-tau levels and GCS scores. Therefore, future researches on suppression of cis P-tau production or removing previously produced cis P-tau could be a suitable approach in treating TBI in order to prevent tauopathies and future neurodegeneration.	[Sisakht, Alireza Mohsenian; Azar, Maziar] Iran Univ Med Sci, Rasool Akram Hosp, Dept Neurosurg, Tehran, Iran; [Sisakht, Alireza Mohsenian] Iran Univ Med Sci, Student Res Comm, Tehran, Iran; [Karamzade-Ziarati, Najme] Univ Tehran Med Sci, Shariati Hosp, Res Ctr Nucl Med, Tehran, Iran; [Jahanbakhshi, Amin] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran; [Shahpasand, Koorosh; Aghababaei, Samareh] Royan Inst Stem Cell Biol & Technol ACECR, Cell Sci Res Ctr, Dept Brain & Cognit Sci, Tehran, Iran; [Aghababaei, Samareh; Zamanzadeh, Selva] Islamic Azad Univ, Fac Adv Sci & Technol, Dept Mol Biol, Pharmaceut Sci Branch, Tehran, Iran; [Ahmadvand, Omid] Islamic Azad Univ, Tehran Med Sci Branch, Tehran, Iran; [Fattahi, Arash] Iran Univ Med Sci, 7tir Hosp, Dept Neurosurg, Tehran, Iran		Jahanbakhshi, A (corresponding author), Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran.; Shahpasand, K (corresponding author), Royan Inst Stem Cell Biol & Technol ACECR, Cell Sci Res Ctr, Dept Brain & Cognit Sci, Tehran, Iran.	jahanbakhshi.a@iums.ac.ir; shahpasand09@gmail.com	Fattahi, Arash/M-3492-2017	Fattahi, Arash/0000-0002-1874-6527			Abu Hamdeh S, 2018, BRAIN PATHOL, V28, P451, DOI 10.1111/bpa.12532; Albayram O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45234-8; Albayram Onder, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000443; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; IQBAL K, 1991, MOL NEUROBIOL, V5, P399, DOI 10.1007/BF02935561; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kim N, 2021, PROG NEUROBIOL, V203, DOI 10.1016/j.pneurobio.2021.102072; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu J, 2015, ARCH PHYS MED REHAB, V96, P702, DOI 10.1016/j.apmr.2014.10.026; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Qiu CX, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aaz7615; Selvakumar GP, 2020, EXP NEUROBIOL, V29, P230, DOI 10.5607/en20017; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Smith DH, 2018, BRAIN PATHOL, V28, P463, DOI 10.1111/bpa.12534; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030	43	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.												10.1080/01616412.2021.2022921		JAN 2022	7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YA5SX	WOS:000738393800001	34979886				2022-02-06	
J	Warren, KL; Garcia, JJ				Warren, Karlita L.; Garcia, James J.			Centering race/ethnicity: Differences in traumatic brain injury inpatient rehabilitation outcomes	PM&R			English	Article; Early Access							INSURANCE STATUS; FUNCTIONAL OUTCOMES; DISCHARGE DESTINATION; ETHNIC DISPARITIES; UNITED-STATES; RACE; CARE; ASSOCIATION; BIAS	Background Persons of color have a higher incidence of traumatic brain injury (TBI) and experience disparities in the quality and quantity of interventions received, discharge disposition, functional outcomes, and mortality rate post TBI. Objective To examine racial/ethnic differences in rehabilitation outcomes for patients with TBI. Design Multiyear (2005-2016) and retrospective cohort using secondary data analysis from inpatient rehabilitation facilities (IRFs) across the United States. Setting eRehabData participating IRFs throughout the United States. Patients Forty-one thousand eight hundred forty-seven adults with a diagnosis of TBI, admitted to U.S. eRehabData participating IRFs. Interventions Not applicable. Main Outcome Measures Inpatient rehabilitation functional outcomes and discharge disposition. Results Participants were 41,847 non-Hispanic Whites (NHWs), Hispanics, non-Hispanic Asians (NHAs), and non-Hispanic Blacks (NHBs) aged 18-107 years. NHWs were used as the reference group. NHBs had the longest length of stay (17.65 +/- 14.96). At admission, NHB, Hispanic, and NHA races/ethnicities were significantly associated with 1-3 point lower motor, cognitive, and total Functional Independence Measure (FIM) scores. NHB race was significantly associated with less than 1-point lower cognitive, motor, and total efficiency FIM scores. At discharge, NHB race was significantly associated with 1-2 point lower motor, cognitive, and total FIM scores; Hispanics and NHA race were associated with less than 1-point lower cognitive FIM scores. Compared to NHWs, Hispanic ethnicity was associated with greater odds of a discharge to home (odds ratio = 1.16, 95% confidence interval = 1.06-1.27). Conclusion Contrary to established literature on functionality differences 1 year post TBI, the current study found racial/ethnic differences in functional outcomes during inpatient rehabilitation. These findings suggest a need for cultural competence/sensitivity in the care of racial/ethnic persons and centering potential contributing factors for racial/ethnic differences in TBI rehabilitation outcomes.	[Warren, Karlita L.] Keck Grad Inst, Sch Med, 535 Watson Dr, Claremont, CA 91711 USA; [Garcia, James J.] Univ La Verne, Coll Hlth & Community Well Being, Dept Psychol, La Verne, CA USA; [Garcia, James J.] Casa Colina Hosp & Ctr Healthcare, Dept Neuropsychol & Psychol, Pomona, CA USA		Warren, KL (corresponding author), Keck Grad Inst, Sch Med, 535 Watson Dr, Claremont, CA 91711 USA.	karlita_warren@kgi.edu		Warren, Karlita/0000-0001-6350-6189; Garcia, James/0000-0002-5028-3200			American Medical Rehabilitation Providers Association, EREHABDATA; [Anonymous], 2019, FACT SHEET CODING GU; [Anonymous], TBI GET FACTS; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bekelis K, 2015, ANN SURG, V262, P9, DOI 10.1097/SLA.0000000000001239; Budnick HC, 2017, J SURG RES, V215, P231, DOI 10.1016/j.jss.2017.03.062; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cohen J., 1983, APPL MULTIPLE REGRES; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Evans R S, 2016, Yearb Med Inform, VSuppl 1, pS48, DOI 10.15265/IYS-2016-s006; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Jaffe KM, 2015, ARCH PHYS MED REHAB, V96, P1371, DOI 10.1016/j.apmr.2015.04.017; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Missios S, 2016, INJURY, V47, P154, DOI 10.1016/j.injury.2015.06.037; Oyesanya TO, 2021, BRAIN INJURY, V35, P661, DOI 10.1080/02699052.2021.1895317; Rosenthal M., 1996, J HEAD TRAUMA REHAB, V11, P69; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; SPSS Statistics for Macintosh, 2019, VERSION 260 IBM CORP; Wolfson AM, 2000, ARCH PHYS MED REHAB, V81, P1567, DOI 10.1053/apmr.2000.16345; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	32	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R												10.1002/pmrj.12737		JAN 2022	9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	YB2UP	WOS:000738874200001	34773442				2022-02-06	
J	Williamson, TL; Adil, SM; Shalita, C; Charalambous, LT; Mitchell, T; Yang, ZD; Parente, BA; Lee, HJ; Ubel, PA; Lemmon, ME; Galanos, AN; Lad, SP; Komisarow, JM				Williamson, Theresa L.; Adil, Syed M.; Shalita, Chidyaonga; Charalambous, Lefko T.; Mitchell, Taylor; Yang, Zidanyue; Parente, Beth A.; Lee, Hui-Jie; Ubel, Peter A.; Lemmon, Monica E.; Galanos, Anthony N.; Lad, Shivanand P.; Komisarow, Jordan M.			Palliative Care Consultations in Patients with Severe Traumatic Brain Injury: Who Receives Palliative Care Consultations and What Does that Mean for Utilization?	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Palliative care; Racial disparity; Health care resource utilization	OF-LIFE CARE; END; VALIDATION; HOSPITALS; MORTALITY; OUTCOMES; OLDER; CODE	Background Palliative care has the potential to improve goal-concordant care in severe traumatic brain injury (sTBI). Our primary objective was to illuminate the demographic profiles of patients with sTBI who receive palliative care encounters (PCEs), with an emphasis on the role of race. Secondary objectives were to analyze PCE usage over time and compare health care resource utilization between patients with or without PCEs. Methods The National Inpatient Sample database was queried for patients age >= 18 who had a diagnosis of sTBI, defined by using International Classification of Diseases, 9th Revision codes. PCEs were defined by using International Classification of Diseases, 9th Revision code V66.7 and trended from 2001 to 2015. To assess factors associated with PCE in patients with sTBI, we performed unweighted generalized estimating equations regression. PCE association with decision making was modeled via its effect on rate of percutaneous endoscopic gastrostomy (PEG) tube placement. To quantify differences in PCE-related decisions by race, race was modeled as an effect modifier. Results From 2001 to 2015, the proportion of palliative care usage in patients with sTBI increased from 1.5 to 36.3%, with 41.6% White, 22.3% Black, and 25% Hispanic patients with sTBI having a palliative care consultation in 2015, respectively. From 2008 to 2015, we identified 17,673 sTBI admissions. White and affluent patients were more likely to have a PCE than Black, Hispanic, and low socioeconomic status patients. Across all races, patients receiving a PCE resulted in a lower rate of PEG tube placement; however, White patients exhibited a larger reduction of PEG tube placement than Black patients. Patients using palliative care had lower total hospital costs (median $16,368 vs. $26,442, respectively). Conclusions Palliative care usage for sTBI has increased dramatically this century and it reduces resource utilization. This is true across races, however, its usage rate and associated effect on decision making are race-dependent, with White patients receiving more PCE and being more likely to decline the use of a PEG tube if they have had a PCE.	[Williamson, Theresa L.; Adil, Syed M.; Shalita, Chidyaonga; Charalambous, Lefko T.; Mitchell, Taylor; Parente, Beth A.; Lad, Shivanand P.; Komisarow, Jordan M.] Duke Univ, Dept Neurosurg, Med Ctr, Box 3807, Durham, NC 27710 USA; [Yang, Zidanyue; Lee, Hui-Jie] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC 27710 USA; [Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27710 USA; [Lemmon, Monica E.] Duke Univ, Dept Pediat, Med Ctr, Durham, NC 27710 USA; [Galanos, Anthony N.] Duke Univ, Dept Med, Div Palliat Care, Med Ctr, Durham, NC 27710 USA		Williamson, TL (corresponding author), Duke Univ, Dept Neurosurg, Med Ctr, Box 3807, Durham, NC 27710 USA.	Theresa.Williamson@duke.edu		Komisarow, Jordan/0000-0003-3919-7931	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002553]	Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002553. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agency for Healthcare Research and Quality Rockville MD, 2011, HCUP US NIS OV; Agency for Healthcare Research and Quality Rockville MD, 2008, HEALTHC COST UT PROJ; [Anonymous], 2015, ICD 10 COD GUID TRAU; [Anonymous], 2008, CONS PRIC IND; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Assmann SF, 1996, EPIDEMIOLOGY, V7, P286, DOI 10.1097/00001648-199605000-00012; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bonner GJ, 2021, AM J HOSP PALLIAT ME, V38, P547, DOI 10.1177/1049909120916127; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Clark DE, 2009, ICDPIC STATA MODULE; Cohen SM, 2020, DYSPHAGIA, V35, P787, DOI 10.1007/s00455-019-10084-z; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Dumanovsky T, 2016, J PALLIAT MED, V19, P8, DOI 10.1089/jpm.2015.0351; Feder SL, 2018, AM J HOSP PALLIAT ME, V35, P959, DOI 10.1177/1049909117747519; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Givler A, 2021, STATPEARLS; Houchens RL, HCUP US METHODS SERI; Hua M, 2017, J PALLIAT MED, V20, P372, DOI 10.1089/jpm.2016.0363; Hwang F, 2020, J SURG RES, V246, P224, DOI 10.1016/j.jss.2019.09.002; Johnson KS, 2013, J PALLIAT MED, V16, P1329, DOI 10.1089/jpm.2013.9468; Jones RC, 2021, J INTENSIVE CARE MED, V36, P1258, DOI 10.1177/0885066620945911; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Livingston DH, 2011, CAN MED ASSOC J, V183, P1570, DOI 10.1503/cmaj.110974; McGraw C, 2021, J TRAUMA ACUTE CARE, V90, P305, DOI 10.1097/TA.0000000000002983; Morrison RS, 2011, HEALTH AFFAIR, V30, P454, DOI 10.1377/hlthaff.2010.0929; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Mosenthal AC, 2020, JAMA SURG, V155, P731, DOI 10.1001/jamasurg.2020.1810; Murthy SB, 2016, CRIT CARE MED, V44, P575, DOI 10.1097/CCM.0000000000001391; Ormseth CH, 2018, NEUROCRIT CARE, V29, P419, DOI 10.1007/s12028-018-0554-4; Roeland EJ, 2016, J NATL COMPR CANC NE, V14, P439, DOI 10.6004/jnccn.2016.0050; Ruck JM, 2018, J PALLIAT MED, V21, P1300, DOI 10.1089/jpm.2018.0003; Singh T, 2017, STROKE, V48, P2534, DOI 10.1161/STROKEAHA.117.016893; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; Waters C M, 2000, J Community Health Nurs, V17, P25, DOI 10.1207/S15327655JCHN1701_03; Williamson T, 2020, JAMA SURG, V155, P723, DOI 10.1001/jamasurg.2020.1790; World Health Organization, WHO DEF PALL CAR; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183	41	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01366-2		JAN 2022	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YB7XQ	WOS:000739220600001	34988887				2022-02-06	
J	Davis, DP; Bosson, N; Guyette, FX; Wolfe, A; Bobrow, BJ; Olvera, D; Walker, RG; Levy, M				Davis, Daniel P.; Bosson, Nichole; Guyette, Francis X.; Wolfe, Allen; Bobrow, Bentley J.; Olvera, David; Walker, Robert G.; Levy, Michael			Optimizing Physiology During Prehospital Airway Management: An NAEMSP Position Statement and Resource Document	PREHOSPITAL EMERGENCY CARE			English	Article						airway management; guidelines; physiology; preoxygenation; resuscitation	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; CARBON-DIOXIDE; EMERGENCY-DEPARTMENT; APNEIC OXYGENATION; ENDOTRACHEAL-TUBES; PULSE OXIMETRY; TEAM PERFORMANCE; VENTILATION; HYPOTENSION	Airway management is a critical component of resuscitation but also carries the potential to disrupt perfusion, oxygenation, and ventilation as a consequence of airway insertion efforts, the use of medications, and the conversion to positive-pressure ventilation. NAEMSP recommends: Airway management should be approached as an organized system of care, incorporating principles of teamwork and operational awareness. EMS clinicians should prevent or correct hypoxemia and hypotension prior to advanced airway insertion attempts. Continuous physiological monitoring must be used during airway management to guide the timing of, limit the duration of, and inform decision making during advanced airway insertion attempts. Initial and ongoing confirmation of advanced airway placement must be performed using waveform capnography. Airway devices must be secured using a reliable method. Perfusion, oxygenation, and ventilation should be optimized before, during, and after advanced airway insertion. To mitigate aspiration after advanced airway insertion, EMS clinicians should consider placing a patient in a semi-upright position. When appropriate, patients undergoing advanced airway placement should receive suitable pharmacologic anxiolysis, amnesia, and analgesia. In select cases, the use of neuromuscular blocking agents may be appropriate.	[Davis, Daniel P.; Olvera, David] Air Methods Corp, Englewood, CO 80111 USA; [Bosson, Nichole] Los Angeles Cty EMS Agcy, Santa Fe Springs, CA USA; [Bosson, Nichole] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Bosson, Nichole] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Guyette, Francis X.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Guyette, Francis X.] STAT MedEvac, West Mifflin, PA USA; [Wolfe, Allen] LifeLink III, Minneapolis, MN USA; [Bobrow, Bentley J.] Univ Texas Houston, McGovern Sch Med, Houston, TX USA; [Walker, Robert G.] Stryker Med, Washington, DC USA; [Levy, Michael] Univ Alaska Anchorage, Anchorage Coll Hlth, Washington Wyoming Alaska Montana Idaho WWAMI Sch, Anchorage, AK USA; [Levy, Michael] Areawide EMS, Anchorage, AK USA		Davis, DP (corresponding author), Air Methods Corp, Englewood, CO 80111 USA.	danieldavismd@gmail.com		Walker, Robert/0000-0002-5503-8327			Alexiou VG, 2009, J CRIT CARE, V24, P515, DOI 10.1016/j.jcrc.2008.09.003; ASA, STAND BAS AN MON; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Baez AA, 2022, PREHOSP EMERG CARE, V26, P88, DOI 10.1080/10903127.2021.1994676; Binks MJ, 2017, AM J EMERG MED, V35, P1542, DOI 10.1016/j.ajem.2017.06.046; BITTO T, 1985, J THORAC CARDIOV SUR, V89, P585; Bodily JB, 2016, ANN EMERG MED, V67, P389, DOI 10.1016/j.annemergmed.2015.06.006; Braithwaite S, 2022, PREHOSP EMERG CARE, V26, P64, DOI 10.1080/10903127.2021.1994069; Braude D, 2006, ANN EMERG MED, V47, P581, DOI 10.1016/j.annemergmed.2006.02.030; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casey JD, 2019, NEW ENGL J MED, V380, P811, DOI 10.1056/NEJMoa1812405; Davis DP, 2008, PREHOSP EMERG CARE, V12, P46, DOI 10.1080/10903120701710470; Davis DP, 2006, PREHOSP EMERG CARE, V10, P356, DOI 10.1080/10903120600725751; Davis Daniel P, 2015, Air Med J, V34, P82, DOI 10.1016/j.amj.2014.12.007; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Silva LOJE, 2017, ANN EMERG MED, V70, P483, DOI 10.1016/j.annemergmed.2017.05.001; Eastwood GM, 2020, CURR OPIN CRIT CARE, V26, P251, DOI 10.1097/MCC.0000000000000720; Eismann H, 2019, RESUSCITATION, V138, P141, DOI 10.1016/j.resuscitation.2019.03.010; Elmer J, 2020, PREHOSP EMERG CARE, V24, P461, DOI 10.1080/10903127.2019.1670300; Fernandez R, 2008, ACAD EMERG MED, V15, P1104, DOI 10.1111/j.1553-2712.2008.00250.x; Gardner A, 2005, AUST CRIT CARE, V18, P158, DOI 10.1016/S1036-7314(05)80029-3; Grmec S, 2002, INTENS CARE MED, V28, P701, DOI 10.1007/s00134-002-1290-x; GUGGENBERGER H, 1989, ACTA ANAESTH SCAND, V33, P112, DOI 10.1111/j.1399-6576.1989.tb02871.x; Guyette FX, 2019, PREHOSP EMERG CARE, V23, P764, DOI 10.1080/10903127.2019.1593564; Hicks C, 2018, EMERG MED CLIN N AM, V36, P1, DOI 10.1016/j.emc.2017.08.003; Jarvis JL, 2022, PREHOSP EMERG CARE, V26, P42, DOI 10.1080/10903127.2021.1990447; Jarvis JL, 2018, ANN EMERG MED, V72, P272, DOI 10.1016/j.annemergmed.2018.01.044; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Johnson NJ, 2019, RESUSCITATION, V135, P37, DOI 10.1016/j.resuscitation.2019.01.009; Johnson NJ, 2018, CHEST, V153, P1466, DOI 10.1016/j.chest.2017.11.012; Jones CPL, 2018, ANAESTHESIA, V73, P12, DOI 10.1111/anae.14136; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036; Kundra P, 2018, INDIAN J ANAESTH, V62, P159, DOI 10.4103/ija.IJA_164_18; Lacerda RS, 2017, PREHOSP DISASTER MED, V32, P615, DOI 10.1017/S1049023X17006719; Landsperger JS, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2440-7; Lee JS, 2005, ACTA ANAESTH SCAND, V49, P759, DOI 10.1111/j.1399-6576.2005.00698.x; Lembersky O, 2020, AM J EMERG MED, V38, P466, DOI 10.1016/j.ajem.2019.05.010; da Silva PSL, 2012, ANESTH ANALG, V114, P1003, DOI 10.1213/ANE.0b013e31824b0296; Lucy MJ, 2018, PEDIATR ANESTH, V28, P788, DOI 10.1111/pan.13389; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Mort Thomas C, 2007, J Intensive Care Med, V22, P157, DOI 10.1177/0885066607299525; Nawrocki PS, 2020, PREHOSP EMERG CARE, V24, P188, DOI 10.1080/10903127.2019.1588443; ORNATO JP, 1992, ANN EMERG MED, V21, P518, DOI 10.1016/S0196-0644(05)82517-X; Page D, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1926-4; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Pavlov I, 2017, AM J EMERG MED, V35, P1184, DOI 10.1016/j.ajem.2017.06.029; Poirier MP, 1998, AM J EMERG MED, V16, P350, DOI 10.1016/S0735-6757(98)90125-5; Reader TW, 2009, CRIT CARE MED, V37, P1787, DOI 10.1097/CCM.0b013e31819f0451; Sakles JC, 2016, INTERN EMERG MED, V11, P983, DOI 10.1007/s11739-016-1396-8; Segal N, 2012, RESUSCITATION, V83, P1025, DOI 10.1016/j.resuscitation.2012.03.025; Shafi S, 2005, J TRAUMA, V59, P1140, DOI 10.1097/01.ta.0000196434.88182.77; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Silvestri S, 2017, RESUSCITATION, V115, P192, DOI 10.1016/j.resuscitation.2017.01.002; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stassen W, 2014, SAMJ S AFR MED J, V104, P424, DOI [10.7196/SAMJ.7494, 10.7196/samj.7494]; Stephens RJ, 2019, RESP CARE, V64, P595, DOI 10.4187/respcare.06888; Stoltze AJ, 2015, J CRIT CARE, V30, P495, DOI 10.1016/j.jcrc.2015.02.013; VAGHADIA H, 1989, CAN J ANAESTH, V36, P560, DOI 10.1007/BF03005386; Vithalani VD, 2017, RESUSCITATION, V119, P1, DOI 10.1016/j.resuscitation.2017.07.019; Wagner-Berger HG, 2003, RESUSCITATION, V56, P191, DOI 10.1016/S0300-9572(02)00347-7; Walker RG, 2018, PREHOSP EMERG CARE, V22, P300, DOI 10.1080/10903127.2017.1380095; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009946.pub2; Weant KA, 2021, AM J EMERG MED, V50, P71, DOI 10.1016/j.ajem.2021.07.006; Weaver SJ, 2010, JT COMM J QUAL PATIE, V36, P133, DOI 10.1016/S1553-7250(10)36022-3; Weingart S, 2015, CLIN EXP EMERG MED, V2, P131, DOI 10.15441/ceem.15.010; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Wiegand D., 2017, AACN PROCEDURE MANUA; Wimalasena Y, 2015, ANN EMERG MED, V65, P371, DOI 10.1016/j.annemergmed.2014.11.014	74	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 4	2022	26			1	SI		72	79		10.1080/10903127.2021.1992056			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	YE0WI	WOS:000740852400009	35001819	hybrid			2022-02-06	
J	Hedaya, R; Lubar, J				Hedaya, Robert; Lubar, Joel			Reversal of Acquired Prosopagnosia Using Quantitative Electroencephalography-Guided Laser Therapy	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article; Early Access						prosopagnosia; seizures; qEEG; Alzheimer's; MCI; photobiomodulation	TRAUMATIC BRAIN-INJURY	Background: Currently treatment for prosopagnosia is limited.Methods: We report the reversal of acquired associative-type prosopagnosia (AAP) using quantitative electroencephalography (qEEG)-guided transcranial laser therapy (qGLT) in a subject with temporal lobe epilepsy (TLE) and mild cognitive impairment (MCI).Results: Objective and subjective measures of improvement in AAP, TLE, and MCI are presented. Additional improvement, measured through qEEG, was found 1-month post-treatment.Conclusions: There was no recurrence of AAP for 1 year. We conclude that further research into the utility of qGLT in the treatment of AAP is warranted.	[Hedaya, Robert] Georgetown Univ, Sch Med, Inst Funct Med, Whole Psychiat & Brain Recovery Ctr, Rockville, MD 21245 USA; [Hedaya, Robert] Georgetown Univ, Sch Med, Inst Funct Med, Whole Psychiat & Brain Recovery Ctr, Washington, DC 21245 USA; [Lubar, Joel] Univ Tennessee, Southeastern Neurofeedback Inst Inc, Pompano Beach, FL USA		Hedaya, R (corresponding author), Georgetown Univ, Sch Med, Inst Funct Med, Whole Psychiat & Brain Recovery Ctr, Rockville, MD 21245 USA.; Hedaya, R (corresponding author), Georgetown Univ, Sch Med, Inst Funct Med, Whole Psychiat & Brain Recovery Ctr, Washington, DC 21245 USA.	rhedayamd@yahoo.com					Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Bate S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00491; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Blonz ER, 2017, J ALZHEIMERS DIS, V60, P1223, DOI 10.3233/JAD-170549; Chao LL, 2019, PHOTOBIOMODULATION P, V37, P133, DOI 10.1089/photob.2018.4555; Corrow SL, 2016, EYE BRAIN, V8, DOI 10.2147/EB.S92838; das Neves MF, 2020, LASER MED SCI, V35, P1459, DOI 10.1007/s10103-019-02920-3; Davies-Thompson J, 2017, J COGNITIVE NEUROSCI, V29, P573, DOI 10.1162/jocn_a_01063; DeGutis JM., 2013, VISION SCI SOC ANN M; DeGutis JM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00561; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Henderson TA, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00187; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Luo M, 2015, GENET MOL RES, V14, P5407, DOI 10.4238/2015.May.22.10; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Santos L, 2019, BRAIN STIMUL, V12, P810, DOI 10.1016/j.brs.2019.02.009; Serrage H, 2019, PHOTOCH PHOTOBIO SCI, V18, P1877, DOI 10.1039/c9pp00089e; Technologies TC., 2012, CORTICAL FUNCTIONS; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thatcher RW, 2012, HDB QUANTITATIVE ELE; Yao XY, 2018, CURR NEUROPHARMACOL, V16, P1320, DOI 10.2174/1570159X16666180321100439; Zomorrodi R., 2017, COMPLEMENTARY EEG EV	28	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMOD PHOTOMED	Photobiomodulation Photomed. Laser Surg.												10.1089/photob.2021.0048		JAN 2022	6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YB5YG	WOS:000739086900001	34981964				2022-02-06	
J	Klein, SP; De Sloovere, V; Meyfroidt, G; Depreitere, B				Klein, Samuel P.; De Sloovere, Veerle; Meyfroidt, Geert; Depreitere, Bart			Differential Hemodynamic Response of Pial Arterioles Contributes to a Quadriphasic Cerebral Autoregulation Physiology	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						cerebral blood flow; cerebral perfusion pressure; cerebrovascular autoregulation	TRAUMATIC BRAIN-INJURY; LARGE ANIMAL-MODELS; BLOOD-FLOW; LOWER LIMIT; PRESSURE; CIRCULATION; STIMULATION; HYPOTENSION; REACTIVITY; STROKE	Background Cerebrovascular autoregulation (CA) regulates cerebral vascular tone to maintain near-constant cerebral blood flow during fluctuations in cerebral perfusion pressure (CPP). Preclinical and clinical research has challenged the classic triphasic pressure-flow relationship, leaving the normal pressure-flow relationship unclear. Methods and Results We used in vivo imaging of the hemodynamic response in pial arterioles to study CA in a porcine closed cranial window model during nonpharmacological blood pressure manipulation. Red blood cell flux was determined in 52 pial arterioles during 10 hypotension and 10 hypertension experiments to describe the pressure-flow relationship. We found a quadriphasic pressure-flow relationship with 4 distinct physiological phases. Smaller arterioles demonstrated greater vasodilation during low CPP when compared with large arterioles (P<0.01), whereas vasoconstrictive capacity during high CPP was not significantly different between arterioles (P>0.9). The upper limit of CA was defined by 2 breakpoints. Increases in CPP lead to a point of maximal vasoconstriction of the smallest pial arterioles (upper limit of autoregulation [ULA] 1). Beyond ULA1, only larger arterioles maintain a limited additional vasoconstrictive capacity, extending the buffer for high CPP. Beyond ULA2, vasoconstrictive capacity is exhausted, and all pial arterioles passively dilate. There was substantial intersubject variability, with ranges of 29.2, 47.3, and 50.9 mm Hg for the lower limit, ULA1, and ULA2, respectively. Conclusions We provide new insights into the quadriphasic physiology of CA, differentiating between truly active CA and an extended capacity to buffer increased CPP with progressive failure of CA. In this experimental model, the limits of CA widely varied between subjects.	[Klein, Samuel P.; Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [De Sloovere, Veerle] Univ Hosp Leuven, Dept Anesthesiol, Leuven, Belgium; [Meyfroidt, Geert] Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium		Klein, SP (corresponding author), Univ Hosp Brussels, Dept Neurosurg, Laarbeeklaan 101, B-1090 Jette, Belgium.	samuel.klein@uzbrussel.be		Klein, Samuel/0000-0001-5595-4440; Depreitere, Bart/0000-0002-7458-0648	ohnson & Johnson Research Chair	This work was supported in part by a Johnson & Johnson Research Chair in profound analysis of cerebrovascular autoregulation at KU Leuven University.	Aaslid R, 2007, STROKE, V38, P1465, DOI 10.1161/STROKEAHA.106.473462; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; BUSIJA DW, 1985, PEDIATR RES, V19, P1210, DOI 10.1203/00006450-198511000-00020; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Dorrance AM., 2016, HYPERTENSION STROKE, P81; Drummond JC, 1997, ANESTHESIOLOGY, V86, P1431, DOI 10.1097/00000542-199706000-00034; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; FARACI FM, 1987, AM J PHYSIOL, V252, pH738, DOI 10.1152/ajpheart.1987.252.4.H738; Fog M, 1937, ARCH NEURO PSYCHIATR, V37, P351, DOI 10.1001/archneurpsyc.1937.02260140137007; Fog M, 1938, J NEUROL PSYCHIATRY, V1, P187, DOI 10.1136/jnnp.1.3.187; Fog M, 1939, ARCH NEURO PSYCHIATR, V41, P260, DOI 10.1001/archneurpsyc.1939.02270140046003; Forbes HS, 1937, ARCH NEURO PSYCHIATR, V37, P334, DOI 10.1001/archneurpsyc.1937.02260140120006; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Klein SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50046-x; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; KONTOS HA, 1989, STROKE, V20, P1; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Numan T, 2014, MED ENG PHYS, V36, P1487, DOI 10.1016/j.medengphy.2014.08.001; O'Leary H, 2009, PEDIATRICS, V124, P302, DOI 10.1542/peds.2008-2004; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; Pham P, 2019, NEUROCRIT CARE, V30, P201, DOI 10.1007/s12028-018-0600-2; RHODIN JAG, 1967, J ULTRA MOL STRUCT R, V18, P181, DOI 10.1016/S0022-5320(67)80239-9; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Schmidt B, 2009, J NEUROTRAUM, V26, P651, DOI 10.1089/neu.2008.0784; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Vutskits L, 2014, PEDIATR ANESTH, V24, P22, DOI 10.1111/pan.12307; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2047-9980		J AM HEART ASSOC	J. Am. Heart Assoc.	JAN 4	2022	11	1							e022943	10.1161/JAHA.121.022943			17	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	YC7AA	WOS:000739838600001	34935426	Green Published, gold			2022-02-06	
J	Lyng, JW; Guyette, FX; Levy, M; Bosson, N				Lyng, John W.; Guyette, Francis X.; Levy, Michael; Bosson, Nichole			Prehospital Manual Ventilation: An NAEMSP Position Statement and Resource Document	PREHOSPITAL EMERGENCY CARE			English	Article						bag-valve-mask; manual ventilation; EMS; airway management	BAG-VALVE-MASK; HEART-ASSOCIATION GUIDELINES; HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; PEAK FLOW-RATE; CARDIOPULMONARY-RESUSCITATION; TIDAL VOLUME; RANDOMIZED CROSSOVER; PULSE OXIMETRY; LIFE-SUPPORT	Manual ventilation using a self-inflating bag device paired with a facemask (bag-valve-mask, or BVM ventilation) or invasive airway (bag-valve-device, or BVD ventilation) is a fundamental airway management skill for all Emergency Medical Services (EMS) clinicians. Delivery of manual ventilations is challenging. Several strategies and adjunct technologies can increase the effectiveness of manual ventilation. NAEMSP recommends: All EMS clinicians must be proficient in bag-valve-mask ventilation. BVM ventilation should be performed using a two-person technique whenever feasible. EMS clinicians should use available techniques and adjuncts to achieve optimal mask seal, improve airway patency, optimize delivery of the correct rate, tidal volume, and pressure during manual ventilation, and allow continual assessment of manual ventilation effectiveness.	[Lyng, John W.] Univ Minnesota, Sch Med, Dept Emergency Med, Minneapolis, MN 55455 USA; [Guyette, Francis X.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA USA; [Levy, Michael] Univ Alaska Anchorage, WWAMI Sch Med Educ Anchorage, Anchorage Coll Hlth, Anchorage, AK USA; [Levy, Michael] Areawide EMS Anchorage, Anchorage, AK USA; [Bosson, Nichole] Los Angeles Cty EMS Agcy, Santa Fe Springs, CA USA; [Bosson, Nichole] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Bosson, Nichole] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Lyng, JW (corresponding author), Univ Minnesota, Sch Med, Dept Emergency Med, Minneapolis, MN 55455 USA.	jlyngmd@gmail.com		Lyng, John/0000-0001-5191-5700			Aguilar SA, 2012, J EMERG MED, V42, P424, DOI 10.1016/j.jemermed.2011.06.127; Althunayyan SM, 2021, INTERN EMERG MED, V16, P1043, DOI 10.1007/s11739-020-02547-1; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; AUGUSTINE JA, 1987, AM J EMERG MED, V5, P267, DOI 10.1016/0735-6757(87)90348-2; Bates Jason H T, 2020, Crit Care Explor, V2, pe0299, DOI 10.1097/CCE.0000000000000299; Bauman EB, 2010, RESUSCITATION, V81, P1161, DOI 10.1016/j.resuscitation.2010.05.005; Becker HJ, 2020, PEDIATR EMERG CARE, V36, pE695, DOI 10.1097/PEC.0000000000001314; Beitler JR, 2016, CLIN CHEST MED, V37, P633, DOI 10.1016/j.ccm.2016.07.004; Benger JR, 2018, JAMA-J AM MED ASSOC, V320, P779, DOI 10.1001/jama.2018.11597; Bernhard M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3619159; BOIDIN MP, 1985, BRIT J ANAESTH, V57, P306, DOI 10.1093/bja/57.3.306; Bouvet L, 2014, ANESTHESIOLOGY, V120, P326, DOI 10.1097/ALN.0000000000000094; Cattano Davide, 2014, F1000Res, V3, P239, DOI 10.12688/f1000research.5471.1; Cattano Davide, 2014, F1000Res, V3, P204, DOI 10.12688/f1000research.5131.1; Cordioli RL, 2019, CURR OPIN CRIT CARE, V25, P37, DOI 10.1097/MCC.0000000000000573; Corso RM, 2016, REV BRAS ANESTESIOL, V66, P298, DOI [10.1016/j.bjane.2014.09.003, 10.1016/j.bjan.2016.02.007]; Dafilou B, 2020, WEST J EMERG MED, V21, P722, DOI 10.5811/westjem.2020.3.45788; Davidovic L, 2005, ANN EMERG MED, V46, P37, DOI 10.1016/j.annemergmed.2005.02.005; DAVIDSON JAH, 1993, BRIT MED J, V307, P372, DOI 10.1136/bmj.307.6900.372; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Doerges V, 1999, RESUSCITATION, V43, P31, DOI 10.1016/S0300-9572(99)00117-3; ElGanzouri AR, 1996, ANESTH ANALG, V82, P1197, DOI 10.1097/00000539-199606000-00017; ELLING R, 1983, ANN EMERG MED, V12, P765, DOI 10.1016/S0196-0644(83)80254-6; Elliott Malcolm, 2006, Aust Crit Care, V19, P139, DOI 10.1016/S1036-7314(06)80027-5; Feldman JM, 2015, ANESTH ANALG, V120, P165, DOI 10.1213/ANE.0000000000000472; FRUMIN MJ, 1959, ANESTHESIOLOGY, V20, P789, DOI 10.1097/00000542-195911000-00007; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Gerber L, 2021, J EMERG MED, V61, P252, DOI 10.1016/j.jemermed.2021.03.005; Gerstein NS, 2013, J CLIN ANESTH, V25, P193, DOI 10.1016/j.jclinane.2012.10.009; Golzari SE, 2014, INT J PREVENTIVE MED, V5, P489; Grauman S, 2021, SCAND J TRAUMA RESUS, V29, DOI 10.1186/s13049-021-00885-3; Hart D, 2013, J EMERG MED, V44, P1028, DOI 10.1016/j.jemermed.2012.11.005; HESS D, 1985, AM J EMERG MED, V3, P292, DOI 10.1016/0735-6757(85)90049-X; HUTTON P, 1993, BRIT MED J, V307, P457, DOI 10.1136/bmj.307.6902.457; Jarvis JL, 2018, RESUSCITATION, V130, P57, DOI 10.1016/j.resuscitation.2018.07.002; JESUDIAN MCS, 1985, CRIT CARE MED, V13, P122, DOI 10.1097/00003246-198502000-00015; Joffe AM, 2010, ANESTHESIOLOGY, V113, P873, DOI 10.1097/ALN.0b013e3181ec6414; Cereceda-Sanchez FJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030358; Kern KB, 2010, RESUSCITATION, V81, P206, DOI 10.1016/j.resuscitation.2009.10.015; Kheterpal S, 2006, ANESTHESIOLOGY, V105, P885, DOI 10.1097/00000542-200611000-00007; Khoury A, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0674-7; Kim JH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198907; Kim SH, 2014, ANAESTHESIA, V69, P53, DOI 10.1111/anae.12502; Kleinman ME, 2015, CIRCULATION, V132, pS414, DOI 10.1161/CIR.0000000000000259; Koh KF, 2002, ANN ACAD MED SINGAP, V31, P253; Kroll M, 2019, PREHOSP EMERG CARE, V23, P210, DOI 10.1080/10903127.2018.1489020; Lacerda RS, 2017, PREHOSP DISASTER MED, V32, P615, DOI 10.1017/S1049023X17006719; Langeron O, 2000, ANESTHESIOLOGY, V92, P1229, DOI 10.1097/00000542-200005000-00009; Law JA, 2013, CAN J ANESTH, V60, P1089, DOI 10.1007/s12630-013-0019-3; Lee HM, 2008, EMERG MED J, V25, P632, DOI 10.1136/emj.2007.053678; Lim JS, 2012, AM J EMERG MED, V30, P1068, DOI 10.1016/j.ajem.2011.07.003; Losert H, 2006, ARCH INTERN MED, V166, P2375, DOI 10.1001/archinte.166.21.2375; Lovat R, 2008, INTENS CARE MED, V34, P355, DOI 10.1007/s00134-007-0850-5; Lucy MJ, 2018, PEDIATR ANESTH, V28, P788, DOI 10.1111/pan.13389; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Matioc AA, 2012, J CLIN ANESTH, V24, P167, DOI 10.1016/j.jclinane.2010.04.002; McInnes AD, 2011, RESUSCITATION, V82, P1025, DOI 10.1016/j.resuscitation.2011.03.020; Mumma JM, 2018, HUM FACTORS, V60, P212, DOI 10.1177/0018720817744729; Na JU, 2013, ACTA ANAESTH SCAND, V57, P1186, DOI 10.1111/aas.12169; Nehme Z, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-4; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Niebauer JM, 2011, PEDIATRICS, V128, pE1195, DOI 10.1542/peds.2010-3696; O'Neill JF, 2007, RESUSCITATION, V73, P82, DOI 10.1016/j.resuscitation.2006.09.012; Otten D, 2014, ANN EMERG MED, V63, P6, DOI 10.1016/j.annemergmed.2013.07.014; Panchal AR, 2020, CIRCULATION, V142, pS366, DOI 10.1161/CIR.0000000000000916; Poulton DA, 2011, RESUSCITATION, V82, P175, DOI 10.1016/j.resuscitation.2010.10.012; Reed P, 2017, PREHOSP DISASTER MED, V32, P625, DOI 10.1017/S1049023X17006860; Roberts K, 2005, EMERG MED J, V22, P394, DOI 10.1136/emj.2004.021402; Roberts S, 2013, BRIT J ANAESTH, V111, P676, DOI 10.1093/bja/aet324; SAFAR P, 1959, J APPL PHYSIOL, V14, P760, DOI 10.1152/jappl.1959.14.5.760; Scott JB, 2021, AM J EMERG MED, V45, P446, DOI 10.1016/j.ajem.2020.09.091; Seet MM, 2009, EUR J ANAESTH, V26, P913, DOI 10.1097/EJA.0b013e328329b0ab; Sherren PB, 2011, ANAESTHESIA, V66, P563, DOI 10.1111/j.1365-2044.2011.06695.x; Siegler J, 2017, PREHOSP EMERG CARE, V21, P74, DOI 10.1080/10903127.2016.1227003; Sinex JE, 1999, AM J EMERG MED, V17, P59, DOI 10.1016/S0735-6757(99)90019-0; Soleimanpour Maryam, 2018, Anesth Pain Med, V8, pe74226, DOI 10.5812/aapm.74226; Soleimanpour M, 2016, J CARDIOVASC THORAC, V8, P147, DOI 10.15171/jcvtr.2016.30; Stone BJ, 1998, RESUSCITATION, V38, P3, DOI 10.1016/S0300-9572(98)00068-9; STONEHAM MD, 1993, ANAESTHESIA, V48, P575, DOI 10.1111/j.1365-2044.1993.tb07119.x; Strzelecki C, 2020, CLIN TEACH, V17, P41, DOI 10.1111/tct.13008; Uhm D, 2021, BMC EMERG MED, V21, DOI 10.1186/s12873-021-00451-1; Umesh G, 2018, INDIAN J ANAESTH, V62, P780, DOI 10.4103/ija.IJA_228_18; Umesh G, 2014, J CLIN MONIT COMPUT, V28, P269, DOI 10.1007/s10877-013-9531-9; Vithalani VD., 2019, PREHOSP EMERG CARE, V24, P127; von Goedecke A, 2004, RESUSCITATION, V63, P131, DOI 10.1016/j.resuscitation.2004.04.012; Wagner-Berger HG, 2003, RESUSCITATION, V57, P193, DOI 10.1016/S0300-9572(03)00032-7; Wang HE, 2018, JAMA-J AM MED ASSOC, V320, P769, DOI 10.1001/jama.2018.7044; Wayne M A, 2001, Prehosp Emerg Care, V5, P73, DOI 10.1080/10903120190940371; Wenzel V, 1998, CRIT CARE MED, V26, P364, DOI 10.1097/00003246-199802000-00042; WILLIAMSON JA, 1993, ANAESTH INTENS CARE, V21, P602, DOI 10.1177/0310057X9302100518; Yamada A, 2012, INTERNAL MED, V51, P1517, DOI 10.2169/internalmedicine.51.7015; Zobrist B, 2016, AM J EMERG MED, V34, P1991, DOI 10.1016/j.ajem.2016.07.030; Zweiker D, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5100132	94	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 4	2022	26			1	SI		23	31		10.1080/10903127.2021.1981506			9	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	YE0WI	WOS:000740852400004	35001826	hybrid			2022-02-06	
J	Moulden, HM; Myers, C; Lori, A; Chaimowitz, G				Moulden, Heather M.; Myers, Casey; Lori, Anastasia; Chaimowitz, Gary			The Relationship Between and Correlates of Problematic Sexual Behavior and Major Mental Illness	FRONTIERS IN PSYCHOLOGY			English	Article						sexual abuse; mental illness; psychosis; sexual offending; forensic	TRAUMATIC BRAIN-INJURY; RECIDIVISM; OFFENDERS; RISK	While research has consistently found that general distress and psychopathology are not predictive of sexual recidivism, examination of specific syndromes and their relationship to offending has revealed a potentially more complicated relationship. One proposed mechanism for the mixed findings with respect to major mental illness and sexual offending may be the confound of neurological injury. As identified in Mann et al. (2010) work on psychologically meaningful risk factors, mental illness represents an area in need of more study given the indirect influence it may exert on risk. To this end, the current paper summarizes the study of the relationship between neurological injury, psychosis and problematic sexual behavior among two Canadian samples of forensic and civil psychiatric patients. In the first study we observed higher than expected rates of sexually-themed psychotic symptoms (45%) and problematic sexual behavior (PSB; 40%) among a combined group of forensic and civil psychiatric patients (n = 109). Indeed 70 percent of those individuals who engaged in PSB endorsed sexually-themed psychotic symptoms. While comorbidity is common amongst this group, brain injury appeared to represent a specific liability. Compared to those who did not engage in PSB, those who did were almost 4x (OR = 3.83) more likely to have a documented history of brain injury (e.g., traumatic and acquired brain injury, including fetal alcohol syndrome). In the second study we sought to replicate this finding in a larger forensic sample of 1,240. However, the recorded rates of brain injury were significantly less, such that no relationship to PSB was observed. Based on the mixed findings to date, including our own data, questions remain about the nature of a potential shared vulnerability for psychosis and PSB previously postulated. Among psychiatrically complex individuals who engage in PSB, understanding etiology and links to risk are helpful, but perhaps more importantly is attention to the mechanisms through which symptoms confer risk (e.g., problem solving, sexual disinhibition, social/intimacy deficits) and how best to treat and manage them.	[Moulden, Heather M.; Chaimowitz, Gary] St Josephs Healthcare Hamilton, Forens Psychiat Program, Hamilton, ON, Canada; [Moulden, Heather M.; Chaimowitz, Gary] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Myers, Casey; Lori, Anastasia] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada		Moulden, HM (corresponding author), St Josephs Healthcare Hamilton, Forens Psychiat Program, Hamilton, ON, Canada.; Moulden, HM (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	hmoulden@stjoes.ca			St. Joseph's Healthcare Hamilton	St. Joseph's Healthcare Hamilton has kindly agreed to provide financial support for open access publication fees.	Abracen J, 2016, J INTERPERS VIOLENCE, V31, P1842, DOI 10.1177/0886260515570745; Abracen J, 2014, INT J OFFENDER THER, V58, P765, DOI 10.1177/0306624X13485930; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Bonta J, 2014, AGGRESS VIOLENT BEH, V19, P278, DOI 10.1016/j.avb.2014.04.014; Cantor JM, 2008, J PSYCHIATR RES, V42, P167, DOI 10.1016/j.jpsychires.2007.10.013; Cantor JM, 2013, J SEX MED, V10, P298; Chaimowitz G, 2021, CAN J PSYCHIAT, DOI 10.1177/07067437211023103; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Drake Christopher R, 2004, Crim Behav Ment Health, V14, P108, DOI 10.1002/cbm.576; Guidry L.L., 2008, S 116 ANN CONV AM PS; Kargel C, 2017, HUM BRAIN MAPP, V38, P1092, DOI 10.1002/hbm.23443; Kelley SM, 2015, J AGGRESS CONFL PEAC, V7, P258, DOI 10.1108/JACPR-02-2015-0162; Langstrom N, 2004, SEX ABUSE-J RES TR, V16, P139, DOI 10.1023/B:SEBU.0000023062.56389.ed; Levenson JS, 2016, SEX ABUSE-J RES TR, V28, P340, DOI 10.1177/1079063214535819; Mann RE, 2010, SEX ABUSE-J RES TR, V22, P191, DOI 10.1177/1079063210366039; Moulden H.M., 2020, WHAT WORKS SEXUAL OF; Moulden HM, 2017, INT PERSP FOREN MENT, P265; Moulden HM, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0863-x; Moulden HM, 2014, J SEX AGGRESS, V20, P172, DOI 10.1080/13552600.2013.794903; Sachdev P, 2001, J NEUROPSYCH CLIN N, V13, P533, DOI 10.1176/appi.neuropsych.13.4.533; Schiltz K, 2007, ARCH GEN PSYCHIAT, V64, P737, DOI 10.1001/archpsyc.64.6.737; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Skeem JL, 2014, LAW HUMAN BEHAV, V38, P212, DOI 10.1037/lhb0000054; Stinson JD, 2021, INT J FORENSIC MENT, V20, P374, DOI 10.1080/14999013.2021.1895375; Tenbergen G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00344; Ward T, 2006, AGGRESS VIOLENT BEH, V11, P44, DOI 10.1016/j.avb.2005.05.002; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	27	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JAN 4	2022	12								719082	10.3389/fpsyg.2021.719082			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	YO1KQ	WOS:000747706100001	35058832	Green Published, gold			2022-02-06	
J	Small, C; Dagra, A; Martinez, M; Williams, E; Lucke-Wold, B				Small, Coulter; Dagra, Abeer; Martinez, Melanie; Williams, Eric; Lucke-Wold, Brandon			Examining the role of astrogliosis and JNK signaling in post-traumatic epilepsy	EGYPTIAN JOURNAL OF NEUROSURGERY			English	Article						Post-traumatic epilepsy; Traumatic brain injury; JNK signaling; Astrocytes; Animal model	ASTROCYTES; SEIZURES; GLIOSIS; KINASES	Objective Post-traumatic epilepsy is a devastating complication of traumatic brain injury that has no targeted pharmacological therapy. Previous literature has explored the role of the c-Jun N-terminal kinase (JNK) pathway in epilepsy and the creation of epileptogenic foci by reactive astrogliosis; however, the relationship between reactive astrogliosis and the c-Jun N-terminal kinase signaling pathway in the development of post-traumatic epilepsy has not been thoroughly examined. Methods Four experimental groups, consisting of c57/b16 male mice, were examined: (1) control, (2) traumatic brain injury of graded severity (mild, moderate, severe), (3) sub-convulsive kainic acid alone without traumatic brain injury (15 mg/kg i.p.), and (4) sub-convulsive kainic acid administered 72 h after moderate traumatic brain injury. Modified Racine scale from 1 to 72 h and total beam breaks at 72 h were used to assess seizure activity. Immunohistochemistry and western blot were utilized to examine astrogliosis (GFAP), microglia activation (IBA-1), and phosphorylated JNK in prefrontal cortex samples collected from the contracoup side at 72 h post-injury. Results Astrogliosis, measured by GFAP, was increased after traumatic brain injury and increased commensurately based on the degree of injury. Mice with traumatic brain injury demonstrated a four-fold increase in phosphorylated JNK: p < 0.001. Sub-convulsive kainic acid administration did not increase seizure activity nor phosphorylation of JNK in mice without traumatic brain injury; however, sub-convulsive kainic acid administration in mice with moderate traumatic brain injury did increase phosphorylated JNK. Seizure activity was worse in mice, with traumatic brain injury, administered kainic acid than mice administered kainic acid. Conclusions Reactive astrocytes may have dysfunctional glutamate regulation causing an increase in phosphorylated JNK after kainic acid administration. Future studies exploring the effects of JNK inhibition on post-traumatic epilepsy are recommended.	[Small, Coulter] Univ Florida, Coll Med, 1104 Newell Dr, Gainesville, FL 32610 USA; [Small, Coulter; Dagra, Abeer; Martinez, Melanie; Williams, Eric; Lucke-Wold, Brandon] Univ Florida, Dept Neurosurg, 1505 SW Archer Rd, Gainesville, FL 32610 USA		Small, C (corresponding author), Univ Florida, Coll Med, 1104 Newell Dr, Gainesville, FL 32610 USA.; Small, C (corresponding author), Univ Florida, Dept Neurosurg, 1505 SW Archer Rd, Gainesville, FL 32610 USA.	colt.pauzar@ufl.edu					Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; La Rocca M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.591662; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Mukherjee PK, 1999, J BIOL CHEM, V274, P6493, DOI 10.1074/jbc.274.10.6493; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Ostrow LW, 2011, BIOCHEM BIOPH RES CO, V410, P81, DOI 10.1016/j.bbrc.2011.05.109; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Pugh MJ, J NEUROTRAUM, V2021; Ranaivo HR, 2011, J NEUROTRAUM, V28, P1757, DOI 10.1089/neu.2011.1799; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Soncin LD, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2021.108083; Tai TY, 2017, NEUROSCIENCE, V349, P35, DOI 10.1016/j.neuroscience.2017.02.024; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Xu SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01149; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zimmermann LL, 2017, CURR OPIN NEUROL, V30, P580, DOI 10.1097/WCO.0000000000000505	26	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2520-8225		EGYPT J NEUROSURG	Egypt. J. Neurosurg.	JAN 4	2022	37	1							1	10.1186/s41984-021-00141-x			7	Clinical Neurology; Surgery	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Surgery	XZ9AP	WOS:000737938500001	35035475	Green Accepted, gold			2022-02-06	
J	Spronk, I; Polinder, S; Bonsel, GJ; Janssen, MF; Haagsma, JA				Spronk, Inge; Polinder, Suzanne; Bonsel, Gouke J.; Janssen, M. F.; Haagsma, Juanita A.			Adding a fatigue item to the EQ-5D-5L improves its psychometric performance in the general population	JOURNAL OF PATIENT-REPORTED OUTCOMES			English	Article						EQ-5D; Health-related quality of life; Fatigue; Bolt-on; General population	QUALITY-OF-LIFE; BOLT-ON DIMENSIONS; 5-LEVEL VERSION; HEALTH-STATUS; IMPACT; EUROQOL; PREVALENCE; PREFERENCES; SYMPTOMS; IDENTIFY	Background Fatigue is a common and often disturbing sequela of serious chronic health conditions. In the widely applied HRQL instrument, the EQ-5D, this aspect is not included directly, for its assumed lack of additional information. We investigated the validity of this assumption by determining the gain-if any-of an additional fatigue item to the EQ-5D-5L in a general population sample. Methods A Dutch general population sample (including diseased people) completed a web-based survey including the EQ-5D-5L and the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). The RPQ fatigue item was used to create the EQ-5D-5L + Fatigue. We head-to-head compared the psychometric performance contrasting the EQ-5D-5L and EQ-5D-5L + Fatigue: distribution (e.g. ceiling), informativity cf. Shannon's indices, convergent validity, domain dependency, and explanatory power. Results were compared between subgroups with and without >= 1 chronic health condition. Results The study population consisted of 3027 persons of whom 52% had a chronic health condition. The mean EQ-5D-5L utility score was 0.83 and 48% experienced some degree of fatigue. Adding the fatigue item to the EQ-5D-5L decreased the ceiling effect, increased absolute informativity (HMODIFIER LETTER PRIME = 6.44 vs. HMODIFIER LETTER PRIME = 4.90) and relative informativity (JMODIFIER LETTER PRIME = 0.46 vs. JMODIFIER LETTER PRIME = 0.42). The extra fatigue item slightly increased convergent validity (Spearman's rank correlation coefficient = - 0.61 vs. - 0.62). Domain dependency analysis showed that all EQ-5D-5L domains are dominant over the fatigue item. Explanatory power of the EQ-5D-5L + Fatigue was higher compared to the EQ-5D-5L (R-2 = 0.42 vs. 0.39). The gain is substantially larger in the subgroup with chronic health conditions. Conclusions Adding a fatigue item to the EQ-5D-5L improved all psychometric performance criteria of the enriched instrument in the general population. Effects are substantially larger in the subgroup with chronic health conditions, indicating that adding a fatigue item to the EQ-5D-5L is especially relevant in evaluating the HRQL of diseased people.	[Spronk, Inge; Polinder, Suzanne; Haagsma, Juanita A.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Spronk, Inge] Maasstad Hosp, Assoc Dutch Burn Ctr, Rotterdam, Netherlands; [Bonsel, Gouke J.] EuroQol Grp Execut Off, Rotterdam, Netherlands; [Janssen, M. F.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands		Spronk, I (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Spronk, I (corresponding author), Maasstad Hosp, Assoc Dutch Burn Ctr, Rotterdam, Netherlands.	i.spronk@erasmusmc.nl		Spronk, Inge/0000-0001-9571-576X	EuroQol [20180330]	This study was funded by EuroQol (grant number: 20180330).	Basu N, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0662-y; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brooks RG, 2015, EUROQOL WORKING PAPE; Cohen J., 1988, STAT POWER ANAL BEHA, VChap. 1, P1; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Cullen W, 2002, IRISH J MED SCI, V171, P10, DOI 10.1007/BF03168931; Dellenmark-Blom M, 2019, QUAL LIFE RES, V28, P1389, DOI 10.1007/s11136-019-02119-7; Devlin N, 2020, METHODS ANALYSING RE, DOI [10.1007/978-3-030-47622-9, DOI 10.1007/978-3-030-47622-9]; Devlin NJ, 2004, QUAL LIFE RES, V13, P1265, DOI 10.1023/B:QURE.0000037495.00959.9b; Efthymiadou O, 2019, HEALTH POLICY, V123, P159, DOI 10.1016/j.healthpol.2018.12.003; EuroQol Research Foundation, 2019, EQ5D3L RES FDN; Finch AP, 2021, MED DECIS MAKING, V41, P89, DOI 10.1177/0272989X20969686; Finch AP, 2017, VALUE HEALTH, V20, P1362, DOI 10.1016/j.jval.2017.06.002; Fiteni F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5579-3; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Kluthcovsky ACGC, 2012, SUPPORT CARE CANCER, V20, P1901, DOI 10.1007/s00520-011-1293-7; Geraerds AJLM, 2021, VALUE HEALTH, V24, P901, DOI 10.1016/j.jval.2020.12.011; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Gudex C, 2005, EQ 5D CONCEPTS METHO, P19; Guyatt GH., 1996, QUALITY LIFE PHARMAC, P41; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Janssen MFB, 2007, QUAL LIFE RES, V16, P895, DOI 10.1007/s11136-006-9160-6; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krabbe PFM, 1999, J CLIN EPIDEMIOL, V52, P293, DOI 10.1016/S0895-4356(98)00163-2; Linde L, 2008, J RHEUMATOL, V35, P1528; Longworth L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18090; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Ophuis RH, 2019, QUAL LIFE RES, V28, P1941, DOI 10.1007/s11136-019-02156-2; Perneger TV, 2011, INT J QUAL HEALTH C, V23, P52, DOI 10.1093/intqhc/mzq068; Pickard AS, 2007, MED CARE, V45, P259, DOI 10.1097/01.mlr.0000254515.63841.81; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rupp I, 2004, ARTHRIT RHEUM-ARTHR, V51, P578, DOI 10.1002/art.20539; Shah K, 2016, IMPORTANT ASPECTS HL; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Spronk I, 2021, HEALTH QUAL LIFE OUT, V19, DOI 10.1186/s12955-021-01771-3; Spronk I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197507; Swinburn P, 2013, VALUE HEALTH, V16, P1156, DOI 10.1016/j.jval.2013.10.003; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Volksgezondheidenzorg.info, 2020, AANTAL MENSEN MET CH; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yang YL, 2015, VALUE HEALTH, V18, P52, DOI 10.1016/j.jval.2014.09.004; Yang YL, 2014, MED DECIS MAKING, V34, P42, DOI 10.1177/0272989X13480428	45	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2509-8020		J PATIENT-REP OUTCOM	J. Patient-Rep. Outcomes	JAN 4	2022	6	1							1	10.1186/s41687-021-00406-x			10	Health Care Sciences & Services; Health Policy & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	YA8RA	WOS:000738592400001	34982262	gold, Green Published			2022-02-06	
J	Stocks, JK; Shields, AN; DeBoer, AB; Cerny, BM; Buckley, CMO; Ovsiew, GP; Jennette, KJ; Resch, ZJ; Basurto, KS; Song, W; Pliskin, NH; Soble, JR				Stocks, Jane K.; Shields, Allison N.; DeBoer, Adam B.; Cerny, Brian M.; Buckley, Caitlin M. Ogram; Ovsiew, Gabriel P.; Jennette, Kyle J.; Resch, Zachary J.; Basurto, Karen S.; Song, Woojin; Pliskin, Neil H.; Soble, Jason R.			The impact of visual memory impairment on Victoria Symptom Validity Test performance: A known-groups analysis	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Assessment; diagnosis; measurement; statistics; memory; tests	TRAUMATIC BRAIN-INJURY; TEST CUTOFF SCORES; CROSS-VALIDATION; RECOGNITION TRIAL; PROCESSING SPEED; WORKING-MEMORY; EFFICIENCY; INDICATOR; ENHANCE	Objective We assessed the effect of visual learning and recall impairment on Victoria Symptom Validity Test (VSVT) accuracy and response latency for Easy, Difficult, and Total Items. Method A sample of 163 adult patients administered the VSVT and Brief Visuospatial Memory Test-Revised were classified as valid (114/163) or invalid (49/163) groups via independent criterion performance validity tests (PVTs). Classification accuracies for all VSVT indices were examined for the overall sample, and separately for subgroups based on visual memory functioning. Results In the overall sample, all indices produced acceptable classification accuracy (areas under the curve [AUCs] >= 0.79). When stratified by visual learning/recall impairment, accuracy indices yielded acceptable classification for both the unimpaired (AUCs >= 0.79) and impaired subsamples (AUCs >= 0.75). Latency indices had acceptable classification accuracy for the unimpaired subsample (AUCs >= 0.74), but accuracy and sensitivity dropped for the impaired sample (AUCs >= 0.67). Conclusions VSVT accuracy and response latency yielded acceptable classification accuracies in the overall sample, and this effect was maintained in those with and without visual learning/recall impairment for the accuracy indices. Findings indicate that the VSVT is a psychometrically robust PVT with largely invariant cut-scores, even in the presence of bona fide visual learning/recall impairment.	[Stocks, Jane K.; Shields, Allison N.; DeBoer, Adam B.; Cerny, Brian M.; Buckley, Caitlin M. Ogram; Ovsiew, Gabriel P.; Jennette, Kyle J.; Resch, Zachary J.; Basurto, Karen S.; Song, Woojin; Pliskin, Neil H.; Soble, Jason R.] Univ Illinois, Dept Psychiat, Coll Med, 912 S Wood St,MC 913, Chicago, IL 60612 USA; [Stocks, Jane K.] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Shields, Allison N.] Northwestern Univ, Dept Psychol, Evanston, IL USA; [DeBoer, Adam B.] Wheaton Coll, Dept Psychol, Wheaton, IL 60187 USA; [Cerny, Brian M.] IIT, Dept Psychol, Chicago, IL 60616 USA; [Song, Woojin; Pliskin, Neil H.; Soble, Jason R.] Univ Illinois, Dept Neurol, Coll Med, Chicago, IL 60612 USA		Stocks, JK (corresponding author), Univ Illinois, Dept Psychiat, Coll Med, 912 S Wood St,MC 913, Chicago, IL 60612 USA.	janestocks2018@u.northwestern.edu		Stocks, Jane/0000-0002-1778-330X; Resch, Zachary/0000-0002-3199-6168			Abramson DA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1774378; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Benedict R. H., 1997, PSYCHOL ASSESSMENT R; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cerny BM, 2022, ARCH CLIN NEUROPSYCH, V37, P146, DOI 10.1093/arclin/acab038; Cerny BM, 2021, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2021.1872575; Cohen CD, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1908596; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Green P., 2003, GREENS WORD MEMORY T; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jennette KJ, 2021, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2021.1900398; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Neale AC, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1799076; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Patrick SD, 2021, CLIN NEUROPSYCHOL, V35, P1154, DOI 10.1080/13854046.2020.1716997; Pliskin JI, 2021, ASSESSMENT, V28, P1871, DOI 10.1177/1073191120929093; Power Michael, 2013, Evid Based Med, V18, P5, DOI 10.1136/eb-2012-100645; Resch ZJ, 2021, NEUROPSYCHOL REV, V31, P331, DOI 10.1007/s11065-021-09477-5; Resch ZJ, 2020, ASSESSMENT, DOI 10.1177/1073191120983919; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Resch ZJ, 2021, ASSESSMENT, V28, P1614, DOI 10.1177/1073191120911102; Rhoads T, 2021, J CLIN EXP NEUROPSYC, V43, P437, DOI 10.1080/13803395.2021.1945540; Roberson CJ, 2013, CLIN NEUROPSYCHOL, V27, P495, DOI 10.1080/13854046.2012.737027; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Scimeca LM, 2021, DEV NEUROPSYCHOL, V46, P347, DOI 10.1080/87565641.2021.1951270; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Silk-Eglit GM, 2016, ARCH CLIN NEUROPSYCH, V31, P231, DOI 10.1093/arclin/acv108; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Soble JR, 2021, PSYCHOL ASSESSMENT, V33, P568, DOI 10.1037/pas0001018; Soble JR, 2020, PSYCHOL ASSESSMENT, V32, P1087, DOI 10.1037/pas0000854; Soble JR, 2020, PSYCHOL INJ LAW, V13, P44, DOI 10.1007/s12207-019-09370-w; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Strauss GP, 2015, NEUROPSYCHOLOGY, V29, P282, DOI 10.1037/neu0000113; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Tam JW, 2013, CLIN NEUROPSYCHOL, V27, P962, DOI 10.1080/13854046.2013.797500; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; White DJ, 2020, J CLIN EXP NEUROPSYC, V42, P459, DOI 10.1080/13803395.2020.1758634	62	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2021911		JAN 2022	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YB7HL	WOS:000739178500001	34985401				2022-02-06	
J	Uretsky, M; Bouix, S; Killiany, RJ; Tripodis, Y; Martin, B; Palmisano, J; Mian, AZ; Buch, K; Farris, C; Daneshvar, DH; Dwyer, B; Goldstein, L; Katz, D; Nowinski, C; Cantu, R; Kowall, N; Huber, BR; Stern, RA; Alvarez, VE; Stein, TD; McKee, A; Mez, J; Alosco, ML				Uretsky, Madeline; Bouix, Sylvain; Killiany, Ronald J.; Tripodis, Yorghos; Martin, Brett; Palmisano, Joseph; Mian, Asim Z.; Buch, Karen; Farris, Chad; Daneshvar, Daniel H.; Dwyer, Brigid; Goldstein, Lee; Katz, Douglas; Nowinski, Christopher; Cantu, Robert; Kowall, Neil; Huber, Bertrand Russell; Stern, Robert A.; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann; Mez, Jesse; Alosco, Michael L.			Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; DYSFUNCTION; CONCUSSION; PATHOLOGY; DEMENTIA; PLAYERS; LESIONS	Background and Objectives Late neuropathologies of repetitive head impacts from contact sports can include chronic traumatic encephalopathy (CTE) and white matter degeneration. White matter hyperintensities (WMH) on fluid-attenuated inversion recovery (FLAIR) MRI scans are often viewed as microvascular disease from vascular risk, but might have unique underlying pathologies and risk factors in the setting of repetitive head impacts. We investigated the neuropathologic correlates of antemortem WMH in brain donors exposed to repetitive head impacts. The association between WMH and repetitive head impact exposure and informant-reported cognitive and daily function were tested. Methods This imaging-pathologic correlation study included symptomatic male decedents exposed to repetitive head impacts. Donors had antemortem FLAIR scans from medical records and were without evidence of CNS neoplasm, large vessel infarcts, hemorrhage, or encephalomalacia. WMH were quantified using log-transformed values for total lesion volume (TLV), calculated using the lesion prediction algorithm from the Lesion Segmentation Toolbox. Neuropathologic assessments included semiquantitative ratings of white matter rarefaction, cerebrovascular disease, hyperphosphorylated tau (p-tau) severity (CTE stage, dorsolateral frontal cortex), and beta-amyloid (A beta). Among football players, years of play was a proxy for repetitive head impact exposure. Retrospective informant-reported cognitive and daily function were assessed using the Cognitive Difficulties Scale (CDS) and Functional Activities Questionnaire (FAQ). Regression models controlled for demographics, diabetes, hypertension, and MRI resolution. Statistical significance was defined as p <= 0.05. Results The sample included 75 donors: 67 football players and 8 nonfootball contact sport athletes or military veterans. Dementia was the most common MRI indication (64%). Fifty-three (70.7%) had CTE at autopsy. Log TLV was associated with white matter rarefaction (odds ratio [OR] 2.32, 95% confidence interval [CI] 1.03, 5.24; p = 0.04), arteriolosclerosis (OR 2.38, 95% CI 1.02, 5.52; p = 0.04), CTE stage (OR 2.58, 95% CI 1.17, 5.71; p = 0.02), and dorsolateral frontal p-tau severity (OR 3.03, 95% CI 1.32, 6.97; p = 0.01). There was no association with A beta. More years of football play was associated with log TLV (unstandardized beta 0.04, 95% CI 0.01, 0.06; p = 0.01). Greater log TLV correlated with higher FAQ (unstandardized beta 4.94, 95% CI 0.42, 8.57; p = 0.03) and CDS scores (unstandardized beta 15.35, 95% CI -0.27, 30.97; p = 0.05). Discussion WMH might capture long-term white matter pathologies from repetitive head impacts, including those from white matter rarefaction and p-tau, in addition to microvascular disease. Prospective imaging-pathologic correlation studies are needed. Classification of Evidence This study provides Class IV evidence of associations between FLAIR white matter hyperintensities and neuropathologic changes (white matter rarefaction, arteriolosclerosis, p-tau accumulation), years of American football play, and reported cognitive symptoms in symptomatic brain donors exposed to repetitive head impacts.	[Uretsky, Madeline; Killiany, Ronald J.; Tripodis, Yorghos; Daneshvar, Daniel H.; Dwyer, Brigid; Goldstein, Lee; Katz, Douglas; Nowinski, Christopher; Cantu, Robert; Kowall, Neil; Huber, Bertrand Russell; Stern, Robert A.; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann; Mez, Jesse; Alosco, Michael L.] Boston Univ, Alzheimers Dis Res Ctr, Boston, MA 02215 USA; [Uretsky, Madeline; Killiany, Ronald J.; Tripodis, Yorghos; Daneshvar, Daniel H.; Dwyer, Brigid; Goldstein, Lee; Katz, Douglas; Nowinski, Christopher; Cantu, Robert; Kowall, Neil; Huber, Bertrand Russell; Stern, Robert A.; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann; Mez, Jesse; Alosco, Michael L.] Boston Univ, CTE Ctr, Dept Neurol, Boston, MA 02215 USA; [Killiany, Ronald J.; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA; [Killiany, Ronald J.] Boston Univ, Sch Med, Ctr Biomed Imaging, Boston, MA 02215 USA; [Mian, Asim Z.; Farris, Chad] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02215 USA; [Farris, Chad; Stein, Thor D.; McKee, Ann; Mez, Jesse] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02215 USA; [Goldstein, Lee; Kowall, Neil; Stein, Thor D.; McKee, Ann] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02215 USA; [Goldstein, Lee] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Goldstein, Lee] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA; [Cantu, Robert; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02215 USA; [Bouix, Sylvain] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Martin, Brett; Palmisano, Joseph] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA 02215 USA; [Buch, Karen] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Daneshvar, Daniel H.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Dwyer, Brigid; Katz, Douglas] Boston Univ, Coll Engn, Braintree Rehabil Hosp, Boston, MA 02215 USA; [Goldstein, Lee] Boston Univ, Coll Engn, Dept Biomed Elect & Comp Engn, Boston, MA 02215 USA; [Nowinski, Christopher; Cantu, Robert] Concuss Legacy Fdn, Boston, MA USA; [Cantu, Robert] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Huber, Bertrand Russell; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann] US Dept Vet Affairs, VA Boston Healthcare Syst, Jamaica Plain, MA USA; [Huber, Bertrand Russell; Alvarez, Victor E.] VA Boston Healthcare, Natl Ctr PTSD, Jamaica Plain, MA USA; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann] Dept Vet Affairs Med Ctr, Bedford, MA USA		Alosco, ML (corresponding author), Boston Univ, Alzheimers Dis Res Ctr, Boston, MA 02215 USA.; Alosco, ML (corresponding author), Boston Univ, CTE Ctr, Dept Neurol, Boston, MA 02215 USA.	malosco@bu.edu		Uretsky, Madeline/0000-0002-7604-3619; Farris, Chad/0000-0002-1133-3834	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG057902, AG06234, RF1AG054156, K23AG046377]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115266, U01NS086659, K23NS102399]; National Institute of Aging Boston University AD Center [P30AG072978, 0572063345-5]; Department of Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01-CX001038]; Nick and Lynn Buoniconti Foundation; BU-CTSI Grant [1UL1TR001430]	This work was supported by grant funding from NIA (AG057902, AG06234, RF1AG054156, K23AG046377), NINDS (U54NS115266, U01NS086659, K23NS102399), National Institute of Aging Boston University AD Center (P30AG072978; supplement 0572063345-5), Department of Veterans Affairs Merit Award (I01-CX001038), the Nick and Lynn Buoniconti Foundation, and BU-CTSI Grant 1UL1TR001430. The views, opinions, and findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. Funders did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Adams JW, 2020, ACTA NEUROPATHOL, V140, P851, DOI 10.1007/s00401-020-02206-x; Alosco ML, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00928-y; Alosco ML, 2020, ACTA NEUROPATHOL, V140, P495, DOI 10.1007/s00401-020-02197-9; Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2018, J ALZHEIMERS DIS, V63, P1347, DOI 10.3233/JAD-180017; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Arfanakis K, 2020, J ALZHEIMERS DIS, V73, P333, DOI 10.3233/JAD-190687; Bieniek KF, 2021, J NEUROPATH EXP NEUR, V80, P210, DOI 10.1093/jnen/nlab001; Boyle PA, 2018, ANN NEUROL, V83, P74, DOI 10.1002/ana.25123; Brickman AM, 2015, NEUROSCI LETT, V592, P54, DOI 10.1016/j.neulet.2015.03.005; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chokesuwattanaskul A, 2020, SLEEP MED, V68, P80, DOI 10.1016/j.sleep.2019.11.1262; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dallaire-Theroux C, 2017, J ALZHEIMERS DIS, V57, P575, DOI 10.3233/JAD-161028; de Bresser J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20084-y; de Havenon A, 2019, NEUROLOGY, V92, pE1168, DOI 10.1212/WNL.0000000000007093; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Habes M, 2018, NEUROLOGY, V91, pE964, DOI 10.1212/WNL.0000000000006116; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Huynh K, 2021, NEUROLOGY, V96, pE1743, DOI 10.1212/WNL.0000000000011638; Kandel Benjamin M, 2016, Alzheimers Dement (Amst), V4, P18, DOI 10.1016/j.dadm.2016.03.001; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Li JF, 2020, NEUROIMAGE, V215, DOI 10.1016/j.neuroimage.2020.116789; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McAleese KE, 2017, ACTA NEUROPATHOL, V134, P459, DOI 10.1007/s00401-017-1738-2; McAleese KE, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0240-0; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McNair D. M., 1983, ASSESSMENT GERIATRIC; Mez J, 2021, ALZHEIMERS DEMENT, V17, P1709, DOI 10.1002/alz.12338; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Power MC, 2015, NEUROLOGY, V84, P841, DOI 10.1212/WNL.0000000000001283; Puzo C, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0521-0; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Shim YS, 2015, DEMENT GERIATR COGN, V39, P92, DOI 10.1159/000366411; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tosto G, 2015, ALZHEIMERS DEMENT, V11, P1510, DOI 10.1016/j.jalz.2015.05.014; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wirth AM, 2019, J MAGN RESON IMAGING, V50, P552, DOI 10.1002/jmri.26577	50	0	0	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 4	2022	98	1					E27	E39		10.1212/WNL.0000000000013012			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XS5CV	WOS:000732927800004	34819338				2022-02-06	
J	de Barros, JLVM; Cardoso, MG; Machado, CA; Vieira, ELM; Faleiro, RM; Pedroso, VSP; Silva, ACSE; de Souza, LC; Teixeira, AL; de Miranda, AS				Vieira Monteiro de Barros, Joao Luis; Cardoso, Maira Gloria; Machado, Caroline Amaral; Marciano Vieira, Erica Leandro; Faleiro, Rodrigo Moreira; Pietra Pedroso, Vinicius Sousa; Simoes e Silva, Ana Cristina; de Souza, Leonardo Cruz; Teixeira, Antonio Lucio; de Miranda, Aline Silva		Minas Gerais'Traumatic Brain Injur	The potential role of renin-angiotensin system in mild traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article; Early Access						Mild traumatic brain injury; Renin-angiotensin system; Angiotensin II; ACE; Angiotensin-(1-7); ACE2		Traumatic brain injury (TBI) is a serious public health problem, affecting 69 million people worldwide annually. Mild TBI (mTBI) comprises the majority of the cases and remains the most neglected TBI severity. Its intricate pathophysiology involves complex cellular and molecular processes that remain uncomprehended. Although the renin-angiotensin system (RAS) has its well-known roles in blood pressure regulation and fluid balance, accumulating evidence demonstrates its active expression and signaling in the central nervous system. Over the past years, pre-clinical studies have been supporting the role of RAS in mTBI. However, particularly for human TBI, evidence is still missing. Herein, we investigated peripheral levels of angiotensin II (Ang II) and angiotensin-converting enzyme (ACE), components of RAS classical axis, as well as angiotensin-(1-7) [Ang-(1-7)] and ACE2, components of RAS counter-regulatory axis, in 28 mTBI patients and 24 healthy controls. In the first 24 h, mTBI patients displayed lower ACE (p = 0.0004) and ACE2 (p = 0.0047) concentrations and an increase in Ang II (p = 0.0234) and Ang-(1-7) (p = 0.0225) levels compared to controls. Interestingly, at 30 days follow-up, mTBI patients increased the levels of ACE (p = 0.0415) and ACE2 (p = 0.0416) along with a decrease in Ang II (p = 0.0039) and Ang-(1-7) (p = 0.0015) concentrations compared with their measures at 24 h after TBI. Also, our receiver operating curve (ROC) analysis demonstrated that ACE concentration was a good predictor of mTBI diagnosis (AUC = 0.798, p < 0.0001). The current study provides the first clinical evidence of RAS molecule's involvement in mTBI and their possible role as discriminating biomarkers.	[Vieira Monteiro de Barros, Joao Luis; Cardoso, Maira Gloria; Marciano Vieira, Erica Leandro; Pietra Pedroso, Vinicius Sousa; Simoes e Silva, Ana Cristina; de Souza, Leonardo Cruz; de Miranda, Aline Silva] Univ Fed Minas Gerais UFMG, Fac Med, Lab Interdisciplinar Invest Med LIIM, Av Prof Alfredo Balena 190,Sala 281, BR-30130100 Belo Horizonte, MG, Brazil; [Machado, Caroline Amaral; de Miranda, Aline Silva] Univ Fed Minas Gerais, Dept Morfol, Lab Neurobiol, Inst Ciencias Biol, Bloco 03,Sala 245,Av Antonio Carlos 6627, BR-31270910 Belo Horizonte, MG, Brazil; [Faleiro, Rodrigo Moreira] Fundacao Hosp Estado Minas Gerais FHEMIG, Hosp Joao XXIII, Av Prof Alfredo Balena 400, BR-30130100 Belo Horizonte, MG, Brazil; [de Souza, Leonardo Cruz; de Miranda, Aline Silva] Univ Fed Minas Gerais UFMG, Programa Posgrad Neurociencias, Belo Horizonte, MG, Brazil; [de Souza, Leonardo Cruz] Univ Fed Minas Gerais, Dept Clin Med, Fac Med, Belo Horizonte, MG, Brazil; [Teixeira, Antonio Lucio] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, 6410 Fannin St 1014, Houston, TX 77030 USA; [Teixeira, Antonio Lucio] Santa Casa BH Ensino & Pesquisa, Belo Horizonte, MG, Brazil		de Miranda, AS (corresponding author), Univ Fed Minas Gerais UFMG, Fac Med, Lab Interdisciplinar Invest Med LIIM, Av Prof Alfredo Balena 190,Sala 281, BR-30130100 Belo Horizonte, MG, Brazil.; de Miranda, AS (corresponding author), Univ Fed Minas Gerais, Dept Morfol, Lab Neurobiol, Inst Ciencias Biol, Bloco 03,Sala 245,Av Antonio Carlos 6627, BR-31270910 Belo Horizonte, MG, Brazil.; de Miranda, AS (corresponding author), Univ Fed Minas Gerais UFMG, Programa Posgrad Neurociencias, Belo Horizonte, MG, Brazil.	jlvmb@yahoo.com; maira.gcardoso@gmail.com; carolineamachado@gmail.com; ericalmvieira@gmail.com; faleirorm@gmail.com; viniciuspietra@yahoo.com.br; acssilva@hotmail.com; leocruzsouza@hotmail.com; altexr@gmail.com; mirandas.aline@gmail.com			NARSAD Young Investigator Grant from Brain & Behavior Research FoundationNARSAD [25414]; "For Women in Science"-L'Oreal Brazil-UNESCO-Brazilian Academy of Science; FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian National Council for Scientific and Technological Development (CNPq-bolsa de produtividade em pesquisa)	This work was supported by the 2016 NARSAD Young Investigator Grant from Brain & Behavior Research Foundation (grant #25414), 2019 "For Women in Science"-L'Oreal Brazil-UNESCO-Brazilian Academy of Science (ABC), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). ACSS, ALT, and LCS are supported by Brazilian National Council for Scientific and Technological Development (CNPq-bolsa de produtividade em pesquisa).	Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; D'Ardes D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083003; Deshotels MR, 2014, HYPERTENSION, V64, P1368, DOI 10.1161/HYPERTENSIONAHA.114.03743; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Janatpour ZC, 2019, J NEUROTRAUM, V36, P3115, DOI 10.1089/neu.2019.6376; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Nakagawa P, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-019-1011-2; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Rocha NP, 2018, CURR MED CHEM, V25, P3333, DOI 10.2174/0929867325666180226102358; SCHUNKERT H, 1993, CIRC RES, V72, P312, DOI 10.1161/01.RES.72.2.312; Santos RAS, 2018, PHYSIOL REV, V98, P505, DOI 10.1152/physrev.00023.2016; Tabish SANS., 2014, INT J SCI RES, V3, P382; Vadhan JD, 2021, PHARMACOL THERAPEUT, V218, DOI 10.1016/j.pharmthera.2020.107684; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172	19	0	0	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.												10.1007/s10072-021-05856-1		JAN 2022	7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YA6GB	WOS:000738428000001	34982298				2022-02-06	
J	Schumm, SN; Gabrieli, D; Meaney, DF				Schumm, Samantha N.; Gabrieli, David; Meaney, David F.			Plasticity impairment exposes CA3 vulnerability in a hippocampal network model of mild traumatic brain injury	HIPPOCAMPUS			English	Article; Early Access						hippocampus; mild traumatic brain injury; network; phase coherence; plasticity impairment	STATE FUNCTIONAL CONNECTIVITY; TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; DENTATE GYRUS; SYNAPTIC PLASTICITY; NEURONAL OSCILLATIONS; GAMMA OSCILLATIONS; EPILEPTIC ACTIVITY; RAT HIPPOCAMPUS; COMPUTER-MODEL	Proper function of the hippocampus is critical for executing cognitive tasks such as learning and memory. Traumatic brain injury (TBI) and other neurological disorders are commonly associated with cognitive deficits and hippocampal dysfunction. Although there are many existing models of individual subregions of the hippocampus, few models attempt to integrate the primary areas into one system. In this work, we developed a computational model of the hippocampus, including the dentate gyrus, CA3, and CA1. The subregions are represented as an interconnected neuronal network, incorporating well-characterized ex vivo slice electrophysiology into the functional neuron models and well-documented anatomical connections into the network structure. In addition, since plasticity is foundational to the role of the hippocampus in learning and memory as well as necessary for studying adaptation to injury, we implemented spike-timing-dependent plasticity among the synaptic connections. Our model mimics key features of hippocampal activity, including signal frequencies in the theta and gamma bands and phase-amplitude coupling in area CA1. We also studied the effects of spike-timing-dependent plasticity impairment, a potential consequence of TBI, in our model and found that impairment decreases broadband power in CA3 and CA1 and reduces phase coherence between these two subregions, yet phase-amplitude coupling in CA1 remains intact. Altogether, our work demonstrates characteristic hippocampal activity with a scaled network model of spiking neurons and reveals the sensitive balance of plasticity mechanisms in the circuit through one manifestation of mild traumatic injury.	[Schumm, Samantha N.; Gabrieli, David; Meaney, David F.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Schumm, Samantha/0000-0003-4399-5362; Meaney, David/0000-0002-0954-4122	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS088176]; Paul G. Allen Frontiers Group [12347]	National Institute of Neurological Disorders and Stroke, Grant/Award Number: NS088176; Paul G. Allen Frontiers Group, Grant/Award Number: 12347	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; AIKA Y, 1994, EXP BRAIN RES, V99, P267; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Andersen P, 2000, BRAIN RES, V886, P165, DOI 10.1016/S0006-8993(00)02991-7; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bezaire MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18566; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Camunas-Mesa LA, 2013, NEURAL COMPUT, V25, P1191, DOI 10.1162/NECO_a_00433; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Chavlis S, 2017, HIPPOCAMPUS, V27, P89, DOI 10.1002/hipo.22675; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Colgin LL, 2015, CURR OPIN NEUROBIOL, V31, P45, DOI 10.1016/j.conb.2014.08.001; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Cutsuridis V, 2010, HIPPOCAMPUS, V20, P423, DOI 10.1002/hipo.20661; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Effenberger F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004420; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; FERSTER D, 1992, J NEUROSCI, V12, P1262; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fink CG, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0024-15.2015; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Gabrieli D, 2021, NEURAL COMPUT, V33, P67, DOI 10.1162/neco_a_01343; Gabrieli D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234749; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Graben PB, 2013, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00100; Hanslmayr S, 2014, NEUROIMAGE, V85, P648, DOI 10.1016/j.neuroimage.2013.05.121; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Hulsemann MJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00573; Hummos A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182648; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Izhikevich E.M, 2007, DYNAMICAL SYSTEMS NE, DOI [10.7551/mitpress/2526.001.0001, DOI 10.7551/MITPRESS/2526.001.0001]; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jin JJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00170; Koch Christof, 1999, P1; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kress GJ, 2008, J NEUROPHYSIOL, V100, P281, DOI 10.1152/jn.90295.2008; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lein PJ, 2011, METHODS MOL BIOL, V758, P115, DOI 10.1007/978-1-61779-170-3_8; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malerba P, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004880; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mazzoni A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004584; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Mehrotra S. C, 2016, INTRO EEGAND SPEECH, P19, DOI DOI 10.1016/B978-0-12-804490-2.00002-6; MILES R, 1988, J NEUROPHYSIOL, V60, P1481, DOI 10.1152/jn.1988.60.4.1481; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morgan RJ, 2007, PROG BRAIN RES, V163, P639, DOI 10.1016/S0079-6123(07)63035-0; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sanjay M, 2015, HIPPOCAMPUS, V25, P1336, DOI 10.1002/hipo.22440; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schumm SN, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00018; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley DA, 2013, J NEUROPHYSIOL, V110, P1070, DOI 10.1152/jn.00911.2012; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Struber M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00936-3; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Tamura M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02108-9; Tejada J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003601; Tetzlaff C, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00047; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tripathy SJ, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00040; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Wheeler DW, 2015, ELIFE, V4, DOI 10.7554/eLife.09960; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Zenke F, 2017, CURR OPIN NEUROBIOL, V43, P166, DOI 10.1016/j.conb.2017.03.015; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	129	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus												10.1002/hipo.23402		JAN 2022	20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XY9EX	WOS:000737268800001	34978378				2022-02-06	
J	Walusimbi, M; Dossa, AY; Faryar, K; Markert, RJ; McCarthy, MC				Walusimbi, Mbaga; Dossa, Avafia Y.; Faryar, Kiran; Markert, Ronald J.; McCarthy, Mary C.			Upper Extremity Deep Venous Thrombosis Risk Factors, Associated Morbidity and Mortality in Trauma Patients	WORLD JOURNAL OF SURGERY			English	Article							MOLECULAR-WEIGHT HEPARIN; BRAIN-INJURY; THROMBOEMBOLISM PROPHYLAXIS; ENOXAPARIN PROPHYLAXIS; VEIN THROMBOSIS; TISSUE-FACTOR	Background The literature on upper extremity deep venous thrombosis (UEDVT) is not as abundant as that on lower extremities. This study aimed to identify the risk factors for UEDVT, associated mortality and morbidity in trauma patients and the impact of pharmacological prophylaxis therein. Methods A 3-year retrospective review of patients admitted to a Level 1 trauma center was conducted. Patients aged 18 years or older who had experienced a traumatic event and had undergone an upper extremity ultrasound (UEUS) were included in the study. Multiple logistic regression was used to identify independent risk factors that contributed to UEDVT. Results A total of 6,607 patients were admitted due to traumatic injuries during the study period, of whom 5.6% (373) had at least one UEUS during their hospitalization. Fifty-six (15%) were diagnosed with an UEDVT, as well as three non-fatal pulmonary emboli (PE) and four (7.1%) deaths, p = 0.03. Pharmacological prophylaxis with low-molecular-weight heparin (LMWH) or unfractionated heparin showed a protective effect against UEDVT; among the patients positive for UEDVT, 14 of 186 patients (7.5%) received LMWH, while 42 of 195 (21.5%) did not receive LMWH (p < 0.001). Multiple logistic regression revealed that the presence of upper extremity fractures, peripherally inserted central catheter (PICC) lines, and traumatic brain injury (TBI) were independent risk factors for UEDVT. Conclusions UEDVT are associated with a higher mortality. The presence of upper extremity fractures, PICC lines, and TBI were independent risk factors for UEDVTs. Further, pharmacological prophylaxis reduces the risk of UEDVT.	[Walusimbi, Mbaga; Dossa, Avafia Y.; Faryar, Kiran; Markert, Ronald J.; McCarthy, Mary C.] Wright State Univ, Dept Surg, Sch Med, 128 E Apple St,Suite 7000 Weber Ctr Hlth Educ, Dayton, OH 45409 USA		Walusimbi, M (corresponding author), Wright State Univ, Dept Surg, Sch Med, 128 E Apple St,Suite 7000 Weber Ctr Hlth Educ, Dayton, OH 45409 USA.	mbaga.walusimbi@wright.edu					Adla Deepthi Nandan, 2004, Eur J Orthop Surg Traumatol, V14, P177, DOI 10.1007/s00590-004-0151-4; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bernardi E, 2006, SEMIN THROMB HEMOST, V32, P729, DOI 10.1055/s-2006-951458; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Constans J, 2008, THROMB HAEMOSTASIS, V99, P202, DOI 10.1160/TH07-08-0485; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; FREEARK RJ, 1967, ARCH SURG-CHICAGO, V95, P567; Gando S, 1997, CRIT CARE MED, V25, P1820, DOI 10.1097/00003246-199711000-00019; Gando S, 1999, J TRAUMA, V47, P719, DOI 10.1097/00005373-199910000-00017; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Greene MT, 2015, AM J MED, V128, P986, DOI 10.1016/j.amjmed.2015.03.028; Hingorani A, 2005, J VASC SURG, V41, P476, DOI 10.1016/j.jvs.2004.12.038; Hingorani A, 1997, J VASC SURG, V26, P853, DOI 10.1016/S0741-5214(97)70100-9; Hingorani A, 2006, ANN VASC SURG, V20, P297, DOI 10.1007/s10016-006-9040-0; Joffe HV, 2004, CIRCULATION, V110, P1605, DOI 10.1161/01.CIR.0000142289.94369.D7; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Kommareddy A, 2002, SEMIN THROMB HEMOST, V28, P89, DOI 10.1055/s-2002-20567; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Lindblad B, 1988, Eur J Vasc Surg, V2, P161, DOI 10.1016/S0950-821X(88)80069-0; Lobo BL, 2009, J HOSP MED, V4, P417, DOI 10.1002/jhm.442; Malinoski D, 2013, J TRAUMA ACUTE CARE, V74, P454, DOI 10.1097/TA.0b013e31827a0b2f; Marnejon T, 2012, J VASC ACCESS, V13, P231, DOI 10.5301/jva.5000039; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Peivandi MT, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-28; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57; Sawyer Gregory A, 2011, Orthopedics, V34, P141, DOI 10.3928/01477447-20101221-27; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020	34	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAR	2022	46	3					561	567		10.1007/s00268-021-06383-y		JAN 2022	7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YS2LX	WOS:000737673300001	34981151				2022-02-06	
J	Zhang, L; Levenson, CW; Salazar, VC; Biederman, J; Zafonte, R; Bhide, PG				Zhang, Lin; Levenson, Cathy W.; Salazar, Valentina Cea; Biederman, Joseph; Zafonte, Ross; Bhide, Pradeep G.			Repetitive Mild Traumatic Brain Injury in an Awake, Unanesthetized Mouse Model of Perinatal Nicotine Exposure Produces Transient Novelty-Seeking and Depression-Like Behaviors	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						ADHD; concussion; attention; depression; nicotine; novelty-seeking; traumatic brain injury	DEFICIT HYPERACTIVITY DISORDER; MATERNAL SMOKING; RISK-FACTOR; ATTENTION; CONCUSSION; ADHD; PREGNANCY; ANXIETY; SAMPLE; ADULTS	Attention deficit hyperactivity disorder (ADHD) can be a risk factor for repetitive mild traumatic brain injury (mTBI) or concussions such as those that can occur in contact sports. Individuals with ADHD also appear to have a higher risk of poor neurocognitive outcomes after repetitive mTBI. Findings from clinical studies examining the interactions between ADHD and repetitive mTBI vary, likely because of variabilities in experimental design and outcome measures. We used a mouse model of perinatal nicotine exposure (PNE), which displays behavioral, neuroanatomical, and neurotransmitter features consistent with ADHD and subjected the mice to repetitive mTBI. We used a closed head model of mTBI in awake, unanesthetized mice to mimic concussions in humans. The mTBI was repeated three times daily for seven days. The mice in the PNE-mTBI group took longer to regain consciousness after the mTBI and showed transient novelty-seeking and depression-like behaviors. Before the repetitive mTBI, the mice in the PNE group showed attention deficit, which persisted after the mTBI. The mice in the control (non-PNE) group showed a transient attention deficit after the repetitive mTBI but not any of the other behavioral changes seen in the PNE-mTBI group. These findings from an unanesthetized mouse model with a pre-existing condition show that ADHD and repetitive mTBI together contribute to transient novelty-seeking and depression-like behavior supporting the notion that untreated ADHD may be a risk factor for poor neurocognitive outcomes after concussions.	[Zhang, Lin; Levenson, Cathy W.; Salazar, Valentina Cea; Bhide, Pradeep G.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; [Biederman, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat Pediat Psychopharmacol, Boston, MA 02115 USA; [Zafonte, Ross] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Brigham & Womens Hosp, Charlestown, MA 02214 USA; [Zafonte, Ross] Harvard Med Sch, Charlestown, MA USA		Bhide, PG (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA.	Pradeep.bhide@med.fsu.edu					Alkam T, 2013, PSYCHOPHARMACOLOGY, V230, P451, DOI 10.1007/s00213-013-3175-9; Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; BIEDERMAN J, 1994, PSYCHIAT RES, V53, P13, DOI 10.1016/0165-1781(94)90092-2; Biederman J, 2004, J CLIN PSYCHIAT, V65, P3; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Biederman J, 2012, WORLD J BIOL PSYCHIA, V13, P60, DOI 10.3109/15622975.2011.562243; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chasle V, 2016, CHILD NERV SYST, V32, P2357, DOI 10.1007/s00381-016-3230-z; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Cook NE, 2021, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.606879; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Hayton SJ, 2012, ALCOHOL CLIN EXP RES, V36, P594, DOI 10.1111/j.1530-0277.2011.01668.x; Iverson GL, 2021, CLIN J SPORT MED, V31, P438, DOI 10.1097/JSM.0000000000000773; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Izzy S, 2021, J NEUROTRAUM, V38, P1834, DOI 10.1089/neu.2020.7484; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Milberger S, 1998, J CLIN CHILD PSYCHOL, V27, P352, DOI 10.1207/s15374424jccp2703_11; Milberger S, 1996, AM J PSYCHIAT, V153, P1138; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nowak MK, 2022, J ATTEN DISORD, V26, P125, DOI 10.1177/1087054720969977; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piazza P.V., 1990, Behav Pharmacol, V1, P339; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shultz SR, 2020, J NEUROTRAUM, V37, P2381, DOI 10.1089/neu.2018.6149; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10534; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zhang L, 2021, DEV NEUROSCI-BASEL, V43, P63, DOI 10.1159/000515198; Zhang L, 2021, CEREB CORTEX, V31, P483, DOI 10.1093/cercor/bhaa238; Zhang L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198064; Zhu JM, 2017, INT J DEV NEUROSCI, V58, P26, DOI 10.1016/j.ijdevneu.2017.01.014; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	59	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0268		JAN 2022	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YB5YN	WOS:000739087600001	34913733				2022-02-06	
J	Barrett, CA; Hoover, DL				Barrett, Carrie A.; Hoover, Donald L.			Differential screen and treatment of vestibular dysfunction in an elderly patient: A case report	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article; Early Access						Post-concussion; concussion elderly; labyrinthine concussion; multiple canal BPPV	PAROXYSMAL POSITIONAL VERTIGO; TRAUMATIC BRAIN-INJURY; UNITED-STATES; OLDER; REHABILITATION; DIZZINESS; ACCURACY; DECLINE	Background/Purpose Concussion sequelae in the elderly is under recognized and negatively impacts quality of life. Labyrinthine concussion (LC) is an uncommon diagnosis, as is multiple canal (MC) benign paroxysmal positional vertigo (BPPV). This case report highlights physical therapist (PT) evaluation and treatment of an elderly male misdiagnosed with LC and successfully treated for MC BPPV. Case Description A 72 year old male presented to his PT 23 days after falling off a ladder, resulting in a mild traumatic brain injury (mTBI). Diagnosed with LC, he was referred to PT due to ongoing symptoms of "falling backwards," poor gait, and diminished mobility. PT examination revealed an atypical BPPV. Thus, the patient was treated in two PT visits, which included canalith repositioning techniques and neuromuscular reeducation. Outcomes The PT diagnosis was MC BPPV, including the right lateral and left posterior semicircular canals. Initial positive findings of Head Impulse Test, Bow and Lean Test, Dix-Hallpike, and Roll Test were negative on the last visit. Patient-Specific Functional Scale improved from 0 to 9.9 (10 being no limitations). The patient progressed from minimum assistance to independence in bed mobility, transfers, gait, and previous activities. Discussion The patient's presentation was atypical in signs and symptoms with a diagnosis of LC. PT examination and intervention successfully resolved the patient's signs and symptoms within two visits. Further research is needed regarding identification and treatment of elderly individuals with head injuries, such as MC BPPV, as well as the efficacy of a PT seeing patients shortly after mTBI.	[Barrett, Carrie A.; Hoover, Donald L.] Western Michigan Univ, Phys Therapy Program, Kalamazoo, MI 49008 USA		Barrett, CA (corresponding author), Phys Therapy Program, Kalamazoo, MI 49008 USA.	carrie.barrett@wmich.edu					Abbott JH, 2014, J CLIN EPIDEMIOL, V67, P681, DOI 10.1016/j.jclinepi.2013.11.002; Alouche SR, 2021, NEUROREHAB NEURAL RE, V35, P185, DOI 10.1177/1545968320981955; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anagnostou E, 2014, J NEUROL, V261, P866, DOI 10.1007/s00415-014-7290-2; Aslan H., 2018, EUR J RHINOL ALLERGY, V1, P12; Bartholomew RA, 2020, LARYNGOSCOPE INVEST, V5, P267, DOI 10.1002/lio2.360; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Chandler MJ, 2004, J CLIN EXP NEUROPSYC, V26, P1128, DOI 10.1080/13803390490515540; Chase JAD, 2018, CLIN NURS RES, V27, P81, DOI 10.1177/1054773816677063; Choi JY, 2015, NEUROLOGY, V84, P2238, DOI 10.1212/WNL.0000000000001640; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Choi S, 2018, LARYNGOSCOPE, V128, P2600, DOI 10.1002/lary.27142; Churpek MM, 2015, CRIT CARE MED, V43, P816, DOI 10.1097/CCM.0000000000000818; Colucci D, 2017, HEARING J, V70, P44; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Oliveira AKD, 2015, BRAZ J OTORHINOLAR, V81, P197, DOI 10.1016/j.bjorl.2014.06.002; DeGrauw X, 2016, J SAFETY RES, V56, P105, DOI 10.1016/j.jsr.2015.11.002; Emos MC., 2018, NEUROANATOMY UPPER M; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Friedman Jules M, 2004, Med Health R I, V87, P296; Fruth SJ., 2017, FUNDAMENTALS PHYS TH; Gordon CR, 2008, PROG BRAIN RES, V171, P519, DOI 10.1016/S0079-6123(08)00674-2; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Hansson EE, 2005, GERONTOLOGY, V51, P386, DOI 10.1159/000088702; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Jozefowicz-Korczynska M, 2018, ADV CLIN EXP MED, V27, P1355, DOI 10.17219/acem/69708; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kim CH, 2016, EUR ARCH OTO-RHINO-L, V273, P3003, DOI 10.1007/s00405-016-3894-8; Macdonald NK, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00141; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Oron Y, 2015, LARYNGOSCOPE, V125, P1959, DOI 10.1002/lary.25138; Perez N, 2003, OTOL NEUROTOL, V24, P913, DOI 10.1097/00129492-200311000-00016; Richter RR, 2005, PHYS THER, V85, P589; Salturk Z, 2020, ACTA OTO-LARYNGOL, V140, P977, DOI 10.1080/00016489.2020.1805123; Server EA, 2018, ACTA OTO-LARYNGOL, V138, P1, DOI 10.1080/00016489.2017.1373849; Shim Dae Bo, 2014, Korean J Audiol, V18, P126, DOI 10.7874/kja.2014.18.3.126; Sirois MJ, 2013, J AM GERIATR SOC, V61, P1661, DOI 10.1111/jgs.12482; Swartz R, 2005, AM FAM PHYSICIAN, V71, P1115; Whitney SL., 2007, VESTIBULAR REHABILIT, V3rd	42	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.												10.1080/09593985.2021.2012858		JAN 2022	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XZ4ZL	WOS:000737661300001	34978248				2022-02-06	
J	Abreu, V; Vaz, R; Chamadoira, C; Rebelo, V; Reis, C; Costa, F; Martins, J; Gillies, MJ; Aziz, TZ; Pereira, EAC				Abreu, V; Vaz, R.; Chamadoira, C.; Rebelo, V; Reis, C.; Costa, F.; Martins, J.; Gillies, M. J.; Aziz, T. Z.; Pereira, E. A. C.			Thalamic deep brain stimulation for post-traumatic neuropathic limb pain: Efficacy at five years' follow-up and effective volume of activated brain tissue	NEUROCHIRURGIE			English	Article							GENERAL-POPULATION; NEUROSTIMULATION; EPIDEMIOLOGY	Chronic neuropathic pain affects 7%-10% of the population. Deep brain stimulation (DBS) has shown variable but promising results in its treatment. This study prospectively assessed the long-term effectiveness of DBS in a series of patients with chronic neuropathic pain, correlating clinical results with neuroimaging. Sixteen patients received 5 years' post-surgical follow-up in a single center. Six had phantom limb pain after amputation and 10 had deafferentation pain after traumatic brachial plexus injury. Patientreported outcome measures were completed before and after surgery, using VAS, UWNPS, BPI and SF-36 scores. Neuroimaging evaluated electrode location and effective volumes of activated tissue (VAT). Two subgroups were created based on the percentage of VAT superimposed upon the ventroposterolateral thalamic nucleus (eVAT), and clinical outcomes were compared. Analgesic effect was assessed at 5 years and compared to preoperative pain, with an improvement on VAS of 76.4% (p = 0.0001), on UW-NPS of 35.2% (p = 0.3582), on BPI of 65.1% (p = 0.0505) and on SF-36 of 5% (p = 0.7406). Eight patients with higher eVAT showed improvement on VAS of 67.5% (p = 0.0017) while the remaining patients, with lower eVAT, improved by 50.6% (p = 0.03607). DBS remained effective in improving chronic neuropathic pain after 5 years. While VPL-targeting contributes to success, analgesia is also obtained by stimulating surrounding posterior ventrobasal thalamic structures and related spinothalamocortical tracts. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Abreu, V] Ctr Hosp Univ Porto, Dept Neuroradiol, Rua Prof Antao de Almeida Garrett 76,12 Andar, P-4250041 Porto, Portugal; [Abreu, V; Vaz, R.; Aziz, T. Z.; Pereira, E. A. C.] Univ Porto, Fac Med, Porto, Portugal; [Vaz, R.; Chamadoira, C.] Ctr Hosp Univ Sao Joao, Dept Neurosurg, Porto, Portugal; [Vaz, R.] Neurociences Unity Hosp Cuf, Porto, Portugal; [Rebelo, V] Ctr Hosp Univ Sao Joao, Pain Unit, Porto, Portugal; [Reis, C.; Costa, F.] Ctr Hosp Univ Sao Joao, Dept Neuroradiol, Porto, Portugal; [Martins, J.] Medtronic, Porto, Portugal; [Gillies, M. J.; Aziz, T. Z.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Pereira, E. A. C.] St Georges Univ London, Inst Mol & Clin Neurosci, Neurosci Res Ctr, London, England		Abreu, V (corresponding author), Ctr Hosp Univ Porto, Dept Neuroradiol, Rua Prof Antao de Almeida Garrett 76,12 Andar, P-4250041 Porto, Portugal.	vrlsa1993@gmail.com		Gillies, Martin/0000-0002-4391-713X; Sousa Abreu, Vasco/0000-0001-8942-275X			Abreu V, 2017, NEUROMODULATION, V20, P504, DOI 10.1111/ner.12620; Ashburn MA, 1999, LANCET, V353, P1865, DOI 10.1016/S0140-6736(99)04088-X; Boccard SGJ, 2013, NEUROSURGERY, V72, P221, DOI 10.1227/NEU.0b013e31827b97d6; Coffey RJ, 2001, PAIN MED, V2, P183, DOI 10.1046/j.1526-4637.2001.01029.x; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Deer TR, 2020, PAIN MED, V21, P1415, DOI 10.1093/pm/pnz371; Dones I, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080138; Frizon LA, 2020, NEUROSURGERY, V86, P191, DOI 10.1093/neuros/nyy552; Green AL, 2006, CEPHALALGIA, V26, P561, DOI 10.1111/j.1468-2982.2005.01068.x; Gybels JM, 1989, PHYSL PATHOLOGICAL M, V11, P60; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; Heath R., 1954, STUDIES SCHIZOPHRENI; Hell F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00314; Levy RM, 2003, NEUROSURG CLIN N AM, V14, P389, DOI 10.1016/S1042-3680(03)00036-6; Marchand S, 2003, PAIN, V105, P481, DOI 10.1016/S0304-3959(03)00265-3; MARK VH, 1965, POSTGRAD MED, V37, P563, DOI 10.1080/00325481.1965.11695514; NARAKAS A, 1978, CLIN ORTHOP RELAT R, P71; National Institute for Health and Care Excellence, IPG382 NAT I HLTH CA; Nizard J, 2012, DISCOV MED, V14, P237; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Papuc E, 2013, ANN AGR ENV MED, P14; Pereira EAC, 2011, NEUROSTIMULATION TRE, V1, P187; Pereira EAC, 2007, EXPERT REV MED DEVIC, V4, P591, DOI 10.1586/17434440.4.5.591; Pereira EAC, 2014, NEUROTHERAPEUTICS, V11, P496, DOI 10.1007/s13311-014-0278-x; Pereira EAC, 2009, NEUROMODULATION, VOLS 1 AND 2, P499, DOI 10.1016/B978-0-12-374248-3.00039-2; Rasche Dirk, 2006, Neurosurg Focus, V21, pE8; Rokyta R, 2012, PHYSIOL RES, V61, pS23, DOI 10.33549/physiolres.932392; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Viswanathan A, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13236; Yamamoto T, 2006, STEREOT FUNCT NEUROS, V84, P180, DOI 10.1159/000094958; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Young RF, 1997, NEUROSURGICAL MANAGE, P283	34	0	0	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	JAN	2022	68	1					52	60		10.1016/j.neuchi.2021.06.006			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XY4CW	WOS:000736923600008	34166646				2022-02-06	
J	Ahn, S; Logan, JG				Ahn, Soojung; Logan, Jeongok G.			Perceived role overload and physical symptom experience among caregivers of older adults: The moderating effect of social support	GERIATRIC NURSING			English	Article						Caregivers; Caregiver burden; Health status; Pain; Social support	TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; STRESS PROCESS; HEALTH; DEMENTIA; ASSOCIATION; ANXIETY; BURDEN; IMPACT; CARE	We investigated the association between perceived role overload and physical symptom experience, and the potential moderating effect of social support among caregivers of older adults. We analyzed data of 1,471 caregivers obtained from the 2017 National Study of Caregiving. In the survey, participants were assessed for physical symptoms (pain, limited leg strength, and low energy), symptom-related activity limitations, per-ceived role overload, and informal/formal support sources. We performed multiple logistic regression analy-ses with interaction terms. Caregivers who perceived higher role overload were more likely to experience the physical symptoms and frequent limited activities due to the symptoms. The associations of perceived role overload with pain and low energy, respectively, were attenuated among caregivers with high informal support. The moderating effect of formal support appeared to be the opposite in relation to pain. Caregivers who perceived high burden may benefit from their informal support to prevent detrimental effects of care-giving on physical health. (c) 2021 Elsevier Inc. All rights reserved.	[Ahn, Soojung; Logan, Jeongok G.] Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA		Ahn, S (corresponding author), Univ Virginia, Sch Nursing, Charlottesville, VA 22903 USA.	sa4ve@virginia.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [NIA U01AG032947]; Johns Hopkins Bloomberg School of Public HealthJohns Hopkins University	The authors received no financial support for the research, authorship, and/or publication of this article from funding agencies in the public, commercial, or not-for-profit sectors. National Health and Aging Trends Study (NHATS) and National Study of Caregiving (NSOC) are sponsored by the National Institute on Aging (NIA U01AG032947) through a cooperative agreement with the Johns Hopkins Bloomberg School of Public Health.	Adams KB, 2008, INT PSYCHOGERIATR, V20, P508, DOI 10.1017/S1041610207006278; Barth J, 2010, PSYCHOSOM MED, V72, P229, DOI 10.1097/PSY.0b013e3181d01611; Bass DM, 1996, J GERONTOL B-PSYCHOL, V51, pS121, DOI 10.1093/geronb/51B.3.S121; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Cantwell J, 2014, RES DEV DISABIL, V35, P2215, DOI 10.1016/j.ridd.2014.05.012; Chang HY, 2010, ARCH GERONTOL GERIAT, V50, P267, DOI 10.1016/j.archger.2009.04.006; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; Campos-Puente AD, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183250; Denno MS, 2013, ARCH PHYS MED REHAB, V94, P1731, DOI 10.1016/j.apmr.2013.03.014; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fekete C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017369; Folkman S., 1984, STRESS; Freedman VA, 2019, 24 NHATS NSOC; Freedman VA., 2019, NATL STUDY CAREGIVIN; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Hannibal KE, 2014, PHYS THER, V94, P1816, DOI 10.2522/ptj.20130597; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Haugland BSM, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02859; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Ivey K, 2018, GERONTOLOGIST, V58, P913, DOI 10.1093/geront/gnx099; Kent EE, 2019, J ONCOL PRACT, V15, P96, DOI 10.1200/JOP.18.00522; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Leggett AN, 2021, J APPL GERONTOL, V40, P763, DOI 10.1177/0733464820914481; Liang JM, 2020, J AGING HEALTH, V32, P1345, DOI 10.1177/0898264320926062; Lovell B, 2012, PSYCHONEUROENDOCRINO, V37, P534, DOI 10.1016/j.psyneuen.2011.08.003; Lovell B, 2011, NEUROSCI BIOBEHAV R, V35, P1342, DOI 10.1016/j.neubiorev.2011.02.007; Lu Yueh-Feng Yvonne, 2007, Clin Nurs Res, V16, P29, DOI 10.1177/1054773806295238; Lyons JG, 2015, J GERONTOL A-BIOL, V70, P1018, DOI 10.1093/gerona/glv001; Mausbach BT, 2012, AGING MENT HEALTH, V16, P27, DOI 10.1080/13607863.2011.615738; Mize TD, 2019, SOCIOL SCI, V6, P81, DOI 10.15195/v6.a4; National Alliance for Caregiving and AARP, 2020, CAR US 2020 AARP RES; Ownsworth T, 2010, PSYCHO-ONCOLOGY, V19, P1116, DOI 10.1002/pon.1663; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Schoenmakers B, 2010, AGING MENT HEALTH, V14, P44, DOI 10.1080/13607860902845533; Sherwood PR, 2005, J AGING HEALTH, V17, P125, DOI 10.1177/0898264304274179; Sit JWH, 2004, J CLIN NURS, V13, P816, DOI 10.1111/j.1365-2702.2004.00943.x; Son J, 2007, J AGING HEALTH, V19, P871, DOI 10.1177/0898264307308568; Trivedi Madhukar H, 2004, Prim Care Companion J Clin Psychiatry, V6, P12; Uchino BN, 2018, HEALTH PSYCHOL, V37, P462, DOI 10.1037/hea0000594; Verbakel E, 2018, J GERONTOL B-PSYCHOL, V73, P1099, DOI 10.1093/geronb/gbw047; Wang ZX, 2018, INT J GERIATR PSYCH, V33, P1198, DOI 10.1002/gps.4910; Williams SW, 2008, J GERONTOL B-PSYCHOL, V63, pS171, DOI 10.1093/geronb/63.3.S171	45	0	0	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4572	1528-3984		GERIATR NURS	Geriatr. Nurs.	JAN-FEB	2022	43						197	205		10.1016/j.gerinurse.2021.11.021			9	Geriatrics & Gerontology; Gerontology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nursing	YC3KE	WOS:000739593100001	34922280				2022-02-06	
J	Al-Onaizi, MA; Theriault, P; Lecordier, S; Prefontaine, P; Rivest, S; ElAli, A				Al-Onaizi, Mohammed A.; Theriault, Peter; Lecordier, Sarah; Prefontaine, Paul; Rivest, Serge; ElAli, Ayman			Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Alzheimer 's disease; Amyloid-beta; Erythropoietin-derived peptides; Bone marrow transplantation; Monocytes; Immunomodulation; Memory	ALZHEIMER-LIKE PATHOLOGY; AMYLOID-BETA DEPOSITION; TRAUMATIC BRAIN-INJURY; MOUSE MODEL; SPATIAL MEMORY; DISEASE; MICROGLIA; IMPROVES; PROTEIN; CELLS	Alzheimer's disease (AD) pathology is characterized by amyloid-beta (A beta) deposition and tau hyperphosphorylation, accompanied by a progressive cognitive decline. Monocytes have been recently shown to play a major role in modulating A beta pathology, and thereby have been pointed as potential therapeutic targets. However, the main challenge remains in identifying clinically relevant interventions that could modulate monocyte immune functions in absence of undesired off-target effects. Erythropoietin (EPO), a key regulator of erythrocyte production, has been shown to possess immunomodulatory potential and to provide beneficial effects in preclinical models of AD. However, the transition to use recombinant human EPO in clinical trials was hindered by unwanted erythropoietic effects that could lead to thrombosis. Here, we used a recently identified nonerythropoietic analogue of EPO, ARA 290, to evaluate its therapeutic potential in AD therapy. We first evaluated the effects of early systemic ARA 290 administration on AD-like pathology in an early-onset model, represented by young APP/PS1 mice. Our findings indicate that ARA 290 early treatment decelerated A beta pathology progression in APP/PS1 mice while improving cognitive functions. ARA 290 potently increased the levels of total monocytes by specifically stimulating the generation of Ly6CLow patrolling subset, which are implicated in clearing A beta from the cerebral vasculature, and subsequently reducing overall A beta burden in the brain. Moreover, ARA 290 increased the levels of monocyte progenitors in the bone marrow. Using chimeric APP/PS1 mice in which Ly6CLow patrolling subset are selectively depleted, ARA 290 was inefficient in attenuating A beta pathology and ameliorating cognitive functions in young animals. Interestingly, ARA 290 effects were compromised when delivered in a late-onset model, represented by aged APP1/PS1. In aged APP/PS1 mice in which AD-like pathology is at advanced stages, ARA 290 failed to reverse A beta pathology and to increase the levels of circulating monocytes. Our study suggests that ARA 290 early systemic treatment could prevent AD-like progression via modulation of monocyte functions by specifically increasing the ratio of patrolling monocytes.	[Al-Onaizi, Mohammed A.] Kuwait Univ, Fac Med, Dept Anat, Kuwait, Kuwait; [Theriault, Peter; Lecordier, Sarah; Prefontaine, Paul; Rivest, Serge; ElAli, Ayman] Univ Laval, CHU Quebec, Res Ctr, Neurosci Axis, Quebec City, PQ, Canada; [Lecordier, Sarah; ElAli, Ayman] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Al-Onaizi, Mohammed A.; Theriault, Peter; Prefontaine, Paul; Rivest, Serge] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ, Canada		ElAli, A (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Neurosci Axis T2 33, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	ayman.el-ali@crchudequebec.ulaval.ca		ElAli, Ayman/0000-0002-4048-6039	Scottish Rite Charitable Foundation of Canada (SRCFC) [17106]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2017-06119]; Fonds de recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec [35170]; Research Sector at Kuwait University [ZM03/16]; CIHR foundation scheme grantCanadian Institutes of Health Research (CIHR)	his work is supported by grants from the Scottish Rite Charitable Foundation of Canada (SRCFC) (#17106) , the Natural Sciences and Engineering Research Council of Canada (NSERC) (#RGPIN-2017-06119) , and the Fonds de recherche du Quebec - Sante (FRQS) (#35170) (all to AEA) . MAO received support from the Research Sector at Kuwait University grant number ZM03/16, and sabbatical funding as a visiting scientist to Universite Laval. SR holds a CIHR Tier 1 Canada Research Chair in neuroimmunology and a CIHR foundation scheme grant. AEA holds a CIHR Tier 2 Canada Research Chair in molecular and cellular neurovascular interactions.	Al-Onaizi MA, 2017, CEREB CORTEX, V27, P1615, DOI 10.1093/cercor/bhv349; Armand-Ugon M, 2015, J ALZHEIMERS DIS, V45, P407, DOI [10.3233/JAD-141389, 10.3233/JAD-150002]; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banach M, 2010, CURR VASC PHARMACOL, V8, P731, DOI 10.2174/157016110793563915; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bengoetxea Xabier, 2015, Front Biosci (Schol Ed), V7, P10; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cabinio M, 2018, J ALZHEIMERS DIS, V66, P1131, DOI 10.3233/JAD-180250; Chang R, 2020, MOL PHARMACEUT, V17, P360, DOI 10.1021/acs.molpharmaceut.9b01211; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Dahan A, 2013, MOL MED, V19, P334, DOI 10.2119/molmed.2013.00122; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; ElAli A, 2016, NEUROPSYCHOPHARMACOL, V41, P1297, DOI 10.1038/npp.2015.279; ElAli A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-75; Fan Z, 2015, BRAIN, V138, P3685, DOI 10.1093/brain/awv288; Maleki AF, 2021, NEUROTHERAPEUTICS, V18, P889, DOI 10.1007/s13311-020-00998-0; Maleki AF, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01893-3; Fernando G, 2018, BEHAV SCI, V8, DOI 10.3390/bs8020026; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; Fleisher AS, 2012, LANCET NEUROL, V11, P1057, DOI 10.1016/S1474-4422(12)70227-2; Garzon F, 2018, J ALZHEIMERS DIS, V65, P1469, DOI 10.3233/JAD-180668; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gonzalez-Velasquez FJ, 2008, J NEUROCHEM, V104, P500, DOI 10.1111/j.1471-4159.2007.04988.x; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hassouna I, 2016, MOL PSYCHIATR, V21, P1752, DOI 10.1038/mp.2015.212; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hohsfield LA, 2015, EXP GERONTOL, V65, P8, DOI 10.1016/j.exger.2015.03.002; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hooshmandi E, 2018, NEUROSCIENCE, V388, P405, DOI 10.1016/j.neuroscience.2018.08.001; Huang B, 2018, J CELL MOL MED, V22, P3330, DOI 10.1111/jcmm.13608; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jarero-Basulto JJ, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13120424; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koronyo Y, 2015, BRAIN, V138, P2399, DOI 10.1093/brain/awv150; LeBlanc NJ, 2019, MOL NEUROBIOL, V56, P6521, DOI 10.1007/s12035-019-1539-9; Lee ST, 2012, J NEUROCHEM, V120, P115, DOI 10.1111/j.1471-4159.2011.07534.x; Li C, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134286; Li F, 2006, CURR NEUROVASC RES, V3, P187, DOI 10.2174/156720206778018758; Li YP, 2015, BRAIN RES, V1618, P159, DOI 10.1016/j.brainres.2015.05.031; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu YQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090942, 10.1371/journal.pone.0085282]; Lopez OL, 2019, HAND CLINIC, V167, P139, DOI 10.1016/B978-0-12-804766-8.00009-1; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lubas A, 2010, ARCH MED SCI, V6, P533, DOI 10.5114/aoms.2010.14464; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Maiese K, 2012, INT J MOL SCI, V13, P11102, DOI 10.3390/ijms130911102; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Menet R, 2020, NEUROCHEM INT, V141, DOI 10.1016/j.neuint.2020.104881; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Miskowiak KW, 2015, BIOL PSYCHIAT, V78, P270, DOI 10.1016/j.biopsych.2014.12.013; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Polgarova K, 2011, FEMS IMMUNOL MED MIC, V62, P190, DOI 10.1111/j.1574-695X.2011.00801.x; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Rodriguez Cruz Y, 2017, J ALZHEIMERS DIS, V55, P231, DOI 10.3233/JAD-160500; Cruz YR, 2010, THESCIENTIFICWORLDJO, V10, P2288, DOI 10.1100/tsw.2010.215; Saresella M, 2014, J ALZHEIMERS DIS, V38, P403, DOI 10.3233/JAD-131160; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Soulet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053942; Sun JH, 2019, NEUROMOL MED, V21, P12, DOI 10.1007/s12017-019-08524-y; Tazangi PE, 2015, PHARMACOL BIOCHEM BE, V130, P15, DOI 10.1016/j.pbb.2014.12.011; Theriault P, 2016, ONCOTARGET, V7, P67808, DOI 10.18632/oncotarget.12179; Theriault P, 2016, ONCOTARGET, V7, P35552, DOI 10.18632/oncotarget.9652; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Van den Broeck L, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00092; van Velzen M, 2014, EXPERT OPIN INV DRUG, V23, P541, DOI 10.1517/13543784.2014.892072; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151	108	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2022	99						363	382		10.1016/j.bbi.2021.07.016			20	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	XN7DI	WOS:000729660600012	34343617				2022-02-06	
J	Algahtany, MA				Algahtany, M. A.			Extra-axial hematomas due to road traffic accidents and their outcome: a ten-year study	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traffic accident; Brain injury; EDH; SDH; SAH; Survival	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; FUNCTIONAL RECOVERY; SUBDURAL-HEMATOMA; EPIDURAL HEMATOMA; MORTALITY; EPIDEMIOLOGY; POPULATION; PREVENTION; SYSTEM	OBJECTIVE: The main objectives of this study were to describe the epidemiological characteristics, the associated factors and outcomes of extra-axial hematoma (EAH) in patients of traumatic brain injury (TBI) due to road traffic accident (RTA) and to assess their survival probability after 6 and 12 months to RTA. PATIENTS AND METHODS: This was a retrospective record-based study. A total of 520 patients diagnosed with EAH due to RTA-related TBI were studied. This study covered ten years from January 1, 2010, to December 31, 2019. Descriptive statistics, including frequencies, percentages, mean, standard deviation, median and range were used. To test for significance in the difference between proportions, a chi-square test was applied and adjusted standardized residual to confirm the differences between groups. The Kaplan-Meier curve was plotted, and mean survival rates were calculated for each type of EAH. A two-sided p-value less than 0.05 (5%) at 95% CI was considered to be statistically significant. RESULTS: EAH occurred in 42.1% of RTA-related TBI. Subdural hematoma (SDH) was the most common RTA-related EAH. Age and sex differences exist in the type of EAH with male preponderance and a significantly higher rate of SDH in patients aged 55 years or above. The total EHA mortality was 18.7%, and most occurred within the first month of the incident. Traumatic subarachnoid hemorrhage (tSAH) was associated with poorer outcome in terms of mortality. Epidural hematoma (EDH) has the best prognosis and survival probability at six months and one year from the accident. CONCLUSIONS: Extra-axial hematomas are very common in RTA-related TBIs and have high mortality. SDH is the most common, tSAH had the highest mortality, while EDH has the best survival. Aggressive efforts are compulsory to reduce RTA-related TBI.	[Algahtany, M. A.] King Khalid Univ, Coll Med, Dept Surg, Div Neurosurg, Abha, Saudi Arabia		Algahtany, MA (corresponding author), King Khalid Univ, Coll Med, Dept Surg, Div Neurosurg, Abha, Saudi Arabia.	mbalgahtany@kku.edu.sa					Algahtany MA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126623; Alghnam S, 2017, ANN SAUDI MED, V37, P1, DOI 10.5144/0256-4947.2017.1; Areas FZ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00432; Basamh M, 2016, CAN J NEUROL SCI, V43, P74, DOI 10.1017/cjn.2015.232; Bir SC, 2015, CLIN NEUROL NEUROSUR, V138, P99, DOI 10.1016/j.clineuro.2015.07.021; DeNicola E, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00215; Depreitere B, INTRACRANIAL PRESSUR; Elkbuli A, 2020, WORLD J SURG, V44, P1492, DOI 10.1007/s00268-020-05381-w; Eom KS, 2019, J KOREAN NEUROSURG S, V62, P243, DOI 10.3340/jkns.2018.0017; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Guatta R, 2021, ACTA NEUROCHIR, V163, P3209, DOI 10.1007/s00701-020-04622-0; Gutowski P, 2018, WORLD NEUROSURG, V118, pE166, DOI 10.1016/j.wneu.2018.06.147; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kuhn EN, 2018, WORLD NEUROSURG, V119, pE374, DOI 10.1016/j.wneu.2018.07.168; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lenzi J, 2017, BRIT J NEUROSURG, V31, P78, DOI 10.1080/02688697.2016.1226253; Liew TYS, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00037; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nakamura N, 2002, NEUROL RES, V24, P45, DOI 10.1179/016164102101199530; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Rau CS, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234787; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wang JW, 2018, MED SCI MONITOR, V24, P3256, DOI 10.12659/MSM.908728	34	0	0	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.		2022	26	1					120	129					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YM1YJ	WOS:000746376400017	35049027				2022-02-06	
J	Allen, JH; Yengo-Kahn, AM; Vittetoe, KL; Greeno, A; Ghani, MOA; Unni, P; Lovvorn, HN; Bonfield, CM				Allen, Jackson H.; Yengo-Kahn, Aaron M.; Vittetoe, Kelly L.; Greeno, Amber; Ghani, Muhammad Owais Abdul; Unni, Purnima; Lovvorn, Harold N., III; Bonfield, Christopher M.			The impact of helmet use on neurosurgical care and outcomes after pediatric all-terrain vehicle and dirt bike crashes: a 10-year single-center experience	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						all-terrain vehicle; ATV; dirt bike; helmet; traumatic brain injury; injury prevention; public health; trauma	TRAUMATIC BRAIN-INJURY; AGE-RELATED PATTERNS; CHILDREN; ATV; PREVENTION; RIDERS	OBJECTIVE All-terrain vehicle (ATV) and dirt bike crashes frequently result in traumatic brain injury. The authors performed a retrospective study to evaluate the role of helmets in the neurosurgical outcomes of pediatric patients involved in ATV and dirt bike crashes who were treated at their institution during the last decade. METHODS The authors analyzed data on all pediatric patients involved in ATV or dirt bike crashes who were evaluated at a single regional level I pediatric trauma center between 2010 and 2019. Patients were excluded if the crash occurred in a competition (n = 70) or if helmet status could not be determined (n = 18). Multivariable logistic regression was used to analyze the association of helmet status with the primary outcomes of 1) neurosurgical consultation, 2) intracranial injury (including skull fracture), and 3) moderate or severe traumatic brain injury (MSTBI) and to control for literaturebased, potentially confounding variables. RESULTS In total, 680 patients were included (230 [34%] helmeted patients and 450 [66%] unhelmeted patients). Helmeted patients were more frequently male (81% vs 66%). Drivers were more frequently helmeted (44.3%) than passengers (10.5%, p < 0.001). Head imaging was performed to evaluate 70.9% of unhelmeted patients and 48.3% of helmeted patients (p < 0.001). MSTBI (8.0% vs 1.7%, p = 0.001) and neurosurgical consultation (26.2% vs 9.1%, p < 0.001) were more frequent among unhelmeted patients. Neurosurgical injuries, including intracranial hemorrhage (16% vs 4%, p < 0.001) and skull fracture (18% vs 4%, p < 0.001), were more common in unhelmeted patients. Neurosurgical procedures were required by 2.7% of unhelmeted patients. One helmeted patient (0.4%) required placement of an intracranial pressure monitor, and no other helmeted patients required neurosurgical procedures. After adjustment for age, sex, driver status, vehicle type, and injury mechanism, helmet use significantly reduced the odds of neurosurgical consultation (OR 0.250, 95% CI 0.140-0.447, p < 0.001), intracranial injury (OR 0.172, 95% CI 0.087-0.337, p < 0.001), and MSTBI (OR 0.244, 95% CI 0.079-0.758, p = 0.015). The unadjusted absolute risk reduction provided by helmet use equated to a number-needed-to-helmet of 6 riders to prevent 1 neurosurgical consultation, 4 riders to prevent 1 intracranial injury, and 16 riders to prevent 1 MSTBI. CONCLUSIONS Helmet use remains problematically low among young ATV and dirt bike riders, especially passengers. Expanding helmet use among these children could significantly reduce the rates of intracranial injury and MSTBI, as well as the subsequent need for neurosurgical procedures. Promoting helmet use among recreational ATV and dirt bike riders must remain a priority for neurosurgeons, public health officials, and injury prevention professionals.	[Allen, Jackson H.; Vittetoe, Kelly L.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Bonfield, Christopher M.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Greeno, Amber; Ghani, Muhammad Owais Abdul; Unni, Purnima; Lovvorn, Harold N., III] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN USA		Yengo-Kahn, AM (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.	a.yengo@vumc.org			National Center for Advancing Translational Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]	REDCap, which was used for data management, is supported by a grant from the National Center for Advancing Translational Sciences/National Institutes of Health (no. UL1 TR000445) .	Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; American Academy of Orthopaedic Surgeons American Association of Orthopaedic Surgeons, 2015, POS STAT ALL TERR VE; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Brandenburg Mark A, 2005, J Okla State Med Assoc, V98, P194; Brann M, 2012, INJURY PREV, V18, P234, DOI 10.1136/injuryprev-2011-040132; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Carr AM, 2004, NEUROSURGERY, V54, P861, DOI 10.1227/01.NEU.0000114922.46342.38; DeCuypere M, 2016, J NEUROSURG-PEDIATR, V17, P595, DOI 10.3171/2015.7.PEDS15285; Denning GM, 2013, INJURY PREV, V19, P250, DOI 10.1136/injuryprev-2012-040548; Flaherty MR, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1164; Ganti Latha, 2013, Adv Prev Med, V2013, P450195, DOI 10.1155/2013/450195; Gibbs L, 1997, J La State Med Soc, V149, P276; Gorski TF, 2003, AM SURGEON, V69, P895; HARGARTEN SW, 1991, AM J EMERG MED, V9, P149, DOI 10.1016/0735-6757(91)90178-M; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helmkamp JC, 2012, PUBLIC HEALTH REP, V127, P364, DOI 10.1177/003335491212700404; Helmkamp J, 2007, PEDIATRICS, V119, P223, DOI 10.1542/peds.2006-2890; JENNETT B, 1975, LANCET, V1, P480; Jennissen CA, 2014, ANN FAM MED, V12, P310, DOI 10.1370/afm.1663; Kellum E, 2008, J PEDIATR ORTHOPED, V28, P854, DOI 10.1097/BPO.0b013e31818e198f; Kluemper C, 2010, UROLOGY, V75, P1162, DOI 10.1016/j.urology.2009.08.068; Larson AN, 2012, MED SPORT SCI, V58, P158, DOI 10.1159/000338728; Li D, 2020, CLIN PEDIATR, V59, P1141, DOI 10.1177/0009922819901011; Lister DG, 1998, J PEDIATR SURG, V33, P1081, DOI 10.1016/S0022-3468(98)90535-8; Mangano FT, 2006, J NEUROSURG, V105, P2, DOI 10.3171/ped.2006.105.1.2; Mangus RS, 2004, INJURY PREV, V10, P56, DOI 10.1136/ip.2003.002626; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; McBride AS, 2011, PEDIATR EMERG CARE, V27, P97, DOI 10.1097/PEC.0b013e31820942f8; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pomerantz WJ, 2005, PEDIATRICS, V115, P704, DOI 10.1542/peds.2004-1304; Rattan R, 2018, J TRAUMA ACUTE CARE, V84, P1017, DOI [10.1097/TA.0000000000001828, 10.1097/ta.0000000000001828]; Rivara F P, 1999, Inj Prev, V5, P194; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; Sawyer JR, 2012, J PEDIATR ORTHOPED, V32, P435, DOI 10.1097/BPO.0b013e318259f2b9; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Shults RA, 2013, PEDIATRICS, V132, P282, DOI 10.1542/peds.2013-0751; Streeter RA, 2009, ANN REPORT ATV RELAT; Topping J., 2020, 2020 REPORT DEATHS I; Towner E, 2002, HEALTH PROMOT INT, V17, P273, DOI 10.1093/heapro/17.3.273; Unni P, 2012, J TRAUMA ACUTE CARE, V73, pS277, DOI 10.1097/TA0b013e31826b00d7; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040	44	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2022	29	1					106	114		10.3171/2021.6.PEDS21225			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	YE0KC	WOS:000740820500005	34638104	Bronze			2022-02-06	
J	Alvikas, J; Zenati, M; Campwala, I; Jansen, JO; Hassoune, A; Phelos, H; Okonkwo, DO; Neal, MD				Alvikas, Jurgis; Zenati, Mazen; Campwala, Insiyah; Jansen, Jan O.; Hassoune, Adnan; Phelos, Heather; Okonkwo, David O.; Neal, Matthew D.			Rapid detection of platelet inhibition and dysfunction in traumatic brain injury: A prospective observational study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Platelet function testing; platelet transfusion; intracranial hemorrhage; brain injuries; traumatic	CLOPIDOGREL RESPONSIVENESS; INTRACRANIAL HEMORRHAGE; LABORATORY EVALUATION; ASPIRIN; ANTIPLATELET; TRANSFUSION; AGGREGOMETRY; REACTIVITY; RESISTANCE; THERAPY	BACKGROUND: Rapid platelet function testing is frequently used to determine platelet function in patients with traumatic intracranial hemorrhage (tICH). Accuracy and clinical significance of decreased platelet response detected by these tests is not well understood. We sought to determine whether VerifyNow and whole blood aggregometry (WBA) can detect poor platelet response and to elucidate its clinical signi ficance for tICH patients. METHODS: We prospectively enrolled patients with isolated tICH between 2018 and 2020. Demographics, medical history, injury characteristics, and patient outcomes were recorded. Platelet function was determined by VerifyNow and WBA testing at the time of arrival to the trauma bay and 6 hours later. RESULTS: A total of 221 patients were enrolled, including 111 patients on no antiplatelet medication, 78 on aspirin, 6 on clopidogrel, and 26 on aspirin and clopidogrel. In the trauma bay, 29.7% and 67.7% of patients on no antiplatelet medication had poor platelet response on VerifyNow and WBA, respectively. Among patients on aspirin, 72.2% and 82.2% had platelet dysfunction on VerifyNow and WBA. Among patients on clopidogrel, 67.9% and 88.9% had platelet dysfunction on VerifyNow and WBA. Patients with nonresponsive platelets had similar in-hospital mortality (3 [3.0%] vs. 6 [6.3%], p= 0.324), tICH plogiession (26 [27.1%] vs. 24 [26.1%], p = 0.877), intensive care unit admission rates (34 [34.3%] vs. 38 [40.0%), p = 0.415), and length of stay (3 [interquartile range, 2-8] vs. 3.2 [interquartile range, 2-7], p = 0.818) to those with responsive platelets. Platelet transfusion did not improve platelet response or patient outcomes. CONCLUSION: Rapid platelet function testing detects a highly prevalent poor platelet response among patients with tICH, irrespective of antiplatelet medication use. VerifyNow correlated fairly with whole blood aggregometry among patients with tICH and platelet responsiveness detectable by these tests did not correlate with clinical outcomes. In addition, our results suggest that platelet transfusion may not improve clinical outcomes in patients with tICH. Copyright (C) 2021 The Author (s). Published by Wolters Kluwer Health on behalf of the American Association for the Surgery of Trauma.	[Alvikas, Jurgis; Zenati, Mazen; Hassoune, Adnan; Phelos, Heather; Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Dept Surg, F1271-2 PUH 200 Lothrop St, Pittsburgh, PA 15213 USA; [Campwala, Insiyah] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Jansen, Jan O.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol & Nay, Pittsburgh, PA 15213 USA		Neal, MD (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, F1271-2 PUH 200 Lothrop St, Pittsburgh, PA 15213 USA.	nealm2@upmc.edu			Burroughs Wellcome FundBurroughs Wellcome Fund; Instrumentation Laboratory [R35 GM119526-04, F32 HL149207]	The University of Pittsburgh holds a Physician-Scientist Institutional Award fromthe Burroughs Wellcome Fund (J.A.). Thisworkwas supported by the following grants: Instrumentation Laboratory (PI. Matthew D. Neal, MD), R35 GM119526-04 (PI: Matthew D. Neal, MD) and F32 HL149207 (PI: Jurgis Alvikas, MD).	Alvikas J, 2020, J TRAUMA ACUTE CARE, V88, P847, DOI 10.1097/TA.0000000000002640; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Fakhry SM, 2021, J TRAUMA ACUTE CARE, V90, P215, DOI 10.1097/TA.0000000000002985; Favaloro EJ., 2017, HEMOSTASIS THROMBOSI; Gengo FM, 2008, J CLIN PHARMACOL, V48, P335, DOI 10.1177/0091270007313324; Gozal Yair M, 2017, Surg Neurol Int, V8, P48, DOI 10.4103/sni.sni_265_16; Gremmel T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129666; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Ivandic BT, 2006, CLIN CHEM, V52, P383, DOI 10.1373/clinchem.2005.059535; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; Kim CH, 2017, RADIOLOGY, V282, P542, DOI 10.1148/radiol.2016160542; Kim JT, 2015, STROKE, V46, P2534, DOI 10.1161/STROKEAHA.115.009428; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lokhandwala AM, 2021, J SURG RES, V257, P239, DOI 10.1016/j.jss.2020.07.076; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Neubauer H, 2008, THROMB HAEMOSTASIS, V99, P357, DOI 10.1160/TH07-10-0624; Nielsen HL, 2008, THROMB RES, V123, P267, DOI 10.1016/j.thromres.2008.03.023; Pamukcu B, 2007, J THROMB THROMBOLYS, V23, P213, DOI 10.1007/s11239-006-9043-2; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Sibbing D, 2008, THROMB HAEMOSTASIS, V99, P121, DOI 10.1160/TH07-07-0478; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Smock KJ, 2011, AM J HEMATOL, V86, P1032, DOI 10.1002/ajh.22112; Smock KJ, 2010, AM J HEMATOL, V85, P358, DOI 10.1002/ajh.21674; Sternberg Z, 2013, J STROKE CEREBROVASC, V22, P725, DOI 10.1016/j.jstrokecerebrovasdis.2011.11.009; Thorn S, 2019, TRANSFUSION, V59, P3536, DOI 10.1111/trf.15526; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vulliamy P, 2021, PLATELETS, V32, P295, DOI 10.1080/09537104.2020.1718633	29	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2022	92	1					167	176		10.1097/TA.0000000000003427			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	XR1JJ	WOS:000731994300031	34629458	hybrid, Green Published			2022-02-06	
J	Amo-Aparicio, J; Garcia-Garcia, J; Puigdomenech, M; Francos-Quijorna, I; Skouras, DB; Dinarello, CA; Lopez-Vales, R				Amo-Aparicio, Jesus; Garcia-Garcia, Joana; Puigdomenech, Maria; Francos-Quijorna, Isaac; Skouras, Damaris B.; Dinarello, Charles A.; Lopez-Vales, Ruben			Inhibition of the NLRP3 inflammasome by OLT1177 induces functional protection and myelin preservation after spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Inflammasome; NLRP3; Interleukin 1; Interleukin 18; OLT1177; Spinal cord injury	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MOLECULAR PLATFORM; NEUROPATHIC PAIN; ACTIVATION; IL-18; INTERLEUKIN-1; RECOVERY; DAPANSUTRILE; MECHANISMS	Spinal cord injury (SCI) leads to irreversible functional deficits due to the disruption of axons and the death of neurons and glial cells. The inflammatory response that occurs in the injured spinal cord results in tissue degeneration; thus, targeting inflammation after acute SCI is expected to ameliorate histopathological evidence indicative of damage and, consequently, reduce functional disabilities. Interleukin 1 beta (IL-113) and interleukin 18 (IL-18) are pro-inflammatory cytokines members of the IL-1 family that initiate and propagate inflammation. Here, we report that protein levels of IL-113 and IL-18 were increased in spinal cord parenchyma after SCI, but with different expression profiles. Whereas levels of IL-113 were rapidly increased reaching peak levels at 12 h after the injury, levels of IL-18 did not increase until 7 days after the injury. Since activation of the NLRP3 inflammasome is required for the processing and release of IL-113 and IL-18, we intraperitoneally administered OLT1177, a selective inhibitor of the NLRP3 inflammasome, to reduce the contribution of these cytokines to SCI. At a dose of 200 mg/kg, OLT1177 protected against neurological deficits and histological evidence of damage. OLT1177 also reduced the levels of IL-113 in the spinal cord after contusion injury and diminished the accumulation of neutrophils and macrophages at later time points. These data suggest that targeting the NLRP3 inflammasome with OLT1177 could be a novel therapeutic strategy to arrest neuroinflammation and reduce functional impairments after acute SCI in humans.	[Amo-Aparicio, Jesus; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Garcia-Garcia, Joana; Puigdomenech, Maria; Lopez-Vales, Ruben] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Ctr Invest & Biomed Red Sobre Enfermedades Neurog, Inst Neurociencies, Bellaterra 08193, Catalonia, Spain; [Francos-Quijorna, Isaac] Kings Coll London, Regenerat Grp, Wolfson Ctr AgeRelated Dis, IoPPN, London, England; [Skouras, Damaris B.] Olatec Therapeut LLC, New York, NY 10065 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen, Dept Med, Med Ctr, NL-6500 Nijmegen, Netherlands		Lopez-Vales, R (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Ctr Invest & Biomed Red Sobre Enfermedades Neurog, Inst Neurociencies, Bellaterra 08193, Catalonia, Spain.	Ruben.lopez@uab.cat					Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Amo-Aparicio Jesus, 2018, Curr Protoc Immunol, V123, pe57, DOI 10.1002/cpim.57; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Boato F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-6; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chen QL, 2021, BIOMED PHARMACOTHER, V138, DOI 10.1016/j.biopha.2021.111442; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Ciaramella A, 2014, NEUROIMMUNOMODULAT, V21, P8, DOI 10.1159/000354764; Committee Membership:, 2012, Top Spinal Cord Inj Rehabil, V18, P85, DOI 10.1310/sci1801-85; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2019, NAT REV RHEUMATOL, V15, P612, DOI 10.1038/s41584-019-0277-8; Fleischmann RM, 2003, ARTHRITIS RHEUM-US, V48, P927, DOI 10.1002/art.10870; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Hasturk AE, 2015, NEUROSCIENCES, V20, P124, DOI 10.17712/nsj.2015.2.20140483; Hou BH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2565-2; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jiang W, 2016, SPINE, V41, pE330, DOI 10.1097/BRS.0000000000001287; Jiao JH, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00037; Kluck V, 2020, LANCET RHEUMATOL, V2, pE270, DOI [10.1016/s2665-9913(20)30065-5, 10.1016/S2665-9913(20)30065-5]; Li T, 2018, INT J NEUROSCI, V128, P778, DOI 10.1080/00207454.2018.1424154; Libby P, 2007, NUTR REV, V65, pS140, DOI 10.1301/nr.2007.dec.S140-S146; Lin XL, 2019, EUR REV MED PHARMACO, V23, P1891, DOI 10.26355/eurrev_201903_17226; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu ZY, 2019, NEUROLOGY, V93, pE841, DOI 10.1212/WNL.0000000000007998; Lonnemann N, 2020, P NATL ACAD SCI USA, V117, P32145, DOI 10.1073/pnas.2009680117; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Marchetti C, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1664-2; Marchetti C, 2018, P NATL ACAD SCI USA, V115, pE1530, DOI 10.1073/pnas.1716095115; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McFarlane K, 2020, J NEUROTRAUM, V37, P1983, DOI 10.1089/neu.2019.6931; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Mori I, 2001, VIROLOGY, V287, P163, DOI 10.1006/viro.2001.1029; Muldoon LL, 2013, J CEREBR BLOOD F MET, V33, P13, DOI 10.1038/jcbfm.2012.153; Mullard A, 2019, NAT REV DRUG DISCOV, V18, P405, DOI 10.1038/d41573-019-00086-9; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pilat D, 2016, MOL CELL NEUROSCI, V71, P114, DOI 10.1016/j.mcn.2015.12.013; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Sanchez-Fernandez A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02578; Schif-Zuck S, 2005, J IMMUNOL, V174, P4307, DOI 10.4049/jimmunol.174.7.4307; Shiraishi Y, 2021, J ORTHOP SCI, V26, P487, DOI 10.1016/j.jos.2020.04.006; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Toldo S, 2019, J CARDIOVASC PHARM, V73, P215, DOI 10.1097/FJC.0000000000000658; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Walker CL, 2019, J NEUROTRAUM, V36, P1974, DOI 10.1089/neu.2018.6233; Wohlford GF, 2021, J CARDIOVASC PHARM, V77, P49, DOI 10.1097/FJC.0000000000000931; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yates AG, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02050-6; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zrzavy T, 2021, BRAIN, V144, P144, DOI 10.1093/brain/awaa360	63	0	0	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2022	347								113889	10.1016/j.expneurol.2021.113889			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WP0FA	WOS:000712817300003	34624330				2022-02-06	
J	Andrews, E; Jildeh, TR; Abbas, MJ; Lindsay-Rivera, K; Berguson, J; Okoroha, KR				Andrews, Erickson; Jildeh, Toufic R.; Abbas, Muhammad J.; Lindsay-Rivera, Kevin; Berguson, Jon; Okoroha, Kelechi R.			Concussions in the National Hockey League: Analysis of Incidence, Return to Play, and Performance	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; NHL; hockey; performance; injury	SPORT-RELATED CONCUSSION; SHORT-TERM; NHL; EPIDEMIOLOGY; INJURIES; TIME	Background: Concussion injuries are common in professional hockey; however, their effect on player performance remains unclear. Purpose: To quantify the effect of concussions on the performance of position players in the National Hockey League (NHL). Study Design: Cohort study; Level of evidence, 3. Methods: Concussion data from the NHL were collected using publicly available databases for the seasons between 2009-2010 and 2015-2016, coinciding with new NHL concussion rules. Age, body mass index, position, number of concussions during a player's NHL career, games played, and time on ice were recorded. Basic and advanced performance metrics were collected for 1 season pre- and postconcussion (short-term period) and 3 seasons before and after concussion (long-term period) to assess short- and long-term changes in performance. A control group of players without an identified concussion who competed during the study period was assembled for comparison. Wilcoxon signed rank tests were used to evaluate pre- to postconcussion data in the short- and long-term settings as well as to compare the cohorts at each time point. Results: Overall, 48 players were identified as having a concussion during the study period. Players missed 17.2 +/- 15.1 days (mean +/- standard deviation) and 7.5 +/- 6.9 games postconcussion. There were no significant differences in any metric when pre- and postconcussion intraseason performance was assessed. Athletes who were concussed demonstrated significantly deceased performance metrics (assists per 60 minutes, points per 60 minutes, Corsi percentage, and Fenwick percentage) in the 3 years after the concussion as compared with the year before injury (P < .05). However, no difference was found between the concussed group and matched control group in the short- or long-term period. Players with concussion played fewer career games (856.4 +/- 287.4 vs 725.7 +/- 215.0; P < .05) than did controls. Conclusion: A high rate of NHL players were able to return to play after a concussion injury. Players with concussion did not experience a reduction in performance metrics in the short- or long-term setting when compared with matched controls. The concussed cohort maintained a similar workload up to 3 seasons postconcussion but played in fewer career games when compared with matched controls.	[Andrews, Erickson; Jildeh, Toufic R.; Abbas, Muhammad J.; Lindsay-Rivera, Kevin; Berguson, Jon; Okoroha, Kelechi R.] Henry Ford Hosp, Detroit, MI 48202 USA; [Andrews, Erickson; Jildeh, Toufic R.; Abbas, Muhammad J.; Lindsay-Rivera, Kevin] Henry Ford Hosp, Dept Orthopaed Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Jildeh, Toufic R.] SUNY Downstate Med Ctr, Dept Orthopaed Surg, Brooklyn, NY USA; [Berguson, Jon] Mayo Clin, Rochester, MN USA		Jildeh, TR (corresponding author), Henry Ford Hosp, Dept Orthopaed Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	touficjildeh@gmail.com			Arthrex	T.R.J. has received education payments from DePuy and Pinnacle and hospitality payments from Exactech and Zimmer Biomet. K.R.O. has received grant support from Arthrex; education payments from Arthrex, Medwest, Pinnacle, and Smith & Nephew; and hospitality payments from Stryker and Wright Medical. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; BIASCA N, 1995, UNFALLCHIRURG, V98, P283; Buckley TA, 2019, J ATHL TRAINING, V54, P527, DOI 10.4085/1062-6050-200-18; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Erickson BJ, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114548831; Erickson BJ, 2014, AM J SPORT MED, V42, P536, DOI 10.1177/0363546513510890; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Jildeh TR, 2019, AM J SPORT MED, V47, P2717, DOI 10.1177/0363546519864581; Kerr ZY, 2017, NEUROL CLIN, V35, P409, DOI 10.1016/j.ncl.2017.03.001; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kuhn Andrew W, 2016, Concussion, V1, pCNC1, DOI 10.2217/cnc.15.1; Marshall NE, 2018, ARTHROSCOPY, V34, P473, DOI 10.1016/j.arthro.2017.08.298; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Parsons JT, 2018, HAND CLINIC, V158, P257, DOI 10.1016/B978-0-444-63954-7.00025-2; Patel BH, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119854199; Sabesan VJ, 2018, OPEN ACCESS J SPORTS, V9, P253, DOI 10.2147/OAJSM.S157433; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SIM FH, 1987, AM J SPORT MED, V15, P30, DOI 10.1177/036354658701500105; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	29	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN	2022	10	1							23259671211052069	10.1177/23259671211052069			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	YP2GA	WOS:000748443200001	35097141	Green Accepted			2022-02-06	
J	Arpalahti, A; Haapanen, A; Puolakkainen, T; Abio, A; Thoren, H; Snall, J				Arpalahti, A.; Haapanen, A.; Puolakkainen, T.; Abio, A.; Thoren, H.; Snall, J.			Assault-related facial fractures: does the injury mechanism matter?	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						physical abuse; maxillofacial injuries; jaw fractures; violence; traumatic brain injuries	MAXILLOFACIAL INJURIES; INTERPERSONAL VIOLENCE	This study clarified the injury characteristics and occurrence of associated injuries in patients with assault-related facial fractures. Data from 840 assault-related facial fracture patients were included; demographic factors, facial fracture type, associated injuries, alcohol use, and injury mechanisms were recorded. Assault mechanisms most often included combinations of different mechanisms (57.5%) and resulted in the victim falling (50.1%). The perpetrator was most commonly a stranger (52.5%) and acted alone (57.7%). A total of 123 patients (14.6%) had associated injuries, with the most common being traumatic brain injury. Associated injuries occurred most frequently in patients with combined fractures of the facial thirds (24.2%) and upper third fractures (42.9%). The most significant differentiating factors for associated injuries were the number of perpetrators, falling, the use of an offensive weapon, and if the events of the assault remained unknown. In adjusted logistic regression analyses, statistically significant associations with associated injuries were found for age (odds ratio (OR) 1.05, 95% confidence interval (CI) 1.03-1.07; P < 0.001), falling due to the assault (OR 2.87, 95% CI 1.49-5.50; P = 0.002), and upper third facial fractures (OR 6.93, 95% CI 2.06-23.33; P = 0.002). A single punch also caused severe injuries and should therefore not be overlooked, as this can be as dangerous as other assault mechanisms.	[Arpalahti, A.; Haapanen, A.; Puolakkainen, T.; Snall, J.] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Arpalahti, A.; Haapanen, A.; Puolakkainen, T.; Snall, J.] Helsinki Univ Hosp, Helsinki, Finland; [Abio, A.] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Injury Epidemiol & Prevent Res Grp, Turku, Finland; [Abio, A.] Univ Turku, Turku, Finland; [Abio, A.] Heidelberg Univ, Heidelberg Inst Global Hlth HIGH, Heidelberg, Germany; [Thoren, H.] Univ Turku, Inst Dent, Dept Oral & Maxillofacial Surg, Turku, Finland; [Thoren, H.] Turku Univ Hosp, Dept Oral & Maxillofacial Dis, Turku, Finland		Arpalahti, A (corresponding author), Helsinki Univ Hosp, Dept Oral & Maxillofacial Dis, FI-00029 Helsinki, Finland.	annamari.arpalahti@helsinki.fi		Arpalahti, Annamari/0000-0002-7389-9462; , Anne/0000-0002-4568-3509	Paulo Foundation; Helsinki University Hospital Fund	No funding was received for this study. J. S. was funded by the Paulo Foundation and J.S., A.A., A.H., and T.P. by the Helsinki University Hospital Fund.	Bellamy JL, 2013, J ORAL MAXIL SURG, V71, P1556, DOI 10.1016/j.joms.2013.04.007; Beogo R, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.119.3379; Boffano P, 2015, OR SURG OR MED OR PA, V119, P385, DOI 10.1016/j.oooo.2014.12.004; Chrcanovic BR, 2012, ORAL MAXILLOFAC SURG, V16, P3, DOI 10.1007/s10006-011-0280-y; Ferreira MC, 2014, DENT TRAUMATOL, V30, P15, DOI 10.1111/edt.12047; Follmar KE, 2007, J TRAUMA, V63, P831, DOI 10.1097/TA.0b013e3181492f41; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hirvikangas R, 2020, OR SURG OR MED OR PA, V130, P236, DOI 10.1016/j.oooo.2020.03.041; Kim YJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011110; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lee KH, 2007, ANZ J SURG, V77, P695, DOI 10.1111/j.1445-2197.2007.04189.x; Lee KH, 2009, J ORAL MAXIL SURG, V67, P1878, DOI 10.1016/j.joms.2009.04.117; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; Scheyerer Max J, 2015, J Trauma Manag Outcomes, V9, P4, DOI 10.1186/s13032-015-0025-2; Schreiber J, 2016, J LAW MED ETHICS, V44, P332, DOI 10.1177/1073110516654126; Thoren H, 2010, J ORAL MAXIL SURG, V68, P805, DOI 10.1016/j.joms.2009.09.057; Toivari M, 2019, J ORAL MAXIL SURG, V77, P565, DOI 10.1016/j.joms.2018.10.020; Toivari M, 2018, J ORAL MAXIL SURG, V76, P388, DOI 10.1016/j.joms.2017.09.019; Varjonen EA, 2018, J ORAL MAXIL SURG, V76, DOI 10.1016/j.joms.2018.03.035; Yamamoto K, 2019, J CRANIOFAC SURG, V30, pE312, DOI 10.1097/SCS.0000000000005306	24	0	0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JAN	2022	51	1					91	97		10.1016/j.ijom.2021.06.001			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	YG9CS	WOS:000742777700012	34175177	hybrid			2022-02-06	
J	Baracaldo-Santamaria, D; Ariza-Salamanca, DF; Corrales-Hernandez, MG; Pachon-Londono, MJ; Hernandez-Duarte, I; Calderon-Ospina, CA				Baracaldo-Santamaria, Daniela; Ariza-Salamanca, Daniel Felipe; Corrales-Hernandez, Maria Gabriela; Pachon-Londono, Maria Jose; Hernandez-Duarte, Isabella; Calderon-Ospina, Carlos-Alberto			Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside	PHARMACEUTICS			English	Article						excitotoxicity; traumatic brain injury; novel therapeutics; NMDA receptor; GABA; vitamin B12; astrocyte; calcium; oxidative stress; neuroinflammation	ACID TRANSPORTER-2 EXPRESSION; LONG-TERM DISABILITY; GLUTAMATE-RECEPTOR 5; FUNCTIONAL RECOVERY; NMDA RECEPTOR; HIPPOCAMPAL NEUROGENESIS; NERVE REGENERATION; OXIDATIVE STRESS; NEURONAL DEATH; UNITED-STATES	Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause neuronal death through mechanical forces that disrupt cell architecture, and other secondary consequences through mechanisms such as inflammation, oxidative stress, programmed cell death, and, most importantly, excitotoxicity. This review aims to provide a comprehensive understanding of the many classical and novel pathways implicated in tissue damage following TBI. We summarize the preclinical evidence of potential therapeutic interventions and describe the available clinical evaluation of novel drug targets such as vitamin B12 and ifenprodil, among others.	[Baracaldo-Santamaria, Daniela; Corrales-Hernandez, Maria Gabriela; Pachon-Londono, Maria Jose; Hernandez-Duarte, Isabella; Calderon-Ospina, Carlos-Alberto] Univ Rosario, Sch Med & Hlth Sci, Dept Biomed Sci, Pharmacol Unit, Bogota 111221, Colombia; [Ariza-Salamanca, Daniel Felipe] Univ Rosario, Sch Med & Hlth Sci, Med & Hlth Sci Educ Res Grp, Bogota 111221, Colombia; [Calderon-Ospina, Carlos-Alberto] Univ Rosario, Sch Med & Hlth Sci, Ctr Res Genet & Genom CIGGUR, GENIUROS Res Grp, Bogota 111221, Colombia		Calderon-Ospina, CA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Dept Biomed Sci, Pharmacol Unit, Bogota 111221, Colombia.; Calderon-Ospina, CA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Res Genet & Genom CIGGUR, GENIUROS Res Grp, Bogota 111221, Colombia.	daniela.baracaldo@urosario.edu.co; daniel.ariza@urosario.edu.co; maria.corrales@urosario.edu.co; mariajo.pachon@urosario.edu.co; isabella.hernandez@urosario.edu.co; carlos.calderon@urosario.edu.co	Calderon-Ospina, Carlos-Alberto/I-4037-2016	Calderon-Ospina, Carlos-Alberto/0000-0002-7305-8727; Baracaldo, Daniela/0000-0002-1285-456X			Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Adamo AM, 2010, BIOFACTORS, V36, P117, DOI 10.1002/biof.91; Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Al Bander Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207618; Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; An Y, 2011, J INFLAMM RES, V4, P11, DOI 10.2147/JIR.S15357; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Andersson U, 2018, EXPERT OPIN THER TAR, V22, P263, DOI 10.1080/14728222.2018.1439924; Arizzi MN, 2004, LIFE SCI, V74, P1001, DOI 10.1016/j.lfs.2003.07.024; Barnes SA, 2018, BIOL PSYCHIAT, V83, P955, DOI 10.1016/j.biopsych.2018.03.001; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Boothe DL, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00236; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Chen CH, 2015, J MED ULTRASOUND, V23, P104, DOI 10.1016/j.jmu.2015.02.001; Chiang VSC, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.589882; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Coomber B, 2008, SYNAPSE, V62, P746, DOI 10.1002/syn.20547; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Daglas M, 2019, CELL REP, V29, P1178, DOI 10.1016/j.celrep.2019.09.046; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; de Sousa MC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246249; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Denault J.-B., 2001, CURR PROTOC PROTEIN, V26, P21; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Dominguez MI, 2003, NEUROSCIENCE, V116, P791, DOI 10.1016/S0306-4522(02)00731-5; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; El-Far AH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103613; Fan H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01973-4; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fei MX, 2020, BIOCHEM BIOPH RES CO, V523, P361, DOI 10.1016/j.bbrc.2019.12.003; Feigin VL, 2021, JAMA NEUROL, V78, P165, DOI 10.1001/jamaneurol.2020.4152; Feng D, 2014, NEUROSCIENCE, V268, P21, DOI 10.1016/j.neuroscience.2014.02.053; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57; Ghosh S, 2020, ACS CHEM NEUROSCI, V11, P2045, DOI 10.1021/acschemneuro.0c00368; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gonzalez-Reyes RE, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00427; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo HQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11947-x; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hammond FM, 2018, PM&R, V10, P993, DOI 10.1016/j.pmrj.2018.02.010; Hanell A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.570566; Hansen KB, 2018, J GEN PHYSIOL, V150, P1081, DOI 10.1085/jgp.201812032; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Hayes CL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32366-6; Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002; Hellmich HL, 2004, NEUROSCI LETT, V355, P221, DOI 10.1016/j.neulet.2003.10.074; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hu YL, 2020, GLIA, V68, P1031, DOI 10.1002/glia.23760; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ismail H, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100943; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jankovic M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189832; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kang DW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42183-0; Kanmani TR, 2019, INDIAN J CRIT CARE M, V23, P220, DOI 10.5005/jp-journals-10071-23164; Khazdouz Maryam, 2018, Journal of Dietary Supplements, V15, P1, DOI 10.1080/19390211.2017.1304486; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kloda A, 2007, P NATL ACAD SCI USA, V104, P1540, DOI 10.1073/pnas.0609649104; Kostic M, 2013, REV NEUROSCIENCE, V24, P71, DOI 10.1515/revneuro-2012-0062; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE66, DOI 10.1097/HTR.0000000000000477; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Kyyriainen J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910555; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lamichhane S, 2018, METHODS, V149, P3, DOI 10.1016/j.ymeth.2018.04.029; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; Laurans L, 2018, NAT MED, V24, P1113, DOI 10.1038/s41591-018-0060-4; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Levenson Cathy W, 2020, Med Sci (Basel), V8, DOI 10.3390/medsci8030036; Levenson CW, 2005, NUTR REV, V63, P122, DOI 10.1111/j.1753-4887.2005.tb00130.x; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim SW, 2021, BMC NEUROSCI, V22, DOI 10.1186/s12868-021-00659-8; Liu S, 2019, NEUROTHERAPEUTICS, V16, P1320, DOI 10.1007/s13311-019-00748-x; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lucke-Wold BP, 2018, NUTR NEUROSCI, V21, P79, DOI [10.1080/1028415x.2016.1236174, 10.1080/1028415X.2016.1236174]; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maneshi MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39610; Manivannan S, 2021, NEUROPHARMACOLOGY, V183, DOI 10.1016/j.neuropharm.2020.108400; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Nakayama R, 2002, ANESTHESIOLOGY, V96, P705, DOI 10.1097/00000542-200203000-00029; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Newell-Rogers MK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207448; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ngo Vivian, 2019, Clin Pract Cases Emerg Med, V3, P16, DOI 10.5811/cpcem.2018.11.39667; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Pajarillo E, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.03.002; Palacios-Filardo J, 2019, CURR OPIN NEUROBIOL, V54, P37, DOI 10.1016/j.conb.2018.08.009; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Park JY, 2013, NEURAL REGEN RES, V8, P3401, DOI 10.3969/j.issn.1673-5374.2013.36.005; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qu WR, 2020, CEREB CORTEX, V30, P3859, DOI 10.1093/cercor/bhaa002; Raad M, 2014, NEUROSCIENCE, V281, P16, DOI 10.1016/j.neuroscience.2014.08.045; Redell JB, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113372; Rigotto G, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10082046; Villanueva JR, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12020094; Ryan KC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239153; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Saglam E, 2021, J NEUROIMMUNOL, V352, DOI 10.1016/j.jneuroim.2021.577476; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Samson AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33746; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheithauer TPM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.571731; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shakkour Z, 2021, NEUROSCIENTIST, V27, P620, DOI 10.1177/1073858420961078; Shen CY, 2020, MOLECULES, V25, DOI 10.3390/molecules25235591; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Sommer JB, 2017, EUR J NEUROSCI, V45, P238, DOI 10.1111/ejn.13483; Spritzer SD, 2015, NEUROLOGIST, V19, P61, DOI 10.1097/NRL.0000000000000001; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Sun DD, 2020, BRAIN RES, V1732, DOI 10.1016/j.brainres.2020.146682; Sun GC, 2020, BRAIN RES BULL, V162, P84, DOI 10.1016/j.brainresbull.2020.05.009; Sun HZ, 2012, ARCH MED SCI, V8, P924, DOI 10.5114/aoms.2012.31623; Suzuki K, 2017, ACTA BIOMATER, V53, P250, DOI 10.1016/j.actbio.2017.02.004; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Tamaddonfard E, 2014, Drug Res (Stuttg), V64, P470, DOI 10.1055/s-0033-1363219; Tasker RC, 2012, LANCET NEUROL, V11, P389, DOI 10.1016/S1474-4422(12)70084-4; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wang YB, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122698; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00406; Wu JC, 2020, NEUROSCIENCE, V440, P160, DOI 10.1016/j.neuroscience.2020.05.045; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu DF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0930-6; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yano T, 2001, RESUSCITATION, V50, P117, DOI 10.1016/S0300-9572(00)00369-5; Yi NX, 2019, NEURAL REGEN RES, V14, P1919, DOI 10.4103/1673-5374.259619; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang LJ, 2020, ARCH BIOCHEM BIOPHYS, V682, DOI 10.1016/j.abb.2020.108302; Zhang M, 2019, EXP THER MED, V18, P467, DOI 10.3892/etm.2019.7632; Zhang YN, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02079-1; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhao YL, 2011, ANESTH ANALG, V113, P1152, DOI 10.1213/ANE.0b013e318230b3fd; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; Zhu SJ, 2015, CURR OPIN PHARMACOL, V20, P14, DOI 10.1016/j.coph.2014.10.009	205	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4923		PHARMACEUTICS	Pharmaceutics	JAN	2022	14	1							152	10.3390/pharmaceutics14010152			26	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	YN4DV	WOS:000747211000001	35057048	gold, Green Accepted			2022-02-06	
J	Beidler, E; Bacon, CEW; Hattrup, N; Powers, C; Saitz, L; McLeod, TV				Beidler, Erica; Bacon, Cailee E. Welch; Hattrup, Nicholas; Powers, Cassidy; Saitz, Lilly; McLeod, Tamara Valovich			p Going Beyond the State Law: Investigating High School Sport-Related Concussion Protocols	JOURNAL OF ATHLETIC TRAINING			English	Article						secondary school athletics; policies and procedures; compliance; document analysis	EMERGENCY PREPAREDNESS; POSITION STATEMENT; POLICY; INJURY; MANAGEMENT; IMPLEMENTATION; EDUCATION; RATES	Context: State laws provide general guidelines for sport related concussion (SRC) management but do not comprehensively address the multiple layers of management for this complex injury. Although high schools are encouraged to develop SRC protocols that include both state law tenets and additional management practices, the execution of these protocols warrants examination. Objective: To investigate state law compliance and practice components included in high school SRC protocols and determine whether the degree of sports medicine coverage influenced protocol quality. Design: Qualitative document analysis. Setting: High school athletics. Patients or Other Participants: In total, 184 Pennsylvania high schools (24.3% of schools statewide; full-time athletic trainers [ATs] = 149, part-time ATs = 13, missing = 22) voluntarily provided copies of their protocols from the 2018- 2019 academic year. Main Outcome Measure(s): Four ATs conducted document analyses using a 67-item component analysis guide. Frequencies were computed for included protocol components related to the state law, preparticipation and prevention, recognition and assessment, and management. The difference in the total number of included components (maximum = 60) by sports medicine coverage was assessed using a Mann-Whitney U test. Results: Heterogeneity existed in the components included in the submitted protocols. Only 23.4% included all mandatory state law tenets. Immediate removal from play was noted in 67.4% of protocols, whereas only 1.6% contained prevention strategies. Return to play was addressed more frequently than return to learn (74.5% versus 32.6%). The sample had a mean of 15.5 6 9.7 total components per protocol. Schools with fulltime sports medicine coverage had more protocol components than those with part-time ATs (15 [interquartile range = 8.5-22.5] versus 6 [3-10.5] median components; U = 377.5, P , .001). Conclusions: School-level written SRC protocols were often missing components of the state law and additional best practice recommendations. Full-time sports medicine coverage in high schools is recommended to increase SRC protocol and health care quality.	[Beidler, Erica; Powers, Cassidy] Duquesne Univ, Dept Athlet Training, 600 Forbes Ave, Pittsburgh, PA 15282 USA; [Bacon, Cailee E. Welch; McLeod, Tamara Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [Bacon, Cailee E. Welch; McLeod, Tamara Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA; [Hattrup, Nicholas] Boston Univ, Athlet Training Serv, Boston, MA 02215 USA; [Saitz, Lilly] Mt Holyoke Coll, Dept Environm Studies, S Hadley, MA 01075 USA		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu			Duquesne University Undergraduate Summer Research Fellowship - Charles Henry Leach II Fund	Support for this project was provided to Lilly Saitz by the Duquesne University Undergraduate Summer Research Fellowship, which was funded by the Charles Henry Leach II Fund. We thank Ian Shadle, DPT, ATC, and Rebekah Gardiner, MS, ATC, for the time and effort they dedicated to assessing high school SRC protocols for this study. We acknowledge Tracey Covassin, PhD, ATC; Brian Vesci, DAT, ATC; Kari Best, DAT, ATC; and Greg Janik, DAT, ATC, for their external reviews and constructive feedback during the development of the assessment instrument. We also thank Jamie Carroll for his contributions to the graphic design of the figure included in this report. Lastly, we express our sincere gratitude to the Pennsylvania high schools that supported and contributed their SRC protocols to this project.	Adams WM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727262; [Anonymous], Concussion safety protocol template; [Anonymous], Interassociation consensus: diagnosis and management of sport-related concussion best practices; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Champagne AA, 2019, MED SCI SPORT EXER, V51, P2366, DOI 10.1249/MSS.0000000000002046; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Coxe KA, 2020, J ADOLESCENT HEALTH, V66, P233, DOI 10.1016/j.jadohealth.2019.08.016; Cuff SC, 2019, RES SPORTS MED, V27, P11, DOI 10.1080/15438627.2018.1502186; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; Ernst W, 2020, J ATHL TRAINING, V55, P448, DOI 10.4085/1062-6050-212-19; Feiss R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082665; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Holmes A, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00057; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Kajankova M, 2017, J SCHOOL HEALTH, V87, P409, DOI 10.1111/josh.12508; Kerr ZY, 2019, J ATHL TRAINING, V54, P749, DOI 10.4085/1062-6050-373-18; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McLeod TCV, 2019, J ATHL TRAINING, V54, P133, DOI 10.4085/1062-6050-35-18; Myers RK, 2018, CLIN PEDIATR, V57, P645, DOI 10.1177/0009922817732146; National Federation of State High School Associations (NFHS) Sports Medicine Advisory Committee (SMAC), SUGG GUID MAN CONC S; Parsons JT, 2018, HAND CLINIC, V158, P257, DOI 10.1016/B978-0-444-63954-7.00025-2; Pfaller AY, 2019, AM J SPORT MED, V47, P2294, DOI 10.1177/0363546519860120; Pierpoint Lauren A, 2018, Inj Epidemiol, V5, P29, DOI 10.1186/s40621-018-0159-6; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sanchez-Vaznaugh EV, 2012, AM J PREV MED, V42, P452, DOI 10.1016/j.amepre.2012.01.008; Scarneo-Miller SE, 2020, J ATHL TRAINING, V55, P80, DOI 10.4085/1062-6050-484-18; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schwartz MB, 2012, J SCHOOL HEALTH, V82, P262, DOI 10.1111/j.1746-1561.2012.00696.x; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sullivan L, 2020, J PUBLIC HEALTH MAN, V26, pS84, DOI 10.1097/PHH.0000000000001128; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Wallace J, 2019, HEALTH EDUC J, V78, P315, DOI 10.1177/0017896918806935; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	49	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2022	57	1					32	43		10.4085/1062-6050-0505.20			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YL7KX	WOS:000746068300004	34129675	gold			2022-02-06	
J	Bick, H; Wasfie, T; Labond, V; Hella, JR; Pearson, E; Barber, KR				Bick, Heather; Wasfie, Tarik; Labond, Virginia; Hella, Jennifer R.; Pearson, Eric; Barber, Kimberly R.			Traumatic brain injury in the elderly with high Glasgow coma scale and low injury severity scores: Factors influencing outcomes	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Injury severity score; Traumatic brain injury; Glasgow coma scale	OLDER PATIENTS; HEMATOMA; RATES; AGE	Background: Current trauma activation guidelines do not clearly address age as a risk factor when leveling trauma patients. Glasgow coma scale (GCS) and mode of injury play a major role in leveling trauma patients. We studied the above relationship in our elderly patients presenting with traumatic head injury. Methods: This study was a retrospective analysis of patients who presented to the emergency department with traumatic brain injuries. We classified the 270 patients into two groups. Group A was 64 years and younger, and group B was 65 years and older. Their GCS, ISS, age, sex, comorbidities, and anticoagulant use were abstracted. The primary outcome was mortality and length of stay. The groups were compared using an independent student's t-test and Chi-square analysis. The Cox regression analysis was used to analyze differences in the outcome while adjusting for the above factors. Results: There were 140 patients in group A, and 130 patients in group B who presented to the ED with a GCS of 14-15 and an ISS of below 15. The mean ISS significantly differed between group A (6.2 +/- 6.8) vs (7.9 +/- 3.2) in group B (p < 0.0001). The most common diagnosis in group A was concussion (57.3%), while in group B was subdural and subarachnoid hemorrhage (55%). In group B, 13.8% presented as a level one or level two trauma activation. The mean hospital and intensive care stay for group A was 2.1 (+/- 1.9) days and 0.9 (+/- 1.32) days, respectively, versus 4.2 (+/- 3.04) days and 2.4 (+/- 2.02 days) for the elderly group B. Mortality in group A was zero and in group B was 3.8%. Cox regression analysis showed age as an independent predictor of death as well as length of stay. Conclusion: Elderly traumatic brain injury patients presenting to the ED with minor trauma and high GCS should be triaged at a higher level in most cases. (c) 2021 Elsevier Inc. All rights reserved.	[Bick, Heather; Labond, Virginia; Pearson, Eric] Ascension Genesys Hosp, Emergency Dept, Grand Blanc, MI USA; [Wasfie, Tarik] Ascension Genesys Hosp, Dept Trauma Serv, Grand Blanc, MI USA; [Hella, Jennifer R.; Barber, Kimberly R.] Ascension Genesys Hosp, Dept Clin & Acad Res, Grand Blanc, MI USA		Wasfie, T (corresponding author), Ascension Genesys, 1 Genesys Pkwy, Grand Blanc, MI 48439 USA.	twasfie@gmail.com					Ahmed N, 2015, EUR J TRAUMA EMERG S, V41, P307, DOI 10.1007/s00068-014-0432-5; Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; [Anonymous], 2014, RESOURCES OPTIMAL CA, P39; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benjamin ER, 2018, J EMERG MED, V55, P278, DOI 10.1016/j.jemermed.2018.02.001; Campbell-Furtick M, 2016, AM J SURG, V212, P781, DOI 10.1016/j.amjsurg.2015.12.018; Carr BW, 2018, J TRAUMA ACUTE CARE, V85, P598, DOI 10.1097/TA.0000000000001986; Charles EJ, 2018, AM SURGEON, V84, P392; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Hachem LD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20447; Ho T, 2019, INT J SURG OPEN, V20, P20, DOI 10.1016/j.ijso.2019.09.007; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Mitchell EM, 2021, CONCENTRATION HEALTH; Moore BJ, 2020, COST EMERGENCY DEP V; Morris RS, 2020, J TRAUMA ACUTE CARE, V88, P416, DOI 10.1097/TA.0000000000002569; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Stanton MW, 2005, HIGH CONCENTRATION U; TEASDALE G, 1974, LANCET, V2, P81; Techar K, 2019, J SURG RES, V242, P4, DOI 10.1016/j.jss.2019.04.006; Uberoi N, 2012, STAT BRIEF 387 MED E; Vincent G. K., 2010, NEXT 4 DECADES OLDER; Vincent GK., 2010, NEXT 4 DECADES OLDER, P25	24	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2022	51						354	357		10.1016/j.ajem.2021.11.005			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XI3JP	WOS:000726012700015	34808458				2022-02-06	
J	Boas, SM; Joyce, KL; Cowell, RM				Boas, Stephanie M.; Joyce, Kathlene L.; Cowell, Rita M.			The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention	ANTIOXIDANTS			English	Article						transcription; antioxidant defense; central nervous system; astrocytes; KEAP1	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; NF-KAPPA-B; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; MOTOR-NEURON; RESPONSE ELEMENT	Oxidative stress has been implicated in the etiology and pathobiology of various neurodegenerative diseases. At baseline, the cells of the nervous system have the capability to regulate the genes for antioxidant defenses by engaging nuclear factor erythroid 2 (NFE2/NRF)-dependent transcriptional mechanisms, and a number of strategies have been proposed to activate these pathways to promote neuroprotection. Here, we briefly review the biology of the transcription factors of the NFE2/NRF family in the brain and provide evidence for the differential cellular localization of NFE2/NRF family members in the cells of the nervous system. We then discuss these findings in the context of the oxidative stress observed in two neurodegenerative diseases, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), and present current strategies for activating NFE2/NRF-dependent transcription. Based on the expression of the NFE2/NRF family members in restricted populations of neurons and glia, we propose that, when designing strategies to engage these pathways for neuroprotection, the relative contributions of neuronal and non-neuronal cell types to the overall oxidative state of tissue should be considered, as well as the cell types which have the greatest intrinsic capacity for producing antioxidant enzymes.	[Boas, Stephanie M.; Joyce, Kathlene L.; Cowell, Rita M.] Southern Res, Dept Neurosci, 2000 9th Ave South, Birmingham, AL 35205 USA; [Boas, Stephanie M.; Joyce, Kathlene L.; Cowell, Rita M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1720 2nd Ave South, Birmingham, AL 35294 USA		Cowell, RM (corresponding author), Southern Res, Dept Neurosci, 2000 9th Ave South, Birmingham, AL 35205 USA.; Cowell, RM (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1720 2nd Ave South, Birmingham, AL 35294 USA.	boas2@uab.edu; kjoyce@uab.edu; rcowell@southernresearch.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01 NS101958-06, 1R21 NS124209-01, 1R01 NS124037-01]	This work was supported by National Institutes of Health awards 5R01 NS101958-06 (RMC), 1R21 NS124209-01 (RMC), 1R01 NS124037-01 (RMC).	Ahlgren-Beckendorf JA, 1999, GLIA, V25, P131, DOI 10.1002/(SICI)1098-1136(19990115)25:2<131::AID-GLIA4>3.0.CO;2-6; Ahuja M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2111643118; Alam ZI, 1997, J NEUROCHEM, V69, P1326; An HY, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0658-x; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Appolinario PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125146; Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Bakkar N, 2015, MOL CELL BIOL, V35, P2385, DOI 10.1128/MCB.00087-15; Bakshi R, 2019, ANN NEUROL, V85, P593, DOI 10.1002/ana.25436; Balendra R, 2018, NAT REV NEUROL, V14, P544, DOI 10.1038/s41582-018-0047-2; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Baxter PS, 2016, FREE RADICAL BIO MED, V100, P147, DOI 10.1016/j.freeradbiomed.2016.06.027; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Bayer H, 2017, NEUROBIOL DIS, V97, P36, DOI 10.1016/j.nbd.2016.11.001; Beach TG, 2009, ACTA NEUROPATHOL, V117, P613, DOI [10.1007/s00401-009-0538-8, 10.1007/s00401-010-0664-3]; Beckers J, 2021, AUTOPHAGY, V17, P3306, DOI 10.1080/15548627.2021.1872189; Bell KFS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8066; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Berg D, 2006, NEUROTOX RES, V9, P1, DOI 10.1007/BF03033302; Bergstrom P, 2014, AMYOTROPH LAT SCL FR, V15, P130, DOI 10.3109/21678421.2013.839708; Bhakkiyalakshmi E, 2018, IMMUNITY AND INFLAMMATION IN HEALTH AND DISEASE: EMERGING ROLES OF NUTRACEUTICALS AND FUNCTIONAL FOODS IN IMMUNE SUPPORT, P149, DOI 10.1016/B978-0-12-805417-8.00012-3; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Blanco-Suarez E, 2017, J PHYSIOL-LONDON, V595, P1903, DOI 10.1113/JP270988; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Boyd SD, 2020, MOLECULES, V25, DOI 10.3390/molecules25051086; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; Brown DR, 2013, BIOCHEM SOC T, V41, P1513, DOI 10.1042/BST20130130; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao X, 2017, AGING CELL, V16, P1180, DOI 10.1111/acel.12654; Cardin JA, 2018, TRENDS NEUROSCI, V41, P689, DOI 10.1016/j.tins.2018.07.015; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Castellani RJ, 2000, ACTA NEUROPATHOL, V100, P111, DOI 10.1007/s004010050001; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Cheng KC, 2019, EBIOMEDICINE, V45, P25, DOI 10.1016/j.ebiom.2019.06.022; Cheng YJ, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6630281; Chiu CC, 2015, EXP NEUROL, V263, P244, DOI 10.1016/j.expneurol.2014.09.016; Chiu HF, 2017, PHARM BIOL, V55, P1041, DOI 10.1080/13880209.2017.1288750; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Cloer EW, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00644-17; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Cookson MR, 2017, ADV NEUROBIOL, V14, P227, DOI 10.1007/978-3-319-49969-7_12; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Corenblum MJ, 2016, AGING CELL, V15, P725, DOI 10.1111/acel.12482; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Cuadrado A, 2019, NAT REV DRUG DISCOV, V18, P295, DOI 10.1038/s41573-018-0008-x; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Daniels CML, 2012, J NEUROSCI, V32, P10507, DOI 10.1523/JNEUROSCI.1494-12.2012; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053; Jacquet AD, 2021, ELIFE, V10, DOI [10.7554/eLife.73062, 10.7554/eLife.73062.sa1, 10.7554/eLife.73062.sa2]; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; Deckl P, 2020, ACTA NEUROPATHOL, V139, P119, DOI 10.1007/s00401-019-02093-x; Deighton RF, 2014, P NATL ACAD SCI USA, V111, pE1818, DOI 10.1073/pnas.1402097111; Delcambre S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00881; Dell'Orco M, 2016, BBA-GENE REGUL MECH, V1859, P315, DOI 10.1016/j.bbagrm.2015.11.009; Deng ZQ, 2020, AUTOPHAGY, V16, P917, DOI 10.1080/15548627.2019.1644076; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1994, ANN NEUROL, V35, P38, DOI 10.1002/ana.410350107; di Domenico A, 2019, STEM CELL REP, V12, P213, DOI 10.1016/j.stemcr.2018.12.011; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dinkova-Kostova AT, 2018, FEBS J, V285, P3576, DOI 10.1111/febs.14379; Dolgacheva LP, 2019, J BIOENERG BIOMEMBR, V51, P175, DOI 10.1007/s10863-019-09798-4; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Doorn KJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0090-1; Dougherty SE, 2014, NEUROSCIENCE, V271, P137, DOI 10.1016/j.neuroscience.2014.04.023; DOUGLAS KT, 1987, ADV ENZYMOL RAMB, V59, P103; Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018; Farg MA, 2012, NEUROBIOL AGING, V33, P2855, DOI 10.1016/j.neurobiolaging.2012.02.009; Fecher C, 2019, NAT NEUROSCI, V22, P1731, DOI 10.1038/s41593-019-0479-z; Ferreira SA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00247; Ferrer I, 1999, DEMENT GERIATR COGN, V10, P55, DOI 10.1159/000051214; Filippini A, 2019, CELL MOL NEUROBIOL, V39, P161, DOI 10.1007/s10571-019-00649-9; FORNO LS, 1992, ANN NY ACAD SCI, V648, P6, DOI 10.1111/j.1749-6632.1992.tb24519.x; Foster A, 2019, MOL CELL NEUROSCI, V98, P32, DOI 10.1016/j.mcn.2019.04.001; Foster AD, 2020, MOL CELL NEUROSCI, V108, DOI 10.1016/j.mcn.2020.103539; Friedlich AL, 2007, MOL PSYCHIATR, V12, P222, DOI 10.1038/sj.mp.4001937; Galaris D, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118535; Gan F, 2020, INT J BIOL MACROMOL, V146, P18, DOI 10.1016/j.ijbiomac.2019.11.221; Garza-Lombo Carla, 2018, Current Opinion in Toxicology, V8, P102, DOI 10.1016/j.cotox.2018.05.002; Gazaryan IG, 2016, NEURAL REGEN RES, V11, P1708, DOI 10.4103/1673-5374.194706; Gergues MM, 2018, BRAIN RES, V1701, P103, DOI 10.1016/j.brainres.2018.08.033; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Gonzalez-Hunt CP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74195-6; Goode A, 2016, MOL CELL NEUROSCI, V76, P52, DOI 10.1016/j.mcn.2016.08.004; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Grosch J, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00293; Grunblatt E, 2016, J NEURAL TRANSM, V123, P83, DOI 10.1007/s00702-014-1320-1; Guerrero EN, 2019, HUM MOL GENET, V28, P2459, DOI 10.1093/hmg/ddz062; Guerrero EN, 2016, PROG NEUROBIOL, V145, P78, DOI 10.1016/j.pneurobio.2016.09.004; Guo M, 2020, BRAIN, V143, P1476, DOI 10.1093/brain/awaa090; Guo Q, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081850; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Hadano S, 2016, HUM MOL GENET, V25, P3321, DOI 10.1093/hmg/ddw180; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hare DJ, 2016, BRAIN, V139, P1026, DOI 10.1093/brain/aww022; Harlan BA, 2019, FASEB J, V33, P7084, DOI 10.1096/fj.201802752R; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hepp DH, 2016, J NEUROPATH EXP NEUR, V75, P936, DOI 10.1093/jnen/nlw070; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; HIRSCH EC, 1991, J NEUROCHEM, V56, P446, DOI 10.1111/j.1471-4159.1991.tb08170.x; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hossaini M, 2011, J NEUROPATH EXP NEUR, V70, P662, DOI 10.1097/NEN.0b013e31822581ac; Howlett EH, 2017, HUM MOL GENET, V26, P4340, DOI 10.1093/hmg/ddx320; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Hushpulian DM, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.673205; Ibrahim L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9101025; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Izrael M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00824; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; James SA, 2015, CHEM SCI, V6, P2952, DOI 10.1039/c5sc00233h; Jamilloux Y, 2018, J BIOL CHEM, V293, P12563, DOI 10.1074/jbc.RA117.000435; Jang JH, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.004; Jayaram S, 2021, NEUROCHEM INT, V145, DOI 10.1016/j.neuint.2021.105014; Jellinger KA, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 3: Q-Z, P203; Jeon GS, 2019, MOL NEUROBIOL, V56, P2007, DOI 10.1007/s12035-018-1218-2; Jimenez-Blasco D, 2015, CELL DEATH DIFFER, V22, P1877, DOI 10.1038/cdd.2015.49; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kaidery NA, 2013, ANTIOXID REDOX SIGN, V18, P139, DOI 10.1089/ars.2011.4491; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; Katsuoka F, 2016, GENE, V586, P197, DOI 10.1016/j.gene.2016.03.058; Kawaguchi Y, 2019, J NEUROPHYSIOL, V121, P2222, DOI 10.1152/jn.00778.2018; Kenna K.P., 2017, MOL CELLULAR THERAPI, P43, DOI [10.1016/B978-0-12-802257-3.00003-1, DOI 10.1016/B978-0-12-802257-3.00003-1]; Khalil B, 2017, NEURAL REGEN RES, V12, P1052, DOI 10.4103/1673-5374.211179; Khan SS, 2021, ELIFE, V10, DOI [10.5061/DRYAD.76HDR7SXX, 10.7554/eLife.67900, 10.7554/eLife.67900.sa1, 10.7554/eLife.67900.sa2]; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim S, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.107989; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Knott C, 2000, MOL CELL NEUROSCI, V16, P724, DOI 10.1006/mcne.2000.0914; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; KOHAR I, 1995, FREE RADICAL BIO MED, V19, P197, DOI 10.1016/0891-5849(95)00010-U; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Kok JR, 2021, CELL MOL LIFE SCI, V78, P5707, DOI 10.1007/s00018-021-03872-0; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Kwon MJ, 2017, PHARMACOL RES, V119, P169, DOI 10.1016/j.phrs.2017.02.003; Kwon YJ, 2020, J MED FOOD, V23, P12, DOI 10.1089/jmf.2019.4459; Lapucci A, 2017, NEUROSCI LETT, V656, P120, DOI 10.1016/j.neulet.2017.07.033; Lastres-Becker I, 2016, ANTIOXID REDOX SIGN, V25, P61, DOI 10.1089/ars.2015.6549; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li WS, 2021, J NEUROL, V268, P1351, DOI 10.1007/s00415-020-10283-x; LI Y, 1992, J BIOL CHEM, V267, P15097; LI Y, 1992, BIOCHEM BIOPH RES CO, V188, P992, DOI 10.1016/0006-291X(92)91329-O; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Lin CH, 2016, HUM MOL GENET, V25, P1965, DOI 10.1093/hmg/ddw068; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin YE, 2021, ELIFE, V10, DOI [10.7554/eLife.73753, 10.7554/eLife.73753.sa0, 10.7554/eLife.73753.sa1, 10.7554/eLife.73753.sa2]; Lingappan Krithika, 2018, Current Opinion in Toxicology, V7, P81, DOI 10.1016/j.cotox.2017.11.002; Liu PF, 2019, J BIOL CHEM, V294, P18131, DOI 10.1074/jbc.RA119.009591; Liu T, 2021, FREE RADICAL BIO MED, V168, P129, DOI 10.1016/j.freeradbiomed.2021.03.034; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Lucas EK, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00441; Lucas EK, 2014, J NEUROSCI, V34, P14375, DOI 10.1523/JNEUROSCI.1222-14.2014; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Ma D, 2010, J BIOL CHEM, V285, P39087, DOI 10.1074/jbc.M110.151688; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Maciel R, 2018, EXP NEUROL, V307, P155, DOI 10.1016/j.expneurol.2018.06.008; Manuvakhova MS, 2011, J NEUROSCI RES, V89, P58, DOI 10.1002/jnr.22526; Marchetti B, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101664; Marcus JM, 2021, NEUROCHEM INT, V148, DOI 10.1016/j.neuint.2021.105077; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Martin-Bastida A, 2021, J NEURAL TRANSM, V128, P15, DOI 10.1007/s00702-020-02271-2; Masrori P, 2020, EUR J NEUROL, V27, P1918, DOI 10.1111/ene.14393; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; McMeekin LJ, 2021, NEUROSCIENCE, V479, P70, DOI 10.1016/j.neuroscience.2021.10.007; McMeekin LJ, 2020, NEUROSCIENCE, V435, P73, DOI 10.1016/j.neuroscience.2020.03.036; McMeekin LJ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020352; McMeekin LJ, 2018, J NEUROSCI, V38, P3273, DOI 10.1523/JNEUROSCI.0848-17.2018; Meiser J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-34; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Mitsui S, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0373-8; Molodykh OP, 2020, B EXP BIOL MED+, V168, P400, DOI 10.1007/s10517-020-04718-8; Mulvaney KM, 2016, J BIOL CHEM, V291, P23719, DOI 10.1074/jbc.M116.729418; Muramatsu H, 2013, GENES CELLS, V18, P899, DOI 10.1111/gtc.12083; Murphy P, 2000, MECH DEVELOP, V97, P141, DOI 10.1016/S0925-4773(00)00413-5; Murphy TH, 2001, J NEUROCHEM, V76, P1670, DOI 10.1046/j.1471-4159.2001.00157.x; Namani A, 2019, AGING-US, V11, P12600, DOI 10.18632/aging.102590; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Nandi A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9613090; Nellessen A, 2020, METAB BRAIN DIS, V35, P353, DOI 10.1007/s11011-019-00488-z; Neymotin A, 2011, FREE RADICAL BIO MED, V51, P88, DOI 10.1016/j.freeradbiomed.2011.03.027; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Northrop A, 2020, MOL BIOL CELL, V31, P2158, DOI 10.1091/mbc.E20-04-0238; Nural H, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-23; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Olivares D, 2009, INT J MOL SCI, V10, P1226, DOI 10.3390/ijms10031226; Onodera K, 2000, EMBO J, V19, P1335, DOI 10.1093/emboj/19.6.1335; Orimo S, 2011, NEUROPATH APPL NEURO, V37, P791, DOI 10.1111/j.1365-2990.2011.01194.x; Orrell RW, 1997, J NEUROL SCI, V153, P46, DOI 10.1016/S0022-510X(97)00181-0; Orrell RW, 1999, J NEUROL SCI, V169, P56, DOI 10.1016/S0022-510X(99)00216-6; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Paisan-Ruiz C, 2013, J PARKINSON DIS, V3, P85, DOI 10.3233/JPD-130192; Pajares M, 2017, REDOX BIOL, V11, P543, DOI 10.1016/j.redox.2017.01.006; Pan PK, 2016, CELL MOL BIOL, V62, P11, DOI [10.14715/cmb/2016.62.14.2, 10.14715/cmb/ 2016.62.14.2]; Pang SYY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0165-9; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Penndorf D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183684; Pensato V, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020412; Qiu AQ, 2021, NEUROIMAGE, V224, DOI 10.1016/j.neuroimage.2020.117426; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Requardt RP, 2010, J NEUROCHEM, V115, P483, DOI 10.1111/j.1471-4159.2010.06940.x; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Robledinos-Anton N, 2017, REDOX BIOL, V13, P393, DOI 10.1016/j.redox.2017.06.010; Rojo AI, 2018, REDOX BIOL, V18, P173, DOI 10.1016/j.redox.2018.07.006; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Rose J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.536682; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenblum LT, 2017, ADV NEUROBIOL, V16, P117, DOI 10.1007/978-3-319-55769-4_6; Ross D, 2004, METHOD ENZYMOL, V382, P115; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rub U, 2002, J NEUROL S3, V249, DOI DOI 10.1007/S00415-002-1301-4; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Russo I, 2019, NEUROBIOL DIS, V129, P67, DOI 10.1016/j.nbd.2019.05.012; Salamatina A, 2020, NEUROSCIENCE, V450, P81, DOI 10.1016/j.neuroscience.2020.08.011; Sanyal A, 2020, MOVEMENT DISORD, V35, P760, DOI 10.1002/mds.27994; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schapansky J, 2015, NEUROSCIENCE, V302, P74, DOI 10.1016/j.neuroscience.2014.09.049; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; Seeley WW, 2008, CURR OPIN NEUROL, V21, P701, DOI 10.1097/WCO.0b013e3283168e2d; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shang YL, 2016, BRAIN RES, V1647, P65, DOI 10.1016/j.brainres.2016.03.036; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; Singh Francois, 2021, Elife, V10, DOI 10.7554/eLife.67604; Singh F, 2021, BIOCHEM SOC T, V49, P551, DOI 10.1042/BST20190236; Singh PK, 2020, ANNU REV CELL DEV BI, V36, P237, DOI 10.1146/annurev-cellbio-100818-125512; Skibinski G, 2017, P NATL ACAD SCI USA, V114, P1165, DOI 10.1073/pnas.1522872114; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Stavoe AKH, 2019, ANNU REV CELL DEV BI, V35, P477, DOI 10.1146/annurev-cellbio-100818-125242; Stokholm MG, 2017, LANCET NEUROL, V16, P789, DOI 10.1016/S1474-4422(17)30173-4; Streubel-Gallasch L, 2021, MOL NEUROBIOL, V58, P3119, DOI 10.1007/s12035-021-02327-8; Takanashi M, 2001, PARKINSONISM RELAT D, V7, P311, DOI 10.1016/S1353-8020(00)00050-X; Tam OH, 2019, CELL REP, V29, P1164, DOI 10.1016/j.celrep.2019.09.066; Tang MP, 2018, NEUROBIOL AGING, V63, P128, DOI 10.1016/j.neurobiolaging.2017.12.001; Tanji K, 2013, J NEUROPATH EXP NEUR, V72, P18, DOI 10.1097/NEN.0b013e31827b5713; Tank EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05049-z; Tarantini S, 2018, J GERONTOL A-BIOL, V73, P853, DOI 10.1093/gerona/glx177; Tian YP, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029638; Tolosa E, 2020, NAT REV NEUROL, V16, P97, DOI 10.1038/s41582-019-0301-2; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tremblay R, 2016, NEURON, V91, P260, DOI 10.1016/j.neuron.2016.06.033; Trist BG, 2019, AGING CELL, V18, DOI 10.1111/acel.13031; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Tsuiji H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14966-w; Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14; Tu JY, 2015, J NEUROSCI, V35, P14727, DOI 10.1523/JNEUROSCI.1304-15.2015; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/314082; Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y; Ueno M, 2018, CELL REP, V23, P1286, DOI 10.1016/j.celrep.2018.03.137; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Vaaga CE, 2014, CURR OPIN NEUROBIOL, V29, P25, DOI 10.1016/j.conb.2014.04.010; Vallee A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00745; van Muiswinkel FL, 2004, NEUROBIOL AGING, V25, P1253, DOI 10.1016/j.neurobiolaging.2003.12.010; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Venkateshappa C, 2012, NEUROCHEM RES, V37, P358, DOI 10.1007/s11064-011-0619-7; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Vernier M, 2020, GENE DEV, V34, P544, DOI 10.1101/gad.330746.119; Villamena FA, 2013, MOLECULAR BASIS OF OXIDATIVE STRESS: CHEMISTRY, MECHANISMS, AND DISEASE PATHOGENESIS, P1, DOI 10.1002/9781118355886; von Otter M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-36; Wallings RL, 2020, ELIFE, V9, DOI 10.7554/eLife.56214; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang CJ, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00265-y; Wang FM, 2014, MOL MED REP, V9, P2453, DOI 10.3892/mmr.2014.2087; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36669; Wang L, 2020, EUR J MED CHEM, V199, DOI 10.1016/j.ejmech.2020.112385; Wang XX, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8861358; Watkins J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76070-w; Wen J, 2021, NEUROPHARMACOLOGY, V182, DOI 10.1016/j.neuropharm.2020.108380; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Weyemi U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03948-9; White MA, 2018, NAT NEUROSCI, V21, P552, DOI 10.1038/s41593-018-0113-5; Wu F, 2018, J BIOMED NANOTECHNOL, V14, P1837, DOI 10.1166/jbn.2018.2638; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Wu XW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228559; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Yang R, 2016, NEUROCHEM RES, V41, P1818, DOI 10.1007/s11064-016-1897-x; Yang TT, 2013, BRAIN STRUCT FUNCT, V218, P1051, DOI 10.1007/s00429-012-0446-x; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Yu XJ, 2013, NEUROLOGY, V80, P492, DOI 10.1212/WNL.0b013e31827f0ebb; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Yunusova Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00106; Zamudio F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01952-9; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zellner S, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2021.01.009; Zhang DF, 2016, PAK J PHARM SCI, V29, P1365; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang W, 2020, SYNAPSE, V74, DOI 10.1002/syn.22174; Zhang W, 2016, NAT NEUROSCI, V19, P557, DOI 10.1038/nn.4257; Zhang YN, 2015, CELL CYCLE, V14, P2011, DOI 10.1080/15384101.2015.1044188; Zhao M, 2018, MOL CELLS, V41, P818, DOI 10.14348/molcells.2018.0243; Zhao Y, 2018, NEUROBIOL DIS, V120, P76, DOI 10.1016/j.nbd.2018.09.003; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456; Zhu ZJ, 2016, BBA-MOL BASIS DIS, V1862, P518, DOI 10.1016/j.bbadis.2016.01.002; Zweig JA, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110767	355	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	JAN	2022	11	1							8	10.3390/antiox11010008			35	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	YO2OX	WOS:000747785700001	35052512	Green Accepted, Green Published			2022-02-06	
J	Bozkurt, I; Ozturk, Y; Guney, G; Arslan, B; Gulbahar, O; Guvenc, Y; Senturk, S; Yaman, ME				Bozkurt, Ismail; Ozturk, Yasar; Guney, Guven; Arslan, Burak; Gulbahar, Ozlem; Guvenc, Yahya; Senturk, Salim; Yaman, Mesut Emre			Effects of pirfenidone on experimental head injury in rats	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Pirfenidone; traumatic brain injury; neuroprotective; anti-inflammatory; anti-oxidant	NEURON-SPECIFIC ENOLASE; PROTEIN	Traumatic brain injury (TBI) continues to be a significant public healthcare concern. Neuroinflammation that occurs in the secondary phase of TBI leads to cognitive and physical dysfunction. A number of therapeutic modalities have been evaluated in an attempt to find a suitable treatment. The only drug approved for the treatment of idiopathic pulmonary fibrosis, pirfenidone, has been evaluated for its antifibrotic, anti-inflammatory, and anti-oxidant properties for various disorders, but this is the first study to examine its effects in an experimental TBI model. Twenty-four Wistar rats were randomly divided into three groups: control, trauma, and pirfenidone. The two latter groups underwent experimental diffuse cortical injury mimicking TBI. Neurological assessment was performed using the Garcia test, histological analysis was performed to examine neuroprotective and anti-inflammatory effects, and biochemical analyses of neuron-specific enolase (NSE), S-100B, caspase-3, and thiobarbituric acid reactive substances were performed. The pirfenidone group had a better Garcia test score (P=0.001), an increased anti-inflammatory effect (P<0.001), and an enhanced neuroprotective effect (P=0.007) along with decreased NSE, S100B, and TBARS levels compared to the trauma group. However, pirfenidone did not show a beneficial effect on caspase-3 levels. Pirfenidone may help decrease mortality and morbidity rates after TBI through its anti-inflammatory and antioxidant effects.	[Bozkurt, Ismail] Cankiri State Hosp, Neurosurg Clin, Cankiri, Turkey; [Ozturk, Yasar] Yenimahalle Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Guney, Guven] Hitit Univ, Dept Pathol, Sch Med, Corum, Turkey; [Arslan, Burak; Gulbahar, Ozlem] Gazi Univ, Dept Med Biochem, Fac Med, Ankara, Turkey; [Arslan, Burak] Ercis State Hosp, Dept Med Biochem, Van, Turkey; [Guvenc, Yahya] Marmara Univ Hosp, Dept Neurosurg, Istanbul, Turkey; [Senturk, Salim] Mem Spine Ctr, Neurosurg Clin, Istanbul, Turkey; [Yaman, Mesut Emre] Gazi Univ Hosp, Dept Neurosurg, Ankara, Turkey		Bozkurt, I (corresponding author), Cankiri State Hosp, Neurosurg Clin, Cankiri, Turkey.; Bozkurt, I (corresponding author), Cankiri State Hosp, Dept Neurosurg, TR-18100 Cankiri, Turkey.	ibozkurt85@gmail.com					Carter NJ, 2011, DRUGS, V71, P1721, DOI 10.2165/11207710-000000000-00000; Castro-Torres RD, 2014, J MOL NEUROSCI, V52, P193, DOI 10.1007/s12031-013-0121-6; Dutta Deepika, 2017, Indian Journal of Physiology and Pharmacology, V61, P416; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Helbok R, 2018, HAND CLINIC, V146, P237, DOI 10.1016/B978-0-12-804279-3.00014-9; Herman ST, 2018, HDB NEUROEMERGENCY C, P189; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matute-Blanch C, 2018, HAND CLINIC, V146, P67, DOI 10.1016/B978-0-12-804279-3.00005-8; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Park SH, 2018, WORLD NEUROSURG, V118, pE534, DOI 10.1016/j.wneu.2018.06.234; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Salazar-Montes A, 2008, EUR J PHARMACOL, V595, P69, DOI 10.1016/j.ejphar.2008.06.110; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Walker JE, 2001, MULT SCLER J, V7, P305, DOI 10.1191/135245801681138004	24	0	0	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2022	15	1					20	28					9	Oncology; Pathology	Emerging Sources Citation Index (ESCI)	Oncology; Pathology	YP1FL	WOS:000748374000002					2022-02-06	
J	Brett, BL; Kerr, ZY; Aggarwal, NT; Chandran, A; Mannix, R; Walton, S; DeFreese, JD; Echemendia, RJ; Guskiewicz, KM; McCrea, MA; Meehan, WP				Brett, Benjamin L.; Kerr, Zachary Y.; Aggarwal, Neelum T.; Chandran, Avinash; Mannix, Rebekah; Walton, Samuel; DeFreese, J. D.; Echemendia, Ruben J.; Guskiewicz, Kevin M.; McCrea, Michael A.; Meehan, William P.			Cumulative Concussion and Odds of Stroke in Former National Football League Players	STROKE			English	Article						aging; cerebrovascular accident; concussion; mild traumatic brain injury; stroke; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RISK; ASSOCIATION	Background and Purpose: Postmortem and experimental studies indicate a potential association between repeated concussions and stroke risk in older contact sport athletes. We examined the relationship between concussion and stroke history in former National Football League players aged >= 50 years. Methods: Former professional football players aged >= 50 years who played >= 1 year in the National Football League were enrolled in the cross-sectional study. Indirect standardization was used to calculate overall and decade-specific standardized prevalence ratios. Logistic regression using Firth's bias reduction method examined the association between lifetime concussion history 0 (n=119; 12.2%), 1 to 2 (n=152; 15.5%), 3 to 5 (n=242; 24.7%), 6 to 9 (201; 20.5%), and 10+(n=265; 27.1%) and stroke. Adjusted odds ratios for stroke were calculated for concussion history groups, age, and coronary artery disease and/or myocardial infarction. Results: The 979 participants who met inclusion criteria had a mean age of 65.0 +/- 9.0 years (range, 50-99). The prevalence of stroke was 3.4% (n=33), significantly lower than expected based on rates of stroke in US men aged 50 and over (standardized prevalence ratio=0.56, Z= -4.56, P<0.001). Greater odds of stroke history were associated with concussion history (10+ versus 0, adjusted odds ratio [95% CI]=5.51 [1.61-28.95]), cardiovascular disease (adjusted odds ratio [95% CI]=2.24 [1.01-4.77]), and age (1-year-increase adjusted odds ratio [95% CI]=1.07 [1.02-1.11]). Conclusions: The prevalence of stroke among former National Football League players aged >= 50 years was lower than the general population, with significantly increased risk among those with 10 or more prior concussions. Findings add to the evidence suggesting that traumatic brain injuries are associated with increased risk of stroke. Clinically, management of cardio- and cerebrovascular health may be pertinent to those with a history of multiple prior concussions.	[Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Wauwatosa, WI USA; [Kerr, Zachary Y.; Chandran, Avinash; Walton, Samuel; DeFreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Aggarwal, Neelum T.] Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Chandran, Avinash] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Mannix, Rebekah; Meehan, William P.] Boston Childrens Hosp, Boston, MA USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates Inc, State Coll, PA USA		Brett, BL (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	bbrett@mcw.edu		Walton, Samuel/0000-0003-2647-5701; Brett, Benjamin/0000-0003-2849-4658; Kerr, Zachary/0000-0003-1423-1259; Chandran, Avinash/0000-0002-2949-3668; Echemendia, Ruben/0000-0001-6116-8462	National Football League; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG073528-01]	This article was funded by the National Football League and supported by the National Institute on Aging (K23AG073528-01).	Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Brett BL, 2021, J NEUROL NEUROSUR PS, V92, P282, DOI 10.1136/jnnp-2020-324244; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Ghaznawi R, 2021, NEUROLOGY, V96, pE2172, DOI 10.1212/WNL.0000000000011827; Koton S, 2020, STROKE, V51, P3264, DOI 10.1161/STROKEAHA.120.030063; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; National Center for Health Statistics, NATL HLTH INTERVIEW; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350	9	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2022	53	1					E5	E8		10.1161/STROKEAHA.121.035607			4	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	XT2RW	WOS:000733442300004	34839696	Bronze			2022-02-06	
J	Brooks, JC; Shavelle, RM; Strauss, DJ; Hammond, FM; Harrison-Felix, CL				Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.; Hammond, Flora M.; Harrison-Felix, Cynthia L.			Life Expectancy of 1-Year Survivors of Traumatic Brain Injury, 1988-2019: Updated Results From the TBI Model Systems	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Life expectancy; Rehabilitation; Survival; Traumatic brain injuries	LONG-TERM SURVIVAL; MORTALITY	YY Objective: To update the life expectancy estimates according to age, sex, mobility, and feeding skills reported in the 2015 study of Brooks et al. To examine trends in survival over the past decade. Design: Observational cohort study. Setting: Poisson regression and life table analysis applied to long-term follow-up data on United States (US) Traumatic Brain Injury (TBI) Model Systems patients recorded in the national database. Functional mobility and feeding skills were assessed with FIM. Participants: A total of 14,803 persons with TBI during the years 1988-2019 who underwent inpatient rehabilitation and provided at least 1 long-term assessment of functional skills 1 year or more postinjury (N=14,803). Interventions: Not applicable. Main Outcome Measures: Survival, mortality rates, and life expectancy. Results: Life expectancy was lower than that of the age-and sex-matched general population. Older age and severity of functional impairments were risk factors for mortality (both P<.0001 in regression models). Among ambulatory individuals, mortality was 51% (95% confidence interval, 35%-69%) higher in men than women. Life expectancy of 20-year-old women who walked well (FIM ambulation score 7) was 55 (SE=0.8) additional years to age 75, representing a reduction of 6.9 years from the normal general population figure. For 20-year-old men who walked well, the life expectancy was 49 (SE=0.5) additional years, representing a reduction of 8.1 years from normal. Life expectancies for men and women who did not walk and were fed by others were much lower. There was no significant change in mortality rates during the study period (hazard ratio, 1.008; P=.07). Conclusions: There has been no significant change in the long-term survival of persons with TBI in the US since the late 1980s. The life expectancies reported here are similar to those reported in the 2015 study of Brooks et al, although they are more precise because of the larger sample size and longer follow-up. (C) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.] Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA; [Hammond, Flora M.] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Harrison-Felix, Cynthia L.] Craig Hosp, Englewood, CO USA; [Harrison-Felix, Cynthia L.] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA		Brooks, JC (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.	Brooks@LifeExpectancy.org			National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education	The Traumatic Brain Injury (TBI) Model Systems National Database is a multicenter study of the TBI Model Systems Centers Program and is supported by the National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDRR, or the US Department of Education.	Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P994, DOI 10.1016/j.apmr.2015.02.003; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Groswasser Z, 2018, BRAIN INJURY, V32, P149, DOI 10.1080/02699052.2017.1379614; Ulfarsson T, 2014, BRAIN INJURY, V28, P1675, DOI 10.3109/02699052.2014.947625; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	10	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2022	103	1					176	179		10.1016/j.apmr.2021.05.015			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XW1IJ	WOS:000735381500020	34462114				2022-02-06	
J	Bruijel, J; Quaedflieg, CWEM; Otto, T; van de Ven, V; Stapert, SZ; van Heugten, C; Vermeeren, A				Bruijel, J.; Quaedflieg, C. W. E. M.; Otto, T.; van de Ven, V.; Stapert, S. Z.; van Heugten, C.; Vermeeren, A.			Task-induced subjective fatigue and resting-state striatal connectivity following traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury (TBI); Fatigue; Resting-state fMRI; Functional connectivity; Striatum; Default mode network (DMN)	DEFAULT-MODE NETWORK; ATTENTION DEFICITS; COGNITIVE FATIGUE; SEVERITY; SLEEP; SCALE	Background: People with traumatic brain injury (TBI) often experience fatigue, but an understanding of the neural underpinnings of fatigue following TBI is still lacking. This study used resting-state functional magnetic resonance imaging (rs-fMRI) to examine associations between functional connectivity (FC) changes and task induced changes in subjective fatigue in people with moderate-severe TBI. Methods: Sixteen people with moderate-severe TBI and 17 matched healthy controls (HC) performed an adaptive N-back task (working memory task) to induce cognitive fatigue. Before and after the task they rated their state fatigue level and underwent rs-fMRI. Seed-to-voxel analyses with seeds in areas involved in cognitive fatigue, namely the striatum and default mode network (DMN) including, medial prefrontal cortex and posterior cingulate cortex, were performed Results: The adaptive N-back task was effective in inducing fatigue in both groups. Subjective task-induced fatigue was positively associated with FC between striatum and precuneus in people with TBI, while there was a negative association in HC. In contrast, subjective task-induced fatigue was negatively associated with FC between striatum and cerebellum in the TBI group, while there was no association in HC. Similar associations between task-induced subjective fatigue and DMN FC were found across the groups. Conclusions: Our results suggest that the subjective experience of fatigue was linked to DMN connectivity in both groups and was differently associated with striatal connectivity in people with moderate-severe TBI compared to HC. Defining fatigue-induced neuronal network changes is pertinent to the development of treatments that target abnormal neuronal activity after TBI.	[Bruijel, J.; Quaedflieg, C. W. E. M.; Stapert, S. Z.; van Heugten, C.; Vermeeren, A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Bruijel, J.; Stapert, S. Z.; van Heugten, C.] Limburg Brain Injury Ctr, Limburg, Netherlands; [Otto, T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Work & Social Psychol, Maastricht, Netherlands; [van de Ven, V.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Stapert, S. Z.] Zuyderland Med Ctr, Dept Med Psychol, Sittard Geleen, Netherlands; [van Heugten, C.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol,Med Ctr, Maastricht, Netherlands		Bruijel, J (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	jessica.bruijel@maastrichuniversity.nl		Bruijel, Jessica/0000-0002-2656-5152	Maastricht University	The study described in this manuscript was funded by Maastricht University. The study protocol and results were presented at the Dutch Neuroscience Meeting in June 2021, an online meeting. We would like to thank Anouk Broers and Britt Fleischeuer for help with the data collection, and Lisbeth Evers for help with designing the experiment.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Beaulieu-Bonneau Simon, 2017, Neuropsychol Rehabil, V27, P983, DOI 10.1080/09602011.2016.1162176; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Bittencourt-Villalpando M, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102534; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bostan Andreea C, 2018, Nat Rev Neurosci, V19, P338, DOI 10.1038/s41583-018-0002-7; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Buysse D J, 1989, Psychiatry Res, V28, P193; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chen MH, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10110930; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Clemens B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40180; Daniel R, 2014, NEUROBIOL LEARN MEM, V114, P90, DOI 10.1016/j.nlm.2014.05.002; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; de Souza NL, 2020, BRAIN INJURY, V34, P1646, DOI 10.1080/02699052.2020.1832257; Dobryakova E, 2020, CORTEX, V126, P16, DOI 10.1016/j.cortex.2020.01.003; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Esposito F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094222; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K. J., 1994, HUMAN BRAIN MAPPING, V1, P210; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Grigg O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013311; Hampson JP, 2015, NEUROIMAGE-CLIN, V8, P305, DOI 10.1016/j.nicl.2015.04.022; Hogestol EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210375; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Johansson B., 2014, TRAUMATIC BRAIN INJU, DOI [10.5772/57311, DOI 10.5772/57311]; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Klein-Flugge MC, 2016, J NEUROSCI, V36, P10002, DOI 10.1523/JNEUROSCI.0292-16.2016; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lamichhane B, 2020, NEUROIMAGE, V212, DOI 10.1016/j.neuroimage.2020.116683; Mak LE, 2017, BRAIN CONNECT, V7, P25, DOI 10.1089/brain.2016.0438; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Massar SAA, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00843; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Moller MC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00496; Muller T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24927-7; Muller T, 2019, NEUROPSYCHOLOGIA, V123, P141, DOI 10.1016/j.neuropsychologia.2018.04.030; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pierce JE, 2020, SOC COGN AFFECT NEUR, V15, P599, DOI 10.1093/scan/nsaa076; Pinheiro JC, 2020, nlme: Linear and Nonlinear Mixed Effects Models_. R package version 31-151; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; R Development Core Team, 2012, R LANG ENV STAT COMP; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Vassena E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091008; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4]; Widyanti A, 2013, INT J IND ERGONOM, V43, P70, DOI 10.1016/j.ergon.2012.11.003; Wylie GR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78768-3; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zijlstra F.R.H., 1995, EFFICIENCY WORK BEHA	68	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2022	33								102936	10.1016/j.nicl.2022.102936			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YI8FV	WOS:000744079400004	35007852	gold, Green Published			2022-02-06	
J	Burns, J; Rohl, S; Marth, D; Proctor, D; Amin, R; Sekhon, C				Burns, James; Rohl, Stephen; Marth, Daniel; Proctor, Drexel; Amin, Raid; Sekhon, Carol			Which Clinical Features of Children on Initial Presentation to the Emergency Department With Head Injury Are Associated With Clinically Important Traumatic Brain Injury, Classification as Abuse, and Poor Prognosis?	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; abusive head trauma; prognosis; mechanism of head trauma	YOUNG-CHILDREN; RETINAL HEMORRHAGES; HISTORY	Background Pediatric traumatic brain injury (TBI) and abusive head trauma (AHT) are leading causes of morbidity and mortality. Clinicians may not be aware of AHT at presentation to the emergency department (ED). Objective The objective of this study was to determine which clinical features associated with head injury in children on initial presentation to the ED trauma bay predict 3 outcomes including clinically important TBI (CiTBI), classification as confirmed abuse by Child Protection Team (CPT), and poor neurologic status on hospital discharge. Participants and Setting Inclusion for this study were children 3 years or younger, presenting to the ED with significant TBI. In addition, presentations where the mechanism of injury was not verifiable such as with falls, being struck by object, or no mechanism of injury reported by caregiver were included. Methods Researchers used 3 sources of information for this analysis: a regional trauma registry, hospital records, and the CPT database. Clinical features included demographics, mechanisms of injury, physical, radiological findings, and CPT classification. Results On pairwise analysis, seizures, apnea, and no mechanism of injury reported by caregiver were the only clinical features related to all 3 outcomes (P < 0.001). Rib fractures (relative risk [RR], 3.3; P < 0.001), long bone fractures (RR, 3.1; P < 0.001), retinal hemorrhages (RR, 3.0; P < 0.001), seizures (RR, 3.6; P < 0.001), apnea (RR, 4.4; P < 0.001), and younger than 6 months (RR, 1.8; P < 0.001) were related to AHT. On multivariable logistic regression, no mechanism of injury reported by caregiver and seizures remained significantly related to CiTBI; seizures and retinal hemorrhage remained significantly related to classification as abuse by CPT, and no mechanism of injury by the caregiver, apnea, and seizures were significantly related to poor outcome on hospital discharge. Conclusions No mechanism of injury reported by the caregiver, seizures, and apnea at the time of presentation to the ED are important features associated with CiTBI, classification as AHT, and poor prognosis. In addition, younger age, retinal hemorrhage, rib, and long bone fractures were found to be important clinical features associated with AHT.	[Burns, James; Rohl, Stephen; Marth, Daniel; Proctor, Drexel; Amin, Raid; Sekhon, Carol] Studer Family Childrens Hosp Ascens Sacred Heart, Pediat Trauma Res Team, Pensacola, FL USA		Burns, J (corresponding author), Univ Florida, 5153 North Ninth Ave, Pensacola, FL 32504 USA.	james.burns@ufl.edu					Amagasa S, 2016, AM J EMERG MED, V34, P1863, DOI 10.1016/j.ajem.2016.06.085; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Cowley LE, 2015, PEDIATRICS, V136, P290, DOI 10.1542/peds.2014-3993; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Hansen JB, 2018, PEDIATR EMERG CARE, V34, P665, DOI 10.1097/PEC.0000000000001605; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; John SM, 2013, J TRAUMA ACUTE CARE, V74, P276, DOI 10.1097/TA.0b013e318270d82e; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Narang SK, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0203; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	21	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E254	E258		10.1097/PEC.0000000000002239			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600065	32925700				2022-02-06	
J	Cacolice, PA; Ebbs, CM				Cacolice, Paul A.; Ebbs, Corinne M.			Therapy Dog Intervention Decreases Stress and Increases Arousal in College Students	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						canine; undergraduate; wellness; mental health	DEPRESSION; CONCUSSION; SYMPTOMS	Clinical Question: What is the effect of CT intervention on the stress and arousal levels of undergraduate students? Clinical Bottom Line: There is Level A-B evidence showing that the use of therapy dogs decreases stress and elevates arousal in female undergraduate students, with little evidence available for other populations.	[Cacolice, Paul A.] Westfield State Univ, Athlet Training Program, Westfield, MA 01086 USA; [Ebbs, Corinne M.] Westfield State Univ, Ely Lib, Westfield, MA 01086 USA		Cacolice, PA (corresponding author), Westfield State Univ, Athlet Training Program, Westfield, MA 01086 USA.	pcacolice@westfield.ma.edu					[Anonymous], 2017, TABERS MED DICT, V23rd, P2249; [Anonymous], 2017, THENEWS OBSERVE 0602; [Anonymous], 2005, MCGRAW HILL CONCISE; [Anonymous], 2007, STROBE STAT; [Anonymous], 2015, BARKPOST 0611; Arousal, 2017, TABERS MED DICT, V23rd, P173; Bahniuk C., 2019, MEET 5 PUPPIES WORKI; Capatides C., 2017, UNC BASEBALL INTRO T; CEBM, 2011, OCEBM LEVELS EVIDENC; Crump C, 2015, N AM J PSYCHOL, V17, P575; Delgado C, 2018, NURS EDUC, V43, P149, DOI 10.1097/NNE.0000000000000451; Fiocco AJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070707; Gouttebarge V, 2019, BRIT J SPORT MED, V53, P700, DOI 10.1136/bjsports-2019-100671; Zafra-Tanaka JH, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-2009-z; Portney L.G., 2009, FDN CLIN RES APPL PR; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Scott J, 2019, ATHLETIC BUSINESS; Training & Conditioning, 2019, TRAINING CONDITIONIN; Triathlete, 2017, ATHLETES ARE USING D; Ward-Griffin E, 2018, STRESS HEALTH, V34, P468, DOI 10.1002/smi.2804; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Wood E, 2018, J MENT HEALTH, V27, P263, DOI 10.1080/09638237.2017.1385737; WWLP, 2020, DOG THER HELP STUD W; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013	25	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JAN	2022	27	1					1	5		10.1123/ijatt.2020-0108			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	YB1IS	WOS:000738775300001					2022-02-06	
J	Campbell, M; Zagel, AL; Ortega, H; Kreykes, N; Tu, A; Linabery, AM; Plasencia, L; Krause, E; Bergmann, KR				Campbell, Maryellen; Zagel, Alicia L.; Ortega, Henry; Kreykes, Nathan; Tu, Albert; Linabery, Amy M.; Plasencia, Laura; Krause, Ernest; Bergmann, Kelly R.			Quality Indicators for Children With Traumatic Brain Injury After Transition to an American College of Surgeons Level I Pediatric Trauma Center	PEDIATRIC EMERGENCY CARE			English	Article						traumatic brain injury; intracranial injury; trauma; trauma center	COMPUTED-TOMOGRAPHY; MORTALITY; OUTCOMES; ASSOCIATION; IMPACT; ADULT	Objective The aim of the study was to compare quality indicators, including frequency of acute surgical and emergent interventions, and resource utilization before and after American College of Surgeons (ACS) level I trauma verification among children with moderate or severe traumatic brain injury (TBI). Methods This is a retrospective review of patients younger than 18 years treated for moderate or severe TBI, as determined by International Classification of Disease codes. Our institution obtained ACS level I trauma verification in 2013. Outcomes during the pre-ACS (June 2003-May 2008), interim (June 2008-May 2013), and post-ACS (June 2013-May 2018) periods were compared via nonparametric tests. Tests for linear trend were conducted using Cochran-Armitage tests for categorical data and by linear regression for continuous variables. Results There were 677 children with moderate or severe TBIs (pre-ACS, 125; interim, 198; post-ACS, 354). Frequency of any surgical intervention increased significantly in the post-ACS period (12.2%) compared with interim (5.1%) and pre-ACS periods (5.6%, P = 0.007). More children in the post-ACS period required intracranial pressure monitoring (P = 0.017), external ventricular drain placement (P = 0.003), or endotracheal intubation (P = 0.001) compared with interim and pre-ACS periods. There was no significant change in time to operating room (P = 0.514), frequency of decompression (P = 0.096), or time to decompression (P = 0.788) between study periods. The median time to head CT decreased significantly in the post-ACS period (26 minutes; interquartile range [IQR], 9-60) compared with interim (36 minutes; IQR, 21-69) and pre-ACS periods (53 minutes; IQR, 36-89; P < 0.001). Frequency of repeat head computed tomography decreased significantly in the post-ACS period (30.2%) compared with interim (56.1%) and pre-ACS periods (64.0%, P-trend = 0.044). Conclusions Transition to an ACS level I trauma verification was associated with improvements in quality indicators for children with moderate or severe TBI.	[Campbell, Maryellen] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Zagel, Alicia L.; Linabery, Amy M.] Childrens Minnesota Res Inst, Minneapolis, MN USA; [Ortega, Henry; Krause, Ernest; Bergmann, Kelly R.] Childrens Minnesota, Dept Emergency Med, 2525 Chicago Ave S,Mail Stop 32-1488, Minneapolis, MN 55404 USA; [Kreykes, Nathan; Plasencia, Laura] Childrens Minnesota, Trauma Serv, Minneapolis, MN 55404 USA; [Tu, Albert] Childrens Hosp Eastern Ontario, Div Pediat Neurosurg, Ottawa, ON, Canada; [Linabery, Amy M.] Childrens Minnesota, Neurosci Inst, Minneapolis, MN 55404 USA		Bergmann, KR (corresponding author), Childrens Minnesota, Dept Emergency Med, 2525 Chicago Ave S,Mail Stop 32-1488, Minneapolis, MN 55404 USA.	Kelly.Bergmann@childrensmn.org		Tu, Albert/0000-0002-8238-9202; Zagel, Alicia/0000-0002-9168-1862			Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; American College of Surgeons, 2014, RESOURCES OPTIMAL CA, V6; Bardes JM, 2018, J PEDIATR SURG, V53, P1523, DOI 10.1016/j.jpedsurg.2017.09.017; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Centers for Disease Control and Prevention, 2017, MAN TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2020, NATL HLTH STAT REPOR; Centers for Disease Control and Prevention. National Center for Health Statistics, 2007, INJURY US 2007 CHART; Chalouhi N, 2020, NEUROSURGERY, V86, P107, DOI 10.1093/neuros/nyy634; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Coon E, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2137; Doolin EJ, 1999, J PEDIATR SURG, V34, P885, DOI 10.1016/S0022-3468(99)90392-5; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Flaherty BF, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0385; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P308, DOI 10.1001/archsurg.2011.1327; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Healthcare Cost and Utilization Project, 2020, CHRON COND IND; Howe J, 2014, J TRAUMA ACUTE CARE, V76, P292, DOI 10.1097/TA.0000000000000119; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Michelson KA, 2017, EMERG MED J, V34, P8, DOI 10.1136/emermed-2016-205989; Mowery NT, 2011, J TRAUMA, V70, P1317, DOI 10.1097/TA.0b013e3182175199; Myers SR, 2019, PEDIATR EMERG CARE, V35, P1, DOI 10.1097/PEC.0000000000000902; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Reisner A, 2018, J NEUROSURG-PEDIATR, V22, P165, DOI 10.3171/2018.2.PEDS17562; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Simpson Amelia J, 2012, Int J Crit Illn Inj Sci, V2, P149, DOI 10.4103/2229-5151.100893; Smith DC, 2011, J EMERG MED, V41, P90, DOI 10.1016/j.jemermed.2009.11.003; Stelfox HT, 2010, CRIT CARE MED, V38, P1187, DOI 10.1097/CCM.0b013e3181d455fe; Stylianos S, 2007, J TRAUMA, V63, pS96, DOI 10.1097/TA.0b013e31815acc42; Tang OY, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19486; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vernon DD, 1999, PEDIATRICS, V103, P20, DOI 10.1542/peds.103.1.20; Walther AE, 2014, J TRAUMA ACUTE CARE, V77, P109, DOI 10.1097/TA.0000000000000277; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805	39	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E329	E336		10.1097/PEC.0000000000002276			8	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600080	33109937				2022-02-06	
J	Castellani, GB; Miccoli, G; Cava, FC; Salucci, P; Colombo, V; Maietti, E; Palandri, G				Castellani, Giovanna B.; Miccoli, Giovanni; Cava, Francesca C.; Salucci, Pamela; Colombo, Valentina; Maietti, Elisa; Palandri, Giorgio			From Shunt to Recovery: A Multidisciplinary Approach to Hydrocephalus Treatment in Severe Acquired Brain Injury Rehabilitation	BRAIN SCIENCES			English	Article						rehabilitation outcome; brain injuries; hydrocephalus; ventriculoperitoneal shunt; cerebrospinal fluid	DISABILITY RATING-SCALE; POSTTRAUMATIC HYDROCEPHALUS; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; INPATIENT REHABILITATION; IMPLANTATION; COMPENSATION; DISORDERS; OUTCOMES; VALVE	Background: Hydrocephalus among Severe Acquired Brain Injury (SABI) patients remains overlooked during rehabilitation. Methods: A retrospective cohort study was carried out of traumatic and non-traumatic SABI patients with hydrocephalus, consecutively admitted over 9 years in a tertiary referral specialized rehabilitation hospital. Patients were treated with ventriculoperitoneal shunt before or during inpatient rehabilitation and assessed using the Level of Cognitive Functioning Scale and Disability Rating Scale. Logistic regression models were used to identify predictors of post-surgical complications. Linear regression models were used to investigate predictors of hospital length of stay (LOS), disability, and cognitive function. Results: Of the 82 patients, 15 had post-surgical complications and 16 underwent cranioplasty. Shunt placement complication risk was higher when fixed vs. when programmable pressure valves were used. A total of 56.3% achieved functional improvement at discharge and 88.7% improved in cognitive function; of the 82 patients, 56% were discharged home. In multiple regression analyses, higher disability at discharge was related to cranioplasty and longer LOS, while poorer cognitive function was associated with cranioplasty. Increase in LOS was associated with increasing time to shunt and decreasing age. Conclusions: A significant improvement in cognitive and functional outcomes can be achieved. Cranioplasty increased LOS, and fixed pressure valves were related to poorer outcomes.	[Castellani, Giovanna B.; Cava, Francesca C.; Salucci, Pamela; Colombo, Valentina] Montecatone Rehabil Inst, I-40026 Bologna, Italy; [Miccoli, Giovanni] Univ Napoli Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Div Neurosurg, I-80138 Naples, Italy; [Maietti, Elisa] Univ Bologna, Dept Biomed & Neuromotor Sci, Alma Mater Studiorum, I-40126 Bologna, Italy; [Palandri, Giorgio] Bellaria Hosp, Inst Neurol Sci Bologna IRCCS, Dept Neurosurg, I-40139 Bologna, Italy		Castellani, GB (corresponding author), Montecatone Rehabil Inst, I-40026 Bologna, Italy.	giovanna.castellani@montecatone.com; gmiccoli9013@gmail.com; francesca.cava@montecatone.com; pamela.salucci@montecatone.com; valentina.colombo@montecatone.com; elisa.maietti2@unibo.it; giopalandri@gmail.com		Castellani, Giovanna Barbara/0000-0001-6099-3874; Palandri, Giorgio/0000-0002-9306-0242			Bendel P, 2010, AM J NEURORADIOL, V31, P370, DOI 10.3174/ajnr.A1804; BLACK PM, 1994, NEUROSURGERY, V34, P1110, DOI 10.1227/00006123-199406000-00040; Bonow RH, 2018, NEUROSURGERY, V83, P732, DOI 10.1093/neuros/nyx470; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Chen KH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017568; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P49, DOI 10.1016/j.clineuro.2012.04.012; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; Dehdashti AR, 2004, J NEUROSURG, V101, P402, DOI 10.3171/jns.2004.101.3.0402; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Flannery J, 2001, J Neurosci Nurs, V33, P50; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Galeoto G, 2020, ANN IG MED PREV COMU, V32, P16, DOI 10.7416/ai.2020.2326; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Grabljevec K, 2018, EUR J PHYS REHAB MED, V54, P971, DOI 10.23736/S1973-9087.18.05502-8; Guyot LL, 2000, NEUROL RES, V22, P25; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Huang X, 2014, J CRANIOFAC SURG, V25, P1280, DOI 10.1097/SCS.0000000000000583; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kim Ho Soo, 2015, Korean J Neurotrauma, V11, P58, DOI 10.13004/kjnt.2015.11.2.58; Kowalsky RJ, 2018, J PHYS ACT HEALTH, V15, P788, DOI [10.1123/jpah.2017-0639, 10.3171/2017.7.JNS17555]; Lalou AD, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00184-6; Li G, 2008, BRAIN INJURY, V22, P333, DOI 10.1080/02699050801958353; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Miyake H, 2000, J NEUROSURG, V92, P181, DOI 10.3171/jns.2000.92.1.0181; Qian C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005140; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Rossato E, 2021, NEUROL SCI, V42, P2747, DOI 10.1007/s10072-020-04852-1; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tribl G, 2000, BRAIN INJURY, V14, P345; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang YD, 2020, J INTEGR NEUROSCI, V19, P31, DOI 10.31083/j.jin.2020.01.1231; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Williams MW, 2017, REHABIL PSYCHOL, V62, P407, DOI 10.1037/rep0000168	45	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2022	12	1							3	10.3390/brainsci12010003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YL8SD	WOS:000746156300001	35053746	Green Published, Green Accepted			2022-02-06	
J	Chai, WN; Wu, YF; Wu, ZM; Xie, YF; Shi, QH; Dan, W; Zhan, Y; Zhong, JJ; Tang, W; Sun, XCA; Jiang, L				Chai, Wei-Na; Wu, Yi-Fan; Wu, Zhi-Min; Xie, Yan-Feng; Shi, Quan-Hong; Dan, Wei; Zhan, Yan; Zhong, Jian-Jun; Tang, Wei; Sun, Xiao-Chuan; Jiang, Li			Neat1 decreases neuronal apoptosis after oxygen and glucose deprivation	NEURAL REGENERATION RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; LONG NONCODING RNA; STRESS-INDUCED APOPTOSIS; ALTERED EXPRESSION; CASPASE-2; TRANSCRIPT; PROTEIN; MODEL	Studies have shown that downregulation of nuclear-enriched autosomal transcript 1 (Neat1) may adversely affect the recovery of nerve function and the increased loss of hippocampal neurons in mice. Whether Neat1 has protective or inhibitory effects on neuronal cell apoptosis after secondary brain injury remains unclear. Therefore, the effects of Neat1 on neuronal apoptosis were observed. C57BL/6 primary neurons were obtained from the cortices of newborn mice and cultured in vitro, and an oxygen and glucose deprivation cell model was established to simulate the secondary brain injury that occurs after traumatic brain injury in vitro. The level of Neat1 expression in neuronal cells was regulated by constructing a recombinant adenovirus to infect neurons, and the effects of Neat1 expression on neuronal apoptosis after oxygen and glucose deprivation were observed. The experiment was divided into four groups: the control group, without any treatment, received normal culture; the oxygen and glucose deprivation group were subjected to the oxygen and glucose deprivation model protocol; the Neat1 overexpression and Neat1 downregulation groups were treated with Neat1 expression intervention techniques and were subjected to the in oxygen and glucose deprivation protocol. The protein expression levels of neurons p53-induced death domain protein 1 (PIDD1, a pro-apoptotic protein), caspase-2 (an apoptotic priming protein), cytochrome C (a pro-apoptotic protein), and cleaved caspase-3 (an apoptotic executive protein) were measured in each group using the western blot assay. To observe changes in the intracellular distribution of cytochrome C, the expression levels of cytochrome C in the cytoplasm and mitochondria of neurons from each group were detected by western blot assay. Differences in the cell viability and apoptosis rate between groups were detected by cell-counting kit 8 assay and terminal deoxynucleotidyl transferase dUTP nick-end labeling assay, respectively. The results showed that the apoptosis rate, PIDD1, caspase-2, and cleaved caspase-3 expression levels significantly decreased, and cell viability significantly improved in the Neat1 overexpression group compared with the oxygen and glucose deprivation group; however, Neat1 downregulation reversed these changes. Compared with the Neat1 downregulation group, the cytosolic cytochrome C level in the Neat1 overexpression group significantly decreased, and the mitochondrial cytochrome C level significantly increased. These data indicate that Neat1 upregulation can reduce the release of cytochrome C from the mitochondria to the cytoplasm by inhibiting the PIDD1-caspase-2 pathway, reducing the activation of caspase-3, and preventing neuronal apoptosis after oxygen and glucose deprivation, which might reduce secondary brain injury after traumatic brain injury. All experiments were approved by the Animal Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, China, on December 19, 2020 (approval No. 2020-895).	[Chai, Wei-Na; Wu, Yi-Fan; Wu, Zhi-Min; Xie, Yan-Feng; Shi, Quan-Hong; Dan, Wei; Zhan, Yan; Zhong, Jian-Jun; Tang, Wei; Sun, Xiao-Chuan; Jiang, Li] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China		Sun, XCA; Jiang, L (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing, Peoples R China.	sunxiaochuan@cqmu.edu.cn; drjiangli2019@163.com			Youth Science Foundation Project of the National Natural Science Foundation of China [81701226]	This work was supported by the Youth Science Foundation Project of the National Natural Science Foundation of China, No. 81701226 (to LJ).	Bewig B, 2000, BIOTECHNIQUES, V28, P870, DOI 10.2144/00285bm08; Bock FJ, 2012, ONCOGENE, V31, P4733, DOI 10.1038/onc.2011.639; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Clark RSB, 2007, J CEREBR BLOOD F MET, V27, P316, DOI 10.1038/sj.jcbfm.9600338; Di Donato N, 2016, AM J HUM GENET, V99, P1117, DOI 10.1016/j.ajhg.2016.09.010; Di Y, 2021, NEURAL REGEN RES, V16, P1877, DOI 10.4103/1673-5374.306098; Feng ST, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104553; Gong W, 2016, ONCOTARGET, V7, P62208, DOI 10.18632/oncotarget.11403; Guo J, 2016, MOL NEUROBIOL, V53, P3154, DOI 10.1007/s12035-015-9222-2; Guru SC, 1997, GENOME RES, V7, P725, DOI 10.1101/gr.7.7.725; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Janssens S, 2012, CELL DEATH DIFFER, V19, P13, DOI 10.1038/cdd.2011.162; Jiang L, 2015, NEUROSCIENCE, V301, P375, DOI 10.1016/j.neuroscience.2015.06.005; Kim IR, 2009, APOPTOSIS, V14, P1039, DOI 10.1007/s10495-009-0375-1; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li Z, 2016, TUMOR BIOL, V37, P673, DOI 10.1007/s13277-015-3843-y; Marr RA, 1998, INT J ONCOL, V12, P509; Pei XX, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.019; Reng CM, 2020, ZHONGGUO ZUZHI GONGC, V24, P1130; Richter V, 2015, CELL MOL LIFE SCI, V72, P3695, DOI 10.1007/s00018-015-1950-y; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sunwoo JS, 2017, MOL NEUROBIOL, V54, P1577, DOI 10.1007/s12035-016-9928-9; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tang YL, 2020, NEURAL REGEN RES, V15, P2262, DOI 10.4103/1673-5374.284996; Wang XW, 2020, NEURAL REGEN RES, V15, P2073, DOI 10.4103/1673-5374.282258; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Xie LL, 2018, CANCER SCI, V109, P3686, DOI 10.1111/cas.13830; Yang C, 2017, ONCOTARGET, V8, P2672, DOI 10.18632/oncotarget.13737; Yang LJ, 2014, NEURAL REGEN RES, V9, P513, DOI 10.4103/1673-5374.130077; Zanelli SA, 2015, NEUROSCIENCE, V310, P279, DOI 10.1016/j.neuroscience.2015.09.046; Zhang QN, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00998; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	35	0	0	8	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2022	17	1					163	169		10.4103/1673-5374.314313			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	SS2OU	WOS:000661581500034	34100452	Green Published, gold			2022-02-06	
J	Chin, WS; Liao, SC; Pan, SC; Guo, YLL				Chin, Wei-Shan; Liao, Shih-Cheng; Pan, Shin-Chun; Guo, Yue-Liang Leon			Occupational and Non-occupational Injuries Can Result in Prolonged Augmentation of Psychiatric Disorders	JOURNAL OF EPIDEMIOLOGY			English	Article						psychiatric disorders; occupational injury; trauma and stress-related disorder; depression	NATIONAL-HEALTH INSURANCE; POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY; IV ALCOHOL-ABUSE; SOCIOECONOMIC-STATUS; EPIDEMIOLOGIC SURVEY; UNITED-STATES; PREVALENCE; COMORBIDITY; DEPRESSION	Background: The long-term effects of occupational injury (OI) on psychiatric diseases are unclear. This study assessed and compared the effects of OI, no injury (control), and non-OI (NOI) on the development of psychiatric diseases. Methods: We used Taiwan's National Health Insurance Research Database to investigate the incidence of psychiatric disorders in OI, NOI, and control groups. The subjects were aged 20-50 years, actively employed in 2000, and did not have history of injury or psychiatric disorders. All subjects were followed from 2000 and were classified into OI, NOI, and control groups according to occurrence of target injury later on. Individuals in each group were matched by age, sex, insurance premium before the index date, and year of the index date. Psychiatric disease-free days were compared among the groups using survival analysis and Cox regression. Results: We included a total of 12,528 patients for final analysis, with 4,176 in each group. Compared with the control group, the OI group had an increased occurrence of trauma and stress-related disorder, depressive disorders, anxiety disorders, and alcohol and other substance dependence. These increases were similar to those in the NOI group. Elevated cumulative incidence rate of any psychiatric disorders was observed among those with OI or NOI up to 10 years after injury. Conclusion: We confirmed that OI and NOI induced psychiatric disorders. These findings highlight the need for workers' compensation mechanisms to consider long-term psychological care among injured workers.	[Chin, Wei-Shan] Natl Taiwan Univ NTU, Sch Nursing, Coll Med, Taipei, Taiwan; [Chin, Wei-Shan; Liao, Shih-Cheng; Guo, Yue-Liang Leon] NTU Hosp, Taipei, Taiwan; [Liao, Shih-Cheng] Natl Taiwan Univ NTU, Dept Psychiat, Coll Med, Taipei, Taiwan; [Pan, Shin-Chun; Guo, Yue-Liang Leon] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Zhunan, Taiwan; [Guo, Yue-Liang Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Rm 339,3F,17 Syujhou Rd, Taipei 10055, Taiwan		Guo, YLL (corresponding author), Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Rm 339,3F,17 Syujhou Rd, Taipei 10055, Taiwan.	leonguo@ntu.edu.tw	; LIAO, SHIH-CHENG/C-5665-2017	GUO, Yue Leon/0000-0002-8530-4809; LIAO, SHIH-CHENG/0000-0003-4129-0879	National Health Research Institute, TaiwanNational Health Research Institutes - Taiwan [NHRI-107-EMSP04]	This work was supported by National Health Research Institute, Taiwan (NHRI-107-EMSP04).	Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Bryant RA, 2016, J CLIN PSYCHIAT, V77, pE648, DOI 10.4088/JCP.14m09661; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Casey R, 2017, J OCCUP ENVIRON MED, V59, P486, DOI 10.1097/JOM.0000000000000998; Chen LW, 2007, HEALTH ECON, V16, P223, DOI 10.1002/hec.1160; Chien IC, 2007, CAN J PSYCHIAT, V52, P28, DOI 10.1177/070674370705200106; Chien IC, 2004, PSYCHIAT SERV, V55, P691, DOI 10.1176/appi.ps.55.6.691; Chin WS, 2017, EUR ARCH PSY CLIN N, V267, P507, DOI 10.1007/s00406-016-0762-x; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; European Commission, REP CURR SIT REL OCC; Fernando DT, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7080-y; Foa EB, 2006, J CLIN PSYCHIAT, V67, P15; Forbes D, 2016, J CLIN PSYCHIAT, V77, P807, DOI 10.4088/JCP.15m09854; Forbes D, 2015, J CLIN PSYCHIAT, V76, P1193, DOI 10.4088/JCP.14m09075; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P737, DOI 10.1002/da.20845; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Harvey SB, 2012, AM J EPIDEMIOL, V176, P1177, DOI 10.1093/aje/kws248; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Keogh JP, 2000, AM J IND MED, V38, P498, DOI 10.1002/1097-0274(200011)38:5<498::AID-AJIM2>3.0.CO;2-I; Keyes KM, 2008, ADDICTION, V103, P1120, DOI 10.1111/j.1360-0443.2008.02218.x; Kim J, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-303, 10.1186/1471-2261-13-55]; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kuehner C, 2017, LANCET PSYCHIAT, V4, P146, DOI 10.1016/S2215-0366(16)30263-2; Lin KH, 2014, PSYCHIAT RES, V219, P645, DOI 10.1016/j.psychres.2014.06.015; Lin KH, 2014, J OCCUP REHABIL, V24, P1, DOI 10.1007/s10926-013-9431-3; Lin KH, 2012, J OCCUP HEALTH, V54, P289, DOI 10.1539/joh.11-0211-OA; MacEachen E, 2010, J OCCUP REHABIL, V20, P349, DOI 10.1007/s10926-010-9229-5; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; NHIRD) NHIRD, INTR DAT SUBS NAT HL; O'Donnell ML, 2016, J CLIN PSYCHIAT, V77, pE473, DOI 10.4088/JCP.14m09721; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Patten SB, 2010, CAN J PSYCHIAT, V55, P313, DOI 10.1177/070674371005500507; Remes O, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.497; Shadloo B, 2016, IRAN J PUBLIC HEALTH, V45, P623; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Sohlman B, 1999, ACTA PSYCHIAT SCAND, V99, P102, DOI 10.1111/j.1600-0447.1999.tb07207.x; Stone J, 2016, J BURN CARE RES, V37, pE166, DOI 10.1097/BCR.0000000000000323; The International Labour Organization, 2010, ILO LIST OCC DIS REV; United States Department of Labor Bureau of Labor Statistics, OCCUPATIONAL INJURY; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	50	0	0	1	4	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	HONGO MT BLDG, 4 FL, 7-2-2, HONGO, BUNKYO-KU, TOKYO, JAPAN	0917-5040			J EPIDEMIOL	J. Epidemiol.	JAN	2022	32	1					12	20		10.2188/jea.JE20200374			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XQ6AJ	WOS:000731626200001	33041319	gold, Green Published			2022-02-06	
J	Choi, Y; Park, JH; Hong, KJ; Ro, YS; Song, KJ; Do Shin, S				Choi, Yeongho; Park, Jeong Ho; Hong, Ki Jeong; Ro, Young Sun; Song, Kyoung Jun; Do Shin, Sang			Development and validation of a prehospital-stage prediction tool for traumatic brain injury: a multicentre retrospective cohort study in Korea	BMJ OPEN			English	Article						accident & emergency medicine; neurological injury; trauma management	HEAD-INJURY; TRIAGE; IDENTIFICATION; ALGORITHMS; PROGNOSIS; MODELS; SIGNS	Objectives Predicting diagnosis and prognosis of traumatic brain injury (TBI) at the prehospital stage is challenging; however, using comprehensive prehospital information and machine learning may improve the performance of the predictive model. We developed and tested predictive models for TBI that use machine learning algorithms using information that can be obtained in the prehospital stage. Design This was a multicentre retrospective study. Setting and participants This study was conducted at three tertiary academic emergency departments (EDs) located in an urban area of South Korea. The data from adult patients with severe trauma who were assessed by emergency medical service providers and transported to three participating hospitals between 2014 to 2018 were analysed. Results We developed and tested five machine learning algorithms-logistic regression analyses, extreme gradient boosting, support vector machine, random forest and elastic net (EN)-to predict TBI, TBI with intracranial haemorrhage or injury (TBI-I), TBI with ED or admission result of admission or transferred (TBI with non-discharge (TBI-ND)) and TBI with ED or admission result of death (TBI-D). A total of 1169 patients were included in the final analysis, and the proportions of TBI, TBI-I, TBI-ND and TBI-D were 24.0%, 21.5%, 21.3% and 3.7%, respectively. The EN model yielded an area under receiver-operator curve of 0.799 for TBI, 0.844 for TBI-I, 0.811 for TBI-ND and 0.871 for TBI-D. The EN model also yielded the highest specificity and significant reclassification improvement. Variables related to loss of consciousness, Glasgow Coma Scale and light reflex were the three most important variables to predict all outcomes. Conclusion Our results inform the diagnosis and prognosis of TBI. Machine learning models resulted in significant performance improvement over that with logistic regression analyses, and the best performing model was EN.	[Choi, Yeongho; Park, Jeong Ho; Hong, Ki Jeong; Ro, Young Sun; Song, Kyoung Jun; Do Shin, Sang] Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea; [Choi, Yeongho; Park, Jeong Ho; Hong, Ki Jeong; Ro, Young Sun; Do Shin, Sang] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Song, Kyoung Jun] Seoul Metropolitan Govt Seoul Natl Univ, Dept Emergency Med, Boramae Med Ctr, Seoul, South Korea		Park, JH (corresponding author), Seoul Natl Univ Hosp, Lab Emergency Med Serv, Biomed Res Inst, Seoul, South Korea.; Park, JH (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea.	timthe@gmail.com		Park, Jeong Ho/0000-0001-6330-9820; Choi, Yeongho/0000-0003-3866-1237	Seoul National University Hospital Research Fund [04-2019-0680]	This study was supported by grant No. '04-2019-0680' from the Seoul National University Hospital Research Fund.	Abujaber A, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00738-5; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; ESPOSITO TJ, 1995, ARCH SURG-CHICAGO, V130, P171; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FRIES GR, 1994, ANN EMERG MED, V24, P885, DOI 10.1016/S0196-0644(94)70207-1; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Kim Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/18959; Maslove DM, 2013, J AM MED INFORM ASSN, V20, P544, DOI 10.1136/amiajnl-2012-000929; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Menard S., 2002, APPL LOGISTIC REGRES, V2nd; Miller PR, 2017, J AM COLL SURGEONS, V224, P680, DOI 10.1016/j.jamcollsurg.2016.12.053; Nakada T, 2016, AM J EMERG MED, V34, P88, DOI 10.1016/j.ajem.2015.09.048; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ocak G, 2009, LANGENBECK ARCH SURG, V394, P285, DOI 10.1007/s00423-008-0340-4; Oostema JA, 2015, STROKE, V46, P1513, DOI 10.1161/STROKEAHA.115.008650; Park JH, 2019, RESUSCITATION, V142, P127, DOI 10.1016/j.resuscitation.2019.07.020; Pelieu Iris, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7010012; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Reisner AT, 2013, APPL CLIN INFORM, V4, P392, DOI 10.4338/ACI-2013-04-RA-0023; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Swan PY, 2009, WEST J EMERG MED, V10, P208; ter Avest E, 2021, EMERG MED J, V38, P21, DOI 10.1136/emermed-2020-209635; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; Whiting MD, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.599268; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Workowski Kimberly A., 2010, Morbidity and Mortality Weekly Report, V59, P1; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JAN	2022	12	1							e055918	10.1136/bmjopen-2021-055918			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH5DU	WOS:000743189000012	35022177	gold, Green Accepted			2022-02-06	
J	Cogan, AM; Pape, TLB; Yeaw, J; DeKoven, M; Anupindi, R; Jordan, N				Cogan, Alison M.; Pape, Theresa L. Bender; Yeaw, Jason; DeKoven, Mitch; Anupindi, Ruthwik; Jordan, Neil			Health Care Resource Utilization and Costs for Adults With Mild Traumatic Brain Injury With Chronic Vestibular Impairment	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Costs and cost analysis; Health care costs; Pos-tural balance; Rehabilitation	BALANCE DISORDERS; PERFORMANCE; CONCUSSION; DIZZINESS; REHABILITATION; MEDICAID; SYMPTOMS; DISEASE; QUALITY; BURDEN	Objective: To quantify the economic burden of all-cause health care resource utilization (HCRU) among adults with and without chronic vestibular impairment (CVI) after a mild traumatic brain injury (mTBI). Setting: IQVIA Integrated Data Warehouse. Participants: People with mTBI+CVI (n=20,441) matched on baseline age, sex, year of mTBI event, and Charlson Comorbidity Index (CCI) score to people with mTBI only (n=20,441) (N=40,882). Main Outcome Measures: All-cause health HCRU and costs at 12 and 24 months post mTBI diagnosis. Results: People with mTBI+CVI had significantly higher all-cause HCRU and costs at both time points than those with mTBI only. Multivariable regression analysis showed that, when controlling for baseline variables, costs of care were 1.5 times higher for mTBI+CVI than mTBI only. Conclusions: People who developed CVI after mTBI had greater overall HCRU and costs for up to 2 years after the injury event compared with people who did not develop CVI after controlling for age, sex, region, and CCI score. Further research on access to follow-up services and effectiveness of interventions to address CVI is warranted. Archives of Physical Medicine and Rehabilitation 2022;103:90-7 Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine.	[Cogan, Alison M.] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, Washington, DC USA; [Pape, Theresa L. Bender; Jordan, Neil] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Dept Vet Affairs, Hines, IL USA; [Pape, Theresa L. Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Yeaw, Jason; DeKoven, Mitch; Anupindi, Ruthwik] IQVIA Inc, Falls Church, VA USA; [Jordan, Neil] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA; [Jordan, Neil] Dept Behav Sci & Prevent Med, Chicago, IL USA		Cogan, AM (corresponding author), VA Greater Los Angeles Healthcare Syst, Ctr Study Healthcare Innovat Implementat & Policy, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	Alison.cogan@va.gov		Cogan, Alison/0000-0002-6800-1988; Bender Pape, Theresa/0000-0001-7738-5963	Helius Medical Technologies; Polytrauma/TBI Advanced Fellowship from the Veterans Administration Office of Academic Affiliations	Helius Medical Technologies provided financial support for the editorial development of the manuscript. Authors J.Y., M.D., and R.A. are employees of IQVIA, which received funding from Helius Medical Technologies for this study. Dr Bender Pape reports serving on the scientific advisory board of Helius. For the remaining authors (A.M.C., N.J.), none were reported. At the time this work was completed, Dr Cogan was supported by a Polytrauma/TBI Advanced Fellowship from the Veterans Administration Office of Academic Affiliations.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Artman LK, 2013, J VOCAT REHABIL, V39, P13, DOI 10.3233/JVR-130638; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Campbell JD, 2014, MULT SCLER RELAT DIS, V3, P227, DOI 10.1016/j.msard.2013.09.004; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Centers for Disease Control and Prevention, PERC DISTR TBI REL E; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chase CA, 2012, AM J OCCUP THER, V66, P284, DOI 10.5014/ajot.2012.005017; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Decker SL, 2013, JAMA-J AM MED ASSOC, V309, P2579, DOI 10.1001/jama.2013.7106; Hobson DE, 2012, PARKINSONISM RELAT D, V18, P930, DOI 10.1016/j.parkreldis.2012.04.026; Jha AK, 2011, HEALTH AFFAIR, V30, P1904, DOI 10.1377/hlthaff.2011.0027; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Lampiasi Nick, 2010, Care Manag J, V11, P122; Langlois J, TRAUMATIC BRAIN INJU; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lin HW, 2012, LARYNGOSCOPE, V122, P1858, DOI 10.1002/lary.23376; Maskell F, 2007, BRAIN INJURY, V21, P741, DOI 10.1080/02699050701472109; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Mehra Maneesha, 2014, J Med Econ, V17, P637, DOI 10.3111/13696998.2014.928639; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Rand D, 2011, AGE AGEING, V40, P297, DOI 10.1093/ageing/afr037; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Weir S, 2018, MOVEMENT DISORD, V33, P974, DOI 10.1002/mds.27302; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	39	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2022	103	1					90	+		10.1016/j.apmr.2021.08.017			16	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	XW1IJ	WOS:000735381500013	34634230				2022-02-06	
J	Costello, K; Greenwald, BD				Costello, Kellianne; Greenwald, Brian D.			Update on Domestic Violence and Traumatic Brain Injury: A Narrative Review	BRAIN SCIENCES			English	Article						traumatic brain injury; domestic violence; intimate partner violence; post-traumatic stress disorder	INTIMATE-PARTNER-VIOLENCE; WOMEN; HEALTH; SYMPTOMS; VICTIMS; OUTCOMES; HEAD; PROFESSIONALS; EXPERIENCES; SURVIVORS	Research on traumatic brain injury (TBI) as a result of domestic violence has greatly increased in the past decade, with publications addressing the prevalence, diagnosis, evaluation, and treatment. Although TBI due to domestic violence has recently been found to occur quite frequently, it was not widely understood until the 1990s. Individuals who suffer from domestic violence TBI often experience sequelae such as decreased cognitive functioning, memory loss, and PTSD. The goal of this article is to increase awareness about TBI secondary to domestic violence, with the intent that it will highlight areas for future research on the diagnosis, evaluation, and treatment of TBI in this population. The articles in this study were first found using the search terms traumatic brain injury and domestic violence. Although, in recent years, there has been a significant increase in research on TBI due to domestic violence, the overall conclusion of this review article is that there is still a need for future research in many areas including the effects on minority populations, the effects of COVID-19, and improvements of screening tools.	[Costello, Kellianne] Rutgers Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Greenwald, Brian D.] Rutgers Robert Wood Johnson Med Sch, Dept Phys Med & Rehabil, Piscataway, NJ 08854 USA; [Greenwald, Brian D.] Hackensack Median Hlth JFK Johnson Rehabil Inst, Edison, NJ 08820 USA; [Greenwald, Brian D.] Hackensack Meridian Sch Med, Dept Phys Med & Rehabil, Nutley, NJ 07110 USA		Greenwald, BD (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Phys Med & Rehabil, Piscataway, NJ 08854 USA.; Greenwald, BD (corresponding author), Hackensack Median Hlth JFK Johnson Rehabil Inst, Edison, NJ 08820 USA.; Greenwald, BD (corresponding author), Hackensack Meridian Sch Med, Dept Phys Med & Rehabil, Nutley, NJ 07110 USA.	kc1113@rwjms.rutgers.edu; brian.greenwald@hmhn.org					Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Ayton D, 2021, TRAUMA VIOLENCE ABUS, V22, P3, DOI 10.1177/1524838018821951; Ballan MS, 2017, AM J MENS HEALTH, V11, P1436, DOI 10.1177/1557988315606966; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Baxter K, 2019, J AGGRESS MALTREAT T, V28, P660, DOI 10.1080/10926771.2019.1602089; Bermea AM, 2021, PRIMARY CARE, V48, P329, DOI 10.1016/j.pop.2021.02.006; Birkley EL, 2016, J TRAUMA STRESS, V29, P397, DOI 10.1002/jts.22129; Bressler A, 2014, SCI AM MIND, V25, P38, DOI [10.1038/scientificamericanmind0914-38, DOI 10.1038/SCIENTIFICAMERICANMIND0914-38]; Brown J, 2019, J AGGRESS MALTREAT T, V28, P764, DOI 10.1080/10926771.2019.1603176; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Casper ST, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112688; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Crowe A, 2015, PARTN ABUSE, V6, P157, DOI 10.1891/1946-6560.6.2.157; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Dyar C, 2021, J INTERPERS VIOLENCE, V36, pNP8824, DOI 10.1177/0886260519846856; Ellis TW, 2019, J AGGRESS MALTREAT T, V28, P838, DOI 10.1080/10926771.2019.1595803; Faugno D, 2013, ADV EMERG NURS J, V35, P314, DOI 10.1097/TME.0b013e3182aa05d3; Foushee JP, 2017, RADIOL TECHNOL, V89, P83; Furlow Bryant, 2013, Radiol Technol, V84, p273CT; Furlow Bryant, 2010, Radiol Technol, V82, P133; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Higbee M, 2019, J AGGRESS MALTREAT T, V28, P826, DOI 10.1080/10926771.2019.1653412; Hunnicutt G, 2019, J AGGRESS MALTREAT T, V28, P677, DOI 10.1080/10926771.2019.1587656; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Iverson KM, 2020, J INTERPERS VIOLENCE, V35, P2422, DOI 10.1177/0886260517702491; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lifshitz J, 2019, J AGGRESS MALTREAT T, V28, P655, DOI 10.1080/10926771.2019.1644693; Linton KF, 2015, BRAIN INJURY, V29, P639, DOI 10.3109/02699052.2014.989406; Liu LY, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01104-4; Mariani M, 2020, SEMIN NEUROL, V40, P370, DOI 10.1055/s-0040-1713624; McClane GE, 2001, J EMERG MED, V21, P311, DOI 10.1016/S0736-4679(01)00400-0; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; Meyer JE, 2021, J INTERPERS VIOLENCE, DOI 10.1177/08862605211016362; Moreira DN, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101606; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Nemeth JM, 2019, J AGGRESS MALTREAT T, V28, P744, DOI 10.1080/10926771.2019.1591562; Peitzmeier SM, 2019, J INTERPERS VIOLENCE, V34, P2376, DOI 10.1177/0886260519827660; Price Snedaker K, 2020, BRAIN INJ PROF, V17, P8; Pritchard E, 2019, HEALTH SOC CARE COMM, V27, P1283, DOI 10.1111/hsc.12770; Ralston B, 2019, J AGGRESS MALTREAT T, V28, P732, DOI 10.1080/10926771.2019.1637988; Richards J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18137070; Rivara F, 2019, HEALTH AFFAIR, V38, P1622, DOI 10.1377/hlthaff.2019.00480; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; Rowe RK, 2021, J NEUROTRAUM, V38, P2301, DOI 10.1089/neu.2021.0022; Schechter DS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181066; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shifflett C.M, 2017, WOMENS HLTH ACT, V42, P6; Smirl JD, 2019, BRAIN INJURY, V33, P1529, DOI 10.1080/02699052.2019.1658129; St Ivany A, 2019, J AGGRESS MALTREAT T, V28, P785, DOI 10.1080/10926771.2019.1632400; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Stephenson R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062592; Stockman JK, 2015, J WOMENS HEALTH, V24, P62, DOI 10.1089/jwh.2014.4879; Trudel T.M., 2011, EXCEPT PARENT, V41, P33; Uretsky M, 2020, SEMIN NEUROL, V40, P461, DOI 10.1055/s-0040-1713621; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Wong J, 2014, CONTEMP NURSE, V46, P170, DOI 10.5172/conu.2014.46.2.170; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	65	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2022	12	1							122	10.3390/brainsci12010122			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YN7OD	WOS:000747442900001	35053865	gold, Green Accepted			2022-02-06	
J	Dierickx, EE; Scarneo-Miller, SE; Casa, DJ				Dierickx, Erin E.; Scarneo-Miller, Samantha E.; Casa, Douglas J.			High School Coaches' Knowledge and Behaviors for Emergency Preparedness	INTERNATIONAL SPORT COACHING JOURNAL			English	Article						EAP adoption; EAP components; emergency action plan; Precaution Adoption Process Model; sport safety	ASSOCIATION POSITION STATEMENT; PREVENTING SUDDEN-DEATH; STAGE MODEL; CONCUSSION; ATHLETICS; IMPLEMENTATION; PREDICTORS; EDUCATION; PROGRAMS; ADOPTION	Emergency action plans (EAPs) are considered best practice for the preparation of catastrophic events in sports and, when adequate, can effectively improve patient outcomes. The EAPs should include a collaboration of all personnel involved in the sporting activities, with high school coaches being well-positioned to implement these plans. Therefore, coaches can have a direct influence on the health and safety of their athletes through their involvement in an emergency response. The purpose of this study was to evaluate the understanding and adoption of EAPs as reported by coaches. A web-based questionnaire assessed adoption of an EAP; decisional stages for adoption of components of an EAP; and various characteristics (e.g., access to an athletic trainer facilitators and barriers). A total of 720 responses were included in this study. Nearly 25% of coaches reported being unaware if their school had an EAP, and coaches were more likely to adopt a comprehensive EAP if their school had access to an athletic trainer. A majority of coaches perceived financial assistance as a facilitator and financial limitations as a barrier for EAP implementation. The findings of this investigation illustrate the need for improved coaches' educational awareness of emergency preparedness strategies within the high school setting.	[Dierickx, Erin E.; Casa, Douglas J.] Univ Connecticut, Dept Kinesiol, Korey Stringer Inst, Storrs, CT 06269 USA; [Scarneo-Miller, Samantha E.] West Virginia Univ, Sch Med, Div Athlet Training, Morgantown, WV 26506 USA		Dierickx, EE (corresponding author), Univ Connecticut, Dept Kinesiol, Korey Stringer Inst, Storrs, CT 06269 USA.	Erin.dierickx@uconn.edu			National Athletic Trainers' Association Research & Education Foundation	This study was funded by a grant from the National Athletic Trainers' Association Research & Education Foundation.	Andersen JC, 2002, J ATHL TRAINING, V37, P99; Anderson R, 2019, RESUSCITATION, V135, P153, DOI 10.1016/j.resuscitation.2018.10.033; [Anonymous], 2020, 2018 2019 HIGH SCH A; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Blalock SJ, 1996, HEALTH PSYCHOL, V15, P84, DOI 10.1037/0278-6133.15.2.84; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu, 2019, 36 ANN REPORT FALL 1; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2013, J ATHL TRAINING, V48, P546, DOI 10.4085/1062-6050-48.4.12; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Collins CL, 2015, J PRIM PREV, V36, P323, DOI 10.1007/s10935-015-0402-7; Costanza ME, 2005, PREV MED, V41, P707, DOI 10.1016/j.ypmed.2004.12.013; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Deutsch, 2019, ICHPER SD J RES, V10, P7; Drezner JA, 2009, CIRCULATION, V120, P518, DOI 10.1161/CIRCULATIONAHA.109.855890; Elliott JO, 2007, SEIZURE-EUR J EPILEP, V16, P424, DOI 10.1016/j.seizure.2007.02.016; Govender K, 2016, EMERG MED J, V33, P351, DOI 10.1136/emermed-2014-204404; Hamilton R, 2005, J ADV NURS, V51, P288, DOI 10.1111/j.1365-2648.2005.03491.x; Hollis S, 2000, RESUSCITATION, V44, P171, DOI 10.1016/S0300-9572(00)00134-9; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; KIMBERLY GH, 2015, CIRCULATION, V132, P10; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Liaw SY, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00271-3; Monroe Anna, 2009, N C Med J, V70, P198; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Olympia RP, 2007, PEDIATR EMERG CARE, V23, P703, DOI 10.1097/PEC.0b013e318155adfc; Pike AM, 2019, J ATHL TRAINING, V54, P361, DOI 10.4085/1062-6050-28-18; Post EG, 2019, J ATHL TRAINING, V54, P1074, DOI 10.4085/1062-6050-207-18; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Scarneo SE, 2019, J ATHL TRAINING, V54, P99, DOI 10.4085/1062-6050-82-18; Scarneo-Miller SE, 2020, J ATHL TRAINING, V55, P80, DOI 10.4085/1062-6050-484-18; Scarneo-Miller SE, 2019, J APPL SPORT MANAG, V11, P1, DOI 10.18666/JASM-2019-V11-I3-9240; Sullivan N., 2015, INT J NURS ED SCHOLA, V12, P37, DOI 10.1515/ijnes-2014-0012; Wasilko SM, 2013, SPORTS HEALTH, V5, P548, DOI 10.1177/1941738113484250; Weinstein N.D., 2008, HLTH BEHAV HLTH ED T, P123	40	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2328-918X	2328-9198		INT SPORT COACH J	Int. Sport Coach J.	JAN	2022	9	1					40	50		10.1123/iscj.2020-0110			11	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	XR9OU	WOS:000732550700005					2022-02-06	
J	Dinnes, CR; Hux, K				Dinnes, Carly R.; Hux, Karen			Informal Written Language Analysis Methods: Case Examples of Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							DISCOURSE PRODUCTION; COMMUNICATION; INTERVENTION; PERFORMANCE; ADOLESCENTS; MANAGEMENT; COHERENCE; MODERATE; PROGRESS; MILD	Purpose: Written expression challenges following traumatic brain injury (TBI) in adults have received little clinical attention but can substantially affect quality of life and the success of reintegration efforts. Assessment tools and procedures are lacking despite the likelihood of post-TBI problems with microstructure (e.g., productivity, spelling accuracy) and macrostructure (e.g., topic adherence, organization) aspects of written language. The lack of standardized procedures forces reliance on informal methods to determine writing strengths and challenges. Method: A combination of assessment procedures allowed for evaluation of the productivity and efficiency, adherence to writing conventions (e.g., spelling, sentence structure, punctuation), and macrostructure organization (e.g., story grammar, topic adherence) of written narratives collected from five adults with TBI. Results: Use of multiple assessment methods revealed disparate writing challenges across the five case examples. The differing writing profiles underscore the necessity of evaluating multiple aspects of written narratives. Conclusions: The described analysis methods can help clinicians determine areas of strength and challenge in written work generated by adults with TBI. Examination of multiple aspects of writing is key to garnering a comprehensive appraisal of post-TBI writing.	[Dinnes, Carly R.] Bowling Green Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA; [Hux, Karen] Qual Living Inc, Omaha, NE USA		Dinnes, CR (corresponding author), Bowling Green Univ, Dept Commun Sci & Disorders, Bowling Green, OH 43403 USA.	cdinnes@bgsu.edu		Hux, Karen/0000-0001-9462-1876; Dinnes, Carly/0000-0003-4405-7642	Barkley Trust, University of Nebraska-Lincoln	This work was supported in part by the Barkley Trust, University of Nebraska-Lincoln.	Brown A. J., 2012, THESIS ARIZONA STATE; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Chang PFJ, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020867; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dinnes C, 2018, AM J SPEECH-LANG PAT, V27, P1523, DOI 10.1044/2018_AJSLP-18-0025; Dinnes C, 2018, COMMUN DISORD Q, V39, P490, DOI 10.1177/1525740117716416; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Ellis C, 2016, INT J LANG COMM DIS, V51, P359, DOI 10.1111/1460-6984.12213; Fyrberg A, 2013, J INTERACT RES COM D, V4, P157, DOI 10.1558/jircd.v4i2.157; Graham S, 2005, CONTEMP EDUC PSYCHOL, V30, P207, DOI 10.1016/j.cedpsych.2004.08.001; Graham S., 2007, WRITING NEXT EFFECTI; Gregg N, 2011, NEUROPSYCHOLOGIST HB, P301; Hagen C., 2000, TBI REH MAN CAR ENV; Hayes J. R., 1980, COGNITIVE PROCESS, P3, DOI DOI 10.4324/9781315630274; Hooper SR, 2002, J LEARN DISABIL-US, V35, P2, DOI 10.1177/002221940203500101; Hunt K. W., 1965, GRAMMATICAL STRUCTUR; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Ignacio PL, 2019, PSYCHOL SCHOOLS, V56, P1482, DOI 10.1002/pits.22286; Jewell J, 2005, SCHOOL PSYCHOL REV, V34, P27; Kaplan E., 2001, BOSTON NAMING TEST; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Le K, 2012, AM J SPEECH-LANG PAT, V21, pS115, DOI 10.1044/1058-0360(2012/11-0114); Lindsey A, 2019, AM J SPEECH-LANG PAT, V28, P330, DOI 10.1044/2018_AJSLP-17-0151; Loomis B. M., 2015, THESIS E ILLINOIS U; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Mortensen L., 2004, ADV SPEECH LANGUAGE, V6, P15, DOI [10.1080/14417040410001669462, DOI 10.1080/14417040410001669462]; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Piccinelli M, 1999, J PSYCHOSOM RES, V46, P455, DOI 10.1016/S0022-3999(98)00126-3; Powell-Smith K. A., 2004, ADM SCORING WRITTEN; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Saddler B, 2013, READ WRIT Q, V29, P20, DOI 10.1080/10573569.2013.741945; Scardamalia M., 1987, ADV APPL PSYCHOLINGU, V2, P142; Schleppegrell, 2018, LIFESPAN DEV WRITING, P271, DOI [10.1080/00461520.2018.1481406, DOI 10.1080/00461520.2018.1481406]; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Wechsler D., 2009, TEST PREMORBID FUNCT; Wheeler L, 2014, NEUROREHABILITATION, V34, P29, DOI 10.3233/NRE-131007; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248	42	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JAN	2022	31	1					203	220		10.1044/2021_AJSLP-21-00196			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YK2KE	WOS:000745047800014	34962829				2022-02-06	
J	Duncan, E; Mojica, M; Ching, K; Harwayne-Gidansky, I				Duncan, Ellen; Mojica, Michael; Ching, Kevin; Harwayne-Gidansky, Ilana			Low Concordance Between Pediatric Emergency Attendings and Pediatric Residents for Predictors of Serious Intracranial Injury	PEDIATRIC EMERGENCY CARE			English	Article						brain injuries; diagnostic; decision support systems; clinical; medical education	GLASGOW COMA SCALE; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CANCER; RISK; CHILDREN	Objectives Minor head trauma is a common cause of pediatric emergency room visits. The Pediatric Emergency Care Applied Research Network head trauma clinical decision rules (PECARN-CDR) are designed to assist clinicians in determining which patients require imaging. However, only minimal data are available on the accuracy of residents' assessments using PECARN-CDR. Prior research suggests that trainees often come to erroneous conclusions about pediatric head trauma. The objective of the present study was to assess concordance between pediatric residents' and attending physicians' assessments of children with low-risk head trauma, with the ultimate goal of improving education in pediatric trauma assessment. Methods This is a retrospective cohort study analyzing concordance between pediatric residents and pediatric emergency attendings who provided PECARN-CDR-based evaluations of low-risk head injuries. It is a planned subanalysis based on a prospectively collected, multicenter data set tracking pediatric head trauma encounters from July 2014 to June 2019. Results Data were collected from 436 pediatric residents, who encountered 878 patients. In the case of patients younger than 2 years, low concordance between residents and attendings was observed for the following elements of the PECARN-CDR: severe mechanism (kappa = 0.24), palpable skull fracture (kappa = 0.23), Glasgow Coma Scale (GCS) score less than 15 (kappa = 0.14), and altered mental status (AMS; kappa = -0.03). There was moderate to high agreement between residents and attendings for loss of consciousness (kappa = 0.71), nonfrontal hematoma (kappa = 0.48), and not acting normally per parent (kappa = 0.35). In the case of patients older than 2 years, there was low concordance for signs of basilar skull fracture (kappa = 0.28) and GCS score less than 15 (kappa = 0.10). Concordance was high to moderate for history of vomiting (kappa = 0.88), loss of consciousness (kappa = 0.67), severe headache (kappa = 0.50), severe mechanism (kappa = 0.44), and AMS (kappa = 0.42). Residents were more conservative, that is, more likely to report a positive finding, in nearly all components of the PECARN-CDR. Conclusions Resident assessment of children presenting to the ED with minor head trauma is often poorly concordant with attending assessment on the major predictors of clinically important traumatic brain injury (abnormal GCS, AMS, signs of skull fracture) based on the PECARN-CDR. Future work may explore the reasons for low concordance and seek ways to improve pediatric resident education in the diagnosis and management of trauma.	[Duncan, Ellen; Mojica, Michael] NYU, Bellevue Hosp Ctr, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Duncan, Ellen; Mojica, Michael] NYU, Bellevue Hosp Ctr, Sch Med, Dept Pediat, New York, NY 10016 USA; [Ching, Kevin] Cornell Med Ctr, Dept Emergency Med, New York, NY USA; [Ching, Kevin] Cornell Med Ctr, Dept Pediat, New York, NY USA; [Harwayne-Gidansky, Ilana] Stony Brook Childrens Hosp, Dept Pediat, Stony Brook, NY USA		Duncan, E (corresponding author), Bellevue Hosp Ctr, 462 First Ave,Adm Bldg Room A526, New York, NY 10016 USA.	Ellen.1.duncan@gmail.com		Duncan, Ellen/0000-0002-7633-0845			Aldeen AZ, 2006, ACAD EMERG MED, V13, P860, DOI 10.1197/j.aem.2006.03.557; Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Committee on Pediatric Emergency Medicine Council on Injury; Violence and Poison Prevention Section on Critical Care Section on Orthopaedics Section on Surgery Section on Transport Medicine Pediatric Trauma Society and Society of Trauma Nurses Pediatric Committee, 2016, PEDIATRICS, V138; DiBrito SR, 2018, J PEDIATR SURG, V53, P1789, DOI 10.1016/j.jpedsurg.2017.12.027; Dobson Joseph V, 2003, Med Educ Online, V8, P4337, DOI 10.3402/meo.v8i.4337; Drews JD, 2019, J SURG RES, V241, P112, DOI 10.1016/j.jss.2019.03.038; Jolley DL, 2019, PEDIATR EMERG CARE, V35, P199, DOI 10.1097/PEC.0000000000001757; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lodwick DL, 2019, J SURG RES, V241, P294, DOI 10.1016/j.jss.2019.04.014; Lodwick DL, 2018, J SURG RES, V232, P475, DOI 10.1016/j.jss.2018.04.024; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; MANGIONE S, 1995, ACAD EMERG MED, V2, P622, DOI 10.1111/j.1553-2712.1995.tb03601.x; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mittiga Matthew R, 2010, J Grad Med Educ, V2, P571, DOI 10.4300/JGME-D-10-00106.1; Mookherjee S, 2013, J GEN INTERN MED, V28, P1090, DOI 10.1007/s11606-013-2380-x; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Ri H., PRAISE PHYS EXAMINAT	23	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E422	E425		10.1097/PEC.0000000000002313			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600096	33273432				2022-02-06	
J	Eagle, SR; Feder, A; Manderino, LM; Mucha, A; Holland, CL; Collins, MW; Kontos, AP				Eagle, Shawn R.; Feder, Abigail; Manderino, Lisa M.; Mucha, Anne; Holland, Cyndi L.; Collins, Michael W.; Kontos, Anthony P.			Concurrent validity of the Vestibular/Ocular Motor Screening (VOMS) tool with the Dizziness Handicap Inventory (DHI) among adolescents with vestibular symptoms/impairment following concussion	PHYSICAL THERAPY IN SPORT			English	Article						Dizziness; Vestibular; Concussion; Adolescents; VOMS tool; DHI	SPORT-RELATED CONCUSSION; RECOVERY; YOUTH	Objective: To determine whether the Vestibular/Ocular Motor Screening (VOMS) tool demonstrates concurrent validity with the Dizziness Handicap Inventory (DHI) in a sample of concussed athletes referred for vestibular therapy and whether DHI items were predictive of VOMS outcomes. Design: Cross-sectional cohort study. Setting: Concussion specialty/vestibular therapy clinic. Methods: Adolescents (n = 55; 15.4 +/- 1.6 years) with diagnosed sport-related concussion (SRC) with vestibular symptoms and/or impairment between October 2018-February 2020. Patients completed VOMS and DHI at initial visit. Seven individual VOMS and twenty-five DHI items, VOMS and DHI total score and three DHI sub-scales, were compared with Spearman correlations. Three backwards linear regression (LR) models were built to predict 1. VOMS vestibular symptoms, 2. VOMS ocular symptoms, and 3. near-point of convergence-distance (NPC-distance) using individual DHI items as predictors. Results: Spearman correlations (p) identified DHI items with moderate to strong associations for VOMS items. DHI sub-scales demonstrated moderate-to-strong correlations with VOMS items (p = 0.30-0.59). Total DHI score demonstrated a moderate-to-strong association with HSAC (p = 0.30), VSAC (p = 0.32), and SP (p = 0.61). Results from the LRs predicting VOMS ocular symptoms (R (Alsalaheen et al., 2010) = 0.56; p < 0.001), and VOMS vestibular symptoms (R (Alsalaheen et al., 2010) = 0.23; p = 0.01), and NPC-distance (R (Alsalaheen et al., 2010) = 0.56; p 0.001) included significant DHI predictors. Conclusions: There was moderate-to-strong associations between VOMS and 56% of DHI items (i.e., p 0.30).	[Eagle, Shawn R.; Feder, Abigail; Manderino, Lisa M.; Holland, Cyndi L.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15203 USA; [Mucha, Anne] Univ Pittsburgh, UPMC Sports Med Concuss Program, Ctr Rehabil Serv, Pittsburgh, PA 15203 USA		Eagle, SR (corresponding author), Univ Pittsburgh, 3850 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu			Chuck Noll Foundation	This study was funded by a research grant from the Chuck Noll Foundation.	Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Bamiou DE, 2000, SCAND AUDIOL, V29, P238, DOI 10.1080/010503900750022862; Buttner Fionn, 2021, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000667; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Elbin RJ, 2021, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2021.1911806; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hoffer ME, 2015, NEUROL CLIN, V33, P661, DOI 10.1016/j.ncl.2015.04.004; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mueller M, 2015, J CLIN EPIDEMIOL, V68, P211, DOI 10.1016/j.jclinepi.2014.10.004; Ojha S, 2020, OTOL NEUROTOL, V41, pE295, DOI 10.1097/MAO.0000000000002530; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Tiwari D, 2020, PEDIATR PHYS THER, V32, P382, DOI 10.1097/PEP.0000000000000741	22	0	0	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2022	53						34	39		10.1016/j.ptsp.2021.11.003			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XV1SR	WOS:000734731000006	34785482				2022-02-06	
J	Elmer, CK; McLeod, TCV				Elmer, Carlie K.; McLeod, Tamara C. Valovich			Do Cognitive Behavioral Therapy Techniques Reduce Symptom Duration in Children and Adolescents Who Have Sustained a Mild Traumatic Brain Injury?	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						concussion; rehabilitation; persisting symptoms; prolonged recovery	POSITION STATEMENT; INTERVENTION; CONCUSSION; SPORTS	Focused Clinical Question: Does cognitive behavioral therapy (CBT) reduce concussion symptoms among children and adolescents following mild traumatic brain injury? Clinical Bottom Line: Based on the results of this critically appraised topic, there is moderate evidence to support the use of CBT as a treatment intervention to reduce complaints of persistent concussion symptoms in children and adolescents.	[Elmer, Carlie K.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [Elmer, Carlie K.; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA.; McLeod, TCV (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA.	tmcleod@atsu.edu		Valovich McLeod, Tamara/0000-0001-9082-8722			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Fisher E, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003968.pub5; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kontos AP, 2020, NEUROSURGERY, V87, P348, DOI 10.1093/neuros/nyz545; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Sigurvinsdottir AL, 2020, NORD J PSYCHIAT, V74, P168, DOI 10.1080/08039488.2019.1686653; Sullivan KA, 2020, DISABIL REHABIL, V42, P2243, DOI 10.1080/09638288.2018.1558292; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504	22	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JAN	2022	27	1					6	11		10.1123/ijatt.2020-0096			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	YB1IS	WOS:000738775300002					2022-02-06	
J	Escudero, D; Astola, I; Balboa, S; Leoz, B; Meilan, A; Del Busto, C; Quindos, B; Forcelledo, L; Vizcaino, D; Martin, L; Salgado, E; Vina, L				Escudero, D.; Astola, I; Balboa, S.; Leoz, B.; Meilan, A.; del Busto, C.; Quindos, B.; Forcelledo, L.; Vizcaino, D.; Martin, L.; Salgado, E.; Vina, L.			Clinico-radiological related to early brain death factors	MEDICINA INTENSIVA			English	Article						Brain death; Organ donation; Transplantation; Prognostic factors; Severe stroke	PRIMARY INTRACEREBRAL HEMORRHAGE; HEALTH-CARE PROFESSIONALS; ORGAN DONORS; DONATION; VOLUME; PREDICTION; STATEMENT; RECOVERY; STROKE; SCORE	Objective: To identify clinical and radiological factors associated to early evolution to brain death (BD), defined as occurring within the first 24 h. Design: A retrospective cohort study was made covering the period 2015-2017. Setting: An adult Intensive Care Unit (ICU). Patients/methods: Epidemiological, clinical and imaging (CT scan) parameters upon admission to the ICU in patients evolving to BD. Results: A total of 166 patients with BD (86 males, mean age 62.7 years) were analyzed. Primary cause: intracerebral hemorrhage 42.8%, subarachnoid hemorrhage 18.7%, traumatic brain injury 17.5%, anoxia 9%, stroke 7.8%, other causes 4.2%. Epidemiological data: arterial hypertension 50%, dyslipidemia 34%, smoking 33%, antiplatelet medication 21%, alcoholism 19%, anticoagulant therapy 15%, diabetes 15%. The Glasgow Coma Score (GCS) upon admission was 3 in 68.8% of the cases in early BD versus in 38.2% of the cases in BD occurring after 24 h (p = 0.0001). Eightyfive patients presented supratentorial hematomas with a volume of 90.9 ml in early BD versus 82.7 ml in BD > 24 h (p = 0.54). The mean midline shift was 10.7 mm in early BD versus 7.8 mm in BD > 24 h (p = 0.045). Ninety-one patients presented ventriculomegaly and 38 additionally ependymal transudation (p = 0.021). Thirty-six patients with early BD versus 24 with BD > 24 h presented complete effacement of basal cisterns (p = 0.005), sulcular effacement (p = 0.013), loss of cortico-subcortical differentiation (p = 0.0001) and effacement of the suprasellar cistern (p = 0.005). The optic nerve sheath measurements showed no significant differences between groups. Conclusions: Early BD (>24 h) was associated to GCS < 5, midline shift, effacement of the basal cisterns, cerebral sulci and suprasellar cistern, and ependymal transudation. (C) 2021 Published by Elsevier Espan tilde a, S.L.U.	[Escudero, D.; Astola, I; Balboa, S.; Leoz, B.; del Busto, C.; Quindos, B.; Forcelledo, L.; Martin, L.; Salgado, E.; Vina, L.] Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain; [Meilan, A.; Vizcaino, D.] Hosp Univ Cent Asturias, Secc Neurorradiol, Serv Radiol, Oviedo, Spain		Escudero, D (corresponding author), Hosp Univ Cent Asturias, Serv Med Intens, Oviedo, Spain.	lolaescudero@telefonica.net					Akpinar E, 2019, J CRANIOFAC SURG, V30, pE667, DOI 10.1097/SCS.0000000000005733; Bodi MA, 2015, MED INTENSIVA, V39, P337, DOI 10.1016/j.medin.2014.07.010; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; de la Rosa G, 2012, AM J TRANSPLANT, V12, P2507, DOI 10.1111/j.1600-6143.2012.04138.x; Manoel ALD, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2749-2; Escudero D, 2015, ANAESTHESIA, V70, P1130, DOI 10.1111/anae.13065; Escudero D, 2015, MED INTENSIVA, V39, P366, DOI 10.1016/j.medin.2015.01.008; Escudero D, 2015, MED INTENSIVA, V39, P244, DOI 10.1016/j.medin.2014.11.005; Escudero D, 2009, MED INTENSIVA, V33, P185, DOI 10.1016/S0210-5691(09)71215-X; Escudero D, 2009, NEUROCRIT CARE, V11, P261, DOI 10.1007/s12028-009-9243-7; Galbois A, 2013, TRANSPL INT, V26, P517, DOI 10.1111/tri.12084; Gross BA, 2019, JAMA-J AM MED ASSOC, V321, P1295, DOI 10.1001/jama.2019.2413; Hallevi H, 2009, CRIT CARE MED, V37, P969, DOI 10.1097/CCM.0b013e318198683a; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Holloway RG, 2014, STROKE, V45, P1887, DOI 10.1161/STR.0000000000000015; Humbertjean L, 2016, TRANSPL INT, V29, P299, DOI 10.1111/tri.12695; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Jansen NE, 2012, TRANSPL INT, V25, P830, DOI 10.1111/j.1432-2277.2012.01505.x; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P341, DOI 10.3340/jkns.2009.45.6.341; Kimberly WT, 2020, NEUROCRIT CARE, V32, P84, DOI 10.1007/s12028-019-00841-1; Koenig Matthew A, 2019, Handb Clin Neurol, V161, P89, DOI 10.1016/B978-0-444-64142-7.00042-4; Kompanje EJO, 2014, INTENS CARE MED, V40, P1387, DOI 10.1007/s00134-014-3398-1; LoPresti MA, 2014, J NEUROL SCI, V345, P3, DOI 10.1016/j.jns.2014.06.057; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1432-0; Martin-Delgado MC, 2019, AM J TRANSPLANT, V19, P1782, DOI 10.1111/ajt.15253; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; van Donkelaar CE, 2019, STROKE, V50, P837, DOI 10.1161/STROKEAHA.118.023902; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; You SJ, 2019, STROKE, V50, P1409, DOI 10.1161/STROKEAHA.118.024403	36	0	0	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JAN	2022	46	1					1	7					7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YD3LZ	WOS:000740277500001	34802992				2022-02-06	
J	Farhat, I; Moore, L; Porgo, TV; Assy, C; Belcaid, A; Berthelot, S; Stelfox, HT; Gabbe, BJ; Lauzier, F; Clement, J; Turgeon, AF				Farhat, Imen; Moore, Lynne; Porgo, Teegwende Valerie; Assy, Coralie; Belcaid, Amina; Berthelot, Simon; Stelfox, Henry T.; Gabbe, Belinda J.; Lauzier, Francois; Clement, Julien; Turgeon, Alexis F.			Interhospital Variations in Resource Use Intensity for In-hospital Injury Deaths A Retrospective Multicenter Cohort Study	ANNALS OF SURGERY			English	Article						cohort study; deaths; end-of-life care; injury; resource use; trauma; trauma system; withdrawal of life-sustaining therapy	LIFE-SUSTAINING THERAPY; TRAUMATIC BRAIN-INJURY; CARE-UNIT; WITHDRAWAL; CENTERS	Objective: Evaluate interhospital variation in resource use for in-hospital injury deaths. Background: Significant variation in resource use for end-of-life care has been observed in the US for chronic diseases. However, there is an important knowledge gap on end-of-life resource use for trauma patients. Methods: We conducted a multicenter, retrospective cohort study of injury deaths following hospitalization in any of the 57 trauma centers in a Canadian trauma system (2013-2016). Resource use intensity was measured using activity-based costing (2016 $CAN) according to time of death (72 h, 3-14 d, >= 14 d). We used multilevel log-linear regression to model resource use and estimated interhospital variation using intraclass correlation coefficients (ICC). Results: Our study population comprised 2044 injury deaths. Variation in resource use between hospitals was observed for all 3 time frames (ICC = 6.5%, 6.6%, and 5.9% for < 72 h, 3-14 d, and >= 14 d, respectively). Interhospital variation was stronger for allied health services (ICC = 18 to 26%), medical imaging (ICC = 4 to 10%), and the ICU (ICC = 5 to 6%) than other activity centers. We observed stronger interhospital variation for patients < 65 years of age (ICC = 11 to 34%) than those >= 65 (ICC = 5 to 6%) and for traumatic brain injury (ICC = 5 to 13%) than other injuries (ICC = 1 to 8%). Conclusions: We observed variation in resource use intensity for injury deaths across trauma centers. Strongest variation was observed for younger patients and those with traumatic brain injury. Results may reflect variation in level of care decisions and the incidence of withdrawal of life-sustaining therapies.	[Farhat, Imen; Moore, Lynne; Porgo, Teegwende Valerie; Assy, Coralie; Turgeon, Alexis F.] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Farhat, Imen; Moore, Lynne; Porgo, Teegwende Valerie; Assy, Coralie; Berthelot, Simon; Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Ctr Rech,CHU Quebec,Hop Enfant Jesus, Quebec City, PQ, Canada; [Belcaid, Amina; Clement, Julien] Inst Natl Excellence Sante & Serv Sociaux INESSS, Quebec City, PQ, Canada; [Berthelot, Simon] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Dept Med & Community Hlth Sci, Calgary, AB, Canada; [Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Clement, Julien] Univ Laval, Dept Surg, Quebec City, PQ, Canada		Farhat, I (corresponding author), Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada.; Farhat, I (corresponding author), Univ Laval, Populat Hlth & Optimal Hlth Practices Res Unit, Trauma Emergency Crit Care Med, Ctr Rech,CHU Quebec,Hop Enfant Jesus, Quebec City, PQ, Canada.	imen.farhat.1@ulaval.ca			Fonds de Recherche du Quebec -Sante (FRQS) [112775]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [358052]; FRQS	This study was funded by Fonds de Recherche du Quebec -Sante (FRQS) (grant #112775) and the Canadian Institutes of Health Research (CIHR) (grant #358052). Dr LM, SB, and FL are recipients of a research salary award from the FRQS. Dr AFT is the chairholder of the Canada Research Chair in Critical Care Neurology and Trauma.	Campbell MK, 2005, CLIN TRIALS, V2, P99, DOI 10.1191/1740774505cn071oa; Canby JBt, 1995, HEALTHC FINANC MANAG, V49, P4; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Centers for Disease Control and Prevention, COST INJ VIOL US 201; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 10 LEAD CAUS DEATH A; Chan Y C, 1993, Health Care Manage Rev, V18, P71; Chernick M. R., 2011, INT ENCY STAT SCI, P169, DOI [10.1007/978-3-642-04898-2_150, DOI 10.1007/978-3-642-04898-2_150]; Committee on Trauma American College of Surgeons, 2014, RESOURCES OPTIMAL CA; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fakhry SM, 2013, J AM COLL SURGEONS, V216, P607, DOI 10.1016/j.jamcollsurg.2012.12.031; Franklin GA, 2011, SURGERY, V150, P854, DOI 10.1016/j.surg.2011.07.065; Gerges PRA, 2018, CAN J ANESTH, V65, P996, DOI 10.1007/s12630-018-1171-6; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mark NM, 2015, INTENS CARE MED, V41, P1572, DOI 10.1007/s00134-015-3810-5; Ministere de la Sante et des Services sociaux, 1987, CADR NORM SYST MED E; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore L, 2016, JAMA SURG, V151, P622, DOI 10.1001/jamasurg.2015.5484; Moore Lynne, 2013, J Emerg Trauma Shock, V6, P95, DOI 10.4103/0974-2700.110754; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Statistics Canada, 2017, HLTH FACT SHEETS 10; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thomas JW, 2004, RISK ADJUSTMENT MEAS; Trauma Association of Canada, 2011, TRAUM SYST ACCR GUID; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; World Health Organization, 2014, INJ VIOL FACTS 2014	31	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JAN	2022	275	1					E107	E114		10.1097/SLA.0000000000003922			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XP3UD	WOS:000730792700036	32398484				2022-02-06	
J	Ferraro, FR; Feltman, K				Ferraro, F. Richard; Feltman, Kathryn			Does having had a concussion aid in knowing about concussion knowledge?	CURRENT PSYCHOLOGY			English	Article						Concussion; College students; Concussion knowledge	BRAIN-INJURY	Students who self-reported having had a concussion (C, n = 25) or not having had a concussion (NC, n = 63) took the Sports Concussion Knowledge questionnaire (9 true statements/17 false statements about concussions), responding true or false to each statement and indicating their confidence level (0-100%) in their answer. They also took the Executive Function Index. Groups did not differ on TT statements (true statements responded to as true) and TF statements (true statements responded to as false), F's < 1.0. However, for the FF statements (false statements responded to as false), the C group (79% correct) was more accurate than the NC group (74% correct; p < .05). Confidence levels were high for both groups (78-80%). For the FT statements (false statements responded to as being true), the C group (21% errors) was more accurate than the NC group (26% errors; p < .05). Confidence levels were, again, high 70%. No group differences emerged for the EFI. Those in the C group a) were more accurate when indicating a false statement was false and b) displayed less misconception about Sports Concussions. In some cases, having had a concussion facilitates concussion knowledge.	[Ferraro, F. Richard; Feltman, Kathryn] Univ North Dakota, Dept Psychol, Sch Med & Hlth Sci, 2921 Columbia Hall,501 N Columbia Rd,Stop 8380, Grand Forks, ND 58202 USA; [Feltman, Kathryn] US Army, Aeronaut Res Lab, Ft Rucker, AL USA		Ferraro, FR (corresponding author), Univ North Dakota, Dept Psychol, Sch Med & Hlth Sci, 2921 Columbia Hall,501 N Columbia Rd,Stop 8380, Grand Forks, ND 58202 USA.	f.richard.ferraro@email.und.edu					Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Kurowski BG., 2014, J TRAUMA INJURY INFE, V50, P209; Lee HR, 2016, INT J ATHL THER TRAI, V21, P53, DOI 10.1123/ijatt.2014-0087; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Randolph C., 1998, REPEATABLE BATTERY A; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn	11	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	JAN	2022	41	1					86	89		10.1007/s12144-019-0163-1			4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	YC8TP	WOS:000739958700008					2022-02-06	
J	Fraser, MA; Kilchrist, LM; Kuo, MC				Fraser, Melissa A.; Kilchrist, Leah M.; Kuo, Michael			Concussion Baseline Retesting Is Necessary When Initial Scores Are Low	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						CNS Vital Signs; NeuroCom; Senaptec Sensory Station; symptoms; nearpoint convergence; coordination	SPORT-RELATED CONCUSSION; COMPUTERIZED DYNAMIC POSTUROGRAPHY; SENSORY ORGANIZATION TEST; HIGH-SCHOOL; RELIABILITY; PERFORMANCE; ABILITIES; RECOVERY; VALIDITY	Objective: To determine whether (1) initial baseline scores are significantly better for those who have valid (initial valid) versus invalid scores (initial invalid) on their concussion baseline testing, (2) retesting results in significantly improved baseline scores, and (3) there is a significant difference in scores between those who have valid scores on their initial attempt and those who retook baseline tests (retest valid). Design: Prospective, repeated-measures. Setting: Two years of collegiate preparticipation concussion baseline testing. Participants: Five hundred forty-seven male and female Division I collegiate athletes (19.02 +/- 1.31 years, female = 217). Independent Variables: Participants were divided into initial valid and initial invalid. The retest group was further divided into their initial (initial invalid) and final valid attempt (retest valid). Main Outcome Measures: Data were analyzed to determine the relationship between the 3 groups and overall initial and final scores on 28 individual items: total symptoms score, coordination, near-point convergence, CNS Vital Signs (CNSVS), Senaptec Sensory Station, and Neurocom Sensory Organization Test (SOT). Results: The initial valid group scored significantly better than the initial invalid group on 8 CNSVS items and 5 Senaptec items (P < 0.002). The retest valid scores were significantly better compared with the initial invalid scores on 17 items (P < 0.002). Conclusions: Retesting is recommended for individuals who score below acceptable ranges. This is important because athletes may experience a learning effect and are highly motivated during postinjury testing, so accurate baseline scores are imperative for athlete safety. Completion time for the coordination test may be a more informative option.	[Fraser, Melissa A.; Kilchrist, Leah M.; Kuo, Michael] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX 78666 USA		Fraser, MA (corresponding author), Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX 78666 USA.	missyfraser@txstate.edu					Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Anderson MN, 2020, BRAIN INJURY, V34, P369, DOI 10.1080/02699052.2020.1724332; Bernstein J, 2009, AM J AUDIOL, V18, P34, DOI 10.1044/1059-0889(2009/08-0024); Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2009, ARCH PHYS MED REHAB, V90, P145, DOI 10.1016/j.apmr.2008.06.025; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; French J, 2019, AM J SPORT MED, V47, P3263, DOI 10.1177/0363546519875137; Gao YP, 2015, OPTOMETRY VISION SCI, V92, P679, DOI 10.1097/OPX.0000000000000599; Gilrein TE., 2014, THESIS U N CAROLINA; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Krasich K, 2016, J MOTOR BEHAV, V48, P401, DOI 10.1080/00222895.2015.1113918; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Pawlukiewicz A, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117734496; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Phillips JT R, 2015, J EYE MOVEMENT RES, V8, P1; Pletcher ER, 2017, J ATHL TRAINING, V52, P129, DOI 10.4085/1062-6050-52.1.05; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Walton SR, 2018, MED SCI SPORT EXER, V50, P1377, DOI 10.1249/MSS.0000000000001592; Wang LL, 2015, ACTA PSYCHOL, V157, P74, DOI 10.1016/j.actpsy.2015.02.005; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	39	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					E40	E51		10.1097/JSM.0000000000000872			12	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000014	33239512				2022-02-06	
J	Garay, M; Silver, J; Reynolds, AW; Hess, J; Armstrong, D; Hennrikus, W				Garay, Mariano; Silver, Jeremy; Reynolds, Alan W.; Hess, Joseph; Armstrong, Douglas; Hennrikus, William			Golf cart injuries in children: the experience of trauma centers in a single state in the USA	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						concussion; fracture; golf carts; intracranial hemorrhage; trauma	EJECTION; HEAD	Golf carts remain a source of morbidity in children. We aimed to establish the incidence and injury characteristics of pediatric patients injured due to golf cart usage over an 11-year period. This is a retrospective study using a single state trauma database of patients ages 0-17 years admitted to a trauma center and who sustained injures while a golf cart was in use. Thirteen Pediatric and Adult Trauma Centers within the state of Pennsylvania were evaluated from 1 January 2004 to 31 December 2014. The inclusion criteria were met by 108 patients. The mean annual incidence of injuries was 0.35/100 000. The median age of patients was 11 years. The median hospital length of stay and injury severity score were 2 days and 9.5, respectively. The majority of the patients (75.9%) sustained at least one bone fracture. Skull fractures were more prevalent (43.5%), whereas extremity fractures were sustained by 26.9% of patients. Intracranial hemorrhages were sustained by 29.6% of patients. Ejections and rollovers accounted for 58.3% and 31.4% of patient injuries, respectively. The concussion rate was 26.9%. Neither age group nor sex was associated with a difference in fractures, intracranial hemorrhage or concussions. Golf cart injuries in pediatric patients commonly stem from ejections and rollover mechanisms resulting in skull fractures, extremity fractures, intracranial hemorrhages and concussions. The overall incidence of injury was 0.35 cases per 100 000. Further efforts are needed to increase awareness of these injuries and modify regulations regarding the use of golf carts in the pediatric population.	[Garay, Mariano; Reynolds, Alan W.] Allegheny Gen Hosp, Dept Orthopaed Surg, Pittsburgh, PA 15212 USA; [Silver, Jeremy] Penn State Univ, Penn State Coll Med, Coll Med, Hershey, PA USA; [Hess, Joseph] Penn State Hershey Childrens Hosp, Div Pediat Surg, Hershey, PA USA; [Armstrong, Douglas] Penn State Hershey Med Ctr, Dept Orthopaed Surg, 30 Hope Dr,Bldg A, Hershey, PA 17033 USA; [Hennrikus, William] Penn State Hershey Med Ctr, Penn State Coll Med, Dept Orthopaed Surg, Hershey, PA USA		Hennrikus, W (corresponding author), Penn State Hershey Med Ctr, Dept Orthopaed Surg, 30 Hope Dr,Bldg A, Hershey, PA 17033 USA.	WLH5k@hotmail.com	liu, ting/AAA-1112-2022	Reynolds, Alan/0000-0003-4252-7321			Ahmad A., 2008, AAP NEWS, V29, P17; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Denning GM, 2014, PEDIATRICS, V134, P1094, DOI 10.1542/peds.2014-1993; Denning GM, 2013, INJURY PREV, V19, P250, DOI 10.1136/injuryprev-2012-040548; Kelly EG, 1996, ORTHOPEDICS, V19, P519; Linnaus ME, 2017, J PEDIATR SURG, V52, P327, DOI 10.1016/j.jpedsurg.2016.09.003; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Miller B, 2016, INT J PEDIATR OTORHI, V88, P38, DOI 10.1016/j.ijporl.2016.06.041; Miller BL, 2011, OTOLARYNG HEAD NECK, V144, P883, DOI 10.1177/0194599810396790; Passaro K T, 1996, Inj Prev, V2, P124, DOI 10.1136/ip.2.2.124; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Schau K, 2013, ACCIDENT ANAL PREV, V59, P574, DOI 10.1016/j.aap.2013.07.025; Sciarretta JD, 2016, AM SURGEON, V82, pE36; Seluga KJ, 2006, ACCIDENT ANAL PREV, V38, P1151, DOI 10.1016/j.aap.2006.04.023; Seluga KJ, 2005, ACCIDENT ANAL PREV, V37, P801, DOI 10.1016/j.aap.2005.03.022; Seluga KJ, 2009, ACCIDENT ANAL PREV, V41, P839, DOI 10.1016/j.aap.2009.04.017; Senate Bill 785, 2017, SENATE BILL 785; Shannon SF, 2018, J PEDIATR ORTHOPED, V38, P403, DOI 10.1097/BPO.0000000000000838; Starnes JR, 2018, AM J EMERG MED, V36, P1049, DOI 10.1016/j.ajem.2018.03.002; Swischuk LE, 2010, EMERG RADIOL, V17, P257, DOI 10.1007/s10140-010-0857-z; Topping J., 2020, GROUP, P1; Tracy BM, 2020, J PEDIATR SURG, V55, P451, DOI 10.1016/j.jpedsurg.2018.04.042; U.S. Census Bureau, 2010, INT EST RES POP COUN; U.S. Census Bureau Population Division, 2019, ANN EST RES POP SEL; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029; White LC, 2013, INT J PEDIATR OTORHI, V77, P414, DOI 10.1016/j.ijporl.2012.11.043	26	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2022	31	1					E44	E48		10.1097/BPB.0000000000000884			5	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Pediatrics	XF6LP	WOS:000724181300015	34101676				2022-02-06	
J	Gardner, A; McLean, TW; Winslow, JE				Gardner, Alison; McLean, Thomas W.; Winslow, James E. I. I. I. I. I. I.			Computed Tomography Scans in Children With Hemophilia After Minor Head Trauma	PEDIATRIC EMERGENCY CARE			English	Article						hemophilia; head injury; traumatic brain injury	INTRACRANIAL HEMORRHAGE; POPULATION; RADIATION; CANCER	Objectives Children with hemophilia have the usual childhood risk of falls and head trauma. Head computed tomographies (HCTs) are fast, detailed, and readily available, but increased radiation exposure in the pediatric population is now recognized as causing increased brain malignancy. By examining the incidence of intracranial cerebral hemorrhage in this population, we will be able to weigh risks and benefits of HCT use more accurately. Methods Using a retrospective chart review, we examined past medical records of pediatric patients, aged 0 to 15 years, with hemophilia presenting to 1 academic medical center. Primary outcomes included number of head CTs ordered, total and per patient over the years studied, and the incidence of positive findings, as defined by presence of blood products as documented by radiologist final read/interpretation. Results The mean number of head CTs per child was 2.5 (range, 1-10). None of the HCT scans were read as intracranial cerebral hemorrhage, and none of the patients had findings that lead to neurosurgical intervention. In a sensitivity analysis, applying Pediatric Emergency Care Applied Research Network head injury criteria, 11 HCT scans would be ordered for a reduction of 80 HCTs, or a decrease of 2 HCT scans per child. No incidence of intracranial cerebral hemorrhage would have been missed. Conclusions Our findings suggest that in the child with hemophilia and a history of minor head trauma, exposure to the radiation of a HCT based on the diagnosis of hemophilia alone may not be necessary but that imaging decisions need to be made in conjunction with clinical examination findings and neurologic status.	[Gardner, Alison] Wake Forest Baptist Hlth, Dept Pediat & Emergency Med, Winston Salem, NC USA; [McLean, Thomas W.] Wake Forest Baptist Hlth, Dept Pediat Hematol Oncol, Winston Salem, NC USA; [Winslow, James E. I. I. I. I. I. I.] Wake Forest Baptist Hlth, Dept Emergency Med, Winston Salem, NC USA		Gardner, A (corresponding author), Wake Forest Sch Med, Dept Emergency Med & Pediat, Med Ctr Blvd, Winston Salem, NC 27157 USA.	agardner@wakehealth.edu					Antunes SV, 2003, HAEMOPHILIA, V9, P573, DOI 10.1046/j.1365-2516.2003.00789.x; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; DIETRICH AM, 1994, J PEDIATR SURG, V29, P28, DOI 10.1016/0022-3468(94)90517-7; EYSTER ME, 1978, BLOOD, V51, P1179; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nelson MD, 1999, HAEMOPHILIA, V5, P306; Traivaree C, 2007, HAEMOPHILIA, V13, P552, DOI 10.1111/j.1365-2516.2007.01545.x; Witmer CM, 2009, PEDIATR BLOOD CANCER, V53, P406, DOI 10.1002/pbc.22126	11	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E27	E28		10.1097/PEC.0000000000002595			2	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600013	34986584				2022-02-06	
J	Glass, NE; Riccardi, J; Horng, H; Kacprzynski, G; Sifri, Z				Glass, Nina E.; Riccardi, Julia; Horng, Helen; Kacprzynski, Gregory; Sifri, Ziad			Platelet dysfunction in patients with traumatic intracranial hemorrhage: Do desmopressin and platelet therapy help or harm?	AMERICAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Antiplatelet therapy; Outcomes research	ANTIPLATELET AGENTS; BRAIN-INJURY; PREINJURY ANTICOAGULANTS; IMPROVE OUTCOMES; TRANSFUSION; CLOPIDOGREL; MORTALITY; IMPACT; RISK; CARE	Background: Pre-injury anti-platelet use has been associated with increased risk of progression of traumatic intracranial hemorrhage (TICH) and worse outcomes. VerifyNow (R) assays assess platelet inhibition due to aspirin/clopidogrel. This study assesses the outcomes of patients with TICH and platelet dysfunction treated with desmopressin and/or platelets. Methods: We performed a retrospective chart review of patients with mild TICH at a level 1 trauma center 1/1/2013-6/1/2016. Patients with documented platelet dysfunction who received desmopressin and/or platelets were compared to those who were untreated. Primary outcomes were progression of TICH and neurologic outcomes at discharge. Results: Of 565 patients with a mild TICH, 200 patients had evidence of platelet dysfunction (a positive VerifyNow (R) assay). Patients had similar baseline demographics, injury characteristics, and rate of TICH progression; but patients who received desmopressin and/or platelets had worse Glasgow Outcomes Score at discharge. Conclusion: Treatment of patients with mild TICH and platelet dysfunction with desmopressin and/or platelets did not affect TICH progression but correlated with worse neurologic status at discharge. (C) 2021 Elsevier Inc. All rights reserved.	[Glass, Nina E.; Riccardi, Julia; Kacprzynski, Gregory; Sifri, Ziad] Rutgers New Jersey Med Sch, Div Trauma & Surg Crit Care, Dept Surg, 185 S Orange Ave, Newark, NJ 07101 USA; [Horng, Helen] Univ Hosp, Clin Pharm, 150 Bergen St, Newark, NJ 07101 USA; [Riccardi, Julia] Univ Calif Davis, Dept Surg, 2335 Stockton Blvd, Sacramento, CA 95817 USA; [Kacprzynski, Gregory] Rutgers Robert Wood Johnson Med Sch, Dept Emergency Med, MEB 104,One Robert Wood Johnson Pl, New Brunswick, NJ 08903 USA		Glass, NE (corresponding author), Rutgers New Jersey Med Sch, Div Trauma & Surg Crit Care, Dept Surg, 185 S Orange Ave, Newark, NJ 07101 USA.	ng470@njms.rutgers.edu; jriccardi@ucdavis.edu; hornghs@uhnj.org; gregkac@njms.rutgers.edu; sifrizi@njms.rutgers.edu		Glass, Nina/0000-0002-6821-4289			[Anonymous], 2015, C TRAUM BRAIN INJ US; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Bhatt DL, 2011, INTERVENT CARDIOL, V3, P515; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Brogi E, 2020, WORLD NEUROSURG, V141, P455, DOI 10.1016/j.wneu.2020.03.216; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Downey DM, 2009, AM SURGEON, V75, P1100; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Francoeur CL, 2019, J NEUROSURG, V130, P502, DOI 10.3171/2017.7.JNS17990; Godino C, 2009, THROMB J, V7, DOI 10.1186/1477-9560-7-4; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Karve S, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/846163; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Klauber, J NEUROTRAUMA S1, P6292; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Kulvatunyou N., 2019, J SURG REV, V236, P224; MAJOR J, 2009, THE J, V26, P871; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Reddy S, 2014, AM SURGEON, V80, P975; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Ste vcrberg, 2005, NEUROSURGERY, VLK6657, pi011; Suzuki Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097328; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zarrin DA, 2019, NEUROSURGERY, V85, P543	39	0	0	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2022	223	1					131	136		10.1016/j.amjsurg.2021.07.050			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XQ6JZ	WOS:000731653700024	34446216				2022-02-06	
J	Haddadi, K; Moradi, S; Asadian, L; Montazer, SH; Hosseininejad, SM; Golikhatir, I; Kenari, SA; Alaee, A; Bozorgi, F				Haddadi, Kaveh; Moradi, Siavash; Asadian, Leila; Montazer, Seyed Hosein; Hosseininejad, Seyed Mohammad; Golikhatir, Iraj; Kenari, Saeid Abedian; Alaee, Abdulrassol; Bozorgi, Farzad			Aldolase C Profiling in Serum after Mild Traumatic Brain Injury: A Prospective Cohort Study	IRANIAN JOURNAL OF MEDICAL SCIENCES			English	Article						Serum; Brain injuries; Traumatic; Biomarker	FIBRILLARY ACIDIC PROTEIN; TERMINAL HYDROLASE-L1; COMPUTED-TOMOGRAPHY; CEREBROSPINAL-FLUID; BIOMARKERS; S100B; GFAP; PANEL	Background: After a traumatic brain injury (TBI), in addition to clinical indices, the serum level of neurological biomarkers may provide valuable diagnostic and prognostic information. The present study aimed to investigate the aldolase C (ALDOC) profile in serum for early diagnosis of brain damage in patients with mild TBI (mTBI) presented to the Emergency Department (ED). Methods: A single-center prospective cohort study was carried out in 2018-2019 at Imam Khomeini Hospital affiliated with Mazandaran University of Medical Sciences, Sari, Iran. A total of 89 patients with mTBI were enrolled in the study. Blood samples were taken within three hours after head trauma to measure ALDOC serum levels. Brain CT scan was used as the gold standard. Statistical analysis was performed using the Kruskal Wallis, Mann-Whitney U, and Chi square tests. The receiver-operating characteristic (ROC) curve plot was used to determine the optimal cutoff point for ALDOC. The sensitivity and specificity of the determined cutoff point were calculated. P values less than 0.05 were considered statistically significant. Results: Of the 89 patients, the CT scan findings showed a positive TBI in 30 (33.7%) of the patients and in 59 (66.3%) a negative TBI. The median ALDOC serum level in the patients with positive CT scan findings (8.35 ng/mL [IQR: 1.65]) was significantly higher than those with negative CT scan findings (5.3 ng/mL [IQR: 6.9]) (P<0.001). The optimal cutoff point for ALDOC serum level was 6.95 ng/mL, and the area under the curve was 99.6% (P<0.001). The sensitivity and specificity of the determined cutoff point were 100% and 98%, respectively. Conclusion: The ALDOC serum level in patients with mTBI significantly correlates with the pathologic findings of the brain CT scan. This biomarker, with 100% sensitivity, is a suitable tool to detect brain structural abnormalities in mTBI patients.	[Haddadi, Kaveh] Mazandaran Univ Med Sci, Orthoped Res Ctr, Sch Med, Dept Neurosurg, Sari, Iran; [Moradi, Siavash] Mazandaran Univ Med Sci, Educ Dev Ctr, Sch Med, Sari, Iran; [Asadian, Leila] Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran; [Montazer, Seyed Hosein; Bozorgi, Farzad] Mazandaran Univ Med Sci, Orthoped Res Ctr, Sch Med, Dept Emergency Med, Sari, Iran; [Hosseininejad, Seyed Mohammad] Mazandaran Univ Med Sci, Diabet Res Ctr, Sch Med, Dept Emergency Med, Sari, Iran; [Golikhatir, Iraj] Mazandaran Univ Med Sci, Sch Med, Dept Emergency Med, Sari, Iran; [Kenari, Saeid Abedian] Mazandaran Univ Med Sci, Immunogenet Res Ctr, Sari, Iran; [Alaee, Abdulrassol] Mazandaran Univ Med Sci, Sch Med, Dept Radiol, Sari, Iran		Bozorgi, F (corresponding author), Imam Khomeini Hosp, Dept Emergency, Amir Mazandarani Ave, Sari 4816633131, Iran.	emergencmed@yahoo.com					Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Ichkova A, 2017, J CEREBR BLOOD F MET, V37, P3276, DOI 10.1177/0271678X17724683; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; ONeil ME, 2013, COMPLICATIONS MILD T, DOI [10.1017/S135561771300146X, DOI 10.1017/S135561771300146X]; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	31	0	0	0	0	SHIRAZ UNIV MEDICAL SCIENCES	SHIRAZ	ZAND ST, SHIRAZ, FARS 00000, IRAN	0253-0716	1735-3688		IRAN J MED SCI	Iran. J. Med. Sci.	JAN	2022	47	1					33	39		10.30476/ijms.2021.87692.1831			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	YD0DR	WOS:000740052800005	35017775				2022-02-06	
J	Hakiminia, B; Alikiaie, B; Khorvash, F; Mousavi, S				Hakiminia, Bahareh; Alikiaie, Babak; Khorvash, Fariborz; Mousavi, Sarah			Targeting Mitochondrial and Brain Injury Markers in Acquired Brain Injuries: A Randomized, Double-Blind, Placebo-Controlled Study with Melatonin	ADVANCED PHARMACEUTICAL BULLETIN			English	Article						Brain injury; Melatonin; Mitochondria; Oxidative stress	OXIDATIVE STRESS; CIRCADIAN-RHYTHM; PATHOPHYSIOLOGY; STROKE; DELIRIUM; DAMAGE; MODEL	Purpose: Oxidative stress-induced mitochondrial damage is the main event in acquired brain injuries (ABI). This study aimed to evaluate the effects of melatonin, a mitochondria-targeted antioxidant, on mitochondrial and brain injury markers, and the clinical outcomes of patients with ABI. Methods: In this randomized controlled trial, intensive care unit (ICU) or neurology patients with ABI (n=60) received melatonin (21 mg/day) or placebo tablets, within the first 72 hours of injury onset for five days. As a primary endpoint, serum levels of malondialdehyde (MDA), S100B and C-reactive protein (CRP) were compared at baseline, and after five days' intervention. Secondary endpoints included assessment of Glasgow Coma Scale (GCS) and sequential organ failure assessment (SOFA) (at the end of day 5), Rancho Los Amigos Revised Scale (RLAS-R) and modified Rankin Scale (mRS) (at the end of month 3), the duration of mechanical ventilation, the lengths of ICU and hospital stays, and in-hospital and three-month mortality. Results: There were no significant effects of melatonin on the primary and secondary outcomes. However, the subgroup analysis showed a significant reduction in S100B in patients with non-traumatic brain injuries, receiving melatonin versus placebo (P: 0.016). Conclusion: This study showed that melatonin supplementation in the early phase of brain injury had no significant effects on the injury markers and clinical outcomes of patients with ABI. However, it reduced the level of S100B in the non-traumatic subgroup. Further larger-scale studies are needed to determine the effects of melatonin on the ABI and its subgroups.	[Hakiminia, Bahareh; Mousavi, Sarah] Isfahan Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm & Pharm Practice, Esfahan, Iran; [Alikiaie, Babak] Isfahan Univ Med Sci, Alzahra Hosp, Dept Anesthesiol & Intens Care, Esfahan, Iran; [Khorvash, Fariborz] Isfahan Univ Med Sci, Alzahra Hosp, Dept Neurol, Esfahan, Iran		Mousavi, S (corresponding author), Isfahan Univ Med Sci, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm & Pharm Practice, Esfahan, Iran.	s.mousavi@pharm.mui.ac.ir		Hakiminia, Bahareh/0000-0003-2669-2837	Isfahan University of Medical Sciences [397732]	This study was granted by the research deputy of Isfahan University of Medical Sciences (grant number: 397732) .	Acuna-Castroviejo D, 2003, ADV EXP MED BIOL, V527, P549; Altun A, 2007, INT J CLIN PRACT, V61, P835, DOI 10.1111/j.1742-1241.2006.01191.x; Anumakonda V, 2017, EC PULMONOL RESP MED, V3, P151; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Bellapart J, 2012, BRIT J ANAESTH, V108, P572, DOI 10.1093/bja/aes035; Bhattacharya P, 2014, LIFE SCI, V100, P97, DOI 10.1016/j.lfs.2014.01.085; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Dessap AM, 2015, CHEST, V148, P1231, DOI 10.1378/chest.15-0525; Dianatkhah M., 2017, THESIS TEHRAN U MED; Dianatkhah M, 2017, J RES PHARM PRACT, V6, P173, DOI 10.4103/jrpp.JRPP_17_49; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dorman PJ, 1996, STROKE, V27, P1507, DOI 10.1161/01.STR.27.9.1507; Duberley KEC, 2013, J INHERIT METAB DIS, V36, P63, DOI 10.1007/s10545-012-9511-0; Engstrom ALL, 2010, SCAND J OCCUP THER, V17, P233, DOI [10.1080/11038120903191806, 10.3109/11038120903191806]; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Foley HM, 2019, COMPLEMENT THER MED, V42, P65, DOI 10.1016/j.ctim.2018.11.003; Gariballa SE, 2002, QJM-INT J MED, V95, P685, DOI 10.1093/qjmed/95.10.685; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gitto E, 2001, PEDIATR RES, V50, P756, DOI 10.1203/00006450-200112000-00021; Guo ZN, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01146; Hagen C, 1972, LEVELS COGNITIVE FUN, P6; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Hosseinjani H, 2018, J IRANIAN SOC ANAEST, V40, P11; Ji MH, 2018, INFLAMMATION, V41, P515, DOI 10.1007/s10753-017-0708-0; Johr J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228474; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; Kurdi MS, 2013, INDIAN J ANAESTH, V57, P137, DOI 10.4103/0019-5049.111837; Lekic T, 2010, J NEUROTRAUM, V27, P627, DOI 10.1089/neu.2009.1163; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Mistraletti G, 2015, MINERVA ANESTESIOL, V81, P1298; Mistraletti G, 2010, J PINEAL RES, V48, P142, DOI 10.1111/j.1600-079X.2009.00737.x; Nunn A, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/9482876; Olofsson K, 2004, ACTA ANAESTH SCAND, V48, P679, DOI 10.1111/j.0001-5172.2004.00401.x; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Panahi Y, 2018, J PHARMACOPUNCT, V21, P226, DOI 10.3831/KPI.2018.21.026; Paprocka J, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/9626715; Pedreira PR, 2008, AM J PHYSIOL-LUNG C, V295, pL820, DOI 10.1152/ajplung.90211.2008; Pradeep H, 2012, FOLIA NEUROPATHOL, V50, P219, DOI 10.5114/fn.2012.30522; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ramos E, 2017, FREE RADICAL BIO MED, V104, P32, DOI 10.1016/j.freeradbiomed.2017.01.005; Reiter RJ, 2017, CELL MOL LIFE SCI, V74, P3863, DOI 10.1007/s00018-017-2609-7; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Rouini M, 2020, J PHARM CARE, V8, P3, DOI [10.18502/jpc.v8i1.2740, DOI 10.18502/JPC.V8I1.2740]; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Vaage J, 2001, J THORAC CARDIOV SUR, V122, P853, DOI 10.1067/mtc.2001.119055; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Vestri A, 2014, BRAIN INJURY, V28, P1102, DOI 10.3109/02699052.2014.910698; Wang ML, 2018, INTERACT CARDIOV TH, V26, P761, DOI 10.1093/icvts/ivx440; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Wu GC, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1325-2; Zhao L, 2015, J PINEAL RES, V59, P230, DOI 10.1111/jpi.12254	54	0	0	0	0	TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES	TABRIZ	DANESHGHAH ST, TABRIZ, REPUBLIC ISLAMIC 51664-14766, IRAN	2228-5881	2251-7308		ADV PHARM BULL	Adv. Pharm. Bull.		2022	12	1					118	127		10.34172/apb.2022.013			10	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	YB8SW	WOS:000739275800013		gold			2022-02-06	
J	Hasjim, BJ; Grigorian, A; Schubl, SD; Lekawa, M; Kim, D; Bernal, N; Nahmias, J				Hasjim, Bima J.; Grigorian, Areg; Schubl, Sebastian D.; Lekawa, Michael; Kim, Dennis; Bernal, Nicole; Nahmias, Jeffry			Helmets Protect Pediatric Bicyclists From Head Injury and Do Not Increase Risk of Cervical Spine Injury	PEDIATRIC EMERGENCY CARE			English	Article						trauma; traumatic brain injury; bicycle collision; head injury; nonhelmeted; spine injury; cervical spine injury; cervical spine fracture; spinal cord injury; cervical cord injury	BRAIN-INJURY; CHILDREN; MOTORCYCLE; LEGISLATION; MORTALITY; EXPERIENCE; FRACTURES; DEATHS; RACE	Objectives Only 21 states have mandatory helmet laws for pediatric bicyclists. This study sought to determine the incidence of helmeted riders among pediatric bicyclists involved in a collision and hypothesized the risk of a serious head and cervical spine injuries to be higher in nonhelmeted bicyclists (NHBs) compared with helmeted bicyclists (HBs). Methods The Pediatric Trauma Quality Improvement Program (2014-2016) was queried for pediatric (age <16 years) bicyclists involved in a collision. Helmeted bicyclists were compared with NHBs. A serious injury was defined by an abbreviated injury scale grade of greater than 2. Results From 3693 bicyclists, 3039 (82.3%) were NHBs. Compared with HBs, NHBs were more often Black (21.6% vs 3.8%, P < 0.001), Hispanic (17.5% vs 9.3%, P < 0.001), without insurance (4.6% vs 2.4%, P = 0.012), and had a higher rate of a serious head injury (24.6% vs 9.3%, P < 0.001). Both groups had similar rates of complications and mortality (P > 0.05). The associated risk of a serious head (odds ratio = 3.17, P < 0.001) and spine injury (odds ratio = 0.41, P = 0.012) were higher and lower respectively in NHBs. Associated risks for cervical spine fracture or cord injury were similar (P > 0.05). Conclusions Pediatric bicyclists involved in a collision infrequently wear helmets, and NHBs was associated with higher risks of serious head injury. However, the associated risk of serious spine injury among NHBs was lower. The associated risks for cervical spine fracture or cervical cord injuries were similar. Nonhelmeted bicyclists were more likely to lack insurance and to be Black or Hispanic. Targeted outreach programs may help decrease the risk of injury, especially in at-risk demographics.	[Hasjim, Bima J.; Grigorian, Areg; Schubl, Sebastian D.; Lekawa, Michael; Bernal, Nicole; Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, Irvine, CA 92717 USA; [Kim, Dennis] LA Cty Harbor UCLA Med Ctr, Div Trauma Acute Care Surg Surg Crit Care, Torrance, CA USA		Hasjim, BJ (corresponding author), Univ Calif Irvine, Irvine Med Ctr, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	bjhasjim@gmail.com					Ali B, 2019, BRAIN INJURY, V33, P1425, DOI 10.1080/02699052.2019.1631483; American College of Surgeons, TRAUM QUAL IMPR PROG; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Babcock L, 2018, PEDIATR EMERG CARE, V34, P677, DOI 10.1097/PEC.0000000000000819; Bergenstal John, 2012, W V Med J, V108, P78; BERGMAN AB, 1990, AM J DIS CHILD, V144, P727, DOI 10.1001/archpedi.1990.02150300127033; Castle SL, 2012, J SURG RES, V173, P327, DOI 10.1016/j.jss.2010.10.031; Centers for Disease Control and Prevention, 2017, WEB BAS INJ STAT QUE; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Dellinger AM, 2010, J SAFETY RES, V41, P375, DOI 10.1016/j.jsr.2010.05.003; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Goslar PW, 2008, J TRAUMA, V64, P190, DOI 10.1097/TA.0b013e3180f62eec; Gulack BC, 2015, SURGERY, V158, P556, DOI 10.1016/j.surg.2015.02.025; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Kaushik Ruchi, 2015, Inj Epidemiol, V2, P16; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Konrad CJ, 1996, J TRAUMA, V41, P854, DOI 10.1097/00005373-199611000-00016; Kraemer John D, 2016, Inj Epidemiol, V3, P21; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; Li GH, 2001, JAMA-J AM MED ASSOC, V285, P893, DOI 10.1001/jama.285.7.893; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; McAdams RJ, 2018, ACCIDENT ANAL PREV, V118, P11, DOI 10.1016/j.aap.2018.05.019; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Onen MR, 2015, J SPINE, V04; Ooi SS, 2011, ASIA-PAC J PUBLIC HE, V23, P608, DOI 10.1177/1010539511413750; Page PS, 2018, J NEUROSURG-SPINE, V28, P607, DOI 10.3171/2017.7.SPINE17540; Park GJ, 2019, INJURY, V50, P657, DOI 10.1016/j.injury.2019.01.030; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Scott LR, 2019, BRAIN INJURY, V33, P1597, DOI 10.1080/02699052.2019.1650201; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Shah S, 2007, INJURY PREV, V13, P316, DOI 10.1136/ip.2007.016048; Short SS, 2013, J SURG RES, V184, P383, DOI 10.1016/j.jss.2013.03.042; Sosin DM, 1996, PEDIATRICS, V98, P868; Sullins VF, 2014, J PEDIATR SURG, V49, P1000, DOI 10.1016/j.jpedsurg.2014.01.038; Teisch LF, 2015, PEDIATR SURG INT, V31, P1021, DOI 10.1007/s00383-015-3756-2; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Williams C, 2018, J SURG RES, V222, P231, DOI 10.1016/j.jss.2017.11.006	45	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E360	E364		10.1097/PEC.0000000000002290			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600085	33181791				2022-02-06	
J	He, XJ; Huang, YM; Liu, YC; Zhang, XC; Yue, PJ; Ma, XP; Miao, ZZ; Long, XB; Yang, YP; Wan, XY; Lei, J; Shu, K; Lei, T; Gan, C; Zhang, HQ				He, Xuejun; Huang, Yimin; Liu, Yanchao; Zhang, Xincheng; Yue, Pengjie; Ma, Xiaopeng; Miao, Zhuangzhuang; Long, Xiaobing; Yang, Yiping; Wan, Xueyan; Lei, Jin; Shu, Kai; Lei, Ting; Gan, Chao; Zhang, Huaqiu			BAY61-3606 attenuates neuroinflammation and neurofunctional damage by inhibiting microglial Mincle/Syk signaling response after traumatic brain injury	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						traumatic brain injury; microglia; BAY61-3606; macrophage-inducible C-type lectin/spleen tyrosine kinase/NF-kappa B signaling pathway; neuroinflammation	NLRP3 INFLAMMASOME; EXPRESSION; PATHWAY; CELLS	Neuroinflammatory processes mediated by microglial activation and subsequent neuronal damage are the hallmarks of traumatic brain injury (TBI). As an inhibitor of the macrophage-inducible C-type lectin (Mincle)/spleen tyrosine kinase (Syk) signaling pathway, BAY61-3606 (BAY) has previously demonstrated anti-inflammatory effects on some pathological processes, such as acute kidney injury, by suppressing the inflammatory macrophage response. In the present study, the potential effects of BAY on microglial phenotype and neuroinflammation after TBI were investigated. BAY (3 mg/kg) was first administered into mice by intraperitoneal injection after TBI induction in vivo and microglia were also treated with BAY (2 mu M) in vitro. The levels of inflammatory factors in microglia were assessed using reverse transcription-quantitative PCR and ELISA. Cortical neuron, myelin sheath, astrocyte and cerebrovascular endothelial cell markers were detected using immunofluorescence. The levels of components of the Mincle/Syk/NF-kappa B signaling pathway [Mincle, phosphorylated (p)-Syk and NF-kappa B], in addition to proteins associated with inflammation (ASC, caspase-1, TNF-alpha, IL-1 beta and IL-6), apoptosis (Bax and Bim) and tight junctions (Claudin-5), were measured via western blotting and ELISA. Migration and chemotaxis of microglial cells were evaluated using Transwell and agarose spot assays. Neurological functions of the mice were determined in vivo using the modified neurological severity scoring system and a Morris water maze. The results of the present study revealed that the expression levels of proteins in the Mincle/Syk/NF-kappa B signaling pathway (including Mincle, p-Syk and p-NF-kappa B), inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6), proteins involved in inflammation (ASC and caspase-1), apoptotic markers (Bax and Bim) and the tight junction protein Claudin-5 were significantly altered post-TBI. BAY treatment reversed these effects in both the cerebral cortex extract-induced cell model and the controlled cortical impact mouse model. BAY was also revealed to suppress activation of the microglial proinflammatory phenotype and microglial migration. In addition, BAY effectively attenuated TBI-induced neurovascular unit damage and neurological function deficits. Taken together, these findings provided evidence that BAY may inhibit the Mincle/Syk/NF-kappa B signaling pathway in microglia; this in turn could attenuate microglia-mediated neuroinflammation and improve neurological deficits following TBI.	[He, Xuejun; Huang, Yimin; Liu, Yanchao; Zhang, Xincheng; Yue, Pengjie; Ma, Xiaopeng; Miao, Zhuangzhuang; Long, Xiaobing; Yang, Yiping; Wan, Xueyan; Lei, Jin; Shu, Kai; Lei, Ting; Gan, Chao; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China		Gan, C; Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	zhanghq_04@yahoo.com; ganchao17@outlook.com			Natural Science Foundation of Hubei provinceNatural Science Foundation of Hubei Province [WJ2019Z008]; Natural Science Foundation of Tongji Hospital [2020JZKT651]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801235]	The present study was supported by the Natural Science Foundation of Hubei province (grant no. WJ2019Z008), the Natural Science Foundation of Tongji Hospital (grant no. 2020JZKT651) and the Natural Science Foundation of China (grant no. 81801235). In addition, The First Affiliated Hospital, School of Medicine, Shihezi University provided a stipend for Xuejun He.	Arumugam TV, 2017, J CEREBR BLOOD F MET, V37, P2098, DOI 10.1177/0271678X16661201; Barnhart CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124521; Begum G, 2018, GLIA, V66, P126, DOI 10.1002/glia.23232; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Cueto FJ, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03146; Drouin M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00251; Dzharullaeva AS, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/3835720; Fouad K, 2021, NAT REV NEUROL, V17, P53, DOI 10.1038/s41582-020-00436-x; He Y, 2015, STROKE, V46, P2277, DOI 10.1161/STROKEAHA.115.010088; Hong X, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106988; Huang YM, 2020, AM J TRANSL RES, V12, P6351; Ifuku M, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01031-3; Iizasa E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22620-3; Inoue T, 2017, KIDNEY INT, V91, P526, DOI 10.1016/j.kint.2016.11.026; Kawata K, 2012, J AUTOIMMUN, V39, P315, DOI 10.1016/j.jaut.2012.04.004; Kezic A, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6305439; Khan A, 2020, ORG BIOMOL CHEM, V18, P425, DOI 10.1039/c9ob02302j; Kim H, 2019, ADV SCI, V6, DOI 10.1002/advs.201900513; Kim JW, 2018, AM J PATHOL, V188, P967, DOI 10.1016/j.ajpath.2017.12.010; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146073; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; Li CJ, 2020, CANCER IMMUNOL RES, V8, P1004, DOI 10.1158/2326-6066.CIR-19-0782; Li Q, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.109007; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu ZH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176291; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Long XB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01761-0; Lv LL, 2017, KIDNEY INT, V91, P587, DOI 10.1016/j.kint.2016.10.020; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; N'diaye M, 2020, J CLIN INVEST, V130, P838, DOI 10.1172/JCI125857; Nam HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144218; Pandori WJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007923; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Rauen K, 2020, CRIT CARE MED, V48, P1157, DOI 10.1097/CCM.0000000000004387; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Roth S, 2016, CELL REP, V17, P2572, DOI 10.1016/j.celrep.2016.11.018; Schierwagen R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01352; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Shen C, 2015, RESTOR NEUROL NEUROS, V33, P531, DOI 10.3233/RNN-150514; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Tan RZ, 2020, FASEB J, V34, P15029, DOI 10.1096/fj.202000261RRR; Tanaka M, 2020, J EXP MED, V217, DOI 10.1084/jem.20192230; Tighe RM, 2018, AM J RESP CELL MOL, V59, P257, DOI 10.1165/rcmb.2017-0357OC; Tummler C, 2019, CANCERS, V11, DOI 10.3390/cancers11020202; Vaccari JCD, 2015, J NEUROTRAUM, V32, P228, DOI 10.1089/neu.2014.3436; Vazquez-Rosa E, 2020, P NATL ACAD SCI USA, V117, P27667, DOI 10.1073/pnas.2010430117; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Winston CN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01005; Wu HJ, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-020-02041-7; Xie Y, 2017, BRAIN BEHAV IMMUN, V60, P346, DOI 10.1016/j.bbi.2016.11.004; Xiong J, 2020, INT J MOL MED, V46, P1003, DOI 10.3892/ijmm.2020.4655	53	0	0	6	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	JAN	2022	49	1								10.3892/ijmm.2021.5060			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XC9FT	WOS:000722317200001	34751408	hybrid, Green Published			2022-02-06	
J	Huijben, JA; Pisica, D; Ceyisakar, I; Stocchetti, N; Citerio, G; Maas, AIR; Steyerberg, EW; Menon, DK; van der Jagt, M; Lingsma, HF				Huijben, Jilske A.; Pisica, Dana; Ceyisakar, Iris; Stocchetti, Nino; Citerio, Giuseppe; Maas, Andrew I. R.; Steyerberg, Ewout W.; Menon, David K.; van der Jagt, Mathieu; Lingsma, Hester F.		ICU Stratum	Pharmaceutical Venous Thrombosis Prophylaxis in Critically Ill Traumatic Brain Injury Patients	NEUROTRAUMA REPORTS			English	Article						intensive care units; traumatic brain injuries; venous thrombosis	DEEP-VEIN THROMBOSIS; ENOXAPARIN PROPHYLAXIS; CENTER-TBI; EFFICACY; HEPARIN; SAFETY; RISK; ANTICOAGULATION	The aims of this study are to describe the use of pharmaceutical venous thromboembolism (pVTE) prophylaxis in patients with traumatic brain injury (TBI) in Europe and study the association of pVTE prophylaxis with outcome. We included 2006 patients >= 18 years of age admitted to the intensive care unit from the CENTER-TBI study. VTE events were recorded based on clinical symptoms. Variation between 54 centers in pVTE prophylaxis use was assessed with a multi-variate random-effect model and quantified with the median odds ratio (MOR). The association between pVTE prophylaxis and outcome (Glasgow Outcome Scale-Extended at 6 months) was assessed at center level with an instrumental variable analysis and at patient level with a multi-variate proportional odds regression analysis and a propensity-matched analysis. A time-dependent Cox survival regression analysis was conducted to determine the effect of pVTE prophylaxis on survival during hospital stay. The association between VTE prophylaxis and computed tomography (CT) progression was assessed with a logistic regression analysis. Overall, 56 patients (2%) had a VTE during hospital stay. The majority, 1279 patients (64%), received pVTE prophylaxis, with substantial between-center variation (MOR, 2.7; p < 0.001). A moderate association with improved outcome was found at center level (odds ratio [OR], 1.2 [0.7-2.1]) and patient level (multi-variate adjusted OR, 1.4 [1.1-1.7], and propensity adjusted OR, 1.5 [1.1-2.0]), with similar results in subgroup analyses. Survival was higher with the use of pVTE prophylaxis (p < 0.001). We found no clear effect on CT progression (OR, 0.9; CI [0.6-1.2]). Overall, practice policies for pVTE prophylaxis vary substantially between European centers, whereas pVTE prophylaxis may contribute to improved outcome.Trial registration number is NCT02210221 at ClinicalTrials.gov, registered on August 6, 2014 (first patient enrollment on December 19, 2014).	[Huijben, Jilske A.; Pisica, Dana; Ceyisakar, Iris; Steyerberg, Ewout W.; Lingsma, Hester F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, POB 2040, NL-3000 CA Rotterdam, Netherlands; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Erasmus MC, Dept Intens Care Adults, Rotterdam, Netherlands; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Milan, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care, Monza, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England		Huijben, JA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.a.huijben@erasmusmc.nl					Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CENTER-TBI, 2021, ETH APPR; Chelladurai Yohalakshmi, 2013, F1000Res, V2, P132, DOI 10.12688/f1000research.2-132.v1; Cnossen MC, 2018, CLIN EPIDEMIOL, V10, P841, DOI 10.2147/CLEP.S154500; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wahl WL, 2011, J TRAUMA, V71, P399; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	25	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JAN 1	2022	2	1					4	14		10.1089/neur.2021.0037			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YE0QZ	WOS:000740838400001	35112104	gold			2022-02-06	
J	Islam, MN; Thosingha, O; Danaidutsadeekul, S; Viwatwongkasem, C				Islam, Muhammad Nurul; Thosingha, Orapan; Danaidutsadeekul, Suporn; Viwatwongkasem, Chukiat			Factors Explaining Quality of Life among People with Moderate to Severe Traumatic Brain Injury in Bangladesh: A Cross-Sectional Study	PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH			English	Article						Bangladesh; caregiver; depression; quality of life; social support; traumatic brain injury	PREPAREDNESS; CAREGIVERS; COGNITION; SCALE	Traumatic brain injury leads to mortality and disability with consequences for the poor quality of life of people. Litle study regarding the quality of life of people with traumatic brain injury in Bangladesh exists. This cross-sectional study aims to examine the quality of life and its influencing factors among people with moderate to severe traumatic brain injury. The participants were 249 people with moderate to severe traumatic brain injury, and their caregivers recruited from three public hospitals in Bangladesh. Data were collected through questionnaires including socio-demographic, the Injury Related Illness and Injury Severity Score questionnaire, the Charlson Comorbidity Index, the Modified Barthel Index, the Patients Health Questionnaire-9, the MOS-Social Support Survey, the Quality of Life after Brain Injury (QOLIBRI), the caregiver socio-demographic, and the Caregiver Preparedness Scale. Data were analyzed using descriptive statistics, Pearson's correlation test, and stepwise multiple regression model. Results showed that majority of the people reported a poor quality of life. Stepwise multiple regression analysis revealed that social support, caregiver preparedness, depression, and income, were significant factors and could explain 37% variance of quality of life. To improve the quality of life among people with traumatic brain injury, nurses should seek significant resources to support them, perform emotional support to prevent depression and prepare their caregivers with knowledge and proper skills for patients' care. Eventually, they can have healthy transition and obtain desirable health outcomes with good quality of life.	[Islam, Muhammad Nurul] Mahidol Univ, Ramathibodi Hosp, Fac Nursing, Salaya, Nakhon Pathom, Thailand; [Islam, Muhammad Nurul] Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Salaya, Nakhon Pathom, Thailand; [Thosingha, Orapan] Mahidol Univ, Fac Nursing, Salaya, Nakhon Pathom, Thailand; [Thosingha, Orapan] Chulabhorn Royal Acad, Fac Nursing, Bangkok, Thailand; [Danaidutsadeekul, Suporn] Mahidol Univ, Fac Nursing, Dept Surg Nursing, Salaya, Nakhon Pathom, Thailand; [Viwatwongkasem, Chukiat] Mahidol Univ, Fac Publ Hlth, Dept Biostat, Salaya, Nakhon Pathom, Thailand		Thosingha, O (corresponding author), Mahidol Univ, Fac Nursing, Salaya, Nakhon Pathom, Thailand.; Thosingha, O (corresponding author), Chulabhorn Royal Acad, Fac Nursing, Bangkok, Thailand.	islambd2000@yahoo.com; orapan.tho@cra.ac.th; suporn.dan@mahidol.ac.th; chukiat.viw@mahidol.ac.th			Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh	The authors are very grateful to the Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh, for providing scholarship and other ongoing support to complete this study. The authors also especially thank all participants for their cooperation and contribution.	Abbasi SA, 2019, J CLIN RES BIOETH, V10, P335, DOI [10.35248/2155- 9627.19.10.335, DOI 10.35248/2155-9627.19.10.335]; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; ARCHBOLD PG, 1990, RES NURS HEALTH, V13, P375, DOI 10.1002/nur.4770130605; Azman A, 2020, J HEALTH RES, V34, P495, DOI 10.1108/JHR-07-2019-0138; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J., 2013, STAT POWER ANAL BEHA; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gopaul R, 2016, CHINESE NEUROSURGICA, V2, P33, DOI [10.1186/ s41016-016-0044-5, DOI 10.1186/S41016-016-0044-5]; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Islam MJ, 2011, BANGLADESH J MED SCI, V10, P112; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Leijdesdorff HA, 2018, INT SURG, V103, P158, DOI 10.9738/INTSURG-D-17-00104.1; Lieshout K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176386; Meleis AI, 2010, TRANSITION THEORY MI; Mondol MA, 2013, J DHAKA MED COLL, V22, P45; Nolte M., 1999, THESIS QUEENS U; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Pucciarelli G, 2014, HEART LUNG, V43, P555, DOI 10.1016/j.hrtlng.2014.08.004; Rasmussen MS, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100670; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Reddy RP, 2017, INDIAN J PSYCHOL MED, V39, P32, DOI 10.4103/0253-7176.198940; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Songwathana P, 2018, INT J BEHAV SCI, V13, P82; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; WHO, 1996, WHOQOL BREF INTR ADM; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; World Health Organization, 2019, PROC TRANSL AD INSTR; Xiong C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029072; Zimmerman A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240528	38	0	0	0	0	THAILAND NURSING & MIDWIFERY COUNCIL	NONTHABURI	NAGARINDRASRI BLDG, MINISTRY PUBLIC HEALTH, NONTHABURI, 11000, THAILAND	1906-8107			PAC RIM INT J NURS R	Pac. Rim Int. J. Nurs. Res.	JAN-MAR	2022	26	1					146	160					15	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	YL1DS	WOS:000745640500011					2022-02-06	
J	Islam, MN; Thosingha, O; Danaidutsadeekul, S; Viwatwongkasem, C				Islam, Muhammad Nurul; OrapanThosingha; Danaidutsadeekul, Suporn; Viwatwongkasem, Chukiat			Factors Explaining Quality of Life among People with Moderate to Severe Traumatic Brain Injury in Bangladesh: A Cross-Sectional Study	PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH			English	Article						Bangladesh; caregiver; depression; quality of life; social support; traumatic brain injury	PREPAREDNESS; CAREGIVERS; COGNITION; SCALE	Traumatic brain injury leads to mortality and disability with consequences for the poor quality of life of people. Little study regarding the quality of life of people with traumatic brain injury in Bangladesh exists. This cross-sectional study aims to examine the quality of life and its influencing factors among people with moderate to severe traumatic brain injury. The participants were 249 people with moderate to severe traumatic brain injury, and their caregivers recruited from three public hospitals in Bangladesh. Data were collected through questionnaires including socio-demographic, the Injury Related Illness and Injury Severity Score questionnaire, the Charlson Comorbidity Index, the Modified Barthel Index, the Patients Health Questionnaire-9, the MOS-Social Support Survey, the Quality of Life after Brain Injury (QOLIBRI), the caregiver socio-demographic, and the Caregiver Preparedness Scale. Data were analyzed using descriptive statistics, Pearson's correlation test, and stepwise multiple regression model. Results showed that majority of the people reported a poor quality of life. Stepwise multiple regression analysis revealed that social support, caregiver preparedness, depression, and income, were significant factors and could explain 37% variance of quality of life. To improve the quality of life among people with traumatic brain injury, nurses should seek significant resources to support them, perform emotional support to prevent depression and prepare their caregivers with knowledge and proper skills for patients' care. Eventually, they can have healthy transition and obtain desirable health outcomes with good quality of life.	[Islam, Muhammad Nurul] Mahidol Univ, Fac Nursing, Fac Med, Ramathibodi Hosp, Salaya, Nakhon Pathom, Thailand; [Islam, Muhammad Nurul] Mahidol Univ, Ramathibodi Sch Nursing, Fac Med, Ramathibodi Hosp, Salaya, Nakhon Pathom, Thailand; [OrapanThosingha] Mahidol Univ, Fac OfNursing, Salaya, Nakhon Pathom, Thailand; [OrapanThosingha] Chulabhorn Royal Acad, Fac Nursing, Bangkok, Thailand; [Danaidutsadeekul, Suporn] Mahidol Univ, Fac Nursing, Dept Surg Nursing, Salaya, Nakhon Pathom, Thailand; [Viwatwongkasem, Chukiat] Mahidol Univ, Fac Publ Hlth, Dept Biostat, Salaya, Nakhon Pathom, Thailand		Thosingha, O (corresponding author), Mahidol Univ, Fac OfNursing, Salaya, Nakhon Pathom, Thailand.; Thosingha, O (corresponding author), Chulabhorn Royal Acad, Fac Nursing, Bangkok, Thailand.	islambd2000@yahoo.com; orapan.tho@cra.ac.th; suporn.dan@mahidol.ac.th; chukiat.viw@mahidol.ac.th			Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh	The authors are very grateful to the Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh, for providing scholarship and other ongoing support to complete this study. The authors also especially thank all participants for their cooperation and contribution.	Abbasi SA, 2019, J CLIN RES BIOETH, V10, P335, DOI [10.35248/2155- 9627.19.10.335, DOI 10.35248/2155-9627.19.10.335]; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; ARCHBOLD PG, 1990, RES NURS HEALTH, V13, P375, DOI 10.1002/nur.4770130605; Azman A, 2020, J HEALTH RES, V34, P495, DOI 10.1108/JHR-07-2019-0138; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Born K, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0966-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J., 1988, STAT POWER ANAL BEHA; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Gopaul R, 2016, CHINESE NEUROSURGICA, V2, P33, DOI [10.1186/ s41016-016-0044-5, DOI 10.1186/S41016-016-0044-5]; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Islam MJ, 2011, BANGLADESH J MED SCI, V10, P112; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Leijdesdorff HA, 2018, INT SURG, V103, P158, DOI 10.9738/INTSURG-D-17-00104.1; Lieshout K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176386; Meleis AI, 2010, TRANSITION THEORY MI; Mondol MA, 2013, J DHAKA MED COLL, V22, P45; Nolte M., 1999, THESIS QUEENS U; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Pucciarelli G, 2014, HEART LUNG, V43, P555, DOI 10.1016/j.hrtlng.2014.08.004; Rasmussen MS, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100670; Rauen K, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01391-3; Reddy RP, 2017, INDIAN J PSYCHOL MED, V39, P32, DOI 10.4103/0253-7176.198940; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Songwathana P, 2018, INT J BEHAV SCI, V13, P82; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; WHO, 1996, WHOQOL BREF INTR ADM; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; World Health Organization, 2019, PROC TRANSL AD INSTR; Xiong C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029072; Zimmerman A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240528	38	0	0	0	0	THAILAND NURSING & MIDWIFERY COUNCIL	NONTHABURI	NAGARINDRASRI BLDG, MINISTRY PUBLIC HEALTH, NONTHABURI, 11000, THAILAND	1906-8107			PAC RIM INT J NURS R	Pac. Rim Int. J. Nurs. Res.	JAN-MAR	2022	26	1					150	164					15	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	XO7PR	WOS:000730373300012					2022-02-06	
J	Jiang, S; Wang, YQ; Tang, YF; Lu, X; Guo, D				Jiang, Shan; Wang, Yong-Qiang; Tang, Yifei; Lu, Xi; Guo, Dan			p Environmental Enrichment Protects Against Sepsis-Associated Encephalopathy-Induced Learning and Memory Deficits by Enhancing the Synthesis and Release of Vasopressin in the Supraoptic Nucleus	JOURNAL OF INFLAMMATION RESEARCH			English	Article						sepsis associated encephalopathy; environmental enrichment; vasopressin; learning and memory; vasopressin receptor 1a	TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; VOLUNTARY EXERCISE; RAT HIPPOCAMPUS; MOUSE MODEL; BDNF; NEUROGENESIS; INHIBITION; ASTROCYTES	Background: As a severe complication of sepsis, sepsis-associated encephalopathy (SAE) usually manifests as impaired learning and memory ability in survivors. Previous studies have reported that environmental enrichment (EE) can increase the learning and memory ability in different brain injury models. However, there has been no research on the possible positive effect of EE on SAE. Aim: The present study aimed to test the effect of EE on SAE-induced impairment of learning and memory and its related mechanisms. Methods: A Morris water maze test (MWM) was used to evaluate the learning and memory ability of SAE rats that received EE housing or not. The expression of vasopressin (VP) was assessed using immunofluorescence microscopy and enzyme-linked immunosorbent assays (ELISAs). The synthesis of VP in the supraoptic nucleus (SON) was determined using quantitative real-time reverse transcription-PCR analysis. Moreover, inflammatory markers and brain-derived neurotrophic factor (BDNF) were detected using ELISA. Results: The results showed that SAE induced a decreased learning and memory ability, while EE reversed this impairment. EE also enhanced the synthesis and secretion of VP in the SON. Blocking the action of VP in the hippocampus interrupted the EE-induced amelioration of learning and memory impairment. Moreover, EE induced changes to the levels of BDNF and cytokines in the hippocampus and these effects were mediated by VP binding to the VP receptor 1a. Conclusion: Our findings demonstrated that the enhanced synthesis and secretion of VP in the SON are a key determinant responsible for EE-induced alleviation of learning and memory deficits caused by SAE.	[Jiang, Shan; Tang, Yifei; Lu, Xi; Guo, Dan] China Japan Friendship Hosp, Dept Rehabil Med, 2 Ying Hua Yuan East St, Beijing 100029, Peoples R China; [Wang, Yong-Qiang] Sunshine Union Hosp, Dept Ophthalmol, Weifang 261071, Shandong, Peoples R China		Jiang, S (corresponding author), China Japan Friendship Hosp, Dept Rehabil Med, 2 Ying Hua Yuan East St, Beijing 100029, Peoples R China.	landjiang@126.com			Natural Science Foundation of Beijing Municipality (CN) [7212102]; National Natural Science Foundation of China (CN)National Natural Science Foundation of China (NSFC) [81201514, 81472168]; Elite Medical Professionals project of China-Japan Friendship Hospital [ZRJY2021-BJ04]	This study was supported by the Natural Science Foundation of Beijing Municipality (CN) (Grant No.7212102), National Natural Science Foundation of China (CN) (Grant No.81201514 and Grant No.81472168) and Elite Medical Professionals project of China-Japan Friendship Hospital (Grant No.ZRJY2021-BJ04).	Adam N, 2013, EXPERT REV ANTI-INFE, V11, P211, DOI [10.1586/eri.12.159, 10.1586/ERI.12.159]; Alescio-Lautier B, 1998, PROG BRAIN RES, V119, P501; Alescio-Lautier B, 2000, EUR J PHARMACOL, V405, P63, DOI 10.1016/S0014-2999(00)00542-2; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Balapattabi K, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12639; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Bambah-Mukku D, 2014, J NEUROSCI, V34, P12547, DOI 10.1523/JNEUROSCI.0324-14.2014; Barrett CE, 2013, HORM BEHAV, V63, P518, DOI 10.1016/j.yhbeh.2013.01.005; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Bourgognon Julie-Myrtille, 2020, Brain Neurosci Adv, V4, p2398212820979802, DOI 10.1177/2398212820979802; Briones TL, 2004, BRAIN RES, V1018, P130, DOI 10.1016/j.brainres.2004.06.001; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Canning CG, 2020, NAT REV NEUROL, V16, P409, DOI 10.1038/s41582-020-0370-2; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Choe KY, 2015, NEURON, V85, P549, DOI 10.1016/j.neuron.2014.12.048; Cilz NI, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12535; Comim CM, 2011, NEUROCHEM RES, V36, P304, DOI 10.1007/s11064-010-0320-2; Della Giustina A, 2020, MOL NEUROBIOL, V57, P4451, DOI 10.1007/s12035-020-02032-y; DEWIED D, 1993, FRONT NEUROENDOCRIN, V14, P251, DOI 10.1006/frne.1993.1009; Diaz R, 2016, INT J DEV NEUROSCI, V53, P35, DOI 10.1016/j.ijdevneu.2016.06.006; Esvald EE, 2020, J NEUROSCI, V40, P1405, DOI 10.1523/JNEUROSCI.0367-19.2019; Galeano P, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00406; Gardoni F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-14; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Goncalves LV, 2018, BEHAV BRAIN RES, V348, P171, DOI 10.1016/j.bbr.2018.04.023; Gong XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1301-7; Harris J, 2017, MOL IMMUNOL, V86, P10, DOI 10.1016/j.molimm.2017.02.013; Hernandez VS, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00092; Hilario WF, 2016, J MOL NEUROSCI, V60, P453, DOI 10.1007/s12031-016-0831-7; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hoshino K, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.637703; Imamura Y, 2011, NEUROSCIENCE, V187, P63, DOI 10.1016/j.neuroscience.2011.04.063; Iwashyna TJ, 2016, AM J RESP CRIT CARE, V194, P782, DOI 10.1164/rccm.201603-0619ED; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Ji MH, 2017, ONCOTARGET, V8, P82376, DOI 10.18632/oncotarget.19595; Ji MH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0401-x; Jiang S, 2014, NEUROCHEM RES, V39, P833, DOI 10.1007/s11064-014-1277-3; Johansson BB, 1999, ACT NEUR S, V73, P51; Kartalou GI, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21238957; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Keymoradzadeh A, 2020, BEHAV BRAIN RES, V394, DOI 10.1016/j.bbr.2020.112814; Li J, 2020, PHARMAZIE, V75, P344, DOI 10.1691/ph.2020.0395; Lippert-Gruener M, 2007, EXP NEUROL, V203, P82, DOI 10.1016/j.expneurol.2006.07.025; Lu Qiaoqiao, 2021, Handb Clin Neurol, V180, P65, DOI 10.1016/B978-0-12-820107-7.00005-7; Mazeraud A, 2016, CLIN CHEST MED, V37, P333, DOI 10.1016/j.ccm.2016.01.013; McBride MA, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.624272; Mestriner RG, 2015, BEHAV BRAIN RES, V278, P257, DOI 10.1016/j.bbr.2014.10.005; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nenov MN, 2019, BIOCHEM BIOPH RES CO, V518, P486, DOI 10.1016/j.bbrc.2019.08.072; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; Novkovic T, 2015, HIPPOCAMPUS, V25, P1, DOI 10.1002/hipo.22342; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Osso LA, 2015, CELL, V163, P1574, DOI 10.1016/j.cell.2015.12.001; Panja D, 2014, CELL REP, V9, P1430, DOI 10.1016/j.celrep.2014.10.016; Porterfield VM, 2012, BRAIN BEHAV IMMUN, V26, P1249, DOI 10.1016/j.bbi.2012.08.001; Prescott HC, 2017, ANN AM THORAC SOC, V14, P230, DOI 10.1513/AnnalsATS.201605-398OC; Redell JB, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113372; Rello J, 2017, ADV THER, V34, P2393, DOI 10.1007/s12325-017-0622-8; Rico-Barrio I, 2019, ADDICT BIOL, V24, P969, DOI 10.1111/adb.12667; Rocha M, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104906; Rodriguez-Ortega E, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00177; Rojas-Carvajal M, 2021, EUR J NEUROSCI, DOI 10.1111/ejn.15160; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Salehzadeh Melody, 1800, Endocrinology, V163, DOI 10.1210/endocr/bqab244; Santos NN, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12604; Sayiner FD, 2021, J MATERN-FETAL NEO M, V34, P2600, DOI 10.1080/14767058.2019.1670162; Schuch CP, 2016, NEUROSCI LETT, V617, P101, DOI 10.1016/j.neulet.2016.02.015; Segovia G, 2006, BRAIN RES BULL, V70, P8, DOI 10.1016/j.brainresbull.2005.11.005; Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Siami S, 2010, CRIT CARE MED, V38, P1962, DOI 10.1097/CCM.0b013e3181eb9acf; Sun XM, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147109; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; Tang BL, 2020, NEURAL REGEN RES, V15, P10, DOI 10.4103/1673-5374.264440; Terry AV, 2009, FRONT NEUROSCI, P267; Tian JM, 2020, CELL MOL NEUROBIOL, V40, P521, DOI 10.1007/s10571-019-00750-z; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Van Dessel P, 2019, TRENDS COGN SCI, V23, P368, DOI 10.1016/j.tics.2019.02.001; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Xiong YF, 2011, J NEUROSCI RES, V89, P256, DOI 10.1002/jnr.22548; Yang C, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.121; Yuan H, 2010, J NEUROSCI RES, V88, P1364, DOI 10.1002/jnr.22297; Yuan M, 2021, BEHAV BRAIN RES, V410, DOI 10.1016/j.bbr.2021.113357; Zhang L, 2013, NEUROSCIENCE, V228, P139, DOI 10.1016/j.neuroscience.2012.10.010; Zhang XX, 2021, INT J NEUROSCI, V131, P641, DOI 10.1080/00207454.2020.1797722; Zhao LX, 2003, J NEUROSCI, V23, P4228; Zhou ZJZ, 2020, EUR J PHARMACOL, V869, DOI 10.1016/j.ejphar.2019.172857	92	0	0	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-7031		J INFLAMM RES	J. Inflamm. Res.		2022	15						363	379		10.2147/JIR.S345108			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YK9RR	WOS:000745541300003	35079222	gold, Green Accepted			2022-02-06	
J	Kerschner, AE; Huber, DL; Brett, BL; Meier, TB; Nelson, LD; McCrea, MA				Kerschner, Anna E.; Huber, Daniel L.; Brett, Benjamin L.; Meier, Timothy B.; Nelson, Lindsay D.; McCrea, Michael A.			Age-Group Differences and Annual Variation in Return-To-Play Practices After Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; concussion; sports injuries; recovery; return-to-play	FREE WAITING PERIOD; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; TIME; SYMPTOMS; ZURICH; YOUTH	Objective: To examine return-to-play (RTP) practice differences between high school and collegiate athletes, as well as the stability (ie, year-by-year) in these practices over a 5-year period. We hypothesized that similar protocols for treatment will be comparable across competition levels and that these practices will vary year-to-year. Design: Prospective cohort study. Setting: Nine high schools and 4 National Collegiate Athletic Association Division III colleges in Southeastern Wisconsin. Participants and Independent Variables: Two-hundred seventy-three (N = 273) athletes with sport-related concussions (SRCs). Independent predictors included competition level (high school, n = 88 vs collegiate, n = 185) and year-of-injury. Outcome Measures: Athletes were evaluated prospectively for differences in symptom duration, symptom free waiting period (SFWP), and time to RTP, as well as longitudinal changes in management. Results: High school and collegiate athletes experienced comparable median symptom duration (high school, 6.0 days, interquartile range (IQR) = 3.5-11.0; college, 6.0 days, IQR = 4.0-9.0, P = 0.95), SFWP (high school, 5.0 days, IQR = 3.0-8.0; college, 5.0 days, IQR = 3.0-7.0, P = 0.12), and total time to RTP (high school, 10.5 days, IQR = 7.0-16.0; college, 11.0 days, IQR = 8.0-14.0 days, P = 0.94). A Cox regression analysis revealed a nonsignificant trend toward longer SFWPs in high school athletes (P = 0.055; hazard ratio = 1.347, confidence interval = 0.99-1.83). Among football players, SFWPs in 2017 (Median = 3.5 days, IQR = 1.5-5.0 days) were significantly longer than those in 2014 (Median = 5.0 days, IQR = 4.0-8.5 days, P = 0.029) after correction for multiple comparisons. Conclusion: Similar postinjury and RTP management practices were observed at the high school and collegiate levels after SRCs. Symptom duration and time from injury to unrestricted RTP were comparable, although high school athletes may have longer SFWPs.	[Kerschner, Anna E.; Huber, Daniel L.; Brett, Benjamin L.; Meier, Timothy B.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Ctr Neurotrauma Res CNTR, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; Clinical and Translational Science Institute [1ULI-RR031973 (201)]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [8ULITR000055, UL1TR001436]	Supported by the US Army Medical Research and Materiel Command (award no. W81XWH-12-1-0004) and the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research (award no. W81XWH-14-1-0561). The REDCap electronic database used for this project was supported by the Clinical and Translational Science Institute (grant 1ULI-RR031973 (201)), National Center for Advancing Translational Sciences, and National Institutes of Health (NIH) (grants 8ULITR000055 and UL1TR001436). Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the NIH.	[Anonymous], 2018, REP C MAN TRAUM BRAI; [Anonymous], WIAA concussion policy; [Anonymous], Concussion diagnosis and management best practices; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Helmick K., 2006, DEFENSE VETERANS BRA; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kuhn AW, 2017, NEUROSURGERY, V64, P211, DOI 10.1093/neuros/nyx294; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Stelzer JW, 2019, NEUROSURGERY, V85, pE592, DOI 10.1093/neuros/nyz217; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002	29	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					E52	E60		10.1097/JSM.0000000000000871			9	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000016	32941381				2022-02-06	
J	Killien, EY; Rivara, FP; Dervan, LA; Smith, MB; Watson, RS				Killien, Elizabeth Y.; Rivara, Frederick P.; Dervan, Leslie A.; Smith, Mallory B.; Watson, R. Scott			Components of Health-Related Quality of Life Most Affected Following Pediatric Critical Illness	CRITICAL CARE MEDICINE			English	Article						follow-up studies; health-related quality of life; intensive care units; outcome assessment; pediatric	TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; INTENSIVE-CARE; IMPROVEMENT INTERVENTION; INFANT SCALES; CHILDREN; OUTCOMES; RELIABILITY; VALIDITY; PEDSQL(TM)-4.0	OBJECTIVES: To evaluate which individual elements of health-related quality of life contribute most to decline in overall health-related quality of life status following pediatric critical care. DESIGN: Retrospective cohort study. SETTING: Seattle Children's Hospital. PATIENTS: ICU patients age 1 month to 18 years admitted between December 2011 and February 2017. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We assessed health-relatedquality of life decline from baseline to postdischarge (median, 6 wk) and determined the individual items of the Pediatric Quality of Life Inventory Infant Scales (< 2 yr) and Generic Core Scales (2-18 yr) with the highest prevalence of decline. We used multivariable regression to estimate the risk of decline in each of seven thematic categories by patient age, baseline health status, diagnosis, Pediatric Risk of Mortality score, and ICU length of stay. Decline from baseline health-related quality of life occurred in 22.5% of 539 patients. Items most commonly affected for infants less than 2 years were primarily emotional (cranky/crying, sleep, and self-soothing). Children 2-18 years most commonly experienced declines in physical functioning (play/exercise, lifting, and pain). Across the entire cohort, declines in categories of energy (31.5%), activity (31.0%), sleep (28.0%), and fear (24.7%) were most commonly endorsed. Risk of decline in each category varied with patient age, medical complexity, and diagnosis. CONCLUSIONS: Deconditioning, sleep, fear, and pain are important targets for intervention to improve health-related quality of life outcomes for critically ill children.	[Killien, Elizabeth Y.; Dervan, Leslie A.; Smith, Mallory B.; Watson, R. Scott] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Killien, Elizabeth Y.; Rivara, Frederick P.; Smith, Mallory B.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Div Gen Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Dervan, Leslie A.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Killien, Elizabeth Y.; Rivara, Frederick P.; Dervan, Leslie A.; Smith, Mallory B.; Watson, R. Scott] Seattle Childrens Hosp, Seattle, WA USA		Killien, EY (corresponding author), Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA.; Killien, EY (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	elizabeth.killien@seattlechildrens.org			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 T32 HD057822-08]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHD T32 training grant [T32 HD057822-11]	Supported, in part, by the National Institute of Child Health and Human Development grant 5 T32 HD057822-08. Dr. Killien's institution received funding from the National Institute of Child Health and Human Development (NICHD). Drs. Killien and Smith received support for article research from the National Institutes of Health. Dr. Smith received funding from a NICHD T32 training grant (T32 HD057822-11). The remaining authors have disclosed that they do not have any potential conflicts of interest. This work was performed at Seattle Children's Hospital, Seattle, WA.	Aspesberro F, 2016, PEDIATR CRIT CARE ME, V17, pE272, DOI 10.1097/PCC.0000000000000727; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brueton VC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003821; Colville G, 2008, AM J RESP CRIT CARE, V177, P976, DOI 10.1164/rccm.200706-857OC; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Cunha F, 2012, J PEDIAT-BRAZIL, V88, P25, DOI 10.2223/JPED.2151; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Field-Ridley A, 2016, PEDIATR CRIT CARE ME, V17, P53, DOI 10.1097/PCC.0000000000000538; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Knoester H, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-21; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; Kudchadkar SR, 2020, CRIT CARE MED, V48, P634, DOI 10.1097/CCM.0000000000004291; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Maddux AB, 2020, CRIT CARE MED, V48, pE1313, DOI 10.1097/CCM.0000000000004595; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Merritt C, 2018, PEDIATR CRIT CARE ME, V19, pE105, DOI 10.1097/PCC.0000000000001409; Morrison Anne L, 2002, Pediatr Crit Care Med, V3, P1, DOI 10.1097/00130478-200201000-00001; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Polic B, 2013, EUR J PEDIATR, V172, P85, DOI 10.1007/s00431-012-1843-0; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rabbitts JA, 2015, J PAIN, V16, P1334, DOI 10.1016/j.jpain.2015.09.005; Rennick JE, 2015, PEDIATRICS, V135, pE289, DOI 10.1542/peds.2014-2174; Rennick JE, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200206000-00002; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Simon TD, 2014, PEDIATRICS, V133, pE1647, DOI 10.1542/peds.2013-3875; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Taylor A, 2003, INTENS CARE MED, V29, P795, DOI 10.1007/s00134-003-1690-6; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Watson RS, 2019, AM J RESP CRIT CARE, V200, P900, DOI 10.1164/rccm.201810-1881OC; Watson RS, 2018, J PEDIATR-US, V198, P16, DOI 10.1016/j.jpeds.2017.12.084; Wieczorek B, 2016, PEDIATR CRIT CARE ME, V17, pE559, DOI 10.1097/PCC.0000000000000983; Zimmerman JJ, 2020, CRIT CARE MED, V48, P329, DOI 10.1097/CCM.0000000000004123	44	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2022	50	1					E20	E30		10.1097/CCM.0000000000005230			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	XP3PG	WOS:000730780000004	34415865				2022-02-06	
J	Kim, M; Hong, SK; Jeon, SR; Roh, SW; Lee, S				Kim, Moinay; Hong, Suk Kyung; Jeon, Sang Ryong; Roh, Sung Woo; Lee, Seungjoo			Treatment Outcome and Risk Factors Associated with Diffuse Axonal Injury in Patients with Moderate to Severe Head Injury	TURKISH NEUROSURGERY			English	Article						Brain injury; Diffuse axonal injury; Head trauma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; PROGNOSTIC VALUE; STEM INJURY; MRI; COMA; CLASSIFICATION; EPIDEMIOLOGY; DIAGNOSIS; LESIONS	AIM: To evaluate diffuse axonal injury (DAI) patients according to DAI stage to identify risk factors that may affect clinical outcome. MATERIAL and METHODS: A total of 992 traumatic brain injury (TBI) patients visited our hospital between 2011 and 2016. Thirty-seven patients diagnosed with DAI were enrolled in this study and stratified by DAI stage: Stage I, 20 patients (54.1%); Stage II, 4 patients (10.8%); and Stage III, 13 patients (35.1%). RESULTS: The mean age and the median follow-up period were 45.43 years and 13 months, respectively. Patient demographic data and clinical findings on admission showed no differences according to DAI stage, except for the revised trauma score (RTS) (p=0.026). In univariate analysis, stages I and II vs. III (p=0.001) and stages I vs. II and III (p=0.019), transfusion within 24 hours of visit (p=0.033), shock or cardiac arrest (p=0.006), traumatic subarachnoid hemorrhage (T-SAH) (p=0.011), and subdural hematoma (SDH) (p=0.009) were significantly correlated with Glasgow outcome score (GOS). In multivariate analysis, DAI stage I and II vs. III (p=0.005) and SDH (p=0.040) were significant. CONCLUSION: Clinically, Stage II was more correlated with Stage I, rather than stage III. Stage III showed a much poorer outcome compared to stages I and II. Magnetic resonance imaging (MRI) should be promptly performed in all TBI patients when a patient's level of consciousness and cranialcomputed tomography (CT) does not match, as there is a possibility of stage III DAI.	[Kim, Moinay; Jeon, Sang Ryong; Roh, Sung Woo; Lee, Seungjoo] Univ Ulsan, Asan Med Ctr, Dept Neurol Surg, Coll Med, Seoul, South Korea; [Hong, Suk Kyung] Univ Ulsan, Asan Med Ctr, Dept Surg, Div Trauma & Surg Crit Care,Coll Med, Seoul, South Korea; [Lee, Seungjoo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurosurg,Div Neurosurg Crit Care, Seoul, South Korea		Lee, S (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Neurol Surg, Coll Med, Seoul, South Korea.; Lee, S (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Neurosurg,Div Neurosurg Crit Care, Seoul, South Korea.	rghree@amc.seoul.kr					Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Chew BG, 2012, J NEUROSURG, V117, P722, DOI 10.3171/2012.6.JNS111736; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Eum SW, 1998, J KOREAN NEUROSURG S, V27, P1668; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; JENNETT B, 1975, LANCET, V1, P480; Jeong HW, 2017, J KOREAN NEUROSURG S, V60, P710, DOI 10.3340/jkns.2016.1010.001; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lee HS, 1990, J KOREAN NEUROSURG S, V19, P1101; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stawicki Stanislaw P, 2017, Int J Crit Illn Inj Sci, V7, P23, DOI 10.4103/IJCIIS.IJCIIS_2_17; TEASDALE G, 1974, LANCET, V2, P81; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857	48	0	0	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2022	32	1					6	15		10.5137/1019-5149.JTN.28132-19.4			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YH5SZ	WOS:000743228600001	33759150	Bronze			2022-02-06	
J	Kirschen, MP; LaRovere, K; Balakrishnan, B; Erklauer, J; Francoeur, C; Ganesan, SL; Jayakar, A; Lovett, M; Luchette, M; Press, CA; Wolf, M; Ferrazzano, P; Wainwright, MS; Appavu, B				Kirschen, Matthew P.; LaRovere, Kerri; Balakrishnan, Binod; Erklauer, Jennifer; Francoeur, Conall; Ganesan, Saptharishi Lalgudi; Jayakar, Anuj; Lovett, Marlina; Luchette, Matthew; Press, Craig A.; Wolf, Michael; Ferrazzano, Peter; Wainwright, Mark S.; Appavu, Brian		Pediat Neurocritical Care Res Grp	A Survey of Neuromonitoring Practices in North American Pediatric Intensive Care Units	PEDIATRIC NEUROLOGY			English	Article						Neuromonitoring; Pediatric neurocritical care; Intracranial pressure; EEG	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL ADULTS; NEUROCRITICAL CARE; CONSENSUS STATEMENT; FLOW VELOCITIES; CONTINUOUS EEG; CHILDREN; REACTIVITY; GUIDELINES; MANAGEMENT	Background: Neuromonitoring is the use of continuous measures of brain physiology to detect clinically important events in real-time. Neuromonitoring devices can be invasive or non-invasive and are typically used on patients with acute brain injury or at high risk for brain injury. The goal of this study was to characterize neuromonitoring infrastructure and practices in North American pediatric intensive care units (PICUs). Methods: An electronic, web-based survey was distributed to 70 North American institutions partici-pating in the Pediatric Neurocritical Care Research Group. Questions related to the clinical use of neu-romonitoring devices, integrative multimodality neuromonitoring capabilities, and neuromonitoring infrastructure were included. Survey results were presented using descriptive statistics. Results: The survey was completed by faculty at 74% (52 of 70) of institutions. All 52 institutions measure intracranial pressure and have electroencephalography capability, whereas 87% (45 of 52) use near-infrared spectroscopy and 40% (21/52) use transcranial Doppler. Individual patient monitoring de-cisions were driven by institutional protocols and collaboration between critical care, neurology, and neurosurgery attendings. Reported device utilization varied by brain injury etiology. Only 15% (eight of 52) of institutions utilized a multimodality neuromonitoring platform to integrate and synchronize data from multiple devices. A database of neuromonitoring patients was maintained at 35% (18 of 52) of institutions. Funding for neuromonitoring programs was variable with contributions from hospitals (19%, 10 of 52), private donations (12%, six of 52), and research funds (12%, six of 52), although 73% (40 of 52) have no dedicated funds. Conclusions: Neuromonitoring indications, devices, and infrastructure vary by institution in North American pediatric critical care units. Noninvasive modalities were utilized more liberally, although not uniformly, than invasive monitoring. Further studies are needed to standardize the acquisition, inter-pretation, and reporting of clinical neuromonitoring data, and to determine whether neuromonitoring systems impact neurological outcomes. (c) 2021 Elsevier Inc. All rights reserved.	[Kirschen, Matthew P.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [LaRovere, Kerri] Boston Childrens Hosp, Harvard Med Sch, Dept Neurol, Boston, MA USA; [Balakrishnan, Binod] Med Coll Wisconsin, Div Pediat Crit Care Med, Childrens Wisconsin, Milwaukee, WI 53226 USA; [Erklauer, Jennifer] Texas Childrens Hosp, Dept Crit Care Med, Houston, TX 77030 USA; [Erklauer, Jennifer] Texas Childrens Hosp, Dept Neurol, Houston, TX 77030 USA; [Francoeur, Conall] Univ Laval, Dept Pediat, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Ganesan, Saptharishi Lalgudi] Western Univ, Childrens Hosp Western Ontario, Dept Paediat, Schulich Sch Med & Dent, London, ON, Canada; [Jayakar, Anuj] Nicklaus Childrens Hosp, Dept Neurol, Miami, FL USA; [Lovett, Marlina] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Div Crit Care Med,Coll Med, Columbus, OH 43210 USA; [Luchette, Matthew] Boston Childrens Hosp, Harvard Med Sch, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Press, Craig A.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Aurora, CO 19104 USA; [Press, Craig A.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Wolf, Michael] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN USA; [Ferrazzano, Peter] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Div Crit Care Med, Madison, WI USA; [Wainwright, Mark S.] Univ Washington, Sch Med, Div Pediat Neurol, Seattle, WA USA; [Appavu, Brian] Univ Arizona, Coll Med, Dept Neurosci, Barrow Neurol Inst,Phoenix Childrens Hosp, Phoenix, AZ USA		Kirschen, MP (corresponding author), Childrens Hosp Philadelphia, Dept Crit Care Med, 3401 Civ Ctr Blvd,Wood 6108, Philadelphia, PA 19104 USA.	kirschenm@chop.edu	Press, Craig Adam/K-1307-2019	Press, Craig Adam/0000-0003-4435-206X; Kirschen, Matthew/0000-0003-3585-2687	PNCRG	The authors thank the PNCRG for its support.	Appavu B, 2021, NEUROCRIT CARE, V35, P640, DOI 10.1007/s12028-021-01279-0; Appavu B, 2021, NEUROCRIT CARE, V34, P537, DOI 10.1007/s12028-020-01058-3; Appavu B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01261; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Fergusson NA, 2021, CRIT CARE MED, V49, P1333, DOI 10.1097/CCM.0000000000004945; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Kirschen M, RESUSCITATION, V168, P110; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; LaRovere KL, 2020, PEDIATR CRIT CARE ME, V21, P67, DOI 10.1097/PCC.0000000000002118; LaRovere KL, 2018, PEDIATR CRIT CARE ME, V19, P1039, DOI 10.1097/PCC.0000000000001708; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Lee JK, 2014, RESUSCITATION, V85, P1387, DOI 10.1016/j.resuscitation.2014.07.006; O'Brien NF, 2021, J PEDIATR INTENSIVE, V10, P133, DOI 10.1055/s-0040-1715128; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; Press CA, 2017, PEDIATR CRIT CARE ME, V18, P64, DOI 10.1097/PCC.0000000000001016; Rasulo FA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2781-2; Rivera Lara Lucia, 2018, Continuum (Minneap Minn), V24, P1776, DOI 10.1212/CON.0000000000000671; Riviello JJ, 2021, NEUROL CLIN, V39, P847, DOI 10.1016/j.ncl.2021.04.006; Sekhon MS, 2019, RESUSCITATION, V141, P96, DOI 10.1016/j.resuscitation.2019.05.036; Sinha S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17449; Tasker RC, 2009, CURR OPIN PEDIATR, V21, P724, DOI 10.1097/MOP.0b013e328331e813; Topjian AA, 2019, CIRCULATION, V140, pE194, DOI 10.1161/CIR.0000000000000697; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006; Young AMH, 2018, PEDIATR RES, V83, P41, DOI 10.1038/pr.2017.215	30	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	JAN	2022	126						125	130		10.1016/j.pediatrneurol.2021.11.002			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	XV3QF	WOS:000734859900001	34864306				2022-02-06	
J	Kunisek, L; Ilijas, KM; Medved, I; Ferencic, A; Erdeljac, D; Arbanas, S; Kunisek, J				Kunisek, Leon; Ilijas, Koviljka Matusan; Medved, Igor; Ferencic, Antun; Erdeljac, Danijela; Arbanas, Silvia; Kunisek, Juraj			Cardiomyocytes calpain 2 expression: Diagnostic forensic marker for sudden cardiac death caused by early myocardial ischemia and an indicator of the duration of myocardial agonal period?	MEDICAL HYPOTHESES			English	Article						Calpain; Sudden cardiac death; Early myocardial ischemia; Acute myocardial infarction; Forensic pathology; Immunohistochemistry		Sudden cardiac death (SCD) is an unexpected natural death of cardiac etiology and occurs within one hour of the onset of cardiac symptoms in an apparently healthy subject or within 24 h if death is not witnessed. The diagnosis of early myocardial ischemia (EMI) or acute myocardial infarction (AMI) after death is a challenge for forensic pathologists especially when death occurs in a short period of time after the onset of myocardial ischemia. Disorder of cardiomyocytes Ca2+ homeostasis caused by myocardial ischemia during SCD can lead to the activation of calcium-activated non-lysosomal cysteine protease, including calpains. They serve as a proteolytic unit for cell balance and also participate in the processes of apoptosis and necrosis. Agony is a period that precedes somatic death that differs from cellular agony which may evolve for hours after somatic death lasting differently depending on the cell type and mechanism of death. We hypothesize that the expression of calpain 2 in cardiomyocytes could be a specific and sensitive diagnostic forensic marker for SCD caused by EMI and an indicator of the duration of myocardial agonal period. We will conduct a retrospective study that will prove this hypothesis on the respondents who died of SCD by EMI and AMI, instant death by head gunshot and hanging. There is no data on such an analysis in the available literature. The standard hematoxylin-eosin staining will be used to detect cardiac tissue damage. The expression of calpain 2 in cardiomyocytes will be analyzed immunohistochemically. In SCD caused by EMI we expect lower level of calpain 2 expressionin comparison to AMI due to shorter duration of dying. Similar, we predict in the remote region lower calpain 2 expression than in the region of ischemia for both EMI and AMI. In instant death caused by perforating traumatic brain injury we expect mild or no calpain 2 expression throughout the whole myocardium because of very short (immediate) duration of dying. In death caused by hanging calpain 2 expression throughout the whole myocardium should be strong because of longer cellular agonal period. We expect that our results would indicate the immediate activation of calpain 2 in different causes of cardiomyocytes death. From the degree of expression of calpain 2 we could conclude about the duration of cardiomyocytes agony so calpain 2 could be used as a marker for the assessment the duration of somatic and cellular agony.	[Kunisek, Leon; Medved, Igor; Erdeljac, Danijela] Univ Hosp Ctr Rijeka, Dept Cardiothorac Surg, Div Cardiac Surg, Kresimirova 42, Rijeka 51000, Croatia; [Ilijas, Koviljka Matusan] Univ Hosp Ctr Rijeka, Dept Pathol & Cytol, Kresimirova 42, Rijeka, Croatia; [Ferencic, Antun; Arbanas, Silvia] Univ Rijeka, Fac Med, Dept Forens Med & Criminalist, Rijeka, Croatia; [Kunisek, Juraj] Special Hosp Med Rehabil Crikven, Thalassotherapia Crikven, Gajevo Setaliste 21, Crikvenica, Croatia		Kunisek, L (corresponding author), Univ Hosp Ctr Rijeka, Dept Cardiothorac Surg, Div Cardiac Surg, Kresimirova 42, Rijeka 51000, Croatia.	leon.kunisek@gmail.com			University of Rijeka [13.06.1.2.31]	The preliminary experiments were financed by the financial support of University of Rijeka, grant No. 13.06.1.2.31.		0	0	0	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JAN	2022	158								110738	10.1016/j.mehy.2021.110738			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	YG9BZ	WOS:000742775800013	34863067				2022-02-06	
J	Lang, E; Neuschwander, A; Fave, G; Abback, PS; Esnault, P; Geeraerts, T; Harrois, A; Hanouz, JL; Kipnis, E; Leone, M; Legros, V; Mellati, N; Pottecher, J; Hamada, S; Pirracchio, R				Lang, Elodie; Neuschwander, Arthur; Fave, Gersende; Abback, Paer-Selim; Esnault, Pierre; Geeraerts, Thomas; Harrois, Anatole; Hanouz, Jean-Luc; Kipnis, Eric; Leone, Marc; Legros, Vincent; Mellati, Nouchan; Pottecher, Julien; Hamada, Sophie; Pirracchio, Romain		Traumabase Grp	Clinical decision support for severe trauma patients: Machine learning based definition of a bundle of care for hemorrhagic shock and traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Hemorrhagic shock; traumatic brain injury; machine learning; bundle of care; compliance	MANAGEMENT GUIDELINES; MORTALITY; TRANSFUSION; SCORE	BACKGROUND Deviation from guidelines is frequent in emergency situations, and this may lead to increased mortality. Probably because of time constraints, 55% is the greatest reported guidelines compliance rate in severe trauma patients. This study aimed to identify among all available recommendations a reasonable bundle of items that should be followed to optimize the outcome of hemorrhagic shocks (HSs) and severe traumatic brain injuries (TBIs). METHODS We first estimated the compliance with French and European guidelines using the data from the French TraumaBase registry. Then, we used a machine learning procedure to reduce the number of recommendations into a minimal set of items to be followed to minimize 7-day mortality. We evaluated the bundles using an external validation cohort. RESULTS This study included 5,924 trauma patients (1,414 HS and 4,955 TBI) between 2011 and August 2019 and studied compliance to 36 recommendation items. Overall compliance rate to recommendation items was 71.6% and 66.9% for HS and TBI, respectively. In HS, compliance was significantly associated with 7-day decreased mortality in univariate analysis but not in multivariate analysis (risk ratio [RR], 0.91; 95% confidence interval [CI], 0.90-1.17; p = 0.06). In TBI, compliance was significantly associated with decreased mortality in univariate and multivariate analysis (RR, 0.85; 95% CI, 0.75-0.92; p = 0.01). For HS, the bundle included 13 recommendation items. In the validation cohort, when this bundle was applied, patients were found to have a lower 7-day mortality rate (RR, 0.46; 95% CI, 0.27-0.63; p = 0.01). In TBI, the bundle included seven items. In the validation cohort, when this bundle was applied, patients had a lower 7-day mortality rate (RR, 0.55; 95% CI, 0.34-0.71; p = 0.02). DISCUSSION Using a machine-learning procedure, we were able to identify a subset of recommendations that minimizes 7-day mortality following traumatic HS and TBI. These two bundles remain to be evaluated in a prospective manner.	[Lang, Elodie; Neuschwander, Arthur; Fave, Gersende; Hamada, Sophie] Hop Europeen Georges Pompidou, AP HP, Dept Anesthesia & Crit Care Med, Clichy, France; [Abback, Paer-Selim] Hop Beaujon, Dept Anesthesia & Crit Care Med, Clichy, France; [Esnault, Pierre] Hia St Anne, Dept Anesthesia & Crit Care Med, Toulouse, France; [Geeraerts, Thomas] CHU Toulouse, Dept Anesthesia & Crit Came Med, Toulouse, France; [Harrois, Anatole] CHU Bicetre, Dept Anesthesia & Crit Care Med, Le Kremlin Bicetre, France; [Hanouz, Jean-Luc] CHU Caen, Dept Anesthesia & Crit Care Med, Caen, France; [Kipnis, Eric] CHU Lille, Dept Anesthesia & Crit Care Malicine, Lille, France; [Leone, Marc] Hop Nord Marseille, Dept Anesthesia & Crit Care Med, Marseille, France; [Legros, Vincent] CHU Reims, Dept Anesthesia & Crit Care Med, Reims, France; [Mellati, Nouchan] Chr Metz Thionville, Dept Anesthesia & Crit Care Med, Metz, France; [Pottecher, Julien] CHU Strasbourg, Dept Anesthesia & Crit Care Med, Strasbourg, France; [Pirracchio, Romain] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Dept Anesthesia & Crit Care Med, San Francisco, CA USA		Pirracchio, R (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, 1001 Potrero Ave, San Francisco, CA 94110 USA.	Romain.Pirracchio@ucsf.edu		Harrois, Anatole/0000-0002-5098-4656			American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Bhangu A, 2013, INJURY, V44, P1693, DOI 10.1016/j.injury.2012.07.193; Brodie Steven, 2007, J R Army Med Corps, V153, P310; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; COUNTS RB, 1979, ANN SURG, V190, P91, DOI 10.1097/00000658-197907000-00020; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Diringer MN, 2016, ACTA NEUROCHIR SUPPL, V121, P3, DOI 10.1007/978-3-319-18497-5_1; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Gauss T, 2019, JAMA SURG, V154, P1117, DOI 10.1001/jamasurg.2019.3475; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2018, LANCET, V392, P1789, DOI [DOI 10.1016/S0140-6736(18)32279-7, 10.1016/S0140-6736(18)32279-7]; Godier A, 2016, BRIT J ANAESTH, V117, P592, DOI 10.1093/bja/aew317; Hamada SR, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1092-5; Haute autorite de Sante, 2013, NIV PREUV GRAD REC B; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lakstein D, 2003, J TRAUMA, V54, pS221, DOI 10.1097/01.TA.0000047227.33395.49; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leone M, 2012, CRIT CARE MED, V40, P3189, DOI 10.1097/CCM.0b013e31826571f2; Mitra B, 2011, EUR J EMERG MED, V18, P137, DOI 10.1097/MEJ.0b013e328342310e; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Sahuquillo J, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub3; Savage SA, 2013, J TRAUMA ACUTE CARE, V74, P396, DOI 10.1097/TA.0b013e31827a3639; TEASDALE G, 1974, LANCET, V2, P81; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	35	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2022	92	1					135	143		10.1097/TA.0000000000003401			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	XR1JJ	WOS:000731994300027	34554136				2022-02-06	
J	Latini, F; Fahlstrom, M; Vedung, F; Stensson, S; Larsson, EM; Lubberink, M; Tegner, Y; Haller, S; Johansson, J; Wall, A; Antoni, G; Marklund, N				Latini, Francesco; Fahlstrom, Markus; Vedung, Fredrik; Stensson, Staffan; Larsson, Elna-Marie; Lubberink, Mark; Tegner, Yelverton; Haller, Sven; Johansson, Jakob; Wall, Anders; Antoni, Gunnar; Marklund, Niklas			Refined Analysis of Chronic White Matter Changes after Traumatic Brain Injury and Repeated Sports-Related Concussions: Of Use in Targeted Rehabilitative Approaches?	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; sport related concussion; memory impairment; diffusion tensor imaging; white matter lesions; rehabilitative approaches	TENSOR IMAGING PARAMETERS; CORPUS-CALLOSUM; AXONAL INJURY; COGNITIVE REHABILITATION; POSTCONCUSSION SYNDROME; MILD; MEMORY; INTEGRITY; IMPAIRMENT; DTI	Traumatic brain injury (TBI) or repeated sport-related concussions (rSRC) may lead to long-term memory impairment. Diffusion tensor imaging (DTI) is helpful to reveal global white matter damage but may underestimate focal abnormalities. We investigated the distribution of post-injury regional white matter changes after TBI and rSRC. Six patients with moderate/severe TBI, and 12 athletes with rSRC were included >= 6 months post-injury, and 10 (age-matched) healthy controls (HC) were analyzed. The Repeatable Battery for the Assessment of Neuropsychological Status was performed at the time of DTI. Major white matter pathways were tracked using q-space diffeomorphic reconstruction and analyzed for global and regional changes with a controlled false discovery rate. TBI patients displayed multiple classic white matter injuries compared with HC (p < 0.01). At the regional white matter analysis, the left frontal aslant tract, anterior thalamic radiation, and the genu of the corpus callosum displayed focal changes in both groups compared with HC but with different trends. Both TBI and rSRC displayed worse memory performance compared with HC (p < 0.05). While global analysis of DTI-based parameters did not reveal common abnormalities in TBI and rSRC, abnormalities to the fronto-thalamic network were observed in both groups using regional analysis of the white matter pathways. These results may be valuable to tailor individualized rehabilitative approaches for post-injury cognitive impairment in both TBI and rSRC patients.	[Latini, Francesco; Vedung, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Med Sci, Sect Neurosurg, S-75185 Uppsala, Sweden; [Fahlstrom, Markus; Larsson, Elna-Marie; Haller, Sven] Uppsala Univ, Dept Surg Sci, Sect Radiol, S-75185 Uppsala, Sweden; [Stensson, Staffan] Uppsala Univ Hosp, Rehabil & Pain Ctr, S-75185 Uppsala, Sweden; [Lubberink, Mark; Wall, Anders] Uppsala Univ Hosp, PET Ctr, S-75185 Uppsala, Sweden; [Lubberink, Mark] Uppsala Univ Hosp, Med Phys, S-75185 Uppsala, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Educ & Technol, Div Hlth Med & Rehabil, S-97187 Lulea, Sweden; [Haller, Sven] Affidea CDRC Ctr Diagnost Radiolog Carouge SA, CH-1227 Geneva, Switzerland; [Johansson, Jakob] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol, S-75185 Uppsala, Sweden; [Wall, Anders] Uppsala Univ, Dept Surg Sci, Sect Nucl Med & PET, S-75185 Uppsala, Sweden; [Antoni, Gunnar] Uppsala Univ, Dept Med Chem, S-75185 Uppsala, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Sect Neurosurg, S-22184 Lund, Sweden		Latini, F (corresponding author), Uppsala Univ, Dept Med Sci, Sect Neurosurg, S-75185 Uppsala, Sweden.	francesco.latini@neuro.uu.se; markus.fahlstrom@radiol.uu.se; fredrik.vedung@neuro.uu.se; staffan.stenson@akademiska.se; elnamarielarsson@me.com; mark.lubberink@radiol.uu.se; yelverton@tegner.com; sven.haller@surgsci.uu.se; jakob.johansson@surgsci.uu.se; anders.wall@akademiska.se; gunnar.antoni@ilk.uu.se; niklas.marklund@neuro.uu.se	Fahlstrom, Markus/AAT-4041-2020	Fahlstrom, Markus/0000-0002-2502-6026; Haller, Sven/0000-0001-7433-0203	Swedish Brain Foundation [FO2020-0147, FO2019-0190, FO2018-0166]; Swedish Research Council (SRC)Swedish Research Council [2018-02500_VR]; SRC under EU-ERA-NET NEURON CnsAFlame; Swedish Research Council for Sport Science [P2019-0133, P2020-0116, P2021-0105]; Bissen Brain Walk and Selander Foundation	Swedish Brain Foundation FO2020-0147, FO2019-0190, FO2018-0166, Swedish Research Council (SRC) 2018-02500_VR, SRC under the framework of EU-ERA-NET NEURON CnsAFlame, Swedish Research Council for Sport Science P2019-0133, P2020-0116, P2021-0105, Bissen Brain Walk and Selander Foundation-all to N.M.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andreasen S., LTD COLOCALIZATION M; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Baker CM, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.926; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Carrera E, 2006, NEUROLOGY, V66, P1817, DOI 10.1212/01.wnl.0000219679.95223.4c; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chen SHA, 1997, BRAIN INJURY, V11, P197; de Bourbon-Teles J, 2014, CURR BIOL, V24, P993, DOI 10.1016/j.cub.2014.03.024; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Dick AS, 2019, CORTEX, V111, P148, DOI 10.1016/j.cortex.2018.10.015; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Feigl GC, 2014, WORLD NEUROSURG, V81, P144, DOI 10.1016/j.wneu.2013.01.004; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Glickstein M, 2008, CORTEX, V44, P914, DOI 10.1016/j.cortex.2008.04.001; GUZE SB, 1995, AM J PSYCHIAT, V152, P1228, DOI 10.1176/ajp.152.8.1228; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Houri J, 2018, PHYS IMAG RADIAT ONC, V6, P39, DOI 10.1016/j.phro.2018.04.003; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Knight S, 2019, ARCH PHYS MED REHAB, V100, P711, DOI 10.1016/j.apmr.2018.05.031; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; La Corte E, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.641586; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latini F, 2021, EUR J NEUROL, V28, P2789, DOI 10.1111/ene.14903; Latini F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211243; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marklund N, 2019, J INTERN MED, V285, P608, DOI 10.1111/joim.12900; Marklund N, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102665; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; McIntyre M, 2021, AM J PHYS MED REHAB, V100, P193, DOI 10.1097/PHM.0000000000001586; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; McKeithan Lydia, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030044; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Mohamed AZ, 2021, BIOL PSYCHIAT-COGN N, V6, P1100, DOI 10.1016/j.bpsc.2021.04.014; Mohammadian M, 2020, J NEUROTRAUM, V37, P2616, DOI 10.1089/neu.2020.7081; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Nishio Y, 2014, NEUROPSYCHOLOGIA, V53, P264, DOI 10.1016/j.neuropsychologia.2013.11.025; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Raskin SA, 2018, CLIN NEUROPSYCHOL, V32, P891, DOI 10.1080/13854046.2018.1455898; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rickards TA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1748032; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sweeney-Reed CM, 2015, ELIFE, V4, DOI 10.7554/eLife.07578; Sweeney-Reed CM, 2014, ELIFE, V3, DOI 10.7554/eLife.05352; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Vergani F, 2014, J NEUROL NEUROSUR PS, V85, P1377, DOI 10.1136/jnnp-2013-307492; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Yaldizli O, 2014, MULT SCLER J, V20, P356, DOI 10.1177/1352458513496880; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang J, 2019, J NEUROL NEUROSUR PS, V90, P98, DOI 10.1136/jnnp-2017-317691; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02950-3	92	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2022	11	2							358	10.3390/jcm11020358			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YN9AT	WOS:000747543900001	35054052	gold, Green Accepted			2022-02-06	
J	Lauretta, MP; Melotti, RM; Sangermano, C; George, AM; Badenes, R; Bilotta, F				Lauretta, Maria Paola; Melotti, Rita Maria; Sangermano, Corinne; George, Anneliya Maria; Badenes, Rafael; Bilotta, Federico			Homocysteine Plasmatic Concentration in Brain-Injured Neurocritical Care Patients: Systematic Review of Clinical Evidence	JOURNAL OF CLINICAL MEDICINE			English	Article						homocysteine; cerebrovascular disease; perioperative care	TRANSIENT ISCHEMIC ATTACK; METHYLENETETRAHYDROFOLATE REDUCTASE; RISK-FACTOR; STROKE; ASSOCIATION; HYPERHOMOCYSTEINEMIA; ANTIPLATELET; POLYMORPHISM; SUBANALYSIS	Background: Hyperhomocysteinemia (HHcy) is considered as an independent risk factor for several diseases, such as cardiovascular, neurological and autoimmune conditions. Atherothrombotic events, as a result of endothelial dysfunction and increased inflammation, are the main mechanisms involved in vascular damage. This review article reports clinical evidence on the relationship between the concentration of plasmatic homocysteine (Hcy) and acute brain injury (ABI) in neurocritical care patients. Materials and methods: a systematic search of articles in the PubMed and EMBASE databases was conducted, of which only complete studies, published in English in peer-reviewed journals, were included. Results: A total of 33 articles, which can be divided into the following 3 subchapters, are present: homocysteine and acute ischemic stroke (AIS); homocysteine and traumatic brain injury (TBI); homocysteine and intracranial hemorrhage (ICH)/subarachnoid hemorrhage (SAH). This confirms that HHcy is an independent risk factor for ABI and a marker of poor prognosis in the case of stroke, ICH, SAH and TBI. Conclusions: Several studies elucidate that Hcy levels influence the patient's prognosis in ABI and, in some cases, the risk of recurrence. Hcy appears as biochemical marker that can be used by neuro-intensivists as an indicator for risk stratification. Moreover, a nutraceutical approach, including folic acid, the vitamins B6 and B12, reduces the risk of thrombosis, cardiovascular and neurological dysfunction in patients with severe HHcy that were admitted for neurocritical care.	[Lauretta, Maria Paola] Univ Bologna, IRCCS Policlin S Orsola Malpighi Bologna, Dept Anaesthesia & Pain Management, I-40138 Bologna, Italy; [Melotti, Rita Maria] Univ Bologna, IRCCS Policlin S Orsola Malpighi Bologna, Alma Mater Studiorum, Dept Anaesthesia & Pain Management, I-40138 Bologna, Italy; [Sangermano, Corinne; George, Anneliya Maria; Bilotta, Federico] Sapienza Univ Rome, Umberto I Hosp, Dept Anaesthesia Intens Care & Pain Management, I-00161 Rome, Italy; [Badenes, Rafael] Univ Valencia, Hosp Clin, Dept Anesthesiol & Surg Trauma Intens Care, Valencia 46010, Spain		Badenes, R (corresponding author), Univ Valencia, Hosp Clin, Dept Anesthesiol & Surg Trauma Intens Care, Valencia 46010, Spain.	mariapaola.lauretta@aosp.bo.it; ritamaria.melotti@aosp.bo.it; corinne.sangermano@gmail.com; anneliya.george16201@gmail.com; rafaelbadenes@gmail.com; federico.bilotta@uniroma1.it		Badenes, Rafael/0000-0001-7017-0150; MELOTTI, RITA MARIA/0000-0001-6258-6607			Bagi Z, 2002, ARTERIOSCL THROM VAS, V22, P28, DOI 10.1161/hq0102.101127; Bernstein JE, 2018, CUREUS, V10, DOI 10.7759/cureus.3529; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Cheng G, 2019, MED SCI MONITOR, V25, P240, DOI 10.12659/MSM.908692; Cochrane Review Group, 2007, SYST REV INT 10 PAT, P1; Ding R, 2012, J NEUROL SCI, V312, P26, DOI 10.1016/j.jns.2011.08.029; Ferlazzo N, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-62; Forti P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.460; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Gao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144431; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; Hatefi M, 2017, WORLD NEUROSURG, V97, P70, DOI 10.1016/j.wneu.2016.09.080; Hendrix P, 2018, J NEUROSURG, V128, P1771, DOI 10.3171/2017.2.JNS162933; Huang X, 2017, NEUROLOGY, V89, P2101, DOI [10.1212/WNL.0000000000004648, 10.1212/wnl.0000000000004648]; Ientile Riccardo, 2010, Front Biosci (Schol Ed), V2, P359; Jin L, 2001, Med Sci Monit, V7, P585; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kokturk N, 2011, CLIN APPL THROMB-HEM, V17, P487, DOI 10.1177/1076029610378499; Kumar M, 2018, METAB BRAIN DIS, V33, P1617, DOI 10.1007/s11011-018-0268-5; Kwon HM, 2014, STROKE, V45, P871, DOI 10.1161/STROKEAHA.113.004099; Li JJ, 2020, ARTERIOSCL THROM VAS, V40, P839, DOI 10.1161/ATVBAHA.119.313741; McGuinness LA, 2021, RES SYNTH METHODS, V12, P55, DOI 10.1002/jrsm.1411; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n71; Poddar R, 2001, CIRCULATION, V103, P2717; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Santilli F, 2016, VASC PHARMACOL, V78, P1, DOI 10.1016/j.vph.2015.06.009; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136; Shu XJ, 2017, EUR REV MED PHARMACO, V21, P2538; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Tinelli C, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00049; vonEckardstein A, 1997, NEW ENGL J MED, V337, P1632; Wang BY, 2018, BRIT J NUTR, V120, P1122, DOI 10.1017/S0007114518002477; Yin JY, 2018, CLIN CHIM ACTA, V479, P132, DOI 10.1016/j.cca.2018.01.011; Zhao M, 2017, STROKE, V48, P1183, DOI 10.1161/STROKEAHA.116.015324; Zhong CK, 2017, MOL NEUROBIOL, V54, P2022, DOI 10.1007/s12035-016-9799-0; Zhou FF, 2015, J STROKE CEREBROVASC, V24, P784, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.005; Zhu ZB, 2019, ATHEROSCLEROSIS, V287, P30, DOI 10.1016/j.atherosclerosis.2019.05.028	38	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2022	11	2							394	10.3390/jcm11020394			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YN2ME	WOS:000747096400001	35054087	gold, Green Accepted			2022-02-06	
J	Li, B; Li, D; Ni, HB; Liu, CL; Xiong, J; Liu, HX; Gao, R; Zhang, L; Chen, G				Li, Bing; Li, Di; Ni, Haibo; Liu, Chenglin; Xiong, Jian; Liu, Huixiang; Gao, Rong; Zhang, Li; Chen, Gang			The circadian clock regulator Bmal1 affects traumatic brain injury in rats through the p38 MAPK signalling pathway	BRAIN RESEARCH BULLETIN			English	Article						Bmal1; P38 MAPK; TBI; Circadian rhythms	MESSENGER-RNA; EXPRESSION; MICE; RHYTHMS; SLEEP; ERK	Traumatic brain injury (TBI) is still one of the main causes of death and disability worldwide. Bmal1 (brain and muscle Arnt-like protein-1) is the most central factor of the circadian rhythms that control life and cells. Studies have shown that Bmal1 is involved in inflammation, oxidative stress, vasodilation, glucose and lipid metabolism. This study explored the effect of Bmal1 on secondary brain injury after TBI in rats and the possible mechanism. We established a rat model of TBI induced by the free fall of a weight in rats. The Western blotting and immunofluorescence results showed that the Bmal1 levels decreased in the cerebral cortex after TBI, especially at 48 h. The effects of Bmal1 levels on rats after TBI were evaluated by brain oedema measurement, adhesive removal tests, behavioural tests, and TUNEL and FJC staining. We found that the recombinant Bmal1 protein increased Bmal1 levels after TBI and reduced brain oedema, neurobehavioural injury, somatosensory disturbances, and nerve cell necrosis and apoptosis. The ELISA results showed that Bmal1 overexpression could reduce the inflammatory factors IL-4 and TNF-alpha after TBI. In contrast, inhibiting Bmal1 expression had the opposite effect. The changes in Bmal1 levels were closely related to the phosphorylation of p38 MAPK after TBI. In conclusion, a decrease in Bmal1 after TBI may exacerbate pathological symptoms in vivo by activating p38 MAPK phosphorylation.	[Li, Bing; Ni, Haibo; Liu, Chenglin; Liu, Huixiang; Gao, Rong; Zhang, Li] Soochow Univ, Dept Neurosurg, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Li, Di] Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Xiong, Jian] Soochow Univ, Dept Rehabil, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Brain & Nerve Res Lab, Affiliated Hosp 1, Suzhou, Peoples R China		Gao, R; Zhang, L (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China.	714866001@qq.com; zhangli_syy@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801238, 81901254]	This work was supported by grants from National Natural Science Foundation of China (Nos. 81801238 and Nos. 81901254) .	Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bose S, 2016, NEUROCHEM RES, V41, P1390, DOI 10.1007/s11064-016-1843-y; Bose S, 2010, ENDOCRINOLOGY, V151, P2287, DOI 10.1210/en.2009-1252; Chen GJ, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117636; Cortes D, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-020-00114-y; Culnan E, 2019, NEUROL CLIN, V37, P527, DOI 10.1016/j.ncl.2019.04.003; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duan AW, 2020, J SAFETY RES, V73, P161, DOI 10.1016/j.jsr.2020.02.010; Gao F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00357; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Goldsmith CS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3896-y; Goldsmith CS, 2013, ADV GENET, V84, P1, DOI 10.1016/B978-0-12-407703-4.00001-3; Gwon D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072352; Harvey JRM, 2020, PHYSIOL REV, V100, P1415, DOI 10.1152/physrev.00027.2019; Hosoda H, 2019, CYTOTECHNOLOGY, V71, P453, DOI 10.1007/s10616-018-0266-9; Huh KR, 2020, CLIN EXP EMERG MED, V7, P81, DOI 10.15441/ceem.19.076; Khan S, 2018, LANCET NEUROL, V17, P1098, DOI 10.1016/S1474-4422(18)30335-1; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2010, AGING-US, V2, P285; Li B, 2021, CELL MOL NEUROBIOL, V41, P795, DOI 10.1007/s10571-020-00887-2; Li D, 2018, CNS NEUROSCI THER, V24, P906, DOI 10.1111/cns.12833; Li D, 2018, BRAIN RES, V1688, P15, DOI 10.1016/j.brainres.2017.10.018; Liang TY, 2021, NEUROMOL MED, V23, P267, DOI 10.1007/s12017-020-08611-5; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Lystad RP, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000445; Malik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139655; Mattis J, 2016, TRENDS ENDOCRIN MET, V27, P192, DOI 10.1016/j.tem.2016.02.003; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Morioka N, 2015, NEUROCHEM INT, V90, P9, DOI 10.1016/j.neuint.2015.06.013; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakazato R, 2017, J NEUROSCI, V37, P10052, DOI 10.1523/JNEUROSCI.3639-16.2017; Ni HB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00674; Ni HB, 2018, EXP NEUROL, V304, P102, DOI 10.1016/j.expneurol.2018.03.003; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Rosenwasser AM, 2015, SLEEP MED CLIN, V10, P403, DOI 10.1016/j.jsmc.2015.08.003; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Wu XY, 2019, ENVIRON POLLUT, V252, P1455, DOI 10.1016/j.envpol.2019.06.042; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhang J, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106715	46	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JAN	2022	178						17	28		10.1016/j.brainresbull.2021.11.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YJ0UQ	WOS:000744254900003	34774994				2022-02-06	
J	Li, L; Luo, Q; Shang, B; Yang, XM; Zhang, Y; Pan, QL; Wu, N; Tang, W; Du, DL; Sun, XC; Jiang, L				Li, Lin; Luo, Qing; Shang, Bin; Yang, Xiaomin; Zhang, Yuan; Pan, Qiuling; Wu, Na; Tang, Wei; Du, Donglin; Sun, Xiaochuan; Jiang, Li			Selective activation of cannabinoid receptor-2 reduces white matter injury via PERK signaling in a rat model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Cannabinoid receptor-2; White matter injury; Endoplasmic reticulum (ER) stress; Microglia; macrophage polarization; Oligodendrocytes	MICROGLIAL ACTIVATION; MICROGLIA/MACROPHAGE POLARIZATION; INHIBITION; MEMORY; DAMAGE; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION; IMPAIRMENT	Background and purpose: Traumatic brain injury (TBI) destroys white matter, and this destruction is aggravated by secondary neuroinflammatory reactions. Although white matter injury (WMI) is strongly correlated with poor neurological function, understanding of white matter integrity maintenance is limited, and no available therapies can effectively protect white matter. One candidate approach that may fulfill this goal is cannabinoid receptor 2 (CB2) agonist treatment. Here, we confirmed that a selective CB2 agonist, JWH133, protected white matter after TBI. Methods: The motor evoked potentials (MEPs), open field test, and Morris water maze test were used to assess neurobehavioral outcomes. Brain tissue loss, WM damage, Endoplasmic reticulum stress (ER stress), microglia responses were evaluated after TBI. The functional integrity of WM was measured by diffusion tensor imaging (DTI) and transmission electron microscopy (TEM). Primary microglia and oligodendrocyte cocultures were used for additional mechanistic studies. Results: JWH133 increased myelin basic protein (MBP) and neurofilament heavy chain (NF200) levels and anatomic preservation of myelinated axons revealed by DTI and TEM. JWH133 also increased the numbers of oligodendrocyte precursor cells and mature oligodendrocytes. Furthermore, JWH133 drove microglial polarization toward the protective M2 phenotype and modulated the redistribution of microglia in the striatum. Further investigation of the underlying mechanism revealed that JWH133 downregulated phosphorylation of the protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase (PERK) signaling pathway and its downstream signals eukaryotic translation initiation factor 2 alpha (eIF2 alpha), activating transcription factor 4 (ATF4) and Growth arrest and DNA damage-inducible protein (GADD34); this downregulation was followed by p-Protein kinase B(pAkt) upregulation. In primary cocultures of microglia and oligodendrocytes, JWH133 decreased phosphorylated PERK expression in microglia stimulated with tunicamycin and facilitated oligodendrocyte survival. These data reveal that JWH133 ultimately alleviates WMI and improves neurological behavior following TBI. However, these effects were prevented by SR144528, a selective CB2 antagonist. Conclusions: This work illustrates the PERK-mediated interaction between microglia and oligodendrocytes. In addition, the results are consistent with recent findings that microglial polarization switching accelerates WMI, highlighting a previously unexplored role for CB2 agonists. Thus, CB2 agonists are potential therapeutic agents for TBI and other neurological conditions involving white matter destruction.	[Li, Lin; Yang, Xiaomin; Zhang, Yuan; Pan, Qiuling; Wu, Na; Tang, Wei; Du, Donglin; Sun, Xiaochuan; Jiang, Li] Chongqing Med Univ, Affiliated Hosp 1, Neural Injury & Protect Lab, Dept Neurosurg, Chongqing 400016, Peoples R China; [Li, Lin; Shang, Bin] Nanchong Cent Hosp, Dept Neurosurg, Nanchong, Peoples R China; [Luo, Qing] Nanchong Cent Hosp, Dept Ultrasound, Nanchong, Peoples R China		Sun, XC; Jiang, L (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Neural Injury & Protect Lab, Dept Neurosurg, Chongqing 400016, Peoples R China.	sunxch1445@qq.com; drjiangli2019@163.com			National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [8170051808]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8207052904]	This work was supported by grants from the National Natural Science Foundation for Youth of China (Grant number 8170051808) and National Natural Science Foundation of China (Grant number 8207052904).	Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Chen BK, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01778-1; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang ZJ, 2020, CNS NEUROSCI THER, V26, P698, DOI 10.1111/cns.13298; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Komorowska-Muller JA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96285-9; Krebs-Kraft DL, 2010, P NATL ACAD SCI USA, V107, P20535, DOI 10.1073/pnas.1005003107; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Li L, 2018, BRAIN RES, V1697, P113, DOI 10.1016/j.brainres.2018.06.006; Li L, 2015, TRANSL STROKE RES, V6, P467, DOI 10.1007/s12975-015-0425-7; Liew HK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111326; Lin Li, 2017, Front Immunol, V8, P112, DOI 10.3389/fimmu.2017.00112; Liu H, 2018, BRAIN RES, V1700, P118, DOI 10.1016/j.brainres.2018.07.006; Liu XL, 2020, J CLIN NEUROSCI, V77, P55, DOI 10.1016/j.jocn.2020.05.043; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; NOGGE G, 1979, J MED ENTOMOL, V16, P263, DOI 10.1093/jmedent/16.3.263; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pu AN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01895-1; Sen N, 2019, NEUROSCIENTIST, V25, P420, DOI 10.1177/1073858418816611; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shin YH, 2021, ANGEW CHEM INT EDIT, V60, P1831, DOI 10.1002/anie.202013915; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Tang J, 2017, NEUROPHARMACOLOGY, V119, P157, DOI 10.1016/j.neuropharm.2017.01.027; Vekaria HJ, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104866; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang YW, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1002-7; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Xia M, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00098; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xing GQ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00161; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang J, 2021, BIOMATER SCI-UK, V9, P745, DOI 10.1039/c9bm01446b; Zhang LY, 2020, THERANOSTICS, V10, P74, DOI 10.7150/thno.35841; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330	55	0	0	6	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2022	347								113899	10.1016/j.expneurol.2021.113899			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WY9II	WOS:000719590200006	34678230	hybrid, Green Submitted			2022-02-06	
J	Lidin, E; Skold, MK; Angeria, M; Davidsson, J; Risling, M				Lidin, Erik; Skold, Mattias K.; Angeria, Maria; Davidsson, Johan; Risling, Marten			Hippocampal Expression of Cytochrome P450 1B1 in Penetrating Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; sex differences; hippocampus	INFLAMMATORY RESPONSE; RAT; GENDER; PROGESTERONE; CYP1B1; METABOLISM; ESTROGENS; MODERATE; GENE	Hippocampal dysfunction contributes to multiple traumatic brain injury sequala. Female rodents' outcome is superior to male which has been ascribed the neuroprotective sex hormones 17 beta-estradiol and progesterone. Cytochrome P450 1B1 (CYP1B1) is an oxidative enzyme influencing the neuroinflammatory response by creating inflammatory mediators and metabolizing neuroprotective 17 beta-estradiol and progesterone. In this study, we aimed to describe hippocampal CYP1B1 mRNA expression, protein presence of CYP1B1 and its key redox partner Cytochrome P450 reductase (CPR) in both sexes, as well as the effect of penetrating traumatic brain injury (pTBI). A total 64 adult Sprague Dawley rats divided by sex received pTBI or sham-surgery and were assigned survival times of 1-, 3-, 5- or 7 days. CYP1B1 mRNA was quantified using in-situ hybridization and immunohistochemistry performed to verify protein colocalization. CYP1B1 mRNA expression was present in all subregions but greatest in CA2 irrespective of sex, survival time or intervention. At 3-, 5- and 7 days post-injury, expression in CA2 was reduced in male rats subjected to pTBI compared to sham-surgery. Females subjected to pTBI instead exhibited increased expression in all CA subregions 3 days post-injury, the only time point expression in CA2 was greater in females than in males. Immunohistochemical analysis confirmed neuronal CYP1B1 protein in all hippocampal subregions, while CPR was limited to CA1 and CA2. CYP1B1 mRNA is constitutively expressed in both sexes. In response to pTBI, females displayed a more urgent but brief regulatory response than males. This indicates there may be sex-dependent differences in CYP1B1 activity, possibly influencing inflammation and neuroprotection in pTBI.	[Lidin, Erik; Skold, Mattias K.; Angeria, Maria; Risling, Marten] Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, S-17177 Stockholm, Sweden; [Skold, Mattias K.] Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Dept Mech & Maritime Sci, S-41296 Gothenburg, Sweden		Lidin, E (corresponding author), Karolinska Inst, Dept Neurosci, Expt Traumatol Unit, S-17177 Stockholm, Sweden.	erik.lidin@ki.se; mattias.skold@ki.se; maria.angeria@ki.se; johan.davidsson@chalmers.se; Marten.Risling@ki.se			Swedish Armed Forces [AF.9221006]	FundingThis research was funded by the Swedish Armed Forces (AF.9221006).	Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BHATTACHARYYA KK, 1995, J BIOL CHEM, V270, P11595, DOI 10.1074/jbc.270.19.11595; Cembrowski MS, 2019, NAT REV NEUROSCI, V20, P193, DOI 10.1038/s41583-019-0125-5; CHRISTOU M, 1995, MOL CELL ENDOCRINOL, V115, P41, DOI 10.1016/0303-7207(95)03668-W; Czosnyka M, 2008, ACTA NEUROCHIR SUPPL, V102, P25, DOI 10.1007/978-3-211-85578-2_5; Davidsson J, 2016, METHODS MOL BIOL, V1462, P267, DOI 10.1007/978-1-4939-3816-2_16; Davidsson J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00051; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dell'Aquila M, 2021, HISTOL HISTOPATHOL, V36, P795, DOI 10.14670/HH-18-319; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Drozdzik A, 2014, ARCH ORAL BIOL, V59, P434, DOI 10.1016/j.archoralbio.2014.02.003; Dudek SM, 2016, NAT REV NEUROSCI, V17, P89, DOI 10.1038/nrn.2015.22; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Ghadiri T, 2019, NEUROSCI LETT, V709, DOI 10.1016/j.neulet.2019.134384; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guennoun R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155271; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Henderson CJ, 2006, TOXICOL LETT, V162, P111, DOI 10.1016/j.toxlet.2005.10.016; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Kato A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00149; Li F, 2017, PHARMACOL THERAPEUT, V178, P18, DOI 10.1016/j.pharmthera.2017.03.007; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Maayah ZH, 2017, MOL CELL BIOCHEM, V429, P151, DOI 10.1007/s11010-017-2943-y; Mannella P, 2010, HORM MOL BIOL CLIN I, V4, P609, DOI 10.1515/HMBCI.2010.078; Mishra S, 2018, STEM CELL REP, V10, P1705, DOI 10.1016/j.stemcr.2018.04.024; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Palenski TL, 2013, AM J PHYSIOL-CELL PH, V305, pC1170, DOI 10.1152/ajpcell.00139.2013; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Renic M, 2009, J CEREBR BLOOD F MET, V29, P629, DOI 10.1038/jcbfm.2008.156; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roland JJ, 2014, J NEUROSCI, V34, P506, DOI 10.1523/JNEUROSCI.2352-13.2014; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Schultz C, 2014, FRONT NEUROL NEUROSC, V34, P6, DOI 10.1159/000360925; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Silva-Alves MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169214; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Taxier LR, 2020, NAT REV NEUROSCI, V21, P535, DOI 10.1038/s41583-020-0362-7; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yu XM, 2019, INT J BIOCHEM CELL B, V110, P111, DOI 10.1016/j.biocel.2019.03.001; Ziegler N, 2016, J NEUROSCI, V36, P8921, DOI 10.1523/JNEUROSCI.0148-16.2016	51	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2022	23	2							722	10.3390/ijms23020722			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	YN3NP	WOS:000747168300001	35054909	gold, Green Published, Green Accepted			2022-02-06	
J	Lin, PH; Kuo, LT; Luh, HT				Lin, Ping-Hung; Kuo, Lu-Ting; Luh, Hui-Tzung			The Roles of Neurotrophins in Traumatic Brain Injury	LIFE-BASEL			English	Article						neurotrophins; traumatic brain injury; nerve growth factor; brain-derived neurotrophic factor; NT-3; NT-4; 5	NERVE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; NEURAL STEM-CELLS; CEREBROSPINAL FLUID BARRIER; CONTROLLED CORTICAL IMPACT; FUNCTIONAL RECOVERY; RAT MODEL; HIPPOCAMPAL NEUROGENESIS; VOLUNTARY EXERCISE; COGNITIVE FUNCTION	Neurotrophins are a collection of structurally and functionally related proteins. They play important roles in many aspects of neural development, survival, and plasticity. Traumatic brain injury (TBI) leads to different levels of central nervous tissue destruction and cellular repair through various compensatory mechanisms promoted by the injured brain. Many studies have shown that neurotrophins are key modulators of neuroinflammation, apoptosis, blood-brain barrier permeability, memory capacity, and neurite regeneration. The expression of neurotrophins following TBI is affected by the severity of injury, genetic polymorphism, and different post-traumatic time points. Emerging research is focused on the potential therapeutic applications of neurotrophins in managing TBI. We conducted a comprehensive review by organizing the studies that demonstrate the role of neurotrophins in the management of TBI.	[Lin, Ping-Hung] Natl Taiwan Univ, Sch Med, Dept Med Educ, Taipei 100, Taiwan; [Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Luh, Hui-Tzung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 235, Taiwan; [Luh, Hui-Tzung] Taipei Med Univ, Taipei Neurosci Inst, New Taipei 235, Taiwan; [Luh, Hui-Tzung] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 100, Taiwan		Luh, HT (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 235, Taiwan.; Luh, HT (corresponding author), Taipei Med Univ, Taipei Neurosci Inst, New Taipei 235, Taiwan.; Luh, HT (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Taipei 100, Taiwan.	b03401063@ntu.edu.tw; ltkuo@ntu.edu.tw; 17260@s.tmu.edu.tw					Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Akyol O, 2018, EXP NEUROL, V307, P82, DOI 10.1016/j.expneurol.2018.06.002; Alison MR, 2002, J PATHOL, V197, P419, DOI 10.1002/path.1187; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Aly Riham Mohamed, 2020, Stem Cell Investig, V7, P8, DOI 10.21037/sci-2020-001; Andero R, 2014, PROG MOL BIOL TRANSL, V122, P169, DOI 10.1016/B978-0-12-420170-5.00006-4; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Barker PA, 2020, J PAIN RES, V13, P1223, DOI 10.2147/JPR.S247472; Barretto TA, 2020, STEM CELLS DEV, V29, P198, DOI 10.1089/scd.2019.0135; Bates B, 2002, NEUROBIOL DIS, V9, P24, DOI 10.1006/nbdi.2001.0458; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bonilla C, 2014, CYTOTHERAPY, V16, P1501, DOI 10.1016/j.jcyt.2014.07.007; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; BRACCI-LAUDIERO L, 1992, NEUROSCI LETT, V147, P9; BRADSHAW RA, 1993, TRENDS BIOCHEM SCI, V18, P48, DOI 10.1016/0968-0004(93)90052-O; Bukovics P, 2014, PEPTIDES, V60, P18, DOI 10.1016/j.peptides.2014.07.001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chaudhry V, 2000, MUSCLE NERVE, V23, P189, DOI 10.1002/(SICI)1097-4598(200002)23:2<189::AID-MUS7>3.3.CO;2-#; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen T, 2017, NEUROCHEM RES, V42, P3073, DOI 10.1007/s11064-017-2340-7; CHENG B, 1994, BRAIN RES, V650, P331, DOI 10.1016/0006-8993(94)91801-5; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chou W, 2018, MOL NEUROBIOL, V55, P8602, DOI 10.1007/s12035-018-1011-2; Choumerianou DM, 2008, TISSUE ENG PART B-RE, V14, P53, DOI 10.1089/teb.2007.0216; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Cordeira JW, 2010, J NEUROSCI, V30, P2533, DOI 10.1523/JNEUROSCI.5768-09.2010; Cuello AC, 1996, PROG BRAIN RES, V109, P347; Dai WL, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00556-3; Das M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49428-y; Debeir T, 1999, P NATL ACAD SCI USA, V96, P4067, DOI 10.1073/pnas.96.7.4067; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; Deng QJ, 2018, CELL MOL NEUROBIOL, V38, P467, DOI 10.1007/s10571-017-0490-4; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Feng Y, 2017, MOL MED REP, V16, P654, DOI 10.3892/mmr.2017.6619; Finan JD, 2018, J ALZHEIMERS DIS, V65, P1055, DOI 10.3233/JAD-180585; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Giacobbo BL, 2019, MOL NEUROBIOL, V56, P3295, DOI 10.1007/s12035-018-1283-6; Giarratana AO, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01175; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Gincberg G, 2018, CYTOTHERAPY, V20, P245, DOI 10.1016/j.jcyt.2017.11.008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Grey Vijaylaxmi, 2003, J Cyst Fibros, V2, P195, DOI 10.1016/S1569-1993(03)00097-3; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griffioen KJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.030; Grundy PL, 2004, MOL BRAIN RES, V120, P188, DOI 10.1016/j.molbrainres.2003.09.018; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Guo XX, 2018, NEUROBIOL DIS, V113, P59, DOI 10.1016/j.nbd.2018.02.004; Gustafsson D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073582; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEYMACH JV, 1995, J BIOL CHEM, V270, P12297, DOI 10.1074/jbc.270.20.12297; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Houlton J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00790; Hoyland A, 2009, NUTR RES REV, V22, P220, DOI 10.1017/S0954422409990175; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Knuckey NW, 1996, MOL BRAIN RES, V40, P1; Kovesdi E, 2008, NEUROTOX RES, V13, P71, DOI 10.1007/BF03033558; KOZLOWSKI GP, 1986, NEUROL CLIN, V4, P907, DOI 10.1016/S0733-8619(18)30954-X; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; Krishna G, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801055; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Leung LY, 2016, J TRAUMA ACUTE CARE, V81, P860, DOI 10.1097/TA.0000000000001206; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29; Luo ML, 2019, NEUROCHEM RES, V44, P2765, DOI 10.1007/s11064-019-02897-z; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Madathil S.K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; MANESS LM, 1994, NEUROSCI BIOBEHAV R, V18, P143, DOI 10.1016/0149-7634(94)90043-4; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Martinez-Drudis L, 2021, BEHAV BRAIN RES, V400, DOI 10.1016/j.bbr.2020.113048; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Munoz MJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00044; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Nakamachi T, 2010, ACTA NEUROCHIR SUPPL, V106, P43, DOI 10.1007/978-3-211-98811-4_6; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; PERSSON H, 1993, CURR OPIN NEUROL NEU, V6, P11; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Portbury SD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183683; Qi LF, 2018, J CRANIOFAC SURG, V29, P1689, DOI 10.1097/SCS.0000000000005042; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ren YZ, 2020, J NEUROCHEM, V154, P530, DOI 10.1111/jnc.14962; Reyes-Izquierdo T, 2013, BRIT J NUTR, V110, P420, DOI 10.1017/S0007114512005338; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rothman SM, 2012, ANN NY ACAD SCI, V1264, P49, DOI 10.1111/j.1749-6632.2012.06525.x; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sahenk Z, 2005, NEUROLOGY, V65, P681, DOI 10.1212/01.WNL.0000171978.70849.c5; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; SCOTT DE, 1977, CELL TISSUE RES, V179, P235; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Shaito A, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102829; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P112, DOI 10.1196/annals.1403.008; Sharma HS, 2007, PROG BRAIN RES, V162, P459, DOI 10.1016/S0079-6123(06)62023-2; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Shin MS, 2016, INT NEUROUROL J, V20, pS49, DOI 10.5213/inj.1632616.308; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Shioda S, 2004, REGUL PEPTIDES, V122, P39; Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001; Skinner SJM, 2006, XENOTRANSPLANTATION, V13, P284, DOI 10.1111/j.1399-3089.2006.00310.x; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stumm R, 2007, J NEUROCHEM, V103, P1666, DOI 10.1111/j.1471-4159.2007.04895.x; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Ultsch MH, 1999, J MOL BIOL, V290, P149, DOI 10.1006/jmbi.1999.2816; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wang TY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01835-z; Wang YM, 2019, TURK NEUROSURG, V29, P750, DOI 10.5137/1019-5149.JTN.25463-18.2; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Wu K, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1428-1; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Xu HY, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.920855; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Ying Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052998; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zeng F, 2011, BIOCHEM PHARMACOL, V82, P1500, DOI 10.1016/j.bcp.2011.06.040; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017	207	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-1729		LIFE-BASEL	Life-Basel	JAN	2022	12	1							26	10.3390/life12010026			22	Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Microbiology	YN5PE	WOS:000747309600001	35054419	gold, Green Accepted			2022-02-06	
J	Liu, XT; Liu, CM; Teng, ZQ				Liu, Xiao-Tian; Liu, Chang-Mei; Teng, Zhao-Qian			Mouse model of voluntary movement deficits induced by needlestick injuries to the primary motor cortex	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Mouse model; Voluntary movement deficit; Traumatic brain injury; Primary Motor cortex	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; FORELIMB; NEURONS; DEGENERATION; LESIONS; RATS	Background: Motor handicap is prevalent in patients with traumatic brain injury, but currently. there is a challenging task to prevent the degeneration of motor neurons and to fully recover the. voluntary movement after injury. New method: For the first time, we propose to apply needlestick injuries to the primary motor cortex to create mouse model of voluntary movement deficits. Rotarod test, cylinder test and forepaw grip strength test were used to assay motor coordination of both C57BL/6 J and the triple immunodeficient NCG mice. Immunofluorescence staining of PKC-gamma, UCHL1, GFAP, Iba1 and Fluoro-Jade C was performed to analyze the numbers of motor neurons, microglia, astrocytes and degenerating neurons. Results: Mice on either C57BL/6 J or immunodeficient background with the unilateral primary motor cortex injury exhibit motor neuron death, activation of glial cells and deficits in voluntary movement. Conclusions: The main finding of this study was that the unilateral primary motor cortex injured by needlesticks leads to reactive gliosis, motor neuron death and voluntary movement deficits in mice. This needlestick injury model of primary motor cortex might be useful for future exploration of underlying mechanisms of motor neuron degeneration and of promising treatment modalities such as cell transplantation to improve locomotor deficiency following neurotrauma.	[Liu, Xiao-Tian; Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, 3 A Datun Rd, Beijing 100101, Peoples R China; [Liu, Xiao-Tian; Liu, Chang-Mei; Teng, Zhao-Qian] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100408, Peoples R China; [Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China; [Liu, Chang-Mei; Teng, Zhao-Qian] Chinese Acad Sci, Beijing Inst Stem Cell & Regenerat Med, Beijing 100101, Peoples R China		Liu, CM; Teng, ZQ (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, 3 A Datun Rd, Beijing 100101, Peoples R China.	liuchm@ioz.ac.cn; tengzq@ioz.ac.cn					Alam A, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-02005-x; Anderson KD, 2009, EXP NEUROL, V220, P9, DOI 10.1016/j.expneurol.2009.06.012; CENCI MAL MARTIN, 2005, UTILITY 6 HYDROXYDOP; De La Rochere P, 2018, TRENDS IMMUNOL, V39, P748, DOI 10.1016/j.it.2018.07.001; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Geribaldi-Doldan N, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0913-2; Gherardini L, 2015, CEREB CORTEX, V25, P202, DOI 10.1093/cercor/bht217; Gomis-Gonzalez M, 2021, MOL NEUROBIOL, V58, P617, DOI 10.1007/s12035-020-02135-6; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Jara JH, 2015, CEREB CORTEX, V25, P4259, DOI 10.1093/cercor/bhu318; Lieu A, 2013, J NEUROIMMUNOL, V256, P43, DOI 10.1016/j.jneuroim.2013.01.003; Limanaqi F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00628; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Liu C, 2021, GLIA, V69, P1292, DOI 10.1002/glia.23966; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001; Morecraft RJ, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00068; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Paxinos GF, 2001, KBJ MOUSE BRAIN STER, V2nd; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Shoemaker LD, 2010, BIOESSAYS, V32, P197, DOI 10.1002/bies.200900114; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Tamakoshi K, 2014, BEHAV BRAIN RES, V260, P34, DOI 10.1016/j.bbr.2013.11.034; Wang ZM, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00325-8; Welberg L, 2012, NAT REV NEUROSCI, V13, DOI [10.1038/nrn3282, 10.1038/nrn3277]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Yasvoina MV, 2013, J NEUROSCI, V33, P7890, DOI 10.1523/JNEUROSCI.2787-12.2013; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0	36	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 1	2022	365								109380	10.1016/j.jneumeth.2021.109380			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	WL0CK	WOS:000710084300007	34634284				2022-02-06	
J	Louahem, D; Jeandel, C; Aldugman, T; Joly-Monrigal, P; Cottalorda, J; Delpont, M				Louahem, Djamel; Jeandel, Clement; Aldugman, Tariq; Joly-Monrigal, Pauline; Cottalorda, Jerome; Delpont, Marion			Closed reduction by trans-physealantegrade elastic stable intramedullary nailing in acute pediatric Monteggia fractures: a report of 22 cases	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						closed reduction; elastic stable intramedullary nailing stabilization; Monteggia fracture	SURGICAL-TREATMENT; CHILDREN; LESIONS; DISLOCATIONS; MANAGEMENT; CHILDHOOD; OSTEOTOMY; FIXATION; ULNA	Treatment of acute pediatric Monteggia fractures is still debated. The aim of this study was to assess the efficacy of strategy based on closed reduction by trans-physeal antegrade elastic stable intramedullary nailing (ESIN) of the ulnar fracture. Retrospective analysis of 22 patients (13 boys and nine girls) treated for acute Monteggia fractures between May 2008 and August 2018 was performed. Mean age at injury was 6.6 years. Mean follow-up was 4.5 years. On the basis of the Bado classification, 15 lesions were of type I, three types III and four types IV. All the patients were managed with closed reduction and ESIN of the ulna fracture within 2-19 h of arrival. Intraoperative stability of reduction of the radial head was checked under fluoroscopic control in pronation and supination. Outcomes were assessed with the Bruce et al. scoring system. Closed alignment of the ulnar fracture by ESIN had simultaneously reduced and stabilized the radial head dislocation in all patients. At the final follow-up, all the patients had excellent results. Complete healing of the fracture occurred in 6 weeks and the elastic nail removed at 3-6 months postoperatively. There was no case of instability or subluxation or re-dislocation of the radial head. No olecranon epiphysiodesis or growth disorders were noticed. Early diagnosis and management of acute pediatric Monteggia fractures by closed reduction and ESIN achieve excellent clinical and radiographic outcomes.	[Louahem, Djamel; Jeandel, Clement; Aldugman, Tariq; Joly-Monrigal, Pauline; Cottalorda, Jerome; Delpont, Marion] Hop Lapeyronie, Serv Chirurg Orthoped Pediat, 191 Ave doyen Gaston Giraud, F-34295 Montpellier 5, France		Cottalorda, J (corresponding author), Hop Lapeyronie, Serv Chirurg Orthoped Pediat, 191 Ave doyen Gaston Giraud, F-34295 Montpellier 5, France.	jerome.cottalorda@gmail.com					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bae DS, 2016, J PEDIATR ORTHOPED, V36, pS67, DOI 10.1097/BPO.0000000000000765; Bae DS, 2005, OPER TECH ORTHOP, V15, P308, DOI 10.1053/j.oto.2005.08.001; BOUYALA JM, 1988, REV CHIR ORTHOP, V74, P173; Boyd HB., 1940, SURG GYNECOL OBSTET, V71, P86; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; Corradin Marco, 2016, Eur J Orthop Surg Traumatol, V26, P469, DOI 10.1007/s00590-016-1774-y; David-West KS, 2005, INJURY, V36, P1206, DOI 10.1016/j.injury.2004.12.033; Delpont M, 2014, ORTHOP TRAUMATOL-SUR, V100, P803, DOI 10.1016/j.otsr.2014.06.022; Deshpande S, 2001, J ORTHOP TRAUMA, V15, P373, DOI 10.1097/00005131-200106000-00014; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P251; Foran I, 2017, J PEDIATR ORTHOPED, V37, pE335, DOI 10.1097/BPO.0000000000001001; FOWLES JV, 1983, J BONE JOINT SURG AM, V65, P1276, DOI 10.2106/00004623-198365090-00008; Gicquel P, 2003, J PEDIATR ORTHOPED, V23, P398, DOI 10.1097/00004694-200305000-00024; Gicquel P., 2005, OPERAT ORTHOP TRAUMA, V1, P51; GLEESON AP, 1994, J ACCID EMERG MED, V11, P192; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Guven M, 2008, ACTA ORTHOP TRAUMATO, V42, P90; Gyr BM, 2004, J PEDIATR ORTHOP B, V13, P402, DOI 10.1097/01202412-200411000-00011; Hetthessy JR, 2021, INJURY, V52, pS57, DOI 10.1016/j.injury.2020.02.033; Kuminack KF, 2010, Z ORTHOP UNFALLCHIR, V148, P54, DOI 10.1055/s-0029-1186190; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; Leonidou A, 2012, J PEDIATR ORTHOPED, V32, P352, DOI 10.1097/BPO.0b013e31825611fc; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; Liao SJ, 2019, INJURY, V50, P1237, DOI 10.1016/j.injury.2019.04.017; Monteggia GB., 1814, I SURG; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; Papandrea R, 2000, CLIN ORTHOP RELAT R, P115; PEIRO A, 1977, J BONE JOINT SURG AM, V59, P92, DOI 10.2106/00004623-197759010-00017; Ramski DE, 2015, J PEDIATR ORTHOPED, V35, P115, DOI 10.1097/BPO.0000000000000213; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; STOREN G, 1959, Acta Chir Scand, V116, P144; VINZ H, 1991, ZBL CHIR, V116, P143; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728, DOI 10.1302/0301-620X.67B5.4055870; Wilkins KE, 2002, J PEDIATR ORTHOPED, V22, P548, DOI 10.1097/01.BPO.0000019211.02000.60; Yuan Z, 2020, J PEDIATR ORTHOP B, V29, P438, DOI 10.1097/BPB.0000000000000645	38	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JAN	2022	31	1					43	49		10.1097/BPB.0000000000000831			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	XF6LP	WOS:000724181300014	33165215				2022-02-06	
J	Lu, Q; Xiong, J; Yuan, Y; Ruan, ZW; Zhang, Y; Chai, B; Li, L; Cai, SF; Xiao, J; Wu, YQ; Huang, P; Zhang, HY				Lu, Qi; Xiong, Jun; Yuan, Yuan; Ruan, Zhanwei; Zhang, Yu; Chai, Bo; Li, Lei; Cai, Shufang; Xiao, Jian; Wu, Yanqing; Huang, Peng; Zhang, Hongyu			p Minocycline improves the functional recovery after traumatic brain injury via inhibition of aquaporin-4	INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES			English	Article						Traumatic brain injury (TBI); Minocycline; Aquaporin-4 (AQP4); Blood-brain barrier (BBB); Astrocytes	BARRIER DAMAGE; MOUSE MODEL; EDEMA; DISRUPTION; AQP4; ASTROCYTES; MECHANISMS; PROTECTS; TARGET	Traumatic brain injury (TBI) is one of the main concerns worldwide as there is still no comprehensive therapeutic intervention. Astrocytic water channel aquaporin-4 (AQP-4) system is closely related to the brain edema, water transport at blood-brain barrier (BBB) and astrocyte function in the central nervous system (CNS). Minocycline, a broad-spectrum semisynthetic tetracycline antibiotic, has shown anti-inflammation, anti-apoptotic, vascular protection and neuroprotective effects on TBI models. Here, we tried to further explore the underlying mechanism of minocycline treatment for TBI, especially the relationship of minocycline and AQP4 during TBI treatment. In present study, we observed that minocycline efficaciously reduces the elevation of AQP4 in TBI mice. Furthermore, minocycline significantly reduced neuronal apoptosis, ameliorated brain edema and BBB disruption after TBI. In addition, the expressions of tight junction protein and astrocyte morphology alteration were optimized by minocycline administration. Similar results were found after treating with TGN-020 (an inhibitor of AQP4) in TBI mice. Moreover, these effects were reversed by cyanamide (CYA) treatment, which notably upregulated AQP4 expression level in vivo. In primary cultured astrocytes, small-interfering RNA (siRNA) AQP4 treatment prevented glutamate-induced astrocyte swelling. To sum up, our study suggests that minocycline improves the functional recovery of TBI through reducing AQP4 level to optimize BBB integrity and astrocyte function, and highlights that the AQP4 may be an important therapeutic target during minocycline treating for TBI.	[Lu, Qi; Xiong, Jun; Yuan, Yuan; Zhang, Yu; Chai, Bo; Li, Lei; Xiao, Jian; Zhang, Hongyu] Wenzhou Med Univ, Sch Pharmaceut Sci, Cixi Biomed Res Inst, Wenzhou Wound Repair & Regenerat Key Lab, Wenzhou 325000, Zhejiang, Peoples R China; [Yuan, Yuan] Zhejiang Prov Hosp Integrated Tradit Chinese & We, Hangzhou Red Cross Hosp, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Ruan, Zhanwei] Wenzhou Med Univ, Affiliated Hosp 3, Ruian Peoples Hosp, Dept Emergency, Wenzhou 325000, Zhejiang, Peoples R China; [Cai, Shufang; Wu, Yanqing] Wenzhou Univ, Biomed Collaborat Innovat Ctr Wenzhou, Inst Life Sci, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Wenzhou 325035, Zhejiang, Peoples R China; [Huang, Peng] Wenzhou Med Univ, Affiliated Hosp 3, Ruian Peoples Hosp, Dept Pharm, Wenzhou 325200, Zhejiang, Peoples R China; [Zhang, Hongyu] Wenzhou Med Univ, Affiliated Hosp, Zhuji Peoples Hosp, Dept Pharm, Shaoxing 311899, Zhejiang, Peoples R China		Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Cixi Biomed Res Inst, Wenzhou Wound Repair & Regenerat Key Lab, Wenzhou 325000, Zhejiang, Peoples R China.; Wu, YQ (corresponding author), Wenzhou Univ, Biomed Collaborat Innovat Ctr Wenzhou, Inst Life Sci, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Wenzhou 325035, Zhejiang, Peoples R China.; Huang, P (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Ruian Peoples Hosp, Dept Pharm, Wenzhou 325200, Zhejiang, Peoples R China.; Zhang, HY (corresponding author), Wenzhou Med Univ, Affiliated Hosp, Zhuji Peoples Hosp, Dept Pharm, Shaoxing 311899, Zhejiang, Peoples R China.	yqwu220946@yeah.net; huangpeng0769@126.com; st_hyz@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772450, 81972150, 81801233]; Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ18H150003, LQ20C200015]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-028]	This work was supported by research grants from the National Natural Science Foundation of China (81772450, 81972150 and 81801233) and the Zhejiang Provincial Natural Science Foundation (LQ18H150003 and LQ20C200015), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-028).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chen AQ, 2016, BRAIN, V139, P242, DOI 10.1093/brain/awv328; Chu HL, 2017, CEREBROVASC DIS, V44, P10, DOI 10.1159/000460261; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eilam R, 2018, GLIA, V66, P1098, DOI 10.1002/glia.23304; Glober Nancy K, 2019, Neurosci J, V2019, P2831501, DOI 10.1155/2019/2831501; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P1005, DOI 10.1038/jcbfm.2015.12; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huang Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00584; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; Ikeshima-Kataoka H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081306; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kimbrough IF, 2015, BRAIN, V138, P3716, DOI 10.1093/brain/awv327; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Leitao RA, 2018, MOL NEUROBIOL, V55, P2056, DOI 10.1007/s12035-017-0439-0; Li Y, 2018, NEUROCHEM RES, V43, P1339, DOI 10.1007/s11064-018-2549-0; Li YH, 2018, INFLAMMATION, V41, P2196, DOI 10.1007/s10753-018-0862-z; Liu WT, 2011, AUTOPHAGY, V7, P166, DOI 10.4161/auto.7.2.14043; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Min YJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00511; Monai H, 2019, P NATL ACAD SCI USA, V116, P11010, DOI 10.1073/pnas.1817347116; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Shi ZF, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00116; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sorensen AG, 2001, J CLIN ONCOL, V19, P551, DOI 10.1200/JCO.2001.19.2.551; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Sun YL, 2018, ARCH TOXICOL, V92, P1407, DOI 10.1007/s00204-017-2148-x; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Verkman AS, 2017, EXPERT OPIN THER TAR, V21, P1161, DOI 10.1080/14728222.2017.1398236; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Wasserman JK, 2007, EXP NEUROL, V207, P227, DOI 10.1016/j.expneurol.2007.06.025; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Xiao M, 2014, CNS NEUROSCI THER, V20, P385, DOI 10.1111/cns.12267; Yan XD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00006; Yang F, 2015, NEUROSCIENCE, V304, P250, DOI 10.1016/j.neuroscience.2015.07.051; Yang Y, 2018, NEUROBIOL DIS, V114, P95, DOI 10.1016/j.nbd.2018.02.012; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068595; Yew WP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1379-y; Zhao F, 2011, STROKE, V42, P3587, DOI 10.1161/STROKEAHA.111.623926; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	62	0	0	3	3	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-2288			INT J BIOL SCI	Int. J. Biol. Sci.		2022	18	1					441	458		10.7150/ijbs.64187			18	Biochemistry & Molecular Biology; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	YF0FT	WOS:000741493200005	34975343	Green Published, gold			2022-02-06	
J	Luo, Y; Zou, P; Wang, K; Li, XM; Wang, J				Luo, Yan; Zou, Ping; Wang, Kai; Li, Xiaomei; Wang, Jing			Prevalence and Risk Factors of Urinary Incontinence Among Elderly Adults in Rural China A Cross-Sectional Survey	JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING			English	Article						Prevalence; Risk factors; Urinary incontinence	OVERACTIVE BLADDER; DUAL INCONTINENCE; TRACT SYMPTOMS; OLDER WOMEN; QUALITY; POPULATION; SLEEP; MEN; IMPAIRMENT; DISABILITY	PURPOSE: The purpose of this study was to explore the prevalence of urinary incontinence (UI) and several subtypes: (stress, urge, and mixed UI) and the influence of multiple factors on the likelihood of UI. DESIGN: Epidemiological study based on cross-sectional data collection. SUBJECTS AND SETTING: The sample comprised 1279 inhabitants 65 years and older residing in 10 villages randomly selected from the Shanxi province, located in North China. METHODS: The presence and types of UI were assessed using the International Consultation of Incontinence Questionnaire-Short Form. Sociodemographic parameters were also recorded, along with data on lifestyle, bowel function, and medical conditions. The Activity of Daily Living Scale and Mini-Mental State Examination instruments were used to evaluate physical and cognitive functions, respectively. A multivariate logistic regression model with the backward method was employed to identify factors associated with UI. RESULTS: The prevalence of any UI among the rural Chinese elderly 65 years and older was 46.8%, with a female predominance (56.3% in females vs 35.0% in males). The most common incontinence subtype in women was mixed UI (n = 170, 24.0%), followed by stress UI (n = 131, 18.5%) and urge UI (n = 97, 13.7%). The most prevalent form of UI in males was urge UI (n = 190, 33.2%), followed by stress UI (n = 5, 0.9%) and mixed UI (n = 5, 0.9%). Less than one quarter of respondents (17%, n = 102) of participants with UI had consulted a doctor. Multivariate analysis found that poorer physical function, poor quality of sleep, and fecal incontinence were common factors associated with UI in both women and men. In women, higher body mass index and constipation were also independent correlates, as were poor vision and heart disease in men. Poorer physical function was associated with all UI subtypes. For female stress UI, poorer cognitive status, tea drinking, and hypertension also emerged as independent risk factors. Heart disease was an independent risk factor in both female and male urge UI; as was consumption of a non-plant-based diet for female mixed and urge UI; nonfarmer and traumatic brain injury for female urge UI; and poor vision and fecal incontinence in male urge UI. CONCLUSIONS: Chinese rural citizens showed a high UI prevalence, but only a small proportion had consulted a health care provider. Physical function decline was the most important contributor to UI among participants. Individualized intervention programs targeting modifiable risk factors among high-risk populations should be developed.	[Luo, Yan; Li, Xiaomei; Wang, Jing] Xi An Jiao Tong Univ, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China; [Zou, Ping] Nipissing Univ, Sch Nursing, Fac Educ & Profess Studies, North Bay, ON, Canada; [Wang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China		Wang, J (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, 76 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.	ly442597723@126.com; pingz@nipissingu.ca; kay_wang@hust.edu.cn; roselee8825@163.com; novowj@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601224]	This study was supported by the National Natural Science Foundation of China (grant number: 81601224).	Amaral MOP, 2015, INT J GYNECOL OBSTET, V131, P82, DOI 10.1016/j.ijgo.2015.03.041; Aniuliene R, 2016, UROL J, V13, P2552; Botlero R, 2011, J UROLOGY, V185, P1331, DOI 10.1016/j.juro.2010.11.080; Bresee C, 2014, FEMALE PELVIC MED RE, V20, P328, DOI 10.1097/SPV.0000000000000093; Buckley BS, 2010, UROLOGY, V76, P265, DOI 10.1016/j.urology.2009.11.078; Bulut TY, 2020, J WOUND OSTOMY CONT, V47, P166, DOI 10.1097/WON.0000000000000615; Cerruto MA, 2013, UROL INT, V90, P1, DOI 10.1159/000339929; Drennan VM, 2013, NEUROUROL URODYNAM, V32, P314, DOI 10.1002/nau.22333; Erekson EA, 2015, FEMALE PELVIC MED RE, V21, P170, DOI 10.1097/SPV.0000000000000136; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ge J, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1118, DOI 10.1177/1010539511429370; Ge TJ, 2017, UROLOGY, V109, P67, DOI 10.1016/j.urology.2017.07.039; Gorina Yelena, 2014, Vital Health Stat 3, P1; Huang AJ, 2007, OBSTET GYNECOL, V109, P909, DOI 10.1097/01.AOG.0000258277.01497.4b; Imamura M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003505.pub5; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; KOYANO W, 1986, ARCH GERONTOL GERIAT, V5, P197, DOI 10.1016/0167-4943(86)90022-1; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li Y, 2007, MED CARE, V45, P1116, DOI 10.1097/MLR.0b013e31812da820; Lian WQ, 2019, INT UROGYNECOL J, V30, P1629, DOI 10.1007/s00192-019-03941-w; Liu B, 2014, INT J CLIN EXP MED, V7, P686; Lopes MA, 2016, ARCH GERONTOL GERIAT, V66, P134, DOI 10.1016/j.archger.2016.05.010; Markland AD, 2008, J AM GERIATR SOC, V56, P285, DOI 10.1111/j.1532-5415.2007.01509.x; Mishra GD, 2010, BJU INT, V106, P1170, DOI 10.1111/j.1464-410X.2010.09321.x; Miu DKY, 2010, GERIATR GERONTOL INT, V10, P177, DOI 10.1111/j.1447-0594.2009.00574.x; Murukesu RR, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6870-6; Nazaripanah NS, 2018, SLEEP SCI, V11, P106, DOI 10.5935/1984-0063.20180020; Nyman MH, 2017, J CLIN NURS, V26, P3345, DOI 10.1111/jocn.13686; Omli R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-47; Esparza AO, 2018, APPL NURS RES, V40, P68, DOI 10.1016/j.apnr.2017.12.007; Pedersen LS, 2017, ACTA OBSTET GYN SCAN, V96, P939, DOI 10.1111/aogs.13149; Pourhoseingholi MA, 2009, J GASTROINTEST LIVER, V18, P151; Sadananda P, 2011, NEUROUROL URODYNAM, V30, P708, DOI 10.1002/nau.21137; Schumpf LF, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0414-7; Shaw C., 2017, MEDICINE, V45, P23; Shin KR, 2008, J KOREAN ACAD NURS, V38, P573, DOI 10.4040/jkan.2008.38.4.573; Sumardi R, 2014, ACTA MED INDONES, V46, P175; Sumarsono B, 2020, LUTS, V12, P223, DOI 10.1111/luts.12308; Syan R, 2016, BJU INT, V117, P20, DOI 10.1111/bju.13187; Tetley J., 2018, NURSING OLDER PEOPLE; Teunissen TAM, 2004, INT UROGYNECOL J, V15, P10, DOI 10.1007/s00192-003-1106-8; Tsai YC, 2009, INT UROL NEPHROL, V41, P795, DOI 10.1007/s11255-009-9523-3; Vaughan CP, 2011, MT SINAI J MED, V78, P558, DOI 10.1002/msj.20276; Wang CL, 2015, J CLIN NURS, V24, P1112, DOI 10.1111/jocn.12729; Wang YL, 2015, INT UROGYNECOL J, V26, P911, DOI 10.1007/s00192-015-2626-8; Winkelman WD, 2018, FEMALE PELVIC MED RE, V24, P76, DOI 10.1097/SPV.0000000000000547; Wu JM, 2015, J AM GERIATR SOC, V63, P947, DOI 10.1111/jgs.13385; Wu XH, 2011, GYNECOL OBSTET INVES, V71, P262, DOI 10.1159/000320333; Yang DZ, 2008, CLIMACTERIC, V11, P329, DOI 10.1080/13697130802239075; Yoshimura K, 2013, INT J UROL, V20, P911, DOI 10.1111/iju.12074; Zhang XF, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0538-9; Zhu L, 2008, MENOPAUSE, V15, P566, DOI 10.1097/gme.0b013e31816054ac	52	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1071-5754	1528-3976		J WOUND OSTOMY CONT	J. Wound Ostomy Cont. Nurs.	JAN-FEB	2022	49	1					78	86		10.1097/WON.0000000000000829			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	YI1HQ	WOS:000743607500012	35040817				2022-02-06	
J	McPherson, JI; Saleem, GT; Haider, MN; Leddy, JJ; Torres, DM; Willer, B				McPherson, Jacob I.; Saleem, Ghazala T.; Haider, M. Nadir; Leddy, John J.; Torres, Daniel M.; Willer, Barry			Practical Management: Telehealth Examination for Sport-Related Concussion in the Outpatient Setting	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; telehealth; examination		This article presents the telehealth version of the Buffalo Concussion Physical Examination (BCPE) (Tele-BCPE). It is a brief, focused telehealth PE for use in the outpatient setting by sports medicine physicians, pediatricians, neurologists, and primary care physicians. It is derived from the BCPE and includes general considerations for providers performing telehealth services and instructions for adapting traditional clinical tests for virtual use. The Tele-BCPE includes an orthostatic intolerance screen, examination of the cranial nerves, and tests of the oculomotor, vestibular, and cervical systems. It is meant to be used at initial and follow-up outpatient visits for patients acutely after concussion and in those with prolonged symptoms. This telehealth PE, when combined with other assessments, can help provide direct treatment to patients at any stage after concussion and reduce barriers to healthcare access posed by the COVID-19 pandemic and for patients living in rural or underserved areas.	[McPherson, Jacob I.; Saleem, Ghazala T.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Rehabil Sci, Buffalo, NY USA; [Haider, M. Nadir; Leddy, John J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Torres, Daniel M.] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		McPherson, JI (corresponding author), SUNY Buffalo, Dept Rehabil Sci, 534 Kimball Tower, Buffalo, NY 14214 USA.	jim6@buffalo.edu; ghazalas@buffalo.edu; haider@buffalo.edu; leddy@buffalo.edu; Daniel.Torres@nyulangone.org; bswiller@buffalo.edu					Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Dorsey ER, 2020, LANCET, V395, P859, DOI 10.1016/S0140-6736(20)30424-4; Ellis MJ, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1573163; Haider MN, 2021, BRAIN INJURY, V35, P226, DOI 10.1080/02699052.2021.1871951; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Petersen SMB, 2015, J MAN MANIP THER, V23, P61, DOI 10.1179/2042618614Y.0000000085; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Services USCfMMST , 2020, TEL SERV; Tenforde AS, 2020, PM&R, V12, P926, DOI 10.1002/pmrj.12422; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Wongworawat MD, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.01095	15	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					72	75		10.1097/JSM.0000000000000972			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000021	34483240				2022-02-06	
J	Meehan, A; Post, A; Hoshizaki, TB; Gilchrist, MD				Meehan, Andrew; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Investigation of an Ice Hockey Helmet Test Protocol Representing Three Concussion Event Types	JOURNAL OF TESTING AND EVALUATION			English	Article						ice hockey; standard; impact test; concussion	SYSTEMATIC VIDEO ANALYSIS; MAXIMUM PRINCIPAL STRAIN; TRAUMATIC BRAIN-INJURIES; DYNAMIC-RESPONSE; CORPUS-CALLOSUM; LEAGUE NHL; HEAD; ACCELERATION; RECONSTRUCTION; IMPACTS	Although ice hockey helmet standards mitigate the risk of catastrophic head injuries, the risk of concussion remains high. To improve protection, helmets need to be evaluated using impact conditions reflecting how concussions occur in ice hockey. The purpose of this research was to evaluate how three helmet impact tests represent three common concussive events in ice hockey. An ice drop test (representing head-to-ice impacts), 30 degrees and 45 degrees anvil boards drop tests (representing head-to-boards impacts), and medium and high shoulder compliance pneumatic ram tests (representing shoulder-to-head impacts) were performed on a hybrid III headform. Finite element analysis using the University College Dublin Brain Trauma Model was conducted to calculate maximum principal strain (MPS). The mean dynamic response and MPS from each helmet test were compared to a dataset of concussive injury reconstructions. Stepwise forward multiple linear regressions identified the dynamic response variables producing the strongest relationship with MPS for each helmet test and concussion reconstructions. The results indicated that the ice and boards drop test and shoulder ram test had magnitudes and relationships between variables similar to the concussion reconstructions. The proposed testing methodologies in this study closely approximated concussion mechanics in ice hockey and inform improved helmet test standards and design.	[Meehan, Andrew; Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, 125 Univ St, Ottawa, ON K1N 6N5, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin D4, Ireland		Post, A (corresponding author), Univ Ottawa, Sch Human Kinet, 125 Univ St, Ottawa, ON K1N 6N5, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin D4, Ireland.	apost@uottawa.ca					[Anonymous], 2019, ND00217M19A NAT OP C; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; Clark JM, 2020, SPORT BIOMECH, V19, P510, DOI 10.1080/14763141.2018.1510975; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cournoyer J, 2019, J ATHL TRAINING, V54, P765, DOI 10.4085/1062-6050-253-18; de Grau S, 2020, P I MECH ENG P-J SPO, V234, P98, DOI 10.1177/1754337119871866; de Grau S, 2020, SPORTS ENG, V23, DOI 10.1007/s12283-020-00325-y; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Foreman S., 2011, 23 INT SOC BIOM C BR; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Ice Hockey Helmets, 2015, ICE HOCKEY HELMETS C; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan A., 2019, THESIS U OTTAWA; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Newman J A, 2000, Stapp Car Crash J, V44, P215; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2019, 42 CAN MED BIOL ENG; Post A., 2014, INT RES COUNC BIOM I; Post A., 2016, INT RES COUNC BIOM I; Post A, 2021, COMPUT METHOD BIOMEC, V24, P1, DOI 10.1080/10255842.2020.1805442; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Potvin BM, 2019, J BIOMECH, V91, P43, DOI 10.1016/j.jbiomech.2019.05.002; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Ruan J. S., 1994, THESIS WAYNE STATE U; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Smith G, 2018, J BIG DATA-GER, V5, DOI 10.1186/s40537-018-0143-6; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Taylor K, 2019, P I MECH ENG P-J SPO, V233, P503, DOI 10.1177/1754337119857434; Taylor K, 2019, COMPUT METHOD BIOMEC, V22, P1047, DOI 10.1080/10255842.2019.1626840; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, 39 STAPP CAR CRASH C	63	0	0	1	1	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA	0090-3973	1945-7553		J TEST EVAL	J. Test. Eval.	JAN	2022	50	1					465	478		10.1520/JTE20200436			14	Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	XX7EZ	WOS:000736455200001					2022-02-06	
J	Memmini, AK; Van Pelt, KL; Wicklund, A; Breedlove, KM; Broglio, SP				Memmini, Allyssa K.; Van Pelt, Kathryn L.; Wicklund, Alissa; Breedlove, Katherine M.; Broglio, Steven P.			p Evaluating Adult Decision-Making Modifiers in Support of Youth Contact-Sport Participation	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; collision sports; survey research	HIGH-SCHOOL; KNOWLEDGE; CONCUSSIONS; ATTITUDES; INJURY	Context: Nearly 44 million youth participate in organized youth sports programs in the United States each year. However, approximately 25% of parents have considered removing their children from sports due to the fear of concussion. Objective: To determine which adult decision-making modifiers (eg, gender, educational attainment, career type) influenced support for youth contact-sports participation. Design: Cross-sectional study. Setting: Midwestern university and medical center. Patients or Other Participants: Convenience sample of staff and faculty (N = 5761; 73.9% female) from 2017 to 2018. Main Outcome Measure(s): Support for youth contact sports participation using multivariate binary logistic regression to calculate odds ratios and 95% CIs. Results: The sample was split between adults with children (AWCs; n = 3465, age = 45.39 +/- 13.27 years, 76.72% female) and adults without children (AWOCs; n = 2296, age = 30.84 +/- 9.01 years, 70.26% female). Among AWCs, those who obtained a bachelor's degree or higher were more likely to support contact-sports participation. Females were more inclined to allow all contact sports, specifically football (odds ratio [OR] = 2.22; 95% CI =1.64, 3.01) and ice hockey (OR =1.98; 95% CI = 1.42, 2.78). Overall, previous adult sport participation, increasing number of children, and child gender were significant modifying variables in greater support of youth contact-sports participation among AWCs (P , .001). Among AWOCs, previous sport participation in football (OR = 3.27; 95% CI = 2.14, 4.87), ice hockey (OR = 4.26; 95% CI = 2.23, 8.17), or soccer (OR = 2.29; 95% CI = 1.48, 3.54) increased the likelihood of an adult supporting contact-sports participation. Lastly, all adults were less inclined to support a daughter participating in any contact sport than a son. Conclusions: These results reveal adult-and child-specific variables that may influence youth contact-sports participation. These decisions may be developed through the lens of certain gender role beliefs and may lead adults to perceive certain sports as more appropriate for sons than daughters.	[Memmini, Allyssa K.; Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, 830 N Univ Ave, Ann Arbor, MI 48109 USA; [Van Pelt, Kathryn L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Wicklund, Alissa] Orthopaed & Spine Ctr Rockies, Ft Collins, CO USA; [Breedlove, Katherine M.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Breedlove, Katherine M.] Brigham & Womens Hosp, Ctr Clin Spect, 75 Francis St, Boston, MA 02115 USA		Memmini, AK (corresponding author), Univ Michigan, Michigan Concuss Ctr, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	amemmini@umich.edu					[Anonymous], 2019, 2018 2019 HIGH SCH A; [Anonymous], 2020, STAT PLAY 2020 REP I; Baxter-Jones ADG, 2003, J SPORT MED PHYS FIT, V43, P250; BEM SL, 1981, PSYCHOL REV, V88, P354, DOI 10.1037/0033-295X.88.4.354; Dimeo F, 2012, HYPERTENSION, V60, P653, DOI 10.1161/HYPERTENSIONAHA.112.197780; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harrison PA, 2003, J SCHOOL HEALTH, V73, P113, DOI 10.1111/j.1746-1561.2003.tb03585.x; Heinze JE, 2017, YOUTH SOC, V49, P634, DOI 10.1177/0044118X14553580; Kay MC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117742370; Kim S, 2021, J ADOLESCENT HEALTH, V68, P184, DOI 10.1016/j.jadohealth.2020.04.029; Kroshus E, 2019, SOC SCI MED, V222, P359, DOI 10.1016/j.socscimed.2018.12.037; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Martinez-Gomez D, 2020, PROG CARDIOVASC DIS, V62, P522, DOI 10.1016/j.pcad.2019.11.010; McLeod TV, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119832399; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; O'Brien KH, 2019, TOP LANG DISORD, V39, P313, DOI 10.1097/TLD.0000000000000190; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schatz P, 2020, DEV NEUROPSYCHOL, V45, P110, DOI 10.1080/87565641.2020.1766464; Schulman A, 2020, SOCCER PARTICIPATION; Solmon MA, 2003, J TEACH PHYS EDUC, V22, P261, DOI 10.1123/jtpe.22.3.261; Sone JY, 2018, J NEUROSURG-PEDIATR, V22, P1, DOI 10.3171/2018.1.PEDS17640; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Weiss MR, 2004, DEV SPORT EXERCISE P, P145, DOI DOI 10.1016/J.PSYCHSPORT.2010.05.001; Williamson J, 2010, ARCH INTERN MED, V170, P124, DOI 10.1001/archinternmed.2009.491	29	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2022	57	1					44	50		10.4085/1062-6050-0125.21			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YL7KX	WOS:000746068300005	35040986	gold			2022-02-06	
J	Meulenbroek, P; O'Neil-Pirozzi, TM; Sohlberg, MM; Lemoncello, R; Byom, L; Ness, B; MacDonald, S; Phillips, B				Meulenbroek, Peter; O'Neil-Pirozzi, Therese M.; Sohlberg, McKay Moore; Lemoncello, Rik; Byom, Lindsey; Ness, Bryan; MacDonald, Sheila; Phillips, Brian		ANCDS TBI Writing Comm	Tutorial: The Speech-Language Pathologist's Role in Return to Work for Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							VOCATIONAL-REHABILITATION; COMMUNICATION ABILITY; SUPPORTED EMPLOYMENT; SOCIAL EFFECTIVENESS; SELF-AWARENESS; JOB STABILITY; OUTCOMES; HEALTH; INTERVENTIONS; COGNITION	Purpose: Return to work (RTW) is a major life participation metric used for persons with a traumatic brain injury (TBI). Speech-language pathologists (SLPs) have clinical expertise in the cognitive-communication aspects of TBI. This clinical focus article aims to support the clinical practice of SLPs by summarizing key interprofessional vocational rehabilitation (VR) models and illustrating the role of the SLP throughout the RTW process with a case study. Method: This clinical focus article was written by the Academy of Neurologic Communication Disorders and Sciences TBI Research Group along with a VR expert. Authors engaged in deliberative, agenda-based discussions beginning with a literature review based on previous systematic studies. Discussions explored relevant VR and SLP practices. Results: This clinical focus article presents key VR models in parallel with SLP assessment and treatment to illustrate best practice patterns in an RTW field with a dearth of SLP-specific literature. We summarize general VR approaches and four evidence-supported VR models for adults with TBI. We highlight how a model of interprofessional assessment can assist with planning and communication of important work-related concerns. We illustrate how the chronological model of work return can assist with developing goals and planning treatment. Conclusions: SLPs play an important role in identifying, managing, and collaborating with an RTW team following TBI. A working knowledge of VR models can assist with improving the dialogue between SLPs and VR professionals and can inform practice when working with persons with TBI who have work return as a goal.	[Meulenbroek, Peter] Univ Kentucky, Commun Sci & Disorders, Lexington, KY 40506 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Commun Sci & Disorders, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Harvard Traumat Brain Injury Model Syst, Boston, MA USA; [Sohlberg, McKay Moore] Univ Oregon, Commun Disorders & Sci, Eugene, OR 97403 USA; [Lemoncello, Rik] Pacific Univ, Sch Commun Sci & Disorders, Forest Grove, OR USA; [Byom, Lindsey] Univ Chapel Hill, Div Speech & Hearing Sci, Dept Allied Hlth Sci, Chapel Hill, NC USA; [Ness, Bryan] Calif Baptist Univ, Commun Sci & Disorders, Riverside, CA USA; [MacDonald, Sheila] Univ Toronto, Sheila MacDonald & Associates, Toronto, ON, Canada; [Phillips, Brian] Utah State Univ, Special Educ & Rehabil Counseling, Logan, UT 84322 USA		Meulenbroek, P (corresponding author), Univ Kentucky, Commun Sci & Disorders, Lexington, KY 40506 USA.	meulenbroek@uky.edu		Phillips, Brian/0000-0002-0317-8635; MacDonald, Sheila/0000-0002-0932-2060; Sohlberg, McKay/0000-0001-8554-3343; Byom, Lindsey/0000-0002-2457-1735; Meulenbroek, Peter/0000-0003-4233-9910			Alves F., 2021, ROUTLEDGE HDB TRANSL; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; American Speech-Language-Hearing Association, 2004, PREF PRACT PATT PROF; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Becker D., 2015, EVIDENCEBASED SUPPOR, V3rd; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Blustein DL, 2011, J VOCAT BEHAV, V79, P1, DOI 10.1016/j.jvb.2010.10.004; Bond G. R., 1992, HDB PSYCHIAT REHABIL, P244; Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030; Carew D., 2008, PSYCHOL APPROACHES R, P403, DOI [10.1002/9781444301762.ch16, DOI 10.1002/9781444301762.CH16]; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Corrigan PW, 2001, CLIN PSYCHOL-SCI PR, V8, P334, DOI 10.1093/clipsy/8.3.334; CRISP R, 1992, J REHABIL, V58, P27; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; CSIKSZENTMIHALYI M, 1989, J PERS SOC PSYCHOL, V56, P815, DOI 10.1037/0022-3514.56.5.815; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Elliott T. R., 2005, HDB VOCATIONAL PSYCH, V3rd, P319; Etuknwa A, 2019, J OCCUP REHABIL, V29, P679, DOI 10.1007/s10926-019-09832-7; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fride Y, 2015, TOP STROKE REHABIL, V22, P317, DOI 10.1179/1074935714Z.0000000013; FURNHAM A, 1983, HUM RELAT, V36, P135, DOI 10.1177/001872678303600204; GILBRIDE DD, 1992, J REHABIL, V58, P34; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gormley M, 2019, BRAIN INJURY, V33, P1567, DOI 10.1080/02699052.2019.1658222; Gourdeau J, 2020, DISABIL REHABIL, V42, P552, DOI 10.1080/09638288.2018.1503733; Hagner D, 2000, COFFEE BREAKS BIRTHD, V1st; Hart T, 2019, REHABIL PSYCHOL, V64, P435, DOI 10.1037/rep0000290; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hergenrather KC, 2015, REHABIL RES POL EDUC, V29, P2, DOI 10.1891/2168-6653.29.1.2; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Jacobs HE, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199710000-00003; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kennedy M. R, 2020, PERSPECTIVES ASHA SP, V5, P88, DOI [10.1044/2019_PERSP-19-00092, DOI 10.1044/2019_PERSP-19-00092]; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Keyton J., 2013, J BUS COMMUN, V50, P152, DOI [10.1177/0021943612474990, DOI 10.1177/0021943612474990]; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Macaden AS, 2010, DISABIL REHABIL, V32, P1140, DOI 10.3109/09638280903311594; MALEC JF, 1995, MAYO CLIN PROC, V70, P1165, DOI 10.4065/70.12.1165; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Meulenbroek P., 2020, SOCIAL IMPERATIVE GE, P181; Meulenbroek P, 2021, ASSISTING SURVIVORS, V3rd; Meulenbroek P, 2019, J SPEECH LANG HEAR R, V62, P3367, DOI 10.1044/2019_JSLHR-L-18-0466; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Modini M, 2016, AUSTRALAS PSYCHIATRY, V24, P331, DOI 10.1177/1039856215618523; Moriarty O, 2014, CURR OPIN SUPPORT PA, V8, P130, DOI 10.1097/SPC.0000000000000054; Mueser KT, 2016, CURR OPIN PSYCHIATR, V29, P196, DOI 10.1097/YCO.0000000000000247; Niemeier JP, 2010, J VOCAT REHABIL, V33, P167, DOI 10.3233/JVR-2010-0525; Novak JA, 2011, J VOCAT REHABIL, V35, P193, DOI 10.3233/JVR-2011-0571; O'Neill J, 2015, J DISABIL POLICY STU, V26, P111, DOI 10.1177/1044207315583900; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Phillips BN, 2018, REHABIL COUNS BULL, V62, P30, DOI 10.1177/0034355217747690; Phillips BN, 2016, REHABIL COUNS BULL, V60, P16, DOI 10.1177/0034355215601073; Phillips BN, 2014, REHABIL PSYCHOL, V59, P386, DOI 10.1037/rep0000011; Pinto AD, 2018, ANN FAM MED, V16, P447, DOI 10.1370/afm.2286; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Sluss DM, 2007, ACAD MANAGE REV, V32, P9; Solway S., 2002, DASH OUTCOME MEASURE; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; Tjulin A, 2010, J OCCUP REHABIL, V20, P311, DOI 10.1007/s10926-009-9209-9; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Trexler LE, 2018, J VOCAT REHABIL, V49, P195, DOI 10.3233/JVR-180965; U.S. Department of Labor, 2021, O NET; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vine B, 2004, GETTING THINGS DONE, DOI [10.1075/pbns.124, DOI 10.1075/PBNS.124]; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P., 1988, VOCATIONAL REHABILIT; Wehman P, 2016, RES DEV DISABIL, V53-54, P61, DOI 10.1016/j.ridd.2016.01.015; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Wyse JJ, 2020, PSYCHOL SERV, V17, P65, DOI 10.1037/ser0000283; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	86	0	0	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JAN	2022	31	1					188	202		10.1044/2021_AJSLP-21-00129			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YK2KE	WOS:000745047800013	34929113				2022-02-06	
J	Miller, GF; DePadilla, L; Jones, SE; Lionbarger, M; Thigpen, S				Miller, Gabrielle F.; DePadilla, Lara; Jones, Sherry Everett; Lionbarger, Michael; Thigpen, Sally			Prevalence of Concussion-Related Policies and Practices Among Public School Districts in the United States, 2012 and 2016	JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE			English	Article						concussion; school policies; TBI	SPORT-RELATED CONCUSSION; EDUCATION; CHILDREN; COACH; LAWS	Background: Beginning in 2009, there was an increase in the number of states with laws addressing 3 different components of youth sports-related concussion prevention and management: concussion education, removal from play, and medical clearance requirements before allowing an athlete to return to play. Schools are an important setting to implement policies and practices related to concussions, as many youth participate in organized sports through school venues. Objective: To examine whether the prevalence of concussion-related policies and practices adopted by school districts changed from 2012 to 2016. Methods: This study used nationally representative data from the 2012 and 2016 School Health Policies and Practices Study to examine whether the prevalence of 4 concussion-related policies and practices changed during 2012 and 2016 and whether comprehensive policies changed during the same time frame. Comprehensive policies were defined as those that address removal from play after injury, medical clearance before returning to play, and concussion-related educational materials and sessions for parents and student athletes. Results: Among school districts nationwide, the prevalence of each of the 4 concussion-related policies and practices significantly increased during 2012 and 2016. The prevalence of comprehensive policies significantly increased from 51.6% in 2012 to 66.7% in 2016. While these findings are promising, it is important to note that one-third of districts still lacked comprehensive policies in 2016 and only 71% of districts provided educational sessions in 2016. Conclusions: The findings in this study highlight improvements in school districts nationwide in adopting concussion-related policies and practices. Policies such as requiring educational sessions allow parents and student athletes to learn about concussions and understand the importance of reporting a concussion or concussion symptoms.	[Miller, Gabrielle F.; Thigpen, Sally] Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS S106-08, Atlanta, GA 30341 USA; [DePadilla, Lara] Ctr Dis Control & Prevent, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; [Jones, Sherry Everett; Lionbarger, Michael] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV Aids Viral Hepatitis STD & TB Preven, Atlanta, GA 30341 USA		Miller, GF (corresponding author), Ctr Dis Control & Prevent, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS S106-08, Atlanta, GA 30341 USA.	ygm3@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bell JM, 2019, AM J LIFESTYLE MED, V13, P172, DOI 10.1177/1559827616688883; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brener ND, 2003, J SCHOOL HEALTH, V73, P29, DOI 10.1111/j.1746-1561.2003.tb06556.x; Brener ND., 2013, METHODS SCH HLTH POL, pCH2; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Doucette ML, 2016, J LAW MED ETHICS, V44, P503, DOI 10.1177/1073110516667946; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Center for HIV/AIDS VH STD and TB Prevention, 2017, RES SCH HLTH POL PRA; National Conference of State Legislatures, 2017, RET TO LEARN STAT LA; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rose Sean C, 2016, Concussion, V1, pCNC4, DOI 10.2217/cnc.15.4; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Summerlin-Long SK, 2009, J SCHOOL HEALTH, V79, P184, DOI 10.1111/j.1746-1561.2009.00388.x; The Policy Surveillance Program, 2017, LAWATLAS PROJ; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	27	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-4659	1550-5022		J PUBLIC HEALTH MAN	J. Public Health Manag. Pract.	JAN-FEB	2022	28	1			SI		E194	E197		10.1097/PHH.0000000000001239			4	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XA2BG	WOS:000720458700044	32956289				2022-02-06	
J	Miller, M; Williams, R; Pagulayan, K; Barber, J; Ehde, DM; Hoffman, J				Miller, Megan; Williams, Rhonda; Pagulayan, Kathleen; Barber, Jason; Ehde, Dawn M.; Hoffman, Jeanne			Correlates of sleep disturbance in Veterans with traumatic brain injury and chronic pain: A cross-sectional study	DISABILITY AND HEALTH JOURNAL			English	Article						TBI; Pain; Sleep	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PERFORMANCE; INSOMNIA; PREVALENCE; DEPRESSION; MILD; PTSD; SEVERITY; COMORBIDITY; ACTIGRAPHY	Background: Few studies have investigated sleep in Veterans with comorbid traumatic brain injury (TBI) and chronic pain. Objective: To describe mood and cognitive correlates with sleep disturbance in a sample of Veterans with both TBI and chronic pain. Research method: Cross-sectional, correlational analyses were completed using baseline data from a randomized controlled trial comparing psychosocial treatments for pain in Veterans with TBI. Enrollment occurred between July 2015 and January 2017. Self-report measures of hours slept, insomnia severity, depression and PTSD symptoms were collected along with a brief neuropsychological assessment. Results: Participants (n = 221) were an average age of 37.2 years (SD = 8.2) and mostly male (89%). Participants reported sleeping an average of 4.9 h a night (SD = 1.4) with an average Insomnia Severity Index (ISI) score of 17.4 (SD = 5.4) suggesting moderate insomnia symptoms. Fewer hours slept was associated with higher depression scores (r =-0.28, p < 0.001) and slower processing speed (r = 0.23, p < 0.001). Increasing insomnia severity was associated with greater depression (r = 0.57, p < 0.001) and PTSD symptoms (r = 0.44, p < 0.001), and slower processing speed (r =-0.22, p < 0.001). Conclusions: The average ISI score was above the clinical cut off for insomnia diagnosis. Results suggest that those with more severe insomnia symptoms report higher depression and PTSD symptoms as well as exhibit slower processing speed. Improving sleep in this population may be important for improving outcome following TBI. Published by Elsevier Inc.	[Miller, Megan; Williams, Rhonda; Pagulayan, Kathleen] VA Puget Sound Hlth Care Syst, S-RCS-117,1660 S Columbian Way, Seattle, WA 98108 USA; [Williams, Rhonda; Barber, Jason; Ehde, Dawn M.; Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Pagulayan, Kathleen] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Miller, M (corresponding author), VA Puget Sound Hlth Care Syst, S-RCS-117,1660 S Columbian Way, Seattle, WA 98108 USA.	megan.miller5@va.gov		Hoffman, Jeanne/0000-0002-3525-3839; Ehde, Dawn/0000-0002-9555-2347	Department of Defense US Army Medical Research and Material Command, Congressional Directed Medical Research Program [W81XWH-12-2-0109]	This work was supported by the Department of Defense US Army Medical Research and Material Command, Congressional Directed Medical Research Program (Grant #W81XWH-12-2-0109) , awarded to Jeanne Hoffman, Ph.D. This work was also sup-ported in part with resources and facilities at VA Puget Sound Health Care System and the University of Washington School of Medicine.	Aasvik J, 2018, ARCH CLIN NEUROPSYCH, V33, P14, DOI 10.1093/arclin/acx040; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bell T, 2018, J CLIN EXP NEUROPSYC, V40, P698, DOI 10.1080/13803395.2017.1422699; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Dimsdale JE, 2007, J CLIN SLEEP MED, V3, P33; Dragioti E, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0137-3; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Fleming MK, 2020, NEUROREHAB NEURAL RE, V34, P661, DOI 10.1177/1545968320929669; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Gruber SA, 2007, NEUROPSYCHOL REV, V17, P299, DOI 10.1007/s11065-007-9041-y; Higgins DM, 2018, CLIN J PAIN, V34, P262, DOI 10.1097/AJP.0000000000000536; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoffman JM, 2019, CONTEMP CLIN TRIALS, V76, P112, DOI 10.1016/j.cct.2018.12.004; HOLM S, 1979, SCAND J STAT, V6, P65; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Jensen MP, 2001, PAIN, V91, P317, DOI 10.1016/S0304-3959(00)00459-0; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kaufmann CN, 2019, BEHAV SLEEP MED, V17, P12, DOI 10.1080/15402002.2016.1266490; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Law EF, 2018, HEADACHE, V58, P1060, DOI 10.1111/head.13355; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Mai E, 2008, SLEEP MED CLIN, V3, P167, DOI 10.1016/j.jsmc.2008.02.001; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Martindale SL, 2017, REHABIL PSYCHOL, V62, P563, DOI 10.1037/rep0000159; Mosti CB, 2019, REHABIL PSYCHOL, V64, P475, DOI 10.1037/rep0000283; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ord AS, 2021, REHABIL PSYCHOL, V66, P31, DOI 10.1037/rep0000333; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smith S, 2001, J SLEEP RES, V10, P229, DOI 10.1046/j.1365-2869.2001.00262.x; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Strauss E, 1990, REY OSTERRIETH AUDIT, P776; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wei Y, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00377; Westermeyer J, 2007, J ANXIETY DISORD, V21, P966, DOI 10.1016/j.janxdis.2006.11.009; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	54	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JAN	2022	15	1							101203	10.1016/j.dhjo.2021.101203			6	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	XQ2SD	WOS:000731399400026	34479850				2022-02-06	
J	Nadeem, MS; Kazmi, I; Ullah, I; Muhammad, K; Anwar, F				Nadeem, Muhammad Shahid; Kazmi, Imran; Ullah, Inam; Muhammad, Khushi; Anwar, Firoz			Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment	ANTIOXIDANTS			English	Article						garlic; allicin; biosynthesis; therapeutic; antioxidant; neuroprotective; cognitive impairment	INDUCED MITOCHONDRIAL DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; QUALITY-OF-LIFE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; THERAPEUTIC TARGET; SIGNALING PATHWAY; TRAUMATIC BRAIN	Allicin (diallylthiosulfinate) is a defense molecule produced by cellular contents of garlic (Allium sativum L.). On tissue damage, the non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) is converted to allicin in an enzyme-mediated process catalysed by alliinase. Allicin is hydrophobic in nature, can efficiently cross the cellular membranes and behaves as a reactive sulfur species (RSS) inside the cells. It is physiologically active molecule with the ability to oxidise the thiol groups of glutathione and between cysteine residues in proteins. Allicin has shown anticancer, antimicrobial, antioxidant properties and also serves as an efficient therapeutic agent against cardiovascular diseases. In this context, the present review describes allicin as an antioxidant, and neuroprotective molecule that can ameliorate the cognitive abilities in case of neurodegenerative and neuropsychological disorders. As an antioxidant, allicin fights the reactive oxygen species (ROS) by downregulation of NOX (NADPH oxidizing) enzymes, it can directly interact to reduce the cellular levels of different types of ROS produced by a variety of peroxidases. Most of the neuroprotective actions of allicin are mediated via redox-dependent pathways. Allicin inhibits neuroinflammation by suppressing the ROS production, inhibition of TLR4/MyD88/NF-kappa B, P38 and JNK pathways. As an inhibitor of cholinesterase and (AChE) and butyrylcholinesterase (BuChE) it can be applied to manage the Alzheimer's disease, helps to maintain the balance of neurotransmitters in case of autism spectrum disorder (ASD) and attention deficit hyperactive syndrome (ADHD). In case of acute traumatic spinal cord injury (SCI) allicin protects neuron damage by regulating inflammation, apoptosis and promoting the expression levels of Nrf2 (nuclear factor erythroid 2-related factor 2). Metal induced neurodegeneration can also be attenuated and cognitive abilities of patients suffering from neurological diseases can be ameliorates by allicin administration.	[Nadeem, Muhammad Shahid; Kazmi, Imran; Anwar, Firoz] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Ullah, Inam; Muhammad, Khushi] Hazara Univ, Dept Biotechnol & Genet Engn, Mansehra 21300, Pakistan		Nadeem, MS; Kazmi, I (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia.	mhalim@kau.edu.sa; ikazmi@kau.edu.sa; drinamullah34@gmail.com; khushi.muhammad@gmail.com; anwarfiroz2000@gmail.com		Kazmi, Imran/0000-0003-1881-5219; Nadeem, Muhammad Shahid/0000-0003-4112-0925	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFPRP-236-130-1442]; DSR, Jeddah, Saudi Arabia	The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number IFPRP-236-130-1442 and King Abdulaziz University, DSR, Jeddah, Saudi Arabia.	Aarsland D, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00280-3; Abdel-Daim MM, 2017, CANCER CHEMOTH PHARM, V80, P745, DOI 10.1007/s00280-017-3413-7; Adhikarla SV, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11111373; Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Alamir A, 2021, CURR ISSUES MOL BIOL, V43, P187, DOI 10.3390/cimb43010016; Albrecht F, 2017, MOLECULES, V22, DOI 10.3390/molecules22050770; Almatroodi S.A, 2020, PHARMANEST INT J ADV, V11, P1; Angelova DM, 2019, J NEUROCHEM, V151, P676, DOI 10.1111/jnc.14860; Asgharpour M, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/6667453; Ashfaq F., 2021, BIOL CLIN SCI RES J, DOI [10.54112/bcsrj.v2021i1.53, DOI 10.54112/BCSRJ.V2021I1.53]; Ba L, 2019, PHYTOMEDICINE, V58, DOI 10.1016/j.phymed.2018.11.025; Bajwa E, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4050796; Bal VH, 2022, AUTISM, V26, P62, DOI 10.1177/13623613211020618; Barrios H, 2013, AGING MENT HEALTH, V17, P287, DOI 10.1080/13607863.2012.747083; Batoryna M, 2019, J MICROB BIOTEC FOOD, V9, P643, DOI 10.15414/jmbfs.2019/20.9.3.643-647; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bellezza I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01280; Bhat AN, 2021, AUTISM RES, V14, P202, DOI 10.1002/aur.2453; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Budson A.E., 2021, MEMORY LOSS ALZHEIME; Burtenshaw D, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040090; Cai PR, 2021, J AGR FOOD CHEM, V69, P9451, DOI 10.1021/acs.jafc.1c03794; Calcia MA, 2016, PSYCHOPHARMACOLOGY, V233, P1637, DOI 10.1007/s00213-016-4218-9; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Chan JYY, 2013, PHYTOTHER RES, V27, P637, DOI 10.1002/ptr.4796; Chen SS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-321; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Cheng H, 2021, TOXICS, V9, DOI 10.3390/toxics9060142; Cheng Ying, 2021, Oxid Med Cell Longev, V2021, P5005136, DOI 10.1155/2021/5005136; Cho SJ, 2006, NUTRITION, V22, P1177, DOI 10.1016/j.nut.2006.08.011; Christiansen L, 2021, GERONTOL GERIATR MED, V7, DOI 10.1177/23337214211018924; Chung LY, 2006, J MED FOOD, V9, P205, DOI 10.1089/jmf.2006.9.205; Cloete SJ, 2021, CHEM BIOL DRUG DES, V97, P854, DOI 10.1111/cbdd.13814; Cordaro M, 2021, METABOLITES, V11, DOI 10.3390/metabo11010037; Cui TW, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110240; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; Dasari R, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104923; de Oliveira LG, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.624919; Deng LL, 2021, DRUG CHEM TOXICOL, DOI 10.1080/01480545.2021.1979030; Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598; Ding GL, 2016, EXP THER MED, V11, P2553, DOI 10.3892/etm.2016.3179; Edres HA, 2021, ENVIRON SCI POLLUT R, V28, P58768, DOI 10.1007/s11356-021-14800-x; El-Sahar AE, 2021, INT J NEUROPSYCHOPH, V24, P158, DOI 10.1093/ijnp/pyaa078; Eli I, 2021, NEUROL CLIN, V39, P471, DOI 10.1016/j.ncl.2021.02.004; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faisal A.N, 2021, ANN ROM SOC CELL BIO, V25, P10921; Farhang M, 2021, AGING MENT HEALTH, DOI 10.1080/13607863.2021.1958145; Fernandez-Blazquez MA, 2021, AGING MENT HEALTH, V25, P814, DOI 10.1080/13607863.2020.1725803; Fernandez-Vizarra E, 2021, FEBS LETT, V595, P1062, DOI 10.1002/1873-3468.13995; Ferro F, 2020, SEMIN CELL DEV BIOL, V98, P129, DOI 10.1016/j.semcdb.2019.05.029; Fisher JJ, 2021, J PHYSIOL-LONDON, V599, P1291, DOI 10.1113/JP280593; Fujisawa H, 2008, BIOSCI BIOTECH BIOCH, V72, P2877, DOI 10.1271/bbb.80381; Gao WQ, 2019, METAB BRAIN DIS, V34, P1267, DOI 10.1007/s11011-019-00443-y; Gao Y, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/7848027; Garica-Trejo EMA, 2016, OXID MED CELL LONGEV, V2016, P1, DOI 10.1155/2016/3850402; Ghazanfari N, 2021, J NEUROSCI RES, V99, P2976, DOI 10.1002/jnr.24934; Gruhlke M., 2014, RECENT ADV REDOX ACT; Gruhlke MCH, 2012, PLANT PHYSIOL BIOCH, V59, P98, DOI 10.1016/j.plaphy.2012.03.016; Gu J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00104; Guo Y, 2021, J NEUROL, V268, P2713, DOI 10.1007/s00415-020-09757-9; Guterres AN, 2020, ONCOGENE, V39, P5811, DOI 10.1038/s41388-020-01405-w; Han LP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2641248; Hao Z.H.A.N.G., 2016, NAT PROD RES DEV, V28, P685; Hinwood M, 2012, CEREB CORTEX, V22, P1442, DOI 10.1093/cercor/bhr229; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Horev-Azaria L, 2009, EUR J NUTR, V48, P67, DOI 10.1007/s00394-008-0762-3; Huang H, 2017, J SCI FOOD AGR, V97, P1359, DOI 10.1002/jsfa.7874; Hughes J, 2005, PHYTOCHEMISTRY, V66, P187, DOI 10.1016/j.phytochem.2004.11.009; Ilic D.P., 2011, FACTA U SER PHYS CHE, V9, P9, DOI [10.2298/FUPCT1101009I, DOI 10.2298/FUPCT1101009I]; Jiang GJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3155; Jiang X, 2015, INT J ORAL MAX SURG, V44, P1540, DOI 10.1016/j.ijom.2015.06.015; Jiang XW, 2012, OR SURG OR MED OR PA, V113, P500, DOI 10.1016/j.oooo.2011.09.007; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Joshi AU, 2018, PHARMACOL RES, V138, P2, DOI 10.1016/j.phrs.2018.08.010; Kaarniranta K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102374; Kabir MT, 2021, MOL NEUROBIOL, V58, P1, DOI 10.1007/s12035-020-02096-w; Kaur S, 2021, J BIOL INORG CHEM, V26, P495, DOI 10.1007/s00775-021-01866-8; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Killeen DJ, 2018, AM J ENOL VITICULT, V69, P394, DOI 10.5344/ajev.2018.17063; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Koca FD, 2020, BIOTECHNOL LETT, V42, P1683, DOI 10.1007/s10529-020-02877-2; Kong XY, 2017, ONCOTARGET, V8, P104492, DOI 10.18632/oncotarget.22355; Kumar S, 2015, INDIAN J PHARMACOL, V47, P444, DOI 10.4103/0253-7613.161274; Kurusu T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00427; Lai L, 2017, LIFE SCI, V169, P69, DOI 10.1016/j.lfs.2016.09.006; Colin-Gonzalez AL, 2017, GASTROINTESTINAL TISSUE: OXIDATIVE STRESS AND DIETARY ANTIOXIDANTS, P275, DOI 10.1016/B978-0-12-805377-5.00020-5; Lawson LD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070812; Lee SH, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050739; Li CL, 2020, EUR J PHARMACOL, V876, DOI 10.1016/j.ejphar.2020.173052; Li C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/434692; Li L, 2021, BRAIN BEHAV IMMUN, V91, P740, DOI 10.1016/j.bbi.2020.10.007; Li Q, 2017, EUR J MED CHEM, V132, P294, DOI 10.1016/j.ejmech.2017.03.062; Li XH, 2012, CARDIOVASC DRUG THER, V26, P457, DOI 10.1007/s10557-012-6415-z; Li XH, 2010, NEUROSCIENCES, V15, P237; Lindhout IA, 2021, NEUROCHEM INT, V148, DOI 10.1016/j.neuint.2021.105117; Liu C, 2010, J NUTR BIOCHEM, V21, P1238, DOI 10.1016/j.jnutbio.2009.11.001; Liu H, 2015, CELL PHYSIOL BIOCHEM, V36, P966, DOI 10.1159/000430271; Liu SZ, 2019, TRANSPL P, V51, P2060, DOI 10.1016/j.transproceed.2019.04.039; Liu YY, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02081-7; Lu S, 2020, CIRC RES, V126, pE80, DOI 10.1161/CIRCRESAHA.119.316288; Lv RX, 2015, LIFE SCI, V143, P114, DOI 10.1016/j.lfs.2015.11.001; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Maitisha G, 2021, MOL BIOL REP, V48, P7261, DOI 10.1007/s11033-021-06722-1; Marchese A, 2016, TRENDS FOOD SCI TECH, V52, P49, DOI 10.1016/j.tifs.2016.03.010; Martins N, 2016, FOOD CHEM, V211, P41, DOI 10.1016/j.foodchem.2016.05.029; Marucci G, 2021, NEUROPHARMACOLOGY, V190, DOI 10.1016/j.neuropharm.2020.108352; Mayer JS, 2021, NEUROSCI BIOBEHAV R, V121, P307, DOI 10.1016/j.neubiorev.2020.12.018; McMahon BK, 2012, J AM CHEM SOC, V134, P10725, DOI 10.1021/ja300887k; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Melino S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071581; Mohamed SMH, 2021, PLOS ONE, V16, DOI [10.1371/journal.pone.0256228, 10.34894/K3EIJX]; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/NCHEMBIO.1142, 10.1038/nchembio.1142]; Muller-Nedebock AC, 2021, MOVEMENT DISORD, V36, P815, DOI 10.1002/mds.28475; Musavi H., 2018, J HERBMED PHARM, V7, P306, DOI [DOI 10.15171/JHP.2018.46, 10.15171/jhp.2018.46]; Nadeem MS, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11111635; Nahas R, 2011, CAN FAM PHYSICIAN, V57, P31; Nan B, 2021, FOOD CHEM TOXICOL, V148, DOI 10.1016/j.fct.2020.111937; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Norat P, 2020, NPJ REGEN MED, V5, DOI 10.1038/s41536-020-00107-x; Olson KR, 2020, ANTIOXID REDOX SIGN, V33, P1125, DOI 10.1089/ars.2020.8132; Omar S H, 2010, Saudi Pharm J, V18, P51, DOI 10.1016/j.jsps.2009.12.007; Osman M, 2012, POL J PATHOL, V63, P248, DOI 10.5114/PJP.2012.32772; Ozawa Y, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101779; Paglialunga S, 2015, DIABETOLOGIA, V58, P1071, DOI 10.1007/s00125-015-3531-x; Palvannan T, 2018, ENVIRON TOXICOL PHAR, V58, P21, DOI 10.1016/j.etap.2017.12.006; Pascual M, 2021, IUBMB LIFE, V73, P900, DOI 10.1002/iub.2510; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Diaz LSP, 2018, J MOL CELL CARDIOL, V124, P1, DOI 10.1016/j.yjmcc.2018.09.009; Qu Y, 2021, NEUROSCI BIOBEHAV R, V128, P479, DOI 10.1016/j.neubiorev.2021.07.007; Quartier A, 2019, HUM MUTAT, V40, P2021, DOI 10.1002/humu.23836; Ortega DR, 2021, TOXICS, V9, DOI 10.3390/toxics9020023; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Rendra E, 2019, IMMUNOBIOLOGY, V224, P242, DOI 10.1016/j.imbio.2018.11.010; Ried K, 2013, NUTR REV, V71, P282, DOI 10.1111/nure.12012; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Rong YL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1571-8; Sajid M., 2014, Pakistan Journal of Food Sciences, V24, P108; Saleh H.S, 2017, J ED PURE SCI, V7, P96; Salehi B, 2019, TRENDS FOOD SCI TECH, V86, P502, DOI 10.1016/j.tifs.2019.03.003; Sanchez-Sanchez MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030624; Sarvizadeh M, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.650256; Schwartz IF, 2002, CLIN SCI, V102, P487, DOI 10.1042/CS20010221; Shabab T, 2017, INT J NEUROSCI, V127, P624, DOI 10.1080/00207454.2016.1212854; Sharifi-Rad J, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245555; Sheen L.Y., 2021, RES SQ, P1, DOI [10.21203/rs.3.rs-519786/v1, DOI 10.21203/RS.3.RS-519786/V1]; Shen N, 2019, MED SCI MONITOR, V25, P2567, DOI 10.12659/MSM.914114; Shi XE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122909; Shoji T, 2007, J REPROD IMMUNOL, V75, P82, DOI 10.1016/j.jri.2007.05.002; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; Srivastava IN, 2016, NEUROBIOL DIS, V85, P144, DOI 10.1016/j.nbd.2015.10.001; Sun DS, 2021, ENVIRON SCI POLLUT R, V28, P39625, DOI 10.1007/s11356-021-13392-w; Sun HH, 2021, MOL CELL BIOCHEM, V476, P435, DOI 10.1007/s11010-020-03919-z; Tang FT, 2016, J CARDIOVASC PHARM, V68, P257, DOI 10.1097/FJC.0000000000000410; Teng E, 2012, AM J GERIAT PSYCHIAT, V20, P1016, DOI 10.1097/JGP.0b013e31826ce640; Toygar I, 2020, J WOUND CARE, V29, P388, DOI 10.12968/jowc.2020.29.7.388; Trio PZ, 2014, FOOD FUNCT, V5, P833, DOI 10.1039/c3fo60479a; Tu G, 2016, MOL MED REP, V13, P2320, DOI 10.3892/mmr.2016.4797; Varga ZV, 2015, AM J PHYSIOL-HEART C, V309, pH1453, DOI 10.1152/ajpheart.00554.2015; Vecchio I, 2021, J CENT NERV SYST DIS, V13, DOI 10.1177/11795735211029113; Verhagen H, 2001, BRIT J NUTR, V86, pS111, DOI 10.1079/BJN2001343; Vogel JW, 2021, NAT MED, V27, P871, DOI 10.1038/s41591-021-01309-6; Vuda M, 2016, MITOCHONDRION, V31, P63, DOI 10.1016/j.mito.2016.10.005; Wang L, 2012, ARCH TOXICOL, V86, P879, DOI 10.1007/s00204-012-0845-z; Wang SY, 2016, MOL MED REP, V14, P3086, DOI 10.3892/mmr.2016.5651; Wang W, 2014, BRAIN RES, V1544, P54, DOI 10.1016/j.brainres.2013.12.004; Wang X, 2021, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.572484; Wang ZY, 2009, FREE RADICAL BIO MED, V46, P1032, DOI 10.1016/j.freeradbiomed.2008.11.027; Wu J, 2021, J MOL MED, V99, P713, DOI 10.1007/s00109-021-02046-6; Wu L, 2021, PHARMACOLOGY, V106, P275, DOI 10.1159/000511961; Wu Z, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7498528; Xian MH, 2021, FOOD FUNCT, V12, P8056, DOI [10.1039/d1fo01144h, 10.1039/D1FO01144H]; Xiao LL, 2021, ECOTOX ENVIRON SAFE, V222, DOI 10.1016/j.ecoenv.2021.112465; Yang DQ, 2017, BIOL TRACE ELEM RES, V176, P192, DOI 10.1007/s12011-016-0821-1; Yoo DY, 2014, FOOD CHEM TOXICOL, V72, P1, DOI 10.1016/j.fct.2014.06.023; Yoshimoto N, 2019, J EXP BOT, V70, P4123, DOI 10.1093/jxb/erz243; You LT, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102635; Yuan Y, 2021, J AGR FOOD CHEM, V69, P12837, DOI 10.1021/acs.jafc.1c05014; Zainal M, 2021, SAUDI DENT J, V33, P105, DOI 10.1016/j.sdentj.2020.01.008; Zeb F, 2018, PAK J PHARM SCI, V31, P1935; Zhai BQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21421-x; Zhang CH, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101113; Zhang H, 2018, TISSUE CELL, V50, P89, DOI 10.1016/j.tice.2017.11.002; Zhang R S, 1992, Zhongguo Zhong Xi Yi Jie He Za Zhi, V12, P28; Zhang W, 2021, NEURAL REGEN RES, V16, P6, DOI 10.4103/1673-5374.286954; Zhao JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42286-8; Zhao M, 2014, NEUROSCIENCE, V269, P93, DOI 10.1016/j.neuroscience.2014.03.039; Zhong JQ, 2017, DERMATOL THER, V30, DOI 10.1111/dth.12429; Zhong Y, 2020, J CELL MOL MED, V24, P11936, DOI 10.1111/jcmm.15815; Zhong ZF, 2021, NEUROSCIENCE, V463, P97, DOI [10.1016/j.neuroscience.2021.01.0310306-4522/, 10.1016/j.neuroscience.2021.01.031]; Zhu JW, 2012, NEUROCHEM INT, V61, P640, DOI 10.1016/j.neuint.2012.06.021; Zrzavy T, 2021, BRAIN, V144, P144, DOI 10.1093/brain/awaa360	197	0	0	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	JAN	2022	11	1							87	10.3390/antiox11010087			19	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	YM4CP	WOS:000746524500001	35052591	gold, Green Accepted			2022-02-06	
J	Nayeri, ND; Chenari, HA; Esmaeili, M; Farsi, Z; Baumann, SL				Nayeri, Nahid Dehghan; Chenari, Hadi Ahmadi; Esmaeili, Maryam; Farsi, Zahra; Baumann, Steven L.			Caring for Patients in a Coma Following a Traumatic Brain Injury in Iran	NURSING SCIENCE QUARTERLY			English	Article						caring; coma; Iran; traumatic brain injury		The study described here is the process of caring for patients in a coma following a traumatic brain injury (TBI) in Iran. The data that were analyzed come from in-depth semistructured interviews of 20 key participants and associated memos and field notes. The MAXQDA 10 qualitative analysis software was used to assist with the coding of the data. Ten catagories and 26 subcategories were identified from the primary analysis, which fit well into four themes. The main themes that were identified were chaos and confusion, inconsistent quality, multilateral support, and improving care. The processes of caring for persons in a coma following a TBI were found to be an ever-changing, multidimensional, context-dependent process.	[Nayeri, Nahid Dehghan; Esmaeili, Maryam] Univ Tehran Med Sci, Nursing & Midwifery Care Res Ctr, Sch Nursing & Midwifery, Tehran, Iran; [Chenari, Hadi Ahmadi] Birjand Univ Med Sci, Ferdows Sch Paramed & Hlth, Dept Med Surg Nursing, Birjand, Iran; [Farsi, Zahra] Aja Univ Med Sci, Fac Nursing, Res & Community Hlth Dept, Tehran, Iran; [Baumann, Steven L.] CUNY Hunter Coll, 82 Sherman Ave, Williston Pk, NY 11596 USA		Baumann, SL (corresponding author), CUNY Hunter Coll, 82 Sherman Ave, Williston Pk, NY 11596 USA.	sbaumann@hunter.cuny.edu		abbaszadeh, seyyed mohammad/0000-0002-4429-5942; Baumann, Steven/0000-0002-2155-848X			Abbaszadeh A, 2014, J MED ETHICS HIST ME, V7; Asadian L., 2015, Journal of Mazandaran University of Medical Sciences, V24, pPe208; Borgen IMH, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4195-5; Corner EJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026348; Courtright Katherine R., 2014, Rev. bras. ter. intensiva, V26, P205, DOI 10.5935/0103-507X.20140031; D'Ippolito M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2824081; Lamiani G, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02902; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Navidian A., 2014, IRAN J NURSING, V26, P16; Nayeri ND, 2020, J FAM MED PRIM CARE, V9, P4815, DOI 10.4103/jfmpc.jfmpc_878_20; Quintel M, 2017, INTENS CARE MED, V43, P1723, DOI 10.1007/s00134-017-4872-3; Ranjan P, 2015, J CLIN DIAGN RES, V9, pJE01, DOI 10.7860/JCDR/2015/12072.5712; Shokati Ahmad Abad M., 2013, IRANIAN J NURSING RE, V8, P47; Shorofi S.A., 2014, CLIN EXCELLENCE, V3, P46; Steppacher Inga, 2018, BMC Psychol, V6, P58, DOI 10.1186/s40359-018-0272-x; Strauss, 2008, BASICS QUALITATIVE R; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826	17	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0894-3184	1552-7409		NURS SCI QUART	Nurs. Sci. Q.	JAN	2022	35	1					111	118		10.1177/08943184211051372			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	XV4UQ	WOS:000734939900021	34939493				2022-02-06	
J	Nazerian, P; De Stefano, G; Lumini, E; Fucini, P; Nencioni, A; Paladini, B; Lazzeri, C; Peris, A; Grifoni, S				Nazerian, Peiman; De Stefano, Giuliano; Lumini, Enrico; Fucini, Paolo; Nencioni, Andrea; Paladini, Barbara; Lazzeri, Chiara; Peris, Adriano; Grifoni, Stefano			Comparison of out of hospital cardiac arrest due to acute brain injury vs other causes	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Acute brain injury; Cardiac arrest; Subarachnoid hemorrhage; Intracerebral hemorrhage	SUBARACHNOID HEMORRHAGE; FEATURES; DISEASE	Background: Acute brain injury (ABI) can cause out of hospital cardiac arrest (OHCA). The aim of this study was to compare clinical features, mortality and potential for organ donation in patients with OHCA due to ABI vs other causes. Methods: From January 2017 to December 2018, all adult patients presenting to ED for OHCA were considered for the study. Two physicians established the definitive cause of OHCA, according to clinical, laboratory, diagnostic imaging and autoptic findings. Clinical features in patients with OHCA due to ABI or other causes were compared. Results: 280 patients were included in the analysis. ABI was the third most frequent cause of OHCA (21, 7.5%); ABIs were 8 subarachnoid hemorrhage, 8 intracerebral hemorrhage, 2 ischemic stroke, 2 traumatic spinal cord injury and 1 status epilepticus respectively. Neurological prodromes such as seizure, headache and focal neurological signs were significantly more frequent in patients with OHCA due to ABI (OR 5.34, p = 0.03; OR 12.90, p = 0.02; and OR 66.53, p < 0.01 respectively) while among non-neurological prodromes chest pain and dyspnea were significantly more frequent in patients with OHCA due to other causes (OR 14.5, p < 0.01; and OR 10.4, p = 0.02 respectively). Anisocoria was present in 19% of patients with OHCA due to ABI vs 2.7% due to other causes (OR 8.47, p < 0.01). In 90.5% of patients with ABI and in 53.1% of patients with other causes the first cardiac rhythm was non shockable (OR 8.1; p = 0.05). Multivariate logistic regression analysis revealed that older age, active smoking, post traumatic OHCA, neurological prodromes, anisocoria at pupillary examination were independently associated with OHCA due to ABI. Patients with ABI showed a higher mortality compared with the other causes group (19 pts., 90.5% versus 167 pts., 64.5%; p = 0.015). Potential organ donors were more frequent among ABI than other causes group (10 pts., 47.6% vs 75 pts., 28.9%) however the difference did not reach the statistical significance (p = 0.07). Conclusions: ABI is the third cause of OHCA. Neurological prodromes, absence of chest pain and dyspnea before cardiac arrest, anisocoria and initial non-shockable rhythm might suggest a neurological etiology of the cardiac arrest. Patients with OHCA due to ABI has an unfavorable outcome, however, they could be candidate to organ donation. (c) 2021 Elsevier Inc. All rights reserved.	[Nazerian, Peiman; De Stefano, Giuliano; Lumini, Enrico; Fucini, Paolo; Nencioni, Andrea; Paladini, Barbara; Grifoni, Stefano] Careggi Univ Hosp, Dept Emergency Med, Largo Brambilla 3, I-50134 Florence, Italy; [Lazzeri, Chiara; Peris, Adriano] Careggi Univ Hosp, Intens Care Unit, Florence, Italy; [Lazzeri, Chiara; Peris, Adriano] Careggi Univ Hosp, Reg ECMO Referral Ctr, Florence, Italy		De Stefano, G (corresponding author), Careggi Univ Hosp, Dept Emergency Med, Largo Brambilla 3, I-50134 Florence, Italy.	destefanog@aou-careggi.toscana.it					Arnaout M, 2015, CRIT CARE MED, V43, P453, DOI 10.1097/CCM.0000000000000722; Carter RM, 2017, PREHOSP DISASTER MED, V32, P523, DOI 10.1017/S1049023X17006446; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; Hubner P, 2014, J EMERG MED, V47, P660, DOI 10.1016/j.jemermed.2014.07.029; Kauppila JP, 2018, RESUSCITATION, V122, P76, DOI 10.1016/j.resuscitation.2017.11.064; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Li B, 2018, J THORAC DIS, V10, pE490, DOI 10.21037/jtd.2018.06.13; Miyata K, 2014, J STROKE CEREBROVASC, V23, P446, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.024; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Peris A, 2018, MINERVA ANESTESIOL, V84, P1387, DOI 10.23736/S0375-9393.18.12635-6; Skrifvars MB, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-75; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	12	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2022	51						304	307		10.1016/j.ajem.2021.10.045			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XI3JP	WOS:000726012700006	34798571				2022-02-06	
J	Ou, Y; Clifton, BA; Li, JH; Sandlin, D; Li, N; Wu, L; Zhang, CM; Chen, TW; Huang, J; Yu, Y; Allison, J; Fan, F; Roman, RJ; Shaffery, J; Zhou, W; Pang, Y; Zhu, H				Ou, Yang; Clifton, Brad A.; Li, Jinghui; Sandlin, David; Li, Na; Wu, Li; Zhang, Chunming; Chen, Tianwen; Huang, Jun; Yu, Yue; Allison, Jerome; Fan, Fan; Roman, Richard J.; Shaffery, James; Zhou, Wu; Pang, Yi; Zhu, Hong			Traumatic brain injury induced by exposure to blast overpressure via ear canal	NEURAL REGENERATION RESEARCH			English	Article							NEUROINFLAMMATION; INFLAMMATION; EXPRESSION; ALZHEIMERS; MICROGLIA; DAMAGE; LEADS	Exposure to explosive shockwave often leads to blast-induced traumatic brain injury in military and civilian populations. Unprotected ears are most often damaged following exposure to blasts. Although there is an association between tympanic membrane perforation and TBI in blast exposure victims, little is known about how and to what extent blast energy is transmitted to the central nervous system via the external ear canal. The present study investigated whether exposure to blasts directed through the ear canal causes brain injury in Long-Evans rats. Animals were exposed to a single blast (0-30 pounds per square inch (psi)) through the ear canal, and brain injury was evaluated by histological and behavioral outcomes at multiple time-points. Blast exposure not only caused tympanic membrane perforation but also produced substantial neuropathological changes in the brain, including increased expression of c-Fos, induction of a profound chronic neuroinflammatory response, and apoptosis of neurons. The blast-induced injury was not limited only to the brainstem most proximal to the source of the blast, but also affected the forebrain including the hippocampus, amygdala and the habenula, which are all involved in cognitive functions. Indeed, the animals exhibited long-term neurological deficits, including signs of anxiety in open field tests 2 months following blast exposure, and impaired learning and memory in an 8-arm maze 12 months following blast exposure. These results suggest that the unprotected ear canal provides a locus for blast waves to cause TBI. This study was approved by the Institutional Animal Care and Use Committee at the University of Mississippi Medical Center (Animal protocol# 0932E, approval date: September 30, 2016 and 0932F, approval date: September 27, 2019).	[Ou, Yang; Chen, Tianwen; Huang, Jun; Yu, Yue; Allison, Jerome; Zhou, Wu; Zhu, Hong] Univ Mississippi, Departmant Otolaryngol & Head Neck Surg, Med Ctr, Jackson, MS 39216 USA; [Zhou, Wu; Zhu, Hong] Univ Mississippi, Dept Neurobiol & Anat Sci, Med Ctr, Jackson, MS 39216 USA; [Clifton, Brad A.; Sandlin, David] Univ Mississippi, MD Program, Sch Med, Med Ctr, Jackson, MS USA; [Sandlin, David] Univ Mississippi, Grad Program Neurosci, Med Ctr, Jackson, MS USA; [Pang, Yi] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Fan, Fan; Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Shaffery, James] Univ Mississippi, Dept Psychiat & Human Behav, Med Ctr, Jackson, MS USA; [Li, Jinghui; Li, Na; Wu, Li] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Zhang, Chunming] Shanxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Taiyuan, Shanxi, Peoples R China		Zhu, H (corresponding author), Univ Mississippi, Departmant Otolaryngol & Head Neck Surg, Med Ctr, Jackson, MS 39216 USA.; Zhu, H (corresponding author), Univ Mississippi, Dept Neurobiol & Anat Sci, Med Ctr, Jackson, MS 39216 USA.; Pang, Y (corresponding author), Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA.	ypang@umc.edu; hozhu@umc.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 DC017293, R01 DC018919, AG050049, AG057842, P20GM104357, HL138685]	This study was supported by the National Institutes of Health (NIH) grants R21 DC017293 (to HZ, WZ), R01 DC018919 (to HZ, WZ), AG050049 (to FF), AG057842 (to FF), P20GM104357 (to FF, RJR), and HL138685 (to RJR).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Akula P, 2015, BIOMED ENG LETT, V5, P281, DOI 10.1007/s13534-015-0204-0; Bartels T, 2020, SCIENCE, V370, P66, DOI 10.1126/science.abb8587; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Czigner A, 2004, INT J MOL MED, V14, P247; de Regloix SB, 2017, J ROY ARMY MED CORPS, V163, P333, DOI 10.1136/jramc-2016-000733; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dougherty AL, 2018, BRAIN INJURY, V32, P1423, DOI 10.1080/02699052.2018.1496476; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Guzman-Martinez L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01008; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Kim JH, 2020, J NEUROPATH EXP NEUR, V79, P605, DOI 10.1093/jnen/nlaa026; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Leng FD, 2021, NAT REV NEUROL, V17, P157, DOI 10.1038/s41582-020-00435-y; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Penley SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50940; Rusiecki J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1624-z; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Sandlin David S, 2018, J Otol, V13, P44, DOI 10.1016/j.joto.2018.01.001; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yang Y, 2018, CURR OPIN NEUROBIOL, V48, P90, DOI 10.1016/j.conb.2017.10.024; Yu Y, 2020, J OTOL, V15, P77, DOI 10.1016/j.joto.2020.01.003	43	0	0	7	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2022	17	1					115	121		10.4103/1673-5374.314311			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	SS2OU	WOS:000661581500028	34100446	Green Published, gold			2022-02-06	
J	Ozturk, ED; Chanfreau-Coffinier, C; Sakamoto, MS; Delano-Wood, L; Merritt, VC				Ozturk, Erin D.; Chanfreau-Coffinier, Catherine; Sakamoto, McKenna S.; Delano-Wood, Lisa; Merritt, Victoria C.		VA Million Vet Program	Characterization of Million Veteran Program (MVP) enrollees with Comprehensive Traumatic Brain Injury Evaluation (CTBIE) data: An analysis of neurobehavioral symptoms	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Traumatic brain injury; Post-concussive symptoms; CTBIE; Military veterans; Behavioral health	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; PSYCHIATRIC DIAGNOSES; COMBAT VETERANS; HEALTH; TBI; INVENTORY; VALIDITY; PTSD; IRAQ	The purpose of this study was to examine neurobehavioral symptom reporting in a large sample of military veterans (N = 12,144) who completed the Comprehensive Traumatic Brain Injury Evaluation (CTBIE) and enrolled in the VA's Million Veteran Program (MVP). The CTBIE is a clinician-administered interview that assesses for historical, deployment-related traumatic brain injury (TBI) and evaluates symptoms using the Neurobehavioral Symptom Inventory (NSI). Clinicians completing the CTBIE made clinical determinations about participants' (1) TBI diagnostic status (i.e., CTBIE+ or CTBIE-) and (2) current symptom etiology (i.e., Symptom Resolution, TBI, Behavioral Health, Comorbid TBI + Behavioral Health [Comorbid], or Other). We evaluated the association of TBI diagnostic status and symptom etiology group with neurobehavioral symptoms. Results showed a significant association between TBI diagnostic status and all NSI variables, with CTBIE+ veterans endorsing greater symptoms than CTBIE- veterans. There was also a significant association between symptom etiology group and all NSI variables; specifically, the Comorbid and Behavioral Health groups generally endorsed significantly greater symptoms compared to the other groups. Follow-up analyses showed that relative to the Symptom Resolution group, the Comorbid and Behavioral Health groups had increased odds of severe/very severe cognitive and affective symptoms, whereas the TBI and Other groups did not. Finally, presence of psychiatric symptoms, pain, post-traumatic amnesia, loss of consciousness, and blast exposure significantly predicted Comorbid symptom etiology group membership. Findings from this large epidemiologic MVP study have relevant clinical implications and further highlight the importance of prioritizing integrated behavioral health interventions for this vulnerable population.	[Ozturk, Erin D.] San Diego State Univ Univ Calif, San Diego Joint Doctoral Program, San Diego, CA USA; [Chanfreau-Coffinier, Catherine] VA Salt Lake City Hlth Care Syst, VA Informat & Comp Infrastruct VINCI, Salt Lake City, UT USA; [Sakamoto, McKenna S.; Delano-Wood, Lisa; Merritt, Victoria C.] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA 92161 USA; [Delano-Wood, Lisa; Merritt, Victoria C.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Delano-Wood, Lisa; Merritt, Victoria C.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA 92161 USA.	victoria.merritt@va.gov		Merritt, Victoria/0000-0001-5683-4168	VA Clinical Science Research & Development Service of the U.S. Department of Veterans AffairsUS Department of Veterans Affairs [IK2 CX001952]; National Science FoundationNational Science Foundation (NSF)	This work was supported by a Career Development Award awarded to Dr. Merritt from the VA Clinical Science Research & Development Service (IK2 CX001952) of the U.S. Department of Veterans Affairs. Erin D. Ozturk was funded by the National Science Foundation Graduate Research Fellowship Program.	Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Bouldin ED, 2021, J HEAD TRAUMA REHAB, V36, P10, DOI 10.1097/HTR.0000000000000574; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fihn SD, 2014, HEALTH AFFAIR, V33, P1203, DOI 10.1377/hlthaff.2014.0054; Fortier CB, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000008; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gray M, 2020, BRAIN INJURY, V34, P535, DOI 10.1080/02699052.2020.1725979; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Menatti ARR, 2020, J HEAD TRAUMA REHAB, V35, pE36, DOI 10.1097/HTR.0000000000000467; Merritt VC, 2020, J PSYCHIATR RES, V130, P224, DOI 10.1016/j.jpsychires.2020.08.006; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Ozturk ED, 2018, J PHYSIOL ANTHROPOL, V37, DOI 10.1186/s40101-018-0164-z; Pape TLB, 2018, ARCH PHYS MED REHAB, V99, P1370, DOI 10.1016/j.apmr.2017.11.017; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Polimanti R, 2017, J NEUROTRAUM, V34, P781, DOI 10.1089/neu.2016.4550; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Radigan LJ, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000361; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sorg SF, 2021, J INT NEUROPSYCH SOC, V27, P305, DOI 10.1017/S1355617720000879; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Venkatesan Umesh M, 2021, Arch Phys Med Rehabil, DOI 10.1016/j.apmr.2021.08.012; Vosa L, 2019, BRAIN INJURY, V33, P1165, DOI 10.1080/02699052.2019.1637024	53	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JAN	2022	145						230	242		10.1016/j.jpsychires.2021.12.032			13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XX9BJ	WOS:000736581300011	34942434				2022-02-06	
J	Pajerski, DM; Harlan, MD; Ren, DX; Tuite, PK				Pajerski, Dawn M.; Harlan, Melissa D.; Ren, Dianxu; Tuite, Patricia K.			A Clinical Nurse Specialist-Led Initiative to Reduce Catheter-Associated Urinary Tract Infection Rates Using a Best Practice Guideline	CLINICAL NURSE SPECIALIST			English	Article						best practice guideline; catheter-associated urinary tract infection; clinical nurse specialist; quality improvement		Purpose The purpose of this clinical nurse specialist-led initiative was to reduce catheter-associated urinary tract infection rates to less than 1 infection per 1000 catheter days, to reduce catheter device utilization, and to improve staff adherence to documentation requirements on a traumatic brain injury rehabilitation unit. Description of the Project Catheter-associated urinary tract infections are costly hospital-acquired infections increasing length of stay and morbidity for patients. Following an education intervention, a best practice initiative was implemented. Staff performance based on electronic health record documentation, infection rates, and device utilization were compared before and after a bundle of interventions including education, staff competency, simulation, and audits. Outcomes Catheter-associated urinary tract infection rates were reduced from 16.67 to 0 per 1000 catheter days and device utilization ratio from 0.122 to 0.056 per patient day. The unit maintained zero infections upon project completion. Following initiative implementation, documentation improved related to urinary catheter necessity, daily care interventions, patient education, and urine output. Conclusion This initiative resulted in reductions in device utilization and catheter infection rates, which were maintained following project completion. Adherence to documentation audit criteria also improved.	[Pajerski, Dawn M.; Harlan, Melissa D.] Univ Pittsburgh, Sch Nursing, Acute & Tertiary Care, Pittsburgh, PA 15261 USA; [Ren, Dianxu] Univ Pittsburgh, Stat Support, Pittsburgh, PA USA; [Tuite, Patricia K.] Univ Pittsburgh, Nursing Practice Program, Pittsburgh, PA USA; [Tuite, Patricia K.] Univ Pittsburgh, Adult Gerontol CNS Area Concentrat, Pittsburgh, PA USA		Pajerski, DM (corresponding author), Univ Pittsburgh, Sch Nursing, 336 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA.	dmp113@pitt.edu; mdh71@pitt.edu; dir8@pitt.edu; ptuite@pitt.edu					Centers for Disease Control and Prevention, 2017, HEALTHC ASS INF CATH; Davies PE, 2018, AM J INFECT CONTROL, V46, P758, DOI 10.1016/j.ajic.2017.11.032; Durant DJ, 2017, AM J INFECT CONTROL, V45, P1331, DOI 10.1016/j.ajic.2017.07.020; Hollenbeak CS, 2018, AM J INFECT CONTROL, V46, P751, DOI 10.1016/j.ajic.2018.01.015; Joint Commission, 2019, NAT PAT SAF GOAL 07; Langley GJ., 2009, IMPROVEMENT GUIDE PR, V2nd; Lo E, 2014, INFECT CONT HOSP EP, V35, P464, DOI [10.1017/S0899823X00193845, 10.1086/675718]; Meddings J, 2017, J HOSP MED, V12, P356, DOI 10.12788/jhm.2724; Meddings J, 2014, BMJ QUAL SAF, V23, P277, DOI 10.1136/bmjqs-2012-001774; Odgaard L, 2018, J NEUROSCI NURS, V50, P149, DOI 10.1097/JNN.0000000000000365; Quinn P, 2015, NURS ECON, V33, P320; Schwartz BC, 2015, AM J INFECT CONTROL, V43, P348, DOI 10.1016/j.ajic.2014.12.006; University of Pittsburgh Medical Center [UPMC], 2018, RED CATH ASS UR TRAC	13	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-6274	1538-9782		CLIN NURSE SPEC	Clin. Nurse Spec.	JAN-FEB	2022	36	1					20	28		10.1097/NUR.0000000000000643			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	XC3JQ	WOS:000721913800008	34843191				2022-02-06	
J	Passler, JS; Sander, AM; Temkin, NR; Barber, J; Gardner, RC; Manley, GT				Passler, Jesse S.; Sander, Angelle M.; Temkin, Nancy R.; Barber, Jason; Gardner, Raquel C.; Manley, Geoffrey T.		TRACK-TBI Investigators	Depression in Older Adults 12 Months After Traumatic Brain Injury: A TRACK-TBI Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aging; Brain injuries; traumatic; Cohort studies; Depression; Rehabilitation	MINOR DEPRESSION; MAJOR DEPRESSION; FUNCTIONAL DISABILITY; PREVALENCE; HEALTH; REHABILITATION; MANAGEMENT; DISORDERS; VALIDITY; MODERATE	Objective: To investigate depression at 12 months after traumatic brain injury (TBI) in older adults compared with younger adults. Design: Prospective longitudinal cohort study of persons with medically documented mild, moderate, and severe TBI at 12 months postinjury. Setting: Eighteen participating Level 1 trauma centers in the United States. Participants: Participants with TBI (N=1505) and primary outcome data at 12-month follow-up. Interventions: Not applicable. Main Outcome Measures: Patient Health Questionnaire-9(PHO-9) Results: PHQ-9 total scores were significantly lower for older adults (age >= 65y; M=3.2) compared with younger adults (age<65y; M=5.0; B=-1.63, P<.001), indicating fewer depressive symptoms in older adults. Age did not interact with education, sex, race/ethnicity, psychiatric history, substance use, or Glasgow Coma Scale severity to affect PHQ-9 scores. Of the 29% of older adults who endorsed symptoms consistent with depression, 14% were classified as minor depression and 15% as major depression. The odds of older adults falling in the major depression vs no depression group were significantly lower (decreased by 56%) compared with younger adults (odds ratio=0.44, P=.001). Conclusions: At 12 months post-TBI, older adults endorse lower depressive symptoms than their younger counterparts and are less likely to experience major depression; however, over one-fourth of older adults endorsed symptoms consistent with depression, warranting evaluation and treatment. Archives of Physical Medicine and Rehabilitation 2022;103:83-9 (c) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Passler, Jesse S.; Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Passler, Jesse S.; Sander, Angelle M.] TIRR Mem Hermann, Brain Injuty Res Ctr, Houston, TX USA; [Sander, Angelle M.] Harris Hlth Syst, Dept Phys Med & Rehabil, Houston, TX USA; [Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Gardner, Raquel C.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Gardner, Raquel C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Manley, Geoffrey T.] Brain & Spinal Injury Ctr, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, Phys Med & Rehabil, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090]; Department of Defense (DoD) US Army Medical Research Acquisition Activity [W81XWH-14-2-0176]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0016]	` Supported by the National Institute of Neurological Disorders and Stroke (grant no. U01NS086090), Department of Defense (DoD) US Army Medical Research Acquisition Activity (grant no. W81XWH-14-2-0176), and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant no. 90DPTB0016). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, or DoD and you should not assume endorsement by the federal government.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Centers for Disease Control and Prevention, 2021, DEPR NORM PART GROW; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Costa MV, 2016, REV BRAS PSIQUIATR, V38, P154, DOI 10.1590/1516-4446-2015-1818; Cuijpers P, 2004, J AFFECT DISORDERS, V79, P71, DOI 10.1016/S0165-0327(02)00348-8; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Erler KS, 2020, INT REV PSYCHIATR, V32, P12, DOI 10.1080/09540261.2019.1656175; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Gallagher D, 2018, AM J GERIAT PSYCHIAT, V26, P819, DOI 10.1016/j.jagp.2018.05.002; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Howland RH, 2008, PSYCHOTHER PSYCHOSOM, V77, P384, DOI 10.1159/000151519; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kaup AR, 2016, JAMA PSYCHIAT, V73, P525, DOI 10.1001/jamapsychiatry.2016.0004; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kok RM, 2017, JAMA-J AM MED ASSOC, V317, P2114, DOI 10.1001/jama.2017.5706; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Phelan E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-63; Rapaport MH, 2002, AM J PSYCHIAT, V159, P637, DOI 10.1176/appi.ajp.159.4.637; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valkanova Vyara, 2017, Practitioner, V261, P11	41	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2022	103	1					83	89		10.1016/j.apmr.2021.08.021			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	XW1IJ	WOS:000735381500012	34587508				2022-02-06	
J	Perrin, PB; Klyce, DW; Fisher, LB; Juengst, SB; Hammond, FM; Gary, KW; Niemeier, JP; Bergquist, TF; Bombardier, CH; Rabinowitz, AR; Zafonte, RD; Wagner, AK				Perrin, Paul B.; Klyce, Daniel W.; Fisher, Lauren B.; Juengst, Shannon B.; Hammond, Flora M.; Gary, Kelli W.; Niemeier, Janet P.; Bergquist, Thomas F.; Bombardier, Charles H.; Rabinowitz, Amanda R.; Zafonte, Ross D.; Wagner, Amy K.			Relations Among Suicidal Ideation, Depressive Symptoms, and Functional Independence During the 10 Years After Traumatic Brain Injury: A Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Depression; Functional status; Rehabili-tation; Suicidal ideation	1ST YEAR; RISK; VALIDITY; ASSOCIATIONS; PREVALENCE; TELEPHONE; THERAPY; PEOPLE	Objective: To investigate relative causality in relations among suicidal ideation (SI), depressive symptoms, and functional independence over the first 10 years after traumatic brain injury (TBI). Design: Prospective longitudinal design with data collected through the Traumatic Brain Injury Model Systems (TBIMS) network at acute rehabilitation hospitalization as well as 1, 2, 5, and 10 years after injury. Setting: United States Level I/II trauma centers and inpatient rehabilitation centers with telephone follow-up. Participants: Individuals enrolled into the TBIMS National Database (N=9539) with at least 1 SI score at any follow-up data collection (72.1% male; mean age, 39.39y). Interventions: Not applicable. Main Outcome Measures: Patient Health Questionnaire-9 and FIM at years 1, 2, 5, and 10 post injury. Results: A cross-lagged panel structural equation model, which is meant to indirectly infer causality through longitudinal correlational data, sug-gested that SI, depressive symptoms, and functional independence each significantly predicted themselves over time. Within the model, bivariate correlations among variables were all significant within each time point. Between years 1 and 2 and between years 2 and 5, depressive symptoms had a larger effect on SI than SI had on depressive symptoms. Between years 5 and 10, there was reciprocal causality between the 2 variables. Functional independence more strongly predicted depressive symptoms than the reverse between years 1 and 2 as well as years 2 and 5, but its unique effects on SI over time were extremely marginal or absent after controlling for depressive symptoms. Conclusions: A primary goal for rehabilitation and mental health providers should be to monitor and address elevated symptoms of depression as quickly as possible before they translate into SI, particularly for individuals with TBI who have reduced functional independence. Doing so may be a key to breaking the connection between low functional independence and SI. Archives of Physical Medicine and Rehabilitation 2022;103:69-74 Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine.	[Perrin, Paul B.; Klyce, Daniel W.] Cent Virginia Vet Affairs Hlth Care Syst, Richmond, VA USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Klyce, Daniel W.] Sheltering Arms Inst, Richmond, VA USA; [Klyce, Daniel W.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA; [Fisher, Lauren B.] MA Gen Hosp, Dept Psychiat, Boston, MA USA; [Fisher, Lauren B.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Juengst, Shannon B.] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Gary, Kelli W.] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; [Niemeier, Janet P.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med & Sci, Rochester, MN USA; [Bombardier, Charles H.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross D.] Harvard Med Sch, Boston, MA 02115 USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil,Ctr Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Dept Neurosci,Ctr Neurosci, Pittsburgh, PA USA		Perrin, PB (corresponding author), Virginia Commonwealth Univ, Cent Virginia Vet Affairs Hlth Care Syst, Dept Psychol, 800 West Franklin St,Rm 201,POB 842018, Richmond, VA 23284 USA.; Perrin, PB (corresponding author), Virginia Commonwealth Univ, Cent Virginia Vet Affairs Hlth Care Syst, Dept Phys Med & Rehabil, 800 West Franklin St,Rm 201,POB 842018, Richmond, VA 23284 USA.	pperrin@veu.edu	Perrin, Paul/L-5373-2015	Perrin, Paul/0000-0003-2070-215X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0005, 90DPTB0011, 90DRTB0002, 90DPTB0013, 90DPTB0012, 90DPTB0004, 90DPTB0008, 90DPTB0015]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): Virginia Commonwealth University TBI Model System (#90DPTB0005); Spaulding/Harvard TBI Model System (#90DPTB0011); Indiana University TBI Model System (#90DRTB0002); North Texas TBI Model System (#90DPTB0013); Mayo Clinic TBI Model System (#90DPTB0012); Moss TBI Model System (#90DPTB0004); University of Washington TBI Model System(#90DPTB0008); and University of Alabama TBI Model System (#90DPTB0015), a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Awan N, 2021, J HEAD TRAUMA REHAB, V36, pE18, DOI 10.1097/HTR.0000000000000588; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bryson CN, 2017, DEATH STUD, V41, P399, DOI 10.1080/07481187.2017.1320340; Cariello AN, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176045; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fiedorowicz JG, 2021, J AFFECT DISORDERS, V281, P623, DOI 10.1016/j.jad.2020.11.101; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Goldney RD, 2001, MED J AUSTRALIA, V175, P546, DOI 10.5694/j.1326-5377.2001.tb143717.x; Greer N, 2020, J HEAD TRAUMA REHAB, V35, P1, DOI 10.1097/HTR.0000000000000478; Hamaker EL, 2015, PSYCHOL METHODS, V20, P102, DOI 10.1037/a0038889; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hedegaard Holly, 2018, NCHS Data Brief, P1; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2017, J NEUROPSYCH CLIN N, V29, P260, DOI 10.1176/appi.neuropsych.16100217; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; KENNY DA, 1975, PSYCHOL BULL, V82, P887, DOI 10.1037/0033-2909.82.6.887; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; McIntire KS, 2021, BRAIN INJURY, V35, P151, DOI 10.1080/02699052.2020.1861656; Meyers L.S., 2016, APPL MULTIVARIATE RE; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Rossom RC, 2017, J AFFECT DISORDERS, V215, P77, DOI 10.1016/j.jad.2017.03.037; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson GK, 2019, SUICIDE PREVENTION N; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	40	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2022	103	1					69	74		10.1016/j.apmr.2021.07.790			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	XW1IJ	WOS:000735381500010	34364849				2022-02-06	
J	Picetti, E; Rosenstein, I; Balogh, ZJ; Catena, F; Taccone, FS; Fornaciari, A; Votta, D; Badenes, R; Bilotta, F				Picetti, Edoardo; Rosenstein, Israel; Balogh, Zsolt J.; Catena, Fausto; Taccone, Fabio S.; Fornaciari, Anna; Votta, Danilo; Badenes, Rafael; Bilotta, Federico			Perioperative Management of Polytrauma Patients with Severe Traumatic Brain Injury Undergoing Emergency Extracranial Surgery: A Narrative Review	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; polytrauma; bleeding; hemorrhagic shock; simultaneous multisystem surgery; anesthesia; perioperative management	INTRAOPERATIVE SECONDARY INSULTS; INTRACRANIAL-PRESSURE; HEAD-INJURY; BLOOD-PRESSURE; DAMAGE CONTROL; HYPOTENSION; MORTALITY; RESUSCITATION; ADULT; OXYGEN	Managing the acute phase after a severe traumatic brain injury (TBI) with polytrauma represents a challenging situation for every trauma team member. A worldwide variability in the management of these complex patients has been reported in recent studies. Moreover, limited evidence regarding this topic is available, mainly due to the lack of well-designed studies. Anesthesiologists, as trauma team members, should be familiar with all the issues related to the management of these patients. In this narrative review, we summarize the available evidence in this setting, focusing on perioperative brain protection, cardiorespiratory optimization, and preservation of the coagulative function. An overview on simultaneous multisystem surgery (SMS) is also presented.	[Picetti, Edoardo; Fornaciari, Anna] Parma Univ Hosp, Dept Anesthesia & Intens Care, I-43100 Parma, Italy; [Rosenstein, Israel; Votta, Danilo; Bilotta, Federico] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Dept Anesthesiol & Crit Care, I-00161 Rome, Italy; [Balogh, Zsolt J.] Univ Newcastle, John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2305, Australia; [Catena, Fausto] Bufalini Hosp, Dept Gen & Emergency Surg, I-47521 Cesena, Italy; [Taccone, Fabio S.] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium; [Badenes, Rafael] Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Intens Care, Valencia 46010, Spain		Badenes, R (corresponding author), Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Intens Care, Valencia 46010, Spain.	edoardopicetti@hotmail.com; 1867369@studenti.uniroma1.it; Zsolt.Balogh@health.nsw.gov.au; faustocatena@gmail.com; ftaccone@ulb.ac.be; anna.fornaciari@outlook.it; danilovotta@gmail.com; rafaelbadenes@gmail.com; bilotta@tiscali.it		Badenes, Rafael/0000-0001-7017-0150			Abuzeid AM, 2019, CURR OPIN CRIT CARE, V25, P661, DOI 10.1097/MCC.0000000000000668; Algarra NN, 2017, J NEUROSURG ANESTH, V29, P228, DOI 10.1097/ANA.0000000000000292; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Badenes R, 2015, BRIT J ANAESTH, V115, P68, DOI 10.1093/bja/aev379; Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baekgaard JS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03274-x; Baksaas-Aasen K, 2021, INTENS CARE MED, V47, P49, DOI 10.1007/s00134-020-06266-1; Bossers SM, 2021, JAMA NEUROL, V78, P338, DOI 10.1001/jamaneurol.2020.4596; Branson RD, 2013, RESP CARE, V58, P86, DOI 10.4187/respcare.02251; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Briain DO, 2018, NEUROCRIT CARE, V29, P443, DOI 10.1007/s12028-018-0553-5; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Callcut RA, 2019, J TRAUMA ACUTE CARE, V86, P864, DOI 10.1097/TA.0000000000002205; Cannon JW, 2018, NEW ENGL J MED, V378, P1852, DOI 10.1056/NEJMc1802361; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carver D, 2020, ANN SURG, V271, P958, DOI 10.1097/SLA.0000000000003175; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2020, J NEUROTRAUM, V37, P1291, DOI 10.1089/neu.2017.5599; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Chovanes J, 2012, SURG CLIN N AM, V92, P859, DOI 10.1016/j.suc.2012.04.002; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Citerio G, 2015, CRIT CARE MED, V43, P1630, DOI 10.1097/CCM.0000000000001019; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; French CJ, 2017, ANN SURG, V265, P54, DOI 10.1097/SLA.0000000000001746; Fujita Y, 2014, CHILD NERV SYST, V30, P1201, DOI 10.1007/s00381-014-2353-3; Gao GY, 2020, LANCET NEUROL, V19, P670, DOI 10.1016/S1474-4422(20)30182-4; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hardcastle TC, 2017, WORLD J SURG, V41, P1153, DOI 10.1007/s00268-016-3530-1; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hernandez AM, 2013, SOUTH MED J, V106, P679, DOI 10.1097/SMJ.0000000000000030; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Ito K, 2019, J TRAUMA ACUTE CARE, V86, P160, DOI 10.1097/TA.0000000000002083; Kim MW, 2018, PREHOSP EMERG CARE, V22, P485, DOI 10.1080/10903127.2017.1416433; Kinoshita T, 2021, WORLD J EMERG SURG, V16, DOI 10.1186/s13017-020-00344-x; Kinoshita T, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0218-x; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Kirkpatrick AW, 2014, INJURY, V45, P1413, DOI 10.1016/j.injury.2014.01.021; Kuza CM, 2017, ANESTH ANALG, V125, P1960, DOI 10.1213/ANE.0000000000002450; Kvint S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17447; Loftus TJ, 2021, J AM COLL SURGEONS, V232, P560, DOI 10.1016/j.jamcollsurg.2020.11.008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marhong J, 2014, RESP CARE, V59, P1597, DOI 10.4187/respcare.03405; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Moore EE, 2018, J TRAUMA ACUTE CARE, V84, pS35, DOI 10.1097/TA.0000000000001797; Moore JM, 2016, CLIN NEUROL NEUROSUR, V148, P13, DOI 10.1016/j.clineuro.2016.06.012; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0270-1; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0229-2; Picetti E, 2017, NEUROSURGERY, V81, pE2, DOI 10.1093/neuros/nyx086; Richter Torsten, 2011, J Emerg Trauma Shock, V4, P251, DOI 10.4103/0974-2700.82215; Robba C, 2021, LANCET NEUROL, V20, P548, DOI 10.1016/S1474-4422(21)00138-1; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Servadei F, 2015, WORLD NEUROSURG, V83, P732, DOI 10.1016/j.wneu.2015.01.031; Smith M, 2015, BRIT J ANAESTH, V115, P488, DOI 10.1093/bja/aev230; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Smith M, 2018, ANESTHESIOLOGY, V128, P401, DOI 10.1097/ALN.0000000000001885; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stahel P., 2005, EUR J TRAUMA, V31, P200, DOI [10.1007/s00068-005-2028-6, DOI 10.1007/S00068-005-2028-6]; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stockinger ZT, 2004, MIL MED, V169, P609, DOI 10.7205/MILMED.169.8.609; Taccone FS, 2020, INTENS CARE MED, V46, P1261, DOI 10.1007/s00134-019-05879-5; Tiruvoipati R, 2018, JAMA NEUROL, V75, P818, DOI 10.1001/jamaneurol.2018.0123; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Umemura Y, 2021, J TRAUMA ACUTE CARE, V90, P232, DOI 10.1097/TA.0000000000003020; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Volovici V, 2019, J NEUROTRAUM, V36, P988, DOI 10.1089/neu.2018.6086; Volovici V, 2019, WORLD NEUROSURG, V125, pE515, DOI 10.1016/j.wneu.2019.01.116; Watson X, 2017, ANAESTHESIA, V72, P7, DOI 10.1111/anae.13737; Wiegers EJA, 2021, LANCET NEUROL, V20, P627, DOI 10.1016/S1474-4422(21)00162-9; Yamakawa K, 2019, ACUTE MED SURG, V6, P247, DOI 10.1002/ams2.412; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205	102	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2022	11	1							18	10.3390/jcm11010018			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YO8TG	WOS:000748205900001	35011760	Green Published			2022-02-06	
J	Rawlins, MLW; Johnson, BR; Register-Mihalik, JK; DeAngelis, K; Schmidt, JD; D'Lauro, CJ				Rawlins, Michelle L. Weber; Johnson, Brian R.; Register-Mihalik, Johna K.; DeAngelis, Karin; Schmidt, Julianne D.; D'Lauro, Christopher J.			States Air Force Academy Cadets' Unprompted Knowledge of Concussions and "Bell Ringers'' or "Dings'': Perceived Differences and Similarities	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; military academy; concussion recognition; concussion signs and symptoms	SPORT; EPIDEMIOLOGY; INJURY	Context: After a possible concussion mechanism, cadets are unlikely to have a list of concussion signs and symptoms at their disposal. As such, unprompted concussion knowledge may be an essential factor in personal recognition of injury. Objective: To explore determinants that contributed to United States Air Force Academy (USAFA) cadets' disclosure of a concussion. This research focused on 1 of 8 overall discovered themes of unprompted concussion knowledge. Design: Qualitative study. Setting: Military academy. Patients or Other Participants: Cadets at the USAFA (males = 23, females = 11, age = 19.91 +/- 1.14 years). Main Outcome Measure(s): We conducted 34 semistructured interviews. The transcribed text was analyzed in a 5-cycle process. From this process, 8 overall themes emerged, including unprompted concussion knowledge. Subthemes were concussion definition, concussion symptoms, "bell-ringer'' or "ding'' definition, "bell-ringer'' or " ding'' symptoms, and concussion versus "bell ringer'' or "ding.'' Results: Many participants were able to describe a concussion fairly accurately. The most commonly listed concussion signs and symptoms were dizziness (n = 22/34, 64.7%); "can't remember''/"memory loss''/"forgetful'' (n = 19/34, 55.9%); and headache (n = 16/34, 47.1%). The cadet participants characterized the most common bell-ringer or ding signs and symptoms as dizziness (n = 2/34, 5.9%) and headache (n = 2/34, 5.9%). Cadets also described how a bell ringer or ding differs from a concussion, often commenting that concussions were more severe than bell ringers or dings. Conclusions: Overall, USAFA cadet participants listed common concussion signs and symptoms. However, they perceived differences between a concussion and a bell ringer or ding. Although decreasing the use of colloquial terms for concussion is recommended, use of these terms when examining a concussion history may be helpful. Concussion-education interventions should continue to focus on describing concussion signs and symptoms using cadets' own words to describe the injury (eg, "forgetful'') but differentiating between what may and may not be a concussion and encouraging individuals to consult health care providers regarding possible concussion symptoms.	[Rawlins, Michelle L. Weber] San Diego State Univ, San Diego, CA 92182 USA; [Johnson, Brian R.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Register-Mihalik, Johna K.] Univ N Carolina, Chapel Hill, NC 27515 USA; [DeAngelis, Karin] US Air Force Acad, Colorado Springs, CO 80840 USA; [Schmidt, Julianne D.] Univ Georgia, Athens, GA 30602 USA		Rawlins, MLW (corresponding author), 5500 Campanile Dr, San Diego, CA 92128 USA.	Mrawlins@sdsu.edu			National Collegiate Athletic Association-Department of Defense Research Grand Challenge: "Changing Attitudes About Concussions in Young and Emerging Adults; US Air Force Summer Faculty Fellowship Program	This project was funded with support from the National Collegiate Athletic Association-Department of Defense Research Grand Challenge: "Changing Attitudes About Concussions in Young and Emerging Adults.'' Additional support for this project was obtained from the US Air Force Summer Faculty Fellowship Program.	Anderson R., 2011, 5 WAYS DOING QUALITA, P243; [Anonymous], HEADS; [Anonymous], Barrow Brainbook; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Lincoln Y. S, 1986, NEW DIRECTIONS PROGR, V30, P73, DOI [DOI 10.1002/EV.1427, 10.1002/ev.1427]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Rawlins Michelle L Weber, 2020, J Clin Transl Res, V5, P186; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Suzuki LA, 2007, COUNS PSYCHOL, V35, P295, DOI 10.1177/0011000006290983; Thinkfirst,, NAT INJ PREV FDN; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Wertz F.J., 2011, 5 WAYS DOING QUALITA	26	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2022	57	1					25	31		10.4085/1062-6050-0685.20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YL7KX	WOS:000746068300003		gold			2022-02-06	
J	Rizwana, N; Agarwal, V; Nune, M				Rizwana, Nasera; Agarwal, Vipul; Nune, Manasa			Antioxidant for Neurological Diseases and Neurotrauma and Bioengineering Approaches	ANTIOXIDANTS			English	Article						antioxidants; oxidative stress; neurotrauma; neuroregeneration; bioengineering approaches	CENTRAL-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; SPINAL-CORD-INJURY; OXIDATIVE STRESS; VITAMIN-E; FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; NEURODEGENERATIVE DISEASES; NATURAL ANTIOXIDANTS; FREE-RADICALS	Antioxidants are a class of molecules with an innate affinity to neutralize reactive oxygen species (ROS), which are known to cause oxidative stress. Oxidative stress has been associated with a wide range of diseases mediated by physiological damage to the cells. ROS play both beneficial and detrimental roles in human physiology depending on their overall concentration. ROS are an inevitable byproduct of the normal functioning of cells, which are produced as a result of the mitochondrial respiration process. Since the establishment of the detrimental effect of oxidative stress in neurological disorders and neurotrauma, there has been growing interest in exploring antioxidants to rescue remaining or surviving cells and reverse the neurological damage. In this review, we present the survey of different antioxidants studied in neurological applications including neurotrauma. We also delve into bioengineering approaches developed to deliver antioxidants to improve their cellular uptake in neurological applications.	[Rizwana, Nasera; Nune, Manasa] MIRM, MAHE, Manipal 576104, India; [Agarwal, Vipul] Univ New South Wales, Sch Chem Engn, CAMD, Sydney, NSW 2052, Australia		Nune, M (corresponding author), MIRM, MAHE, Manipal 576104, India.; Agarwal, V (corresponding author), Univ New South Wales, Sch Chem Engn, CAMD, Sydney, NSW 2052, Australia.	nasera.rizwana@learner.manipal.edu; agarwalvipul84@gmail.com; manasa.nune@manipal.edu		Nune, Manasa/0000-0001-5328-5693; Agarwal, Vipul/0000-0002-6239-5410	Manipal Academy of Higher Education-University of New South Wales Collaborative Research Seed Funding; Department of Science & Technology Start-Up Research Grant, India [SRG/2019/002130]; National Health & Medical Research Council, AustraliaNational Health and Medical Research Council of Australia; Early Career Fellowship [GNT1139060]; Manipal Academy of Higher Education	This research was funded by Manipal Academy of Higher Education-University of New South Wales Collaborative Research Seed Funding, Department of Science & Technology Start-Up Research Grant, India, Grant Number SRG/2019/002130 and National Health & Medical Research Council, Australia, Early Career Fellowship, grant number GNT1139060 and The APC was funded by Manipal Academy of Higher Education.	Abbas M, 2009, EUR PHYS J E, V28, P285, DOI 10.1140/epje/i2008-10437-9; Abd El-Hack ME, 2020, INT J BIOL MACROMOL, V164, P2726, DOI 10.1016/j.ijbiomac.2020.08.153; Agarwal V, 2018, NANOSCALE, V10, P16365, DOI 10.1039/c8nr04284e; Agarwal V, 2014, TOXICOL RES-UK, V3, P223, DOI 10.1039/c4tx00004h; Alzoubi KH, 2019, PHYSIOL BEHAV, V206, P200, DOI 10.1016/j.physbeh.2019.04.011; Amini S, 2020, INT J BIOL MACROMOL, V159, P154, DOI 10.1016/j.ijbiomac.2020.05.073; Amjed N, 2020, INT J BIOL MACROMOL, V154, P1149, DOI 10.1016/j.ijbiomac.2019.11.097; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Arai MA, 2013, MOL BIOSYST, V9, P2489, DOI 10.1039/c3mb70083f; Eleutherio ECA, 2021, ARCH BIOCHEM BIOPHYS, V697, DOI 10.1016/j.abb.2020.108701; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; Ayuso MI, 2017, ACS CHEM NEUROSCI, V8, P2202, DOI 10.1021/acschemneuro.7b00126; Azizi A, 2014, INT J SURG, V12, P76, DOI 10.1016/j.ijsu.2013.10.002; Barbosa RA, 2016, PHARM BIOL, V54, P993, DOI 10.3109/13880209.2015.1091844; Barriga-Gonzalez G, 2017, CURR ORG CHEM, V21, P2062, DOI 10.2174/1385272821666170228131324; Baydas G, 2003, TOXICOL LETT, V137, P169, DOI 10.1016/S0378-4274(02)00400-9; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Bedir T, 2020, MAT SCI ENG C-MATER, V110, DOI 10.1016/j.msec.2020.110741; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Boido M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42848-w; BROGDEN RN, 1975, DRUGS, V9, P251, DOI 10.2165/00003495-197509040-00005; Brown DI, 2015, CIRC RES, V116, P531, DOI 10.1161/CIRCRESAHA.116.303584; Cacabelos R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030551; Caleja C, 2017, FOOD CHEM, V216, P342, DOI 10.1016/j.foodchem.2016.08.075; Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810; Cancela S, 2020, EUR J PHARMACOL, V871, DOI 10.1016/j.ejphar.2020.172926; Cardoso BR, 2017, MOL PSYCHIATR, V22, P328, DOI 10.1038/mp.2016.196; Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; Chen HQ, 2007, NEUROSCI LETT, V417, P112, DOI 10.1016/j.neulet.2006.11.045; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Chioua M, 2019, ACS CHEM NEUROSCI, V10, P2703, DOI 10.1021/acschemneuro.9b00152; Cinelli MA, 2020, MED RES REV, V40, P158, DOI 10.1002/med.21599; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; d'Ischia M, 2020, ANGEW CHEM INT EDIT, V59, P11196, DOI 10.1002/anie.201914276; Silva RPD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172585; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057; de Carvalho FMD, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050726; Del Prado-Audelo ML, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020056; Deletraz A, 2020, ACS OMEGA, V5, P30989, DOI 10.1021/acsomega.0c03907; Deletraz A, 2020, J ORG CHEM, V85, P6073, DOI 10.1021/acs.joc.0c00563; Demir M, 2017, ANAL CELL PATHOL, V2017, P1, DOI 10.1155/2017/2805370; Dhall A, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080097; Santos DKDD, 2020, INT J BIOL MACROMOL, V150, P169, DOI 10.1016/j.ijbiomac.2020.02.052; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Dominguez-Robles J, 2020, INT J BIOL MACROMOL, V145, P92, DOI 10.1016/j.ijbiomac.2019.12.146; Dragsted LO, 2003, INT J VITAM NUTR RES, V73, P112, DOI 10.1024/0300-9831.73.2.112; Du J, 2018, BIOMATER SCI-UK, V6, P1299, DOI 10.1039/c8bm00260f; El-Naggar NEA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42129; Eleftheriadou D, 2020, SMALL, V16, DOI 10.1002/smll.201907308; Eller N, 1999, OCCUP MED-OXFORD, V49, P389, DOI 10.1093/occmed/49.6.389; Eroglu E, 2012, GREEN CHEM, V14, P2682, DOI 10.1039/c2gc35970g; Fang XT, 2019, J PHOTOCH PHOTOBIO B, V191, P83, DOI 10.1016/j.jphotobiol.2018.11.016; Fernandez-Castro P, 2015, J CHEM TECHNOL BIOT, V90, P796, DOI 10.1002/jctb.4634; Filley CM, 2004, J NEUROPATH EXP NEUR, V63, P1; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Fornasari BE, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.554257; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Glorieux C, 2017, BIOL CHEM, V398, P1095, DOI 10.1515/hsz-2017-0131; Goncalves RDR, 2005, BIOL PHARM BULL, V28, P1129, DOI 10.1248/bpb.28.1129; Greenberg MM, 1997, ENVIRON RES, V72, P1, DOI 10.1006/enrs.1996.3686; Greenlee H, 2012, CANCER-AM CANCER SOC, V118, P2048, DOI 10.1002/cncr.26526; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Gruber N, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081185; Gul S, 2005, SURG NEUROL, V64, P355, DOI 10.1016/j.surneu.2005.03.036; Gunawan C, 2019, ACS OMEGA, V4, P9473, DOI 10.1021/acsomega.9b00521; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Herz H, 1997, FREE RADICAL RES, V26, P19, DOI 10.3109/10715769709097781; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Ho D, 2015, ACS NANO, V9, P1767, DOI 10.1021/nn506607x; HOPE PL, 1984, LANCET, V2, P366; Hosomi A, 1998, NEUROSCI LETT, V256, P159, DOI 10.1016/S0304-3940(98)00785-X; Jahromi HK, 2020, MAT SCI ENG C-MATER, V109, DOI 10.1016/j.msec.2019.110564; Jastrzebska M, 2002, J PHOTOCH PHOTOBIO B, V66, P201, DOI 10.1016/S1011-1344(02)00268-3; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jiang B, 2019, INT J BIOL MACROMOL, V139, P21, DOI 10.1016/j.ijbiomac.2019.07.134; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; KamalEldin A, 1997, J AM OIL CHEM SOC, V74, P375, DOI 10.1007/s11746-997-0093-1; Karadag A, 2009, FOOD ANAL METHOD, V2, P41, DOI 10.1007/s12161-008-9067-7; Kashi TSJ, 2012, INT J NANOMED, V7, P221, DOI 10.2147/IJN.S27709; Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, pe20, DOI 10.1111/j.1755-5922.2010.00137.x; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Kou S, 2021, INT J BIOL MACROMOL, V169, P85, DOI 10.1016/j.ijbiomac.2020.12.005; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Krishnaiah D, 2011, FOOD BIOPROD PROCESS, V89, P217, DOI 10.1016/j.fbp.2010.04.008; de Melo CML, 2020, INT J BIOL MACROMOL, V162, P1725, DOI 10.1016/j.ijbiomac.2020.08.003; Lampe KJ, 2009, BIOTECHNOL BIOENG, V103, P1214, DOI 10.1002/bit.22352; Lasker S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56538-0; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Lee JC, 2018, BBA-MOL CELL BIOL L, V1863, P980, DOI 10.1016/j.bbalip.2018.05.007; Lee P, 2019, IUBMB LIFE, V71, P424, DOI 10.1002/iub.1993; Lee YM, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03355-3; Li BB, 2018, NEW J CHEM, V42, P7237, DOI 10.1039/c7nj04914e; Li CW, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00200; Liang RM, 2020, BIOMATERIALS, V230, DOI 10.1016/j.biomaterials.2019.119601; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Liu HT, 2015, REV NEUROSCIENCE, V26, P105, DOI 10.1515/revneuro-2014-0041; Liu XD, 2019, ECOTOX ENVIRON SAFE, V172, P33, DOI 10.1016/j.ecoenv.2019.01.048; Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967; Lu LDY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03169; Lundgren C, 2018, J MATERN-FETAL NEO M, V31, P1595, DOI 10.1080/14767058.2017.1321628; M F Griffin, 2014, Open Orthop J, V8, P199, DOI 10.2174/1874325001408010199; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Mahumane GD, 2018, BIOMATER SCI-UK, V6, P2812, DOI 10.1039/c8bm00422f; Marco-Contelles J, 2020, J MED CHEM, V63, P13413, DOI 10.1021/acs.jmedchem.0c00976; Marino A, 2017, BBA-GEN SUBJECTS, V1861, P386, DOI 10.1016/j.bbagen.2016.11.022; Marrazzo P, 2020, BIOENGINEERING-BASEL, V7, DOI 10.3390/bioengineering7030104; MCLAUGHLIN PJ, 1979, J AM DIET ASSOC, V75, P647; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Menorca RMG, 2013, HAND CLIN, V29, P317, DOI 10.1016/j.hcl.2013.04.002; Merzlyak A, 2009, NANO LETT, V9, P846, DOI 10.1021/nl8036728; Migliaccio L, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00162; Milbourn HR, 2017, DISCOV MED, V23, P361; Milisav I, 2018, SUBCELL BIOCHEM, V90, P1, DOI 10.1007/978-981-13-2835-0_1; Moattari M, 2018, ANN PLAS SURG, V81, P335, DOI 10.1097/SAP.0000000000001566; Moise AR, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111619; MOONEN G, 1990, PROG BRAIN RES, V86, P63; Moreno-Garcia A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10010124; Morry J, 2017, REDOX BIOL, V11, P240, DOI 10.1016/j.redox.2016.12.011; Moskow J, 2019, BIOACT MATER, V4, P107, DOI 10.1016/j.bioactmat.2018.09.001; Mrakic-Sposta S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1767265; Nadeem Ahmed, 2008, Ther Adv Respir Dis, V2, P215, DOI 10.1177/1753465808094971; Nahhas AF, 2019, PHOTODERMATOL PHOTO, V35, P420, DOI 10.1111/phpp.12423; Nelson BC, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5020015; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; Nonell S, 2016, COMPR SER PHOTOCH, V13, P1; Nune M, 2019, J TISSUE ENG REGEN M, V13, P1059, DOI 10.1002/term.2860; Nune M, 2019, MAT SCI ENG C-MATER, V94, P17, DOI 10.1016/j.msec.2018.09.014; Nune M, 2017, NANOMEDICINE-UK, V12, P219, DOI 10.2217/nnm-2016-0323; Nune M, 2016, MAT SCI ENG C-MATER, V62, P329, DOI 10.1016/j.msec.2016.01.057; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Palacio C., 2016, OXIDATIVE STRESS ANT, P493; Pantavos A, 2015, INT J CANCER, V136, P2178, DOI 10.1002/ijc.29249; Papa S, 2016, BIOMATERIALS, V75, P13, DOI 10.1016/j.biomaterials.2015.10.015; Papa S, 2013, ACS NANO, V7, P9881, DOI 10.1021/nn4036014; Paquette David W, 2002, Compend Contin Educ Dent, V23, P15; Penrice J, 1997, PEDIATR RES, V41, P795, DOI 10.1203/00006450-199706000-00001; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Piotrowska DG, 2019, ACS OMEGA, V4, P8581, DOI 10.1021/acsomega.9b00189; Qi ZP, 2020, J NANOMATER, V2020, DOI 10.1155/2020/3068173; Qian Y, 2019, ISCIENCE, V12, P216, DOI 10.1016/j.isci.2019.01.013; Qian Y, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12516; Ralph J, 2019, CURR OPIN BIOTECH, V56, P240, DOI 10.1016/j.copbio.2019.02.019; Reiter RJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23020509; Reiter RJ, 2017, CELL MOL LIFE SCI, V74, P3863, DOI 10.1007/s00018-017-2609-7; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Renault H, 2019, CURR OPIN BIOTECH, V56, P105, DOI 10.1016/j.copbio.2018.10.011; Rienecker SB, 2015, J PHYS CHEM B, V119, P14994, DOI 10.1021/acs.jpcb.5b08970; Righi AA, 2011, J SCI FOOD AGR, V91, P2363, DOI 10.1002/jsfa.4468; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Rocha-Ferreira E, 2015, NEUROSCIENCE, V311, P292, DOI 10.1016/j.neuroscience.2015.10.035; Rocha-Ferreira E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01351; ROSENBERG NL, 1988, ANN NEUROL, V23, P611, DOI 10.1002/ana.410230614; Rubio L, 2018, CHEM-BIOL INTERACT, V291, P7, DOI 10.1016/j.cbi.2018.06.002; Sadidi H, 2020, MOLECULES, V25, DOI 10.3390/molecules25194559; Saikolappan S, 2019, CANCER LETT, V452, P132, DOI 10.1016/j.canlet.2019.03.020; Sairazi NSM, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/6565396; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Salles MB, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5340-z; Samadian H, 2019, J MATER SCI-MATER M, V30, DOI 10.1007/s10856-019-6309-8; Samantaray PK, 2020, NANOSCALE ADV, V2, P2824, DOI 10.1039/c9na00747d; Samarghandian S, 2017, BIOMED PHARMACOTHER, V87, P223, DOI 10.1016/j.biopha.2016.12.105; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Schaich KM, 2015, J FUNCT FOODS, V14, P111, DOI 10.1016/j.jff.2015.01.043; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Sergeeva V, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4398695; Seven ES, 2019, FASEB J, V33; Shah R, 2019, CELL CHEM BIOL, V26, P1594, DOI 10.1016/j.chembiol.2019.09.007; Shokouhi G, 2008, CHILD NERV SYST, V24, P111, DOI 10.1007/s00381-007-0366-x; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; Singh A, 2019, BIOMACROMOLECULES, V20, P662, DOI 10.1021/acs.biomac.8b01308; Soliman GM, 2010, MACROMOL BIOSCI, V10, P278, DOI 10.1002/mabi.200900259; Stokes P., 2020, MALE INFERTILITY CON, P543; Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Turkan F, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22340; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vaiserman A, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00447; Vanholme R, 2019, CURR OPIN BIOTECH, V56, P230, DOI 10.1016/j.copbio.2019.02.018; Villalva MD, 2021, NANOMEDICINE-UK, V16, P1595, DOI 10.2217/nnm-2021-0104; Wang J, 2018, COLLOID SURFACE B, V169, P356, DOI 10.1016/j.colsurfb.2018.05.021; Wang Y, 2020, J CONTROL RELEASE, V323, P613, DOI 10.1016/j.jconrel.2020.04.042; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581; Woolley JF, 2013, TRENDS BIOCHEM SCI, V38, P556, DOI 10.1016/j.tibs.2013.08.009; Yamato M, 2003, FREE RADICAL BIO MED, V35, P1619, DOI 10.1016/j.freeradbiomed.2003.09.013; Yao YJ, 2020, BIOMATERIALS, V232, DOI 10.1016/j.biomaterials.2019.119726; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005; Yeung AWK, 2021, ANTIOXID REDOX SIGN, V34, P402, DOI 10.1089/ars.2019.7952; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yu X, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8364848; Yuce S, 2015, ANN PLAS SURG, V74, P684, DOI 10.1097/SAP.0000000000000026; Zalewska A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2606120; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515	200	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	JAN	2022	11	1							72	10.3390/antiox11010072			24	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	YO0QL	WOS:000747653100001	35052576	gold, Green Accepted			2022-02-06	
J	Robba, C; Aspide, R; Pegoli, M; Kondratyeva, E; Gritti, P; Fustini, MF; Battaglini, D; Pelosi, P; Hutchinson, PJ; Helmy, A; Bortolotti, C; Zenesini, C; Bilotta, F				Robba, Chiara; Aspide, Raffaele; Pegoli, Marianna; Kondratyeva, Ekaterina; Gritti, Paolo; Fustini, Marco F.; Battaglini, Denise; Pelosi, Paolo; Hutchinson, Peter J.; Helmy, Adel; Bortolotti, Carlo; Zenesini, Corrado; Bilotta, Federico			Pituitary Dysfunction After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						pituitary dysfunction; subarachnoid hemorrhage; neurological outcome; endocrine	TRAUMATIC BRAIN-INJURY; NEUROENDOCRINE DYSFUNCTION; ACUTE-PHASE; HIGH-RISK; HYPOPITUITARISM; DEFICIENCY; PREVALENCE; GUIDELINES; MANAGEMENT; SURVIVORS	Background: The prevalence of pituitary dysfunction after aneurysmal subarachnoid hemorrhage (aSAH) remains incompletely elucidated. Furthermore, it is not clear whether these abnormalities impact patient outcomes. The aim of this study was to evaluate the prevalence of pituitary dysfunction after aSAH and its effect on outcomes. Methods: We carried out a prospective, cohort study including adult patients (18 y of age or older) with a diagnosis of aSAH who were admitted to the intensive care unit in 3 centers between January 2017 and January 2019. Exclusion criteria were previous hypopituitarism, hormonal replacement therapies for pituitary dysfunction or any corticosteroid treatment. Endocrine function was tested within the first 48 hours after aSAH onset (acute phase), after 1 to 3 weeks (subacute phase), and after 6 to 12 months (chronic phase). Clinical outcomes were assessed at 6 to 12 months using the modified Rankin Scale. Results: Fifty-six patients were included in the study; all were studied in the acute phase, 34 were studied in the subacute phase, and 49 in the chronic phase. Pituitary dysfunction was identified in 92.3% (95% confidence interval; [CI]: 86.6%-98.0%) of cases in the acute phase, in 83.3% (95% CI: 70.8%-95.8%) in the subacute phase, and in 83.3% (95% CI: 72.7%-93.9%) of cases in the chronic phase. The most commonly identified abnormality was dysfunction of the pituitary-gonadal axis. There was no correlation between pituitary dysfunction and clinical outcome. Conclusion: Pituitary dysfunction is common after aSAH, but does not affect 6 to 12-month clinical outcomes.	[Robba, Chiara; Battaglini, Denise; Pelosi, Paolo] IRCCS Oncol & Neurosci, Policlin San Martino, Dept Anesthesia & Intens Care, Genoa, Italy; [Aspide, Raffaele; Pegoli, Marianna] IRCCS Ist Sci Neurol Bologna, Anesthesia & Neurointens Care Unit, Bologna, Italy; [Fustini, Marco F.] IRCCS Ist Sci Neurol Bologna, Pituitary Unit, Bologna, Italy; [Bortolotti, Carlo] IRCCS Ist Sci Neurol Bologna, Neurosurg Unit, Bologna, Italy; [Zenesini, Corrado] IRCCS Ist Sci Neurol Bologna, Epidemiol & Biostat Unit, Bologna, Italy; [Gritti, Paolo] Osped Papa Giovanni XXIII, Dept Anaesthesia & Crit Care Med, Bergamo, Italy; [Bilotta, Federico] Univ Rome Sapienza, Dept Anesthesiol, Rome, Italy; [Robba, Chiara] Univ Cambridge, Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; [Hutchinson, Peter J.; Helmy, Adel] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Hutchinson, Peter J.; Helmy, Adel] Univ Cambridge, Cambridge, England; [Kondratyeva, Ekaterina] Almazov Natl Med Res Ctr, Polenov Neurosurg Inst Branch, Minimally Conscious State Res Grp, St Petersburg, Russia		Robba, C (corresponding author), IRCCS Oncol & Neurosci, Policlin San Martino, Dept Anesthesia & Intens Care, Genoa, Italy.; Robba, C (corresponding author), Univ Cambridge, Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England.	kiarobba@gmail.com	Battaglini, Denise/X-6446-2019; Faustini-Fustini, Marco/AAU-7933-2020; aspide, raffaele/Q-2565-2019	Battaglini, Denise/0000-0002-6895-6442; aspide, raffaele/0000-0003-4256-9812; Zenesini, Corrado/0000-0002-9855-8197; Gritti, Paolo/0000-0001-9870-1507; Helmy, Adel/0000-0002-0531-0556	NIHR-Research Professorship; Cambridge BRCGeneral Electric; Brain Injury Medtech Co-operative; Global Health Research Group on Neurotrauma	P.J.H. was supported by the NIHR-Research Professorship, Cambridge BRC, Brain Injury Medtech Co-operative and Global Health Research Group on Neurotrauma. The remaining authors have no funding or conflicts of interest to disclose.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Pereira JLB, 2013, CLINICS, V68, P745, DOI 10.6061/clinics/2013(06)04; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Can A, 2016, NEUROSURGERY, V79, P253, DOI 10.1227/NEU.0000000000001157; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; CROMPTON MR, 1963, BRAIN, V86, P301, DOI 10.1093/brain/86.2.301; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; DOCZI T, 1981, NEUROSURGERY, V9, P394, DOI 10.1227/00006123-198110000-00008; Giritharan S, 2017, PITUITARY, V20, P624, DOI 10.1007/s11102-017-0825-7; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Higham CE, 2016, LANCET, V388, P2403, DOI 10.1016/S0140-6736(16)30053-8; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2012, PITUITARY, V15, P505, DOI 10.1007/s11102-011-0357-5; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; Mangieri P, 2003, ARQ NEURO-PSIQUIAT, V61, P14, DOI 10.1590/S0004-282X2003000100003; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Robba C, 2016, PITUITARY, V19, P522, DOI 10.1007/s11102-016-0733-2; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6	29	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2022	34	1					44	50		10.1097/ANA.0000000000000705			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	XJ4ZX	WOS:000726799100013	32604221				2022-02-06	
J	Schlag, H; Neuhoff, J; Castein, J; Hoffmann, C; Kandziora, F				Schlag, Holger; Neuhoff, Jonathan; Castein, Jens; Hoffmann, Christoph; Kandziora, Frank			Rupture of the Superior Sagittal Sinus in Penetrating Head Injury-Management of a Rare Trauma Mechanism	JOURNAL OF NEUROLOGICAL SURGERY REPORTS			English	Article						penetrating head injury; superior sagittal sinus; penetrating brain injury; fractures	INTRACRANIAL-PRESSURE; BRAIN-INJURY	Civilian penetrating head injury caused by foreign objects is rare in Germany (Europe), but can result in complex neurovascular damage. We report on a patient who in suicidal intent inflicted on himself a penetrating brain injury near the vertex with a captive bolt gun. A laceration at the junction of the middle to the posterior third of the superior sinus occurred by bolt and bone fragments leading to critical stenosis and subsequent thrombosis. Upon surgery, the proximal and distal sinus openings were completely thrombosed. The sinus laceration was closed by suture and the intraparenchymal bone fragments were retrieved. Postoperative angiography disclosed persistent occlusion of the superior sagittal sinus. The patient did not develop any symptoms due to venous congestion (edema, hemorrhage), suggesting sufficient collateral venous outflow. The patient completely recovered despite the complexity of the lesion.	[Schlag, Holger; Neuhoff, Jonathan; Castein, Jens; Hoffmann, Christoph; Kandziora, Frank] BG Unfallklin Frankfurt Am Main GmbH, Ctr Spinal Surg & Neurotraumatol, Friedberger Landstr 430, D-60389 Frankfurt, Germany		Schlag, H (corresponding author), BG Unfallklin Frankfurt Am Main GmbH, Ctr Spinal Surg & Neurotraumatol, Friedberger Landstr 430, D-60389 Frankfurt, Germany.	holger.schlag@bgu-frankfurt.de					Aarabi B, 2000, Neurosurg Focus, V8, pe1; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; [Anonymous], 2001, J TRAUMA, V51, pS34; [Anonymous], 2001, J TRAUMA, V51, pS7; [Anonymous], 2001, J TRAUMA, V51, pS3; Ares WJ, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19495; Aziz MM, 2019, TURK NEUROSURG, V29, P856, DOI 10.5137/1019-5149.JTN.25572-18.2; Birk DM, 2015, J NEUROSURG, V123, P81, DOI 10.3171/2014.10.JNS141349; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; de Holanda LF, 2016, WORLD NEUROSURG, V90, P420, DOI 10.1016/j.wneu.2016.03.015; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; Fries R, 2012, ANIMAL, V6, P1124, DOI 10.1017/S1751731111002667; Kim You-Sub, 2015, Korean J Neurotrauma, V11, P118, DOI 10.13004/kjnt.2015.11.2.118; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Ma Jingjian, 2002, Neurosurg Focus, V12, pecp1; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mathew Jacob Eapen, 2010, Surg Neurol Int, V1, P52, DOI 10.4103/2152-7806.69379; Moussa WMM, 2016, ACTA NEUROCHIR, V158, P895, DOI 10.1007/s00701-016-2764-x; Pircher R, 2017, INT J LEGAL MED, V131, P1557, DOI 10.1007/s00414-017-1539-0; Sani S, 2005, J NEUROSURG, V103, P567, DOI 10.3171/jns.2005.103.3.0567	22	0	0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2193-6358	2193-6366		J NEUROL SURG REP	J. Neurol. Surg. Rep.	JAN	2022	83	01					E3	E7		10.1055/s-0041-1742103			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YE0KZ	WOS:000740822800002	35028277	Green Published, gold			2022-02-06	
J	Schoenfeld, R; Drendel, A; Ahamed, SI; Thomas, D				Schoenfeld, Robert; Drendel, Amy; Ahamed, Sheikh Iqbal; Thomas, Danny			Longitudinal Assessment of Acute Concussion Outcomes Through SMS Text (ConText Study)	PEDIATRIC EMERGENCY CARE			English	Article						mTBI; concussion; mHealth; SMS text messaging	SOMATIC SYMPTOMS; RECOVERY-TIME; CHRONIC PAIN; HIGH-SCHOOL; SPORT; CHILDREN; REST	Objective Mild traumatic brain injury (mTBI), or concussion, is a common health problem that has seen a recent increase in US adolescents. This study uses SMS text messaging (a mobile health [mHealth] tool) to report patient symptoms. We aim to better characterize mTBI recovery and hypothesize that this mHealth tool will have high retention rates and correlate with a conventional means of assessing symptoms, the Post-Concussion Symptom Inventory (PCSI). Methods A prospective observational cohort pilot study. Thirty-one pediatric patients with acute mTBI were recruited to characterize their injury and report their symptoms via text messaging. Patients reported symptoms once every 3 days for the first 21 days, then once a week for 6 weeks. Results There was a strong and positive correlation between the PCSI and the mHealth tool (rs = 0.875, P < 0.000, n = 22). Retention was 74% until symptom resolution and 42% until study completion. Patients with balance deficits had a significantly higher somatization score than those with normal balance (6.53 +/- 3.25 vs 2.56 +/- 2.30, t(22) = 3.211, P < 0.01). Conclusions This pilot study demonstrates that this tool is a valid and easy-to-use method of reporting pediatric mTBI symptoms-it replicates and identifies novel findings. Our results suggest that there may be a relationship between balance and the manifestation of somatic symptoms. Retention rates were lower than predicted, indicating that text messaging may not be the ideal format in this population. Text messaging may still have other applications for short-term communication/symptom measurement.	[Schoenfeld, Robert] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Drendel, Amy; Thomas, Danny] Med Coll Wisconsin, Childrens Hosp Wisconsin, Dept Pediat, Sect Emergency Med, Milwaukee, WI USA; [Ahamed, Sheikh Iqbal] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA		Thomas, D (corresponding author), Childrens Corp Ctr, Pediat Emergency Med, 999 N 92nd St, Milwaukee, WI 53226 USA.	dthomas@mcw.edu			Children's Research Institute	` This study was supported by the Children's Research Institute.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson M, 2018, TEENS SOCIAL MEDIA T; Anhoj Jacob, 2004, J Med Internet Res, V6, pe42, DOI 10.2196/jmir.6.4.e42; [Anonymous], 2013, Br J Sports Med, V47, P259; [Anonymous], 2018, MOBILE FACT SHEET; [Anonymous], 2003, REPORT C MILD TRAUMA; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Burns LC, 2015, J PAIN RES, V8, P21, DOI 10.2147/JPR.S64730; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gass JJ, 2013, APPL PSYCHOPHYS BIOF, V38, P257, DOI 10.1007/s10484-013-9231-8; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Laederach-Hofmann K, 2008, BIOL PSYCHOL, V79, P243, DOI 10.1016/j.biopsycho.2008.06.003; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Parkerson HA, 2013, J PAIN, V14, P1383, DOI 10.1016/j.jpain.2013.06.004; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tak LM, 2010, PSYCHOTHER PSYCHOSOM, V79, P179, DOI 10.1159/000296136; Taubman B, 2016, J CHILD NEUROL, V31, P1607, DOI 10.1177/0883073816667194; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	41	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2022	38	1					E37	E42		10.1097/PEC.0000000000002596			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	YA0YC	WOS:000738068600019	34986585				2022-02-06	
J	Scibilia, A; Gallinaro, P; Todeschi, J; Chibbaro, S; Dannhoff, G; Ollivier, I; Bozzi, MT; Ganau, M; Proust, F; Cebula, H				Scibilia, A.; Gallinaro, P.; Todeschi, J.; Chibbaro, S.; Dannhoff, G.; Ollivier, I; Bozzi, M. T.; Ganau, M.; Proust, F.; Cebula, H.			Surgical management of persistent post-traumatic trans-tentorial brain hernia	NEUROCHIRURGIE			English	Article						Traumatic brain injury; Trans-tentorial brain hernia; Temporal lobe disengagement; Intracranial pressure	DECOMPRESSIVE CRANIECTOMY; TRANSTENTORIAL HERNIATION; INJURY; CISTERNOSTOMY; LOBECTOMY	Introduction. - Temporal engagement may persist after etiologic surgical treatment of acute subdural hematoma (ASH) without clinical improvement despite normalized intracranial pressure (ICP). The aim of this study was to assess the feasibility of secondary direct temporal lobe disengagement (DTLD) after surgery for supratentorial ASH and to evaluate clinical outcome. Materials and methods. - This was a retrospective analysis of 4 patients undergoing secondary DTLD. Patient data were recorded at admission, pre-and postoperatively and at 6 months' follow-up (FU): age, gender, Rotterdam score, Glasgow Coma Scale (GCS), neurological deficits, oculomotor nerve palsy (ONP), ICP, midline shift, complications and Extended Glasgow Outcome Scale (GOS-E). Results. - At postoperative evaluation 48 h after DTLD, we observed a significant improvement in GCS score (initial 6 +/- 3, preoperative 7 +/- 3, postoperative 14 +/- 1; P = 0.02), midline shift (initial 16 +/- 3 mm, preoperative 13 +/- 5 mm, postoperative 9 +/- 2 mm; P = 0.049) and ONP (P = 0.01). In all cases, early postop-erative imaging documented visualization of a patent ipsilateral peri-mesencephalic cistern. At 6-month FU, GOS-E showed 75% good recovery and 25% disability. Complete ONP recovery was observed in 75% of patients (P = 0.01). Neurological deficits were present at FU in 25% of patients. No surgery-related complications or mortality were recorded. Conclusions. - In traumatic brain injury, secondary DTLD may allow simple, effective and safe management of trans-tentorial uncal herniation, avoiding more challenging procedures. Clinical results are promising, as this technique seems to favorably influence neurological outcome in this selected subgroup of patients with persistent clinical and radiological signs of temporal engagement after etiological treatment with normal ICP values. (c) 2021 Elsevier Masson SAS. All rights reserved.	[Scibilia, A.; Gallinaro, P.; Todeschi, J.; Chibbaro, S.; Dannhoff, G.; Ollivier, I; Bozzi, M. T.; Ganau, M.; Proust, F.; Cebula, H.] Univ Strasbourg, Div Neurosurg, 1 Ave Moliere, F-67200 Strasbourg, France		Scibilia, A (corresponding author), Univ Strasbourg, Div Neurosurg, 1 Ave Moliere, F-67200 Strasbourg, France.	ninoscib98@gmail.com	Scibilia, Antonino/K-7941-2016				ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen PR, 2006, NEUROSURGERY, V58, P1040, DOI 10.1227/01.NEU.0000215853.95187.5E; Cherian I, 2019, WORLD NEUROSURG, V131, P385, DOI 10.1016/j.wneu.2019.07.082; Giammattei L, 2020, ACTA NEUROCHIR, V162, P469, DOI 10.1007/s00701-020-04222-y; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Hakan A K, 2019, Asian J Neurosurg, V14, P436, DOI 10.4103/ajns.AJNS_240_18; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; LITOFSKY NS, 1994, NEUROSURGERY, V34, P628, DOI 10.1227/00006123-199404000-00009; Loftus CM., 2018, NEUROSURGICAL EMERGE, V3rd; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mori K, 1998, ACTA NEUROCHIR, V140, P1239, DOI 10.1007/s007010050244; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Signorelli F, 2020, J NEUROINTERV SURG, V12, P964, DOI 10.1136/neurintsurg-2020-015802; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	19	0	0	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	JAN	2022	68	1					44	51		10.1016/j.neuchi.2021.06.012			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XY4CW	WOS:000736923600007	34224727				2022-02-06	
J	Shafiee, S; Ehteshami, S; Moosazadeh, M; Aghapour, S; Haddadi, K				Shafiee, Sajad; Ehteshami, Saeed; Moosazadeh, Mahmoodd; Aghapour, Saeed; Haddadi, Kaveh			Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury	CASPIAN JOURNAL OF INTERNAL MEDICINE			English	Article						Amantadine; Zolpidem; Traumatic brain injury; Diffuse axonal injury	CLOSED-HEAD-INJURY; VEGETATIVE STATE; DOPAMINE; AROUSAL	Background: A constituent of diffuse axonal injury (DAI) is supposed to be present in about 1/3 of all severe traumatic brain injury (TBI) as specified by pathologic documents. Diffuse axonal injury is categorized by extensive injury to axons in the brain. A rise in the incidences of TBI, and the limited study to verified effect of drugs like amantadine and zolpidem in improving the consciousness levels of patients with acute traumatic brain injury with axonal injury enthused us to initiate this study in the acute TBI patients. Methods: In our randomized, controlled trial involving patients with acute severe TBI, we studied 66 patients in 3 groups. Group 1 (n=22) received oral amantadine, Group 2 (n=22) received oral zolpidem, whereas group 3 (n=22) received placebo, the first 8 days after injury respectively. The primary outcome measures included GCS (Glashow coma scale) through the initial admission, a complete medical history was recorded, and each patient had a meticulous physical and neurological investigation. Results: We found that the administration of amantadine in an acute phase after injury improved the rate of patients GCS and GOS (Glasgow Outcome Scale) compared with zolpidem and placebo groups, but without any significant statistical difference. Conclusion: Our results has emphasized that because amantadine has intense biochemical effects on several ways, it appears to be beneficial in acute period after DAI-associated TBI.	[Shafiee, Sajad; Ehteshami, Saeed; Haddadi, Kaveh] Mazandaran Univ Med Sci, Orthoped Res Ctr, Dept Neurosurg, Sari, Iran; [Moosazadeh, Mahmoodd] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Noncommun Ble Dis Inst, Sari, Iran; [Aghapour, Saeed] Mazandaran Univ Med Sci, Fac Med, Dept Neurosurg, Sari, Iran		Haddadi, K (corresponding author), Mazandaran Univ Med Sci, Orthoped Res Ctr, Sari, Iran.	kavehhaddadi56@gmail.com			Mazandaran University of Medical Sciences, North of Iran	This study was a Neurosurgery specialty thesis of Dr. Saeed Aghapour financially supported by Mazandaran University of Medical Sciences, North of Iran and was approved by the Clinical Research Development unit of Imam Khomeini Hospital, MAZUMS.	Abbasivash R, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069518824851; AOKI FY, 1985, CLIN PHARMACOL THER, V37, P128, DOI 10.1038/clpt.1985.24; Asadian L., 2015, Journal of Mazandaran University of Medical Sciences, V24, pPe208; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BAKAY RAE, 1986, NEUROSURGERY, V18, P234, DOI 10.1227/00006123-198602000-00023; BENNETT M, 1995, IRISH MED J, V88, P59; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Chandler M C, 1988, Brain Inj, V2, P309; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss RP, 2000, S AFR MED J, V90, P68; Diaz-Marchan PG, 1996, NEUROTRAUMA, V1st, P137; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gilman AG, 1980, PHARM BASIS THERAPEU, V6th, P71; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; LANGTRY HD, 1990, DRUGS, V40, P291, DOI 10.2165/00003495-199040020-00008; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; MACCHIO GJ, 1993, ARCH PHYS MED REHAB, V74, P1119, DOI 10.1016/0003-9993(93)90072-I; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Pallan Tony V, 2014, J Vasc Interv Neurol, V7, P23; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; Povlishock JT, 1996, TRAUMATIC BRAIN INJU, V1st, P51; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Snyman N, 2010, NEUROPEDIATRICS, V41, P223, DOI 10.1055/s-0030-1269893; Tbeadom A, 2017, YOUMANS WINN NEUROLO, V8th, P2748; WHYTE J, 1998, REHABILITATION MED P, P1191; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014	43	0	0	0	0	BABOL UNIV MEDICAL SCIENCES	BABOL	ENGLISH JOURNAL OFFICE, GANJ AFROOZ AVE, BABOL, 00000, IRAN	2008-6164	2008-6172		CASP J INTERN MED	Casp. J. Intern. Med.		2022	13	1					113	121		10.22088/cjim.13.1.113			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XU0JT	WOS:000733963400016					2022-02-06	
J	Shemesh, D; Aburus, O; Turgeman, G; Bookasis, D				Shemesh, David; Aburus, Ohad; Turgeman, Gadi; Bookasis, David			Quantification of the effectivity of laser therapy shortly following brain injury via dual-wavelength laser imaging	OPTICS AND LASER TECHNOLOGY			English	Article						Low-level laser therapy; Closed brain injury; Mouse model; Cerebral hemodynamics response; Cerebral blood flow; Dual-wavelength laser speckle contrast imaging	CEREBRAL METABOLIC-RATE; BLOOD-FLOW; LIGHT THERAPY; OXYGEN CMRO2; HEAD-INJURY; IN-VIVO; TEMPERATURE; TISSUE; PATHOPHYSIOLOGY; NEUROPROTECTION	Treatment of traumatic brain injury, within a few minutes and even before transportation to the nearest medical facility, can significantly curtail injury severity and even prevent death. The primary aim of this study was to evaluate the effect of laser irradiation as a therapeutic intervention tool immediately following brain injury. To this end, a dual-wavelength laser speckle contrast imaging (DW-LSCI) system based on two laser sources at two wavelengths 532 and 660 nm was employed to monitor changes in cerebral blood flow, tissue saturation and rate of oxygen consumption in a mouse model of intact head injury. In addition, structural changes of tissue were evaluated using linear approximation to Rayleigh-MIE scattering in the range between the two laser wavelengths. Furthermore, cerebral tissue temperature was imaged by a thermal camera providing additional information on physiological brain tissue condition. Experiments were conducted on anesthetized mice (n = 6, female) subjected to a closed head weight-drop model of focal brain injury. After 5 min of baseline measurement, focal brain injury was induced and measurements were conducted for 10 min. Low-level laser therapy (LLLT) was than administrated for a duration of 15 min with uniform exposure of 45 J/cm(2) from a CW diode laser source (810 nm). Concurrently, measurements were carried out over the treatment time interval. Laser illumination was then blocked and measurements continued for another 20 min, followed by euthanasia. In comparison to baseline measurements, noticeable variations were revealed post-injury which indicate the severity of brain damage. The use of LLLT inhibited the development of complications in the injured mice by increasing blood flow and saturation and overall oxygen consumption level over the injured area which highlights its effectiveness as a neuroprotective agent immediately following brain injury. Different doses of low-level laser irradiation were also tested (n = 12) with less effectiveness on cerebral parameters. The results presented here support our hypothesis that a high dose of laser irradiation as a first aid can attenuate the injury and save the brain from further worse outcome. To the best of our knowledge, the implementation of the DW-LSCI system to monitor brain hemodynamic and metabolic response to LLLT shortly after head injury in intact mouse brain has not been previously reported.	[Shemesh, David; Aburus, Ohad; Bookasis, David] Ariel Univ, Dept Elect & Elect Engn, IL-407000 Ariel, Israel; [Turgeman, Gadi] Ariel Univ, Dept Mol Biol, IL-407000 Ariel, Israel; [Turgeman, Gadi] Ariel Univ, Dept Premed studies, IL-407000 Ariel, Israel		Bookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-407000 Ariel, Israel.	davida@ariel.ac.il					Abookasis D, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.2.025003; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116007; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.045003; Al-Watban FAH, 2004, J CLIN LASER MED SUR, V22, P15, DOI 10.1089/104454704773660921; Alfano R.R., 2019, NEUROPHOTONICS BIOME; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; [Anonymous], ULTIMATE GUIDE LOW L, P200; Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Bigio I., 2016, QUANTITATIVE BIOMEDI; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boas D.A., 2011, HDB BIOMEDICAL OPTIC; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Braga RA, 2016, OPT ENG, V55, DOI 10.1117/1.OE.55.12.121702; Bronzino J.D., 2006, MED DEVICES SYSTEMS; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Buxton RB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00139; Carroll J, 2015, J ORTHOP RHEUMATOL, V2, DOI [10.15406/mojor.2015.02.00068, DOI 10.15406/MOJOR.2015.02.00068]; Chang Y., 2018, NEUROPSYCHIATRY-LOND, V8, P477; Chong SP, 2015, BIOMED OPT EXPRESS, V6, P3941, DOI 10.1364/BOE.6.003941; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Costantini I, 2019, BIOMED OPT EXPRESS, V10, P5251, DOI 10.1364/BOE.10.005251; Czosnyka M, 2018, J EMERG CRIT CARE ME, V2, P1; Davis MA, 2016, BIOMED OPT EXPRESS, V7, P759, DOI 10.1364/BOE.7.000759; Denstedt M, 2013, PROC SPIE, V8565, DOI 10.1117/12.2001087; Deutsch A, 2004, PROC SPIE, V5317, P116, DOI 10.1117/12.528601; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Diakides N.A., 2008, MED INFRARED IMAGING; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Dima R, 2018, ALTERN THER HEALTH M, V24, P8; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Duncan DD, 2008, J OPT SOC AM A, V25, P9, DOI 10.1364/JOSAA.25.000009; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fox DJ, 2006, APPL OPTICS, V45, P3009, DOI 10.1364/AO.45.003009; Frostig R.D., 2019, VIVO OPTICAL IMAGING, V2nd; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hamblin M.R., 2017, HDB LOW LEVEL LASER, V1st; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Jakovels D., 2014, SPIE P, VIV; Jawad MM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128001; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Joensen J, 2012, PHOTOMED LASER SURG, V30, P688, DOI 10.1089/pho.2012.3306; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Kainerstorfer JM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470094; Kalmbach AS, 2012, J NEUROPHYSIOL, V108, P3138, DOI 10.1152/jn.00557.2012; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kim H, 2019, CURR OPT PHOTONICS, V3, P555, DOI 10.3807/COPP.2019.3.6.555; Kim S, 2014, LASER MED SCI, V29, P637, DOI 10.1007/s10103-013-1376-4; Kim S, 2019, BIOMED OPT EXPRESS, V10, P2956, DOI 10.1364/BOE.10.002956; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kofman I, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.106009; Kunz Alexander, 2009, Handb Clin Neurol, V92, P283, DOI 10.1016/S0072-9752(08)01914-3; Li H, 2014, OPT EXPRESS, V22, P21079, DOI 10.1364/OE.22.021079; Li YY, 2016, OPT EXPRESS, V24, P8382, DOI 10.1364/OE.24.008382; Liu K., BIOMED OPT EXP, V12, P3571; Liu PY, 2014, NMR BIOMED, V27, P332, DOI 10.1002/nbm.3067; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu HY, 2015, OPT LETT, V40, P1193, DOI 10.1364/OL.40.001193; Luo ZC, 2009, OPT LETT, V34, P1480, DOI 10.1364/OL.34.001480; Madsen S. J., 2013, OPTICAL METHODS INST; Mantineo M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.098002; Mou YS, 2013, J NEUROSCI METH, V213, P1, DOI 10.1016/j.jneumeth.2012.11.006; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Ng Y.K., APPL INFRARED BIOMED, V1st, P201; Nguyen TTA, 2012, BIOMED OPT EXPRESS, V3, P1200, DOI 10.1364/BOE.3.001200; Parenti SI, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108002; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rahman S, 2016, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-016-0138-1; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Richardson J.T.E., 2002, CLIN NEUROPSYCHOLOGI, V2nd; Rodnitzky R.L., 1982, ARCH NEUROL-CHICAGO, V39, P675; Rold an M., SENSORS-BASEL, V21, P1581; Ruddock R.W., 2013, BASIC INFRARED THERM; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sankaran V, 2002, J BIOMED OPT, V7, P300, DOI 10.1117/1.1483318; Sato M, 2012, APPL OPTICS, V51, P1436, DOI 10.1364/AO.51.001436; Shi R, 2015, BIOMED OPT EXPRESS, V6, P1977, DOI 10.1364/BOE.6.001977; Singh A., 2013, J DENT MED SCI, V3, P75; Soleimanzad H, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.1.015008; Soukup J, 2007, ACTA ANAESTH SCAND, V51, P872, DOI 10.1111/j.1399-6576.2007.01356.x; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Sun ZB, 2015, J ELECTRON IMAGING, V24, DOI 10.1117/1.JEI.24.5.053006; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Thompson O, 2011, BIOMED OPT EXPRESS, V2, P1021, DOI 10.1364/BOE.2.001021; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Tichauer KM, 2009, J APPL PHYSIOL, V106, P1506, DOI 10.1152/japplphysiol.91156.2008; Tsao J.W., 2020, TRAUMATIC BRAIN INJU; Tuchin V.V., TISSUE OPTICS LIGHT, P200; Tuchin V. V., 2006, OPTICAL POLARIZATION; Vollmer M., 2010, INFRARED THERMAL IMA; Wan P, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.3.035007; Wang J, 2013, OPT LETT, V38, P3690, DOI 10.1364/OL.38.003690; Wang Y, 2017, OPT LETT, V42, P4655, DOI 10.1364/OL.42.004655; Wang Y, 2017, OPT LETT, V42, P57, DOI 10.1364/OL.42.000057; Weigl W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25351-6; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953; Wu Q., 2010, SPIE P, VV; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yang BC, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.201960117; Yang O, 2012, OPT LETT, V37, P3957, DOI 10.1364/OL.37.003957; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang LK, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17122811; Zhao MR, 2007, EPILEPSIA, V48, P2059, DOI 10.1111/j.1528-1167.2007.01229.x; Zheng C, 2018, BIOMED OPT EXPRESS, V9, P5962, DOI 10.1364/BOE.9.005962; Zheng YJ, 2009, LECT NOTES COMPUT SC, V5762, P852; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	114	0	0	10	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0030-3992	1879-2545		OPT LASER TECHNOL	Opt. Laser Technol.	JAN	2022	145								107506	10.1016/j.optlastec.2021.107506			13	Optics; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Physics	UR9KO	WOS:000697058900005		Bronze			2022-02-06	
J	Sia, RK; Ryan, DS; Brooks, DI; Kagemann, JM; Bower, KS; French, LM; Justin, GA; Colyer, MH				Sia, Rose K.; Ryan, Denise S.; Brooks, Daniel, I; Kagemann, Janice M.; Bower, Kraig S.; French, Louis M.; Justin, Grant A.; Colyer, Marcus H.			The Impact of Combat Ocular Trauma and Traumatic Brain Injury on Vision- and Health-Related Quality of Life Among US Military Casualties	MILITARY MEDICINE			English	Article							NEUROBEHAVIORAL SYMPTOM INVENTORY; VISUAL DYSFUNCTION; IRAQI; TBI; EYE	Purpose: The purpose of this study was to assess visual and health-related quality of life (QOL) among U.S. military service members who sustained combat ocular trauma (COT) with or without associated traumatic brain injury (TBI). Methods: This was a single-center, prospective observational study of U.S. service members (n= 88) with COT who were treated at Walter Reed National Military Medical Center. Participants completed the National Eye Institute Visual Function Questionnaire (VFQ-25) at enrollment and at follow-up (>1 year) and supplemental surveys: Neurobehavioral Symptom Inventory, the Medical Outcomes 36-item Short Form Survey (SF-36), and Mayo-Portland Adaptability Inventory. Results: Initial and follow-up VFQ-25 showed a statistically significant increase in median scores for near activities (initial: 75.0, follow-up 83.3; P=.004) and peripheral vision (initial: 50.0, follow-up: 75.0; P=.009) and in composite scores (initial: 79.5, follow-up: 79.8; P=.022). Comparing those who did (n= 78) and did not (n= 8) have a TBI history, there were no significant differences in median change in VFQ-25 composite scores (with TBI: 2.3 vs. no TBI: 10.7; P=.179). Participants with a TBI history had a significantly lower median SF-36 General Health score (with TBI: 67.5 vs. no TBI: 92.5; P=.009) Conclusions: Vision-related QOL of COT patients is generally good in the long term. However, those with both COT and a history of TBI conditions showed significantly worse functioning in several domains than those without TBI. As TBI is a common finding in COT, this association is an important factor impacting this population's overall clinical presentation and daily functions.	[Sia, Rose K.; Ryan, Denise S.] Ft Belvoir Community Hosp, Warfighter Refract Eye Surg Program, Ft Belvoir, VA 22060 USA; [Sia, Rose K.; Ryan, Denise S.] Ft Belvoir Community Hosp, Res Ctr Ft Belvoir, Ft Belvoir, VA 22060 USA; [Sia, Rose K.; Ryan, Denise S.; Kagemann, Janice M.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD 20817 USA; [Brooks, Daniel, I] Walter Reed Natl Mil Med Ctr, Dept Res Programs, Bethesda, MD 20889 USA; [Kagemann, Janice M.; Justin, Grant A.; Colyer, Marcus H.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Bower, Kraig S.] Johns Hopkins Univ, Wilmer Eye Inst, Lutherville Timonium, MD 21093 USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Justin, Grant A.; Colyer, Marcus H.] Walter Reed Natl Mil Med Ctr, Ophthalmol Serv, Bethesda, MD 20889 USA		Sia, RK (corresponding author), Ft Belvoir Community Hosp, Warfighter Refract Eye Surg Program, Ft Belvoir, VA 22060 USA.; Sia, RK (corresponding author), Ft Belvoir Community Hosp, Res Ctr Ft Belvoir, Ft Belvoir, VA 22060 USA.; Sia, RK (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD 20817 USA.			french, louis/0000-0002-9451-0604			Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Kondo T, 2013, OPHTHAL PLAST RECONS, V29, P51, DOI 10.1097/IOP.0b013e318275b754; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Malec JF, MAYO PORTLAND ADAPTA; Mangione CM, NATL EYE I 25 ITEM V; McLaughlin A, 2017, MIL MED, V182, P239, DOI 10.7205/MILMED-D-16-00139; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; O'Rourke J, 2019, J HEAD TRAUMA REHAB, V34, P30, DOI 10.1097/HTR.0000000000000405; RAND, 36 IT SHORT FORM SUR; Scott RAH, 2015, TRAUMA, V17, P83, DOI 10.1177/1460408614539621; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Steeves JKE, 2008, SPATIAL VISION, V21, P509, DOI 10.1163/156856808786451426; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Waid-Ebbs JK, 2020, ARCH PHYS MED REHAB, V101, P789, DOI 10.1016/j.apmr.2019.10.191; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033	27	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2022	187	1-2					209	215		10.1093/milmed/usab233			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YJ5CG	WOS:000744549200052	34117765				2022-02-06	
J	Sicard, V; Moore, RD				Sicard, Veronik; Moore, Robert Davis			The relation of learning disabilities to the long-term outcomes of concussion	PSYCHOLOGY OF SPORT AND EXERCISE			English	Article						Electrophysiological studies; Developmental and learning disabilities; Emotions; emotional processing; Executive functions; Head injury; Traumatic brain injury; Assessment	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; COGNITIVE CONTROL; DEVELOPMENTAL DYSLEXIA; PERSISTENT INFLUENCE; SPORT CONCUSSION; READING DISORDER; BASE-LINE; CHILDREN; MILD	Objective: This study sought to cross-sectionally evaluate the relation between learning disorders (LD) and longterm concussion outcomes. Method: Seventy-three asymptomatic male university athletes (23 history of concussion with LD; 24 history of concussion no LD; 26 controls) completed the Beck Depression Inventory-2 (BDI-II), the Profile of Mood States (POMS), the Cogstate battery, and an Oddball task during which event-related brain potentials were recorded. Results: Concussed athletes with LD exhibited greater depressive symptoms (BDI-II), greater total mood disturbance (POMS), decreased accuracy on the One-Card Learning and the N-back task (Cogstate), decreased accuracy on the Oddball task, and reduced ERN amplitude relative to both the concussed athletes without a LD and controls. Concussed athletes with LD also exhibited prolonged P3 latency relative to controls. Irrespective of LD, concussed athletes exhibited increased anger-hostility and decreased Pe amplitudes relative to controls. No differences were observed in P3a amplitude or latency. Conclusion: Having LD may be a significant factor moderating the neurophysiological, cognitive and psychoaffective outcomes of concussion, and may explain a significant portion of the persistent deficits observed by researchers and clinicians.	[Sicard, Veronik] Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, 921 Assembly St, Columbia, SC 29208 USA		Sicard, V (corresponding author), Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada.	vsicard@cheo.on.ca		Sicard, Veronik/0000-0003-2452-934X			American Psychiatric Association, 2003, DIAGN STAT MAN MENT; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT., 1996, BECK DEPRESSION INVE, pB9; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Burgio-Murphy A, 2007, BIOL PSYCHOL, V75, P75, DOI 10.1016/j.biopsycho.2006.12.003; Cantu R., 2012, CONCUSSIONS OUR KIDS; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Frank Y, 1998, CLIN ELECTROENCEPHAL, V29, P188, DOI 10.1177/155005949802900412; Gaddis SM, 2013, SOC SCI RES, V42, P1, DOI 10.1016/j.ssresearch.2012.08.002; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Horowitz-Kraus T, 2014, J LEARN DISABIL-US, V47, P208, DOI 10.1177/0022219412453084; Hudac CM, 2018, INT J PSYCHOPHYSIOL, V132, P135, DOI 10.1016/j.ijpsycho.2017.09.020; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maciejewska B, 2013, FOLIA PHONIATR LOGO, V65, P129, DOI 10.1159/000354167; Mahe G, 2014, CLIN NEUROPHYSIOL, V125, P69, DOI 10.1016/j.clinph.2013.06.005; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McNair DM, 1971, PROFILE MOOD STATES; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore R. D., 2015, BRAIN IMAGING BEHAV, DOI [10.1007/s11682-015-9473-6, DOI 10.1007/S11682-015-9473-6]; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Olvet DM, 2009, PSYCHOPHYSIOLOGY, V46, P957, DOI 10.1111/j.1469-8986.2009.00848.x; Olvet DM, 2009, BRAIN RES, V1284, P89, DOI 10.1016/j.brainres.2009.05.079; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pagani LS, 2020, AM J LIFESTYLE MED, V14, P187, DOI 10.1177/1559827618793350; Papagiannopoulou EA, 2017, ANN DYSLEXIA, V67, P99, DOI 10.1007/s11881-016-0122-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2012, RES Q EXERCISE SPORT, V83, P553; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Silver CH, 2008, ARCH CLIN NEUROPSYCH, V23, P217, DOI 10.1016/j.acn.2007.09.006; Taroyan NA, 2007, CLIN NEUROPHYSIOL, V118, P845, DOI 10.1016/j.clinph.2006.11.273; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Van De Voorde S, 2010, BIOL PSYCHOL, V84, P176, DOI 10.1016/j.biopsycho.2010.01.011; Wood H, 2015, NAT REV NEUROL, V11, P607, DOI [10.1038/nrneurol.2015.37, 10.1038/nrneurol.2015.148, 10.1038/nrneurol.2015.9, 10.1038/nrneurol.2015.105, 10.1038/nrneurol.2015.40, 10.1038/nrneurol.2015.204, 10.1038/nrneurol.2015.149, 10.1038/nrneurol.2015.205]; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	59	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1469-0292	1878-5476		PSYCHOL SPORT EXERC	Psychol. Sport Exerc.	JAN	2022	58								102101	10.1016/j.psychsport.2021.102101			9	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	XF4YS	WOS:000724078100003					2022-02-06	
J	Siedhoff, HR; Chen, S; Balderrama, A; Sun, GY; Koopmans, B; DePalma, RG; Cui, JK; Gu, ZZ				Siedhoff, Heather R.; Chen, Shanyan; Balderrama, Ashley; Sun, Grace Y.; Koopmans, Bastijn; DePalma, Ralph G.; Cui, Jiankun; Gu, Zezong			Long-Term Effects of Low-Intensity Blast Non-Inertial Brain Injury on Anxiety-Like Behaviors in Mice: Home-Cage Monitoring Assessments	NEUROTRAUMA REPORTS			English	Article						anxiety-like behaviors; home-cage monitoring; primary open-field blast; spontaneous activity		Mild traumatic brain injury induced by low-intensity blast (LIB) exposure poses concerns in military personnel. Using an open-field, non-inertial blast model and assessments by conventional behavioral tests, our previous studies revealed early-phase anxiety-like behaviors in LIB-exposed mice. However, the impact of LIB upon long-term anxiety-like behaviors requires clarification. This study applied a highly sensitive automated home-cage monitoring (HCM) system, which minimized human intervention and environmental changes, to assess anxiety-like responses in mice 3 months after LIB exposure. Initial assessment of 72-h spontaneous activities in a natural cage condition over multiple light and dark phases showed altered sheltering behaviors. LIB-exposed mice exhibited a subtle, but significantly decreased, duration of short shelter visits as compared to sham controls. Other measured responses between LIB-exposed mice and sham controls were insignificant. When behavioral assessments were performed in a challenged condition using an aversive spotlight, LIB-exposed mice demonstrated a significantly higher frequency of movements of shorter distance and duration per movement. Taken together, these findings demonstrated the presence of chronic anxiety-like behaviors assessed by the HCM system under both natural and challenged conditions in mice occurring post-LIB exposure. This model thus provides a platform to test for screening and interventions on anxiety disorders occurring after LIB non-inertial brain injury.	[Siedhoff, Heather R.; Chen, Shanyan; Balderrama, Ashley; Cui, Jiankun; Gu, Zezong] Harry S Truman Mem Vet Hosp Res Serv, Columbia, MO USA; [Siedhoff, Heather R.; Chen, Shanyan; Balderrama, Ashley; Cui, Jiankun; Gu, Zezong] Univ Missouri, Dept Pathol & Anat Sci, Sch Med, 1 Hosp Dr, Columbia, MO 65212 USA; [Sun, Grace Y.] Univ Missouri, Dept Biochem, Sch Med, Columbia, MO USA; [Koopmans, Bastijn] Sylics Synaptol BV, Bilthoven, Netherlands; [DePalma, Ralph G.] Res & Dev, Dept Vet Affairs, Washington, DC USA; [DePalma, Ralph G.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Gu, ZZ (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Sch Med, 1 Hosp Dr, Columbia, MO 65212 USA.	guze@health.missouri.edu			Department of Veterans Affairs Offices of Research & Development (VA ORD) the LAMb/ShEEP programsUS Department of Veterans Affairs; BLRD [UFR-002-18F, I01 BX004313-01A1]; DoD Congressionally Directed Medical Research Programs (CDMRP) [AZ180043]; University of Missouri	This publication was made possible, in part, by funding from the Department of Veterans Affairs Offices of Research & Development (VA ORD) the LAMb/ShEEP programs; the BLR&D Director Service program (UFR-002-18F), Open-Field Blast (OFB) Core, and the Collaborative Merit Review for TBI Research Program (I01 BX004313-01A1); as well as the DoD Congressionally Directed Medical Research Programs (CDMRP) for the Peer Reviewed Alzheimers Research Program Convergence Science Research Award (PRARP-CSRA; AZ180043) and the research funds of the University of Missouri (to Z.G.).	Aarts E, 2015, BEHAV BRAIN RES, V294, P123, DOI 10.1016/j.bbr.2015.06.011; Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Aravind A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00990; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Black DW, 2004, EPIDEMIOLOGY, V15, P135, DOI 10.1097/01.EDE.0000103188.18059.21; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Boutte AM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.6445; Cernak I., 2018, NEUROTRAUMA COMPREHE, P285; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Clemens L., 2014, P MEAS BEH 2014 WAG; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Defense and Veterans Brain Injury Center (DVBIC), 2021, TOT 2000 2021 Q2 DOD; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Engelbeen S, 2021, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.629043; Fatima S, 2013, FWU J SOC SCI, V7, P165; Gidron Y., 2013, ENCY BEHAV MED, P1989, DOI DOI 10.1007/978-1-4419-1005-9; Gilpin NW, 2015, BIOL PSYCHIAT, V77, P859, DOI 10.1016/j.biopsych.2014.09.008; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Grieco F, 2021, FRONT BEHAV NEUROSCI, V15, DOI 10.3389/fnbeh.2021.735387; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoffman AN, 2019, BEHAV PHARMACOL, V30, P115, DOI 10.1097/FBP.0000000000000461; Horikawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035727; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Logan S, 2018, GEROSCIENCE, V40, P123, DOI 10.1007/s11357-018-0019-x; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maroteaux G, 2012, GENES BRAIN BEHAV, V11, P772, DOI 10.1111/j.1601-183X.2012.00820.x; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Georgina G, 2021, J NEUROTRAUM, V38, P2030, DOI 10.1089/neu.2020.7398; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Phipps H, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.559318; Ratliff WA, 2019, EXP NEUROL, V315, P9, DOI 10.1016/j.expneurol.2019.01.020; Redfern WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181068; Richter SH, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00383; Robinson L, 2013, BEHAV BRAIN RES, V250, P148, DOI 10.1016/j.bbr.2013.04.041; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Rutter B, 2021, MIL MED, V186, P601, DOI 10.1093/milmed/usaa290; Saviola F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68008-z; Schindler AG, 2021, J NEUROTRAUM, V38, P940, DOI 10.1089/neu.2020.7061; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Song HL, 2018, NEURAL REGEN RES, V13, P1516, DOI 10.4103/1673-5374.237110; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Stuhmiller J.H., 1991, CONVENTIONAL WARFARE, P241; Voikar V, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.575434; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	53	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	JAN 1	2022	3	1					27	38		10.1089/neur.2021.0063			12	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YL1CF	WOS:000745636600001		gold			2022-02-06	
J	Skeel, R; Maffett, A; Feder, A; Mitzkovitz, C; Lesica, S				Skeel, Reid; Maffett, Anissa; Feder, Abigail; Mitzkovitz, Cayla; Lesica, Sofia			Youth Concussion Management Practices Among Athletic Trainers: A Vignette-Based Survey	JOURNAL OF SPORT REHABILITATION			English	Article						head; brain; recommendations; rest	SPORT-RELATED CONCUSSION; REST; SYMPTOMS; RETURN; PLAY; CARE	Context : Recovery protocols for treatment of sports concussion have received widespread adoption across the country. While stages of recovery and treatment are relatively clearly defined, there remains variability in implementation of specific recommendations, particularly regarding activities that constitute rest during stages calling for limitations on activity participation. Specific recommendations being employed by practitioners have not been previously assessed. In an aim to document current concussion management practices in the field, athletic trainers were surveyed regarding how activities that may constitute rest are utilized and defined. Design: The study was based on a cross-sectional vignette-based survey. Methods: The sample used was a geographically representative convenience sample of United States-based high school athletic trainers. E-mails were sent to 2146 potential survey respondents yielding a final sample of 226 athletic trainers. Data were gathered for questions concerning recommendations for follow-up care and rest based on provided vignettes, factors considered when developing recommendations, and differences in recommendations associated with varying symptom presentations. The percentage of practitioners that would utilize each potential recommendation was used to characterize results. Results: Participants demonstrated consensus on the importance of physical and cognitive rest as well as school accommodations (all greater than 97% endorsement). Greater variability was present for recommendations regarding pain medication for headache, repeating baseline cognitive testing, and engaging in subsymptom threshold activities. Recommendations for attending but not participating in games and practice yielded conflicting information. Conclusions: Responses indicated general consensus regarding factors considered when making recommendations. There was also consensus regarding general recommendations for activity limitation following recovery with almost all participants strongly recommending cognitive and physical rest, in accordance with consensus guidelines. However, substantial differences were found for specific activities that should be limited or encouraged following youth concussion. Further research concerning the relationship between community and social interaction and clinical outcomes after concussion is warranted.	[Skeel, Reid; Maffett, Anissa; Feder, Abigail; Mitzkovitz, Cayla; Lesica, Sofia] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA		Skeel, R (corresponding author), Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA.	reid.skeel@cmich.edu					Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Craton N, 2014, CURR SPORT MED REP, V13, P201, DOI 10.1249/JSR.0000000000000072; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hang B, 2019, CLIN PEDIATR EMERG M, V20, P71; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00362; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2019, J HEAD TRAUMA REHAB, V34, pE40, DOI 10.1097/HTR.0000000000000474; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	28	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2022	31	1					69	76		10.1123/jsr.2021-0068			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	YB1OA	WOS:000738789300010	34564069				2022-02-06	
J	Smith, AD; Teague, AJ; Naik, A; Janbahan, M; Smith, EJ; Krist, DT; Parupalli, S; Teal, K; Hassaneen, W				Smith, Alexander D.; Teague, Alexander J.; Naik, Anant; Janbahan, Mika; Smith, Emily J.; Krist, David T.; Parupalli, Sindhu; Teal, Kevin; Hassaneen, Wael			Robotic external ventricular drain placement for acute neurosurgical care in low-resource settings: feasibility considerations and a prototype design	NEUROSURGICAL FOCUS			English	Article						neurosurgical navigation; global health; inexpensive robot; external ventricular drain; traumatic brain injury; hydrocephalus	HYDROCEPHALUS; ACCURACY; GUIDANCE	OBJECTIVE Emergency neurosurgical care in lower-middle-income countries faces pronounced shortages in neurosurgical personnel and infrastructure. In instances of traumatic brain injury (TBI), hydrocephalus, and subarachnoid hemorrhage, the timely placement of external ventricular drains (EVDs) strongly dictates prognosis and can provide necessary stabilization before transfer to a higher-level center of care that has access to neurosurgery. Accordingly, the authors have developed an inexpensive and portable robotic navigation tool to allow surgeons who do not have explicit neurosurgical training to place EVDs. In this article, the authors aimed to highlight income disparities in neurosurgical care, evaluate access to CT imaging around the world, and introduce a novel, inexpensive robotic navigation tool for EVD placement. METHODS By combining the worldwide distribution of neurosurgeons, CT scanners, and gross domestic product with the incidence of TBI, meningitis, and hydrocephalus, the authors identified regions and countries where development of an inexpensive, passive robotic navigation system would be most beneficial and feasible. A prototype of the robotic navigation system was constructed using encoders, 3D-printed components, machined parts, and a printed circuit board. RESULTS Global analysis showed Montenegro, Antigua and Barbuda, and Seychelles to be primary candidates for implementation and feasibility testing of the novel robotic navigation system. To validate the feasibility of the system for further development, its performance was analyzed through an accuracy study resulting in accuracy and repeatability within 1.53 +/- 2.50 mm (mean +/- 2 x SD, 95% CI). CONCLUSIONS By considering regions of the world that have a shortage of neurosurgeons and a high incidence of EVD placement, the authors were able to provide an analysis of where to prioritize the development of a robotic navigation system. Subsequently, a proof-of-principle prototype has been provided, with sufficient accuracy to target the ventricles for EVD placement.	[Smith, Alexander D.; Teague, Alexander J.; Naik, Anant; Janbahan, Mika; Smith, Emily J.; Krist, David T.; Parupalli, Sindhu; Teal, Kevin; Hassaneen, Wael] Univ Illinois, Carle Illinois Coll Med, Urbana, IL USA; [Teal, Kevin; Hassaneen, Wael] Carle Fdn Hosp, Neurosci Inst, Dept Neurol Surg, Urbana, IL USA		Hassaneen, W (corresponding author), Carle Fdn Hosp, Neurosci Inst, Urbana, IL 61801 USA.	wael.mostafa@carle.com			Innovation Pathway Grant from the Carle Illinois College of Medicine	This research was supported by an Innovation Pathway Grant from the Carle Illinois College of Medicine.	AlAzri A, 2017, ACTA NEUROCHIR, V159, P1399, DOI 10.1007/s00701-017-3201-5; [Anonymous], Global Neurosurgical Workforce Map-2016 World Neurosurgery Workforce; Bassan H, 2012, EUR J PAEDIATR NEURO, V16, P662, DOI 10.1016/j.ejpn.2012.04.002; Berry C, 2008, NEUROSURGERY, V62, P913, DOI 10.1227/01.neu.0000318177.95288.cb; CARDOZA JD, 1988, RADIOLOGY, V169, P711, DOI 10.1148/radiology.169.3.3055034; Chau CYC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091422; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dormont D, 2010, AM J NEURORADIOL, V31, P15, DOI 10.3174/ajnr.A1644; Dossani RH, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMvcm1805314; Easley CJ, 2009, LAB CHIP, V9, P1119, DOI 10.1039/b816575k; Eftekhar B, 2016, J NEUROSURG, V125, P754, DOI 10.3171/2015.6.JNS1588; Ellens NR, 2019, NEUROSURGERY, V84, P235, DOI 10.1093/neuros/nyy090; GDP by country, GDP COUNTRY; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Hricak H, 2021, LANCET ONCOL, V22, pE136, DOI 10.1016/S1470-2045(20)30751-8; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kimchi G, 2020, BRIT J NEUROSURG, V34, P470, DOI 10.1080/02688697.2020.1761292; Kuo MF, 2020, BIOMED J, V43, P268, DOI 10.1016/j.bj.2020.03.006; Lange F, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9081612; Lollis SS, 2008, J NEUROSURG, V108, P269, DOI 10.3171/JNS/2008/108/2/0269; Mansouri A, 2018, WORLD NEUROSURG, V117, pE679, DOI 10.1016/j.wneu.2018.06.111; Miller T., 2016, ENSURING ADEQUATE NE; Miyake S, 2020, ANAT SCI INT, V95, P564, DOI 10.1007/s12565-020-00545-z; Mukhopadhyay S, 2019, J NEUROSURG, V130, P1142, DOI 10.3171/2018.10.JNS171723; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Ojo OA, 2015, J NEUROSCI RURAL PRA, V6, P304, DOI 10.4103/0976-3147.158743; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Qalab A, 2016, J PAK MED ASSOC, V66, pS72; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P623, DOI 10.1016/j.jocn.2013.09.001; Schulz C, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/197364; Shibata Y, 2007, NEUROL SCI, V28, P87, DOI 10.1007/s10072-007-0792-2; Silverstein, 2016, ATLANTIC; South A, 2011, R J, V3, P35; Tariq A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17419; Tully HM, 2014, EUR J MED GENET, V57, P359, DOI 10.1016/j.ejmg.2014.06.002; Wilson TJ, 2013, J NEUROSURG, V119, P66, DOI 10.3171/2012.11.JNS111384; WONG WB, 1994, SPINE, V19, P1451, DOI 10.1097/00007632-199407000-00005; Zunt JR, 2018, LANCET NEUROL, V17, P1061, DOI 10.1016/S1474-4422(18)30387-9	40	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	JAN	2022	52	1								10.3171/2021.10.FOCUS21544			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YE1XP	WOS:000740923400005	34973667	gold			2022-02-06	
J	Spiteri, C; Williams, G; Kahn, M; Ponsford, J; McKay, A				Spiteri, Courtney; Williams, Gavin; Kahn, Michelle; Ponsford, Jennie; McKay, Adam			Factors Associated With Physical Therapy Engagement During the Period of Posttraumatic Amnesia	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						agitation; cognitive impairment; physical therapy; posttraumatic amnesia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; AGITATED BEHAVIOR; REHABILITATION; SCALE; PARTICIPATION; PHYSIOTHERAPY; RELIABILITY; STROKE; COGNITION	Background and Purpose: Physical therapy is important in the management of traumatic brain injury (TBI) and associated multi-trauma. Providing therapy during the posttraumatic amnesia (PTA) phase is challenging, given that hallmark features including confusion, amnesia, agitation, and fatigue may impede the person's ability to engage in and benefit from rehabilitation. To date, there is little empirical evidence to guide the provision of therapy during PTA. This observational study aimed to explore the frequency, duration, location, and engagement of physical therapy provision during PTA and the impact of cognition, agitation, and fatigue. Summary of Key Points: The majority of patients were found to meaningfully engage and participate in physical therapy for the majority of sessions. Only a small proportion were unable to participate in physical therapy. Patient refusal and fatigue were identified as the most prominent barriers to rehabilitation. Despite fatigue and agitation reaching clinical levels, therapy could still successfully proceed on most occasions. Recommendations for Clinical Practice: Physical therapy is feasible during the acute recovery stages after TBI. Current results support the notion that therapy should commence early to minimize secondary complications and promote the recovery of mobility. A patient-centered therapeutic model that tailors the therapeutic approach to meet the individual's current physical and fluctuating cognitive capabilities may be most suited for this population. Clinicians working with people after TBI need experience in understanding and managing the cognitive limitations and associated symptoms of PTA to optimize the provision of therapy. These findings could inform guidelines for the management of patients in PTA.	[Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Monash Univ, Clayton, Vic, Australia; [Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Williams, Gavin; Kahn, Michelle] Epworth Healthcare, Richmond, Vic, Australia; [Williams, Gavin] Univ Melbourne, Parkville, Vic, Australia		Spiteri, C (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	baxter@monash.edu					ABIKUS, 2007, EV BAS REC REH MOD S; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bernhardt J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006187.pub2; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Gosselink R, 2011, NETH J CRIT CARE, V15, P66; Hassett L., 2005, PHYSIOTHERAPY ACUTE; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Hellweg S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/768456; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lamontagne ME., 2016, INESSS ONF CLIN PRAC; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lindmark B., 2009, ADV PHYSIOTHER, V10, P138; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parker Ann, 2013, Curr Phys Med Rehabil Rep, V1, P307; Ponsford J., RETRAINING ACTIVITIE; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2021, J NEUROTRAUM, V38, P1060, DOI 10.1089/neu.2020.7299; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Pryor J, 2004, DISABIL REHABIL, V26, P974, DOI 10.1080/09638280410001702397; Raina KD, 2016, J HEAD TRAUMA REHAB, V31, pE41, DOI 10.1097/HTR.0000000000000196; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sommers J, 2015, CLIN REHABIL, V29, P1051, DOI 10.1177/0269215514567156; Spiteri C, 2021, ARCH PHYS MED REHAB, V102, P378, DOI 10.1016/j.apmr.2020.06.024; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2019, NEUROPSYCHOL REHABIL, V29, P1655, DOI 10.1080/09602011.2018.1441033; Turner-Stokes L., 2003, REHABILITATION FOLLO; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Williams G, 2016, GAIT POSTURE, V43, P265, DOI 10.1016/j.gaitpost.2015.10.009; Yen HC, 2020, NEUROREHAB NEURAL RE, V34, P72, DOI 10.1177/1545968319893294; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4	50	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JAN	2022	46	1			SI		41	49		10.1097/NPT.0000000000000380			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XR2IZ	WOS:000732061000007	34628437	Bronze			2022-02-06	
J	Stanbouly, D; Besmer, AV; Chuang, SK				Stanbouly, Dani; Besmer, Alexander, V; Chuang, Sung-Kiang			Exploring the Severity of Craniomaxillofacial Injuries From Horseback Riding	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniomaxillofacial trauma; horseback riding	EQUESTRIAN INJURIES; MANAGEMENT; PATTERNS	Purpose: The purpose of our study is to assess the severity of craniomaxillofacial injuries from horseback-riding accidents. Materials and Methods: This is a 20-year retrospective crosssectional study of the National Electronic Injury Surveillance System. Injuries from the activity of horseback-riding were included if they occurred in the craniomaxillofacial complex. Study predictors were derived from both patient and injury characteristics. The study outcome was the presence or absence (probability) of hospital admission from the emergency department. A multiple logistic regression model was created to model the odds of admission using all significant univariate predictors. Results: The final sample consisted of 6730 patients. The decrease in horseback riding injuries from 2000 to 2019 was significant (P = 0.042). The mean age of the sample was 27.80 years (range: 2-91 years). Gender-wise, females composed the majority of injured horseback riders (71.9%). Over two-thirds of the sample consisted of White patients (68.1%). Over three-fourths of the injuries occurred in the head (80.9%), rendering it the most frequently injured region of the craniomaxillofacial complex. The most common primary diagnoses were internal organ injury (40.2%). On univariate analysis, the admission rates were significantly associated with gender (P< 0.01), age group (P< 0.01), body part injured (P< 0.01), diagnosis (P< 0.01), location of injury (P< 0.01) and mechanism of injury (P< 0.05). Relative to young adults, children (odds ratio [OR], 1.579; 95% OR confidence interval [CI] [1.31, 1.91]; P< 0.01), adults (OR, 1.857; 95% OR CI [1.55, 2.22]; P< 0.01), and seniors (OR, 3.738; 95% ORCI [2.73, 5.12]; P < 0.01) were each independently associated with an increased odds of admission. Relative to the mouth, the head had 4.8 odds of admission (P< 0.01) and the face had 2.5 odds ofadmission (P < 0.01). Relative to contusions/abrasion, concussions (OR, 3.542; 95% OR CI [2.28, 5.49]; P < 0.01) and internal organ injuries (OR, 9.020; 95% OR CI [5.90, 13.79]; P< 0.01), lacerations (OR, 1.946; 95% ORCI [1.17, 3.24]; P< 0.05), and fractures (OR, 32.068; 95% ORCI [20.53, 50.09]; P< 0.01) were each independently associated with increased odds of admission relative to contusions. Direct trauma from a horse (OR, 1.422; 95% OR CI [1.06, 1.91]; P< 0.05) was associated with independently increased odds of admission relative to other injuries. Injuries that took place in a farm (OR, 1.617; 95% OR CI [1.25, 2.09]; P < 0.01) and a street (OR, 2.735; 95% OR CI [1.83, 4.09]; P < 0.01) were each independently associated with increased odds of admission. Finally, relative to females, males (OR, 1.374; 95% OR CI [1.20, 1.57]; P < 0.01) were independently associated with increased odds of admission. Conclusions: Many variables contribute to the chance of hospital admission from horseback riding. Fractures seem to be the leading risk factor for hospital admission, therefore, future study may look into how to reduce the incidence of fractures through the employment of more protective equipment than helmets for horseback riders.	[Stanbouly, Dani; Besmer, Alexander, V] Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA; [Chuang, Sung-Kiang] Univ Penn, Sch Dent Med, Dept Oral & Maxillofacial Surg, Philadelphia, PA USA; [Chuang, Sung-Kiang] Brockton Oral & Maxillofacial Surg Inc, Brockton, MA USA; [Chuang, Sung-Kiang] Good Samaritan Hosp, Dept Oral & Maxillofacial Surg, Brockton, MA USA; [Chuang, Sung-Kiang] Kaohsiung Med Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Kaohsiung, Taiwan		Stanbouly, D (corresponding author), Columbia Univ, Coll Dent Med, 630 West 168th St, New York, NY 10032 USA.	ds3840@cumc.columbia.edu					[Anonymous], 2020, FILEHORSEBACK RIDING; [Anonymous], CURRENT TRENDS INJUR; [Anonymous], 2019, NATL ELECT INJURY SU; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; Blomkvist AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189598; Braun TL, 2017, SEMIN PLAST SURG, V31, P73, DOI 10.1055/s-0037-1601381; Caglar E, 2006, DENT TRAUMATOL, V22, P287, DOI 10.1111/j.1600-9657.2005.00374.x; Camargo F, 2018, COGENT FOOD AGR, V4, DOI 10.1080/23311932.2018.1432168; Demontiero O, 2012, THER ADV MUSCULOSKEL, V4, P61, DOI 10.1177/1759720X11430858; Eckert V, 2011, CLIN J SPORT MED, V21, P353, DOI 10.1097/JSM.0b013e318221840f; Esmaeelinejad M, 2018, MAXILLOFACIAL FRACTU, P53, DOI [10.5772/intechopen.76166, DOI 10.5772/INTECHOPEN.76166]; Fearon JA, 1997, PLAST RECONSTR SURG, V100, P862, DOI 10.1097/00006534-199709001-00006; Lee RH, 1997, PLAST RECONSTR SURG, V99, P1544, DOI 10.1097/00006534-199705000-00012; MCMIKEN DF, 1990, EQUINE VET J, V22, P73, DOI 10.1111/j.2042-3306.1990.tb04214.x; Meredith L, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000398; Sahni R, 2007, VASC HEALTH RISK MAN, V3, P701; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN-FEB	2022	33	1					62	65		10.1097/SCS.0000000000008004			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XW2VB	WOS:000735482400031	34334745				2022-02-06	
J	Sun, XY; Hu, YT; Zhou, H; Wang, S; Zhou, C; Lin, L; Zhu, TY; Ge, J; Han, JJ; Zhou, Y; Jin, GL; Wang, YQ; Zu, J; Shi, HJ; Yang, XX; Zan, K; Wang, J; Hua, F				Sun, Xiaoyu; Hu, Yuting; Zhou, Hui; Wang, Shang; Zhou, Chao; Lin, Li; Zhu, Taiyang; Ge, Ji; Han, Jingjing; Zhou, Yan; Jin, Guoliang; Wang, Yuqiao; Zu, Jie; Shi, Hongjuan; Yang, Xingxing; Zan, Kun; Wang, Jun; Hua, Fang			Inhibition of progesterone receptor membrane component-1 exacerbates neonatal hypoxic-ischemic cerebral damage in male mice	EXPERIMENTAL NEUROLOGY			English	Article						Pgrmc1; Neonatal; Hypoxic-ischemic cerebral injury; Neurological function; Signaling pathway	TRAUMATIC BRAIN-INJURY; BINDING-PROTEIN 25-DX; EXPRESSION; PGRMC1; LOCALIZATION; PROTECTION; LEVEL	This study investigated the expression of progesterone receptor membrane component 1 (pgrmc1) in the brains of male and female mice, and the effect of inhibiting pgrmc1 on neonatal hypoxic-ischemic (HI) cerebral injury in male mice. A mouse model of neonatal HI brain injury was established, and AG205, a specific antagonist of pgrmc1, was injected into the left lateral cerebral ventricle 1 h before HI. Histological staining, behavior testing, Western blots, and quantitative PCR (qPCR) were employed to evaluate pgrmc1 expression, brain damage, neurological function, and molecular mechanisms. Results demonstrated that the mRNA and protein levels of pgrmc1 increased significantly in the cortex and hippocampus 72 h after HI without sex differences. The inhibition of pgrmc1 exacerbated the neonatal brain damage in the acute stage of HI in male mice as seen in the increase in brain water content, infarction area, and neuronal death. Inhibition of pgrmc1 also aggravated the neurological dysfunction and anxiety induced by HI brain injury. In addition, inhibition of pgrmc1 activated the NF-kB signaling and NF-Kappa B-mediated cytokines, and inhibited BDNF/PI3K/AKT pathway in the brains of the newborn HI mice. The results indicated that pgrmc1 inhibition exacerbated the brain damage in newborn male mice subjected to HI by activating I Kappa B alpha/NF Kappa B signaling and inhibiting BDNF/PI3K/Akt pathway.	[Sun, Xiaoyu; Hu, Yuting; Zhou, Hui; Wang, Shang; Zhou, Chao; Lin, Li; Zhu, Taiyang; Ge, Ji; Han, Jingjing; Zhou, Yan; Jin, Guoliang; Wang, Yuqiao; Zu, Jie; Shi, Hongjuan; Yang, Xingxing; Zan, Kun; Hua, Fang] Xuzhou Med Univ, Dept Neurol, Affiliated Hosp, 84 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China; [Hu, Yuting] Xuzhou Med Univ, Affiliated Hosp, Dept Rehabil Med, Xuzhou, Jiangsu, Peoples R China; [Sun, Xiaoyu] Nanjing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Nanjing, Peoples R China; [Wang, Jun] Xuzhou Med Univ, Affiliated Hosp, Dept Pediat, Xuzhou, Jiangsu, Peoples R China; [Zhou, Hui; Wang, Shang; Zhou, Chao; Lin, Li; Zhu, Taiyang; Ge, Ji; Han, Jingjing; Zhou, Yan; Jin, Guoliang; Wang, Yuqiao; Zu, Jie; Shi, Hongjuan; Yang, Xingxing; Zan, Kun; Hua, Fang] Xuzhou Med Univ, Inst Neurol Dis, Xuzhou, Jiangsu, Peoples R China		Hua, F (corresponding author), Xuzhou Med Univ, Dept Neurol, Affiliated Hosp, 84 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China.	huafang@xzhmu.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571469, 82171420]	This work was supported by National Nature Science Foundation of China to FH (81571469 and 82171420).	Allen RS, 2016, RESTOR NEUROL NEUROS, V34, P947, DOI 10.3233/RNN-160672; Allen RS, 2015, INVEST OPHTH VIS SCI, V56, P2880, DOI 10.1167/iovs.14-16070; Bali N, 2013, ENDOCRINOLOGY, V154, P2468, DOI 10.1210/en.2012-2109; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Ballot DE, 2020, SAMJ S AFR MED J, V110, P308, DOI 10.7196/SAMJ.2020.v110i4.14311; Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Cahill MA, 2017, BIOSCI TRENDS, V11, P179, DOI 10.5582/bst.2017.01009; Chang JH, 2016, J ETHNOPHARMACOL, V194, P1032, DOI 10.1016/j.jep.2016.11.005; Cippitelli A, 2017, BRAIN BEHAV IMMUN, V64, P320, DOI 10.1016/j.bbi.2017.02.001; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Dong SY, 2018, EXP NEUROL, V306, P190, DOI 10.1016/j.expneurol.2018.05.013; Fabres RB, 2020, CELL MOL NEUROBIOL, V40, P1417, DOI 10.1007/s10571-020-00827-0; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Guennoun R, 2008, BRAIN RES REV, V57, P493, DOI 10.1016/j.brainresrev.2007.05.009; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Hua F, 2009, BIOCHEM BIOPH RES CO, V390, P678, DOI 10.1016/j.bbrc.2009.10.027; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; Jackson ACW, 2016, J NEUROCHEM, V136, P63, DOI 10.1111/jnc.13388; Kawarai Y, 2018, ENDOCRINOLOGY, V159, P2264, DOI 10.1210/en.2018-00148; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Li XJ, 2014, EXP THER MED, V7, P1311, DOI 10.3892/etm.2014.1589; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Losel RM, 2008, STEROIDS, V73, P929, DOI 10.1016/j.steroids.2007.12.017; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Neubauer H, 2013, CLIMACTERIC, V16, P509, DOI 10.3109/13697137.2013.800038; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2019, BIOL REPROD, V100, P1571, DOI 10.1093/biolre/ioz043; Peluso JJ, 2018, REPRODUCTION, V156, P365, DOI 10.1530/REP-18-0155; Peluso JJ, 2012, ENDOCRINOLOGY, V153, P3929, DOI 10.1210/en.2011-2096; Petersen SL, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00164; Qin YB, 2015, J STEROID BIOCHEM, V154, P302, DOI 10.1016/j.jsbmb.2015.01.002; Sakamoto H, 2004, NEUROSCIENCE, V126, P325, DOI 10.1016/j.neuroscience.2004.04.003; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Simiyu IN, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0876-y; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Sun F, 2016, ENDOCRINOLOGY, V157, P2067, DOI 10.1210/en.2015-1610; Teakel SL, 2020, BIOCHEM BIOPH RES CO, V524, P64, DOI 10.1016/j.bbrc.2019.12.108; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XY, 2014, INT J NEUROSCI, V124, P42, DOI 10.3109/00207454.2013.817407; Willibald M, 2017, HORM METAB RES, V49, P595, DOI 10.1055/s-0043-113635; Wojcik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140536; Wu ZG, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117360; Zeng CB, 2016, MOL IMAGING BIOL, V18, P172, DOI 10.1007/s11307-015-0891-z; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhong Y, 2019, INT J MOL MED, V43, P294, DOI 10.3892/ijmm.2018.3933; Zhou C, 2019, AGING-US, V11, P7257, DOI 10.18632/aging.102260; Zhu XY, 2019, J STEROID BIOCHEM, V185, P90, DOI 10.1016/j.jsbmb.2018.07.014	50	0	0	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2022	347								113893	10.1016/j.expneurol.2021.113893			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WI8AJ	WOS:000708577900003	34653511	hybrid			2022-02-06	
J	Surtees, TL; Kumar, I; Garton, HJL; Rivas-Rodriguez, F; Parmar, H; McCaffery, H; Riebe-Rodgers, J; Shellhaas, RA				Surtees, Taryn-Leigh; Kumar, Ishani; Garton, Hugh J. L.; Rivas-Rodriguez, Francisco; Parmar, Hemant; McCaffery, Harlan; Riebe-Rodgers, Jane; Shellhaas, Renee A.			Levetiracetam Prophylaxis for Children Admitted With Traumatic Brain Injury	PEDIATRIC NEUROLOGY			English	Article						Pediatric; Traumatic brain injury; Seizure prophylaxis; Early posttraumatic seizure	EARLY POSTTRAUMATIC SEIZURES; HEAD-INJURY; PREVENTION; PHENYTOIN; MODERATE; TRIAL	Background: Prophylactic antiseizure medications (ASMs) for pediatric traumatic brain injury (TBI) are understudied. We evaluated clinical and radiographic features that inform prescription of ASMs for pediatric TBI. We hypothesized that despite a lack of evidence, levetiracetam is the preferred prophylactic ASM but that prophylaxis is inconsistently prescribed. Methods: This retrospective study assessed children admitted with TBI from January 1, 2017, to December 31, 2019. TBI severity was defined using Glasgow Coma Scale (GCS) scores. Two independent neuroradiologists reviewed initial head computed tomography and brain magnetic resonance imaging. Fisher exact tests and descriptive and regression analyses were conducted. Results: Among 167 children with TBI, 44 (26%) received ASM prophylaxis. All 44 (100%) received levetiracetam. Prophylaxis was more commonly prescribed for younger children, those with neurosurgical intervention, and abnormal neuroimaging (particularly intraparenchymal hematoma) (odds ratio = 10.3, confidence interval 1.8 to 58.9), or GCS <= 12. Six children (13.6%), all on ASM, developed early post-traumatic seizures (EPTSs). Of children with GCS <= 12, four of 17 (23.5%) on levetiracetam prophylaxis developed EPTSs, higher than the reported rate for phenytoin. Conclusions: Although some studies suggest it may be inferior to phenytoin, levetiracetam was exclusively used for EPTS prophylaxis. Intraparenchymal hematoma >1 cm was the single neuroimaging feature associated with ASM prophylaxis regardless of the GCS score. Yet these trends are not equivalent to optimal evidence-based management. We still observed important variability in neuroimaging characteristics and TBI severity for children on prophylaxis. Thus, further study of ASM prophylaxis and prevention of pediatric EPTSs is warranted. (C) 2021 Elsevier Inc. All rights reserved.	[Surtees, Taryn-Leigh] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Kumar, Ishani; McCaffery, Harlan; Riebe-Rodgers, Jane; Shellhaas, Renee A.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Garton, Hugh J. L.] Univ Michigan, Neurosurg, Ann Arbor, MI 48109 USA; [Rivas-Rodriguez, Francisco; Parmar, Hemant] Univ Michigan, Radiol, Ann Arbor, MI 48109 USA		Surtees, TL (corresponding author), Washington Univ, Sch Med, Pediat Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	tarynsurtees@gmail.com		Shellhaas, Renee/0000-0002-3175-3908; Parmar, Hemant/0000-0002-1274-7617	Charles Woodson Pediatric Research Fund at the of of Pediatrics	This research was supported by the Charles Woodson Pediatric Research Fund at the of of Pediatrics.	Abbreviated Injury Scale (AIS), 2019, ABBR INJ SCAL AIS; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Kolf Meghan J, 2020, J Pediatr Pharmacol Ther, V25, P241, DOI 10.5863/1551-6776-25.3.241; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ostahowski PJ, 2016, J NEUROSURG-PEDIATR, V18, P499, DOI 10.3171/2016.4.PEDS1698; Pearl PL, 2013, EPILEPSIA, V54, pe135, DOI 10.1111/epi.12326; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Shellhaas RA, 2017, PEDIATR NEUROL, V75, P73, DOI 10.1016/j.pediatrneurol.2017.06.011; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wright C, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00192; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	21	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	JAN	2022	126						114	119		10.1016/j.pediatrneurol.2021.10.009			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	YJ0KC	WOS:000744227200003	34839268				2022-02-06	
J	Takao, H; Watanabe, D; Tani, S; Ohashi, H; Ishibashi, T; Takeshita, K; Murakami, S; Nishimoto, T; Yuge, K; Karagiozov, K; Abe, T; Murayama, Y				Takao, Hiroyuki; Watanabe, Dai; Tani, Satoshi; Ohashi, Hiroki; Ishibashi, Toshihiro; Takeshita, Kohei; Murakami, Shigeyuki; Nishimoto, Tetsuya; Yuge, Kohei; Karagiozov, Kostadin; Abe, Toshiaki; Murayama, Yuichi			Use of a Simulation Model to Investigate the Mechanisms of Sports-related Head Injuries	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						sports head injury; head injury simulation; concussion		A simulation model was developed to better understand the mechanisms of brain injuries in sports. A three-dimensional model comprising approximately 1.22 million elements was constructed from cranial computed tomography images of adult male volunteers by the voxel method. To simulate contact sports that permit actions such as tackling, a sinusoidal wave with duration of 10 ms and maximum acceleration of 2000 m/s(2) was applied to the lowest point of the model to apply rotational acceleration to the head from different directions. The von Mises stress was then observed at five points in the coronal plane of the brain: cingulate gyrus (CG), corpus callosum (CC), brain stem (BS), lateral temporal lobe (LT), and medial temporal lobe (MT). LS-DYNA universal finite element analysis software with explicit time integration was used for the analysis. Concentrations of stress started to appear in the CC and BS at 10 ms post-impact, after which they also became evident in the CG and MT. The maximum changes in stress at each location occurred 10-15 ms post-impact. The von Mises stress was 9-14 kPa in the CG, 8-24 kPa in the CC, 12-24 kPa in the BS, 7-12 kPa in the LT, and 12-18 kPa in the MT. The highest stress in every part of the brain occurred after lateral impact, followed by oblique impact and sagittal impact. Such simulations may help elucidate the mechanisms of brain injuries in sports and help develop measures to prevent chronic traumatic encephalopathy.	[Takao, Hiroyuki; Tani, Satoshi; Ohashi, Hiroki; Ishibashi, Toshihiro; Karagiozov, Kostadin; Abe, Toshiaki; Murayama, Yuichi] Jikei Univ, Dept Neurosurg, Sch Med, Tokyo, Japan; [Takao, Hiroyuki; Takeshita, Kohei] Jikei Univ, Dept Innovat Med Informat Technol, Sch Med, Tokyo, Japan; [Watanabe, Dai] Shibaura Inst Technol, Dept Syst Engn & Sci, Tokyo, Japan; [Murakami, Shigeyuki] Murakami Clin, Dept Neurosurg, Tokyo, Japan; [Nishimoto, Tetsuya] Nihon Univ, Coll Engn, Biomechan Res Unit, Koriyama, Fukushima, Japan; [Yuge, Kohei] Seikei Univ, Fac Sci & Technol, Musashino, Tokyo, Japan		Takao, H (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, Div Endovasc Neurosurg,Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	takao@jikei.ac.jp						0	0	0	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2022	62	1					13	18		10.2176/nmc.oa.2021-0149			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YI5FK	WOS:000743873200001	34645717	gold, Green Accepted			2022-02-06	
J	Tanenbaum, Z; Prasad, N; Bhardwaj, P; Welschmeyer, A; Harley, EH				Tanenbaum, Zachary; Prasad, Navin; Bhardwaj, Priya; Welschmeyer, Alexandra; Harley, Earl H.			Fireworks Injuries to the Head and Neck: A Retrospective Analysis Between 2008 and 2017	JOURNAL OF BURN CARE & RESEARCH			English	Article							CHILDREN	This study examines firework-associated head and neck injuries in the United States from 2008 to 2017 obtained from a single epidemiology source. The National Electronic Injury Surveillance System (NEISS) was used to collect epidemiologic data and retrospectively analyze firework-associated injuries from 2008 to 2017. Injury types included burns, concussions, contusions, foreign bodies, hematomas, internal organ injury, lacerations, and puncture wounds. Four hundred and thirty-one individuals were originally included; however, 14 participants were excluded due to inadequate injury information. Chi-squared analyses were performed between the following categorical variables: gender vs body part injured, patient age vs injury type, and patient age vs body part injured. About 417 injuries to the head and neck (67.4% male, 32.6% female) were treated in NEISS-reporting emergency departments during the 10-year period. Sixty-nine percent of the injuries occurred in July. Body parts injured included the ear (10.6%), face (61.6%), head (13.0%), mouth (4.8%), and neck (10.0%). Chi-squared analysis demonstrated an association between gender and body part injured (P = .0001). Patient age (P = .066) was independent of injury type. Children aged 0 to 12 years had the highest probability of being injured (40.2%), then adults 22 and older (33.1%) and adolescents 13 to 21 years (26.9%). Given that the preponderance of injuries caused by fireworks occurred primarily in minors, pediatricians should screen for any household firework use during the anticipatory guidance portion of well-child checks, which we believe would improve patient safety and decrease injury rates.	[Tanenbaum, Zachary; Prasad, Navin; Bhardwaj, Priya; Welschmeyer, Alexandra; Harley, Earl H.] Georgetown Univ, Sch Med, Washington, DC USA; [Harley, Earl H.] MedStar Georgetown Univ Hosp, Dept Otolaryngol, 3800 Reservoir Rd NW,Gorman Bldg,1st Floor, Washington, DC 20007 USA		Harley, EH (corresponding author), MedStar Georgetown Univ Hosp, Dept Otolaryngol, 3800 Reservoir Rd NW,Gorman Bldg,1st Floor, Washington, DC 20007 USA.	harleye@gunet.georgetown.edu		Tanenbaum, Zachary/0000-0002-3072-8719			Alinia Siros, 2013, J Inj Violence Res, V5, P11, DOI 10.5249/jivr.v5i1.146; Billock RM, 2017, CLIN PEDIATR, V56, P535, DOI 10.1177/0009922816664063; Conover K, 2018, PEDIATR ANN, V47, pE112, DOI 10.3928/19382359-20180220-02; Dandu KV, 2017, OTOLARYNG HEAD NECK, V156, P853, DOI 10.1177/0194599817695546; Di Benedetto GM, 2009, PLAST RECONSTR SURG, V124, p172E, DOI 10.1097/PRS.0b013e3181a83a30; Frimmel S, 2017, KLIN MONATSBL AUGENH, V234, P611, DOI 10.1055/s-0042-123515; John D, 2015, INDIAN J OPHTHALMOL, V63, P843, DOI 10.4103/0301-4738.171966; Mehta NK, 2020, FACIAL PLAST SURG, V36, P659, DOI 10.1055/s-0040-1714116; Moore JX, 2014, INJURY, V45, P1704, DOI 10.1016/j.injury.2014.06.024; Myers J, 2017, J BURN CARE RES, V38, pE79, DOI 10.1097/BCR.0000000000000435; Puri V, 2009, J PLAST RECONSTR AES, V62, P1103, DOI 10.1016/j.bjps.2007.12.080; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Smittenberg MN, 2010, SAMJ S AFR MED J, V100, P525, DOI 10.7196/SAMJ.3964; Tu Y, 2019, 1 US CONS PROD SAF C, P1; United States Census Bureau, 2018, ANN EST RES POP SEL; US Census Bureau, US CENS BUR QUICKF; US Consumer Product Safety Commission, 2019, NATL EL INJ SURV SYS; Vassilia K, 2004, BURNS, V30, P151, DOI 10.1016/j.burns.2003.09.019; WILSON RS, 1982, OPHTHALMOLOGY, V89, P291; Witsaman RJ, 2006, PEDIATRICS, V118, P296, DOI 10.1542/peds.2006-0790; Xie PP, 2020, EUR ARCH OTO-RHINO-L, V277, P453, DOI 10.1007/s00405-019-05710-3; Yasmeh S, 2018, AM J EMERG MED, V36, P897, DOI 10.1016/j.ajem.2017.09.040; Ying SY, 2001, BURNS, V27, P39, DOI 10.1016/S0305-4179(00)00062-0	23	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	JAN-FEB	2022	43	1					202	206		10.1093/jbcr/irab133			5	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	YI7EI	WOS:000744007600027	34363657				2022-02-06	
J	Taylor, A; Martinez-Quinones, P; Huang, E; Robinson, T; White, CQ				Taylor, Ashley; Martinez-Quinones, Patricia; Huang, Ellen; Robinson, Tim; White, Cassandra Q.			Effective use of weight-based enoxaparin for deep vein thrombosis chemoprophylaxis in patients with traumatic brain injury	AMERICAN JOURNAL OF SURGERY			English	Article						Weight-based enoxaparin; Anti-factor xa; Venous thromboembolism; Chemoprophylaxis; Traumatic brain injury	VENOUS THROMBOEMBOLISM PROPHYLAXIS; CRITICALLY-ILL TRAUMA; XA LEVELS; RISK; ANTICOAGULATION; PREVENTION; GUIDELINES; MANAGEMENT; SAFETY	Background: Enoxaparin is the recommended agent for deep vein thrombosis (DVT) chemoprophylaxis in trauma patients. Current literature suggests weight-based dosing is superior to standard dosing for adequate chemoprophylaxis. Literature regarding the use of weight-based enoxaparin in the setting of traumatic brain injury ( TBI) however is limited. Methods: A retrospective analysis of adult trauma patients admitted between January 1, 2018 to February 28, 2019 was performed. Sixty-six patients with TBI receiving weight-based enoxaparin met inclusion criteria. Incidence of intracranial hemorrhage (ICH) expansion was the primary endpoint. Newly diagnosed venous thromboembolism (VTE) and death were secondary endpoints. Results: Two patients, out of sixty-six, had progression of their TBI requiring surgical intervention. Newly diagnosed VTE occurred in one patient. No deaths were due to ICH expansion or VTE. Conclusions: Use of weight-based enoxaparin dosing in the setting of TBI shows promise without an increased incidence of ICH expansion when compared to other studies. Level of Evidence and Study Type: Level IV, Therapeutic. (C) 2021 Elsevier Inc. All rights reserved.	[White, Cassandra Q.] Augusta Univ, Dept Surg, Div Trauma Surg Crit Care, 1120 15th St,BB-4415, Augusta, GA 30912 USA; [Martinez-Quinones, Patricia] Augusta Univ, Dept Surg, 1120 15th St,BI-4072, Augusta, GA 30912 USA; [Taylor, Ashley; Huang, Ellen; Robinson, Tim] Augusta Univ, Med Ctr, Dept Pharm, 1120 15th St, Augusta, GA 30912 USA		White, CQ (corresponding author), Augusta Univ, Dept Surg, Div Trauma Surg Crit Care, 1120 15th St,BB-4415, Augusta, GA 30912 USA.	ataylor8@augusta.edu; pmartinezquinon@augusta.edu; ehuang@augusta.edu; tirobinson@augusta.edu; caswhite@augusta.edu					Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Baharvahdat Humain, 2019, Surg Neurol Int, V10, P10, DOI 10.4103/sni.sni_112_18; Buesing KL, 2015, SURG CLIN N AM, V95, P285, DOI 10.1016/j.suc.2014.11.005; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Costantini TW, 2013, J TRAUMA ACUTE CARE, V74, P128, DOI 10.1097/TA.0b013e3182788fa7; Dorffler-Melly J, 2002, LANCET, V359, P849, DOI 10.1016/S0140-6736(02)07920-5; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Guyatt GH, 2012, CHEST, V141, pE185S, DOI 10.1378/chest.11-2289; Haas CE, 2005, J TRAUMA, V59, P1336, DOI 10.1097/01.ta.0000197354.69796.bd; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; Mayr AJ, 2002, THROMB RES, V105, P201, DOI 10.1016/S0049-3848(02)00028-2; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Nunez JM, 2015, AM SURGEON, V81, P605; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Priglinger U, 2003, CRIT CARE MED, V31, P1405, DOI 10.1097/01.CCM.0000059725.60509.A0; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Singer GA, 2016, J TRAUMA ACUTE CARE, V81, P1101, DOI 10.1097/TA.0000000000001193; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021; Yogaratnam D, 2004, PHARMACOTHERAPY, V24, P1793, DOI 10.1592/phco.24.17.1793.52344	26	0	0	1	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2022	223	1					146	150		10.1016/j.amjsurg.2021.07.030			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XQ6JZ	WOS:000731653700026	34340862				2022-02-06	
J	Taylor, SC; Ondruschka, B; Kieser, DC; Hammer, N; Lee, M; Hooper, GJ; Kranioti, E				Taylor, Seth C.; Ondruschka, Benjamin; Kieser, David C.; Hammer, Niels; Lee, Matthew; Hooper, Gary J.; Kranioti, Elena			Ballistic trauma caused by military rifles: experimental study based on synthetic skull proxies	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article; Early Access						Military rifles; Gunshot wound head trauma; Synbone (R); Ballistic simulations; Experiments	BRAIN MODEL; BONE; GUNSHOT; TISSUE	Rifles are often involved in violent deaths such as homicide and suicide. Consequently, expert knowledge and experimental forensic investigations are important to clarify the nature of ballistic trauma when applied to the human head and neurocranium. This study investigated differences in entrance wound morphology with Synbone (R) spheres which are described as being comparable to human flat bones. A series of ballistic experiments were conducted using two different rifle calibers (5.56 x 45 mm and 7.62 x 39 mm Full Metal Jacket (FMJ)). Synbone (R) spheres were used for close-range 0.3 m simulated executions as well as at 25 m and 35 m to simulate urban and military engagements. Results were compared with previously published experimental studies using similar military ammunition. In our study, entry wound morphology closely resembles real forensic cases compared to exit wound and overall shape morphology independently of the distance and the caliber. Circumferential delamination was clearly visible with full metal jacket (FMJ) rounds, yielding similar damage pattern morphology to the human crania. This study documented the presence of hydraulic burst or shock in all ten rounds from all three distances. Kronlein shots were also observed in some cases. Synbone (R) spheres constitute an acceptable synthetic surrogate for ballistic experiments. The present study offers new initial data on the behavior of Synbone (R) proxies in ballistic testing of military ammunitions; FMJ gunshot injuries to the human head, for distances that have not previously been published, suggesting that efficient tests can take place under these conditions. Further research on experimental ballistics with a larger number of controlled factors and multiple repetitions is recommended to verify the results of this pilot study before applied in forensic simulations.	[Taylor, Seth C.; Kieser, David C.; Hooper, Gary J.] Univ Otago, Dept Orthopaed & Musculoskeletal Med, Christchurch, New Zealand; [Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Hamburg, Germany; [Hammer, Niels] Med Univ Graz, Dept Macroscop & Clin Anat, Graz, Austria; [Hammer, Niels] Univ Hosp Leipzig, Dept Trauma Orthoped & Plast Surg, Leipzig, Germany; [Hammer, Niels] Fraunhofer Inst Machine Tools & Forming Technol, Dresden, Germany; [Lee, Matthew; Kranioti, Elena] Univ Crete, Med Sch, Dept Forens Sci, Forens Med Unit, Iraklion, Greece		Taylor, SC (corresponding author), Univ Otago, Dept Orthopaed & Musculoskeletal Med, Christchurch, New Zealand.	22sethtaylor@gmail.com		Taylor, Seth/0000-0003-1457-9335	University of Otago	University of Otago.	[Anonymous], CBS NEWS; [Anonymous], 2020, AMM WOLF STEEL CAS A; [Anonymous], 2020, CONFL ARM RES; Aspects B., 2005, FORENSIC NEUROPATHOL, P151; Bir C, 2016, FORENSIC SCI INT, V261, P1, DOI 10.1016/j.forsciint.2016.01.023; Cdc.gov, 2020, FASTSTATS; Dettmeyer RB, 2014, FORENSIC MED, P155; Di Maio VJM, 1999, GUNSHOT WOUNDS PRACT; Fragkouli K, 2018, J FORENSIC LEG MED, V53, P1, DOI 10.1016/j.jflm.2017.10.004; Hejna P, 2011, INT J LEGAL MED, V125, P587, DOI 10.1007/s00414-011-0553-x; Henwood BJ, 2020, J MATER SCI, V55, P3022, DOI 10.1007/s10853-019-04231-y; HUELKE DF, 1967, AM J ANAT, V120, P123, DOI 10.1002/aja.1001200110; Hwang K, 1999, J CRANIOFAC SURG, V10, P395, DOI 10.1097/00001665-199909000-00004; Kimmerle EH, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P1, DOI 10.1201/9781420009118; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P87; Kneubuehl BP, 2003, FORENSIC SCI INT, V138, P44, DOI 10.1016/j.forsciint.2003.08.003; Mahoney P, 2019, INT J LEGAL MED, V133, P163, DOI 10.1007/s00414-018-1832-6; Mahoney P, 2019, INT J LEGAL MED, V133, P151, DOI 10.1007/s00414-018-1802-z; Ondruschka Benjamin, 2016, Arch Kriminol, V238, P207; Ruchonnet A, 2019, FORENSIC SCI INT, V301, P350, DOI 10.1016/j.forsciint.2019.05.051; Simpson E, 2002, AM J PHYS ANTHROPOL, V118, P121, DOI 10.1002/ajpa.10073; Smith MJ, 2015, LEGAL MED-TOKYO, V17, P427, DOI 10.1016/j.legalmed.2015.06.007; Taylor SC, 2020, BMJ MIL HEAL; Taylor Seth C, 2020, BMJ Mil Health, DOI 10.1136/bmjmilitary-2019-001369; Taylor SC, 2018, FORENSIC SCI INT, V282, P157, DOI 10.1016/j.forsciint.2017.11.032; Thali MJ, 2002, AM J FOREN MED PATH, V23, P223, DOI 10.1097/00000433-200209000-00003; Thali MJ, 2002, FORENSIC SCI INT, V125, P190, DOI 10.1016/S0379-0738(01)00638-7; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Torimitsu S, 2015, FORENSIC SCI INT, V252, DOI 10.1016/j.forsciint.2015.04.029	29	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.												10.1007/s12024-021-00432-7		JAN 2022	7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	XY4EZ	WOS:000736929200001	34973121	hybrid			2022-02-06	
J	Terry, DP; Jurick, SM; Huebschmann, NA; Silverberg, ND; Maxwell, BA; Zafonte, R; Berkner, PD; Iverson, GL				Terry, Douglas P.; Jurick, Sarah M.; Huebschmann, Nathan A.; Silverberg, Noah D.; Maxwell, Bruce A.; Zafonte, Ross; Berkner, Paul D.; Iverson, Grant L.			Sleep Insufficiency and Baseline Preseason Concussion-Like Symptom Reporting in Youth Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						athletes; sleep; sleep deprivation; cognition; brain concussion	POSTCONCUSSION-LIKE SYMPTOMS; LIFE-STYLE FACTORS; HIGH-SCHOOL; POSITION STATEMENT; GENDER-DIFFERENCES; RESTRICTION; ADOLESCENTS; PERFORMANCE; ASSOCIATION; SEX	Objective: To examine the association between insufficient sleep and baseline symptom reporting in healthy student athletes. Design: Cross-sectional cohort study. Setting: Preseason testing for student athletes. Participants: Student athletes (n = 19 529) aged 13 to 19 years who completed the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), including the number of hours slept the night before, and denied having developmental/health conditions, a concussion in the past 6 months, and a previous history of 2 or more concussions. Independent Variables: Total hours of sleep the night before testing (grouped by <= 5, 5.5-6.5, 7-8.5, and >= 9 hours), gender, and concussion history. Main Outcome Measures: Symptom burden on the Post-Concussion Symptom Scale (modified to exclude sleep-related items), cognitive composite scores, and prevalence of athletes who reported a symptom burden resembling the International Classification of Diseases, 10th Revision (ICD-10) diagnosis of postconcussional syndrome (PCS). Results: Fewer hours of sleep, gender (ie, girls), and 1 previous concussion (vs 0) were each significantly associated with higher total symptom scores in a multivariable model (F = 142.01, P < 0.001, R-2 = 0.04). When a gender-by-sleep interaction term was included, the relationship between sleep and symptoms was stronger for girls compared with boys. In healthy athletes who slept <= 5 hours, 46% of girls and 31% of boys met the criteria for ICD-10 PCS compared with 16% of girls and 11% of boys who slept >= 9 hours. Sleep duration was not meaningfully associated with neurocognitive performance. Conclusions: Insufficient sleep the night before testing is an important factor to consider when interpreting symptom reporting, especially for girls. It will be helpful for clinicians to take this into account when interpreting both baseline and postinjury symptom reporting.	[Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Terry, Douglas P.; Huebschmann, Nathan A.; Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Terry, Douglas P.; Zafonte, Ross; Iverson, Grant L.] A Red Sox Fdn & Massachusetts Gen Hosp Program, Home Base, Charlestown, MA USA; [Jurick, Sarah M.] VA San Diego Healthcare Syst, Dept Psychol, San Diego, CA USA; [Jurick, Sarah M.] Univ Calif San Diego, Dept Psychiat, La Jolla Village Dr, San Diego, CA 92103 USA; [Huebschmann, Nathan A.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabilitat Hosp, Massachusetts Gen Hosp,Brigham & Womens Hosp, Boston, MA 02115 USA; [Berkner, Paul D.] Univ New England, Coll Osteopath Med, Biddeford, ME USA; [Iverson, Grant L.] Spaulding Rehabil Hosp & Spaulding Res Inst, Charlestown, MA USA		Terry, DP (corresponding author), Ctr Hlth & Rehabil Res, 79-96 13th St, Charlestown, MA 02129 USA.	dterry@mgh.harvard.edu			Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	The data were gathered as part of the Maine Concussion Management Initiative (MCMI) under the direction of the principal investigator Dr P. D. Berkner. The authors thank the Maine Athletic Trainers' Association for its collaboration with the MCMI. G. L. Iverson, PhD, acknowledges unrestricted philanthropic support from ImPACT Applications, Inc, the Mooney-Reed Charitable Foundation, National Rugby League, Boston Bolts, Heinz Family Foundation, and Spaulding Research Institute. Dr Noah Silverberg acknowledges research salary support from a Health Professional Investigator award from the Michael Smith Foundation for Health Research.	Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Balasundaram AP, 2017, PM&R, V9, P866, DOI 10.1016/j.pmrj.2017.01.004; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; Beebe DW, 2018, CLIN J SPORT MED, V28, P395, DOI 10.1097/JSM.0000000000000454; BLAU JN, 1990, CEPHALALGIA, V10, P157, DOI 10.1046/j.1468-2982.1990.1004157.x; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dinges DF, 1997, SLEEP, V20, P267; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fallone G, 2001, PERCEPT MOTOR SKILL, V93, P213, DOI 10.2466/PMS.93.4.213-229; Galland BC, 2017, SLEEP HEALTH, V3, P77, DOI 10.1016/j.sleh.2017.02.001; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hysing M, 2013, J SLEEP RES, V22, P549, DOI 10.1111/jsr.12055; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Montgomery DC., 2012, INTRO LINEAR REGRESS, V5th, P215; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; National Collegiate Athletic Association, 2016, INTERASSOCIATION CON; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Reddy R, 2017, J SLEEP RES, V26, P516, DOI 10.1111/jsr.12484; Regestein Q, 2010, PSYCHIAT RES, V176, P34, DOI 10.1016/j.psychres.2008.11.006; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Rossa KR, 2014, J ADOLESCENT HEALTH, V55, P287, DOI 10.1016/j.jadohealth.2013.12.034; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Tonetti L, 2008, CHRONOBIOL INT, V25, P745, DOI 10.1080/07420520802394191; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	40	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					46	55		10.1097/JSM.0000000000000882			10	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000015	34009800				2022-02-06	
J	Tooby, J; Weaving, D; Al-Dawoud, M; Tierney, G				Tooby, James; Weaving, Dan; Al-Dawoud, Marwan; Tierney, Gregory			Quantification of Head Acceleration Events in Rugby League: An Instrumented Mouthguard and Video Analysis Pilot Study	SENSORS			English	Article						biomechanics; head impact; concussion; subconcussion; kinematics	CONCUSSION; BIOMECHANICS; INJURIES; IMPACTS	Instrumented mouthguards (iMG) were used to collect head acceleration events (HAE) in men's professional rugby league matches. Peak linear acceleration (PLA), peak angular acceleration (PAA) and peak change in angular velocity (Delta PAV) were collected using custom-fit iMG set with a 5 g single iMG-axis recording threshold. iMG were fitted to ten male Super League players for thirty-one player matches. Video analysis was conducted on HAE to identify the contact event; impacted player; tackle stage and head loading type. A total of 1622 video-verified HAE were recorded. Approximately three-quarters of HAE (75.7%) occurred below 10 g. Most (98.2%) HAE occurred during tackles (59.3% to tackler; 40.7% to ball carrier) and the initial collision stage of the tackle (43.9%). The initial collision stage resulted in significantly greater PAA and Delta PAV than secondary contact and play the ball tackle stages (p < 0.001). Indirect HAE accounted for 29.8% of HAE and resulted in significantly greater Delta PAV (p < 0.001) than direct HAE, but significantly lower PLA (p < 0.001). Almost all HAE were sustained in the tackle, with the majority occurring during the initial collision stage, making it an area of focus for the development of player protection strategies for both ball carriers and tacklers. League-wide and community-level implementation of iMG could enable a greater understanding of head acceleration exposure between playing positions, cohorts, and levels of play.	[Tooby, James] Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Tooby, James; Weaving, Dan; Tierney, Gregory] Leeds Beckett Univ, Carnegie Sch Sport, Carnegie Appl Rugby Res CARR Ctr, Leeds LS1 3HE, W Yorkshire, England; [Weaving, Dan; Al-Dawoud, Marwan] Leeds Rhinos Rugby League Club, Leeds LS5 3BW, W Yorkshire, England; [Tierney, Gregory] Ulster Univ, Fac Life & Hlth Sci, Sch Sport, Sport & Exercise Sci Res Inst, Belfast BT15 1ED, Antrim, North Ireland		Tooby, J (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England.; Tooby, J (corresponding author), Leeds Beckett Univ, Carnegie Sch Sport, Carnegie Appl Rugby Res CARR Ctr, Leeds LS1 3HE, W Yorkshire, England.	j.tooby@leedsbeckett.ac.uk; d.a.weaving@leedsbeckett.ac.uk; marwan.al-dawoud@leedsrugby.com; G.Tierney@ulster.ac.uk					Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bian KW, 2020, BIOMECH MODEL MECHAN, V19, P2323, DOI 10.1007/s10237-020-01341-4; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Carey L, 2021, SPORTS MED-OPEN, V7, DOI 10.1186/s40798-021-00353-3; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cunningham J, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000356; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Kieffer E.E., 2020, USING IN MOUTH SENSO; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Miller LE, 2020, BIOMECH MODEL MECHAN, V19, P1003, DOI 10.1007/s10237-019-01267-6; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Naughton M, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-019-0233-9; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tierney G, 2021, SPORT BIOMECH, DOI 10.1080/14763141.2021.2016929; Tierney G, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2021-001125; Tierney GJ, 2020, J BIOMECH, V110, DOI 10.1016/j.jbiomech.2020.109969; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wang T, 2021, ANN BIOMED ENG, V49, P3189, DOI 10.1007/s10439-021-02868-y; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Zhao W, 2019, REGIONAL BRAIN INJUR, P619	29	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	JAN	2022	22	2							584	10.3390/s22020584			11	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	YN3TR	WOS:000747184100001	35062545	gold, Green Accepted			2022-02-06	
J	Garcia, AVT; Vega-Hernandez, MC; Rubio, CA; Perez-Fernandez, M				Torres Garcia, Ana Victoria; Vega-Hernandez, Maria Concepcion; Anton Rubio, Concha; Perez-Fernandez, Miguel			Mental Health in Women Victims of Gender Violence: Descriptive and Multivariate Analysis of Neuropsychological Functions and Depressive Symptomatology	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						abused women; neuropsychological sequelae; attention; memory; depressive symptomatology; Luria-DNA battery	INTIMATE PARTNER-VIOLENCE; TRAUMATIC BRAIN-INJURY; SELECTIVE ATTENTION; EXECUTIVE FUNCTIONS; ANXIETY DISORDERS; DOMESTIC VIOLENCE; FEMALE VICTIMS; CHILDREN; MEMORY; CONSEQUENCES	Female victims of abuse, as well as suffering from psychopathological disorders such as depression, can have neuropsychological sequelae affecting memory and attention, with serious consequences, both physical and psychological, in their daily lives. Therefore, the objective of this study is to analyse these sequelae that affect attention and memory, as well as the possible association of these sequelae to depression. A total of 68 women, victims of gender-based violence, between the ages of 15 and 62 participated in this study. The Luria DNA Battery (Neuropsychological Diagnosis of Adults) by Manga and Ramos (2000); and the Beck Depression Inventory (2011) were applied. It is shown that female victims of gender-based violence present poor short-term memory, attentional control, and score low on the Luria-DNA battery. Of these women, 60% suffer from some relevant type of depression. Through HJ-Biplot analysis, a direct relationship was found between memory and attentional control with the total score of the Luria battery. However, an inverse relationship was found between short-term memory and depression. In addition, three well-differentiated clusters of female victims of gender-based violence were identified. It is concluded that a lower rate of depression is observed in female victims of abuse when they have a more intact short-term memory.	[Torres Garcia, Ana Victoria; Perez-Fernandez, Miguel] Univ Salamanca, Fac Psychol, Dept Personal Psychol Evaluat & Treatment, Ciudad Jardin Campus, Salamanca 37005, Spain; [Vega-Hernandez, Maria Concepcion] Univ Salamanca, Higher Polytech Sch Zamora, Dept Stat, Viriato Campus, Zamora 49029, Spain; [Anton Rubio, Concha] Univ Salamanca, Fac Psychol, Dept Social Psychol & Anthropol, Ciudad Jardin Campus, Salamanca 37005, Spain		Garcia, AVT (corresponding author), Univ Salamanca, Fac Psychol, Dept Personal Psychol Evaluat & Treatment, Ciudad Jardin Campus, Salamanca 37005, Spain.; Rubio, CA (corresponding author), Univ Salamanca, Fac Psychol, Dept Social Psychol & Anthropol, Ciudad Jardin Campus, Salamanca 37005, Spain.	avit@usal.es; mvegahdz@usal.es; canton@usal.es; mipefe@usal.es					Airaksinen E, 2004, PSYCHOL MED, V34, P83, DOI 10.1017/S0033291703008559; Amor P.J., 2002, INT J CLIN HLTH PSYC, V2, P227, DOI DOI 10.5944/RPPC.V0L.2.NUM.1.1997.3830; Arias I., 2008, PREVENCION VIOLENCIA, P165; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Barnett O. W., 2001, TRAUMA VIOLENCE ABUS, V2, P3, DOI DOI 10.1177/1524838001002001001; Barrera M, 2013, J CHILD SEX ABUS, V22, P625, DOI 10.1080/10538712.2013.811141; Baune BT, 2012, J AFFECT DISORDERS, V141, P441, DOI 10.1016/j.jad.2012.02.041; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT., 1979, COGNITIVE THERAPY DE; Bilder R.M., 1991, MED ENFERM MENT EVAL, P183; Billoux S, 2016, J FAM VIOLENCE, V31, P897, DOI 10.1007/s10896-016-9838-7; Boira S, 2016, PSYCHOSOC INTERV, V25, P9, DOI 10.1016/j.psi.2015.07.008; BROWNE A, 1993, AM PSYCHOL, V48, P1077, DOI 10.1037/0003-066X.48.10.1077; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cerezo A.I., 2000, HOMICIDIO PAREJA TRA; Davins M., MUJERES MALTRATADAS; De la Ossa C.A., 2018, PSICOGENTE, V21, P403; Delara M., 2016, MENT HLTH FAM MED, V12, P119, DOI [DOI 10.25149/1756-8358.1201004, 10.25149/1756-8358.1201004]; Echeburua E., 1997, REV PSICOPATOL PSICO, V2, P7, DOI [10.5944/rppc.vol.2.num.1.1997.3830, DOI 10.5944/RPPC.VOL.2.NUM.1.1997.3830]; Echeburua E., 1995, MANUAL PSICOPATOLOGI, V2; Echeburua Odriozola E., 2002, ACCION PSICOL, V1, P135; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Emerson CS, 2005, ARCH CLIN NEUROPSYCH, V20, P539, DOI 10.1016/j.acn.2004.10.003; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Navarro CG, 2020, ANSIEDAD ESTRES, V26, P39, DOI 10.1016/j.anyes.2020.01.003; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Gonzalez-Ortega I., 2015, PSYCHOPATHOLOGY WOME, P713; Gunther T, 2004, J AFFECT DISORDERS, V82, P265, DOI 10.1016/j.jad.2003.11.004; Harvey PO, 2004, J PSYCHIATR RES, V38, P567, DOI 10.1016/j.jpsychires.2004.03.003; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Herrera-Guzman I, 2010, J AFFECT DISORDERS, V123, P341, DOI 10.1016/j.jad.2009.10.009; Hidalgo N., 2012, COGNITIVE EFFECTS WO; Hirigoyen M.F., 2006, MUJERES MALTRATADAS; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kolb B., 2006, NEUROPSICOLOGIA HUMA; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Labrador F.J., 2004, MUJERES VICTIMAS VIO; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Torices MIM, 2016, BEHAV PSYCHOL, V24, P361; McLaughlin J, 2012, CLIN PSYCHOL REV, V32, P677, DOI 10.1016/j.cpr.2012.08.002; Mertin P, 2001, Violence Vict, V16, P645; Michopoulos I, 2006, EUR PSYCHIAT, V21, P361, DOI 10.1016/j.eurpsy.2006.03.008; Mocan O, 2014, ANXIETY STRESS COPIN, V27, P509, DOI 10.1080/10615806.2014.888419; Muris P, 2008, CHILD PSYCHIAT HUM D, V39, P455, DOI 10.1007/s10578-008-0101-1; Nieto-Librero A.B., 2019, PACKAGE BIPLOTBOOTGU; Orsini D.L., 1988, NEUROPSYCHOLOGY CASE, P1; Otalvaro L.E.O, 2015, PSICOL CARIBE, V32, P145; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Pedraza-Linares Olga Lucía, 2019, Acta Med Colomb, V44, P66; Porrua C., 2010, INF PSICOL, V99, P53; Portellano Perez J.A., 2007, NEUROPSICOLOGIA INFA; Reinholdt-Dunne ML, 2012, J COGN PSYCHOL, V24, P54, DOI 10.1080/20445911.2011.560111; Rodriguez D.M., 2000, EDICIONES; Rodriguez D.M, 1999, CLIN HLTH, V10, P331; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Saeedi A, 2021, COGN NEURODYNAMICS, V15, P239, DOI 10.1007/s11571-020-09619-0; Seedat Soraya, 2005, Violence Vict, V20, P87, DOI 10.1891/088667005780927665; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Sugg N, 2015, MED CLIN N AM, V99, P629, DOI 10.1016/j.mcna.2015.01.012; Toren P, 2000, J ANXIETY DISORD, V14, P239, DOI 10.1016/S0887-6185(99)00036-5; Torres Garcia A.V., 2019, POLITICAS PUBLICAS D, V477, P490; Torres Garcia A.V, 2014, THESIS U SALAMANCA; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Vetere G, 2019, NAT NEUROSCI, V22, P933, DOI 10.1038/s41593-019-0389-0; Villardon MPG., 1986, QUESTIOO, V10, P13; Weiland-Fiedler P, 2004, J AFFECT DISORDERS, V82, P253, DOI 10.1016/j.jad.2003.10.009; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	73	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JAN	2022	19	1							346	10.3390/ijerph19010346			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	YH2JC	WOS:000742997400001	35010609	Green Published, gold			2022-02-06	
J	Underwood, EL; Redell, JB; Maynard, ME; Kobori, N; Hylin, MJ; Hood, KN; West, RK; Zhao, J; Moore, AN; Dash, PK				Underwood, Erica L.; Redell, John B.; Maynard, Mark E.; Kobori, Nobuhide; Hylin, Michael J.; Hood, Kimberly N.; West, Rebecca K.; Zhao, Jing; Moore, Anthony N.; Dash, Pramod K.			Metformin Reduces Repeat Mild Concussive Injury Pathophysiology	ENEURO			English	Article						axonal injury; cognitive dysfunction; mild traumatic brain injury; oxygen consumption rate; repeat concussion; tissue respiration	TRAUMATIC BRAIN-INJURY; IMPAIRED AXONAL-TRANSPORT; MITOCHONDRIAL DYSFUNCTION; COGNITIVE IMPAIRMENT; MEMORY IMPAIRMENT; MOUSE MODEL; OXIDATIVE STRESS; CELL-DEATH; RAT-BRAIN; AMPK	Mild traumatic brain injury (mTBI) can initiate complex pathophysiological changes in the brain. Numerous cellular and molecular mechanisms underlying these pathologic changes are altered after injury, including those involved in energy utilization, excitotoxicity, ionic disturbances, and inflammation. It is thought that targeting multiple mechanisms may be necessary to produce meaningful reductions in brain pathology and to improve outcome. Previous studies have reported that the anti-diabetic drug metformin can also affect inflammatory, cell survival, and metabolic outcomes, possibly by acting on multiple targets and/or pathways. We therefore questioned whether metformin treatment can reduce pathology after repeat mild closed head injury (rmCHI) in male C57Bl/6 mice. We found that metformin, administered acutely after each head impact, resulted in markedly reduced white matter damage, astrogliosis, loss of hippocampal parvalbumin neurons, and improved mitochondrial function. In addition, both motor and cognitive functions were significantly improved when tested after discontinuation of the treatment. These studies suggest that metformin may be beneficial as a treatment for repeat concussion.	[Underwood, Erica L.; Redell, John B.; Maynard, Mark E.; Kobori, Nobuhide; Hylin, Michael J.; Hood, Kimberly N.; West, Rebecca K.; Zhao, Jing; Moore, Anthony N.; Dash, Pramod K.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Hylin, Michael J.] Southern Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA; [Maynard, Mark E.] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77204 USA		Dash, PK (corresponding author), Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA.	p.dash@uth.tmc.edu		Hylin, Michael/0000-0002-8600-3047	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS086301, NS101686]; Gilson Longenbaugh Foundation/Mission Connect; T32 grant from National Institute of General Medical Sciences [2T32GM008792-16]	This work was supported in part by grants from the National Institutes of Health (NS086301, NS101686) , and funds made available by the Gilson Longenbaugh Foundation/Mission Connect to P.K.D. Salary support for E.L.U. was provided by a T32 grant (2T32GM008792-16) from National Institute of General Medical Sciences.	Alimoradi N, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01921-z; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bano D, 2018, NEUROSCI LETT, V663, P79, DOI 10.1016/j.neulet.2017.08.048; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bonnefont-Rousselot D, 2003, METABOLISM, V52, P586, DOI 10.1053/meta.2003.50093; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Broussard JI, 2020, J NEUROTRAUM, V37, P227, DOI 10.1089/neu.2019.6766; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cantu D, 2020, BRAIN INJURY, V34, P1489, DOI 10.1080/02699052.2020.1807056; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carron SF, 2020, J COMP NEUROL, V528, P175, DOI 10.1002/cne.24746; Chen SC, 2017, MOL CELL ENDOCRINOL, V440, P57, DOI 10.1016/j.mce.2016.11.011; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Cuyas E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00657; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Deschemin JC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12976-2; Detaille D, 2002, BIOCHEM PHARMACOL, V63, P1259, DOI 10.1016/S0006-2952(02)00858-4; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Fontaine E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00753; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ge XH, 2017, PHYSIOL BEHAV, V170, P115, DOI 10.1016/j.physbeh.2016.12.021; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Inayat H, 2019, IMMUNOL INVEST, V48, P618, DOI 10.1080/08820139.2019.1586917; Izzo A, 2017, HUM MOL GENET, V26, P1056, DOI 10.1093/hmg/ddx016; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kaneto H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052596; Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021; Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030; Kim TS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221810027; Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643; Krysiak R, 2020, J CLIN PHARMACOL, V60, P164, DOI 10.1002/jcph.1507; Krysiak R, 2018, EXP CLIN ENDOCR DIAB, V126, P342, DOI 10.1055/s-0043-122224; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Labuzek K, 2010, PHARMACOL REP, V62, P956; LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023; Lengyel E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.026; Li WJ, 2019, AGING DIS, V10, P949, DOI 10.14336/AD.2019.0120; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Matsuzaki S, 2015, BIOCHEMISTRY-US, V54, P2011, DOI 10.1021/bi501473h; Maynard ME, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113207; Maynard ME, 2019, J NEUROTRAUM, V36, P2147, DOI 10.1089/neu.2018.6155; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; NEWTON I, 1994, PESTIC SCI, V41, P187, DOI 10.1002/ps.2780410304; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Oliveira WH, 2016, BRAIN RES, V1644, P149, DOI 10.1016/j.brainres.2016.05.013; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Ou ZR, 2018, BRAIN BEHAV IMMUN, V69, P351, DOI 10.1016/j.bbi.2017.12.009; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Park JW, 2017, WORLD J GASTROENTERO, V23, P5196, DOI 10.3748/wjg.v23.i28.5196; Pecinova A, 2019, BIOFACTORS, V45, P703, DOI 10.1002/biof.1548; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Povlishock J T, 1992, Hum Cell, V5, P345; Rahimi S, 2020, METAB BRAIN DIS, V35, P1135, DOI 10.1007/s11011-020-00594-3; Ruddy RM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1912; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Solskov L, 2008, BASIC CLIN PHARMACOL, V103, P82, DOI 10.1111/j.1742-7843.2008.00234.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sultuybek GK, 2019, CLIN EXP PHARMACOL P, V46, P413, DOI 10.1111/1440-1681.13073; Taheri A, 2019, J NEUROL, V266, P1988, DOI 10.1007/s00415-019-09366-1; Tang GM, 2017, ONCOTARGET, V8, P97977, DOI 10.18632/oncotarget.20105; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; Thinnes A, 2021, BRAIN RES BULL, V170, P211, DOI 10.1016/j.brainresbull.2021.02.018; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Tucker LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222153; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang SH, 2020, CLIN CANCER RES, V26, P4921, DOI 10.1158/1078-0432.CCR-20-0113; Wang YL, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00170; Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Xu XY, 2021, PROTEIN CELL, V12, P769, DOI 10.1007/s13238-021-00858-3; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhang CS, 2016, CELL METAB, V23, P399, DOI 10.1016/j.cmet.2016.02.017; Zhu J, 2019, ACS CHEM NEUROSCI, V10, P4864, DOI 10.1021/acschemneuro.9b00584	115	0	0	1	1	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	JAN-FEB	2022	9	1							0421-21.2021	10.1523/ENEURO.0421-21.2021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI9JX	WOS:000744158400001	34903525	gold			2022-02-06	
J	van Alphen, B; Stewart, S; Iwanaszko, M; Xu, FK; Li, KY; Rozenfeld, S; Ramakrishnan, A; Itoh, TQ; Sisobhan, S; Qin, ZH; Lear, BC; Allada, R				van Alphen, Bart; Stewart, Samuel; Iwanaszko, Marta; Xu, Fangke; Li, Keyin; Rozenfeld, Sydney; Ramakrishnan, Anujaianthi; Itoh, Taichi Q.; Sisobhan, Shiju; Qin, Zuoheng; Lear, Bridget C.; Allada, Ravi			Glial immune-related pathways mediate effects of closed head traumatic brain injury on behavior and lethality in Drosophila	PLOS BIOLOGY			English	Article							NF-KAPPA-B; STRESS-RESPONSE; HOST-DEFENSE; MOUSE MODEL; SLEEP; ACTIVATION; EXPRESSION; NEUROINFLAMMATION; INFLAMMATION; PLASTICITY	In traumatic brain injury (TBI), the initial injury phase is followed by a secondary phase that contributes to neurodegeneration, yet the mechanisms leading to neuropathology in vivo remain to be elucidated. To address this question, we developed a Drosophila head-specific model for TBI termed Drosophila Closed Head Injury (dCHI), where well-controlled, nonpenetrating strikes are delivered to the head of unanesthetized flies. This assay recapitulates many TBI phenotypes, including increased mortality, impaired motor control, fragmented sleep, and increased neuronal cell death. TBI results in significant changes in the transcriptome, including up-regulation of genes encoding antimicrobial peptides (AMPs). To test the in vivo functional role of these changes, we examined TBI-dependent behavior and lethality in mutants of the master immune regulator NF-kappa B, important for AMP induction, and found that while sleep and motor function effects were reduced, lethality effects were enhanced. Similarly, loss of most AMP classes also renders flies susceptible to lethal TBI effects. These studies validate a new Drosophila TBI model and identify immune pathways as in vivo mediators of TBI effects.	[van Alphen, Bart; Stewart, Samuel; Iwanaszko, Marta; Xu, Fangke; Li, Keyin; Rozenfeld, Sydney; Ramakrishnan, Anujaianthi; Itoh, Taichi Q.; Sisobhan, Shiju; Qin, Zuoheng; Lear, Bridget C.; Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Iwanaszko, Marta] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med Biostat, Chicago, IL USA		Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	r-allada@northwestern.edu		Qin, Zuoheng/0000-0003-1792-697X	Department of DefenseUnited States Department of Defense [W81XWH-20-1-0211, W81XWH-16-1-0166]; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [D12AP00023]	The authors thank Eugenie Bang for conducting the experiments that assessed TBI susceptibility and sleep and motor impairments in wild-type and NF-?B null flies. The authors thank Dr. Rosemary Braun for supervising the bioinformatic analyses and reviewing the initial draft of this manuscript.	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barone MC, 2013, JOVE-J VIS EXP, DOI 10.3791/50339; Bartholomew NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15298; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bouleau S, 2015, J ALZHEIMERS DIS, V45, P1015, DOI 10.3233/JAD-142802; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Cardillo G, 2008, LOGRANK COMPARING SU; Casci I, 2015, BRAIN RES, V1607, P47, DOI 10.1016/j.brainres.2014.09.064; Castillo JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1690-2; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Comoglio F, 2015, CELL REP, V11, P821, DOI 10.1016/j.celrep.2015.03.070; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davis A E, 2000, Crit Care Nurs Q, V23, P1; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dissel S, 2015, BRAIN BEHAV IMMUN, V47, P75, DOI 10.1016/j.bbi.2014.09.019; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fischer JA, 2018, ANESTH ANALG, V126, P1979, DOI 10.1213/ANE.0000000000002906; Francesconi M, 2014, NATURE, V505, P208, DOI 10.1038/nature12772; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gaudet PL M., 2010, GENE ONTOLOGY ANNOTA; Graber DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0298-4; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hanson MA, 2019, ELIFE, V8, DOI [10.7554/eLife.44341, 10.7554/eLife.44341.001]; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; HIRSCH J, 1961, SCIENCE, V134, P835, DOI 10.1126/science.134.3482.835; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang YM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001703; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jansen R, 2016, MOL PSYCHIATR, V21, P444, DOI 10.1038/mp.2015.94; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007; Krauss JKJ, 2007, MOVEMENT DISORDERS T, P469; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kuo TH, 2012, JOVE-J VIS EXP, DOI 10.3791/4355; Kuo TH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-17; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lewis EA, 2016, J NEUROSCI METH, V265, P89, DOI 10.1016/j.jneumeth.2015.07.026; Liao SE, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00706; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Logan MA, 2007, NEURON GLIA BIOL, V3, P63, DOI [10.1017/S1740925X07000646, 10.1017/S1740925X0700049X]; Logan MA, 2012, NAT NEUROSCI, V15, P722, DOI 10.1038/nn.3066; Losada-Perez M, 2018, J NEUROGENET, V32, P78, DOI 10.1080/01677063.2018.1464568; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; McCall K, 2009, METHODS MOL BIOL, V559, P343, DOI 10.1007/978-1-60327-017-5_24; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Ng FS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00146; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pankova K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163986; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Purice MD, 2017, ELIFE, V6, DOI 10.7554/eLife.23611; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saikumar J, 2020, P NATL ACAD SCI USA, V117, P17269, DOI 10.1073/pnas.2003909117; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh P, 2020, CURR BIOL, V30, P1063, DOI 10.1016/j.cub.2019.12.065; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Stanhope BA, 2020, CURR BIOL, V30, P1092, DOI 10.1016/j.cub.2020.02.057; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Sudmeier LJ, 2015, G3-GENES GENOM GENET, V5, P2299, DOI 10.1534/g3.115.021782; Sun MK, 2017, JOVE-J VIS EXP, DOI 10.3791/55602; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Thomas J, 2012, PLANT J, V72, P935, DOI 10.1111/tpj.12004; Thomasy H, 2016, J NEUROSCI, V36, P11587, DOI 10.1523/JNEUROSCI.2799-16.2016; Tindell SJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01432-z; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Ueno T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00303; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; West RJH, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/381281; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wingo AP, 2015, BRAIN BEHAV IMMUN, V43, P184, DOI 10.1016/j.bbi.2014.09.016; Wu MN, 2008, SLEEP, V31, P465, DOI 10.1093/sleep/31.4.465; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Zhu L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217603; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	145	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1544-9173	1545-7885		PLOS BIOL	PLoS. Biol.	JAN	2022	20	1							e3001456	10.1371/journal.pbio.3001456			32	Biochemistry & Molecular Biology; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	YO5CD	WOS:000747956100001	35081110	gold, Green Accepted			2022-02-06	
J	van der Ende, NAM; Roozenbeek, B; Berkhemer, OA; Koudstaal, PJ; Boiten, J; van Dijk, EJ; Roos, YBWEM; van Oostenbrugge, RJ; Majoie, CBLM; van Zwam, W; Lingsma, HF; van der Lugt, A; Dippel, DWJ				van der Ende, Nadinda A. M.; Roozenbeek, Bob; Berkhemer, Olvert A.; Koudstaal, Peter J.; Boiten, Jelis; van Dijk, Ewoud J.; Roos, Yvo B. W. E. M.; van Oostenbrugge, Robert J.; Majoie, Charles B. L. M.; van Zwam, Wim; Lingsma, Hester F.; van der Lugt, Aad; Dippel, Diederik W. J.		MR CLEAN Investigators	Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial	STROKE			English	Article						algorithm; clinical trial; ischemic stroke; odds ratio; telephone	TRAUMATIC BRAIN-INJURY; MEASUREMENT ERROR; CLINICAL-TRIALS; SCALE; MISCLASSIFICATION; RELIABILITY; AGREEMENT; IMPACT; BIAS	BACKGROUND AND PURPOSE: Blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging. Unblinding can result in misclassified outcomes and biased treatment effect estimates. An outcome adjudication committee assures blinded outcome assessment, but the added value for trials with prospective randomized open blinded end point design and subjective outcomes is unknown. We aimed to assess the degree of misclassification of modified Rankin Scale (mRS) scores by a central assessor and its impact on treatment effect estimates in a stroke trial with prospective randomized open blinded end point design. METHODS: We used data from the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). The primary outcome was the mRS at 90 days. Standardized, algorithm-based telephone interviews to assess the mRS were conducted from a central location by an experienced research nurse, unaware but not formally blinded to treatment allocation (central assessor). Masked reports of these interviews were adjudicated by a blinded outcome committee. Misclassification was defined as an incorrect classification of the mRS by the central assessor. The effect of endovascular treatment on the mRS was assessed with multivariable ordinal logistic regression. RESULTS: In MR CLEAN, 53/500 (10.6%) of the mRS scores were misclassified. The degree and direction of misclassification did not differ between treatment arms (P=0.59). Benefit of endovascular treatment was shown on the mRS when scored by the central assessor (adjusted common odds ratio, 1.60 [95% CI, 1.16-2.21]) and the outcome adjudication committee (adjusted common odds ratio, 1.67 [95% CI, 1.21-2.20]). CONCLUSIONS: Misclassification by the central assessor was small, randomly distributed over treatment arms, and did not affect treatment effect estimates. This study suggests that the added value of a blinded outcome adjudication committee is limited in a stroke trial with prospective randomized open blinded end point design applying standardized, algorithm-based outcome assessment by a central assessor, who is unaware but not formally blinded to treatment allocation.	[van der Ende, Nadinda A. M.; Roozenbeek, Bob; Berkhemer, Olvert A.; Koudstaal, Peter J.; Dippel, Diederik W. J.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [van der Ende, Nadinda A. M.; Roozenbeek, Bob; Berkhemer, Olvert A.; van der Lugt, Aad] Erasmus MC Univ Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Lingsma, Hester F.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Berkhemer, Olvert A.; Majoie, Charles B. L. M.] Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, Amsterdam, Netherlands; [Berkhemer, Olvert A.; Roos, Yvo B. W. E. M.] Univ Amsterdam, Dept Neurol, Amsterdam UMC, Amsterdam, Netherlands; [Boiten, Jelis] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [van Dijk, Ewoud J.] Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Dept Neurol, Maastricht, Netherlands; [van Zwam, Wim] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Dept Radiol & Nucl Med, Maastricht, Netherlands		van der Ende, NAM (corresponding author), Erasmus MC Univ Med Ctr, Dept Neurol & Radiol & Nucl Med, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	n.vanderende@erasmusmc.nl	van Dijk, Ewoud J/J-7951-2012	Berkhemer, Olvert/0000-0002-2212-6128; van Zwam, Wim/0000-0003-1631-7056; Koudstaal, Peter/0000-0003-4998-9609; van der Ende, Nadinda/0000-0003-4681-8388; van Oostenbrugge, robert/0000-0003-1032-9099; Majoie, Charles/0000-0002-7600-9568	Dutch Heart FoundationNetherlands Heart Foundation; Angiocare BV; Medtronic/Covidien/EV3; MEDAC gmbh/LAMEPRO; Penumbra Inc; Stryker; Top Medical/Concentric	The MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) was partly funded by the Dutch Heart Foundation and by unrestricted grants from Angiocare BV, Medtronic/Covidien/EV3, MEDAC gmbh/LAMEPRO, Penumbra Inc, Stryker, and Top Medical/Concentric. All funding sources had no role in the study design and conduct; collection, management, analysis, and interpretation of data; preparation, review, or approval of the article; and decision to submit the article for publication.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Dechartres A, 2009, J CLIN EPIDEMIOL, V62, P695, DOI 10.1016/j.jclinepi.2008.09.011; Diakou LAN, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000043.pub2; DIPPEL DWJ, 1995, ANN NEUROL, V38, P832, DOI 10.1002/ana.410380521; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Godolphin PJ, 2020, EUR STROKE J, V5, P174, DOI 10.1177/2396987320910047; Godolphin PJ, 2019, STROKE, V50, P2187, DOI 10.1161/STROKEAHA.119.025019; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hrobjartsson A, 2013, CAN MED ASSOC J, V185, pE201, DOI 10.1503/cmaj.120744; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Lopez-Cancio E, 2015, STROKE, V46, P3405, DOI 10.1161/STROKEAHA.115.010909; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2012, J NEUROTRAUM, V29, P719, DOI 10.1089/neu.2010.1746; MAHONEY F I, 1965, Md State Med J, V14, P61; Myer L, 2004, SEX TRANSM INFECT, V80, P318, DOI 10.1136/sti.2003.006536; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; van Smeden M, 2020, INT J EPIDEMIOL, V49, P338, DOI 10.1093/ije/dyz251; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	26	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2022	53	1					61	69		10.1161/STROKEAHA.121.035301			9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	XT2RW	WOS:000733442300020	34607469	hybrid, Green Published			2022-02-06	
J	Van Deynse, H; Cools, W; Depreitere, B; Hubloue, I; Kazadi, CI; Kimpe, E; Moens, M; Pien, K; Van Belleghem, G; Putman, K				Van Deynse, Helena; Cools, Wilfried; Depreitere, Bart; Hubloue, Ives; Kazadi, Carl Ilunga; Kimpe, Eva; Moens, Maarten; Pien, Karen; Van Belleghem, Griet; Putman, Koen			Quantifying injury severity for traumatic brain injury with routinely collected health data	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury severity; Traumatic brain injury; Brain injury; ICISS; NISS; ISS; ICD-10-CM	IN-HOSPITAL MORTALITY; CARE-UNIT ADMISSION; INTERNATIONAL-CLASSIFICATION; ADMINISTRATIVE DATA; VALIDATION; DISCHARGE; LENGTH; SCORE; PERFORMANCE; DATABASES	Background: Routinely collected health data (RCHD) offers many opportunities for traumatic brain injury (TBI) research, in which injury severity is an important factor. Objective: The use of clinical injury severity indices in a context of RCHD is explored, as are alternative measures created for this specific purpose. To identify useful scales for full body injury severity and TBI severity this study focuses on their performance in predicting these currently used indices, while accounting for age and comorbidities. Data: This study utilized an extensive population-based RCHD dataset consisting of all patients with TBI admitted to any Belgian hospital in 2016. Methods: Full body injury severity is scored based on the (New) Injury Severity Score ((N)ISS) and the ICD-based Injury Severity Score (ICISS). For TBI specifically, the Abbreviated Injury Scale (AIS) Head, Loss of Consciousness and the ICD-based Injury Severity Score for TBI injuries (ICISS) were used in the analysis. These scales were used to predict three outcome variables strongly related to injury severity: in-hospital death, admission to intensive care and length of hospital stay. For the prediction logistic regressions of the different injury severity scales and TBI severity indices were used, and error rates and the area under the receiver operating curve were evaluated visually. Results: In general, the ICISS had the best predictive performance (error rate between 0.06 and 0.23; AUC between 0.82 [0.81;0.83] and 0.86 [0.85;0.86]). A clearly increasing error rate can be noticed with advancing age and accumulating comorbidity. Conclusion: Both for full body injury severity and TBI severity, the ICISS tends to outperform other scales. It is therefore the preferred scale for use in research on TBI in the context of RCHD. In their current form, the severity scales are not suitable for use in older populations. (c) 2021 Elsevier Ltd. All rights reserved.	[Van Deynse, Helena; Kazadi, Carl Ilunga; Kimpe, Eva; Van Belleghem, Griet; Putman, Koen] Vrije Univ Brussel, Interuniv Ctr Hlth Econ Res, Dept Publ Hlth, Brussels, Belgium; [Cools, Wilfried] Vrije Univ Brussel, Interfac Ctr Data Proc & Stat, Brussels, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Univ Ziekenhuis Leuven, Dept Neurosurg, Leuven, Belgium; [Hubloue, Ives] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium; [Moens, Maarten] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Neurosurg, Brussels, Belgium; [Moens, Maarten] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Dept Radiol, Brussels, Belgium; [Pien, Karen] Univ Ziekenhuis Brussel, Dept Med Registrat, Brussels, Belgium		Van Deynse, H (corresponding author), Vrije Univ Brussel, Fac Pharm & Med, Bldg K,Laarbeeklaan 103, B-1090 Brussels, Belgium.	helena.van.deynse@vub.be	cools, wilfried/AAE-4534-2019	cools, wilfried/0000-0002-3458-0336	Research Foundation FlandersFWO [1S52420N]; King Baudouin Foundation/Fund Benevermedex [2019-J5162090214585]	This study received financial support from the Research Foundation Flanders (Grant number: 1S52420N) and the King Baudouin Foundation/Fund Benevermedex (Grant number: 2019-J5162090214585).	Abajas-Bustillo R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216206; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Assareh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147087; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bergstrom MF, 2011, INJURY PREV, V17, P108, DOI 10.1136/ip.2010.028951; Clark David E, 2018, Inj Epidemiol, V5, P11, DOI 10.1186/s40621-018-0149-8; Clark DE, 2010, ICDPIC STATA MODULE; Committee on Medical Aspect of Automotive Safety, 1971, JAMA-J AM MED ASSOC, V215, P277; Cook A, 2013, STAT SOFTWARE COMPON; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fortin Martin, 2017, CMAJ Open, V5, pE729, DOI 10.9778/cmajo.20170029; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Glerum KM, 2019, INJURY PREV, V25, P90, DOI 10.1136/injuryprev-2017-042519; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Hedegaard Holly, 2019, Natl Health Stat Report, P1; Hedegaard Holly, 2016, Natl Health Stat Report, P1; Lavoie A, 2005, INJURY, V36, P477, DOI 10.1016/j.injury.2004.09.039; Loftis KL, 2016, TRAFFIC INJ PREV, V17, P1, DOI 10.1080/15389588.2016.1191069; Lujic S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183817; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Moore C, 2016, TMPM TRAUMA MORTALIT; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Osler TM, 2019, J TRAUMA ACUTE CARE, V86, P891, DOI 10.1097/TA.0000000000002194; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Sun JW, 2017, MED CARE, V55, P1046, DOI 10.1097/MLR.0000000000000824; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tamim H, 2008, INJURY, V39, P115, DOI 10.1016/j.injury.2007.06.007; Van Belleghem G, 2016, INJURY, V47, P141, DOI 10.1016/j.injury.2015.08.025; Wang MD, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0265-y; Weijermars W, 2021, STICHTING WETENSCHAP, P2014; Welke KF, 2008, CARDIOL YOUNG, V18, P137, DOI 10.1017/S1047951108002837; World Health Organization, 2021, INT STAT CLASS DIS R	39	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2022	53	1					11	20		10.1016/j.injury.2021.10.013			10	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	YD5DY	WOS:000740434000003	34702594				2022-02-06	
J	Vorn, R; Suarez, M; White, JC; Martin, CA; Kim, HS; Lai, C; Yun, SJ; Gill, JM; Lee, HYH				Vorn, Rany; Suarez, Maiko; White, Jacob C.; Martin, Carina A.; Kim, Hyung-Suk; Lai, Chen; Yun, Si-Jung; Gill, Jessica M.; Lee, Hyunhwa			Exosomal microRNA Differential Expression in Plasma of Young Adults with Chronic Mild Traumatic Brain Injury and Healthy Control	BIOMEDICINES			English	Article						mild traumatic brain injury; microRNA; exomiRNA; exosome	ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; NEURODEGENERATION; IDENTIFICATION; HIPPOCAMPUS; SYMPTOMS; SINGLE; GAMMA; GABA	Chronic mild traumatic brain injury (mTBI) has long-term consequences, such as neurological disability, but its pathophysiological mechanism is unknown. Exosomal microRNAs (exomiRNAs) may be important mediators of molecular and cellular changes involved in persistent symptoms after mTBI. We profiled exosomal microRNAs (exomiRNAs) in plasma from young adults with or without a chronic mTBI to decipher the underlying mechanisms of its long-lasting symptoms after mTBI. We identified 25 significantly dysregulated exomiRNAs in the chronic mTBI group (n = 29, with 4.48 mean years since the last injury) compared to controls (n = 11). These miRNAs are associated with pathways of neurological disease, organismal injury and abnormalities, and psychological disease. Dysregulation of these plasma exomiRNAs in chronic mTBI may indicate that neuronal inflammation can last long after the injury and result in enduring and persistent post-injury symptoms. These findings are useful for diagnosing and treating chronic mTBIs.	[Vorn, Rany; Martin, Carina A.; Kim, Hyung-Suk; Lai, Chen] NINR, NIH, Bethesda, MD 20814 USA; [Suarez, Maiko] Univ Nevada, Sch Med, Las Vegas, NV 89102 USA; [White, Jacob C.] Univ Nevada, Coll Liberal Arts, Las Vegas, NV 89154 USA; [Yun, Si-Jung] Yotta Biomed LLC, Bethesda, MD 20817 USA; [Gill, Jessica M.] Johns Hopkins Univ, Sch Nursing & Med, Baltimore, MD 21205 USA; [Gill, Jessica M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA		Lee, HYH (corresponding author), Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA.	rany.vorn@nih.gov; suarem2@unlv.nevada.edu; whitej31@unlv.nevada.edu; carina.martin@nih.gov; kimhy@mail.nih.gov; laichi@mail.nih.gov; sijungyun@yottabiomed.com; JessicaGill@jhu.edu; hyunhwa.lee@unlv.edu					Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Argandona EG, 2012, CURR NEUROVASC RES, V9, P72; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Benigni M, 2016, NEUROMOL MED, V18, P551, DOI 10.1007/s12017-016-8396-8; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention (CDC), 2003, C MILD TRAUM BRAIN I; Chaban V, 2020, J NEUROTRAUM, V37, P2120, DOI 10.1089/neu.2019.6963; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Huang AYS, 2020, NEURON, V106, P992, DOI 10.1016/j.neuron.2020.03.025; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Joilin G, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00186; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Rokad D, 2017, BRAIN RES BULL, V133, P60, DOI 10.1016/j.brainresbull.2016.12.003; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sheinerman KS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0316-0; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Watson CN, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00364; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Winder AD, 2017, CANCER-AM CANCER SOC, V123, P1144, DOI 10.1002/cncr.30477; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	52	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	JAN	2022	10	1							36	10.3390/biomedicines10010036			11	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	YN2SY	WOS:000747114100001	35052715	gold, Green Accepted			2022-02-06	
J	Wallace, J; Beidler, E; Register-Mihalik, JK; Hibbler, T; Bretzin, A; DeMedal, S; Kerr, ZY				Wallace, Jessica; Beidler, Erica; Register-Mihalik, Johna K.; Hibbler, Tamaria; Bretzin, Abigail; DeMedal, Spencer; Kerr, Zachary Y.			Examining Concussion Nondisclosure in Collegiate Athletes Using a Health Disparities Framework and Consideration of Social Determinants of Health	JOURNAL OF ATHLETIC TRAINING			English	Article						race; socioeconomic status; traumatic brain injuries	REPORTING BEHAVIORS; RACIAL DISPARITIES; KNOWLEDGE; RECOGNITION; SPORT; CARE; RACE	Context: Limited research exists concerning the relationship between the social determinants of health (SDOHs), including race, socioeconomic status (SES), health care access and physical environment and concussion nondisclosure in collegiate athletes. However, among high school athletes, disparities have been noted, with Black athletes who attended under-resourced schools and lacked access to an athletic trainer (AT) disclosing fewer concussions. Objective: To investigate whether concussion nondisclosure disparities existed by (1) race, (2) SES, or (3) AT health care access before college and understand the differential reasons for concussion nondisclosure between White and Black collegiate athletes. Design: Cross-sectional study. Setting: Collegiate athletics. Participants: A total of 735 college athletes (84.6% White, 15.4% Black). Main Outcome Measure(s): Participants completed a questionnaire that directly assessed concussion nondisclosure, including reasons for not reporting a suspected concussion. With the premise of investigating SDOHs, race was the primary exposure of interest. The outcome of interest, nondisclosure, was assessed with a binary (yes or no) question, "Have you ever sustained a concussion that you did not report to your coach, AT, parent, teammate, or anyone else?'' Results: Among the White and Black athletes, 15.6% and 17.7%, respectively, reported a history of concussion nondisclosure. No differences were found by race for distributions of history of concussion nondisclosure (P=.57). Race was not associated with concussion nondisclosure when evaluated as an effect modification measure or confounder, and no significant associations were noted by SES or high school AT access. Differences by race for reported reasons for nondisclosure were present for "At the time, I did not think it was a concussion'' (P=.045) and "I thought my teammates would think I am weak'' (P=.03), with Black athletes selecting these more frequently than White athletes. Conclusions: These data help to contextualize race and its intersection with other SDOHs that could influence concussion nondisclosure outcomes in collegiate athletes.	[Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Athlet Training Program, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Hibbler, Tamaria] Michigan State Univ, Dept Athlet, E Lansing, MI 48824 USA; [Bretzin, Abigail] Univ Penn, Dept Epidemiol, Philadelphia, PA 19104 USA; [DeMedal, Spencer] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, Athlet Training Program, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu					Agyemang K, 2010, INT REV SOCIOL SPORT, V45, P419, DOI 10.1177/1012690210374691; [Anonymous], Sport sponsorship, participation, and demographics search; Aschengrau A, 2008, ESSENTIALS EPIDEMIOL, V2nd; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Bimper AY, 2013, J BLACK PSYCHOL, V39, P107, DOI 10.1177/0095798412454676; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brown KT, 2003, J APPL SOC PSYCHOL, V33, P1379, DOI 10.1111/j.1559-1816.2003.tb01954.x; Callahan Christine E, 2020, J Athl Train, DOI 10.4085/211-20; Cooper JN, 2012, SOCIOL MIND, V2, P261, DOI [10.4236/SM.2012.23035, DOI 10.4236/SM.2012.23035]; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Harwell M, 2010, EDUC RESEARCHER, V39, P120, DOI 10.3102/0013189X10362578; Jones WA, 2017, J COLL STUDENT DEV, V58, P564, DOI 10.1353/csd.2017.0043; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lempke LB, 2021, HEALTH PROMOT PRACT, V22, P649, DOI 10.1177/1524839920920289; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Milroy JJ, 2020, J ADOLESCENT HEALTH, V66, P705, DOI 10.1016/j.jadohealth.2020.01.027; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rubin LM, 2016, J STUDY SPORTS ATHL, V10, P185, DOI 10.1080/19357397.2016.1258966; Wallace J, 2020, J SAFETY RES, V75, P166, DOI 10.1016/j.jsr.2020.09.007; Wallace J, 2021, J RACIAL ETHN HEALTH, V8, P1079, DOI 10.1007/s40615-020-00864-x; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wiggins DK, 2014, INT J HIST SPORT, V31, P181, DOI 10.1080/09523367.2013.857313; Williams DR, 2015, JAMA-J AM MED ASSOC, V314, P555, DOI 10.1001/jama.2015.9260	37	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2022	57	1					16	24		10.4085/1062-6050-0054.21			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	YL7KX	WOS:000746068300002	35040984	gold			2022-02-06	
J	Wallen, TE; Singer, KE; Morris, MC; Blakeman, T; Stevens-Topie, SM; Strilka, R; Pritts, TA; Goodman, MD				Wallen, Taylor E.; Singer, Kathleen E.; Morris, Mackenzie C.; Blakeman, Thomas; Stevens-Topie, Sabre M.; Strilka, Richard; Pritts, Timothy A.; Goodman, Michael D.			Blood product resuscitation mitigates the effects of aeromedical evacuation after polytrauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Whole blood; aeromedical evacuation; inflammation; cytokine	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; HYPOXIA; TRANSFUSION; SEVOFLURANE; PLATELETS; HYPOBARIA; PROPOFOL; PLASMA; FLOW	BACKGROUND: The combined injury of traumatic brain injury and hemorrhagic shock has been shown to worsen coagulopathy and systemic inflammation, thereby increasing posttraumatic morbidity and mortality. Aeromedical evacuation to definitive care may exacerbate postinjury morbidity because of the inherent hypobaric hypoxic environment. We hypothesized that blood product resuscitation may mitigate the adverse physiologic effects of postinjury flight. METHODS: An established porcine model of controlled cortical injury was used to induce traumatic brain injury. Intracerebral monitors were placed to record intracranial pressure, brain tissue oxygenation, and cerebral perfusion. Each of the 42 pigs was hemorrhaged to a goal mean arterial pressure of 40 +/- 5 mm Hg for 1 hour. Pigs were grouped according to resuscitation strategy used-Lactated Ringer's (LR) or shed whole blood (WB)-then placed in an altitude chamber for 2 hours at ground, 8,000 ft, or 22,000 ft, and then observed for 4 hours. Hourly blood samples were analyzed for proinflammatory cytokines and lactate. Internal jugular vein blood flow was monitored continuously for microbubble formation with altitude changes. RESULTS: Cerebral perfusion, tissue oxygenation, and intracranial pressure were unchanged among the six study groups. Venous microbubbles were not observed even with differing altitude or resuscitation strategy. Serum lactate levels from hour 2 of flight to the end of observation were significantly elevated in 22,000 + LR compared with 8,000 + LR and 22,000 + WB. Serum IL-6 levels were significantly elevated in 22,000 + LR compared with 22,000 + WB, 8,000 + LR and ground+LR at hour 1 of observation. Serum tumor necrosis factor-alpha was significantly elevated at hour 2 of flight in 8,000 + LR versus ground+LR, and in 22,000 + LR vs. 22,000 + WB at hour 1 of observation. Serum IL-1 beta was significantly elevated hour 1 of flight between 8,000 + LR and ground+LR. CONCLUSION: Crystalloid resuscitation during aeromedical transport may cause a prolonged lactic acidosis and proinflammatory response that can predispose multiple-injury patients to secondary cellular injury. This physiologic insult may be prevented by using blood product resuscitation strategies. Copyright (C) 2021 American Association for the Surgery of Trauma.	[Wallen, Taylor E.; Singer, Kathleen E.; Morris, Mackenzie C.; Blakeman, Thomas; Stevens-Topie, Sabre M.; Strilka, Richard; Pritts, Timothy A.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	michael.goodman@uc.edu			United States Air Force School of Aerospace Medicine, Aeromedical Research Department [FA8650-18-2-6G29]; United States Air Force Research Laboratory, 711th Human Performance Wing (Aeromedical Research Department, Fifth St. Building, Wright-Patterson Air Force Base, Ohio)	This work was funded by grant number FA8650-18-2-6G29 from the United States Air Force School of Aerospace Medicine, Aeromedical Research Department. The United States Air Force Research Laboratory, 711th Human Performance Wing (Aeromedical Research Department, 2510 Fifth St. Building 840, Wright-Patterson Air Force Base, Ohio 45433) was the awarding and administering acquisition office.	Airforce US, 2020, CV 22 OSPR; de Quiros YB, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00310; Cantle PM, 2017, SURG CLIN N AM, V97, P999, DOI 10.1016/j.suc.2017.06.002; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Gruen DS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16869; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; Johannigman JA, 2015, MIL MED, V180, P50, DOI 10.7205/MILMED-D-14-00381; Jung AD, 2020, MIL MED, V185, pE473, DOI 10.1093/milmed/usz346; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Lopez K, 2021, SHOCK, V56, P601, DOI 10.1097/SHK.0000000000001716; Maddry JK, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0169-2; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; Mizokami K., 2017, POP MECH; POWELL MR, 1983, UNDERSEA BIOMED RES, V10, P217; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sheppard FR, 2018, J TRAUMA ACUTE CARE, V85, P1055, DOI 10.1097/TA.0000000000002046; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Tamm M, 1998, AM J RESP CELL MOL, V19, P653, DOI 10.1165/ajrcmb.19.4.3058	23	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2022	92	1					12	20		10.1097/TA.0000000000003433			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	XR1JJ	WOS:000731994300006	34932039				2022-02-06	
J	Wang, LY; Zhang, D; Ren, YK; Guo, S; Li, JR; Ma, SS; Yao, MH; Guan, FX				Wang, Luyu; Zhang, Dan; Ren, Yikun; Guo, Shen; Li, Jinrui; Ma, Shanshan; Yao, Minghao; Guan, Fangxia			Injectable hyaluronic acid hydrogel loaded with BMSC and NGF for traumatic brain injury treatment	MATERIALS TODAY BIO			English	Article						Injectable hydrogel; Dual-enzymatic crosslinking; Bone mesenchymal stem cell; Nerve growth factor; Traumatic brain injury	MESENCHYMAL STEM-CELLS; POTENTIAL APPLICATION; COMBINATION; SCAFFOLD; THERAPY; PEPTIDE	Injectable hydrogel has the advantage to fill the defective area and thereby shows promise as therapeutic implant or cell/drug delivery vehicle for tissue repair. In this study, an injectable hyaluronic acid hydrogel in situ dual enzymatically cross-linked by galactose oxidase (GalOx) and horseradish peroxidase (HRP) was synthesized and optimized, and the therapeutic effect of this hydrogel encapsulated with bone mesenchymal stem cells (BMSC) and nerve growth factors (NGF) for traumatic brain injury (TBI) mice was investigated. Results from in vitro experiments showed that either tyramine-modified hyaluronic acid hydrogels (HT) or NGF loaded HT hydrogels (HT/NGF) possessed good biocompatibility. More importantly, the HT hydrogels loaded with BMSC and NGF could facilitate the survival and proliferation of endogenous neural cells probably by neurotrophic factors release and neuroinflammation regulation, and consequently improved the neurological function recovery and accelerated the repair process in a C57BL/6 TBI mice model. All these findings highlight that this injectable, BMSC and NGF-laden HT hydrogel has enormous potential for TBI and other tissue repair therapy.	[Wang, Luyu; Zhang, Dan; Ren, Yikun; Guo, Shen; Li, Jinrui; Ma, Shanshan; Yao, Minghao; Guan, Fangxia] Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Peoples R China		Yao, MH; Guan, FX (corresponding author), Zhengzhou Univ, Sch Life Sci, 100 Sci Rd, Zhengzhou 450001, Peoples R China.	yao453343550@zzu.edu.cn; guanfx@zzu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [U1804198]; Zhongyuan Thousand Talents Project [204200510013]; Henan Overseas Expertise introduction Center for Discipline Innovation [CXJD2021002]	This work was financially supported by the National Natural Science Foundation of China (U1804198) from Minghao Yao, Zhongyuan Thousand Talents Project (204200510013) and Henan Overseas Expertise introduction Center for Discipline Innovation (CXJD2021002) from Fangxia Guan. We also thank the facility support of the Center of Advanced Analysis & Gene Sequencing, Zhengzhou University.	Alizadeh A, 2020, J TISSUE VIABILITY, V29, P359, DOI 10.1016/j.jtv.2020.06.008; Balcucho J, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10091692; Carbonara M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00885; Castro KC, 2021, INT J BIOL MACROMOL, V173, P251, DOI 10.1016/j.ijbiomac.2021.01.100; Chen J, 2019, J CELL PHYSIOL, V234, P23097, DOI 10.1002/jcp.28873; Ciafre S, 2020, RIV PSICHIATR, V55, P4, DOI 10.1708/3301.32713; Cofano F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112698; Cortes H, 2020, CELL MOL BIOL, V66, P191, DOI 10.14715/cmb/2020.66.4.23; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Das M, 2019, REV NEUROSCIENCE, V30, P839, DOI 10.1515/revneuro-2019-0002; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dimatteo R, 2018, ADV DRUG DELIVER REV, V127, P167, DOI 10.1016/j.addr.2018.03.007; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Feng JF, 2020, LANCET NEUROL, V19, P5, DOI 10.1016/S1474-4422(19)30447-8; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Graca MFP, 2020, CARBOHYD POLYM, V241, DOI 10.1016/j.carbpol.2020.116364; Han Z, 2017, MOL CELL BIOCHEM, V428, P149, DOI 10.1007/s11010-016-2925-5; Hu XL, 2020, J CELL MOL MED, V24, P8166, DOI 10.1111/jcmm.15478; Keen Mohammad Abid, 2017, Skinmed, V15, P441; Kim SH, 2018, BIOMATERIALS, V178, P401, DOI 10.1016/j.biomaterials.2018.04.057; Li HQ, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4243102; Li JR, 2021, INT J BIOL MACROMOL, V187, P200, DOI 10.1016/j.ijbiomac.2021.07.111; Li LL, 2018, ACS APPL MATER INTER, V10, P13283, DOI 10.1021/acsami.7b17054; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Li ZQ, 2020, BIOMED PHYS ENG EXPR, V6, DOI 10.1088/2057-1976/ab8fc6; Liu SW, 2017, ACTA BIOMATER, V60, P167, DOI 10.1016/j.actbio.2017.07.024; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Morris DC, 2017, NEUROSCI LETT, V659, P7, DOI 10.1016/j.neulet.2017.08.064; Mukherjee N, 2020, SOFT MATTER, V16, P10046, DOI 10.1039/d0sm00885k; Panaro MA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060901; Rauti R, 2020, ISR J CHEM, V60, P1141, DOI 10.1002/ijch.201900052; Ravina K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123782; Rocco ML, 2018, CURR NEUROPHARMACOL, V16, P1455, DOI 10.2174/1570159X16666180412092859; Schafer S, 2021, IN VIVO, V35, P2035, DOI 10.21873/invivo.12472; Schwarz S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61852-z; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Shojaati G, 2018, STEM CELL TRANSL MED, V7, P487, DOI 10.1002/sctm.17-0258; Solomon B, 2018, SEMIN CANCER BIOL, V52, P228, DOI 10.1016/j.semcancer.2018.01.008; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Vasvani S, 2020, INT J BIOL MACROMOL, V151, P1012, DOI 10.1016/j.ijbiomac.2019.11.066; Wang LY, 2020, RSC ADV, V10, P2870, DOI 10.1039/c9ra09531d; Wang YH, 2018, CURR STEM CELL RES T, V13, P608, DOI 10.2174/1574888X13666180720100738; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Yao MH, 2019, BIOMATER SCI-UK, V7, P4088, DOI 10.1039/c9bm00749k; Yasuhara T, 2020, CNS NEUROSCI THER, V26, P595, DOI 10.1111/cns.13247; Zeeshan M, 2019, J TRAUMA ACUTE CARE, V87, P1140, DOI 10.1097/TA.0000000000002484; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang YL, 2020, NEUROREHAB NEURAL RE, V34, P616, DOI 10.1177/1545968320926164; Zhang Y, 2017, ACTA BIOMATER, V53, P100, DOI 10.1016/j.actbio.2017.02.028; Zhou YX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00301	55	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2590-0064			MATER TODAY BIO	Mater. Today Bio	JAN	2022	13								100201	10.1016/j.mtbio.2021.100201			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	YI8UP	WOS:000744118200006	35024600	Green Published, gold			2022-02-06	
J	Wei, SC				Wei, ShengCheng			Clinical Value of Bilateral Balanced Frontotemporoparietal Decompressive Craniectomy in Severe Diffuse Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Bilateral balanced frontotemporoparietal decompressive craniectomy; prognosis; severe diffuse traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA; SURGERY	Objective: To explore the clinical value of bilateral balanced frontotemporoparietal decompressive craniectomy (bbDC) in severe diffuse traumatic brain injury by comparison to the unilateral frontotemporoparietal decompressive craniectomy (uDC). Materials and methods: Twenty three patients with severe diffuse traumatic brain injury from April 2015 to December 2019 were selected, including 10 cases underwent bbDC (bilateral group) and 13 cases underwent uDC (unilateral group). Compared with the postsurgical intracranial pressure (ICP), cerebral perfusion pressure, cerebral blood flow volume, postsurgical imaging score, the occurrence of complications as well as the 6 month outcome (Glasgow Outcome Scale, GOS) of two groups. Results: 1. The postsurgical ICP was lower in the bbDC group than in the uDC group, while the postsurgical CCP and cerebral blood flow volume were higher in the bbDC group than in the uDC group. 2. Postsurgical imaging scores of the bbDC group were lower, indicating that the decompression effect of bbDC was more exhaustive than that of the uDC group. 3. The incidence of intraoperative acute cerebral bulging was lower in bbDC group than in uDC group. 4. The bbDC could effectively reduce the proportion of patients with the worst prognosis (dead+vegetative state). Conclusion: For patients with severe, diffuse traumatic brain injury combined with bilateral or unilateral pupil dilation, bilateral balanced decompression craniotomy is an effective method, which should be performed as soon as possible. As compared to unilateral decompression, the decompression effect on the brainstem is more thorough; the incidence of acute cerebral bulging, postoperative incisional hernia, and postoperative cerebral infarction involving a large area are reduced. ICP can be better controlled, cerebral perfusion pressure and cerebral blood flow increases, improving the patient's survival rate, quality of life, and prognosis.	[Wei, ShengCheng] Shandong Univ, Hosp 2, Cheeloo Coll Med, Dept Neurosurg, Jinan 250033, Shandong, Peoples R China		Wei, SC (corresponding author), Shandong Univ, Hosp 2, Cheeloo Coll Med, Dept Neurosurg, Jinan 250033, Shandong, Peoples R China.	shengcheng77@163.com					Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Brown DA, 2017, HAND CLINIC, V140, P299, DOI 10.1016/B978-0-444-63600-3.00016-7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Green SM, 2017, ANN EMERG MED, V70, P158, DOI 10.1016/j.annemergmed.2016.12.016; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Talari HR, 2019, WORLD NEUROSURG, V125, pE139, DOI 10.1016/j.wneu.2018.12.221; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Yamal JM, 2019, J NEUROTRAUM, V36, P2484, DOI 10.1089/neu.2018.5939	18	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN-FEB	2022	33	1					279	283		10.1097/SCS.0000000000008121			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XW2VB	WOS:000735482400079	34967525				2022-02-06	
J	Weiner, AR; Durbin, JR; Lunardi, SR; Li, AY; Hannah, TC; Schupper, AJ; Gal, JS; Jumreornvong, O; Spiera, Z; Ali, M; Marayati, NF; Gometz, A; Lovell, MR; Choudhri, TF				Weiner, Alden R.; Durbin, John R.; Lunardi, Susie R.; Li, Adam Y.; Hannah, Theodore C.; Schupper, Alexander J.; Gal, Jonathan S.; Jumreornvong, Oranicha; Spiera, Zachary; Ali, Muhammad; Marayati, Naoum Fares; Gometz, Alex; Lovell, Mark R.; Choudhri, Tanvir F.			Incidence and Severity of Concussions Among Young Soccer Players Based on Age, Sex, and Player Position	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; soccer; age; sex; gender; position	STATES HIGH-SCHOOL; EPIDEMIOLOGY; SYMPTOMS; INJURY; GENDER	Background: Previously studied risk factors for sports-related concussion in soccer players include sex, age, and player position. However, prior studies were limited in number, they reported conflicting results, and most did not assess initial concussion severity. Purpose/Hypothesis: The purpose of this study was to conduct an in-depth analysis of soccer players across key demographic groups (sex, age, position) for both concussion incidence and severity. It was hypothesized that concussion incidence and severity would be higher among male players, players aged >= 17 years, and goalkeepers. Study Design: Cohort study; Level of evidence, 3. Methods: The authors analyzed baseline and postinjury ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) scores for athletes aged 12 to 22 years between July 2009 and June 2019. Players were assigned to an age group based on when they had their most recent baseline test. Concussion incidence and concussion severity index were compared using t tests and multivariate logistic regression. Results: For 1189 individuals who reported soccer as their primary sport, 1032 contributed 1754 baseline ImPACT tests (some individuals had multiple baseline tests), whereas 445 individuals were suspected of sustaining a concussion and then referred for a postinjury 1 test. Of these players, 254 (24.6%) had both a baseline and a postinjury test and were analyzed for concussion severity. Linear regression showed that forwards had a lower incidence of ImPACT-proxied concussions than goalkeepers had (P = .008). Female players had a significantly higher incidence of ImPACT concussions compared with male players (mean, 0.07 [female] vs 0.04 [male] concussions per person-year; P = .05). Players in the >= 17-year age group had a higher incidence of ImPACT concussions than players in the 15- to 16-year age group (P = .04), although the 15- to 16-year age group had more severe concussions than the >= 17-year age group (mean severity index, 2.91 [age 15-16 years] vs 1.73 [age >= 17 years]; P = .001). Conclusion: Female soccer players experienced a higher incidence of concussion than did male players, and goalkeepers experienced a greater incidence of ImPACT concussions than did forwards. Players of both sexes and all positions in the 15- to 16-year age group showed increased initial concussion severity compared with the >= 17-year age group, despite a lower comparative incidence of ImPACT concussions. Further study is needed to understand whether sex and player position affect concussion severity.	[Weiner, Alden R.; Durbin, John R.; Lunardi, Susie R.; Li, Adam Y.; Hannah, Theodore C.; Schupper, Alexander J.; Gal, Jonathan S.; Jumreornvong, Oranicha; Spiera, Zachary; Ali, Muhammad; Marayati, Naoum Fares; Gometz, Alex; Lovell, Mark R.; Choudhri, Tanvir F.] Mt Sinai Hosp, New York, NY 10029 USA; [Weiner, Alden R.; Durbin, John R.; Li, Adam Y.; Hannah, Theodore C.; Schupper, Alexander J.; Jumreornvong, Oranicha; Spiera, Zachary; Ali, Muhammad; Marayati, Naoum Fares; Choudhri, Tanvir F.] Icahn Sch Med Mt Sinai, Neurosurg Dept, 1468 Madison Ave,Annenberg Bldg,8th Floor,Room 88, New York, NY 10029 USA; [Lunardi, Susie R.; Gometz, Alex] Concuss Management New York, New York, NY USA; [Gal, Jonathan S.] Icahn Sch Med Mt Sinai, Dept Anesthesiol Perioperat & Pain Med, New York, NY 10029 USA; [Lovell, Mark R.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA		Weiner, AR (corresponding author), Icahn Sch Med Mt Sinai, Neurosurg Dept, 1468 Madison Ave,Annenberg Bldg,8th Floor,Room 88, New York, NY 10029 USA.	aldenweiner@gmail.com		Hannah, Theodore/0000-0001-6527-9725			Armstrong N, 2020, INJURY PREV, V26, P334, DOI 10.1136/injuryprev-2019-043242; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P216, DOI 10.1093/arclin/acx059; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Centers for Disease Control and Prevention United States, 2012, PRINC EP PUBL HLTH P; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; National Federation of State High School Associations, 2019, 2018 19 HIGH SCH ATH; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Streissguth M, 2019, AMER MADE MUSIC SER, P1, DOI 10.2519/jospt.2019.8582; Theye Fred, 2004, Clin Med Res, V2, P165; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Weber AE, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120921746; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	30	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN	2022	10	1							23259671211059216	10.1177/23259671211059216			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	YP2DU	WOS:000748437400001	35083358	Green Accepted			2022-02-06	
J	Wen, PS; Waid-Ebbs, JK; Heaton, SC; Starosciak, AK; Gonzalez-Arias, S				Wen, Pey-Shan; Waid-Ebbs, J. Kay; Heaton, Shelley C.; Starosciak, Amy K.; Gonzalez-Arias, Sergio			Examining the Item-Level Factor Structure of the Behavior Rating Inventory of Executive Function-Adult Version Within a Traumatic Brain Injury Sample	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Executive function; Factor analysis; sta-tistical; Psychometrics; Rehabilitation	CONFIRMATORY FACTOR-ANALYSIS; BRIEF-A; VALIDATION; ATTENTION; SCALE	Objective: To conduct the first item-level exploration of scale and index structure of the self-report Behavior Rating Inventory of Executive Function-Adult version (BRIEF-A) in traumatic brain injury (TBI). Design: This was an observational cross-sectional study design using secondary data. We conducted exploratory factor analyses (EFA) to explore the index structure and scale structure of the BRIEF-A. We conducted EFA with all 70 items of the BRIEF-A to examine the index structure. Based on the finding of index structure, we conducted EFA on the 30 items of the Behavioral Regulation Index (BRI) and the 40 items of the Meta cognitive Index (MI). Setting: Data were collected through 5 studies in outpatient and community settings in the southeast United States. Participants: Individuals (N=338) aged 18-89 years with a history of mild to severe TBI who were able to speak English fluently. Interventions: Not applicable. Main Outcome Measures: The BRIEF-A. Results: The 2-factor structure aligned with the BRIEF-A manual at the index level. Scale structure for the MI (40 items) resulted in 1 factor, whereas the BRI (30 items) could be represented by either a 2-or 3-factor structure. The 2-factor structure of the BRI is more parsimonious and matched other factor analyses derived from the sum of scale items. Conclusions: We confirmed the manual designated index structure (BRI and MI) of the BRIEF-A but took precautions against using the 9 scales. Instead, we recommend using the 2 designated index scores and 2 newly identified composite scores representing Behavioral Control Trait and Emotional Control Trait. Archives of Physical Medicine and Rehabilitation 2022;103:52-61 Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine.	[Wen, Pey-Shan] Georgia State Univ, Byrdine F Lewis Coll Nursing & Hlth Profess, Dept Occupat Therapy, 140 Decatur St SE,Room 1250, Atlanta, GA 30303 USA; [Waid-Ebbs, J. Kay] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr Excellence, Gainesville, FL USA; [Heaton, Shelley C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Starosciak, Amy K.] Baptist Hlth South Florida, Miami Neurosci Inst, Ctr Res, Miami, FL USA; [Gonzalez-Arias, Sergio] Baptist Hlth South Florida, Miami Neurosci Inst, Div Neurosurg, Miami, FL USA		Wen, PS (corresponding author), Georgia State Univ, Byrdine F Lewis Coll Nursing & Hlth Profess, Dept Occupat Therapy, 140 Decatur St SE,Room 1250, Atlanta, GA 30303 USA.	pwen@gsu.edu		Wen, Pey-Shan/0000-0002-8921-8801	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21HD045869-03]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (Boston Rehabilitation Outcome Center) [5R24HD065688-05, 4500001629]; Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Pre-Doctoral Fellowship AwardUS Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Career Development AwardUS Department of Veterans Affairs	Supported by by the National Institutes of Health (grant no. R21#5R21HD045869-03), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Boston Rehabilitation Outcome Center; grant no. 5R24HD065688-05, subaward no. 4500001629), and the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Pre-Doctoral Fellowship Award and Career Development Award.	Barkley RA, 2000, J AM ACAD CHILD PSY, V39, P1064, DOI 10.1097/00004583-200008000-00025; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Biederman J, 2019, J PSYCHIATR RES, V117, P15, DOI 10.1016/j.jpsychires.2019.06.012; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Brown SW, 2006, MEM COGNITION, V34, P1464, DOI 10.3758/BF03195911; Bulzacka E, 2013, MENT ILLN, V5, P14, DOI 10.4081/mi.2013.e4; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Carvalho JO, 2016, APPL NEUROPSYCH-ADUL, V23, P125, DOI 10.1080/23279095.2015.1012759; Christ SE, 2020, NEUROPSYCHOLOGY, V34, P456, DOI 10.1037/neu0000625; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Garlinghouse MA, 2010, SCHIZOPHR RES, V120, P71, DOI 10.1016/j.schres.2010.02.1067; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Hagen E, 2019, J SUBST ABUSE TREAT, V97, P21, DOI 10.1016/j.jsat.2018.11.010; Ignjatovic VB, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01238; Jacobson K, 2020, PM&R, V12, P581, DOI 10.1002/pmrj.12273; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Rotenberg-Shpigelman S, 2008, ISRAELI J OCCUP THER, V17, pH77; Roth RM, 2005, BRIEF BEHAV RATING I; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Rouel M, 2016, EAT BEHAV, V23, P58, DOI 10.1016/j.eatbeh.2016.07.010; Shaw S, 2015, PSYCHOL ASSESSMENT, V27, P138, DOI 10.1037/a0038195; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087	30	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2022	103	1					52	61		10.1016/j.apmr.2021.07.789			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	XW1IJ	WOS:000735381500008	34371016				2022-02-06	
J	Winkler, SL; Marszalek, J; Wang, XP; Finch, D; Rakoczy, C; Delikat, J; Kelleher, V; Williams, M; Zuniga, E; Rice, C; Pollard, K; Cockerham, G				Winkler, Sandra L.; Marszalek, Jacob; Wang, Xinping; Finch, Dezon; Rakoczy, Chrystyna; Delikat, Jemy; Kelleher, Valerie; Williams, Michael; Zuniga, Esteban; Rice, Candice; Pollard, Kendra; Cockerham, Glenn			Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Vision Rehabilitation Utilization	OPTOMETRY AND VISION SCIENCE			English	Article								SIGNIFICANCE Visual dysfunction is frequently associated with traumatic brain injury (TBI). Although evidence regarding the prevalence of symptoms of this population has been published, little is known about health care utilization. A retrospective review of the data derived from the Department of Veterans Affairs (VA)-mandated "Traumatic Brain Injury Specific Ocular Health and Visual Functioning Examination for Polytrauma Rehabilitation Center Patients" provided a unique opportunity to investigate vision rehabilitation utilization. PURPOSE The purpose of this study was to understand (a) the frequency of vision rehabilitation follow-up visits at 6, 12, and 24 months; (b) the association between follow-up and demographic, comorbidity, and severity of TBI covariates as well as ocular and visual symptoms, geographic access, and evaluating facility; and (c) why some veterans did not follow up with recommendations. METHODS Retrospective and survey designs were used. The sample included 2458 veterans who served in the Operation Enduring Freedom/Operation Iraqi Freedom conflicts and received care at one of the five VA Polytrauma Rehabilitation Centers between January 1, 2008, and December 31, 2017. Quantitative and qualitative descriptive analyses and stepwise logistic regression were performed. RESULTS About 60% of veterans followed up with recommended vision rehabilitation with visits equally split between VA Polytrauma Rehabilitation Centers and community VA facilities. For each 10-year increase in age, there was a corresponding reduction of 12% in the odds of follow-up. Veterans with decreased visual field had 50% greater odds of follow-up than those who did not. Veterans with difficulty reading had 59% greater odds of follow-up than those who did not. Those who had a double vision had 45% greater odds of follow-up than those who did not. CONCLUSIONS Our findings suggest that the need for vision rehabilitation may extend as long as 2 years after TBI. Access to vision rehabilitation is complicated by the paucity of available neuro-optometric services.	[Winkler, Sandra L.; Finch, Dezon; Rakoczy, Chrystyna; Delikat, Jemy; Kelleher, Valerie] James A Haley VA Hosp, Tampa, FL 33612 USA; [Marszalek, Jacob] Univ Missouri, Kansas City, MO 64110 USA; [Wang, Xinping] North Florida South Georgia Vet Hlth Care Syst, Gainesville, FL USA; [Williams, Michael; Zuniga, Esteban] VA Natl Program Off, Blind Rehabil Serv, Washington, DC USA; [Rice, Candice] Lexington VA Hlth Care Syst, Lexington, KY USA; [Pollard, Kendra] Minneapolis VA Healthcare Syst, Minneapolis, MN USA; [Cockerham, Glenn] VHA Ophthalmol Serv, Washington, DC USA; [Cockerham, Glenn] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Winkler, SL (corresponding author), James A Haley VA Hosp, Tampa, FL 33612 USA.	sandra.winkler@va.gov; marszalekj@umkc.edu; xinping.wang@va.gov; dezon.finch@va.gov; chrystyna.rakoczy@va.gov; jemy.delikat@va.gov; valerie.kelleher@va.gov; Michael.Williams14@va.gov; Esteban.zuniga2@va.gov; candice.rice@va.gov; kendra.pollard@va.gov; glenn.cockerham@va.gov			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01 HX002279]	U.S. Department of Veterans Affairs (I01 HX002279; to SLW).	Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Fox Sandra M, 2019, Phys Med Rehabil Clin N Am, V30, P171, DOI 10.1016/j.pmr.2018.09.001; Hamilton AB, 2013, J GEN INTERN MED, V28, pS510, DOI 10.1007/s11606-013-2347-y; Kapoor B., 2019, TXB TRAUMATIC BRAIN, V3rd ed, P507; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Reynolds Mark E, 2019, MSMR, V26, P13; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Stroupe KT, 2005, MED CARE, V43, P453, DOI 10.1097/01.mlr.0000160377.82164.d3; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Warren M, AM OCCUPATIONAL THER	11	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2022	99	1					3	8		10.1097/OPX.0000000000001824			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	XX2RX	WOS:000736150800002	34882609	Bronze			2022-02-06	
J	Winkler, SL; Finch, D; Wang, XP; Toyinbo, P; Marszalek, J; Rakoczy, CM; Rice, CE; Pollard, K; Rhodes, MA; Eldred, K; Llanos, I; Peterson, M; Williams, M; Zuniga, E; White, H; Delikat, J; Ballistrea, L; White, K; Cockerham, GC				Winkler, Sandra L.; Finch, Dezon; Wang, Xinping; Toyinbo, Peter; Marszalek, Jacob; Rakoczy, Chrystyna M.; Rice, Candice E.; Pollard, Kendra; Rhodes, Matthew A.; Eldred, Kia; Llanos, Imelda; Peterson, Michael; Williams, Michael; Zuniga, Esteban; White, Helen; Delikat, Jemy; Ballistrea, Lisa; White, Keith; Cockerham, Glenn C.			Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Recommendations for Rehabilitation	OPTOMETRY AND VISION SCIENCE			English	Article							BLAST	SIGNIFICANCE We know the prevalence of traumatic brain injury (TBI)-related vision impairment and ocular injury symptoms. Lacking is an understanding of health care utilization to treat these symptoms. Utilization knowledge is important to structuring access to treatment, identifying clinical training needs, and providing evidence of the effectiveness of treatment. PURPOSE This article reports rehabilitation, glasses/contacts, and imaging/photography/video recommendations made by optometrists and ophthalmologists as part of the Department of Veterans Affairs-mandated Performance of Traumatic Brain Injury Specific Ocular Health and Visual Functioning Examination administered to veterans with TBI at Department of Veterans Affairs polytrauma specialty facilities. METHODS Using a retrospective design, natural language processing, and descriptive and regression statistics, data were analyzed for 2458 Operation Enduring Freedom/Operation Iraqi Freedom veterans who were administered the mandated examination between 2008 and 2017. RESULTS Of the 2458 veterans, vision rehabilitation was recommended for 24%, glasses/contacts were recommended for 57%, and further imaging/photography/video testing was recommended for 58%. Using key words in the referral, we determined that 37% of veterans were referred to blind rehabilitation, 16% to occupational therapy, and 3% to low-vision clinics. More than 50% of the referrals could have been treated by blind rehabilitation, occupational therapy, or low-vision clinics. Rehabilitation referrals were significantly associated with younger age, floaters, photosensitivity, double vision, visual field and balance deficits, dizziness, and difficulty reading. In comparison, prescriptions for glasses and contacts were associated with older age, photosensitivity, blurred vision, decreased visual field and night vision, difficulty reading, and dry eye. Imaging/photography/video testing was associated with floaters, photosensitivity, and headache. CONCLUSIONS Findings delineate service delivery models available to veterans with TBI-related vision impairment. The challenge these data address is the lack of clear paths from diagnosis of TBI to identification of vision dysfunction deficits to specialized vision rehabilitation, and finally to community reintegration and community based-vision rehabilitation.	[Winkler, Sandra L.; Finch, Dezon; Toyinbo, Peter; Rakoczy, Chrystyna M.; Llanos, Imelda; Delikat, Jemy; Ballistrea, Lisa; White, Keith] James A Haley Vet Hosp & Clin Hosp, Tampa, FL 33612 USA; [Wang, Xinping] North Florida South Georgia Vet Hlth Care Syst, Gainesville, FL USA; [Marszalek, Jacob] Univ Missouri Kansas City, Kansas City, MO USA; [Rice, Candice E.] Lexington VA Hlth Care Syst, Lexington, KY USA; [Pollard, Kendra] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Rhodes, Matthew A.] Southern Arizona VA Hlth Care Syst, Tucson, AZ USA; [Eldred, Kia] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Peterson, Michael] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Williams, Michael; Zuniga, Esteban] VA Natl Program Off, Blind Rehabil Serv, Washington, DC USA; [White, Helen] DoD VA Vis Ctr Excellence, Falls Church, VA USA; [Cockerham, Glenn C.] VA Ophthalmol Serv, Palo Alto, CA USA; [Cockerham, Glenn C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Winkler, SL (corresponding author), James A Haley Vet Hosp & Clin Hosp, Tampa, FL 33612 USA.	Sandra.Winkler@va.gov; Dezon.Finch@va.gov; Xinping.Wang@va.gov; Peter.Toyinbo@va.gov; Jacob.Marszalek@va.gov; CHRYSTYNA.RAKOCZY@GMAIL.COM; Candice.Rice@va.gov; Kendra.Pollard@va.gov; Matthew.Rhodes@va.gov; kia.eldred-mcgee@va.govkeldredmcgee@sbcglobal.net; Imelda.llanos@va.gov; Michael.peterson3@va.gov; michael.williams14@va.gov; Esteban.zuniga2@va.gov; Helenawhite915@aol.com; Jemy.Delikat@va.gov; Lisa.Ballistrea@va.gov; Keith.White2@va.gov; glenn.cockerham@va.gov			U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01HX002279]	U.S. Department of Veterans Affairs (I01HX002279; to SLW).	Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Cowper-Ripley Diane C, 2019, Fed Pract, V36, P122; Department of Veterans Affairs (VA), 2008, PERF TRAUM BRAIN INJ; Frick KD., 2012, COSTS MIL EYE INJ VI; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hale-Gallardo JL, 2020, J MULTIDISCIP HEALTH, V13, P559, DOI 10.2147/JMDH.S247267; LaVela SL, 2004, SOC SCI MED, V59, P2387, DOI 10.1016/j.socscimed.2004.06.033; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Merezhinskaya N, 2019, OPTOMETRY VISION SCI, V96, P542, DOI 10.1097/OPX.0000000000001407; O'Neil M., 2014, VISUAL DYSFUNCTION P; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sutter P., 1995, TRAUMATIC BRAIN INJU, P187; Vision Center of Excellence. Walter Reed National Military Medical Center, 2015, CLIN REC EYE CAR PRO; Wong CA, 2011, JT COMM J QUAL PATIE, V37, P81, DOI 10.1016/S1553-7250(11)37010-9	16	0	0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2022	99	1					9	17		10.1097/OPX.0000000000001828			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	XX2RX	WOS:000736150800003	34882607	Bronze			2022-02-06	
J	Winter, D; Braw, Y				Winter, Daniella; Braw, Yoram			COVID-19: Impact of diagnosis threat and suggestibility on subjective cognitive complaints	INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY			English	Article						COVID-19; Post COVID-19 Neuro-logical Syndrome&nbsp; (PCNS); Diagnosis threat; Cognitive complaints; Experiment	PLASMA AMYLOID-BETA; NEGATIVE EXPECTATIONS; FAILURES	Background/Objective: A subset of recovered COVID-19 patients report persistent neu-rological symptoms. These include non-specific symptoms (e.g., headaches and fatigue) which were found to be affected by psychological processes in other disorders (e.g., post-concussion syndrome, PCS, after mild traumatic brain injury). The current study assessed the impact of diagnosis threat (i.e., information regarding the long-term neurological impact of COVID-19) and suggestibility on endorsed symptoms of both recovered patients and healthy controls. Method: Recovered patients (n = 90) and healthy controls (n = 210) described their cognitive functioning after being randomly assigned to: (a) Experimental group: These participants read an article that explored long-term neurological symptoms among COVID-19 survivors. (b) Control group: These participants read an article providing general information regarding the disease. Results: Recovered patients, but not healthy controls, endorsed more symptoms in the experi-mental condition compared to the control condition. Moreover, suggestibility was correlated with endorsement of symptoms. Conclusions: Post COVID-19 neurological symptoms may, at least partially, be affected by non-neurological factors such as diagnosis threat. Information regarding long-term effects of COVID-19 may skew reported symptoms with highly suggestible individuals particularly susceptible to these effects. Further research, however, is needed to validate and elaborate upon these initial findings. (c) 2021 Asociacion Espanola de Psicologia Conductual. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).	[Winter, Daniella; Braw, Yoram] Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel		Braw, Y (corresponding author), Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel.	yoramb@ariel.ac.il		Braw, Yoram/0000-0002-5656-4863			Brailovskaia J, 2020, INT J CLIN HLTH PSYC, V20, P183, DOI 10.1016/j.ijchp.2020.06.002; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bueno-Notivol J, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2020.07.007; Cantero JL, 2016, J GERONTOL A-BIOL, V71, P1210, DOI 10.1093/gerona/glw022; Carrigan N, 2016, NEUROSCI BIOBEHAV R, V63, P29, DOI 10.1016/j.neubiorev.2016.01.010; Carter-Allison SN, 2016, ARCH CLIN NEUROPSYCH, V31, P727, DOI 10.1093/arclin/acw062; Chen XL, 2021, J NEUROL, V268, P392, DOI 10.1007/s00415-020-10067-3; Colloca L, 2020, NEW ENGL J MED, V382, P554, DOI 10.1056/NEJMra1907805; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Evers AWM, 2020, PSYCHOTHER PSYCHOSOM, V90, P49, DOI 10.1159/000510738; Fiorenzato E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246204; Fresson M, 2019, NEUROPSYCHOL REHABIL, V29, P1637, DOI 10.1080/09602011.2018.1439756; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Goertz YMJ, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00542-2020; GUDJONSSON GH, 1987, PERS INDIV DIFFER, V8, P347, DOI 10.1016/0191-8869(87)90035-3; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; HUFF MJ, 2018, JOURNALOFEXPERIMENTA; Jelicic, 2020, PSYCHOL CONSCIOUS, DOI [10.1037/cns0000224, DOI 10.1037/CNS0000224]; Kirsch I. E, 1999, EXPECTANCIES SHAPE E, pxiv; Kocjan GZ, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2020.08.002; Kotov RI, 2004, SHORT SUGGESTIBILITY; LAI CC, 2020, INTERNATIONALJOURNAL, V55; Liang LY, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00064; Llado-Saz S, 2015, NEUROBIOL AGING, V36, P2791, DOI 10.1016/j.neurobiolaging.2015.06.023; Manai M, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000699; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Merckelbach H., 2018, PSYCHOL CONSCIOUS, V5, P384, DOI [10.1037/cns0000159, DOI 10.1037/CNS0000159]; MONTALVAN V, 2020, CLINICALNEUROLOGYAND; Nelson Benjamin W, 2020, PLoS One, V15, pe0241990, DOI 10.1371/journal.pone.0241990; Nitzan U, 2015, J AFFECT DISORDERS, V185, P8, DOI 10.1016/j.jad.2015.06.028; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Pulido CM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072430; Rabinowitz Y. G., 2020, ETHICS MED PUBLIC HL, V14; Ray MK, 2020, EAT BEHAV, V37, DOI 10.1016/j.eatbeh.2020.101380; Ritchie K, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa069; Schwarz KA, 2018, PSYCHOL HEALTH MED, V23, P99, DOI 10.1080/13548506.2017.1332375; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sun B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020386; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; WIJERATNE T, 2020, JOURNALOFTHENEUROLOG; Wilhelm O, 2010, J INDIVID DIF, V31, P1, DOI 10.1027/1614-0001/a000001	44	0	0	22	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1697-2600	1576-7329		INT J CLIN HLTH PSYC	Int. J. Clin. Health Psychol.	JAN-APR	2022	22	1							100253	10.1016/j.ijchp.2021.100253			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	XK0MM	WOS:000727170200004	34054975	gold, Green Published			2022-02-06	
J	Wu, CR; Du, MR; Yu, RQ; Cheng, YQ; Wu, BY; Fu, JY; Tan, WL; Zhou, Q; Balawi, E; Liao, ZB				Wu, Chenrui; Du, Mengran; Yu, Renqiang; Cheng, Yuqi; Wu, Biying; Fu, Jiayuanyuan; Tan, Weilin; Zhou, Qiang; Balawi, Ehab; Liao, Z. B.			A novel mechanism linking ferroptosis and endoplasmic reticulum stress via the circPtpn14/miR-351-5p/5-LOX signaling in melatonin-mediated treatment of traumatic brain injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Traumatic brain injury; Melatonin; Ferroptosis; Endoplasmic reticulum stress; Blood-brain barrier; circRNA; microRNA	IRON-METABOLISM; INTRACRANIAL-PRESSURE; CELL-DEATH; IN-VITRO; BARRIER; DISRUPTION; HEMORRHAGE; EXPRESSION; PHYSIOLOGY; ALIGNMENT	Traumatic brain injury (TBI) can lead to disability or devastating consequences with few established treatments. Although ferroptosis has been shown to be involved in TBI, the underlying mechanism was rarely known. Melatonin has been indicated to exhibit neuroprotective activities. However, the anti-ferroptotic effects of melatonin on TBI have not yet to be elucidated. We aimed to investigate whether ferroptosis was induced in humans after TBI and whether ferroptosis inhibition by melatonin could protect against blood-brain barrier (BBB) damage after TBI in vivo and in vitro. Circular RNAs (circRNAs) are highly expressed in the brain. For the first time, differentially expressed circRNA after melatonin treatment for TBI were detected by RNA sequencing. We found that lipid peroxidation was induced in humans after TBI, while melatonin significantly improved brain function of mice after TBI and alleviated ferroptosis and endoplasmic reticulum (ER) stress in vivo and in vitro. A total of 1826 differentially expressed circRNAs were found (fold change 2, Q < 0.01), including 921 downregulated and 905 up-regulated circRNAs in the injured brain tissues of TBI mice receiving melatonin treatment. Mechanistically, melatonin administration reduced the level of circPtpn14 (mmu_circ_0000130), which functioned by acting as a miR-351-5p sponge to positively regulate the expression of the ferroptosis-related 5-lipoxygenase (5-LOX). Moreover, circPtpn14 overexpression partly abolished the inhibitory effects of melatonin on ferroptosis. Collectively, our findings provide the first evidence that melatonin could exert anti-ferroptotic and anti-ER stress effects in brain injury by alleviating lipid peroxidation via the circPtpn14/miR-351-5p/5-LOX signaling.	[Wu, Chenrui; Du, Mengran; Cheng, Yuqi; Wu, Biying; Fu, Jiayuanyuan; Tan, Weilin; Zhou, Qiang; Balawi, Ehab; Liao, Z. B.] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China; [Yu, Renqiang] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing 400016, Peoples R China		Liao, ZB (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	liaozb123@cqmu.edu.cn	Wu, Chenrui/ABG-9791-2021	Wu, Chenrui/0000-0002-4933-6918; liao, ZB/0000-0003-4591-9689; Balawi, Ehab/0000-0003-1316-0268	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771355]; Natural Science Foundation of Chongqing Science and Technology Bureau [CSTC2015jcyjA10096]	This work was supported by the National Natural Science Foundation of China (No. 81771355) and Natural Science Foundation of Chongqing Science and Technology Bureau (CSTC2015jcyjA10096).	Al-Ameri LT, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9010010; Alborzinia N, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0212-6; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Bektas O, 2014, BRAIN DEV-JPN, V36, P130, DOI 10.1016/j.braindev.2013.03.002; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Cheng Y.Q., NEURAL REGEN RES, V17, P812; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; Cuzzocrea S, 2000, J PINEAL RES, V29, P217, DOI 10.1034/j.1600-0633.2002.290404.x; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Derry PJ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.603043; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dzitoyeva S, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/209596; Fong CY, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011786.pub2; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.biochem.63.1.383; Gao M, 2019, BIOMATERIALS, V223, DOI 10.1016/j.biomaterials.2019.119486; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gaschler MM, 2018, ACS CHEM BIOL, V13, P1013, DOI 10.1021/acschembio.8b00199; Gorman MR, 2020, MOL CELL ENDOCRINOL, V503, DOI 10.1016/j.mce.2019.110687; Guo JP, 2018, CANCER RES TREAT, V50, P445, DOI 10.4143/crt.2016.572; Hanan M, 2017, RNA BIOL, V14, P1028, DOI 10.1080/15476286.2016.1255398; Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93; Hemphill M, 2020, J NEUROTRAUM, V37, P2424, DOI 10.1089/neu.2018.6220; Howe KL, 2021, NUCLEIC ACIDS RES, V49, pD884, DOI 10.1093/nar/gkaa942; Huang YN, 2018, THERANOSTICS, V8, P5929, DOI 10.7150/thno.28029; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Keep RF, 2018, J CEREBR BLOOD F MET, V38, P1255, DOI 10.1177/0271678X18774666; Khalaf S, 2019, J NEUROTRAUM, V36, P43, DOI 10.1089/neu.2017.5617; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koskenkorva-Frank TS, 2013, FREE RADICAL BIO MED, V65, P1174, DOI 10.1016/j.freeradbiomed.2013.09.001; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HC, 2020, AGING-US, V12, P21687, DOI 10.18632/aging.103975; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YC, 2021, CELL MOL NEUROBIOL, V41, P263, DOI 10.1007/s10571-020-00850-1; Liu J, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1453; Liu L, 2019, NEUROSCIENCE, V408, P105, DOI 10.1016/j.neuroscience.2019.03.038; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Luongo A., ADV CHILD DEV BEHAV, V60, P229; Ma HD, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9067610; Ma Y, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110251; Maass PG, 2017, J MOL MED, V95, P1179, DOI 10.1007/s00109-017-1582-9; Magtanong L, 2019, DEV NEUROSCI-BASEL, V40, P382, DOI 10.1159/000496922; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Rui TY, 2020, HISTOL HISTOPATHOL, V35, P1105, DOI 10.14670/HH-18-229; Rui TY, 2021, J PINEAL RES, V70, DOI 10.1111/jpi.12704; Shahrokhi N, 2018, IRAN J BASIC MED SCI, V21, P301, DOI 10.22038/ijbms.2018.25928.6377; Shen LS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00594; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Stolwijk JM, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101518; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Thirupathi A, 2019, ADV EXP MED BIOL, V1173, P1, DOI 10.1007/978-981-13-9589-5_1; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang SF, 2018, ACS NANO, V12, P12380, DOI 10.1021/acsnano.8b06399; Wang YJ, 2020, J PINEAL RES, V69, DOI 10.1111/jpi.12666; Wang YJ, 2021, NEUROPSYCHOL REHABIL, V31, P211, DOI 10.1080/09602011.2019.1682622; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Wu JC, 2020, J NEUROCHEM, V153, P710, DOI 10.1111/jnc.14963; Wu YQ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01157-x; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xu T, 2019, J CELL MOL MED, V23, P4900, DOI 10.1111/jcmm.14511; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zhao J, 2018, EXP NEUROL, V302, P22, DOI 10.1016/j.expneurol.2017.12.015; Zhou N, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa021; Zhu HX, 2020, NEUROSCIENCE, V428, P50, DOI 10.1016/j.neuroscience.2019.12.018; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	97	0	0	7	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	JAN	2022	178						271	294		10.1016/j.freeradbiomed.2021.12.007			24	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	XV4AE	WOS:000734885800001	34883251	hybrid			2022-02-06	
J	Wu, ZY; Cao, M; Di, X; Wu, K; Gao, Y; Li, XB				Wu, Ziyan; Cao, Meng; Di, Xin; Wu, Kai; Gao, Yu; Li, Xiaobo			Regional Topological Aberrances of White Matter- and Gray Matter-Based Functional Networks for Attention Processing May Foster Traumatic Brain Injury-Related Attention Deficits in Adults	BRAIN SCIENCES			English	Article						traumatic brain injury (TBI); post-TBI attention deficits; visual sustained-attention task (VSAT); graph theoretic technique (GTT); white matter tracts	LONG-TERM CONSEQUENCES; SUSTAINED-ATTENTION; COGNITIVE IMPAIRMENT; CORTICAL THICKNESS; SEX-DIFFERENCES; NEUROCOGNITIVE PERFORMANCE; CORPUS-CALLOSUM; LOW-FREQUENCY; SOCCER; CONNECTIVITY	Traumatic brain injury (TBI) is highly prevalent in adults. TBI-related functional brain alterations have been linked with common post-TBI neurobehavioral sequelae, with unknown neural substrates. This study examined the systems-level functional brain alterations in white matter (WM) and gray matter (GM) for visual sustained-attention processing, and their interactions and contributions to post-TBI attention deficits. Task-based functional MRI data were collected from 42 adults with TBI and 43 group-matched normal controls (NCs), and analyzed using the graph theoretic technique. Global and nodal topological properties were calculated and compared between the two groups. Correlation analyses were conducted between the neuroimaging measures that showed significant between-group differences and the behavioral symptom measures in attention domain in the groups of TBI and NCs, respectively. Significantly altered nodal efficiencies and/or degrees in several WM and GM nodes were reported in the TBI group, including the posterior corona radiata (PCR), posterior thalamic radiation (PTR), postcentral gyrus (PoG), and superior temporal sulcus (STS). Subjects with TBI also demonstrated abnormal systems-level functional synchronization between the PTR and STS in the right hemisphere, hypo-interaction between the PCR and PoG in the left hemisphere, as well as the involvement of systems-level functional aberrances in the PCR in TBI-related behavioral impairments in the attention domain. The findings of the current study suggest that TBI-related systems-level functional alterations associated with these two major-association WM tracts, and their anatomically connected GM regions may play critical role in TBI-related behavioral deficits in attention domains.	[Wu, Ziyan; Li, Xiaobo] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA; [Cao, Meng; Di, Xin; Li, Xiaobo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Wu, Kai] South China Univ Technol, Sch Biomed Sci & Engn, Guangzhou 510630, Peoples R China; [Gao, Yu] CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; [Gao, Yu] CUNY, Grad Ctr, New York, NY 10016 USA		Li, XB (corresponding author), New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ 07102 USA.; Li, XB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	zw255@njit.edu; meng.cao@njit.edu; xin.di@njit.edu; kaiwu@scut.edu.cn; yugao@brooklyn.cuny.edu; xiaobo.li@njit.edu	Di, Xin/B-2009-2009	Di, Xin/0000-0002-2422-9016	New Jersey Commission on Brain Injury Research [CBIR17PIL012]; National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH109791, R15MH117368]	FundingThis work was supported by research grants from the New Jersey Commission on Brain Injury Research (CBIR17PIL012) and the National Institutes of Mental Health (R03MH109791, R15MH117368).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Antonakakis M, 2020, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00090; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; BARKLEY RA, 1990, J CONSULT CLIN PSYCH, V58, P775, DOI 10.1037/0022-006X.58.6.775; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Chamard E, 2014, PROG NEUROL SURG, V28, P75, DOI 10.1159/000358766; Chiang HL, 2015, J PSYCHIATR NEUROSCI, V40, P325, DOI 10.1503/jpn.140106; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Emos M.C., 2021, NEUROANATOMY INTERNA; Epstein J.N., 2006, CONNERS ADULT ADHD D; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Frieden T.R., 2015, REPORT C TRAUMATIC B; Gawryluk JR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00239; Gawryluk JR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-56; George K., 2021, NEUROANATOMY THALAMO; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; HALPERIN JM, 1990, J CHILD PSYCHOL PSYC, V31, P455, DOI 10.1111/j.1469-7610.1990.tb01582.x; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hibino S, 2013, NEUROL MED-CHIR, V53, P299, DOI 10.2176/nmc.53.299; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jia XY, 2021, J NEUROTRAUM, V38, P2686, DOI 10.1089/neu.2021.0017; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klarborg B, 2013, HUM BRAIN MAPP, V34, P3216, DOI 10.1002/hbm.22139; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li MW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103104118; Li XB, 2012, J AM ACAD CHILD PSY, V51, P1197, DOI 10.1016/j.jaac.2012.08.013; Li XB, 2012, SCHIZOPHR RES, V141, P128, DOI 10.1016/j.schres.2012.07.026; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mallat S., 1999, WAVELET TOUR SIGNAL; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mazerolle EL, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-84; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagel BJ, 2011, J AM ACAD CHILD PSY, V50, P283, DOI 10.1016/j.jaac.2010.12.003; Nicole M., 2018, FUNDAMENTALS COGNITI, V2nd; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Ogren JA, 2018, NEUROIMAGE-CLIN, V20, P205, DOI 10.1016/j.nicl.2018.07.015; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Owens JA, 2018, BRAIN INJURY, V32, P776, DOI 10.1080/02699052.2018.1451656; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pang JC, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.022418; Pavuluri MN, 2009, BIOL PSYCHIAT, V65, P586, DOI 10.1016/j.biopsych.2008.10.015; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Petley L, 2018, BRAIN INJURY, V32, P464, DOI 10.1080/02699052.2018.1429022; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Sharma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175979; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Siegel JS, 2017, J CEREBR BLOOD F MET, V37, P2665, DOI 10.1177/0271678X17709198; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stave EA, 2017, J CHILD NEUROL, V32, P458, DOI 10.1177/0883073816685652; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Vargo JM, 1999, J TRAUMA, V47, P265, DOI 10.1097/00005373-199908000-00008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2014, CEREB CORTEX, V24, P2036, DOI 10.1093/cercor/bht056; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wright NF, 2015, J NEUROSCI, V35, P5480, DOI 10.1523/JNEUROSCI.4945-14.2015; Wu ZY, 2018, CNS NEUROSCI THER, V24, P539, DOI 10.1111/cns.12811; Xia SG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00162; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	110	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2022	12	1							16	10.3390/brainsci12010016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	YL6QH	WOS:000746013100001	35053760	gold, Green Accepted, Green Submitted			2022-02-06	
J	Yan, XJ; Li, YB; Liu, W; Wu, HY; Yu, GF				Yan, Xin-Jiang; Li, Yang-Bo; Liu, Wei; Wu, Hua-Yong; Yu, Guo-Feng			p Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						traumatic brain injury; C1q; severity; functional outcome; biomarkers	SYSTEM; HEAD	Objective: Complement C1q is implicated in neuroinflammation. We intended to discern the relationship between serum C1q levels and severity in addition to prognosis following traumatic brain injury (TBI). Methods: In this prospective, observational study, serum C1q levels were quantified in 188 TBI patients and 188 healthy controls. Glasgow coma scale (GCS) and Rotterdam computed tomography (CT) classification were used as clinical and radiological indicators of severity. Patients with extended Glasgow outcome scale (GOSE) score of 1-4 at 6 months after trauma were considered to have a poor outcome. Multiple logistic regression model was built to ascertain the independent association of serum C1q levels with 6-month poor outcome. Receiver operating characteristic (ROC) curve was configured for analysis of prognostic capability with respect to serum C1q levels. Results: TBI patients exhibited substantially higher serum C1q levels than controls (median, 223.9 mg/l versus 75.4 mg/l). Serum C1q levels of patients were tightly correlated with GCS score (r = -0.671), Rotterdam CT classification (r = 0.604) and GOSE score (r = -0.581). An area under the ROC curve was yielded of 0.793 (95% confidence interval = 0.728-0.849), and serum C1q levels above 345.5 mg/l discriminated the risk of 6-month poor outcome with 59.6% sensitivity and 92.6% specificity. Serum C1q levels above 345.5 mg/l retained as an independent predictor for 6-month poor outcome with odds ratio of 4.922 (95% confidence interval = 1.552-15.606; P = 0.017). Conclusion: Elevated serum C1q levels are closely correlated with traumatic severity and independently predicted the risk of long-term poor prognosis after TBI.	[Yan, Xin-Jiang; Li, Yang-Bo; Liu, Wei; Yu, Guo-Feng] Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Neurosurg, Quzhou Affiliated Hosp, Quzhou, Peoples R China; [Wu, Hua-Yong] Wenzhou Med Univ, Quzhou Peoples Hosp, Neurosurg Intens Care Unit, Quzhou Affiliated Hosp, Quzhou, Peoples R China		Yu, GF (corresponding author), Wenzhou Med Univ, Quzhou Peoples Hosp, Dept Neurosurg, Quzhou Affiliated Hosp, Quzhou, Peoples R China.	yuguofeng79@aliyun.com					Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Ciechanowska A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010045; Dalakas MC, 2020, NAT REV NEUROL, V16, P601, DOI 10.1038/s41582-020-0400-0; Datta D, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1683-1; Ditillo M, 2011, J TRAUMA, V71, P373; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Fonseca MI, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0814-9; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Killen MJ, 2019, EXPERT REV NEUROTHER, V19, P227, DOI 10.1080/14737175.2019.1582332; Kim BS, 2010, ATHEROSCLEROSIS, V212, P682, DOI 10.1016/j.atherosclerosis.2010.07.007; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Ma WC, 2012, CELL IMMUNOL, V274, P72, DOI 10.1016/j.cellimm.2012.02.001; Mack WJ, 2006, J NEUROSCI RES, V83, P883, DOI 10.1002/jnr.20775; Roselli F, 2018, J NEUROTRAUM, V35, P226, DOI 10.1089/neu.2017.5168; Schafer MKH, 2000, J IMMUNOL, V164, P5446, DOI 10.4049/jimmunol.164.10.5446; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Ten VS, 2005, STROKE, V36, P2244, DOI 10.1161/01.STR.0000182237.20807.d0; Wang DD, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105363; Zhao XW, 2017, CLIN LAB, V63, P915, DOI 10.7754/Clin.Lab.2016.161033	22	0	0	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2022	18						47	55		10.2147/NDT.S348682			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	YH0AD	WOS:000742838800001	35035218	gold, Green Published			2022-02-06	
J	Yan, ZC; Zhang, HZ; Zhang, Z; Wang, XD; Wei, M; Wang, XD				Yan, Zhengcun; Zhang, Hengzhu; Zhang, Zhen; Wang, Xiaodong; Wei, Min; Wang, Xingdong			Clinical Study of Cranioplasty Combined With Ipsilateral Ventriculoperitoneal Shunt in the Treatment of Skull Defects With Hydrocephalus	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cranioplasty; decompressive craniotomy; hydrocephalus; skull defect; ventriculoperitoneal shunt	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; COMPLICATIONS	Objective: To explore the clinical effect and safety of cranioplasty combined with ipsilateral ventriculoperitoneal shunts in the treatment of skull defects with hydrocephalus. Methods: The clinical data of 78 patients with skull defects with hydrocephalus were analyzed retrospectively. All patients were treated with cranioplasty and ventriculoperitoneal shunts in 1 stage, including 35 cases of cranioplasty combined with ipsilateral ventriculoperitoneal shunts (ipsilateral operation group) and 43 cases of contralateral operations (contralateral operation group). Results: The incision length (28.97 +/- 4.55 cm), operation time (139.00 +/- 42.27 minutes), and intraoperative hemorrhage (174.57 +/- 79.35 mL) in the ipsilateral operation group were significantly better than those in the contralateral operation group (respectively they were 37.15 +/- 5.83 cm, 214.07 +/- 34.35 minutes, and 257.21 +/- 72.02 mL), and the difference was statistically significant (t = 6.786, 8.656, and 4.815, all P < 0.05). The degree of postoperative hydrocephalus was significantly improved in both groups, but there was no statistically significant difference in the degree of hydrocephalus between the 2 groups (P> 0.05). Among the postoperative complications, there was no statistically significant difference in infection, epilepsy, subdural effusion, titanium plate effusion, or excessive cerebrospinal fluid drainage between the 2 groups (P> 0.05), but the incidence of intracranial hemorrhage in the ipsilateral operation group (2.86%) was significantly lower than that in the contralateral operation group (20.93%, chi(2) = 4.138, P = 0.042). The postoperative Glasgow Coma Scale scores of the 2 groups were improved compared with those before the operation (P< 0.05), and there was no statistically significant difference in the postoperative Glasgow Coma Scale scores (P> 0.05). At 6 months after surgery, there was no statistically significant difference in Glasgow Outcome Scale effectiveness between the 2 groups (chi(2) = 0.005, P = 0.944). Conclusions: Cranioplasty combined with ipsilateral ventriculoperitoneal shunt has the same therapeutic effect as a contralateral operation, but it has the advantage of a short operation time, less intraoperative trauma, less bleeding, and less risk of intracranial hemorrhage, which is suitable for clinical applications.	[Yan, Zhengcun; Zhang, Hengzhu] Soochow Univ, Affiliated Hosp 2, Suzhou, Suzhou Province, Peoples R China; [Yan, Zhengcun; Zhang, Hengzhu; Wang, Xiaodong; Wei, Min; Wang, Xingdong] Yangzhou Univ, Clin Med Coll, Yangzhou, Jiangsu, Peoples R China; [Zhang, Zhen] Nanjing Med Univ, Affiliated Suzhou Sci & Technol Town Hosp, Suzhou, Peoples R China		Zhang, HZ (corresponding author), Soochow Univ, Affiliated Hosp 2, Suzhou, Suzhou Province, Peoples R China.	zhanghengzhu@sina.com					Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Goedemans T, 2020, J NEUROL, V267, P1312, DOI 10.1007/s00415-020-09695-6; Gordon CR, 2019, OPER NEUROSURG, V17, P608, DOI 10.1093/ons/opz003; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Jung Young Taek, 2015, Korean J Neurotrauma, V11, P93, DOI 10.13004/kjnt.2015.11.2.93; Konig M, 2010, SKULL BASE-INTERD AP, V20, P119, DOI 10.1055/s-0029-1238216; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Li G, 2008, BRAIN INJURY, V22, P333, DOI 10.1080/02699050801958353; Lyon K, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.05.024; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Mitchell KAS, 2020, J CRANIOFAC SURG, V31, P1998, DOI 10.1097/SCS.0000000000006730; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Peraio S, 2017, J NEUROSURG SCI, V61, P673, DOI 10.23736/S0390-5616.16.03427-X; Roth J, 2011, NEUROSURGERY, V68, pE271, DOI 10.1227/NEU.0b013e3181fe6165; Ting CW, 2020, J CLIN NEUROSCI, V79, P45, DOI 10.1016/j.jocn.2020.07.015; Topjian AA, 2014, NEUROCRIT CARE, V21, P294, DOI 10.1007/s12028-013-9946-7; Tsianaka E, 2021, J CRANIOFAC SURG, V32, P530, DOI 10.1097/SCS.0000000000007344; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2017, BRAIN INJURY, V31, P1651, DOI 10.1080/02699052.2017.1332781	22	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN-FEB	2022	33	1					289	293		10.1097/SCS.0000000000008227			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XW2VB	WOS:000735482400081	34608006				2022-02-06	
J	Yang, ZS; Simovic, MO; Edsall, PR; Liu, B; Cancio, TS; Batchinsky, AI; Cancio, LC; Li, YS				Yang, Zhangsheng; Simovic, Milomir O.; Edsall, Peter R.; Liu, Bin; Cancio, Tomas S.; Batchinsky, Andriy I.; Cancio, Leopoldo C.; Li, Yansong			HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma	BIOMOLECULES			English	Article						HMGB1; trauma; hemorrhagic shock; inflammation; multiple organ failure	MOBILITY GROUP BOX-1; TISSUE-DAMAGE; C1 INHIBITOR; INFLAMMATORY RESPONSES; THERAPEUTIC TARGET; IMPROVES SURVIVAL; IMMUNE-RESPONSE; INJURY; ACTIVATION; BINDING	Several preclinical and clinical reports have demonstrated that levels of circulating high mobility group box 1 protein (HMGB1) are increased early after trauma and are associated with systemic inflammation and clinical outcomes. However, the mechanisms of the interaction between HMGB1 and inflammatory mediators that lead to the development of remote organ damage after trauma remain obscure. HMGB1 and inflammatory mediators were analyzed in plasma from 54 combat casualties, collected on admission to a military hospital in Iraq, and at 8 and 24 h after admission. In total, 45 (83%) of these patients had traumatic brain injury (TBI). Nine healthy volunteers were enrolled as controls. HMGB1 plasma levels were significantly increased in the first 8 h after admission, and were found to be associated with systemic inflammatory responses, injury severity score, and presence of TBI. These data provided the rationale for designing experiments in rats subjected to blast injury and hemorrhage, to explore the effect of HMGB1 inhibition by CX-01 (2-O, 3-O desulfated heparin). Animals were cannulated, then recovered for 5-7 days before blast injury in a shock tube and volume-controlled hemorrhage. Blast injury and hemorrhage induced an early increase in HMGB1 plasma levels along with severe tissue damage and high mortality. CX-01 inhibited systemic HMGB1 activity, decreased local and systemic inflammatory responses, significantly reduced tissue and organ damage, and tended to increase survival. These data suggest that CX-01 has potential as an adjuvant treatment for traumatic hemorrhage.	[Yang, Zhangsheng; Simovic, Milomir O.; Edsall, Peter R.; Liu, Bin; Cancio, Tomas S.; Batchinsky, Andriy I.; Cancio, Leopoldo C.; Li, Yansong] US Army Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA; [Simovic, Milomir O.; Batchinsky, Andriy I.; Li, Yansong] Geneva Fdn, Tacoma, WA 98402 USA		Cancio, LC; Li, YS (corresponding author), US Army Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA.; Li, YS (corresponding author), Geneva Fdn, Tacoma, WA 98402 USA.	Zhangsheng.yang.ctr@mail.mil; msimovic@genevausa.org; peter.r.edsall.civ@mail.mil; bin.liu4.ctr@mail.mil; tomas.s.cancio.ctr@mail.mil; abatchinsky@genevausa.org; Leopoldo.c.cancio.civ@mail.mil; ysli916@gmail.com			DoD US Army Medical Research & Development Command [C_038_2014]; DoD US Army Medical Research & Development Command FY15 Broad Agency Announcement [BA150301]	This research was supported by the DoD US Army Medical Research & Development Command (C_038_2014) and by the DoD US Army Medical Research & Development Command FY15 Broad Agency Announcement (BA150301).	Andersson U, 2018, EXPERT OPIN THER TAR, V22, P263, DOI 10.1080/14728222.2018.1439924; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Arbore G, 2016, EUR J IMMUNOL, V46, P1563, DOI 10.1002/eji.201546131; Bianchi ME, 2017, IMMUNOL REV, V280, P74, DOI 10.1111/imr.12601; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; Campbell JC, 2016, SHOCK, V46, P177, DOI 10.1097/SHK.0000000000000677; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; Chambers JA, 2019, MIL MED, V184, P67, DOI 10.1093/milmed/usy185; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Cheng ZX, 2019, CRIT CARE MED, V47, pE677, DOI 10.1097/CCM.0000000000003839; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Deng MH, 2019, J LEUKOCYTE BIOL, V106, P161, DOI 10.1002/JLB.3MIR1218-497R; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Eppensteiner J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127925; Ge Y, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051044; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Griffin KL, 2014, AM J RESP CELL MOL, V50, P684, DOI 10.1165/rcmb.2013-0338RC; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Jiang LL, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/7206451; Kim SY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00705; Kovacsovics TJ, 2018, BLOOD ADV, V2, P381, DOI 10.1182/bloodadvances.2017013391; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Li YS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202594; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Liu TY, 2019, P NATL ACAD SCI USA, V116, P23254, DOI 10.1073/pnas.1907490116; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lucca JJD, 2013, J SURG RES, V179, P153, DOI 10.1016/j.jss.2012.10.017; Lucca JJD, 2012, SHOCK, V38, P82, DOI 10.1097/SHK.0b013e31825a3522; Lucca JJD, 2011, J TRAUMA, V71, pS151, DOI 10.1097/TA.0b013e318221aa4c; Lusczek ER, 2017, J TRAUMA ACUTE CARE, V82, P309, DOI 10.1097/TA.0000000000001277; Ma KC, 2018, AM J RESP CRIT CARE, V197, P300, DOI 10.1164/rccm.201612-2460PP; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nagata K, 2018, J TRAUMA ACUTE CARE, V84, P727, DOI 10.1097/TA.0000000000001819; Nishibori M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122650; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Osuka A, 2014, ACUTE MED SURG, V1, P63, DOI 10.1002/ams2.17; Ottestad W, 2019, CRIT CARE MED, V47, pE614, DOI 10.1097/CCM.0000000000003800; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Rasmuson J, 2019, FASEB J, V33, P10443, DOI 10.1096/fj.201900627R; Relja B, 2018, EUR J TRAUMA EMERG S, V44, P301, DOI 10.1007/s00068-018-0962-3; Rittirsch D, 2016, ANN SURG, V264, P1125, DOI 10.1097/SLA.0000000000001553; Rodell TC, 1996, IMMUNOPHARMACOLOGY, V33, P279, DOI 10.1016/0162-3109(96)00071-9; Roh JS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e27; Roquilly A, 2012, Ann Fr Anesth Reanim, V31, pe97, DOI 10.1016/j.annfar.2012.04.012; Saxena S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102582; Sharma L, 2014, J IMMUNOTOXICOL, V11, P260, DOI 10.3109/1547691X.2013.839587; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Tang YT, 2021, IMMUNITY, V54, P454, DOI 10.1016/j.immuni.2021.01.007; VanPatten S, 2018, J MED CHEM, V61, P5093, DOI 10.1021/acs.jmedchem.7b01136; Venereau E, 2013, MOL IMMUNOL, V55, P76, DOI 10.1016/j.molimm.2012.10.037; Vijayakumar EC, 2019, CURR DRUG TARGETS, V20, P1474, DOI 10.2174/1389450120666190618125100; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00484; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Yang ZS, 2019, MIL MED, V184, P282, DOI 10.1093/milmed/usy412; Yu SL, 2019, J BIOL CHEM, V294, P8384, DOI 10.1074/jbc.RA118.006508; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao HL, 2016, CRIT CARE MED, V44, P1000, DOI 10.1097/CCM.0000000000001603; Zwaini Z, 2017, CURR GENE THER, V17, P411, DOI 10.2174/1566523218666180214093043	69	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2218-273X		BIOMOLECULES	Biomolecules	JAN	2022	12	1							101	10.3390/biom12010101			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO3HR	WOS:000747834900001	35053249	Green Accepted, gold			2022-02-06	
J	Zhang, HH; Li, YD; Xun, Y; Liu, H; Wei, CX; Wang, H; Yang, XP; Yuan, SS; Liu, N; Xiang, SL				Zhang, Huihui; Li, Yadan; Xun, Yu; Liu, Hui; Wei, Chenxi; Wang, Hao; Yang, Xiaoping; Yuan, Shishan; Liu, Ning; Xiang, Shuanglin			Polydatin protects neuronal cells from hydrogen peroxide damage by activating CREB/Ngb signaling	MOLECULAR MEDICINE REPORTS			English	Article						polydatin; cAMP response element-binding protein; neuroglobin; hydrogen peroxide; neuronal cells	SEVERE HEMORRHAGIC-SHOCK; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; MITOCHONDRIAL DYSFUNCTION; NEUROGLOBIN GENE; INFLAMMATION; INJURY; DEATH; PERMEABILITY; INVOLVEMENT	Oxidative stress-induced neuronal cell death contributes significantly to the physiological processes of a number of neurological disorders. Polydatin (PD) has been reported to protect against Alzheimer's disease (AD), ischemic stroke and traumatic brain injury. However, the underlying neuroprotective mechanisms remain to be elucidated. The current study suggested that PD activates AKT/cAMP response element-binding protein (CREB) signaling and induces neuroglobin (Ngb) to protect neuronal cells from hydrogen peroxide (H2O2) in vitro. PD inhibited the H2O2-induced neuronal cell death of primary mouse cortical neurons and N2a cells. Functional studies showed that PD attenuated H2O2-induced mitochondrial dysfunction and mitochondrial reactive oxygen species production. Mechanistically, PD was verified to induce the phosphorylation of AKT and CREB and increase the protein level of Ngb. The luciferase assay results showed that Ngb transcriptional activity was activated by CREB, especially after PD treatment. It was further indicated that PD increased the transcription of Ngb by enhancing the binding of CREB to the promoter region of Ngb. Finally, Ngb knockdown largely attenuated the neuroprotective role of PD against H2O2. The results indicated that PD protected neuronal cells from H2O2 by activating CREB/Ngb signaling in neuronal cells, indicating that PD has a neuroprotective effect against neurodegenerative diseases.	[Zhang, Huihui; Yang, Xiaoping; Yuan, Shishan; Liu, Ning] Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha 410081, Hunan, Peoples R China; [Li, Yadan; Liu, Hui] Changsha Environm Protect Coll, Dept Environm Sci, 10 Jinggui Rd, Changsha 410004, Hunan, Peoples R China; [Xun, Yu; Wei, Chenxi; Xiang, Shuanglin] Hunan Normal Univ, Sch Life Sci, State Key Lab Dev Biol Freshwater Fish, 36 Lushan Rd, Changsha 410081, Hunan, Peoples R China; [Wang, Hao] Southern Med Univ, Dept Neurosurg, Affiliated Hosp Integrated Tradit Chinese & Weste, Guangzhou 510020, Guangdong, Peoples R China		Li, YD (corresponding author), Changsha Environm Protect Coll, Dept Environm Sci, 10 Jinggui Rd, Changsha 410004, Hunan, Peoples R China.; Xiang, SL (corresponding author), Hunan Normal Univ, Sch Life Sci, State Key Lab Dev Biol Freshwater Fish, 36 Lushan Rd, Changsha 410081, Hunan, Peoples R China.	yadande2020@gmail.com; xshlin@hunnu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972642]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2018JJ3337]; Research Foundation of Education Bureau of Hunan Province [16C0018, 17B162]; Hunan Provincial Health Commission Project [C2016045]; Huxiang High-Level Talent Innovation Team [2018RS3072]	The present study was funded in part by the National Natural Science Foundation of China (grant no. 81972642), the Natural Science Foundation of Hunan Province (grant no. 2018JJ3337), the Research Foundation of Education Bureau of Hunan Province (grant nos. 16C0018 and 17B162), the Hunan Provincial Health Commission Project (grant no. C2016045) and the Huxiang High-Level Talent Innovation Team (grant no. 2018RS3072).	Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Bai H, 2020, NEUROCHEM INT, V134, DOI 10.1016/j.neuint.2020.104671; Bonnefont-Rousselot D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050250; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chen YP, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-4; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gu LN, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103688; Huang BX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02527; Huang TJ, 2003, DIABETES, V52, P2129, DOI 10.2337/diabetes.52.8.2129; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Kamat CD, 2008, J ALZHEIMERS DIS, V15, P473; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Li L, 2019, NEURAL REGEN RES, V14, P1573, DOI 10.4103/1673-5374.255972; Li PY, 2015, EXPERT OPIN THER TAR, V19, P997, DOI 10.1517/14728222.2015.1054806; Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022; Ling YN, 2016, CLIN SCI, V130, P1641, DOI 10.1042/CS20160082; Liu H, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0294-2; Liu N, 2018, J ALZHEIMERS DIS, V64, P1163, DOI 10.3233/JAD-180163; Liu N, 2016, CNS NEUROL DISORD-DR, V15, P629, DOI 10.2174/1871527315666160321105612; Liu N, 2013, NEUROSCI LETT, V534, P333, DOI 10.1016/j.neulet.2012.11.025; Liu N, 2012, BIOCHEM J, V443, P153, DOI 10.1042/BJ20111856; Lv RX, 2019, INT IMMUNOPHARMACOL, V70, P28, DOI 10.1016/j.intimp.2019.02.006; Lv RX, 2019, LIFE SCI, V217, P119, DOI 10.1016/j.lfs.2018.11.053; Mylroie H, 2015, CARDIOVASC RES, V106, P509, DOI 10.1093/cvr/cvv131; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Poddar MK, 2021, METAB BRAIN DIS, V36, P781, DOI 10.1007/s11011-021-00673-z; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; See V, 2001, J BIOL CHEM, V276, P35049, DOI 10.1074/jbc.M104988200; Shah FA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00663; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Tang KS, 2021, CURR NEUROPHARMACOL, V19, P127, DOI 10.2174/1570159X18666200611144825; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wang XB, 2017, INT J CLIN EXP MED, V10, P15250; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Ye J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12252-3; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhan JH, 2020, J CELL MOL MED, V24, P5317, DOI 10.1111/jcmm.15187; Zhang SZ, 2020, NEUROCHEM INT, V139, DOI 10.1016/j.neuint.2020.104815; Zhao XJ, 2018, REDOX BIOL, V18, P124, DOI 10.1016/j.redox.2018.07.002; Zhao XM, 2020, J MOL NEUROSCI, V70, P1332, DOI 10.1007/s12031-020-01546-3; Zhou TF, 2016, AM J PHYSIOL-CELL PH, V311, pC572, DOI 10.1152/ajpcell.00093.2016	49	0	0	8	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2022	25	1							9	10.3892/mmr.2021.12525			10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	XA0MW	WOS:000720353500001	34751416	hybrid, Green Published			2022-02-06	
J	Zynda, AJ; Wagner, KJ; Liu, J; Chung, JS; Miller, SM; Wilson, PL; Ellis, HB				Zynda, Aaron J.; Wagner, K. John; Liu, Jie; Chung, Jane S.; Miller, Shane M.; Wilson, Philip L.; Ellis, Henry B.			Epidemiology of Pediatric Basketball Injuries Presenting to Emergency Departments: Sex- and Age-Based Patterns	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						adolescent; basketball; child; descriptive epidemiology; injury; recreation; sports	ANTERIOR CRUCIATE LIGAMENT; SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; HIGH-SCHOOL SPORTS; 1ST DECADE; PREVENTION; CHILDREN; RISK; CONCUSSIONS; PROGRAMS; GENDER	Background: There is limited epidemiologic data on pediatric basketball injuries and the comparison of these injuries before and after adolescence and between male and female athletes. Purpose: To assess common sex- and age-based injury patterns in pediatric basketball players. Study Design: Descriptive epidemiology study. Methods: Injury data from the National Electronic Injury Surveillance System (NEISS) and participation data from the National Sporting Goods Association were used to complete this study. Data on pediatric basketball injuries between January 2012 and December 2018 in patients aged 7 to 11 years (childhood) and 12 to 17 years (adolescence) were extracted and used to calculate national injury incidence rates with 95% CIs. Sex and age group patterns were examined utilizing Pearson chi-square tests. Z tests were conducted for the comparison of injury rates between female and male athletes in each age group and overall injury rate across age groups. Results: An average of 9582 basketball injuries were reported annually in the NEISS, which calculated to an annual national estimate of 294,920 injuries. The most common diagnoses were ankle strain/sprain (17.7%), finger strain/sprain/fracture (12.1%), concussion/head injury (9.4%), knee strain/sprain (4.5%), and facial laceration (3.3%). There was a significant increase in injury prevalence in adolescents (12- to 17-year-old category: 238,678 injuries per year) when compared with childhood (7- to 11-year-old category: 56,242 injuries per year) (P < .0001). Concussions/head injuries occurred at a high rate in childhood, second only to finger strain/sprain/fracture, and at a similar rate in females and males (injuries per 100,000 athlete-days: 4.9 [95% CI, 3.1-6.7] vs. 5.9 [4.3-7.5], respectively; P = .41). From childhood to adolescence, injury prevalence increased for all areas and across both sexes, except for female finger strain/sprain/fracture; however, the rate of increase for concussion/head injuries and knee injuries was significantly higher in female compared with male athletes (P < .0001 for both). In adolescents, ankle injuries were the most common injury overall. Conclusion: Ankle injuries continue to be the most predominant pediatric basketball injury. However, disproportionate rates of both knee and concussion/head injuries in female athletes during adolescent basketball are of concern and have implications for injury prevention.	[Zynda, Aaron J.; Wagner, K. John; Liu, Jie; Chung, Jane S.; Miller, Shane M.; Wilson, Philip L.; Ellis, Henry B.] Scottish Rite Children, Dallas, TX USA; [Zynda, Aaron J.] Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA; [Chung, Jane S.; Miller, Shane M.; Wilson, Philip L.; Ellis, Henry B.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Zynda, AJ (corresponding author), Michigan State Univ, 308 W Circle Dr, E Lansing, MI 48824 USA.	zyndaaar@msu.edu					Agel J, 2007, J ATHL TRAINING, V42, P202; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Ahmad CS, 2006, AM J SPORT MED, V34, P370, DOI 10.1177/0363546505280426; Allen AN, 2019, J ATHL TRAINING, V54, P1179, DOI 10.4085/1062-6050-330-18; [Anonymous], 2019, SPORTS PART US 2019; BAILEY DA, 1989, J BONE JOINT SURG AM, V71A, P1225, DOI 10.2106/00004623-198971080-00016; Blackman K., 2018, NAT C STAT LEG; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Brown T, 2019, CLIN PEDIATR, V58, P199, DOI 10.1177/0009922818810879; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Carter CW, 2018, J AM ACAD ORTHOP SUR, V26, P447, DOI 10.5435/JAAOS-D-16-00607; Clifton DR, 2018, J ATHL TRAINING, V53, P1037, DOI 10.4085/1062-6050-150-17; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dick R, 2007, J ATHL TRAINING, V42, P194; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gornitzky AL, 2016, AM J SPORT MED, V44, P2716, DOI 10.1177/0363546515617742; Grimm NL, 2015, AM J SPORT MED, V43, P2049, DOI 10.1177/0363546514556737; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Jackson TJ, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113499130; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; McGuine TA, 2011, AM J SPORT MED, V39, P1840, DOI 10.1177/0363546511406242; MICHELI LJ, 1983, ORTHOP CLIN N AM, V14, P337; Morscher E, 1968, Reconstr Surg Traumatol, V10, P3; Pappas E, 2011, SPORTS HEALTH, V3, P331, DOI 10.1177/1941738111409861; PHILLIPS DF, 1974, HOSPITALS, V48, P47; Powell JW, 1999, J ATHL TRAINING, V34, P277; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sadoghi P, 2012, J BONE JOINT SURG AM, V94A, P769, DOI 10.2106/JBJS.K.00467; Schroeder T., 2001, NEISS SAMPLE DESIGN; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; Smith GA, 1998, PEDIATRICS, V101, P406, DOI 10.1542/peds.101.3.406; Stracciolini A, 2020, CLIN J SPORT MED, V30, P526, DOI 10.1097/JSM.0000000000000645; Swart E, 2014, J BONE JOINT SURG AM, V96A, P705, DOI 10.2106/JBJS.M.00560; Tummala SV, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118805400; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Yeh PC, 2012, AM J SPORT MED, V40, P589, DOI 10.1177/0363546511428601; Zamarripa A, 2017, J PEDIATR-US, V181, P229, DOI 10.1016/j.jpeds.2016.10.071; Zynda Aaron J, 2020, Int J Exerc Sci, V13, P87	45	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN	2022	10	1							23259671211066503	10.1177/23259671211066503			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	YP2EV	WOS:000748440100001	35071658	Green Accepted			2022-02-06	
J	Jackson, CE; Currao, A; Fonda, JR; Kenna, A; Milberg, WP; McGlinchey, RE; Fortier, CB				Jackson, Colleen E.; Currao, Alyssa; Fonda, Jennifer R.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.; Fortier, Catherine B.			Research utility of a CAPS-IV and CAPS-5 hybrid interview: Posttraumatic stress symptom and diagnostic concordance in recent-era US veterans	JOURNAL OF TRAUMATIC STRESS			English	Article; Early Access							DSM-IV; PTSD; DISORDER; MILITARY; GENDER	The Clinician-Administered PTSD Scale (CAPS) is used to measure posttraumatic stress symptoms (PTSS) and diagnose posttraumatic stress disorder (PTSD). However, its use, particularly in settings involving longitudinal assessment, has been complicated by changes in the diagnostic criteria between the fourth and fifth editions of the Diagnostic and Statistical Manual of Mental Disorders (i.e., DSM-IV and DSM-5, respectively). The current sample included trauma-exposed U.S. veterans who were deployed in support of military operations following the September 11, 2001, terrorist attacks (N = 371) and were enrolled in a longitudinal study focused on deployment-related stress and traumatic brain injury. A hybrid clinical interview using item wording from the CAPS for DSM-IV (CAPS-IV) with the addition of items unique to the CAPS for DSM-5 (CAPS-5) was used to assess both DSM-IV and DSM-5 PTSD diagnostic criteria, allowing for the calculation of separate total scores and diagnoses. Diagnostic agreement, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and interrater reliability between CAPS-IV and CAPS-5 were evaluated for the entire sample and stratified by gender. We found high diagnostic agreement (92.9%-95.4%), sensitivity (94.4%-98.2%), specificity (91.7%-92.8%), PPV (89.5%-93.0%), NPV (95.7%-98.1%), and interrater reliability,kappa = 0.86-0.91,) for both men and women. The current study supports the use of a hybrid PTSD diagnostic interview assessing both DSM-IV and DSM-5 diagnostic criteria, particularly in situations such as longitudinal studies that may require a feasible method of incorporating changes in diagnostic criteria from the DSM-IV to the DSM-5.	[Jackson, Colleen E.] VA Boston Healthcare Syst, Psychol Serv, Boston, MA USA; [Jackson, Colleen E.; Fonda, Jennifer R.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Currao, Alyssa; Fonda, Jennifer R.; Kenna, Alexandra; Milberg, William P.; McGlinchey, Regina E.; Fortier, Catherine B.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.; Fortier, Catherine B.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.; Fortier, Catherine B.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Fortier, CB (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave, Boston, MA 02130 USA.	regina_mcglinchey@hms.harvard.edu; catherine_fortier@hms.harvard.edu	Fortier, Catherine/AAS-2163-2021	Fortier, Catherine/0000-0002-8953-9904; Fonda, Jennifer/0000-0001-9482-2918	VA through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center [B3001-C]; VA Clinical Science Research and Development Merit Review [CX01327]; VA Rehabilitation Research and Development Merit Review [RX002907]; National Institutes of Health National Center for Complementary and Integrative Health NCCIH grant [R21 AT009430-01]	The authors report no conflicts of interest or financial disclosures. This research was supported by the VA through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center (B3001-C); aVAClinical Science Research and Development Merit Review (CX01327) to ReginaE. Mc Glinchey; aVA Rehabilitation Research and Development MeritReview (RX002907) toCatherine B. Fortier; and a National Institutes of Health National Center for Complementary and Integrative Health NCCIH grant (R21 AT009430-01) toWilliam P. Milberg. The contents within do not represent the views of theVAor the United States government.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bhattarai J, 2020, PSYCHOL SERV, V17, P75, DOI 10.1037/ser0000285; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brown W, 2016, MIL PSYCHOL, V28, P418, DOI 10.1037/mil0000133; Carmassi C, 2014, J AFFECT DISORDERS, V160, P55, DOI 10.1016/j.jad.2014.02.028; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Friedman MJ, 2013, J TRAUMA STRESS, V26, P548, DOI 10.1002/jts.21840; Hoge CW, 2016, JAMA PSYCHIAT, V73, P750, DOI 10.1001/jamapsychiatry.2016.0647; Karstoft KI, 2014, PSYCHOL ASSESSMENT, V26, P321, DOI 10.1037/a0034889; Kelber MS, 2021, J PSYCHIATR RES, V133, P16, DOI 10.1016/j.jpsychires.2020.12.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Moshier SJ, 2019, J TRAUMA STRESS, V32, P799, DOI 10.1002/jts.22438; National Center for PTSD, CLIN ADM PTSD SCAL D; Peters WJ, 2020, J AUTISM DEV DISORD, V50, P1898, DOI 10.1007/s10803-019-03941-1; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P493, DOI 10.1002/da.22364; Uher R, 2014, DEPRESS ANXIETY, V31, P459, DOI 10.1002/da.22217; Weathers F.W., 1993, ANN M INT SOC TRAUM; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW, 2013, CLIN ADM PTSD SCALE; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress												10.1002/jts.22771		DEC 2021	11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	XY1WC	WOS:000736770600001	34973042				2022-02-06	
J	Masneuf, S; Imbach, LL; Buchele, F; Colacicco, G; Penner, M; Moreira, CG; Ineichen, C; Jahanshahi, A; Temel, Y; Baumann, CR; Noain, D				Masneuf, Sophie; Imbach, Lukas L.; Buchele, Fabian; Colacicco, Giovanni; Penner, Marco; Moreira, Carlos G.; Ineichen, Christian; Jahanshahi, Ali; Temel, Yasin; Baumann, Christian R.; Noain, Daniela			Altered sleep intensity upon DBS to hypothalamic sleep-wake centers in rats	TRANSLATIONAL NEUROSCIENCE			English	Article						deep brain stimulation; sleep; wake behavior; ventrolateral preoptic nucleus; perifornical area of the posterior lateral hypothalamus; slow-wave activity	TRAUMATIC BRAIN-INJURY; ELECTRICAL-STIMULATION; OREXIN NEURONS; BASAL FOREBRAIN; CELL-BODIES; MCH NEURONS; ACTIVATION; DEPRIVATION; DISCHARGE; AXONS	Deep brain stimulation (DBS) has been scarcely investigated in the field of sleep research. We hypothesize that DBS onto hypothalamic sleep- and wake-promoting centers will produce significant neuromodulatory effects and potentially become a therapeutic strategy for patients suffering severe, drug-refractory sleep-wake disturbances. We aimed to investigate whether continuous electrical high-frequency DBS, such as that often implemented in clinical practice, in the ventrolateral preoptic nucleus (VLPO) or the perifornical area of the posterior lateral hypothalamus (PeFLH), significantly modulates sleep-wake characteristics and behavior. We implanted healthy rats with electroencephalographic/electromyographic electrodes and recorded vigilance states in parallel to bilateral bipolar stimulation of VLPO and PeFLH at 125 Hz and 90 mu A over 24 h to test the modulating effects of DBS on sleep-wake proportions, stability and spectral power in relation to the baseline. We unexpectedly found that VLPO DBS at 125 Hz deepens slow-wave sleep (SWS) as measured by increased delta power, while sleep proportions and fragmentation remain unaffected. Thus, the intensity, but not the amount of sleep or its stability, is modulated. Similarly, the proportion and stability of vigilance states remained altogether unaltered upon PeFLH DBS but, in contrast to VLPO, 125 Hz stimulation unexpectedly weakened SWS, as evidenced by reduced delta power. This study provides novel insights into non-acute functional outputs of major sleep-wake centers in the rat brain in response to electrical high-frequency stimulation, a paradigm frequently used in human DBS. In the conditions assayed, while exerting no major effects on the sleep-wake architecture, hypothalamic high-frequency stimulation arises as a provocative sleep intensity-modulating approach.	[Masneuf, Sophie; Imbach, Lukas L.; Buchele, Fabian; Penner, Marco; Moreira, Carlos G.; Baumann, Christian R.; Noain, Daniela] Univ Zurich, Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Noain, Daniela] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Noain, Daniela] Univ Zurich, Ctr Competence Sleep & Hlth, Zurich, Switzerland; [Colacicco, Giovanni] Univ Zurich, Inst Anat, Zurich, Switzerland; [Ineichen, Christian] Univ Zurich, Psychiat Hosp, Dept Psychiat, Preclin Lab Translat Res Affect Disorders,DPPP, Zurich, Switzerland; [Jahanshahi, Ali; Temel, Yasin] Maastricht Univ, Dept Neurosurg, Med Ctr, Maastricht, Netherlands		Noain, D (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland.; Noain, D (corresponding author), Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland.; Noain, D (corresponding author), Univ Zurich, Ctr Competence Sleep & Hlth, Zurich, Switzerland.	daniela.noain@usz.ch		Ineichen, Christian/0000-0002-6087-0644	HSM-II program of the Canton of Zurich; Forschungskredit of the University of Zurich; Clinical Research Priority Program Sleep and Health of the University of Zurich	This work was supported by the HSM-II program of the Canton of Zurich (CRB), by the Forschungskredit of the University of Zurich (DN), and by the Clinical Research Priority Program Sleep and Health of the University of Zurich (CRB).	Adamantidis A, 2015, NAT NEUROSCI, V18, P1202, DOI 10.1038/nn.4106; Adamantidis A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.031.2009; Agostinelli LJ, 2017, J COMP NEUROL, V525, P1668, DOI 10.1002/cne.24158; Alam MA, 2014, J NEUROPHYSIOL, V111, P287, DOI 10.1152/jn.00504.2013; Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Apergis-Schoute J, 2015, J NEUROSCI, V35, P5435, DOI 10.1523/JNEUROSCI.5269-14.2015; Aum DJ, 2018, FRONT BIOSCI-LANDMRK, V23, P162, DOI 10.2741/4586; Baumann CR, 2005, LANCET NEUROL, V4, P673, DOI 10.1016/S1474-4422(05)70196-4; Bilge MT, 2018, PSYCHIAT CLIN N AM, V41, P373, DOI 10.1016/j.psc.2018.04.003; Bilk V, 2015, EPILEPSY RES, V109, P119, DOI 10.1016/j.eplepsyres.2014.10.019; Blanco-Centurion C, 2016, EUR J NEUROSCI, V44, P2846, DOI 10.1111/ejn.13410; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Deboer T, 2009, J SLEEP RES, V18, P357, DOI 10.1111/j.1365-2869.2008.00728.x; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Eggermann E, 2003, J NEUROSCI, V23, P1557; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gallopin T, 2005, NEUROSCIENCE, V134, P1377, DOI 10.1016/j.neuroscience.2005.05.045; Gradinaru V, 2020, SCIENCE, V369, P637, DOI 10.1126/science.abd2660; Grill Warren M., 2001, Thalamus & Related Systems, V1, P269, DOI 10.1016/S1472-9288(01)00025-5; Hamani C, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0140-17.2017; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Konadhode RR, 2015, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00244; Kroeger D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06590-7; Lee SH, 2012, NEURON, V76, P209, DOI 10.1016/j.neuron.2012.09.012; Li FW, 2011, BEHAV BRAIN RES, V224, P376, DOI 10.1016/j.bbr.2011.06.021; Miocinovic S, 2009, EXP NEUROL, V216, P166, DOI 10.1016/j.expneurol.2008.11.024; Noain D, 2018, J NEUROTRAUM, V35, P85, DOI 10.1089/neu.2017.5067; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; Nowak LG, 1998, EXP BRAIN RES, V118, P489, DOI 10.1007/s002210050305; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper Clifford B, 2013, Continuum (Minneap Minn), V19, P19, DOI 10.1212/01.CON.0000427215.07715.73; Scammell T, 1998, P NATL ACAD SCI USA, V95, P7754, DOI 10.1073/pnas.95.13.7754; Scammell TE, 2001, NEUROSCIENCE, V107, P653, DOI 10.1016/S0306-4522(01)00383-9; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Strecker RE, 2000, BEHAV BRAIN RES, V115, P183, DOI 10.1016/S0166-4328(00)00258-8; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; Tan SKH, 2010, NEUROSURGERY, V67, P1073, DOI 10.1227/NEU.0b013e3181ee3580; Tobler I, 1997, J NEUROSCI, V17, P1869; Tortorella S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00216; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Zalocusky KA., 2013, CURRENT CHALLENGES O, P23	47	0	0	3	3	DE GRUYTER POLAND SP Z O O	WARSAW	BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	DEC 31	2021	12	1					611	625		10.1515/tnsci-2020-0202			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YA9DI	WOS:000738624700001	35070444	Green Accepted, Green Submitted, gold			2022-02-06	
J	Farley, P; Salisbury, D; Murfee, JR; Buckley, CT; Taylor, CN; Doll, A; Polite, NM; Mbaka, MI; Kinnard, CM; Butts, CC; Simmons, JD; Lee, YLL				Farley, Paige; Salisbury, Daniel; Murfee, John R.; Buckley, Colin T.; Taylor, Catherine N.; Doll, Alissa; Polite, Nathan M.; Mbaka, Maryann, I; Kinnard, Christopher M.; Butts, Charles Caleb; Simmons, Jon D.; Lee, Yann-Leei L.			The Relationship between Serum Sodium, Serum Osmolality, and Intracranial Pressure in Patients with Traumatic Brain Injury Treated with Hyperosmolar Therapy	AMERICAN SURGEON			English	Article; Early Access						Trauma; critical care; ICU	HYPERTENSION	Background Treatment of elevated intracranial pressure (ICP) in traumatic brain injury (TBI) is controversial. Hyperosmolar therapy is used to prevent cerebral edema in these patients. Many intensivists measure direct correlates of these agents-serum sodium and osmolality. We seek to provide context on the utility of using these measures to estimate ICP in TBI patients. Materials and Methods Patients admitted with TBI who required ICP monitoring from 2008 to 2012 were included. Intracranial pressure, serum sodium, and serum osmolality were assessed prior to hyperosmotic therapy then at 6, 12, 18, 24, 48, and 72 hours after admission. A linear regression was performed on sodium, osmolality, and ICP at baseline and serum sodium and osmolality that corresponded with ICP for 6-72-hour time points. Results 136 patients were identified. Patients with initial measures were included in the baseline analysis (n = 29). Patients who underwent a craniectomy were excluded from the 6-72-hour analysis (n = 53). Initial ICP and serum sodium were not significantly correlated (R2 .00367, P = .696). Initial ICP and serum osmolality were not significantly correlated (R2 .00734, P = .665). Intracranial pressure and serum sodium 6-72 hours after presentation were poorly correlated (R2 .104, P < .0001), as were ICP and serum osmolality at 6-72 hours after presentation (R2 .116, P < .0001). Discussion Our results indicate initial ICP is not correlated with serum sodium or osmolality suggesting these are not useful initial clinical markers for ICP estimation. The association between ICP and serum sodium and osmolality after hyperosmolar therapy was poor, thus may not be useful as surrogates for direct ICP measurements.	[Farley, Paige; Salisbury, Daniel; Murfee, John R.; Buckley, Colin T.; Taylor, Catherine N.; Doll, Alissa; Polite, Nathan M.; Mbaka, Maryann, I; Kinnard, Christopher M.; Butts, Charles Caleb; Simmons, Jon D.; Lee, Yann-Leei L.] Univ S Alabama, Dept Surg, Div Trauma & Acute Care Surg, Coll Med, Mobile, AL USA		Lee, YLL (corresponding author), USA Hlth Univ Hosp, 2451 Univ Hosp Dr,Suite 10-1, Mobile, AL 36617 USA.	yllee@health.southalabama.edu		Farley, Paige/0000-0002-5766-601X			Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bothwell SW, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0129-6; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Marko NF, 2012, AM J RESP CRIT CARE, V185, P467, DOI 10.1164/rccm.201109-1698ED; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Schizodimos T, 2020, J ANESTH, V34, P741, DOI 10.1007/s00540-020-02795-7; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	12	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211058627	10.1177/00031348211058627		DEC 2021	4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YB6RP	WOS:000739137300001	34969299				2022-02-06	
J	Lawn, RB; Jha, SC; Liu, JX; Sampson, L; Murchland, AR; Sumner, JA; Roberts, AL; Disner, SG; Grodstein, F; Kang, JH; Kubzansky, LD; Chibnik, LB; Koenen, KC				Lawn, Rebecca B.; Jha, Shaili C.; Liu, Jiaxuan; Sampson, Laura; Murchland, Audrey R.; Sumner, Jennifer A.; Roberts, Andrea L.; Disner, Seth G.; Grodstein, Francine; Kang, Jae H.; Kubzansky, Laura D.; Chibnik, Lori B.; Koenen, Karestan C.			The association of posttraumatic stress disorder, depression, and head injury with mid-life cognitive function in civilian women	DEPRESSION AND ANXIETY			English	Article; Early Access						cognition; cogstate; depression; head injury; mild traumatic brain injury; posttraumatic stress disorder; women	TRAUMATIC BRAIN-INJURY; ALZHEIMER-DISEASE; PTSD SYMPTOMS; OLDER-PEOPLE; RISK; METAANALYSIS; CONCUSSION; COMMUNITY; ADULTS	Background Despite evidence linking posttraumatic stress disorder (PTSD), depression, and head injury, separately, with worse cognitive performance, investigations of their combined effects on cognition are limited in civilian women. Methods The Cogstate Brief Battery assessment was administered in 10,681 women from the Nurses' Health Study II cohort, mean age 64.9 years (SD = 4.6). Psychological trauma, PTSD, depression, and head injury were assessed using online questionnaires. In this cross-sectional analysis, we used linear regression models to estimate mean differences in cognition by PTSD/depression status and stratified by history of head injury. Results History of head injury was prevalent (36%), and significantly more prevalent among women with PTSD and depression (57% of women with PTSD and depression, 21% of women with no psychological trauma or depression). Compared to having no psychological trauma or depression, having combined PTSD and depression was associated with worse performance on psychomotor speed/attention ( beta = -.15, p = .001) and learning/working memory ( beta = -.15, p < .001). The joint association of PTSD and depression on worse cognitive function was strongest among women with past head injury, particularly among those with multiple head injuries. Conclusions Head injury, like PTSD and depression, was highly prevalent in this sample of civilian women. In combination, these factors were associated with poorer performance on cognitive tasks, a possible marker of future cognitive health. Head injury should be further explored in future studies of PTSD, depression and cognition in women.	[Lawn, Rebecca B.; Jha, Shaili C.; Liu, Jiaxuan; Sampson, Laura; Murchland, Audrey R.; Chibnik, Lori B.; Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Kresge 505, Boston, MA 02115 USA; [Sumner, Jennifer A.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Roberts, Andrea L.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Disner, Seth G.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Disner, Seth G.] Univ Minnesota, Dept Psychiat & Behav Sci, Sch Med, Minneapolis, MN USA; [Grodstein, Francine] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Kang, Jae H.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Kang, Jae H.] Harvard Med Sch, Boston, MA 02115 USA; [Kubzansky, Laura D.; Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Chibnik, Lori B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Koenen, Karestan C.] Massachusetts Gen Hosp, Dept Psychiat, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA		Lawn, RB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Kresge 505, Boston, MA 02115 USA.	rlawn@hsph.harvard.edu		Jha, Shaili/0000-0002-1208-6839; Roberts, Andrea/0000-0001-5023-4399; Lawn, Rebecca/0000-0002-4353-4155; Sumner, Jennifer/0000-0002-0217-7171	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HL098048, U01 CA176726]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH101269]	National Institutes of Health, Grant/Award Numbers: T32 HL098048, U01 CA176726; National Institute of Mental Health, Grant/Award Number: R01 MH101269	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Chau DT, 2017, BIOL PSYCHIAT-COGN N, V2, P318, DOI 10.1016/j.bpsc.2017.01.003; Childress JE, 2013, J NEUROPSYCH CLIN N, V25, P12, DOI 10.1176/appi.neuropsych.12010003; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Elzinga BM, 2002, J AFFECT DISORDERS, V70, P1, DOI 10.1016/S0165-0327(01)00351-2; Fitzgerald JM, 2018, HARVARD REV PSYCHIAT, V26, P116, DOI 10.1097/HRP.0000000000000185; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Gorelick PB, 2010, ANN NY ACAD SCI, V1207, P155, DOI 10.1111/j.1749-6632.2010.05726.x; Gunak MM, 2020, BRIT J PSYCHIAT, V217, P600, DOI 10.1192/bjp.2020.150; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kaup AR, 2019, J NEUROTRAUM, V36, P338, DOI 10.1089/neu.2018.5695; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Koyama AK, 2015, NEUROEPIDEMIOLOGY, V45, P264, DOI 10.1159/000439592; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo HB, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170338; Maruff Paul, 2013, BMC Psychol, V1, P30, DOI 10.1186/2050-7283-1-30; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Morgan CA, 2001, AM J PSYCHIAT, V158, P1239, DOI 10.1176/appi.ajp.158.8.1239; O'Brien JT, 2020, J NEUROL NEUROSUR PS, V91, P158, DOI 10.1136/jnnp-2019-321652; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Phipps H, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.559318; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Sampson Laura, 1800, Am J Geriatr Psychiatry, DOI 10.1016/j.jagp.2021.10.017; Schnurr P., 1999, BRIEF TRAUMA QUESTIO; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Snyder HM, 2016, ALZHEIMERS DEMENT, V12, P1186, DOI 10.1016/j.jalz.2016.08.004; Sumner JA, 2018, BRAIN BEHAV IMMUN, V69, P203, DOI 10.1016/j.bbi.2017.11.013; Sumner JA, 2017, DEPRESS ANXIETY, V34, P356, DOI 10.1002/da.22600; Tejada-Vera Betzaida, 2013, NCHS Data Brief, P1; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Valera EM, 2019, J AGGRESS MALTREAT T, V28, P695, DOI 10.1080/10926771.2019.1581864; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Winning A, 2017, AM J PREV MED, V52, P753, DOI 10.1016/j.amepre.2017.01.040; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Zaninotto P, 2018, J EPIDEMIOL COMMUN H, V72, P685, DOI 10.1136/jech-2017-210116	56	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety												10.1002/da.23233		DEC 2021	13	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	XX7BE	WOS:000736445300001	34970809				2022-02-06	
J	Mofatteh, M				Mofatteh, Mohammad			p Examining the association between traumatic brain injury and headache	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Traumatic brain injury; Headache; Post-traumatic headache; Migraine; Tension-type headache; Neurology	CHRONIC POSTTRAUMATIC HEADACHE; CEREBRAL-BLOOD-FLOW; MEDICATION-OVERUSE HEADACHE; TENSION-TYPE HEADACHE; POST-CONCUSSION SYNDROME; NECROSIS-FACTOR-ALPHA; CHRONIC PAIN; CHRONIC MIGRAINE; STRESS-DISORDER; RESTING-STATE	Traumatic brain injury is a common and major cause of disability and death that might require emergency neurological and neurosurgical interventions. Traumatic brain injury can result in temporary or permanent physical, cognitive and psychological impairments. One of the most common complications associated with traumatic brain injury is post-traumatic headache, associated with significant disability and reduced quality of life. Post-traumatic headache is a public health concern that can affect the long-term outcome of traumatic brain injury patients. Clinical symptoms of post-traumatic headache significantly overlap with common primary headaches such as migraine and tension-type headaches. Beyond neurobiological factors, psychological factors can play crucial roles in the initiation and sustainment of post-traumatic headache. While neurological mechanisms underlying post-traumatic headache remains unknown, different studies suggest various mechanisms such as physical damages to the cranial nerves and neck structure, hyper-sensitization of the pain modulatory pathway, and inflammation as underlying causes for the neurobiology of headache. I explore the hypothesis that traumatic brain injury is associated with headaches. In particular, I provide an overview of the neurobiology of post-traumatic headache, its diagnosis, presenting recent findings on the etiology, explaining similarities and differences between with primary headaches such as migraine and tension-type headache, discuss pharmacological and non-pharmacological interventions for the treatments, as well headache.	[Mofatteh, Mohammad] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland		Mofatteh, M (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland.	mmofatteh01@qub.ac.uk					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Alhilali LM, 2017, AM J NEURORADIOL, V38, P691, DOI 10.3174/ajnr.A5073; Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Baker VB, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0943-2; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bendtsen L, 2000, CEPHALALGIA, V20, P486, DOI 10.1046/j.1468-2982.2000.00070.x; Benemei S, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01135-0; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Capi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072585; Caponnetto V, 2021, J HEADACHE PAIN, V22, DOI 10.1186/s10194-021-01281-z; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Chan TLH, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1080-2; Chanraud S, 2014, CEPHALALGIA, V34, P605, DOI 10.1177/0333102413519514; Chiapparini L, 2009, NEUROL SCI, V30, pS71, DOI 10.1007/s10072-009-0077-z; Chong CD, 2021, CEPHALALGIA, V41, P943, DOI 10.1177/0333102421991819; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Chou KH, 2017, CEPHALALGIA, V37, P1152, DOI 10.1177/0333102416668657; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; D'Amico D, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010246; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Defrin R, 2010, PAIN, V151, P489, DOI 10.1016/j.pain.2010.08.009; Delic J, 2016, RADIOLOGY, V279, P859, DOI 10.1148/radiol.2015151388; DENKER PG, 1954, NEUROLOGY, V4, P912, DOI 10.1212/WNL.4.12.912; Devor M, 2002, J NEUROSURG, V96, P532, DOI 10.3171/jns.2002.96.3.0532; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Dresler T, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0988-x; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Emerson NM, 2014, PAIN, V155, P566, DOI 10.1016/j.pain.2013.12.004; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferraro S, 2012, PAIN MED, V13, P255, DOI 10.1111/j.1526-4637.2011.01183.x; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Friedman BW, 2008, ANN EMERG MED, V52, P399, DOI 10.1016/j.annemergmed.2007.09.027; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; Friedman Mark H, 2002, Heart Dis, V4, P212, DOI 10.1097/00132580-200207000-00003; GAWEL MJ, 1992, CEPHALALGIA, V12, P9, DOI 10.1046/j.1468-2982.1992.1201009.x; Gee JR, 2003, HEADACHE, V43, P276, DOI 10.1046/j.1526-4610.2003.03053.x; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Goffaux P, 2014, BRAIN TOPOGR, V27, P366, DOI 10.1007/s10548-013-0291-0; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Guglielmetti M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114024; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Habibzadeh P, 2021, CRIT REV CL LAB SCI, V58, P385, DOI 10.1080/10408363.2021.1884640; Habibzadeh P, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01280-5; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hay SI, 2017, LANCET, V389, pE1; Herd Anthony, 1994, Journal of Emergency Medicine, V12, P849, DOI 10.1016/0736-4679(94)90496-0; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0774-6; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Jang SH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014306; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Jensen RH, 2018, HEADACHE, V58, P339, DOI 10.1111/head.13067; Jia ZH, 2017, NEUROIMAGE-CLIN, V14, P130, DOI 10.1016/j.nicl.2017.01.019; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Kabbouche MA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e62; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kong J, 2006, HUM BRAIN MAPP, V27, P715, DOI 10.1002/hbm.20213; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Krainin Benjamin M, 2011, J Spec Oper Med, V11, P38; Kwon M, 2014, PAIN PRACT, V14, P656, DOI 10.1111/papr.12145; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lambru G, 2021, PAIN THER, V10, P1, DOI 10.1007/s40122-020-00220-1; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lanteri-Minet M, 2011, CEPHALALGIA, V31, P837, DOI 10.1177/0333102411398400; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; LARSSON LI, 1976, BRAIN RES, V113, P400, DOI 10.1016/0006-8993(76)90951-3; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Leung S, 2013, HEADACHE, V53, P491, DOI 10.1111/head.12042; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Liang HX, 2012, BIOL OPEN, V1, P1200, DOI 10.1242/bio.20122287; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lippert-Gruner M, 2012, NEUROL NEUROCHIR POL, V46, P591, DOI 10.5114/ninp.2012.32109; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lucas S., 2015, BRAIN NEUROTRAUMA; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Luo DS, 2012, PAIN PHYSICIAN, V15, P187; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McMahon S B, 1993, Curr Opin Neurobiol, V3, P602, DOI 10.1016/0959-4388(93)90062-4; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Michels L, 2017, CEPHALALGIA, V37, P764, DOI 10.1177/0333102416652625; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Mofatteh M., AM J NEURODEGENERATI, V2021, P1; Mofatteh M, 2021, AIMS NEUROSCI, V8, P477, DOI 10.3934/Neuroscience.2021025; Mofatteh M, 2021, ELIFE, V10, DOI 10.7554/eLife.72104; Mofatteh M, 2021, AIMS PUBLIC HEALTH, V8, P36, DOI 10.3934/publichealth.2021004; Mofatteh M, 2020, AIMS NEUROSCI, V7, P299, DOI 10.3934/Neuroscience.2020016; Mofatteh M, 2017, CELL, V169, P178, DOI 10.1016/j.cell.2017.03.004; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestvold K, 2005, ACTA NEUROL SCAND, V112, P13, DOI 10.1111/j.1600-0404.2005.00344.x; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; Nordhaug LH, 2019, J NEUROTRAUM, V36, P3244, DOI 10.1089/neu.2018.6328; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Olesen J, 2004, CEPHALALGIA, V24, P9; OSullivan C., 2018, MED FAMILLE CANADIEN, V64, P634; Packard RC, 2000, HEADACHE, V40, P736, DOI 10.1046/j.1526-4610.2000.00128.x; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Pompili M, 2016, INT J PSYCHIAT MED, V51, P442, DOI 10.1177/0091217416680804; Pompili M, 2010, NEUROPSYCH DIS TREAT, V6, P81; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Riechers Ronald G 2nd, 2015, Handb Clin Neurol, V128, P567, DOI 10.1016/B978-0-444-63521-1.00036-4; Sahbaie P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55739-x; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Schwedt TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099791; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Serafini G, 2012, EUR REV MED PHARMACO, V16, P1389; Serafini G, 2012, J HEADACHE PAIN, V13, P661, DOI 10.1007/s10194-012-0493-y; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30322-3; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; TAYLOR AR, 1966, LANCET, V2, P178; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Trottier ED, 2012, AM J EMERG MED, V30, P456, DOI 10.1016/j.ajem.2010.12.020; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Xue T, 2013, NMR BIOMED, V26, P1051, DOI 10.1002/nbm.2917; Yang FC, 2015, J NEUROL NEUROSUR PS, V86, P437, DOI 10.1136/jnnp-2014-308122; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeeberg P, 2005, CEPHALALGIA, V25, P1159, DOI 10.1111/j.1468-2982.2005.00980.x; Zhang JL, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0692-z	194	0	0	0	0	IMR PRESS	ROBINSON	112 ROBINSON RD, ROBINSON, SINGAPORE	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	DEC 30	2021	20	4					1079	1094		10.31083/j.jin2004109			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YJ4XR	WOS:000744537200028	34997731	gold			2022-02-06	
J	Rose, SC; Yeates, KO; Nguyen, JT; Pizzimenti, NM; Ercole, PM; McCarthy, MT				Rose, Sean C.; Yeates, Keith Owen; Nguyen, Joseph T.; Pizzimenti, Natalie M.; Ercole, Patrick M.; McCarthy, Matthew T.			Exposure to Head Impacts and Cognitive and Behavioral Outcomes in Youth Tackle Football Players Across 4 Seasons	JAMA NETWORK OPEN			English	Article							HIGH-SCHOOL FOOTBALL; 1ST EXPOSURE; LATER-LIFE; CONTACT; AGE	IMPORTANCE Repetitive head impacts have been posited to contribute to neurocognitive and behavioral difficulties in contact sport athletes. OBJECTIVE To identify associations between cognitive and behavioral outcomes and head impacts measured in youth tackle football players over 4 seasons of play. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study was conducted from July 2016 through January 2020, spanning 4 football seasons. The setting was a youth tackle football program and outpatient medical clinic. Players were recruited from 4 football teams composed of fifth and sixth graders, and all interested players who volunteered to participate were enrolled. Data analysis was performed from March 2020 to June 2021. EXPOSURES Impacts were measured using helmet-based sensors during practices and games throughout 4 consecutive seasons of play. Impacts were summed to yield cumulative head impact gravitational force equivalents per season. MAIN OUTCOMES AND MEASURES Ten cognitive and behavioral measures were completed before and after each football season. RESULTS There were 70 male participants aged 9 to 12 years (mean [SD] age, 10.6 [0.64] years), with 18 completing all 4 years of the study. At the post-season 1 time point, higher cumulative impacts were associated with lower self-reported symptom burden (beta = -0.6; 95% CI, -1.0 to -0.2; P =.004). After correcting for multiple comparisons, no other associations were found between impacts and outcome measures. At multiple times throughout the study, premorbid attentiondeficit/hyperactivity disorder, anxiety, and depression were associated with worse cognitive or behavioral scores, whereas a premorbid headache disorder or history of concussion was less often associated with outcomes. CONCLUSIONS AND RELEVANCE In this cohort of youth tackle football players, premorbid conditions, including attention-deficit/hyperactivity disorder, anxiety, and depression, were associated with cognitive and behavioral outcomes more often than cumulative impact.	[Rose, Sean C.] Ohio State Univ, Nationwide Childrens Hosp, Child Neurol, 700 Childrens Dr, Columbus, OH 43205 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Nguyen, Joseph T.; Ercole, Patrick M.] Sansom Consulting, San Antonio, TX USA; [Pizzimenti, Natalie M.] MORE Fdn, Phoenix, AZ USA; [McCarthy, Matthew T.] Summit Hlth, Florham Pk, NJ USA		Rose, SC (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Child Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.	sean.rose@nationwidechildrens.org			MORE Foundation; Riddell; ElMindA	MORE Foundation funded the study and provided staff and administrative support. Riddell and ElMindA provided grants and equipment to MORE Foundation.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Beckwith JG., 2014, 38 ANN M AM SOC BIOM; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Chu JJ, 2012, ANN BIOMED ENG, V40, P203, DOI 10.1007/s10439-011-0410-6; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Iverson GL, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.647314; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Maerlender A, 2021, J INT NEUROPSYCH SOC, V27, P113, DOI 10.1017/S1355617720000685; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Rose SC, 2021, J CHILD NEUROL, V36, P768, DOI 10.1177/08830738211004490; Rose SC, 2019, J NEUROTRAUM, V36, P2803, DOI 10.1089/neu.2019.6519; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358	17	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	DEC 30	2021	4	12							e2140359	10.1001/jamanetworkopen.2021.40359			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XZ9LP	WOS:000737967300003	34967882	Green Published, gold			2022-02-06	
J	Burke, J; Gugger, J; Ding, K; Kim, JA; Foreman, B; Yue, JK; Puccio, AM; Yuh, EL; Sun, XY; Rabinowitz, M; Vassar, MJ; Taylor, SR; Winkler, EA; Deng, HS; McCrea, M; Stein, MB; Robertson, CS; Levin, HS; Dikmen, S; Temkin, NR; Barber, J; Giacino, JT; Mukherjee, P; Wang, KKW; Okonkwo, DO; Markowitz, AJ; Jain, S; Lowenstein, D; Manley, GT; Diaz-Arrastia, R				Burke, John; Gugger, James; Ding, Kan; Kim, Jennifer A.; Foreman, Brandon; Yue, John K.; Puccio, Ava M.; Yuh, Esther L.; Sun, Xiaoying; Rabinowitz, Miri; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Deng, Hansen; McCrea, Michael; Stein, Murray B.; Robertson, Claudia S.; Levin, Harvey S.; Dikmen, Sureyya; Temkin, Nancy R.; Barber, Jason; Giacino, Joseph T.; Mukherjee, Pratik; Wang, Kevin K. W.; Okonkwo, David O.; Markowitz, Amy J.; Jain, Sonia; Lowenstein, Daniel; Manley, Geoffrey T.; Diaz-Arrastia, Ramon		TRACK-TBI Investigators	Association of Posttraumatic Epilepsy With 1-Year Outcomes After Traumatic Brain Injury	JAMA NETWORK OPEN			English	Article							CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; LATE SEIZURES; PREVENTION; PREVALENCE; TBI	IMPORTANCE Posttraumatic epilepsy (PTE) is a recognized sequela of traumatic brain injury (TBI), but the long-term outcomes associated with PTE independent of injury severity are not precisely known. OBJECTIVE To determine the incidence, risk factors, and association with functional outcomes and self-reported somatic, cognitive, and psychological concerns of self-reported PTE in a large, prospectively collected TBI cohort. DESIGN, SETTING, AND PARTICIPANTS This multicenter, prospective cohort study was conducted as part of the Transforming Research and Clinical Knowledge in Traumatic Brain Injury study and identified patients presenting with TBI to 1 of 18 participating level 1 US trauma centers from February 2014 to July 2018. Patients with TBI, extracranial orthopedic injuries (orthopedic controls), and individuals without reported injuries (eg, friends and family of participants; hereafter friend controls) were prospectively followed for 12 months. Data were analyzed from January 2020 to April 2021. EXPOSURE Demographic, imaging, and clinical informationwas collected according to TBI Common Data Elements. Incidence of self-reported PTE was assessed using the National Institute of Neurological Disorders and Stroke Epilepsy Screening Questionnaire (NINDS-ESQ). MAIN OUTCOMES AND MEASURES Primary outcomes included Glasgow Outcome Scale Extended, Rivermead CognitiveMetric (RCM; derived from the Rivermead Post Concussion Symptoms Questionnaire), and the Brief Symptom Inventory-18 (BSI). RESULTS Of 3296 participants identified as part of the study, 3044met inclusion criteria, and 1885 participants (mean [SD] age, 41.3 [17.1] years; 1241 [65.8%] men and 644 [34.2%] women) had follow-up information at 12 months, including 1493 patients with TBI; 182 orthopedic controls, 210 uninjured friend controls; 41 patients with TBI (2.8%) and no controls had positive screening results for PTE. Compared with a negative screening result for PTE, having a positive screening result for PTE was associated with presenting Glasgow Coma Scale score (8.1 [4.8] vs.13.5 [3.3]; P <.001) as well as with anomalous acute head imaging findings (risk ratio, 6.42 [95% CI, 2.71-15.22]). After controlling for age, initial Glasgow Coma Scale score, and imaging findings, compared with patients with TBI and without PTE, patients with TBI and with positive PTE screening results had significantly lower GlasgowOutcome Scale Extended scores (mean [SD], 6.1 [1.7] vs 4.7 [1.5]; P <.001), higher BSI scores (mean [SD], 50.2 [10.7] vs 58.6 [10.8]; P =.02), and higher RCM scores (mean [SD], 3.1 [2.6] vs 5.3 [1.9]; P =.002) at 12 months. CONCLUSIONS AND RELEVANCE In this cohort study, the incidence of self-reported PTE after TBI was found to be 2.8% andwas independently associated with unfavorable outcomes. These findings highlight the need for effective antiepileptogenic therapies after TBI.	[Burke, John; Yue, John K.; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Burke, John; Yue, John K.; Yuh, Esther L.; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Mukherjee, Pratik; Markowitz, Amy J.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101,POB 0899, San Francisco, CA 94143 USA; [Gugger, James; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, 51 N 39th St,Andrew Mutch Bldg,Room 409, Philadelphia, PA 19104 USA; [Ding, Kan] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX USA; [Kim, Jennifer A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Puccio, Ava M.; Rabinowitz, Miri; Deng, Hansen; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat & Publ Hlth, San Diego, CA 92103 USA; [Robertson, Claudia S.; Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Crit Care, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Giacino, Joseph T.] Harvard Med Sch, Spaulding Rehabil Hosp, Rehabil Neuropsychol, Boston, MA 02115 USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat & Neurosci, Gainesville, FL USA; [Lowenstein, Daniel] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA		Markowitz, AJ (corresponding author), Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101,POB 0899, San Francisco, CA 94143 USA.; Diaz-Arrastia, R (corresponding author), Univ Penn, Dept Neurol, 51 N 39th St,Andrew Mutch Bldg,Room 409, Philadelphia, PA 19104 USA.	amymarkowitz@gmail.com; ramon.diaz-arrastia@pennmedicine.upenn.edu			One Mind; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS086090, U54 NS115322, U01 NS114140]; DODUnited States Department of Defense [W81XWH1910861, W81XWH-14-2-0176, W81XWH-18-2-0042]	This studywas supported by grants from One Mind (Ms Markowitz), NIH NINDS (grant No. U01 NS086090, U54 NS115322 [Dr Diaz-Arrastia], U01 NS114140 [Dr Diaz-Arrastia], and U01 NS086090 [Dr Manley]), DOD (grant No. W81XWH1910861 [Dr Diaz-Arrastia], W81XWH-14-2-0176 [Dr Diaz-Arrastia], W81XWH-14-2-0176 [Dr Manley], and W81XWH-18-2-0042 [Dr Manley]).	Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Annegers JF., 1996, TREATMENT EPILEPSY P, P165; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Deeks J., STAT ALGORITHMS REV; Derogatis LR., 2004, USE PSYCHOL TESTING, P1; Friedman D, 2013, NEUROLOGY, V80; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Loring DW, 2011, EPILEPSIA, V52, P1186, DOI 10.1111/j.1528-1167.2011.03018.x; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Pagano M, 2000, PRINCIPLES BIOSTATIS, V2nd; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Saleem Maha N, 2019, Ann Clin Transl Neurol, V6, P2601, DOI 10.1002/acn3.50950; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Willmore LJ, 2010, NEUROLOGY, V75, P202, DOI 10.1212/WNL.0b013e3181e8e94f; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	33	0	0	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	DEC 29	2021	4	12							e2140191	10.1001/jamanetworkopen.2021.40191			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XZ9KF	WOS:000737963700003	34964854	gold, Green Published			2022-02-06	
J	LeMay, CC; Stinson, JD				LeMay, Carrie C.; Stinson, Jill D.			Persons With Histories of Traumatic Brain Injury and Problematic Sexual Behavior: An Exploratory Analysis	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article; Early Access						sexual offending; sexual behavior problems; problematic sexual behavior; traumatic brain injury; intellectual disability; cognitive impairment	HEAD-INJURIES; POPULATION; PREVALENCE; PEDOPHILIA; OFFENDERS; INDIVIDUALS; PREDICTORS; OFFENSES; MEN	Persons with traumatic brain injuries (TBI) who have engaged in problematic or illegal sexual behavior present with complex assessment and intervention needs yet remain understudied within the empirical literature. In the current exploratory analysis, important differences in adaptive and clinical functioning, adverse childhood experiences, and criminal offense history are examined in 25 persons with previous brain injury, 118 persons with intellectual disability but no known TBI, and 103 persons with no history of brain injury or intellectual disability, all of whom have engaged in problematic sexual behavior and who were residing in secure forensic inpatient care. Group differences were examined using comparisons of means and chi-squares. Results highlight important differences in education and employment experiences, diagnostic presentation, exposure to childhood maltreatment, and justice system involvement and characteristics of their sexual offense victims. Associations with prior literature and future research directions are discussed.	[LeMay, Carrie C.] Memphis VA Med Ctr, Memphis, TN USA; [Stinson, Jill D.] East Tennessee State Univ, Johnson City, TN 37614 USA		Stinson, JD (corresponding author), East Tennessee State Univ, Dept Psychol, Box 70649, Johnson City, TN 37614 USA.	dr.jill.stinson@hotmail.com		Stinson, Jill/0000-0003-4158-4850			Adjorlolo S, 2016, J FORENSIC PSYCHI PS, V27, P349, DOI 10.1080/14789949.2016.1141431; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU DIAGNOSTIC STAT MANU; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Blanchard R, 2003, ARCH SEX BEHAV, V32, P573, DOI 10.1023/A:1026093612434; Blanchard R, 2002, ARCH SEX BEHAV, V31, P511, DOI 10.1023/A:1020659331965; Boccia M, 2017, BRAIN IMAGING BEHAV, V11, P278, DOI 10.1007/s11682-016-9505-x; Burns JM, 2003, ARCH NEUROL-CHICAGO, V60, P437, DOI 10.1001/archneur.60.3.437; Cantor JM, 2008, J PSYCHIATR RES, V42, P167, DOI 10.1016/j.jpsychires.2007.10.013; Cantor JM, 2015, ARCH SEX BEHAV, V44, P2161, DOI 10.1007/s10508-015-0629-7; Cantor JM, 2012, ARCH SEX BEHAV, V41, P749, DOI 10.1007/s10508-012-9954-2; Chester V, 2018, PSYCHOL CRIME LAW, V24, P400, DOI 10.1080/1068316X.2017.1302583; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Fabian JM, 2010, AGGRESS VIOLENT BEH, V15, P209, DOI 10.1016/j.avb.2009.12.004; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gerwinn H, 2015, J PSYCHIATR RES, V68, P246, DOI 10.1016/j.jpsychires.2015.07.002; Herrick S.E., 2014, J LAW ENFORCEMENT, V4, P18; Ireland C., 2008, BRIT J FORENSIC PRAC, V10, P18, DOI [10.1108/14636646200800010, DOI 10.1108/14636646200800010]; Kneer J, 2019, J PSYCHIATR RES, V108, P48, DOI 10.1016/j.jpsychires.2018.01.012; Kolb B., 2009, FUNDAMENTALS HUMAN N; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Langevin R, 2006, BRAIN COGNITION, V60, P206; Langevin R, 2011, INT J OFFENDER THER, V55, P5, DOI 10.1177/0306624X09360968; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; Mendez MF, 2000, J NEUROPSYCH CLIN N, V12, P71, DOI 10.1176/jnp.12.1.71; Moreno J., 2016, INT J PSYCHOL, V51, P86; Nicolle A, 2014, CURR ISS THINK REASO, P154; Poeppl TB, 2013, J PSYCHIATR RES, V47, P678, DOI 10.1016/j.jpsychires.2013.01.003; Poeppl TB, 2011, J SEX MED, V8, P1660, DOI 10.1111/j.1743-6109.2011.02248.x; Ponseti J, 2012, ARCH GEN PSYCHIAT, V69, P187, DOI 10.1001/archgenpsychiatry.2011.130; Rodriguez M., 2014, NEUROPSYCHOLOGICAL S; Sapolsky RM, 2004, PHILOS T R SOC B, V359, P1787, DOI 10.1098/rstb.2004.1547; Schiffer B, 2008, NEUROIMAGE, V41, P80, DOI 10.1016/j.neuroimage.2008.02.008; Schiltz K, 2007, ARCH GEN PSYCHIAT, V64, P737, DOI 10.1001/archpsyc.64.6.737; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Spinella M., 2006, INT J FORENSIC PSYCH, V1, P84; Stinson J.D., 2008, SEX OFFENDING CAUSAL; Stinson JD, 2021, INT J FORENSIC MENT, V20, P374, DOI 10.1080/14999013.2021.1895375; Stinson JD, 2016, CHILD ABUSE NEGLECT, V61, P13, DOI 10.1016/j.chiabu.2016.09.005; Stinson JD, 2011, CRIM JUSTICE BEHAV, V38, P885, DOI 10.1177/0093854811409872; Stinson JD, 2008, VIOLENCE VICTIMS, V23, P35, DOI 10.1891/0886-6708.23.1.35; Stoleru S, 2012, NEUROSCI BIOBEHAV R, V36, P1481, DOI 10.1016/j.neubiorev.2012.03.006; Sung Hung-En, 2010, J Correct Health Care, V16, P178, DOI 10.1177/1078345810366287; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Wechsler, 1997, WECHSLER ADULT INTEL; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Young MH, 2010, INT J OFFENDER THER, V54, P92, DOI 10.1177/0306624X08322373	57	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X	1552-6933		INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.											0306624X211066831	10.1177/0306624X211066831		DEC 2021	24	Criminology & Penology; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	XZ9PB	WOS:000737976400001	34963350				2022-02-06	
J	Afzal, M; Kazmi, I; Quazi, AM; Khan, SA; Zafar, A; Al-Abbasi, FA; Imam, F; Alharbi, KS; Alzarea, SI; Yadav, N				Afzal, Muhammad; Kazmi, Imran; Quazi, Anwarulabedin Mohsin; Khan, Shah Alam; Zafar, Ameeduzzafar; Al-Abbasi, Fahad A.; Imam, Faisal; Alharbi, Khalid Saad; Alzarea, Sami, I; Yadav, Neelam			6-Shogaol Attenuates Traumatic Brain Injury-Induced Anxiety/Depression-like Behavior via Inhibition of Oxidative Stress-Influenced Expressions of Inflammatory Mediators TNF-alpha, IL-1 beta, and BDNF: Insight into the Mechanism	ACS OMEGA			English	Article; Early Access							BURYING BEHAVIOR; DISORDERS; ANXIETY; GINGER; NEUROINFLAMMATION; HIPPOCAMPUS; FLUOXETINE; MODELS	Anxiety and depression are among the major traumatic brain injury-induced psychiatric disorders in survivors. The present study was undertaken to investigate the beneficial effects of 6-Shogaol against depression-like behavior and anxiety, induced by traumatic brain injury (TBI), in mice. The mice were administered either fluoxetine, vehicle, or three different doses (10, 20 and 30 mg/kg/day, i.p.) of 6-Shogaol after 10 days of impact-accelerated TBI. The treatment was continued for 14 consecutive days. Elevated plus maze test, marble burying test, staircase test, and social interaction test were employed to investigate the effect of 6-Shogaol on anxiety-like behavior. The impact of treatment on depression-like behavior was assessed using hyper-emotionality behavior or open-field exploration test. The expressions of brain-derived neurotrophic factor (BDNF), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and malondialdehyde (MDA) levels in brain tissue and brain water were measured to elucidate possible mechanisms involved. 6-Shogaol treatment (higher dose) was able to attenuate anxiety/depression-like behaviors in mice with TBI. 6-Shogaol treatment also altered MDA formation and expressions of TNF-alpha and IL-1 beta that act as major inflammation-inducing cytokines in brain tissue. Additionally, brain BDNF levels were also affected by 6-Shogaol treatment. Although the lower dose of 6-Shogaol was able to rectify inflammation and BDNF expression in brain tissue, it was unable to improve anxiety/depression-like behaviors. 6-Shogaol treatment produced beneficial effects for TBI-induced anxiety/depression-like behaviors in mice, which could be attributed to the reduction of lipid peroxidation, inflammation, and enhanced BDNF expression.	[Kazmi, Imran; Al-Abbasi, Fahad A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Afzal, Muhammad; Quazi, Anwarulabedin Mohsin; Alharbi, Khalid Saad; Alzarea, Sami, I] Jouf Univ, Coll Pharm, Dept Pharmacol, Sakaka 72341, Aljouf, Saudi Arabia; [Khan, Shah Alam] Natl Univ Sci & Technol, Coll Pharm, Dept Pharmaceut Chem, Mascat 130, Oman; [Zafar, Ameeduzzafar] Jouf Univ, Coll Pharm, Dept Pharmaceut, Sakaka 72341, Aljouf, Saudi Arabia; [Imam, Faisal] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh 11451, Saudi Arabia; [Yadav, Neelam] Cent Council Res Ayurved Sci, New Delhi 110058, India		Afzal, M (corresponding author), Jouf Univ, Coll Pharm, Dept Pharmacol, Sakaka 72341, Aljouf, Saudi Arabia.	afzalgufran@gmail.com			Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia [375213500]	1. The authors acknowledge Deputyship for Research & Innovation, Ministry of Education, Saudi Arabia, for all sorts of financial support via the grant number "375213500". 2. The authors also give their sincere gratitude to the central laboratory of Jouf University, Sakaka, Aljouf, Saudi Arabia.	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; Balogun F. O., 2020, STUDIES GINGER, DOI [10.5772/intechopen.88848, DOI 10.5772/INTECHOPEN.88848]; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Chanchal R, 2015, AVICENNA J PHYTOMEDI, V5, P282; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Ha SK, 2012, NEUROPHARMACOLOGY, V63, P211, DOI 10.1016/j.neuropharm.2012.03.016; Han Q., 2017, ONCOTARGET, V8, P275; Hussein UK, 2017, MOLECULES, V22, DOI 10.3390/molecules22111928; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Izumi J, 1997, PHARMACOL BIOCHEM BE, V57, P883, DOI 10.1016/S0091-3057(96)00455-8; Kim DG, 2019, EXP NEUROBIOL, V28, P247, DOI 10.5607/en.2019.28.2.247; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kosari-Nasab M, 2018, LIFE SCI, V213, P198, DOI 10.1016/j.lfs.2018.10.040; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Majidi J, 2016, BRAIN RES BULL, V120, P1, DOI 10.1016/j.brainresbull.2015.10.009; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Mohammed Z. M., 2020, J BIOMED THER SCI, V7, P120; Moon M, 2014, BIOCHEM BIOPH RES CO, V449, P8, DOI 10.1016/j.bbrc.2014.04.121; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Ogushi Y., 2020, MED BULL FUKUOKA UNI, V47, P53; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Park G, 2013, ACTA PHARMACOL SIN, V34, P1131, DOI 10.1038/aps.2013.57; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Polich G, 2019, HAND CLINIC, V165, P253, DOI 10.1016/B978-0-444-64012-3.00015-0; Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rizzetti DA, 2016, NEUROCHEM INT, V101, P30, DOI 10.1016/j.neuint.2016.10.002; Sapkota A, 2019, BIOMOL THER, V27, DOI 10.4062/biomolther.2018.089; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shim S, 2012, FOOD CHEM TOXICOL, V50, P597, DOI 10.1016/j.fct.2011.11.042; Shim S, 2011, FOOD CHEM TOXICOL, V49, P2734, DOI 10.1016/j.fct.2011.08.012; Shohami E, 2011, OXID STRESS APPL BAS, P99, DOI 10.1007/978-1-60327-514-9_7; Silver J., 2005, TXB TRAUMATIC BRAIN, V1st, P12; Uday G, 2007, EUR J PHARMACOL, V563, P155, DOI 10.1016/j.ejphar.2007.02.016; Wang Y, 2020, NEUROSCI LETT, V736, DOI 10.1016/j.neulet.2020.135250; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457	44	0	0	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega												10.1021/acsomega.1c04155		DEC 2021	9	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	XZ9DW	WOS:000737947000001	35036685	Green Published, gold			2022-02-06	
J	Knippenberg, E; Timmermans, A; Coolen, J; Neven, K; Hallet, P; Lemmens, J; Spooren, A				Knippenberg, Els; Timmermans, Annick; Coolen, Jolijn; Neven, Katrien; Hallet, Peter; Lemmens, Jolien; Spooren, Annemie			Efficacy of a technology-based client-centred training system in neurological rehabilitation: a randomised controlled trial	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Client-centred; Task-oriented; Rehabilitation; Technology; Efficacy	TRAUMATIC BRAIN-INJURY; FATIGUE IMPACT SCALE; MOTOR FUNCTION-TEST; VIRTUAL-REALITY; CHRONIC STROKE; DOSE-RESPONSE; MULTIPLE-SCLEROSIS; HEALTH SURVEY; VIDEO GAMES; XBOX KINECT	Background A client-centred task-oriented approach has advantages towards motivation and adherence to therapy in neurorehabilitation, but it is costly to integrate in practice. An intelligent Activity-based Client-centred Training (i-ACT), a low-cost Kinect-based system, was developed which integrates a client-centred and task-oriented approach. The objectives were (1) to investigate the effect of additional i-ACT training on functioning. And (2) to assess whether training with i-ACT resulted in more goal oriented training. Methods A single-blind randomised controlled trial was performed in 4 Belgian rehabilitation centres with persons with central nervous system deficits. Participants were randomly allocated through an independent website-based code generator using blocked randomisation (n = 4) to an intervention or control group. The intervention group received conventional care and additional training with i-ACT for 3 x 45 min/week during 6 weeks. The control group received solely conventional care. Functional ability and performance, quality of life (QoL), fatigue, trunk movement, and shoulder active range of motion (AROM) were assessed at baseline, after 3 weeks and 6 weeks of training, and 6 weeks after cessation of training. Data were analysed using non-parametric within and between group analysis. Results 47 persons were randomised and 45 analysed. Both intervention (n = 25) and control (n = 22) group improved over time on functional ability and performance as measured by the Wolf Motor Function Test, Manual Ability Measure-36, and Canadian Occupational Performance Measure, but no major differences were found between the groups on these primary outcome measures. Regarding QoL, fatigue, trunk movement, and shoulder AROM, no significant between group differences were found. High adherence for i-ACT training was found (i.e. 97.92%) and no adverse events, linked to i-ACT, were reported. In the intervention group the amount of trained personal goals (88%) was much higher than in the control group (46%). Conclusions Although additional use of i-ACT did not have a statistically significant added value regarding functional outcome over conventional therapy, additional i-ACT training provides more individualised client-centred therapy, and adherence towards i-ACT training is high. A higher intensity of i-ACT training may increase therapy effects, and should be investigated in future research. Trial registration: ClinicalTrials.gov Identifier NCT02982811. Registered 29 November 2016.	[Knippenberg, Els; Lemmens, Jolien; Spooren, Annemie] PXL Univ Appl Sci & Arts, Ctr Expertise Innovat Care, Dept Healthcare, Guffenslaan 39, B-3500 Hasselt, Belgium; [Knippenberg, Els; Timmermans, Annick; Spooren, Annemie] Hasselt Univ, Fac Rehabil Sci, REVAL, Gebouw A, B-3590 Diepenbeek, Belgium; [Coolen, Jolijn] Rehabil & MS Ctr, Noorderhart, Boemerangstr 2, B-3900 Pelt, Belgium; [Neven, Katrien] St Trudo Hosp, Diestersteenweg 100, B-3800 St Truiden, Belgium; [Hallet, Peter] Ziekenhuis Oost Limburg, Campus Sint Barbara,Bessemerstr 478, B-3620 Lanaken, Belgium; [Lemmens, Jolien] Multifunctioneel Ctr, Sint Gerardus, Sint Gerardusdreef 1, B-3590 Diepenbeek, Belgium		Knippenberg, E (corresponding author), PXL Univ Appl Sci & Arts, Ctr Expertise Innovat Care, Dept Healthcare, Guffenslaan 39, B-3500 Hasselt, Belgium.; Knippenberg, E (corresponding author), Hasselt Univ, Fac Rehabil Sci, REVAL, Gebouw A, B-3590 Diepenbeek, Belgium.	els.knippenberg@pxl.be			Interreg V-A Euregio Meuse-Rhine (EMR) programme; Provincie Limburg (Belgium); Vlaams Agentschap Innoveren en Ondernemen (Belgium)	This study, as part of the i2-CoRT project (www.i2-CoRT.eu), has been cofinanced with a grant from the Interreg V-A Euregio Meuse-Rhine (EMR) programme, as well as funding from Provincie Limburg (Belgium) and Vlaams Agentschap Innoveren en Ondernemen (Belgium). The Interreg EMR program has invested almost EUR 100 million in the development of the Interregregion until 2020. With the investment of EU funds in Interreg projects, the European Union directly invests in the economic development, innovation, territorial development and social inclusion and education of this region.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; AbilityLab RIoCdbaSR, 2021, MED OUTC STUD SHORT; Dos Santos LRA, 2015, J STROKE CEREBROVASC, V24, P2298, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.010; Almhdawi KA, 2016, OCCUP THER INT, V23, P444, DOI 10.1002/oti.1447; Birkenmeier RL, 2010, NEUROREHAB NEURAL RE, V24, P620, DOI 10.1177/1545968310361957; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Bonnechere B, 2016, INT J REHABIL RES, V39, P277, DOI 10.1097/MRR.0000000000000190; Brokaw EB, 2015, TECHNOL HEALTH CARE, V23, P143, DOI 10.3233/THC-140880; Canadian Association of Occupational Therapists, 2002, ENABLING OCCUPATION; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Chan CC., 1997, OCCUP THER INT, V4, P231; Chen CC, 2010, ARCH PHYS MED REHAB, V91, P414, DOI 10.1016/j.apmr.2009.11.012; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Donnelly C, 2004, SPINAL CORD, V42, P302, DOI 10.1038/sj.sc.3101589; Feys P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0043-3; Field A, 2013, DISCOVERING STAT USI; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hsu SS, 2010, STROKE, V41, P821, DOI 10.1161/STROKEAHA.109.574160; Jonsdottir J, 2018, MULT SCLER RELAT DIS, V19, P25, DOI 10.1016/j.msard.2017.10.010; Kim WS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011173; Knippenberg E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147641; Knippenberg E, 2020, TECHNOL HEALTH CARE, V28, P355, DOI 10.3233/THC-191854; Knippenberg E, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0270-x; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Kos D, 2003, ACTA NEUROL BELG, V103, P185; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lamers I, 2019, MULT SCLER RELAT DIS, V34, P119, DOI 10.1016/j.msard.2019.06.014; Lamers I, 2015, PHYS THER, V95, P65, DOI 10.2522/ptj.20130588; Lamers I, 2014, MULT SCLER J, V20, P775, DOI 10.1177/1352458514525677; Lamers I, 2014, ARCH PHYS MED REHAB, V95, P1184, DOI 10.1016/j.apmr.2014.02.023; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Lang CE, 2015, CURR OPIN NEUROL, V28, P549, DOI 10.1097/WCO.0000000000000256; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lee G, 2013, J PHYS THER SCI, V25, P595, DOI 10.1589/jpts.25.595; Levin MF, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0003-9; Llorens R, 2015, ARCH PHYS MED REHAB, V96, P418, DOI 10.1016/j.apmr.2014.10.019; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Lozano-Quilis JA, 2014, JMIR SERIOUS GAMES, V2, P43, DOI 10.2196/games.2933; Mills RJ, 2010, J NEUROL NEUROSUR PS, V81, P1049, DOI 10.1136/jnnp.2008.151340; Ng AKY, 2008, HONG KONG J OCCUP TH, V18, P20, DOI 10.1016/S1569-1861(08)70009-3; Paquin K, 2016, DISABIL REHABIL, V38, P2144, DOI 10.3109/09638288.2015.1114155; Park DS, 2017, J STROKE CEREBROVASC, V26, P2313, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.019; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; RAND coorperation, 36 IT SHORT FORM SUR; Saposnik G, 2016, LANCET NEUROL, V15, P1019, DOI 10.1016/S1474-4422(16)30121-1; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Simsek TT, 2016, INT J NEUROSCI, V126, P1061, DOI 10.3109/00207454.2015.1115993; Sin H, 2013, AM J PHYS MED REHAB, V92, P871, DOI 10.1097/PHM.0b013e3182a38e40; Spooren AIF, 2011, SPINAL CORD, V49, P1049, DOI 10.1038/sc.2011.54; Strong S, 1999, Can J Occup Ther, V66, P122; Timmermans AAA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-45; van der Zee KIS R., 1993, METEN ALGEMENE GEZON; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Verheyden G, 2006, SOUTH AFR J PHYSIOTH, V62, P23; Verheyden G, 2006, CLIN REHABIL, V20, P451, DOI 10.1191/0269215505cr955oa; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Waddell KJ, 2014, AM J OCCUP THER, V68, P444, DOI 10.5014/ajot.2014.011619; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	64	0	0	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	DEC 28	2021	18	1							184	10.1186/s12984-021-00977-2			16	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	XV3IN	WOS:000734839900002	34961531	gold, Green Published			2022-02-06	
J	Lu, ZN; Yeates, EO; Grigorian, A; Algeo, RG; Kuza, CM; Chin, TL; Donnelly, M; Kong, A; Nahmias, J				Lu, Zachary N.; Yeates, Eric O.; Grigorian, Areg; Algeo, Russell G.; Kuza, Catherine M.; Chin, Theresa L.; Donnelly, Megan; Kong, Allen; Nahmias, Jeffry			Alcohol is not associated with increased mortality in adolescent traumatic brain injury patients	PEDIATRIC SURGERY INTERNATIONAL			English	Article; Early Access						Adolescent; Traumatic brain injury; Alcohol; Mortality; Outcomes; Database	SEVERITY; SURVIVAL; LEVEL	Purpose Compared to adults, there is a paucity of data regarding the association of a positive alcohol screen (PAS) and outcomes in adolescent patients with traumatic brain injury (TBI). We hypothesize adolescent TBI patients with a PAS on admission to have increased mortality compared to patients with a negative alcohol screen. Methods The 2017 Trauma Quality Improvement Program database was queried for patients aged 13-17 years presenting with a TBI and serum alcohol screen. Patients with missing information regarding midline shift on imaging and Glasgow Coma Scale (GCS) score were excluded. A multivariable logistic regression analysis for mortality was performed. Results From 2553 adolescent TBI patients with an alcohol screen, 220 (8.6%) had a PAS. Median injury severity scores and rates of penetrating trauma (all p > 0.05) were similar between alcohol positive and negative patients. Patients with a PAS had a similar mortality rate (13.2% vs. 12.1%, p = 0.64) compared to patients with a negative screen. Multivariate logistic regression controlling for risk factors associated with mortality revealed a PAS to confer a similar risk of mortality compared to alcohol negative patients (p = 0.40). Conclusion Adolescent TBI patients with a PAS had similar associated risk of mortality compared to patients with a negative alcohol screen.	[Lu, Zachary N.; Yeates, Eric O.; Algeo, Russell G.; Chin, Theresa L.; Donnelly, Megan; Kong, Allen; Nahmias, Jeffry] Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA; [Grigorian, Areg] Univ Southern Calif USC, Dept Surg, 1520 San Pablo St,Suite 4300, Los Angeles, CA 90033 USA; [Kuza, Catherine M.] Univ Southern Calif, Keck Sch Med, Dept Anesthesiol, 1250 San Pablo St,Suite 3600, Los Angeles, CA 90033 USA		Nahmias, J (corresponding author), Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	znlu@hs.uci.edu; yeatese@hs.uci.edu; areg.grigorian@med.usc.edu; russellalgeo@berkeley.edu; catherine.kuza@med.usc.edu; chintl1@hs.uci.edu; mrdonnel@hs.uci.edu; konga@hs.uci.edu; jnahmias@hs.uci.edu					Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Aziz H, 2015, J TRAUMA ACUTE CARE, V79, P463, DOI 10.1097/TA.0000000000000777; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; El-Menyar A, 2019, BRAIN INJURY, V33, P419, DOI 10.1080/02699052.2018.1553065; Guilhaume-Correa F, 2020, J NEUROSCI RES, V98, P557, DOI 10.1002/jnr.24535; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; HICKS BA, 1990, J PEDIATR SURG, V25, P944, DOI 10.1016/0022-3468(90)90235-2; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Noh H, 2011, J KOREAN MED SCI, V26, P431, DOI 10.3346/jkms.2011.26.3.431; Okidi R, 2020, BJS OPEN, V4, P320, DOI 10.1002/bjs5.50243; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Rao AJ, 2018, WORLD NEUROSURG, V112, pE216, DOI 10.1016/j.wneu.2018.01.025; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Scheyerer MJ, 2014, EMERG MED J, V31, P813, DOI 10.1136/emermed-2013-202804; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	29	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.												10.1007/s00383-021-05057-z		DEC 2021	9	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	XV1OP	WOS:000734720400001	34958420	hybrid			2022-02-06	
J	Vedaei, F; Newberg, AB; Alizadeh, M; Muller, J; Shahrampour, S; Middleton, D; Zabrecky, G; Wintering, N; Bazzan, AJ; Monti, DA; Mohamed, FB				Vedaei, Faezeh; Newberg, Andrew B.; Alizadeh, Mahdi; Muller, Jennifer; Shahrampour, Shiva; Middleton, Devon; Zabrecky, George; Wintering, Nancy; Bazzan, Anthony J.; Monti, Daniel A.; Mohamed, Feroze B.			Resting-State Functional MRI Metrics in Patients With Chronic Mild Traumatic Brain Injury and Their Association With Clinical Cognitive Performance	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; resting-state functional magnetic resonance imaging; fractional amplitude of low-frequency fluctuation; regional homogeneity; functional connectivity; cognitive performance	DEFAULT-MODE NETWORK; REGIONAL HOMOGENEITY; CONNECTIVITY; FMRI; AMPLITUDE; HEALTHY	Mild traumatic brain injury (mTBI) accounts for more than 80% of people experiencing brain injuries. Symptoms of mTBI include short-term and long-term adverse clinical outcomes. In this study, resting-state functional magnetic resonance imaging (rs-fMRI) was conducted to measure voxel-based indices including fractional amplitude of low-frequency fluctuation (fALFF), regional homogeneity (ReHo), and functional connectivity (FC) in patients suffering from chronic mTBI; 64 patients with chronic mTBI at least 3 months post injury and 40 healthy controls underwent rs-fMRI scanning. Partial correlation analysis controlling for age and gender was performed within mTBI cohort to explore the association between rs-fMRI metrics and neuropsychological scores. Compared with controls, chronic mTBI patients showed increased fALFF in the left middle occipital cortex (MOC), right middle temporal cortex (MTC), and right angular gyrus (AG), and increased ReHo in the left MOC and left posterior cingulate cortex (PCC). Enhanced FC was observed from left MOC to right precuneus; from right MTC to right superior temporal cortex (STC), right supramarginal, and left inferior parietal cortex (IPC); and from the seed located at right AG to left precuneus, left superior medial frontal cortex (SMFC), left MTC, left superior temporal cortex (STC), and left MOC. Furthermore, the correlation analysis revealed a significant correlation between neuropsychological scores and fALFF, ReHo, and seed-based FC measured from the regions with significant group differences. Our results demonstrated that alterations of low-frequency oscillations in chronic mTBI could be representative of disruption in emotional circuits, cognitive performance, and recovery in this cohort.	[Vedaei, Faezeh; Newberg, Andrew B.; Alizadeh, Mahdi; Muller, Jennifer; Shahrampour, Shiva; Middleton, Devon; Bazzan, Anthony J.; Mohamed, Feroze B.] Thomas Jefferson Univ, Dept Radiol, Jefferson Integrated Magnet Resonance Imaging Ctr, Philadelphia, PA 19107 USA; [Newberg, Andrew B.; Zabrecky, George; Wintering, Nancy; Monti, Daniel A.] Thomas Jefferson Univ, Marcus Inst Integrat Hlth, Dept Integrat Med & Nutr Sci, Philadelphia, PA 19107 USA		Mohamed, FB (corresponding author), Thomas Jefferson Univ, Dept Radiol, Jefferson Integrated Magnet Resonance Imaging Ctr, Philadelphia, PA 19107 USA.	feroze.mohamed@jefferson.edu					Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Bittencourt-Villalpando M, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102534; Che KL, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00656; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Fu SS, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101951; Golestani AM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00546; Grabner RH, 2013, HUM BRAIN MAPP, V34, P1013, DOI 10.1002/hbm.21489; Guo H, 2019, WORLD NEUROSURG, V121, pE630, DOI 10.1016/j.wneu.2018.09.178; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jiao FY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00566; Ke J, 2018, CELL PHYSIOL BIOCHEM, V48, P99, DOI 10.1159/000491666; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Konstantinou N, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01163; Lemme J, 2021, J NEUROTRAUM, V38, P1632, DOI 10.1089/neu.2020.7189; Li FF, 2020, CNS NEUROSCI THER, V26, P1083, DOI 10.1111/cns.13430; Lin X, 2020, J AFFECT DISORDERS, V277, P358, DOI 10.1016/j.jad.2020.08.007; Liu Y., 2018, NEUROL NEUROSURGERY, V1, P1, DOI [10.15761/nns.1000106, DOI 10.15761/NNS.1000106]; Mak LE, 2017, BRAIN CONNECT, V7, P25, DOI 10.1089/brain.2016.0438; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Mo YT, 2020, PSYCHIAT RES, V294, DOI 10.1016/j.psychres.2020.113461; Muller J, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102681; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheth C, 2021, BEHAV BRAIN RES, V396, DOI 10.1016/j.bbr.2020.112882; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sinke MRT, 2021, J NEUROTRAUM, V38, P1642, DOI 10.1089/neu.2020.7151; Stephenson DD, 2020, J MAGN RESON IMAGING, V52, P1701, DOI 10.1002/jmri.27249; Stillman M.J., 2008, HEADACHE, V48, P1243, DOI [10.1111/j.1526-4610.2008.01220.x, DOI 10.1111/J.1526-4610.2008.01220.X]; Tagliazucchi E, 2017, NEUROIMAGE, V160, P55, DOI 10.1016/j.neuroimage.2017.06.026; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Wang PS, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-1992-4; Wang XX, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00029; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yang J, 2020, CLIN IMAG, V65, P47, DOI 10.1016/j.clinimag.2020.04.004; Yang L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00975; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Yue YM, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00141; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhao ZY, 2018, HUM BRAIN MAPP, V39, P4373, DOI 10.1002/hbm.24277; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	60	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 27	2021	15								768485	10.3389/fnhum.2021.768485			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YK3VL	WOS:000745144700001	35027887	gold, Green Published			2022-02-06	
J	Garcia-Mendez, N; Briceno-Santana, M; Totomoch-Serra, A; Manterola, C; Otzen, T; Valdez, PS; Campos-Duran, R; Reyna, GC				Garcia-Mendez, Nayely; Briceno-Santana, Miguel; Totomoch-Serra, Armando; Manterola, Carlos; Otzen, Tamara; Valdez, Patricia Solis; Campos-Duran, Ramon; Reyna, Guillermo Careaga			The hemodynamic effects of diazepam versus dexmedetomidine in the treatment of alcohol withdrawal syndrome: A randomized clinical trial	MEDICINA CLINICA			English	Article						Alcohol withdrawal delirium; Alcohol withdrawal seizures; Substance withdrawal syndrome; Dexmedetomidine; Benzodiazepines	MANAGEMENT; IMPLEMENTATION; RECEPTORS; SEDATION; PROTOCOL; THERAPY	Background: Dexmedetomidine (DEX) is an alpha-2 adrenergic drug used for short sedation and as an alternative to diazepam (DZP) in the treatment of alcohol withdrawal syndrome (AWS). Purpose: This study aims to compare the hemodynamic effect of DZP versus DEX on heart rate (HR) and blood pressure in patients with AWS. Methods: Prospective randomized clinical trial that includes 40 patients with AWS from Merida, Yucatan, Mexico. Results: Forty patients were randomly divided into two groups: one group DZP (n = 20) patients received diazepam (doses 5-20 mg IV) and the other group (n = 20) received DEX (dexmedetomidine infusion .2-.7 mcg/kg/min). We obtained statistical significance in sedation with the DEX group in the degree of traumatic brain injury I/II (p = .003). The DEX group remained haemodynamically stable in the first 24 h, the mean HR (73.85 +/- 8.39) was significant comparing both groups (p = .002). In the comparison of the figures for the DEX group with the DZP (143.85 +/- 2.30-137.95 +/- 5.62) the SBP was significant with a (p = .0001). Furthermore, DEX treatment was shorter. Conclusion: Although DEX is not indicated for the routine treatment of AWS, this study proposes a positive effect on HR, SBP and fewer days of treatment compared to the standard DZP treatment for AWS. Clinical Trials.gov ID: NCT03877120-https://clinicaltrials.gov/ct2/show/NCT03877120. (c) 2020 Elsevier Espana, S.L.U. All rights reserved.	[Garcia-Mendez, Nayely; Manterola, Carlos; Otzen, Tamara] Univ La Frontera, PhD Program Med Sci, Temuco, Chile; [Briceno-Santana, Miguel] Hosp Gen Agustin OHoran, Dept Internal Med, Merida, Yucatan, Mexico; [Totomoch-Serra, Armando; Manterola, Carlos; Otzen, Tamara] Univ La Frontera, Ctr Excellence Morphol & Surg Studies CEMyQ, Temuco, Chile; [Garcia-Mendez, Nayely; Campos-Duran, Ramon; Reyna, Guillermo Careaga] Inst Mexicano Seguro Social IMSS, Hosp Gen Ctr Med Nacl La Raza, Mexico City, DF, Mexico; [Valdez, Patricia Solis] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico		Garcia-Mendez, N (corresponding author), Univ La Frontera, PhD Program Med Sci, Temuco, Chile.; Garcia-Mendez, N (corresponding author), Inst Mexicano Seguro Social IMSS, Hosp Gen Ctr Med Nacl La Raza, Mexico City, DF, Mexico.	ayeyigmendez@comunidad.unam.mx					[Anonymous], 2018, GLOBAL STATUS REPORT; Beg Muna, 2016, Perm J, V20, P49, DOI 10.7812/TPP/15-113; Carlson RW, 2012, CRIT CARE CLIN, V28, P549, DOI 10.1016/j.ccc.2012.07.004; CELENTANO JJ, 1988, BRAIN RES, V455, P377, DOI 10.1016/0006-8993(88)90098-4; Cho JS, 2016, AM J THER, V23, pE369, DOI 10.1097/MJT.0000000000000074; Contet Candice, 2012, Curr Psychopharmacol, V1, P301; Eberly Mary E, 2016, Hosp Pharm, V51, P752; Enoch MA, 2008, PHARMACOL BIOCHEM BE, V90, P95, DOI 10.1016/j.pbb.2008.03.007; Ferenchak TA, 2017, J ADDICT NURS, V28, P188, DOI 10.1097/JAN.0000000000000191; Frazee EN, 2014, J CRIT CARE, V29, P298, DOI 10.1016/j.jcrc.2013.11.016; Gertler R, 2001, Proc (Bayl Univ Med Cent), V14, P13; Guerzoni S, 2018, PHARMACOL RES, V133, P65, DOI 10.1016/j.phrs.2018.04.024; Hoy SM, 2011, DRUGS, V71, P1481, DOI 10.2165/11207190-000000000-00000; Jawa RS, 2014, AM J SURG, V208, P781, DOI 10.1016/j.amjsurg.2014.04.007; Jesse S, 2017, ACTA NEUROL SCAND, V135, P4, DOI 10.1111/ane.12671; Kumar S, 2004, PHARMACOL THERAPEUT, V101, P211, DOI 10.1016/j.pharmthera.2003.12.001; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Martijena ID, 2002, SYNAPSE, V45, P86, DOI 10.1002/syn.10085; Menda F, 2010, ANN CARD ANAESTH, V13, P16, DOI 10.4103/0971-9784.58829; Mirijello A, 2015, DRUGS, V75, P353, DOI 10.1007/s40265-015-0358-1; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Morisot N, 2017, GENES BRAIN BEHAV, V16, P139, DOI 10.1111/gbb.12363; Mueller SW, 2014, CRIT CARE MED, V42, P1131, DOI 10.1097/CCM.0000000000000141; Naaz Shagufta, 2014, J Clin Diagn Res, V8, pGE01, DOI 10.7860/JCDR/2014/9624.4946; NORMA Oficial Mexicana, 2012, NOM004SSA32012; ROMACH MK, 1991, ANNU REV MED, V42, P323, DOI 10.1146/annurev.me.42.020191.001543; Seymore RJ, 2019, J PAIN PALLIAT CARE, V33, P34, DOI 10.1080/15360288.2019.1629520; Shin HJ, 2017, MINERVA ANESTESIOL, V83, P1042, DOI 10.23736/S0375-9393.17.11794-3; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Silva JM, 2019, REGION ANESTH PAIN M, V44, P319, DOI 10.1136/rapm-2018-100120; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Sychla H, 2017, EUR ADDICT RES, V23, P211, DOI 10.1159/000480380; Tang CL, 2018, NEURAL REGEN RES, V13, P280, DOI 10.4103/1673-5374.226399; UMBRICHTSCHNEITER A, 1991, AM J MED, V91, P110, DOI 10.1016/0002-9343(91)90002-F; Villatoro-Velazquez JA, 2015, ENCUESTA NACL CONSUM; Waye C, 2015, SOUTH MED J, V108, P23, DOI 10.14423/SMJ.0000000000000216; Wong A, 2015, AM J DRUG ALCOHOL AB, V41, P382, DOI 10.3109/00952990.2015.1058390; Yavarovich ER, 2019, ASS DEXMEDETOMIDINE, V1, P1	38	0	0	1	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0025-7753	1578-8989		MED CLIN-BARCELONA	Med. Clin.	DEC 24	2021	157	12					561	568		10.1016/j.medcli.2020.09.023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH6PV	WOS:000725555100009	33423824				2022-02-06	
J	Lv, B; Hu, LH; Fang, H; Sun, DY; Hou, YT; Deng, J; Zhang, HD; Xu, J; He, LL; Liang, YF; Chen, CB				Lv, Bo; Hu, Linhui; Fang, Heng; Sun, Dayong; Hou, Yating; Deng, Jia; Zhang, Huidan; Xu, Jing; He, Linling; Liang, Yufan; Chen, Chunbo			Development and Validation of a Nomogram Incorporating Colloid Osmotic Pressure for Predicting Mortality in Critically Ill Neurological Patients	FRONTIERS IN MEDICINE			English	Article						colloid osmotic pressure; mortality; critically ill neurological patients; nomogram; predicting	TRAUMATIC BRAIN-INJURY; ACUTE PHYSIOLOGY SCORE; GLASGOW COMA SCALE; APACHE-II; MANAGEMENT; GUIDELINES; BALANCE; COHORT	Backgrounds: The plasma colloid osmotic pressure (COP) values for predicting mortality are not well-estimated. A user-friendly nomogram could predict mortality by incorporating clinical factors and scoring systems to facilitate physicians modify decision-making when caring for patients with serious neurological conditions.Methods: Patients were prospectively recruited from March 2017 to September 2018 from a tertiary hospital to establish the development cohort for the internal test of the nomogram, while patients recruited from October 2018 to June 2019 from another tertiary hospital prospectively constituted the validation cohort for the external validation of the nomogram. A multivariate logistic regression analysis was performed in the development cohort using a backward stepwise method to determine the best-fit model for the nomogram. The nomogram was subsequently validated in an independent external validation cohort for discrimination and calibration. A decision-curve analysis was also performed to evaluate the net benefit of the insertion decision using the nomogram.Results: A total of 280 patients were enrolled in the development cohort, of whom 42 (15.0%) died, whereas 237 patients were enrolled in the validation cohort, of which 43 (18.1%) died. COP, neurological pathogenesis and Acute Physiology and Chronic Health Evaluation II (APACHE II) score were predictors in the prediction nomogram. The derived cohort demonstrated good discriminative ability, and the area under the receiver operating characteristic curve (AUC) was 0.895 [95% confidence interval (CI), 0.840-0.951], showing good correction ability. The application of this nomogram to the validation cohort also provided good discrimination, with an AUC of 0.934 (95% CI, 0.892-0.976) and good calibration. The decision-curve analysis of this nomogram showed a better net benefit.Conclusions : A prediction nomogram incorporating COP, neurological pathogenesis and APACHE II score could be convenient in predicting mortality for critically ill neurological patients.	[Lv, Bo; Fang, Heng; Deng, Jia; Zhang, Huidan; Xu, Jing; He, Linling; Liang, Yufan; Chen, Chunbo] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Crit Care Med, Guangzhou, Peoples R China; [Lv, Bo; Chen, Chunbo] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China; [Lv, Bo; Hou, Yating] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Prov Geriatr Inst, Dept Gen Practice, Guangzhou, Peoples R China; [Hu, Linhui; Fang, Heng] Maoming Peoples Hosp, Dept Crit Care Med, Maoming, Peoples R China; [Hu, Linhui] Maoming Peoples Hosp, Dept Clin Res Ctr, Maoming, Peoples R China; [Sun, Dayong] Longgang Dist Cent Hosp, Dept Emergency, Shenzhen, Peoples R China; [Hou, Yating] Maoming Peoples Hosp, Dept Oncol, Maoming, Peoples R China; [Chen, Chunbo] Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangdong Prov Peoples Hosp, Dept Intens Care,Unit Cardiac Surg, Guangzhou, Peoples R China		Chen, CB (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Crit Care Med, Guangzhou, Peoples R China.; Chen, CB (corresponding author), Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China.; Chen, CB (corresponding author), Guangdong Acad Med Sci, Guangdong Cardiovasc Inst, Guangdong Prov Peoples Hosp, Dept Intens Care,Unit Cardiac Surg, Guangzhou, Peoples R China.	gghccm@163.com					Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Boer KR, 2008, INTENS CARE MED, V34, P664, DOI 10.1007/s00134-007-0941-3; Brown G, 2001, CRIT CARE MED, V29, P1714, DOI 10.1097/00003246-200109000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen WS, 2018, JPEN-PARENTER ENTER, V42, P132, DOI 10.1177/0148607116667282; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Deng YY, 2016, MINI-REV MED CHEM, V16, P917, DOI 10.2174/1389557516666160304151233; Deng YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04627-3; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Habermehl C, 2011, OPT EXPRESS, V19, P18636, DOI 10.1364/OE.19.018636; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hu LH, 2019, CLIN NUTR, V38, P2799, DOI 10.1016/j.clnu.2018.12.008; Kish JL, 2016, J VET EMERG CRIT CAR, V26, P675, DOI 10.1111/vec.12517; Klanderman RB, 2020, VOX SANG, V115, P664, DOI 10.1111/vox.12932; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Li XY, 2017, J AM SOC NEPHROL, V28, P1286, DOI 10.1681/ASN.2016030342; Lv B, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1839-2; Ma JC, 2021, BMC NEPHROL, V22, DOI 10.1186/s12882-021-02388-w; Martin GS, 2000, CRIT CARE, V4, pS21, DOI 10.1186/cc966; Martins CB, 2020, J TRANSL INTERN MED, V8, P201, DOI 10.2478/jtim-2020-0031; Mehta RI, 2013, J NEUROPATH EXP NEUR, V72, P871, DOI 10.1097/NEN.0b013e3182a32e40; Ookawara S, 2014, THER APHER DIAL, V18, P202, DOI 10.1111/1744-9987.12070; Park SK, 2009, J KOREAN MED SCI, V24, P420, DOI 10.3346/jkms.2009.24.3.420; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P98, DOI 10.17116/neiro201680198-106; Rahbar E, 2014, SHOCK, V41, P181, DOI 10.1097/SHK.0000000000000101; Ramesh VJ, 2011, J NEUROSURG ANESTH, V23, P183, DOI 10.1097/ANA.0b013e31821cb9ec; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schuiling WJ, 2005, NEUROSURGERY, V57, P230, DOI 10.1227/01.NEU.0000166536.42876.9C; TEASDALE G, 1974, LANCET, V2, P81; Truelsen T., 2006, GLOBAL BURDEN CEREBR; van IJzendoorn M, 2020, J TRANSL INTERN MED, V8, P165, DOI 10.2478/jtim-2020-0026; WONG DT, 1995, CRIT CARE MED, V23, P1177, DOI 10.1097/00003246-199507000-00005; Yoon JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195628; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Zou ZH, 2013, ACTA MEDICA MEDITERR, V29, P295	38	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	DEC 24	2021	8								765818	10.3389/fmed.2021.765818			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH4QE	WOS:000743153000001	35004737	gold, Green Published			2022-02-06	
J	Ma, RN; He, YX; Bai, FP; Song, ZP; Chen, MS; Li, M				Ma, Rui Na; He, Yi Xuan; Bai, Fu Ping; Song, Zhi Peng; Chen, Ming Sheng; Li, Min			Machine Learning Model for Predicting Acute Respiratory Failure in Individuals With Moderate-to-Severe Traumatic Brain Injury	FRONTIERS IN MEDICINE			English	Article						acute respiratory failure; machine learning; XGBoost model; logistic regression; traumatic brain injury		Background: There is a high incidence of acute respiratory failure (ARF) in moderate or severe traumatic brain injury (M-STBI), worsening outcomes. This study aimed to design a predictive model for ARF.Methods: Adult patients with M-STBI [3 <= Glasgow Coma Scale (GCS) <= 12] with a definite history of brain trauma and abnormal head on CT images, obtained from September 2015 to May 2017, were included. Patients with age >80 years or <18 years, multiple injuries with TBI upon admission, or pregnancy (in women) were excluded. Two models based on machine learning extreme gradient boosting (XGBoost) or logistic regression, respectively, were developed for predicting ARF within 48 h upon admission. These models were evaluated by out-of-sample validation. The samples were assigned to the training and test sets at a ratio of 3:1.Results: In total, 312 patients were analyzed including 132 (42.3%) patients who had ARF. The GCS and the Marshall CT score, procalcitonin (PCT), and C-reactive protein (CRP) on admission significantly predicted ARF. The novel machine learning XGBoost model was superior to logistic regression model in predicting ARF [area under the receiver operating characteristic (AUROC) = 0.903, 95% CI, 0.834-0.966 vs. AUROC = 0.798, 95% CI, 0.697-0.899; p < 0.05].Conclusion: The XGBoost model could better predict ARF in comparison with logistic regression-based model. Therefore, machine learning methods could help to develop and validate novel predictive models.	[Ma, Rui Na] Fourth Mil Med Univ, Affiliated Hosp 2, Dept Pulm & Crit Care Med, Xian, Peoples R China; [He, Yi Xuan; Song, Zhi Peng; Chen, Ming Sheng; Li, Min] Fourth Mil Med Univ, Affiliated Hosp 2, Neurocrit Care Unit, Dept Neurosurg, Xian, Peoples R China; [Bai, Fu Ping] Lin Fen Ctr Hosp, Dept Neurosurg, Lin Fen, Peoples R China		Li, M (corresponding author), Fourth Mil Med Univ, Affiliated Hosp 2, Neurocrit Care Unit, Dept Neurosurg, Xian, Peoples R China.	neursylm@fmmu.edu.cn			Youth Innovation Fund of the Second Affiliated Hospital of Fourth Military Medical University [2021LCYJ026]	Funding This study was funded by the Youth Innovation Fund of the Second Affiliated Hospital of Fourth Military Medical University (Grant No. 2021LCYJ026).	Abd El Aziz MA, 2020, UPDATES SURG, V72, P977, DOI 10.1007/s13304-020-00892-6; Abujaber A, 2021, BRAIN INJURY, V35, P1095, DOI 10.1080/02699052.2021.1959060; Bartoletti M, 2020, CLIN MICROBIOL INFEC, V26, P1545, DOI 10.1016/j.cmi.2020.08.003; Brandenburg R, 2017, CLIN TOXICOL, V55, P4, DOI 10.1080/15563650.2016.1222616; Canet J, 2015, EUR J ANAESTH, V32, P458, DOI 10.1097/EJA.0000000000000223; Ciftci F, 2017, WIEN KLIN WOCHENSCHR, V129, P680, DOI 10.1007/s00508-017-1182-2; Collins GS, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0241-z; Cooper JP, 2021, LIVER TRANSPLANT, DOI 10.1002/lt.26318; Decavele M, 2021, J NEUROL, V268, P2141, DOI 10.1007/s00415-021-10396-x; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Gannon WD, 2018, CHEST, V153, P1387, DOI 10.1016/j.chest.2018.01.006; Gupta H, 2011, CHEST, V140, P1207, DOI 10.1378/chest.11-0466; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Jalali A, 2021, ANESTH ANALG, V132, P160, DOI 10.1213/ANE.0000000000004988; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Le S, 2020, J CRIT CARE, V60, P96, DOI 10.1016/j.jcrc.2020.07.019; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800; Mathioudakis NN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.30913; Mathis MR, 2020, ANESTH ANALG, V130, P1188, DOI 10.1213/ANE.0000000000004630; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Poignant S, 2021, NEUROCRIT CARE, DOI 10.1007/s12028-021-01298-x; Ross BJ, 1996, AM SURGEON, V62, P19; Carabias CS, 2020, WORLD NEUROSURG, V134, pE120, DOI 10.1016/j.wneu.2019.09.143; van Niftrik CHB, 2019, NEUROSURGERY, V85, pE756, DOI 10.1093/neuros/nyz145; Wu ZS, 2020, CLIN INFECT DIS, V71, pS400, DOI 10.1093/cid/ciaa1518; Zhang ZH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.03.29; Zhang ZZ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2411-z; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35	31	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	DEC 24	2021	8								793230	10.3389/fmed.2021.793230			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH4XS	WOS:000743173100001	35004766	Green Published, gold			2022-02-06	
J	Mazaharally, M; Stojanovski, S; Trossman, R; Szulc-Lerch, K; Chakravarty, MM; Colella, B; Glazer, J; Green, RE; Wheeler, AL				Mazaharally, Maria; Stojanovski, Sonja; Trossman, Rebecca; Szulc-Lerch, Kamila; Chakravarty, M. Mallar; Colella, Brenda; Glazer, Joanna; Green, Robin E.; Wheeler, Anne L.			Patterns of change in cortical morphometry following traumatic brain injury in adults	HUMAN BRAIN MAPPING			English	Article; Early Access						atrophy; cortical surface area; cortical thickness; longitudinal; traumatic brain injury	WHITE-MATTER INTEGRITY; DIFFUSION-TENSOR; LONGITUDINAL CHANGES; CEREBRAL-CORTEX; SURFACE-AREA; MODERATE; THICKNESS; ATROPHY; CONNECTIVITY; VOLUME	Progressive cortical volumetric loss following moderate-severe traumatic brain injury (TBI) has been observed; however, regionally specific changes in the structural determinants of cortical volume, namely, cortical thickness (CT) and cortical surface area (CSA), are unknown and may inform the patterns and neural substrates of neurodegeneration and plasticity following injury. We aimed to (a) assess differences in CT and CSA between TBI participants and controls in the early chronic stage post-injury, (b) describe longitudinal changes in cortical morphometry following TBI, and (c) examine how regional changes in CT and CSA are associated. We acquired magnetic resonance images for 67 participants with TBI at up to 4 time-points spanning 5 months to 7 years post-injury, and 18 controls at 2 time-points. In the early chronic stage, TBI participants displayed thinner cortices than controls, predominantly in frontal regions, but no CSA differences. Throughout the chronic period, TBI participants showed widespread CT reductions in posterior cingulate/precuneus regions and moderate CT increase in frontal regions. Additionally, CSA showed a significant decrease in the orbitofrontal cortex and circumscribed increase in posterior regions. No changes were identified in controls. Relationships between regional cortical changes in the same morphological measure revealed coordinated patterns within participants, whereas correlations between regions with CT and CSA change yielded bi-directional relationships. This suggests that these measures may be differentially affected by neurodegenerative mechanisms such as transneuronal degeneration following TBI and that degeneration may be localized to the depths of cortical sulci. These findings emphasize the importance of dissecting morphometric contributions to cortical volume change.	[Mazaharally, Maria; Stojanovski, Sonja; Trossman, Rebecca; Wheeler, Anne L.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Stojanovski, Sonja; Wheeler, Anne L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Szulc-Lerch, Kamila] Univ Oxford, Wellcome Ctr Integrat Neuroimaging, Nuffield Dept Clin Neurosci, FMRIB, Oxford, England; [Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Colella, Brenda; Glazer, Joanna; Green, Robin E.] Toronto Rehabil Inst, Res Dept, Cognit Neurorehabil Sci Lab, Toronto, ON, Canada; [Green, Robin E.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada		Wheeler, AL (corresponding author), Hosp Sick Children, Res Inst, 686 Bay St, Toronto, ON M5G 0A4, Canada.; Green, RE (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	robin.green@uhn.ca; anne.wheeler@sickkids.ca			Toronto Rehabilitation Institute under the Provincial Rehabilitation Research Program from the Ministry of Health and LongTerm Care in Ontario; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by the Toronto Rehabilitation Institute which receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and LongTerm Care in Ontario. Funding was also provided by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asmamaw Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7800-3; Belchev Zorry, 2021, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000696; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meyer M, 2014, CEREB CORTEX, V24, P2541, DOI 10.1093/cercor/bht094; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; R Development Core Team, 2012, R LANG ENV STAT COMP; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shao MH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00878; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Terpstra AR, 2017, NEUROREHAB NEURAL RE, V31, P1063, DOI 10.1177/1545968317736817; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Deynse H, 2019, BRAIN INJURY, V33, P1234, DOI 10.1080/02699052.2019.1641224; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wright IC, 1999, CEREB CORTEX, V9, P366, DOI 10.1093/cercor/9.4.366; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	61	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.												10.1002/hbm.25761		DEC 2021	13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	XU1BT	WOS:000734010300001	34953011	gold			2022-02-06	
J	Ceranoglu, TA; Cassano, P; Hoskova, B; Green, A; Dallenbach, N; DiSalvo, M; Biederman, J; Joshi, G				Ceranoglu, Tolga Atilla; Cassano, Paolo; Hoskova, Barbora; Green, Allison; Dallenbach, Nina; DiSalvo, Maura; Biederman, Joseph; Joshi, Gagan			Transcranial Photobiomodulation in Adults with High-Functioning Autism Spectrum Disorder: Positive Findings from a Proof-of-Concept Study	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article; Early Access						autism; photobiomodulation; treatment; developmental disorders; near-infrared	PERVASIVE DEVELOPMENTAL DISORDER; TRAUMATIC BRAIN-INJURY; LASER THERAPY; COGNITIVE PERFORMANCE; CHILDREN; ADOLESCENTS; SAFETY	Objective: To assess the efficacy and safety of transcranial photobiomodulation (tPBM) in adults with autism spectrum disorder (ASD).Methods: Adults with high-functioning-ASD, between 18 and 59 years of age, were enrolled to receive twice a week tPBM for 8 weeks in an open-label single group design. ASD symptom severity was assessed at baseline, midpoint, and end-point, by clinician-, self-, and informant-rated measures. Treatment response was defined as a >= 30% reduction in Social Responsiveness Scale-2nd Edition (SRS-2) total score and ASD Clinical Global Impression-Improvement score <= 2. Any possible adverse events were recorded at each visit. Paired-samples t-test analyses were performed.Results: Eleven participants were enrolled, and 10 participants (9 males; 30.0 +/- 11.9 years) completed the study. One participant withdrew consent before baseline. All 10 completers were included in efficacy and safety analyses. Five participants (50%) met responder criteria at end-point. Overall, 8-week tPBM was associated with significant reduction in SRS-2 total scores at end-point (SRS-2: -30.6 +/- 23, p < 0.001) particularly in Social Awareness (-3.0 +/- 1.9, p < 0.001), Social Communication (-10.3 +/- 6, p < 0.001), Social Motivation (-5.0 +/- 2.4, p < 0.001), and Restricted/Repetitive Behaviors (-7.4 +/- 4.1, p < 0.001). There were statistically significant improvements at end-point in Global Assessment of Functioning scores (+12.8 +/- 4.2, p < 0.001) and Quality of Life Enjoyment and Satisfaction Questionnaire scores (+6.0 +/- 7.9, p = 0.02). Three participants experienced transient, mild side effects (insomnia, headache, and warmth at treatment application site). No adverse events required changes in tPBM protocol. Adherence rate was 98%.Conclusions: tPBM is a safe and feasible treatment approach that has the potential to treat core features of ASD. Further research is necessary and warranted.ClinicalTrials.gov Identifier: NCT03724552.	[Ceranoglu, Tolga Atilla; Hoskova, Barbora; Green, Allison; Dallenbach, Nina; DiSalvo, Maura; Biederman, Joseph; Joshi, Gagan] Massachusetts Gen Hosp, Dept Psychiat, Alan & Lorraine Bressler Clin & Res Program Autis, 55 Fruit St,WRN 624, Boston, MA 02114 USA; [Ceranoglu, Tolga Atilla; Hoskova, Barbora; Green, Allison; Dallenbach, Nina; DiSalvo, Maura; Biederman, Joseph; Joshi, Gagan] Massachusetts Gen Hosp, Dept Psychiat, Clin & Res Program Pediat Psychopharmacol, Boston, MA 02114 USA; [Ceranoglu, Tolga Atilla; Cassano, Paolo; Hoskova, Barbora; Green, Allison; Dallenbach, Nina; DiSalvo, Maura; Biederman, Joseph; Joshi, Gagan] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Cassano, Paolo] Massachusetts Gen Hosp, Dept Psychiat, Div Neuropsychiat, Boston, MA 02114 USA		Ceranoglu, TA (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Alan & Lorraine Bressler Clin & Res Program Autis, 55 Fruit St,WRN 624, Boston, MA 02114 USA.	aceranoglu@mgh.harvard.edu			Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder; MGH Pediatric Psychopharmacology Council Fund	This study is funded by Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder and the MGH Pediatric Psychopharmacology Council Fund.	Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Cassano P, 2019, PHOTOBIOMOD PHOTOMED, V37, P651, DOI 10.1089/photob.2019.4678; Cassano P, 2018, PHOTOMED LASER SURG, V36, P634, DOI 10.1089/pho.2018.4490; Cassano P, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.1.015004; Cassano P, 2019, LASER SURG MED, V51, P127, DOI 10.1002/lsm.23011; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen ACH, 2011, PHOTOMED LASER SURG, V29, P383, DOI 10.1089/pho.2010.2837; Constantino JN., 2012, SOCIAL RESPONSIVENES; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hume K, 2018, AUTISM, V22, P40, DOI 10.1177/1362361317722029; Hwang MH, 2015, PHOTOCHEM PHOTOBIOL, V91, P403, DOI 10.1111/php.12415; Jackson PA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00473; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Joshi G, 2010, J AUTISM DEV DISORD, V40, P1361, DOI 10.1007/s10803-010-0996-9; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Leavitt M, 2009, CLIN DRUG INVEST, V29, P283, DOI 10.2165/00044011-200929050-00001; Leisman G, 2018, ADV EXP MED BIOL, V1116, P111, DOI 10.1007/5584_2018_234; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; Mochizuki-Oda N, 2002, NEUROSCI LETT, V323, P207, DOI 10.1016/S0304-3940(02)00159-3; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2020, PHOTOBIOMOD PHOTOMED, V38, P115, DOI 10.1089/photob.2019.4630; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; Owen R, 2009, PEDIATRICS, V124, P1533, DOI 10.1542/peds.2008-3782; Roth RM, 2005, BRIEF A BEHAV RATING; Siniscalco D, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020056; StataCorp, 2019, STATA STAT SOFTWARE; Stigler KA, 2004, J CHILD ADOL PSYCHOP, V14, P49, DOI 10.1089/104454604773840481; SVERD J, 1995, CHILD PSYCHIAT HUM D, V25, P221; Sverd Jeffrey, 2003, J Psychiatr Pract, V9, P111, DOI 10.1097/00131746-200303000-00003; Tantawy SA, 2019, LASER MED SCI, V34, P793, DOI 10.1007/s10103-018-2665-8; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Wozniak J, 1997, J AM ACAD CHILD PSY, V36, P1552, DOI 10.1016/S0890-8567(09)66564-3; Yamaura M, 2009, LASER SURG MED, V41, P282, DOI 10.1002/lsm.20766; Yuan Yaoshen, 2020, Neurophotonics, V7, P015009, DOI 10.1117/1.NPh.7.1.015009; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	48	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMOD PHOTOMED	Photobiomodulation Photomed. Laser Surg.												10.1089/photob.2020.4986		DEC 2021	9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XT4YL	WOS:000733594800001	34941429				2022-02-06	
J	Hatakeyama, T; Kawakita, K; Kawai, N; Shishido, H; Yamamoto, Y; Nishiyama, Y; Miyake, K				Hatakeyama, Tetsuhiro; Kawakita, Kenya; Kawai, Nobuyuki; Shishido, Hajime; Yamamoto, Yuka; Nishiyama, Yoshihiro; Miyake, Keisuke			Temporal and spatial changes in reactive astrogliosis examined by F-18-THK5351 positron emission tomography in a patient with severe traumatic brain injury	EUROPEAN JOURNAL OF HYBRID IMAGING			English	Article						F-18-THK5351; Traumatic brain injury; Reactive astrogliosis; Positron emission tomography	ASTROCYTES; PATHOLOGY; PET	Background The positron emission tomography (PET) radioligand F-18-THK5351 is now used to evaluate monoamine oxidase B expression in the reactive astrogliosis seen in various central nervous diseases. Traumatic brain injury (TBI) is known to induce reactive astrogliosis in the lesion site. This is a first report to examine the spatial and temporal changes in reactive astrogliosis as evaluated by F-18-THK5351 after a severe TBI. Case presentation A 27-year-old man suffering from a severe TBI with multiple brain contusions was examined using F-18-THK5351 PET/CT in the subacute and chronic phases after the injury. The first PET scan, performed 46 days after the TBI, showed intense uptake of F-18-THK5351 in and around the brain contusions. The second PET scan, performed 271 days after the TBI, showed reduced uptake of F-18-THK5351 at the original sites of the brain contusions and increased uptakes in the white matter surrounding the contusions and the corpus callosum. The patient exhibited sustained improvement of neuropsychological impairment between the two PET examinations and remarkable recovery from the severe TBI. Conclusions There were evident temporal and spatial changes in F-18-THK5351 uptake in the traumatized brain between the two PET examinations. These changes may have been related to the remarkable neurological recovery in this patient. The degree and distribution of reactive astrogliosis detected by F-18-THK5351 PET may be useful in assessing pathophysiology and predicting prognosis in TBI patients.	[Hatakeyama, Tetsuhiro; Miyake, Keisuke] Kagawa Univ, Dept Neurol Surg, Fac Med, Miki, Kagawa, Japan; [Kawakita, Kenya; Shishido, Hajime] Kagawa Univ Hosp, Dept Emergency & Crit Care Med, Miki, Kagawa, Japan; [Kawai, Nobuyuki] Kagawa Rehabil Hosp, Dept Neurological Surg, 1114 Tamura Cho, Takamatsu, Kagawa 7618057, Japan; [Yamamoto, Yuka; Nishiyama, Yoshihiro] Kagawa Univ, Dept Diagnost Radiol, Fac Med, Miki, Kagawa, Japan		Kawai, N (corresponding author), Kagawa Rehabil Hosp, Dept Neurological Surg, 1114 Tamura Cho, Takamatsu, Kagawa 7618057, Japan.	nobu@kagawa-reha.net					Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Harada R, 2018, J NUCL MED, V59, P671, DOI 10.2967/jnumed.117.197426; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Ishibashi K, 2020, BMC MED IMAGING, V20, DOI 10.1186/s12880-020-00481-4; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Ng KP, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0253-y; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Takami Y, 2020, CLIN NUCL MED, V45, pE491, DOI 10.1097/RLU.0000000000003165; Tronel C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040802; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	16	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2510-3636		EUR J HYBRID IMAG	Eur. J. Hybrid Imag.	DEC 23	2021	5	1							26	10.1186/s41824-021-00121-2			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	XT1DG	WOS:000733335400001	34939155	Green Published, gold			2022-02-06	
J	Hwang, JHA; Fraser, EE; Downing, MG; Ponsford, JL				Hwang, Jill H. A.; Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.			A qualitative study on the attitudes and approaches of Australian clinicians in addressing sexuality after acquired brain injury	DISABILITY AND REHABILITATION			English	Article; Early Access						Sexuality; acquired brain injury; rehabilitation; traumatic brain injury; stroke; qualitative	HEALTH-CARE; STROKE; EXPERIENCES; REHABILITATION; INDIVIDUALS; DYSFUNCTION; IMPACT; CONSEQUENCES; RECOGNITION; INFORMATION	Purpose Studies indicate that up to 50% of survivors of acquired brain injury (ABI) experience persistent changes in sexuality. However, research on clinicians' perspectives in addressing sexuality issues post-ABI is limited. This study explored the attitudes and approaches, barriers and facilitators, and training preferences of Australian clinicians in addressing sexuality in individuals post-ABI. Method Purposive sampling was used to recruit 20 Australian multi-disciplinary clinicians from a related survey study. Semi-structured interviews were conducted and qualitatively analysed using thematic analysis. Results Three broad themes were identified: ABI results in multi-faceted changes in sexuality; there is a fundamental discomfort in talking about sexuality; and, strategies proposed by clinicians may help to improve sexuality support. Participants also provided suggestions for sexuality training, which they believed should start at university. Conclusion Most clinicians are aware of sexuality issues post-ABI but fail to adequately address sexuality in individuals post-ABI due to personal levels of discomfort, perpetuated by institutional factors. Therefore, participants believe that changes made at individual and institutional levels may increase sexuality support for individuals with ABI. However, further research on the causes and treatment of sexual problems and patient perspectives is required to provide the evidence-based guidelines and training programs that clinicians require.	[Hwang, Jill H. A.; Fraser, Elinor E.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Hwang, JHA (corresponding author), Monash Univ, Sch Psychol Sci, Turner Inst Brain & Mental Hlth, Clayton, Vic 3800, Australia.	jill.hwang@monash.edu	; Ponsford, Jennie/H-8341-2014	Hwang, Jill/0000-0001-8044-029X; Fraser, Elinor/0000-0001-5679-4362; Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X			Ahmad T., 2017, SEX SEXUALITY BRAIN; AIHW, 2007, DISABILITY AUSTR ACQ; Akinpelu AO, 2013, AFR HEALTH SCI, V13, P639, DOI 10.4314/ahs.v13i3.17; Australian Institute of Health and Welfare, 2020, HLTH WORKF; Australian Institute of Health and Welfare, 2007, DISABILITY AUSTR ACQ; Biggs A, 2013, RES PAPER SERIES 201; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Arango-Lasprilla J, 2017, SEX DISABIL, V35, P473, DOI 10.1007/s11195-017-9503-y; Arango-Lasprilla JC, 2017, BRAIN INJURY, V31, P1605, DOI 10.1080/02699052.2017.1332784; Couldrick L, 2010, INT J THER REHABIL, V17, P290, DOI 10.12968/ijtr.2010.17.6.48152; Denzin N. K, 2005, SAGE HDB QUALITATIVE, V3rd; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Dyer K, 2014, DISABIL REHABIL, V36, P1431, DOI 10.3109/09638288.2013.859747; Forbat L, 2012, BJU INT, V109, P98, DOI 10.1111/j.1464-410X.2011.10257.x; Fox S, 2020, REHABIL NURS, V45, P16, DOI 10.1097/rnj.0000000000000144; Fraser EE, 2021, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2021.1934486; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gosling J, 1999, BRAIN INJURY, V13, P785; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kamalakannan SK, 2015, ANN INDIAN ACAD NEUR, V18, P66, DOI 10.4103/0972-2327.151047; Kim JH, 2008, J KOREAN ACAD NURS, V38, P483, DOI 10.4040/jkan.2008.38.3.483; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lever S, 2017, DISABIL REHABIL, V39, P2011, DOI 10.1080/09638288.2016.1213897; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McGrath M, 2019, CLIN REHABIL, V33, P293, DOI 10.1177/0269215518793483; Mellor RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078802; Melnyk BM, 2007, WORLDV EVID-BASED NU, V4, P123, DOI 10.1111/j.1741-6787.2007.00094.x; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mitchell C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002088.pub3; Moreno A, 2015, NEUROREHABILITATION, V37, P99, DOI 10.3233/NRE-151243; Nilsson MI, 2017, J SEX MED, V14, P797, DOI 10.1016/j.jsxm.2017.04.061; Norman Kay, 2015, Nurs Manag (Harrow), V22, P33, DOI 10.7748/nm.22.8.33.s28; Pieters R, 2018, DISABIL REHABIL, V40, P732, DOI 10.1080/09638288.2016.1271026; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Prior S, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010025; Richards A, 2016, DISABIL REHABIL, V38, P1471, DOI 10.3109/09638288.2015.1106595; Rosenbaum T, 2014, J SEX MED, V11, P15, DOI 10.1111/jsm.12343; Sander AM., 2011, SEXUALITY TRAUMATIC; Simpson G., 2003, YOU ME GUIDE SEX SEX, V2 ed; Stead ML, 2003, BRIT J CANCER, V88, P666, DOI 10.1038/sj.bjc.6600799; Stein J, 2013, DISABIL REHABIL, V35, P1842, DOI 10.3109/09638288.2012.754953; Stroke Foundation, 2018, NAT STROK AUD REH SE; Svensson P, 2017, CULT HEALTH SEX, V19, P752, DOI 10.1080/13691058.2016.1259503; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; World Health Organisation, 2006, DEF SEX HLTH REP TEC; Yang YJ, 2018, AM J MENS HEALTH, V12, P913, DOI 10.1177/1557988317750970	55	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.2012605		DEC 2021	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XU1FP	WOS:000734020300001	34951561				2022-02-06	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Perez-Cejas, A; Ramos-Gomez, L; Sole-Violan, J; Caceres, JJ; Ferrer-Moure, C; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Perez-Cejas, Antonia; Ramos-Gomez, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Ferrer-Moure, Carmen; Jimenez, Alejandro			Association between serum concentrations of anti-apoptotic B-cell lymphoma-2 protein and traumatic brain injury mortality	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS			English	Article; Early Access						Bcl2; patients; mortality; trauma; injury; brain	CEREBROSPINAL-FLUID; APACHE-II; DEATH; BCL-2; INCREASES; SEVERITY	Background There are scarce and contradictory data existing about B-cell lymphoma 2 (Bcl2), one of the Bcl2 family of anti-apoptotic proteins, in traumatic brain injury (TBI) patients. Thus, the objective of this study was to analyze whether blood concentrations of Bcl2 are associated with mortality. Methods Patients with isolated and severe TBI, defined as <10 points of the Injury Severity Score (ISS) in non-cranial aspects and <9 points in Glasgow Coma Scale (GCS), were included. This was an observational and prospective study carried out in five Intensive Care Units. Serum Bcl2 concentrations on day 1 of TBI were determined. Results Serum Bcl2 concentrations were lower (p < 0.001) in surviving patients (n = 59) compared to non-survivors (n = 24). We found an association between serum Bcl2 levels and mortality controlling for age and GCS (OR = 1.149; 95% CI = 1.056-1.251; p = 0.001) and controlling for computer tomography findings (OR = 1.147; 95% CI = 1.056-1.246; p = 0.001). Conclusions This study reports for the first time an association between serum Bcl2 levels and 30-day mortality in TBI patients.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Gonzalez-Rivero, Agustin F.; Ferrer-Moure, Carmen] Hosp Univ Canarias, Lab Dept, Santa Cruz De Tenerife, Spain; [Perez-Cejas, Antonia] Hosp Univ Canarias, Lab Dept, Tenerife, Spain; [Ramos-Gomez, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin CIBERES, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Santa Cruz De Tenerife, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, Tenerife 38320, Spain.	lorentemartin@msn.com			Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European CommissionSpanish Government	This study was supported by a grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Dai YX, 2018, BIOMED PHARMACOTHER, V108, P774, DOI 10.1016/j.biopha.2018.09.091; Deng HS, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56060300; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Indharty Rr Suzy, 2013, Asian J Neurosurg, V8, P83, DOI 10.4103/1793-5482.116381; Kleinbaum D. G., 1998, APPL REGRESSION ANAL, P281; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lorente L, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2021.105717; Lorente L, 2021, NEUROL SCI, V42, P3631, DOI 10.1007/s10072-021-05048-x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Rocchetti NS, 2018, REV NEUROLOGIA, V67, P121, DOI 10.33588/rn.6704.2018077; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; TEASDALE G, 1974, LANCET, V2, P81; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Xue ZL, 2017, BIOCHEM BIOPH RES CO, V486, P589, DOI 10.1016/j.bbrc.2017.03.097; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	29	0	0	0	0	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	1473-7159	1744-8352		EXPERT REV MOL DIAGN	Expert Rev. Mol. Diagn.												10.1080/14737159.2022.2016394		DEC 2021	5	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	XU4UI	WOS:000734261500001	34878357				2022-02-06	
J	Wilde, EA; Hyseni, I; Lindsey, HM; Faber, J; McHenry, JM; Bigler, ED; Biekman, BD; Hollowell, LL; McCauley, SR; Hunter, JV; Ewing-Cobbs, L; Aitken, ME; MacLeod, M; Chu, ZLD; Noble-Haeusslein, LJ; Levin, HS				Wilde, Elisabeth A.; Hyseni, Ilirjana; Lindsey, Hannah M.; Faber, Jessica; McHenry, James M.; Bigler, Erin D.; Biekman, Brian D.; Hollowell, Laura L.; McCauley, Stephen R.; Hunter, Jill V.; Ewing-Cobbs, Linda; Aitken, Mary E.; MacLeod, Marianne; Chu, Zili D.; Noble-Haeusslein, Linda J.; Levin, Harvey S.			A Preliminary DTI Tractography Study of Developmental Neuroplasticity 5-15 Years After Early Childhood Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						pediatric traumatic brain injury; diffusion tensor imaging; tractography; brain development; neuroplasticity; structural neuroimaging	ADULT HUMAN BRAIN; EDITION CVLT-II; WHITE-MATTER; DIFFUSION MRI; SUBVENTRICULAR ZONE; CRITERION VALIDITY; DENTATE GYRUS; NEUROGENESIS; HIPPOCAMPAL; CELLS	Plasticity is often implicated as a reparative mechanism when addressing structural and functional brain development in young children following traumatic brain injury (TBI); however, conventional imaging methods may not capture the complexities of post-trauma development. The present study examined the cingulum bundles and perforant pathways using diffusion tensor imaging (DTI) in 21 children and adolescents (ages 10-18 years) 5-15 years after sustaining early childhood TBI in comparison with 19 demographically-matched typically-developing children. Verbal memory and executive functioning were also evaluated and analyzed in relation to DTI metrics. Beyond the expected direction of quantitative DTI metrics in the TBI group, we also found qualitative differences in the streamline density of both pathways generated from DTI tractography in over half of those with early TBI. These children exhibited hypertrophic cingulum bundles relative to the comparison group, and the number of tract streamlines negatively correlated with age at injury, particularly in the late-developing anterior regions of the cingulum; however, streamline density did not relate to executive functioning. Although streamline density of the perforant pathway was not related to age at injury, streamline density of the left perforant pathway was significantly and positively related to verbal memory scores in those with TBI, and a moderate effect size was found in the right hemisphere. DTI tractography may provide insight into developmental plasticity in children post-injury. While traditional DTI metrics demonstrate expected relations to cognitive performance in group-based analyses, altered growth is reflected in the white matter structures themselves in some children several years post-injury. Whether this plasticity is adaptive or maladaptive, and whether the alterations are structure-specific, warrants further investigation.	[Wilde, Elisabeth A.; Lindsey, Hannah M.; Bigler, Erin D.] Univ Utah, Traumat Brain Injury & Concuss Ctr, Dept Neurol, Salt Lake City, UT 84112 USA; [Wilde, Elisabeth A.; Hyseni, Ilirjana; Biekman, Brian D.; Hollowell, Laura L.; McCauley, Stephen R.; Hunter, Jill V.; MacLeod, Marianne; Levin, Harvey S.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.; Chu, Zili D.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Hyseni, Ilirjana; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lindsey, Hannah M.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Faber, Jessica] Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA; [McHenry, James M.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Hunter, Jill V.; Chu, Zili D.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Aitken, Mary E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA		Wilde, EA (corresponding author), Univ Utah, Traumat Brain Injury & Concuss Ctr, Dept Neurol, Salt Lake City, UT 84112 USA.; Wilde, EA (corresponding author), Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Wilde, EA (corresponding author), Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA.	elisabeth.wilde@hsc.utah.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21-NS065937]	The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS) grant R21-NS065937 granted to LN-H and HSL.	Abhinav K, 2014, BBA-MOL BASIS DIS, V1842, P2286, DOI 10.1016/j.bbadis.2014.08.002; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Anderson LB, 2017, J CLIN EXP NEUROPSYC, V39, P890, DOI 10.1080/13803395.2016.1277513; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Clausi MG, 2016, NEURAL REGEN RES, V11, P45, DOI 10.4103/1673-5374.175041; Cohen J., 2013, STAT POWER ANAL BEHA; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis EL, 2021, NEUROLOGY, V97, pE298, DOI 10.1212/WNL.0000000000012222; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hevner RF, 1996, J COMP NEUROL, V372, P384, DOI 10.1002/(SICI)1096-9861(19960826)372:3<384::AID-CNE4>3.0.CO;2-Z; Hoogenraad F., 2002, MULTICENTER EVALUATI; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Johnson MH, 2005, DEV PSYCHOBIOL, V46, P287, DOI 10.1002/dev.20057; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lindsey HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01296; Lindsey HM, 2020, BRAIN IMAGING BEHAV, V14, P1626, DOI 10.1007/s11682-019-00093-9; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Ni H, 2006, AM J NEURORADIOL, V27, P1776; Niimi Y, 2018, PEDIATR RES, V83, P385, DOI 10.1038/pr.2017.261; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Plemel JR, 2017, NAT REV DRUG DISCOV, V16, P617, DOI 10.1038/nrd.2017.115; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Rudrauf D, 2008, CORTEX, V44, P1084, DOI 10.1016/j.cortex.2008.05.005; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Villoslada P, 2019, BRAIN, V142, P233, DOI 10.1093/brain/awy349; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Witter M, 2012, MOUSE NERVOUS SYSTEM, P112, DOI 10.1016/B978-0-12-369497-3.10005-6; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	70	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 23	2021	12								734055	10.3389/fneur.2021.734055			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YK1RA	WOS:000744997600001	35002913	gold, Green Published			2022-02-06	
J	Xu, WD; Yue, SL; Wang, P; Wen, B; Zhang, XJ				Xu, Wende; Yue, Shenglei; Wang, Peng; Wen, Bin; Zhang, Xiaojue			Systemic inflammation in traumatic brain injury predicts poor cognitive function	IMMUNITY INFLAMMATION AND DISEASE			English	Article; Early Access						cognitive function; systemic inflammation; traumatic brain injury	TRANSGENIC MICE; MOCA; INTERLEUKIN-1-BETA; CYTOKINES; RELEASE; CELLS	Background: Traumatic brain injury (TBI) impairs cognitive function. Systemic inflammation plays important role in cognitive deficits. It remains unclear if systemic inflammation in TBI is associated with poor cognitive function. Methods: From January 2018 to December 2020, two groups of subjects were recruited: patients with TBI (n = 120), and healthy control (n = 120), followed up to 3 months. Blood was collected from TBI patients and healthy control, and serum inflammatory cytokines including interferon-alpha (IFN-alpha), interleukin-1 beta (IL-1 beta), IL-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF-alpha) were measured at baseline and end of 3 months. Multivariate regression was used for analysis for the relationship between cognitive function and inflammatory cytokines. Results: Inflammatory cytokines were higher in patients with brain injury and remained high at end of 3 months. Some cytokines such as IFN-alpha, IL-1 beta, IL-6, and TNF-alpha were associated with worsening memory and predicted poor performance. Conclusion: Systemic inflammation in patients with TBI predicts poor cognitive function.	[Xu, Wende; Wang, Peng; Wen, Bin] First Peoples Hosp Tianshui, Dept Neurosurg, Tianshui, Gansu, Peoples R China; [Yue, Shenglei] Sishui Cty Hosp, Dept Neurosurg, Jining, Shandong, Peoples R China; [Zhang, Xiaojue] Lanling Cty Peoples Hosp, Dept Neurosurg, 4 Jiankang St,Middle Sect Huibao Rd, Linyi 277799, Shandong, Peoples R China		Zhang, XJ (corresponding author), Lanling Cty Peoples Hosp, Dept Neurosurg, 4 Jiankang St,Middle Sect Huibao Rd, Linyi 277799, Shandong, Peoples R China.	zzxjxiaojue@163.com					Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Algethamy Haifa, 2020, Mater Sociomed, V32, P148, DOI 10.5455/msm.2020.32.148-157; Chen SHA, 1997, BRAIN INJURY, V11, P197; Ciesielska N, 2016, PSYCHIATR POL, V50, P1039, DOI 10.12740/PP/45368; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; De Luca R, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/9268179; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Serrano Cecilia M., 2020, Dement. neuropsychol., V14, P145, DOI 10.1590/1980-57642020dn14-020007; Shahbazian LM, 1999, METABOLISM, V48, P1397, DOI 10.1016/S0026-0495(99)90149-X; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Viviani B, 2007, INT REV NEUROBIOL, V82, P247, DOI 10.1016/S0074-7742(07)82013-7; Wang BR, 2019, NEUROPSYCH DIS TREAT, V15, P2647, DOI 10.2147/NDT.S212328; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wei HL, 2018, BIOCHEM BIOPH RES CO, V503, P467, DOI 10.1016/j.bbrc.2018.04.154; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003	31	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2050-4527		IMMUN INFLAMM DIS	IMMUN. INFLAMM. DIS.												10.1002/iid3.577		DEC 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XT1FF	WOS:000733340600001	34939360	gold			2022-02-06	
J	Baskin, B; Lee, SJ; Skillen, E; Wong, KTA; Rau, H; Hendrickson, RC; Pagulayan, K; Raskind, MA; Peskind, ER; Phillips, PEM; Cook, DG; Schindler, AG				Baskin, Britahny; Lee, Suhjung Janet; Skillen, Emma; Wong, Katrina; Rau, Holly; Hendrickson, Rebecca C.; Pagulayan, Kathleen; Raskind, Murray A.; Peskind, Elaine R.; Phillips, Paul E. M.; Cook, David G.; Schindler, Abigail G.			Repetitive Blast Exposure Increases Appetitive Motivation and Behavioral Inflexibility in Male Mice	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; executive function; veteran; motivation; blast; behavioral flexibility	TRAUMATIC BRAIN-INJURY; OEF/OIF VETERANS; DEFICITS; PERFORMANCE; EXPRESSION; RESPONSES; DISORDER; MEMORY; MODEL; IRAQ	Blast exposure (via detonation of high explosives) represents a major potential trauma source for Servicemembers and Veterans, often resulting in mild traumatic brain injury (mTBI). Executive dysfunction (e.g., alterations in memory, deficits in mental flexibility, difficulty with adaptability) is commonly reported by Veterans with a history of blast-related mTBI, leading to impaired daily functioning and decreased quality of life, but underlying mechanisms are not fully understood and have not been well studied in animal models of blast. To investigate potential underlying behavioral mechanisms contributing to deficits in executive functioning post-blast mTBI, here we examined how a history of repetitive blast exposure in male mice affects anxiety/compulsivity-like outcomes and appetitive goal-directed behavior using an established mouse model of blast mTBI. We hypothesized that repetitive blast exposure in male mice would result in anxiety/compulsivity-like outcomes and corresponding performance deficits in operant-based reward learning and behavioral flexibility paradigms. Instead, results demonstrate an increase in reward-seeking and goal-directed behavior and a congruent decrease in behavioral flexibility. We also report chronic adverse behavioral changes related to anxiety, compulsivity, and hyperarousal. In combination, these data suggest that potential deficits in executive function following blast mTBI are at least in part related to enhanced compulsivity/hyperreactivity and behavioral inflexibility and not simply due to a lack of motivation or inability to acquire task parameters, with important implications for subsequent diagnosis and treatment management.	[Baskin, Britahny; Lee, Suhjung Janet; Skillen, Emma; Wong, Katrina; Cook, David G.; Schindler, Abigail G.] VA Puget Sound Hlth Care Syst, VA Northwest Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Baskin, Britahny; Skillen, Emma; Wong, Katrina; Hendrickson, Rebecca C.; Pagulayan, Kathleen; Raskind, Murray A.; Peskind, Elaine R.; Phillips, Paul E. M.; Cook, David G.; Schindler, Abigail G.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Baskin, Britahny; Phillips, Paul E. M.; Cook, David G.; Schindler, Abigail G.] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA; [Rau, Holly; Hendrickson, Rebecca C.; Pagulayan, Kathleen; Raskind, Murray A.; Peskind, Elaine R.] VA Puget Sound Hlth Care Syst, VA Northwest Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Phillips, Paul E. M.; Cook, David G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Dept Med, Seattle, WA USA		Schindler, AG (corresponding author), VA Puget Sound Hlth Care Syst, VA Northwest Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.; Schindler, AG (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.; Schindler, AG (corresponding author), Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA.	aschind@u.washington.edu					Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Gray M, 2020, BRAIN INJURY, V34, P535, DOI 10.1080/02699052.2020.1725979; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Karr JE, 2019, J CLIN EXP NEUROPSYC, V41, P680, DOI 10.1080/13803395.2019.1611740; Kawa L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.540144; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Maria-Rios CE, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00006; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Modrak CG, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147084; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Pagulayan KF, 2020, BRAIN IMAGING BEHAV, V14, P949, DOI 10.1007/s11682-018-9987-9; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Russell AL, 2018, NEUROSCIENCE, V392, P1, DOI 10.1016/j.neuroscience.2018.09.014; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schindler AG, 2021, ALCOHOL CLIN EXP RES, V45, P1051, DOI 10.1111/acer.14605; Schindler AG, 2021, J NEUROTRAUM, V38, P940, DOI 10.1089/neu.2020.7061; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanielian T., 2008, RAND CTR MILITARY HL; Treadway MT, 2013, CURR DIR PSYCHOL SCI, V22, P244, DOI 10.1177/0963721412474460; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Vonder Haar C, 2013, BEHAV BRAIN RES, V240, P153, DOI 10.1016/j.bbr.2012.11.029; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	46	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	DEC 22	2021	15								792648	10.3389/fnbeh.2021.792648			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	YF2UO	WOS:000741668500001	35002648	Green Published, gold			2022-02-06	
J	Dipnall, JF; Rivara, FP; Lyons, RA; Ameratunga, S; Brussoni, M; Lecky, FE; Bradley, C; Beck, B; Lyons, J; Schneeberg, A; Harrison, JE; Gabbe, BJ				Dipnall, Joanna F.; Rivara, Frederick P.; Lyons, Ronan A.; Ameratunga, Shanthi; Brussoni, Mariana; Lecky, Fiona E.; Bradley, Clare; Beck, Ben; Lyons, Jane; Schneeberg, Amy; Harrison, James E.; Gabbe, Belinda J.			Predictors of health-related quality of life following injury in childhood and adolescence: a pooled analysis	INJURY PREVENTION			English	Article; Early Access						disability; public health; longitudinal	TRAUMATIC BRAIN-INJURY; GLOBAL BURDEN; OUTCOMES; CHILDREN; RELIABILITY; PEDSQL(TM)-4.0; VALIDITY; DISEASE	Background Injury is a leading contributor to the global disease burden in children and places children at risk for adverse and lasting impacts on their health-related quality of life (HRQoL) and development. This study aimed to identify key predictors of HRQoL following injury in childhood and adolescence. Methods Data from 2259 injury survivors (<18 years when injured) were pooled from four longitudinal cohort studies (Australia, Canada, UK, USA) from the paediatric Validating Injury Burden Estimates Study (VIBES-Junior). Outcomes were the Paediatric Quality of Life Inventory (PedsQL) total, physical, psychosocial functioning scores at 1, 3-4, 6, 12, 24 months postinjury. Results Mean PedsQL total score increased with higher socioeconomic status and decreased with increasing age. It was lower for transport-related incidents, >= 1 comorbidities, intentional injuries, spinal cord injury, vertebral column fracture, moderate/severe traumatic brain injury and fracture of patella/tibia/fibula/ankle. Mean PedsQL physical score was lower for females, fracture of femur, fracture of pelvis and burns. Mean PedsQL psychosocial score was lower for asphyxiation/non-fatal submersion and muscle/tendon/dislocation injuries. Conclusions Postinjury HRQoL was associated with survivors' socioeconomic status, intent, mechanism of injury and comorbidity status. Patterns of physical and psychosocial functioning postinjury differed according to sex and nature of injury sustained. The findings improve understanding of the long-term individual and societal impacts of injury in the early part of life and guide the prioritisation of prevention efforts, inform health and social service planning to help reduce injury burden, and help guide future Global Burden of Disease estimates.	[Dipnall, Joanna F.; Lyons, Ronan A.; Ameratunga, Shanthi; Beck, Ben; Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Dipnall, Joanna F.] Deakin Univ, Sch Med, Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Lyons, Ronan A.; Lyons, Jane; Gabbe, Belinda J.] Swansea Univ, Hlth Data Res UK, Swansea, W Glam, Wales; [Lyons, Ronan A.] Swansea Univ, Natl Ctr Populat Hlth & Wellbeing Res, Swansea, W Glam, Wales; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Ameratunga, Shanthi] Kidz First Hosp, Auckland, New Zealand; [Ameratunga, Shanthi] Counties Manukau Dist Hlth Board, Populat Hlth Directorate, Auckland, New Zealand; [Brussoni, Mariana] Univ British Columbia, Sch Populat & Publ Hlth, Dept Pediat, Vancouver, BC, Canada; [Brussoni, Mariana; Schneeberg, Amy] British Columbia Childrens Hosp, British Columbia Injury Res & Prevent Unit, Res Inst, Vancouver, BC, Canada; [Lecky, Fiona E.] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Lecky, Fiona E.] Salford Royal Hosp, Emergency Dept, Salford, Lancs, England; [Bradley, Clare] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Bradley, Clare] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Schneeberg, Amy] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Harrison, James E.] Flinders Univ S Australia, Flinders Inst Hlth & Med Res, Adelaide, SA, Australia		Dipnall, JF (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	jo.dipnall@monash.edu		Beck, Ben/0000-0003-3262-5956	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [NHMRC-APP1142325]; UKBOI: Policy Research Programme, Department of Health [0010009]; VSTR: Department of Health and Human Services (Victoria), Transport Accident Commission (TAC); CHAI: US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; BCCH-LIO: Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-104028]; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Mariana Brussoni: BCCH Research Institute; Belinda Gabbe: Australian Research Council Future FellowshipAustralian Research Council [FT170100048]; Michael Smith Foundation for Health Research Scholar AwardMichael Smith Foundation for Health Research	VIBES--Junior project: National Health and Medical Research Council of Australia (NHMRC--APP1142325); UKBOI: Policy Research Programme, Department of Health (#0010009); VSTR: Department of Health and Human Services (Victoria), Transport Accident Commission (TAC); CHAI: US Centers for Disease Control and Prevention; BCCH--LIO: Canadian Institutes of Health Research (#TIR--104028), Michael Smith Foundation for Health Research. Mariana Brussoni: BCCH Research Institute and Michael Smith Foundation for Health Research Scholar Award. Belinda Gabbe: Australian Research Council Future Fellowship (FT170100048).	Ameratunga S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010043; Borschmann R, 2017, LANCET CHILD ADOLESC, V1, P195, DOI 10.1016/S2352-4642(17)30007-X; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cavallo F, 2006, QUAL LIFE RES, V15, P1577, DOI 10.1007/s11136-006-0037-5; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dipnall JF, 2014, METHODS, V69, P237, DOI 10.1016/j.ymeth.2014.07.001; Gabbe BJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024755; Gabbe BJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-30; Garma SI, 2011, J PEDIATR PSYCHOL, V36, P226, DOI 10.1093/jpepsy/jsq037; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gokdemir MT., 2012, J CURR SURG, V2, P17, DOI [10.4021/jcs19e, DOI 10.4021/JCS19E]; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Harvey A, 2009, B WORLD HEALTH ORGAN, V87, P390, DOI 10.2471/BLT.08.059808; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Johnson KA, 2007, J SPINAL CORD MED, V30, pS71, DOI 10.1080/10790268.2007.11754608; Jones KM, 2019, BRAIN INJURY, V33, P884, DOI 10.1080/02699052.2019.1606445; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lambregts S, 2019, BRAIN INJURY; Lyons RA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-317; Manglick MP, 2018, ARCH DIS CHILD, V103, P784, DOI 10.1136/archdischild-2017-314051; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; Michel G, 2009, QUAL LIFE RES, V18, P1147, DOI 10.1007/s11136-009-9538-3; Miller CM, 2013, J TRAUMA ACUTE CARE, V75, P250, DOI 10.1097/TA.0b013e3182930fb7; Mitchell RJ, 2017, INJURY, V48, P1776, DOI 10.1016/j.injury.2017.06.002; Peden M, 2009, WORLD REPORT CHILD I; Poorman GW, 2019, INT J SPINE SURG, V13, P68, DOI 10.14444/6009; Rivara F P, 2001, Inj Prev, V7, P210, DOI 10.1136/ip.7.3.210; Rivara FP, 2002, INJURY PREV, V8, pIV5, DOI 10.1136/ip.8.suppl_4.iv5; Rivara FP, 2007, J TRAUMA, V63, pS52, DOI 10.1097/TA.0b013e31815aca0a; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robson Karen., 2015, MULTILEVEL MODELING; Ryder C, 2020, CRIT PUBLIC HEALTH, V30, P352, DOI 10.1080/09581596.2019.1581918; Schneeberg A, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0523-6; Spronk I, 2018, J TRAUMA ACUTE CARE, V85, P1110, DOI 10.1097/TA.0000000000002072; Stevens MW, 2012, ARCH PEDIAT ADOL MED, V166, P74, DOI 10.1001/archpediatrics.2011.694; Thanh NX, 2006, HEALTH POLICY, V78, P249, DOI 10.1016/j.healthpol.2005.10.003; Twisk J, 2013, J CLIN EPIDEMIOL, V66, P1022, DOI 10.1016/j.jclinepi.2013.03.017; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Willis CD, 2006, INJURY, V37, P1185, DOI 10.1016/j.injury.2006.07.011	44	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.												10.1136/injuryprev-2021-044309		DEC 2021	10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XT8SR	WOS:000733851300001	34937765				2022-02-06	
J	Frohlich, J; Johnson, MA; McArthur, DL; Lutkenhoff, ES; Dell'Italia, J; Real, C; Shrestha, V; Spivak, NM; Tejeda, JER; Vespa, PM; Monti, MM				Frohlich, Joel; Johnson, Micah A.; McArthur, David L.; Lutkenhoff, Evan S.; Dell'Italia, John; Real, Courtney; Shrestha, Vikesh; Spivak, Norman M.; Tejeda, Jesus E. Ruiz; Vespa, Paul M.; Monti, Martin M.			Sedation-Induced Burst Suppression Predicts Positive Outcome Following Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury (TBI); burst suppression; barbiturates; coma; disorders of consciousness; EEG biomarker; Glasgow Coma Scale (GCS); Glasgow Outcome Scale extended (GOSe)	NEUROLOGICAL PROGNOSTICATION; COMA; CARE; RESUSCITATION; CONSCIOUSNESS; GUIDELINES	While electroencephalogram (EEG) burst-suppression is often induced therapeutically using sedatives in the intensive care unit (ICU), there is hitherto no evidence with respect to its association to outcome in moderate-to-severe neurological patients. We examined the relationship between sedation-induced burst-suppression (SIBS) and outcome at hospital discharge and at 6-month follow up in patients surviving moderate-to-severe traumatic brain injury (TBI). For each of 32 patients recovering from coma after moderate-to-severe TBI, we measured the EEG burst suppression ratio (BSR) during periods of low responsiveness as assessed with the Glasgow Coma Scale (GCS). The maximum BSR was then used to predict the Glasgow Outcome Scale extended (GOSe) at discharge and at 6 months post-injury. A multi-model inference approach was used to assess the combination of predictors that best fit the outcome data. We found that BSR was positively associated with outcomes at 6 months (P = 0.022) but did not predict outcomes at discharge. A mediation analysis found no evidence that BSR mediates the effects of barbiturates or propofol on outcomes. Our results provide initial observational evidence that burst suppression may be neuroprotective in acute patients with TBI etiologies. SIBS may thus be useful in the ICU as a prognostic biomarker.	[Frohlich, Joel; Johnson, Micah A.; Lutkenhoff, Evan S.; Dell'Italia, John; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [McArthur, David L.; Real, Courtney; Shrestha, Vikesh; Spivak, Norman M.; Tejeda, Jesus E. Ruiz; Vespa, Paul M.; Monti, Martin M.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg,Brain Injury Res Ctr BIRC, Los Angeles, CA 90095 USA		Frohlich, J (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	joelfrohlich@gmail.com		Frohlich, Joel/0000-0001-8382-4344			Barton K., 2019, R PACKAGE VERSION; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chemali J, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056017; Crone JS, 2020, NEUROSCI CONSCIOUS, V6, DOI 10.1093/nc/niaa008; Doyle PW, 1999, BRIT J ANAESTH, V83, P580, DOI 10.1093/bja/83.4.580; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Forgacs PB, 2017, ANN CLIN TRANSL NEUR, V4, P119, DOI 10.1002/acn3.385; Frohlich J, 2022, HUM BRAIN MAPP, DOI 10.1002/hbm.25725; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Hyvarinen A, 1999, ISCAS '99: PROCEEDINGS OF THE 1999 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL 5, P57, DOI 10.1109/ISCAS.1999.777510; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jordan KG, 2006, EPILEPSIA, V47, P41, DOI 10.1111/j.1528-1167.2006.00659.x; Martino C, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-0289-3; Niedermeyer E, 1999, CLIN ELECTROENCEPHAL, V30, P99, DOI 10.1177/155005949903000305; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rossetti AO, 2017, CLIN NEUROPHYS PRACT, V2, P76, DOI 10.1016/j.cnp.2017.03.001; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Schiff N.D., 2016, BRAIN FUNCTION RESPO, P195, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; TEASDALE G, 1974, LANCET, V2, P81; Tingley D, 2014, J STAT SOFTW, V59; Westover MB, 2013, J NEUROSCI METH, V219, P131, DOI 10.1016/j.jneumeth.2013.07.003	24	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 22	2021	12								750667	10.3389/fneur.2021.750667			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YF2ZO	WOS:000741681500001	35002918	gold, Green Published			2022-02-06	
J	Shun, PLW; Swaine, B; Bottari, C				Lam Wai Shun, Priscilla; Swaine, Bonnie; Bottari, Carolina			Clinical reasoning underlying acute care occupational therapists' assessment of rehabilitation potential after stroke or brain injury: A constructivist grounded theory study	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article; Early Access						acute care; clinical reasoning; qualitative research; stroke; traumatic brain injury	DECISION-MAKING; BOTTOM-UP; TOP-DOWN	Introduction In acute care hospitals, clinicians are expected to rapidly provide recommendations regarding patients' rehabilitation potential and candidacy for postacute rehabilitation. Some studies have investigated factors influencing referral to rehabilitation, but few have examined clinical reasoning underlying referral decisions. This study aimed to investigate what occupational therapists were thinking about (factors influencing reasoning), how they reasoned (thought processes) when evaluating stroke or traumatic brain injury patients' rehabilitation potential, and how they decided on referral to postacute rehabilitation. Methods Using a constructivist grounded theory approach, the clinical reasoning of 10 acute care occupational therapists working in a large Canadian city was examined. Participant recruitment, data collection, and analysis were performed simultaneously following theoretical sampling procedures. Therapists' thoughts on patients' rehabilitation potential were collected twice (during chart consultation and initial patient assessment) using think-aloud protocols and semi-structured interviews. Constant comparison, memoing, and diagramming methods were employed during coding to help categorisation and conceptualisation. Findings Numerous patient, clinician, and organisation-related factors were found to influence clinical reasoning. Occupational therapists interpreted these factors in an attempt to (1) predict recovery, (2) estimate rehabilitation potential, and (3) determine rehabilitation candidacy. They used two types of thought processes: (1) building a representation of patients' rehabilitation potential (involving eight steps including gathering and interpreting factors); (2) activating bottom-up and top-down scripts (comparing the expected impact of impairments on activity performance to behaviours observed during activity performance). Furthermore, an algorithm was developed describing how occupational therapists decide on referral to postacute rehabilitation. Conclusion Findings can be used to teach students and novice occupational therapists how to identify and interpret key factors in the assessment of stroke or traumatic brain injury patients' rehabilitation potential. Results also provide insight on cognitive processes that can be taught for efficient assessment of rehabilitation potential and decision-making regarding referral to postacute rehabilitation.	[Lam Wai Shun, Priscilla; Swaine, Bonnie; Bottari, Carolina] Univ Montreal, Fac Med, Sch Rehabil, Occupat Therapy, Montreal, PQ, Canada; [Lam Wai Shun, Priscilla; Swaine, Bonnie; Bottari, Carolina] Ctr Interdisciplinary Res Rehabil Greater Montrea, 6363 Chemin Hudson Pavillon Lindsay IURDPM, Montreal, PQ H3S 1M9, Canada		Shun, PLW (corresponding author), Ctr Interdisciplinary Res Rehabil Greater Montrea, 6363 Chemin Hudson Pavillon Lindsay IURDPM, Montreal, PQ H3S 1M9, Canada.	priscilla.lam.wai.shun@umontreal.ca		Swaine, Bonnie/0000-0001-7638-2090	Canadian Occupational Therapy Foundation; Centre for Interdisciplinary Research in Rehabilitation; Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec [31896]; Ordre des Ergotherapeutes du Quebec; Faculty of Graduate and Postdoctoral Studies at Universite de Montreal; School of Rehabilitation at Universite de Montreal	Canadian Occupational Therapy Foundation; Centre for Interdisciplinary Research in Rehabilitation; Fonds de Recherche du Quebec -Sante, Grant/Award Number: 31896; Ordre des Ergotherapeutes du Quebec; Faculty of Graduate and Postdoctoral Studies at Universite de Montreal; School of Rehabilitation at Universite de Montreal	Boyt Schell B. A., 2014, WILLARD SPACKMANS OC, P384; Bradley G, 2021, BRIT J OCCUP THER, DOI 10.1177/03080226211011386; Britton L, 2016, AUST OCCUP THER J, V63, P257, DOI 10.1111/1440-1630.12298; Britton L, 2015, AUST OCCUP THER J, V62, P370, DOI 10.1111/1440-1630.12227; Brown T, 2010, BRIT J OCCUP THER, V73, P95, DOI 10.4276/030802210X12682330090334; Chamaz K., 2014, CONSTRUCTING GROUNDE; Chapparo C., 2019, CLIN REASONING HLTH, V4th, P271; Creek J., 2005, BRIT J OCCUP THER, V68, P281, DOI [10.1177/030802260506800607, DOI 10.1177/030802260506800607]; Crennan M, 2010, PHYS OCCUP THER GERI, V28, P33, DOI 10.3109/02703180903381060; Custers EJFM, 2015, MED TEACH, V37, P457, DOI 10.3109/0142159X.2014.956052; Dey I., 1999, GROUNDING GROUNDED T, DOI [10.1016/B978-012214640-4/50011-5, DOI 10.1016/B978-012214640-4/50011-5]; Enderby P, 2017, DISABIL REHABIL, V39, P709, DOI 10.3109/09638288.2016.1160448; ERICSSON KA, 1980, PSYCHOL REV, V87, P215, DOI 10.1037/0033-295X.87.3.215; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Griffin SUSAN D., 2001, Occup Ther Int, V8, P184, DOI 10.1002/oti.145; Hamby J.R., 2017, OCCUPATIONAL THERAPY, V2nd, P83, DOI [10.7139/2017.978-1-56900-415-9.006, DOI 10.7139/2017.978-1-56900-415-9.006]; Higgs J, 2019, CLIN REASONING HLTH, V4th, P3; Hooper B., 2018, CLIN PROFESSIONAL RE, V2nd, P13; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Kringle EA, 2018, J INT NEUROPSYCH SOC, V24, P572, DOI 10.1017/S1355617718000085; Shun PLW, 2020, DISABIL REHABIL, DOI 10.1080/09638288.2020.1779825; Longley V, 2019, CLIN REHABIL, V33, P304, DOI 10.1177/0269215518808000; Lubarsky Stuart, 2015, Can Med Educ J, V6, pe61; Lundgren-Laine H, 2010, QUAL HEALTH RES, V20, P565, DOI 10.1177/1049732309354278; Marnane K, 2021, DISABIL REHABIL, DOI 10.1080/09638288.2021.1918770; Mattingly C, 1994, CLIN REASONING FORMS; Moulton CAE, 2007, ACAD MED, V82, pS109, DOI 10.1097/ACM.0b013e3181405a76; Paskins Z, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-101; Pelaccia T, 2011, MED EDUC ONLINE, V16, DOI 10.3402/meo.v16i0.5890; Saldana J., 2014, OXFORD HDB QUALITATI; Shotwell M.P., 2017, OCCUPATIONAL THERAPY, V2nd ed., P37; Shun PLW, 2017, AUST OCCUP THER J, V64, P149, DOI 10.1111/1440-1630.12327; Unsworth CA, 2005, AM J OCCUP THER, V59, P31, DOI 10.5014/ajot.59.1.31; Weinstock-Zlotnick G, 2004, AM J OCCUP THER, V58, P594, DOI 10.5014/ajot.58.5.594; Willems Deborah, 2012, Healthc Policy, V7, pe105; Williams MW, 2021, DISABIL REHABIL, V43, P33, DOI 10.1080/09638288.2019.1613682; Wondergem R, 2017, CEREBROVASC DIS, V43, P1, DOI 10.1159/000451034	38	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.												10.1111/1440-1630.12781		DEC 2021	13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	XS5XR	WOS:000732982000001	34939206				2022-02-06	
J	Rostami, E; Gustafsson, D; Hanell, A; Howells, T; Lenell, S; Lewen, A; Enblad, P				Rostami, Elham; Gustafsson, David; Hanell, Anders; Howells, Timothy; Lenell, Samuel; Lewen, Anders; Enblad, Per			Prognosis in moderate-severe traumatic brain injury in a Swedish cohort and external validation of the IMPACT models	ACTA NEUROCHIRURGICA			English	Article; Early Access						Traumatic brain injury; Head trauma; Outcome measures; Recovery; Human studies	INTERNATIONAL MISSION; CLINICAL-TRIALS; CRASH; OUTCOMES; RANDOMIZATION; ADULTS; SCORE; TOOL	Background A major challenge in management of traumatic brain injury (TBI) is to assess the heterogeneity of TBI pathology and outcome prediction. A reliable outcome prediction would have both great value for the healthcare provider, but also for the patients and their relatives. A well-known prediction model is the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) prognostic calculator. The aim of this study was to externally validate all three modules of the IMPACT calculator on TBI patients admitted to Uppsala University hospital (UUH). Method TBI patients admitted to UUH are continuously enrolled into the Uppsala neurointensive care unit (NICU) TBI Uppsala Clinical Research (UCR) quality register. The register contains both clinical and demographic data, radiological evaluations, and outcome assessments based on the extended Glasgow outcome scale extended (GOSE) performed at 6 months to 1 year. In this study, we included 635 patients with severe TBI admitted during 2008-2020. We used IMPACT core parameters: age, motor score, and pupillary reaction. Results The patients had a median age of 56 (range 18-93), 142 female and 478 male. Using the IMPACT Core model to predict outcome resulted in an AUC of 0.85 for mortality and 0.79 for unfavorable outcome. The CT module did not increase AUC for mortality and slightly decreased AUC for unfavorable outcome to 0.78. However, the lab module increased AUC for mortality to 0.89 but slightly decreased for unfavorable outcome to 0.76. Comparing the predicted risk to actual outcomes, we found that all three models correctly predicted low risk of mortality in the surviving group of GOSE 2-8. However, it produced a greater variance of predicted risk in the GOSE 1 group, denoting general underprediction of risk. Regarding unfavorable outcome, all models once again underestimated the risk in the GOSE 3-4 groups, but correctly predicts low risk in GOSE 5-8. Conclusions The results of our study are in line with previous findings from centers with modern TBI care using the IMPACT model, in that the model provides adequate prediction for mortality and unfavorable outcome. However, it should be noted that the prediction is limited to 6 months outcome and not longer time interval.	[Rostami, Elham; Gustafsson, David; Hanell, Anders; Howells, Timothy; Lenell, Samuel; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Neurosurg, S-75237 Uppsala, Sweden; [Lenell, Samuel] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden		Gustafsson, D (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, S-75237 Uppsala, Sweden.	elham.rostami@neuro.uu.se; david.gustafsson@neuro.uu.se; anders.hanell@neuro.uu.se; timothy.howells@lul.se; samuel.lenell@neuro.uu.se; anders.lewen@neuro.uu.se; per.enblad@neuro.uu.se		Gustafsson, David/0000-0002-2534-8842	Uppsala University; SciLife, the Swedish Society for Medical Research	Open access funding provided by Uppsala University. Elham Rostami is a Wallenberg Clinical Fellow supported by SciLife, the Swedish Society for Medical Research.	[Anonymous], R version 4.0.5(2019) R: A language and environment for statistical computing; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Egea-Guerrero JJ, 2018, J HEAD TRAUMA REHAB, V33, P46, DOI 10.1097/HTR.0000000000000292; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Staples JA, 2016, BRAIN INJURY, V30, P899, DOI 10.3109/02699052.2016.1146964; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	24	0	0	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.												10.1007/s00701-021-05040-6		DEC 2021	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XT8XO	WOS:000733864000001	34936014	hybrid			2022-02-06	
J	Zuckerman, DA; Giacino, JT; Bodien, YG				Zuckerman, David A.; Giacino, Joseph T.; Bodien, Yelena G.			Traumatic Brain Injury: What Is a Favorable Outcome?	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						Glasgow Outcome Scale; outcome; traumatic brain injury	QUALITY-OF-LIFE; PREDICTORS; MODERATE	Traumatic brain injury (TBI) results in disparate outcomes ranging from persistent disorders of consciousness to symptom resolution. Despite the breadth and complexity of TBI recovery, most clinical trials dichotomize outcome by establishing an arbitrary cut-point, above and below which recovery is described as "favorable" and "unfavorable," respectively. For example, the widely used eight-level Glasgow Outcome Scale-Extended (GOSE) is typically collapsed into these two categories. Dichotomizing the GOSE into "favorable" and "unfavorable" outcome may limit detection of treatment effects in TBI clinical trials, contribute to imprecise prognostic counseling, and unduly influence decision-making with regard to withdrawal of life-sustaining therapy. We illustrate the lack of standardization in defining "unfavorable" and "favorable" TBI outcome on the GOSE by identifying the broad range of cut-points, from a score of 3 (part-time supervision in the home required) to 7 (presence of some residual of symptoms), that have been used to dichotomize the GOSE. We also highlight the ethical concerns related to characterizing TBI outcomes solely from the perspective of investigators and clinicians, rather than patients and caregivers. Finally, we suggest that a pragmatic, immediate solution to GOSE dichotomization is to report the likelihood of achieving each of the eight GOSE outcome levels and propose a study design for a new patient- and caregiver-centered TBI outcome metric.	[Zuckerman, David A.] Harvard Med Sch, Ctr Bioeth, Boston, MA USA; [Giacino, Joseph T.; Bodien, Yelena G.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Bodien, Yelena G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 101 Merrimac St 300, Boston, MA 02114 USA		Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 101 Merrimac St 300, Boston, MA 02114 USA.	ybodien@mgh.harvard.edu					Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Edlow BL, 2021, NEUROCRIT CARE, V35, P68, DOI 10.1007/s12028-021-01227-y; Hammond FM, 2021, NEUROCRIT CARE, V35, P55, DOI 10.1007/s12028-021-01289-y; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Huber M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010091; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Ranson J, 2019, J NEUROTRAUM, V36, P2493, DOI 10.1089/neu.2018.5998; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Eijck M, 2018, J NEUROTRAUM, V35, P2357, DOI 10.1089/neu.2018.5650; Van Scoy LJ, 2021, J MIX METHOD RES, V15, P567, DOI 10.1177/1558689820970686; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	22	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0356		DEC 2021	3	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YG6RC	WOS:000742612100001	34861770				2022-02-06	
J	White, RD; Turner, RP; Arnold, N; Bernica, A; Lewis, BN; Swatzyna, RJ				White, Rebecca D.; Turner, Robert P.; Arnold, Noah; Bernica, Annie; Lewis, Brigitte N.; Swatzyna, Ronald J.			Treating Severe Traumatic Brain Injury: Combining Neurofeedback and Hyperbaric Oxygen Therapy in a Single Case Study	CLINICAL EEG AND NEUROSCIENCE			English	Article; Early Access						neurofeedback; hyperbaric oxygen therapy; HBOT; TBI; posttraumatic epilepsy; EEG	MEMORY; DAMAGE	In 2014, a 26-year-old male was involved in a motor vehicle accident resulting in a severe traumatic brain injury (TBI). The patient sustained a closed-head left temporal injury with coup contrecoup impact to the frontal region. The patient underwent a left side craniotomy and was comatose for 26 days. After gaining consciousness, he was discharged to a brain injury treatment center that worked with physical, speech, and occupational issues. He was discharged after eight months with significant speech, ambulation, spasticity, and cognitive issues as well as the onset of posttraumatic epilepsy. His parents sought hyperbaric oxygen treatment (HBOT) from a doctor in Louisiana. After 165 dives, the HBOT doctor recommended an addition of neurofeedback (NFB) therapy. In March 2019 the patient started NFB therapy intermixed with HBOT. The combination of NFB and HBOT improved plasticity and functionality in the areas of injury and the correlated symptoms including short-term memory, personality, language, and executive function, as well as significantly reducing the incidence of seizures. Severe brain injuries often leave lasting deficits with little hope for major recovery and there is a need for further research into long-term, effective neurological treatments for severe brain injuries. These results suggest that HBOT combined with NFB may be a viable option in treating severe brain injuries and should be investigated.	[White, Rebecca D.; Arnold, Noah; Bernica, Annie; Lewis, Brigitte N.; Swatzyna, Ronald J.] Houston Neurosci Brain Ctr, Houston, TX 77098 USA; [Turner, Robert P.] Network Neurol Hlth, Charleston, SC USA		White, RD (corresponding author), Houston Neurosci Brain Ctr, Houston, TX 77098 USA.	becca.white@pop.belmont.edu		White, Rebecca/0000-0002-3300-7095; Turner, Robert/0000-0001-9839-0649			Ariza M, 2006, BRAIN INJURY, V20, P1053, DOI 10.1080/02699050600909862; Bola M, 2015, CORTEX, V67, P134, DOI 10.1016/j.cortex.2015.03.020; Bola M, 2014, NEUROLOGY, V83, P542, DOI 10.1212/WNL.0000000000000672; Catroppa C., 2016, NEW FRONTIERS PEDIAT; Chen AJ., 2012, TRAUMA BRAIN INJ, P273, DOI [https://doi.org/10.1007/978-0-387-87887-4_15, DOI 10.1007/978-0-387-87887-4_15]; Egner Tobias, 2006, Expert Rev Neurother, V6, P247, DOI 10.1586/14737175.6.2.247; Fridriksson J, 2015, CEREB CORTEX, V25, P4689, DOI 10.1093/cercor/bhu152; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gaudet I, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00062; Georges A., 2020, STATPEARLS; Gray SN, 2017, MED ACUPUNCT, V29, P215, DOI 10.1089/acu.2017.1220; Hammond D.C., 2007, J NEUROTHERAPY, V10, P25, DOI [10.1300/J184v10n04_04, DOI 10.1300/J184V10N04_04]; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009183; Kraitsy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097750; Marzbani H, 2016, BASIC CLIN NEUROSCI, V7, P143, DOI 10.15412/J.BCN.03070208; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Reddy RP, 2009, INDIAN J NEUROTRAUM, V6, P87, DOI 10.1016/S0973-0508(09)80037-3; Richman M., 2019, SCI DAILY; Sharma S, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.612073; Sreedharan S, 2019, BRAIN CONNECT, V9, P613, DOI 10.1089/brain.2019.0674; STERMAN MB, 1972, ELECTROEN CLIN NEURO, V33, P89, DOI 10.1016/0013-4694(72)90028-4; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wang C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00571	28	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.											15500594211068255	10.1177/15500594211068255		DEC 2021	13	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XX5NE	WOS:000736341300001	34931544				2022-02-06	
J	Gordon, K; Gulidov, I; Koryakin, S; Smyk, D; Makeenkova, T; Gogolin, D; Lepilina, O; Golovanova, O; Semenov, A; Dujenko, S; Medvedeva, K; Mardynsky, Y				Gordon, Konstantin; Gulidov, Igor; Koryakin, Sergey; Smyk, Daniil; Makeenkova, Tatyana; Gogolin, Danil; Lepilina, Olga; Golovanova, Olga; Semenov, Alexey; Dujenko, Sergey; Medvedeva, Kira; Mardynsky, Yuri			Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity	RADIATION ONCOLOGY			English	Article						Proton therapy; Fixed beam; Chordoma; Chondrosarcoma; Pencil beam; IMPT	PHOTON; TUMORS; HEAD	Aim This study presents an analysis (efficacy and toxicity) of outcomes in patients with skull-base chordomas or chondrosarcomas treated with a fixed horizontal pencil proton beam. Background Chordomas (CAs) and chondrosarcomas (CSAs) are rare tumours that are usually located near the base of the skull and very close to the brain's most critical structures. Proton therapy (PT) is often considered the best radiation treatment for these diseases, but it is still a limited resource. Active scanning PT delivered via a fixed pencil beamline might be a promising option. Methods This is a single-centre experience describing the results of proton therapy for 31 patients with CA (n = 23) or CSA (n = 8) located near the base of the skull. Proton therapy was utilized by a fixed pencil beamline with a chair to position the patient between May 2016 and November 2020. Ten patients underwent resection (32.2%), 15 patients (48.4%) underwent R2 resection, and 6 patients had unresectable tumours (19.4%). In 4 cases, the tumours had been previously irradiated. The median PT dose was 70 GyRBE (relative biological efficacy, 1.1) [range, 60 to 74] with 2.0 GyRBE per fraction. The mean GTV volume was 25.6 cm(3) [range, 4.2-115.6]. Patient demographics, pathology, treatment parameters, and toxicity were collected and analysed. Radiation-induced reactions were assessed according to the Common Terminology Criteria for Adverse Events (CTCAE) v 4.0. Results The median follow-up time was 21 months [range, 4 to 52]. The median overall survival (OS) was 40 months. The 1- and 2-year OS was 100%, and the 3-year OS was 66.3%. Four patients died due to non-cancer-related reasons, 1 patient died due to tumour progression, and 1 patient died due to treatment-related injuries. The 1-year local control (LC) rate was 100%, the 2-year LC rate was 93.7%, and the 3-year LC rate was 85.3%. Two patients with CSA exhibited progression in the neck lymph nodes and lungs. All patients tolerated PT well without any treatment interruptions. We observed 2 cases of >= grade 3 toxicity, with 1 case of grade 3 myelitis and 1 case of grade 5 brainstem injury. Conclusion Treatment with a fixed proton beam shows promising disease control and an acceptable toxicity rate, even the difficult-to-treat subpopulation of patients with skull-base chordomas or chondrosarcomas requiring dose escalation.	[Gordon, Konstantin; Gulidov, Igor; Smyk, Daniil; Makeenkova, Tatyana; Gogolin, Danil; Semenov, Alexey; Medvedeva, Kira; Mardynsky, Yuri] A Tsyb Med Radiol Res Ctr MRRC, Dept Proton Therapy, 4 Korolev St, Obninsk 249036, Russia; [Gordon, Konstantin] Peoples Friendship Univ Russia, Med Inst, Dept Histol Cytol & Embryol, Moscow, Russia; [Koryakin, Sergey; Lepilina, Olga; Golovanova, Olga; Dujenko, Sergey] A Tsyb Med Radiol Res Ctr, Dept Radiophys, Obninsk, Russia		Gordon, K (corresponding author), A Tsyb Med Radiol Res Ctr MRRC, Dept Proton Therapy, 4 Korolev St, Obninsk 249036, Russia.; Gordon, K (corresponding author), Peoples Friendship Univ Russia, Med Inst, Dept Histol Cytol & Embryol, Moscow, Russia.	dr_gordon@yahoo.com		Smyk, Daniil/0000-0002-3557-662X			Ares C, 2009, INT J RADIAT ONCOL, V75, P1111, DOI 10.1016/j.ijrobp.2008.12.055; Balakin VE, 2018, KNE ENERGY, V3, P45, DOI [10.18502/ken.v3i2.1790, DOI 10.18502/KEN.V3I2.1790]; Blanchard P, 2018, SEMIN RADIAT ONCOL, V28, P53, DOI 10.1016/j.semradonc.2017.08.004; Deraniyagala RL, 2014, J NEUROL SURG PART B, V75, P53, DOI 10.1055/s-0033-1354579; Devicienti S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-47; Doyen J, 2016, CANCER TREAT REV, V43, P104, DOI 10.1016/j.ctrv.2015.12.007; Durante M, 2019, BRIT J CANCER, V120, P777, DOI 10.1038/s41416-018-0329-x; Fabiano S, 2020, RADIOTHER ONCOL, V145, P81, DOI 10.1016/j.radonc.2019.12.013; Feuvret L, 2016, INT J RADIAT ONCOL, V95, P312, DOI 10.1016/j.ijrobp.2015.12.016; Fossati P, 2016, REP PRACT ONCOL RADI, V21, P336, DOI 10.1016/j.rpor.2016.03.007; Goitein M, 2010, RADIOTHER ONCOL, V95, P23, DOI 10.1016/j.radonc.2009.06.012; Gordon K, 2021, REP PRACT ONCOL RADI, V26, P203, DOI 10.5603/RPOR.a2021.0029; Grosshans DR, 2014, INT J RADIAT ONCOL, V90, P540, DOI 10.1016/j.ijrobp.2014.07.005; Gulidov I. A., 2016, Voprosy Onkologii (St. Petersburg), V62, P570; Hall DC, 2017, INT J RADIAT ONCOL, V97, P1087, DOI 10.1016/j.ijrobp.2017.01.236; Hug EB, 1999, J NEUROSURG, V91, P432, DOI 10.3171/jns.1999.91.3.0432; KOEHLER A M, 1977, Medical Physics (Woodbury), V4, P297; Kremenevski N, 2020, NEUROENDOCRINOLOGY, V110, P836, DOI 10.1159/000509386; Munzenrider JE, 1999, STRAHLENTHER ONKOL, V175, P57, DOI 10.1007/BF03038890; Noel G, 2005, ACTA ONCOL, V44, P700, DOI 10.1080/02841860500326257; Palm RF, 2019, CANCER-AM CANCER SOC, V125, P642, DOI 10.1002/cncr.31958; Parzen JS, 2021, CUREUS, V13, DOI 10.7759/cureus.15278; Scoccianti S, 2015, RADIOTHER ONCOL, V114, P230, DOI 10.1016/j.radonc.2015.01.016; Sun JY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.694749; Verburg JM, 2013, MED PHYS, V40, DOI 10.1118/1.4810942; Vrionis FD., 2004, NEURO-ONCOLOGY, V6, P166, DOI [10.1215/S1152851703200065, DOI 10.1215/S1152851703200065]; Yan SS, 2016, INT J RADIAT ONCOL, V95, P224, DOI 10.1016/j.ijrobp.2015.09.033	27	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1748-717X		RADIAT ONCOL	Radiat. Oncol.	DEC 20	2021	16	1							238	10.1186/s13014-021-01961-9			8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	XQ9OJ	WOS:000731869800004	34930352	gold, Green Published			2022-02-06	
J	Kanser, RJ; Rapport, LJ; Hanks, RA; Patrick, SD				Kanser, Robert J.; Rapport, Lisa J.; Hanks, Robin A.; Patrick, Sarah D.			Time and money: Exploring enhancements to performance validity research designs	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Malingering; performance validity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MEMORY MALINGERING TOMM; COGNITIVELY INTACT; NORMATIVE DATA; TESTS; DYSFUNCTION; INCENTIVES; VALIDATION; EFFICIENCY; ACCURACY	Introduction The study examined the effect of preparation time and financial incentives on healthy adults' ability to simulate traumatic brain injury (TBI) during neuropsychological evaluation. Method A retrospective comparison of two TBI simulator group designs: a traditional design employing a single-session of standard coaching immediately before participation (SIM-SC; n = 46) and a novel design that provided financial incentive and preparation time (SIM-IP; n = 49). Both groups completed an ecologically valid neuropsychological test battery that included widely-used cognitive tests and five common performance validity tests (PVTs). Results Compared to SIM-SC, SIM-IP performed significantly worse and had higher rates of impairment on tests of processing speed and executive functioning (Trails A and B). SIM-IP were more likely than SIM-SC to avoid detection on one of the PVTs and performed somewhat better on three of the PVTs, but the effects were small and non-significant. SIM-IP did not demonstrate significantly higher rates of successful simulation (i.e., performing impaired on cognitive tests with <2 PVT failures). Overall, the rate of the successful simulation was similar to 40% with a liberal criterion, requiring cognitive impairment defined as performance >1 SD below the normative mean. At a more rigorous criterion defining impairment (>1.5 SD below the normative mean), successful simulation approached 35%. Conclusions Incentive and preparation time appear to add limited incremental effect over traditional, single-session coaching analog studies of TBI simulation. Moreover, these design modifications did not translate to meaningfully higher rates of successful simulation and avoidance of detection by PVTs.	[Kanser, Robert J.; Rapport, Lisa J.; Patrick, Sarah D.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Kanser, Robert J.] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Kanser, RJ (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA.	robert.kanser@med.unc.edu			National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90IFOO92, 90DPTB0006]; Wayne State University Graduate School Thesis and Dissertation grants	This research was supported by grants from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR; Rapport, 90IFOO92; Hanks, 90DPTB0006) and Wayne State University Graduate School Thesis and Dissertation grants (Kanser, Bashem).	Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Elhai JD, 2007, J PERS ASSESS, V88, P328, DOI 10.1080/00223890701332136; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P864, DOI 10.1080/13854046.2013.786758; Kanser RJ, 2020, NEUROPSYCHOLOGY, V34, P308, DOI 10.1037/neu0000613; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee, 2005, FORENSIC NEUROPSYCHO, P209; Larrabee, 2007, ASSESSMENT MALINGERE, P334; Larrabee G.J., 2011, FORENSIC NEUROPSYCHO; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; Ovsiew GP, 2020, J CLIN EXP NEUROPSYC, V42, P473, DOI 10.1080/13803395.2020.1758635; Patrick SD, 2021, NEUROPSYCHOLOGY, V35, P472, DOI 10.1037/neu0000747; Reitan R, 1985, HALSTEAD REITAN NEUR; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Rogers R, 2008, CLIN ASSESSMENT MALI; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shum DHK, 2004, ARCH CLIN NEUROPSYCH, V19, P817, DOI 10.1016/j.acn.2003.10.002; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A., 1973, SYMBOL DIGITS MODALI; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WechslerD, 2001, WECHSLER TEST ADULT; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; WETTER MW, 1995, PROF PSYCHOL-RES PR, V26, P474, DOI 10.1037/0735-7028.26.5.474	50	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2019740		DEC 2021	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XR9WN	WOS:000732570800001	34932422				2022-02-06	
J	Buriti, AKL; Gil, D				Lima Buriti, Ana Karina; Gil, Daniela			Mild Traumatic Brain Injury: Long-Term Follow-Up of Central Auditory Processing After Auditory Training	JOURNAL OF AUDIOLOGY AND OTOLOGY			English	Article						Traumatic brain injury; Hearing; Auditory perception; Electrophysiology; Neuronal plasticity	P300	Background and Objectives: Even a mild traumatic brain injury can impair the peripheral and central parts of the auditory system. The objective was to compare the performance of individuals with mild traumatic brain injury in behavioral and electrophysiological central auditory tests before and after formal auditory training, and to verify the stability of these measures over time. Subjects and Methods: Ten 16- to 64-year-old individuals diagnosed with mild traumatic brain injury underwent behavioral and electrophysiological assessment of the central auditory processing in three stages: before, right after, and six months after formal auditory training. Results: Statistically significant differences were observed for speech by white noise, synthetic sentence identification, sound localization, verbal sequential memory, and duration pattern tests in the assessment six months after formal auditory training. No statistically significant differences were observed between the P300 assessments, either with tone-burst or speech stimulus, in N2 and P3 latencies, and P3 amplitude. Conclusions: The results of the behavioral assessment of the central auditory processing improved, while the P300 remained stable with both stimuli, six months after completing formal auditory training. This demonstrates that auditory training has long-term benefits for people with mild traumatic brain injury.	[Lima Buriti, Ana Karina; Gil, Daniela] Univ Fed Sao Paulo UNIFESP, Dept Speech Language & Hearing Disorders Fonoaudi, 802 Botueatu St, BR-04023900 Sao Paulo, Brazil		Buriti, AKL (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Speech Language & Hearing Disorders Fonoaudi, 802 Botueatu St, BR-04023900 Sao Paulo, Brazil.	anak_buriti@yahoo.com.br	Gil, Daniela/C-9801-2012	Gil, Daniela/0000-0002-8647-6813; Buriti, Ana Karina Lima Buriti/0000-0001-9504-9795			Batista PB., 2016, ACOUSTICALLY CONTROL; Murphy CFB, 2011, CLINICS, V66, P713, DOI 10.1590/S1807-59322011000400030; Castan Andrea Tortosa Marangoni, 2017, Rev. CEFAC, V19, P126, DOI 10.1590/1982-0216201719110916; Chermak G, 2008, HEAR J, V61, P36; Chermak Gail D., 2002, Seminars in Hearing, V23, P297, DOI 10.1055/s-2002-35878; Chermak GD, 2009, ASHA LEAD, V14, P16, DOI [DOI 10.1044/LEADER.FTR3.14152009.16, 10.1044/leader.FTR3.14152009.16]; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Avila RRD, 2014, PSICOL-REFLEX CRIT, V27, P547, DOI 10.1590/1678-7153.201427316; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Figueiredo CC, 2015, EINSTEIN-SAO PAULO, V13, P535, DOI 10.1590/S1679-45082015AO3379; Filippini Renata, 2014, Audiol., Commun. Res., V19, P112, DOI 10.1590/S2317-64312014000200003; Gil D., 2017, HEALTH-LONDON, V9, P975; Gil D., 2015, P 30 INT AUD M 2015; Gil D., 2013, REV CEFAC, V15, P1427; Gil D, 2006, THESIS UNIFESP SAO P; Hare C., 2002, SEMIN HEAR, V23, P263, DOI DOI 10.1055/S-2002-35862; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Kaplan H., 1978, AUDIOMETRIC INTERPRE, P94; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Limongi, 2004, TRATADO FONOAUDIOLOG, P547; Matas Carla Gentile, 2011, Rev. soc. bras. fonoaudiol., V16, P37, DOI 10.1590/S1516-80342011000100008; McPherson DL., 1996, LATE POTENTIALS AUDI; Megale RL, 2002, PRO-FONO REV ATUAL C, V14, P93; Musiek Frank E., 1998, Seminars in Hearing, V19, P357, DOI 10.1055/s-0028-1082983; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Perez AP, 2017, INT ARCH OTORHINOLAR, V21, P134, DOI 10.1055/s-0036-1583527; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Quinto SMS, 2017, MUNDO SAUDE, V41, P212, DOI 10.15343/0104-7809.20174102212222; Vander Werff Kathy R., 2016, Seminars in Hearing, V37, P216, DOI 10.1055/s-0036-1584409; Williams EJ., CENTRAL AUDITORY PRO	32	0	0	0	0	KOREAN AUDIOLOGICAL SOC	SEOUL	DEPT OTORHINOLARY-HEAD&NECK SURG, SEOUL ST MARYS HOSP, CATHOLIC UNIV KOREA COLL MED, #505BANGPO-DONG, SEOUL, 06591, SOUTH KOREA	2384-1621	2384-1710		J AUDIOL OTOL	J. Audiol. Otol.	JAN	2022	26	1					22	30		10.7874/jao.2021.00360		DEC 2021	9	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	YI5EZ	WOS:000733392500001	34922419	gold, Green Accepted			2022-02-06	
J	Luo, LZ; Langley, C; Moreno-Lopez, L; Kendrick, K; Menon, DK; Stamatakis, EA; Sahakian, BJ				Luo, Lizhu; Langley, Christelle; Moreno-Lopez, Laura; Kendrick, Keith; Menon, David K.; Stamatakis, Emmanuel A.; Sahakian, Barbara J.			Depressive symptoms following traumatic brain injury are associated with resting-state functional connectivity	PSYCHOLOGICAL MEDICINE			English	Article; Early Access						Depression; functional connectivity; resting-state fMRI; traumatic brain injury	MAJOR DEPRESSION; METAANALYSIS; COGNITION; SEVERITY; CORTEX	Background To determine whether depressive symptoms in traumatic brain injury (TBI) patients were associated with altered resting-state functional connectivity (rs-fc) or voxel-based morphology in brain regions involved in emotional regulation and associated with depression. Methods In the present study, we examined 79 patients (57 males; age range = 17-70 years, M +/- s.d. = 38 +/- 16.13; BDI-II, M +/- s.d. = 9.84 +/- 8.67) with TBI. We used structural MRI and resting-state fMRI to examine whether there was a relationship between depression, as measured with the Beck Depression Inventory (BDI-II), and the voxel-based morphology or functional connectivity in regions previously identified as involved in emotional regulation in patients following TBI. Patients were at least 4 months post-TBI (M +/- s.d. = 15.13 +/- 11.67 months) and the severity of the injury included mild to severe cases [Glasgow Coma Scale (GCS), M +/- s.d. = 6.87 +/- 3.31]. Results Our results showed that BDI-II scores were unrelated to voxel-based morphology in the examined regions. We found a positive association between depression scores and rs-fc between limbic regions and cognitive control regions. Conversely, there was a negative association between depression scores and rs-fc between limbic and frontal regions involved in emotion regulation. Conclusion These findings lead to a better understanding of the exact mechanisms that contribute to depression following TBI and better inform treatment decisions.	[Luo, Lizhu; Langley, Christelle; Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, England; [Luo, Lizhu; Kendrick, Keith] Univ Elect Sci & Technol China, Clin Hosp Chengdu Brain Sci Inst, MOE Key Lab Neuroinformat, Chengdu 611731, Peoples R China; [Moreno-Lopez, Laura; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Cambridge CB2 0QQ, England; [Stamatakis, Emmanuel A.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England		Sahakian, BJ (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge CB2 0SZ, England.	bjs1001@cam.ac.uk		Kendrick, Keith/0000-0002-0371-5904	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31800961, 31530032]; Sichuan Science and Technology Program [2018JY0361]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2021T140094]; China Scholarship CouncilChina Scholarship Council [201908510070]; Wellcome Trust Collaborative AwardWellcome Trust [200181/Z/15/Z]; Stephen Erskine Fellowship Queens' College Cambridge	This work was supported by the National Natural Science Foundation of China (LL, grant number 31800961; KK, grant number 31530032); Sichuan Science and Technology Program (LL, grant number 2018JY0361); China Postdoctoral Science Foundation (LL, grant number 2021T140094); China Scholarship Council (LL, 201908510070); Wellcome Trust Collaborative Award (CL, grant number 200181/Z/15/Z); and Stephen Erskine Fellowship Queens' College Cambridge (ES). Professor Barbara J Sahakian research forms part of the NIHR MedTech and in vitro diagnostic Co-operative (MIC) and the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health theme.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Clark L, 2009, ANNU REV NEUROSCI, V32, P57, DOI 10.1146/annurev.neuro.31.060407.125618; Cooney RE, 2010, COGN AFFECT BEHAV NE, V10, P470, DOI 10.3758/CABN.10.4.470; Cullen KR, 2016, J CHILD ADOL PSYCHOP, V26, P705, DOI 10.1089/cap.2015.0232; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Finkelstein E., 2006, INCIDENCE EC BURDEN; Haber S.N, 2011, NEUROBIOLOGY SENSATI; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; JENNETT B, 1975, LANCET, V1, P480; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00134-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Liu CH, 2017, J CLIN PSYCHIAT, V78, pE372, DOI 10.4088/JCP.15m10022; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pandya M, 2012, CURR PSYCHIAT REP, V14, P634, DOI 10.1007/s11920-012-0322-7; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Robinson OJ, 2012, AM J PSYCHIAT, V169, P152, DOI 10.1176/appi.ajp.2011.11010137; Roiser Jonathan P, 1800, Neuropsychopharmacology, V37, P117, DOI 10.1038/npp.2011.183; Roiser JP, 2013, CNS SPECTRUMS, V18, P139, DOI 10.1017/S1092852913000072; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Savulich G, 2018, PSYCHOL MED, V48, P1397, DOI 10.1017/S0033291718000892; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Slowinski A, 2019, J NEUROPSYCH CLIN N, V31, P220, DOI 10.1176/appi.neuropsych.18070158; Smith APR, 2006, NEURON, V49, P631, DOI 10.1016/j.neuron.2005.12.025; Taber KH, 2004, J NEUROPSYCH CLIN N, V16, P127, DOI 10.1176/appi.neuropsych.16.2.127; TEASDALE G, 1974, LANCET, V2, P81; Wilson L, 2021, J NEUROL NEUROSUR PS, V92, P407, DOI 10.1136/jnnp-2020-324492; Yang XH, 2017, J AFFECT DISORDERS, V218, P284, DOI 10.1016/j.jad.2017.04.053	46	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.											PII S0033291721004724	10.1017/S0033291721004724		DEC 2021	8	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	XQ3TG	WOS:000731469900001		hybrid			2022-02-06	
J	Miller, MR; Robinson, M; Fischer, L; DiBattista, A; Patel, MA; Daley, M; Bartha, R; Dekaban, GA; Menon, RS; Shoemaker, JK; Diamandis, EP; Prassas, I; Fraser, DD				Miller, Michael R.; Robinson, Michael; Fischer, Lisa; DiBattista, Alicia; Patel, Maitray A.; Daley, Mark; Bartha, Robert; Dekaban, Gregory A.; Menon, Ravi S.; Shoemaker, J. Kevin; Diamandis, Eleftherios P.; Prassas, Ioannis; Fraser, Douglas D.			Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics	FRONTIERS IN NEUROLOGY			English	Article						concussion; protein; biomarker; diagnosis; athlete	TRANSLATIONAL RESEARCH; PROTEIN; SYMPTOMS	Sport concussions can be difficult to diagnose and if missed, they can expose athletes to greater injury risk and long-lasting neurological disabilities. Discovery of objective biomarkers to aid concussion diagnosis is critical to protecting athlete brain health. To this end, we performed targeted proteomics on plasma obtained from adolescent athletes suffering a sports concussion. A total of 11 concussed male athletes were enrolled at our academic Sport Medicine Concussion Clinic, as well as 24 sex-, age- and activity-matched healthy control subjects. Clinical evaluation was performed and blood was drawn within 72 h of injury. Proximity extension assays were performed for 1,472 plasma proteins; a total of six proteins were considered significantly different between cohorts (P < 0.01; five proteins decreased and one protein increased). Receiver operating characteristic curves on the six individual protein biomarkers identified had areas-under-the-curves (AUCs) for concussion diagnosis >= 0.78; antioxidant 1 copper chaperone (ATOX1; AUC 0.81, P = 0.003), secreted protein acidic and rich in cysteine (SPARC; AUC 0.81, P = 0.004), cluster of differentiation 34 (CD34; AUC 0.79, P = 0.006), polyglutamine binding protein 1 (PQBP1; AUC 0.78, P = 0.008), insulin-like growth factor-binding protein-like 1 (IGFBPL1; AUC 0.78, P = 0.008) and cytosolic 5'-nucleotidase 3A (NT5C3A; AUC 0.78, P = 0.009). Combining three of the protein biomarkers (ATOX1, SPARC and NT5C3A), produced an AUC of 0.98 for concussion diagnoses (P < 0.001; 95% CI: 0.95, 1.00). Despite a paucity of studies on these three identified proteins, the available evidence points to their roles in modulating tissue inflammation and regulating integrity of the cerebral microvasculature. Taken together, our exploratory data suggest that three or less novel proteins, which are amenable to a point-of-care immunoassay, may be future candidate biomarkers for screening adolescent sport concussion. Validation with protein assays is required in larger cohorts.	[Miller, Michael R.; Fraser, Douglas D.] Western Univ, Dept Pediat, London, ON, Canada; [Miller, Michael R.; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Robinson, Michael] Western Univ, Sch Hlth Studies, London, ON, Canada; [Robinson, Michael; Shoemaker, J. Kevin] Western Univ, Sch Kinesiol, London, ON, Canada; [Robinson, Michael; Fischer, Lisa] Western Univ, Dept Family Med, London, ON, Canada; [DiBattista, Alicia] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [DiBattista, Alicia; Fraser, Douglas D.] Neurolytixs Inc, Toronto, ON, Canada; [Patel, Maitray A.; Daley, Mark] Western Univ, Dept Epidmiol, London, ON, Canada; [Daley, Mark] Western Univ, Dept Comp Sci, London, ON, Canada; [Bartha, Robert; Menon, Ravi S.] Western Univ, Dept Med BioPhys, London, ON, Canada; [Bartha, Robert; Dekaban, Gregory A.; Menon, Ravi S.] Robarts Res Inst, London, ON, Canada; [Dekaban, Gregory A.] Western Univ, Dept MicroBiol & Immunol, London, ON, Canada; [Diamandis, Eleftherios P.; Prassas, Ioannis] Univ Toronto, Dept Pathol & Lab Med, Toronto, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Depatment Clin Neurol Sci, London, ON, Canada		Fraser, DD (corresponding author), Western Univ, Dept Pediat, London, ON, Canada.; Fraser, DD (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.; Fraser, DD (corresponding author), Neurolytixs Inc, Toronto, ON, Canada.; Fraser, DD (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.; Fraser, DD (corresponding author), Western Univ, Depatment Clin Neurol Sci, London, ON, Canada.	douglas.fraser@lhsc.on.ca	Daley, Mark/B-5679-2015	Daley, Mark/0000-0002-6939-9772			Al-Haj L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal2434; Alkabie S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0657-9; [Anonymous], 2010, NE SAS US GROUP P; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brisson AR, 2012, PEDIATRICS, V129, P153, DOI 10.1542/peds.2011-0134; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gillio-Meina C, 2013, PEDIATRICS, V131, P754, DOI 10.1542/peds.2012-1181; Greenwood Christina, 2015, Biomol Detect Quantif, V4, P10, DOI 10.1016/j.bdq.2015.04.002; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harriss AB, 2020, CLIN J SPORT MED, V30, pE147, DOI 10.1097/JSM.0000000000000714; Hasan KM, 2018, NEUROIMAG CLIN N AM, V28, P31, DOI 10.1016/j.nic.2017.09.001; Hatori Y, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030025; Hatori Y, 2013, ANTIOXID REDOX SIGN, V19, P945, DOI 10.1089/ars.2012.5086; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Jaiser SR, 2010, J NEUROL, V257, P869, DOI 10.1007/s00415-010-5511-x; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kelner GS, 2000, J BIOL CHEM, V275, P580, DOI 10.1074/jbc.275.1.580; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Lech T, 2007, BIOL TRACE ELEM RES, V118, P10, DOI 10.1007/s12011-007-0014-z; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lutsenko S, 2010, METALLOMICS, V2, P596, DOI 10.1039/c0mt00006j; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mannix R, 2020, J NEUROTRAUM, V37, P2029, DOI 10.1089/neu.2019.6956; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mendis DB, 1998, NEUROCHEM RES, V23, P1117, DOI 10.1023/A:1020720405428; Miller MR, 2021, J NEUROTRAUM, V38, P1608, DOI 10.1089/neu.2020.7125; Page T, 1997, P NATL ACAD SCI USA, V94, P11601, DOI 10.1073/pnas.94.21.11601; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Pascovici D, 2016, PROTEOMICS, V16, P2448, DOI 10.1002/pmic.201600044; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Zhong W, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22767-z	43	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 20	2021	12								787480	10.3389/fneur.2021.787480			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YB2NX	WOS:000738856800001	34987469	Green Published, gold			2022-02-06	
J	Waltzman, D; Daugherty, J; Sarmiento, K; Haarbauer-Krupa, J; Campbell, H; Ferrell, D				Waltzman, Dana; Daugherty, Jill; Sarmiento, Kelly; Haarbauer-Krupa, Juliet; Campbell, Hillary; Ferrell, Deanna			Prevalence of Suspected Concussions Among K-12 Students in Utah: Findings From Utah's Student Injury Reporting System	JOURNAL OF SCHOOL HEALTH			English	Article; Early Access						concussion; injury; surveillance; kids; children; schools	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SCHOOL; EQUIPMENT; CHILDREN; SPORTS; RISK	BACKGROUND To inform prevention strategies, this study provides incidence, factors, and actions taken when a suspected concussion occurred in K-12 schools in Utah. METHODS Data were collected using Utah's Student Injury Reporting System (SIRS) from the academic years 2011-2012 to 2018-2019. SIRS is a unique online system that tracks injuries that occur in the school setting among K-12 students in Utah. Descriptive statistics were computed to characterize students with a suspected concussion. Chi-square (chi(2)) analysis looking at characteristics by school level was also conducted. RESULTS Over 63,000 K-12 students in Utah sustained an injury at school during the study period. Suspected concussions comprised 10% of all injuries. The prevalence of concussions was highest among males (60.6%) and elementary school students (42.6%) and most often occurred outdoors (57.6%) or on a playground/playfield (33.9%), and in sports- and recreation-related activities (75.1%) (specifically contact sports, 24.0%). Most students with a suspected concussion were absent 1 day or less from school (71.4%) but about 68% were seen by a medical professional. Further, there were differences by school level. Females and students playing contact sports had a higher percentage of suspected concussions as school level increased, whereas males and concussions sustained during school hours had a lower percentage of suspected concussions as school level increased. CONCLUSIONS SIRS enables schools in Utah to identify groups at risk for concussion, as well as activities most commonly associated with these injuries, within the school environment. Using this information, schools may implement targeted prevention strategies to protect students.	[Waltzman, Dana; Sarmiento, Kelly] Natl Ctr Injury Prevent & Control, Div Injury Prevent, Ctr Dis Control & Prevent, 4770 Buford Highway,Mail Stop F62, Atlanta, GA 30341 USA; [Daugherty, Jill] Natl Ctr Injury Prevent & Control, Div Injury Prevent, Ctr Dis Control & Prevent, 4770 Buford Highway,Chamblee Campus,Bldg 106-9110, Atlanta, GA 30341 USA; [Haarbauer-Krupa, Juliet] Natl Ctr Injury Prevent & Control, Traumat Brain Injury Team, Appl Sci Branch, Div Injury Prevent,Ctr Dis Control & Prevent CDC, 4770 Buford Highway NE,MS S106-9, Atlanta, GA 30341 USA; [Campbell, Hillary] Utah Dept Hlth, Violence & Injury Prevent Program, Salt Lake City, UT 84116 USA; [Ferrell, Deanna] Utah Dept Hlth, Violence & Injury Prevent Program VIPP, 288 North 1460 West,POB 142106, Salt Lake City, UT 84114 USA		Waltzman, D (corresponding author), Natl Ctr Injury Prevent & Control, Div Injury Prevent, Ctr Dis Control & Prevent, 4770 Buford Highway,Mail Stop F62, Atlanta, GA 30341 USA.	dwaltzman@cdc.gov; xdu1@cdc.gov; egz8@cdc.gov; JHaarbauerKrupa@cdc.gov; hmcdermott@utah.gov; deannaferrell@utah.gov					Aldahir PCF, 2014, AGRON J, V106, P1297, DOI 10.2134/agronj13.0489; [Anonymous], 2010, ASS SCH BASED PHYS A; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Bacon CEW, 2017, J INTERPROF CARE, V31, P725, DOI 10.1080/13561820.2017.1345873; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Carzoo SA., 2015, ATHL TRAIN SPORTS HL, V7, P144; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Chalmers D J, 1996, Inj Prev, V2, P98, DOI 10.1136/ip.2.2.98; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Davies SC., 2018, CONT SCH PSYCHOL, V22, P1; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery CA, 2019, JAMA PEDIATR, V173, P309, DOI 10.1001/jamapediatrics.2018.5498; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Halpern B, 1988, Am J Sports Med, V16 Suppl 1, pS113; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Hinkson E, NURSING SERVICES UTA; Jastifer JR, 2019, SPORTS HEALTH, V11, P84, DOI 10.1177/1941738118793378; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moses S., FAMILY PRACTICE NOTE; Mott A, 1997, LANCET, V349, P1874, DOI 10.1016/S0140-6736(96)10343-3; Nauta J, 2014, J SCI MED SPORT, V17, P165, DOI 10.1016/j.jsams.2013.07.011; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Thompson LL, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2151; U.S. Consumer Product Safety Commission, 2010, PUBL PLAYGR SAF HDB, V325; Utah Violence Injury Prevention Program, STUD INJ; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Waltzman D, 2021, SPORTS HEALTH, V13, P454, DOI 10.1177/1941738121992324; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Yaramothu C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100257; Yau RK, 2019, SPORTS HEALTH, V11, P32, DOI 10.1177/1941738118807122; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	49	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health												10.1111/josh.13126		DEC 2021	11	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	XU2RP	WOS:000734119200001	34927246				2022-02-06	
J	Baiden, P; Morgan, MA; Logan, MW				Baiden, Philip; Morgan, Mark A.; Logan, Matthew W.			Sports- and Physical Activity-Related Concussions, Binge Drinking and Marijuana Use among Adolescents: The Mediating Role of Depression and Suicidal Ideation	SUBSTANCE USE & MISUSE			English	Article; Early Access						Sports- and physical activity-related concussions; traumatic brain injury; binge drinking; marijuana use; depression; suicidal ideation; adolescents	TRAUMATIC BRAIN-INJURY; SELF-MEDICATION HYPOTHESIS; PRESCRIPTION OPIOID MISUSE; MENTAL-HEALTH OUTCOMES; SUBSTANCE USE; HIGH-SCHOOL; CANNABIS USE; UNITED-STATES; RISK-FACTORS; ALCOHOL-USE	Background Although past studies have examined the adverse impact of sports- and physical activity-related concussions (SPACs) on health and mental health outcomes, there is a dearth of research investigating the association between SPACs and binge drinking and marijuana use. Objective The objective of this study is to examine the cross-sectional association between SPACs and binge drinking and marijuana use among adolescents and whether symptoms of depression and suicidal ideation mediate this association. Methods Data for this study came from the 2017 and 2019 National Youth Risk Behavior Survey. An analytic sample of 17,175 adolescents aged 14-18 years (50.2% male) was analyzed using binary logistic regression. Results Of the 17,175 adolescents, 13.7% engaged in binge drinking and 19.3% used marijuana 30 days preceding the survey date. Approximately one in seven (14.1%) adolescents had SPACs during the past year. Upon controlling for the effects of other factors, adolescents who had SPACs had 1.74 times higher odds of engaging in binge drinking (AOR = 1.74, p<.001, 95% CI = 1.47-2.06) and 1.42 times higher odds of using marijuana (AOR = 1.42, p<.001, 95% CI = 1.24-1.62) than those who did not have SPACs. Symptoms of depression and suicidal ideation explained 12% of the association between SPACs and binge drinking, and 19% of the association between SPACs and marijuana use. Conclusions Understanding the association between SPACs and substance use and mental health could contribute to early identification of adolescents who may engage in substance use.	[Baiden, Philip] Univ Texas Arlington, Sch Social Work, 211 S Cooper St,Box 19129, Arlington, TX 76019 USA; [Morgan, Mark A.] Univ Dayton, Dept Criminal Justice & Secur Studies, Dayton, OH 45469 USA; [Logan, Matthew W.] Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX USA		Baiden, P (corresponding author), Univ Texas Arlington, Sch Social Work, 211 S Cooper St,Box 19129, Arlington, TX 76019 USA.	philip.baiden@uta.edu		Baiden, Philip/0000-0003-3877-2594			Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Austin AE, 2018, CHILD YOUTH SERV REV, V86, P84, DOI 10.1016/j.childyouth.2018.01.023; Baiden P, 2021, SSM-POPUL HLTH, V15, DOI 10.1016/j.ssmph.2021.100820; Baiden P, 2020, J PSYCHIATR RES, V125, P13, DOI 10.1016/j.jpsychires.2020.02.029; Baiden P, 2020, CHILD ABUSE NEGLECT, V102, DOI 10.1016/j.chiabu.2020.104417; Baiden P, 2019, PSYCHIAT RES, V281, DOI 10.1016/j.psychres.2019.112586; Baiden P, 2019, J AFFECT DISORDERS, V259, P317, DOI 10.1016/j.jad.2019.08.063; Baiden P, 2014, J SUBST USE, V19, P18, DOI 10.3109/14659891.2012.727522; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beaulieu-Bonneau S, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000341; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chang HK, 2019, J AFFECT DISORDERS, V250, P21, DOI 10.1016/j.jad.2019.02.059; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corrigan JD, 2020, J NEUROTRAUM, V37, P1637, DOI 10.1089/neu.2019.6897; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Darke S, 2013, ADDICTION, V108, P659, DOI 10.1111/j.1360-0443.2012.04001.x; DePadilla L, 2020, J SCH NURS, DOI 10.1177/1059840520977319; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Drane CF, 2017, ADDICT BEHAV, V66, P60, DOI 10.1016/j.addbeh.2016.11.001; Edwards KM, 2020, J INTERPERS VIOLENCE, DOI 10.1177/0886260520938506; El Hayek S, 2020, J NEUROL SCI, V411, DOI 10.1016/j.jns.2020.116711; Eyolfson E, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01994-z; Farmer RF, 2016, DRUG ALCOHOL DEPEN, V164, P38, DOI 10.1016/j.drugalcdep.2016.04.021; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Fuller-Thomson E, 2016, CHILD CARE HLTH DEV, V42, P725, DOI 10.1111/cch.12351; Garland EL, 2013, J BEHAV MED, V36, P175, DOI 10.1007/s10865-012-9413-5; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Gomez J, 2015, COMMUNITY MENT HLT J, V51, P833, DOI 10.1007/s10597-015-9894-0; Groenman AP, 2017, J AM ACAD CHILD PSY, V56, P556, DOI 10.1016/j.jaac.2017.05.004; Gualano MR, 2015, EUR J PUBLIC HEALTH, V25, P444, DOI 10.1093/eurpub/cku207; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hammond CJ, 2020, INT REV PSYCHIATR, V32, P221, DOI 10.1080/09540261.2020.1713056; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoeben EM, 2016, J CRIM JUST, V47, P108, DOI 10.1016/j.jcrimjus.2016.08.001; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Ilie G, 2017, INJURY, V48, P285, DOI 10.1016/j.injury.2016.09.030; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Irwin SL, 2020, HEADACHE, V60, P1076, DOI 10.1111/head.13824; Jones CM, 2020, MMWR-MORBID MORTAL W, V69, P38, DOI 10.15585/mmwr.su6901a5; Kaasboll C, 2018, J CHILD ADOLES SUBST, V27, P238, DOI 10.1080/1067828X.2018.1462281; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kaup AR, 2019, J NEUROTRAUM, V36, P338, DOI 10.1089/neu.2018.5695; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Kim DS, 2010, INT J PUBLIC HEALTH, V55, P551, DOI 10.1007/s00038-010-0169-9; Knell G, 2020, AM J SPORT MED, V48, P2534, DOI 10.1177/0363546520938776; Kort-Butler LA, 2017, SUBST USE MISUSE, V52, P1019, DOI 10.1080/10826084.2016.1268632; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lemyre A, 2019, AM J DRUG ALCOHOL AB, V45, P230, DOI 10.1080/00952990.2018.1536882; Ling DI, 2020, CLIN ORTHOP RELAT R, V478, P1469, DOI 10.1097/CORR.0000000000000995; Lisha NE, 2010, ADDICT BEHAV, V35, P399, DOI 10.1016/j.addbeh.2009.12.032; Lowry R, 2021, AM J PREV MED, V60, P352, DOI 10.1016/j.amepre.2020.10.018; Lowry R, 2019, AM J PREV MED, V57, P733, DOI 10.1016/j.amepre.2019.08.016; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Maniglio R, 2015, AGGRESS VIOLENT BEH, V25, P252, DOI 10.1016/j.avb.2015.09.002; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mantey DS, 2021, J PSYCHIATR RES, V132, P191, DOI 10.1016/j.jpsychires.2020.10.022; Mantey DS, 2020, J AFFECT DISORDERS, V263, P684, DOI 10.1016/j.jad.2019.11.047; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McGuine TA, 2019, AM J SPORT MED, V47, P3514, DOI 10.1177/0363546519880175; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Oliverio R, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.546775; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Pfaller AY, 2019, AM J SPORT MED, V47, P2294, DOI 10.1177/0363546519860120; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Piccinelli C, 2018, INT J PUBLIC HEALTH, V63, P325, DOI 10.1007/s00038-018-1076-8; Priesman E, 2018, J PSYCHOACTIVE DRUGS, V50, P133, DOI 10.1080/02791072.2017.1371362; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rivara FP, 2020, JAMA PEDIATR, V174, P79, DOI 10.1001/jamapediatrics.2019.4006; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; SAMHSA, 2019, KEY SUBSTANCE USE ME; Sami M, 2015, BRAIN INJURY, V29, P1383, DOI 10.3109/02699052.2015.1046491; Sarmiento K, 2020, J SCH NURS, DOI 10.1177/1059840520945389; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Scheer JR, 2021, PSYCHOL SEX, V12, P37, DOI 10.1080/19419899.2019.1690031; Schulenberg J., 2020, MONITORING FUTURE NA, P19; Schwartz JA, 2021, JUSTICE Q, V38, P196, DOI 10.1080/07418825.2019.1599044; Seeley JR, 2019, DRUG ALCOHOL DEPEN, V194, P45, DOI 10.1016/j.drugalcdep.2018.09.012; Semrud-Clikeman M., 2016, J PEDIATR NEUROPSYCH, V2, P58, DOI [10.1007/s40817-015-0010-8, DOI 10.1007/S40817-015-0010-8, https://doi.org/10.1007/s40817-015-0010-8]; Sharma P, 2018, J AM ACAD CHILD PSY, V57, pS138, DOI 10.1016/j.jaac.2018.09.026; Stewart SL, 2013, SUBST USE MISUSE, V48, P404, DOI 10.3109/10826084.2013.765482; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Townsend L, 2007, CLIN CHILD FAM PSYCH, V10, P295, DOI 10.1007/s10567-007-0023-7; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Underwood JM, 2020, MMWR-MORBID MORTAL W, V69, P1, DOI 10.15585/mmwr.su6901a1; United States Department of Health and Human Services, 2004, NIAAA NEWSLETTER, P3; Veliz P, 2021, SUBST ABUS, V42, P183, DOI 10.1080/08897077.2019.1671938; Veliz P, 2019, J ADOLESCENT HEALTH, V64, P272, DOI 10.1016/j.jadohealth.2018.08.023; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wadsworth E, 2019, ADDICT BEHAV, V90, P171, DOI 10.1016/j.addbeh.2018.10.050; Wahlquist VE, 2021, SPORTS MED, V51, P51, DOI 10.1007/s40279-020-01376-8; Wangnoo T, 2020, J NEUROTRAUM, V37, P1401, DOI 10.1089/neu.2018.5721; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3; Yngwe MA, 2001, J EPIDEMIOL COMMUN H, V55, P556, DOI 10.1136/jech.55.8.556; Zullig KJ, 2015, SUBST USE MISUSE, V50, P1678, DOI 10.3109/10826084.2015.1027931	122	0	0	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse												10.1080/10826084.2021.2019779		DEC 2021	12	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	XX5UO	WOS:000736360500001	34967277				2022-02-06	
J	Doan, BK; Heaton, KJ; Self, BP; Samuels, MAB; Adam, GE				Doan, Brandon K.; Heaton, Kristin J.; Self, Brian P.; Samuels, Michelle A. Butler; Adam, Gina E.			Quantifying head impacts and neurocognitive performance in collegiate boxers Head Impacts and Neurocognition in Collegiate Boxers	JOURNAL OF SPORTS SCIENCES			English	Article; Early Access						Acceleration; head impact; boxing; concussion; neuropsychological	FOOTBALL; CONCUSSION; EXERCISE; INJURY; ACCELERATION; MECHANISMS; EXPOSURE	Head impacts and neurocognition were quantified in 27 intercollegiate male boxers engaged in two, two-minute sparring rounds. Head impacts were measured using Instrumented Boxing Headgear (IBH). Pre and post-sparring neurocognitive performance was compared using two computerized neuropsychological test batteries (CNTs): Immediate Post-concussion Assessment and Cognitive Testing (ImPACT (TM)) and Automated Neuropsychological Assessment Metrics - Military Battery (ANAM4 (R) MIL). An average of 27.63 +/- 17.87 impacts above the 9.6 g IBH threshold were recorded per boxer, with average peak linear acceleration of 23.48 +/- 15.20 g and average peak rotational acceleration of 1761.40 +/- 1064.34 rad/s(2). Small, but measurable declines in delayed memory and improvement in response time from pre- to post-bout were noted. Number of impacts and concussion history predicted degraded memory performance. This is a runique quantificationof head impacts in collegiate boxing, which were similar in frequency and location, but lower in magnitude as compared to amateur boxing. Improved understanding of impact kinematics may enhance safety in boxing and other contact sports. Subtle post-bout decrements in delayed memory performance and mild improvement in response time reinforce prior research and provide evidence of congruence in our two CNT assessments, which may facilitate comparisons of outcomes across settings utilizing these tests.	[Doan, Brandon K.] Georgia Gwinnett Coll, Sch Sci & Technol, Exercise Sci, 1000 Univ Ctr Lane, Lawrenceville, GA 30043 USA; [Heaton, Kristin J.] US Army Res Inst Environm Med, Natick, MA USA; [Self, Brian P.] Calif Polytech State Univ San Luis Obispo, Mech Engn, San Luis Obispo, CA 93407 USA; [Samuels, Michelle A. Butler] US Air Force Acad, Usaf Acad, Dept Behav Sci & Leadership, Colorado Springs, CO USA; [Adam, Gina E.] US Army Med Mat Dev Act USAMMDA, Ft Detrick, MD USA		Doan, BK (corresponding author), Georgia Gwinnett Coll, Sch Sci & Technol, Exercise Sci, 1000 Univ Ctr Lane, Lawrenceville, GA 30043 USA.	bdoan@ggc.edu			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-1-0021]; Ph.D. Air Force Surgeon General (US)	U.S. Army Medical Research and Materiel Command, Award Number: W81XWH-08-1-0021 | Recipient: Kristin J Heaton, Ph.D. Air Force Surgeon General (US), Award Number: None | Recipient: Brandon K Doan, Ph.D.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; [Anonymous], 2004, IMPACT APPL; [Anonymous], 2021, SPSS STAT; Backaitis S.H, 1981, HEAD NECK INJURY CRI; Bartsch A, 2020, MIL MED, V185, P190, DOI 10.1093/milmed/usz334; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beusenberg MC., 2000, P INT RES C BIOM IMP; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chu, 2006, J BIOMECH, V39, DOI https://doi.org/10.1016/s0021-9290(06)83518-9; Cognitive Science Research Center U of O, 2012, AUT NEUR ASS METR VE; Cohen J., 1988, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davranche K, 2006, J SPORT SCI, V24, P323, DOI 10.1080/02640410500132165; Dickinson P, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0043-2; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eppinger RH., 1996, TRAUMATIC BRAIN INJU, P19; Greenwald, 2006, J BIOMECHANICS S1, P39, DOI [https://doi.org/10.1016/s0021-9290(06)83517-7, DOI 10.1016/s0021-9290(06)83517-7]; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; HEILBRONNER RL, 1991, AM J SPORT MED, V19, P376, DOI 10.1177/036354659101900409; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Huber CM, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/2325967120984423; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knox T, 2004, P 5 INT C ENG SPORT, V2, P52; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lee B, 2014, REV ARTES MARCIALES, V9, P106, DOI 10.18002/rama.v9i2.1175; Leeds DD, 2019, MIL MED, V184, P206, DOI 10.1093/milmed/usy415; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Newman J, 1982, AGARD C P IMP INJ CA; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Proposed New A, 2000, 44 STAPP CAR CRASH C, DOI [10.4271/2000-01-SC16, DOI 10.4271/2000-01-SC16]; Renault B, 1989, 33 STAPP CAR CRASH C, DOI [10.4271/892435, DOI 10.4271/892435]; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sandmo SB, 2019, AM J SPORT MED, V47, P974, DOI 10.1177/0363546519826953; Saunders TD, 2020, CLIN BIOMECH, V74, P14, DOI 10.1016/j.clinbiomech.2020.02.003; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00069; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Tabachnick BG., 2012, USING MULTIVARIATE S; Thibault L.E.O.A., 1993, BIOMECHANICS IMPACT, P411; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	63	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.												10.1080/02640414.2021.2001175		DEC 2021	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XR9PG	WOS:000732551900001	34930100				2022-02-06	
J	Dretsch, MN; Trachik, B; Taylor, M; Kotov, R; Krueger, R				Dretsch, Michael N.; Trachik, Benjamin; Taylor, Maura; Kotov, Roman; Krueger, Robert			Variability in the stability of personality traits across a single combat deployment	MILITARY PSYCHOLOGY			English	Article; Early Access						Impulsive sensation seeking; neuroticism; anxiety; military; PTSD; aggression; hostility; combat exposure; concussion	TRAUMATIC BRAIN-INJURY; SENSATION SEEKING; PAST CONCUSSIONS; HURRICANE SANDY; EXPOSURE; MILITARY; BEHAVIOR; AGE; PSYCHOPATHOLOGY; NEUROTICISM	This study assessed changes in measures of personality traits across a 12-month combat deployment in a sample of conventional US Army soldiers. Results revealed Impulsive Sensation-Seeking (ImpSS) and Sociability (Sy) decreased significantly, whereas Neuroticism-Anxiety (N-Anx) increased. Changes in ImpSS scores were mainly attributed to age, but were inversely related to increases in traumatic stress symptoms. Combat exposure, concussion, age, education, and changes in traumatic stress scores all independently contributed to changes in N-Anx scores. Changes in Sy were not associated with any of the data available from pre-deployment or deployment measures. Changes in Aggression-hostility (Agg-Hos) and Activity (Act) across the deployment were not significant. The findings suggest significant variability in the stability of personality traits when exposed to combat stress and injury while deployed, which may be influenced by factors such as age and education.	[Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.; Trachik, Benjamin; Taylor, Maura] US Army Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis Mcchord, WA 98443 USA; [Kotov, Roman] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Krueger, Robert] Univ Minnesota, Dept Psychol, Minneapolis, MN USA		Dretsch, MN (corresponding author), US Army Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis Mcchord, WA 98443 USA.	Michael.n.dretsch.mil@mail.mil			US Army Medical Research and Development Command (USAMRDC) - Military Operational Medical Research Program (MOMRP)	This is supported by US Army Medical Research and Development Command (USAMRDC) - Military Operational Medical Research Program (MOMRP).<SUP>3</SUP>	Bartone Paul T, 2009, Leadership & Organization Development Journal, V30, P498, DOI 10.1108/01437730910981908; Braender M, 2013, PUBLIC ADMIN REV, V73, P466, DOI 10.1111/puar.12046; Bramsen I, 2002, PERS INDIV DIFFER, V32, P747, DOI 10.1016/S0191-8869(01)00077-0; Breivik G, 2019, SAGE OPEN, V9, DOI 10.1177/2158244018824498; Brose A, 2013, EMOTION, V13, P940, DOI 10.1037/a0032401; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chase HW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.60; DeYoung CG, 2008, J ABNORM PSYCHOL, V117, P947, DOI 10.1037/a0013742; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fiedler ER, 2004, MIL MED, V169, P207, DOI 10.7205/MILMED.169.3.207; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Harden KP, 2011, DEV PSYCHOL, V47, P739, DOI 10.1037/a0023279; Harris MA, 2016, PSYCHOL AGING, V31, P862, DOI 10.1037/pag0000133; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hopwood CJ, 2011, J PERS SOC PSYCHOL, V100, P545, DOI 10.1037/a0022409; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; Johnson J.L., 2009, INDIVIDUAL DIFFERENC, V7, P1; Keane T.M., 1991, PCL M DSM 4; Koffel E, 2016, PSYCHOL MED, V46, P209, DOI 10.1017/S0033291715001798; Kopala-Sibley DC, 2016, PSYCHOL MED, V46, P865, DOI 10.1017/S0033291715002378; Kopala-Sibley DC, 2016, J ABNORM PSYCHOL, V125, P471, DOI 10.1037/abn0000152; Kotov R, 2018, WORLD PSYCHIATRY, V17, P24, DOI 10.1002/wps.20478; MacManus D, 2015, EPIDEMIOL REV, V37, P196, DOI 10.1093/epirev/mxu006; Mann FD, 2017, PERS INDIV DIFFER, V105, P30, DOI 10.1016/j.paid.2016.09.018; McCormack L, 2002, MIL PSYCHOL, V14, P179, DOI 10.1207/S15327876MP1403_1; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Ogle CM, 2014, J PERS, V82, P93, DOI 10.1111/jopy.12037; Oshio A, 2018, PERS INDIV DIFFER, V127, P54, DOI 10.1016/j.paid.2018.01.048; Parmak M, 2012, MIL PSYCHOL, V24, P551, DOI 10.1080/08995605.2012.742843; Parslow RA, 2006, PSYCHOL MED, V36, P387, DOI 10.1017/S0033291705006306; Querengasser J., 2014, BMC PSYCHOL, V2, P14, DOI [DOI 10.1186/2050-7283-2-14, 10.1186/2050-7283-2-14]; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Stevanovic A, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30964; Thomassen AG, 2018, MIL PSYCHOL, V30, P142, DOI 10.1080/08995605.2018.1425065; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Yoo Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191198; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	43	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.												10.1080/08995605.2021.2003147		DEC 2021	10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	XQ0MX	WOS:000731250600001					2022-02-06	
J	Ruan, Z; Lu, Q; Wang, JE; Zhou, M; Liu, SQ; Zhang, HX; Durvasula, A; Wang, YJ; Wang, YA; Luo, WB; Wang, YF				Ruan, Zhi; Lu, Qing; Wang, Jennifer E.; Zhou, Mi; Liu, Shuiqiao; Zhang, Hongxia; Durvasula, Akshay; Wang, Yijie; Wang, Yanan; Luo, Weibo; Wang, Yingfei			MIF promotes neurodegeneration and cell death via its nuclease activity following traumatic brain injury	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						MIF; Traumatic brain injury; Neurodegeneration; Cell death	MIGRATION INHIBITORY FACTOR; POLY(ADP-RIBOSE) POLYMERASE; MICE; ACTIVATION; DEFICITS	Traumatic brain injury (TBI), often induced by sports, car accidents, falls, or other daily occurrences, is a primary non-genetically related risk factor for the development of subsequent neurodegeneration and neuronal cell death. However, the molecular mechanisms underlying neurodegeneration, cell death, and neurobehavioral dysfunction following TBI remain unclear. Here, we found that poly(ADP-ribose) polymerase-1 (PARP-1) was hyperactivated following TBI and its inhibition reduced TBI-induced brain injury. Macrophage migration inhibitory factor (MIF), a newly identified nuclease involved in PARP-1-dependent cell death, was translocated from the cytosol to the nucleus in cortical neurons following TBI and promoted neuronal cell death in vivo. Genetic deletion of MIF protected neurons from TBI-induced dendritic spine loss, morphological complexity degeneration, and subsequent neuronal cell death in mice. Moreover, MIF knockout reduced the brain injury volume and improved long-term animal behavioral rehabilitation. These neuroprotective effects in MIF knockout mice were reversed by the expression of wild-type MIF but not nuclease-deficient MIF mutant. In contrast, genetic deletion of MIF did not alter TBI-induced neuroinflammation. These findings reveal that MIF mediates TBI-induced neurodegeneration, neuronal cell death and neurobehavioral dysfunction through its nuclease activity, but not its pro-inflammatory role. Targeting MIF's nuclease activity may offer a novel strategy to protect neurons from TBI.	[Ruan, Zhi; Lu, Qing; Wang, Jennifer E.; Zhou, Mi; Liu, Shuiqiao; Zhang, Hongxia; Durvasula, Akshay; Wang, Yijie; Wang, Yanan; Luo, Weibo; Wang, Yingfei] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Luo, Weibo] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Wang, Yingfei] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Wang, Yingfei] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Dallas, TX 75390 USA; [Lu, Qing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pharmacol, Wuhan 430030, Peoples R China		Wang, YF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.; Wang, YF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.; Wang, YF (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Brain Inst, Dallas, TX 75390 USA.	yingfei.wang@utsouthwestern.edu	ruan, zhi/AAC-5421-2019		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R00NS078049]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R35GM124693]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG066166]; Darrell K Royal Research Fund (DKR); Welch FoundationThe Welch Foundation [I-1939-20170325, I-1903-20190330]; CPRIT-HIHR [RP170671]; TIBIR pilot Grant; University of Texas (UT) Southwestern Medical Center Startup funds; UT Rising Stars	This work was supported by grants from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke R00NS078049, National Institute of General Medical Sciences R35GM124693, and National Institute on Aging R01AG066166, Darrell K Royal Research Fund (DKR), Welch Foundation (I-1939-20170325), CPRIT-HIHR RP170671, TIBIR pilot Grant, the University of Texas (UT) Southwestern Medical Center Startup funds and UT Rising Stars to Y.W., and the Welch Foundation I-1903-20190330 to W.L.	Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Barr Taura L, 2007, J Neurosci Nurs, V39, P278; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Bolos Marta, 2017, BioMolecular Concepts, V8, P37, DOI 10.1515/bmc-2016-0029; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chen Y, 2018, J CLIN INVEST, V128, P1937, DOI 10.1172/JCI95089; Das R, 2019, CELL MOL LIFE SCI, V76, P3681, DOI 10.1007/s00018-019-03132-2; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Harper JM, 2010, FASEB J, V24, P2436, DOI 10.1096/fj.09-152223; Inacio AR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-75; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Kam TI, 2018, SCIENCE, V362, P557, DOI 10.1126/science.aat8407; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Liu SQ, 2022, J NEUROCHEM, V160, P74, DOI 10.1111/jnc.15464; Liu YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16927-9; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Nasiri E, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00163-5; Newell-Rogers MK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207448; Paldino E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102286; Rulten SL, 2014, NUCLEIC ACIDS RES, V42, P307, DOI 10.1093/nar/gkt835; Sakata K, 2010, GENES BRAIN BEHAV, V9, P712, DOI 10.1111/j.1601-183X.2010.00605.x; Sanchez-Bezanilla S, 2019, EXP NEUROL, V318, P232, DOI 10.1016/j.expneurol.2019.05.001; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Simoes AP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0351-1; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Wang YJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23264-z; Wang YJ, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102651; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zhang S, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0508-x	47	0	0	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JAN	2022	79	1								10.1007/s00018-021-04037-9		DEC 2021	20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	YC9LO	WOS:000731391900005	34921640				2022-02-06	
J	Velez, JR; Tabassum, A; Bolufe-Rohler, A; Alvarez, A; Liu, K; Poirier, A; VanTil, LD				Velez, Julian Reyes; Tabassum, Anika; Bolufe-Rohler, Antonio; Alvarez, Alexander; Liu, Kai; Poirier, Alain; VanTil, Linda D.			Characteristics of Canadian Veterans reimbursed for cannabis for medical purposes: Life After Service Survey 2016	JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH			English	Article; Early Access						Canada; cannabis; chronic conditions; Life After Service Study; Veterans; Veterans Affairs Canada	POSTTRAUMATIC-STRESS-DISORDER; MILITARY VETERANS; SUBSTANCE USE; MARIJUANA USE; CHRONIC PAIN; PREVALENCE; TRENDS	LAY SUMMARY This research explored the demographic, military service, and health characteristics associated with cannabis for medical purposes (CMP) reimbursements among Veterans Affairs Canada (VAC) clients and respondents of the Life After Service Survey 2016 (LASS). Of the initial number of indicators selected contained in LASS 2016 survey, some specific variables were significantly associated with CMP reimbursement, from which physical/mental health and well-being indicators, such as anxiety, posttraumatic stress disorder (PTSD), depression, bowel ulcer, traumatic brain injury, chronic pain, needing help with tasks, psychological distress, and having three of more conditions of the PTSD diagnosis, were positively associated with CMP. Moreover, unemployment, having low income (< $5,000), a difficult adjustment, being very dissatisfied with life, having low social support, a weak community belonging, and reporting high stress also increased the odds of being reimbursed. These results will help to identify a preliminary profile of VAC clients with higher need for CMP reimbursement. Introduction: Cannabis is used to self-treat a wide range of symptoms and conditions. However, there is scarce information describing the characteristics of Canadian Veterans being reimbursed by Veterans Affairs Canada (VAC) for cannabis used for medical purposes (CMP). The objective of this study was to explore the demographic and military service characteristics and chronic conditions associated with CMP reimbursement of VAC clients responding to the 2016 Life After Service Survey (LASS). Methods: This study linked the VAC reimbursement information for CMP and data from the 2016 LASS. In total, 1,480 LASS survey participants were VAC clients and were included in this study. Both descriptive and bivariate analyses were performed to explore the population characteristics (46 demographic, military, and well-being variables) associated with CMP reimbursement. Results: Of the 1,480 VAC clients in this study, 72 were reimbursed for CMP. Of the 46 variables, 22 were significant. Several variables from different domains were associated with CMP reimbursement in the bivariate analysis: anxiety, posttraumatic stress disorder, depression, bowel ulcer, traumatic brain injury, chronic pain, 12-Item Short Form Survey (SF-12) scores, psychological distress, suicidal ideation, requiring help with tasks, financial status, unemployment, low income, dissatisfaction with finances, and satisfaction with family members. Discussion: These results provide preliminary information on Canadian Veterans reimbursed for CMP. Further studies that can identify larger numbers of Veterans reimbursed for CMP are needed to further explore these characteristics with multivariate approaches.	[Velez, Julian Reyes; Poirier, Alain; VanTil, Linda D.] Vet Affairs Canada, Res Directorate, Charlottetown, PE C1A 8M9, Canada; [Tabassum, Anika] Vet Affairs Canada, Business Intelligence Unit, Charlottetown, PE, Canada; [Bolufe-Rohler, Antonio; Alvarez, Alexander; Liu, Kai] Univ Prince Edward Isl, Sch Math & Computat Sci, Charlottetown, PE, Canada		Velez, JR (corresponding author), Vet Affairs Canada, Res Directorate, Charlottetown, PE C1A 8M9, Canada.	Julian.reyesvelez@veterans.gc.ca					Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Betthauser K, 2015, AM J HEALTH-SYST PH, V72, P1279, DOI 10.2146/ajhp140523; Boden MT, 2018, J STUD ALCOHOL DRUGS, V79, P853, DOI 10.15288/jsad.2018.79.853; Boden MT, 2013, AM J ADDICTION, V22, P277, DOI 10.1111/j.1521-0391.2012.12018.x; Bonn-Miller MO, 2013, PSYCHOL TRAUMA-US, V5, P193, DOI 10.1037/a0026621; Borges G, 2016, J AFFECT DISORDERS, V195, P63, DOI 10.1016/j.jad.2016.02.007; Burns KEA, 2015, CAN MED ASSOC J, V187, pE198, DOI 10.1503/cmaj.140545; Busse JW, FEASIBILITY USING VA, P23; Canada VA., 2019, CANN MED PURP INT; Davis AK, 2016, ADDICT BEHAV, V63, P132, DOI 10.1016/j.addbeh.2016.07.006; Elikkottil Jaseena, 2009, J Opioid Manag, V5, P341; Feingold D, 2019, INT J MENT HEALTH AD, V17, P217, DOI 10.1007/s11469-018-0012-8; Grenier K, 2020, CAN J NEUROL SCI, V47, P11, DOI 10.1017/cjn.2019.298; Han B, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.13025; Han B, 2018, DRUG ALCOHOL DEPEN, V186, P120, DOI 10.1016/j.drugalcdep.2018.01.022; Hawley LA, 2018, ARCH PHYS MED REHAB, V99, P1584, DOI 10.1016/j.apmr.2018.02.003; Hergert DC, 2021, J NEUROTRAUM, V38, P1904, DOI 10.1089/neu.2020.7148; Hill KP, 2017, POL ARCH INTERN MED, V127, P785, DOI 10.20452/pamw.4123; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Hindocha C, 2020, J DUAL DIAGN, V16, P120, DOI 10.1080/15504263.2019.1652380; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; MacCallum CA, 2018, EUR J INTERN MED, V49, P12, DOI 10.1016/j.ejim.2018.01.004; MacKillop J, 2018, J MIL VETERAN FAM HL, V4, P2, DOI [10.3138/jmvfh.4.2.002, DOI 10.3138/JMVFH.4.2.002]; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Metrik Jane, 2018, Transl Issues Psychol Sci, V4, P6, DOI 10.1037/tps0000133; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Prud'homme M, 2015, SUBST ABUS-RES TREAT, V9, P33, DOI 10.4137/SART.S25081; Rintala DH, 2010, AM J PHYS MED REHAB, V89, P840, DOI 10.1097/PHM.0b013e3181f1c4ec; Rotermann M, 2018, HEALTH REP, V29, P3; Russo EB, 2017, ADV PHARMACOL, V80, P67, DOI 10.1016/bs.apha.2017.03.004; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith PA., 2017, J PAIN MANAGEMENT, V10, P397; Statistics Canada, 2019, STAT CAN QUAL GUID, V6th; Sterniczuk R., 2016, J MILITARY VETERAN F, V2, P43, DOI [10.3138/jmvfh.3836, DOI 10.3138/JMVFH.3836]; Turna J, 2021, CLIN PSYCHOL REV, V84, DOI 10.1016/j.cpr.2021.101958; Turna J, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152188; Van Til L., 2017, WELL BEING CANADIAN; Veterans Affairs, 2016, REV MAR MED PURP INT; Veterans Affairs Canada, 2017, MON WELL BEING VET V; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358	42	0	0	0	0	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA		2368-7924		J MIL VETERAN FAM HL	J. Mil. Veteran Fam. Hlth.												10.3138/jmvfh-2021-0072		DEC 2021	12	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	XW6ZT	WOS:000735765300001					2022-02-06	
J	Bukhari, RA; Kinney, AR; Edelstein, J; Malcolm, MP				Bukhari, Rayyan A.; Kinney, Adam R.; Edelstein, Jessica; Malcolm, Matt P.			Change in Activity Performance Mediates the Relationship between Occupational Therapy Utilization and Discharge Disposition among Adults with Traumatic Brain Injuries	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article; Early Access						Acute care; health services research; occupational therapy; rehabilitation	REHABILITATION; OUTCOMES; CARE; DISPARITIES; DISORDERS; MOBILITY; HISTORY	A retrospective cross-sectional study was conducted on 435 adults with TBI who received occupational therapy services in an acute care trauma center hospital. Outcome measures were (1) occupational therapy utilization based on billed minutes of occupational therapy evaluation and treatment (low vs. high); (2) Activity Measure for Post-Acute Care (AM-PAC) "6-Clicks" to assess activities of daily living level of assistance; and (3) Discharge disposition (community vs. institution). Community discharge included home and supported living facilities. Institutional discharge involved long term care, rehabilitation facility, short term hospital, and skilled nursing facility. Results indicated that change in ADL performance, between admission and discharge, partially mediated the relationship between occupational therapy utilization and community discharge (OR = 0.80, p = .003). High occupational therapy utilization (vs. low) was associated with greater change in ADL performance (beta = 0.39, p < .001). Greater change in ADL performance was associated with lower odds of community discharge (OR = 0.96, p < .001). Independent of change in ADL performance, higher occupational therapy utilization was associated with significantly lower odds for community discharge (OR = 0.57, p = 0.023). In conclusion, patients who received more occupational therapy were less likely to be community discharged, as mediated by change in ADL performance. This result can provide direction for future research exploring acute care occupational therapy utilization and discharge disposition.	[Bukhari, Rayyan A.; Edelstein, Jessica; Malcolm, Matt P.] Colorado State Univ, Dept Occupat Therapy, 200 Occupational Therapy Bldg, Ft Collins, CO 80523 USA; [Bukhari, Rayyan A.] King Saud bin Abdulaziz Univ Hlth Sci, Dept Occupat Therapy, Jeddah, Saudi Arabia; [Kinney, Adam R.] Rocky Mt Mental Illness Res, Dept Vet Affairs, Educ & Clin Ctr, Aurora, CO USA; [Kinney, Adam R.] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Malcolm, Matt P.] Colorado State Univ, Colorado Sch Publ Hlth, Ft Collins, CO 80523 USA		Malcolm, MP (corresponding author), Colorado State Univ, Dept Occupat Therapy, 200 Occupational Therapy Bldg, Ft Collins, CO 80523 USA.	matt.malcolm@colostate.edu		Bukhari, Rayyan/0000-0002-6529-3081	Colorado State University	We thank the health services research team at Colorado State University for their support, useful discussions, and comments on the manuscript.	Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brown AW, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104746; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Centers for Medicare & Medicaid Services (CMS), 2019, FIS YEAR 2021 HOSP I; Centers for Medicare & Medicaid Services (CMS), 2019, MED CLAIMS PROC MAN; Department of Health and Human Service, 2019, FED REGISTER, V84, P51836; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gosseries O, 2011, FRONT COLLECT, P29, DOI 10.1007/978-3-642-18047-7_2; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Jacobs E, 2006, MILBANK Q, V84, P111, DOI 10.1111/j.1468-0009.2006.00440.x; Jette DU, 2015, PHYS THER, V95, P758, DOI 10.2522/ptj.20140174; Jette DU, 2014, PHYS THER, V94, P1252, DOI 10.2522/ptj.20130359; Jette DU, 2014, PHYS THER, V94, P379, DOI 10.2522/ptj.20130199; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Kanchan A, 2018, INDIAN J PSYCHIAT, V60, P38, DOI 10.4103/psychiatry.IndianJPsychiatry_118_17; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lo J, 2021, ARCH PHYS MED REHAB, V102, P115, DOI 10.1016/j.apmr.2020.04.001; MacKinnon DP, 2007, CLIN TRIALS, V4, P499, DOI 10.1177/1740774507083434; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Moore BJ, 2017, MED CARE, V55, P698, DOI 10.1097/MLR.0000000000000735; Muthen LK, 1998, MPLUS USERS GUIDE, V8th; O'Brien SR, 2018, ARCH PHYS MED REHAB, V99, P107, DOI 10.1016/j.apmr.2017.07.012; Oyesanya TO, 2020, BRAIN INJURY, V34, P1222, DOI 10.1080/02699052.2020.1797172; Pritchard KT, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2018.732002; Rodakowski J, 2017, J AM GERIATR SOC, V65, P1748, DOI 10.1111/jgs.14873; Saposnik G, 2008, STROKE, V39, P3360, DOI 10.1161/STROKEAHA.108.521344; Sorensen M, 2020, PATIENT SAF SURG, V14, DOI 10.1186/s13037-019-0227-z; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Van Baalen B, 2008, BRAIN INJURY, V22, P25, DOI 10.1080/02699050701810662; Waehrens Eva Ejlersen, 2007, Scand J Occup Ther, V14, P250, DOI 10.1080/11038120601182974; Wasey J. O., 2019, ICD COMORBIDITY CALC; Werner RM, 2019, JAMA INTERN MED, V179, P617, DOI 10.1001/jamainternmed.2018.7998; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Zarshenas S, 2020, PM&R, V12, P339, DOI 10.1002/pmrj.12260; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403	35	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care												10.1080/07380577.2021.2018752		DEC 2021	17	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	XU5LZ	WOS:000734307400001	34955087				2022-02-06	
J	Byard, K; Gosling, AS; Tucker, P; Richmond, J; Ashton, R; Pickering, A; Charles, F; Fine, H; Reed, J				Byard, Katie; Gosling, A. Sophie; Tucker, Peter; Richmond, Josephine; Ashton, Rebecca; Pickering, Andrea; Charles, Florence; Fine, Howard; Reed, Jonathan			Reflections on the physical, executive developmental and systems applied framework in child neuropsychological rehabilitation	CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article; Early Access						Children; brain injury; neuropsychological; rehabilitation	TRAUMATIC BRAIN-INJURY; BEHAVIORAL INTERVENTIONS; PSYCHOSOCIAL OUTCOMES; PRELIMINARY EFFICACY; YOUNG-CHILDREN; PLASTICITY; TBI; RECOVERY	This paper describes the influence of the Physical, Executive, Developmental and Systems (PEDS) framework on the delivery of community-based child neuropsychological rehabilitation and how it has been enhanced by the proliferation of neuroscientific, neuropsychological and psychosocial research and evidence-base in childhood brain injury and rehabilitation over the past decade. The paper signposts to some of the key models, theories and concepts currently shaping service delivery. Application of the PEDS framework in a clinical case is described.	[Byard, Katie; Gosling, A. Sophie; Tucker, Peter; Pickering, Andrea; Fine, Howard; Reed, Jonathan] Recolo UK Ltd, Dept Clin Psychol, 10 Harley St, London W1G 9PF, England; [Richmond, Josephine; Ashton, Rebecca; Charles, Florence] Recolo UK Ltd, Dept Educ Psychol, London, England		Byard, K (corresponding author), Recolo UK Ltd, Dept Clin Psychol, 10 Harley St, London W1G 9PF, England.	katie.byard@recolo.co.uk					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2001, DEV NEUROPSYCHOL; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Ashton R., 2015, NEUROPSYCHOLOGICAL R, P237; Astle DE, 2015, J NEUROSCI, V35, P6277, DOI 10.1523/JNEUROSCI.4517-14.2015; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Barkham M, 2003, CLIN PSYCHOL PSYCHOT, V10, P319, DOI 10.1002/cpp.379; Battista C, 2018, NPJ SCI LEARN, V3, DOI 10.1038/s41539-017-0017-2; Bennett E., 2021, NEUROPSYCHOLOGIST, P21; Blakemore, 2018, INVENTING OURSELVES; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Byard K., 2015, NEUROPSYCHOLOGICAL R, P173, DOI [10.1057/9781137388223_9, DOI 10.1057/9781137388223_9]; Byard K., 2019, PSYCHOL THERAPY ACQU, P43; Byard Katie, 2011, Clin Child Psychol Psychiatry, V16, P165, DOI 10.1177/1359104511403582; Camm S, 2021, NEUROPSYCHOL REHABIL, V31, P621, DOI 10.1080/09602011.2020.1722714; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Gilmore JH, 2018, NAT REV NEUROSCI, V19, P123, DOI 10.1038/nrn.2018.1; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI [DOI 10.4236/OJTR.2015.32007, 10.4236/ojtr.2015.32007]; Hendry LB., 2002, LIFESPAN DEV RESOURC; Jim J., 2019, PSYCHOL THERAPY PAED; Johnson MH, 2011, DEV COGN NEUROS-NETH, V1, P7, DOI 10.1016/j.dcn.2010.07.003; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Law D, 2018, WORKING GOALS PSYCHO; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McPherson K.M., 2017, REHABILITATION GOAL, P105; Pearson-Fuhrhop KM, 2012, CURR OPIN NEUROL, V25, P682, DOI 10.1097/WCO.0b013e32835a360a; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Reed J., 2008, CHILD NEUROPSYCHOL; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Stark D., 2019, PSYCHOL THERAPY ACQU, P27, DOI [10.4324/9780429296932-3, DOI 10.4324/9780429296932-3]; Tate RL, 2019, BRAIN IMPAIR, V20, P276, DOI 10.1017/BrImp.2019.28; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tucker P., 2015, NEUROPSYCHOLOGICAL R, P151, DOI [10.1057/9781137388223_8, DOI 10.1057/9781137388223_8]; Tucker P., 2020, TELEREHABILITATION B; Van Horn JD, 2015, BRAIN IMAGING BEHAV, V9, P1, DOI 10.1007/s11682-015-9365-9; Wade S.L., 2015, NEUROPSYCHOLOGICAL R, P43, DOI [10.1057/9781137388223_3, DOI 10.1057/9781137388223_3]; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Watson S., 2015, NEUROPSYCHOLOGICAL R, P106, DOI [10.1057/9781137388223_6, DOI 10.1057/9781137388223_6]; Watson S., 2019, PSYCHOL THERAPY ACQU, P43, DOI [10.4324/9780429296932-4, DOI 10.4324/9780429296932-4]; World Health Organization, 2001, INT CLASS FUNCT DIS; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	60	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1359-1045	1461-7021		CLIN CHILD PSYCHOL P	Clin. Child Psychol. Psychiatry											13591045211062384	10.1177/13591045211062384		DEC 2021	13	Psychology, Clinical; Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	XW4YN	WOS:000735626800001	34920675				2022-02-06	
J	Goodchild, K; Fleming, J; Copley, JA				Goodchild, Katherine; Fleming, Jennifer; Copley, Jodie A.			Assessments of Functional Cognition Used with Patients following Traumatic Brain Injury in Acute Care: A Survey of Australian Occupational Therapists	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article; Early Access						Cognition; assessment; functional cognition; traumatic brain injury; acute care	EXECUTIVE FUNCTIONS; PERFORMANCE; CLIENTS; ADULTS	This study aimed to describe how occupational therapists working in acute care settings in Australia assess cognitive function in patients with TBI, the influences on assessment choice, and clinician perceptions of performance-based assessment. An online survey was completed by 81 occupational therapists. The most common method of cognitive assessment was reported as non-standardized observation of functional tasks (94.7%), followed by carer-report / self-report (93%). Despite their being positive perceptions of performance-based assessment there was limited use in practice. Assessment use was impacted by practical and organizational constraints including access to assessment resources, time and the built environment in acute care.	[Goodchild, Katherine] STARS Surg Treatment & Rehabil Serv, Occupat Therapy Dept, Brisbane, Qld, Australia; [Goodchild, Katherine; Fleming, Jennifer; Copley, Jodie A.] Univ Queensland, Sch Hlth & Rehabil Sci, Occupat Therapy, Brisbane, Qld, Australia		Goodchild, K (corresponding author), Surg Treatment & Rehabil Serv, Brisbane, Qld, Australia.	katherine.goodchild@health.qld.gov.au	; Copley, Jodie/D-9668-2015	Goodchild, Katherine/0000-0003-0556-0958; Fleming, Jennifer/0000-0002-5603-2410; Copley, Jodie/0000-0001-8373-5990	Royal Brisbane and Women's Hospital Foundation	This work was supported by the Royal Brisbane and Women's Hospital Foundation.	Al-Heizan MO, 2020, NEUROPSYCHOL REHABIL, V30, P961, DOI 10.1080/09602011.2018.1531767; Alotaibi NM, 2009, OCCUP THER HEALTH CA, V23, P302, DOI 10.3109/07380570903222583; Asaba E, 2017, OCCUP THER INT, DOI 10.1155/2017/7602805; Bottari C, 2011, OTJR-OCCUP PART HEAL, V31, pS61, DOI 10.3928/15394492-20101108-10; Bottari C, 2009, BRAIN INJURY, V23, P322, DOI 10.1080/02699050902788436; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cooke Deirdre M, 2006, Scand J Occup Ther, V13, P49, DOI 10.1080/11038120500363014; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Douglas Alison, 2007, Can J Occup Ther, V74, P370; Edlin K., 2018, NZ J OCCUPATIONAL TH, V65, P4; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fisher A.G, 1995, ASSESSMENT MOTOR PRO; Fisher AG, 2013, SCAND J OCCUP THER, V20, P162, DOI 10.3109/11038128.2012.754492; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Giles G.M., 2019, FUNCTIONAL COGNITION, V1st, P31; Giles GM, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.715001; Giles GM, 2010, AM J OCCUP THER, V64, P182, DOI 10.5014/ajot.64.1.182; Grieve J.I, 2013, NEUROPSYCHOLOGY OCCU; Holmqvist K, 2014, BRAIN INJURY, V28, P1365, DOI 10.3109/02699052.2014.919529; Jaywant A, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1810710; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jung MA, 2013, ANN REHABIL MED-ARM, V37, P57, DOI 10.5535/arm.2013.37.1.57; Kiernan R.J., 1995, COGNISTAT THE NEUROB; Law M, 1990, Can J Occup Ther, V57, P82; Manee FS, 2020, OCCUP THER INT, V2020, DOI 10.1155/2020/8914372; Morrison MT, 2015, AM J OCCUP THER, V69, P117, DOI 10.5014/ajot.2015.011528; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nielsen LM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0376-1; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Poncet F, 2017, NEUROPSYCHOL REHABIL, V27, P618, DOI 10.1080/09602011.2016.1268171; Pye Victoria, 2016, BMC Res Notes, V9, P90, DOI 10.1186/s13104-016-1893-x; Rotenberg S., 2019, FUNCTIONAL COGNITION, P39; Sansonetti D, 2013, AUST OCCUP THER J, V60, P334, DOI 10.1111/1440-1630.12069; Skidmore ER, 2017, AM J GERIAT PSYCHIAT, V25, P483, DOI 10.1016/j.jagp.2016.12.020; Stigen L, 2018, SCAND J OCCUP THER, V25, P88, DOI 10.1080/11038128.2016.1272633; Tan-Rapues C, 2018, NZ J OCCUPATIONAL TH, V65, P28; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Wesson J., 2019, FUNCTIONAL COGNITION, P7; Wesson J, 2016, NEUROSCI BIOBEHAV R, V68, P335, DOI 10.1016/j.neubiorev.2016.05.024; Wolf TJ, 2009, AM J OCCUP THER, V63, P621, DOI 10.5014/ajot.63.5.621	41	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care												10.1080/07380577.2021.2020389		DEC 2021	19	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	XY2SC	WOS:000736827800001	34971350				2022-02-06	
J	Huang, XJ; Su, GJ; Wu, CW; Sha, XS; Zou, JF; Liu, XS; Li, M; He, Y				Huang, Xian-jian; Su, Gao-jian; Wu, Chu-wei; Sha, Xiao-song; Zou, Jun-feng; Liu, Xian-sheng; Li, Min; He, Yun			Knockdown of rno_circRNA_009194 Improves Outcomes in Traumatic Brain Injury Rats through Inhibiting Voltage-Gated Sodium Channel Nav1.3	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						circRNA_009194; circRNA microarray; miR-145-3p; Nav1; 3; Sp1; traumatic brain injury	GENE-TRANSFER; UP-REGULATION; EXPRESSION; NEURONS; HOMER1B/C; ISCHEMIA; NA(V)1.3; DEFICITS; NOMENCLATURE; LENTIVIRUS	Excessive activation of voltage-gated sodium channel Nav1.3 has been recently reported in secondary traumatic brain injury (TBI). However, the molecular mechanisms underlying regulating voltage-gated sodium channel (Nav1.3) have not been well understood. The present study used a TBI rat model induced by a fluid percussion device and performed a circular RNA (circRNA) microarray (n = 3) to profile the altered circRNAs in the hippocampus after TBI. After polymerase chain reaction (PCR) validation, certain circRNAs were selected to investigate the function and mechanism in regulating Nav1.3 in the TBI rat model by intracerebroventricular injection with lentivirus. The neurological outcome was evaluated by Morris water maze test, modified Neurological Severity Score (mNSS), brain water content measurement, and hematoxylin and eosin staining. The related molecular mechanisms were explored with PCR, Western blotting, luciferase reporter, chromatin immunoprecipitation assay, and electrophoretic mobility shift assay (EMSA). A total of 347 circRNAs were observed to be differentially expressed (fold change [FC] >= 1.2 and p < 0.05) after TBI, including 234 up-regulated and 113 down-regulated circRNAs. Among 10 validated circRNAs, we selected circRNA_009194 with the maximized up-regulated fold change (n = 5, FC = 4.45, p < 0.001) for the in vivo functional experiments. Down-regulation of circRNA_009194 resulted in a 27.5% reduced mNSS in rat brain (n = 6, p < 0.01) after TBI and regulated the expression levels of miR-145-3p, Sp1, and Nav1.3, which was reversed by sh-miR-145-3p or Sp1/Nav1.3 overexpression (n = 5, p < 0.05). Mechanistically, circRNA_009194 might act as a sponge for miR-145-3p to regulate Sp1-mediated Nav1.3. This study demonstrated that circRNA_009194 knockdown could improve neurological outcomes in TBI in vivo by inhibiting Nav1.3, directly or indirectly.	[Huang, Xian-jian; Su, Gao-jian; Wu, Chu-wei; Sha, Xiao-song; Zou, Jun-feng; Liu, Xian-sheng] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg,Shenzhen Key Lab Neurosurg, Shenzhen, Guangdong, Peoples R China; [Li, Min] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Radiol, Shenzhen, Guangdong, Peoples R China; [He, Yun] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Intens Care Unit, Shenzhen, Guangdong, Peoples R China		Huang, XJ (corresponding author), 3002 Sungang Rd, Shenzhen 518035, Peoples R China.	xjhuang@email.szu.edu.cn			national natural science foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301062]; Shenzhen Science and Technology Program [JCYJ20180228163034627]; Shenzhen Double Chain Grant [[2018]256]; Shenzhen Key Laboratory of Neurosurgery	This project was supported by the national natural science foundation of China (81301062), Shenzhen Science and Technology Program ( JCYJ20180228163034627), Shenzhen Double Chain Grant [2018]256, and Shenzhen Key Laboratory of Neurosurgery.	Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cui ZM, 2015, NEUROCHEM RES, V40, P204, DOI 10.1007/s11064-014-1460-6; Ehrengruber MU, 2001, MOL CELL NEUROSCI, V17, P855, DOI 10.1006/mcne.2001.0982; Estacion M, 2010, EXP NEUROL, V224, P362, DOI 10.1016/j.expneurol.2010.04.012; Gamberini L, 2019, J EMERG MED, V56, P657, DOI 10.1016/j.jemermed.2019.02.005; Gerstein H, 2013, NEUROBIOL AGING, V34, P1963, DOI 10.1016/j.neurobiolaging.2013.02.006; Gimse K, 2018, NEUROBIOL LEARN MEM, V156, P17, DOI 10.1016/j.nlm.2018.10.005; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Guo F, 2008, BRAIN RES BULL, V75, P179, DOI 10.1016/j.brainresbull.2007.10.005; Hains BC, 2005, BRAIN, V128, P2359, DOI 10.1093/brain/awh623; Hains BC, 2003, J NEUROSCI, V23, P8881; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Holland KD, 2008, NEUROSCI LETT, V433, P65, DOI 10.1016/j.neulet.2007.12.064; House CD, 2010, CANCER RES, V70, P6957, DOI 10.1158/0008-5472.CAN-10-1169; Huang WD, 2012, NEURAL REGEN RES, V7, P2176, DOI 10.3969/j.issn.1673-5374.2012.028.002; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kammermeier PJ, 2008, J NEUROSCI, V28, P8560, DOI 10.1523/JNEUROSCI.1830-08.2008; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Li MX, 2019, PROG NEURO-PSYCHOPH, V95, DOI 10.1016/j.pnpbp.2019.109682; Li XB, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0976-0; Liu CZ, 2006, EXP NEUROL, V201, P452, DOI 10.1016/j.expneurol.2006.04.025; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Liu Y, 2021, J CELL BIOCHEM, V122, P1252, DOI 10.1002/jcb.29568; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rong DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0958-6; Rong ZH, 2019, MOL THER-NUCL ACIDS, V18, P999, DOI 10.1016/j.omtn.2019.10.023; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Siqueira SRDT, 2009, NEUROSCIENCE, V164, P573, DOI 10.1016/j.neuroscience.2009.08.037; Suy Simeng, 2012, J Clin Exp Oncol, V1, DOI 10.4172/2324-9110.1000102; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Wix-Ramos R, 2011, CAN J PHYSIOL PHARM, V89, P753, DOI [10.1139/y11-073, 10.1139/Y11-073]; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Xiao T, 2018, METALLOMICS, V10, P1328, DOI 10.1039/c8mt00207j; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xie R, 2021, J NEURORESTORATOLOGY, V9, P60, DOI 10.26599/JNR.2021.9040001; Xu LL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1041-2; Yang Y, 2020, J NEURORESTORATOLOGY, V8, P270, DOI 10.26599/JNR.2020.9040025; Zhao JW, 2019, PEERJ, V7, DOI 10.7717/peerj.8324; Zheng Y, 2020, BIOCHEM CELL BIOL, V98, P396, DOI 10.1139/bcb-2019-0211; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033	54	0	0	6	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7520		DEC 2021	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS5SR	WOS:000732969000001	34726508				2022-02-06	
J	Ko, J; Park, U; Kim, D; Kang, SW				Ko, Juhee; Park, Ukeob; Kim, Daekeun; Kang, Seung Wan			Quantitative Electroencephalogram Standardization: A Sex- and Age-Differentiated Normative Database	FRONTIERS IN NEUROSCIENCE			English	Article						QEEG; standardization; age; sex; normative; database; brain disease	TRAUMATIC BRAIN-INJURY; EEG THETA/BETA RATIO; ALPHA ASYMMETRY; MATURATION; SYMPTOMS; DISEASE; REGION; POWER; ADHD	We describe the utility of a standardized index (Z-score) in quantitative EEG (QEEG) capable of when referenced to a resting-state, sex- and age-differentiated QEEG normative database (ISB-NormDB). Our ISB-NormDB comprises data for 1,289 subjects (553 males, 736 females) ages 4.5 to 81 years that met strict normative data criteria. A de-noising process allowed stratification based on QEEG variability between normal healthy men and women at various age ranges. The ISB-NormDB data set that is stratified by sex provides a unique, highly accurate ISB-NormDB model (ISB-NormDB: ISB-NormDB-Male, ISB-NormDB-Female). To evaluate the trends and accuracy of the ISB-NormDB, we used actual data to compare Z-scores obtained through the ISB-NormDB with those obtained through a traditional QEEG normative database to confirm that basic trends are maintained in most bands and are sensitive to abnormal test data. Finally, we demonstrate the value of our standardized index of QEEG, and highlight it's capacity to minimize the confounding variables of sex and age in any analysis.	[Ko, Juhee; Park, Ukeob; Kim, Daekeun; Kang, Seung Wan] iMedi Sync Inc, Seoul, South Korea; [Kang, Seung Wan] Seoul Natl Univ, Natl Stand Reference Data Ctr Korean EEG, Coll Nursing, Seoul, South Korea		Kang, SW (corresponding author), iMedi Sync Inc, Seoul, South Korea.; Kang, SW (corresponding author), Seoul Natl Univ, Natl Stand Reference Data Ctr Korean EEG, Coll Nursing, Seoul, South Korea.	drdemian@snu.ac.kr			Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea) [20003641]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [S2799665]	This work was supported by the Technology Innovation Program (Grant No. 20003641, Development and Dissemination on National Standard Reference Data) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea), and this study was supported by a grant from Korea's Ministry of SMEs and Startups (MSS) (Grant No. S2799665).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angelidis A, 2016, BIOL PSYCHOL, V121, P49, DOI 10.1016/j.biopsycho.2016.09.008; Arikan MK, 2019, J AFFECT DISORDERS, V254, P1, DOI 10.1016/j.jad.2019.05.007; Arns M, 2016, CLIN NEUROPHYSIOL, V127, P509, DOI 10.1016/j.clinph.2015.05.032; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Arns Martijn, 2008, Journal of Integrative Neuroscience, V7, P421, DOI 10.1142/S0219635208001897; Baik K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84243-4; Barry RJ, 2017, BIOL PSYCHOL, V129, P293, DOI 10.1016/j.biopsycho.2017.09.010; Bennett CN, 2018, CLIN EEG NEUROSCI, V49, P433, DOI 10.1177/1550059417744899; Bentes C, 2018, CLIN NEUROPHYSIOL, V129, P1680, DOI 10.1016/j.clinph.2018.05.021; Bian ZJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00011; Brown J, 2019, J AGGRESS MALTREAT T, V28, P764, DOI 10.1080/10926771.2019.1603176; Cantor D.S., 1999, INTRO QUANTITATIVE E, P3, DOI [10.1016/b978-012243790-8/50002-x, DOI 10.1016/B978-012243790-8/50002-X]; Faridi F., 2021, NR, V8, P121, DOI [10.15540/nr.8.2.121, DOI 10.15540/NR.8.2.121]; Gartstein MA, 2020, DEVELOPMENTAL SCI, V23, DOI 10.1111/desc.12891; Gray SN, 2017, MED ACUPUNCT, V29, P215, DOI 10.1089/acu.2017.1220; Gupta R., 2020, NR, V7, P75, DOI [10.15540/nr.7.2.75, DOI 10.15540/NR.7.2.75]; Hastie TJ, 1990, GEN ADDITIVE MODELS; He XT, 2017, INT J NEUROSCI, V127, P66, DOI 10.3109/00207454.2016.1143823; Hermens DF, 2005, CLIN NEUROPHYSIOL, V116, P1455, DOI 10.1016/j.clinph.2005.02.012; Kaiser AK, 2018, NEUROPSYCH DIS TREAT, V14, P1493, DOI 10.2147/NDT.S137776; Karlsgodt KH, 2015, HUM BRAIN MAPP, V36, P4954, DOI 10.1002/hbm.22989; Keizer AW, 2021, CLIN EEG NEUROSCI, V52, P82, DOI 10.1177/1550059419874945; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Popa LL, 2021, CLIN EEG NEUROSCI, V52, P201, DOI 10.1177/1550059420971122; MATTHIS P, 1980, ELECTROEN CLIN NEURO, V49, P626, DOI 10.1016/0013-4694(80)90403-4; Medici D., 2018, AJAP, V7, P57, DOI [10.11648/j.ajap.20180705.11, DOI 10.11648/J.AJAP.20180705.11]; Musaeus CS, 2018, J ALZHEIMERS DIS, V64, P1359, DOI 10.3233/JAD-180300; Pavlenko VB, 2009, NEUROPHYSIOLOGY+, V41, P337, DOI 10.1007/s11062-010-9111-2; Ribas Valdenilson Ribeiro, 2018, Dement. neuropsychol., V12, P264, DOI 10.1590/1980-57642018dn12-030007; Rice GM, 2019, AEROSP MED HUM PERF, V90, P369, DOI 10.3357/AMHP.5227.2019; Robertson MM, 2019, J NEUROPHYSIOL, V122, P2427, DOI 10.1152/jn.00388.2019; Roh JH, 2011, CLIN NEUROPHYSIOL, V122, P2169, DOI 10.1016/j.clinph.2011.03.023; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Snyder SM, 2006, J CLIN NEUROPHYSIOL, V23, P440, DOI 10.1097/01.wnp.0000221363.12503.78; Snyder SM, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.330; Tarrant J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01280; Tedrus GM, 2019, CLIN EEG NEUROSCI, V50, P348, DOI 10.1177/1550059418793553; Tement S, 2016, BIOL PSYCHOL, V114, P1, DOI 10.1016/j.biopsycho.2015.11.005; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher R.W., 1998, DATABASES NEUROTHER, V2, P8, DOI [10.1300/j184v02n04_02, DOI 10.1300/J184V02N04_02]; Tomescu MI, 2018, DEV COGN NEUROS-NETH, V31, P58, DOI 10.1016/j.dcn.2018.04.011; Valdes-Sosa PA, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00829-7; Wakefield JC, 2016, ANNU REV CLIN PSYCHO, V12, P105, DOI 10.1146/annurev-clinpsy-032814-112800; Wolf H, 2003, ACTA NEUROL SCAND, V107, P52, DOI 10.1034/j.1600-0404.107.s179.10.x	46	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 17	2021	15								766781	10.3389/fnins.2021.766781			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YB2JE	WOS:000738844500001	34975376	gold, Green Published			2022-02-06	
J	Kroshus, E; Lowry, SJ; Garrett, K; Hays, R; Hunt, T; Chrisman, SPD				Kroshus, Emily; Lowry, Sarah J.; Garrett, Kimberly; Hays, Rachel; Hunt, Tamerah; Chrisman, Sara P. D.			Development of a scale to measure expected concussion reporting behavior	INJURY EPIDEMIOLOGY			English	Article						Concussion; Expected behavior; Measure development	DECISION-MAKING; SPORT; DISCLOSURE; RECOMMENDATIONS; INTENTIONS; MODEL	Background Most concussion education aims to increase athlete self-report of concussive symptoms. Although the population burden of concussion is high, frequency with which this injury occurs on a given sports team in a given season is relatively low. This means that powering concussion education evaluation studies to measure change in post-injury symptom reporting behavior requires what is often a prohibitively large sample size. Thus, evaluation studies are typically powered to measure proximal cognitions. Expected reporting behavior, a cognition that reflects planned and reactive decision-making, is a theoretically indicated construct for inclusion in evaluation studies. However, previously no scales were available to measure this construct with demonstrated reliability and validity among youth athletes. The objective of this study was to develop and assess the validity of a brief single-factor scale to measure expected youth athlete concussion reporting behavior (CR-E) in a sample of youth athletes. Methods A mixed methods approach was used, including cognitive interviews with youth athletes, and quantitative item reduction and validation. Participants were youth athletes (aged 9-16) from the Seattle metropolitan and rural south-Georgia regions. After refining an initial pool of items using cognitive interviews with a diverse group of youth athletes (n = 20), a survey containing these items was administered to youth soccer and football players (n = 291). Item reduction statistics and sequential confirmatory factor analyses were used to reduce the initial scale using a randomly selected half of the sample. Then, a final confirmatory factor analysis and validation tests were applied to the other half of the sample of youth athletes. Predictive validation was conducted longitudinally in a separate sample of youth athletes (n = 155). Results Internal consistency was high (alpha = 0.89), model fit was excellent, validation tests were in the hypothesized directions, and the scale was feasible to use. Using the finalized 4-item scale, we observed that less than one-third of youth soccer and football athletes expect to "always" tell their coach about symptoms of a suspected concussion. Conclusions The CR-E measure should be included in future studies evaluating concussion education programming in youth athlete populations.	[Kroshus, Emily; Lowry, Sarah J.; Garrett, Kimberly; Chrisman, Sara P. D.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, 1920 Terry Ave, Seattle, WA 98101 USA; [Hunt, Tamerah] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, POB 8076, Statesboro, GA 30460 USA; [Kroshus, Emily; Chrisman, Sara P. D.] Univ Washington, Dept Pediat, 6200 NE 74th St,Ste 110, Seattle, WA 98115 USA		Kroshus, E (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, 1920 Terry Ave, Seattle, WA 98101 USA.; Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 6200 NE 74th St,Ste 110, Seattle, WA 98115 USA.	ekroshus@uw.edu		Kroshus, Emily/0000-0002-7484-2601	Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) [U01CE002880]	This study was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) through cooperative funding agreement U01CE002880. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Boateng GO, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00149; Brown T., 2019, J SPORT BEHAV, V42, P19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cabrera-Nguyen P., 2010, J SOC SOC WORK RES, V1, P99, DOI [10.5243/jsswr.2010.8, DOI 10.5243/JSSWR.2010.8]; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Cranmer GA, 2018, INT J SPORT COMMUN, V11, P241, DOI 10.1123/ijsc.2017-0120; Desai AD, 2018, HEALTH SERV RES, V53, P3084, DOI 10.1111/1475-6773.12864; DeVellis R.F, 2016, SCALE DEV THEORY APP; Farrell AD, 2000, PSYCHOL ASSESSMENT, V12, P394, DOI 10.1037//1040-3590.12.4.394; Gerrard M, 2008, DEV REV, V28, P29, DOI 10.1016/j.dr.2007.10.001; Hodge K, 2011, J SPORT EXERCISE PSY, V33, P527, DOI 10.1123/jsep.33.4.527; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Knafl K, 2007, RES NURS HEALTH, V30, P224, DOI 10.1002/nur.20195; Kneavel ME, 2020, J ATHL TRAINING, V55, P456, DOI 10.4085/1062-6050-0182.19; Kroshus E, 2020, BRIT J SPORT MED, V54, P1314, DOI 10.1136/bjsports-2020-102185; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Morgado FFR, 2017, PSICOL-REFLEX CRIT, V30, P1, DOI 10.1186/s41155-016-0057-1; O'Connor S, 2020, PHYSICIAN SPORTSMED, V48, P186, DOI 10.1080/00913847.2019.1671141; Pennock KF, 2020, INT REV SPORT EXER P, DOI 10.1080/1750984X.2020.1824243; Rawlins Michelle L Weber, 2020, J Clin Transl Res, V5, P186; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Urdan T., 2006, SELF EFFICACY BELIEF; WARSHAW PR, 1985, J EXP SOC PSYCHOL, V21, P213, DOI 10.1016/0022-1031(85)90017-4; Wayment HA, 2020, HEALTH EDUC BEHAV, V47, P91, DOI 10.1177/1090198119879216; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127	41	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	DEC 17	2021	8	1							70	10.1186/s40621-021-00364-4			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XQ0LN	WOS:000731247000001	34920752	Green Published, gold			2022-02-06	
J	Sundaramurthy, A; Kote, VB; Pearson, N; Boiczyk, GM; McNeil, EM; Nelson, AJ; Subramaniam, DR; Rubio, JE; Monson, K; Hardy, WN; VandeVord, PJ; Unnikrishnan, G; Reifman, J				Sundaramurthy, Aravind; Kote, Vivek Bhaskar; Pearson, Noah; Boiczyk, Gregory M.; McNeil, Elizabeth M.; Nelson, Allison J.; Subramaniam, Dhananjay Radhakrishnan; Rubio, Jose E.; Monson, Kenneth; Hardy, Warren N.; VandeVord, Pamela J.; Unnikrishnan, Ginu; Reifman, Jaques			A 3-D Finite-Element Minipig Model to Assess Brain Biomechanical Responses to Blast Exposure	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						blast-induced traumatic brain injury; vasculature; brain biomechanical responses; shock tube; blast exposure; finite-element model	HEAD; PIG	Despite years of research, it is still unknown whether the interaction of explosion-induced blast waves with the head causes injury to the human brain. One way to fill this gap is to use animal models to establish "scaling laws" that project observed brain injuries in animals to humans. This requires laboratory experiments and high-fidelity mathematical models of the animal head to establish correlates between experimentally observed blast-induced brain injuries and model-predicted biomechanical responses. To this end, we performed laboratory experiments on Gottingen minipigs to develop and validate a three-dimensional (3-D) high-fidelity finite-element (FE) model of the minipig head. First, we performed laboratory experiments on Gottingen minipigs to obtain the geometry of the cerebral vasculature network and to characterize brain-tissue and vasculature material properties in response to high strain rates typical of blast exposures. Next, we used the detailed cerebral vasculature information and species-specific brain tissue and vasculature material properties to develop the 3-D high-fidelity FE model of the minipig head. Then, to validate the model predictions, we performed laboratory shock-tube experiments, where we exposed Gottingen minipigs to a blast overpressure of 210 kPa in a laboratory shock tube and compared brain pressures at two locations. We observed a good agreement between the model-predicted pressures and the experimental measurements, with differences in maximum pressure of less than 6%. Finally, to evaluate the influence of the cerebral vascular network on the biomechanical predictions, we performed simulations where we compared results of FE models with and without the vasculature. As expected, incorporation of the vasculature decreased brain strain but did not affect the predictions of brain pressure. However, we observed that inclusion of the cerebral vasculature in the model changed the strain distribution by as much as 100% in regions near the interface between the vasculature and the brain tissue, suggesting that the vasculature does not merely decrease the strain but causes drastic redistributions. This work will help establish correlates between observed brain injuries and predicted biomechanical responses in minipigs and facilitate the creation of scaling laws to infer potential injuries in the human brain due to exposure to blast waves.	[Sundaramurthy, Aravind; Kote, Vivek Bhaskar; Subramaniam, Dhananjay Radhakrishnan; Rubio, Jose E.; Unnikrishnan, Ginu; Reifman, Jaques] United States Army Med Res & Dev Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 20315 USA; [Sundaramurthy, Aravind; Kote, Vivek Bhaskar; Subramaniam, Dhananjay Radhakrishnan; Rubio, Jose E.; Unnikrishnan, Ginu] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Pearson, Noah; Monson, Kenneth] Univ Utah, Dept Mech Engn, Salt Lake City, UT USA; [Boiczyk, Gregory M.; Monson, Kenneth] Univ Utah, Dept Biomed Engn, Salt Lake City, UT USA; [McNeil, Elizabeth M.; Nelson, Allison J.; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Nelson, Allison J.; Hardy, Warren N.; VandeVord, Pamela J.] Virginia Tech, Ctr Injury Biomech, Blacksburg, VA USA		Reifman, J (corresponding author), United States Army Med Res & Dev Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 20315 USA.	jaques.reifman.civ@mail.mil		McNeil, Elizabeth/0000-0003-3439-3722	U.S. Army Medical Research and Development Command [W81XWH20C0031]	& nbsp;This work was supported by the U.S. Army Medical Research and Development Command under Contract No. W81XWH20C0031.	Alexander SL, 2019, J MECH BEHAV BIOMED, V96, P96, DOI 10.1016/j.jmbbm.2019.04.010; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell ED, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039625; Bryden DW, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519872213; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Kalra A, 2017, SHOCK WAVES, V27, P947, DOI 10.1007/s00193-017-0760-6; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Pierrat B, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00801; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; Subramaniam DR, 2021, BIOMED ENG ONLINE, V20, DOI 10.1186/s12938-021-00847-x; Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11; Unnikrishnan G, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4049889; Unnikrishnan G, 2019, ANN BIOMED ENG, V47, P2033, DOI 10.1007/s10439-019-02277-2; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Wu TT, 2021, J NEUROTRAUM, V38, P1879, DOI 10.1089/neu.2020.7445; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	26	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	DEC 17	2021	9								757755	10.3389/fbioe.2021.757755			15	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	YB2IO	WOS:000738842900001	34976963	Green Published, gold			2022-02-06	
J	Bohm, JK; Schaeben, V; Schafer, N; Guting, H; Lefering, R; Thorn, S; Schochl, H; Zipperle, J; Grottke, O; Rossaint, R; Stanworth, S; Curry, N; Maegele, M				Boehm, Julia K.; Schaeben, Victoria; Schaefer, Nadine; Gueting, Helge; Lefering, Rolf; Thorn, Sophie; Schoechl, Herbert; Zipperle, Johannes; Grottke, Oliver; Rossaint, Rolf; Stanworth, Simon; Curry, Nicola; Maegele, Marc		CENTER-TBI Participants Investigat	Extended Coagulation Profiling in Isolated Traumatic Brain Injury: A CENTER-TBI Analysis	NEUROCRITICAL CARE			English	Article; Early Access						CENTER-TBI; Coagulopathy; Fibrin monomers; Progressive intracranial hemorrhage; Thrombin generation; Traumatic brain injury	THROMBIN ACTIVATABLE FIBRINOLYSIS; HEMORRHAGIC PROGRESSION; COAGULOPATHY; HYPOPERFUSION; INHIBITOR; PATHWAYS; CARE	Background Trauma-induced coagulopathy in traumatic brain injury (TBI) remains associated with high rates of complications, unfavorable outcomes, and mortality. The underlying mechanisms are largely unknown. Embedded in the prospective multinational Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, coagulation profiles beyond standard conventional coagulation assays were assessed in patients with isolated TBI within the very early hours of injury. Methods Results from blood samples (citrate/EDTA) obtained on hospital admission were matched with clinical and routine laboratory data of patients with TBI captured in the CENTER-TBI central database. To minimize confounding factors, patients with strictly isolated TBI (iTBI) (n = 88) were selected and stratified for coagulopathy by routine international normalized ratio (INR): (1) INR < 1.2 and (2) INR >= 1.2. An INR > 1.2 has been well adopted over time as a threshold to define trauma-related coagulopathy in general trauma populations. The following parameters were evaluated: quick's value, activated partial thromboplastin time, fibrinogen, thrombin time, antithrombin, coagulation factor activity of factors V, VIII, IX, and XIII, protein C and S, plasminogen, D-dimer, fibrinolysis-regulating parameters (thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor 1, antiplasmin), thrombin generation, and fibrin monomers. Results Patients with iTBI with INR >= 1.2 (n = 16) had a high incidence of progressive intracranial hemorrhage associated with increased mortality and unfavorable outcome compared with patients with INR < 1.2 (n = 72). Activity of coagulation factors V, VIII, IX, and XIII dropped on average by 15-20% between the groups whereas protein C and S levels dropped by 20%. With an elevated INR, thrombin generation decreased, as reflected by lower peak height and endogenous thrombin potential (ETP), whereas the amount of fibrin monomers increased. Plasminogen activity significantly decreased from 89% in patients with INR < 1.2 to 76% in patients with INR >= 1.2. Moreover, D-dimer levels significantly increased from a mean of 943 mg/L in patients with INR < 1.2 to 1,301 mg/L in patients with INR >= 1.2. Conclusions This more in-depth analysis beyond routine conventional coagulation assays suggests a counterbalanced regulation of coagulation and fibrinolysis in patients with iTBI with hemostatic abnormalities. We observed distinct patterns involving key pathways of the highly complex and dynamic coagulation system that offer windows of opportunity for further research. Whether the changes observed on factor levels may be relevant and explain the worse outcome or the more severe brain injuries by themselves remains speculative.	[Boehm, Julia K.; Schaeben, Victoria; Schaefer, Nadine; Gueting, Helge; Lefering, Rolf; Maegele, Marc] Witten Herdecke Univ, Fac Hlth, Dept Med, Inst Res Operat Med, Ostmerheimer Str 200,Bldg 38, D-51109 Cologne, Germany; [Thorn, Sophie] Alfred Hlth, Emergency & Trauma Ctr, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Schoechl, Herbert] Paracelsus Med Univ, Acad Teaching Hosp, AUVA Trauma Hosp, Dept Anesthesiol & Intens Care, Doktor Franz Rehrl Pl 5, A-5010 Salzburg, Austria; [Schoechl, Herbert; Zipperle, Johannes] AUVA Trauma Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria; [Grottke, Oliver; Rossaint, Rolf] RWTH Aachen Univ Hosp, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Stanworth, Simon] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, NHS Blood & Transplant, Headley Way, Oxford OX3 9DU, England; [Curry, Nicola] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford Haemophilia & Thrombosis Ctr, Old Rd, Oxford OX3 7LE, England; [Curry, Nicola] NIHR BRC Haematol Theme, Old Rd, Oxford OX3 7LE, England; [Maegele, Marc] Witten Herdecke Univ, Cologne Merheim Med Ctr, Dept Traumatol Orthoped Surg & Sports Traumatol, Campus Cologne Merheim,Ostmerheimer Str 200, D-51109 Cologne, Germany		Maegele, M (corresponding author), Witten Herdecke Univ, Fac Hlth, Dept Med, Inst Res Operat Med, Ostmerheimer Str 200,Bldg 38, D-51109 Cologne, Germany.; Maegele, M (corresponding author), Witten Herdecke Univ, Cologne Merheim Med Ctr, Dept Traumatol Orthoped Surg & Sports Traumatol, Campus Cologne Merheim,Ostmerheimer Str 200, D-51109 Cologne, Germany.	Marc.Maegele@t-online.de		Radoi, Andreea/0000-0002-0677-3544	European UnionEuropean Commission [602150]; Hannelore Kohl Foundation [2014014]; Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL. The research described in this article was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant agreement No. 602150 (CENTER-TBI). This research received further financial support for hemostatic analysis from the Hannelore Kohl Foundation under Grant agreement No. 2014014 (TBI study).	Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; Bohm JK, 2021, NEUROCRIT CARE, V35, P184, DOI 10.1007/s12028-020-01151-7; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Esnault P, 2020, NEUROCRIT CARE, V33, P182, DOI 10.1007/s12028-019-00882-6; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Kalgudi S, 2021, NEUROCRIT CARE, V34, P227, DOI 10.1007/s12028-020-01026-x; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Levy JH, 2013, TRANSFUSION, V53, P1120, DOI 10.1111/j.1537-2995.2012.03865.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2020, SEMIN THROMB HEMOST, V46, P155, DOI 10.1055/s-0040-1702178; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Mathieu F, 2020, J NEUROTRAUM, V37, P2069, DOI 10.1089/neu.2019.6911; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Refaai MA, 2018, THROMB HAEMOSTASIS, V118, P1856, DOI 10.1055/s-0038-1673684; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Subedi PP., 2016, J SOC SURG NEPAL, V17, P21, DOI [10.3126/jssn.v17i1.15177, DOI 10.3126/JSSN.V17I1.15177]; Zhang J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011774	28	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01400-3		DEC 2021	15	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XP5DY	WOS:000730887100003	34918214	hybrid			2022-02-06	
J	Erdivanli, B; Ozdemir, A; Sen, A; Mercantepe, T; Kazdal, H; Uydu, HA; Tumkaya, L				Erdivanli, Basar; Ozdemir, Abdullah; Sen, Ahmet; Mercantepe, Tolga; Kazdal, Hizir; Uydu, Huseyin Avni; Tumkaya, Levent			Protective effect of thymoquinone in preventing trauma-related damage: an experimental study	BIOMARKERS			English	Article						Rat; traumatic head injury; thymoquinone; caspase-3; glutathione; Na; K-ATPase; malondialdehyde	BRAIN-INJURY; LIPID-PEROXIDATION; NIGELLA-SATIVA; DEATH; ACTIVATION; ALPHA	Background Secondary injury is a potentially modifiable factor of outcome in traumatic brain injury. This study aimed to investigate thymoquinone's effects on trauma-induced neuronal damage. Methods Eighteen adult female Sprague-Dawley rats were assigned into three groups following ketamine and xylazine anaesthesia (n = 6): Control, Trauma, Trauma + Thymoquinone. First dose of thymoquinone was administered three hours after the trauma. Results The trauma group showed significant oedema, vascular congestion, and ischaemia. Also, caspase-3 activity and malondialdehyde content of brain tissue was significantly increased, and Na,K-ATPase activity and glutathione levels were significantly reduced. Thymoquinone significantly reduced oedema, vascular congestion, ischaemia, and caspase-3 activity compared with the trauma group. While Na,K-ATPase activity and glutathione levels was similar to the Control group, malondialdehyde content was similar to the trauma group. Conclusions This study showed that low dose thymoquinone exhibited a neuroprotective effect following severe traumatic brain injury, if administered within three hours of injury. Similar levels of glutathione and malondialdehyde suggest no antioxidant effect. Significant reduction in oedema and ischaemia in the neuron cells and partially preserved activity of Na,K-ATPase suggest that thymoquinone protects mitochondrial functions and energy levels of the neuronal cells following severe traumatic brain injury.	[Erdivanli, Basar; Ozdemir, Abdullah; Kazdal, Hizir] Recep Tayyip Erdogan Univ, Fac Med, Dept Anesthesiol & Reanimat, SehitlerCaddesi 74, TR-53010 Rize, Turkey; [Sen, Ahmet] Samsun Educ & Training Hosp, Fac Med, Dept Anesthesiol & Reanimat, Samsun, Turkey; [Mercantepe, Tolga; Tumkaya, Levent] Recep Tayyip Erdogan Univ, Fac Med, Dept Histol & Embryol, Rize, Turkey; [Uydu, Huseyin Avni] Recep Tayyip Erdogan Univ, Fac Med, Dept Biochem, Rize, Turkey		Erdivanli, B (corresponding author), Recep Tayyip Erdogan Univ, Fac Med, Dept Anesthesiol & Reanimat, SehitlerCaddesi 74, TR-53010 Rize, Turkey.	basar.erdivanli@erdogan.edu.tr			Scientific Research Projects Committee of Recep Tayyip Erdogan University [TSA-2018-808]	This work was supported by the Scientific Research Projects Committee of Recep Tayyip Erdogan University under [Grant No. TSA-2018-808].	Alarcon JD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009986.pub2; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cortes D, 2021, NPJ REGEN MED, V6, DOI 10.1038/s41536-020-00114-y; Dajani EZ, 2016, J PHYSIOL PHARMACOL, V67, P801; Farkhondeh T, 2018, DOSE-RESPONSE, V16, DOI 10.1177/1559325818761455; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gholamnezhad Z, 2016, J ETHNOPHARMACOL, V190, P372, DOI 10.1016/j.jep.2016.06.061; Giustarini D, 2011, MECH AGEING DEV, V132, P141, DOI 10.1016/j.mad.2011.02.001; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kertmen H, 2015, ARCH MED SCI, V11, P1119, DOI 10.5114/aoms.2015.54869; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lorente L, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4828-5; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Mohany M, 2012, J TOXICOL SCI, V37, P1; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Ogurlu M, 2017, EUR ARCH OTO-RHINO-L, V274, P743, DOI 10.1007/s00405-016-4319-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okidi R, 2020, BJS OPEN, V4, P320, DOI 10.1002/bjs5.50243; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Somayajulu M, 2005, NEUROBIOL DIS, V18, P618, DOI 10.1016/j.nbd.2004.10.021; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; USTUN N, 2014, TURK ASS TRAUMA EMER, V20, P328; YOSHIMURA K, 1973, J BIOCHEM, V74, P389; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhu YY, 2006, NEUROSCI LETT, V393, P122, DOI 10.1016/j.neulet.2005.08.072	35	0	0	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers	JAN 2	2022	27	1					95	100		10.1080/1354750X.2021.2016972		DEC 2021	6	Biotechnology & Applied Microbiology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Toxicology	YH7BU	WOS:000731220300001	34890510				2022-02-06	
J	Hagglund, L; Olivecrona, M; Koskinen, LOD				Hagglund, Linda; Olivecrona, Magnus; Koskinen, Lars-Owe D.			Correlation of Cerebral and Subcutaneous Glycerol in Severe Traumatic Brain Injury and Association with Tissue Damage	NEUROCRITICAL CARE			English	Article; Early Access						Traumatic brain injury; Glycerol; S-100B; Neuron-specific enolase; Microdialysis; Brain computed tomography; Outcome	BARRIER; CARE; ICP	Background This study is a substudy of a prospective consecutive double-blinded randomized study on the effect of prostacyclin in severe traumatic brain injury (sTBI). The aims of the present study were to investigate whether there was a correlation between brain and subcutaneous glycerol levels and whether the ratio of interstitial glycerol in the brain and subcutaneous tissue (glycerol(brain/sc)) was associated with tissue damage in the brain, measured by using the Rotterdam score, S-100B, neuron-specific enolase (NSE), the Injury Severity Score (ISS), the Acute Physiology and Chronic Health Evaluation Score (APACHE II), and trauma type. A potential association with clinical outcome was explored. Methods Patients with sTBI aged 15-70 years presenting with a Glasgow Coma Scale Score <= 8 were included. Brain and subcutaneous adipose tissue glycerol levels were measured through microdialysis in 48 patients, of whom 42 had complete data for analysis. Brain tissue damage was also evaluated by using the Rotterdam classification of brain computed tomography scans and the biochemical biomarkers S-100B and NSE. Results In 60% of the patients, a positive relationship in glycerol(brain/sc) was observed. Patients with a positive correlation of glycerol(brain/sc) had slightly higher brain glycerol levels compared with the group with a negative correlation. There was no significant association between the computed tomography Rotterdam score and glycerol(brain/sc). S-100B and NSE were associated with the profile of glycerol(brain/sc). Our results cannot be explained by the general severity of the trauma as measured by using the Injury Severity Score or Acute Physiology and Chronic Health Evaluation Score. Conclusions We have shown that peripheral glycerol may flux into the brain. This effect is associated with worse brain tissue damage. This flux complicates the interpretation of brain interstitial glycerol levels. We remind the clinicians that a damaged blood-brain barrier, as seen in sTBI, may alter the concentrations of various substances, including glycerol in the brain. Awareness of this is important in the interpretation of the data bedside as well in research.	[Hagglund, Linda; Koskinen, Lars-Owe D.] Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden; [Olivecrona, Magnus] Orebro Univ, Orebro Univ Hosp, Sect Neurosurg, Dept Anesthesia & Intens Care, Orebro, Sweden; [Olivecrona, Magnus] Orebro Univ, Fac Hlth & Med, Dept Med Sci, Orebro, Sweden		Koskinen, LOD (corresponding author), Umea Univ, Dept Clin Sci, Neurosci, Umea, Sweden.	Lars-Owe.Koskinen@umu.se		Koskinen, Lars-Owe/0000-0003-3528-8502	Umea University; Umea Clinical Neuroscience Research Fund; Tore Nilsson Fund; Kempe Fund; Capio Research Fund; Vasterbotten County Council	Open access funding provided by Umea University. This study was financially supported by the Umea Clinical Neuroscience Research Fund; Umea University; a regional agreement between Umea University and Vasterbotten County Council on cooperation in the field of medicine, odontology, and health; the Tore Nilsson Fund; the Kempe Fund; the Capio Research Fund; and Umea University.	Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; JANSSON PA, 1992, J CLIN INVEST, V89, P1610, DOI 10.1172/JCI115756; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Koskinen LOD, 2019, NEUROCRIT CARE, V31, P494, DOI 10.1007/s12028-019-00741-4; Koskinen LOD, 2015, NEUROCRIT CARE, V22, P26, DOI 10.1007/s12028-014-0030-8; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; MEYER JS, 1975, CIRCULATION, V51, P701, DOI 10.1161/01.CIR.51.4.701; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Pedersen K, 2015, NEUROEPIDEMIOLOGY, V45, P20, DOI 10.1159/000381780; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	0	0	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01412-z		DEC 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XP5DY	WOS:000730887100001	34914037	hybrid, Green Published			2022-02-06	
J	Mayer, AR; Dodd, AB; Rannou-Latella, JG; Stephenson, DD; Dodd, RJ; Ling, JM; Mehos, CJ; Robertson-Benta, CR; Reddy, SP; Kinsler, RE; Vermillion, MS; Gigliotti, AP; Sicard, V; Lloyd, AL; Erhardt, EB; Gill, JM; Lai, C; Guedes, VA; Chaudry, IH				Mayer, Andrew R.; Dodd, Andrew B.; Rannou-Latella, Julie G.; Stephenson, David D.; Dodd, Rebecca J.; Ling, Josef M.; Mehos, Carissa J.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Kinsler, Rachel E.; Vermillion, Meghan S.; Gigliotti, Andrew P.; Sicard, Veronik; Lloyd, Amy L.; Erhardt, Erik B.; Gill, Jessica M.; Lai, Chen; Guedes, Vivian A.; Chaudry, Irshad H.			17 alpha-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial	CRITICAL CARE			English	Article						Hypovolemia; Brain injuries; Traumatic; Estrogens; Swine; Hemodynamics; Multiple trauma	BLOOD-LOSS; ESTROGEN; GENDER; 17-BETA-ESTRADIOL; BIOMARKERS; BARRIER; 17-ALPHA-ETHYNYLESTRADIOL-3-SULFATE; RESUSCITATION; ACTIVATION; EFFICACY	Background Traumatic brain injury (TBI) and severe blood loss resulting in hemorrhagic shock (HS) represent leading causes of trauma-induced mortality, especially when co-occurring in pre-hospital settings where standard therapies are not readily available. The primary objective of this study was to determine if 17 alpha-ethinyl estradiol-3-sulfate (EE-3-SO4) increases survival, promotes more rapid cardiovascular recovery, or confers neuroprotection relative to Placebo following TBI + HS. Methods All methods were approved by required regulatory agencies prior to study initiation. In this fully randomized, blinded preclinical study, eighty (50% females) sexually mature (190.64 +/- 21.04 days old; 28.18 +/- 2.72 kg) Yucatan swine were used. Sixty-eight animals received a closed-head, accelerative TBI followed by removal of approximately 40% of circulating blood volume. Animals were then intravenously administered EE-3-SO4 formulated in the vehicle at 5.0 mg/mL (dosed at 0.2 mL/kg) or Placebo (0.45% sodium chloride solution) via a continuous pump (0.2 mL/kg over 5 min). Twelve swine were included as uninjured Shams to further characterize model pathology and replicate previous findings. All animals were monitored for up to 5 h in the absence of any other life-saving measures (e.g., mechanical ventilation, fluid resuscitation). Results A comparison of Placebo-treated relative to Sham animals indicated evidence of acidosis, decreased arterial pressure, increased heart rate, diffuse axonal injury and blood-brain barrier breach. The percentage of animals surviving to 295 min post-injury was significantly higher for the EE-3-SO4 (28/31; 90.3%) relative to Placebo (24/33; 72.7%) cohort. EE-3-SO4 also restored pulse pressure more rapidly post-drug administration, but did not confer any benefits in terms of shock index. Primary blood-based measurements of neuroinflammation and blood brain breach were also null, whereas secondary measurements of diffuse axonal injury suggested a more rapid return to baseline for the EE-3-SO4 group. Survival status was associated with biological sex (female > male), as well as evidence of increased acidosis and neurotrauma independent of EE-3-SO4 or Placebo administration. Conclusions EE-3-SO4 is efficacious in promoting survival and more rapidly restoring cardiovascular homeostasis following polytraumatic injuries in pre-hospital environments (rural and military) in the absence of standard therapies. Poly-therapeutic approaches targeting additional mechanisms (increased hemostasis, oxygen-carrying capacity, etc.) should be considered in future studies.	[Mayer, Andrew R.; Dodd, Andrew B.; Rannou-Latella, Julie G.; Stephenson, David D.; Dodd, Rebecca J.; Ling, Josef M.; Robertson-Benta, Cidney R.; Reddy, Sharvani Pabbathi; Vermillion, Meghan S.; Gigliotti, Andrew P.; Sicard, Veronik] Mind Res Network, Lovelace Biomed Res Inst, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Neurol Dept, Sch Med, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Psychiat Dept, Sch Med, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Psychol Dept, Albuquerque, NM 87131 USA; [Mehos, Carissa J.] Univ New Mexico, Neurosci Dept, Sch Med, Albuquerque, NM 87131 USA; [Kinsler, Rachel E.; Lloyd, Amy L.] US Army, Dept Army Civilian, Aeromed Res Lab, Ft Rucker, AL 36362 USA; [Lloyd, Amy L.] US Army, Aeromed Res Lab, Goldbelt Frontier Inc, Ft Rucker, AL USA; [Erhardt, Erik B.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Gill, Jessica M.; Lai, Chen; Guedes, Vivian A.] NIH, Natl Inst Nursing Res, Bldg 10, Bethesda, MD 20892 USA; [Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA		Mayer, AR (corresponding author), Mind Res Network, Lovelace Biomed Res Inst, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.; Mayer, AR (corresponding author), Univ New Mexico, Neurol Dept, Sch Med, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Psychiat Dept, Sch Med, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Psychol Dept, Albuquerque, NM 87131 USA.	amayer@mrn.org		de Alvarenga Guedes, Vivian/0000-0001-8478-2465	Departments of Defense [W81XWH-17-2-0052]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of HealthGeneral Electric [P20GM109089]	This research was supported by a grant from the Departments of Defense (W81XWH-17-2-0052) to Andrew R. Mayer. Histological analysis was performed by the Preclinical Clinical Core Facility at the University of New Mexico Center for Brain Recovery and Repair, which is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant Number P20GM109089.	Akabori H, 2010, SHOCK, V33, P43, DOI 10.1097/SHK.0b013e3181b0ebcb; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; Ardelt AA, 2005, STROKE, V36, P337, DOI 10.1161/01.STR.0000153795.38388.72; Ardelt AA, 2007, EXP NEUROL, V206, P95, DOI 10.1016/j.expneurol.2007.04.002; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Butler FK Jr., 2018, J SPEC OPER MED, V18, P37; Callcut RA, 2019, J TRAUMA ACUTE CARE, V86, P864, DOI 10.1097/TA.0000000000002205; Cannon JW, 2018, NEW ENGL J MED, V378, P370, DOI 10.1056/NEJMra1705649; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Chen JG, 2006, SHOCK, V25, P11, DOI 10.1097/00024382-200606001-00033; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; du Sert NP, 2020, BRIT J PHARMACOL, V177, P3617, DOI [10.1111/bph.15193, 10.1177/0271678X20943823]; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; George RL, 2003, SHOCK, V19, P28, DOI 10.1097/00024382-200301000-00006; Gutierrez G, 2013, INTENS CARE MED, V39, P1359, DOI 10.1007/s00134-013-2937-5; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Hong ZJ, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01491-1; Hsieh YC, 2006, J MOL CELL CARDIOL, V41, P511, DOI 10.1016/j.yjmcc.2006.06.001; Hubbard WJ, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P161, DOI 10.1016/B978-0-12-802686-1.00010-9; Hubbard W, 2015, J SURG RES, V193, P355, DOI 10.1016/j.jss.2014.06.047; Hubbard WJ, 2021, J TRAUMA ACUTE CARE, V90, P353, DOI 10.1097/TA.0000000000002978; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; Kim H, 2010, J TRAUMA, V69, P1266, DOI 10.1097/TA.0b013e3181dbb0b2; Koh EY, 2019, AM J SURG, V218, P501, DOI 10.1016/j.amjsurg.2018.12.022; Kovesdi E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010011; Kumar RG, 2020, J NEUROTRAUM, V37, P2198, DOI 10.1089/neu.2019.6577; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Mayer AR, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.658461; Mayer AR, 2021, SHOCK, V55, P554, DOI 10.1097/SHK.0000000000001653; Mayer AR, 2019, NEUROSCI BIOBEHAV R, V104, P160, DOI 10.1016/j.neubiorev.2019.06.024; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; Muller CR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81717-3; Noorbakhsh MR., 2018, J EMERG CRIT CARE ME, V2, P26; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Scultetus AH, 2020, MIL MED, V185, P57, DOI 10.1093/milmed/usz248; Semenas E, 2010, ACTA ANAESTH SCAND, V54, P343, DOI 10.1111/j.1399-6576.2009.02125.x; Shafi S, 2016, J TRAUMA ACUTE CARE, V81, P780, DOI 10.1097/TA.0000000000001161; Sohrabji F, 2007, GENE EXPRESSION, V13, P311; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trentzsch H, 2014, INJURY, V45, pS20, DOI 10.1016/j.injury.2014.08.013; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	60	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	DEC 16	2021	25	1							428	10.1186/s13054-021-03844-7			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XP5ZC	WOS:000730942200005	34915927	Green Published, gold			2022-02-06	
J	Chen, C; Lu, LN; Zhu, J; Gu, XY; Liu, BF; Li, D; Chen, G				Chen, Chen; Lu, Lina; Zhu, Jie; Gu, Xiaoyu; Liu, Bofei; Li, Di; Chen, Gang			Miro1 provides neuroprotection via the mitochondrial trafficking pathway in a rat model of traumatic brain injury	BRAIN RESEARCH			English	Article						Miro1; Mitochondrial trafficking; Apoptosis; Neuroprotection; Traumatic brain injury	AXONAL-TRANSPORT; MOUSE MODEL; DYNAMICS; NEURONS; DYNEIN; DEGRADATION; DYSFUNCTION; IMPAIRMENT; KINESIN; GTPASE	The outer mitochondrial membrane protein mitochondrial Rho-GTPase 1 (Miro1) is known to be involved in the regulation of mitochondrial transport required for neuronal protection. Previous reports established that disruption of Miro1-dependent mitochondrial movement could result in nervous system diseases such as Parkinson's disease and Alzheimer's disease. This study was designed to explore the expression and mechanisms of Miro1 in secondary brain injury after traumatic brain injury (TBI). A total of 115 male Sprague Dawley rats were used in the weight-drop TBI rat model, and Miro1 in vivo knockdown was performed 24 h before TBI modeling by treatment with Miro1 short-interfering RNA. Real-time polymerase chain reaction, western blot, immunofluorescence, adenosine triphosphate (ATP) level assay, neuronal apoptosis, brain water content measurement, and neurological score analyses were carried out. Our results showed that the mRNA and protein levels of Miro1 were increased after TBI and co-localized with neurons and astrocytes in the peri-injury cortex. Moreover, Miro1 knockdown further exacerbated neuronal apoptosis, brain edema, and neurological deficits at 48 h after TBI, accompanied by impaired mitochondrial transport, reduction of mitochondria number and energy deficiency. Additionally, the apoptosis-related factors Bax upregulation and Bcl-2 downregulation as Miro1 knockdown after TBI implied that antiapoptotic effects on neuroprotection of Miro1, which were verified by the Fluoro-Jade C (FJC) staining and TUNEL staining. In conclusion, these findings suggest that Miro1 probably plays a neuroprotective role against secondary brain injury through the mitochondria trafficking pathway, suggesting that enhancing Miro1 might be a new strategy for the treatment of TBI.	[Chen, Chen; Gu, Xiaoyu; Liu, Bofei] Soochow Univ, Dept Intens Care Unit, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Lu, Lina] Nanjing Med Univ, Dept Radiat Oncol, Affiliated Suzhou Sci & Technol Town Hosp, Suzhou, Peoples R China; [Zhu, Jie] Soochow Univ, Dept Anesthesia, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China; [Li, Di] Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Peoples R China		Liu, BF (corresponding author), Soochow Univ, Dept Intens Care Unit, Affiliated Zhangjiagang Hosp, Suzhou, Peoples R China.; Li, D (corresponding author), Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China.	liubofei.zjg.js@163.com; lidilab@sina.com					Abraham Z, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4037886; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Buhmann CB, 2014, DAN MED J, V61; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Castro IG, 2018, TRAFFIC, V19, P229, DOI 10.1111/tra.12549; Chang CY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0158-8; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chen YH, 2021, ANTIOXID REDOX SIGN, V34, P154, DOI 10.1089/ars.2019.7982; Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00163; Chien L, 2018, BBA-MOL BASIS DIS, V1864, P3001, DOI 10.1016/j.bbadis.2018.06.012; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Davis RE, 2012, J PHARMACOL EXP THER, V342, P598, DOI 10.1124/jpet.112.192104; Devine MJ, 2016, NEUROBIOL DIS, V90, P27, DOI 10.1016/j.nbd.2015.12.008; Eberhardt EL, 2020, PROTEIN SCI, V29, P1269, DOI 10.1002/pro.3839; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064460; Iijima-Ando K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002918; Katsumata K, 2010, AUTOPHAGY, V6, P378, DOI 10.4161/auto.6.3.11262; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Ladokhin AS, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092121; Lahiri V, 2017, AUTOPHAGY, V13, P1259, DOI 10.1080/15548627.2017.1327512; Lee KS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00330; Li D, 2018, CNS NEUROSCI THER, V24, P906, DOI 10.1111/cns.12833; Li D, 2018, BRAIN RES, V1688, P15, DOI 10.1016/j.brainres.2017.10.018; Lopez-Domenech G, 2016, CELL REP, V17, P317, DOI 10.1016/j.celrep.2016.09.004; Martin-Saborido C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011725.pub2; Melkov A, 2016, DEVELOPMENT, V143, P4203, DOI 10.1242/dev.138289; Moller A, 2017, HUM MOL GENET, V26, P4668, DOI 10.1093/hmg/ddx348; Morel M, 2012, ACTA NEUROPATHOL, V123, P71, DOI 10.1007/s00401-011-0901-4; Moschoi R, 2016, BLOOD, V128, P253, DOI 10.1182/blood-2015-07-655860; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Palu RAS, 2019, G3-GENES GENOM GENET, V9, P3995, DOI 10.1534/g3.119.400722; Panchal K, 2021, MITOCHONDRION, V56, P118, DOI 10.1016/j.mito.2020.10.005; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Ponsford J, 2021, J NEUROTRAUM, V38, P1060, DOI 10.1089/neu.2020.7299; Shahen VA, 2018, ACTA HISTOCHEM, V120, P797, DOI 10.1016/j.acthis.2018.09.001; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sleigh JN, 2019, NAT REV NEUROL, V15, P691, DOI 10.1038/s41582-019-0257-2; Stepanova A, 2017, J CEREBR BLOOD F MET, V37, P3649, DOI 10.1177/0271678X17730242; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Tarasova NV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194823; Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107; Tseng N, 2021, J CEREBR BLOOD F MET, V41, P761, DOI 10.1177/0271678X20928147; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vergara RC, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00049; Wang ZX, 2015, MOL NEUROBIOL, V51, P1309, DOI 10.1007/s12035-014-8810-x; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0790-0; Yamaoka S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00350; Yamaoka S, 2011, PLANT CELL REP, V30, P239, DOI 10.1007/s00299-010-0926-5; Yap ZY, 2021, J INHERIT METAB DIS, V44, P388, DOI 10.1002/jimd.12248; Zhang F, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00100; Zhang HF, 2018, BIOCHEM CELL BIOL, V96, P468, DOI 10.1139/bcb-2017-0102; Zheng YR, 2019, CNS NEUROSCI THER, V25, P876, DOI 10.1111/cns.13122; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101	60	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 15	2021	1773								147685	10.1016/j.brainres.2021.147685			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM9VA	WOS:000711425000006	34637761				2022-02-06	
J	El-Menyar, A; Ahmed, K; Hakim, S; Kanbar, A; Mathradikkal, S; Siddiqui, T; Jogol, H; Younis, B; Taha, I; Mahmood, I; Ajaj, A; Atique, S; Alaieb, A; Bahey, AAA; Asim, M; Alinier, G; Castle, NR; Mekkodathil, A; Rizoli, S; Al-Thani, H				El-Menyar, Ayman; Ahmed, Khalid; Hakim, Suhail; Kanbar, Ahad; Mathradikkal, Saji; Siddiqui, Tariq; Jogol, Hisham; Younis, Basil; Taha, Ibrahim; Mahmood, Ismail; Ajaj, Ahmed; Atique, Sajid; Alaieb, Abubaker; Bahey, Ahmed Abdel-Aziz; Asim, Mohammad; Alinier, Guillaume; Castle, Nicholas R.; Mekkodathil, Ahammed; Rizoli, Sandro; Al-Thani, Hassan			Efficacy and safety of the second in-hospital dose of tranexamic acid after receiving the prehospital dose: double-blind randomized controlled clinical trial in a level 1 trauma center	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Trauma; Tranexamic acid; Bleeding; Randomized controlled trial; Prehospital	INCREASED MORTALITY; EARLY COAGULOPATHY; HEMORRHAGE; EPIDEMIOLOGY; TRANSPORT; CRASH-2; IMPACT; TXA	Background Prehospital administration of tranexamic acid (TXA) to injured patients is increasing worldwide. However, optimal TXA dose and need of a second infusion on hospital arrival remain undetermined. We investigated the efficacy and safety of the second in-hospital dose of TXA in injured patients receiving 1 g of TXA in the prehospital setting. We hypothesized that a second in-hospital dose of TXA improves survival of trauma patients. Methods A prospective, double-blind, placebo-controlled randomized, clinical trial included adult trauma patients receiving 1 g of TXA in the prehospital settings. Patients were then blindly randomized to Group I (second 1-g TXA) and Group II (placebo) on hospital arrival. The primary outcome was 24-h (early) and 28-day (late) mortality. Secondary outcomes were thromboembolic events, blood transfusions, hospital length of stay (HLOS) and organs failure (MOF). Results A total of 220 patients were enrolled, 110 in each group. The TXA and placebo groups had a similar early [OR 1.000 (0.062-16.192); p = 0.47] and late mortality [OR 0.476 (95% CI 0.157-1.442), p = 0.18].The cause of death (n = 15) was traumatic brain injury (TBI) in 12 patients and MOF in 3 patients. The need for blood transfusions in the first 24 h, number of transfused blood units, HLOS, thromboembolic events and multiorgan failure were comparable in the TXA and placebo groups. In seriously injured patients (injury severity score > 24), the MTP activation was higher in the placebo group (31.3% vs 11.10%, p = 0.13), whereas pulmonary embolism (6.9% vs 2.9%, p = 0.44) and late mortality (27.6% vs 14.3%, p = 0.17) were higher in the TXA group but did not reach statistical significance. Conclusion The second TXA dose did not change the mortality rate, need for blood transfusion, thromboembolic complications, organ failure and HLOS compared to a single prehospital dose and thus its routine administration should be revisited in larger and multicenter studies.	[El-Menyar, Ayman; Asim, Mohammad; Mekkodathil, Ahammed] Hamad Med Corp HMC, Trauma & Vasc Surg, Clin Res, Hamad Gen Hosp, POB 3050, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Med Clin, Doha, Qatar; [Ahmed, Khalid; Hakim, Suhail; Kanbar, Ahad; Mathradikkal, Saji; Siddiqui, Tariq; Jogol, Hisham; Younis, Basil; Taha, Ibrahim; Mahmood, Ismail; Ajaj, Ahmed; Atique, Sajid; Alaieb, Abubaker; Rizoli, Sandro; Al-Thani, Hassan] HMC, Dept Surg, Trauma Surg, Hamad Gen Hosp, Doha, Qatar; [Bahey, Ahmed Abdel-Aziz] HMC, Trauma Surg, Clin Pharm, Hamad Gen Hosp, Doha, Qatar; [Alinier, Guillaume; Castle, Nicholas R.] HMC, Hamad Med Corp Ambulance Serv, Med City, Doha, Qatar; [Alinier, Guillaume] Weill Cornell Med Qatar, Doha, Qatar; [Alinier, Guillaume] Univ Hertfordshire, Sch Hlth & Social Work, Paramed Div, Hatfield, Herts, England; [Alinier, Guillaume] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England		El-Menyar, A (corresponding author), Hamad Med Corp HMC, Trauma & Vasc Surg, Clin Res, Hamad Gen Hosp, POB 3050, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Med Clin, Doha, Qatar.	aymanco65@yahoo.com	; El-Menyar, Ayman/F-6734-2015	AHMED, KHALID/0000-0003-3576-0555; El-Menyar, Ayman/0000-0003-2584-953X	Qatar National Library	Open Access funding provided by the Qatar National Library.	Al-Jeabory M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051030; Al-Thani H, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084016; Alinier G, 2013, INT PARAMED PRACT, V3, P61; Almuwallad A, 2021, J TRAUMA ACUTE CARE, V90, P901, DOI 10.1097/TA.0000000000003120; Association of Ambulance Chief Executives, 2019, JRCALC CLIN GUID 201; Boudreau RM, 2019, J SURG RES, V233, P132, DOI 10.1016/j.jss.2018.07.074; Brown JB, 2015, PREHOSP EMERG CARE, V19, P79, DOI 10.3109/10903127.2014.936635; Edelman DA, 2007, SHOCK, V27, P134, DOI 10.1097/01.shk.0000239772.18151.18; El-Menyar A, 2019, J SURG RES, V243, P410, DOI 10.1016/j.jss.2019.05.062; El-Menyar A, 2020, AM J EMERG MED, V38, P266, DOI 10.1016/j.ajem.2019.04.051; El-Menyar A, 2018, AM J EMERG MED, V36, P1079, DOI 10.1016/j.ajem.2018.03.033; Fisher AD, 2019, J EMERG MED, V57, P646, DOI 10.1016/j.jemermed.2019.08.027; Grassin-Delyle S, 2018, ANAESTHESIA, V73, P719, DOI 10.1111/anae.14184; Guo JF, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0772-0; Guyette FX, 2021, JAMA SURG, V156, P11, DOI 10.1001/jamasurg.2020.4350; HALT-IT Trial Collaborators, 2020, LANCET, V395, P1927, DOI 10.1016/S0140-6736(20)30848-5; Huebner BR, 2017, WILD ENVIRON MED, V28, pS50, DOI 10.1016/j.wem.2016.12.006; Imach S, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03701-7; Jawa RS, 2016, AM SURGEON, V82, P439; July J, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01694-4; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kunze-Szikszay N, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0314-4; Lawati KA, 2021, INTENS CARE MED, V47, P14, DOI 10.1007/s00134-020-06279-w; Lipsky AM, 2014, INJURY, V45, P66, DOI 10.1016/j.injury.2013.08.025; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; MCIVER B, 1994, J PAIN SYMPTOM MANAG, V9, P341, DOI 10.1016/0885-3924(94)90193-7; Meizoso JP, 2018, J TRAUMA ACUTE CARE, V84, P426, DOI 10.1097/TA.0000000000001792; Menacho AM, 2017, INT PARAMEDIC PRACTI, V7, P18, DOI DOI 10.12968/IPPR.2017.7.2.18; Mitra B, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046522; Moore HB, 2017, J SURG RES, V220, P438, DOI 10.1016/j.jss.2017.04.028; Morris B., 2018, MEDITERR J EMERG MED, V26, P8; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Mrochuk May, 2015, Air Med J, V34, P37, DOI 10.1016/j.amj.2014.09.004; Nadler R, 2014, J TRAUMA ACUTE CARE, V77, pS146, DOI 10.1097/TA.0000000000000325; Napolitano LM, 2017, TRAUMA SURG ACUTE CA, V2, DOI DOI 10.1136/TSACO-2016-000056; Naylor JF., 2017, J SPEC OPER MED, V17, P55; Neeki MM, 2018, WEST J EMERG MED, V19, P977, DOI 10.5811/westjem.2018.8.39336; Neeki MM, 2017, WEST J EMERG MED, V18, P673, DOI 10.5811/westjem.2017.2.32044; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Nishijima DK, 2019, ANN EMERG MED, V74, P79, DOI 10.1016/j.annemergmed.2018.11.018; Pabinger I, 2017, WIEN KLIN WOCHENSCHR, V129, P303, DOI 10.1007/s00508-017-1194-y; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Paudyal P, 2017, EUR J EMERG MED, V24, P44, DOI 10.1097/MEJ.0000000000000323; Perel P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5166; Roberts I, 2015, J THROMB HAEMOST, V13, pS195, DOI 10.1111/jth.12878; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Stansfield R, 2020, SHOCK, V53, P277, DOI 10.1097/SHK.0000000000001389; van Wessem KJP, 2021, WORLD J SURG, V45, P2398, DOI 10.1007/s00268-021-06143-y; Vu Erik Nelson, 2013, Air Med J, V32, P289, DOI 10.1016/j.amj.2013.05.001; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Yokobori S, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00460-5; Zickenrott V, 2017, ANAESTHESIST, V66, P249, DOI 10.1007/s00101-017-0277-5	56	0	0	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01848-0		DEC 2021	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XO9JU	WOS:000730493700001	34910219	hybrid			2022-02-06	
J	Garcia-Rudolph, A; Sauri, J; Garcia-Molina, A; Cegarra, B; Opisso, E; Tormos, JM; Frey, D; Madai, VI; Bernabeu, M				Garcia-Rudolph, Alejandro; Sauri, Joan; Garcia-Molina, Alberto; Cegarra, Blanca; Opisso, Eloy; Maria Tormos, Josep; Frey, Dietmar; Istvan Madai, Vince; Bernabeu, Montserrat			The impact of coronavirus disease 2019 on emotional and behavioral stress of informal family caregivers of individuals with stroke or traumatic brain injury at chronic phase living in a Mediterranean setting	BRAIN AND BEHAVIOR			English	Article						behavioral; COVID-19; emotional; informal caregivers; stress; stroke; traumatic brain injury	DISTRESS; BURDEN; PEOPLE; RISK; COMA; CARE	Introduction Even in nonpandemic times, persons with disabilities experience emotional and behavioral disturbances which are distressing for them and for their close persons. We aimed at comparing the levels of stress in emotional and behavioral aspects, before and during coronavirus disease 2019 (COVID-19), as reported by informal family caregivers of individuals with chronic traumatic brain injury (TBI) or stroke living in the community, considering two different stratifications of the recipients of care (cause and injury severity). Methods We conducted a STROBE-compliant prospective observational study analyzing informal caregivers of individuals with stroke (IC-STROKE) or traumatic brain injury (IC-TBI). IC-STROKE and IC-TBI were assessed in-person before and during COVID-19 online, using the Head Injury Behavior Scale (HIBS). The HIBS comprises behavioral and emotional subtotals (10 items each) and a total-HIBS. Comparisons were performed using the McNemar's test, Wilcoxon signed-rank test or t-test. Recipients of care were stratified according to their injury severity using the National Institutes of Health Stroke Scale (NIHSS) and the Glasgow Coma Scale (GCS). Results One hundred twenty-two informal caregivers (62.3% IC-STROKE and 37.7% IC-TBI) were assessed online between June 2020 and April 2021 and compared to their own assessments performed in-person 1.74 +/- 0.88 years before the COVID-19 lockdown. IC-STROKE significantly increased their level of stress during COVID-19 in five emotional items (impatience, frequent complaining, often disputes topics, mood change and overly sensitive) and in one behavioral item (overly dependent). IC-TBI stress level only increased in one behavioral item (impulsivity). By injury severity, (i) mild (14.7%) showed no significant differences in emotional and behavioral either total-HIBS (ii) moderate (28.7%) showed significant emotional differences in two items (frequent complaining and mood change) and (iii) severe (56.6%) showed significant differences in emotional (often disputes topics) and behavioral (impulsivity) items. Conclusions Our results suggest specific items in which informal caregivers could be supported considering cause or severity of the recipients of care.	[Garcia-Rudolph, Alejandro; Sauri, Joan; Garcia-Molina, Alberto; Cegarra, Blanca; Opisso, Eloy; Maria Tormos, Josep; Bernabeu, Montserrat] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Garcia-Rudolph, Alejandro; Sauri, Joan; Garcia-Molina, Alberto; Cegarra, Blanca; Opisso, Eloy; Maria Tormos, Josep; Bernabeu, Montserrat] Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain; [Garcia-Rudolph, Alejandro; Sauri, Joan; Garcia-Molina, Alberto; Cegarra, Blanca; Opisso, Eloy; Maria Tormos, Josep; Bernabeu, Montserrat] Inst Guttmann Hosp Neurorehabil, Badalona, Spain; [Frey, Dietmar; Istvan Madai, Vince] Charite Univ Med Berlin, Claim Charlie Lab AI Med, Berlin, Germany; [Istvan Madai, Vince] Berlin Inst Hlth BIH, QUEST Ctr Transforming Biomed Res, Berlin, Germany; [Istvan Madai, Vince] Charite Univ Med Berlin, Berlin, Germany; [Istvan Madai, Vince] Birmingham City Univ, Fac Comp Engn & Built Environm, Sch Comp & Digital Technol, Birmingham, W Midlands, England		Garcia-Rudolph, A (corresponding author), Inst Guttmann, Barcelona, Spain.	alejandropablogarcia@gmail.com		Cegarra, Blanca/0000-0002-6138-8649	H2020 Personalised Medicine by Predictive Modeling in Stroke [777107]	H2020Personalised Medicine by Predictive Modeling in Stroke, Grant/Award Number: 777107	[Anonymous], VACCINATION PROGRAM; [Anonymous], 2021, R PROJECT STAT COMPU; Bauer JM, 2015, J POPUL AGEING, V8, P113, DOI 10.1007/s12062-015-9116-0; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Budnick A, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06359-7; Caeiro L, 2013, CEREBROVASC DIS, V35, P507, DOI 10.1159/000350202; Cohen SA, 2021, GERONTOL GERIATR MED, V7, DOI 10.1177/2333721421999279; Dankner R, 2016, INT J REHABIL RES, V39, P326, DOI 10.1097/MRR.0000000000000192; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; EU, 2018, INF CAR EUR EXPL FOR, DOI [10.2767/78836, DOI 10.2767/78836]; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Fronteira I, 2019, EUR J PUBLIC HEALTH, V29, P364; Gaugler JE, 2007, J GERONTOL B-PSYCHOL, V62, pP38, DOI 10.1093/geronb/62.1.P38; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Gottschalk S, 2020, INT J PUBLIC HEALTH, V65, P911, DOI 10.1007/s00038-020-01402-6; Hagell P, 2017, J PAIN SYMPTOM MANAG, V53, P272, DOI 10.1016/j.jpainsymman.2016.09.007; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jorge Ricardo E, 2015, Handb Clin Neurol, V128, P613, DOI 10.1016/B978-0-444-63521-1.00038-8; Kang CY, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102081; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Kim JS, 2017, EXPERT REV NEUROTHER, V17, P1179, DOI 10.1080/14737175.2017.1395281; Laratta S, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6240298; Laxe S, 2020, BRAIN INJURY, V34, P1691, DOI 10.1080/02699052.2020.1830172; Lieshout K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176386; de Arroyabe EL, 2013, AUST J REHABIL COUNS, V19, P84, DOI 10.1017/jrc.2013.13; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; McIntyre M, 2020, DISABIL REHABIL, V42, P754, DOI 10.1080/09638288.2018.1508511; Morimoto T, 2001, INT J REHABIL RES, V24, P221, DOI 10.1097/00004356-200109000-00007; Morrow EL, 2021, ARCH PHYS MED REHAB, V102, P1075, DOI 10.1016/j.apmr.2021.01.064; Nayak M.S.D.P., 2019, IOSR J HUMANITIES SO, V24, P31, DOI [10.9790/0837-2405053138, DOI 10.9790/0837-2405053138]; Oliva-Moreno J, 2018, STROKE, V49, P140, DOI 10.1161/STROKEAHA.117.017575; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pisano F, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.564717; Rodrigues R, 2021, EUR J AGEING, V18, P195, DOI 10.1007/s10433-021-00611-z; Sheth K, 2021, J APPL GERONTOL, V40, P235, DOI 10.1177/0733464820971511; STROBE Statement, 2021, CHECKL IT SHOULD BE; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Villalobos D, 2020, REV NEUROLOGIA, V70, P1, DOI 10.33588/rn.7001.2019313; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; Woodford J, 2018, CLIN GERONTOLOGIST, V41, P293, DOI 10.1080/07317115.2017.1363104	45	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2022	12	1							e32440	10.1002/brb3.2440		DEC 2021	13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	YL7CM	WOS:000730254000001	34910375	gold			2022-02-06	
J	Jang, SH; Kim, SH; Kim, JW; Lee, HD; Cho, MK				Jang, Sung Ho; Kim, Seong Ho; Kim, Jae Woon; Lee, Han Do; Cho, Min Kyeong			Difference in the ascending reticular activating system between vegetative and minimally conscious states following traumatic brain injury	NEUROREPORT			English	Article						ascending reticular activating system; diffusion tensor imaging; diffusion tensor tractography; disorders of consciousness; traumatic brain injury	PREFRONTAL CORTEX; RECOVERY; THALAMUS; CONNECTIVITY; RELEVANCE; PATIENT	Objectives We investigated differences in the ascending reticular activating system (ARAS) between vegetative state (VS) and minimally conscious state (MCS) in patients with traumatic brain injury (TBI) by using diffusion tensor tractography. Methods We recruited TBI patients and normal subjects. We reconstructed the lower ARAS and five parts of upper ARAS [prefrontal cortex (PFC), premotor cortex, primary motor cortex, primary somatosensory cortex, and posterior parietal cortex]. Results Significant differences were observed in the fractional anisotropy (FA) and fiber number (FN) values of the five parts of upper ARAS between the VS and control groups and between the MCS and control groups (P < 0.05), but no differences were detected in the lower ARAS (P > 0.05). The FA and FN values of the PFC in the upper ARAS were significantly different between the VS and MCS groups (P < 0.05). No other significant differences in FA and FN values were detected among the other segments of the upper ARAS or in the lower ARAS (P > 0.05). Conclusion The results indicate that the prefrontal portion of the upper ARAS is the critical area for distinguishing between VS and MCS in patients with TBI.	[Jang, Sung Ho; Cho, Min Kyeong] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Daegu, South Korea; [Kim, Jae Woon] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Daegu, South Korea; [Lee, Han Do] Ulsan Coll Univ, Coll Nat Sci, Dept Phys Therapy, Ulsan, South Korea		Cho, MK (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	jmk09609@hanmail.net			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2021R1A2B5B01001386]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (No. 2021R1A2B5B01001386). S.H.J.: study concept and design, manuscript development, writing, funding, and critical revision of the manuscript for intellectual content. S.H.K.: study concept and design, manuscript development. J.W.K.: acquisition and analysis of data. H.D.L.: study concept, design, and acquisition and analysis of data. M.K.C.: study concept, design, and critical revision of the manuscript for intellectual content.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Edlow BL, 2021, NAT REV NEUROL, V17, P135, DOI 10.1038/s41582-020-00428-x; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005234; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004041; Jang SH, 2015, NEUROLOGY, V84, P1997, DOI 10.1212/WNL.0000000000001563; Jang SH, 2014, YONSEI MED J, V55, P709, DOI 10.3349/ymj.2014.55.3.709; Jang S, 2016, AM J PHYS MED REHAB, V95, pE63, DOI 10.1097/PHM.0000000000000443; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; 장성호, 2017, [The Journal of Korean Society of Physical Therapy, 대한물리치료학회지], V29, P109; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Weng L, 2017, CORTEX, V90, P71, DOI 10.1016/j.cortex.2017.02.011; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416	19	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	DEC 15	2021	32	18					1423	1427		10.1097/WNR.0000000000001747			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WX1CK	WOS:000718341300004	34743167	Green Published			2022-02-06	
J	Kawon, K; Setkowicz, Z; Drozdz, A; Janeczko, K; Chwiej, J				Kawon, Kamil; Setkowicz, Zuzanna; Drozdz, Agnieszka; Janeczko, Krzysztof; Chwiej, Joanna			The methods of vibrational microspectroscopy reveals long-term biochemical anomalies within the region of mechanical injury within the rat brain	SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY			English	Article						Traumatic brain injury; Animal models; Fourier transform infrared; microspectroscopy; Raman microscopy; Principal component analysis (PCA)	NEUROPROTECTANTS FK-506; PROLIFERATIVE RESPONSE; CYCLOSPORINE-A; GLIAL SCAR; PATHOPHYSIOLOGY; SUSCEPTIBILITY; SPECTROSCOPY; HIPPOCAMPUS; CREATINE	Traumatic brain injury (TBI), meaning functional or structural brain damage which appear as a result of the application of the external physical force, constitutes the main cause of death and disability of individuals and a great socioeconomic problem. To search for the new therapeutic strategies for TBI, better knowledge about posttraumatic pathological changes occurring in the brain is necessary. Therefore in the present paper the Fourier transform infrared microspectroscopy and Raman microscopy were used to examine local and remote biochemical changes occurring in the rat brain as a result of focal cortex injury. The site of the injury and the dorsal part of the hippocampal formation together with the above situated cortex and white matter were the subject of the study. The topographic and quantitative biochemical analysis followed with the statistical study using principal component analysis showed significant biomolecular anomalies within the lesion site but not in the area of the dorsal hippocampal formation and in the above situated white matter and cortex. The observed intralesional anomalies included significantly decreased accumulation of lipids and their structural changes within the place of injury. Also the levels of compounds containing phosphate and carbonyl groups were lower within the lesion site comparing to the surrounding cortex. The opposite relation was, in turn, found for the bands characteristic to proteins and cholesterol/cholesterol esters. CO 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).	[Kawon, Kamil; Drozdz, Agnieszka; Chwiej, Joanna] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Setkowicz, Zuzanna; Janeczko, Krzysztof] Jagiellonian Univ, Inst Zool & Biomed Res, Krakow, Poland		Chwiej, J (corresponding author), AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland.	joanna.chwiej@fis.agh.edu.pl		Janeczko, Krzysztof/0000-0002-9544-918X; Kawon, Kamil/0000-0001-9153-6537	Ministry of Education and Science of Poland; Laboratory of Experimental Neuropathology (Institute of Zoology and Biomedical Research, Jagiellonian University) [N18/DBS/000018]; ''Excellence Initiative-Research University"Project	This work was partially financed by the Ministry of Education and Science of Poland and the statutory research fund no. N18/DBS/000018 of the Laboratory of Experimental Neuropathology (Institute of Zoology and Biomedical Research, Jagiellonian University). Part of the presented results were obtained using apparatus bought in frame of the ''Excellence Initiative-Research University"Project granted to AGH UST.	Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Chwiej J, 2011, J BIOL INORG CHEM, V16, P275, DOI 10.1007/s00775-010-0724-0; Chwiej J, 2010, J CHEM NEUROANAT, V40, P140, DOI 10.1016/j.jchemneu.2010.03.008; Chwiej J, 2015, EPILEPSY BEHAV, V49, P40, DOI 10.1016/j.yebeh.2015.04.042; Crupi R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040297; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DAWSON RMC, 1957, BIOL REV, V32, P188, DOI 10.1111/j.1469-185X.1957.tb01562.x; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Drozdz A, 2020, SPECTROCHIM ACTA A, V236, DOI 10.1016/j.saa.2020.118355; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Janeczko K, 1997, BRAIN RES, V770, P237, DOI 10.1016/S0006-8993(97)00873-1; JANECZKO K, 1994, INT J DEV NEUROSCI, V12, P431, DOI 10.1016/0736-5748(94)90027-2; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones EV, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/321209; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kutorasinska J, 2013, ANAL BIOANAL CHEM, V405, P7337, DOI 10.1007/s00216-013-7191-8; Lasch P, 2002, BIOPOLYMERS, V67, P335, DOI 10.1002/bip.10095; Lerouet D, 2021, FUND CLIN PHARMACOL, V35, P524, DOI 10.1111/fcp.12656; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Sendrowski K, 2013, PHARMACOL REP, V65, P555, DOI 10.1016/S1734-1140(13)71033-8; Setkowicz Z, 2004, EPILEPSY RES, V61, P63, DOI 10.1016/j.eplepsyres.2004.06.001; Setkowicz Z, 2003, EPILEPSY RES, V53, P216, DOI 10.1016/S0920-1211(03)00029-9; Setkowicz Z, 2007, EPILEPSY RES, V73, P151, DOI 10.1016/j.eplepsyres.2006.09.001; Skoczen A, 2017, SPECTROCHIM ACTA A, V184, P13, DOI 10.1016/j.saa.2017.04.085; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Tamburini E, 2019, FASEB J, V33, P3112, DOI 10.1096/fj.201801670R; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	35	0	0	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1386-1425	1873-3557		SPECTROCHIM ACTA A	Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.	DEC 15	2021	263								120214	10.1016/j.saa.2021.120214			9	Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Spectroscopy	UJ7YC	WOS:000691495800009	34325168	hybrid			2022-02-06	
J	Koivikko, P; Posti, JP; Mohammadian, M; Lagerstedt, L; Azurmendi, L; Hossain, I; Katila, AJ; Menon, D; Newcombe, VFJ; Hutchinson, PJ; Maanpaa, HR; Tallus, J; Zetterberg, H; Blennow, K; Tenovuo, O; Sanchez, JC; Takala, RSK				Koivikko, Pia; Posti, Jussi P.; Mohammadian, Mehrbod; Lagerstedt, Linnea; Azurmendi, Leire; Hossain, Iftakher; Katila, Ari J.; Menon, David; Newcombe, Virginia F. J.; Hutchinson, Peter John; Maanpaa, Henna-Riikka; Tallus, Jussi; Zetterberg, Henrik; Blennow, Kaj; Tenovuo, Olli; Sanchez, Jean-Charles; Takala, Riikka S. K.			Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						assessment; acute care	BIOMARKERS; FLUID	Background There is substantial interest in blood biomarkers as fast and objective diagnostic tools for traumatic brain injury (TBI) in the acute setting. Methods Adult patients (>= 18) with TBI of any severity and indications for CT scanning and orthopaedic injury controls were prospectively recruited during 2011-2013 at Turku University Hospital, Finland. The severity of TBI was classified with GCS: GCS 13-15 was classified as mild (mTBI); GCS 9-12 as moderate (moTBI) and GCS 3-8 as severe (sTBI). Serum samples were collected within 24 hours of admission and biomarker levels analysed with high-performance kits. The ability of biomarkers to distinguish between severity of TBI and CT-positive and CT-negative patients was assessed. Results Among 189 patients recruited, neurofilament light (NF-L) was obtained from 175 patients with TBI and 40 controls. S100 calcium-binding protein B (S100B), heart fatty-acid binding protein (H-FABP) and interleukin-10 (IL-10) were analysed for 184 patients with TBI and 39 controls. There were statistically significant differences between levels of all biomarkers between the severity classes, but none of the biomarkers distinguished patients with moTBI from patients with sTBI. Patients with mTBI discharged from the ED had lower levels of IL-10 (0.26, IQR=0.21, 0.39 pg/mL), H-FABP (4.15, IQR=2.72, 5.83 ng/mL) and NF-L (8.6, IQR=6.35, 15.98 pg/mL) compared with those admitted to the neurosurgical ward, IL-10 (0.55, IQR=0.31, 1.42 pg/mL), H-FABP (6.022, IQR=4.19, 20.72 ng/mL) and NF-L (13.95, IQR=8.33, 19.93 pg/mL). We observed higher levels of H-FABP and NF-L in older patients with mTBI. None of the biomarkers or their combinations was able to distinguish CT-positive (n=36) or CT-negative (n=58) patients with mTBI from controls. Conclusions S100B, H-FABP, NF-L and IL-10 levels in patients with mTBI were significantly lower than in patients with moTBI and sTBI but alone or in combination, were unable to distinguish patients with mTBI from orthopaedic controls. This suggests these biomarkers cannot be used alone to diagnose mTBI in trauma patients in the acute setting.	[Koivikko, Pia; Katila, Ari J.; Takala, Riikka S. K.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Koivikko, Pia; Katila, Ari J.; Takala, Riikka S. K.] Univ Turku, Anaesthesiol Intens Care Emergency Care & Pain Me, Turku, Finland; [Posti, Jussi P.; Hossain, Iftakher; Maanpaa, Henna-Riikka] Turku Univ Hosp, Dept Neurosurg & Turku Brain Injury, Neuroctr, Turku, Finland; [Posti, Jussi P.; Mohammadian, Mehrbod; Maanpaa, Henna-Riikka; Tenovuo, Olli] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Mohammadian, Mehrbod; Tallus, Jussi; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Neuroctr, Turku, Finland; [Lagerstedt, Linnea; Azurmendi, Leire; Sanchez, Jean-Charles] Univ Geneva, Fac Med, Dept Special Internal Med, Geneva, Switzerland; [Hossain, Iftakher; Hutchinson, Peter John] Univ Cambridge, Neurosurg Unit, Dept Clin Neurosci, Cambridge, England; [Menon, David; Newcombe, Virginia F. J.] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Tallus, Jussi] Univ Turku, Dept Radiol, Turku, Finland; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden		Koivikko, P (corresponding author), TYKS Turku Univ Hosp, Perioperat Serv Intens Care Med & Management, Turku, Finland.	piaknuu@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Takala, Riikka/0000-0001-6342-0043; Newcombe, Virginia/0000-0001-6044-9035	Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Finnish Government's Special Financial Transfer tied to academic research in Health Sciences [11129]; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532, 2017-00915]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grantSKA South Africa [860197]; Centrum for Idrottsforskning [P2019-0198]; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; Swedish government [ALFGBG-715986]; Swedish County Councils, the ALF agreement [ALFGBG-715986]; EUEuropean Commission; UK Dementia Research Institute at UCL	This study was a part of the EU--funded TBI care project (Evidence--based Diagnostic and Treatment Planning Solution for Traumatic Brain Injuries). This work was partially funded by Academy of Finland (Grant #17379, JPP), Finnish Government's Special Financial Transfer tied to academic research in Health Sciences (Grant #11129, JPP). VFJN is supported by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018--02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG--720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809--2016862), the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska--Curie grant agreement no. 860197 (MIRIADE), the UK Dementia Research Institute at UCL and Centrum for Idrottsforskning (#P2019--0198). KB holds the Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences, and is supported by the Swedish Research Council (#2017--00915), the Swedish Alzheimer Foundation (#AF-742881), Hjarnfonden, Sweden (#FO2017--0243) and a grant (#ALFGBG--715986) from the Swedish state under the agreement between the Swedish government and the County Councils, the ALF agreement.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Lippi G, 2014, KARDIOL POL, V72, P527, DOI 10.5603/KP.a2014.0043; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; National Institute for Health and Care Excellence, HEAD INJ ASS EARL MA; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Viswanathan K, 2010, J AM COLL CARDIOL, V55, P2590, DOI 10.1016/j.jacc.2009.12.062; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	25	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2020-209471		DEC 2021	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XR0AY	WOS:000731902800001	34916280	Green Submitted			2022-02-06	
J	Kothari, SF; Nascimento, GG; Jakobsen, MB; Nielsen, JF; Kothari, M				Kothari, Simple F.; Nascimento, Gustavo G.; Jakobsen, Mille B.; Nielsen, Jorgen F.; Kothari, Mohit			Effectiveness of Standard Oral Care Plan During Hospital Stay in Individuals With Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						hospitalization; neurorehabilitation; nursing; oral health; oral hygiene; periodontitis; stroke; traumatic brain injury	HEALTH; STROKE; GINGIVITIS; QUALITY; PERIODONTITIS; ASSOCIATION; DYSPHAGIA; CALCULUS; OUTCOMES	Objective: To investigate the effectiveness of an existing standard oral care program (SOCP) and factors associated with it during hospitalization in individuals with acquired brain injury (ABI).Material and Methods: A total of 61 individuals underwent a SOCP for 4 weeks in a longitudinal observational study. Rapidly noticeable changes in oral health were evaluated by performing plaque, calculus, bleeding on probing (BOP) and bedside oral examination (BOE) at weeks 1 and 5. Individuals' brushing habits, eating difficulties, and the onset of pneumonia were retrieved from their medical records. Association between oral-health outcomes to systemic variables were investigated through multilevel regression models.Results: Dental plaque (P = 0.01) and total BOE score (P < 0.05) decreased over time but not the proportion of dental calculus (P = 0.30), BOP (P = 0.06), and tooth brushing frequency (P = 0.06). Reduction in plaque and BOE over time were negatively associated with higher periodontitis scores at baseline (coef. -6.8; -1.0), respectively, which in turn were associated with an increased proportion of BOP (coef. approximate to 15.0). An increased proportion of calculus was associated with eating difficulties (coef. 2.3) and the onset of pneumonia (coef. 6.2).Conclusions: Nursing care has been fundamental in improving oral health, especially reducing dental plaque and BOE scores. However, our findings indicate a need for improving the existing SOCP through academic-clinical partnerships.	[Kothari, Simple F.; Jakobsen, Mille B.; Nielsen, Jorgen F.; Kothari, Mohit] Aarhus Univ, Dept Clin Med, Hammel Neurorehabil Ctr, Hammel, Denmark; [Kothari, Simple F.; Jakobsen, Mille B.; Nielsen, Jorgen F.; Kothari, Mohit] Aarhus Univ, Univ Res Clin, Hammel, Denmark; [Kothari, Simple F.] Aarhus Univ, Dept Dent & Oral Hlth, Sect Orofacial Pain & Jaw Funct, Aarhus, Denmark; [Nascimento, Gustavo G.] Aarhus Univ, Dept Dent & Oral Hlth, Sect Periodontol, Aarhus, Denmark; [Kothari, Mohit] JSS Acad Higher Educ & Res, JSS Dent Coll & Hosp, Mysore, Karnataka, India		Kothari, M (corresponding author), Aarhus Univ, Dept Clin Med, Hammel Neurorehabil Ctr, Hammel, Denmark.; Kothari, M (corresponding author), Aarhus Univ, Univ Res Clin, Hammel, Denmark.	mohkot@rm.dk		Nascimento, Gustavo/0000-0002-4288-6300; Nielsen, Jorgen Feldbaek/0000-0001-5339-171X; Kothari, Mohit/0000-0002-8191-9769			Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; AINAMO J, 1975, INT DENT J, V25, P229; Ajwani S, 2017, J CLIN NURS, V26, P891, DOI 10.1111/jocn.13520; Bailey RL, 2004, J AM DIET ASSOC, V104, P1273, DOI 10.1016/j.jada.2004.05.210; Brady M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003864.pub2; Cabre M, 2010, AGE AGEING, V39, P39, DOI 10.1093/ageing/afp100; Christou V, 1998, J PERIODONTOL, V69, P759, DOI 10.1902/jop.1998.69.7.759; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Crocombe LA, 2012, J PERIODONTAL RES, V47, P188, DOI 10.1111/j.1600-0765.2011.01420.x; Dai RX, 2015, J DENT, V43, P171, DOI 10.1016/j.jdent.2014.06.005; Dickinson Hazel, 2012, Nurs Stand, V26, P35; Hankemeier A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0469-z; Janket Sok-Ja, 2003, Gerodontology, V20, P41, DOI 10.1111/j.1741-2358.2003.00041.x; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Kothari M, 2017, OR SURG OR MED OR PA, V123, P205, DOI 10.1016/j.oooo.2016.10.024; Kothari M, 2016, BRAIN INJURY, V30, P1103, DOI 10.3109/02699052.2016.1167244; Kothari SF, 2021, BRAIN INJURY, V35, P718, DOI 10.1080/02699052.2021.1891289; Kothari SF, 2021, BRAIN INJURY, V35, P96, DOI 10.1080/02699052.2020.1858497; Kothari SF, 2020, BRAIN INJURY, V34, P1264, DOI 10.1080/02699052.2020.1795720; Kwok C, 2015, J ORAL REHABIL, V42, P65, DOI 10.1111/joor.12229; Lin K., 2020, STATPEARLS; Manresa C, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009376.pub2; Mortensen J, 2020, BRAIN INJURY, V34, P1257, DOI 10.1080/02699052.2020.1800094; Nascimento GG, 2019, EUR J ORAL SCI, V127, P33, DOI 10.1111/eos.12588; Nascimento GG, 2018, ACTA DIABETOL, V55, P653, DOI 10.1007/s00592-018-1120-4; Nascimento GG, 2018, COMMUNITY DENT ORAL, V46, P303, DOI 10.1111/cdoe.12367; Nascimento GG, 2017, AM J EPIDEMIOL, V185, P442, DOI 10.1093/aje/kww187; Nascimento PC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00323; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Odgaard L, 2019, J ORAL REHABIL, V46, P730, DOI 10.1111/joor.12799; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Ortega O, 2014, AGE AGEING, V43, P132, DOI 10.1093/ageing/aft164; Pillai RS, 2018, CEREBROVASC DIS EXTR, V8, P1, DOI 10.1159/000484989; Pow EHN, 2005, INT DENT J, V55, P319, DOI 10.1111/j.1875-595X.2005.tb00330.x; Prendergast V, 2013, INTENS CRIT CARE NUR, V29, P282, DOI 10.1016/j.iccn.2013.04.001; Sundhedsstyrelsen S., 2011, HJERNESKADEREHABILIT; Trombelli L, 2018, J PERIODONTOL, V89, pS46, DOI 10.1002/JPER.17-0576; Trosborg I., 2010, KLINISK RETNINGSLINJ	38	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 15	2021	12								714167	10.3389/fneur.2021.714167			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YA3XX	WOS:000738271300001	34975708	gold, Green Published			2022-02-06	
J	Leister, I; Altendorfer, B; Maier, D; Mach, O; Wutte, C; Grillhoesl, A; Arevalo-Martin, A; Garcia-Ovejero, D; Aigner, L; Grassner, L				Leister, Iris; Altendorfer, Barbara; Maier, Doris; Mach, Orpheus; Wutte, Christof; Grillhoesl, Andreas; Arevalo-Martin, Angel; Garcia-Ovejero, Daniel; Aigner, Ludwig; Grassner, Lukas			Serum Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein Are Related to the Neurological Impairment and Spinal Edema after Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; clinical decision making; diagnostic techniques; spinal cord injuries	CEREBROSPINAL-FLUID; REPRODUCIBLE METHOD; ENOLASE NSE; BIOMARKERS; SEVERITY; BLOOD; MRI; BRAIN; CLASSIFICATION; COMPRESSION	Neurological examination in the acute phase after spinal cord injury (SCI) is often impossible and severely confounded by pharmacological sedation or concomitant injuries. Therefore, diagnostic biomarkers that objectively characterize severity or the presence of SCI are urgently needed to facilitate clinical decision-making. This study aimed to determine if serum markers of neural origin are related to: 1) presence and severity of SCI, and 2) magnetic resonance imaging (MRI) parameters in the very acute post-injury phase. We performed a secondary analysis of serological parameters, as well as MRI findings in patients with acute SCI (n = 38). Blood samples were collected between Days 1-4 post-injury. Serum protein levels of glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), and neurofilament light protein (NfL) were determined. A group of 41 age- and sex-matched healthy individuals served as control group. In the group of individuals with SCI, pre-operative sagittal and axial T2-weighted and sagittal T1-weighted MRI scans were available for 21 patients. Serum markers of neural origin are different among individuals who sustained traumatic SCI depending on injury severity, and the extent of the lesion according to MRI in the acute injury phase. Unbiased Recursive Partitioning regression with Conditional Inference Trees (URP-CTREE) produced preliminary cut-off values for NfL (75.217 pg/mL) and GFAP (73.121 pg/mL), allowing a differentiation between individuals with SCI and healthy controls within the first 4 days after SCI. Serum proteins NfL and GFAP qualify as diagnostic biomarkers for the presence and severity of SCI in the acute post-injury phase, where the reliability of clinical exams is limited.	[Leister, Iris; Maier, Doris; Mach, Orpheus; Aigner, Ludwig; Grassner, Lukas] ParaMove, SCI Res Unit, BG Trauma Ctr Murnau, Murnau, Germany; [Leister, Iris; Maier, Doris; Mach, Orpheus; Wutte, Christof; Aigner, Ludwig; Grassner, Lukas] Paracelsus Med Univ, Salzburg, Austria; [Leister, Iris; Maier, Doris; Mach, Orpheus; Aigner, Ludwig; Grassner, Lukas] BG Trauma Ctr Murnau, Spinal Cord Injury Ctr, Clin Res Unit, Murnau, Germany; [Leister, Iris; Altendorfer, Barbara; Aigner, Ludwig; Grassner, Lukas] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Leister, Iris; Altendorfer, Barbara; Aigner, Ludwig; Grassner, Lukas] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Wutte, Christof] BG Trauma Ctr Murnau, Dept Neurosurg, Murnau, Germany; [Wutte, Christof] BG Trauma Ctr Murnau, Inst Biomech, Murnau, Germany; [Grillhoesl, Andreas] BG Trauma Ctr Murnau, Dept Radiol Neuroradiol & Intervent Radiol, Murnau, Germany; [Arevalo-Martin, Angel; Garcia-Ovejero, Daniel] Hosp Nacl Paraplejicos, Lab Neuroinflammat, SESCAM, Toledo, Spain; [Aigner, Ludwig] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Grassner, Lukas] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria		Grassner, L (corresponding author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.	lukas.grassner@gmail.com		Arevalo-Martin, Angel/0000-0002-0549-6098	Spinal Cord Injury and Tissue Regenera-tion Center Salzburg (SCI-TReCS)	Funding Information The main study on which this posthocanalysis is basedon was funded by the Fundacion Mutua Madrilenain 2014. The assays for serum analysis in this study were funded by the Spinal Cord Injury and Tissue Regenera-tion Center Salzburg (SCI-TReCS).	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Anderson RE, 2003, J CARDIOTHOR VASC AN, V17, P598, DOI 10.1016/S1053-0770(03)00203-9; Arevalo-Martin A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02365; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Choong AMTL, 2019, VASC ENDOVASC SURG, V53, P230, DOI 10.1177/1538574418814612; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; Du WJ, 2018, MED SCI MONITOR, V24, P4510, DOI 10.12659/MSM.907406; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Furlan JC, 2007, SPINE, V32, P2083, DOI 10.1097/BRS.0b013e318145a91c; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Haefeli J, 2017, AM J NEURORADIOL, V38, P648, DOI 10.3174/ajnr.A5021; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Jones A, 2017, CLIN EXP EMERG MED, V4, P121, DOI 10.15441/ceem.17.226; Kalm M, 2017, BRAIN RES, V1668, P12, DOI 10.1016/j.brainres.2017.05.011; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Leister I, 2020, NEUROREHAB NEURAL RE, V34, P95, DOI 10.1177/1545968319899920; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Merisson E, 2016, NEUROCHEM INT, V93, P1, DOI 10.1016/j.neuint.2015.12.003; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Monserrate AE, 2015, JAMA NEUROL, V72, P325, DOI 10.1001/jamaneurol.2014.3974; Pan WH, 2008, CURR PHARM DESIGN, V14, P1620, DOI 10.2174/138161208784705450; Parashari UC, 2011, J CRANIOVERTEBRAL JU, V2, P17, DOI 10.4103/0974-8237.85309; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Puentes F, 2014, J NEUROL NEUROSUR PS, V85, P274, DOI [10.1136/jnnp-2013-305494, 10.1136/jnnp-2013-307454]; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rutges JPHJ, 2017, EUR SPINE J, V26, P2324, DOI 10.1007/s00586-017-5097-4; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Schading S, 2021, CURR NEUROL NEUROSCI, V21, DOI 10.1007/s11910-021-01134-x; Streijger F, 2017, J NEUROTRAUM, V34, P2054, DOI 10.1089/neu.2016.4879; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Tigchelaar S, 2019, J NEUROTRAUM, V36, P2358, DOI 10.1089/neu.2018.6256; Vo AK, 2021, SPINAL CORD, V59, P282, DOI 10.1038/s41393-020-00536-x; Wang LP, 1997, DAN MED BULL, V44, P79; Wei T., 2017, J ROY STAT SOC D-STA, V56, P316; Winnerkvist A, 2007, EUR J CARDIO-THORAC, V31, P637, DOI 10.1016/j.ejcts.2007.01.007; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21170	43	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2021	38	24					3431	3439		10.1089/neu.2021.0264			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XO1RO	WOS:000729970500005	34541888				2022-02-06	
J	Lev, A; Elbaum, T; Berger, C; Braw, Y				Lev, Astar; Elbaum, Tomer; Berger, Corinne; Braw, Yoram			Feigned ADHD Associated Cognitive Impairment: Utility of Integrating an Eye-trAcker and the MOXO-dCPT	JOURNAL OF ATTENTION DISORDERS			English	Article; Early Access						ADHD; continuous performance test; MOXO-dCPT; feigned cognitive impairment; eye tracking	TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY; DIAGNOSIS; SCALE	Objective: The current study assessed the utility of eye-movements measures, gathered while participants performed a commercially available Continuous Performance Test (CPT), to detect feigned ADHD-associated cognitive impairment. Method: Healthy simulators (n = 37), ADHD patients (n = 33), and healthy controls (n = 36) performed an eye-tracker integrated MOXO-dCPT and a stand-alone validity indicator. Results: Simulators gazed significantly longer at regions that were irrelevant for successful MOXO-dCPT performance compared to ADHD patients and healthy controls. This eye-movement measure, however, had lower sensitivity than traditional MOXO-dCPT indices. Discussion: Gaze direction measures, gathered while performing a CPT, show initial promise as validity indicators. Traditional CPT measures, however, are more sensitive and therefore offer a more promising path for the establishment of CPT-based validity indicators. The current study is an initial exploration of the issue and further evaluation of both theoretical and practical aspects is mandated.	[Lev, Astar] Bar Ilan Univ, Ramat Gan, Israel; [Elbaum, Tomer] Ariel Univ, Ind Engn & Management Dept, Ariel, Israel; [Berger, Corinne] Ariel Univ, Dept Sociol, Ariel, Israel; [Braw, Yoram] Ariel Univ, Clin Rehabil Neuropsychol, Ariel, Israel; [Braw, Yoram] Ariel Univ, Forens & Clin Neuropsychol Lab, Dept Psychol, Ariel, Israel		Braw, Y (corresponding author), Ariel Univ, Dept Psychol, POB 3, IL-40700 Ariel, Israel.	yoramb@ariel.ac.il		Braw, Yoram/0000-0002-5656-4863; Berger, Corinne/0000-0002-0389-0622			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Armistead-Jehle P, 2021, DETECTION MALINGERIN, V3rd, P223; Arnold LE, 2020, J ATTEN DISORD, V24, P73, DOI 10.1177/1087054714566076; Barry DM, 2016, ARCH CLIN NEUROPSYCH, V31, P963, DOI 10.1093/arclin/acw070; Ben-Sheetrit J, 2021, J ATTEN DISORD, V25, P14, DOI 10.1177/1087054717743328; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Boone K.B., 2013, CLIN PRACTICE FORENS; Bordoff B, 2017, PSYCHOL INJ LAW, V10, P114, DOI 10.1007/s12207-017-9288-4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Davis J.J., 2021, ASSESSMENT FEIGNED C, V2nd, P283; Dobrakowski P, 2020, CLIN EEG NEUROSCI, V51, P94, DOI 10.1177/1550059419879020; Duchowski A. T., 2017, EYE TRACKING METHODO; Eckstein MK, 2017, DEV COGN NEUROS-NETH, V25, P69, DOI 10.1016/j.dcn.2016.11.001; Elbaum T, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20216386; Faraone SV, 2021, NEUROSCI BIOBEHAV R, V128, P789, DOI 10.1016/j.neubiorev.2021.01.022; Faraone SV, 2020, J AM ACAD CHILD PSY, V59, P100, DOI 10.1016/j.jaac.2019.06.012; First M., 2015, STRUCTURED CLIN INTE; Gamer M., 2018, DETECTING CONCEALED, P169; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Green P, 1994, MANUAL ORAL WORD MEM; Guilmette T.J., 2013, MILD TRAUMATIC BRAIN, P31; Hall CL, 2016, EUR CHILD ADOLES PSY, V25, P677, DOI 10.1007/s00787-015-0798-x; Harrison A.G, 2021, ASSESSMENT FEIGNED C, V2nd, P525; Holmqvist K., 2017, EYE TRACKING COMPREH; Ivanchenko Daria, 1800, J Eye Mov Res, V14, DOI 10.16910/jemr.14.3.3; Jones SM, 2017, BRAIN INJURY, V31, P1131, DOI 10.1080/02699052.2017.1283444; Joseph A, 2019, J ATTEN DISORD, V23, P1610, DOI 10.1177/1087054718799367; Kanser RJ, 2020, NEUROPSYCHOLOGY, V34, P308, DOI 10.1037/neu0000613; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lev A, 2022, J ATTEN DISORD, V26, P245, DOI 10.1177/1087054720972786; Mac Giolla E, 2021, APPL COGNITIVE PSYCH, V35, P385, DOI 10.1002/acp.3777; Mahoney EJ, 2018, J APPL RES MEM COGN, V7, P441, DOI 10.1016/j.jarmac.2018.05.004; Marshall P, 2021, CLIN NEUROPSYCHOL, V35, P165, DOI 10.1080/13854046.2019.1696409; Nicholls CJ, 2020, APPL NEUROPSYCH-CHIL, V9, P307, DOI 10.1080/21622965.2020.1751787; Patrick SD, 2021, NEUROPSYCHOLOGY, V35, P472, DOI 10.1037/neu0000747; Peled J, 2020, NORD J PSYCHIAT, V74, P163, DOI 10.1080/08039488.2019.1686063; Rickards TA, 2018, APPL NEUROPSYCH-ADUL, V25, P219, DOI 10.1080/23279095.2017.1278602; Rogers R., 2018, CLIN ASSESSMENT MALI, P592; Sagar S, 2017, PSYCHOL INJ LAW, V10, P105, DOI 10.1007/s12207-017-9286-6; Schroeder R.W, 2021, ASSESSMENT FEIGNED C, V2nd, P34; Schroeder R.W., 2021, ASSESSMENT FEIGNED C, P11; Scimeca LM, 2021, DEV NEUROPSYCHOL, V46, P347, DOI 10.1080/87565641.2021.1951270; Sherman EMS, 2020, ARCH CLIN NEUROPSYCH, V35, P735, DOI 10.1093/arclin/acaa019; Shumaker B.E.S, 2020, J HLTH SERVICE PSYCH, V46, P119; Sibley MH, 2017, ASSESSMENT, V24, P290, DOI 10.1177/1073191116676890; Skaramagkas Vasileios, 2021, IEEE Rev Biomed Eng, VPP, DOI 10.1109/RBME.2021.3066072; Slobodin O, 2020, EUR ADDICT RES, V26, P151, DOI 10.1159/000506334; Slobodin O, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00441; Smyrnis N, 2019, STUD NEUROSCI, P703, DOI 10.1007/978-3-030-20085-5_16; Stevens A, 2019, J FORENSIC PSYCHI PS, V30, P220, DOI 10.1080/14789949.2018.1539509; Sturdivant, 2013, APPL LOGISITIC REGRE; Sweet JJ, 2021, CLIN NEUROPSYCHOL, V35, P1053, DOI 10.1080/13854046.2021.1896036; Tao L, 2020, NEUROL SCI, V41, P1697, DOI 10.1007/s10072-020-04310-y; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; van der Veen S, 2019, MOVEMENT DISORD, V34, P1602, DOI 10.1002/mds.27828; van Gog T, 2009, COMPUT HUM BEHAV, V25, P325, DOI 10.1016/j.chb.2008.12.021; Vrij A, 2017, LEGAL CRIMINOL PSYCH, V22, P1, DOI 10.1111/lcrp.12088; Walczyk JJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00700; WARD MF, 1993, AM J PSYCHIAT, V150, P885	65	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.											10870547211063643	10.1177/10870547211063643		DEC 2021	11	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	XR7KF	WOS:000732402500001	34911385				2022-02-06	
J	Nakashima, M; Gotoh, M; Hashimoto, K; Endo, M; Murakami-Murofushi, K; Ikeshima-Kataoka, H; Miyamoto, Y				Nakashima, Mari; Gotoh, Mari; Hashimoto, Kei; Endo, Misaki; Murakami-Murofushi, Kimiko; Ikeshima-Kataoka, Hiroko; Miyamoto, Yasunori			The neuroprotective function of 2-carba-cyclic phosphatidic acid: Implications for tenascin-C via astrocytes in traumatic brain injury	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Astrocyte; Lipopolysaccharide; Neuroprotection; Tenascin-C; Traumatic brain injury; 2-carba cyclic phosphatidic acid	EXTRACELLULAR-MATRIX; REACTIVE ASTROCYTES; EXPRESSION; INHIBITION; PROTEIN	We examined the mechanism how 2-carba-cyclic phosphatidic acid (2ccPA), a lipid mediator, regulates neuronal apoptosis in traumatic brain injury (TBI). First, we found 2ccPA suppressed neuronal apoptosis after the injury, and increased the immunoreactivity of tenascin-C (TN-C), an extracellular matrix protein by 2ccPA in the vicinity of the wound region. 2ccPA increased the mRNA expression levels of Tnc in primary cultured astrocytes, and the conditioned medium of 2ccPA-treated astrocytes suppressed the apoptosis of cortical neurons. The neuroprotective effect of TN-C was abolished by knockdown of TN-C. These results indicate that 2ccPA contributes to neuroprotection via TN-C from astrocytes in TBI.	[Nakashima, Mari; Endo, Misaki; Miyamoto, Yasunori] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan; [Nakashima, Mari; Gotoh, Mari; Hashimoto, Kei; Endo, Misaki; Miyamoto, Yasunori] Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan; [Gotoh, Mari; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Res Div Human Welf Sci, Bunkyo Ku, Tokyo, Japan; [Ikeshima-Kataoka, Hiroko] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan		Miyamoto, Y (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan.; Ikeshima-Kataoka, H (corresponding author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan.	ikeshima@1988.jukuin.keio.ac.jp; miyamoto.yasunori@ocha.ac.jp	Miyamoto, Yasunori/M-4018-2018	Miyamoto, Yasunori/0000-0001-9192-4281	Institute for Human Life Innovation, Ochanomizu University; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19K07098]	The authors wish to thank Prof. Toshimichi Yoshida and Prof. Kyoko Imanaka-Yoshida (Mie University Graduate School of Medicine, Tsu, Japan) for providing the TN-C derived from the human glioma cell line. The authors gratefully acknowledge the work of past and present members of the Miyamoto and Murofushi laboratories. This work was supported by the Institute for Human Life Innovation, Ochanomizu University. This work was partly supported by JSPS KAKENHI, [grant number 19K07098 (M.G.)]. M.G. thanks the Research Organization for the Promotion of Global Women's Leadership, Ochanomizu University. We would like to thank Editage (www.editage.com) for English language editing.	Amin DN, 2010, AM J TROP MED HYG, V82, P983, DOI 10.4269/ajtmh.2010.09-0770; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Brellier F, 2011, FEBS LETT, V585, P913, DOI 10.1016/j.febslet.2011.02.023; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Dai Y, 2019, STEM CELLS, V37, P1344, DOI 10.1002/stem.3060; Dobbertin A, 2010, EXP NEUROL, V225, P60, DOI 10.1016/j.expneurol.2010.04.019; Early AN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01800-w; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Fujimoto M, 2016, J NEUROSURG, V124, P1693, DOI 10.3171/2015.4.JNS15484; Fujiwara Y, 2003, J NEUROCHEM, V87, P1272, DOI 10.1046/j.1471-4159.2003.02106.x; George N, 2018, J NEUROSCI RES, V96, P573, DOI 10.1002/jnr.24151; Gotoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051093; Gotoh M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-52; Gotoh M, 2010, EUR J PHARMACOL, V649, P206, DOI 10.1016/j.ejphar.2010.09.052; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griffiths DR, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1767; Hashimoto K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27990-1; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ikeshima-Kataoka H, 2008, NEUROL RES, V30, P701, DOI 10.1179/174313208X289552; Ikeshima-Kataoka H, 2008, IN VIVO, V22, P409; Ikeshima-Kataoka H, 2016, NEUROREPORT, V27, P894, DOI 10.1097/WNR.0000000000000619; Ikeshima-Kataoka H, 2015, J NEUROSCI RES, V93, P121, DOI 10.1002/jnr.23467; IMAI K, 1994, FEBS LETT, V352, P216, DOI 10.1016/0014-5793(94)00960-0; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; Liu L, 2018, MOL NEUROBIOL, V55, P8346, DOI 10.1007/s12035-018-1006-z; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; Minta K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75233-z; Minta K, 2019, CLIN CHEM LAB MED, V57, P1565, DOI 10.1515/cclm-2019-0034; Murakami-Murofushi K, 2002, BBA-MOL CELL BIOL L, V1582, P1, DOI 10.1016/S1388-1981(02)00131-2; MURAKAMIMUROFUSHI K, 1992, J BIOL CHEM, V267, P21512; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; Suzuki Hidenori, 2015, Acta Neurochir Suppl, V120, P117, DOI 10.1007/978-3-319-04981-6_20; Tong XP, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104485; Tucker RP, 2015, INT J BIOCHEM CELL B, V65, P165, DOI 10.1016/j.biocel.2015.06.003; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Wiemann S., FRONT NEUROSCI-SWITZ, V15, P2021; Yamamoto S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0923-5; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Zhao YY, 2017, CLIN CHIM ACTA, V472, P46, DOI 10.1016/j.cca.2017.07.018	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	DEC 15	2021	361								577749	10.1016/j.jneuroim.2021.577749			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	WW8NO	WOS:000718166300004	34688067	hybrid			2022-02-06	
J	Sribnick, EA; Warner, T; Hall, MW				Sribnick, Eric A.; Warner, Timothy; Hall, Mark W.			Traumatic brain injury and hemorrhage in a juvenile rat model of polytrauma leads to immunosuppression and splenic alterations	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Hemorrhage; Rat; Juvenile; Immune suppression; Tumor necrosis factor alpha; Spleen	NECROSIS-FACTOR-ALPHA; NOSOCOMIAL INFECTION; VAGUS NERVE; INTERLEUKIN-10; PATHWAY	Background: Traumatic brain injury (TBI) is a common cause of morbidity and mortality. We have previously shown that TBI with a concurrent extra-cranial injury reliably leads to post-injury suppression of the innate immune system, but the impact of this injury on the adaptive immune system is unknown. We present data showing that combined injury reduced immune response as assayed in both blood and spleen samples and that these changes parallel apoptosis in the spleen. To assess the clinical relevance of these changes, we examined lungs for spontaneous bacterial colonization. Methods: For these studies, prepubescent (28 day old) rats were injured using a controlled cortical impact model and then 25% blood volume removal by arteriotomy, and injured animals were compared with sham injured animals. Blood and spleen samples at post-injury day 1 were incubated with or without immunostimulant and examined for IFN-gamma production using an Eli-Spot assay. Spleen samples were also examined for apoptosis using Annexin V staining, and lungs were harvested and plated on blood agar to examine for spontaneous bacterial colonization. Results: Stimulations of whole blood and spleen samples with phorbol 12-myristate 13-acetate/ionomycin (PMA/ I) at post-injury day 1 were associated with significant decreases in IFN-gamma-positive cells/million in injured animals. Stimulation of whole blood with either PMA/I or pokeweed mitogen led to reduced tumor necrosis factor alpha production. Spleen from injured animals showed a marked increase in apoptosis. Lung samples showed a 300% increase in colonies per plate in injured animals. Conclusions: These data suggest that the combined injury can lead to adaptive immunosuppression, and our findings further suggest a potential role for the spleen in altering leukocyte function following injury.	[Sribnick, Eric A.] Nationwide Childrens Hosp, Div Neurosurg, Dept Surg, Columbus, OH 43205 USA; [Sribnick, Eric A.] Ohio State Univ, Coll Med, Dept Neurosurg, Columbus, OH 43210 USA; [Sribnick, Eric A.; Warner, Timothy; Hall, Mark W.] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, Columbus, OH 43205 USA; [Hall, Mark W.] Nationwide Childrens Hosp, Dept Pediat, Div Crit Care, Columbus, OH 43205 USA		Sribnick, EA (corresponding author), Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43205 USA.	eric.sribnick@nationwidechildrens.org; timothy.warner@nationwidechildrens.org; mark.hall@nationwidechildrens.org					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Batistaki C, 2008, VASC PHARMACOL, V48, P85, DOI 10.1016/j.vph.2007.12.003; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Coccolini F, 2017, CURR TRAUMA REP, V3, P285, DOI 10.1007/s40719-017-0094-y; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Felmet KA, 2005, J IMMUNOL, V174, P3765, DOI 10.4049/jimmunol.174.6.3765; Greathouse KC, 2016, AM J CRIT CARE, V25, P85, DOI 10.4037/ajcc2016432; Hou TY, 2019, J FOOD DRUG ANAL, V27, P404, DOI 10.1016/j.jfda.2019.01.001; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Muszynski JA, 2014, SHOCK, V42, P313, DOI 10.1097/SHK.0000000000000217; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sribnick EA, 2020, PEDIATR CRIT CARE ME, V21, P443, DOI 10.1097/PCC.0000000000002238; Sribnick EA, 2019, J NEUROIMMUNOL, V337, DOI 10.1016/j.jneuroim.2019.577073; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Tiesi G, 2013, SHOCK, V39, P507, DOI 10.1097/SHK.0b013e318293d020; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116	28	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	DEC 15	2021	361								577723	10.1016/j.jneuroim.2021.577723			6	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	WK8HA	WOS:000709961100012	34619426				2022-02-06	
J	Svensson, F; Much, A; Exner, C				Svensson, Frederike; Much, Anne; Exner, Cornelia			Personality changes after acquired brain injury and their effects on rehabilitation outcomes	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Acquired brain injury; Stroke; Personality change; Rehabilitation	QUALITY-OF-LIFE; SELF-AWARENESS; STROKE; DEPRESSION; TRAITS; POSTSTROKE; SYMPTOMS; IMPACT; VULNERABILITY; COGNITION	Acquired brain injury (ABI) is often associated with personality changes. Pre- as well as post-injury personality traits are related to rehabilitation outcomes. However, it largely remains unclear whether post-injury personality shows any associations with rehabilitation outcomes over and above pre-injury personality. Using a case-control design, this study investigated (1) personality changes after ABI from patients' and significant others' perspective, and (2) relations of pre- and post-ABI personality traits to rehabilitation outcomes in the short- and long-term. 40 patients with ABI (85% stroke, 15% traumatic brain injury), 46 healthy controls and their significant others participated. Personality was assessed with NEO-FFI, rehabilitation outcomes (activities, participation, depression) were measured at two and ten months after ABI. Patient-ratings indicated decreases in extraversion and a trend towards reduced conscientiousness. Significant others reported increases in patients' neuroticism. Pre- as well as post-injury personality traits were associated with depression and activities at both short- and long-term timepoints after ABI. The association was strongest for long-term depressive symptoms where personality trait variables accounted for 49% of variance (R-adjusted(2)). Our results confirm that ABI patients and significant others perceive personality changes, albeit in different dimensions. Pre- and post-ABI personality traits showed associations with rehabilitation outcomes, especially with emotional adjustment after the injury.	[Svensson, Frederike; Much, Anne; Exner, Cornelia] Univ Leipzig, Clin Psychol & Psychotherapy, Neumarkt 9-19, D-04109 Leipzig, Germany		Svensson, F (corresponding author), Univ Leipzig, Clin Psychol & Psychotherapy, Neumarkt 9-19, D-04109 Leipzig, Germany.	frederike.svensson@uni-leipzig.de		Svensson, Frederike/0000-0001-8894-0133; Exner, Cornelia/0000-0001-5904-6511			Aben I, 2006, INT PSYCHOGERIATR, V18, P19, DOI 10.1017/S104161020500270X; Aben I, 2002, STROKE, V33, P2391, DOI 10.1161/01.STR.0000029826.41672.2E; [Anonymous], 2013, DIAGN STAT MAN MENT, V5th; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beadle EJ, 2020, NEUROPSYCHOL REHABIL, V30, P393, DOI 10.1080/09602011.2018.1469416; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Costa P. T., 1992, REVISED NEO PERSONAL; Douven E, 2018, J PSYCHOSOM RES, V111, P69, DOI 10.1016/j.jpsychores.2018.05.010; Dwan T, 2019, DISABIL REHABIL, V41, P1119, DOI 10.1080/09638288.2017.1419382; Dwan T, 2017, INT PSYCHOGERIATR, V29, P1157, DOI 10.1017/S1041610217000382; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fortune D.G., 2011, IRISH J PSYCHOL, V32, P61, DOI [https://doi.org/10.1080/03033910.2011.618444, DOI 10.1080/03033910.2011.618444]; Fox J., 2019, R COMPANION APPL REG, V3 rd; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, P215, DOI 10.1176/appi.neuropsych.23.2.215; Greenop KR, 2009, INT PSYCHOGERIATR, V21, P1063, DOI 10.1017/S1041610209990457; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Hochstenbach J, 2005, ARCH PHYS MED REHAB, V86, P1587, DOI 10.1016/j.apmr.2004.11.050; HUTTER BO, 1995, BRIT J NEUROSURG, V9, P465, DOI 10.1080/02688699550041106; Hutter BO, 1998, NEUROPSY NEUROPSY BE, V11, P22; IBM Corp, 2019, IBM SPSS STAT WINDOW; Jokela M, 2014, PSYCHOL MED, V44, P2629, DOI 10.1017/S0033291714000257; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kim SY, 2013, EUR NEUROL, V69, P185, DOI 10.1159/000345699; Kootker JA, 2016, ARCH PHYS MED REHAB, V97, P919, DOI 10.1016/j.apmr.2016.01.019; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; Leonhardt A, 2016, J PSYCHOSOM RES, V82, P17, DOI 10.1016/j.jpsychores.2016.01.005; Lezak, 2008, MANUAL MAYO PORTLAND; Lincoln N.B., 2012, NEUROSCI MED, V3, P83, DOI [DOI 10.4236/NM.2012.31013, https://doi.org/10.4236/nm.2012.31013]; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCrae RR., 1999, HDB PERSONALITY THEO, P139; Mottus R, 2020, EUR J PSYCHOL ASSESS, V36, P289, DOI 10.1027/1015-5759/a000516; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Ostendorf F., 1993, NEO FUNF FAKTOREN IN; R Core Team, 2020, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; RYFF CD, 1991, PSYCHOL AGING, V6, P286, DOI 10.1037/0882-7974.6.2.286; Schmid L, 2014, FORTSCHR NEUROL PSYC, V82, P523, DOI 10.1055/s-0034-1366635; Shaw C, 1999, J ADV NURS, V29, P1246, DOI 10.1046/j.1365-2648.1999.01010.x; Solgajova A, 2017, NEUROENDOCRINOL LETT, V38, P290; Sosnowsky, 2008, DIAGNOSTICA, V1, P1, DOI [10.1026/0012-1924.54.1., DOI 10.1026/0012-1924.54.1, 10.1026/0012-1924.54.1]; Stone J, 2004, J NEUROL NEUROSUR PS, V75, P1708, DOI 10.1136/jnnp.2004.037887; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Weddell RA, 2018, BRAIN INJURY, V32, P442, DOI 10.1080/02699052.2018.1429657; Weddell RA, 2016, BRAIN INJURY, V30, P1362, DOI 10.1080/02699052.2016.1195921; Wilson AE, 2001, J PERS SOC PSYCHOL, V80, P572, DOI 10.1037//0022-3514.80.4.572; Wilson RE, 2017, J RES PERS, V69, P110, DOI 10.1016/j.jrp.2016.06.006; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	57	0	0	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.2011749		DEC 2021	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XQ3SQ	WOS:000731468300001	34913399				2022-02-06	
J	Xu, LZ; Ramadan, S; Akingbade, OE; Zhang, YZ; Alodan, S; Graham, N; Zimmerman, KA; Torres, E; Heslegrave, A; Petrov, PK; Zetterberg, H; Sharp, DJ; Klein, N; Li, B				Xu, Lizhou; Ramadan, Sami; Akingbade, Oluwatomi E.; Zhang, Yuanzhou; Alodan, Sarah; Graham, Neil; Zimmerman, Karl A.; Torres, Elias; Heslegrave, Amanda; Petrov, Peter K.; Zetterberg, Henrik; Sharp, David J.; Klein, Norbert; Li, Bing			Detection of Glial Fibrillary Acidic Protein in Patient Plasma Using On-Chip Graphene Field-Effect Biosensors, in Comparison with ELISA and Single-Molecule Array	ACS SENSORS			English	Article; Early Access						&nbsp; single-molecule array; graphene fi eld-e ff ect transistor; biosensor; glial fi brillary acidic protein	DIAGNOSTIC MARKER; GFAP; BIOMARKERS	Glial fibrillary acidic protein (GFAP) is a discriminative blood biomarker for many neurological diseases, such as traumatic brain injury. Detection of GFAP in buffer solutions using biosensors has been demonstrated, but accurate quantification of GFAP in patient samples has not been reported, yet in urgent need. Herein, we demonstrate a robust on-chip graphene field-effect transistor (GFET) biosensing method for sensitive and ultrafast detection of GFAP in patient plasma. Patients with moderate- severe traumatic brain injuries, defined by the Mayo classification, are recruited to provide plasma samples. The binding of target GFAP with the specific antibodies that are conjugated on a monolayer GFET device triggers the shift of its Dirac point, and this signal change is correlated with the GFAP concentration in the patient plasma. The limit of detection (LOD) values of 20 fg/mL (400 aM) in buffer solution and 231 fg/mL (4 fM) in patient plasma have been achieved using this approach. In parallel, for the first time, we compare our results to the state-of-the-art single-molecule array (Simoa) technology and the classic enzyme-linked immunosorbent assay (ELISA) for reference. The GFET biosensor shows competitive LOD to Simoa (1.18 pg/mL) and faster sample-to-result time (<15 min), and also it is cheaper and more user-friendly. In comparison to ELISA, GFET offers advantages of total detection time, detection sensitivity, and simplicity. This GFET biosensing platform holds high promise for the point-of-care diagnosis and monitoring of traumatic brain injury in GP surgeries and patient homes.	[Xu, Lizhou; Ramadan, Sami; Zhang, Yuanzhou; Alodan, Sarah; Petrov, Peter K.; Klein, Norbert] Imperial Coll London, Dept Mat, London SW7 2AZ, England; [Akingbade, Oluwatomi E.; Graham, Neil; Zimmerman, Karl A.; Sharp, David J.; Li, Bing] Imperial Coll London, Dept Brain Sci, London W12 0BZ, England; [Akingbade, Oluwatomi E.; Graham, Neil; Zimmerman, Karl A.; Li, Bing] UK Dementia Res Inst, Care Res & Technol Ctr, London W12 0BZ, England; [Torres, Elias] Graphenea Semicond, San Sebastian 20009, Spain; [Heslegrave, Amanda; Zetterberg, Henrik] UCL, UK Dementia Res Inst UCL, London WC1E 6BT, England; [Heslegrave, Amanda; Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43141 Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, S-43141 Molndal, Sweden		Klein, N (corresponding author), Imperial Coll London, Dept Mat, London SW7 2AZ, England.; Li, B (corresponding author), Imperial Coll London, Dept Brain Sci, London W12 0BZ, England.; Li, B (corresponding author), UK Dementia Res Inst, Care Res & Technol Ctr, London W12 0BZ, England.	b.li@imperial.ac.uk		Klein, Nigel/0000-0003-3925-9258; Li, Bing/0000-0002-1737-3423; , Sami/0000-0002-0013-731X	UK's Engineering and Physical Science Research Council (EPSRC)UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/P02985X/1]; Alzheimer's Research UK Clinical Research Fellowship [ARUKCRF2017A-1]; UK Dementia Research Institute (DRI) Care Research and Technology Centre; NIHRNational Institute for Health Research (NIHR) [NIHR-RP-011-048]; NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Centre for Blast Injury Studies, Imperial College; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862]; AD Strategic Fund; Alzheimer's AssociationAlzheimer's Association [ADSF21-831376-C, ADSF-21-831381-C, ADSF-21-831377-C]; Olav Thon Foundation; Erling-Persson Family Foundation; Stiftelsen for Gamla Tjanarinnor; Hjarnfonden, Sweden [FO2019-0228]; European Union's Horizon 2020 Marie Sklodowska-Curie grant [860197]; DRI at UCL	This work was supported by an Edmond and Lily Safra Fellow to B.L. (Edmond J. Safra Foundation), the UK's Engineering and Physical Science Research Council (EPSRC) through grant EP/P02985X/1 to N.K., an Alzheimer's Research UK Clinical Research Fellowship to N.G. (ARUKCRF2017A-1), the UK Dementia Research Institute (DRI) Care Research and Technology Centre (B.L., N.G., D.J.S.), an NIHR Professorship (NIHR-RP-011-048) awarded to D.J.S., and the NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust. The research was also supported by the Medical Research Council through a Clinician Scientist Fellowship awarded to D.J.S. who was also supported by the Centre for Blast Injury Studies, Imperial College. H.Z. is a Wallenberg Scholar supported by the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), the AD Strategic Fund and the Alzheimer's Association (#ADSF21-831376-C, #ADSF-21-831381-C and #ADSF-21-831377-C), the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen for Gamla Tjanarinnor, Hjarnfonden, Sweden (#FO2019-0228), the European Union's Horizon 2020 Marie Sklodowska-Curie grant No. 860197 (MIRIADE), and DRI at UCL.	Abdelhak A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33158-8; Agostini M, 2021, BIOSENS BIOELECTRON, V172, DOI 10.1016/j.bios.2020.112774; Arya SK, 2013, LANGMUIR, V29, P6770, DOI 10.1021/la401109r; Bungon T, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.651232; Chatterjee P, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01137-1; Clairembault T, 2014, J NEUROCHEM, V130, P805, DOI 10.1111/jnc.12742; de Almeida SM, 2011, HEADACHE, V51, P1503, DOI 10.1111/j.1526-4610.2011.01959.x; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Gao JW, 2020, ACS APPL ELECTRON MA, V2, P1090, DOI 10.1021/acsaelm.0c00095; Graham NSN, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042093; Huang WG, 2014, CHEM SCI, V5, P416, DOI 10.1039/c3sc52638k; Hwang MT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15330-9; Ishigami A, 2015, J NEUROSCI RES, V93, P1664, DOI 10.1002/jnr.23620; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Khetani S, 2018, ACS SENSORS, V3, P844, DOI 10.1021/acssensors.8b00076; Kim K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13901-z; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Li B, 2020, CARBON, V168, P144, DOI 10.1016/j.carbon.2020.06.048; Liu YP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6461; Ma YS, 2018, NANOTECHNOLOGY, V29, DOI 10.1088/1361-6528/aaabea; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Morales-Narvaez E, 2017, ADV MATER, V29, DOI 10.1002/adma.201604905; Nag A, 2018, SENSOR ACTUAT A-PHYS, V270, P177, DOI 10.1016/j.sna.2017.12.028; O'Brien JT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0404-6; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Ping JL, 2016, ACS NANO, V10, P8700, DOI 10.1021/acsnano.6b04110; Prattis I, 2021, TRENDS BIOTECHNOL, V39, P1065, DOI 10.1016/j.tibtech.2021.01.005; Ramadan S, 2021, ACS APPL MATER INTER, V13, P7854, DOI 10.1021/acsami.0c18293; Seo G, 2020, ACS NANO, V14, P12257, DOI [10.1021/acsnano.0c06726, 10.1021/acsnano.0c02823]; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Song J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606506; Sreeprasad TS, 2013, SMALL, V9, P341, DOI 10.1002/smll.201202196; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Tsang DKH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50412-9; Wang SY, 2020, BIOSENS BIOELECTRON, V165, DOI 10.1016/j.bios.2020.112363; Wang T, 2017, INT J ELECTROCHEM SC, V12, P7341, DOI 10.20964/2017.08.69; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	39	0	0	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2379-3694			ACS SENSORS	ACS Sens.												10.1021/acssensors.1c02232		DEC 2021	10	Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics	XT8PH	WOS:000733842500001	34908400	Green Submitted, hybrid			2022-02-06	
J	Yeh, FC; Irimia, A; Bastos, DCD; Golby, AJ				Yeh, Fang-Cheng; Irimia, Andrei; Bastos, Dhiego Chaves de Almeida; Golby, Alexandra J.			Tractography methods and findings in brain tumors and traumatic brain injury	NEUROIMAGE			English	Article						Diffusion MRI; fiber tracking; tractography; brain tumor; glioma; traumatic brain injury	IN-DIFFUSION MRI; CONSTRAINED SPHERICAL DECONVOLUTION; SUPERIOR LONGITUDINAL FASCICULUS; DEFINITION FIBER TRACTOGRAPHY; TENSOR IMAGING TRACTOGRAPHY; WHITE-MATTER TRACTS; ARCUATE FASCICULUS; CORTICOSPINAL TRACT; PERITUMORAL EDEMA; CORPUS-CALLOSUM	White matter fiber tracking using diffusion magnetic resonance imaging (dMRI) provides a noninvasive approach to map brain connections, but improving anatomical accuracy has been a significant challenge since the birth of tractography methods. Utilizing tractography in brain studies therefore requires understanding of its technical limitations to avoid shortcomings and pitfalls. This review explores tractography limitations and how different white matter pathways pose different challenges to fiber tracking methodologies. We summarize the pros and cons of commonly-used methods, aiming to inform how tractography and its related analysis may lead to questionable results. Extending these experiences, we review the clinical utilization of tractography in patients with brain tumors and traumatic brain injury, starting from tensor-based tractography to more advanced methods. We discuss current limitations and highlight novel approaches in the context of these two conditions to inform future tractography developments.	[Yeh, Fang-Cheng] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Yeh, Fang-Cheng] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Irimia, Andrei] Univ Southern Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Corwin D Denney Res Ctr, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA; [Bastos, Dhiego Chaves de Almeida; Golby, Alexandra J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Golby, Alexandra J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA		Yeh, FC (corresponding author), UPMC Presbyterian, Dept Neurol Surg, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	frank.yeh@pitt.edu	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 100973, U01 CA 199459, P41 EB 015898]; DoDUnited States Department of Defense [W81-XWH-1810413]; USC Hanson-Thorell Research Scholarship; Jennifer Oppenheimer Cancer Research Initiative; Alba Tull Center for Neuro Imaging and Therapeutics - Tull Family Foundation	AI is supported by NIH grant R01 NS 100973 , by DoD award W81-XWH-1810413, and by a USC Hanson-Thorell Research Scholarship. AJG is supported by NIH grants U01 CA 199459 and P41 EB 015898 , and by the Jennifer Oppenheimer Cancer Research Initiative. FY's work is partly supported by the Alba Tull Center for Neuro Imaging and Therapeutics funded by the Tull Family Foundation	Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexopoulos G, 2019, WORLD NEUROSURG, V132, pE305, DOI 10.1016/j.wneu.2019.08.168; Aliotta E, 2018, MAGN RESON MED, V79, P663, DOI 10.1002/mrm.26709; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2015, NEUROIMAGE, V122, P166, DOI 10.1016/j.neuroimage.2015.07.067; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Avesani P, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0073-y; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bastiani M, 2019, NEUROIMAGE, V184, P801, DOI 10.1016/j.neuroimage.2018.09.073; Becker D, 2020, WORLD NEUROSURG, V134, pE596, DOI 10.1016/j.wneu.2019.10.138; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Cai LY, 2021, MAGN RESON MED, DOI 10.1002/mrm.28678; Callaghan P.T., 1991, PRINCIPLES NUCL MAGN; Calvillo M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01423; Celtikci P, 2018, NEURORADIOLOGY, V60, P267, DOI 10.1007/s00234-018-1985-5; Chen ZR, 2015, NEUROIMAGE-CLIN, V7, P815, DOI 10.1016/j.nicl.2015.03.009; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; Christiaens D, 2015, NEUROIMAGE, V123, P89, DOI 10.1016/j.neuroimage.2015.08.008; Cieslak M, 2021, NAT METHODS, V18, P775, DOI [10.1038/s41592-021-01185-5, 10.24433/CO.6311778.V1]; Coenen VA, 2001, NEUROSURGERY, V49, P86, DOI 10.1097/00006123-200107000-00013; Coenen VA, 2011, ACTA NEUROCHIR, V153, P1579, DOI 10.1007/s00701-011-1036-z; Conti E, 2017, HUM BRAIN MAPP, V38, P2333, DOI 10.1002/hbm.23520; Cottaar M, 2021, NEUROIMAGE, V227, DOI 10.1016/j.neuroimage.2020.117693; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/NMETH.2482, 10.1038/nmeth.2482]; Cross AH, 2017, J NEUROIMMUNOL, V304, P81, DOI 10.1016/j.jneuroim.2016.10.002; Dell'Acqua F, 2010, NEUROIMAGE, V49, P1446, DOI 10.1016/j.neuroimage.2009.09.033; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Duffau H, 2014, WORLD NEUROSURG, V81, P56, DOI 10.1016/j.wneu.2013.01.116; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fan QY, 2014, BRAIN CONNECT, V4, P718, DOI 10.1089/brain.2014.0305; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fekonja L, 2019, ACTA NEUROCHIR, V161, P1125, DOI 10.1007/s00701-019-03899-0; Fekonja LS, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.622358; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Finsterbusch J, 2009, MAGN RESON MED, V61, P748, DOI 10.1002/mrm.21899; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Garyfallidis E, 2018, NEUROIMAGE, V170, P283, DOI 10.1016/j.neuroimage.2017.07.015; Genc S, 2020, HUM BRAIN MAPP, V41, P2583, DOI 10.1002/hbm.24964; Girard G, 2017, HUM BRAIN MAPP, V38, P5485, DOI 10.1002/hbm.23741; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Golby AJ, 2011, NEUROSURGERY, V68, P496, DOI 10.1227/NEU.0b013e3182061ebb; Gong S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197056; Grisot G, 2021, NEUROIMAGE, V239, DOI 10.1016/j.neuroimage.2021.118300; Guevara P, 2012, NEUROIMAGE, V61, P1083, DOI 10.1016/j.neuroimage.2012.02.071; Guo FH, 2021, HUM BRAIN MAPP, V42, P367, DOI 10.1002/hbm.25228; Hansen B, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00040; Hansen CB, 2019, MAGN RESON IMAGING, V57, P133, DOI 10.1016/j.mri.2018.11.009; Henderson F, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.11.FOCUS19785; Hervey-Jumper SL, 2019, NEUROSURG CLIN N AM, V30, P85, DOI 10.1016/j.nec.2018.08.005; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoefnagels FWA, 2014, J NEURO-ONCOL, V120, P187, DOI 10.1007/s11060-014-1544-9; Holdsworth SJ, 2008, EUR J RADIOL, V65, P36, DOI 10.1016/j.ejrad.2007.09.016; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Hula WD, 2020, BRAIN, V143, P2532, DOI 10.1093/brain/awaa193; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2020, GEROSCIENCE, V42, P1411, DOI 10.1007/s11357-020-00245-6; Irimia A, 2018, NEUROBIOL AGING, V66, P158, DOI 10.1016/j.neurobiolaging.2018.02.026; Irimia A, 2015, BRAIN IMAGING BEHAV, V9, P678, DOI 10.1007/s11682-014-9321-0; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Irimia A, 2013, CLIN NEUROPHYSIOL, V124, P2129, DOI 10.1016/j.clinph.2013.04.336; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Jakola AS, 2013, ACTA NEUROCHIR, V155, P2227, DOI 10.1007/s00701-013-1869-8; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Kawasaki K, 2017, RADIOL PHYS TECHNOL, V10, P507, DOI 10.1007/s12194-017-0411-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Knosche TR, 2015, HUM BRAIN MAPP, V36, P4116, DOI 10.1002/hbm.22902; Koga T, 2012, INT J RADIAT ONCOL, V82, P799, DOI 10.1016/j.ijrobp.2010.11.046; Kristo G., 2012, EUR RADIOL; Kristo G, 2013, EUR RADIOL, V23, P28, DOI 10.1007/s00330-012-2589-9; Kupper H, 2015, NEUROPEDIATRICS, V46, P72, DOI 10.1055/s-0034-1395346; Kuhnt D, 2012, NEUROSURGERY, V70, P911, DOI 10.1227/NEU.0b013e318237a807; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Leclercq D, 2010, J NEUROSURG, V112, P503, DOI 10.3171/2009.8.JNS09558; Li J, 2017, NEURORADIOLOGY, V59, P1203, DOI 10.1007/s00234-017-1915-y; Li YM, 2016, J NEUROSURG, V124, P977, DOI 10.3171/2015.5.JNS142087; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Lodygensky GA, 2010, BRAIN BEHAV IMMUN, V24, P759, DOI 10.1016/j.bbi.2009.11.005; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Malyarenko DI, 2014, MAGN RESON MED, V71, P1312, DOI 10.1002/mrm.24773; Martino J, 2013, BRAIN STRUCT FUNCT, V218, P105, DOI 10.1007/s00429-012-0386-5; Maruyama K, 2005, J NEUROSURG, V102, P673, DOI 10.3171/jns.2005.102.4.0673; Maruyama K, 2009, J NEUROSURG, V111, P520, DOI 10.3171/2008.4.17521; Maruyania K, 2007, J NEUROSURG, V107, P721, DOI 10.3171/JNS-07/10/0721; Mato D, 2021, NEUROSURGERY, V88, pE190, DOI 10.1093/neuros/nyaa463; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Mesri HY, 2020, NEUROIMAGE, V205, DOI 10.1016/j.neuroimage.2019.116127; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Min ZG, 2013, CLIN NEUROL NEUROSUR, V115, P1366, DOI 10.1016/j.clineuro.2012.12.031; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Neher PF, 2015, MED IMAGE ANAL, V26, P287, DOI 10.1016/j.media.2015.10.011; Nimsky C, 2006, NEUROSURGERY, V58, P292, DOI 10.1227/01.NEU.0000204726.00088.6D; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Nimsky C, 2014, WORLD NEUROSURG, V82, P35, DOI 10.1016/j.wneu.2013.08.035; Norton I, 2017, CANCER RES, V77, pE101, DOI 10.1158/0008-5472.CAN-17-0332; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2017, NEUROIMAGE-CLIN, V13, P138, DOI 10.1016/j.nicl.2016.11.023; O'Donnell LJ, 2014, SCHIZOPHR RES; Ozarslan E, 2013, NEUROIMAGE, V78, P16, DOI 10.1016/j.neuroimage.2013.04.016; Pantelis E, 2010, INT J RADIAT ONCOL, V78, P257, DOI 10.1016/j.ijrobp.2009.10.064; Paquette M., 2019, PENTHERA 3T; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Perrone D, 2015, NEUROIMAGE, V120, P441, DOI 10.1016/j.neuroimage.2015.06.068; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Provenzale JM, 2004, RADIOLOGY, V232, P451, DOI 10.1148/radiol.2322030959; Pujol S, 2015, J NEUROIMAGING, V25, P875, DOI 10.1111/jon.12283; Qazi AA, 2009, NEUROIMAGE, V47, pT98, DOI 10.1016/j.neuroimage.2008.06.034; Radmanesh A, 2015, CLIN NEUROL NEUROSUR, V129, P44, DOI 10.1016/j.clineuro.2014.11.021; Rahman M, 2017, J NEUROSURG, V127, P123, DOI 10.3171/2016.7.JNS16396; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Rheault F, 2019, NEUROIMAGE, V186, P382, DOI 10.1016/j.neuroimage.2018.11.018; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rokem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123272; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Salo RA, 2018, NEUROIMAGE, V172, P404, DOI 10.1016/j.neuroimage.2018.01.087; Sanchez-Catasus C.A., 2020, J NUCL MED; Sanvito F, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00225; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schilling K, 2018, HUM BRAIN MAPP, V39, P1449, DOI 10.1002/hbm.23936; Schilling K, 2016, NEUROIMAGE, V129, P185, DOI 10.1016/j.neuroimage.2016.01.022; Schilling KG, 2021, NEUROIMAGE, V243, DOI 10.1016/j.neuroimage.2021.118502; Schilling KG, 2020, BRAIN STRUCT FUNCT, V225, P2387, DOI 10.1007/s00429-020-02129-z; Schilling KG, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4090; Schilling KG, 2019, NEUROIMAGE, V185, P1, DOI 10.1016/j.neuroimage.2018.10.029; Schilling KG, 2018, NEUROIMAGE, V165, P200, DOI 10.1016/j.neuroimage.2017.10.046; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Sclocco R, 2018, NEUROIMAGE, V168, P412, DOI 10.1016/j.neuroimage.2017.02.052; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sosnovik DE, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-47; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tan ET, 2013, J MAGN RESON IMAGING, V38, P448, DOI 10.1002/jmri.23942; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tong QQ, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0493-8; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tuncer MS, 2021, NEUROIMAGE-CLIN, V29, DOI 10.1016/j.nicl.2020.102541; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Vanderweyen DC, 2020, BRAIN STRUCT FUNCT, V225, P1413, DOI 10.1007/s00429-020-02056-z; Vanegas-Arroyave N, 2016, BRAIN, V139, P1200, DOI 10.1093/brain/aww020; Veraart J, 2016, MAGN RESON MED, V76, P301, DOI 10.1002/mrm.25866; Vos SB, 2017, MAGN RESON MED, V77, P285, DOI 10.1002/mrm.26124; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Warrington S, 2020, NEUROIMAGE, V217, DOI 10.1016/j.neuroimage.2020.116923; Wassermann D, 2016, BRAIN STRUCT FUNCT, V221, P4705, DOI 10.1007/s00429-015-1179-4; Wasserthal J, 2018, NEUROIMAGE, V183, P239, DOI 10.1016/j.neuroimage.2018.07.070; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wilkins B, 2015, NEUROIMAGE, V109, P341, DOI 10.1016/j.neuroimage.2014.12.060; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab; Wu WC, 2017, J MAGN RESON IMAGING, V46, P646, DOI 10.1002/jmri.25664; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yang G, 2019, MAGN RESON MED, V81, P1818, DOI 10.1002/mrm.27539; Yang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40358; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yeh FC, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117329; Yeh FC, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116131; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027; Yeh FC, 2017, MAGN RESON MED, V77, P603, DOI 10.1002/mrm.26143; Yeh FC, 2016, NEUROIMAGE, V125, P162, DOI 10.1016/j.neuroimage.2015.10.053; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Young RJ, 2006, J MAGN RESON IMAGING, V24, P709, DOI 10.1002/jmri.20704; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang HL, 2013, NEUROSURGERY, V73, P1044, DOI 10.1227/NEU.0000000000000146; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61; Ziegler E, 2014, NEUROIMAGE, V99, P498, DOI 10.1016/j.neuroimage.2014.06.033; Zolal A, 2012, NEUROSURGERY, V71, P331, DOI 10.1227/NEU.0b013e31825b1c18; Zollei L, 2019, NEUROIMAGE, V199, P1, DOI 10.1016/j.neuroimage.2019.05.051	232	0	0	7	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	DEC 15	2021	245								118651	10.1016/j.neuroimage.2021.118651			21	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WR8SB	WOS:000714763700004	34673247	gold			2022-02-06	
J	Delage, C; Vignal, N; Guerin, C; Taib, T; Barboteau, C; Mamma, C; Khacef, K; Margaill, I; Sarda-Mantel, L; Rizzo-Padoin, N; Hontonnou, F; Marchand-Leroux, C; Lerouet, D; Hosten, B; Besson, V				Delage, Clement; Vignal, Nicolas; Guerin, Coralie; Taib, Toufik; Barboteau, Clement; Mamma, Celia; Khacef, Kahina; Margaill, Isabelle; Sarda-Mantel, Laure; Rizzo-Padoin, Nathalie; Hontonnou, Fortune; Marchand-Leroux, Catherine; Lerouet, Dominique; Hosten, Benoit; Besson, Valerie			From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; CONTROLLED CORTICAL IMPACT; 18 KDA; MICROGLIA; TSPO; PET; NEUROINFLAMMATION; NEURODEGENERATION; INFLAMMATION; BINDING	Traumatic brain injury (TBI) leads to a deleterious neuroinflammation, originating from microglial activation. Monitoring microglial activation is an indispensable step to develop therapeutic strategies for TBI. In this study, we evaluated the use of the 18-kDa translocator protein (TSPO) in positron emission tomography (PET) and cellular analysis to monitor microglial activation in a mild TBI mouse model. TBI was induced on male Swiss mice. PET imaging analysis with [F-18]FEPPA, a TSPO radiotracer, was performed at 1, 3 and 7 days post-TBI and flow cytometry analysis on brain at 1 and 3 days post-TBI. PET analysis showed no difference in TSPO expression between non-operated, sham-operated and TBI mice. Flow cytometry analysis demonstrated an increase in TSPO expression in ipsilateral brain 3 days post-TBI, especially in microglia, macrophages, lymphocytes and neutrophils. Moreover, microglia represent only 58.3% of TSPO+ cells in the brain. Our results raise the question of the use of TSPO radiotracer to monitor microglial activation after TBI. More broadly, flow cytometry results point the lack of specificity of TSPO for microglia and imply that microglia contribute to the overall increase in TSPO in the brain after TBI, but is not its only contributor.	[Delage, Clement; Taib, Toufik; Mamma, Celia; Khacef, Kahina; Margaill, Isabelle; Marchand-Leroux, Catherine; Lerouet, Dominique; Besson, Valerie] Univ Paris 05, Facufte Pharm Paris, EA4475, Pharmacol Circulat Cerebrale, Paris, France; [Delage, Clement; Vignal, Nicolas; Barboteau, Clement; Marchand-Leroux, Catherine; Lerouet, Dominique; Hosten, Benoit; Besson, Valerie] Univ Paris, Fac Pharm Paris, Inserm UMR S 1144, Optim Isat Therapeut Neuropsychopharmacol, 4 Ave Observ, F-75006 Paris, France; [Vignal, Nicolas; Sarda-Mantel, Laure] Hop Lariboisiere, AP HP, Serv Med Nucl, Paris, France; [Vignal, Nicolas; Sarda-Mantel, Laure; Rizzo-Padoin, Nathalie; Hontonnou, Fortune; Hosten, Benoit] Univ Paris, Inst Rech St Louis, Unite Claude Kellershohn, Paris, France; [Guerin, Coralie] Univ Paris, Innovat Therapies Haemostasis, INSERM, F-75006 Paris, France; [Guerin, Coralie] Inst Curie, Cytometry Core, F-75005 Paris, France; [Guerin, Coralie] Univ Paris, Inserm UMS 3612, CNRS, US25,INSERM,Fac Pharm Paris, Paris, France; [Margaill, Isabelle] Univ Paris, Fac Pharm Paris, Inserm UMR S 1140, Paris, France; [Rizzo-Padoin, Nathalie] Hop Pierre Zobda Quitman, CHU Martinique, Serv Pharm, Fort De France, Martinique, France; [Hontonnou, Fortune] Univ Paris, Inserm UMR S 942, Hop Lariboisiere, Paris, France; [Hosten, Benoit] Hop St Louis, AP HP, Serv Pharm, Paris, France		Delage, C (corresponding author), Univ Paris 05, Facufte Pharm Paris, EA4475, Pharmacol Circulat Cerebrale, Paris, France.; Delage, C (corresponding author), Univ Paris, Fac Pharm Paris, Inserm UMR S 1144, Optim Isat Therapeut Neuropsychopharmacol, 4 Ave Observ, F-75006 Paris, France.	clement.delage@u-paris.fr		Guerin, Coralie/0000-0002-1840-4017	Fondation des Gueules Cassees	This study was partly funded by Fondation des Gueules Cassees (www.gueules-cassees.asso.fr/; FGC to VCB and CML). The funders did not participate in study design, data collection and analysis, publishing decisions, or manuscript preparation.	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Beckers L, 2018, MOL IMAGING BIOL, V20, P94, DOI 10.1007/s11307-017-1099-1; Betlazar C, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020512; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gui YX, 2020, BRAIN PATHOL, V30, P151, DOI 10.1111/bpa.12763; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Herrera-Rivero M, 2015, CLIN TRANSL IMAGING, V3, P391, DOI 10.1007/s40336-015-0151-x; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Lacapere JJ, 2020, TRENDS PHARMACOL SCI, V41, P110, DOI 10.1016/j.tips.2019.11.005; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lee Y, 2020, BMB REP, V53, P20, DOI 10.5483/BMBRep.2020.53.1.273; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Notter T, 2018, MOL PSYCHIATR, V23, P323, DOI 10.1038/mp.2016.248; Pannell M, 2020, GLIA, V68, P280, DOI 10.1002/glia.23716; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Schweitzer PJ, 2010, DRUG DISCOV TODAY, V15, P933, DOI 10.1016/j.drudis.2010.08.012; Shehadeh M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112639; Sridharan S, 2017, MOL IMAGING BIOL, V19, P77, DOI 10.1007/s11307-016-0984-3; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Stratoulias V, 2019, EMBO J, V38, DOI 10.15252/embj.2019101997; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomasi G, 2008, J NUCL MED, V49, P1249, DOI 10.2967/jnumed.108.050583; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Vignal N, 2018, MOLECULES, V23, DOI 10.3390/molecules23061375; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Wimberley C, 2018, J NUCL MED, V59, P307, DOI 10.2967/jnumed.117.195396; Zammit M, 2020, EJNMMI RES, V10, DOI 10.1186/s13550-020-00683-5	48	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 14	2021	11	1							24009	10.1038/s41598-021-03416-3			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XP3OZ	WOS:000730779300099	34907268	Green Published, gold			2022-02-06	
J	Holoyda, KA; Donato, DP; Magno-Padron, DA; Simpson, AM; Agarwal, JP				Holoyda, Kathleen A.; Donato, Daniel P.; Magno-Padron, David A.; Simpson, Andrew M.; Agarwal, Jayant P.			Hand and wrist injuries among collegiate athletes vary with athlete division	INJURY EPIDEMIOLOGY			English	Article						Injury rates; Hand injuries; Wrist injuries; NCAA; College; Division I; Division II; Division III	SURVEILLANCE DESCRIPTIVE EPIDEMIOLOGY; TIME-LOSS INJURIES; 1ST DECADE; CONCUSSION-MANAGEMENT; PHALANGEAL FRACTURES; CONTACT INJURIES; SPORTS; MENS; SYSTEM; METACARPAL	Background The rates, severity and consequences of hand and wrist injuries sustained by National Collegiate Athletic Association athletes are not well characterized. This study describes the epidemiology of hand and wrist injuries among collegiate athletes competing in different divisions. Methods The National Collegiate Athletic Association Injury Surveillance Program (NCAA-ISP) was accessed from 2004 to 2015 for the following sports: baseball, basketball, football, ice hockey, lacrosse, soccer, wrestling, field hockey, gymnastics, softball and volleyball. The data were used to identify all hand and wrist injuries, the specific injury diagnosis, mean time loss of activity following injury, and need for surgery following injury. These were then stratified by gender. Descriptive statistics were performed to examine the association between sports, event type and division. Student's t test was used to calculate p-values for independent variables. Chi-Square test was used to calculate odds ratio. P < 0.05 was considered significant. Results 103,098 hand and wrist injuries were reported in in the studied NCAA sports from 2004 to 2015. Male athletes sustained 72,423 injuries (6.01/10,000 athlete exposure) and female athletes sustained 30,675 injuries (4.13/10,000 athlete exposure). Division I athletes sustained significantly more injuries compared to divisions II and III. Overall, 3.78% of hand and wrist injuries required surgical intervention. A significantly higher percentage of division I athletes (both male and female) underwent surgical intervention compared to divisions II and III. The mean time lost due to hand and wrist injury was 7.14 days for all athletes. Division I athletes missed the fewest days due to injury at 6.29 days though this was not significant. Conclusions Hand and wrist injuries are common among collegiate athletes. Division I athletes sustain higher rates of injuries and higher surgical intervention rates, while tending to miss fewer days due to injury. Improved characterization of divisional differences in hand and wrist injuries can assist injury management and prevention.	[Holoyda, Kathleen A.; Donato, Daniel P.; Magno-Padron, David A.; Simpson, Andrew M.; Agarwal, Jayant P.] Univ Utah, Sch Med, Div Plast & Reconstruct Surg, 30 N 1900 E, Salt Lake City, UT 84132 USA		Agarwal, JP (corresponding author), Univ Utah, Sch Med, Div Plast & Reconstruct Surg, 30 N 1900 E, Salt Lake City, UT 84132 USA.	jay.agarwal@hsc.utah.edu			NCAA	The NCAA Injury Surveillance Program was funded by the NCAA and the data in this program were provided by the Datalys Center for Sports Injury Research and Prevention.	Agel J, 2007, J ATHL TRAINING, V42, P270; AMADIO PC, 1990, HAND CLIN, V6, P379; Athlete NCS, ATHL SCHOL EV YOU NE; Avery DM, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0432-8; Bartels DW, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119835375; Baugh CM, 2020, J ATHL TRAINING, V55, P573, DOI 10.4085/1062-6050-0463-19; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bowers AL, 2008, MED SCI SPORT EXER, V40, P2022, DOI 10.1249/MSS.0b013e318182afe3; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Carver TJ, 2018, SPORTS HEALTH, V10, P234, DOI 10.1177/1941738117745488; Chorney SR, 2017, LARYNGOSCOPE, V127, P1296, DOI 10.1002/lary.26441; Clifton DR, 2018, J ATHL TRAINING, V53, P1025, DOI 10.4085/1062-6050-148-17; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Dalton SL, 2015, AM J SPORT MED, V43, P2671, DOI 10.1177/0363546515599631; Deckey DG, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120953070; Dick R, 2007, J ATHL TRAINING, V42, P211; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Fraser MA, 2017, J ATHL TRAINING, V52, P698, DOI 10.4085/1062-6050-52.3.10; Fry AC., 1991, J STRENGTH COND RES, V5, P126; Gallucci AR, 2017, J ATHL TRAINING, V52, P785, DOI 10.4085/1062-6050-52.3.16; Garstecki MA, 2004, J STRENGTH COND RES, V18, P292; Geissler WB, 2009, HAND CLIN, V25, P409, DOI 10.1016/j.hcl.2009.05.005; Hagglund M, 2013, BRIT J SPORT MED, V47, P974, DOI 10.1136/bjsports-2013-092644; Halim A, 2016, CLIN SPORT MED, V35, P597, DOI 10.1016/j.csm.2016.05.005; HOWSE C, 1994, SPORTS MED, V17, P163, DOI 10.2165/00007256-199417030-00003; Irick E., 2016, NCAA SPORTS SPONSHOR; Joy EA, 2013, J STRENGTH COND RES, V27, P2263, DOI 10.1519/JSC.0b013e31827ef12e; Kerr ZY, 2018, J ATHL TRAINING, V53, P893, DOI 10.4085/1062-6050-166-17; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2017, J ATHL TRAINING, V52, P446, DOI 10.4085/1062-6050-52.2.15; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lynall RC, 2018, J ATHL TRAINING, V53, P938, DOI 10.4085/1062-6050-173-17; NCAA, FIN INT ATHL 2021; NCAA, HLTH SAF 2018; NCAA, GOALS STUD UND STUD; NCAA, 2020, EST PROB COMP PROF A; NCAA, OUR 3 DIV 2021; ORourke P., 2021, AVERAGE ATHLETE 2020; Pierpoint LA, 2019, J ATHL TRAINING, V54, P30, DOI 10.4085/1062-6050-200-17; Powell JW, 2004, J ATHL TRAINING, V39, P56; Rankin J M, 1992, J Athl Train, V27, P344; Silvers-Granelli HJ, 2018, KNEE SURG SPORT TR A, V26, P1975, DOI 10.1007/s00167-018-4895-5; Simpson AM, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120964622; Simpson D, 2006, SCOT MED J, V51, P25; Wahl EP, 2020, CLIN SPORT MED, V39, P401, DOI 10.1016/j.csm.2019.12.002; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	51	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	DEC 14	2021	8	1							69	10.1186/s40621-021-00363-5			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	XO5JU	WOS:000730222400001	34906242	Green Published, gold			2022-02-06	
J	Narad, ME; Epstein, JN; Peugh, J; Foss, KBD; Diekfuss, JA; Bonnette, S; Orban, S; Yuan, WH; Dudley, JA; DiCesare, CA; Reddington, DL; Zhong, W; Nissen, KS; Shafer, JL; Avedesian, JM; Slutsky-Ganesh, AB; Lloyd, RS; Howell, D; Myer, GD				Narad, Megan E.; Epstein, Jeffery N.; Peugh, James; Barber Foss, Kim D.; Diekfuss, Jed A.; Bonnette, Scott; Orban, Sarah; Yuan, Weihong; Dudley, Jonathan A.; DiCesare, Christopher A.; Reddington, Danielle L.; Zhong, Wen; Nissen, Katharine S.; Shafer, Jessica L.; Avedesian, Jason M.; Slutsky-Ganesh, Alexis B.; Lloyd, Rhodri S.; Howell, David; Myer, Gregory D.			Effect of Subconcussive Head Impact Exposure and Jugular Vein Compression on Behavioral and Cognitive Outcomes after a Single Season of High-School Football: A Prospective Longitudinal Trial	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						behavioral; cognitive outcomes; head impact exposure; high-school football; jugular vein compression collar	TRAUMATIC BRAIN-INJURY; NEUROLOGIC FUNCTION; PROFESSIONAL FOOTBALL; PERSISTENT INFLUENCE; CLINICAL MEASURES; YOUTH FOOTBALL; CONCUSSION; ATTENTION; DEFICITS; COLLAR	This prospective longitudinal trial aimed to (1) determine the role of head impact exposure on behavioral/cognitive outcomes, and (2) assess the protective effect(s) of a jugular vein compression (JVC) collar on behavioral/cognitive outcomes after one season of high-school football. Participants included 284 male high-school football players aged 13-18 years enrolled from seven Midwestern high-schools. Schools were allocated to the JVC collar intervention (four teams, 140 players) or no collar/no intervention control (three teams, 144 players) condition. Head impact exposure was measured throughout the season using CSx accelerometers. Outcome measures included post-season parent and adolescent report on Strengths and Weaknesses of ADHD Symptoms and Normal Behavior Scale (SWAN) and Post-Concussion Symptom Inventory (PCSI), as well as adolescent performance on Attention Network Task (ANT), digital Trail Making Task (dTMT), and Cued Switching task. No significant effect of head impact exposure or JVC collar use on post-season SWAN or PCSI scores or performance on dTMT and Cued Switching task were noted. There was no effect of head impact exposure on ANT performance; however, the JVC collar group had greater post-season Alerting network scores than the no collar group (p = 0.026, d = 0.22). Findings provide preliminary evidence that the JVC collar may provide some protection to the alerting attention system. These findings should be interpreted cautiously as a greater understanding of the long-term sequelae of head impact exposure and the role of cumulative head impact exposure behavioral/cognitive outcomes is required.	[Narad, Megan E.; Epstein, Jeffery N.; Peugh, James] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 10006, Cincinnati, OH 45229 USA; [Narad, Megan E.; Epstein, Jeffery N.; Peugh, James] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Barber Foss, Kim D.; Diekfuss, Jed A.] Emory Sports Performance & Res Ctr, Flowery Branch, GA USA; [Bonnette, Scott; Reddington, Danielle L.; Zhong, Wen; Nissen, Katharine S.; Shafer, Jessica L.; Slutsky-Ganesh, Alexis B.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Orban, Sarah] Univ Tampa, Dept Psychol, Tampa, FL USA; [Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Div Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Dudley, Jonathan A.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH 45221 USA; [DiCesare, Christopher A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Avedesian, Jason M.; Myer, Gregory D.] Emory Univ, Sch Med, Dept Orthopaed, Sports Performance & Res Ctr, Flowery Branch, GA USA; [Lloyd, Rhodri S.] Cardiff Metropolitan Univ, Sch Sport & Hlth Sci, Youth Phys Dev Ctr, Cardiff, Wales; [Lloyd, Rhodri S.] AUT Univ, New Zealand SPRINZ, Sport Performance Res Inst, Auckland, New Zealand; [Lloyd, Rhodri S.] Waikato Inst Technol, Ctr Sport Sci & Human Performance, Hamilton, New Zealand; [Lloyd, Rhodri S.] Cyncoed Campus, Hamilton, New Zealand; [Howell, David] Childrens Hosp Colorado, Sport Med Ctr, Aurora, CO USA; [Howell, David] Univ Colorado, Dept Orthoped, Aurora, CO USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, 3333 Burnet Ave,MLC 10006, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	DiCesare, Christopher/AAA-3327-2021	DiCesare, Christopher/0000-0002-6576-4904	Q30 Sports Innovations, LLC	Q30 Sports Innovations, LLC funded the overall project and the development of the jugular compression collars that were provided for use in the current investigation.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Cannon GW, 2016, ADV THER, V33, P1347, DOI 10.1007/s12325-016-0371-0; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Espinoza Tamara R, 1800, Neurotrauma Rep, V2, P232, DOI 10.1089/neur.2020.0022; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lezak, 2003, NEUROPSYCHOLOGICAL A, pPr; Maerlender A, 2021, J INT NEUROPSYCH SOC, V27, P113, DOI 10.1017/S1355617720000685; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Monroe DC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00218; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Mullane JC, 2009, CHILD NEUROPSYCHOL, V15, P321, DOI 10.1080/09297040802348028; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Myer J, 2018, RAD SOC N AM ANN M C; National Federation of State High School Association, 2015, NFHS HDB 2015 2016; National Federation of State High School Association, 2019, PART HIGH SCH SPORTS; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Nilsson KJ, 2019, SPORTS HEALTH, V11, P507, DOI 10.1177/1941738119865264; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Orban SA, 2021, CLIN J SPORT MED, V31, pE298, DOI 10.1097/JSM.0000000000000821; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Rose SC, 2019, J NEUROTRAUM, V36, P2803, DOI 10.1089/neu.2019.6519; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Slobounov S.M., 2020, J CONCUSSION, P4; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Spear LP, 2013, J ADOLESCENT HEALTH, V52, pS7, DOI 10.1016/j.jadohealth.2012.05.006; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; van Duijvenvoorde ACK, 2016, NEUROIMAGE, V124, P409, DOI 10.1016/j.neuroimage.2015.04.069; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Yuan WH, 2018, J NEUROTRAUM, V35, P1248, DOI 10.1089/neu.2017.5262; Yuan WH, 2019, J NEUROTRAUM, V36, P721, DOI 10.1089/neu.2018.5737; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	69	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0078		DEC 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XO1RC	WOS:000729969300001	34779241				2022-02-06	
J	Parker, TD; Rees, R; Rajagopal, S; Griffin, C; Goodliffe, L; Dilley, M; Jenkins, PO				Parker, Thomas D.; Rees, Richard; Rajagopal, Sangeerthana; Griffin, Colette; Goodliffe, Luke; Dilley, Michael; Jenkins, Peter Owen			Post-traumatic amnesia	PRACTICAL NEUROLOGY			English	Article; Early Access						amnesia; cognition; head injury; behavioural disorder	TRAUMATIC BRAIN-INJURY; GALVESTON ORIENTATION; REHABILITATION; AGITATION; MANAGEMENT; RECOVERY; LOG	Post-traumatic amnesia is the transient state of altered brain function that may follow a traumatic brain injury. At a practical level, an individual has emerged from post-traumatic amnesia when he or she is fully orientated and with return of continuous memory. However, the clinical manifestations are often more complex, with numerous cognitive domains commonly affected, as well as behaviour. In the acute setting, post-traumatic amnesia may easily go unrecognised; this is problematic as it has important implications for both immediate management and for longer-term prognosis. We therefore recommend its careful clinical assessment and prospective evaluation using validated tools. Patients in post-traumatic amnesia who have behavioural disturbance can be particularly challenging to manage. Behavioural and environmental measures form the mainstay of its treatment while avoiding pharmacological interventions where possible, as they may worsen agitation. Patients need assessing regularly to determine their need for further rehabilitation and to facilitate safe discharge planning.	[Parker, Thomas D.; Rees, Richard; Rajagopal, Sangeerthana; Griffin, Colette; Goodliffe, Luke; Dilley, Michael; Jenkins, Peter Owen] St Georges Univ Hosp NHS Fdn Trust, Atkinson Morley Neurosci Unit, London, England; [Parker, Thomas D.] Imperial Coll London, Dept Brain Sci, London, England		Jenkins, PO (corresponding author), St Georges Univ Hosp NHS Fdn Trust, London SO22 5DG, England.	peter.jenkins1@nhs.net			NIHR Clinical Lectureship	TDP is funded by a NIHR Clinical Lectureship.	Ashby Gillian Alice, 2015, Pract Neurol, V15, P361, DOI 10.1136/practneurol-2014-000957; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Fleming J, 1999, BRAIN INJURY, V13, P417; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; ROWLAND T, 1995, NEUROREHABILITATION, V5, P219, DOI 10.3233/NRE-1995-5305; Russell W Ritchie, 1932, Edinb Med J, V39, pT25; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Spiteri C, 2021, J HEAD TRAUMA REHAB, V36, P156, DOI 10.1097/HTR.0000000000000607; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]; Zahr NM, 2011, NAT REV NEUROL, V7, P284, DOI 10.1038/nrneurol.2011.42	28	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1474-7758	1474-7766		PRACT NEUROL	Practic. Neurol.												10.1136/practneurol-2021-003056		DEC 2021	10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XP3MZ	WOS:000730774100001	34906998				2022-02-06	
J	Rivara, FP; Marcynyszyn, LA; Wang, J; Chrisman, SPD; Hilt, R; Zatzick, DF; Johnson, AM; Jinguji, T; Quitiquit, C; McCarty, CA				Rivara, Frederick P.; Marcynyszyn, Lyscha A.; Wang, Jin; Chrisman, Sara P. D.; Hilt, Robert; Zatzick, Douglas F.; Johnson, Ashleigh M.; Jinguji, Thomas; Quitiquit, Celeste; McCarty, Carolyn A.			Effect of Collaborative Care for Persistent Postconcussive Symptoms on Academic Function: A Randomized Clinical Trial	JOURNAL OF SCHOOL HEALTH			English	Article; Early Access						adolescence; academic achievement; school attendance; persistent postconcussive symptoms; collaborative care; pediatrics	CONCUSSION; DEPRESSION; MANAGEMENT; CHILDREN; ANXIETY	BACKGROUND There is limited long-term data on the course of school-related problems and academic needs for youth with persistent post-concussive symptoms (PPCS). METHODS This was a randomized trial comparing collaborative care to usual care for 200 youth 11-18 years of age with PPCS. In this report, the main outcomes were academic functioning, GPA, school absences, date of return to school, and school days missed. RESULTS Youth were mean age of 14.7 (SD = 1.7), 62.0% female. New or worsening academic problems occurred in half of participants in both groups at 12 months after injury. Students were most concerned about grades and falling behind. There were no significant differences by study group on school problems or GPA, but number of days missed was lower in the collaborative care group compared at 3 months (12.5 [SD = 14.5] vs 16.1 days [20.4] adjusted relative risk [aRR] 0.67 [95% CI: 0.61, 0.74; p < .001]), 6 months (14.5 [22.1] vs 19.3 [26.6] aRR 0.77 [95% CI: 0.71, 0.84; p < .001]), and 12 months (16.9 [25.4] vs 19.6 [27.7], aRR 0.68 [95% CI: 0.62, 0.74; p < .001]). CONCLUSIONS Youth with PPCS are at high risk of school problems in the year after injury.	[Rivara, Frederick P.; Wang, Jin] Univ Washington, Dept Pediat, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA; [Rivara, Frederick P.] Seattle Childrens Guild Endowed Chair Pediat Res, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Sch Publ Hlth,Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Box 359960,325 Ninth Ave, Seattle, WA 98104 USA; [Marcynyszyn, Lyscha A.; Chrisman, Sara P. D.; Johnson, Ashleigh M.] Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Bldg Cure M-S CURE 3,1920 Terry Ave, Seattle, WA 98101 USA; [Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA; [Hilt, Robert] Univ Washington, Dept Psychiat, Psychiat & Behav Sci, Seattle, WA 98195 USA; [Zatzick, Douglas F.] Univ Washington, Psychiat & Behav Sci, Harborview Med Ctr 325 Ninth Ave,Box 359911, Seattle, WA 98104 USA; [Jinguji, Thomas; Quitiquit, Celeste] Univ Washington, Seattle Childrens Hosp, Dept Pediat, 4800 Sandpoint Way, Seattle, WA 98105 USA; [McCarty, Carolyn A.] Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Pediat, Bldg Cure M-S CURE 3,1920 Terry Ave, Seattle, WA 98101 USA; [McCarty, Carolyn A.] Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Psychol, Bldg Cure M-S CURE 3,1920 Terry Ave, Seattle, WA 98101 USA		Rivara, FP (corresponding author), Univ Washington, Dept Pediat, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA.; Rivara, FP (corresponding author), Seattle Childrens Guild Endowed Chair Pediat Res, Seattle, WA 98104 USA.; Rivara, FP (corresponding author), Univ Washington, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Sch Publ Hlth,Epidemiol, Seattle, WA 98195 USA.; Rivara, FP (corresponding author), Harborview Injury Prevent & Res Ctr, Box 359960,325 Ninth Ave, Seattle, WA 98104 USA.	fpr@uw.edu; lyscha.marcynyszyn@seattlechildrens.org; wangji@uw.edu; sara.chrisman@seattlechildrens.org; robert.hlit@seattlechildrens.org; dzatzick@uw.edu; ashleigh.johnson@seattlechildrens.org; tom.jinguji@seattlechildrens.org; celeste.quitiquit@seattlechildrens.org; cari.mccarty@seattlechildrens.org					Allison MA, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3648; Benemei S, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01135-0; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Caronna E, 2021, NEUROL CLIN, V39, P1, DOI 10.1016/j.ncl.2020.09.001; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; DeMatteo C, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2019-000667; Echemendia RJ, 2018, HAND CLINIC, V158, P179, DOI 10.1016/B978-0-444-63954-7.00018-5; Gioia GA., 2020, J PEDIAT NEUROPSYCOL, V6, P203; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Mahooti N, 2018, CHILD ADOL PSYCH CL, V27, P93, DOI 10.1016/j.chc.2017.08.005; Makki AY., 2016, GLOB PEDIAT HLTH, V3; Mathyssek CM, 2013, INT J METH PSYCH RES, V22, P27, DOI 10.1002/mpr.1380; McCarty CA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0207; McCarty CA, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3662-3; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Monsour DA, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01068-w; Neelakantan M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207602; Payne KM, 2020, JAMA PEDIATR, V174, P1210, DOI 10.1001/jamapediatrics.2020.0898; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Russell K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215900; Russell Kelly, 2017, Concussion, V2, pCNC51, DOI 10.2217/cnc-2017-0009; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Tiwari D, 2019, INT J SPORTS PHYS TH, V14, P282, DOI 10.26603/ijspt20190282; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zimmerman SD, 2021, CLIN SPORT MED, V40, P147, DOI 10.1016/j.csm.2020.08.010	32	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health												10.1111/josh.13123		DEC 2021	9	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	XN8IZ	WOS:000729743200001	34904238				2022-02-06	
J	Baird, TD; Miller, MR; Cameron, S; Fraser, DD; Tijssen, JA				Baird, Talia D.; Miller, Michael R.; Cameron, Saoirse; Fraser, Douglas D.; Tijssen, Janice A.			Clinical and Physiologic Factors Associated With Mode of Death in Pediatric Severe TBI	FRONTIERS IN PEDIATRICS			English	Article						pediatric; critical care; trauma; brain injury; prognosis	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; CHILDREN; MORTALITY; NEUROPROGNOSTICATION; COAGULOPATHY; PARAMETERS; DAMAGE; CARE	Aims and Objectives: Severe traumatic brain injury (sTBI) is the leading cause of death in children. Our aim was to determine the mode of death for children who died with sTBI in a Pediatric Critical Care Unit (PCCU) and evaluate factors associated with mortality.Methods: We performed a retrospective cohort study of all severely injured trauma patients (Injury Severity Score >= 12) with sTBI (Glasgow Coma Scale [GCS] <= 8 and Maximum Abbreviated Injury Scale >= 4) admitted to a Canadian PCCU (2000-2016). We analyzed mode of death, clinical factors, interventions, lab values within 24 h of admission (early) and pre-death (48 h prior to death), and reviewed meeting notes in patients who died in the PCCU.Results: Of 195 included patients with sTBI, 55 (28%) died in the PCCU. Of these, 31 (56%) had a physiologic death (neurologic determination of death or cardiac arrest), while 24 (44%) had withdrawal of life-sustaining therapies (WLST). Median (IQR) times to death were 35.2 (11.8, 86.4) hours in the physiologic group and 79.5 (17.6, 231.3) hours in the WLST group (p = 0.08). The physiologic group had higher partial thromboplastin time (PTT) within 24 h of admission (p = 0.04) and lower albumin prior to death (p = 0.04).Conclusions: Almost half of sTBI deaths in the PCCU were by WLST. There was a trend toward a longer time to death in these patients. We found few early and late (pre-death) factors associated with mode of death, namely higher PTT and lower albumin.	[Baird, Talia D.] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Miller, Michael R.; Cameron, Saoirse; Fraser, Douglas D.; Tijssen, Janice A.] Western Univ, Dept Paediat, London, ON, Canada; [Miller, Michael R.; Cameron, Saoirse; Fraser, Douglas D.; Tijssen, Janice A.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Tijssen, Janice A.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada		Tijssen, JA (corresponding author), Western Univ, Dept Paediat, London, ON, Canada.; Tijssen, JA (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.; Tijssen, JA (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.	janice.tijssen@lhsc.on.ca					Abeytunge Kawmadi, 2021, Neurotrauma Rep, V2, P115, DOI 10.1089/neur.2020.0039; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Association for the Advancement of Automotive Medicine (AAAM), 1995, ABBREVIATED INJURY S; Beaulieu MA, 1999, CAN J NEUROL SCI, V26, P64; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Carney NA, 2003, CRIT CARE MED, V31, pS417, DOI 10.1097/00003246-200306006-00001; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Feudtner C, 2013, PEDIATRICS, V132, P966, DOI 10.1542/peds.2013-2731; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Fontana MS, 2013, J PEDIATR-US, V162, P1107, DOI 10.1016/j.jpeds.2012.12.008; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; HALL SC, 1994, INT ANESTHESIOL CLIN, V32, P1; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Hunfeld M, 2021, PEDIATR CRIT CARE ME, V22, P101, DOI 10.1097/PCC.0000000000002577; Hunfeld M, 2020, EUR J PAEDIATR NEURO, V28, P44, DOI 10.1016/j.ejpn.2020.06.021; Kirschen MP, 2015, SEMIN PEDIATR NEUROL, V22, P187, DOI 10.1016/j.spen.2015.05.004; Kirschen MP, 2014, PEDIATR NEUROL, V51, P663, DOI 10.1016/j.pediatrneurol.2014.07.026; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KRAUS JF, 1987, PEDIATRICS, V79, P501; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Lobo DN, 2001, CLIN SCI, V101, P173, DOI 10.1042/CS20000316; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; McCallum DE, 2000, J PAIN SYMPTOM MANAG, V20, P417, DOI 10.1016/S0885-3924(00)00212-8; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Ralston M., 2006, ALS PROVIDER MANUAL; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Sands R, 2009, NURS CRIT CARE, V14, P235, DOI 10.1111/j.1478-5153.2009.00348.x; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Shemie SD, 2006, CAN MED ASSOC J, V174, pS13, DOI 10.1503/cmaj.045131; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Trowbridge A, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-4182; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	41	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	DEC 13	2021	9								793008	10.3389/fped.2021.793008			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	YH3GX	WOS:000743059600001	34966706	gold, Green Published			2022-02-06	
J	Chandran, A; Boltz, AJ; Morris, SN; Robison, HJ; Nedimyer, AK; Collins, CL; Register-Mihalik, JK				Chandran, Avinash; Boltz, Adrian J.; Morris, Sarah N.; Robison, Hannah J.; Nedimyer, Aliza K.; Collins, Christy L.; Register-Mihalik, Johna K.			Epidemiology of Concussions in National Collegiate Athletic Association (NCAA) Sports: 2014/15-2018/19	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article; Early Access						descriptive; injury surveillance; collegiate	INJURY SURVEILLANCE PROGRAM; HIGH-SCHOOL; RATES; PREVENTION; EDUCATION; NORMS; SEX	Background: Updated epidemiology studies examining sports-related concussions (SRCs) are critical in evaluating recent efforts aimed at reducing the incidence of SRCs in National Collegiate Athletic Association (NCAA) sports. Purpose: To describe the epidemiology of SRCs in 23 NCAA sports during the 2014/15-2018/19 academic years. Study Design: Descriptive epidemiology study. Methods: SRC and exposure data collected in the NCAA Injury Surveillance Program were analyzed. Injury counts, rates, and proportions were used to describe injury characteristics by sport, event type (practices, competitions), injury mechanism (player contact, surface contact, equipment/apparatus contact), and injury history (new, recurrent). Injury rate ratios (IRRs) were used to examine differential injury rates, and injury proportion ratios (IPRs) were used to examine differential distributions. Results: A total of 3497 SRCs from 8,474,400 athlete-exposures (AEs) were reported during the study period (4.13 per 10,000 AEs); the competition-related SRC rate was higher than was the practice-related SRC rate (IRR, 4.12; 95% CI, 3.86-4.41). The highest SRC rates were observed in men's ice hockey (7.35 per 10,000 AEs) and women's soccer (7.15 per 10,000 AEs); rates in women's soccer and volleyball increased during 2015/16-2018/19. Player contact was the most prevalently reported mechanism in men's sports (77.0%), whereas equipment/apparatus contact was the most prevalently reported mechanism in women's sports (39.2%). Sex-related differences were observed in soccer, basketball, softball/baseball, and swimming and diving. Most SRCs reported in men's sports (84.3%) and women's sports (81.1%) were reported as new injuries. Conclusion: Given the increasing SRC rates observed in women's soccer and volleyball during the latter years of the study, these results indicate the need to direct further attention toward trajectories of SRC incidence in these sports. The prevalence of equipment/apparatus contact SRCs in women's sports also suggests that SRC mechanisms in women's sports warrant further investigation. As most SRCs during the study period were reported as new injuries, the prevalence of recurrent SRCs in men's and women's ice hockey is also noteworthy.	[Chandran, Avinash; Boltz, Adrian J.; Morris, Sarah N.; Robison, Hannah J.; Nedimyer, Aliza K.; Collins, Christy L.; Register-Mihalik, Johna K.] Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46220 USA; [Nedimyer, Aliza K.] Univ North Carolina Chapel Hill, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Nedimyer, Aliza K.; Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, STAR Heel Performance Lab, Chapel Hill, NC USA; [Register-Mihalik, Johna K.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA		Chandran, A (corresponding author), Datalys Ctr Sports Injury Res & Prevent, 6151 Cent Ave,Suite 117, Indianapolis, IN 46220 USA.	avinashc@datalyscenter.org		Boltz, Adrian/0000-0002-0168-4892	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Department of Defense (DOD)United States Department of Defense; National Operating Committee on Standards for Athletic Equipment; NATA Foundation; National Football League; NCAA-DOD Mind Matters Research Challenge	DY The National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) was funded by the NCAA. The Datalys Center is an independent nonprofit organization that manages the operations of the NCAA ISP. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organization. (Dr. Avinash Chandran, Adrian J. Boltz, Dr. Sarah N. Morris, Hannah J. Robison, Dr. Christy L. Collins.) J.K.R-M. has received research funding to her institution from the Centers for Disease Control and Prevention, Department of Defense (DOD), National Operating Committee on Standards for Athletic Equipment, NATA Foundation, National Football League, and NCAA-DOD Mind Matters Research Challenge; additionally, she served on USA Football's Football Development. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Brook EM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117714445; Chandran A, 2021, J ATHL TRAINING, V56, P616, DOI 10.4085/1062-6050-406-20; Chandran A, 2020, J ATHL TRAINING, V55, P1027, DOI 10.4085/1062-6050-232-19; Chandran A, 2019, SPORTS MED, V49, P1621, DOI 10.1007/s40279-019-01154-1; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Clark R, 2019, J TRAUMA NURS, V26, P297, DOI 10.1097/JTN.0000000000000468; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Desai N, 2019, J AM ACAD ORTHOP SUR, V27, P459, DOI 10.5435/JAAOS-D-18-00147; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Jeffries KK, 2020, J ATHL TRAINING, V55, P469, DOI 10.4085/1062-6050-142-19; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Ling DI, 2020, CLIN ORTHOP RELAT R, V478, P1469, DOI 10.1097/CORR.0000000000000995; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Nevins D, 2022, SPORT BIOMECH, V21, P212, DOI 10.1080/14763141.2019.1657931; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Reneker JC, 2019, PHYS THER SPORT, V40, P184, DOI 10.1016/j.ptsp.2019.09.012; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rosene JM, 2017, AM J SPORT MED, V45, P2622, DOI 10.1177/0363546517710005; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Stovitz SD, 2012, BRIT J SPORT MED, V46, P960, DOI 10.1136/bjsports-2011-090693; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Weber ML, 2019, BRAIN INJURY, V33, P592, DOI 10.1080/02699052.2019.1568573; Young DE, 2006, J APPL BIOMECH, V22, P25, DOI 10.1123/jab.22.1.25; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	37	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.											03635465211060340	10.1177/03635465211060340		DEC 2021	11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	XO5EQ	WOS:000730208900001	34898299				2022-02-06	
J	Dabas, V; Bhatia, N; Agrawal, G				Dabas, Vineet; Bhatia, Nishant; Agrawal, Gaurang			Both Bone Forearm Fracture with Complex DRUJ Dislocation: What Are the Odds?	JOURNAL OF WRIST SURGERY			English	Article; Early Access						complex DRUJ dislocation; forearm; radius fracture; ulna fracture; wrist	DISTAL RADIOULNAR JOINT	Background Distal radioulnar joint (DRUJ) dislocation can occur as an isolated injury or in association with fracture radius (Galeazzi fracture-dislocation), Essex-Lopresti lesion or, rarely, with fracture of both radius and ulna (termed "Galeazzi type fracture"). DRUJ dislocations can be simple or complex. While simple DRUJ dislocation can be reduced by closed methods once the associated fractures are fixed anatomically, complex dislocation does not reduce by closed means. A complex DRUJ dislocation occurring in a both bone forearm fracture is an extremely unusual pattern of injury. Case Description We describe the clinical presentation, intraop findings, management, and follow-up of two such cases of both bone forearm fracture with complex DRUJ dislocation. In both the cases, the ulnar head was found to be buttonholed through extensor retinaculum between the extensor tendons. Open reduction had to be done via dorsal approach. Timely intervention allowed good results in both the patients. Literature Review Several authors have reported simple DRUJ dislocations in both bone forearm fractures; however, we could come across only three cases of complex DRUJ dislocation in a both bone forearm fracture. A summary of various series and reports on these injuries is presented. Case Relevance Through this case report, we want to highlight this unusual association and emphasize on sequence of fixation, so that this perilous injury pattern is not missed, and favorable outcomes could be obtained through appropriate and timely intervention.	[Dabas, Vineet] Lady Hardinge Med Coll & Associated SSK & KSC Hos, Dept Orthopaed Surg, New Delhi, India; [Bhatia, Nishant; Agrawal, Gaurang] Maulana Azad Med Coll & Associated Lok Nayak Hosp, Dept Orthopaed, New Delhi, India		Bhatia, N (corresponding author), Maulana Azad Med Coll & Associated Lok Nayak Hosp, Dept Orthopaed Surg, Jawaharlal Nehru Marg, New Delhi 110002, India.	bhatianishant1111@gmail.com					Artiaco S, 2020, J ORTHOP TRAUMATOL, V21, DOI 10.1186/s10195-020-00562-8; BRUCKNER JD, 1992, CLIN ORTHOP RELAT R, P90; Budgen A, 1998, ARCH ORTHOP TRAUM SU, V118, P176, DOI 10.1007/s004020050343; HUGHSTON JC, 1962, J BONE JOINT SURG AM, V44, P1664, DOI 10.2106/00004623-196244080-00015; Jain SK., 2018, J CLIN EXP ORTHOP, DOI [10.4172/2471-8416.100053, DOI 10.4172/2471-8416.100053]; JENKINS NH, 1987, INJURY, V18, P40, DOI 10.1016/0020-1383(87)90384-6; MIKIC ZDJ, 1975, J BONE JOINT SURG AM, V57, P1071, DOI 10.2106/00004623-197557080-00006; Ryan Michael K, 2013, Am J Orthop (Belle Mead NJ), V42, pE30; Thomas BP, 2012, INDIAN J ORTHOP, V46, P493, DOI 10.4103/0019-5413.101031; Vaishya R, 2013, CHIN J TRAUMATOL, V16, P344, DOI 10.3760/cma.j.issn.1008-1275.2013.06.005	10	0	0	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2163-3916	2163-3924		J WRIST SURG	J. WRIST SURG.												10.1055/s-0041-1740138		DEC 2021	5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	XN6CX	WOS:000729591800003					2022-02-06	
J	Hunfalvay, M; Murray, NP; Mani, R; Carrick, FR				Hunfalvay, Melissa; Murray, Nicholas P.; Mani, Revathy; Carrick, Frederick Robert			Smooth Pursuit Eye Movements as a Biomarker for Mild Concussion within 7-Days of Injury	BRAIN INJURY			English	Article						SPEM; smooth-pursuit eye movements; eye tracking; oculomotor; concussion	TRAUMATIC BRAIN-INJURY; DEFICITS; SYNCHRONIZATION; ADOLESCENTS; PREVALENCE; DIAGNOSIS; FIXATIONS; SPORT	Aim Deficits in smooth-pursuit eye movements (SPEM) are often associated with mild traumatic brain injury(TBI). Eye tracking tests serve as a quick objective clinical tool to assess such predictive visual tracking. In this study, SPEM was assessed along circular, horizontal and vertical trajectories in adolescents with concussion and age-matched controls. Methods Ninety-one young adolescents with concussion and 140 visually healthy age-matched controls with a mean age of 14 years performed a computerized test of circular, horizontal and vertical tracking task using an eye tracker. Oculomotor tracking was assessed by computing the rate of fixation, saccades and SPEM made while performing the tasks. Results The predictive visual tracking task was able to differentiate the TBI group from the non-TBI group. The TBI group showed a significant difference in the fixation, saccades and SPEM percentages for circular tracking movement compared to the controls. There was a significant difference in fixation and SPEM % for horizontal and vertical tracking. Conclusions Predictive visual tracking, assessed using eye tracking technology, is able to differentiate deficits in oculomotor functions in individuals with and without concussion. The eye tracking technology may serve as a quick objective tool to detect and monitor neural deficits due to TBI.	[Hunfalvay, Melissa] RightEye LLC, Bethesda, MD USA; [Murray, Nicholas P.] East Carolina Univ, Greenville, NC 27858 USA; [Mani, Revathy] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Carrick, Frederick Robert] Univ Cent Florida, Coll Med, Dept Neurol, Orlando, FL 32816 USA; [Carrick, Frederick Robert] Univ Cambridge, Ctr Mental Hlth Res Assoc, Cambridge, England; [Carrick, Frederick Robert] MGH Inst Hlth Prof, Boston, MA USA		Mani, R (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Rupert Myers Bldg North Wing, Kensington, NSW 2032, Australia.	revathy.mani@unsw.edu.au		Murray, Nicholas/0000-0001-9968-2109; Carrick, Frederick/0000-0002-2818-6551	RightEye, LLC	Melissa Hunfalvay is a full-time employee with RightEye, LLC, and has relevant affiliations and financial involvement. Nick Murray, Frederick Robert Carrick and Revathy Mani have no relevant affiliations or involvement.	Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Corwin DJ, 2019, AM J EMERG MED, V37, P1219, DOI 10.1016/j.ajem.2018.09.008; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Haarbauer-Krupa J, 2021, ANN EPIDEMIOL, V54, P11, DOI 10.1016/j.annepidem.2020.11.006; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hunfalvay Melissa, 2020, Concussion, V5, pCNC69, DOI 10.2217/cnc-2019-0013; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kiderman A, 2020, NEUROLOGY, V95, pS2; Kleiser R, 2017, EXP BRAIN RES, V235, P819, DOI 10.1007/s00221-016-4843-x; Komogortsev OV, 2013, BEHAV RES METHODS, V45, P203, DOI 10.3758/s13428-012-0234-9; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Murray NG, 2020, J NEUROTRAUM, V37, P340, DOI 10.1089/neu.2019.6595; Ono S, 2008, PROG BRAIN RES, V171, P161, DOI 10.1016/S0079-6123(08)00621-3; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Tyagi A, 2019, IEEE J TRANSL ENG HE, V5, P1; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Zee, 2015, NEUROLOGY EYE MOVEME	33	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2021	35	14					1682	1689		10.1080/02699052.2021.2012825		DEC 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YP1JQ	WOS:000729329200001	34894915				2022-02-06	
J	Sullivan, K; Keyter, A; Jones, K; Ameratunga, S; Starkey, N; Barker-Collo, S; Webb, J; Theadom, A				Sullivan, Karen; Keyter, Anna; Jones, Kelly; Ameratunga, Shanthi; Starkey, Nicola; Barker-Collo, Suzanne; Webb, James; Theadom, Alice			Atypical symptom reporting after mild traumatic brain injury	BRAIN IMPAIRMENT			English	Article; Early Access						Symptoms; predictors; mild traumatic brain injury; concussion; outcome	POST-CONCUSSION SYNDROME; POSTCONCUSSION SYMPTOMS; SERVICE MEMBERS; PERSISTENT; SCALE; POPULATION; RECOVERY; UTILITY; QUESTIONNAIRE; EXAGGERATION	Objective: Early reporting of atypical symptoms following a mild traumatic brain injury (mTBI) may be an early indicator of poor prognosis. This study aimed to determine the percentage of people reporting atypical symptoms 1-month post-mTBI and explore links to recovery 12 months later in a community-dwelling mTBI sample. Methods: Adult participants (>16 years) who had experienced a mTBI were identified from a longitudinal incidence study (BIONIC). At 1-month post-injury, 260 participants completed the Rivermead Post-Concussion Symptoms Questionnaire (typical symptoms) plus four atypical symptom items (hemiplegia, difficulty swallowing, digestion problems and difficulties with fine motor tasks). At 12 months post-injury, 73.9% (n = 193) rated their overall recovery on a 100-point scale. An ordinal regression explored the association between atypical symptoms at 1 month and recovery at 12 months post-injury (low = 0-80, moderate = 81-99 and complete recovery = 100), whilst controlling for age, sex, rehabilitation received, ethnicity, mental and physical comorbidities and additional injuries sustained at the time of injury. Results: At 1-month post-injury <1% of participants reported hemiplegia, 5.4% difficulty swallowing, 10% digestion problems and 15.4% difficulties with fine motor tasks. The ordinal regression model revealed atypical symptoms were not significant predictors of self-rated recovery at 12 months. Older age at injury and higher typical symptoms at 1 month were independently associated with poorer recovery at 12 months, p < 0.01. Conclusion: Atypical symptoms on initial presentation were not linked to global self-reported recovery at 12 months. Age at injury and typical symptoms are stronger early indicators of longer-term prognosis. Further research is needed to determine if atypical symptoms predict other outcomes following mTBI.	[Sullivan, Karen] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Keyter, Anna] Auckland Univ Technol, Auckland, New Zealand; [Jones, Kelly; Theadom, Alice] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Fac Arts & Social Sci, Hamilton, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Webb, James] Webb Psychol, Auckland, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	Alice.Theadom@aut.ac.nz	Jones, Kelly/G-4127-2015	Jones, Kelly/0000-0001-5692-653X	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192]; Rutherford Discovery Fellowship	This work was supported by the Health Research Council of New Zealand Project Grant (Reference 09/063A and 11/192). Alice Theadom was supported by a Rutherford Discovery Fellowship administered by The Royal Society Te Aparangi.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Cook CJ, 2013, BRIT J SPORT MED, V47, P705, DOI 10.1136/bjsports-2012-091647; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Green K, 2021, J NEUROPSYCH CLIN N, V33, P109, DOI 10.1176/appi.neuropsych.20060159; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kaufman NK, 2019, PSYCHOL INJ LAW, V12, P91, DOI 10.1007/s12207-019-09355-9; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kish RL, 2016, J PHYS EDUC RECREAT, V87, P27, DOI 10.1080/07303084.2016.1216482; Kreutzer R.D, 2012, BRAIN INJURY MED PRI; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lippa SM, 2016, J CLIN EXP NEUROPSYC, V38, P721, DOI 10.1080/13803395.2016.1161732; McCrea M., 2008, MILD TRAUMATIC BRAIN; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Stubbs JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00043; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theadom A, 2018, BRAIN IMPAIR, V19, P119, DOI 10.1017/Brimp.2017.11; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Tyerman A, 2018, PSYCHOL EFFECTS BRAI; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Windle K, 2021, APPL NEUROPSYCH-ADUL, V28, P512, DOI 10.1080/23279095.2019.1660880	42	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000309	10.1017/BrImp.2021.30		DEC 2021	10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XN6PF	WOS:000729623800001					2022-02-06	
J	Thomas, GA; Riegler, KE; Guty, ET; Arnett, PA				Thomas, Garrett A.; Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.			Relationship Between Self-Reported Concomitant Depressive and Anxiety Symptoms and the Post-Concussion Symptoms Scale (PCSS)	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Early Access						Depression; anxiety; comorbidity; affective symptoms; post-concussion symptoms; athletics	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; NORMATIVE DATA; SENSITIVITY; COMORBIDITY; DISORDERS; MIGRAINE; RECOVERY; YOUTH	Objectives: The current study explored how affective disturbances, particularly concomitant anxiety and depressive symptoms, impact baseline symptom self-reporting on the Post-Concussion Symptoms Scale (PCSS) in college athletes. Methods: Athletes were separated into four groups (Healthy Control (HC) (n = 581), Depression Only (n = 136), Anxiety Only (n = 54), Concomitant Depression/Anxiety (n = 62)) based on their anxiety and depression scores. Groups were compared on Total PCSS Score as well as 5 PCSS Symptom Cluster scores (Cognitive, Physical, Affective, Sleep, and Headache). Results: The three affective groups reported significantly greater symptomatology than HCs, with the Concomitant group showing the highest symptomatology scores across all clusters. The depressive symptoms only group also reported significantly elevated symptomatology, compared to HCs, on every symptom cluster except headache. The anxiety symptoms only group differed from HCs on only the cognitive symptoms cluster. Additionally, the Concomitant group reported significantly increased PCSS symptomatology, in terms of total scores and all 5 symptom clusters, compared to the depressive symptoms only and anxiety symptoms only groups. Conclusions: Our findings suggest that athletes experiencing concomitant depressive/anxiety symptoms report significantly greater levels of symptomatology across all 5 PCSS symptom clusters compared to HCs. Further, results suggest that athletes experiencing concomitant affective disturbance tend to report greater symptomatology than those with only one affective disturbance. These findings are important because, despite the absence of concussion, the concomitant group demonstrated significantly elevated symptomatology at baseline. Thus, future comparisons with post-concussion data should account for this increased symptomatology, as test results may be skewed by affective disturbances at baseline.	[Thomas, Garrett A.; Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Thomas, GA (corresponding author), Penn State Univ, 372 Moore Bldg, University Pk, PA 16802 USA.	gat84@psu.edu		Riegler, Kaitlin/0000-0002-3939-4751; Thomas, Garrett/0000-0001-8966-6498; Guty, Erin/0000-0002-6599-2173			Alvaro PK, 2013, SLEEP, V36, P1059, DOI 10.5665/sleep.2810; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Beck ATSB., 2000, BDI FAST SCREEN MED; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Emmanuel J, 1998, BRIT J PSYCHIAT, V173, P35, DOI 10.1192/S0007125000293501; Gadermann AM, 2012, DEPRESS ANXIETY, V29, P797, DOI 10.1002/da.21924; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Guty E, 2018, J INT NEUROPSYCH SOC, V24, P684, DOI 10.1017/S135561771800036X; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; LeMoult J., 2013, PSYCHOPATHOLOGY SCI, P17; Levin H.S., 1989, MILD HEAD INJURY; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; MCNALLY RJ, 1987, J BEHAV THER EXP PSY, V18, P3, DOI 10.1016/0005-7916(87)90065-6; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Nyer M, 2013, DEPRESS ANXIETY, V30, P873, DOI 10.1002/da.22064; Peterson RA., 1987, J ANXIETY DISORD, V1, P117, DOI [10.1016/0887-6185(87)90002-8, DOI 10.1016/0887-6185(87)90002-8]; Pratt LA, 2016, GEN HOSP PSYCHIAT, V39, P39, DOI 10.1016/j.genhosppsych.2015.12.003; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Riegler KE, 2021, J INT NEUROPSYCH SOC, V27, P35, DOI 10.1017/S135561772000065X; Riegler KE, 2020, NEUROPSYCHOLOGY, V34, P63, DOI 10.1037/neu0000582; Riegler KE, 2019, ARCH CLIN NEUROPSYCH, V34, P563, DOI 10.1093/arclin/acy081; Sandin B, 2001, BEHAV RES THER, V39, P213, DOI 10.1016/S0005-7967(00)00009-7; Simms LJ, 2012, PSYCHOL MED, V42, P15, DOI 10.1017/S0033291711000985; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Suls J, 2012, CURR DIR PSYCHOL SCI, V21, P129, DOI 10.1177/0963721412439298; Thomas Garrett A, 1800, J Int Neuropsychol Soc, V28, P177, DOI 10.1017/S1355617721000412; Walczak M, 2018, CLIN PSYCHOL REV, V60, P45, DOI 10.1016/j.cpr.2017.12.005; Wallace J, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117110; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Womble M.N., 2019, NEUROPSYCHOLOGY SPOR, P43, DOI [10.1037/0000114-003, DOI 10.1037/0000114-003]	50	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.											PII S135561772100134X	10.1017/S135561772100134X		DEC 2021	11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XN7PT	WOS:000729692900001	34895377	hybrid			2022-02-06	
J	Tseng, CH; Chen, TT; Chan, MC; Chen, KY; Wu, SM; Shih, MC; Tu, YK				Tseng, Chien-Hua; Chen, Tzu-Tao; Chan, Ming-Cheng; Chen, Kuan-Yuan; Wu, Sheng-Ming; Shih, Ming-Chieh; Tu, Yu-Kang			Impact of Comorbidities on Beneficial Effect of Lactated Ringers vs. Saline in Sepsis Patients	FRONTIERS IN MEDICINE			English	Article						fluid therapy; intensive care; resuscitation; saline; lactated Ringers	BALANCED CRYSTALLOIDS; SEPTIC SHOCK; RESUSCITATION; MANAGEMENT; GLUCOSE	Background: Lactated Ringers reduced mortality more than saline in sepsis patients but increased mortality more than saline in traumatic brain injury patients.Method: This prospective cohort study was conducted in a medical intensive care unit (ICU) in central Taiwan. We applied standard sepsis evaluation protocol and identified heart, lung, liver, kidney, and endocrine comorbidities. We also evaluated resuscitation response with central venous pressure, central venous oxygen saturation, and serum lactate level simultaneously. Propensity-score matching and Cox regression were used to estimate mortality. The competing risk model compared the lengths of hospital stays with the subdistribution hazard ratio (SHR).Results: Overall, 938 patients were included in the analysis. The lactated Ringers group had a lower mortality rate (adjusted hazard ratio, 0.59; 95% CI 0.43-0.81) and shorter lengths of hospital stay (SHR, 1.39; 95% C.I. 1.15-1.67) than the saline group; the differences were greater in patients with chronic pulmonary disease and small and non-significant in those with chronic kidney disease, moderate to severe liver disease and cerebral vascular disease. The resuscitation efficacy was the same between fluid types, but serum lactate levels were significantly higher in the lactated Ringers group than in the saline group (0.12 mg/dl/h; 95% C.I.: 0.03, 0.21), especially in chronic liver disease patients. Compared to the saline group, the lactated Ringers group achieved target glucose level earlier in both diabetes and non-diabetes patients.Conclusion: Lactate Ringer's solution provides greater benefits to patients with chronic pulmonary disease than to those with chronic kidney disease, or with moderate to severe liver disease. Comorbidities are important in choosing resuscitation fluid types.	[Tseng, Chien-Hua; Shih, Ming-Chieh; Tu, Yu-Kang] Natl Taiwan Univ, Inst Epidmiol & Prevent Med, Taipei, Taiwan; [Tseng, Chien-Hua; Chen, Kuan-Yuan; Wu, Sheng-Ming] Taipei Med Univ, Coll Med, Sch Med, Div Pulm Med,Dept Internal Med, Taipei, Taiwan; [Tseng, Chien-Hua] Taipei Med Univ, Shuang Ho Hosp, Div Crit Care Med, Dept Emergency & Crit Care Med, Taipei, Taiwan; [Tseng, Chien-Hua; Chen, Tzu-Tao; Chen, Kuan-Yuan; Wu, Sheng-Ming] Taipei Med Univ, Shuang Ho Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Chan, Ming-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Crit Care & Resp Therapy, Taichung, Taiwan; [Chan, Ming-Cheng] Tunghai Univ, Coll Sci, Taichung, Taiwan; [Chen, Kuan-Yuan] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Tu, Yu-Kang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan		Tu, YK (corresponding author), Natl Taiwan Univ, Inst Epidmiol & Prevent Med, Taipei, Taiwan.; Tu, YK (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Dent, Taipei, Taiwan.	yukangtu@ntu.edu.tw			Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan; MOST [106-2314-B-002-098-MY3]	Funding This work was partly funded by a grant from the Ministry of Science and Technology of Taiwan (grant no. MOST 106-2314-B-002-098-MY3).	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COHEN RD, 1975, ANESTHESIOLOGY, V43, P661, DOI 10.1097/00000542-197512000-00013; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hill NR, 2011, DIABETES TECHNOL THE, V13, P921, DOI 10.1089/dia.2010.0247; Jeppesen JB, 2013, SCAND J CLIN LAB INV, V73, P293, DOI 10.3109/00365513.2013.773591; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kovatchev Boris P, 2003, Diabetes Technol Ther, V5, P817, DOI 10.1089/152091503322527021; Kovatchev BP, 1997, DIABETES CARE, V20, P1655, DOI 10.2337/diacare.20.11.1655; Lanspa MJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13851; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lobo DN, 2014, KIDNEY INT, V86, P1096, DOI 10.1038/ki.2014.105; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Resche-Rigon M, 2006, CRIT CARE, V10, DOI 10.1186/cc3921; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Schoenfeld D, 2006, CRIT CARE, V10, DOI 10.1186/cc3949; Self WH, 2018, NEW ENGL J MED, V378, P819, DOI 10.1056/NEJMoa1711586; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Sterling SA, 2015, CLIN EXP EMERG MED, V2, P197, DOI 10.15441/ceem.15.025; Toporek AH, 2021, AM J RESP CRIT CARE, V203, P1322, DOI 10.1164/rccm.202011-4122LE; Tseng CH, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03419-y; Van Zyl DG, 2012, QJM-INT J MED, V105, P337, DOI 10.1093/qjmed/hcr226; Wyss R, 2014, AM J EPIDEMIOL, V180, P645, DOI 10.1093/aje/kwu181	24	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	DEC 13	2021	8								758902	10.3389/fmed.2021.758902			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV8ER	WOS:000735168800001	34966752	Green Published, gold			2022-02-06	
J	Tseng, HW; Kulina, I; Girard, D; Gueguen, J; Vaquette, C; Salga, M; Fleming, W; Jose, B; Millard, SM; Pettit, AR; Schroder, K; Thomas, G; Wheeler, L; Genet, F; Banzet, S; Alexander, KA; Levesque, JP				Tseng, Hsu-Wen; Kulina, Irina; Girard, Dorothee; Gueguen, Jules; Vaquette, Cedryck; Salga, Marjorie; Fleming, Whitney; Jose, Beulah; Millard, Susan M.; Pettit, Allison R.; Schroder, Kate; Thomas, Gethin; Wheeler, Lawrie; Genet, Francois; Banzet, Sebastien; Alexander, Kylie A.; Levesque, Jean-Pierre			Interleukin-1 Is Overexpressed in Injured Muscles Following Spinal Cord Injury and Promotes Neurogenic Heterotopic Ossification	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article; Early Access						OSTEOIMMUNOLOGY; CYTOKINES; DISEASES AND DISORDERS OF; RELATED TO BONE (OTHER)	MACROPHAGE POLARIZATION; INFLAMMATORY MONOCYTES; GROWTH-FACTOR; FACTOR-I; RECEPTOR; CELLS; DEFICIENCY; INHIBITION; EXPRESSION; IL-1-BETA	Neurogenic heterotopic ossifications (NHOs) form in periarticular muscles after severe spinal cord (SCI) and traumatic brain injuries. The pathogenesis of NHO is poorly understood with no effective preventive treatment. The only curative treatment remains surgical resection of pathological NHOs. In a mouse model of SCI-induced NHO that involves a transection of the spinal cord combined with a muscle injury, a differential gene expression analysis revealed that genes involved in inflammation such as interleukin-1 beta (IL-1 beta) were overexpressed in muscles developing NHO. Using mice knocked-out for the gene encoding IL-1 receptor (IL1R1) and neutralizing antibodies for IL-1 alpha and IL-1 beta, we show that IL-1 signaling contributes to NHO development after SCI in mice. Interestingly, other proteins involved in inflammation that were also overexpressed in muscles developing NHO, such as colony-stimulating factor-1, tumor necrosis factor, or C-C chemokine ligand-2, did not promote NHO development. Finally, using NHO biopsies from SCI and TBI patients, we show that IL-1 beta is expressed by CD68(+) macrophages. IL-1 alpha and IL-1 beta produced by activated human monocytes promote calcium mineralization and RUNX2 expression in fibro-adipogenic progenitors isolated from muscles surrounding NHOs. Altogether, these data suggest that interleukin-1 promotes NHO development in both humans and mice. (c) 2021 American Society for Bone and Mineral Research (ASBMR).	[Tseng, Hsu-Wen; Kulina, Irina; Salga, Marjorie; Fleming, Whitney; Jose, Beulah; Millard, Susan M.; Pettit, Allison R.; Alexander, Kylie A.; Levesque, Jean-Pierre] Univ Queensland, Mater Res Inst, Woolloongabba, Qld, Australia; [Girard, Dorothee; Gueguen, Jules; Banzet, Sebastien] Inst Rech Biomed Armees IRBA, Clamart, France; [Girard, Dorothee; Gueguen, Jules; Banzet, Sebastien] Univ Paris Saclay, INSERM UMR MD 1197, Gif Sur Yvette, France; [Vaquette, Cedryck] Univ Queensland, Sch Dent, Herston, Qld, Australia; [Vaquette, Cedryck] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Regenerat Med, Kelvin Grove, Australia; [Salga, Marjorie; Genet, Francois] Versailles St Quentin Yvelines Univ UVSQ, PMR Dept, Unite Peri Operatoire Handicap UPOH, Garches, France; [Salga, Marjorie; Genet, Francois] Hop Raymond Poincare, Assistance Publ Hop Paris AP HP, UFR Simone Veil Sante, End ICAP,INSERM U1179, Garches, France; [Salga, Marjorie; Genet, Francois] Univ Versailles St Quentin En Yvelines UVSQ, Montigny Le Bretonneux, France; [Salga, Marjorie; Genet, Francois] UFR Simone Veil Sante, END ICAP, INSERM U1179, Montigny Le Bretonneux, France; [Schroder, Kate] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Thomas, Gethin; Wheeler, Lawrie] Univ Queensland, Translat Res Inst, Diamantina Inst, Woolloongabba, Qld, Australia		Alexander, KA; Levesque, JP (corresponding author), Univ Queensland, Stem Cell Biol Grp, Mater Res Inst, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.; Banzet, S (corresponding author), Ctr Transfus Sanguine Armees, Inst Rech Biomeci Armees, INSERM UMR MD 1197, 1 Rue Lieutenant Raoul Batany, F-92140 Clamart, France.	sebastien.banzet@inserm.fr; kylie.alexander@mater.uq.edu.au; jp.levesque@mater.uq.edu.au	Pettit, Allison/O-4462-2019; Alexander, Kylie/P-2666-2016; Girard, Dorothee/AAD-6034-2022; Schroder, Kate/C-6132-2008; Levesque, Jean-Pierre/C-5426-2011; Banzet, Sebastien/C-6448-2008	Pettit, Allison/0000-0003-4707-7892; Alexander, Kylie/0000-0001-5772-0277; Girard, Dorothee/0000-0003-3776-2220; Schroder, Kate/0000-0001-9261-3805; Levesque, Jean-Pierre/0000-0002-7299-6025; GUEGUEN, Jules/0000-0003-1891-1665; Banzet, Sebastien/0000-0003-0785-0019	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [1101620, 1181053]; Congressionally Approved Spinal Cord Injury Research Program of the US Department of Defense [W81XWH-15-1-0606]; Mater Foundation; NHMRCNational Health and Medical Research Council of Australia [1044091, 1136130, 1141131]; University of QueenslandUniversity of Queensland; French Society of Physical and Rehabilitation Medicine; Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) programAustralian GovernmentDepartment of Industry, Innovation and Science; University of QueenslandUniversity of Queensland [UQECR1834805]	The authors thank Prof David Hume for kindly donating recombinant pig CSF-1-Fc.(29) This research was funded in parts by Project Grant 1101620 (JPL, ARP and FG) and Ideas Grant 1181053 (JPL, KAA, HWT, FG, SB) from the National Health and Medical Research Council of Australia (NHMRC), the Congressionally Approved Spinal Cord Injury Research Program of the US Department of Defense award W81XWH-15-1-0606 (JPL and FG), The University of Queensland Early Career Researcher Grant UQECR1834805 (KA), and by funds from the Mater Foundation. JPL was supported by Research Fellowships 1044091 and 1136130 and KS by Research Fellowship 1141131 from the NHMRC. IK was supported by an international student scholarship from The University of Queensland. MS was supported by a student scholarship from the French Society of Physical and Rehabilitation Medicine. The authors also greatly acknowledge the help and advice of Dr Adam Ewing and Dr Kim Summers (Mater Research Institute) and the technical assistance of Marie-Emmanuelle Goriot, Bastien Rival (IRBA, INSERM UMRSMD-1197, Clamart), Denis Clay (INSERM UMS-44 Universite de Paris-Saclay, Villejuif), and Guillaume Genet (Raymond Poincare Hospital, Garches). The authors also acknowledge the technical assistance of "Cochin HistIM Facility" (Paris). The authors also acknowledge the scientific and technical assistance at the Translational Research Institute: The University of Queensland biological resources TRI facility, histology facility, flow cytometry facility, microscopy facility, and the preclinical imaging facility, which is supported by Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program.Authors' roles: HWT, KAA, IK, DG, JG, CV, MS, WF, BJ, SMM, GT, LW, and CV performed the experiments. HWT, KAA, IK, DG, SB, and JPL conceived the experiments and the work. KS provided essential reagents and expertise in IL1 mouse models. HWT, KAA, DG, SB, and JPL wrote the manuscript. HWT, KAA, DG, FG, KS, SB, and JPL edited the manuscript. HWT, KAA, ARP, FG, SB, and JPL obtained funding.	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Alexander KA, 2020, CURR OSTEOPOROS REP, V18, P666, DOI 10.1007/s11914-020-00636-w; Alexander KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00377; Arduini M, 2015, BONE JOINT J, V97B, P899, DOI 10.1302/0301-620X.97B7.35031; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Braza MS, 2018, AM J TRANSPLANT, V18, P1247, DOI 10.1111/ajt.14645; Chan AH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190314; Convente MR, 2018, J BONE MINER RES, V33, P269, DOI 10.1002/jbmr.3304; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Debaud C, 2021, J NEUROTRAUM, V38, P2162, DOI 10.1089/neu.2021.0058; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Gow DJ, 2014, MOL THER, V22, P1580, DOI 10.1038/mt.2014.112; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Gschwandtner M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02759; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Levesque JP, 2018, J BONE MINER RES, V33, P365, DOI 10.1002/jbmr.3346; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; OKeefe RJ, 1997, LAB INVEST, V76, P457; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Rovida E., 2015, P NATL ACAD SCI USA, V6, P379; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Sauter KA, 2014, J LEUKOCYTE BIOL, V96, P265, DOI 10.1189/jlb.2A0114-006R; Sorkin M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14172-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Tozaki-Saitoh H, 2020, J PHARMACOL SCI, V143, P133, DOI 10.1016/j.jphs.2020.03.004; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P1, DOI 10.1016/j.intimp.2005.05.013; Wang YQ, 2015, KIDNEY INT, V88, P1274, DOI 10.1038/ki.2015.295; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; Zakrasek EC, 2019, SPINAL CORD, V57, P214, DOI 10.1038/s41393-018-0199-3; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090	50	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0884-0431	1523-4681		J BONE MINER RES	J. Bone Miner. Res.												10.1002/jbmr.4482		DEC 2021	16	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	XN6QM	WOS:000729627100001	34841579	Green Submitted			2022-02-06	
J	Wilson, BJ; Bright, FAS; Cummins, C; Elder, H; Kayes, NM				Wilson, Bobbie-Jo; Bright, Felicity A. S.; Cummins, Christine; Elder, Hinemoa; Kayes, Nicola M.			'The wairua first brings you together': Maori experiences of meaningful connection in neurorehabilitation	BRAIN IMPAIRMENT			English	Article; Early Access						Wairua; hononga; Maori; connection; whanau perspectives; Indigenous health; therapeutic relationship; neurorehabilitation	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; REHABILITATION; ENGAGEMENT; WORKING; STROKE	Background and Aims: Therapeutic connections enhance patient experience and outcomes after neurological injury or illness. While we have some understanding of the components necessary to optimise therapeutic connections, these have developed from western-centric ideals. This study sought to explore the perspectives of Maori brain injury survivors, and their whanau (wider family and community), to develop more culturally informed understandings of what matters most for Maori in the development and experience of therapeutic connection. Design and Methods: A bicultural approach underpinned by principles of Kaupapa Maori Research was used. Whanau views and experiences were gathered through wananga (focus groups). These perspectives were analysed drawing on Maori methods of noho puku (self-reflection), whanaungatanga (relational linkage) and kaitiakitanga (guardianship). Findings: Three wananga were held with 16 people - 5 brain injury survivors and 11 whanau members. The phrase 'therapeutic connection' did not resonate; instead, people spoke of meaningful connections. For rehabilitation encounters to be meaningful, three layers of connection were acknowledged. The elemental layer features wairua (spirit) and hononga (connection) which both underpinned and surrounded interactions. The relational layer reflects the importance of whanau identity and collectivism, of being valued, known, and interactively spoken with. Finally, the experiential layer consists of relational aspects important within the experience: relationships of reciprocity that are mana-enhancing and grounded in trust. These layers are interwoven, and together serve as a framework for meaningful connections. Conclusions: Meaningful connections in neurorehabilitation are underpinned by wairua and hononga; are multi-layered; are enabled through interactions with people, practice, process and place; are inclusive of whanau and resonate with Maori worldviews. The primacy of wairua and whanau within an interconnected view of health, challenges individualistic notions inherent in western health models and deepens existing understandings of meaningful connections in neurorehabilitation which can guide future rehabilitation research, teaching and practice.	[Wilson, Bobbie-Jo; Bright, Felicity A. S.; Cummins, Christine; Kayes, Nicola M.] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Elder, Hinemoa] Univ Auckland, New Zealand Rangahau Roro Aotearoa, Brain Res, Auckland, New Zealand		Wilson, BJ (corresponding author), Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand.	bjwilson@aut.ac.nz			Brain Research New Zealand Centre of Research Excellence (BRNZ CoRE) Grant [11852]	This work was supported by a Brain Research New Zealand Centre of Research Excellence (BRNZ CoRE) Grant (Grant number: 11852).	Barker-Collo S, 2019, NEW ZEAL MED J, V132, P40; Barnes HM, 2017, QUAL RES, V17, P313, DOI 10.1177/1468794117696031; Bishop M, 2021, DISABIL REHABIL, V43, P1074, DOI 10.1080/09638288.2019.1651909; Bright F, 2021, INT J LANG COMM DIS, V56, P234, DOI 10.1111/1460-6984.12590; Bright FAS, 2018, INT J SOC RES METHOD, V21, P35, DOI 10.1080/13645579.2017.1316044; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Came HA, 2013, KOTUITUI, V8, P64, DOI 10.1080/1177083X.2013.841265; Carlson T., 2016, J INDIGENOUS WELLBEI, V1, P44; Drury N, 2008, INT J MENT HEALTH NU, V17, P317, DOI 10.1111/j.1447-0349.2008.00554.x; Durie M., 1998, WAIORA MAORI HLTH DE, V2nd; Durie MH, 1997, INT J MENT HEALTH, V26, P23, DOI 10.1080/00207411.1997.11449407; Elder H, 2017, AUST NZ J FAM THER, V38, P27, DOI 10.1002/anzf.1206; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Graham R, 2020, AUST NZ J PUBL HEAL, V44, P193, DOI 10.1111/1753-6405.12971; Haitana T, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920953752; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Harwood M, 2010, DISABIL REHABIL, V32, P972, DOI 10.3109/09638281003775378; Health Quality and Safety Commission New Zealand, 2018, WIND QUAL NZS HLTH C; Hudson M., 2010, ARA TIKA GUIDELINES; Kayes NM, 2015, EVIDENCE-BASED NEUROLOGY: MANAGEMENT OF NEUROLOGICAL DISORDERS, 2ND EDITION, P303; Kayes NM, 2012, DISABIL REHABIL, V34, P1907, DOI 10.3109/09638288.2012.670044; Kidd J, 2013, ALTERNATIVE, V9, P125, DOI 10.1177/117718011300900202; Lacey C, 2011, NEW ZEAL MED J, V124, P72; Lawton M, 2018, INT J LANG COMM DIS, V53, P550, DOI 10.1111/1460-6984.12368; McLellan KM, 2014, INT J SPEECH-LANG PA, V16, P529, DOI 10.3109/17549507.2013.864334; Ministry of Research Science and Technology Te Manatu Putaiao, 2007, VIS MAT UNL INN POT; Palmer SC, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1057-4; Parry R, 2014, J PRIM HEALTH CARE, V6, P254, DOI 10.1071/HC14254; Pihama L., 2010, J MAORI STUDIES, V9, P5; Pitama S, 2007, NEW ZEAL J PSYCHOL, V36, P118; Robson B, 2007, HAUORA MAORI STANDAR, P3, DOI 10.1016/j.jana.2007.05.005; Smith L.T., 2012, DECOLONIZING METHODO; Stagg K, 2019, DISABIL REHABIL, V41, P489, DOI 10.1080/09638288.2017.1396366; Terry G, 2020, DISABIL REHABIL, V42, P2334, DOI 10.1080/09638288.2018.1561952; Whitehead D., 2016, NURSING MIDWIFERY RE, V5th; Wilson D, 2018, J CLIN NURS, V27, P3810, DOI 10.1111/jocn.14546; Wilson D, 2012, J CLIN NURS, V21, P2316, DOI 10.1111/j.1365-2702.2011.04042.x	37	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000292	10.1017/BrImp.2021.29		DEC 2021	15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XN6RU	WOS:000729630600001		hybrid			2022-02-06	
J	Alarie, C; Gagnon, I; Gagnon, S; Gendron, D; Girard, C; Maranda-Levesque, X; Swaine, B				Alarie, Christophe; Gagnon, Isabelle; Gagnon, Sara; Gendron, David; Girard, Catherine; Maranda-Levesque, Xavier; Swaine, Bonnie			Physical Activity Interventions in Rehabilitation Programs for Outpatients With Mild Traumatic Brain Injury	RESEARCH QUARTERLY FOR EXERCISE AND SPORT			English	Article; Early Access						Physical activity; cross-sectional survey; exercise prescription; public health	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; EXERCISE; INDIVIDUALS; RECOVER; SLOW	Introduction: There is limited scientific evidence about the optimal content and parameters of physical activity (PA) interventions for rehabilitation outpatients with persisting symptoms of a mild traumatic brain injury (mTBI). Clinicians have thus had to develop services based on their expertise, feasibility and patient needs. Objectives: This study aimed to document PA interventions delivered in specialized programs of a Canadian province offering outpatient rehabilitation services for individuals with persisting symptoms of mTBI to inform clinical intervention development and future research. Materials and methods: Cross-sectional study using an online survey containing 32 multiple choice and short open-ended questions to be answered by program administrators, with their clinical team's input. Content analysis and descriptive statistics were used. Results: Data from 94% of rehabilitation sites (n = 17) revealed that PA interventions are delivered to children (n = 4), adults (n = 15) and older adults (n = 5) with mTBI symptoms lasting >= 1 month to >= 1 year post injury. PA interventions aim to increase participation (n = 14), improve body functions (n = 9), manage persisting mTBI symptoms (n = 5) and improve self-management skills (n = 5) and knowledge (n = 4). Interventions include individual (n = 15) or group-based (n = 12) format, home-programs (n = 7), and teaching/education (n = 6). Most PA interventions include aerobic and resistance exercises. PA dosage parameters vary greatly. Conclusion: Clinical experts use multimodal interventions for rehabilitation program users that target improvement in body functions, participation and symptoms. The results can inform the development, enhancement and evaluation of PA interventions. Studies evaluating the effectiveness of these interventions for this clientele are warranted.	[Alarie, Christophe; Gagnon, Sara; Gendron, David; Girard, Catherine; Maranda-Levesque, Xavier; Swaine, Bonnie] Univ Montreal, Montreal, PQ, Canada; [Alarie, Christophe; Swaine, Bonnie] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Alarie, Christophe; Swaine, Bonnie] Inst Univ Sur Readaptat Deficience Phys Montreal, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp, Hlth Ctr, Montreal, PQ, Canada		Alarie, C (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, CP 6128,SucC Ctr Ville, Montreal, PQ H3C 3J7, Canada.	christophe.alarie@umontreal.ca	Alarie, Christophe/T-4601-2018	Alarie, Christophe/0000-0002-1740-068X	Ecole the readaptation; Faculte de Medecine, Universite de Montreal; Fonds de Recherche du Quebec en SanteFonds de la Recherche en Sante du Quebec	Christophe Alarie received a bursary of Excellence from the Ecole the readaptation, Faculte de Medecine, Universite de Montreal and a Doctoral Training Scolarship from the Fonds de Recherche du Quebec en Sante. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.	Adams J, 2017, PHYSIOTHER CAN, V69, P249, DOI [10.3138/ptc.2015-81ep, 10.3138/ptc.2015-81EP]; Alarie C, 2021, J HEAD TRAUMA REHAB, V36, P205, DOI 10.1097/HTR.0000000000000639; Alarie C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027240; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chrisman SPD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00623; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Department of Veterans Affairs-Department of Defense, 2016, VA DOD CLIN PRACT GU; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gemmell C, 2006, BRAIN INJURY, V20, P151, DOI 10.1080/02699050500442998; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kleffelgaard I, 2019, CLIN REHABIL, V33, P74, DOI 10.1177/0269215518791274; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Langevin P, 2020, MED SCI SPORT EXER, V52, P2491, DOI 10.1249/MSS.0000000000002402; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Slade SC, 2016, BRIT J SPORT MED, V50, P1428, DOI 10.1136/bjsports-2016-096651; Sullivan KA, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0884-9; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; World Health Organization, 2001, INT CLASS FUNCT DIS	30	0	0	3	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0270-1367	2168-3824		RES Q EXERCISE SPORT	Res. Q. Exerc. Sport												10.1080/02701367.2021.1927946		DEC 2021	10	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	XO3CB	WOS:000730065500001	34904917				2022-02-06	
J	Stasolla, F; Caffo, AO; Bottiroli, S; Ciarmoli, D				Stasolla, Fabrizio; Caffo, Alessandro O.; Bottiroli, Sara; Ciarmoli, Donatella			An assistive technology program for enabling five adolescents emerging from a minimally conscious state to engage in communication, occupation, and leisure opportunities	DEVELOPMENTAL NEUROREHABILITATION			English	Article; Early Access						Assistive technology; traumatic brain injuries; post-coma; positive participation; quality of life; social validation	POST-COMA PERSONS; MICROSWITCH-BASED PROGRAMS; BRAIN-COMPUTER-INTERFACE; QUALITY-OF-LIFE; MULTIPLE DISABILITIES; MOTOR IMPAIRMENT; STIMULUS EVENTS; 6 CHILDREN; DISORDERS; ACCESS	Background Post-coma patients emerging from a minimally conscious state may have extensive motor disabilities and pose serious challenges to medical centers and home settings. Objectives To promote academic performance and communication skills of post-coma individuals with traumatic brain injuries emerging from a minimally conscious state through an Assistive Technology setup. To evaluate its effects on the participants' positive participation. To generalize the learning process. To assess the intervention's clinical and social validity. Method Study I included five adolescents exposed to an Assistive Technology setup enabling them with targeted adaptive behaviors. Study II involved fifty external raters in a social validation assessment. Results Data evidenced an improved performance of all the participants during the intervention, assessed through a concurrent multiple baseline design across participants. Social raters favorably scored the use of the technology. Conclusion An Assistive Technology setup may be helpful to enhance the performance and positive participation of adolescents with traumatic brain injuries emerging from a minimally conscious state.	[Stasolla, Fabrizio; Bottiroli, Sara; Ciarmoli, Donatella] Giustino Fortunato Univ Benevento, Benevento, Italy; [Caffo, Alessandro O.] Univ Aldo Moro, Dept Educ Sci, Commun, Psychol, Bari, Italy; [Bottiroli, Sara] IRCCS Mondino Fdn, Pavia, Italy		Stasolla, F (corresponding author), Giustino Fortunato Univ Benevento, Benevento, Italy.	f.stasolla@unifortunato.eu	Bottiroli, Sara/K-7548-2016	Bottiroli, Sara/0000-0002-0151-3962; Stasolla, Fabrizio/0000-0003-1626-9664			Albano V., 2019, TECHNOLOGY DISABILIT, V30, P209, DOI [10.3233/TAD-180216, DOI 10.3233/TAD-180216]; Alves FJ, 2020, IEEE ACCESS, V8, P118664, DOI 10.1109/ACCESS.2020.3005296; Amari A, 2017, REHABIL PSYCHOL, V62, P227, DOI 10.1037/rep0000152; Andresen JM, 2014, CRIT CARE MED, V42, P2244, DOI 10.1097/CCM.0000000000000522; Baldassin V, 2018, QUAL LIFE RES, V27, P597, DOI 10.1007/s11136-018-1804-9; Bernini S, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.623933; Burke H, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043012; Chiapparino C, 2011, LIFE SPAN DISABIL, V14, P45; Collins JC, 2018, J INTELLECT DISABILI, V22, P213, DOI 10.1177/1744629516689336; Columbus, 2017, ADV PSYCHOL RES, P179; CRAWFORD MR, 1993, J DEV PHYS DISABIL, V5, P349; Freda M, 2018, PSICOL SAL, V2018, P129, DOI [10.3280/PDS2018-001008, DOI 10.3280/PDS2018-001008]; Freda Maria Francesca, 2019, Front Psychol, V10, P2609, DOI 10.3389/fpsyg.2019.02609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hansen SM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029392; Hermann B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61180-2; Holz EM, 2015, ARCH PHYS MED REHAB, V96, pS16, DOI 10.1016/j.apmr.2014.03.035; Karlsson Petra, 2018, Dev Neurorehabil, V21, P497, DOI 10.1080/17518423.2017.1362057; Kim EJ, 2012, ANN REHABIL MED-ARM, V36, P428, DOI 10.5535/arm.2012.36.3.428; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Kulyk AV, 2019, ACTA NEUROPSYCHOL, V17, P9, DOI 10.5604/01.3001.0013.1405; Lancioni GE, 2007, PERCEPT MOTOR SKILL, V105, P47, DOI 10.2466/PMS.105.1.47-54; Lancioni GE, 2007, PERCEPT MOTOR SKILL, V104, P1027, DOI 10.2466/PMS.104.3.1027-1034; Lancioni GE, 2004, PERCEPT MOTOR SKILL, V99, P724, DOI 10.2466/PMS.99.6.724-728; Lancioni G, 2010, DEV NEUROREHABIL, V13, P212, DOI 10.3109/17518421003652858; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P379, DOI 10.1007/s10882-008-9104-x; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P209, DOI 10.1007/s10882-008-9105-9; Lancioni GE, 2019, CURR DEV DISORD REP, V6, P126, DOI 10.1007/s40474-019-00165-x; Lancioni GE, 2020, BRAIN INJURY, V34, P921, DOI 10.1080/02699052.2020.1763462; Lancioni GE, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00234; Lancioni GE, 2015, NEUROREHABILITATION, V37, P393, DOI 10.3233/NRE-151269; Lancioni GE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00931; Lancioni GE, 2014, NEUROREHABILITATION, V34, P749, DOI 10.3233/NRE-141075; Lancioni GE, 2014, RES DEV DISABIL, V35, P1110, DOI 10.1016/j.ridd.2014.01.029; Lancioni GE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00025; Lancioni GE, 2013, RES DEV DISABIL, V34, P4232, DOI 10.1016/j.ridd.2013.09.003; Lancioni GE, 2012, COGN PROCESS, V13, P133, DOI 10.1007/s10339-011-0428-6; Lancioni GE, 2011, RES DEV DISABIL, V32, P1638, DOI 10.1016/j.ridd.2011.02.016; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lancioni GE, 2009, DISABIL REHABIL-ASSI, V4, P367, DOI 10.1080/17483100903038584; Lancioni GE, 2009, DEV NEUROREHABIL, V12, P24, DOI 10.1080/17518420902776995; Lancioni GE, 2009, RES DEV DISABIL, V30, P1459, DOI 10.1016/j.ridd.2009.07.006; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; LUSSIERDESROCHE.D, 2017, ASSIST TECHNOL, V12, P290, DOI DOI 10.3109/17483107.2015.1136000; MATAMALAGOMEZ M, 2021, FRONT PSYCHOL, P12; Nagarajan G, 2019, INT J RF TECHNOL-RES, V10, P131, DOI 10.3233/RFT-180167; Naraian S, 2019, SCAND J DISABIL RES, V21, P207, DOI 10.16993/sjdr.589; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Patrick PA, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2019.100840; Pignat JM, 2015, CURR OPIN NEUROL, V28, P587, DOI 10.1097/WCO.0000000000000264; Pistoia F, 2008, BRAIN INJURY, V22, P633, DOI 10.1080/02699050802189693; Quaglini S, 2019, STUD HEALTH TECHNOL, V264, P1755, DOI [10.3233/SHT1190632, 10.3233/SHTI190632]; Sarkar AR, 2020, DISABIL REHABIL-ASSI, V15, P282, DOI 10.1080/17483107.2019.1568593; Shams M, 2020, BIO-MED MATER ENG, V31, P73, DOI 10.3233/BME-201081; Smith DL, 2017, OTJR-OCCUP PART HEAL, V37, p3S, DOI 10.1177/1539449216681276; STASOLLA F, 2021, FRONT PSYCHOL, P12; Stasolla F, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.635426; Stasolla F, 2019, DEV NEUROREHABIL, V22, P527, DOI 10.1080/17518423.2019.1624655; Stasolla F, 2019, DISABIL REHABIL-ASSI, V14, P489, DOI 10.1080/17483107.2018.1467972; Stasolla F, 2017, DEV NEUROREHABIL, V20, P185, DOI 10.3109/17518423.2015.1133724; Stasolla F, 2017, J APPL BEHAV ANAL, V50, P345, DOI 10.1002/jaba.374; Stasolla F, 2017, J DEV PHYS DISABIL, V29, P307, DOI 10.1007/s10882-016-9525-x; Stasolla F, 2014, INT J AMBIENT COMPUT, V6, P56, DOI 10.4018/IJACI.2014070104; Stasolla F, 2015, RES DEV DISABIL, V45-46, P1, DOI 10.1016/j.ridd.2015.07.005; Stasolla F, 2015, COGN PROCESS, V16, P69, DOI 10.1007/s10339-014-0625-1; Stasolla F, 2014, NEUROREHABILITATION, V35, P253, DOI 10.3233/NRE-141112; Stasolla F, 2014, RES DEV DISABIL, V35, P2993, DOI 10.1016/j.ridd.2014.07.045; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Torres EB, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00128; Wolfe K, 2019, BEHAV ANAL PRACT, V12, P491, DOI 10.1007/s40617-019-00336-7	72	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.												10.1080/17518423.2021.2011457		DEC 2021	12	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	XN2SD	WOS:000729359300001	34895026				2022-02-06	
J	Ervin, AM; Schubert, MC; Migliaccio, AA; Perin, J; Coulibaly, H; Millar, JL; Roberts, D; Shelhamer, M; Gold, D; Beauregard, S; Pinto, R; Brungart, D; Ward, BK				Ervin, Ann-Margret; Schubert, Michael C.; Migliaccio, Americo A.; Perin, Jamie; Coulibaly, Hamadou; Millar, Jennifer L.; Roberts, Dale; Shelhamer, Mark; Gold, Daniel; Beauregard, Stephanie; Pinto, Robin; Brungart, Douglas; Ward, Bryan K.		INVENT VPT Res Grp	Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation (INVENT VPT) Trial: study protocol for a randomized controlled crossover trial	TRIALS			English	Article						Vestibular rehabilitation; Vestibulo-ocular reflex; Dizziness; Incremental vestibular adaptation; Imbalance; Service members; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DYSFUNCTION; IMPAIRMENT; VETERANS; NECK; IRAQ; HEAD	Background: A clinical pattern of damage to the auditory, visual, and vestibular sensorimotor systems, known as multi-sensory impairment, affects roughly 2% of the US population each year. Within the population of US military service members exposed to mild traumatic brain injury (mTBI), 15-44% will develop multi-sensory impairment following a mild traumatic brain injury. In the US civilian population, multi-sensory impairment-related symptoms are also a common sequela of damage to the vestibular system and affect similar to 300-500/100,000 population. Vestibular rehabilitation is recognized as a critical component of the management of multi-sensory impairment. Unfortunately, the current clinical practice guidelines for the delivery of vestibular rehabilitation are not evidence-based and primarily rely on expert opinion. The focus of this trial is gaze stability training, which represents the unique component of vestibular rehabilitation. The aim of the Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation (INVENT VPT) trial is to assess the efficacy of a non-invasive, incremental vestibular adaptation training device for normalizing the response of the vestibulo-ocular reflex. Methods: The INVENT VPT Trial is a multi-center randomized controlled crossover trial in which military service members with mTBI and civilian patients with vestibular hypofunction are randomized to begin traditional vestibular rehabilitation or incremental vestibular adaptation and then cross over to the alternate intervention after a prescribed washout period. Vestibulo-ocular reflex function and other functional outcomes are measured to identify the best means to improve the delivery of vestibular rehabilitation. We incorporate ecologically valid outcome measures that address the common symptoms experienced in those with vestibular pathology and multi-sensory impairment. Discussion: The INVENT VPT Trial will directly impact the health care delivery of vestibular rehabilitation in patients suffering from multi-sensory impairment in three critical ways: (1) compare optimized traditional methods of vestibular rehabilitation to a novel device that is hypothesized to improve vestibulo-ocular reflex performance, (2) isolate the ideal dosing of vestibular rehabilitation considering patient burden and compliance rates, and (3) examine whether recovery of the vestibulo-ocular reflex can be predicted in participants with vestibular symptoms.	[Ervin, Ann-Margret; Perin, Jamie; Coulibaly, Hamadou] Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA; [Schubert, Michael C.; Millar, Jennifer L.; Gold, Daniel; Ward, Bryan K.] Johns Hopkins Univ, Sch Med, 601 N Caroline St, Baltimore, MD 21287 USA; [Migliaccio, Americo A.] Neurosci Res Australia, Sydney, NSW, Australia; [Roberts, Dale; Shelhamer, Mark] Johns Hopkins Univ, Sch Med, 1800 Orleans St, Baltimore, MD 21287 USA; [Beauregard, Stephanie] Ft Belvoir Community Hosp, Intrepid Spirit Ctr, Intrepid Pavil,5980 9th St,Bldg 1259, Ft Belvoir, VA 22060 USA; [Pinto, Robin; Brungart, Douglas] Natl Mil Audiol & Speech Ctr, Walter Reed Natl Mil Med Ctr, Bldg 19,Room 5600,4954 North Palmer Rd, Bethesda, MD 20889 USA		Ervin, AM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	aervin@jhu.edu		Ervin, Ann Margret/0000-0002-8610-4403	Department of Defense under the Psychological Health/Traumatic Brain Injury Research Program Complex Traumatic Brain Injury Rehabilitation Research Clinical Trial Award [W8lXWH-l7]	This work is supported by the Department of Defense under the Psychological Health/Traumatic Brain Injury Research Program Complex Traumatic Brain Injury Rehabilitation Research Clinical Trial Award (Grant Award W8lXWH-l7). IVE devices will be built and maintained by Neuroscience Research Australia.	Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clendaniel R., 2013, MEASUREMENT PROPERTI; Defense and Veterans Brain Injury Center, 2009, TBI FACTS; Giray M, 2009, ARCH PHYS MED REHAB, V90, P1325, DOI 10.1016/j.apmr.2009.01.032; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Hall CD, 2010, J NEUROL PHYS THER, V34, P64, DOI 10.1097/NPT.0b013e3181dde6d8; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Meli A, 2006, ACTA OTO-LARYNGOL, V126, P259, DOI 10.1080/00016480500388885; Millar JL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00079; Miller S.., 2011, HYPERBARIC OXYGEN PO; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Roland PS, 2000, OTOLARYNG HEAD NECK, V122, P319, DOI 10.1016/S0194-5998(00)70041-6; Rustemeyer J, 2007, BRIT J ORAL MAX SURG, V45, P556, DOI 10.1016/j.bjoms.2007.01.003; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Teggi R, 2009, J LARYNGOL OTOL, V123, P397, DOI 10.1017/S0022215108002983; Todd CJ, 2018, IEEE T NEUR SYS REH, V26, P1223, DOI 10.1109/TNSRE.2018.2834964; US Department of Veterans Affairs National Center for Veterans Analysis and Statistics, PROJ VET POP 2013 20; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007	31	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	DEC 11	2021	22	1							908	10.1186/s13063-021-05876-4			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XN0VS	WOS:000729233100016	34895314	Green Published, gold, Green Submitted			2022-02-06	
J	Amen, DG; Easton, M				Amen, Daniel G.; Easton, Michael			A New Way Forward: How Brain SPECT Imaging Can Improve Outcomes and Transform Mental Health Care Into Brain Health Care	FRONTIERS IN PSYCHIATRY			English	Article						brain SPECT; evidence-based; brain trauma; dementia; hypofrontality; hyperfrontality; complex cases; brain health	CEREBRAL-BLOOD-FLOW; EMISSION COMPUTED-TOMOGRAPHY; OBSESSIVE-COMPULSIVE DISORDER; DIFFERENTIAL-DIAGNOSIS; ANTERIOR CINGULATE; PERFUSION SPECT; TC-99M HMPAO; PSYCHIATRY; INJURY; COMORBIDITY	In the past three decades, brain single-photon-emission-computed-tomography (SPECT) imaging has garnered a significant, evidence-based foundation for a wide array of indications relevant to the field of clinical psychiatry, including dementia, traumatic brain injuries, seizures, cerebrovascular disease, complex neuropsychiatric presentations, and treatment-resistant disorders. In clinical psychiatric practice, however, SPECT remains underutilized. Only a small percentage of psychiatric clinicians use brain imaging technology. In this article, the authors provide a rationale for shifting the paradigm to one that includes broader use of SPECT in the clinical psychiatric setting, primarily for patients with complex conditions. This paper will outline seven specific clinical applications. Adding neuroimaging tools like SPECT to day-to-day clinical practice can help move psychiatry forward by transforming mental health care, which can be stigmatizing and often shunned by the general public, to brain health care, which the authors argue will be more likely to be embraced by a larger group of people in need.	[Amen, Daniel G.] Amen Clin, Costa Mesa, CA 92626 USA; [Easton, Michael] Rush Univ, Med Ctr, Dept Psychiat, Chicago, IL 60612 USA		Amen, DG (corresponding author), Amen Clin, Costa Mesa, CA 92626 USA.	docamen@amenclinics.com					Al-Kandari FA, 2007, ANN NUCL MED, V21, P439, DOI 10.1007/s12149-007-0050-y; Albon E, 2008, Health Technol Assess, V12, piii; ALEXANDER GE, 1995, J NEUROPSYCH CLIN N, V7, P188; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Amen D., 2005, ORAL CONVERSATION PE; Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P131, DOI 10.1080/02791072.2008.10400622; Amen DG, 2017, J ALZHEIMERS DIS, V56, P261, DOI 10.3233/JAD-160833; Amen Daniel G, 2013, Adv Mind Body Med, V27, P6; Amen Daniel G, 2011, Open Neuroimag J, V5, P40, DOI 10.2174/1874440001105010040; Amen DG., 2020, END MENTAL ILLNESS N; American College of Radiology, 2021, ACR ACNM SNMMI SPR P; APA Council on Children, 2005, ADOLESCENTS FAMILIES; Baulieu F, 2001, J NEUROIMAGING, V11, P112, DOI 10.1111/j.1552-6569.2001.tb00020.x; Blumer D., 1995, NEUROPSYCHIATRY PERS; Bonte FJ, 1997, RADIOLOGY, V202, P793, DOI 10.1148/radiology.202.3.9051035; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; Brockmann H, 2009, PSYCHIAT RES-NEUROIM, V173, P107, DOI 10.1016/j.pscychresns.2008.10.006; Camargo EE, 2001, J NUCL MED, V42, P611; Canadian Association of Nuclear Medicine, 2021, GUIDELINES; Datz FL., 1992, NUCL MED TEACHING PR; Davison CM, 2014, INT J GERIATR PSYCH, V29, P551, DOI 10.1002/gps.4036; Demir B, 2002, PSYCHIAT RES-NEUROIM, V115, P115, DOI 10.1016/S0925-4927(02)00071-9; DEVOUS MD, 1990, SEMIN NUCL MED, V20, P325, DOI 10.1016/S0001-2998(05)80237-5; Devous MD, 1998, J NUCL MED, V39, P285; Diler RS, 2004, YONSEI MED J, V45, P90, DOI 10.3349/ymj.2004.45.1.90; Donta ST, 2012, CLIN NUCL MED, V37, pE219, DOI 10.1097/RLU.0b013e318262ad9b; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Downar J, 2010, ACAD PSYCHIATR, V34, P119, DOI 10.1176/appi.ap.34.2.119; Ehmann T., 2002, EARLY PSYCHOSIS CARE; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; First MB, 2018, AM J PSYCHIAT, V175, P915, DOI 10.1176/appi.ajp.2018.1750701; Frings L, 2021, J ALZHEIMERS DIS, V82, P215, DOI 10.3233/JAD-210062; George MS., 1991, NEUROACTIVATION NEUR; Goethals I, 2005, BEHAV BRAIN RES, V157, P187, DOI 10.1016/j.bbr.2004.06.022; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; Goto H, 2010, AM J NEURORADIOL, V31, P720, DOI 10.3174/ajnr.A1926; Hales RE, 2007, TXB NEUROPSYCHIATRY, VFifth; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Henderson TA., 2018, EPATIENT, V1, P40; Hollander E, 1996, INT CLIN PSYCHOPHARM, V11, P75, DOI 10.1097/00004850-199612005-00007; HOLMAN BL, 1992, J NUCL MED, V33, P1888; Insel T., 2013, NIMH DIRECTOR POST; Insel TR, 2005, JAMA-J AM MED ASSOC, V294, P2221, DOI 10.1001/jama.294.17.2221; Insel tr, 2005, JUDD MARMOR AWARD LE; JACOBS A, 1994, J NUCL MED, V35, P942; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; Jobst K A, 1997, Int Psychogeriatr, V9 Suppl 1, P191, DOI 10.1017/S1041610297004912; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juni JE, 2009, J NUCL MED TECHNOL, V37, P191, DOI 10.2967/jnmt.109.067850; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kucuk NO, 2000, NUCL MED COMMUN, V21, P769, DOI 10.1097/00006231-200008000-00011; Kuhn TS., 1962, STRUCTURE SCI REVOLU; Kuruoglu AC, 1996, BRIT J PSYCHIAT, V169, P348, DOI 10.1192/bjp.169.3.348; Lacerda ALT, 2003, PSYCHIAT RES-NEUROIM, V123, P125, DOI 10.1016/S0925-4927(03)00061-1; Langguth B, 2007, NEUROENDOCRINOL LETT, V28, P633; LEIDERMAN DB, 1991, EPILEPSIA, V32, P417, DOI 10.1111/j.1528-1157.1991.tb04671.x; Lu YY, 2012, ANN NUCL MED, V26, P771, DOI 10.1007/s12149-012-0638-8; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Medina M, 2020, ACAD PSYCHIATR, V44, P311, DOI 10.1007/s40596-019-01156-1; Mega MS, 2000, J NEUROPSYCH CLIN N, V12, P209, DOI 10.1176/appi.neuropsych.12.2.209; Moller K, 2000, CLIN PHYSIOL, V20, P399, DOI 10.1046/j.1365-2281.2000.00276.x; MOURATIDIS B, 1995, CLIN NUCL MED, V20, P842, DOI 10.1097/00003072-199509000-00021; National Library of Medicine, 2021, BRAIN SPECT SEARCH R; Newberg A B, 1995, Neuroimaging Clin N Am, V5, P103; Noel X, 2002, ALCOHOL ALCOHOLISM, V37, P347, DOI 10.1093/alcalc/37.4.347; Oner P, 2008, TURK PSIKIYATR DERG, V19, P13; Pavel D, 2006, BRAIN COGNITION, V60, P211; Power SP, 2016, WORLD J RADIOL, V8, P902, DOI 10.4329/wjr.v8.i12.902; Quirce R, 1999, Rev Esp Med Nucl, V18, P363; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raji CA, 2018, NEUROIMAG CLIN N AM, V28, P67, DOI 10.1016/j.nic.2017.09.003; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Reynolds CF, 2009, ACAD MED, V84, P446, DOI 10.1097/ACM.0b013e31819a8052; Rupright J, 1996, ARCH PHYS MED REHAB, V77, P1205, DOI 10.1016/S0003-9993(96)90150-1; Schnedl WJ, 2013, EUR THYROID J, V2, P116, DOI 10.1159/000348523; Sheeehan W, 2008, J PSYCHIATR PRACT, V14, P318, DOI 10.1097/01.pra.0000336760.88178.e5; SHIH WJ, 1993, CLIN NUCL MED, V18, P506, DOI 10.1097/00003072-199306000-00010; Soderstrom H, 2000, PSYCHIAT RES-NEUROIM, V98, P29, DOI 10.1016/S0925-4927(99)00049-9; Thornton JF, 2014, J NEUROPSYCH CLIN N, V26, P51, DOI 10.1176/appi.neuropsych.12100238; Titlic M, 2009, BRATISL MED J, V110, P105; Vaamonde-Gamo J, 2005, REV NEUROLOGIA, V41, P276, DOI 10.33588/rn.4105.2004561; Vasile RG, 1996, HARVARD REV PSYCHIAT, V4, P27, DOI 10.3109/10673229609030519; Wu J, 1999, AM J PSYCHIAT, V156, P1149; Zhou ZB, 2016, J BIOMED RES, V30, P83, DOI 10.7555/JBR.30.20150126	87	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	DEC 10	2021	12								715315	10.3389/fpsyt.2021.715315			17	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XU5JU	WOS:000734301700001	34955905	Green Published, gold			2022-02-06	
J	Dickerson, MR; Murphy, SF; Urban, MJ; White, Z; VandeVord, PJ				Dickerson, Michelle R.; Murphy, Susan F.; Urban, Michael J.; White, Zakar; VandeVord, Pamela J.			Chronic Anxiety- and Depression-Like Behaviors Are Associated With Glial-Driven Pathology Following Repeated Blast Induced Neurotrauma	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						blast; TBI; neuropsychiatric; hippocampus; motor cortex; astrocytes; dendrites	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; POSTTRAUMATIC-STRESS; SOCIAL NOVELTY; MOUSE MODEL; SOCIABILITY; ASTROCYTES; EXPOSURE; GFAP; HIPPOCAMPUS	Long-term neuropsychiatric impairments have become a growing concern following blast-related traumatic brain injury (bTBI) in active military personnel and Veterans. Neuropsychiatric impairments such as anxiety and depression are common comorbidities that Veterans report months, even years following injury. To understand these chronic behavioral outcomes following blast injury, there is a need to study the link between anxiety, depression, and neuropathology. The hippocampus and motor cortex (MC) have been regions of interest when studying cognitive deficits following blast exposure, but clinical studies of mood disorders such as major depressive disorder (MDD) report that these two regions also play a role in the manifestation of anxiety and depression. With anxiety and depression being common long-term outcomes following bTBI, it is imperative to study how chronic pathological changes within the hippocampus and/or MC due to blast contribute to the development of these psychiatric impairments. In this study, we exposed male rats to a repeated blast overpressure (~17 psi) and evaluated the chronic behavioral and pathological effects on the hippocampus and MC. Results demonstrated that the repeated blast exposure led to depression-like behaviors 36 weeks following injury, and anxiety-like behaviors 2-, and 52-weeks following injury. These behaviors were also correlated with astrocyte pathology (glial-fibrillary acid protein, GFAP) and dendritic alterations (Microtubule-Associated Proteins, MAP2) within the hippocampus and MC regions at 52 weeks. Overall, these findings support the premise that chronic glial pathological changes within the brain contribute to neuropsychiatric impairments following blast exposure.	[Dickerson, Michelle R.; Murphy, Susan F.; Urban, Michael J.; White, Zakar; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Salem, VA 24153 USA		VandeVord, PJ (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.; VandeVord, PJ (corresponding author), Salem VA Med Ctr, Salem, VA 24153 USA.	pvord@vt.edu					Abrahamson EE, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113257; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Agoston DV, 2017, J NEUROTRAUM, V34, pS44, DOI 10.1089/neu.2017.5317; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; [Anonymous], 2019, REP C TRAUM BRAIN IN; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Becker M, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010123; Berger S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091018; Bjork JM, 2016, PSYCHIAT RES, V246, P321, DOI 10.1016/j.psychres.2016.10.008; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cantone M, 2017, ASN NEURO, V9, DOI 10.1177/1759091417711512; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cobb JA, 2016, NEUROSCIENCE, V316, P209, DOI 10.1016/j.neuroscience.2015.12.044; Collins SM, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.04313; Denby E, 2020, J HEAD TRAUMA REHAB, V35, P57, DOI 10.1097/HTR.0000000000000468; Dickerson MR, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00618; Dieter JN, 2019, NEUROSCI INSIGHTS, V14, DOI 10.1177/1179069519892933; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Fakhoury M, 2021, REV NEUROSCIENCE, V32, P289, DOI 10.1515/revneuro-2020-0037; Farhy-Tselnicker I, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0104-y; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Guo ZW, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0691-7; Hall KS, 2014, J REHABIL RES DEV, V51, P285, DOI 10.1682/JRRD.2013.04.0091; Hao ZY, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02490-7; Hellewell SC, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00350; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hubbard WB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28848-2; Jaehne EJ, 2015, BEHAV BRAIN RES, V281, P276, DOI 10.1016/j.bbr.2014.12.044; Johnson AW, 2013, P NATL ACAD SCI USA, V110, P12462, DOI 10.1073/pnas.1307925110; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kashdan TB, 2006, BEHAV RES THER, V44, P561, DOI 10.1016/j.brat.2005.03.010; Law J, 2016, PSYCHONEUROENDOCRINO, V67, P113, DOI 10.1016/j.psyneuen.2016.01.028; Leclercq S, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108238; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lopatina O, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00133; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Ma H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019409118; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; McKibben CE, 2014, J PSYCHOPHARMACOL, V28, P955, DOI 10.1177/0269881114544778; Miles SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184265; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Northoff G, 2021, MOL PSYCHIATR, V26, P92, DOI 10.1038/s41380-020-0814-5; Pallanti S, 2010, J NEUROL, V257, P1362, DOI 10.1007/s00415-010-5533-4; Peng DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120704; Pennisi M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8154969; Rahimpour S., 2016, TRANSLATIONAL RES TR; Ramos I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134675; Rao V, 2019, J NEUROPSYCH CLIN N, V31, P306, DOI 10.1176/appi.neuropsych.17110338; Rein B, 2020, NAT PROTOC, V15, P3464, DOI 10.1038/s41596-020-0382-9; Roddy DW, 2019, BIOL PSYCHIAT, V85, P487, DOI 10.1016/j.biopsych.2018.08.021; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schwerin SC, 2021, J NEUROPATH EXP NEUR, V80, P112, DOI 10.1093/jnen/nlaa157; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Stankevicins L.D.C., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.12.18.423401, DOI 10.1101/2020.12.18.423401]; Sweis BM, 2016, BEHAV BRAIN RES, V296, P149, DOI 10.1016/j.bbr.2015.09.015; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Tough H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4308-6; Traumatic Brain Injury, 2014, COH VET BIOSC; Wassermann EM, 2001, BIOL PSYCHIAT, V50, P377, DOI 10.1016/S0006-3223(01)01210-0; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	78	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	DEC 10	2021	15								787475	10.3389/fnbeh.2021.787475			16	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	YH2WM	WOS:000743032200001	34955781	Green Published, gold			2022-02-06	
J	Fox-Epstein, MH; Baker, SS; Thurston, BC; Morrow, CE; Mentzer, CJ; Mount, MG; Hamrick, AV; Compton, BS; Bendyk, HA; Lombardozzi, IK; Lombardozzi, KA				Fox-Epstein, Malka H.; Baker, Sarah S.; Thurston, Brian C.; Morrow, Charles E.; Mentzer, Caleb J.; Mount, Michael G.; Hamrick, Amy, V; Compton, Barri S.; Bendyk, Heather A.; Lombardozzi, Isabella K.; Lombardozzi, Kristine A.			Safety and Outcome of Intracranial Pressure Monitor Placement Performed by Trauma Critical Care Surgeons	AMERICAN SURGEON			English	Article; Early Access						trauma acute care; trauma; surgical quality; ICU; critical care		Introduction The Brain Trauma Foundation advises intracranial pressure monitor placement (ICPM) following traumatic brain injury (TBI) with a Glasgow Coma Scale (GCS) score <= 8 and an abnormal head computed tomographic scan (CT) finding. Prior studies demonstrated that ICPMs could be placed by non-neurosurgeons. We hypothesized that ICPM placement by trauma critical care surgeons (TCCS) would increase appropriate utilization (AU), decrease time to placement (TTP), and have equivalent complications to those placed by neurosurgeons. Methods We retrospectively reviewed medical records of adult trauma patients admitted with a TBI in a historical control group (HCG) and practice change group (PCG). Demographics, Injury Severity Score (ISS), outcomes, ICPM placement by provider type, and time to placement were identified. Complications and appropriate utilization were recorded. Results 70 patients in the HCG and 84 patients in the PCG met criteria for inclusion. Demographics, arrival GCS, ICU GCS, ISS, and admission APACHE II scores were not statistically significant. AU was 7/70 for HCG vs 19/84 in the PCG (P = .04036). Median TTP was 6.5 hours for HCG vs 5.25 for PCG (P = .9308). Interquartile range showed the data clustered around an earlier placement time, 2.3-14.0 hours, in the PCG. Complications between the 2 groups were not statistically significant, 0/7 for HCG vs 5/19 for PCG (P = .2782). Discussion This study confirms that ICPMs can be safely placed by TCCS. Our results demonstrate that placement of ICPMs by TCCS improves AU and possibly improves TTP.	[Fox-Epstein, Malka H.; Baker, Sarah S.; Thurston, Brian C.; Morrow, Charles E.; Mentzer, Caleb J.; Mount, Michael G.; Hamrick, Amy, V; Compton, Barri S.; Bendyk, Heather A.; Lombardozzi, Isabella K.; Lombardozzi, Kristine A.] Spartanburg Reg Med Ctr, Dept Surg, Spartanburg, SC USA		Fox-Epstein, MH (corresponding author), Spartanburg Reg Healthcare Syst, 101 East Wood St, Spartanburg, SC 29303 USA.	mfoxepstein@vcom.edu					Barber MA, 2012, J TRAUMA ACUTE CARE, V73, P558, DOI 10.1097/TA.0b013e318265cb75; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Ekeh AP, 2014, J TRAUMA ACUTE CARE, V76, P286, DOI 10.1097/TA.0000000000000092; Harris CH, 2002, AM SURGEON, V68, P787; Hoffman H, 2020, WORLD NEUROSURG, V142, pE385, DOI 10.1016/j.wneu.2020.07.022; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238	7	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.											00031348211056278	10.1177/00031348211056278		DEC 2021	4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XO4GD	WOS:000730144300001	34892995				2022-02-06	
J	Williams, LM; Douglas, JM				Williams, Liz M.; Douglas, Jacinta M.			It takes two to tango: The therapeutic alliance in community brain injury rehabilitation	BRAIN IMPAIRMENT			English	Article; Early Access						Traumatic brain injury; community rehabilitation; therapeutic alliance; working alliance; therapeutic relationship	WORKING ALLIANCE; CENTERED PRACTICE; ENGAGEMENT; STROKE; PSYCHOTHERAPY; INTERVENTION; PERSPECTIVES; PREDICTORS; AWARENESS; OUTCOMES	Objective: A positive therapeutic (or working) alliance has been associated with better outcomes for clients in the psychotherapeutic and traumatic brain injury (TBI) rehabilitation literature. The aim of this pilot study was to gain an understanding of the therapeutic alliance in community rehabilitation from the perspectives of adults with TBI and their close others who have completed a community rehabilitation programme. Method: This study used a constructivist, qualitative methodology which applied grounded theory analysis techniques. Using purposeful sampling, three pairs of participants (adults with TBI and close others) who had finished a community rehabilitation programme completed separate in-depth interviews which were transcribed verbatim and progressively analysed using a process of constant comparison. Results: A preliminary framework illustrating participants' experience of a therapeutic alliance was generated, comprising three interconnected themes: being recognised as an individual, working together and feeling personally connected. All participants viewed being able to work together as important in their experience of community rehabilitation and described features that helped and hindered the alliance. Conclusion: These pilot study results demonstrate the importance of the therapeutic alliance to the rehabilitation experience of individuals with TBI and those close to them.	[Williams, Liz M.; Douglas, Jacinta M.] La Trobe Univ, Living Disabil Res Ctr, Sch Allied Hlth, Melbourne, Vic, Australia; [Williams, Liz M.] South Australian Brain Injury Rehabil Serv, Hampstead Rehabil Ctr, Brain Injury Rehabil Community & Home BIRCH, Adelaide, SA, Australia; [Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia		Williams, LM (corresponding author), La Trobe Univ, Living Disabil Res Ctr, Sch Allied Hlth, Melbourne, Vic, Australia.; Williams, LM (corresponding author), South Australian Brain Injury Rehabil Serv, Hampstead Rehabil Ctr, Brain Injury Rehabil Community & Home BIRCH, Adelaide, SA, Australia.	liz.williams@sa.gov.au		Douglas, Jacinta/0000-0003-0940-6624			Ackerman SJ, 2003, CLIN PSYCHOL REV, V23, P1, DOI 10.1016/S0272-7358(02)00146-0; Barber, 2010, THERAPEUTIC ALLIANCE, P7; Birks M., 2011, GROUNDED THEORY PRAC; Bishop M, 2021, DISABIL REHABIL, V43, P1074, DOI 10.1080/09638288.2019.1651909; Bordin E.S., 1994, WORKING ALLIANCE THE; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Bowen C., 2010, RELATIONAL APPROACH; Bright FAS, 2018, INT J LANG COMM DIS, V53, P981, DOI 10.1111/1460-6984.12409; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Callaghan GM, 1996, PSYCHOTHERAPY, V33, P381, DOI 10.1037/0033-3204.33.3.381; Charles N., 2008, GRIEF MATTERS AUSTR, V11, P64; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2; Constantino M.J., 2002, COUNSELING BASED PRO, P81; Constantino Michael J, 2007, Behav Sleep Med, V5, P210; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Danzl Megan M, 2012, J Allied Health, V41, P35; Del Re AC, 2012, CLIN PSYCHOL REV, V32, P642, DOI 10.1016/j.cpr.2012.07.002; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ellis-Hill C, 2008, DISABIL REHABIL, V30, P150, DOI 10.1080/09638280701195462; Elvins R, 2008, CLIN PSYCHOL REV, V28, P1167, DOI 10.1016/j.cpr.2008.04.002; Eubanks-Carter C., 2010, THERAPEUTIC ALLIANCE, P74; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Fluckiger C, 2018, PSYCHOTHERAPY, V55, P316, DOI 10.1037/pst0000172; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Giles GM, 2006, J HEAD TRAUMA REHAB, V21, P168, DOI 10.1097/00001199-200603000-00009; Gracey F., 2012, THE SOCIAL CURE, P273; Green J, 2006, J CHILD PSYCHOL PSYC, V47, P425, DOI 10.1111/j.1469-7610.2005.01516.x; Hatcher RL, 2006, PSYCHOTHERAPY, V43, P292, DOI 10.1037/0033-3204.43.3.292; Horvath A.O., 1994, WORKING ALLIANCE THE, P1; Horvath AO, 2018, PSYCHOTHER RES, V28, P499, DOI 10.1080/10503307.2017.1373204; Horvath AO, 2011, PSYCHOTHERAPY, V48, P9, DOI 10.1037/a0022186; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Horvath AO, 2000, J CLIN PSYCHOL, V56, P163, DOI 10.1002/(SICI)1097-4679(200002)56:2<163::AID-JCLP3>3.0.CO;2-D; Horvath AO, 2001, AUST PSYCHOL, V36, P170, DOI 10.1080/00050060108259650; HOUGAARD E, 1994, SCAND J PSYCHOL, V35, P67, DOI 10.1111/j.1467-9450.1994.tb00934.x; Howgego IM, 2003, AUST NZ J PSYCHIAT, V37, P169, DOI 10.1046/j.1440-1614.2003.01131.x; Jesus TS, 2022, ARCH PHYS MED REHAB, V103, P106, DOI 10.1016/j.apmr.2021.05.005; Kayes NM, 2015, EVIDENCE-BASED NEUROLOGY: MANAGEMENT OF NEUROLOGICAL DISORDERS, 2ND EDITION, P303; Kayes NM, 2012, DISABIL REHABIL, V34, P1907, DOI 10.3109/09638288.2012.670044; Kirsh B, 2006, QUAL HEALTH RES, V16, P1054, DOI 10.1177/1049732306292100; Kissinger DB, 2008, WORK, V31, P309; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Krause Mariane, 2011, Clínica y Salud, V22, P267; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Lawton M, 2020, INT J SPEECH-LANG PA, V22, P59, DOI 10.1080/17549507.2019.1585949; Lawton M, 2018, APHASIOLOGY, V32, P1397, DOI 10.1080/02687038.2018.1441365; Lawton M, 2018, INT J LANG COMM DIS, V53, P550, DOI 10.1111/1460-6984.12368; Lawton M, 2016, ARCH PHYS MED REHAB, V97, P1979, DOI 10.1016/j.apmr.2016.03.031; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; lumer H., 1969, SYMB INTERACT; Lustig D., 2003, J APPL REHABIL COUS, V34, P30; Lustig DC, 2002, REHABIL COUNS BULL, V46, P25; Manchester D, 2001, BRAIN DAM B, P157; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Norcross JC, 2018, PSYCHOTHERAPY, V55, P303, DOI 10.1037/pst0000193; Ownsworth T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P340; Pinsof WM., 1994, WORKING ALLIANCE THE, P173; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Richards L., 2013, README 1 USERS GUIDE; Rowlands L, 2020, NEUROREHABILITATION, V46, P271, DOI 10.3233/NRE-193005; Safran JD, 2011, PSYCHOTHERAPY, V48, P80, DOI 10.1037/a0022140; Schonberger M, 2007, BRAIN INJURY, V21, P825, DOI 10.1080/02699050701499433; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stagg K, 2019, DISABIL REHABIL, V41, P489, DOI 10.1080/09638288.2017.1396366; Terry G, 2020, DISABIL REHABIL, V42, P2334, DOI 10.1080/09638288.2018.1561952; Thompson SJ, 2007, CONTEMP FAM THER, V29, P39, DOI 10.1007/s10591-007-9030-6; Tschuschke V, 2020, J NERV MENT DIS, V208, P56, DOI 10.1097/NMD.0000000000001111; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Ulvenes PG, 2012, PSYCHOTHERAPY, V49, P291, DOI 10.1037/a0027895; Webb CA, 2011, J CONSULT CLIN PSYCH, V79, P279, DOI 10.1037/a0023252; Westra HA, 2011, PSYCHOTHER RES, V21, P472, DOI 10.1080/10503307.2011.581708; Whiffin CJ, 2019, NEUROPSYCHOL REHABIL, V29, P1256, DOI 10.1080/09602011.2017.1387577; Wilson BA, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P1; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Worrall L, 2010, J INTERACT RES COM D, V1, P277, DOI 10.1558/jircd.v1i2.277; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Zelencich L, 2020, NEUROPSYCHOL REHABIL, V30, P1682, DOI 10.1080/09602011.2019.1600554	89	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.											PII S1443964621000267	10.1017/BrImp.2021.26		DEC 2021	18	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XN0KL	WOS:000729203800001					2022-02-06	
J	Yang, F; Peng, C; Peng, LW; Wang, J; Li, YJ; Li, WX				Yang, Fan; Peng, Chi; Peng, Liwei; Wang, Jian; Li, Yuejun; Li, Weixin			A Machine Learning Approach for the Prediction of Traumatic Brain Injury Induced Coagulopathy	FRONTIERS IN MEDICINE			English	Article						traumatic brain injury-induced coagulopathy; TBI-IC; machine learning; external validation; model interpretation	PLATELET DYSFUNCTION; RISK; SEPSIS	Background: Traumatic brain injury-induced coagulopathy (TBI-IC), is a disease with poor prognosis and increased mortality rate.Objectives: Our study aimed to identify predictors as well as develop machine learning (ML) models to predict the risk of coagulopathy in this population.Methods: ML models were developed and validated based on two public databases named Medical Information Mart for Intensive Care (MIMIC)-IV and the eICU Collaborative Research Database (eICU-CRD). Candidate predictors, including demographics, family history, comorbidities, vital signs, laboratory findings, injury type, therapy strategy and scoring system were included. Models were compared on area under the curve (AUC), accuracy, sensitivity, specificity, positive and negative predictive values, and decision curve analysis (DCA) curve.Results: Of 999 patients in MIMIC-IV included in the final cohort, a total of 493 (49.35%) patients developed coagulopathy following TBI. Recursive feature elimination (RFE) selected 15 variables, including international normalized ratio (INR), prothrombin time (PT), sepsis related organ failure assessment (SOFA), activated partial thromboplastin time (APTT), platelet (PLT), hematocrit (HCT), red blood cell (RBC), hemoglobin (HGB), blood urea nitrogen (BUN), red blood cell volume distribution width (RDW), creatinine (CRE), congestive heart failure, myocardial infarction, sodium, and blood transfusion. The external validation in eICU-CRD demonstrated that adapting boosting (Ada) model had the highest AUC of 0.924 (95% CI: 0.902-0.943). Furthermore, in the DCA curve, the Ada model and the extreme Gradient Boosting (XGB) model had relatively higher net benefits (ie, the correct classification of coagulopathy considering a trade-off between false- negatives and false-positives)-over other models across a range of threshold probability values.Conclusions: The ML models, as indicated by our study, can be used to predict the incidence of TBI-IC in the intensive care unit (ICU).	[Yang, Fan; Li, Yuejun] Fourth Mil Med Univ, Tangdu Hosp, Dept Plast Surg & Burns, Xian, Peoples R China; [Peng, Chi] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Peng, Liwei; Wang, Jian; Li, Weixin] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China		Li, WX (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China.	tangdunaowai@163.com		Wang, Jian/0000-0001-7478-1741			Akaraborworn O, 2019, CHIN J TRAUMATOL, V22, P219, DOI 10.1016/j.cjtee.2019.04.004; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chang T, 2021, NEUROPSYCH DIS TREAT, V17, P2905, DOI 10.2147/NDT.S323897; Chen H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685174; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Ellingsen TS, 2015, THROMB HAEMOSTASIS, V113, P193, DOI 10.1160/TH14-04-0335; Gall LS, 2018, CURR OPIN ANESTHESIO, V31, P227, DOI 10.1097/ACO.0000000000000561; GAWAZ MP, 1994, J AM SOC NEPHROL, V5, P36; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lasocki S, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2253-0; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mitra B, 2011, RESUSCITATION, V82, P1208, DOI 10.1016/j.resuscitation.2011.04.007; Muller MC, 2014, CRIT CARE, V18, DOI 10.1186/cc13721; Peltan ID, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1541-9; Perkins ZB, 2021, ANN SURG, V274, pE1119, DOI 10.1097/SLA.0000000000003771; Piagnerelli M, 2003, CRIT CARE MED, V31, P2156, DOI 10.1097/01.CCM.0000079608.00875.14; Pollard TJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.178; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Sohal AS, 2006, THROMB RES, V118, P417, DOI 10.1016/j.thromres.2005.03.032; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tonglet ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0648-0; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Zhang ZH, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.10.97; Zhang ZZ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2411-z; Zhao QY, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.637434; Zoller B, 2014, THROMB RES, V133, P334, DOI 10.1016/j.thromres.2013.12.013	43	0	0	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	DEC 10	2021	8								792689	10.3389/fmed.2021.792689			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI0JY	WOS:000743544900001	34957161	gold, Green Published			2022-02-06	
J	Yang, L; Lei, JF; Ouyang, JY; Li, MZ; Zhan, Y; Feng, XF; Lu, Y; Li, MC; Wang, L; Zou, HY; Zhao, H				Yang, Le; Lei, Jian-feng; Ouyang, Jun-yao; Li, Man-zhong; Zhan, Yu; Feng, Xue-feng; Lu, Yun; Li, Ming-cong; Wang, Lei; Zou, Hai-yan; Zhao, Hui			Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Trillium tschonoskii Maxim. Treatment in a Rat Model of Focal Ischemia	FRONTIERS IN PHARMACOLOGY			English	Article						total saponins from Trillium tschonoskii maxim; ischemia; neurorepair; motor functional recovery; rat model	CEREBRAL-ARTERY OCCLUSION; WHITE-MATTER INJURY; STROKE; CELLS; NEUROPROTECTION; PATHWAY; ACTIVATION; RHIZOME; CANCER	Trillium tschonoskii Maxim. (TTM), is a perennial herb from Liliaceae, that has been widely used as a traditional Chinese medicine treating cephalgia and traumatic hemorrhage. The present work was designed to investigate whether the total saponins from Trillium tschonoskii Maxim. (TSTT) would promote brain remodeling and improve gait impairment in the chronic phase of ischemic stroke. A focal ischemic model of male Sprague-Dawley (SD) rats was established by permanent middle cerebral artery occlusion (MCAO). Six hours later, rats were intragastrically treated with TSTT (120, 60, and 30 mg/kg) and once daily up to day 30. The gait changes were assessed by the CatWalk-automated gait analysis system. The brain tissues injuries, cerebral perfusion and changes of axonal microstructures were detected by multimodal magnetic resonance imaging (MRI), followed by histological examinations. The axonal regeneration related signaling pathways including phosphatidylinositol 3-kinases (PI3K)/protein kinase B (AKT)/glycogen synthase kinase-3 (GSK-3)/collapsin response mediator protein-2 (CRMP-2) were measured by western blotting. TSTT treatment significantly improved gait impairment of rats. MRI analysis revealed that TSTT alleviated tissues injuries, significantly improved cerebral blood flow (CBF), enhanced microstructural integrity of axon and myelin sheath in the ipsilesional sensorimotor cortex and internal capsule. In parallel to MRI findings, TSTT preserved myelinated axons and promoted oligodendrogenesis. Specifically, TSTT interventions markedly up-regulated expression of phosphorylated GSK-3, accompanied by increased expression of phosphorylated PI3K, AKT, but reduced phosphorylated CRMP-2 expression. Taken together, our results suggested that TSTT facilitated brain remodeling. This correlated with improving CBF, encouraging reorganization of axonal microstructure, promoting oligodendrogenesis and activating PI3K/AKT/GSK-3/CRMP-2 signaling, thereby improving poststroke gait impairments.	[Yang, Le; Ouyang, Jun-yao; Li, Man-zhong; Zhan, Yu; Feng, Xue-feng; Lu, Yun; Li, Ming-cong; Wang, Lei; Zou, Hai-yan; Zhao, Hui] Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China; [Yang, Le; Ouyang, Jun-yao; Li, Man-zhong; Zhan, Yu; Feng, Xue-feng; Lu, Yun; Li, Ming-cong; Wang, Lei; Zou, Hai-yan; Zhao, Hui] Beijing Key Lab TCM Collateral Dis Theory Res, Beijing, Peoples R China; [Lei, Jian-feng] Capital Med Univ, Med Imaging Lab Core Facil Ctr, Beijing, Peoples R China		Zou, HY; Zhao, H (corresponding author), Capital Med Univ, Sch Tradit Chinese Med, Beijing, Peoples R China.; Zou, HY; Zhao, H (corresponding author), Beijing Key Lab TCM Collateral Dis Theory Res, Beijing, Peoples R China.	zouhy@ccmu.edu.cn; zhaohuishouyi@ccmu.edu.cn			Scientific Research Common Program of Beijing Municipal Commission of EducationBeijing Municipal Commission of Education [KM201510025011]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973782]	Funding The study was supported by the Scientific Research Common Program of Beijing Municipal Commission of Education (KM201510025011) and the National Natural Science Foundation of China (Grant Nos. 30973782).	Ahmad B, 2021, ONCOTARGETS THER, V14, P1821, DOI 10.2147/OTT.S287354; Aracki-Trenkic A, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105908; Cai BR, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3153082; [陈显兵 Chen Xianbing], 2015, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V40, P622; Dai XJ, 2020, J CEREBR BLOOD F MET, V40, P639, DOI 10.1177/0271678X19830791; Darshit BS, 2016, MOL NEUROBIOL, V53, P6716, DOI 10.1007/s12035-015-9598-z; Domin H, 2018, PROG NEURO-PSYCHOPH, V84, P93, DOI 10.1016/j.pnpbp.2018.02.006; Fang K, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7493694; Gim Sang-A, 2013, Lab Anim Res, V29, P63, DOI 10.5625/lar.2013.29.2.63; Guzik A, 2017, NEUROL NEUROCHIR POL, V51, P60, DOI 10.1016/j.pjnns.2016.11.004; Hatakeyama M, 2020, NEURAL REGEN RES, V15, P16, DOI 10.4103/1673-5374.264442; Hattori T, 2015, DEV NEUROSCI-BASEL, V37, P95, DOI 10.1159/000368396; Kassis H, 2014, NEUROCHEM INT, V77, P17, DOI 10.1016/j.neuint.2014.03.006; Kim HS, 2014, J CEREBR BLOOD F MET, V34, P683, DOI 10.1038/jcbfm.2014.2; Koundal S, 2015, NEUROSCIENCE, V289, P106, DOI 10.1016/j.neuroscience.2014.12.049; Lambert CS, 2014, BEHAV BRAIN RES, V274, P334, DOI 10.1016/j.bbr.2014.08.004; Lee J, 2007, LIFE SCI, V81, P249, DOI 10.1016/j.lfs.2007.05.009; Li D, 2020, STEROIDS, V155, DOI 10.1016/j.steroids.2019.108569; Li MZ, 2018, BIOMED PHARMACOTHER, V103, P989, DOI 10.1016/j.biopha.2018.04.125; Li MZ, 2018, J ETHNOPHARMACOL, V215, P199, DOI 10.1016/j.jep.2018.01.006; Li XF, 2021, J ETHNOPHARMACOL, V274, DOI 10.1016/j.jep.2021.114018; Li YH, 2014, BIOCHEM PHARMACOL, V88, P150, DOI 10.1016/j.bcp.2014.01.018; Li YX, 2021, BRAIN RES, V1753, DOI 10.1016/j.brainres.2020.147224; Lin XH, 2021, MOL CELL BIOCHEM, V476, P2193, DOI 10.1007/s11010-021-04073-w; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu L, 2018, TRANSL STROKE RES, V9, P506, DOI 10.1007/s12975-018-0611-5; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mou K, 2017, INT J CLIN EXP MED, V10, P16771; Oyelaja-Akinsipo OB, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03296; Qiu Yong, 2016, Chinese Pharmacological Bulletin, V32, DOI 10.3969/j.issn.1001-1978.2016.11.014; Ramos-Cejudo J, 2015, STROKE, V46, P221, DOI 10.1161/STROKEAHA.114.006692; Saar G, 2019, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00114; Shahsavani N, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166117; Son JP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246817; Stamatovic SM, 2019, NEUROBIOL DIS, V126, P105, DOI 10.1016/j.nbd.2018.09.006; Tian WS, 2004, SCI CHINA SER B, V47, P142, DOI 10.1360/03yb0002; van Tilborg E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16797-1; Hernandez-Vazquez JMV, 2020, EUR J PHARMACOL, V871, DOI 10.1016/j.ejphar.2020.172942; Wang SX, 2017, INT IMMUNOPHARMACOL, V50, P22, DOI [10.1016/j.intimp.2017.06.008, 10.16790/j.cnki.1009-9239.im.2017.08.004]; Wang Y, 2013, PHARM BIOL, V51, P1321, DOI 10.3109/13880209.2013.790065; Xiong T, 2012, NEUROSCIENCE, V216, P123, DOI 10.1016/j.neuroscience.2012.04.052; Yang XM, 2021, J NAT MED-TOKYO, V75, P207, DOI 10.1007/s11418-020-01451-4; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yu XH, 2018, BRAIN RES, V1680, P127, DOI 10.1016/j.brainres.2017.12.019; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeng GR, 2018, PHYTOMEDICINE, V48, P94, DOI 10.1016/j.phymed.2018.05.003; Zhang C, 2019, MOLECULES, V24, DOI 10.3390/molecules24050875; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011016; Zhang Q, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1845-z; Zhang QX, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000330; Zheng JY, 2021, EXP NEUROL, V337, DOI 10.1016/j.expneurol.2020.113574; Zhou DR, 2021, J ETHNOPHARMACOL, V272, DOI 10.1016/j.jep.2021.113943	53	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	DEC 10	2021	12								763181	10.3389/fphar.2021.763181			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YH3DH	WOS:000743049900001	34955834	gold, Green Published			2022-02-06	
J	Downing, MG; Hicks, AJ; Braaf, S; Myles, DB; Gabbe, BJ; Ponsford, J				Downing, Marina G.; Hicks, Amelia J.; Braaf, Sandy; Myles, Daniel B.; Gabbe, Belinda J.; Ponsford, Jennie			"It's been a long hard road": challenges faced in the first three years following traumatic brain injury	DISABILITY AND REHABILITATION			English	Article; Early Access						Traumatic brain injury; qualitative study; challenges; recovery; outcome	PSYCHIATRIC-DISORDERS; PERSPECTIVES; RECOVERY; MODERATE; OUTCOMES; REHABILITATION; EXPERIENCE; THERAPY; ADULTS; LIFE	Purpose There is limited qualitative research exploring challenges experienced following severe traumatic brain injury (TBI). We investigated challenges to recovery identified by individuals who sustained severe TBI three years earlier or their close others (COs), as well as suggestions for managing these challenges. Materials and methods Nine participants with TBI and 16 COs completed semi-structured interviews. Using reflexive thematic analysis, challenges were identified across several timeframes (i.e., at the injury, acute care, inpatient rehabilitation, outpatient rehabilitation, and at home/other location). Results Challenges experienced across all timeframes included: lack of information and poor communication, pre-existing conditions, missed injuries, and issues with medical staff, and continuity of care. From acute care onwards, there were TBI-related consequences, issues with coping and emotional adjustment, negative outlook, insufficient treatment, lack of support for COs, and issues with compensation and funding for rehabilitation needs. Some challenges were unique to a specific timeframe (e.g., over-stimulating ward setting during acute care, and limited or unsupportive families once injured individuals went home). Suggestions for managing some of the challenges were provided (e.g., information provision, having peer supports). Conclusion Suggestions should be considered to promote successful outcomes following severe TBI.	[Downing, Marina G.; Hicks, Amelia J.; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr MERRC, Melbourne, Vic, Australia; [Downing, Marina G.; Hicks, Amelia J.; Myles, Daniel B.; Ponsford, Jennie] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Melbourne, Vic, Australia; [Braaf, Sandy; Myles, Daniel B.; Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Sch Med, Swansea, W Glam, Wales		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X; Hicks, Amelia/0000-0002-1152-0576	Australian Government's National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1061786]; Department of Health, State Government of Victoria and Transport Accident Commission; Future Fellowship from the Australian Research CouncilAustralian Research Council; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia	This project was funded by the Australian Government's National Health and Medical Research Council (GNT1061786). The Victorian State Trauma Registry (VSTR) is funded by the Department of Health, State Government of Victoria and Transport Accident Commission. BG was supported by a Future Fellowship from the Australian Research Council and PC by a NHMRC Practitioner Fellowship.	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; D'Souza A, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1822882; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Downing M, 2021, NEUROPSYCHOL REHABIL, V31, P889, DOI 10.1080/09602011.2020.1744453; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Evald L, 2018, DISABIL REHABIL, V40, P2250, DOI 10.1080/09638288.2017.1333633; Fabricius AM, 2020, QUAL HEALTH RES, V30, P1033, DOI 10.1177/1049732319900163; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; Gabbe BJ, 2015, INJURY PREV, V21, P348, DOI 10.1136/injuryprev-2014-041336; Glintborg C, 2016, NEUROREHABILITATION, V38, P99, DOI 10.3233/NRE-161301; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hassett L, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003029; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jones C, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19807; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Monaghesh E, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09301-4; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Ponsford J, 2020, NEUROPSYCHOL REHABIL, V30, P85, DOI 10.1080/09602011.2018.1453367; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P158, DOI 10.1097/HTR.0b013e3181e7537e; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434	43	0	0	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.1992517		DEC 2021	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XM7WZ	WOS:000729033600001	34890511				2022-02-06	
J	Maietta, JE; Kuwabara, HC; Keene, J; Ross, SR; Kinsora, TF; Allen, DN				Maietta, Julia E.; Kuwabara, Hana C.; Keene, Jennifer; Ross, Staci R.; Kinsora, Thomas F.; Allen, Daniel N.			Cognitive Profiles Following Sport-Related Concussion in High School Athletes	NEUROPSYCHOLOGY			English	Article; Early Access						concussion; ImPACT; cluster analysis; cognitive profiles; symptoms	VERBAL-LEARNING TEST; RECOVERY; SYMPTOMS; IMPACT; MEMORY; PERFORMANCE; SUBTYPES; HETEROGENEITY; RELIABILITY; CLUSTERS	Objective: Heterogeneity is common following traumatic brain injury (TBI) with important implications for clinical outcome. Research in moderate to severe TBI identifies differentiated cognitive profiles. There is little research investigating potential clusters following sport concussion. Methods: Cluster analysis was used to determine patterns of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) performance at three time points (72 hr, 4-7 days, and 8-30 days postconcussion). Participants included 1,817 high-school athletes (M-age = 15.5; 37.9% female) who completed ImPACT following concussion. Results: Separate cluster analyses of cognitive scores were conducted at each postconcussion timepoint. Results indicated three clusters of cognitive performance within 1 week postinjury, while a two-cluster solution was identified at longer intervals (8-30 days). Clusters differed primarily by level of performance and also exhibited stratified differences in symptom severity and magnitude of change in cognitive function and symptom-reporting from pre- to postconcussion. The lowest performing cluster in each PC group was Mildly-to-Moderately Impaired and exhibited the highest rates of complicated recovery, suggesting an association between the current clusters and protracted recovery. Conclusions: Results provide preliminary evidence that ImPACT can identify clusters of athletes based on cognitive performance postconcussion that differ in clinically meaningful ways, including symptoms, magnitude of change from baseline, and concussion recovery outcomes. Discriminant functions can classify athletes into clusters based on postconcussion scores and a supplemental excel calculator is provided for such purposes. Absence of full demographic data regarding race/ethnicity and socioeconomic status may limit generalizability. Future work should investigate whether these clusters may assist in return-to-play decision-making by identifying at-risk athletes who may benefit from targeted intervention.	[Maietta, Julia E.; Kuwabara, Hana C.; Keene, Jennifer; Allen, Daniel N.] Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA; [Ross, Staci R.; Kinsora, Thomas F.] Ctr Appl Neurosci, Las Vegas, NV USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Box 455030,4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242; Maietta, Julia/0000-0001-5612-6321			Aldenderfer M.S., 1984, CLUSTER ANAL, DOI [10.4135/9781412983648, DOI 10.4135/9781412983648]; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Allen S.., 2020, SYMPTOM REPORTING NE; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Bruce JM, 2017, CLIN NEUROPSYCHOL, V31, P1329, DOI 10.1080/13854046.2017.1311375; Champigny CM, 2020, J NEUROTRAUM, V37, P2632, DOI 10.1089/neu.2020.7079; Charrad M, 2014, J STAT SOFTW, V61, P1; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd ed.; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Echemendia RJ, 2020, CLIN NEUROPSYCHOL, V34, P899, DOI 10.1080/13854046.2019.1690051; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Goldstein G.., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1, DOI 10.1007/978-1-4614-6744-1]; Goldstein G.., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1_2, DOI 10.1007/978-1-4614-6744-1_2]; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Hannah T, 2020, J NEUROSURG-PEDIATR, V26, P171, DOI 10.3171/2020.2.PEDS19709; Harriss AB, 2020, CLIN J SPORT MED, V30, pE147, DOI 10.1097/JSM.0000000000000714; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P721, DOI 10.1007/978-0-387-76978-3_23; Karr JE, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1850867; Kazak AE, 2018, AM PSYCHOL, V73, P1, DOI 10.1037/amp0000263; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langdon S, 2020, SPORTS MED, V50, P1829, DOI 10.1007/s40279-020-01321-9; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M.R., 2020, IMPACT ADM INTERPRET; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maietta JE, 2021, PSYCHOL ASSESSMENT, V33, P746, DOI 10.1037/pas0001014; Maietta JE, 2021, ARCH CLIN NEUROPSYCH, V36, P1438, DOI 10.1093/arclin/acab006; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; MORRIS R, 1981, Journal of Clinical Neuropsychology, V3, P79, DOI 10.1080/01688638108403115; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Ricker, 2018, TXB CLIN NEUROPSYCHO, P141; Ricker J.H., 2018, TXB CLIN NEUROPSYCHO; Ringdahl EN, 2019, DEV NEUROPSYCHOL, V44, P172, DOI 10.1080/87565641.2018.1557190; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schilling S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010351; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Takagi M, 2020, CHILD NEUROPSYCHOL, V26, P54, DOI 10.1080/09297049.2019.1639653; Thaler NS, 2015, APPL NEUROPSYCH-CHIL, V4, P20, DOI 10.1080/21622965.2013.790820; Thaler NS, 2013, ARCH CLIN NEUROPSYCH, V28, P798, DOI 10.1093/arclin/act080; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	71	0	0	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology												10.1037/neu0000787		DEC 2021	17	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XS8IA	WOS:000733144100001	34881949				2022-02-06	
J	Ntikas, M; Hunter, AM; Gallagher, IJ; Di Virgilio, TG				Ntikas, Michail; Hunter, Angus M.; Gallagher, Iain J.; Di Virgilio, Thomas G.			Longer Neurophysiological vs. Clinical Recovery Following Sport Concussion	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						sport-related concussion; intracortical inhibition; Bayesian statistics; transcranial magnetic stimulation (TMS); SCAT5	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; RUGBY UNION; MOTOR; CORTEX; RATES; RISK	Objectives: The objective of this study was to assess if injury-related alterations in the Sport Concussion Assessment Tool-5 (SCAT5) are matched by changes in transcranial magnetic stimulation-derived intracortical inhibition. We hypothesised that neurophysiological measures would take longer to return to normal than recovery assessed by the SCAT5 following sport related concussion (SRC).Methods: Thirteen male contact sport athletes (20.5 & PLUSMN; 4.5 years), who reported a concussion were recruited from local Rugby and American football clubs. Participants were tested at 4 timepoints throughout the concussion recovery period: within 24 h of concussion (day 0), and at 7, 9, and 11 days after concussion. All participants completed the SCAT5 and underwent TMS to assess cortical silent period duration (CSp), a measure of intracortical inhibition.Results: After concussion CSp significantly declined from day 0 (122 & PLUSMN; 28 ms) to day 11 (106 & PLUSMN; 15 ms) [F-(3,F- 33) = 7.80, p < 0.001]. SCAT5 measures of symptom number and severity were significantly decreased [symptom number: ? (2)((3)) = 30.44, p < 0.01; symptom severity: ? (2)((3)) = 25.75, p < 0.001] between the day 0 timepoint and each of the other timepoints. SCAT5 balance errors (mBESS) decreased significantly [F-(3,F- 33) = 19.55, p < 0.001] between the day 0 timepoint and each of the other timepoints. CSp and SCAT5 recovery patterns were different. SCAT5 domains recovered faster showing no further significant changes after day 7, whilst CSp was still decreasing between days 7 and 9. Due to the small sample size we also used a Bayesian linear model to investigate the recovery of CSp and mBESS. The posterior distribution of our Bayesian model provided evidence that CSp decreased at day 7 and it continued to decrease at day 9, unlike mBESS which decreased at day 7 and then reached a plateau.Conclusion: There are clinically important discrepancies between clinical and neurophysiological measures of concussion recovery. This finding has important implications for return to play (RTP) protocols and the prevention of complications after sport concussion.	[Ntikas, Michail] Univ Stirling, Dept Psychol, Stirling, Scotland; [Hunter, Angus M.; Gallagher, Iain J.; Di Virgilio, Thomas G.] Univ Stirling, Dept Physiol, Exercise & Nutr Res Grp, Stirling, Scotland		Ntikas, M (corresponding author), Univ Stirling, Dept Psychol, Stirling, Scotland.	michail.ntikas@stir.ac.uk					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Borg DN, 2018, MED SCI SPORT EXER, V50, P2609, DOI 10.1249/MSS.0000000000001736; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Clark Richard C, 2010, N Am J Sports Phys Ther, V5, P122; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Di Virgilio TG, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00294; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Edwards EK, 2017, BRAIN INJURY, V31, P1348, DOI 10.1080/02699052.2017.1327671; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodrich Ben, 2020, CRAN; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lefebvre G, 2015, BRAIN INJURY, V29, P1032, DOI 10.3109/02699052.2015.1028447; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mengersen KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147311; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mondadori C, 1996, BEHAV BRAIN RES, V77, P223, DOI 10.1016/0166-4328(95)00222-7; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Scott E, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00306; Sport Scotland, 2018, DOUBT SIT THEM OUT, P1; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Tucker R, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-020-00265-8; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; WILSON SA, 1995, ELECTROMYOGR MOTOR C, V97, P246, DOI 10.1016/0924-980X(95)80001-8	44	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	DEC 9	2021	3								737712	10.3389/fspor.2021.737712			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	YB5RR	WOS:000739069800001	34957396	Green Published, gold			2022-02-06	
J	Singh, BK; Dey, B; Boruah, DK; Mukherjee, A; Kumar, S; Sharma, M; Phukan, P				Singh, Binoy K.; Dey, Biswajit; Boruah, Deb K.; Mukherjee, Aishik; Kumar, Sumit; Sharma, Manoranjan; Phukan, Pranjal			Challenges and Outcomes of COVID-19 Positive Neurosurgical Patients: An Institutional Experience With Emphasis on Modifications of Neurosurgical Practice	CUREUS JOURNAL OF MEDICAL SCIENCE			English	Article						postoperative outcomes; neurosurgical challenges; practice modifications; neurosurgical procedures; covid 19	IMPACT	Introduction: There has been a drastic reduction in the number of neurosurgeries performed during the COVID-19 pandemic due to a multitude of challenges prompting restructuring of neurosurgical services. The present study describes the challenges and outcomes of non-elective neurosurgical procedures done on COVID-19 positive patients along with the modifications in neurosurgical practice during the pandemic. Methods: A retrospective study was done in the Department of Neurosurgery over a period of one year and three months. Demographic and clinical details including outcomes of the COVID-19 positive patients, who had undergone non-elective neurosurgical interventions, were collected. Results: Ten patients (3.8%) were COVID-19 positive out of 262 neurosurgical interventions done. The age of the patients ranged from 5 days to 78 years with five males and five females. Out of the 10 patients, five were neurotrauma cases including one patient of head injury with craniovertebral junction injury. The patient with craniovertebral junction injury underwent foramen magnum decompression with C1 lateral mass-C2 pedicle screw on the right and C0-C2 pedicle screw and rod fixation on the left. The rest of the neurotrauma cases underwent craniotomy or burr-hole craniostomy followed by evacuation. Only one patient (10%) had postoperative 30-day mortality. The rest nine patients (90%) survived the post-operative 30-day mortality. The various modifications incorporated in the neurosurgical practice included categorizing the emergency room into various zones, a separate operating theatre for COVID-19 patients, limiting the number of operating members as well as minor modifications in the operating procedures. Conclusions: The postoperative surgical outcome is favorable in COVID-19 positive patients with modifications of the existing neurosurgical practices.	[Singh, Binoy K.; Mukherjee, Aishik; Sharma, Manoranjan] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Neurosurg, Shillong, Meghalaya, India; [Dey, Biswajit] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Pathol, Shillong, Meghalaya, India; [Boruah, Deb K.] Lakhimpur Med Coll, Radiol, Lakhimpur, India; [Kumar, Sumit] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Radiat Oncol, Shillong, Meghalaya, India; [Phukan, Pranjal] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Radiol, Shillong, Meghalaya, India		Singh, BK (corresponding author), North Eastern Indira Gandhi Reg Inst Hlth & Med S, Neurosurg, Shillong, Meghalaya, India.	drbinoysingh@yahoo.com					Al-Jabir A, 2020, INT J SURG, V79, P233, DOI 10.1016/j.ijsu.2020.05.002; Ashkan K, 2021, ACTA NEUROCHIR, V163, P317, DOI 10.1007/s00701-020-04652-8; COVIDsurg Collaborative, 2020, LANCET, V396, P27, DOI 10.1016/S0140-6736(20)31182-X; Diaz-Bello S, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.9.FOCUS20553; Dowlati E, 2020, WORLD NEUROSURG, V143, pE550, DOI 10.1016/j.wneu.2020.08.015; Gupta P, 2020, NEUROL INDIA, V68, P246, DOI 10.4103/0028-3886.283130; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Kalita P, 2021, CUREUS, V13, DOI 10.7759/cureus.17328; Pannullo SC, 2020, CUREUS, V12, DOI 10.7759/cureus.7671; Raheja A, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.9.FOCUS20564; Saurabh A, 2021, CUREUS, V13, DOI 10.7759/cureus.19124; Singh SK, 2021, INTERDISCIP NEUROSUR, V23, DOI 10.1016/j.inat.2020.100895; Toman E, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047063; Venkataram T, 2020, NEUROL INDIA, V68, P595, DOI 10.4103/0028-3886.289004	14	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS J MED SCIENCE	Cureus J Med Sci	DEC 9	2021	13	12							e20287	10.7759/cureus.20287			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XP4HV	WOS:000730828800024	35018273	gold, Green Published			2022-02-06	
J	Vaughn, KA; DeMaster, D; Kook, JH; Vannucci, M; Ewing-Cobbs, L				Vaughn, Kelly A.; DeMaster, Dana; Kook, Jeong Hwan; Vannucci, Marina; Ewing-Cobbs, Linda			Effective connectivity in the default mode network after paediatric traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						anxiety; Bayes theorem; brain injuries; child; magnetic resonance imaging; post-concussion syndrome	STATE FUNCTIONAL CONNECTIVITY; PROSPECTIVE MEMORY PERFORMANCE; CONSCIOUS RESTING STATE; STRUCTURAL CONNECTIVITY; RANDOMIZED-TRIAL; HEAD-INJURY; CHILDREN; ANXIETY; RECOVERY; MRI	Children who experience a traumatic brain injury (TBI) are at elevated risk for a range of negative cognitive and neuropsychological outcomes. Identifying which children are at greatest risk for negative outcomes can be difficult due to the heterogeneity of TBI. To address this barrier, the current study applied a novel method of characterizing brain connectivity networks, Bayesian multi-subject vector autoregressive modelling (BVAR-connect), which used white matter integrity as priors to evaluate effective connectivity-the time-dependent relationship in functional magnetic resonance imaging (fMRI) activity between two brain regions-within the default mode network (DMN). In a prospective longitudinal study, children ages 8-15 years with mild to severe TBI underwent diffusion tensor imaging and resting state fMRI 7 weeks after injury; post-concussion and anxiety symptoms were assessed 7 months after injury. The goals of this study were to (1) characterize differences in positive effective connectivity of resting-state DMN circuitry between healthy controls and children with TBI, (2) determine if severity of TBI was associated with differences in DMN connectivity and (3) evaluate whether patterns of DMN effective connectivity predicted persistent post-concussion symptoms and anxiety. Healthy controls had unique positive connectivity that mostly emerged from the inferior temporal lobes. In contrast, children with TBI had unique effective connectivity among orbitofrontal and parietal regions. These positive orbitofrontal-parietal DMN effective connectivity patterns also differed by TBI severity and were associated with persisting behavioural outcomes. Effective connectivity may be a sensitive neuroimaging marker of TBI severity as well as a predictor of chronic post-concussion symptoms and anxiety.	[Vaughn, Kelly A.; DeMaster, Dana; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Childrens Learning Inst, Houston, TX 77030 USA; [Kook, Jeong Hwan] Merck & Co Inc, Kenilworth, NJ USA; Rice Univ, Dept Stat, Houston, TX 77251 USA		Vaughn, KA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA.	kelly.a.vaughn@uth.tmc.edu			National Science FoundationNational Science Foundation (NSF) [NSF/SES 1659925]; Nicole and Evan Katz Pediatric Neurodevelopmental Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]	National Science Foundation, Grant/ Award Number: NSF/SES 1659925; Nicole and Evan Katz Pediatric Neurodevelopmental Fund; National Institutes of Health, Grant/Award Number: R01 NS046308	Almgren H, 2018, NEUROIMAGE, V183, P757, DOI 10.1016/j.neuroimage.2018.08.053; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2015, NEUROIMAGE, V122, P166, DOI 10.1016/j.neuroimage.2015.07.067; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; [Anonymous], 2018, C MAN TRAUM BRAIN IN; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen GY, 2011, BRAIN CONNECT, V1, P195, DOI 10.1089/brain.2011.0025; Chiang S, 2017, HUM BRAIN MAPP, V38, P1311, DOI 10.1002/hbm.23456; Coutinho JF, 2016, BRAIN IMAGING BEHAV, V10, P147, DOI 10.1007/s11682-015-9375-7; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dhamala M, 2018, NEUROIMAGE, V175, P460, DOI 10.1016/j.neuroimage.2018.04.043; Dollman AK, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00121; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Gentili C, 2009, BRAIN RES BULL, V79, P409, DOI 10.1016/j.brainresbull.2009.02.002; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo Q., 2015, PLOS ONE, DOI [10.1371/journal.pone.0051924.t001, DOI 10.1371/JOURNAL.PONE.0051924.T001]; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hollingshead A.A., 1975, UNPUB; Hu LC, 2019, STAT BIOSCI, V11, P91, DOI 10.1007/s12561-017-9210-3; Imperatori C, 2019, J AFFECT DISORDERS, V246, P611, DOI 10.1016/j.jad.2018.12.071; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kook JH, 2021, NEUROINFORMATICS, V19, P39, DOI 10.1007/s12021-020-09472-w; Lah S, 2018, J NEUROTRAUM, V35, P2036, DOI 10.1089/neu.2017.5250; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Modi S, 2015, PSYCHIAT RES-NEUROIM, V234, P25, DOI 10.1016/j.pscychresns.2015.07.006; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; R Development Core Team, 2012, R LANG ENV STAT COMP; Ransom DM, 2016, J INT NEUROPSYCH SOC, V22, P1038, DOI 10.1017/S1355617716000916; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Samdin SB, 2017, IEEE T BIO-MED ENG, V64, P844, DOI 10.1109/TBME.2016.2580738; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stephens JA, 2018, DEV NEUROREHABIL, V21, P423, DOI 10.1080/17518423.2017.1338777; Stokes PA, 2017, P NATL ACAD SCI USA, V114, pE7063, DOI 10.1073/pnas.1704663114; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; TEASDALE G, 1974, LANCET, V2, P81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Venkalesan UM, 2019, NEUROPSYCHOLOGY, V33, P893, DOI 10.1037/neu0000553; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Ware AL, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102106; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitfield-Gabrieli D, 2015, ARTIFACT DETECTION T; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Woolrich MW, 2012, NEUROIMAGE, V62, P801, DOI 10.1016/j.neuroimage.2011.10.047; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Zhang H., 2016, QUANTITATIVE EVALUAT; Zhang LL, 2015, WIRES COMPUT STAT, V7, P21, DOI 10.1002/wics.1339; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791	104	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JAN	2022	55	1					318	336		10.1111/ejn.15546		DEC 2021	19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YH4LS	WOS:000728519500001	34841600				2022-02-06	
J	Peacock, WF; Kuehl, D; Bazarian, J; Singer, AJ; Cannon, C; Rafique, Z; d'Etienne, JP; Welch, R; Clark, C; Diaz-Arrastia, R				Peacock, W. Frank; Kuehl, Damon; Bazarian, Jeff; Singer, Adam J.; Cannon, Chad; Rafique, Zubaid; d'Etienne, James P.; Welch, Robert; Clark, Carol; Diaz-Arrastia, Ramon			Defining Acute Traumatic Encephalopathy: Methods of the "HEAD Injury Serum Markers and Multi-Modalities for Assessing Response to Trauma" (HeadSMART II) Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; neuropsychiatric testing for TBI; biomarkers for TBI; diagnosis of TBI; prognosis of TBI	BRAIN-INJURY; UNITED-STATES; CONCUSSION; DIAGNOSIS; PREVALENCE; SYMPTOMS; DEATHS; IMPACT	Despite an estimated 2.8 million annual ED visits, traumatic brain injury (TBI) is a syndromic diagnosis largely based on report of loss of consciousness, post-traumatic amnesia, and/or confusion, without readily available objective diagnostic tests at the time of presentation, nor an ability to identify a patient's prognosis at the time of injury. The recognition that "mild" forms of TBI and even sub-clinical impacts can result in persistent neuropsychiatric consequences, particularly when repetitive, highlights the need for objective assessments that can complement the clinical diagnosis and provide prognostic information about long-term outcomes. Biomarkers and neurocognitive testing can identify brain injured patients and those likely to have post-concussive symptoms, regardless of imaging testing results, thus providing a physiologic basis for a diagnosis of acute traumatic encephalopathy (ATE). The goal of the HeadSMART II (HEAD injury Serum markers and Multi-modalities for Assessing Response to Trauma) clinical study is to develop an in-vitro diagnostic test for ATE. The BRAINBox TBI Test will be developed in the current clinical study to serve as an aid in evaluation of patients with ATE by incorporating blood protein biomarkers, clinical assessments, and tools to measure, identify, and define associated pathologic evidence and neurocognitive impairments. This protocol proposes to collect data on TBI subjects by a multi-modality approach that includes serum biomarkers, clinical assessments, neurocognitive performance, and neuropsychological characteristics, to determine the accuracy of the BRAINBox TBI test as an aid to the diagnosis of ATE, defined herein, and to objectively determine a patient's risk of developing post-concussive symptoms.	[Peacock, W. Frank; Rafique, Zubaid] Baylor Coll Med, Houston, TX 77030 USA; [Kuehl, Damon] Carill Clin, Roanoke, VA USA; [Bazarian, Jeff] Univ Rochester, Dept Emergency Med, Rochester, NY USA; [Singer, Adam J.] SUNY Stony Brook, Renaissance Sch Med, Stony Brook, NY USA; [Cannon, Chad] Univ Kansas, Med Ctr, Kansas City, MO USA; [d'Etienne, James P.] John Peter Smith Hlth Syst, Integrat Emergency Serv, Ft Worth, TX USA; [Welch, Robert] Detroit Med Ctr, Detroit, MI USA; [Clark, Carol] William Beaumont Hosp, Royal Oak, MI USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA		Peacock, WF (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	Frankpeacock@gmail.com			BRAINBox Solutions, Inc.	This study received funding from BRAINBox Solutions, Inc. The funder had the following involvement with the study: Study design. All authors were investigators, with their institutions receiving remuneration for the costs to perform this trial.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], MOD DAT EL TRAUM BRA; [Anonymous], 2018, E6 R2 GOOD CLIN PRAC; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corwin DJ, 2020, J EMERG MED, V59, P795, DOI 10.1016/j.jemermed.2020.09.017; Falk H, 2021, J NEUROTRAUM, DOI 10.1089/neu.2021.0137; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Korley FK, 2019, ACAD EMERG MED, DOI 10.1111/acem.13844; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Machin D, 2008, SAMPLE SIZE TABLES C; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; NINDS Common Data Elements: Traumatic Brain Injury , NAT I NEUR DIS STROK; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Richey LN, 2020, INT REV PSYCHIATR, V32, P22, DOI 10.1080/09540261.2019.1657076; Roy D, 2019, BRAIN INJURY, V33, P1064, DOI 10.1080/02699052.2019.1606447; Schneider ALC, 2018, NEW ENGL J MED, V379, P1176, DOI 10.1056/NEJMc1808550; Surveillance Report of Traumatic Brain Injury-related ED Visits Hospitalizations Deaths-United States., 2014, CTR DIS CONTROL PREV; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Yang SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179352	32	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 8	2021	12								733712	10.3389/fneur.2021.733712			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XS6CZ	WOS:000732995800001	34956041	Green Published, gold			2022-02-06	
J	Alghamdi, FS; Alsabbali, DM; Qadi, YH; Albugami, SM; Lary, A				Alghamdi, Fareeda S., Jr.; Alsabbali, Dania M.; Qadi, Yasmin H.; Albugami, Sarah M.; Lary, Ahmed			Patterns and Impact of Traumatic Brain Injury at King Abdulaziz Medical City in Jeddah, Saudi Arabia: A Retrospective Cohort Study	CUREUS			English	Article						subdural hematoma (sdh); fall from height; glasgow coma scale; motor vehicle accident; traumatic brain injuries	GLASGOW COMA SCALE; HEAD-INJURIES; SCORE; EPIDEMIOLOGY; MORTALITY; MODERATE; DEATH	Objectives The objectives of this study are to explore the most common causes, patterns, and seventies of head traumas, to evaluate the outcomes of traumatic head injury (TBI) patients followed in the clinic, and to calculate the prevalence of admitted cases. Methods In our retrospective cohort study, we included all the cases of adults above 18 years old diagnosed with head traumas (171 patients). The inclusion criteria were patients who presented to the emergency department at National Guard Health Affairs (NGHA), Jeddah, Saudi Arabia from 2016 to 202(1. Patients were categorized according to their Glasgow Coma Scale (GCS) score upon admission. Results Of the 171 patients in this study, 151 (88.3%) were males and 20 (11.7%) were females. The median age of our patients was 31 years. Most of the cases had no medical illnesses 124 (72.5%). The most common mechanism of injury was motor vehicle accidents (MVAs) in the majority of our cases (105, 61.4%), followed by falls from heights (34, 19.9%). The commonest computed tomography (CT) finding was subdural hematoma (47, 27.4%). The majority of the associated injuries were thoracic cases (43, 25.1%), followed by spinal (40, 23.4%). Most of the patients were admitted to NGHA (12(1, 7(1.2%), while the rest (51, 29.8%) were transferred from other hospitals. Of the total of 171 patients, 134 (78.4%) were treated conservatively. There were no associations between mortality nor length of stay and patients' demographics, except for GCS on admission showed a significant p-value (<0.005). Conclusion In this study, it was found that the most common causes of TBI are MVAs followed by falls from heights. Therefore, preventive measures such as traffic safety rules need to be addressed.	[Alghamdi, Fareeda S., Jr.; Alsabbali, Dania M.; Qadi, Yasmin H.; Albugami, Sarah M.] King Saud Bin Ahdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia; [Lary, Ahmed] Natl Guard Hlth Affairs, Neurol Surg, Jeddah, Saudi Arabia		Alghamdi, FS (corresponding author), King Saud Bin Ahdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia.	fareeda.gh@hotmail.com					Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Alhabdan S, 2013, ANN SAUDI MED, V33, P52, DOI 10.5144/0256-4947.2013.52; Alnaami Ibrahim, 2019, Neurosci J, V2019, P2782146, DOI 10.1155/2019/2782146; Chesnut RM, 2021, EARLY INDICATORS PRO; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gasco J, 2013, ESSENTIAL NEUROSURGE, DOI [10.1017/S0317167100022666, DOI 10.1017/S0317167100022666]; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Junaid M, 2016, J PAK MED ASSOC, V66, P864; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Narain TP, 2012, RAMAMURTHI TANDONS T, V1; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Sadaka F, 2018, AM J EMERG MED, V36, P1624, DOI 10.1016/j.ajem.2018.01.051; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Shiozaki T, 2005, CURR HYPERTENS REP, V7, P450, DOI 10.1007/s11906-005-0040-1; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Valadka AB, 2011, NEUROTRAUMA EVIDENCE, DOI [10.1017/S0317167100115975, DOI 10.1017/S0317167100115975]; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116	28	0	0	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	DEC 7	2021	13	12							e20246	10.7759/cureus.20246			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	XN4KK	WOS:000729475500003	34912650	gold, Green Published			2022-02-06	
J	El-Menyar, A; Asim, M; Bahey, AAA; Chughtai, T; Alyafai, A; Abdelrahman, H; Rizoli, S; Peralta, R; Al-Thani, H				El-Menyar, Ayman; Asim, Mohammad; Bahey, Ahmed Abdel-Aziz; Chughtai, Talat; Alyafai, Abdulnasser; Abdelrahman, Husham; Rizoli, Sandro; Peralta, Ruben; Al-Thani, Hassan			Beta blocker use in traumatic brain injury based on the high-sensitive troponin status (BBTBBT): methodology and protocol implementation of a double-blind randomized controlled clinical trial	TRIALS			English	Article						Traumatic brain injury; Beta blocker; High-sensitive troponin; Randomized control trial; Functional outcome	CRITICALLY-ILL PATIENTS; SPINAL-CORD-INJURY; EARLY PROPRANOLOL; PREVALENCE; IMPACT	Background: Beta-adrenergic receptor blockers (BB) play an important role in the protection of organs that are susceptible for secondary injury due to stress-induced adrenergic surge. However, the use of BB in traumatic brain injury (TBI) patients is not yet the standard of care which necessitates clear scientific evidence to be used. The BBTBBT study aims to determine whether early administration of propranolol based on the high-sensitive troponin T(HsTnT) status will improve the outcome of TBI patients. We hypothesized that early propranolol use is effective in reducing 10- and 30-day mortality in TBI patients. Secondary outcomes will include correlation between serum biomarkers (troponin, epinephrine, cytokines, enolase, S100 calcium binding protein B) and the severity of injury and the impact of BB use on the duration of hospital stay and functional status at a 3-month period. Methods: The BBTBBT study is a prospective, randomized, double-blinded, placebo-controlled three-arm trial of BB use in mild-to-severe TBI patients based on the HsTnT status. All enrolled patients will be tested for HsTnT at the first 4 and 6 h post-injury. Patients with positive HsTnT will receive BB if there is no contraindication (group 1). Patients with negative HsTnT will be randomized to receive either propranolol (group 2) or placebo (group 3). The time widow for receiving the study treatment is the first 24 h post-injury. Discussion: Early BB use may reduce the catecholamine storm and subsequently the cascade of immune and inflammatory changes associated with TBI. HsTnT could be a useful fast diagnostic and prognostic tool in TBI patients. This study will be of great clinical interest to improve survival and functional outcomes of TBI patients.	[El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp HGH, Clin Res Trauma & Vasc Surg Sect, POB 3050, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Med Clin, Doha, Qatar; [Bahey, Ahmed Abdel-Aziz; Chughtai, Talat; Abdelrahman, Husham; Rizoli, Sandro; Peralta, Ruben; Al-Thani, Hassan] HGH, Trauma Surg Sect, Dept Surg, Doha, Qatar; [Chughtai, Talat] Qatar Univ, Dept Surg, Doha, Qatar; [Alyafai, Abdulnasser] HGH, Dept Surg, Neurosurg, Doha, Qatar		El-Menyar, A (corresponding author), Hamad Gen Hosp HGH, Clin Res Trauma & Vasc Surg Sect, POB 3050, Doha, Qatar.; El-Menyar, A (corresponding author), Weill Cornell Med Coll, Med Clin, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X	Medical Research Center at Hamad Medical Corporation, Doha, Qatar [IRGC-05-SI-18-293]; medical research center at the Hamad Medical Corporation	The BBTBB-RCT is funded by the Medical Research Center at Hamad Medical Corporation, Doha, Qatar, under the category of grant funding "Internal Research Grant Competition" (IRGC-05-SI-18-293). This study is sponsored by the medical research center at the Hamad Medical Corporation, which is governmental non-profit group of hospitals; it oversights, audits, and approves the conduct of this project. It does not have role in the study design, analysis, or writing the final manuscripts.	Al-Otaiby MA, 2011, J SAUDI HEART ASSOC, V23, P3, DOI 10.1016/j.jsha.2010.10.001; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bender M, 2020, INJURY, V51, P1189, DOI 10.1016/j.injury.2020.01.002; Bhatia PM, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015272; Bible LE, 2014, J TRAUMA ACUTE CARE, V77, P54, DOI 10.1097/TA.0000000000000264; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Chen ZF, 2017, J CRIT CARE, V41, P240, DOI 10.1016/j.jcrc.2017.05.035; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Ding HQ, 2021, J TRAUMA ACUTE CARE, V90, P1077, DOI 10.1097/TA.0000000000003094; Edouard AR, 2004, ANESTHESIOLOGY, V101, P1262; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; El-Menyar A, 2019, AM J EMERG MED, V37, P133, DOI 10.1016/j.ajem.2018.10.002; El-Menyar A, 2018, J TRAUMA ACUTE CARE, V85, P646, DOI 10.1097/TA.0000000000001865; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Freund Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10270; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ismail AM, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2020-000533; Khalili H, 2020, WORLD J SURG, V44, P1844, DOI 10.1007/s00268-020-05391-8; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Krishnamoorthy Vijay, 2021, J Neurosurg Anesthesiol, DOI 10.1097/ANA.0000000000000772; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Lim W, 2006, AM J CRIT CARE, V15, P280; Lippi G, 2013, RADIOLOGY, V268, P611, DOI 10.1148/radiol.13130643; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mahmood I, 2016, N AM J MED SCI, V8, P17, DOI 10.4103/1947-2714.175188; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Peden, 2004, GUIDELINES ESSENTIAL; Poe S, 2015, J INVEST MED, V63, P905, DOI 10.1097/JIM.0000000000000239; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Smith Andria, 2009, W V Med J, V105, P29	40	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	DEC 7	2021	22	1							890	10.1186/s13063-021-05872-8			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XL7LJ	WOS:000728323000001	34876207	gold, Green Published			2022-02-06	
J	Har-Even, M; Rubovitch, V; Ratliff, WA; Richmond-Hacham, B; Citron, BA; Pick, CG				Har-Even, Meirav; Rubovitch, Vardit; Ratliff, Whitney A.; Richmond-Hacham, Bar; Citron, Bruce A.; Pick, Chaim G.			Ketogenic Diet as a potential treatment for traumatic brain injury in mice	SCIENTIFIC REPORTS			English	Article							NECROSIS-FACTOR-ALPHA; KETONE-BODIES; CALORIE RESTRICTION; CELL-DEATH; SIRT1; PROTECTS; AGE; PATHOPHYSIOLOGY; RECOGNITION; IMPAIRMENTS	Traumatic brain injury (TBI) is a brain dysfunction without present treatment. Previous studies have shown that animals fed ketogenic diet (KD) perform better in learning tasks than those fed standard diet (SD) following brain injury. The goal of this study was to examine whether KD is a neuroprotective in TBI mouse model. We utilized a closed head injury model to induce TBI in mice, followed by up to 30 days of KD/SD. Elevated levels of ketone bodies were confirmed in the blood following KD. Cognitive and behavioral performance was assessed post injury and molecular and cellular changes were assessed within the temporal cortex and hippocampus. Y-maze and Novel Object Recognition tasks indicated that mTBI mice maintained on KD displayed better cognitive abilities than mTBI mice maintained on SD. Mice maintained on SD post-injury demonstrated SIRT1 reduction when compared with uninjured and KD groups. In addition, KD management attenuated mTBI-induced astrocyte reactivity in the dentate gyrus and decreased degeneration of neurons in the dentate gyrus and in the cortex. These results support accumulating evidence that KD may be an effective approach to increase the brain's resistance to damage and suggest a potential new therapeutic strategy for treating TBI.	[Har-Even, Meirav; Rubovitch, Vardit; Richmond-Hacham, Bar; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Har-Even, Meirav; Pick, Chaim G.] Tel Aviv Univ, Sylvan Adams Sports Inst, IL-6997801 Tel Aviv, Israel; [Ratliff, Whitney A.] Bay Pines VA Healthcare Syst Res & Dev, Lab Mol Biol, 10000 Bay Pines Blvd,151,Bldg 22,Rm 123, Bay Pines, FL 33744 USA; [Citron, Bruce A.] VA New Jersey Hlth Care Syst, Lab Mol Biol Res & Dev, Mailstop 15,Bldg 16,Rm 16-176,385 Tremt Ave, E Orange, NJ 07018 USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-6997801 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, IL-6997801 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-6997801 Tel Aviv, Israel		Har-Even, M; Pick, CG (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel.; Har-Even, M; Pick, CG (corresponding author), Tel Aviv Univ, Sylvan Adams Sports Inst, IL-6997801 Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-6997801 Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, IL-6997801 Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Ctr Biol Addict Dis, IL-6997801 Tel Aviv, Israel.	meiravhe@mail.tau.ac.il; pickc@tauex.tau.ac.il		Richmond-Hacham, Bar/0000-0003-0698-9764	Ari and Regine Aprijaskis Fund [347300-00]; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases [601133461]; Sylvan Adams Sports Institute [0601133671]	This research was funded by the Ari and Regine Aprijaskis Fund, Grant number 347300-00; the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Grant number 601133461; and the Sylvan Adams Sports Institute Grant number 0601133671.	Almeida MF, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12936; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bele MS, 2015, IN VITRO CELL DEV-AN, V51, P546, DOI 10.1007/s11626-015-9867-1; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bough KJ, 1999, EPILEPSY RES, V35, P21, DOI 10.1016/S0920-1211(98)00125-9; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; De Feyter HM, 2016, NEURO-ONCOLOGY, V18, P1079, DOI 10.1093/neuonc/now088; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Dhandapani PK, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14159; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Griffith CM, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/9684061; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; Helenius TO, 2015, MOL BIOL CELL, V26, P2298, DOI 10.1091/mbc.E14-02-0736; Hertz L, 2015, J NEUROCHEM, V134, P7, DOI 10.1111/jnc.13107; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Martin A, 2015, IMMUNOL RES, V61, P187, DOI 10.1007/s12026-014-8557-5; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Moreno CL, 2017, MOL CELL ENDOCRINOL, V455, P33, DOI 10.1016/j.mce.2016.11.013; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Mu J, 2021, NUTR NEUROSCI, DOI 10.1080/1028415X.2021.1875300; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Pasinetti GM, 2015, BBA-MOL BASIS DIS, V1852, P1202, DOI 10.1016/j.bbadis.2014.10.006; Phillips MCL, 2018, MOVEMENT DISORD, V33, P1306, DOI 10.1002/mds.27390; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Qubty D, 2021, J MOL NEUROSCI, V71, P178, DOI 10.1007/s12031-020-01688-4; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ran MZ, 2015, BRAIN RES, V1610, P61, DOI 10.1016/j.brainres.2015.03.043; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ratliff WA, 2021, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-01036-5; Ratliff WA, 2020, J NEUROTRAUM, V37, P1910, DOI 10.1089/neu.2020.7005; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rubovitch V, 2019, J MOL NEUROSCI, V67, P613, DOI 10.1007/s12031-019-01271-6; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Scichilone JM, 2016, J MOL NEUROSCI, V60, P1, DOI 10.1007/s12031-016-0753-4; Stamatovic SM, 2019, NEUROBIOL DIS, V126, P105, DOI 10.1016/j.nbd.2018.09.006; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; VanItallie TB, 2015, METABOLISM, V64, pS51, DOI 10.1016/j.metabol.2014.10.033; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wheless JW, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01821.x; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yuan H, 2020, AGING CELL, V19, DOI 10.1111/acel.13199; Zhang FC, 2018, WORLD NEUROSURG, V120, pE1193, DOI 10.1016/j.wneu.2018.09.037; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	67	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 7	2021	11	1							23559	10.1038/s41598-021-02849-0			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XV3EL	WOS:000734829300058	34876621	Green Published, Green Submitted, gold			2022-02-06	
J	Pawar, RD; Balaji, L; Grossestreuer, AV; Thompson, G; Holmberg, MJ; Issa, MS; Patel, PV; Kronen, R; Berg, KM; Moskowitz, A; Donnino, MW				Pawar, Rahul D.; Balaji, Lakshman; Grossestreuer, Anne V.; Thompson, Garrett; Holmberg, Mathias J.; Issa, Mahmoud S.; Patel, Parth V.; Kronen, Ryan; Berg, Katherine M.; Moskowitz, Ari; Donnino, Michael W.			Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness	ANNALS OF INTERNAL MEDICINE			English	Article; Early Access							SEPTIC SHOCK; WERNICKE ENCEPHALOPATHY; GUIDELINES; DEFICIENCY	Background: Thiamine supplementation is recommended for patients with alcohol use disorder (AUD). The authors hypothesize that critically ill patients with AUD are commonly not given thiamine supplementation. Objective: To describe thiamine supplementation incidence in patients with AUD and various critical illnesses (alcohol withdrawal, septic shock, traumatic brain injury [TBI], and di-abetic ketoacidosis [DKA]) in the United States. Design: Retrospective observational study. Setting: Cerner Health Facts database. Patients: Adult patients with a diagnosis of AUD who were admitted to the intensive care unit with alcohol withdrawal, septic shock, TBI, or DKA between 2010 and 2017. Measurements: Incidence and predicted probability of thi-amine supplementation in alcohol withdrawal and other criti-cal illnesses. Results: The study included 14998 patients with AUD. Mean age was 52.2 years, 77% of participants were male, and in-hospital mortality was 9%. Overall, 7689 patients (51%) received thiamine supplementation. The incidence of thiamine supplementation was 59% for alcohol withdrawal, 26% for septic shock, 41% for TBI, and 24% for DKA. Most of those receiving thiamine (n = 3957 [52%]) received it within 12 hours of presentation in the emergency depart-ment. The predominant route of thiamine administration was enteral (n = 3119 [41%]). Limitation: Specific dosing and duration were not com-pletely captured. Conclusion: Thiamine supplementation was not provided to almost half of all patients with AUD, raising a quality-of-care issue for this cohort. Supplementation was numerically less frequent in patients with septic shock, DKA, or TBI than in those with alcohol withdrawal. These data will be important for the design of quality improvement studies in critically ill patients with AUD. Primary Funding Source: National Institutes of Health.	[Pawar, Rahul D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hosp Med, Boston, MA 02215 USA; [Pawar, Rahul D.; Balaji, Lakshman; Grossestreuer, Anne V.; Thompson, Garrett; Holmberg, Mathias J.; Issa, Mahmoud S.; Patel, Parth V.; Berg, Katherine M.; Moskowitz, Ari] Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Boston, MA 02215 USA; [Balaji, Lakshman; Grossestreuer, Anne V.; Thompson, Garrett; Patel, Parth V.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Holmberg, Mathias J.] Aarhus Univ Hosp, Res Ctr Emergency Med, Dept Clin Med, Aarhus, Denmark; [Holmberg, Mathias J.] Aarhus Univ, Aarhus, Denmark; [Holmberg, Mathias J.] Randers Reg Hosp, Dept Anesthesiol & Intens Care, Randers, Denmark; [Kronen, Ryan] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Berg, Katherine M.; Moskowitz, Ari; Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Moskowitz, Ari] Montefiore Med Ctr, Div Crit Care Med, 111 E 210th St, Bronx, NY 10467 USA; [Donnino, Michael W.] Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Dept Emergency Med, Boston, MA 02215 USA		Donnino, MW (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.; Donnino, MW (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Resuscitat Sci, Dept Emergency Med, Boston, MA 02215 USA.	mdonnino@bidmc.harvard.edu	Pawar, Rahul/ABC-8896-2020	Pawar, Rahul/0000-0002-9347-0129; Holmberg, Mathias Johan/0000-0001-5816-337X	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [1R03 AA026093]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01 DK112886-05, 5K24 HL127101-08]	By grant 1R03 AA026093 from the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health. In addition, Dr. Donnino is supported in part by grants 5R01 DK112886-05 and 5K24 HL127101-08 from the National Institutes of Health.	[Anonymous], 2020, J ADDICT MED, V14, P1, DOI 10.1097/ADM.0000000000000668; Attaluri P, 2018, AM J MED SCI, V356, P382, DOI 10.1016/j.amjms.2018.06.015; Crook MA, 2014, NUTRITION, V30, P953, DOI 10.1016/j.nut.2014.03.003; Dabar G, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0039-7; Day Gregory S, 1800, CMAJ Open, V8, pE383, DOI 10.9778/cmajo.20200029; Donnino MW, 2016, CRIT CARE MED, V44, P360, DOI 10.1097/CCM.0000000000001572; Ferguson RK, 1997, ALCOHOL ALCOHOLISM, V32, P493; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; Holmberg MJ, 2018, J CRIT CARE, V43, P61, DOI 10.1016/j.jcrc.2017.08.022; Isenberg-Grzeda E, 2014, J ADDICT MED, V8, P1, DOI 10.1097/01.ADM.0000435320.72857.c8; Isenberg-Grzeda E, 2012, PSYCHOSOMATICS, V53, P507, DOI 10.1016/j.psym.2012.04.008; Kim HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-18; Lanska Douglas J, 2010, Handb Clin Neurol, V95, P445, DOI 10.1016/S0072-9752(08)02130-1; Latt N, 2014, INTERN MED J, V44, P911, DOI 10.1111/imj.12522; Lei YL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010010; MCCONACHIE I, 1988, INTENS CARE MED, V14, P628; Moskowitz A, 2020, J THORAC DIS, V12, pS78, DOI 10.21037/jtd.2019.12.82; Moskowitz A, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.06.008; Polegato BF, 2019, NUTR CLIN PRACT, V34, P558, DOI 10.1002/ncp.10234; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Saya RP, 2012, N AM J MED SCI, V4, P503, DOI 10.4103/1947-2714.102003; Sinha S, 2019, MAYO CLIN PROC, V94, P1065, DOI 10.1016/j.mayocp.2019.02.018; Subramanya SB, 2010, AM J PHYSIOL-GASTR L, V299, pG23, DOI 10.1152/ajpgi.00132.2010; Thomson AD, 2002, ALCOHOL ALCOHOLISM, V37, P513, DOI 10.1093/alcalc/37.6.513; van Stigt RM, 2019, NETH J CRIT CARE, V27, P93; Wai JM, 2019, J SUBST ABUSE TREAT, V99, P117, DOI 10.1016/j.jsat.2019.01.017; World Health Organization, 1999, THIAM FIC ITS PREV C	27	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.												10.7326/M21-2103		DEC 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN0HD	WOS:000729195200001	34871057				2022-02-06	
J	Zheng, XY; Yi, Q; Xu, XJ; Meng, RL; Ma, SL; Tang, SL; Xu, HF; Xu, YS; Xu, YJ; Yang, Y				Zheng, Xue-Yan; Yi, Qian; Xu, Xiao-Jun; Meng, Rui-Lin; Ma, Shu-Li; Tang, Si-Li; Xu, Hao-Feng; Xu, Ying-Shan; Xu, Yan-Jun; Yang, Yi			Trends and external causes of traumatic brain injury and spinal cord injury mortality in south China, 2014-2018: an ecological study	BMC PUBLIC HEALTH			English	Article						Traumatic brain injury; Spinal cord injury; Mortality; External cause	UNITED-STATES; NEW-ZEALAND; POPULATION; PREVENTION; SURVEILLANCE; DEATHS; FALLS; EPIDEMIOLOGY; AUSTRIA; RISK	Background The epidemiological evidence of traumatic brain injury (TBI) and spinal cord injury (SCI) mortality in mainland China is lacking. We aimed to assess the trends of TBI and SCI mortality, and their association with sex, age, location and external causes of injury in south China. Methods Mortality data were derived from the Disease Surveillance Points (DSPs) system of Guangdong province between 2014 and 2018. We examined the trends in mortality with Cochran-Armitage trend test, and the association between the socio-demographic factors and the TBI and SCI mortality by using negative binomial models. Subgroup analysis was performed by stratifying the external causes of TBI and SCI. Results The age-standardized TBI mortality remained relatively stable (from 11.6 to 15.4 per 100,000), while the SCI mortality increased by 148.3% from 2014 to 2018. Compared with females and urban residents, the adjusted mortality rate ratios of males and rural residents were 2.3 and 2.0 for TBI, and 2.2 and 4.6 for SCI, respectively. TBI and SCI mortality increased substantially with age. Motor vehicle crashes and falls were the leading causes of TBI mortality in residents aged under 75 years and over 75 years, respectively. Falls were the most important external cause for SCI death of all ages. Conclusions Being male, rural and elderly residents are at higher risk of dying from TBI and SCI. The substantial burden of TBI and SCI caused by road traffic crashes and falls has called for the urgent need to improve injury prevention, pre-hospital aid, hospital treatment and recovery.	[Zheng, Xue-Yan; Yi, Qian; Xu, Xiao-Jun; Meng, Rui-Lin; Xu, Hao-Feng; Xu, Ying-Shan; Xu, Yan-Jun] Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China; [Yi, Qian; Ma, Shu-Li; Yang, Yi] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Tang, Si-Li] Southern Med Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China		Xu, YJ (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, 160 Qunxian Rd, Guangzhou, Guangdong, Peoples R China.; Yang, Y (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China.	759888406@qq.com; yangyigz@163.com					Adair T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197047; Barr GC, 2015, J EMERG MED, V48, P366, DOI 10.1016/j.jemermed.2014.09.055; Beck B, 2019, MED J AUSTRALIA, V210, P360, DOI 10.5694/mja2.50143; Chamberlain JD, 2015, NEUROEPIDEMIOLOGY, V44, P182, DOI 10.1159/000382079; Chen JL, 2021, J SPINAL CORD MED, V44, P276, DOI 10.1080/10790268.2019.1654190; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Chinese Center for Disease Control and Prevention National Center for Chronic and Noncommunicable Disease Control and Prevention, 2015, DAT SETS DEATH CAUS; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Dicker D, 2018, LANCET, V392, P1684, DOI [10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9]; Duan LL, 2019, LANCET PUBLIC HEALTH, V4, pE449, DOI 10.1016/S2468-2667(19)30125-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Firsching R, 2001, WORLD J SURG, V25, P1221; Huang RL., 2005, REN KOU YU JING JI, V2, P57; Huang YX, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1111; Hui Z, 2012, BIOMED ENVIRON SCI, V25, P483, DOI 10.3967/0895-3988.2012.04.015; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kessaram T, 2016, DRUG ALCOHOL REV, V35, P412, DOI 10.1111/dar.12328; Li B, 2021, J SPINAL CORD MED, V44, P1005, DOI 10.1080/10790268.2019.1699355; Li L, 2015, B WORLD HEALTH ORGAN, V93, P169, DOI 10.2471/BLT.14.139998; Liu Ming-bo, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P985; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majdan M, 2016, EUR SPINE J, V25, P62, DOI 10.1007/s00586-015-3985-z; Majdan M, 2014, J NEUROTRAUM, V31, P1046, DOI 10.1089/neu.2013.3200; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Population Census Office under the State Council of China National Bureau of Statistics of China, 2012, TAB 2010 POP CENS PE; Sawadogo D, 2020, INJURY, V51, P76, DOI 10.1016/j.injury.2019.08.023; Selvarajah S, 2015, J NEUROTRAUM, V32, P2008, DOI 10.1089/neu.2015.4016; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thurman DJ., 1995, GUIDELINES SURVEILLA; Tian DP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0330-z; US Centers for Disease Control and Prevention, EXT CAUS INJ MORT MA; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Varghese M., 2005, PREHOSPITAL TRAUMA C; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Zhang Y., 2016, J TRAUMA SURG, V18, P328; [张溢华 Zhang Yihua], 2014, [中华创伤杂志, Chinese Journal of Trauma], V30, P1215; Zhou MaiGeng, 2010, Disease Surveillance, V25, P239	50	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	DEC 7	2021	21	1							2225	10.1186/s12889-021-12225-2			14	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	XL7KA	WOS:000728319500001	34876065	Green Published, gold			2022-02-06	
J	Ceyisakar, IE; Huijben, JA; Maas, AIR; Lingsma, HF; van Leeuwen, N				Ceyisakar, Iris E.; Huijben, Jilske A.; Maas, Andrew I. R.; Lingsma, Hester F.; van Leeuwen, Nikki		CENTER-TBI Participants Investigat	Can We Cluster ICU Treatment Strategies for Traumatic Brain Injury by Hospital Treatment Preferences?	NEUROCRITICAL CARE			English	Article; Early Access						Provider profiling; Between-hospital variation; Comparative effectiveness research; Traumatic brain injury	CENTER-TBI; MANAGEMENT; CARE	Background In traumatic brain injury (TBI), large between-center differences in treatment and outcome for patients managed in the intensive care unit (ICU) have been shown. The aim of this study is to explore if European neurotrauma centers can be clustered, based on their treatment preference in different domains of TBI care in the ICU. Methods Provider profiles of centers participating in the Collaborative European Neurotrauma Effectiveness Research in TBI study were used to assess correlations within and between the predefined domains: intracranial pressure monitoring, coagulation and transfusion, surgery, prophylactic antibiotics, and more general ICU treatment policies. Hierarchical clustering using Ward's minimum variance method was applied to group data with the highest similarity. Heat maps were used to visualize whether hospitals could be grouped to uncover types of hospitals adhering to certain treatment strategies. Results Provider profiles were available from 66 centers in 20 different countries in Europe and Israel. Correlations within most of the predefined domains varied from low to high correlations (mean correlation coefficients 0.2-0.7). Correlations between domains were lower, with mean correlation coefficients of 0.2. Cluster analysis showed that policies could be grouped, but hospitals could not be grouped based on their preference. Conclusions Although correlations between treatment policies within domains were found, the failure to cluster hospitals indicates that a specific treatment choice within a domain is not a proxy for other treatment choices within or outside the domain. These results imply that studying the effects of specific TBI interventions on outcome can be based on between-center variation without being substantially confounded by other treatments.	[Ceyisakar, Iris E.; Huijben, Jilske A.; Lingsma, Hester F.; van Leeuwen, Nikki] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Ceyisakar, Iris E.; Maas, Andrew I. R.] Univ Antwerp, Antwerp Univ Hosp, Dept Neurosurg, B-2650 Antwerp, Belgium		Ceyisakar, IE (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, POB 2040, NL-3000 CA Rotterdam, Netherlands.	iris.kohen@gmail.com	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Dark, Paul/0000-0003-3309-0164	European CommissionEuropean CommissionEuropean Commission Joint Research Centre	The authors thank all clinical and research staff at the CENTER-TBI sites for completing the provider profiling questionnaires. Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework	Bragge P., 2015, J NEUROTRAUM, V1478, P1; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang W, 2019, WEBSHOT TAKE SCREENS; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Kolde Raivo, 2019, CRAN; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maechler Martin, 2021, CRAN; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Nakazawa M., 2021, FMSB FUNCTIONS MED S; Neuwirth Erich, 2014, CRAN; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; R Core Team, 2021, R LANG ENV STAT COMP; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Wei T. Y., 2017, R PACKAGE CORRPLOT V; Wickham H., 2020, DPLYR GRAMMAR DATA M	25	0	0	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care												10.1007/s12028-021-01386-y		DEC 2021	11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ9WQ	WOS:000727129000001	34873673	hybrid			2022-02-06	
J	Harlos, AR; Rowson, S				Harlos, Ann R.; Rowson, Steven			The range of bicycle helmet performance at real world impact locations	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article; Early Access						Bicycle helmet; brain injury; biomechanics; helmet standards; concussion	NATIONAL OPERATING COMMITTEE; HEAD-INJURIES; UNITED-STATES; HYBRID III; STANDARDS; DAMAGE	In the United States, all bicycle helmets must comply with the standard created by the Consumer Product Safety Commission (CPSC). In this standard, bike helmets are only required to by tested above an established test line. Unregulated helmet performance below the test line could pose an increased risk of head injury to riders. This study quantified the impact locations of damaged bike helmets from real-world accidents and tested the most commonly impacted locations under CPSC bike helmet testing protocol. Ninety-five real-world impact locations were quantified. The most common impact locations were side-middle (31.6%), rear boss-rim (13.7%), front boss-rim (9.5%), front bossmiddle (9.5%), and rear boss-middle (9.5%). The side-middle, rear boss-rim, and front boss (front boss-middle and front boss-rim regions combined) were used for testing. Two of the most commonly impacted regions were below the test line (front boss-rim and rear boss-rim). Twelve purchased helmet models were tested under CPSC protocol at each location for a total of 36 impacts. An ANOVA test showed that impact location had a strong influence on the variance of peak linear acceleration (PLA) (p = 0.002). A Tukey HSD post hoc test determined that PLA at the side-middle (214.9 +/- 20.8g) and front boss (228.0 +/- 39.6g) locations were significantly higher than the PLA at the rear boss-rim (191.5 +/- 24.2g) location. The highest recorded PLA (318.8g) was at the front boss-rim region. This was the only test that exceeded the 300 g threshold. This study presented a method for quantifying real-world impact locations of damaged bike helmets. Higher variance in helmet performance was found at the regions on or below the test line than at the region above the test line.	[Harlos, Ann R.; Rowson, Steven] Virginia Polytech Inst & State Univ, Biomed Engn & Mech, 325 Stanger St, Blacksburg, VA 24060 USA		Harlos, AR (corresponding author), Virginia Polytech Inst & State Univ, Biomed Engn & Mech, 325 Stanger St, Blacksburg, VA 24060 USA.	harlosa@vt.edu			Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech	The authors would like to acknowledge the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech for their support.<BOLD> </BOLD>	Anlaysis NCFSA, 2018, FAT MOT VEH CRASH OV; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bland ML., 2017, INT CYCL SAF C DAV C; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Deck C., 2014, P INT CYCL SAF C 201; DeMarco AL, 2020, ANN BIOMED ENG, V48, P58, DOI 10.1007/s10439-019-02422-x; Fergus KB, 2019, TRAFFIC INJ PREV, V20, P550, DOI 10.1080/15389588.2019.1620219; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; Gotschi T, 2016, TRANSPORT REV, V36, P45, DOI 10.1080/01441647.2015.1057877; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; King A. I., 2003, IRCOBI C LISB PORT; McIntosh A., 1992, IRCOBI, P51; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mertz Harold J, 2016, Stapp Car Crash J, V60, P625; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Pucher J, 2017, TRANSPORT REV, V37, P689, DOI 10.1080/01441647.2017.1340234; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Surgeons AAON, 2009, SPORTS REL HEAD INJ; Takhounts E. G., 2011, PAPER; Thibault L., 1971, P 15 STAPP CAR CRASH; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Unterharnscheidt FJ., 1971, P 15 STAPP CAR CRASH; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	34	0	0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.											17543371211057721	10.1177/17543371211057721		DEC 2021	7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	XL0MO	WOS:000727848000001					2022-02-06	
J	Korczeniewska, OA; James, MH; Eliav, T; Rider, GK; Mehr, JB; Affendi, H; Aston-Jones, G; Benoliel, R				Korczeniewska, Olga A.; James, Morgan H.; Eliav, Tali; Rider, Giannina Katzmann; Mehr, Jacqueline B.; Affendi, Hafsa; Aston-Jones, Gary; Benoliel, Rafael			Chemogenetic inhibition of trigeminal ganglion neurons attenuates behavioural and neural pain responses in a model of trigeminal neuropathic pain	EUROPEAN JOURNAL OF PAIN			English	Article; Early Access							CHRONIC CONSTRICTION INJURY; PRIMARY AFFERENT NEURONS; RAT INFRAORBITAL NERVE; MIRROR-IMAGE PAIN; CUED REINSTATEMENT; RECEPTORS; EXPRESSION; COCAINE; MECHANISMS; PATHWAY	Background Nerve injury can lead to ectopic activation of injured nociceptorsand central sensitization characterized by allodynia and hyperalgesia. Reduction in the activity of primary afferent neurons has been shown to be sufficient in alleviating peripherally generated pain. The cell bodies of such trigeminal nociceptors are located in the trigeminal ganglia (TG) with central processes that terminate in the brainstem trigeminal nucleus caudalis (TNC). The TG is therefore a strategic locus where afferent input can be manipulated. We hypothesized that chemogenetic inhibition of TG would suppress TNC neuronal activity and attenuate pain behaviour in a rat model of painful traumatic trigeminal neuropathy (PTTN). Methods Trigeminal neuropathic pain was induced in adult male Sprague-Dawley rats (n = 24) via chronic constriction injury to the infraorbital nerve (ION-CCI). Naive and sham rats were used as controls (n = 20/group). Rats within each group received TG-directed microinjections of AAV virus containing either the inhibitory hM4Di-DREADD construct or EGFP. Results In the ION-CCI group, systemic administration of the DREADD agonist clozapine N-oxide (CNO) reversed the hypersensitivity phenotype in animals expressing hM4Di but not EGFP. CNO-mediated activation of hM4Di DREADD in ION-CCI animals was also associated with reduced Fos expression in the TNC elicited by repeated mechanical stimulation of the dermatome ipsilateral to the injury. There was no effect of CNO on pain behaviour or TNC Fos expression in eGFP animals. Conclusion Our results indicate that DREADDs may offer an effective therapeutic approach for treatment of trigeminal neuropathic pain. Significance Trigeminal neuropathic pain is highly resistant to therapy and we are in dire need of novel approaches. This study provides further evidence for the successful application of DREADDs as an effective tool for modulating central nervous system function. CNO mediated activation of hM4Di-DREADDs in the trigeminal ganglion (TG) attenuates nerve injury induced neuropathic pain by acting on hyperactive TG cells. It also establishes the TG as an effective target to manage pain in the face and head. Accessing the TG in clinical populations is a relatively simple and safe procedure, making this approach highly significant. Moreover, the methodology described here has applications in trigeminal neuropathic pain from traumatic other etiologies and in spinal neuropathic pain. Chronic pain syndromes are characterized by a progressive failure of brain centers to adequately inhibit pain and as these are identified, we may be able to target them for therapy. Therefore, our findings might have wide application in chronic pain syndromes.	[Korczeniewska, Olga A.; Rider, Giannina Katzmann; Affendi, Hafsa; Benoliel, Rafael] Rutgers State Univ, Ctr Orofacial Pain & Temporomandibular Disorders, Rutgers Sch Dent Med, Dept Diagnost Sci, Newark, NJ USA; [Korczeniewska, Olga A.; James, Morgan H.; Mehr, Jacqueline B.; Aston-Jones, Gary] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ USA; [James, Morgan H.; Mehr, Jacqueline B.; Aston-Jones, Gary; Benoliel, Rafael] Rutgers State Univ, Brain Hlth Inst, Piscataway, NJ USA; [Eliav, Tali] Rutgers Biomed & Hlth Sci, Sch Grad Studies, Newark, NJ USA		Korczeniewska, OA (corresponding author), Rutgers Sch Dent Med, Ctr Orofacial Pain & Temporomandibular Disorders, Dept Diagnost Sci, D-830 110 Bergen St, Newark, NJ 07101 USA.	korczeol@sdm.rutgers.edu			Brain Health Institute, Rutgers University, Piscataway, NJ; National Health and Medical Research Council of Australia C.J. Martin fellowshipNational Health and Medical Research Council of Australia [1072706]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K99DA045765]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01-DA006214]	The study was conducted with the support from the Brain Health Institute, Rutgers University, Piscataway, NJ. MHJ was supported by a National Health and Medical Research Council of Australia C.J. Martin fellowship (1072706) and National Institute on Drug Abuse (K99DA045765) grant. GAJ was supported by a PHS Award from NIDA (R01-DA006214).	Ahmad Sultan, 2004, Curr Opin Investig Drugs, V5, P67; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; Arguis MJ, 2008, REGION ANESTH PAIN M, V33, P211, DOI 10.1016/j.rapm.2007.12.003; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Benoliel R, 2002, PAIN, V99, P567, DOI 10.1016/S0304-3959(02)00272-5; Benoliel R, 2001, PAIN, V91, P111, DOI 10.1016/S0304-3959(00)00417-6; Benoliel R., 2003, VIRAL TRANSFECTION T; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Cheng CF, 2014, PAIN, V155, P906, DOI 10.1016/j.pain.2014.01.010; Dawes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093338; Devor M., 2005, WALL MELZACKS TXB PA; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Fortress AM, 2015, J NEUROSCI, V35, P1343, DOI 10.1523/JNEUROSCI.2658-14.2015; Fried K, 2001, NEUROSCIENTIST, V7, P155, DOI 10.1177/107385840100700210; Gao L, 2020, J PAIN RES, V13, P927, DOI 10.2147/JPR.S232081; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Hansson P, 2015, EUR J PAIN, V19, P147, DOI 10.1002/ejp.643; Haviv Y, 2014, J ORAL FACIAL PAIN H, V28, P52, DOI 10.11607/jop.1154; Huang Y, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/968218; Imamura Y, 1997, EXP BRAIN RES, V116, P97, DOI 10.1007/PL00005748; James MH, 2018, INT J NEUROPSYCHOPH, V21, P89, DOI 10.1093/ijnp/pyx107; Jancalek R, 2011, ANN NEUROSCI, V18, P123, DOI [10.5214/ans.0972-7531.11183010, 10.5214/ans.0972.7531.11183010]; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Koga K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04972-3; Kondziolka Douglas, 2005, Neurosurg Focus, V18, pE7; Korczeniewska OA, 2020, EUR J PAIN, V24, P967, DOI 10.1002/ejp.1546; Korczeniewska OA, 2017, J ORAL FACIAL PAIN H, V31, P381, DOI 10.11607/ofph.1807; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; MacLaren DAA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0219-16.2016; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; McDermott AM, 2006, EUR J PAIN, V10, P127, DOI 10.1016/j.ejpain.2005.01.014; McGlinchey EM, 2016, J NEUROSCI, V36, P8700, DOI 10.1523/JNEUROSCI.1291-15.2016; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Perkins JR, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-7; RAPPAPORT ZH, 1994, PAIN, V56, P127, DOI 10.1016/0304-3959(94)90086-8; Runegaard AH, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0345-17.2018; Salter MW, 2014, BRAIN, V137, P651, DOI 10.1093/brain/awu028; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Vit JP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-42; VOS BP, 1995, J COMP NEUROL, V357, P362, DOI 10.1002/cne.903570304; VOS BP, 1994, J NEUROSCI, V14, P2708; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zhou QG, 2019, J CLIN INVEST, V129, P310, DOI 10.1172/JCI95731; Zhu H, 2014, NEURON, V82, P723, DOI 10.1016/j.neuron.2014.05.002	51	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1090-3801	1532-2149		EUR J PAIN	Eur. J. Pain												10.1002/ejp.1887		DEC 2021	14	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	XJ3HG	WOS:000726683000001	34767278				2022-02-06	
J	Manavis, J; Blumbergs, P; Jerrett, I; Hanshaw, D; Uzal, F; Finnie, J				Manavis, Jim; Blumbergs, Peter; Jerrett, Ian; Hanshaw, Daren; Uzal, Francisco; Finnie, John			Heterogeneous immunoreactivity of axonal spheroids in focal symmetrical encephalomalacia produced by Clostridium perfringens type D epsilon toxin in sheep	VETERINARY PATHOLOGY			English	Article; Early Access						axonal spheroids; brain; clostridial epsilon toxin; immunohistochemistry; sheep	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY	Since axonal injury (AI) is an important component of many veterinary neurologic disorders, we assessed the relative ability of a panel of antibodies (amyloid precursor protein, 3 subunits of neurofilament protein, protein gene product 9.5, ubiquitin, and synaptophysin) to detect axonal swellings or spheroids. Abundant axonal spheroids found in necrotic internal capsule foci produced in 4 sheep by chronic Clostridium perfringens type D epsilon neurotoxicity provided a model system in which to evaluate this important diagnostic tool. There was heterogeneous labeling of subsets of spheroids by the respective antibodies, suggesting that, in order to detect the complete spectrum of AI in diagnostic cases, a range of antibodies should be used, not only when spheroids are plentiful but also when they are few in number or incompletely developed. The application of insufficient markers in the latter cases can potentially lead to the contribution of AI to lesion pathogenesis being underappreciated.	[Manavis, Jim; Blumbergs, Peter; Finnie, John] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; [Jerrett, Ian] AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia; [Hanshaw, Daren] Gribbles Vet Pathol, Adelaide, SA, Australia; [Uzal, Francisco] Univ Calif Davis, San Bernardino, CA USA		Finnie, J (corresponding author), Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	john.finnie@adelaide.edu.au					Blumbergs P., 2008, GREENFIELDS NEUROPAT, P744; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Dabbs DJ., 2017, DIAGNOSTIC IMMUNOHIS, V5th; Finnie JW, 2020, J VET DIAGN INVEST, V32, P282, DOI 10.1177/1040638719900190; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Kessell AE, 2012, J COMP PATHOL, V147, P62, DOI 10.1016/j.jcpa.2011.09.006; Nibe K, 2009, VET PATHOL, V46, P474, DOI 10.1354/vp.08-VP-0156-U-FL; Pintus D, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0218-3; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Uzal FA., 2016, CLOSTRIDIAL DIS ANIM, P157	12	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0300-9858	1544-2217		VET PATHOL	Vet. Pathol.											03009858211057222	10.1177/03009858211057222		DEC 2021	5	Pathology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Veterinary Sciences	XL4VL	WOS:000728142700001	34872408				2022-02-06	
J	Misale, P; Hassannia, F; Dabiri, S; Brandstaetter, T; Rutka, J				Misale, Priyanka; Hassannia, Fatemeh; Dabiri, Sasan; Brandstaetter, Tom; Rutka, John			Post-traumatic peripheral vestibular disorders (excluding positional vertigo) in workers following head injury	SCIENTIFIC REPORTS			English	Article							DROP ATTACKS; MENIERES-DISEASE; PATIENTS SECONDARY; DIZZINESS; DEHISCENCE; MIGRAINE; PATHOPHYSIOLOGY; CLASSIFICATION; GUIDELINES; DIAGNOSIS	Benign paroxysmal positional vertigo has typically been reported to be the most common cause of post-traumatic dizziness. There is however paucity in the literature about other peripheral vestibular disorders post-head injury. This article provides an overview of other causes of non-positional dizziness post-head trauma from our large institutional experience. The UHN WSIB Neurotology database (n = 4291) between 1998 and 2018 was retrospectively studied for those head-injured workers presenting with non-positional peripheral vestibular disorders. All subjects had a detailed neurotological history and examination and vestibular testing including video nystagmography, video head impulse testing (or a magnetic scleral search coil study), vestibular-evoked myogenic potentials, and audiometry. Imaging studies included routine brain and high-resolution temporal bone CT scans and/or brain MRI. Based on a database of 4291 head-injured workers with dizziness, 244 were diagnosed with non-positional peripheral vertigo. Recurrent vestibulopathy (RV) was the most common cause of non-positional post-traumatic vertigo. The incidence of Meniere's disease in the post-traumatic setting did not appear greater than found in the general population. The clinical spectrum pertaining to recurrent vestibulopathy, Meniere's disease, delayed endolymphatic hydrops, drop attacks, superior semicircular canal dehiscence syndrome, and uncompensated peripheral vestibular loss are discussed.	[Misale, Priyanka; Hassannia, Fatemeh; Dabiri, Sasan; Brandstaetter, Tom; Rutka, John] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto Gen Hosp, Univ Hlth Network, 200 Elizabeth St,8N-873, Toronto, ON M5G 2C4, Canada		Hassannia, F (corresponding author), Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto Gen Hosp, Univ Hlth Network, 200 Elizabeth St,8N-873, Toronto, ON M5G 2C4, Canada.	fatimahassannia@yahoo.com	Dabiri, Sasan/C-8699-2017	Dabiri, Sasan/0000-0002-9791-6810			[Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Bachinger D, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00431; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; Brantberg K, 2005, NEUROLOGY, V64, P2126, DOI 10.1212/01.WNL.0000165953.48914.B0; Carey JP, 2000, ARCH OTOLARYNGOL, V126, P137, DOI 10.1001/archotol.126.2.137; Carr S., 2017, CURR OTORHINOL REP, V5, P142; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; GLASSCOCK ME, 1992, AM J OTOL, V13, P333; Harris JP, 2010, AUDIOL NEURO-OTOL, V15, P318, DOI 10.1159/000286213; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Huang T. S., 2001, ENT-EAR NOSE THROAT, V80, P81; Ishiyama G, 2003, ARCH NEUROL-CHICAGO, V60, P71, DOI 10.1001/archneur.60.1.71; Ishiyama G, 2001, NEUROLOGY, V57, P1103, DOI 10.1212/WNL.57.6.1103; JANZEN VD, 1988, J OTOLARYNGOL, V17, P359; Kamei T., 1991, SURG INNER EAR, P101; Kelm Z, 2018, J AM OSTEOPATH ASSOC, V118, pE22, DOI 10.7556/jaoa.2018.066; Kim JS, 2014, NEW ENGL J MED, V370, P1138, DOI 10.1056/NEJMcp1309481; Lee H, 2005, J NEUROL SCI, V232, P71, DOI 10.1016/j.jns.2005.01.012; LELIEVER WC, 1981, LARYNGOSCOPE, V91, P1; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Liu B., 2016, MED BALITIMORE, V95; Mair IWS., 1996, J AUDIOL MED, V5, P21; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249, DOI 10.1001/archotol.124.3.249; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Mucci V, 2018, J NEUROL, V265, P486, DOI 10.1007/s00415-017-8725-3; Nadol JB, 2010, SCHUKNECHTS PATHOLOG; PAPARELLA MM, 1983, LARYNGOSCOPE, V93, P1004; Popkirov Stoyan, 2018, Pract Neurol, V18, P5, DOI 10.1136/practneurol-2017-001809; Pothier DD, 2018, JAMA OTOLARYNGOL, V144, P906, DOI 10.1001/jamaoto.2018.1863; PULEC JL, 1972, LARYNGOSCOPE, V82, P1703, DOI 10.1288/00005537-197209000-00011; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; RUTKA JA, 1986, J OTOLARYNGOL, V15, P105; SCHUKNECHT HF, 1976, ARCH OTO-RHINO-LARYN, V212, P253, DOI 10.1007/BF00453673; SCHUKNECHT HF, 1978, ANN OTO RHINOL LARYN, V87, P743, DOI 10.1177/000348947808700601; Segal S, 2003, OTOL NEUROTOL, V24, P387, DOI 10.1097/00129492-200305000-00007; SHEPARD NT, 1990, NEUROL CLIN, V8, P459, DOI 10.1016/S0733-8619(18)30367-0; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Staab JP, 2017, J VESTIBUL RES-EQUIL, V27, P191, DOI 10.3233/VES-170622; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Taura A, 2014, ACTA OTO-LARYNGOL, V134, P1140, DOI 10.3109/00016489.2014.936624; Veterans Administration (VA)/Department of Defense (DoD), 2016, CLIN PRACTICE GUIDEL; Viana LM, 2014, LARYNGOSCOPE, V124, P2151, DOI 10.1002/lary.24716; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098	47	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 6	2021	11	1							23436	10.1038/s41598-021-02987-5			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XK7BH	WOS:000727615800041	34873257	gold, Green Published			2022-02-06	
J	Stone, B; Mitchell, S; Miyazaki, Y; Peirce, N; Harland, A				Stone, Ben; Mitchell, Sean; Miyazaki, Yusuke; Peirce, Nicholas; Harland, Andy			A destructible headform for the assessment of sports impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article; Early Access						Headform; projectile testing; impact testing; destructive testing; headform development; biofidelic headform	PROFESSIONAL FOOTBALL; ELASTIC-MODULUS; SURROGATE; BASEBALL; COMPRESSION; CONCUSSION; SIMULANT; DENSITY; MODEL; SKIN	Commercially available headforms, such as the Hybrid-III and EN 960 headforms, have been used effectively to investigate the mechanics of head impacts. These headforms may result in accelerations that are unrepresentative of a human head in some impact scenarios. This may be important when considering impacts that produce areas of high pressure, since skull deformation and resonance excitation may influence the dynamic response. The National Operating Committee on Standards for Athletic Equipment (NOCSAE) headform may produce a more suitable response during these types of impacts due to the more representative skull component. However, permanent deformation may occur in some unprotected impact scenarios, resulting in the entire headform needing to be replaced. This paper outlines the development of a novel, modular and destructible headform (LU headform) that can be used in potentially destructive testing, where individual components can be replaced. The LU headform was modelled after a UK 50th percentile male. The inertial properties of the LU headform were within 6% of those observed in humans. The skull simulant properties were within the range of values reported for human tissue in two build orientations, but lower in one build orientation. The lowest and highest resonance frequencies observed in the headform model were within 5% of those observed in humans. Drop and projectile tests were conducted in line with previous cadaver tests with the observed accelerations within the range reported for post-mortem human subjects. The LU headform offers a practical means of simulating head dynamics during localised unprotected impacts or in protected impacts where local deformation and/or resonance frequency excitation remains possible.	[Stone, Ben; Mitchell, Sean; Harland, Andy] Loughborough Univ, Wolfson Sch Mech Elect & Mfg, Sports Technol Inst, 1 Oakwood Dr, Loughborough LE11 3QF, Leics, England; [Miyazaki, Yusuke] Tokyo Inst Technol, Dept Syst & Control Engn, Tokyo, Japan; [Peirce, Nicholas] England & Wales Cricket Board, London, England; [Peirce, Nicholas] Loughborough Univ, Natl Ctr Sport & Exercise Med, Loughborough, Leics, England		Stone, B (corresponding author), Loughborough Univ, Wolfson Sch Mech Elect & Mfg, Sports Technol Inst, 1 Oakwood Dr, Loughborough LE11 3QF, Leics, England.	bwstone110@gmail.com					Alaoui AH, 2008, J NON-CRYST SOLIDS, V354, P4556, DOI 10.1016/j.jnoncrysol.2008.06.014; Albery C., 2003, P 31 INT WORKSH HUM P 31 INT WORKSH INT, V157, P157; Becker E., 1972, P STAPP CAR CRASH C, P525; Behr M, 2009, INT J CRASHWORTHINES, V14, P477, DOI 10.1080/13588260902826521; Beier G., 1980, IRCOBI C BIRM UK, P218; BELL BA, 1989, ANN ROY COLL SURG, V71, P375; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; BLANTON PL, 1968, AM J PHYS ANTHROPOL, V29, P39, DOI 10.1002/ajpa.1330290113; British Standards, 77432017 BS ISO; British Standards Institute, 2017, 725012017 BS EN ISO; British Standards Institute, 2013, 1782010A12013 BS EN; British Standards Institute, 2012, 52712012 BS EN ISO; BSi, 2012, 8122012 BSI EN; BSi, 2008, 4432008 BSI EN; BSi, 2013, 79282013 BSI; BSi, 2012, 10782012A12012 BSI; Chancey VC, 2007, J BIOMECH, V40, P1953, DOI 10.1016/j.jbiomech.2006.09.007; Crisco JJ, 2009, J APPL BIOMECH, V25, P184, DOI 10.1123/jab.25.2.184; Delotte J, 2008, SURG RADIOL ANAT, V30, P185, DOI 10.1007/s00276-008-0319-4; Elliott BC., 1992, SPORTS MED TRAIN REH, V3, P113, DOI DOI 10.1080/15438629209517008; Falland-Cheung L, 2017, J MECH BEHAV BIOMED, V68, P303, DOI 10.1016/j.jmbbm.2017.02.023; Glaister J, 2017, PROC SPIE, V10137, DOI 10.1117/12.2255640; Granta Design Limited, 2017, CES ED; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hendee SP, 1998, J APPL BIOMECH, V14, P390, DOI 10.1123/jab.14.4.390; Hodgson VR., 1972, P STAPP CAR CRASH C, P1; Hodgson VR., 1967, P STAPP CAR CRASH C; Hodgson VR., 1970, 14 STAPP CAR CRASH C; Hodgson VR., 1973, BREAKING STRENGTH HU; Hrysomallis C, 2009, J SCI MED SPORT, V12, P35, DOI 10.1016/j.jsams.2007.07.013; Hubbard R., 1994, HYBRID, P95; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; KHALIL TB, 1979, J SOUND VIB, V63, P351, DOI 10.1016/0022-460X(79)90679-5; Lin Samuel J, 2008, Semin Plast Surg, V22, P281, DOI 10.1055/s-0028-1095887; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Lyon DH., 1999, INJURY EVALUATION TE; Mahinda H., 2009, INDIAN J FORENSIC ME, V126, P26; Martin PG, 1998, SHOCK VIB, V5, P211, DOI 10.1155/1998/134562; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; Merkle AC, 2010, IFMBE PROC, V32, P22, DOI 10.1007/978-3-642-14998-6_6; Miyazaki Y., 2012, T JPN SOC MECH ENG A, V78, P106; Mohotti D, 2018, COMPUT METH PROG BIO, V158, P193, DOI 10.1016/j.cmpb.2018.02.017; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; NOCSAE, 2015, STAND PERF SPEC NEWL; NOCSAE, 2017, STAND PERF SPEC NEWL; NOCSAE, 2012, STAND PERF SPEC NEWL; NOCSAE, 2016, STAND PERF SPEC NEWL; Payne T, 2016, P I MECH ENG P-J SPO, V230, P5, DOI 10.1177/1754337115582294; Payne T, 2014, PROCEDIA ENGINEER, V72, P533, DOI 10.1016/j.proeng.2014.06.092; Payne T, 2015, J MECH BEHAV BIOMED, V41, P357, DOI 10.1016/j.jmbbm.2014.08.011; PEEBLES L, 1998, HDB ADULT ANTHROPOME; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Penrose T., 1976, AUST J HEAL PHYS ED, V71, P2; Petrone N., 2018, PROC, V2, P269, DOI 10.3390/proceedings2060269; Petrone N, 2019, J SCI MED SPORT, V22, pS78, DOI 10.1016/j.jsams.2019.05.015; Post A, 2016, COMPUT METHOD BIOMEC, V19, P366, DOI 10.1080/10255842.2015.1029921; Raymond D., 2008, THESIS WAYNE STATE U; Reynolds HM., 1975, 750424 SAE, P1132; Roberts Jack C, 2013, Front Bioeng Biotechnol, V1, P13; Rodriguez-Panes A, 2018, MATERIALS, V11, DOI 10.3390/ma11081333; Stalnaker RL., 1973, HUMAN IMPACT RESPONS, P85; Stockill N., 1992, P 10 S INT SOC BIOM, P52; Stone BW, 2017, P I MECH ENG P-J SPO, V231, P324, DOI 10.1177/1754337117703574; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Thomas LM., 1969, 49193MD2603 DA; Viano D., 1997, INT J CRASHWORTHINES, V2, P191; Viano D. C., 1993, CLIN J SPORT MED, P217, DOI [DOI 10.1097/00042752-199310000-00002, 10.1097/00042752-199310000-00002]; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walker L., 1973, STAPP CAR CRASH C CO, P525; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373; Yang N., 2014, ASME 2014 INT MECH E; Yeni YN, 1998, BONE, V22, P79, DOI 10.1016/S8756-3282(97)00227-5; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	76	0	0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.											17543371211055905	10.1177/17543371211055905		DEC 2021	12	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	XL0NU	WOS:000727851200001					2022-02-06	
J	Colon, GTA				Torres Colon, Gabriel A.			Fighting for Family and Glory: Hope, Racialization, and Exploitation in a US Boxing Gym	JOURNAL OF SPORT & SOCIAL ISSUES			English	Article; Early Access						boxing; racialization; hope; exploitation		Relaying on years of ethnographic research and boxers' life stories, this article examines how boxers from racialized and marginalized communities hope for family and glory in a Midwestern U.S. gym. Hope for family is embraced by youth and young adults who develop familial ties with trainers and fellow boxers. Hope for glory begins in gyms but ultimately must be sought in competitive arenas of elite amateur tournaments and professional boxing. Competitive arenas, however, exists in sociocultural systems that capitalize on the brutalization and exploitation of racialized bodies as boxing fanatics crave blood, pain, and concussions. In these contexts, boxers' hope for glory is fulfilled through exploitation-both physical and cultural-of their collective bodies; and hope for glory compromises the relationships and sense of community that are established as boxers pursue hope for family.	[Torres Colon, Gabriel A.] Vanderbilt Univ, Dept Anthropol, Amer Studies Program, 2301 Vanderbilt Pl,VU Stn B 350125, Nashville, TN 37235 USA		Colon, GTA (corresponding author), Vanderbilt Univ, Dept Anthropol, Amer Studies Program, 2301 Vanderbilt Pl,VU Stn B 350125, Nashville, TN 37235 USA.	g.torres@vanderbilt.edu					Allen S.D., 2017, HIST BOXING MEXICO M; Anderson B., 1998, IMAGINED COMMUNITIES; Arbib MA, 2011, ANNU REV ANTHROPOL, V40, P257, DOI 10.1146/annurev-anthro-081309-145722; Arnaldo CR, 2020, IDENTITIES-GLOB STUD, V27, P655, DOI 10.1080/1070289X.2019.1624068; Bernard H.R., 2010, ANAL QUALITATIVE DAT; Brodkin, 1998, JEWS BECAME WHITE FO; Carrington B., 2013, COMPANION SPORT, P1; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; COAKLEY J, 2011, J ALESDE, V1, P67, DOI DOI 10.5380/ALESDE.V1I1.22743; Collins PatriciaHill., 2004, BLACK SEXUAL POLITIC; Colon GAT, 2017, QUAL HEALTH RES, V27, P1077, DOI 10.1177/1049732316669339; Crapanzano V, 2003, CULT ANTHROPOL, V18, P3, DOI 10.1525/can.2003.18.1.3; CSORDAS TJ, 1990, ETHOS, V18, P5, DOI 10.1525/eth.1990.18.1.02a00010; Emerson R.M., 2011, WRITING ETHNOGRAPHIC, VSecond, P21, DOI [10.7208/chicago/9780226206868.001.0001, DOI 10.7208/CHICAGO/9780226206868.001.0001]; Farnell B., 2014, HDB METHODS CULTURAL, P411; Garcia JD, 2013, J AM CULTURE, V36, P323, DOI 10.1111/jacc.12053; Geertz C., 1983, LOCAL KNOWLEDGE FURT; Hein G, 2016, P NATL ACAD SCI USA, V113, P80, DOI 10.1073/pnas.1514539112; High S., 2015, IND SUNSET MAKING N; Jakimow T, 2016, ETHOS, V44, P11, DOI 10.1111/etho.12110; Kelly John D., 2001, REPRESENTED COMMUNIT; Klein A.M., 1993, SUGARBALL AM GAME DO; Lende DH, 2012, ENCULTURED BRAIN: AN INTRODUCTION TO NEUROANTHROPOLOGY, P1; MasciaLees FE, 2011, BLACKW COMPANION ANT, P1, DOI 10.1002/9781444340488; Molina-Guzman I., 2004, COMMUNICATION REV, V7, P205, DOI [DOI 10.1080/10714420490448723, 10.1080/10714420490448723]; Oliver Melvin L., 2006, BLACK WEALTH WHITE W; Osborne AC, 2013, SPORT SOC, V16, P672, DOI 10.1080/17430437.2012.753523; PEACOCK JL, 1993, ETHOS, V21, P367, DOI 10.1525/eth.1993.21.4.02a00010; Rhodes J, 2011, J SPORT SOC ISSUES, V35, P350, DOI 10.1177/0193723511426291; Sugden J., 1996, BOXING SOC INT ANAL; VERBI Software, 2019, MAXQDA 2020; Walle AH, 2013, RETHINKING BUSINESS ANTHROPOLOGY: CULTURAL STRATEGIES IN MARKETING AND MANAGEMENT, P1; Woodward K., 2007, BOXING MASCULINITY I; Yelvington KA, 2001, ANNU REV ANTHROPOL, V30, P227, DOI 10.1146/annurev.anthro.30.1.227	34	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-7235	1552-7638		J SPORT SOC ISSUES	J. Sport Soc. Issues											01937235211062627	10.1177/01937235211062627		DEC 2021	20	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	XL0NE	WOS:000727849600001					2022-02-06	
J	Hong, L; Chen, WD; He, L; Tan, H; Peng, DY; Zhao, GD; Shi, XQ; Wang, L; Liu, MM; Jiang, HH				Hong, Lu; Chen, Weidong; He, Ling; Tan, Hui; Peng, Daiyin; Zhao, Guodong; Shi, Xiaoqian; Wang, Lei; Liu, Mingming; Jiang, Huihui			Effect of Naoluoxintong on the NogoA/RhoA/ROCK pathway by down-regulating DNA methylation in MCAO rats	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Naoluoxintong (NLXT); Ischemic stroke; DNA methylation; NogoA/RhoA/ROCK pathway	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; THERAPEUTIC TARGET; SIGNALING PATHWAY; NOGO-A; STROKE; ISCHEMIA; ROCK; EXPRESSION	Ethnopharmacological relevance: Naoluoxintong (NLXT) is a traditional Chinese Medicine (TCM) prescription that is clinically used in the treatment of ischemic stroke (IS). However, its therapeutic mechanism remains unclear. Aim of the study: To obtain the mechanism of NLXT by observing the protective effects of NLXT on the NogoA/RhoA/Rock pathway in a rat model of IS by regulating DNA methylation. Materials and methods: Rats were divided into five groups using a random number table: normal group, model group, NLXT group, blocker group I (NLXT + SGI-1027) and blocker group II (NLXT + Y27632). The right middle cerebral artery occlusion-reperfusion (MCAO/R) rat model was made, and the regional cerebral blood flow (rCBF) of each group was detected using laser Doppler. The methylation levels of CpG sites of neurite outgrowth inhibitor protein-A (Nogo-A), Nogo receptor (NgR), ras homolog gene family member A (RhoA) and rho-associated coiled-coil protein kinase 2 (ROCK2) genes in rat brain tissue were detected using the bisulfite method. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect NogoA, RhoA, NgR1, NgR2 and ROCK2 mRNA expression in rat brain tissue. NogoA, RhoA, NgR1, NgR2 and ROCK2 proteins were detected using immunoblotting in rat brain tissue. Results: After the modeling of middle cerebral artery occlusion (MCAO), neurological deficit test was made to ensure the success of the modeling. At each time point after surgery, the rCBF of the other groups decreased compared with the normal group (P < 0.01 or P < 0.05). Meanwhile, the rCBF increased in blocker group I as well as blocker group II after 3 days (P < 0.05). There were differences in the DNA methylation sites of NogoA, RhoA, NgR and ROCK2 genes between the model group and the NLXT group (P < 0.05). Compared with the normal group, NogoA, NgR1, NgR2, RhoA and ROCK2 gene expression in the model group increased observably (P < 0.01). In comparison with the model group, NogoA and NgR1 gene expression in the blocker group II was prominently observed on the 1st day. NogoA, NgR1, NgR2, RhoA and ROCK2 gene expression remarkably reduced (P < 0.01) on the 3rd and 7th days. Compared with the normal group, NogoA, RhoA, NgR1, NgR2 and ROCK2 protein expression in the model group increased observably (P < 0.01). In comparison with the model group, NogoA, RhoA, NgR1, NgR2 and ROCK2 protein expression in the other groups declined prominently (P < 0.01). Conclusion: NLXT can reduce the DNA methylation level of NogoA pathway after IS, thus inhibit the expression of NogoA/RhoA/ROCK pathway from producing anti-cerebral ischemia pharmacological effect.	[Hong, Lu; Chen, Weidong; Peng, Daiyin; Zhao, Guodong; Wang, Lei; Liu, Mingming; Jiang, Huihui] Anhui Univ Chinese Med, Sch Pharm, Hefei 230012, Anhui, Peoples R China; [He, Ling; Tan, Hui] Anhui Univ Chinese Med, Key Lab Xinan Med, Minist Educ, Hefei 230012, Anhui, Peoples R China; [Chen, Weidong; Peng, Daiyin; Wang, Lei] Anhui Prov Key Lab Chinese Med Formula, Hefei 230012, Anhui, Peoples R China; [He, Ling; Tan, Hui] Anhui Univ Chinese Med, Sch Tradit Chinese Med, Hefei 230012, Anhui, Peoples R China; [Shi, Xiaoqian] Huaibei Peoples Hosp, Dept Pharm, Huaibei 235000, Anhui, Peoples R China		He, L (corresponding author), Anhui Univ Chinese Med, Sch Tradit Chinese Med, Minist Educ, Key Lab Xinan Med, Meishan Ave 103, Hefei 230012, Anhui, Peoples R China.	helingtc@126.com		He, Ling/0000-0002-6171-1231	Key Programs of Natural Science Research in Colleges of Anhui Province [KJ2019A0452]	This work was supported by the Key Programs of Natural Science Research in Colleges of Anhui Province (KJ2019A0452).	Al-Mahdawi S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00397; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Chang LP, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105071; Chen C., 2018, CLIN J TRADIT CHIN M, V30, P501, DOI [10.16448/j. cjtcm.2018.0152, 03, DOI 10.16448/J.CJTCM.2018.0152,03]; Chen ZZ, 2019, J ETHNOPHARMACOL, V228, P70, DOI 10.1016/j.jep.2018.09.017; Dai N., 2018, CLIN RES PRACT, V3, P128, DOI [10.19347/j.cnki.2096-1413.201832057, DOI 10.19347/J.CNKI.2096-1413.201832057]; Datta J, 2009, CANCER RES, V69, P4277, DOI 10.1158/0008-5472.CAN-08-3669; Deng H., 2017, CHIN FOREIGN MED RES, V15, P133, DOI [10.14033/j.cnki.cfmr.2017.7.072, DOI 10.14033/J.CNKI.CFMR.2017.7.072]; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Forgione N, 2014, WORLD NEUROSURG, V82, pE535, DOI 10.1016/j.wneu.2013.01.009; Galindo LT, 2018, MOL NEUROBIOL, V55, P3185, DOI 10.1007/s12035-017-0565-8; Halder R, 2016, NAT NEUROSCI, V19, P102, DOI 10.1038/nn.4194; Han Y., 2017, ACTA CHIN MED, V32, P2399, DOI [10.16368/j.issn.1674-8999.2017.12.625, DOI 10.16368/J.ISSN.1674-8999.2017.12.625]; Hartley I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077859; He L, 2019, J PHARMACEUT BIOMED, V169, P60, DOI 10.1016/j.jpba.2018.12.046; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hu XL, 2012, PROTEIN CELL, V3, P278, DOI 10.1007/s13238-012-2916-6; Hu YD, 2015, GENETICS, V201, P779, DOI 10.1534/genetics.115.177204; Huat TJ, 2015, INT J MOL SCI, V16, P9693, DOI 10.3390/ijms16059693; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Jiang Hai-shan, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1156; Jiang S, 2018, THERANOSTICS, V8, P4535, DOI 10.7150/thno.25674; Kan QC, 2017, MOL NEUROBIOL, V54, P8404, DOI 10.1007/s12035-016-0333-1; Kumar P, 2013, CNS NEUROL DISORD-DR, V12, P200; Lee MH, 2019, J STROKE, V21, P228, DOI 10.5853/jos.2019.00437; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo Y, 2019, AM J CHINESE MED, V47, P1223, DOI 10.1142/S0192415X19500629; Ma S., 2015, CLIN J TRADIT CHIN M, V27, P1421, DOI [10.16448/j. cjtcm.2015.0531, DOI 10.16448/J.CJTCM.2015.0531]; Mulherkar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11113-3; Nakazaki M, 2017, J NEUROSURG, V127, P917, DOI 10.3171/2016.8.JNS16240; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; O'Doherty AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0060-2; Park SY, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0383-6; Peng XM, 2010, J BIOL CHEM, V285, P2783, DOI 10.1074/jbc.M109.046425; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Sladojevic N, 2017, EXPERT REV NEUROTHER, V17, P1167, DOI 10.1080/14737175.2017.1395700; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Tan Hui, 2020, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V36, P712; [谭辉 Tan Hui], 2016, [中医杂志, Journal of Traditional Chinese Medicine], V57, P1231; Tao HK, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/2186301; Wang CH, 2013, BIOMATERIALS, V34, P3223, DOI 10.1016/j.biomaterials.2012.12.034; Wang KY, 2014, EPIGENOMICS-UK, V6, P353, DOI [10.2217/EPI.14.21, 10.2217/epi.14.21]; Wu SP, 2020, ANN PALLIAT MED, V9, P2913, DOI 10.21037/apm-20-387; Xu XG, 2015, ONCOTARGET, V6, P13925, DOI 10.18632/oncotarget.4215; Yang W., 2013, CLIN J TRADIT CHIN M, V25, P986, DOI [10.16448/j.cjtcm.2013.11.007, DOI 10.16448/J.CJTCM.2013.11.007]; Ye XH, 2010, BRAIN RES, V1323, P174, DOI 10.1016/j.brainres.2010.01.079; Yu ZH, 2018, BRAIN RES, V1685, P9, DOI 10.1016/j.brainres.2018.01.036; Zeng MY, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.566124	55	0	0	9	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	DEC 5	2021	281								114559	10.1016/j.jep.2021.114559			12	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	WD2UU	WOS:000704803200006	34461189				2022-02-06	
J	Li, YT; Zhou, P; Hu, T; Ren, J; Xu, YP; Qiu, Y; Lu, CZ; Li, YH				Li, Yitian; Zhou, Pan; Hu, Ting; Ren, Jie; Xu, Yaping; Qiu, Yan; Lu, Canzhong; Li, Yuhang			NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI)	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Traumatic brain injury (TBI); N-Acylethanolamine acid amidase (NAAA); Palmitoylethanolamide (PEA); Blood -brain barrier (BBB); Peroxisome proliferator activated receptor alpha (PPAR alpha)	ACYLETHANOLAMINE ACID AMIDASE; PALMITOYLETHANOLAMIDE; POTENT; DERIVATIVES; DESIGN; STROKE; MODEL	Traumatic brain injury (TBI) is a leading cause of death worldwide, for which there is currently no comprehensive treatment available. Preventing blood-brain barrier (BBB) disruption is crucial for TBI treatment. Nacylethanolamine acid amidase (NAAA)-regulated palmitoylethanolamide (PEA) signaling play an important role in the control of inflammation. However, the role of NAAA in BBB dysfunction following TBI remains unclear. In the present study, we found that TBI induces the increase of PEA levels in the injured cortex, which prevent the disruption of BBB after TBI. TBI also induces the infiltration of NAAA-contained neutrophils, increasing the contribution of NAAA to the PEA degradation. Neutrophil-derived NAAA weakens PEA/PPAR alpha-mediated BBB protective effects after TBI, facilitates the accumulation of immune cells, leading to secondary expansion of tissue injury. Inactivation of NAAA increased PEA levels in injured site, prevents early BBB damage and improves secondary injury, thereby eliciting long-term functional improvements after TBI. This study identified a new role of NAAA in TBI, suggesting that NAAA is a new important target for BBB dysfunction related CNS diseases.	[Li, Yitian; Zhou, Pan; Hu, Ting; Lu, Canzhong; Li, Yuhang] Chinese Acad Sci, Fujian Inst Res Struct Matter, CAS Key Lab Design & Assembly Funct Nanostruct, Fujian, Peoples R China; [Li, Yitian; Zhou, Pan; Hu, Ting; Lu, Canzhong; Li, Yuhang] Chinese Acad Sci, Fujian Prov Key Lab Nanomat, Fujian, Peoples R China; [Hu, Ting; Lu, Canzhong; Li, Yuhang] Chinese Acad Sci, Xiamen Inst Rare Earth Mat, Haixi Inst, Fujian 361005, Peoples R China; [Li, Yitian; Zhou, Pan; Ren, Jie; Qiu, Yan] Xiamen Univ, Med Coll, Xiamen 361102, Fujian, Peoples R China; [Ren, Jie; Qiu, Yan] Xiamen Univ, Eye Inst, Xiamen 361102, Fujian, Peoples R China; [Xu, Yaping; Li, Yuhang] Fujian Prov Univ, Xiamen Med Coll, Key Lab Funct & Clin Translat Med, Fujian, Peoples R China; [Li, Yitian] Sichuan Mental Hlth Ctr, Hosp Mianyang 3, Dept Clin Pharm, Mianyang 621000, Sichuan, Peoples R China; [Zhou, Pan] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250012, Peoples R China		Li, YH (corresponding author), Chinese Acad Sci, Xiamen Inst Rare Earth Mat, Haixi Inst, Fujian 361005, Peoples R China.	yuhangli@fjirsm.ac.cn			Strategic Priority Research Program of the Chinese Academy of SciencesChinese Academy of Sciences [XDB20000000]; Key Program of Frontier Science, CAS [QYZDJ-SSW-SLH033]; Xiamen Science and Technology Program Project [3502Z20203085]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81602974]; Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2018J05145]; Key laboratory of functional and clinical translational medicine, Fujian province university [XMMC-FCTM201904]	The authors wish to express their sincere appreciation for the Stra-tegic Priority Research Program of the Chinese Academy of Sciences (XDB20000000 to CL) , the Key Program of Frontier Science, CAS (QYZDJ-SSW-SLH033 to CL) , the Xiamen Science and Technology Pro-gram Project (3502Z20203085 to CL) , the National Natural Science Foundation of China (81602974 to YL) , the Natural Science Foundation of Fujian Province (2018J05145 to YL) , Key laboratory of functional and clinical translational medicine, Fujian province university (XMMC-FCTM201904 to YL) .	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Ahmad A, 2012, BRAIN RES, V1477, P45, DOI 10.1016/j.brainres.2012.08.006; Alhouayek M, 2017, BBA-MOL CELL BIOL L, V1862, P474, DOI 10.1016/j.bbalip.2017.01.001; Berger C, 2004, J NEUROCHEM, V88, P1159, DOI 10.1046/j.1471-4159.2003.02244.x; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bonezzi FT, 2016, J PHARMACOL EXP THER, V356, P656, DOI 10.1124/jpet.115.230516; Bottemanne P, 2018, DRUG DISCOV TODAY, V23, P1520, DOI 10.1016/j.drudis.2018.03.007; Burek M, 2019, TRANSL STROKE RES, V10, P672, DOI 10.1007/s12975-018-0683-2; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Di Paola R, 2012, SHOCK, V38, P356, DOI 10.1097/SHK.0b013e318267bbb9; Edwards P, 2005, LANCET, V365, P1957; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Hind WH, 2015, BRIT J PHARMACOL, V172, P3015, DOI 10.1111/bph.13106; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033537; Li YH, 2018, PHARMACOL RES, V132, P7, DOI 10.1016/j.phrs.2018.03.011; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Migliore M, 2016, ANGEW CHEM INT EDIT, V55, P11193, DOI 10.1002/anie.201603746; Pontis S, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105064; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Qiu Y, 2017, RSC ADV, V7, P22699, DOI 10.1039/c7ra02237a; Ren J, 2017, RSC ADV, V7, P12455, DOI 10.1039/c6ra28734d; Ribeiro A, 2015, ACS CHEM BIOL, V10, P1838, DOI 10.1021/acschembio.5b00114; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Tsuboi K, 2007, BBA-MOL CELL BIOL L, V1771, P623, DOI 10.1016/j.bbalip.2007.03.005; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu KN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00818; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13565; Zhou P, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104264	40	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	DEC 5	2021	912								174561	10.1016/j.ejphar.2021.174561			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	XQ7OJ	WOS:000731733600010	34655598				2022-02-06	
J	Yang, Y; Sun, JC; Xiang, Z				Yang, Yun; Sun, Jiachen; Xiang, Zhou			The Short- and Mid-term Follow-Up of Single-Column Fixation in Transverse and Posterior Wall Acetabular Fractures	ORTHOPAEDIC SURGERY			English	Article						Acetabulum; Internal fixation; Kocher-Langenbeck approach; Single column; Transverse and posterior wall fracture	OPERATIVE TREATMENT; DISPLACED FRACTURES; ANTERIOR	Objective To evaluate the radiological and clinical outcomes of the surgical treatment for transverse and posterior wall fractures using single-column posterior fixation. Methods From January 2009 to January 2018, a total of 24 patients with transverse and posterior wall acetabular fractures in our center were included in this retrospective study, including 17 males and seven females with a mean age of 47 years and a minimum follow-up of 1 year. All cases were closed fractures. All fractures were fixed with single-column fixation via the Kocher-Langenbeck approach. Primary outcome measures, including quality of reduction and clinical outcomes, were recorded by an independent observer, who also noted secondary outcome measures, including time to surgery, surgical time, intraoperative blood loss, and postoperative complications. Results Twenty-four patients (range, 26-74 years) included 17 males and seven females. There were 14 cases on the left side and 10 cases on the right side. The mean time from injury to surgery was 7.1 days. Mean intraoperative blood loss and surgical time were 405.4 mL and 135.8 min, respectively. The mean follow-up time was 29.5 months (range 12-96 months). All the acetabular fractures united within 5 months after surgery. The quality of reduction was graded as anatomical in 17 cases (70.8%), imperfect in three cases (12.5%), and poor in four cases (16.7%). According to grading system of Merle d' Aubigne and Postel, clinical outcomes at the final follow-up were excellent in 10 cases (41.7%), good in six cases (25.0%), fair in five cases (20.5%), and poor in three cases (12.5%). The excellent and good rate was 66.7%. There was a significant relation between the quality of reduction and clinical outcomes (P < 0.05). At follow-up, there were one case of sciatic nerve injury, one case of wound infection, two cases of deep vein thrombosis, two cases of avascular necrosis, three cases of heterotopic ossification, and five cases of postoperative traumatic arthritis. Three of these patients underwent reoperation, including one with heterotopic ossification affecting hip movement and two with femoral head necrosis. Conclusions Our study shows that single-column posterior fixation of transverse and posterior wall acetabular fracture through the Kocher-Langenbeck approach can obtain satisfactory radiological and clinical outcomes if there is adequate indirect reduction of the anterior column.	[Yang, Yun; Sun, Jiachen; Xiang, Zhou] Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu, Sichuan, Peoples R China		Xiang, Z (corresponding author), Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu, Sichuan, Peoples R China.	xiangzhou15@hotmail.com		Sun, Jiachen/0000-0002-5478-6198			Beaty, 2007, CAMPBELLS OPERATIVE, P3322; Chang JK, 2001, CLIN ORTHOP RELAT R, P433; Cutrera NJ, 2015, J AM ACAD ORTHOP SUR, V23, P592, DOI 10.5435/JAAOS-D-14-00307; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Fahmy M, 2018, INJURY, V49, P1291, DOI 10.1016/j.injury.2018.05.024; Gansslen A, 2016, ACTA CHIR ORTHOP TR, V83, P141; Gansslen A, 2013, ACTA CHIR ORTHOP TR, V80, P27; Giannoudis PV, 2005, J BONE JOINT SURG BR, V87B, P2, DOI 10.1302/0301-620X.87B1.15605; Giordano V, 2007, EUR J TRAUMA EMERG S, V33, P520, DOI 10.1007/s00068-007-6092-y; Giordano V, 2009, INT J MED SCI, V6, P192; Guerado E, 2010, HIP INT, V20, pS2, DOI 10.5301/HIP.2010.4980; Harris AM, 2008, J ORTHOP TRAUMA, V22, P494, DOI 10.1097/BOT.0b013e3181830d2a; Jakob M, 2006, J TRAUMA, V60, P1364, DOI 10.1097/01.ta.0000208139.97474.f7; Kaempffe F A, 1991, J Orthop Trauma, V5, P439, DOI 10.1097/00005131-199112000-00009; LETOURNEL E, 1980, CLIN ORTHOP RELAT R, P81; MATTA JM, 1994, CLIN ORTHOP RELAT R, P10; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; MAYO KA, 1987, ORTHOP CLIN N AM, V18, P43; Middlebrooks ES, 1997, J ORTHOP TRAUMA, V11, P327, DOI 10.1097/00005131-199707000-00004; Shazar N, 1998, CLIN ORTHOP RELAT R, P215	20	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-7853	1757-7861		ORTHOP SURG	Orthop. Surg.	JAN	2022	14	1					65	72		10.1111/os.12968		DEC 2021	8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	YF3XG	WOS:000726521800001	34866352	Green Published, gold			2022-02-06	
J	van Erp, IAM; van Essen, TA; Fluiter, K; van Zwet, E; van Vliet, P; Baas, F; Haitsma, I; Verbaan, D; Coert, B; de Ruiter, GCW; Moojen, WA; van der Jagt, M; Peul, WC				van Erp, Inge A. M.; van Essen, Thomas A.; Fluiter, Kees; van Zwet, Erik; van Vliet, Peter; Baas, Frank; Haitsma, Iain; Verbaan, Dagmar; Coert, Bert; de Ruiter, Godard C. W.; Moojen, Wouter A.; van der Jagt, Mathieu; Peul, Wilco C.			Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial	TRIALS			English	Article						Traumatic brain injury; C1-inhibitor; Neuroinflammation; Randomized controlled trials	MEMBRANE ATTACK COMPLEX; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; C1-ESTERASE INHIBITOR; SYSTEM; RELIABILITY; GUIDELINES; RECOVERY; DAMAGE; C3	Background: Traumatic brain injury (TBI) is a major cause of death and disability across all ages. After the primary impact, the pathophysiologic process of secondary brain injury consists of a neuroinflammation response that critically leads to irreversible brain damage in the first days after the trauma. A key catalyst in this inflammatory process is the complement system. Inhibiting the complement system could therefore be a therapeutic target in TBI. Objective: To study the safety and efficacy of C1-inhibitor (C1-INH) compared to placebo in patients with TBI. By temporarily blocking the complement system, we hypothesize a decrease in the posttraumatic neuroinflammatory response resulting in a less unfavorable clinical outcome for TBI patients. Methods: CIAO@TBI is a multicenter, randomized, blinded, phase II placebo-controlled trial. Adult TBI patients with GCS < 13 requiring intracranial pressure (ICP) monitoring will be randomized, using block randomization, within 12 h after trauma to one dose 6000 IU C1-INH or placebo. A total of 106 patients will be included, and follow-up will occur up to 12 months. The primary endpoints are (1) Therapy Intensity Level (TIL) Scale, (2) Glasgow Outcome Scale-Extended (GOSE) at 6 months, and (3) complication rate during hospitalization. Outcomes will be determined by a trial nurse blinded for the treatment allocation. Analyses will be conducted in an intention-to-treat analysis. Discussion: We expect that C1-INH administration will be safe and potentially effective to improve clinical outcomes by reducing neuroinflammation in TBI patients.	[van Erp, Inge A. M.; van Essen, Thomas A.; de Ruiter, Godard C. W.; Moojen, Wouter A.; Peul, Wilco C.] Leiden Univ, Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, Med Ctr, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands; [van Erp, Inge A. M.; van Essen, Thomas A.; de Ruiter, Godard C. W.; Moojen, Wouter A.; Peul, Wilco C.] Haga Teaching Hosp, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands; [Fluiter, Kees; Baas, Frank] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [van Zwet, Erik] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [van Vliet, Peter] Haaglanden Med Ctr, Dept Intens Care, The Hague, Netherlands; [Haitsma, Iain] Erasmus MC, Dept Neurosurg, Univ Med Ctr, Rotterdam, Netherlands; [Verbaan, Dagmar; Coert, Bert] Univ Amsterdam, Neurosurg Ctr Amsterdam, Med Ctr, Amsterdam, Netherlands; [van der Jagt, Mathieu] Erasmus MC, Dept Intens Care Adults, Univ Med Ctr, Rotterdam, Netherlands		van Erp, IAM (corresponding author), Leiden Univ, Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, Med Ctr, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands.; van Erp, IAM (corresponding author), Haga Teaching Hosp, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands.	i.a.m.van_erp@umc.nl	Fluiter, Kees/H-2828-2015; van der Jagt, Mathieu/G-1905-2017	Fluiter, Kees/0000-0003-0898-7260; van der Jagt, Mathieu/0000-0003-2566-8325	Hersenstichting Nederland (Dutch Brain Foundation) [DR-2019-00292]; Takeda Development Center Americas, Inc.Takeda Pharmaceutical Company Ltd [IIRNLD-002790]	This project is financially funded by the Hersenstichting Nederland (Dutch Brain Foundation, grant number DR-2019-00292). Takeda Development Center Americas, Inc. funds by providing the trial intervention (Request ID: IIRNLD-002790). The funding bodies have no role in the design of the study; collection, management, analysis, and interpretation of the data; writing of the report; and the decision to submit the report for publication.	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; [Anonymous], 2011, CINRYZE EPAR PUBLIC; BECKER P, 1987, ANAESTHESIST, V36, P301; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bouwmans C, 2015, VALUE HEALTH, V18, P753, DOI 10.1016/j.jval.2015.05.009; Caliezi C, 2002, CRIT CARE MED, V30, P1722, DOI 10.1097/00003246-200208000-00008; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; de Zwaan C, 2002, EUR HEART J, V23, P1670, DOI 10.1053/euhj.2002.3191; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Garrett MC, 2009, BRAIN RES, V1298, P171, DOI 10.1016/j.brainres.2009.04.047; Gompels MM, 2011, EXPERT REV CLIN IMMU, V7, P569, DOI [10.1586/eci.11.50, 10.1586/ECI.11.50]; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Heeres M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-223; Igonin AA, 2012, CRIT CARE MED, V40, P770, DOI 10.1097/CCM.0b013e318236edb8; JENNETT B, 1975, LANCET, V1, P480; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kompanje EJO, 2007, SCI ENG ETHICS, V13, P371, DOI 10.1007/s11948-007-9027-4; Kompanje EJO, 2020, LANCET NEUROL, V19, P1033, DOI 10.1016/S1474-4422(20)30276-3; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Majdan M, 2014, MINERVA ANESTESIOL, V80, P1261; Martinez-Saguer I, 2014, TRANSFUSION, V54, P1552, DOI 10.1111/trf.12501; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Parry J, 2021, EUR J TRAUMA EMERG S, V47, P1491, DOI 10.1007/s00068-020-01407-z; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Takabayashi T, 1996, J IMMUNOL, V156, P3455; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Timmers M., 2019, NED TIJDSCHR GENEES, V163, pD3857; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; WHO, 2016, VIOL INJ PREV DIS VI; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wright DW, 2008, ANN EMERG MED, V51, P355, DOI 10.1016/j.annemergmed.2007.08.021; Yadav K, 2017, JAMA-J AM MED ASSOC, V318, P1385, DOI 10.1001/jama.2017.13276; Yang SX, 2006, J CEREBR BLOOD F MET, V26, P1490, DOI 10.1038/sj.jcbfm.9600305; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	60	0	0	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	DEC 4	2021	22	1							874	10.1186/s13063-021-05833-1			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	XI7IL	WOS:000726280200011	34863258	gold, Green Published			2022-02-06	
J	Balkan, S; Spigel, P; Quartano, J; Foster, H; DeMark, LA; Beaulieu, CL				Balkan, Staci; Spigel, Pamela; Quartano, Jennifer; Foster, Hannah; DeMark, Louis A.; Beaulieu, Cynthia L.			The use of assisted technologies in early aggressive mobilization with an individual in a minimally conscious state: a case report	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						Traumatic brain injury; disorders of consciousness; neurorehabilitation; minimally conscious state; assistive technology; mobilization; physical therapy	TRAUMATIC BRAIN-INJURY; TILT-TABLE; DISORDERS; OUTCOMES; TRENDS; SCALE	Introduction Early neurorehabilitation and passive, upright mobilization strategies have been shown to be beneficial for individuals with disorders of consciousness (DOC). However, literature is limited in illustrating the use of an early, aggressive program with an added focus on dynamic and active upright mobilization. The purpose of this case report is to describe a two-week aggressive, upright standing and walking program with an individual with traumatic brain injury in an acute inpatient rehabilitation setting. The case investigates the association between aggressive mobilization with changes in level of consciousness and daily cognitive, motor and communicative behaviours. Case description A 30-year-old male classified in DOC as minimally conscious state (MCS) participated in an early upright mobilization program. The two-week intervention consisted of aggressive static/passive and dynamic/active upright mobilization activities, involving a multidisciplinary rehabilitation team. Expressive communication, motor responses and current level of consciousness were monitored and assessed twice a day. Additionally, the patient's activation and arousal were subjectively monitored during daily therapy sessions. Results Following the dynamic/active mobilization activities, the patient demonstrated improved expressive communication, motor scores and increased activation and arousal during the mobilizations. After the two-week intervention, he emerged from DOC. Conclusion This case report illustrates intense, more active/dynamic upright mobilization with the use of assisted technologies provides promise as an effective intervention for improving communication, motor responses, arousal and level of consciousness in a patient in MCS. Initiating upright, active activity sooner in the recovery process, may lead to improved outcomes and quicker emergence.	[Balkan, Staci; DeMark, Louis A.] Brooks Rehabil Hosp, Dept Phys Therapy, Jacksonville, FL USA; [Spigel, Pamela; Quartano, Jennifer; Foster, Hannah] Brooks Rehabil Hosp, Brooks Inst Higher Learning, Jacksonville, FL USA; [Beaulieu, Cynthia L.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH USA; [Spigel, Pamela] Equilibrium Inc, Nazareth, PA USA		Balkan, S (corresponding author), 3599 Univ Blvd S,4th Floor SCI Unit, Jacksonville, FL 32216 USA.	staci.balkan@brooksrehab.org					Alam ZA., 2016, ISOR J NURS HLTH SCI, V5, P24; Ansell BJ., 2014, W NEUROSENSORY STIMU, DOI [10.1037/t28459-000, DOI 10.1037/T28459-000]; Craven CTD, 2013, J REHABIL RES DEV, V50, P367, DOI 10.1682/JRRD.2012.02.0027; Eifert B, 2013, ARCH PHYS MED REHAB, V94, P1924, DOI 10.1016/j.apmr.2013.03.030; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Kaewsriwong S, 2015, PAC RIM INT J NURS R, V19, P45; Khalilabadi AJ., 2016, PHARM LETT, V8, P140; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Lnu M., 2012, INT J HEAD NECK SURG, V3, P137; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Riberholt CG, 2013, DAN MED J, V60; Tafreshi AS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00327; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Xie QY, 2017, EXP THER MED, V14, P1277, DOI 10.3892/etm.2017.4639	27	0	0	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2021.2002443		DEC 2021	7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	XM3MO	WOS:000728736000001	34875188				2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Ataxia due to injury of the cortico-ponto-cerebellar tract in patients with mild traumatic brain injury	MEDICINE			English	Article						ataxia; cortico-ponto-cerebellar tract; diffusion tensor imaging; diffusion tensor tractography; mild traumatic brain injury	AXONAL INJURY; PATHOPHYSIOLOGY; PATHWAY; SCALE	Introduction: The cortico-ponto-cerebellar tract (CPCT) is involved in coordination of movement; injury of the CPCT can therefore be accompanied by ataxia. In this study, using diffusion tensor tractography (DTT), we investigated injury of the CPCT in patients with mild traumatic brain injury (TBI). Methods: We recruited 45 consecutive patients with ataxia following mild TBI and 20 normal control subjects. The score of assessment and rating of ataxia (SARA) was used to evaluate of ataxia. The patients were classified into 2 groups based on the SARA; patient group A had with post-traumatic ataxia and patient group B had without post-traumatic ataxia. The fractional anisotropy (FA) value and fiber number (FN) of the CPCT was measured. Results: Significant differences were observed in the FA and FN values of the CPCT between patient group A and the control group and between patient groups A and B (P < .05). In addition, a significant difference was observed in the FA value only of the CPCT between patient group B and the control group (P < .05). However, no significant difference was observed in the FN value of the CPCT between patient group B and the control group (P > .05). Conclusion: By using DTT, injury of the CPCT was demonstrated in patients who showed ataxia following mild TBI. These results suggest that DTT would be useful for evaluation of the CPCT in patients with ataxia after mTBI because mTBI usually does not show any abnormalities on conventional brain MRI.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Lee, Han Do] Ulsan Coll, Dept Phys Therapy, Coll Rehabil Sci, Bongsuro 101, Ulsan, South Korea		Lee, HD (corresponding author), Ulsan Coll, Dept Phys Therapy, Coll Rehabil Sci, Bongsuro 101, Ulsan, South Korea.	lhd890221@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Afifi AK., 2005, FUNCTIONAL NEUROANAT, V2nd edn, P200; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Hong JH, 2011, NEURAL REGEN RES, V6, P76, DOI 10.3969/j.issn.1673-5374.2011.01.013; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008749; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005590; Jang SH, 2010, NEURAL REGEN RES, V5, P1829, DOI 10.3969/j.issn.1673-5374.2010.23.011; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kitamura K, 2008, NEURORADIOLOGY, V50, P285, DOI 10.1007/s00234-007-0351-9; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Marsden J, 2011, CLIN REHABIL, V25, P195, DOI 10.1177/0269215510382495; Mendoza J., 2007, CLIN NEUROANATOMY NE; Min Y, 2012, ANN REHABIL MED-ARM, V36, P887, DOI 10.5535/arm.2012.36.6.887; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sartor-Glittenberg C, 2014, PHYSIOTHER THEOR PR, V30, P138, DOI 10.3109/09593985.2013.819952; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC 3	2021	100	48							e28024	10.1097/MD.0000000000028024			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XH9CB	WOS:000725722600021	35049215	gold			2022-02-06	
J	Peterson, AB; Thomas, KE				Peterson, Alexis B.; Thomas, Karen E.			Incidence of Nonfatal Traumatic Brain Injury-Related Hospitalizations - United States, 2018	MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT			English	Article									[Peterson, Alexis B.; Thomas, Karen E.] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA		Peterson, AB (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	APeterson4@cdc.gov					An KY, 2018, BRAIN INJURY, V32, P832, DOI 10.1080/02699052.2018.1463104; CDC, 2019, PREV FALLS OLD PAT A; CDC, 2021, SURV REP TRAUM BRAIN; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Jin Jill, 2018, JAMA, V319, P1734, DOI 10.1001/jama.2018.4396; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Tavris DR, 2001, ACCIDENT ANAL PREV, V33, P167, DOI 10.1016/S0001-4575(00)00027-0; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561	10	0	0	0	0	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	0149-2195	1545-861X		MMWR-MORBID MORTAL W	MMWR-Morb. Mortal. Wkly. Rep.	DEC 3	2021	70	48					1664	1668					5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	XJ8FS	WOS:000727017100001	34855719	Green Published, gold			2022-02-06	
J	Smith, JL; Trofimova, A; Ahluwalia, V; Garrido, JJC; Hurtado, J; Frank, R; Hodge, A; Gore, RK; Allen, JW				Smith, Jeremy L.; Trofimova, Anna; Ahluwalia, Vishwadeep; Garrido, Jose J. Casado; Hurtado, Julia; Frank, Rachael; Hodge, April; Gore, Russell K.; Allen, Jason W.			The "vestibular neuromatrix": A proposed, expanded vestibular network from graph theory in post-concussive vestibular dysfunction	HUMAN BRAIN MAPPING			English	Article; Early Access						affect; graph theory; post-concussion vestibular dysfunction (PCVD); resting state; vestibular diseases	BECK DEPRESSION INVENTORY; SUPRAMARGINAL GYRUS; FUNCTIONAL CONNECTIVITY; CINGULATE VOLUMES; EYE-MOVEMENTS; BRAIN; ORGANIZATION; SYSTEM; CORTEX; FMRI	Convergent clinical and neuroimaging evidence suggests that higher vestibular function is subserved by a distributed network including visuospatial, cognitive-affective, proprioceptive, and integrative brain regions. Clinical vestibular syndromes may perturb this network, resulting in deficits across a variety of functional domains. Here, we leverage structural and functional neuroimaging to characterize this extended network in healthy control participants and patients with post-concussive vestibular dysfunction (PCVD). Then, 27 healthy control subjects (15 females) and 18 patients with subacute PCVD (12 female) were selected for participation. Eighty-two regions of interest (network nodes) were identified based on previous publications, group-wise differences in BOLD signal amplitude and connectivity, and multivariate pattern analysis on affective tests. Group-specific "core" networks, as well as a "consensus" network comprised of connections common to all participants, were then generated based on probabilistic tractography and functional connectivity between the 82 nodes and subjected to analyses of node centrality and community structure. Whereas the consensus network was comprised of affective, integrative, and vestibular nodes, PCVD participants exhibited diminished integration and centrality among vestibular and affective nodes and increased centrality of visual, supplementary motor, and frontal and cingulate eye field nodes. Clinical outcomes, derived from dynamic posturography, were associated with approximately 62% of all connections but best predicted by amygdalar, prefrontal, and cingulate connectivity. No group-wise differences in diffusion metrics or tractography were noted. These findings indicate that cognitive, affective, and proprioceptive substrates contribute to vestibular processing and performance and highlight the need to consider these domains during clinical diagnosis and treatment planning.	[Smith, Jeremy L.; Trofimova, Anna; Allen, Jason W.] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Ahluwalia, Vishwadeep] Georgia State Univ, Atlanta, GA 30303 USA; [Ahluwalia, Vishwadeep] Georgia Inst Technol, Ctr Adv Brain Imaging, Atlanta, GA 30332 USA; [Garrido, Jose J. Casado; Gore, Russell K.; Allen, Jason W.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Garrido, Jose J. Casado; Gore, Russell K.; Allen, Jason W.] Emory Univ, Atlanta, GA 30322 USA; [Hurtado, Julia; Frank, Rachael; Hodge, April; Gore, Russell K.] Shepherd Ctr, Atlanta, GA USA; [Allen, Jason W.] Emory Univ, Sch Med, Emory Univ Hosp, Dept Neurol, Atlanta, GA 30322 USA		Smith, JL (corresponding author), Emory Univ, Sch Med, Emory Univ Hosp, Dept Radiol & Imaging Sci, 1364 Clifton Rd NE,BG03, Atlanta, GA 30322 USA.	jeremy.lee.smith@emory.edu		Allen, Jason/0000-0002-5274-1105; Smith, Jeremy/0000-0003-0841-5297	Radiological Society of North America (RSNA) [RR1866]; Georgia State/Georgia Tech Center for Advanced Brain Imaging (CABI) Neural Engineering Center; Emory University Department of Radiology and Imaging Sciences	This work was supported by the Radiological Society of North America (RSNA) (Resident Research Grant RR1866) and by seed grants from the Georgia State/Georgia Tech Center for Advanced Brain Imaging (CABI) Neural Engineering Center and the Emory University Department of Radiology and Imaging Sciences.	Allen JW, 2021, AM J NEURORADIOL, V42, P930, DOI 10.3174/ajnr.A7007; Alsalman O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152309; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Beaty RE, 2017, BRAIN COGNITION, V111, P163, DOI 10.1016/j.bandc.2016.12.004; Beck A.T., 1997, BECK ANXIETY INVENTO; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Ben-Shabat E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00248; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Blum S, 2014, COGN NEUROSCI-UK, V5, P150, DOI 10.1080/17588928.2014.975680; Boccia M, 2016, BRAIN IMAGING BEHAV, V10, P226, DOI 10.1007/s11682-015-9387-3; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Brandt T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00047; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Buchanan CR, 2020, NEUROIMAGE, V211, DOI 10.1016/j.neuroimage.2019.116443; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Fox MD, 2005, NEUROIMAGE, V25, P771, DOI 10.1016/j.neuroimage.2004.12.025; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Grove CR, 2021, J VESTIBUL RES-EQUIL, V31, DOI 10.3233/VES-200040; Gudayol-Ferre E, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00582; Hahamy A, 2019, J NEUROSCI, V39, P9328, DOI 10.1523/JNEUROSCI.2599-18.2019; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hankin BL, 2015, J ABNORM PSYCHOL, V124, P54, DOI 10.1037/abn0000030; Hatton SN, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-45; Indovina I, 2020, NEUROIMAGE, V222, DOI 10.1016/j.neuroimage.2020.117247; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jamadar SD, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00749; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; Kellar D, 2018, NEUROIMAGE-CLIN, V18, P413, DOI 10.1016/j.nicl.2018.01.025; Kheradmand A, 2015, CEREB CORTEX, V25, P765, DOI 10.1093/cercor/bht267; Kirsch V, 2018, NEUROIMAGE, V178, P224, DOI 10.1016/j.neuroimage.2018.05.018; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lopez C, 2016, CURR OPIN NEUROL, V29, P74, DOI 10.1097/WCO.0000000000000286; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makin TR, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116943; Mast FW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00044; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; Mochcoyitch MD, 2014, J AFFECT DISORDERS, V167, P336, DOI 10.1016/j.jad.2014.06.041; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mohanty R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57915-w; Monsell EM, 1997, OTOLARYNG HEAD NECK, V117, P394, DOI 10.1016/S0194-5998(97)70132-3; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nashner L., 1993, HDB BALANCE FUNCTION, P308; Oane I, 2020, NEUROIMAGE, V220, DOI 10.1016/j.neuroimage.2020.117059; Passamonti L, 2018, J VESTIBUL RES-EQUIL, V28, P369, DOI 10.3233/VES-190653; Ponzo S, 2018, NEUROPSYCHOLOGIA, V117, P311, DOI 10.1016/j.neuropsychologia.2018.06.020; Poppenk J, 2010, J NEUROSCI, V30, P4707, DOI 10.1523/JNEUROSCI.5466-09.2010; Potok W, 2019, CORTEX, V111, P16, DOI 10.1016/j.cortex.2018.10.010; Preuss N, 2014, BRAIN STIMUL, V7, P133, DOI 10.1016/j.brs.2013.09.003; Raiser TM, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117362; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Riccelli R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00529; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Rosen BQ, 2021, ENEURO, V8, DOI 10.1523/ENEURO.0416-20.2020; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Rudebeck PH, 2014, P NATL ACAD SCI USA, V111, P5391, DOI 10.1073/pnas.1317695111; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Staab JP, 2014, CURR OPIN NEUROL, V27, P118, DOI 10.1097/WCO.0000000000000055; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Trofimova A, 2021, J NEUROIMAGING, V31, P277, DOI 10.1111/jon.12834; Ulusoy M, 1998, J COGN PSYCHOTHER, V12, P163; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Vernet M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00066; Wei F, 1999, J NEUROSCI, V19, P9346; Whitfield-Gabrieli S, 2016, MOL PSYCHIATR, V21, P680, DOI 10.1038/mp.2015.109; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zeharia N, 2019, J NEUROSCI, V39, P7882, DOI 10.1523/JNEUROSCI.0727-18.2019; Zeharia N, 2015, J NEUROSCI, V35, P2845, DOI 10.1523/JNEUROSCI.4246-14.2015; Zhu DJ, 2014, NEUROIMAGE, V102, P184, DOI 10.1016/j.neuroimage.2013.09.071; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	105	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.												10.1002/hbm.25737		DEC 2021	18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	XI7QC	WOS:000726300100001	34862683	gold			2022-02-06	
J	Vestlund, S; Tryggmo, S; Vedin, T; Larsson, PA; Edelhamre, M				Vestlund, Sebastian; Tryggmo, Sebastian; Vedin, Tomas; Larsson, Per-Anders; Edelhamre, Marcus			Comparison of the predictive value of two international guidelines for safe discharge of patients with mild traumatic brain injuries and associated intracranial pathology	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article; Early Access						Intracranial hemorrhage; Traumatic; Skull fractures; Brain injuries; Traumatic; Practice guideline	COMPUTED-TOMOGRAPHY; EXTERNAL VALIDATION; MODEL; CT	Purpose To determine and compare the sensitivity, specificity, and proportion of patients eligible for discharge by the Brain Injury Guidelines and the Mild TBI Risk Score in patients with mild traumatic brain injury and concomitant intracranial injury. Methods Retrospective review of the medical records of adult patients with traumatic intracranial injuries and an initial Glasgow Coma Scale score of 14-15, who sought care at Helsingborg Hospital between 2014/01/01 and 2019/12/31. Both guidelines were theoretically applied. The sensitivity, specificity, and percentage of the cohort that theoretically could have been discharged by either guideline were calculated. The outcome was defined as death, in-hospital intervention, admission to the intensive care unit, requiring emergency intubation due to intracranial injury, decreased consciousness, or seizure within 30 days of presentation. Results Of the 538 patients included, 8 (1.5%) and 10 (1.9%) were eligible for discharge according to the Brain Injury Guidelines and the Mild TBI Risk Score, respectively. Both guidelines had a sensitivity of 100%. The Brain Injury Guidelines had a specificity of 2.3% and the Mild TBI Risk Score had a specificity of 2.9%. Conclusion There was no difference between the two guidelines in sensitivity, specificity, or proportion of the cohort eligible for discharge. Specificity and proportion of cohort eligible for discharge were lower than each guideline's original study. At present, neither guideline can be recommended for implementation in the current or similar settings.	[Vestlund, Sebastian; Tryggmo, Sebastian; Vedin, Tomas; Edelhamre, Marcus] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden; [Larsson, Per-Anders] Skaraborg Hosp, Res & Dev Ctr, Skovde, Sweden		Vestlund, S (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden.	Sebastian.Vestlund@med.lu.se		Vestlund, Sebastian/0000-0002-6539-0455	Lund University; Gorthon Foundation, Helsingborg, Sweden	Open access funding provided by Lund University. This study was funded by grants from the Gorthon Foundation, Helsingborg, Sweden.	Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dolatabadi AA, 2013, TRAUMA MON, V18, P86, DOI 10.5812/traumamon.12023; Grieve FM, 2010, BRIT J RADIOL, V83, P17, DOI 10.1259/bjr/16360063; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Lee B, 2017, CURR PROBL DIAGN RAD, V46, P186, DOI 10.1067/j.cpradiol.2016.11.005; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Plumb AAO, 2009, CLIN RADIOL, V64, P386, DOI 10.1016/j.crad.2008.11.009; Root BK, 2020, JACEP OPEN, V1, P609, DOI 10.1002/emp2.12124; Schwartz LH, 2011, RADIOLOGY, V260, P174, DOI 10.1148/radiol.11101913; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stippler M, 2021, NEUROSURGERY, V88, P773, DOI 10.1093/neuros/nyaa504; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017	26	0	0	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.												10.1007/s00068-021-01842-6		DEC 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XH3UP	WOS:000725363900001	34859266	hybrid			2022-02-06	
J	Bertron, JL; Duvernay, MT; Mitchell, SG; Smith, ST; Maeng, JG; Blobaum, AL; Davis, DC; Meiler, J; Hamm, HE; Lindsley, CW				Bertron, Jeanette L.; Duvernay, Matthew T.; Mitchell, Sidnee G.; Smith, Shannon T.; Maeng, Jae G.; Blobaum, Anna L.; Davis, Dexter C.; Meiler, Jens; Hamm, Heidi E.; Lindsley, Craig W.			Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors	ACS CHEMICAL NEUROSCIENCE			English	Article						PAR4; protease-activated receptor; CNS penetrant; SAR; selectivity	ANTAGONISTS; EXPRESSION; UTILITY	The detailed pharmacology and therapeutic potential of the central PAR4 receptors are poorly understood due to a lack of potent, selective, and brain-penetrant tool compounds. Despite this, robust data with biochemical and genetic tools show the therapeutic potential of PAR4 antagonists in traumatic brain injury, Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders with a neuroinflammatory component. Thus, we performed a functional HTS campaign, identified a fundamentally new PAR4 competitive inhibitor chemotype, optimized this new series (increased potency >45-fold), discovered enantiospecific activity (though opposing preference for human versus mouse PAR4), and engendered high central nervous system penetration (rat K-p's of 0.52 to 4.2 and K-p,K-uu's of 0.52 to 1.2).	[Bertron, Jeanette L.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Bertron, Jeanette L.; Duvernay, Matthew T.; Blobaum, Anna L.; Davis, Dexter C.; Lindsley, Craig W.] Vanderbilt Univ, Warren Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Duvernay, Matthew T.; Mitchell, Sidnee G.; Maeng, Jae G.; Blobaum, Anna L.; Davis, Dexter C.; Hamm, Heidi E.; Lindsley, Craig W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Smith, Shannon T.] Vanderbilt Univ, Ctr Struct Biol, Chem & Phys Biol Program, Nashville, TN 37232 USA; [Meiler, Jens] Univ Leipzig, Inst Drug Discovery, D-04109 Saxony, Germany; [Lindsley, Craig W.] Vanderbilt Univ, Dept Biochem, Dept Chem, Nashville, TN 37232 USA		Lindsley, CW (corresponding author), Vanderbilt Univ, Warren Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA.; Hamm, HE; Lindsley, CW (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Lindsley, CW (corresponding author), Vanderbilt Univ, Dept Biochem, Dept Chem, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu; craig.lindsley@vanderbilt.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01AG068623, 1R01HL133923, 1R21AG073891]	We warmly thank the NIH for support of our programs (1R01AG068623, 1R01HL133923, and 1R21AG073891).	Bender AM, 2018, ACS CHEM NEUROSCI, V9, P1572, DOI 10.1021/acschemneuro.8b00126; Bridges TM, 2013, DRUG METAB DISPOS, V41, P1703, DOI 10.1124/dmd.113.052084; Chen HS, 2008, BIOORGAN MED CHEM, V16, P1262, DOI 10.1016/j.bmc.2007.10.070; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Duvernay M, 2013, MOL PHARMACOL, V83, P781, DOI 10.1124/mol.112.083477; Duvernay MT, 2017, MOL PHARMACOL, V91, P39, DOI 10.1124/mol.116.106666; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Lee FY, 2001, J MED CHEM, V44, P3746, DOI 10.1021/jm010001h; Lindahl TL, 2016, J THROMB HAEMOST, V14, P1639, DOI 10.1111/jth.13374; Luo JN, 2021, NEUROSCI BULL, V37, P242, DOI 10.1007/s12264-020-00601-8; Mao YY, 2010, J CEREBR BLOOD F MET, V30, P1044, DOI 10.1038/jcbfm.2009.283; Miller MM, 2019, J MED CHEM, V62, P7400, DOI 10.1021/acs.jmedchem.9b00186; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Suo ZM, 2003, J BIOL CHEM, V278, P31177, DOI 10.1074/jbc.M302137200; Temple KJ, 2016, BIOORG MED CHEM LETT, V26, P5481, DOI 10.1016/j.bmcl.2016.10.020; Temple KJ, 2016, J MED CHEM, V59, P7690, DOI 10.1021/acs.jmedchem.6b00928; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wen WD, 2014, BIOORG MED CHEM LETT, V24, P4708, DOI 10.1016/j.bmcl.2014.08.021; Wilson SJ, 2018, ARTERIOSCL THROM VAS, V38, P448, DOI 10.1161/ATVBAHA.117.310104; Wong PC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5294; Wu CC, 2002, THROMB HAEMOSTASIS, V87, P1026, DOI 10.1055/s-0037-1613128; Young SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065528	24	0	0	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	NOV 5	2021	12	24					4524	4534		10.1021/acschemneuro.1c00557		DEC 2021	11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	XR0HO	WOS:000731920400005	34855359				2022-02-06	
J	Bittencourt, M; Balart-Sanchez, SA; Maurits, NM; van der Naalt, J				Bittencourt, Mayra; Balart-Sanchez, Sebastian A.; Maurits, Natasha M.; van der Naalt, Joukje			Self-Reported Complaints as Prognostic Markers for Outcome After Mild Traumatic Brain Injury in Elderly: A Machine Learning Approach	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury (mTBI); older age; post-traumatic complaints; post-concussive symptoms; prognosis; recovery; machine learning	POST-CONCUSSION SYMPTOMS; SUPPORT VECTOR MACHINE; OLDER-ADULTS; DIVERGENT MANIFESTATIONS; CERVICAL-SPINE; HEAD-INJURY; PREDICTION; EPIDEMIOLOGY; IRRITABILITY; GUIDELINES	Self-reported complaints are common after mild traumatic brain injury (mTBI). Particularly in the elderly with mTBI, the pre-injury status might play a relevant role in the recovery process. In most mTBI studies, however, pre-injury complaints are neither analyzed nor are the elderly included. Here, we aimed to identify which individual pre- and post-injury complaints are potential prognostic markers for incomplete recovery (IR) in elderly patients who sustained an mTBI. Since patients report many complaints across several domains that are strongly related, we used an interpretable machine learning (ML) approach to robustly deal with correlated predictors and boost classification performance. Pre- and post-injury levels of 20 individual complaints, as self-reported in the acute phase, were analyzed. We used data from two independent studies separately: UPFRONT study was used for training and validation and ReCONNECT study for independent testing. Functional outcome was assessed with the Glasgow Outcome Scale Extended (GOSE). We dichotomized functional outcome into complete recovery (CR; GOSE = 8) and IR (GOSE <= 7). In total 148 elderly with mTBI (median age: 67 years, interquartile range [IQR]: 9 years; UPFRONT: N = 115; ReCONNECT: N = 33) were included in this study. IR was observed in 74 (50%) patients. The classification model (IR vs. CR) achieved a good performance (the area under the receiver operating characteristic curve [ROC-AUC] = 0.80; 95% CI: 0.74-0.86) based on a subset of only 8 out of 40 pre- and post-injury complaints. We identified increased neck pain (p = 0.001) from pre- to post-injury as the strongest predictor of IR, followed by increased irritability (p = 0.011) and increased forgetfulness (p = 0.035) from pre- to post-injury. Our findings indicate that a subset of pre- and post-injury physical, emotional, and cognitive complaints has predictive value for determining long-term functional outcomes in elderly patients with mTBI. Particularly, post-injury neck pain, irritability, and forgetfulness scores were associated with IR and should be assessed early. The application of an ML approach holds promise for application in self-reported questionnaires to predict outcomes after mTBI.	[Bittencourt, Mayra; Balart-Sanchez, Sebastian A.; Maurits, Natasha M.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Bittencourt, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	m.bittencourt.villalpando@umcg.nl	Bittencourt, Mayra/D-3634-2015	Bittencourt, Mayra/0000-0001-5248-9272; /0000-0002-4967-7739			Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Ducos Y, 2021, NEUROCHIRURGIE, V67, P259, DOI 10.1016/j.neuchi.2020.04.129; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hahn T, 2017, MOL PSYCHIATR, V22, P37, DOI 10.1038/mp.2016.201; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kornblith ES, 2020, J HEAD TRAUMA REHAB, V35, pE320, DOI 10.1097/HTR.0000000000000552; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mourao-Miranda J, 2012, PSYCHOL MED, V42, P1037, DOI 10.1017/S0033291711002005; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Stern Y, 2009, J NEUROL SCI, V283, P256, DOI 10.1016/j.jns.2009.02.069; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timmer ML, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00246; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vapnik V., 1995, NATURE STAT LEARNING, DOI [10.1007/978-1-4757-3264-1, DOI 10.1007/978-1-4757-3264-1, 10.1007/978-1-4757-2440-0]; Varoquaux G, 2017, NEUROIMAGE, V145, P166, DOI 10.1016/j.neuroimage.2016.10.038; Venkatesan Umesh M, 1800, J Head Trauma Rehabil, DOI 10.1097/HTR.0000000000000697; Voormolen DC, 2020, BRAIN INJURY, V34, P1001, DOI 10.1080/02699052.2020.1761563; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yang CC, 2013, BRAIN INJURY, V27, P1008, DOI 10.3109/02699052.2013.794975; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Yu JS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.198	55	0	0	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 2	2021	12								751539	10.3389/fneur.2021.751539			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XO8NE	WOS:000730434600001	34925214	gold, Green Published			2022-02-06	
J	Brickell, TA; French, LM; Varbedian, NV; Sewell, JM; Schiefelbein, FC; Wright, MM; Lange, RT				Brickell, Tracey A.; French, Louis M.; Varbedian, Nicole V.; Sewell, Jessie M.; Schiefelbein, Faith C.; Wright, Megan M.; Lange, Rael T.			Relationship satisfaction among spouse caregivers of service members and veterans with comorbid mild traumatic brain injury and post-traumatic stress disorderPalabras clave(sic)(sic)(sic)	FAMILY PROCESS			English	Article; Early Access						health-related quality of life; military spouse caregiver; post-traumatic stress disorder; relationship satisfaction; service member veteran; traumatic brain injury	CENTERED PREVENTIVE INTERVENTION; MENTAL-HEALTH; MILITARY COUPLES; FAMILIES; US; SYMPTOMS; PTSD; EXPERIENCES; CHILDREN; CARE	This study examined relationship satisfaction and health-related quality of life (HRQOL) among spouse caregivers assisting service members and veterans (SMV) with comorbid uncomplicated mild traumatic brain injury (MTBI) and post-traumatic stress disorder (PTSD). Spouse caregivers (N = 205) completed the Couples Satisfaction Index (CSI), 12 HRQOL measures, and the Mayo-Portland Adaptability Inventory 4(th) Edition (MPAI-4). T-scores were classified as "clinically elevated" using a cutoff of >= 60T. The sample was also classified into "Satisfied" (>= 13.5, n = 113, 55.0%) or "Dissatisfied" (<13.5, n = 92, 44.0%) relationship categories. Using stepwise regression analysis, Anxiety, Family Disruption, Vigilance, Emotional Support, Feeling Trapped, and MPAI-4 Adjustment were identified as the strongest predictors of CSI total scores (p < 0.001), accounting for 41.6% of the variance. Squared semi-partial correlations revealed that 18.1% of the variance was shared across all six measures, with 7.8% to 1.5% of unique variance accounted for by each measure separately. When comparing the number of clinically elevated measures simultaneously, the Dissatisfied group consistently had a higher number of clinically elevated scores compared to the Satisfied group (e.g., 3-or-more clinically elevated scores: Dissatisfied = 40.2%, Satisfied = 8.8%, OR = 6.93, H = 0.76). Caring for a SMV with comorbid TBI and PTSD can have a profound impact on the spouse caregiver's HRQOL, relationship satisfaction, and family functioning. The findings from the current study continue to support the need for family involvement in the SMV's treatment plan, but more effort is needed to integrate behavioral health treatment that focuses on the family member's own issues into military TBI and PTSD systems of care.	[Brickell, Tracey A.; French, Louis M.; Varbedian, Nicole V.; Sewell, Jessie M.; Schiefelbein, Faith C.; Wright, Megan M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Traumat Brain Injury Ctr Excellence, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.; Varbedian, Nicole V.; Sewell, Jessie M.; Schiefelbein, Faith C.; Wright, Megan M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Brickell, Tracey A.; Varbedian, Nicole V.; Sewell, Jessie M.; Schiefelbein, Faith C.; Wright, Megan M.; Lange, Rael T.] Gen Dynam Informat Technol, Silver Spring, MD USA; [Brickell, Tracey A.; Lange, Rael T.] Ctr Excellence Post Traumat Stress Disorder, Ottawa, ON, Canada; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Traumat Brain Injury Ctr Excellence, Bldg 51,Room 1502B,4954 N Palmer Rd, Bethesda, MD 20889 USA.	tracey.brickell@gdit.com			Traumatic Brain Injury Center of Excellence (TBICoE)	This work is supported by the Traumatic Brain Injury Center of Excellence (TBICoE).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Badr H, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P213, DOI 10.1007/978-1-4419-7064-0_11; Baker DG, 2009, MIL MED, V174, P773; Bakhurst M, 2018, FAM PROCESS, V57, P241, DOI 10.1111/famp.12285; Bakhurst MG, 2017, J COUPLE RELATSH THE, V16, P167, DOI 10.1080/15332691.2016.1238797; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Brickell T.A., 2021, PSYCHOL TRAUMA-US; Brickell TA, 2020, MIL PSYCHOL, V32, P341, DOI 10.1080/08995605.2020.1754149; Brickell TA, 2020, QUAL LIFE RES, V29, P2781, DOI 10.1007/s11136-020-02529-y; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2018, CLIN CHILD PSYCHOL P, V23, P425, DOI 10.1177/1359104517740405; Bui E, 2018, ISSUES MENT HEALTH N, V39, P850, DOI 10.1080/01612840.2018.1485796; Bui E, 2017, J CHILD FAM STUD, V26, P464, DOI 10.1007/s10826-016-0580-9; Campbell SB, 2019, FAM PROCESS, V58, P908, DOI 10.1111/famp.12393; Campbell SB, 2018, CLIN PSYCHOL REV, V65, P152, DOI 10.1016/j.cpr.2018.08.003; Campbell SB, 2017, BEHAV THER, V48, P222, DOI 10.1016/j.beth.2016.04.006; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P323, DOI 10.1037/rep0000295; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2018, J HEAD TRAUMA REHAB, V33, P342, DOI 10.1097/HTR.0000000000000373; Cook KF, 2015, QUAL LIFE RES, V24, P575, DOI 10.1007/s11136-014-0790-9; Delgado RE, 2018, MIL MED, V183, P379, DOI 10.1093/milmed/usx156; Department of Defense, 2019, 2018 DEM PROF MIL CO; Doncaster E, 2019, J MARITAL FAM THER, V45, P464, DOI 10.1111/jmft.12340; Fredman SJ, 2020, BEHAV THER, V51, P700, DOI 10.1016/j.beth.2019.10.003; Freytes IM, 2017, AM J ORTHOPSYCHIAT, V87, P149, DOI 10.1037/ort0000211; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; HealthMeasures, 2021, PROMIS NEURO QOL ASC; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Monk JK, 2018, J FAM THEOR REV, V10, P566, DOI 10.1111/jftr.12280; Karney BR, 2011, RISK AND RESILIENCE IN U S MILITARY FAMILIES, P23, DOI 10.1007/978-1-4419-7064-0_2; Kratz AL, 2020, REHABIL PSYCHOL, V65, P432, DOI 10.1037/rep0000327; Laifer LM, 2019, J CHILD FAM STUD, V28, P1843, DOI 10.1007/s10826-019-01405-9; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lester Patricia, 2017, Focus (Am Psychiatr Publ), V15, P420, DOI 10.1176/appi.focus.20170027; Lester P, 2016, J AM ACAD CHILD PSY, V55, P14, DOI 10.1016/j.jaac.2015.10.009; Lester P, 2012, AM J PUBLIC HEALTH, V102, pS48, DOI 10.2105/AJPH.2010.300088; Lippa SM, 2020, J NEUROTRAUM, V37, P608, DOI 10.1089/neu.2019.6696; Makhija NJ, 2019, FAM J, V27, P404, DOI 10.1177/1066480719868700; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Maruish M.E., 2017, ASSESSMENT HLTH STAT; McGinn MM, 2017, J FAM PSYCHOL, V31, P111, DOI 10.1037/fam0000224; Meis LA, 2013, PSYCHOL TRAUMA-US, V5, P334, DOI 10.1037/a0028366; Monk JK, 2017, J MARITAL FAM THER, V43, P448, DOI 10.1111/jmft.12230; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Nichols LO, 2016, GERONTOLOGIST, V56, P135, DOI 10.1093/geront/gnu112; Norris D, 2018, J FAM THEOR REV, V10, P657, DOI 10.1111/jftr.12283; Ramchand R., 2014, HIDDEN HEROES AM MIL; Riggs D., 2016, WAR AND FAMILY LIFE, P55, DOI [10.1007/978-3-319-21488-7_4, DOI 10.1007/978-3-319-21488-7_4]; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Saltzman WR, 2016, FAM PROCESS, V55, P633, DOI 10.1111/famp.12238; Schwartz KD., 2020, MIL BEHAV HLTH, V8, P148, DOI [10.1080/21635781.2019.1644260, DOI 10.1080/21635781.2019.1644260]; Skomorovsky A., 2017, MIL BEHAV HLTH, V5, P406, DOI [10.1080/21635781.2017.1335256, DOI 10.1080/21635781.2017.1335256]; Smith VA, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00122; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; The Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU, V2; Van Houtven CH, 2019, MED CARE RES REV, V76, P89, DOI 10.1177/1077558717697015; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Winter L, 2017, BRAIN INJURY, V31, P493, DOI 10.1080/02699052.2017.1283534	67	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-7370	1545-5300		FAM PROCESS	Fam. Process												10.1111/famp.12731		DEC 2021	16	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	XH3AA	WOS:000725310300001	34859431				2022-02-06	
J	Huang, S; Dipnall, JF; Gabbe, BJ; Giummarra, MJ				Huang, Sherry; Dipnall, Joanna F.; Gabbe, Belinda J.; Giummarra, Melita J.			Pain and mental health symptom patterns and treatment trajectories following road trauma: a registry-based cohort study	DISABILITY AND REHABILITATION			English	Article; Early Access						Pain; mental health; recovery; healthcare use; injury	MAJOR TRAUMA; SERVICE UTILIZATION; VEHICLE COLLISION; BRAIN-INJURY; CARE; RECOVERY; OUTCOMES; COMPENSATION; PREVALENCE; RESILIENCE	Purpose This study aimed to characterise recovery from pain and mental health symptoms, and identify whether treatment use facilitates recovery. Methods Victorian State Trauma Registry and Victorian Orthopaedic Trauma Outcomes Registry participants without neurotrauma who had transport injury claims with the Transport Accident Commission from 2007 to 2014 were included (n = 5908). Latent transition analysis of pain Numeric Rating Scale, SF-12, and EQ-5D-3L pain and mental health items from 6 to 12 months, and 12 to 24 months post-injury were used to identify symptom transitions. Results Four transition groups were identified: transition to low problems by 12-months; transition to low problems at 24-months; stable low problems; and no transition from problems. Group-based trajectory modelling of pain and mental health treatments found three treatment trajectories: low/no treatment, a moderate treatment that declined to low treatment 3-12 months post-injury, and increasing treatment over time. Predictors of pain and mental health recovery transitions, identified using multinomial logistic regression, were primarily found to be non-modifiable socioeconomic and health-related characteristics (e.g., higher education, working pre-injury, and not having comorbidities), and low treatment trajectories. Conclusions Targeted and collaborative rehabilitation should be considered for people at risk of persistent pain or mental health symptoms to optimise their recovery, particularly patients with socioeconomic disadvantage.	[Huang, Sherry] ISN Psychol, Inst Social Neurosci, Ivanhoe, Australia; [Dipnall, Joanna F.; Gabbe, Belinda J.; Giummarra, Melita J.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Dipnall, Joanna F.] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, Sch Med, Geelong, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Swansea Univ Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales; [Giummarra, Melita J.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Australia		Giummarra, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	melita.giummarra@monash.edu	; Giummarra, Melita/H-8387-2012	Gabbe, Belinda/0000-0001-7096-7688; Giummarra, Melita/0000-0001-7839-6058	Monash University Helix; Monash eResearch Centre; Department of Health, State Government of Victoria; Transport Accident Commission; Australian Research Council (ARC)Australian Research Council [DE170100726]; ARCAustralian Research Council [FT170100048]	This work was supported by staff within Monash University Helix and the Monash eResearch Centre. The Secure eResearch Platform is underpinned by world-leading infrastructure to ensure ongoing security and privacy of any data is maintained. The Victorian State Trauma Registry (VSTR) is funded by the Department of Health, State Government of Victoria and the Transport Accident Commission. The Victorian Orthopaedic Trauma Outcomes Registry (VOTOR) is funded by the Transport Accident Commission. The researchers were supported by an Australian Research Council (ARC) Discovery Early Career Research Award (DE170100726) to M.J.G. and ARC Future Fellowship (FT170100048) to B.J.G.	A.B.o. Statistics, 2007, NAT SURV MENT HLTH W; Abarda A, 2020, PROCEDIA COMPUT SCI, V170, P1116, DOI 10.1016/j.procs.2020.03.059; Akinwande M.O., 2015, OPEN J STAT, V5, P754, DOI [DOI 10.4236/OJS.2015.57075, 10.4236/ojs.2015.57075]; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Bureau of Statistics, 2001, AUSTR STAND CLASS ED; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berecki-Gisolf J, 2015, INJURY, V46, P1250, DOI 10.1016/j.injury.2015.02.023; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Boscarino JA., 2002, UTILIZATION MENTAL H; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Casey PP, 2015, INJURY, V46, P2118, DOI 10.1016/j.injury.2015.08.038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clay FJ, 2012, PAIN RES MANAG, V17, P35, DOI 10.1155/2012/935194; Collie A, 2013, INJURY, V44, P1514, DOI 10.1016/j.injury.2013.03.006; Department of Health and Aged Care (GISCA), 2001, MEAS REM ACC REM IND; Development ACfC, 2017, ICD10AMACHIACS ACFC, V10th; Devlin A, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.105279; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Gabbe BJ, 2006, J TRAUMA, V61, P1393, DOI 10.1097/01.ta.0000225926.34180.47; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; GaIatzer-Levy IR, 2018, CLIN PSYCHOL REV, V63, P41, DOI 10.1016/j.cpr.2018.05.008; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Giummarra MJ, 2021, J TRANSP HEALTH, V20, DOI 10.1016/j.jth.2020.101003; Giummarra MJ, 2019, J TRANSP HEALTH, V14, DOI 10.1016/j.jth.2019.100581; Giummarra MJ, 2020, PAIN MED, V21, P291, DOI 10.1093/pm/pnz209; Giummarra MJ, 2018, INJURY, V49, P1787, DOI 10.1016/j.injury.2018.08.008; Giummarra MJ, 2018, CLIN PSYCHOL REV, V62, P11, DOI 10.1016/j.cpr.2018.05.001; Giummarra MJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017350; Giummarra MJ, 2016, CLIN J PAIN, V32, P817, DOI 10.1097/AJP.0000000000000342; Giummarra MJ., MENTAL HLTH PAIN INJ; Gopinath B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009303; HAUSMAN J, 1984, ECONOMETRICA, V52, P1219, DOI 10.2307/1910997; James S.L., 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, DOI 10.1016/S0140-6736(18)32279-7]; Janssen B., 2015, EQ 5D 5L USER GUIDE; Kapstad H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-55; Kenardy J, 2017, J AFFECT DISORDERS, V214, P8, DOI 10.1016/j.jad.2017.02.031; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Laursen B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001521; Litchfield F., 2017, COST ROAD CRASHES AU; Littleton SM, 2011, INJURY, V42, P927, DOI 10.1016/j.injury.2010.02.011; Mitchell RJ, 2017, INJURY, V48, P1393, DOI 10.1016/j.injury.2017.04.014; Nagin D.S., 2005, GROUP BASED MODELING; Nagin DS, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P53, DOI 10.1007/978-0-387-77650-7_4; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nguyen TL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197320; Nguyen TQ, 2019, HEALTH INF MANAG J, V48, P127, DOI 10.1177/1833358318769482; Nguyen TQ, 2017, AUST HEALTH REV, V41, P283, DOI 10.1071/AH16050; Noben CY, 2016, J CLIN EPIDEMIOL, V74, P93, DOI 10.1016/j.jclinepi.2015.09.019; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Ozegovic D, 2010, J REHABIL MED, V42, P66, DOI 10.2340/16501977-0466; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Rissanen R, 2017, ACCIDENT ANAL PREV, V108, P308, DOI 10.1016/j.aap.2017.09.013; Rubin D.B., 1987, MULTIPLE IMPUTATION; Ruseckaite R, 2012, INJURY, V43, P1600, DOI 10.1016/j.injury.2011.03.011; Samoborec S, 2020, INJURY PREV, V26, P254, DOI 10.1136/injuryprev-2019-043195; Sterling M., 2011, WHIPLASH, P108; Sterling M, 2011, PAIN, V152, P1272, DOI 10.1016/j.pain.2011.01.056; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Van Belleghem G, 2020, DISABIL REHABIL, V42, P1599, DOI 10.1080/09638288.2018.1531152; Walton DM, 2010, DISABIL REHABIL, V32, P864, DOI 10.3109/09638280903349511; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29	65	0	0	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2021.2008526		DEC 2021	13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	XI2HT	WOS:000725940300001	34871122				2022-02-06	
J	Komoltsev, IG; Tret'yakova, LV; Frankevich, SO; Shirobokova, NI; Volkova, AA; Butuzov, AV; Novikova, MR; Kvichansky, AA; Moiseeva, YV; Onufriev, MV; Bolshakov, AP; Gulyaeva, NV				Komoltsev, Ilia G.; Tret'yakova, Liya V.; Frankevich, Stepan O.; Shirobokova, Natalia I.; Volkova, Aleksandra A.; Butuzov, Alexey V.; Novikova, Margarita R.; Kvichansky, Alexey A.; Moiseeva, Yulia V.; Onufriev, Mikhail V.; Bolshakov, Alexey P.; Gulyaeva, Natalia V.			Neuroinflammatory Cytokine Response, Neuronal Death, and Microglial Proliferation in the Hippocampus of Rats During the Early Period After Lateral Fluid Percussion-Induced Traumatic Injury of the Neocortex	MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Traumatic brain injury; Hippocampus; Neuroinflammation; Microglia; Neurodegeneration; Distant damage; Corticosterone; IL1b; TNF; IL6	BRAIN-INJURY; VENTRAL HIPPOCAMPUS; OXIDATIVE STRESS; PROTEIN-LEVELS; SEVERITY; MODEL	Time course of changes in neuroinflammatory processes in the dorsal and ventral hippocampus was studied during the early period after lateral fluid percussion-induced neocortical traumatic brain injury (TBI) in the ipsilateral and contralateral hemispheres. In the ipsilateral hippocampus, neuroinflammation (increase in expression of pro-inflammatory cytokines) was evident from day 1 after TBI and ceased by day 14, while in the contralateral hippocampus, it was mainly limited to the dorsal part on day 1. TBI induced an increase in hippocampal corticosterone level on day 3 bilaterally and an accumulation of Il1b on day 1 in the ipsilateral hippocampus. Activation of microglia was observed from day 7 in different hippocampal areas of both hemispheres. Neuronal cell loss was detected in the ipsilateral dentate gyrus on day 3 and extended to the contralateral hippocampus by day 7 after TBI. The data suggest that TBI results in distant hippocampal damage (delayed neurodegeneration in the dentate gyrus and microglia proliferation in both the ipsilateral and contralateral hippocampus), the time course of this damage being different from that of the neuroinflammatory response.	[Komoltsev, Ilia G.; Tret'yakova, Liya V.; Frankevich, Stepan O.; Shirobokova, Natalia I.; Volkova, Aleksandra A.; Butuzov, Alexey V.; Novikova, Margarita R.; Kvichansky, Alexey A.; Moiseeva, Yulia V.; Onufriev, Mikhail V.; Bolshakov, Alexey P.; Gulyaeva, Natalia V.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117485, Russia; [Komoltsev, Ilia G.; Frankevich, Stepan O.; Onufriev, Mikhail V.; Gulyaeva, Natalia V.] Res & Clin Ctr Neuropsychiat, Moscow Healthcare Dept, Moscow 115419, Russia		Gulyaeva, NV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117485, Russia.; Gulyaeva, NV (corresponding author), Res & Clin Ctr Neuropsychiat, Moscow Healthcare Dept, Moscow 115419, Russia.	nata_gul@ihna.ru	Novikova, Margarita/AAC-2331-2022; Bolshakov, Alexey P/K-4173-2013; Moiseeva, Yulia/AAC-3450-2022		RFBRRussian Foundation for Basic Research (RFBR) [19-315-90081, 19-015-00258]	This work was supported by RFBR grants 19-315-90081 (NG, LT) and 19-015-00258 (NG, IK, MN).	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bolshakov AP, 2021, BIOCHEMISTRY-MOSCOW+, V86, P156, DOI [10.1134/S0006297921020048, 10.31857/S0320972521020044]; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Eapen B., 2018, REHABILITATION TRAUM; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Grafman J, 2015, HDB CLIN NEUROLOGY; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Gulyaeva NV, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1306, DOI 10.1134/S0006297919110087; Gulyaeva NV, 2015, NEUROCHEM J+, V9, P85, DOI 10.1134/S1819712415020075; Gulyaeva NV, 2019, NEUROCHEM RES, V44, P1306, DOI 10.1007/s11064-018-2662-0; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hiskens M., 2021, TRAUMA CARE, V1, P23, DOI DOI 10.3390/TRAUMACARE1010003; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Podgorny OV, 2021, J NEUROCHEM, V157, P370, DOI 10.1111/jnc.15265; Rowe Rachel K, 2020, Neurotrauma Rep, V1, P113, DOI 10.1089/neur.2020.0019; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Witcher KG, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.146987; Zhang W, 2015, CENT EUR J IMMUNOL, V40, P35, DOI 10.5114/ceji.2015.50831; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041	35	0	0	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.												10.1007/s12035-021-02668-4		DEC 2021	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XH4EA	WOS:000725388500001	34855115	Green Submitted			2022-02-06	
J	Scimeca, LM; Cothran, T; Larson, JE; Held, P				Scimeca, Lauren M.; Cothran, Thomas; Larson, Jon E.; Held, Philip			Factor analysis of the neurobehavioral symptom inventory in veterans with PTSD and no history of mild TBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Neurobehavioral symptom inventory; neurobehavioral symptoms; posttraumatic stress disorder; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; COMPLAINTS; AFGHANISTAN; CHECKLIST; EXPOSURE; PCL-5; RATES	It is well established that long-term postconcussive symptoms following a mild traumatic brain injury (mTBI) are associated with underlying physical, emotional, and behavioral conditions. The Neurobehavioral Symptom Inventory (NSI) is a measure used to assess neurobehavioral symptoms that can occur following a mTBI and has demonstrated a 3- or 4-factor structure in veterans. The present study aimed to investigate the factor structure of veterans with PTSD without a history of mTBI. A confirmatory factor analysis (CFA) was conducted on a sample of 221 treatment-seeking veterans and service members with PTSD and without a history of mTBI. Results supported a 4-factor structure comprised of vestibular, somatic, cognitive, and affective domains in veterans with PTSD. Subsequent, correlational analyses between the four NSI factors and the four subscales of the Posttraumatic Stress Disorder Checklist - Fifth Edition (PCL-5) revealed high correspondence between the cognitive and affective factors of the NSI and the negative alterations in mood and cognitions and hyperarousal symptom subscales of PTSD. Collectively, findings demonstrated that the NSI functions similarly in veterans with PTSD with or without a history of mTBI. Findings suggest that neurobehavioral symptoms assessed by the NSI appear to be nonspecific and not explicitly associated with mTBI.	[Scimeca, Lauren M.; Cothran, Thomas; Held, Philip] Rush Univ, Med Ctr, Dept Psychiat, Chicago, IL 60612 USA; [Scimeca, Lauren M.; Larson, Jon E.] IIT, Dept Psychol, 10 W 35th St, Chicago, IL 60616 USA		Scimeca, LM (corresponding author), IIT, Dept Psychol, 10 W 35th St, Chicago, IL 60616 USA.	lscimeca@hawk.iit.edu		Scimeca, Lauren/0000-0002-4889-2074	National Institute of Health's National Center for Advancing Translational Sciences [KL2 TR002387]; Wounded Warrior Project; RTI International	Philip Held is supported by a career development award from the National Institute of Health's National Center for Advancing Translational Sciences [KL2 TR002387] and receives grant support from Wounded Warrior Project and RTI International.	Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Bahraini NH, 2018, PSYCHOL ASSESSMENT, V30, P1013, DOI 10.1037/pas0000555; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bodapati AS, 2019, CLIN NEUROPSYCHOL, V33, P539, DOI 10.1080/13854046.2018.1482003; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd Edn; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnelly K., 2008, VA QUER NAT M; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Held P, 2020, PSYCHOL TRAUMA-US, V12, P422, DOI 10.1037/tra0000485; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Joreskog K, 1996, LISREL 8 USERS REFER; Jurick SM, 2020, J INT NEUROPSYCH SOC, V26, P108, DOI 10.1017/S1355617719000997; Kaplan D., 2014, NEUROBEHAVIORAL SYMP; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kimerling R, 2000, J TRAUMA STRESS, V13, P115, DOI 10.1023/A:1007729116133; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silverberg ND, 2017, J TRAUMA STRESS, V30, P318, DOI 10.1002/jts.22184; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Zalta AK, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1816-6; Zhang J, 2015, J PSYCHOSOM RES, V79, P100, DOI 10.1016/j.jpsychores.2015.06.001	52	0	0	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.2007386		DEC 2021	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	XI2VM	WOS:000725976000001	34860619				2022-02-06	
J	Sheng, JT; Chen, WQ; Zhuang, DZ; Li, T; Yang, JH; Cai, SR; Chen, XX; Liu, X; Tian, F; Huang, MD; Li, LJ; Li, KS				Sheng, Jiangtao; Chen, Weiqiang; Zhuang, Dongzhou; Li, Tian; Yang, Jinhua; Cai, Shirong; Chen, Xiaoxuan; Liu, Xueer; Tian, Fei; Huang, Mindong; Li, Lianjie; Li, Kangsheng			A Clinical Predictive Nomogram for Traumatic Brain Parenchyma Hematoma Progression	NEUROLOGY AND THERAPY			English	Article; Early Access						Cerebral contusion; Hematoma expansion; Nomogram; Multihematoma fuzzy sign; Monocyte-to-lymphocyte ratio	HEMORRHAGIC PROGRESSION; INTRACEREBRAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; RISK SCORE; CEREBRAL CONTUSIONS; HEAD TRAUMA; INJURY; COAGULOPATHY; VALIDATION; DERIVATION	Introduction Acute traumatic intraparenchymal hematoma (tICH) expansion is a major cause of clinical deterioration after brain contusion. Here, an accurate prediction tool for acute tICH expansion is proposed. Methods A multicenter hospital-based study for multivariable prediction model was conducted among patients (889 patients in a development dataset and 264 individuals in an external validation dataset) with initial and follow-up computed tomography (CT) imaging for tICH volume evaluation. Semi-automated software was employed to assess tICH expansion. Two multivariate predictive models for acute tICH expansion were developed and externally validated. Results A total of 198 (22.27%) individuals had remarkable acute tICH expansion. The novel Traumatic Parenchymatous Hematoma Expansion Aid (TPHEA) model retained several variables, including age, coagulopathy, baseline tICH volume, time to baseline CT time, subdural hemorrhage, a novel imaging marker of multihematoma fuzzy sign, and an inflammatory index of monocyte-to-lymphocyte ratio. Compared with multihematoma fuzzy sign, monocyte-to-lymphocyte ratio, and the basic model, the TPHEA model exhibited optimal discrimination, calibration, and clinical net benefits for patients with acute tICH expansion. A TPHEA nomogram was subsequently introduced from this model to facilitate clinical application. In an external dataset, this device showed good predicting performance for acute tICH expansion. Conclusions The main predictive factors in the TPHEA nomogram are the monocyte-to-lymphocyte ratio, baseline tICH volume, and multihematoma fuzzy sign. This user-friendly tool can estimate acute tICH expansion and optimize personalized treatments for individuals with brain contusion.	[Sheng, Jiangtao; Li, Tian; Chen, Xiaoxuan; Liu, Xueer; Li, Kangsheng] Shantou Univ, Dept Microbiol & Immunol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Med Coll, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China; [Chen, Weiqiang; Zhuang, Dongzhou; Yang, Jinhua; Cai, Shirong] Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Med Coll, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China; [Tian, Fei] Shantou Univ, Dept Neurosurg, Affiliated Hosp 2, Med Coll, Shantou, Guangdong, Peoples R China; [Huang, Mindong] Sun Yat Sen Univ, Dept Neurosurg, Affiliated Jieyang Hosp, Jieyang, Guangdong, Peoples R China; [Li, Lianjie] Xiamen Univ, Dept Neurosurg, Affiliated East Hosp, Med Coll, Fuzhou, Fujian, Peoples R China		Sheng, JT (corresponding author), Shantou Univ, Dept Microbiol & Immunol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Med Coll, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.; Chen, WQ (corresponding author), Shantou Univ, Dept Neurosurg, Affiliated Hosp 1, Med Coll, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	jtsheng@stu.edu.cn; wqchen@stu.edu.cn			China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M633091]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2019A1515010649]; Medical Scientific Research Foundation of Guangdong Province, China [A2017168]	This study was supported by China Postdoctoral Science Foundation (2018M633091); the Natural Science Foundation of Guangdong Province (2019A1515010649); Medical Scientific Research Foundation of Guangdong Province, China (A2017168). Jiangtao Sheng will be funding the journal's Rapid Service Fee for this study.	Adatia K, 2021, NEUROCRIT CARE, V34, P312, DOI 10.1007/s12028-020-00994-4; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Brouwers HB, 2012, STROKE, V43, P1490, DOI 10.1161/STROKEAHA.111.643262; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; FISHER CM, 1971, J NEUROPATH EXP NEUR, V30, P536, DOI 10.1097/00005072-197107000-00015; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lei ZQ, 2016, JAMA SURG, V151, P356, DOI 10.1001/jamasurg.2015.4257; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nasi D, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01186; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Qureshi Adnan I, 2015, J Vasc Interv Neurol, V8, P42; R Core Team-R Foundation for Statistical Computing, R LANG ENV STAT COMP; Regner A, 2018, EXPERT REV MOL DIAGN, V18, P925, DOI 10.1080/14737159.2018.1535904; Rehman L, 2019, J NEUROSCI RURAL PRA, V10, P212, DOI 10.4103/jnrp.jnrp_335_18; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Sharma M, 2016, INDIAN J NEUROTRAUM, V13, P1, DOI 10.1055/s-0036-1580717; Sheng JT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81685-8; Sheng JT, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/5483981; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wang H, 2021, NEUROL THER, V10, P819, DOI 10.1007/s40120-021-00263-2; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zhang LQ, 2021, NEUROCRIT CARE, DOI 10.1007/s12028-021-01320-2	46	0	0	1	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	2193-8253	2193-6536		NEUROL THER	Neurol. Ther.												10.1007/s40120-021-00306-8		DEC 2021	19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XH4DB	WOS:000725386000002	34855160	gold			2022-02-06	
J	Abecassis, IJ; Young, CC; Caldwell, DJ; Feroze, AH; Williams, JR; Meyer, RM; Kellogg, RT; Bonow, RH; Chesnut, RM				Abecassis, Isaac Josh; Young, Christopher C.; Caldwell, David J.; Feroze, Abdullah H.; Williams, John R.; Meyer, R. Michael; Kellogg, Ryan T.; Bonow, Robert H.; Chesnut, Randall M.			The Kempe incision for decompressive craniectomy, craniotomy, and cranioplasty in traumatic brain injury and stroke	JOURNAL OF NEUROSURGERY			English	Article						Kempe; craniectomy incision; traumatic brain injury; surgical technique; decompressive craniectomy; trauma; vascular disorders	HEMICRANIECTOMY	OBJECTIVE Decompressive craniectomy (DC) is an effective, lifesaving option for reducing intracranial pressure (ICP) in traumatic brain injury (TBI), stroke, and other pathologies with elevated ICP. Most DCs are performed via a standard trauma flap shaped like a reverse question mark (RQM), which requires sacrificing the occipital and posterior auricular arteries and can be complicated by wound dehiscence and infections. The Ludwig Kempe hemispherectomy incision (Kempe) entails a T-shaped incision, one limb from the midline behind the hairline to the inion and the other limb from the root of the zygoma to the coronal suture. The authors' objective in this study was to define their implementation of the Kempe incision for DC and craniotomy, report clinical outcomes, and quantify the volume of bone removed compared with the RQM incision. METHODS A retrospective review of a single-surgeon experience with DC in TBI and stroke was performed. Patient demographics, imaging, and outcomes were collected for all DCs from 2015 to 2020, and the incisions were categorized as either Kempe or RQM. Preoperative and postoperative CT scans were obtained and processed using a combination of automatic segmentation (in Python and SimplelTK) with manual cleanup and further subselection in ITK-SNAP. The volume of bone removed was quantified, and the primary outcome was percentage of hemicranium removed. Postoperative surgical wound infections, estimated blood loss (EBL), and length of surgery were compared between the two groups as secondary outcomes. Cranioplasty data were collected. RESULTS One hundred thirty-six patients were included in the analysis; there were 57 patients in the craniotomy group (44 patients with RQM incisions and 13 with Kempe incisions) and 79 in the craniectomy group (41 patients with ROM incisions and 38 Kempe incisions). The mean follow-up for the entire cohort was 251 +/- 368 days. There was a difference in the amount of decompression between approaches in multivariate modeling (39% +/- 11% of the hemicranium was removed via the Kempe incision vs 34% +/- 10% via the RQM incision, p = 0.047), although this did not achieve significance in multivariate modeling. Wound infection rates, EBL, and length of surgery were comparable between the two incision types. No wound infections in either cohort were due to wound dehiscence. Cranioplasty outcomes were comparable between the two incision types. CONCLUSIONS The Kempe incision for craniectomy or craniotomy is a safe, feasible, and effective alternative to the RQM. The authors advocate the Kempe incision in cases in which contralateral operative pathology or subsequent craniofacial/skull base repair is anticipated.	[Abecassis, Isaac Josh; Young, Christopher C.; Caldwell, David J.; Feroze, Abdullah H.; Williams, John R.; Meyer, R. Michael; Bonow, Robert H.; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Bonow, Robert H.] Univ Washington, Harborview Injury Prevent Res Ctr, Seattle, WA USA; [Kellogg, Ryan T.] Univ Virginia Hlth Syst, Dept Neurol Surg, Charlottesville, VA USA		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.	respub2@uw.edu		Kellogg, Ryan/0000-0001-6491-5443			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Das S, 2019, WORLD NEUROSURG, V123, P8, DOI 10.1016/j.wneu.2018.11.176; Day JD, 1998, NEUROSURGERY, V42, P198, DOI 10.1097/00006123-199801000-00045; de Weerd L, 2011, CLIN PLAST SURG, V38, P277, DOI 10.1016/j.cps.2011.03.013; Erfon J, 2019, AESTHET PLAST SURG, V43, P1480, DOI 10.1007/s00266-019-01503-5; Ezer H, 2011, SKULL BASE-INTERD AP, V21, P159, DOI 10.1055/s-0031-1275247; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; HAMMON WM, 1972, J NEUROSURG, V37, P339, DOI 10.3171/jns.1972.37.3.0339; Hinduja A, 2018, J STROKE CEREBROVASC, V27, P418, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.016; Hsu YC, 2019, WORLD NEUROSURG, V124, pE431, DOI 10.1016/j.wneu.2018.12.112; Janatpour ZC, 2019, MIL MED, V184, P929, DOI 10.1093/milmed/usz008; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; KEMPE LG, 1980, J NEUROSURG, V52, P671, DOI 10.3171/jns.1980.52.5.0671; KEMPE LG, 1981, J NEUROSURG, V54, P848; Kempe LG, 1968, OPERATIVE NEUROSURGE, V1, P180; Kobrine A I, 1973, Surg Neurol, V1, P38; Kobrine A I, 1973, Surg Neurol, V1, P34; KOBRINE AI, 1973, MIL MED, V138, P495; LOCKARD B I, 1988, Neurological Research, V10, P81; Lowekamp BC, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00045; Lyon KA, 2019, OPER NEUROSURG, V17, P273, DOI 10.1093/ons/opy399; Martins A N, 1965, Acta Neurochir (Wien), V13, P469, DOI 10.1007/BF02074429; MARTINS AN, 1965, J NEUROSURG, V22, P268, DOI 10.3171/jns.1965.22.3.0268; Mitchell RTM, 2014, CLIN PLAST SURG, V41, P673, DOI 10.1016/j.cps.2014.07.007; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Reid P, 2018, WORLD NEUROSURG, V119, pE922, DOI 10.1016/j.wneu.2018.08.005; Rohrich RJ, 2006, PLAST RECONSTR SURG, V118, P1631, DOI 10.1097/01.prs.0000248397.83578.aa; Schur S, 2020, WORLD NEUROSURG, V137, pE430, DOI 10.1016/j.wneu.2020.01.232; Smith D R, 1969, Acta Neurochir (Wien), V21, P57, DOI 10.1007/BF01405210; Sughrue ME, 2011, J CLIN NEUROSCI, V18, P1201, DOI 10.1016/j.jocn.2011.01.016; Swanson E, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0000000000000034; VANDERARK GD, 1972, NEUROCHIRURGIA, V15, P81; Veldeman M, 2021, J NEUROSURG, V134, P1262; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Yang Ho Seung, 2016, Korean J Neurotrauma, V12, P72, DOI 10.13004/kjnt.2016.12.2.72; Yaniv Z, 2018, J DIGIT IMAGING, V31, P290, DOI 10.1007/s10278-017-0037-8; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	37	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2021	135	6					1807	1816		10.3171/2020.11.JNS203567			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XJ5NE	WOS:000726833600004	34020415				2022-02-06	
J	Almendarez-Sanchez, CA; Reyna-Martinez, E; Vara-Castillo, A; Ruiz-Flores, MI; Alvarez-Vazquez, L; Solorio-Pineda, S; Tafur-Grandett, AA; Sosa-Najera, A; Franco-Jimenez, JA				Adan Almendarez-Sanchez, Cesar; Reyna-Martinez, Eduardo; Vara-Castillo, Alfredo; Inocencio Ruiz-Flores, Milton; Alvarez-Vazquez, Leonardo; Solorio-Pineda, Saul; Alfonso Tafur-Grandett, Abrahan; Sosa-Najera, Antonio; Alfonso Franco-Jimenez, Jose			Cosmetic results of autologous bone cranioplasty after decompressive craniectomy for traumatic brain injury based on a patient questionnaire	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Cosmetic outcome; Cranioplasty; Autologous bone; Traumatic brain injury; Decompressive craniectomy	GRAFT INFECTION; COMPLICATIONS; MULTICENTER	Background: Decompressive craniectomy (DC) after traumatic brain injury (TBI) is a common surgical procedure. Cranioplasty (CP) is undertaken as a routine secondary operation following DC. In neurosurgical trauma centers, patients who require CPs compete with other patients who require emergency neurosurgical intervention and they are not given enough priority. Methods: A retrospective study was conducted of patients who had undergone autologous bone CP after DC for TBI over three years in a 3rd level trauma center in Mexico. All families were administered a questionnaire to assess how the patient judged the cosmetic result of CP. Results: A total of 29 patients agreed to participate in this study. 25 patients (86.2%) were satisfied with the aesthetic result and 4 patients (13.8%) were no satisfied with their CP. 4 cases (13.8%) reported medical complications related to CP. Unsatisfied patients complained most likely about the dented aesthetic look, with a moderate negative correlation between this and cosmetic outcome (rho = -0.483, P = 0.001). Patient age (rho = 0.194, P = 0.314) and defect size (rho = 0.156, P = 0.419) was not related to the assessment of the aesthetic result. A strong negative correlation between postoperative infection and the grade of satisfaction (rho = -0.710, P = 0.001) was also observed. Conclusions: Based on our results, overall most of the patients were satisfied with their CP with an acceptable complication rate.	[Adan Almendarez-Sanchez, Cesar; Reyna-Martinez, Eduardo; Vara-Castillo, Alfredo; Inocencio Ruiz-Flores, Milton; Alfonso Tafur-Grandett, Abrahan; Sosa-Najera, Antonio; Alfonso Franco-Jimenez, Jose] Inst Salud Estado Mexico, Ctr Med Lic Adolfo Lopez Mateos, Dept Neurosurg, Av Nicolas San Juan S-N, Toluca 50010, Estado De Mexic, Mexico; [Alvarez-Vazquez, Leonardo] Inst Mexicano Seguro Social, HGR 220, Dept Neurosurg, Toluca, Estado De Mexic, Mexico; [Solorio-Pineda, Saul] Inst Nacl Rehabil Luis Guillermo Ibarra Ibarra, Spine Surg Serv, Ciudad De Mexico, Mexico; [Sosa-Najera, Antonio] Hosp Angeles Morelia, Grp Neurol Alta Especialidad, Morelia, Michoacan, Mexico		Almendarez-Sanchez, CA (corresponding author), Inst Salud Estado Mexico, Ctr Med Lic Adolfo Lopez Mateos, Dept Neurosurg, Av Nicolas San Juan S-N, Toluca 50010, Estado De Mexic, Mexico.	cesar2hx@hotmail.com; lalo_reyna1@hotmail.com; alfredo.varac@gmail.com; mdruizmilton79@yahoo.com.mx; lejamajm_729@hotmail.com; solorio-ncx@hotmail.com; atafur.grandett@hotmail.com; antonio01986@hotmail.com; franco-doc@hotmail.com		Almendarez-Sanchez, Cesar Adan/0000-0001-7095-967X			Alkhaibary A, 2020, WORLD NEUROSURG, V139, P445, DOI 10.1016/j.wneu.2020.04.211; Coulter IC, 2014, ACTA NEUROCHIR, V156, P1361, DOI 10.1007/s00701-014-2081-1; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Fischer CM, 2012, NEUROL RES, V34, P281, DOI 10.1179/1743132812Y.0000000007; Fricia M, 2019, WORLD NEUROSURG, V121, P160, DOI 10.1016/j.wneu.2018.09.199; Ganau M, 2020, J CLIN NEUROSCI, V74, P98, DOI 10.1016/j.jocn.2020.01.087; Henker C, 2018, J NEUROTRAUM, V35, P1030, DOI 10.1089/neu.2017.5512; Jin SW, 2018, TURK NEUROSURG, V28, P882, DOI 10.5137/1019-5149.JTN.21333-17.2; Kadri PAS, 2004, J NEUROSURG, V100, P517, DOI 10.3171/jns.2004.100.3.0517; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Lee Si Hoon, 2014, Korean J Neurotrauma, V10, P10, DOI 10.13004/kjnt.2014.10.1.10; Morales-Gomez JA, 2019, J NEUROSURG, V130, P1721, DOI 10.3171/2017.12.JNS172574; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; Park SE, 2019, WORLD NEUROSURG, V126, pE1160, DOI 10.1016/j.wneu.2019.02.221; Posti JP, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00223; Raza SM, 2008, NEUROSURGERY, V63, P262, DOI [10.1227/01.NEU.0000297011.27846.62, 10.1227/01.neu.0000317402.46583.c7]; Salam AA, 2018, INTERDISCIP NEUROSUR, V13, P59, DOI 10.1016/j.inat.2018.03.004; Satapathy D, 2019, WORLD NEUROSURG, V129, pE81, DOI 10.1016/j.wneu.2019.05.027; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Yasuhara T, 2020, NEUROL MED-CHIR, V60, P337, DOI 10.2176/nmc.oa.2020-0051; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zingale A, 2003, J Neurosurg Sci, V47, P137	24	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2021	26								101311	10.1016/j.inat.2021.101311			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WA3VQ	WOS:000702817000007		gold			2022-02-06	
J	Amare, AT; Tesfaye, TD; Ali, AS; Woelile, TA; Birlie, TA; Kebede, WM; Tassew, SF; Chanie, ES; Fleke, DG				Amare, Abraham Tsedalu; Tesfaye, Tadesse Dagget; Ali, Awole Seid; Woelile, Tamiru Alene; Birlie, Tekalign Amera; Kebede, Worku Misganew; Tassew, Sheganew Fetene; Chanie, Ermias Sisay; Fleke, Dejen Getaneh			Survival status and predictors of mortality among traumatic brain injury patients in an Ethiopian hospital: A retrospective cohort study	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Glasgow coma scale; Survival status; Bahir Dar	SEVERE HEAD-INJURY; RISK-FACTORS; EPIDEMIOLOGY; PNEUMONIA; MAGNITUDE; COUNTRIES; PATTERNS; OUTCOMES; IMPACT	Introduction: Traumatic brain injury is a major global public health problem causing substantial mortality among the adult population. Hence, this study aimed to determine the predictors of mortality among adult traumatic brain injury patients in Felegehiwot Comprehensive Specialized Hospital in Northwest Ethiopia during 2020. Methods: A retrospective cohort study was conducted at Felegehiwot Comprehensive Specialized Hospital using anonymized patient data obtained from chart review. Descriptive statistics were used to summarise the patient characteristics. The Kaplan-Meier survival curve and log-rank test were used to test for differences in survival status among groups. The Cox proportional hazards regression model was used at the 5% level of significance to determine the net effect of each explanatory variable on time to death. Results: In total, 338 patients aged >= 15 years and diagnosed with traumatic brain injury were included in the analysis. Among these patients, 103 (30.45%) died, giving a crude death rate of 25.53 per 1000 (95% CI: 21.05-30.98) person-days of follow-up. The overall median survival time was 44 days. The independent predictors of mortality after diagnosis of traumatic brain injury were admission Glasgow coma scale score <= 8 (adjusted hazard ratio (AHR): 4.85; 95% confidence interval (CI): 1.73-13.62), bilateral non-reactive pupils at admission (AHR: 2.00 (95% CI: 1.10-3.71), elevated systolic blood pressure at admission (AHR: 0.31; 95% CI:0.11-0.86), elevated diastolic blood pressure at admission (AHR: 3.54; 95% CI: 1.33-9.43), and haematoma evacuation (AHR: 0.42; 95% CI: 0.16-0.90). Discussion: The Survival status of traumatic brain injury patients was relatively low in this study. Glasgow coma scale score, bilateral non-reactive pupils, and elevated blood pressure were significant predictors of mortality. Further prospective follow-up studies that include residence and occupation are recommended.	[Amare, Abraham Tsedalu; Birlie, Tekalign Amera] Debre Tabor Univ, Coll Hlth Sci, Dept Adult Hlth Nursing, Debre Tabor, Ethiopia; [Tesfaye, Tadesse Dagget; Ali, Awole Seid] Bahir Dar Univ, Coll Hlth Sci, Dept Adult Hlth Nursing, Bahir Dar, Ethiopia; [Woelile, Tamiru Alene] Wolaita Sodo Univ, Coll Hlth Sci, Dept Pediat & Neonatal Nursing, Sodo, Ethiopia; [Kebede, Worku Misganew] Debre Berhan Univ, Dept Adult Hlth Nursing Coll Hlth Sci, Debre Berhan, Debre Berhan, Ethiopia; [Tassew, Sheganew Fetene] Debre Tabor Univ, Dept Emergency & Crit Care Nursing Coll Hlth Sci, Debre Tabor, Debre Tabor, Ethiopia; [Chanie, Ermias Sisay; Fleke, Dejen Getaneh] Debre Tabor Univ, Coll Hlth Sci, Dept Pediat & Child Hlth Nursing, Debre Tabor, Ethiopia		Amare, AT (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Adult Hlth Nursing, Debre Tabor, Ethiopia.	tsedalu136@gmail.com	Chanie, Ermias Sisay/ABG-5569-2021	Chanie, Ermias Sisay/0000-0002-3124-5380; Getaneh, Dejen/0000-0002-0816-1744; Birlie, Tekalign Amera/0000-0002-2378-0156; Tsedalu, Abraham/0000-0002-0186-9627	Debre Tabor University	We would like to thank the staff at Felegehiwot Comprehensive Specialized Hospital, including record office workers, data collectors, and supervisors whose assistance was invaluable for the completion of this study. We also thank Debre Tabor University for funding this study.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Areas FZ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00432; Ayele TA, 2017, OPEN ACCESS SURG, V10, P25, DOI 10.2147/OAS.S126043; Boniface Respicious, 2017, Pan Afr Med J, V26, P140, DOI 10.11604/pamj.2017.26.140.10345; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dawodu ST., 2007, E MED WEBMD; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; El-Menyar A, 2018, WORLD J SURG, V42, P1346, DOI 10.1007/s00268-017-4310-2; Eshete A, 2018, ETHIOP J HEALTH SCI, V28, P323, DOI 10.4314/ejhs.v28i3.10; Fathalla H, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18371; Gebrekirkos FA, 2017, ETHIOP MED J, V55; Grigorakos L, 2016, J NEUROSCI CLIN RES, P2; Herrera-Melero MC, 2015, BRAIN INJURY, V29, P1439, DOI 10.3109/02699052.2015.1071428; Howle AA, 2011, BRAIN IMPAIR, V12, P179; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liesirova K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209764; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Onwuchekwa R. C., 2018, Journal of Medicine in the Tropics, V20, P24, DOI 10.4103/jomt.jomt_28_17; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Sut N, 2010, ULUS TRAVMA ACIL CER, V16, P149; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Team Wbd, 2019, NEW COUNTR CLASS INC; Wang KW, 2013, J NEUROSURG, V118, P358, DOI 10.3171/2012.10.JNS127; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; World Bank, 2019, NEW COUNTR CLASS INC	39	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.	DEC	2021	11	4					396	403		10.1016/j.afjem.2021.06.003			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WN2QN	WOS:000711618600003	34703730	Green Published, gold			2022-02-06	
J	Ashina, H; Al-Khazali, HM; Iljazi, A; Ashina, S; Amin, FM; Lipton, RB; Schytz, HW				Ashina, Hakan; Al-Khazali, Haidar Muhsen; Iljazi, Afrim; Ashina, Sait; Amin, Faisal Mohammad; Lipton, Richard B.; Schytz, Henrik Winther			Psychiatric and cognitive comorbidities of persistent post-traumatic headache attributed to mild traumatic brain injury	JOURNAL OF HEADACHE AND PAIN			English	Article						Sleep; Anxiety; Depression; Cognitive impairment; Post-traumatic stress disorder	STRESS-DISORDER; RISK-FACTORS; PREVALENCE; INSTRUMENT; ANXIETY; SYSTEMS; PAIN	Objective To investigate the association of psychiatric and cognitive comorbidities with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (TBI). Methods A total of 100 patients with persistent PTH attributed to mild TBI and 100 age- and gender-matched healthy controls free of mild TBI were enrolled between July 2018 and June 2019. Quality of sleep was evaluated using the Pittsburgh Sleep Quality Index, while symptoms of anxiety and depression were assessed using the Hospital Anxiety and Depression Scale. Cognitive impairment was evaluated using the Montreal Cognitive Assessment questionnaire, while post-traumatic stress disorder (PTSD) was assessed using the Harvard Trauma Questionnaire. Results In 100 patients with persistent PTH, 85% reported poor quality sleep, compared with 42% of healthy controls (P < 0.01). The relative frequency of probable to high risk of anxiety was 52% in the persistent PTH group vs. 8% in healthy controls (P < 0.01), while the relative frequency of probable to high risk of depression was 42% in the persistent PTH group vs. 2% in healthy controls (P < 0.01). Furthermore, 27% of the patients with persistent PTH had mild cognitive impairment while 10% had probable PTSD. Conclusions Poor quality of sleep as well as symptoms suggestive of anxiety and depression were more common in patients with persistent PTH than healthy controls. Clinicians should screen patients with persistent PTH for these comorbidities and develop treatment plans that account for their presence.	[Ashina, Hakan; Al-Khazali, Haidar Muhsen; Iljazi, Afrim; Amin, Faisal Mohammad; Schytz, Henrik Winther] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol,Danish Headache Ctr, Valdemar Hansen Vej 5, DK-2600 Glostrup, Denmark; [Ashina, Hakan] Rigshosp, Dept Neurorehabil & Traumat Brain Injury, Copenhagen, Denmark; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Comprehens Headache Ctr, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Ashina, Sait] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Lipton, Richard B.] Montefiore Headache Ctr, Bronx, NY USA		Schytz, HW (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol,Danish Headache Ctr, Valdemar Hansen Vej 5, DK-2600 Glostrup, Denmark.	henrik.winther.schytz.01@regionh.dk	Lipton, Richard Bruce/AAY-2818-2021	Schytz, Henrik Winther/0000-0002-6262-2986; Ashina, Sait/0000-0003-3973-6640; Ashina, Hakan/0000-0002-6268-727X	Rigshospitalet Research Foundation [F-23340-02]; American Brain Foundation; American Academy of Neurology; International Headache Society	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this Article: The study was supported by a research grant from Rigshospitalet Research Foundation (F-23340-02) as well as a research grant from the American Brain Foundation, American Academy of Neurology and the International Headache Society.	Ashina H, 2021, LANCET NEUROL, V20, P460, DOI 10.1016/S1474-4422(21)00094-6; Ashina H, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01202-6; Ashina H, 2020, ANN NEUROL, V88, P1220, DOI 10.1002/ana.25915; Ashina H, 2020, CEPHALALGIA, V40, P1276, DOI 10.1177/0333102420941115; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina M, 2021, LANCET, V397, P1485, DOI 10.1016/S0140-6736(20)32160-7; Ashina S, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00257-2; Buse DC, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1084-y; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CHIBNALL JT, 1994, HEADACHE, V34, P357, DOI 10.1111/j.1526-4610.1994.hed3406357.x; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Iljazi A, 2020, BRAIN INJURY, V34, P857, DOI 10.1080/02699052.2020.1764104; Iljazi A, 2020, NEUROL SCI, V41, P2737, DOI 10.1007/s10072-020-04458-7; Kim SK, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01103-8; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Wang Shuu-Jiun, 2010, Front Neurol, V1, P16, DOI 10.3389/fneur.2010.00016; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	33	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2021	22	1							83	10.1186/s10194-021-01287-7			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TQ8YP	WOS:000678563800001	34311696	gold, Green Published			2022-02-06	
J	Babl, FE; Rausa, VC; Borland, ML; Kochar, A; Lyttle, MD; Phillips, N; Gilhotra, Y; Dalton, S; Cheek, JA; Furyk, J; Neutze, J; Bressan, S; Davis, GA; Anderson, V; Williams, A; Oakley, E; Dalziel, SR; Crowe, LM; Hearps, SJC				Babl, Franz E.; Rausa, Vanessa C.; Borland, Meredith L.; Kochar, Amit; Lyttle, Mark D.; Phillips, Natalie; Gilhotra, Yuri; Dalton, Sarah; Cheek, John A.; Furyk, Jeremy; Neutze, Jocelyn; Bressan, Silvia; Davis, Gavin A.; Anderson, Vicki; Williams, Amanda; Oakley, Ed; Dalziel, Stuart R.; Crowe, Louise M.; Hearps, Stephen J. C.		Paediat Res Emergency Dept Int Col	Characteristics of concussion based on patient age and sex: a multicenter prospective observational study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; pediatric; emergency department; epidemiology; trauma	EMERGENCY-DEPARTMENT VISITS; SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PEDIATRIC CONCUSSIONS; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; DISTRESS; PARENTS	OBJECTIVE Children with concussion frequently present to emergency departments (EDs). There is limited understanding of the differences in signs, symptoms, and epidemiology of concussion based on patient age. Here, the authors set out to assess the association between age and acute concussion presentations. METHODS The authors conducted a multicenter prospective observational study of head injuries at 10 EDs in Australia and New Zealand. They identified children aged 5 to < 18 years, presenting with a Glasgow Coma Scale score of 13-15, presenting < 24 hours postinjury, with no abnormalities on CT if performed, and one or more signs or symptoms of concussion. They extracted demographic, injury-related, and signs and symptoms information and stratified it by age group (5-8, 9-12, 13 to < 18 years). RESULTS Of 8857 children aged 5 to < 18 years, 4709 patients met the defined concussion criteria (5-8 years, n = 1546; 9-12 years, n = 1617; 13 to < 18 years, n = 1546). The mean age of the cohort was 10.9 years, and approximately 70% of the patients were male. Sport-related concussion accounted for 43.7% of concussions overall, increasing from 19.1% to 48.9% to 63.0% in the 5-8, 9-12, and 13 to < 18 years age groups. The most common acute symptoms postinjury were headache (64.6%), disorientation (36.2%), amnesia (30.0%), and vomiting (27.2%). Vomiting decreased with increasing age and was observed in 41.7% of the 5-8 years group, 24.7% of the 9-12 years group, and 15.4% of the 13 to < 18 years group, whereas reported loss of consciousness (LOC) increased with increasing age, occurring in 9.6% in the 5-8 years group, 21.0% in the 9-12 years group, 36.7% in the 13 to < 18 years group, and 22.4% in the entire study cohort. Headache, amnesia, and disorientation followed the latter trajectory. Symptom profiles were broadly similar between males and females. CONCLUSIONS Concussions presenting to EDs were more sports-related as age increased. Signs and symptoms differed markedly across age groups, with vomiting decreasing and headache, LOC, amnesia, and disorientation increasing with increasing age.	[Babl, Franz E.; Cheek, John A.; Oakley, Ed] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Babl, Franz E.; Rausa, Vanessa C.; Cheek, John A.; Bressan, Silvia; Davis, Gavin A.; Anderson, Vicki; Williams, Amanda; Oakley, Ed; Crowe, Louise M.; Hearps, Stephen J. C.] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Cheek, John A.; Oakley, Ed; Crowe, Louise M.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Melbourne, Vic, Australia; [Anderson, Vicki; Crowe, Louise M.] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Crowe, Louise M.] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Lyttle, Mark D.] Univ West England, Fac Hlth & Life Sci, Bristol, Avon, England; [Phillips, Natalie; Gilhotra, Yuri] Queensland Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Fac Med, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Melbourne, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Furyk, Jeremy] Univ Hosp Geelong, Emergency Dept, Geelong, Vic, Australia; [Furyk, Jeremy] Deakin Univ, Fac Hlth, Sch Med, Geelong, Vic, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Child & Youth Hlth, Auckland, New Zealand; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Res, Parkville, Vic, Australia.	franz.babl@rch.org.au			National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Melbourne Campus Clinician-Scientist Fellowship, Melbourne, Australia; Cure Kids New Zealand	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. Dr. Babl's time was partly funded by an NHMRC Practitioner Fellowship, Canberra, Australia, and a Melbourne Campus Clinician-Scientist Fellowship, Melbourne, Australia. Dr. Dalziel's time was partly funded by Cure Kids New Zealand.	Alsalaheen B, 2021, BRAIN INJURY, V35, P698, DOI 10.1080/02699052.2021.1896034; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Australian Bureau of Statistics, 2015, PARTICIPATION SPORT; Australian Sports Commission, 2018, AUSPLAY FOC CHILDR P; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Cheng J, 2019, SPORTS HEALTH, V11, P486, DOI 10.1177/1941738119877186; Clair R, 2020, APPL NEUROPSYCH-CHIL, V9, P206, DOI 10.1080/21622965.2018.1556102; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Reid Daniel B C, 1800, R I Med J (2013), V103, P71; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Russo RN, 2012, DEV NEUROREHABIL, V15, P13, DOI 10.3109/17518423.2011.625558; Schilling S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010351; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; TEASDALE G, 1983, LANCET, V2, P678; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22; Yaramothu C, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100257; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	41	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2021	28	6					647	656		10.3171/2021.6.PEDS20953			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	XN9ER	WOS:000729800900004	34598158				2022-02-06	
J	Becker, ML; Maietta, JE; Strong, MN; Kuwabara, HC; Kinsora, TF; Ross, SR; Allen, DN				Becker, Megan L.; Maietta, Julia E.; Strong, Michelle N.; Kuwabara, Hana C.; Kinsora, Thomas F.; Ross, Staci R.; Allen, Daniel N.			Spanish and English Language-Based Differences in Cognitive Performance and Symptom Reporting on ImPACT Baseline Concussion Assessment	JOURNAL OF PEDIATRIC NEUROPSYCHOLOGY			English	Article; Early Access						Concussion; Athletes; ImPACT; Spanish; Cultural assessment; Language	NEUROCOGNITIVE PERFORMANCE; POST; EDUCATION; RETURN; NORMS	Differences in performance on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) have been reported between Spanish and English-speaking individuals. The current study addressed whether these differences could be accounted for by primary language preference, language of ImPACT administration, or a combination of the two. Differences in cognitive and symptom domain scores from ImPACT baseline testing were compared for 264 high school athletes. These high school athletes were either monolingual English speakers who were tested in English (EE; n = 88), bilingual Spanish/English speakers who were tested in English (SE; n = 88), or monolingual and bilingual Spanish speakers who were tested in Spanish (SS; n = 88). These participants were selected from a larger sample and individually matched on variables that could contribute to differences in baseline ImPACT performance. Results indicated the EE group performed better on the Visual Motor Speed and Reaction Time cognitive composites than the SE and SS groups. The SS and SE groups also reported significantly more affective symptoms than the EE group, although group differences in the PCSS total score and other domain scores were not significant. These results provide confirmation of differences between language groups' cognitive and symptom reporting on ImPACT, and further suggest that these differences are not primarily accounted for by confounding factors, language of test administration, or primary language preference. Additional research is needed to determine whether these ImPACT cognitive and symptom differences result from test bias, linguistic influences, cultural considerations, or a combination of these and other factors.	[Becker, Megan L.; Maietta, Julia E.; Strong, Michelle N.; Kuwabara, Hana C.; Kinsora, Thomas F.; Ross, Staci R.; Allen, Daniel N.] Univ Nevada, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu					Agranovich AV, 2011, J INT NEUROPSYCH SOC, V17, P692, DOI 10.1017/S1355617711000592; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Ardila A, 2005, NEUROPSYCHOL REV, V15, P185, DOI 10.1007/s11065-005-9180-y; Ardila A., 2007, INT HDB CROSS CULTUR, P23; Blake ML, 2015, ARCH CLIN NEUROPSYCH, V30, P302, DOI 10.1093/arclin/acv021; Brett BL, 2017, DEV NEUROPSYCHOL, V42, P70, DOI 10.1080/87565641.2016.1243114; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd ed.; Echemendia RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P240, DOI 10.1093/arclin/acz077; Fletcher-Janzen E., 2000, HDB CROSS CULTURAL N; Gupta S, 2011, J INT NEUROPSYCH SOC, V17, P163, DOI 10.1017/S1355617710001384; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Judd T, 2009, ARCH CLIN NEUROPSYCH, V24, P127, DOI 10.1093/arclin/acp016; Karr JE, 2021, J ATHL TRAINING, V56, P879, DOI 10.4085/1062-6050-0345.20; Karr JE, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1850867; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell M. R, 2018, IMPACT ADM INTERPRET; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Maietta JE, 2021, PSYCHOL ASSESSMENT, V33, P746, DOI 10.1037/pas0001014; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Puente AE., 2009, MULTICULTURAL PSYCHO, P417; Puente AE., 1998, WISC 3 CLIN USE INTE, P227, DOI [10.1016/B978-012564930-8/50012-7, DOI 10.1016/B978-012564930-8/50012-7]; Rabow MW, 2005, PAIN MED, V6, P235, DOI 10.1111/j.1526-4637.2005.05037.x; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Shuttleworth-Edwards AB, 2016, CLIN NEUROPSYCHOL, V30, P975, DOI 10.1080/13854046.2016.1204011; Shuttleworth-Edwards AB, 2017, S AFR J PSYCHOL, V47, P3, DOI 10.1177/0081246316684465; Suchy Y, 2016, CLIN NEUROPSYCHOL, V30, P973, DOI 10.1080/13854046.2016.1225363; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Treiber FA, 2002, PSYCHOSOM MED, V64, P707, DOI 10.1097/01.PSY.0000021952.59258.1C; Tsushima WT, 2020, CLIN J SPORT MED, V30, P52, DOI 10.1097/JSM.0000000000000567; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	39	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2199-2681	2199-2673		J PEDIATR NEUROPSYCH	J. Pediatr. Neuropsych.												10.1007/s40817-021-00114-w		DEC 2021	10	Psychology, Clinical; Psychology, Developmental; Clinical Neurology; Psychology	Emerging Sources Citation Index (ESCI)	Psychology; Neurosciences & Neurology	XG3DL	WOS:000724636700001					2022-02-06	
J	Belding, JN; Englert, R; Bonkowski, J; Thomsen, CJ				Belding, Jennifer N.; Englert, Robyn; Bonkowski, James; Thomsen, Cynthia J.			Occupational Risk of Low-Level Blast Exposure and TBI-Related Medical Diagnoses: A Population-Based Epidemiological Investigation (2005-2015)	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						blast; low-level blast; high-level blast; TBI; concussion; overpressure; military; epidemiology; healthcare	OPERATION IRAQI FREEDOM; TRAUMATIC BRAIN-INJURY; PERFORMANCE	Because traumatic brain injury (TBI)-most often caused by exposure to high-level blast (HLB)-is a leading cause of medical evacuations of deployed U.S. service members in recent conflicts, researchers seek to identify risk factors for TBI. Previous research using self-reported data has identified low-level blast (LLB) as one such risk factor and suggests an association with susceptibility to and symptoms associated with TBI. This article presents a population-based study of all branches of military service that examines the association between occupational risk for LLB and both clinically diagnosed TBIs-from concussions to severe and penetrating TBIs-and conditions commonly comorbid with concussion. Using archival medical and career records from >2 million service members between 2005-2015, this work demonstrates that occupational risk of LLB is associated with any TBI, mild TBI, moderate TBI, cognitive problems, communication problems, hearing problems, headaches, any behavioral health condition, anxiety, drug abuse/dependence, alcohol abuse/dependence, delirium/dementia, posttraumatic stress disorder, post-concussive syndrome, tinnitus, fatigue, and migraines. Understanding the full scope of the effects of LLB on service members will help ensure the health and readiness of service members and may influence both military policy and clinical practice guidelines for blast-induced injuries.	[Belding, Jennifer N.; Englert, Robyn; Bonkowski, James] Leidos Inc, San Diego, CA 92106 USA; [Belding, Jennifer N.; Englert, Robyn; Bonkowski, James; Thomsen, Cynthia J.] Naval Hlth Res Ctr, San Diego, CA 92106 USA		Belding, JN (corresponding author), Leidos Inc, San Diego, CA 92106 USA.; Belding, JN (corresponding author), Naval Hlth Res Ctr, San Diego, CA 92106 USA.	jennifer.n.belding.ctr@mail.mil; robyn.m.englert.ctr@mail.mil; james.f.bonkowski3.ctr@mail.mil; cynthia.j.thomsen.civ@mail.mil					Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Belanger Heather G, 2020, J Spec Oper Med, V20, P87; Belding JN, 2021, J HEAD TRAUMA REHAB, V36, pE397, DOI 10.1097/HTR.0000000000000715; Belding JN, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.695496; Belding JN, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.628782; Belding JN, 2020, MIL MED, V185, pE538, DOI 10.1093/milmed/usz289; Belding JN, 2020, J NEUROTRAUM, V37, P2219, DOI 10.1089/neu.2020.6997; Bonnette S, 2018, EXP BRAIN RES, V236, P2691, DOI 10.1007/s00221-018-5328-x; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Carr W, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00619; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Defense Manpower Data Center, DEF CAS AN SYST CONF; Denny J W, 2020, BMJ Mil Health, DOI 10.1136/bmjmilitary-2020-001655; Department of Defense and Department of Veterans Affairs, 2016, VA DOD CLIN PRACT GU; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Gunderson EKE, 2005, MIL MED, V170, P172; Kubli LR, 2017, NOISE HEALTH, V19, P227, DOI 10.4103/nah.NAH_58_16; Lee KM, 2020, J AM ASSOC NURSE PRA, V32, P720, DOI 10.1097/JXX.0000000000000532; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Radigan LJ, 2018, J HEAD TRAUMA REHAB, V33, pE51, DOI 10.1097/HTR.0000000000000361; Simmons M.M., 2020, NEUROLOGICAL EFFECTS, DOI [10.7249/RR2350, DOI 10.7249/RR2350]; St Onge Paul, 2011, US Army Med Dep J, P97; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	32	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2021	18	24							12925	10.3390/ijerph182412925			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	YJ7WB	WOS:000744739300001	34948535	Green Published			2022-02-06	
J	Berkowitz, S; Chapman, J; Dori, A; Gofrit, SG; Maggio, N; Shavit-Stein, E				Berkowitz, Shani; Chapman, Joab; Dori, Amir; Gofrit, Shany Guly; Maggio, Nicola; Shavit-Stein, Efrat			Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems	BIOMEDICINES			English	Article						synaptic transmission; node of Ranvier; thrombin; neuroinflammation; C1q; C3; stroke	ACTIVATED RECEPTOR 1; SODIUM-CHANNEL CLUSTERS; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; TISSUE FACTOR ACTIVITY; THROMBIN-RECEPTOR; COGNITIVE IMPAIRMENT; GENE-EXPRESSION; CASCADE; INFLAMMATION	Complement and coagulation are both key systems that defend the body from harm. They share multiple features and are similarly activated. They each play individual roles in the systemic circulation in physiology and pathophysiology, with significant crosstalk between them. Components from both systems are mapped to important structures in the central nervous system (CNS) and peripheral nervous system (PNS). Complement and coagulation participate in critical functions in neuronal development and synaptic plasticity. During pathophysiological states, complement and coagulation factors are upregulated and can modulate synaptic transmission and neuronal conduction. This review summarizes the current evidence regarding the roles of the complement system and the coagulation cascade in the CNS and PNS. Possible crosstalk between the two systems regarding neuroinflammatory-related effects on synaptic transmission and neuronal conduction is explored. Novel treatment based on the modulation of crosstalk between complement and coagulation may perhaps help to alleviate neuroinflammatory effects in diseased states of the CNS and PNS.	[Berkowitz, Shani; Chapman, Joab; Dori, Amir; Gofrit, Shany Guly; Maggio, Nicola; Shavit-Stein, Efrat] Chaim Sheba Med Ctr, Dept Neurol, IL-5266202 Ramat Gan, Israel; [Berkowitz, Shani; Chapman, Joab; Dori, Amir; Maggio, Nicola; Shavit-Stein, Efrat] Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Robert & Martha Harden Chair Mental & Neurol Dis, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Dori, Amir; Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-6997801 Ramat Gan, Israel; [Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, IL-6997801 Tel Aviv, Israel		Shavit-Stein, E (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, IL-5266202 Ramat Gan, Israel.; Shavit-Stein, E (corresponding author), Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, IL-6997801 Tel Aviv, Israel.	shanib2@mail.tau.ac.il; jchapman@tauex.tau.ac.il; amir.dori@sheba.health.gov.il; amir.dori@sheba.health.gov.il; nicola.maggio@sheba.health.gov.il; Efrat.ShavitStein@sheba.health.gov.il	Chapman, Joab/E-4598-2010	Berkowitz, Shani H/0000-0001-6907-8023; Gofrit, Shany/0000-0001-6104-606X; Dori, Amir/0000-0003-4633-1481; Shavit-Stein, Efrat/0000-0003-3373-8397			Abe T, 2020, SHOCK, V54, P198, DOI 10.1097/SHK.0000000000001504; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Alawieh A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6459; Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Anjum A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207533; Antoniak S, 2018, RES PRACT THROMB HAE, V2, P549, DOI 10.1002/rth2.12109; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Baudouin C, 2021, PROG RETIN EYE RES, V83, DOI 10.1016/j.preteyeres.2020.100916; Becker D, 2014, NEUROPHARMACOLOGY, V86, P212, DOI 10.1016/j.neuropharm.2014.07.013; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Beura SK, 2022, MOL NEUROBIOL, V59, P137, DOI 10.1007/s12035-021-02587-4; Blom AM, 2017, J INTERN MED, V282, P116, DOI 10.1111/joim.12606; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Calsavara AJC, 2018, AUST CRIT CARE, V31, P242, DOI 10.1016/j.aucc.2017.06.001; Canobbio I, 2019, RES PRACT THROMB HAE, V3, P564, DOI 10.1002/rth2.12254; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; CARSON SD, 1990, BLOOD, V76, P361; Chamberlain JL, 2021, J NEUROL, V268, P1643, DOI 10.1007/s00415-019-09498-4; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Cong QF, 2020, NAT NEUROSCI, V23, P1067, DOI 10.1038/s41593-020-0672-0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; COUGHLIN SR, 1994, SEMIN HEMATOL, V31, P270; COUGHLIN SR, 1994, P NATL ACAD SCI USA, V91, P9200, DOI 10.1073/pnas.91.20.9200; Crane JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-34; D'Este E, 2017, P NATL ACAD SCI USA, V114, pE191, DOI 10.1073/pnas.1619553114; Dalakas MC, 2020, NAT REV NEUROL, V16, P601, DOI 10.1038/s41582-020-0400-0; Davidson AI, 2017, J PERIPHER NERV SYST, V22, P4, DOI 10.1111/jns.12194; Davis AE, 2008, MOL IMMUNOL, V45, P4057, DOI 10.1016/j.molimm.2008.06.028; De Ceunynck K, 2018, P NATL ACAD SCI USA, V115, pE982, DOI 10.1073/pnas.1718600115; de Jonge RR, 2004, HUM MOL GENET, V13, P295, DOI 10.1093/hmg/ddh029; De Luca C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102128; DESCHEPPER CF, 1991, MOL BRAIN RES, V11, P355, DOI 10.1016/0169-328X(91)90045-Y; Devaux JJ, 2012, AM J PATHOL, V181, P1402, DOI 10.1016/j.ajpath.2012.06.034; Douglas S, 1999, BRIT J HAEMATOL, V107, P22, DOI 10.1046/j.1365-2141.1999.01689.x; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Dutta DJ, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.576609; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; Ellis CA, 1999, J BIOL CHEM, V274, P13718, DOI 10.1074/jbc.274.19.13718; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; Festoff BW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00059; Foley JH, 2016, THROMB RES, V141, pS50, DOI 10.1016/S0049-3848(16)30365-6; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fox OW, 2020, J THROMB HAEMOST, V18, P6, DOI 10.1111/jth.14643; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Garred P, 2021, PHARMACOL REV, V73, P792, DOI 10.1124/pharmrev.120.000072; Gera O, 2018, NEUROSCIENCE, V371, P445, DOI 10.1016/j.neuroscience.2017.12.035; Gera O, 2016, NEUROSCIENCE, V339, P587, DOI 10.1016/j.neuroscience.2016.10.034; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Glazner GW, 1997, DEV BRAIN RES, V99, P148, DOI 10.1016/S0165-3806(96)00213-1; Goetzl EJ, 2020, FASEB J, V34, P3359, DOI 10.1096/fj.201902842R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Gofrit SG, 2019, NEURAL REGEN RES, V14, P2043, DOI 10.4103/1673-5374.262568; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hammond JW, 2020, BRAIN BEHAV IMMUN, V87, P739, DOI 10.1016/j.bbi.2020.03.004; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Han X, 2021, RES PRACT THROMB HAE, V5, P104, DOI 10.1002/rth2.12459; Howard JF, 2018, ANN NY ACAD SCI, V1412, P113, DOI 10.1111/nyas.13522; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Kenawy HI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00215; Keshari RS, 2017, BLOOD, V130, P2678, DOI 10.1182/blood-2017-06-788216; Kira J, 2019, NEUROCHEM INT, V130, DOI 10.1016/j.neuint.2018.12.011; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Krisinger MJ, 2012, BLOOD, V120, P1717, DOI 10.1182/blood-2012-02-412080; Lai WF, 2018, INFLAMMATION, V41, P449, DOI 10.1007/s10753-017-0701-7; Lee JD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1217-2; Levin ME, 2008, PAIN, V137, P182, DOI 10.1016/j.pain.2007.11.005; Li SM, 2020, INT IMMUNOPHARMACOL, V87, DOI 10.1016/j.intimp.2020.106814; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luchena C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2530414; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Mehta N, 2008, STROKE, V39, P3236, DOI 10.1161/STROKEAHA.108.514687; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Mikami T., 2021, NEUROLOGY, P96; Mosnier LO, 2006, FRONT BIOSCI-LANDMRK, V11, P2381, DOI 10.2741/1977; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; MUHLFELDER TW, 1979, J CLIN INVEST, V63, P147, DOI 10.1172/JCI109269; Nesargikar PN, 2012, EUR J MICROBIOL IMMU, V2, P103, DOI 10.1556/EuJMI.2.2012.2.2; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Orhun G, 2019, NOROPSIKIYATRI ARS, V56, P63, DOI 10.29399/npa.23212; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x; Peterson SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11410-x; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Peterson SL, 2014, EXP NEUROL, V258, P35, DOI 10.1016/j.expneurol.2014.04.028; Phongsisay V, 2008, J NEUROIMMUNOL, V205, P101, DOI 10.1016/j.jneuroim.2008.09.016; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; Pompili E, 2021, NEURAL REGEN RES, V16, P1223, DOI 10.4103/1673-5374.300446; Pompili E, 2020, EUR J HISTOCHEM, V64, P104, DOI 10.4081/ejh.2020.3109; Pompili E, 2019, J NEURAL TRANSM, V126, P1259, DOI 10.1007/s00702-019-02075-z; Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004; Quast I, 2016, ANN CLIN TRANSL NEUR, V3, P730, DOI 10.1002/acn3.331; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Rasband MN, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020495; Rosen AM, 2010, ADV EXP MED BIOL, V703, P75, DOI 10.1007/978-1-4419-5635-4_6; Saito H, 2011, J THROMB HAEMOST, V9, P352, DOI 10.1111/j.1538-7836.2011.04362.x; Salcedo RM, 1998, J MOL NEUROSCI, V10, P113, DOI 10.1007/BF02737122; Sallah S, 1997, ANN HEMATOL, V75, P1, DOI 10.1007/s002770050305; Salvany S, 2021, GLIA, V69, P1216, DOI 10.1002/glia.23959; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Shavit E, 2008, BRAIN, V131, P1113, DOI 10.1093/brain/awn005; Shavit-Stein E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248431; Shavit-Stein E, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111552; Shavit-Stein E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103419; Shavit-Stein E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219453; Shavit-Stein E, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01139; Shlobin NA, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040562; Sokolova E, 2008, THROMB HAEMOSTASIS, V100, P576, DOI 10.1160/TH08-03-0131; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stathopoulos P, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.260; Stein ES, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7692182; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Stern RM, 2019, THER ADV HEMATOL, V10, DOI 10.1177/2040620719874728; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Tegla CA, 2011, IMMUNOL RES, V51, P45, DOI 10.1007/s12026-011-8239-5; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang HB, 2017, P NATL ACAD SCI USA, V114, P10948, DOI 10.1073/pnas.1707364114; Wiegner R, 2016, IMMUNOBIOLOGY, V221, P1073, DOI 10.1016/j.imbio.2016.06.005; Willison HJ, 2008, J NEUROIMMUNOL, V201, P172, DOI 10.1016/j.jneuroim.2008.05.028; Winston CN, 2019, ALZH DEMENT-DADM, V11, P61, DOI 10.1016/j.dadm.2018.11.002; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yell PC, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0512-6; Yilmaz M, 2021, NAT NEUROSCI, V24, P214, DOI 10.1038/s41593-020-00763-8; Yin W, 2008, PLATELETS, V19, P225, DOI 10.1080/09537100701777311; Ziabska K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094675; Ziliotto N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00409	146	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	DEC	2021	9	12							1950	10.3390/biomedicines9121950			15	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	XW9RA	WOS:000735945600001	34944766	Green Published			2022-02-06	
J	Biberthaler, P; Musaelyan, K; Krieg, S; Meyer, B; Stimmer, H; Zapf, J; von Matthey, F; Chandran, R; Marino, JA; Beligere, G; Hoffmann, M; Zhang, HW; Datwyler, SA; McQuiston, B				Biberthaler, Peter; Musaelyan, Ksenia; Krieg, Sandro; Meyer, Bernhard; Stimmer, Herbert; Zapf, Julian; von Matthey, Francesca; Chandran, Raj; Marino, Jaime A.; Beligere, Gangamani; Hoffmann, Markus; Zhang, Hongwei; Datwyler, Saul A.; McQuiston, Beth			Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions	NEUROTRAUMA REPORTS			English	Article						blood biomarkers; glial fibrillary acidic protein; point-of-care platform; S100 calcium-binding protein B; traumatic brain injury; ubiquitin C-terminal hydrolase L1	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; SERUM-LEVELS; BIOMARKERS; S100B; SEVERITY; MILD	This pilot study aimed to evaluate the association of plasma ubiquitin C-terminal hydrolase-L1 (UCH-L1), glial fibrillary acidic protein (GFAP), and S100 calcium-binding protein B (S100B) with intracranial abnormalities visible on a computed tomography (CT) scan (CT positive) and injury severity in acute traumatic brain injury (TBI). For these purposes, a cohort of 109 adult TBI patients was recruited within 6 h from the injury event. A hyperacute subcohort of 20 patients who had their blood collected within 2 h from injury was analyzed separately for early acute biomarker levels. Levels of GFAP and UCH-L1 were analyzed using the prototype Abbott i-STAT (TM) TBI Plasma Test (Abbott Laboratories, Abbot Park, IL), alongside S100B measurement (Elecsys; Roche Diagnostics, Penzberg, Germany). In the hyperacute subcohort, GFAP and UCH-L1, but not S100B, levels were significantly higher in the CT-positive group compared to CT-negative patients. AUC values for differentiation between CT-positive and CT-negative patients were 0.97 for GFAP, 0.87 for UCH-L1, and 0.60 for S100B. Severity discrimination, defined by Glasgow Coma Scale (GCS) score, was then analyzed in the total patient cohort. Levels of all three biomarkers were significantly different between mild (GCS, 13-15) and moderate/severe (GCS, 3-12) injury groups. UCH-L1 showed the highest area under the curve value for severity discrimination (0.94), followed by GFAP (0.91) and S100B (0.83). These results support the clinical utility of GFAP and UCH-L1 as TBI biomarkers able to rule out CT-positive injury in acute TBI. Moreover, excellent differentiation of GFAP and UCH-L1 between mild and moderate/severe TBI groups affirms their close association with the underlying pathology.	[Biberthaler, Peter; Zapf, Julian; von Matthey, Francesca] Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, Ismaninger Str 22, D-81675 Munich, Germany; [Krieg, Sandro; Meyer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany; [Stimmer, Herbert] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, Munich, Germany; [Musaelyan, Ksenia; Chandran, Raj; Marino, Jaime A.; Beligere, Gangamani; Hoffmann, Markus; Datwyler, Saul A.; McQuiston, Beth] Core Diagnost, Abbott Pk, IL USA; [Zhang, Hongwei] Abbott Labs, Point Care Div, Abbott Pk, IL 60064 USA		Biberthaler, P (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, Ismaninger Str 22, D-81675 Munich, Germany.; Musaelyan, K (corresponding author), Abbott Labs, Abbott House,Vanwall Business Pk, Maidenhead SL6 4XE, Berks, England.	Peter.Biberthaler@mri.tum.de; Ksenia.Musaelyan@abbott.com	Krieg, Sandro M./L-8902-2016	Krieg, Sandro M./0000-0003-4050-1531	Abbott LaboratoriesAbbott Laboratories; AbbottAbbott Laboratories; US Army Medical Research and Materiel Commands US Army Medical Materiel Development Activity [W81XWH-17-C-0079]	This study was funded by Abbott Laboratories. Abbott has provided blinded analyses of blood biomarkers levels.; The development of Abbotts i-STAT GFAP andUCH-L1 tests were supported by the US Army Medical Research and Materiel Commands US Army Medical Materiel Development Activity under Contract No. W81XWH-17-C-0079. The views, opinions, and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Czeiter E, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102785; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lewis LM, 2020, J NEUROTRAUM, V37, P2624, DOI 10.1089/neu.2020.7071; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Muller M, 2020, INJURY, V51, P812, DOI 10.1016/j.injury.2020.03.012; Okonkwo DO, 2020, J NEUROTRAUM, V37, P2460, DOI 10.1089/neu.2020.7140; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Polacchini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17989; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zock M, 2011, NOTFALL RETTUNGSMED, V14, P261, DOI 10.1007/s10049-011-1425-0; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	37	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					617	625		10.1089/neur.2021.0048			9	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XS5PT	WOS:000732961400001	35018363	gold, Green Published			2022-02-06	
J	Bodien, YG; Barra, A; Temkin, NR; Barber, J; Foreman, B; Vassar, M; Robertson, C; Taylor, SR; Markowitz, AJ; Manley, GT; Giacino, JT; Edlow, BL				Bodien, Yelena G.; Barra, Alice; Temkin, Nancy R.; Barber, Jason; Foreman, Brandon; Vassar, Mary; Robertson, Claudia; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.; Giacino, Joseph T.; Edlow, Brian L.		TRACK-TBI Investigators	Diagnosing Level of Consciousness: The Limits of the Glasgow Coma Scale Total Score	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; consciousness; diagnosis; prognosis; Glasgow Coma Scale; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MOTOR COMPONENT; RECOMMENDATIONS; MORTALITY; SUM	In nearly all clinical and research contexts, the initial severity of a traumatic brain injury (TBI) is measured using the Glasgow Coma Scale (GCS) total score. The GCS total score however, may not accurately reflect level of consciousness, a critical indicator of injury severity. We investigated the relationship between GCS total scores and level of consciousness in a consecutive sample of 2455 adult subjects assessed with the GCS 69,487 times as part of the multi-center Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. We assigned each GCS subscale score combination a level of consciousness rating based on published criteria for the following disorders of consciousness (DoC) diagnoses: coma, vegetative state/unresponsive wakefulness syndrome, minimally conscious state, and post-traumatic confusional state, and present our findings using summary statistics and four illustrative cases. Participants had the following characteristics: mean (standard deviation) age 41.9 (17.6) years, 69% male, initial GCS 3-8 = 13%; 9-12 = 5%; 13-15 = 82%. All GCS total scores between 4-14 were associated with more than one DoC diagnosis; the greatest variability was observed for scores of 7-11. Further, a wide range of total scores was associated with identical DoC diagnoses. Importantly, a diagnosis of coma was only possible with GCS total scores of 3-6. The GCS total score does not accurately reflect level of consciousness based on published DoC diagnostic criteria. To improve the classification of patients with TBI and to inform the design of future clinical trials, clinicians and investigators should consider individual subscale behaviors and more comprehensive assessments when evaluating TBI severity.	[Bodien, Yelena G.; Barra, Alice; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Bodien, Yelena G.; Barra, Alice; Giacino, Joseph T.] Harvard Med Sch, Charlestown, MA USA; [Bodien, Yelena G.; Edlow, Brian L.] Massachusetts Gen Hosp, Ctr Neurotechnol & Neurorecovery, Dept Neurol, Boston, MA 02114 USA; [Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Boston, MA 02115 USA; [Barra, Alice] Univ Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Barra, Alice] Univ Hosp, Ctr Cerveau C2, Liege, Belgium; [Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Vassar, Mary; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Robertson, Claudia] Ben Taub Hosp, Baylor Coll Med, Dept Neurosurg, Houston, TX USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		Bodien, YG (corresponding author), Massachusetts Gen Hosp, 101 Merrimack St,Suite 300, Boston, MA 02114 USA.	ybodien@mgh.harvard.edu			NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS109627, RF1NS115268, UH3NS095554, U01 NS1365885, U01-NS086090]; National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living [90DPCP0008-01-00, 90DP0039]; James S. McDonnell Foundation; Tiny Blue Dot Foundation; U.S. Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176, X81XWH-18-DMRDP-PTCRA]; National Science FoundationNational Science Foundation (NSF) [1014552]; NIH Directors OfficeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2 HD101400]	This study was supported by the NIH National Institute of Neurological Disorders and Stroke (R21NS109627,RF1NS115268, UH3NS095554, U01 NS1365885, U01-NS086090), NIH Directors Office (DP2 HD101400),National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (90DPCP0008-01-00, 90DP0039),James S. McDonnell Foundation, and Tiny Blue Dot Foundation, U.S. Department of Defense (W81XWH-14-2-0176, X81XWH-18-DMRDP-PTCRA), National Science Foundation (1014552)	BHATTY GB, 1993, ACTA NEUROCHIR, V120, P132, DOI 10.1007/BF02112031; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Deeb AP, 2021, J SURG RES, V261, P385, DOI 10.1016/j.jss.2020.12.051; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Giacino JT, 2020, J NEUROTRAUM, V37, P357, DOI 10.1089/neu.2019.6429; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JENNETT B, 1979, J ROY COLL PHYS LOND, V13, P197; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martens G, 2020, ANN PHYS REHABIL MED, V63, P263, DOI 10.1016/j.rehab.2019.10.004; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Posner J.B., 2013, PATHOPHYSIOLOGY SIGN, pPR; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Sherer M., 2020, ARCH PHYS MED REHAB; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1983, LANCET, V2, P678; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zahniser E, 2019, ARCH CLIN NEUROPSYCH, V34, P1165, DOI 10.1093/arclin/acy103	35	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3295	3305		10.1089/neu.2021.0199			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700011	34605668				2022-02-06	
J	Borujeni, MS; Hosseini, SA; Akbarfahimi, N; Vahedi, M; Ebrahimi, E				Borujeni, Mehrdad Saeidi; Hosseini, Seyed Ali; Akbarfahimi, Nazila; Vahedi, Mohsen; Ebrahimi, Elaheh			Cognitive Orientation to Daily Occupational Performance Approach in Iranian Elderly Without Cognitive Impairment: A Single-Subject Study	ARCHIVES OF REHABILITATION			English	Article						Elderly; Activity; Participation; Cognitive Orientation to daily Occupational Performance (CO-OP)	FUNCTIONAL INDEPENDENCE MEASURE; OLDER-PEOPLE; EXECUTIVE DYSFUNCTION; STRATEGY USE; RELIABILITY; ADULTS; SERVICES; VALIDITY; DECLINE; STROKE	Objective The elderly population in Iran is growing. Aging is a natural phenomenon that causes changes in brain structures, including the frontal lobe and its connections, which are responsible for the brain's executive functions. These structural changes lead to problems in cognitive and physical functioning. Older people face problems such as decreased performance in daily activities of life and participation in social activities. In cognitive orientation to the daily occupational performance approach, the participants learn to improve their motor performance using cognitive strategies. The effectiveness of this approach has been reported in stroke, Traumatic Brain Injury (TBI), and some childhood disorders. This study aimed to investigate this approach's feasibility and its effect on the Iranian elderly without cognitive problems. Materials & Methods A single-subject study A-B design with follow-up was conducted. The participants were two older adults referred to Ramsar Health Center, Ramsar City, Iran. Before the intervention, to examine the participants' cognitive status, we used Digit Span Forward to measure attention and Digit Span Backwards and Digit Symbol to measure working memory. The participants' executive function was also assessed by the Wisconsin Card Sorting Test and Independence in Activity of Daily Living (ADL) with Functional Independent Measure (FIM). Each participant selected three functional goals by Canadian Occupational Performance Measure (COPM) for the focus of the Cognitive Orientation to daily Occupational Performance (CO-OP) intervention. After two weeks of evaluating participants' performance on selected goals using the Performance Quality Rating Scale (PQRS) to determine baseline performance, the intervention period began. During this period, a total of 8 to 10 sessions were held for each participant. In these sessions, the participants were first taught global problem-solving strategies (Goal, Plan, Do, Check), and then they were introduced to domain-specific strategies and their importance in executing activities. Afterward, through guided discovery during implementation, they were directed to use these strategies in their execution by guided discovery. During this period, the participant's performance on the selected goals was assessed five times by the PQRS. At the end of the intervention, to evaluate the long-term impact of the intervention, the participant's performance on the selected goals was re-evaluated by the PQRS three times. Results: The PQRS results showed that the performance of the first participant in each of the three selected activities improved. The results of the PQRS for the second participant showed a significant improvement in performance on the two selected goals. However, one of the selected goals did not show a significant change, which may be related to this goal's nature. Participants' net scores in FIM and COPM showed improved performance and satisfaction on selective goals, and performance independence remained constant. Conclusion: The CO-OP approach is feasible in the Iranian elderly population, and the preliminary results indicate the positive impact of this approach on improving the performance in the trained goals. However, given the study limitations in interpreting the results, it is recommended that future studies with a larger sample size be conducted to evaluate the effectiveness and efficacy of this approach. It is also recommended to use alternative tools instead of PQRS to evaluate the results, given the different cultural contexts.	[Borujeni, Mehrdad Saeidi; Akbarfahimi, Nazila; Ebrahimi, Elaheh] Univ Social Welf & Rehabil Sci, Fac Rehabil Sci, Dept Occupat Therapy, Tehran, Iran; [Hosseini, Seyed Ali] Univ Social Welf & Rehabil Sci, Fac Rehabil Sci, Hlth Res Ctr, Dept Occupat Therapy,Social Dept, Tehran, Iran; [Vahedi, Mohsen] Univ Social Welf & Rehabil Sci, Fac Rehabil Sci, Iranian Res Ctr Aging, Dept Biostat & Epidemiol, Tehran, Iran		Akbarfahimi, N (corresponding author), Univ Social Welf & Rehabil Sci, Fac Rehabil Sci, Dept Occupat Therapy, Tehran, Iran.	na.akbarfahimi@uswr.ac.ir		Saeidi Borujeni, Mehrdad/0000-0002-3145-8984			Afshar PF, 2016, GALEN MED J, V5, P1; Aguero-Torres H, 2002, J CLIN EPIDEMIOL, V55, P1007, DOI 10.1016/S0895-4356(02)00461-4; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Banimahdi R, 2019, IRANIAN J AGEING, V14, P64; Baumgartner, 2006, LEARNING ADULTHOOD C; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Carlson MC, 1999, J GERONTOL B-PSYCHOL, V54, pS262, DOI 10.1093/geronb/54B.5.S262; Chehelamirani N, 2016, ARCH REHABIL, V16, P334; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; De Coninck L, 2017, J AM GERIATR SOC, V65, P1863, DOI 10.1111/jgs.14889; Debaere F, 2004, NEUROPSYCHOLOGIA, V42, P855, DOI 10.1016/j.neuropsychologia.2003.12.010; Dehghan L., 2015, MOD REHABIL, V9, P25; FRANZEN MD, 1993, BRAIN INJURY, V7, P525, DOI 10.3109/02699059309008180; Glendinning C, 2008, HEALTH SOC CARE COMM, V16, P54, DOI 10.1111/j.1365-2524.2007.00724.x; Grigsby J, 1998, J AM GERIATR SOC, V46, P590, DOI 10.1111/j.1532-5415.1998.tb01075.x; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Jantzen KJ, 2007, NEUROPSYCHOLOGIA, V45, P673, DOI 10.1016/j.neuropsychologia.2006.07.020; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134, DOI 10.1093/gerona/62.10.1134; Kazdin A., 1982, SINGLE CASE RES DESI; Kazemi N, 2019, SALMAND, V13, P518, DOI 10.32598/SIJA.13.Special-Issue.518; Kratochwill TR., 2014, SINGLE CASE INTERVEN; LEE TD, 1994, QUEST, V46, P328, DOI 10.1080/00336297.1994.10484130; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Martini R, 2015, DISABIL REHABIL, V37, P231, DOI 10.3109/09638288.2014.913702; McEwen S, 2015, NEUROREHAB NEURAL RE, V29, P526, DOI 10.1177/1545968314558602; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; Melis RJF, 2008, J GERONTOL A-BIOL, V63, P283, DOI 10.1093/gerona/63.3.283; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naghdi S, 2016, DISABIL REHABIL, V38, P289, DOI 10.3109/09638288.2015.1036173; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Ottenbacher K. J., 1986, EVALUATING CLIN CHAN; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Peters M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-103; Polatajko HJ, 2012, AM J OCCUP THER, V66, P104, DOI 10.5014/ajot.2012.001784; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P107, DOI 10.1300/J006v20n02_07; Rastegar M, 2017, ARCH REHABIL, V17, P290, DOI 10.21859/jrehab-1704290; Rodger S, 2009, AUST OCCUP THER J, V56, P103, DOI 10.1111/j.1440-1630.2007.00719.x; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Sadeghu R., 2009, POPULATION DEV IRAN; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Sideridis GD, 1996, J BEHAV EDUC, V6, P203, DOI [10.1007/BF02110233, DOI 10.1007/BF02110233]; Soltani S, 2019, ARCH REHABIL, V20, P136, DOI 10.32598/rj.20.2.136; Tobimatsu Y, 2014, BONE JOINT NERVE, V4, P467; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569	48	0	0	2	4	NEGAH SCIENTIFIC PUBLISHER	MUNSTER	NO 60, KOLDE-RING ST, EDITH STEIN KOLLEG, MUNSTER, 00000, GERMANY	2538-6247			ARCH REHABIL	Arch. Rehabil.	WIN	2021	21	4					526	543		10.32598/RJ.21.4.3156.1			18	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	SV2AK	WOS:000663626700007		gold			2022-02-06	
J	Brasil, S; Solla, DJF; Nogueira, RD; Teixeira, MJ; Malbouisson, LMS; Paiva, WD				Brasil, Sergio; Solla, Davi Jorge Fontoura; Nogueira, Ricardo de Carvalho; Teixeira, Manoel Jacobsen; Malbouisson, Luiz Marcelo Sa; Paiva, Wellingson da Silva			A Novel Noninvasive Technique for Intracranial Pressure Waveform Monitoring in Critical Care	JOURNAL OF PERSONALIZED MEDICINE			English	Article						intracranial compliance; intracranial pressure; intracranial hypertension; acute brain injury	BRAIN-INJURY; BLOOD-FLOW; VALIDATION; ULTRASOUND; MANAGEMENT; MODEL; UNIT	Background: We validated a new noninvasive tool (B4C) to assess intracranial pressure waveform (ICPW) morphology in a set of neurocritical patients, correlating the data with ICPW obtained from invasive catheter monitoring. Materials and Methods: Patients undergoing invasive intracranial pressure (ICP) monitoring were consecutively evaluated using the B4C sensor. Ultrasound-guided manual internal jugular vein (IJV) compression was performed to elevate ICP from the baseline. ICP values, amplitudes, and time intervals (P2/P1 ratio and time-to-peak [TTP]) between the ICP and B4C waveform peaks were analyzed. Results: Among 41 patients, the main causes for ICP monitoring included traumatic brain injury, subarachnoid hemorrhage, and stroke. Bland-Altman's plot indicated agreement between the ICPW parameters obtained using both techniques. The strongest Pearson's correlation for P2/P1 and TTP was observed among patients with no cranial damage (r = 0.72 and 0.85, respectively) to the detriment of those who have undergone craniotomies or craniectomies. P2/P1 values of 1 were equivalent between the two techniques (area under the receiver operator curve [AUROC], 0.9) whereas B4C cut-off 1.2 was predictive of intracranial hypertension (AUROC 0.9, p < 000.1 for ICP > 20 mmHg). Conclusion: B4C provided biometric amplitude ratios correlated with ICPW variation morphology and is useful for noninvasive critical care monitoring.	[Brasil, Sergio; Solla, Davi Jorge Fontoura; Nogueira, Ricardo de Carvalho; Teixeira, Manoel Jacobsen; Paiva, Wellingson da Silva] Univ Sao Paulo, Sch Med, Dept Neurol, BR-01246 Sao Paulo, Brazil; [Malbouisson, Luiz Marcelo Sa] Univ Sao Paulo, Sch Med, Dept Intens Care, BR-01246 Sao Paulo, Brazil		Brasil, S (corresponding author), Univ Sao Paulo, Sch Med, Dept Neurol, BR-01246 Sao Paulo, Brazil.	sbrasil@usp.br; davisolla@gmail.com; rcnogueira28@gmail.com; manoeljacobsen@gmail.com; luiz.malbouisson@hc.fm.usp.br; wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040; Brasil, Sergio/0000-0003-2397-9947			Andrade RDP, 2021, IEEE SENS J, V21, P22270, DOI 10.1109/JSEN.2021.3090648; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Brasil S, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11070874; Brasil S, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11080971; Brasil S, 2021, OBES SCI PRACT, V7, P751, DOI 10.1002/osp4.534; Brasil S, 2020, J NEUROSURG, V133, P1220, DOI 10.3171/2019.6.JNS191107; Cabella B, 2016, ACTA NEUROCHIR SUPPL, V122, P93, DOI 10.1007/978-3-319-22533-3_18; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Casault C., 2020, J INTENSIVE CARE SOC, V127, P232, DOI [10.1177/1751143720980273, DOI 10.1177/1751143720980273]; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cho SM, 2020, CRIT CARE MED, V48, pE532, DOI 10.1097/CCM.0000000000004289; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Connolly M, 2014, MED ENG PHYS, V36, P354, DOI 10.1016/j.medengphy.2013.12.003; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Czosnyka M, 2020, ACTA NEUROCHIR, V162, P1815, DOI 10.1007/s00701-020-04424-4; de Andrade AF, 2011, ARQ NEURO-PSIQUIAT, V69, P79, DOI 10.1590/S0004-282X2011000100016; Evensen KB, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00195-3; Fan JY, 2008, AM J CRIT CARE, V17, P545; Ferreira Cesar Biselli, 2015, Rev Bras Ter Intensiva, V27, P315, DOI 10.5935/0103-507X.20150055; Frigieri G, 2018, ACTA NEUROCHIR SUPPL, V126, P75, DOI 10.1007/978-3-319-65798-1_16; Frigieri G, 2018, ACTA NEUROCHIR SUPPL, V126, P107, DOI 10.1007/978-3-319-65798-1_23; Frigieri G., 2020, ADV NEW UNDERST BRAI, V337, P671, DOI [10.5772/intechopen.94143, DOI 10.5772/INTECHOPEN.94143]; Vilela GHF, 2016, ACTA NEUROCHIR SUPPL, V122, P97, DOI 10.1007/978-3-319-22533-3_19; Gomes Ines, 2021, Acta Neurochir Suppl, V131, P135, DOI 10.1007/978-3-030-59436-7_28; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Holmlund P, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0065-2; Kazimierska A, 2021, ACTA NEUROCHIR, V163, P1979, DOI 10.1007/s00701-021-04834-y; Ballestero MFM, 2017, CHILD NERV SYST, V33, P1517, DOI 10.1007/s00381-017-3475-1; Mascarenhas Sergio, 2012, Acta Neurochir Suppl, V114, P117, DOI 10.1007/978-3-7091-0956-4_21; Nag DS, 2019, WORLD J CLIN CASES, V7, P1535, DOI 10.12998/wjcc.v7.i13.1535; Nucci CG, 2016, ACTA NEUROCHIR, V158, P581, DOI 10.1007/s00701-015-2672-5; Nunes Rabelo Nicollas, 2020, J Neurosurg, V134, P1682, DOI 10.3171/2020.9.JNS203395; Paiva WS, 2009, REV NEUROLOGIA, V48, P134, DOI 10.33588/rn.4803.2008575; Paschoal FM, 2017, ARQ NEURO-PSIQUIAT, V75, P470, DOI [10.1590/0004-282X20170076, 10.1590/0004-282x20170076]; Jeng BCP, 2021, J CLIN NEUROSCI, V86, P174, DOI 10.1016/j.jocn.2021.01.021; Portella G, 2005, ACTA NEUROCHIR, V147, P707, DOI 10.1007/s00701-005-0537-z; Rickli C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240570; Robba C, 2021, LANCET NEUROL, V20, P548, DOI 10.1016/S1474-4422(21)00138-1; Robba C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03105-z; TOKUTOMI T, 1985, Neurologia Medico-Chirurgica, V25, P418, DOI 10.2176/nmc.25.418; Vinters HV, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2021.105657; Yeoh TY, 2017, CAN J ANESTH, V64, P854, DOI 10.1007/s12630-017-0903-3	48	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	DEC	2021	11	12							1302	10.3390/jpm11121302			15	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	XZ3ZL	WOS:000737593400001	34945774	Green Published			2022-02-06	
J	Bulgaru-Iliescu, D; Nicolau, A; Rosca, S; Ciureanu, IA; Severin, F				Bulgaru-Iliescu, Diana; Nicolau, Andrei; Rosca, Stefan; Ciureanu, Ioan-Adrian; Severin, Florentina			Pathological Mechanisms and Additional Factors Involved in Complex Neck Traumatology	APPLIED SCIENCES-BASEL			English	Article						complex cervical trauma; mechanism of cervical trauma; morphopathological and pathophysiological factors	INJURIES; HEAD	Background. Cervical trauma can be closed or open, have different degrees of severity, incidence rates, prevalence, or mortality, with variations in the presence of demographic factors. The different types of traumatic injuries have a certain pattern of occurrence depending on criteria related to sex, age, alcohol consumption, and socio-demographic factors. Increasing the rate of trauma is becoming a public health problem and it is necessary to study their epidemiology and implement control strategies. Aims. The objectives of the study are to establish the particularities of epidemiological, morphopathological, and pathophysiological factors involved in complex neck traumatology. Methods. The study group consisted of 384 patients, representative for the population of Moldova, who presented at the ENT Clinic, Hospital "St. Spiridon" Iasi and the Institute of Forensic Medicine, Iasi during 2012-2016, with complex cervical trauma pathology, produced by various mechanisms, such as car accidents, domestic accidents, aggressions, ballistic trauma, self-inflicted attempts, hanging or strangulation. Data were collected from autopsy reports and medical records. Results. Complex cervical trauma occurs with a predisposition in males, with an average age of 43 years, from rural areas. The mechanism of cervical trauma is predominantly self-inflicted-hanging in 78.4% of the total number of cases, followed by 14.8% of stabbing aggression. The majority of neck injuries, both open and closed, are located in anatomical zone II (73.6%), vascular and pharyngeal are produced by stabbing. Psychiatric disorders and blood alcohol levels are correlated with complex cervical trauma caused by self-inflicted mechanism-hanging and can be considered a predictive factor of suicide attempts. Conclusions. Overall, the vast majority of closed neck injuries were caused by the self-inflicted mechanism, attempted suicide by hanging, followed by the accidental mechanism. Regarding the penetrating complex aero-digestive cervical traumas, they were mostly produced by stabbing both in aggression and self-inflicted circumstances. Aggravating addictive factors such as alcoholism and mental disorders require a competent assessment in terms of the indication of institutionalized treatment, prevention of repeated self-inflicted attempts, or social reintegration.	[Bulgaru-Iliescu, Diana; Nicolau, Andrei; Ciureanu, Ioan-Adrian; Severin, Florentina] Univ Med & Pharm Grigore T Popa, Dept Forens Sci, Fac Med, Iasi 700115, Romania; [Rosca, Stefan] Dunarea Jos Univ Galati, Dept Management & Publ Adm, Galati, Romania		Nicolau, A (corresponding author), Univ Med & Pharm Grigore T Popa, Dept Forens Sci, Fac Med, Iasi 700115, Romania.; Rosca, S (corresponding author), Dunarea Jos Univ Galati, Dept Management & Publ Adm, Galati, Romania.	diana.bulgaru@umfiasi.ro; nicolau.andrei@umfiasi.ro; stefan.rosca@ugal.ro; adrian.ciureanu@umfiasi.ro; florentina-s-severin@umfiasi.ro		CIUREANU, IOAN-ADRIAN/0000-0002-9689-8569			Aich M, 2011, BANGLADESH J OTORHIN, V17, P5; Al-Thani Hassan, 2015, J Emerg Trauma Shock, V8, P154, DOI 10.4103/0974-2700.160723; Asberg M, 1997, ANN NY ACAD SCI, V836, P158, DOI 10.1111/j.1749-6632.1997.tb52359.x; Beautrais AL, 2002, SUICIDE LIFE-THREAT, V32, P1, DOI 10.1521/suli.32.1.1.22184; Bietry D, 2015, EUR ARCH OTO-RHINO-L, V272, P3825, DOI 10.1007/s00405-014-3471-y; Bryant Ayesha S, 2007, Thorac Surg Clin, V17, P63, DOI 10.1016/j.thorsurg.2007.02.003; Das J., 2018, TRAUMA OTOLARYNGOLOG, P3; Esposito T.J., 2017, TRAUMA, V8th ed., P18; Harris A., 2016, DIS NOSE THROAT EAR, P311; Herzog M, 2005, LARYNGO RHINO OTOL, V84, P176, DOI 10.1055/s-2004-825873; Holsinger FC, 2007, SALIVARY GLAND DISOR, P1; Kleinsasser N, 2010, EUR MAN MED, P503, DOI 10.1007/978-3-540-68940-9_55; Kontis T.C., 2001, HEAD NECK SURG OTOLA; Lichte P, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-35; Lydiatt M.W., 2009, PENETRATING INJURIES; Maisel R., 1986, OTOLARYNGOLOGY HEAD, P1707; Martin T., 2015, SURGERY, V33, P449, DOI [10.1016/j.mpsur.2015.07.002., DOI 10.1016/J.MPSUR.2015.07.002]; Moeng M., 2017, PENETRATING TRAUMA P, P177; Nason RW, 2001, CAN J SURG, V44, P122; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Nowicki JL, 2018, ANN ROY COLL SURG, V100, P6, DOI 10.1308/rcsann.2017.0191; Ongom Peter A, 2014, J Med Case Rep, V8, P29, DOI 10.1186/1752-1947-8-29; Onotai L O, 2010, Niger J Med, V19, P264; Phelan A., 2017, REHABILITATION PENET, P597; Popa M., 2007, MED LEGALA NOTE CURS, P77; Reddy S.S., 2013, INDIAN J FORENSIC ME, V7, P187; Sachdeva K, 2017, INDIAN J OTOLARYNGOL, V69, P52, DOI 10.1007/s12070-016-1048-3; Saito Naoko, 2014, Keio Journal of Medicine, V63, P23, DOI 10.2302/kjm.2013-0009-RE; Shaefer S.D., 2011, OTOLARYNGOLOGY HEAD; Shetty BSK, 2009, J FORENSIC LEG MED, V16, P492, DOI 10.1016/j.jflm.2009.07.003; Souba W.W., 2007, INJURIES NECK ACS SU; Sperry JL, 2013, J TRAUMA ACUTE CARE, V75, P936, DOI 10.1097/TA.0b013e31829e20e3; Teixeira F, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0091-4; Varghese A, 2013, INDIAN J SURG, V75, P43, DOI 10.1007/s12262-012-0531-7; Wilson V., 2017, PENETRATING TRAUMA P, P601; Woodburne R.T., 1988, ESSENTIALS HUMAN ANA	36	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	DEC	2021	11	24							11863	10.3390/app112411863			13	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	XW2AY	WOS:000735429900001		gold			2022-02-06	
J	Burke, J; Geller, JS; Perez, JR; Naik, K; Vidal, AF; Baraga, MG; Kaplan, LD				Burke, Jonathan; Geller, Joseph S.; Perez, Jose R.; Naik, Kunal; Vidal, Armando F.; Baraga, Michael G.; Kaplan, Lee D.			Effect of Passing Plays on Injury Rates in the National Football League	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						injuries; play type; concussion	PROFESSIONAL FOOTBALL; CONCUSSION	Burke, J, Geller, JS, Perez, JR, Naik, K, Vidal, AF, Baraga, MG, and Kaplan, LD. The effect of passing plays on injury rates in the national football league. J Strength Cond Res 35(12S): S1-S4, 2021-The National Football League (NFL) has one of the highest all-cause injury rates in sports, yet our understanding of extrinsic injury risk factors is limited. The objective of this study was to assess the effect of play type on injury incidence in the NFL. We obtained data for every regular season game played during the 2013-2016 seasons from the official NFL game books. There were 2,721 in-game injuries during the 4 seasons examined, with an overall rate of 1.33 injuries per team per game. For statistical analysis, p < 0.05 was considered significant. Passing plays conferred significantly higher odds of injury than running plays (odds ratio [OR] 1.4, 95% confidence interval [CI]: 1.3-1.5, p < 0.0001). This primarily stems from increased risks in quarterbacks (OR 6.9, 95% CI: 3.6-13.3, p < 0.0001), receivers (OR 5.0, 95% CI: 3.7-6.6, p < 0.0001), and defensive backs (OR 2.3, 95% CI: 1.9-2.7, p < 0.0001). Our study suggests that passing plays confer a greater risk of overall injuries in the NFL when compared with running plays, specifically regarding concussions and core or trunk injuries.	[Burke, Jonathan] NYU, Dept Surg, Sch Med, New York, NY USA; [Geller, Joseph S.; Perez, Jose R.; Naik, Kunal; Baraga, Michael G.; Kaplan, Lee D.] Univ Miami, Miller Sch Med, Sports Med Inst, Miami, FL 33136 USA; [Vidal, Armando F.] Steadman Philippon Res Inst, Vail, CO USA		Geller, JS (corresponding author), Univ Miami, Miller Sch Med, Sports Med Inst, Miami, FL 33136 USA.	Joseph.S.Geller@gmail.com		Geller, Joseph/0000-0003-4213-8975	Arthrex, Inc.; Smith Nephew	L. D. Kaplan is the board or committee member of the American Orthopaedic Society for Sports Medicine and receives other financial or material support from Arthrex, Inc. M. G. Baraga receives other financial or material support from Arthrex, Inc and Smith & Nephew and is a paid consultant for LifeNet Health and Arthrex, Inc. A. F. Vidal is the board or committee member of the American Orthopaedic Society for Sports Medicine; is a paid presenter or speaker for Arthrex, Inc, Vericel, and Smith & Nephew; is a paid consultant for Arthrex, Inc; receives research support from Arthrex, Inc; and is on editorial or governing board of the Video Journal of Sports Medicine. The remaining authors have no disclosures to report.	[Anonymous], HLTH SAFETY RULES CH; [Anonymous], Health & Safety Rules Changes; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Elliott MCCW, 2011, AM J SPORT MED, V39, P843, DOI 10.1177/0363546510394647; Hanson A, 2017, J HEALTH ECON, V53, P87, DOI 10.1016/j.jhealeco.2017.01.004; Kelly BT, 2004, AM J SPORT MED, V32, P328, DOI 10.1177/0363546503261737; Kraeutler MJ, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117691941; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Lynch TS, 2013, AM J SPORT MED, V41, P2904, DOI 10.1177/0363546513504284; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Perez JR, 2020, AM J SPORT MED, V48, P1999, DOI 10.1177/0363546520919989; Shpigel B., 2019, NEW YORK TIMES; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Werner BC, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117726515	16	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	DEC	2021	35			2			S1	S4		10.1519/JSC.0000000000004172			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XE9PK	WOS:000723713500001	34846327	Bronze			2022-02-06	
J	Bykowski, EA; Petersson, JN; Dukelow, S; Ho, C; Debert, CT; Montina, T; Metz, GAS				Bykowski, Elani A.; Petersson, Jamie N.; Dukelow, Sean; Ho, Chester; Debert, Chantel T.; Montina, Tony; Metz, Gerlinde A. S.			Urinary metabolomic signatures as indicators of injury severity following traumatic brain injury: A pilot study	IBRO NEUROSCIENCE REPORTS			English	Article						Traumatic brain injury; Concussion; Metabolomics; Metabolic biomarkers; NMR spectroscopy; Rehabilitation; Functional recovery; Biomarkers	LIQUID-CHROMATOGRAPHY; ADENOSINE; PURINES; BLOOD; TOOL	Background: Analysis of fluid metabolites has the potential to provide insight into the neuropathophysiology of injury in patients with traumatic brain injury (TBI). Objective: Using a H-1 nuclear magnetic resonance (NMR)-based quantitative metabolic profiling approach, this study determined (1) if urinary metabolites change during recovery in patients with mild to severe TBI; (2) whether changes in urinary metabolites correlate to injury severity; (3) whether biological pathway analysis reflects mechanisms that mediate neural damage/repair throughout TBI recovery. Methods: Urine samples were collected within 7 days and at 6-months post-injury in male participants (n = 8) with mild-severe TBI. Samples were analyzed with NMR-based quantitative spectroscopy for metabolomic profiles and analyzed with multivariate statistical and machine learning-based analyses. Results: Lower levels of homovanillate (R = -0.74, p <= 0.001), L-methionine (R = -0.78, p < 0.001), and thymine (R = -0.85, p < 0.001) negatively correlated to injury severity. Pathway analysis revealed purine metabolism to be a primary pathway (p < 0.01) impacted by TBI. Conclusion: This study provides pilot data to support the use of urinary metabolites in clinical practice to better interpret biochemical changes underlying TBI severity and recovery. The discovery of urinary metabolites as biomarkers may assist in objective and rapid identification of TBI severity and prognosis. Thus, H-1 NMR metabolomics has the potential to facilitate the adaptation of treatment programs that are personalized to the patient's needs.	[Bykowski, Elani A.; Petersson, Jamie N.; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB, Canada; [Bykowski, Elani A.; Petersson, Jamie N.; Montina, Tony; Metz, Gerlinde A. S.] Univ Lethbridge, Southern Alberta Genome Sci Ctr, Lethbridge, AB, Canada; [Petersson, Jamie N.; Montina, Tony] Univ Lethbridge, Dept Chem & Biochem, 4401 Univ Dr W, Lethbridge, AB T1K 3M4, Canada; [Dukelow, Sean; Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Dukelow, Sean; Debert, Chantel T.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Ho, Chester] Univ Alberta, Div Phys Med & Rehabil, Edmonton, AB, Canada		Montina, T (corresponding author), Univ Lethbridge, Dept Chem & Biochem, 4401 Univ Dr W, Lethbridge, AB T1K 3M4, Canada.; Debert, CT (corresponding author), Univ Calgary, Dept Clin Neurosci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Metz, GAS (corresponding author), Univ Lethbridge, Dept Neurosci, 4401 Univ Dr W, Lethbridge, AB T1K 3M4, Canada.	chantel.debert@ahs.ca; tony.montina@uleth.ca; gerlinde.metz@uleth.ca		Montina, Tony/0000-0002-9934-9856	Hotchkiss Brain Institute at the University of Calgary; Canadian Institutes of Health Research Project SchemeCanadian Institutes of Health Research (CIHR) [363195]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [05628]; Canadian Institutes of Health Research CGS-M studentshipCanadian Institutes of Health Research (CIHR)	This research was supported by the Hotchkiss Brain Institute at the University of Calgary (C.D., T.M., G.M.), Canadian Institutes of Health Research Project Scheme #363195 (G.M.) and Natural Sciences and Engineering Research Council of Canada Discovery Grant #05628 (G. M.). E.B. was supported by a Canadian Institutes of Health Research CGS-M studentship.	Anderson PE, 2011, METABOLOMICS, V7, P179, DOI 10.1007/s11306-010-0242-7; BAKKEREN JAJM, 1984, CLIN CHIM ACTA, V140, P247, DOI 10.1016/0009-8981(84)90206-7; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bykowski EA, 2021, IBRO NEUROSCI REP, V10, P178, DOI 10.1016/j.ibneur.2021.02.007; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dobrachinski F, 2019, MOL NEUROBIOL, V56, P3145, DOI 10.1007/s12035-018-1296-1; Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P161, DOI 10.1007/978-1-4939-2377-9_13; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FELICE LJ, 1976, ANAL CHEM, V48, P794, DOI 10.1021/ac60370a018; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Jackson EK, 2016, J NEUROCHEM, V137, P142, DOI 10.1111/jnc.13551; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kochanek P.M., 2013, ADENOSINE, P307, DOI [10.1007/978-1-4614-3903-5_, DOI 10.1007/978-1-4614-3903-5]; Lim H.B., 2007, SYSTEMIC COMPLICATIO, DOI [10.1111/j.1365-2044.2007.04998.x, DOI 10.1111/J.1365-2044.2007.04998.X]; Morelli M, 2010, PROG BRAIN RES, V183, P183, DOI 10.1016/S0079-6123(10)83010-9; Naccarato M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-47; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Novotny L, 2000, J PHARMACEUT BIOMED, V24, P125, DOI 10.1016/S0731-7085(00)00403-9; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093736; Popescu C, 2015, J Med Life, V8, P272; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Stovell MG, 2020, J CEREBR BLOOD F MET, V40, P67, DOI 10.1177/0271678X18799176; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tanianskii DA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030524; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Veselkov KA, 2009, ANAL CHEM, V81, P56, DOI 10.1021/ac8011544; Wanner ZR, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.645829; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yamamoto T, 2005, CLIN CHIM ACTA, V356, P35, DOI 10.1016/j.cccn.2005.01.024; Yun YH, 2015, METABOLOMICS, V11, P1539, DOI 10.1007/s11306-015-0803-x; Zhang Y., 2013, SPRINGER SERIES TRAN, V5, P141; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	48	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2667-2421			IBRO NEUROSCI REP	IBRO Neurosci. Rep.	DEC	2021	11						200	206		10.1016/j.ibneur.2021.10.003			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YE4EQ	WOS:000741081500008	34786572	Green Published, gold			2022-02-06	
J	Carlozzi, NE; Choi, SW; Wu, ZK; Miner, JA; Lyden, AK; Graves, C; Wang, JT; Sen, S				Carlozzi, Noelle E.; Choi, Sung Won; Wu, Zhenke; Miner, Jennifer A.; Lyden, Angela K.; Graves, Christopher; Wang, Jitao; Sen, Srijan			An App-Based Just-in-Time Adaptive Self-management Intervention for Care Partners (CareQOL): Protocol for a Pilot Trial	JMIR RESEARCH PROTOCOLS			English	Article						caregivers; quality of life; spinal cord injuries; Huntington disease; hematopoietic stem cell transplantation; feasibility studies; self-management; mobile apps; outcome assessment; mobile phone	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; BEHAVIORAL ACTIVATION TREATMENTS; FAMILY CAREGIVERS; HEAD-INJURY; DEPRESSIVE SYMPTOMS; CLINICAL VALIDITY; PERCEIVED HEALTH; PROMIS MEASURES	Background: Care partners (ie, informal family caregivers) of individuals with health problems face considerable physical and emotional stress, often with a substantial negative impact on the health-related quality of life (HRQOL) of both care partners and care recipients. Given that these individuals are often overwhelmed by their caregiving responsibilities, low-burden self-management interventions are needed to support care partners to ensure better patient outcomes. Objective: The primary objective of this study is to describe an intensive data collection protocol that involves the delivery of a personalized just-in-time adaptive intervention that incorporates passive mobile sensor data feedback (sleep and activity data from a Fitbit [Fitbit LLC]) and real time self-reporting of HRQOL via a study-specific app called CareQOL (University of Michigan) to provide personalized feedback via app alerts. Methods: Participants from 3 diverse care partner groups will be enrolled (care partners of persons with spinal cord injury, care partners of persons with Huntington disease, and care partners of persons with hematopoietic cell transplantation). Participants will be randomized to either a control group, where they will wear the Fitbit and provide daily reports of HRQOL over a 3-month (ie, 90 days) period (without personalized feedback), or the just-in-time adaptive intervention group, where they will wear the Fitbit, provide daily reports of HRQOL, and receive personalized push notifications for 3 months. At the end of the study, participants will complete a feasibility and acceptability questionnaire, and metrics regarding adherence and attrition will be calculated. Results: This trial opened for recruitment in November 2020. Data collection was completed in June 2021, and the primary results are expected to be published in 2022. Conclusions: This trial will determine the feasibility and acceptability of an intensive app-based intervention in 3 distinct care partner groups: care partners for persons with a chronic condition that was caused by a traumatic event (ie, spinal cord injury); care partners for persons with a progressive, fatal neurodegenerative disease (ie, Huntington disease); and care partners for persons with episodic cancer conditions that require intense, prolonged inpatient and outpatient treatment (persons with hematopoietic cell transplantation).	[Carlozzi, Noelle E.; Miner, Jennifer A.; Graves, Christopher] Univ Michigan, Dept Phys Med & Rehabil, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Choi, Sung Won] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Wu, Zhenke; Wang, Jitao] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Lyden, Angela K.] Univ Michigan, Clin Trials Support Off, Ann Arbor, MI 48109 USA; [Sen, Srijan] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Miner, Jennifer/0000-0003-2722-1121; Sen, Srijan/0000-0003-4495-495X; Graves, Christopher/0000-0002-8862-0508; Choi, Sung/0000-0002-6321-3834; Wang, Jitao/0000-0003-4011-3352	National Institutes of Health, National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL146354]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240]	This work was supported by grant numbers R01NR013658 from the National Institutes of Health, National Institute of Nursing Research; R01HL146354 from the National Heart, Lung and Blood Institute; and UL1TR002240 from the National Center for Advancing Translational Sciences. The authors thank the investigators, coordinators, research associates, and assistants who worked on this study and the study participants and organizations who supported the recruitment efforts.	Allen J, 2018, QUAL LIFE RES, V27, P2207, DOI 10.1007/s11136-018-1871-y; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; [Anonymous], 2019, CAR STAT DEM; [Anonymous], 2016, CANC CAR US INT EP C; [Anonymous], 2010, CAR VET SERV HOM REP; Applebaum AJ, 2016, BONE MARROW TRANSPL, V51, P1416, DOI 10.1038/bmt.2016.164; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Aubeeluck Aimee, 2005, Br J Nurs, V14, P452; Aubeeluck AV, 2012, QUAL LIFE RES, V21, P1425, DOI 10.1007/s11136-011-0062-x; Bajaj JS, 2011, ALIMENT PHARM THER, V34, P1123, DOI 10.1111/j.1365-2036.2011.04842.x; Banaszkiewicz K, 2012, J NEURAL TRANSM, V119, P1361, DOI 10.1007/s00702-012-0787-x; Barata A, 2016, CURR HEMATOL MALIG R, V11, P280, DOI 10.1007/s11899-016-0328-z; Bartlett SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138543; Ben-Zeev D, 2014, SCHIZOPHRENIA BULL, V40, P1244, DOI 10.1093/schbul/sbu033; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Bevans MF, 2008, SUPPORT CARE CANCER, V16, P1243, DOI 10.1007/s00520-008-0420-6; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2018, J NEUROL, V265, P1443, DOI 10.1007/s00415-018-8852-5; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2016, J CLIN EPIDEMIOL, V73, P128, DOI 10.1016/j.jclinepi.2015.08.037; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cook KF, 2016, J CLIN EPIDEMIOL, V73, P89, DOI 10.1016/j.jclinepi.2015.08.038; Cook KF, 2012, QUAL LIFE RES, V21, P1021, DOI 10.1007/s11136-011-0011-8; Cotner B, 2017, ARCH PHYS MED REHAB, V98, P97, DOI [10.1016/j.apmr.2017.08.314, DOI 10.1016/J.APMR.2017.08.314]; Cox M., 2012, BR J NEUROSCI NURS, V8, P288, DOI [10.12968/bjnn.2012.8.5.288, DOI 10.12968/BJNN.2012.8.5.288]; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Foxall MJ, 1996, J ADV NURS, V24, P915, DOI 10.1111/j.1365-2648.1996.tb02926.x; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Gawrysiak M, 2009, J COUNS PSYCHOL, V56, P468, DOI 10.1037/a0016383; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Gruber-Baldini AL, 2017, QUAL LIFE RES, V26, P1915, DOI 10.1007/s11136-017-1527-3; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hart T, 2020, NEUROPSYCHOL REHABIL, V30, P1523, DOI 10.1080/09602011.2019.1592761; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hopko DR, 2016, CLIN CASE STUD, V3, P37, DOI [10.1177/1534650103258969, DOI 10.1177/1534650103258969]; Hurria A, 2013, JAMA-J AM MED ASSOC, V310, P1795, DOI 10.1001/jama.2013.280416; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; JOHNSON MD, 1994, LARYNGOSCOPE, V104, P1143; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kappelman MD, 2014, CLIN GASTROENTEROL H, V12, P1315, DOI 10.1016/j.cgh.2013.10.019; Kasturi S, 2018, J RHEUMATOL, V45, P397, DOI 10.3899/jrheum.170590; Katzan IL, 2018, STROKE, V49, P147, DOI 10.1161/STROKEAHA.117.018766; Kent EE, 2016, CANCER-AM CANCER SOC, V122, P1987, DOI 10.1002/cncr.29939; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kratz AL, 2016, QUAL LIFE RES, V25, P1803, DOI 10.1007/s11136-016-1230-9; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lapin B, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004753; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; McCabe MP, 2009, J CLIN PSYCHOL MED S, V16, P355, DOI 10.1007/s10880-009-9168-5; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003161, DOI 10.1002/14651858.CD003161]; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Nahum-Shani I, 2018, ANN BEHAV MED, V52, P446, DOI 10.1007/s12160-016-9830-8; Nahum-Shani I, 2015, HEALTH PSYCHOL, V34, P1209, DOI 10.1037/hea0000306; Northouse Laurel L, 2012, Semin Oncol Nurs, V28, P236, DOI 10.1016/j.soncn.2012.09.006; O'Connor EJ, 2011, QUAL LIFE RES, V20, P703, DOI 10.1007/s11136-010-9804-4; Panting A, 1972, REHABILITATION, V38, P33; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pickett T, 2007, REHABIL PSYCHOL, V52, P311, DOI 10.1037/0090-5550.52.3.311; Pilkonis PA, 2014, J PSYCHIATR RES, V56, P112, DOI 10.1016/j.jpsychires.2014.05.010; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Purvis TE, 2017, SPINE, V42, pE1357, DOI 10.1097/BRS.0000000000002347; Quach CW, 2016, QUAL LIFE RES, V25, P2811, DOI 10.1007/s11136-016-1325-3; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Ready RE, 2008, MOVEMENT DISORD, V23, P721, DOI 10.1002/mds.21920; Reinhard SC, 2008, PATIENT SAFETY QUALI; Riley W, 2008, J AM COLL HEALTH, V57, P245, DOI 10.3200/JACH.57.2.245-248; Rohleder N, 2009, J CLIN ONCOL, V27, P2909, DOI 10.1200/JCO.2008.18.7435; Roscoe LA, 2009, HEALTH COMMUN, V24, P239, DOI 10.1080/10410230902804133; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Salsman JM, 2013, QUAL LIFE RES, V22, P2569, DOI 10.1007/s11136-013-0382-0; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421; Shaffer KM, 2017, HEALTH PSYCHOL, V36, P770, DOI 10.1037/hea0000528; Simoneau TL, 2013, PSYCHO-ONCOLOGY, V22, P2064, DOI 10.1002/pon.3259; Smith A M, 1998, Rehabil Nurs, V23, P252; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Stoop Nicky, 2018, Hand (N Y), V13, P118, DOI 10.1177/1558944717691127; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Temple JL, 2016, BRAIN INJURY, V30, P1672, DOI 10.3109/02699052.2015.1113561; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	124	0	0	0	0	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	DEC	2021	10	12							e32842	10.2196/32842			17	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	YI9NA	WOS:000744166500004	34889775	gold, Green Published			2022-02-06	
J	Chen, AB; Zhang, ZH; Cao, CL; Lu, JJ; Wu, SK; Ma, SH; Feng, Y; Wang, SC; Xu, GZ; Song, J				Chen, Aobo; Zhang, Zhihao; Cao, Chenglong; Lu, Jinjiang; Wu, Shukai; Ma, Shenghui; Feng, Yu; Wang, Shuochen; Xu, Guozheng; Song, Jian			Altered Attention Network in Paratroopers Exposed to Repetitive Subconcussion: Evidence Based on Behavioral and Event-Related Potential Results	JOURNAL OF NEUROTRAUMA			English	Article						alerting; event-related potentials; executive control; paratroopers; subconcussion	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; NEUROPSYCHOLOGICAL PERFORMANCE; VISUOSPATIAL ATTENTION; EXECUTIVE ATTENTION; HEAD-INJURY; CONCUSSION; FOOTBALL; DEFICITS; MECHANISMS	Cognitive impairment caused by repetitive subconcussion has received increasing attention in recent years. Although the dysfunction of attention has been confirmed by neuropsychological research using scales, there is no event-related potentials (ERPs) research. The Attention Network Test (ANT) has been widely used to evaluate the three separate components of attention processing (alerting, orienting, and executive control). Twenty-seven paratroopers exposed to repetitive subconcussion (subconcussion group) and 25 matched healthy control participants (HCs group) were enrolled, and all of them performed the ANT test while continuous scalp electroencephalography data were recorded. On the behavioral performance level, the subconcussion group showed a slower task response, with an especially significant slower reaction time in alerting. Concerning ERP results, reduction amplitudes of cue-N1 in the alerting network were observed, indicating that this group was less able to make efficient use of cues and maintain an alerting state for incoming information. For the orienting network, no difference in N1 amplitude was observed between the two groups. Moreover, there was a reduced P3 amplitude in the executive control network in the subconcussion group compared with the HCs group, suggesting a dysfunction of attentional resource allocation and inhibition control in the former group. This study is, to our knowledge, the first analysis of the altered attention network caused by repetitive subconcussion from the perspectives of behavioral and neuropsychology levels. These preliminary results revealed the possible damage of the alerting and executive control networks and provided a reference for further research on subconcussion cognitive impairment.	[Chen, Aobo; Zhang, Zhihao; Cao, Chenglong; Lu, Jinjiang; Wu, Shukai; Wang, Shuochen; Xu, Guozheng; Song, Jian] Southern Med Univ, Sch Clin Med 1, Guangzhou, Peoples R China; [Chen, Aobo; Zhang, Zhihao; Cao, Chenglong; Lu, Jinjiang; Wu, Shukai; Ma, Shenghui; Feng, Yu; Wang, Shuochen; Xu, Guozheng; Song, Jian] Gen Hosp Chinese PLA Cent Theater Command, Dept Neurosurg, 627 Wuluo Rd, Wuhan 430070, Peoples R China; [Cao, Chenglong] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Ma, Shenghui; Feng, Yu] Wuhan Univ Sci & Technol, Med Coll, Wuhan, Peoples R China		Xu, GZ; Song, J (corresponding author), Gen Hosp Chinese PLA Cent Theater Command, Dept Neurosurg, 627 Wuluo Rd, Wuhan 430070, Peoples R China.	xu-gz@163.com; docsongjian@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571049]; Chinese Scholarship CouncilChina Scholarship Council [202008440671]	This work was supported by funding from the National Natural Science Foundation of China (81571049) and the Chinese Scholarship Council (202008440671)	Abramov DM, 2017, NEUROSCI LETT, V647, P91, DOI 10.1016/j.neulet.2017.03.031; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Cahn BR, 2009, INT J PSYCHOPHYSIOL, V72, P51, DOI 10.1016/j.ijpsycho.2008.03.013; Candrian G, 2018, ANN PHYS REHABIL MED, V61, P18, DOI 10.1016/j.rehab.2017.07.246; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Champagne AA, 2021, BRAIN INJURY, V35, P760, DOI 10.1080/02699052.2021.1906951; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DeSimone JC, 2021, HUM BRAIN MAPP, V42, P2529, DOI 10.1002/hbm.25384; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fer C, 2021, J SCI MED SPORT, V24, P448, DOI 10.1016/j.jsams.2020.11.002; FernandezDuque D, 1997, NEUROPSYCHOLOGIA, V35, P477, DOI 10.1016/S0028-3932(96)00103-0; Fuentes LJ, 2010, DEMENT GERIATR COGN, V29, P139, DOI 10.1159/000275672; Gao W, 2013, CEREB CORTEX, V23, P594, DOI 10.1093/cercor/bhs043; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasler R, 2016, NEUROPSYCHOLOGIA, V87, P120, DOI 10.1016/j.neuropsychologia.2016.05.008; Hill-Jarrett TG, 2015, BRAIN INJURY, V29, P1617, DOI 10.3109/02699052.2015.1075155; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jo HG, 2016, INT J PSYCHOPHYSIOL, V99, P33, DOI 10.1016/j.ijpsycho.2015.11.016; Knapik JJ, 2014, AVIAT SPACE ENVIR MD, V85, P105, DOI 10.3357/ASEM.3788.2014; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lumme V, 2007, PSYCHIAT RES-NEUROIM, V156, P69, DOI 10.1016/j.pscychresns.2006.12.012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Neuhaus AH, 2011, CLIN NEUROPHYSIOL, V122, P90, DOI 10.1016/j.clinph.2010.06.011; Neuhaus AH, 2010, SCHIZOPHR RES, V124, P119, DOI 10.1016/j.schres.2010.08.014; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Rodriguez-Bailon M, 2012, SPAN J PSYCHOL, V15, P967, DOI 10.5209/rev_SJOP.2012.v15.n3.39388; Ruiter KI, 2019, CLIN NEUROPHYSIOL, V130, P111, DOI 10.1016/j.clinph.2018.10.013; Gopalan PRS, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00160; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stone JR, 2020, J NEUROTRAUM, V37, P2468, DOI 10.1089/neu.2020.7141; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vazquez-Marrufo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097226; Williams RS, 2016, BRAIN COGNITION, V102, P65, DOI 10.1016/j.bandc.2015.12.007; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yang TT, 2019, J AFFECT DISORDERS, V245, P130, DOI 10.1016/j.jad.2018.10.104; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zhang DL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18886-7	63	0	0	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3306	3314		10.1089/neu.2021.0253			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700012	34549595				2022-02-06	
J	Chen, CH; Hsieh, YW; Huang, JF; Hsu, CP; Chung, CY; Chen, CC				Chen, Chien-Hung; Hsieh, Yu-Wei; Huang, Jen-Fu; Hsu, Chih-Po; Chung, Chia-Ying; Chen, Chih-Chi			Predictors of In-Hospital Mortality for Road Traffic Accident-Related Severe Traumatic Brain Injury	JOURNAL OF PERSONALIZED MEDICINE			English	Article						traumatic brain injury; children; road traffic accident; mortality; predictors	GLASGOW COMA SCALE; HEAD-INJURY; CHILDREN; RISK; HYPERGLYCEMIA; IMPACT; EPIDEMIOLOGY; COAGULOPATHY; ASSOCIATION; ADOLESCENTS	(1) Background: Road traffic accidents (RTAs) are the leading cause of pediatric traumatic brain injury (TBI) and are associated with high mortality. Few studies have focused on RTA-related pediatric TBI. We conducted this study to analyze the clinical characteristics of RTA-related TBI in children and to identify early predictors of in-hospital mortality in children with severe TBI. (2) Methods: In this 15-year observational cohort study, a total of 618 children with RTA-related TBI were enrolled. We collected the patients' clinical characteristics at the initial presentations in the emergency department (ED), including gender, age, types of road user, the motor components of the Glasgow Coma Scale (mGCS) score, body temperature, blood pressure, blood glucose level, initial prothrombin time, and the intracranial computed tomography (CT) Rotterdam score, as potential mortality predictors. (3) Results: Compared with children exhibiting mild/moderate RTA-related TBI, those with severe RTA-related TBI were older and had a higher mortality rate (p < 0.001). The in-hospital mortality rate for severe RTA-related TBI children was 15.6%. Compared to children who survived, those who died in hospital had a higher incidence of presenting with hypothermia (p = 0.011), a lower mGCS score (p < 0.001), a longer initial prothrombin time (p < 0.013), hyperglycemia (p = 0.017), and a higher Rotterdam CT score (p < 0.001). Multivariate analyses showed that the mGCS score (adjusted odds ratio (OR): 2.00, 95% CI: 1.28-3.14, p = 0.002) and the Rotterdam CT score (adjusted OR: 2.58, 95% CI: 1.31-5.06, p = 0.006) were independent predictors of in-hospital mortality. (4) Conclusions: Children with RTA-related severe TBI had a high mortality rate. Patients who initially presented with hypothermia, a lower mGCS score, a prolonged prothrombin time, hyperglycemia, and a higher Rotterdam CT score in brain CT analyses were associated with in-hospital mortality. The mGCS and the Rotterdam CT scores were predictive of in-hospital mortality independently.	[Chen, Chien-Hung; Chung, Chia-Ying; Chen, Chih-Chi] Chang Gung Univ, Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan 33305, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Dept Occupat Therapy, Sch Med, Taoyuan 33302, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Grad Inst Behav Sci, Sch Med, Taoyuan 33302, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan 33302, Taiwan; [Huang, Jen-Fu; Hsu, Chih-Po] Chang Gung Univ, Chang Gung Mem Hosp, Dept Traumatol & Emergency Surg, Taoyuan 33305, Taiwan		Chen, CC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan 33305, Taiwan.	B9002052@cgmh.org.tw; Ywhsieh@mail.cgu.edu.tw; jenfu0211@yahoo.com.tw; m7831@cgmh.org.tw; chiaying928@yahoo.com; Claudia5477@gmail.com		Chen, Chih-Chi/0000-0001-9132-5289			Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; Chen CC, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11020136; Chen CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030390; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Davis P R, 2005, J R Army Med Corps, V151, P223; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Du RY, 2020, J NEUROSURG-PEDIATR, V25, P361, DOI 10.3171/2019.10.PEDS19377; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Harel O, 2007, EXP AGING RES, V33, P187, DOI 10.1080/03610730701239004; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Irie F., 2010, INJURY, V41, pS30, DOI [10.1016/j.injury.2010.01.021, DOI 10.1016/J.INJURY.2010.01.021]; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lam C, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8191-1; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Pai CW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191221; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Podolsky-Gondim GG, 2018, CHILD NERV SYST, V34, P2455, DOI 10.1007/s00381-018-3989-1; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Sundberg J, 2011, AM J EMERG MED, V29, P1019, DOI 10.1016/j.ajem.2010.06.002; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	50	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	DEC	2021	11	12							1339	10.3390/jpm11121339			9	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	XZ7BZ	WOS:000737804800001	34945809	Green Published			2022-02-06	
J	Chong, CD; Zhang, JW; Li, J; Wu, T; Dumkrieger, G; Nikolova, S; Ross, K; Stegmann, G; Liss, J; Schwedt, TJ; Jayasuriya, S; Berisha, V				Chong, Catherine D.; Zhang, Jianwei; Li, Jing; Wu, Teresa; Dumkrieger, Gina; Nikolova, Simona; Ross, Katherine; Stegmann, Gabriela; Liss, Julie; Schwedt, Todd J.; Jayasuriya, Suren; Berisha, Visar			Altered speech patterns in subjects with post-traumatic headache due to mild traumatic brain injury	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache; Speech; mTBI; Language; Migraine	MIGRAINE; AURA	Background/objective Changes in speech can be detected objectively before and during migraine attacks. The goal of this study was to interrogate whether speech changes can be detected in subjects with post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI) and whether there are within-subject changes in speech during headaches compared to the headache-free state. Methods Using a series of speech elicitation tasks uploaded via a mobile application, PTH subjects and healthy controls (HC) provided speech samples once every 3 days, over a period of 12 weeks. The following speech parameters were assessed: vowel space area, vowel articulation precision, consonant articulation precision, average pitch, pitch variance, speaking rate and pause rate. Speech samples of subjects with PTH were compared to HC. To assess speech changes associated with PTH, speech samples of subjects during headache were compared to speech samples when subjects were headache-free. All analyses were conducted using a mixed-effect model design. Results Longitudinal speech samples were collected from nineteen subjects with PTH (mean age = 42.5, SD = 13.7) who were an average of 14 days (SD = 32.2) from their mTBI at the time of enrollment and thirty-one HC (mean age = 38.7, SD = 12.5). Regardless of headache presence or absence, PTH subjects had longer pause rates and reductions in vowel and consonant articulation precision relative to HC. On days when speech was collected during a headache, there were longer pause rates, slower sentence speaking rates and less precise consonant articulation compared to the speech production of HC. During headache, PTH subjects had slower speaking rates yet more precise vowel articulation compared to when they were headache-free. Conclusions Compared to HC, subjects with acute PTH demonstrate altered speech as measured by objective features of speech production. For individuals with PTH, speech production may have been more effortful resulting in slower speaking rates and more precise vowel articulation during headache vs. when they were headache-free, suggesting that speech alterations were related to PTH and not solely due to the underlying mTBI.	[Chong, Catherine D.; Dumkrieger, Gina; Nikolova, Simona; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Chong, Catherine D.; Wu, Teresa; Schwedt, Todd J.] ASU Mayo Ctr Innovat Imaging, Phoenix, AZ 85004 USA; [Zhang, Jianwei; Liss, Julie; Jayasuriya, Suren; Berisha, Visar] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ USA; [Zhang, Jianwei; Stegmann, Gabriela; Liss, Julie; Jayasuriya, Suren; Berisha, Visar] Arizona State Univ, Coll Hlth Solut, Tempe, AZ USA; [Li, Jing] Georgia Tech, Sch Ind & Syst Engn, Atlanta, GA USA; [Wu, Teresa] Arizona State Univ, Sch Comp Informat Decis Syst Engn, Tempe, AZ USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Jayasuriya, Suren] Arizona State Univ, Sch Arts Media & Engn, Tempe, AZ USA		Chong, CD (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.; Chong, CD (corresponding author), ASU Mayo Ctr Innovat Imaging, Phoenix, AZ 85004 USA.	Chong.Catherine@Mayo.edu		Zhang, Jianwei/0000-0001-6419-2038	National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R61NS113315-01]	This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Award Number 1R61NS113315-01.	Ardila R, 2020, PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2020), P4218; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Auxemery Y, 2020, EUR J TRAUMA DISSOC, DOI [10.1016/j.ejtd.2020.100167, DOI 10.1016/J.EJTD.2020.100167]; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berisha V, 2014, J ACOUST SOC AM, V135, P421, DOI 10.1121/1.4829528; Capi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Stefano V, 2020, J NEUROL NEUROSUR PS, V91, P764, DOI 10.1136/jnnp-2020-322850; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Kirchmann M, 2006, CURR OPIN NEUROL, V19, P286, DOI 10.1097/01.wco.0000227040.16071.a9; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Park JJ, 2020, CAN J NEUROL SCI, V47, P242, DOI 10.1017/cjn.2019.316; Roy N, 2009, PAIN MED, V10, P164, DOI 10.1111/j.1526-4637.2007.00393.x; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Scherer S, 2015, INT CONF ACOUST SPEE, P4789, DOI 10.1109/ICASSP.2015.7178880; Schmidt M, 1996, HDB LOS ANGELES W PS HDB LOS ANGELES W PS; Schwedt TJ, 2019, CEPHALALGIA, V39, P722, DOI 10.1177/0333102418815505; Serafini G, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00149; Serafini G, 2016, CHILD ABUSE NEGLECT, V62, P39, DOI 10.1016/j.chiabu.2016.09.013; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Stockbridge MD, 2020, BRAIN INJURY, V34, P567, DOI 10.1080/02699052.2020.1725836; Talkar T., INT SHANG CHIN INT SHANG CHIN, P135; Tan ZH, 2020, COMPUT SPEECH LANG, V59, P1, DOI 10.1016/j.csl.2019.06.005; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tu M., 2018, ELECT ENG SYSTEMS SC; Vander Werff KR, 2019, BRAIN INJURY, V33, P1320, DOI 10.1080/02699052.2019.1641624; Whitfield JA, 2014, J COMMUN DISORD, V51, P19, DOI 10.1016/j.jcomdis.2014.06.005	29	0	0	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2021	22	1							82	10.1186/s10194-021-01296-6			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU2AZ	WOS:000680843300002	34301180	gold, Green Published, Green Submitted			2022-02-06	
J	Cochrane, F; Siyambalapitiya, S; Cornwell, P				Cochrane, Frances; Siyambalapitiya, Samantha; Cornwell, Petrea			Clinical profile of Aboriginal and Torres Strait Islander adults with stroke and traumatic brain injury at a regional Australian hospital: a retrospective chart audit	BRAIN IMPAIRMENT			English	Article						Indigenous; stroke; brain injury; health care; remote; rehabilitation	INDIGENOUS AUSTRALIANS; CARE	Background: The clinical profile of Aboriginal and Torres Strait Islander adults admitted to hospital with neurological injury is not well documented. Understanding these profiles may enable health professionals to provide more culturally responsive health care for this patient group. This study aimed to report the clinical profile of Aboriginal and Torres Strait Islander adults admitted to a regional Queensland hospital due to stroke or traumatic brain injury (TBI). Method: A 2-year retrospective medical record review of Aboriginal and Torres Strait Islander adults (>= 18 years) admitted to a regional Queensland hospital with principal diagnoses of stroke or TBI. Results: There were 132 Aboriginal and Torres Strait Islander adult stroke (51.5%) or TBI (48.5%) admissions. The mean ages were 56.7 years for stroke and 42.7 years for TBI. The majority of patients (83.3%) were of Aboriginal descent with others identifying as Torres Strait Islander only, or both Aboriginal and Torres Strait Islander. Patients were from 26 diverse home locations across northern Australia, primarily Outer Regional or Remote/Very Remote geographical locations. All patients' language backgrounds were documented as English only. Over 90% of stroke and 50% of TBI patients presented with medical co-morbidities. Conclusions: Patients had diverse geographical locations and cultural backgrounds, with many likely impacted by dislocation from home and country, as well as potential delays in receiving treatment. Despite this diversity, English was documented in patients' medical records as their only language. The majority of patients also presented with multiple medical co-morbidities. Health professionals should consider these factors to ensure patients receive optimum and culturally responsive health care.	[Cochrane, Frances; Siyambalapitiya, Samantha; Cornwell, Petrea] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [Cochrane, Frances] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Siyambalapitiya, Samantha; Cornwell, Petrea] Griffith Univ, Sch Allied Hlth Sci, Brisbane, Qld, Australia		Cochrane, F (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia.; Cochrane, F (corresponding author), James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia.	frances.cochrane1@jcu.edu.au		Siyambalapitiya, Samantha/0000-0001-9310-0809			2M Language Services, 2019, INDIGENOUS LANGUAGE; ABS (Australian Bureau of Statistics), 2018, EST AB TORR STRAIT I; AIHW, 2018, AUSTR HLTH 2018; Armstrong E, 2019, BRAIN IMPAIR, V20, P120, DOI 10.1017/BrImp.2019.19; Aspin C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-143; Australian Bureau of Statistics [ABS], 2016, 1270055005 ABS, V5; Australian Bureau of Statistics [ABS], 2016, ASGS REM STRUCT; Australian Institute of Health and Welfare [AIHW], 2008, HOSP SEP DUE TRAUM B; Australian Institute of Health and Welfare [AIHW], 2019, HOSP INJ AB TORR STR; Balabanski AH, 2018, INT J STROKE, V13, P811, DOI 10.1177/1747493018778113; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Boufous S., 2010, UNDERLYING CAUSES EF; Burnette L.E., 2009, ABORIGINAL ISLANDER, V33, P10, DOI [https://doi.org/10.3316/informit.05312926886123, DOI 10.3316/INFORMIT.05312926886123]; Cadilhac DA, 2017, MED J AUSTRALIA, V206, P345, DOI 10.5694/mja16.00525; Esterman Adrian, 2018, Inj Epidemiol, V5, P40, DOI 10.1186/s40621-018-0172-9; Fitts MS, 2019, BRAIN IMPAIR, V20, P137, DOI 10.1017/BrImp.2019.24; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Helps Y., 2008, HOSP SEPARATIONS DUE; Hersh D, 2019, PATIENT EDUC COUNS, V102, P2310, DOI 10.1016/j.pec.2019.07.029; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12278; Katzenellenbogen JM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-330; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Kelly J., 2012, MANAGING 2 WORLDS TO; Kelly J, 2014, AUST J RURAL HEALTH, V22, P109, DOI 10.1111/ajr.12094; Lopez L, 2011, JT COMM J QUAL PATIE, V37, P437, DOI 10.1016/S1553-7250(11)37055-9; Morgan DJR, 2019, MED J AUSTRALIA, V210, P220, DOI 10.5694/mja2.12107; National Health and Medical Research Council, 2018, ETH COND RES AB TORR; NSW Government, 2016, CLIN ABBR LIST; Queensland Government, 2018, TOWNSV HOSP HLTH SER; Queensland Government, 2019, APP G LANG COD; Queensland Government, 2017, AB TORR STRAIT ISL P; Queensland Health, 2010, AB TORR STRAIT ISL C; Queensland Health, 2014, AB TORR STRAIT ISL P; Ralph AP, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2689-y; State Library of Queensland, 2005, TORR STRAIT ISL LANG; Stroke Foundation, 2019, NAT STROK AUD AC SER; Taylor K., 2014, HLTH CARE INDIGENOUS, V2nd ed.; Thomas SL, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0228-1; Tiedeman C, 2019, INTERN MED J, V49, P962, DOI 10.1111/imj.14303; Vassar M, 2013, J EDUC EVAL HEALTH P, V10, DOI 10.3352/jeehp.2013.10.12	43	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2021	22	3					281	293		10.1017/BrImp.2021.1			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XE3FT	WOS:000723278500003					2022-02-06	
J	Cui, CM; Wang, CS; Jin, F; Yang, MQ; Kong, LS; Han, WX; Jiang, P				Cui, Changmeng; Wang, Changshui; Jin, Feng; Yang, Mengqi; Kong, Lingsheng; Han, Wenxiu; Jiang, Pei			Calcitriol confers neuroprotective effects in traumatic brain injury by activating Nrf2 signaling through an autophagy-mediated mechanism	MOLECULAR MEDICINE			English	Article						Traumatic brain injury; Vitamin D; Autophagy; Keap-Nrf2 system	VITAMIN-D; CELL-DEATH	Background The present study aimed to further explore the potential interaction between oxidative stress and autophagy in the progression of traumatic brain injury (TBI) and therapeutic mechanism of calcitriol, the active form of vitamin D (VitD). Methods Neuroprotective effects of calcitriol were examined following TBI. We further evaluated the impacts of TBI and calcitriol treatment on autophagic process and nuclear factor E2-related factor 2 (Nrf2) signaling. Results We found that treatment of calcitriol markedly ameliorated the neurological deficits and histopathological changes following TBI. The brain damage impaired autophagic flux and impeded Nrf2 signaling, the major regulator in antioxidant response, consequently leading to uncontrolled and excessive oxidative stress. Meanwhile, calcitriol promoted autophagic process and activated Nrf2 signaling as evidenced by the reduced Keap1 expression and enhanced Nrf2 translocation, thereby mitigating TBI-induced oxidative damage. In support, we further found that chloroquine (CQ) treatment abrogated calcitriol-induced autophagy and compromised Nrf2 activation with increased Keap1 accumulation and reduced expression of Nrf2-targeted genes. Additionally, both CQ treatment and Nrf2 genetic knockout abolished the protective effects of calcitriol against both TBI-induced neurological deficits and neuronal apoptosis. Conclusions Therefore, our work demonstrated a neuroprotective role of calcitriol in TBI by triggering Nrf2 activation, which might be mediated by autophagy.	[Cui, Changmeng; Wang, Changshui; Jin, Feng; Kong, Lingsheng] Jining Med Univ, Affiliated Hosp, Dept Neurosurg, Jining, Peoples R China; [Yang, Mengqi; Han, Wenxiu; Jiang, Pei] Jining Med Univ, Jining Peoples Hosp 1, Inst Clin Pharm & Pharmacol, Jining 272011, Peoples R China		Jiang, P (corresponding author), Jining Med Univ, Jining Peoples Hosp 1, Inst Clin Pharm & Pharmacol, Jining 272011, Peoples R China.	jiangpeicsu@sina.com		Jiang, Pei/0000-0002-8360-7427	Natural Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [ZR2018BH016]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81602846, 81901954]; Taishan Scholar Project of Shandong Province [tsqn201812159]; Jining Key Research and Development Program [2019SMNS012]; Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation of Jining Medical University [JYHL2018FZD01]	This work was supported by Natural Science Foundation of Shandong Province (No. ZR2018BH016), National Natural Science Foundation of China (81602846, 81901954), Taishan Scholar Project of Shandong Province (tsqn201812159), Jining Key Research and Development Program (No. 2019SMNS012), Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation of Jining Medical University (JYHL2018FZD01).	Bhowmick S, 2019, J MOL MED, V97, P1627, DOI 10.1007/s00109-019-01851-4; Cass WA, 2012, NEUROCHEM INT, V60, P186, DOI 10.1016/j.neuint.2011.11.010; Chen LL, 2019, AGING CELL, V18, DOI 10.1111/acel.12951; Cui CM, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101295; Cui CM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9245702; Cui CM, 2017, CELL PHYSIOL BIOCHEM, V42, P1888, DOI 10.1159/000479571; Cui XY, 2017, MOL CELL ENDOCRINOL, V453, P131, DOI 10.1016/j.mce.2017.05.035; Deng S, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101453; Di Somma C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112482; Dodson M, 2015, BIOCHEM J, V469, P347, DOI 10.1042/BJ20150568; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; El-Din SS, 2020, STEROIDS, V156, DOI 10.1016/j.steroids.2020.108586; El-Magd NFA, 2020, LIFE SCI, V244, DOI 10.1016/j.lfs.2020.117331; Fan ML, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02762; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Jiang P, 2014, PSYCHOPHARMACOLOGY, V231, P3445, DOI 10.1007/s00213-014-3440-6; Lee DH, 2020, AUTOPHAGY, V16, P1949, DOI 10.1080/15548627.2020.1712108; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Mori T, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa178; Nachliely M, 2019, J STEROID BIOCHEM, V188, P8, DOI 10.1016/j.jsbmb.2018.11.017; Park JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50877-8; Saito Y, 2020, FREE RADICAL BIO MED, V152, P235, DOI 10.1016/j.freeradbiomed.2020.03.012; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Stout DM, 2018, NEUROBIOL STRESS, V9, P241, DOI 10.1016/j.ynstr.2018.09.006; Su SH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1668-0; Tan X, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01551; Tao SS, 2019, ENVIRON TOXICOL, V34, P594, DOI 10.1002/tox.22726; Vazquez-Rosa E, 2020, P NATL ACAD SCI USA, V117, P27667, DOI 10.1073/pnas.2010430117; Zelt JGE, 2015, J PHARMACOL EXP THER, V355, P451, DOI 10.1124/jpet.115.228106; Zhang H, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801014; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005; Zheng DC, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104655; Zheng JQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00097; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227	34	0	0	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1076-1551	1528-3658		MOL MED	Mol. Med.	DEC	2021	27	1							118	10.1186/s10020-021-00377-1			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UW6TI	WOS:000700285200002	34556021	Green Published, gold			2022-02-06	
J	D'Andrea, A; Radmilovic, J; Mele, D; Di Giannuario, G; Rizzo, M; Campanas, M; Riegler, L; Gimelli, A; Khoury, G; Strano, S; Moreo, A				D'Andrea, Antonello; Radmilovic, Jun; Mele, Donato; Di Giannuario, Giovanna; Rizzo, Massimiliano; Campanas, Marco; Riegler, Lucia; Gimelli, Alessia; Khoury, Georgette; Strano, Stefano; Moreo, Antonella		Assoc Nazl Med Cardiologi Osped AN	Transcranial Doppler Eco-color: methodology and usefulness in the study of patent oval foramen in cryptogenic stroke	GIORNALE ITALIANO DI CARDIOLOGIA			Italian	Article						Cryptogenic stroke; Microembolic signals; Middle cerebral artery; Paradoxical embolism; Patent foramen ovale; Transcranial Doppler ultrasonography	TO-LEFT SHUNT; ATRIAL SEPTAL ANEURYSM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ARTERY STENOSIS; ISCHEMIC-STROKE; FLOW VELOCITY; RISK-FACTORS; DIAGNOSIS; ULTRASONOGRAPHY	Non-invasive Doppler ultrasonographic study of cerebral arteries (transcranial Doppler, TCD) has been extensively applied on both outpatient and inpatient settings. It is performed placing a low-frequency (<= 2 MHz) transducer on the scalp of the patient over specific acoustic windows, in order to visualize the intracranial arterial vessels and to evaluate the cerebral blood flow velocity and its alteration in many different conditions. Nowadays a valid indication for TCD in the outpatient setting is the research of right-to-left shunting, responsible for the so-called "paradoxical embolism", most often due to patency of foramen ovale, which is responsible for the majority of cryptogenic strokes occurring in patients younger than 55 years. TCD also allows to classify the grade of severity of such shunts using the so-called "microembolic signal grading score". Therefore, TCD is an essential cardiological exam for the detection of patent foramen ovale, assuming an important role as a first-level examination to guide the subsequent diagnostic-therapeutic management. In addition, TCD has found many useful applications in neurocritical care practice. It is useful for the identification of intracranial vascular stenosis and for the assessment of critical conditions including vasospasm in subarachnoid hemorrhage, traumatic brain injury and brain stem death. It is also used to evaluate cerebral hemodynamic changes after stroke, to investigate cerebral pressure autoregulation, and for the clinical evaluation of cerebral vasomotor reactivity.	[D'Andrea, Antonello; Radmilovic, Jun; Riegler, Lucia] Univ Luigi Vanvitelli Campania, UOC Cardiol UTIC Ernodinam, Nocera Inferiore ASL Salerno, PO Umberto I, Padua, Italy; [Mele, Donato] Univ Padua, Dipartimento Sci Cardiotoracovasc & Sanita Pubbl, Padua, Italy; [Di Giannuario, Giovanna] Osped Infermi, UOC Cardiol, Rimini, Italy; [Rizzo, Massimiliano] Osped San Paolo, ASL Roma 4, UOC Cardiol, Civitavecchia, Italy; [Campanas, Marco] Fdn Poliambulanza, UOC Cardiol, Brescia, Italy; [Gimelli, Alessia] Fdn CNR Reg Toscana Gabriele Monasterio, Pisa, Italy; [Khoury, Georgette] Azienda Osped Santa Maria, UOC Cardiol, Terni, Italy; [Strano, Stefano] Sapienza Univ Roma, Dipartimento Sci Clin Internist Anestesiol & Card, Rome, Italy; [Moreo, Antonella] ASST Grande Osped Metropolitano Niguarda, Dipartimento Cardiotoracovasc De Gasperis, Milan, Italy		D'Andrea, A (corresponding author), Corso Vittorio Emanuele 121A, I-80121 Naples, Italy.	antonellodandrea@libero.it					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P22, DOI [10.1007/978-3-7091-8864-4_3, DOI 10.1007/978-3-7091-8864-4_3]; Antignani P L, 2012, Int Angiol, V31, P1; Anzola GP, 2004, STROKE, V35, P2140, DOI 10.1161/01.STR.0000137764.07815.de; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; ARNOLDS BJ, 1986, ULTRASOUND MED BIOL, V12, P115, DOI 10.1016/0301-5629(86)90016-5; BOGDAHN U, 1990, STROKE, V21, P1680, DOI 10.1161/01.STR.21.12.1680; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; Chiti A, 2015, J STROKE CEREBROVASC, V24, P1287, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.033; Christou I, 2001, J NEUROIMAGING, V11, P236, DOI 10.1111/j.1552-6569.2001.tb00040.x; Clarke N R A, 2004, Eur J Echocardiogr, V5, P176, DOI 10.1016/S1525-2167(03)00076-3; D'Andrea A, 2021, EUR HEART J-CARD IMG, V22, P135, DOI 10.1093/ehjci/jeaa318; D'Andrea A, 2016, J CARDIOVASC ECHOGR, V26, P71, DOI 10.4103/2211-4122.187947; D'Andrea A, 2011, J CARDIOVASC MED, V12, P527, DOI 10.2459/JCM.0b013e32834976d6; Daniels Cathy, 2004, Eur J Echocardiogr, V5, P449, DOI 10.1016/j.euje.2004.04.004; Davies A, 2017, HEART LUNG CIRC, V26, P246, DOI 10.1016/j.hlc.2016.06.1211; Del Sette M, 2007, STROKE, V38, P2254, DOI 10.1161/STROKEAHA.106.479485; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; DROSTE DW, 1989, STROKE, V20, P1005, DOI 10.1161/01.STR.20.8.1005; Elgendy AY, 2020, JAMA NEUROL, V77, P878, DOI 10.1001/jamaneurol.2020.0458; Ghosh S, 2007, POSTGRAD MED J, V83, P173, DOI 10.1136/pgmj.2006.051094; Godart F, 2000, EUR HEART J, V21, P483, DOI 10.1053/euhj.1999.1944; Gonzalez-Alujas T, 2011, REV ESP CARDIOL, V64, P133, DOI [10.1016/j.rec.2010.10.014, 10.1016/j.recesp.2010.10.009]; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hara H, 2005, J AM COLL CARDIOL, V46, P1768, DOI 10.1016/j.jacc.2005.08.038; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Inzitari D, 2006, NEUROL SCI, V27, pS225, DOI 10.1007/s10072-006-0622-y; Inzitari D., 2000, Neurological Sciences, V21, P5; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; Johansson MC, 2010, J AM SOC ECHOCARDIOG, V23, P1136, DOI 10.1016/j.echo.2010.08.004; Kaps M, 2008, EUR NEUROL, V59, P9, DOI 10.1159/000114455; Kent DM, 2013, NEUROLOGY, V81, P619, DOI 10.1212/WNL.0b013e3182a08d59; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; Knauth M, 1997, BRIT MED J, V314, P701, DOI 10.1136/bmj.314.7082.701; Kuhl HP, 1999, J AM COLL CARDIOL, V34, P1823, DOI 10.1016/S0735-1097(99)00412-X; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; Lange MC, 2010, J NEUROL SCI, V293, P106, DOI 10.1016/j.jns.2010.02.003; Lefevre J, 2008, ARCH CARDIOVASC DIS, V101, P213, DOI 10.1016/S1875-2136(08)73695-7; Lin YP, 2015, J MED ULTRASOUND, V23, P129, DOI 10.1016/j.jmu.2015.07.002; Meier B, 2003, CIRCULATION, V107, P5, DOI 10.1161/01.CIR.0000046073.34261.C1; MELTZER RS, 1980, J CLIN ULTRASOUND, V8, P121, DOI 10.1002/jcu.1870080205; Mojadidi MK, 2014, JACC-CARDIOVASC IMAG, V7, P236, DOI 10.1016/j.jcmg.2013.12.011; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Morais LA, 2018, INT HEART J, V59, P1327, DOI 10.1536/ihj.17-489; Nicoletto Heather A, 2009, Am J Electroneurodiagnostic Technol, V49, P14; Ntaios G, J STROKE CEREBROVASC, V30; Patel PM, 2009, MILLERS ANESTHESIA, P305; Paulus J, 2014, INTENS CARE MED, V40, P1783, DOI 10.1007/s00134-014-3447-9; Pristipino C, 2019, EUR HEART J, V40, P3182, DOI 10.1093/eurheartj/ehy649; Pristipino C, 2013, G ITAL CARDIOL, V14, P699, DOI 10.1714/1335.14838; Rajamani K, 2001, BIOMED PHARMACOTHER, V55, P247, DOI 10.1016/S0753-3322(01)00063-4; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Rovira A, 2005, EUR RADIOL, V15, P416, DOI 10.1007/s00330-004-2633-5; Sarkar S, 2007, POSTGRAD MED J, V83, P683, DOI 10.1136/pgmj.2007.058602; Serena J, 1998, STROKE, V29, P1322, DOI 10.1161/01.STR.29.7.1322; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Sorensen SG, 2010, J INTERV CARDIOL, V23, P575, DOI 10.1111/j.1540-8183.2010.00587.x; Souteyrand G, 2006, EUR J ECHOCARDIOGR, V7, P147, DOI 10.1016/j.euje.2005.04.007; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Van Camp G, 2000, AM J CARDIOL, V86, P1284, DOI 10.1016/S0002-9149(00)01224-8; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Woods TD, 2006, J AM SOC ECHOCARDIOG, V19, P215, DOI 10.1016/j.echo.2005.09.023; Wu LA, 2004, ARCH INTERN MED, V164, P950, DOI 10.1001/archinte.164.9.950; Zoghbi WA, 2014, JACC-CARDIOVASC IMAG, V7, P251, DOI 10.1016/j.jcmg.2014.01.007	69	0	0	0	0	PENSIERO SCIENTIFICO EDITORE	ROME	VIA SAN GIOVANNI VALDARNO 8, ROME, ITALY	1827-6806	1972-6481		G ITAL CARDIOL	G. Ital. Cardiol.	DEC	2021	22	12					988	999					12	Cardiac & Cardiovascular Systems	Emerging Sources Citation Index (ESCI)	Cardiovascular System & Cardiology	XJ2CO	WOS:000726603000007	34845401				2022-02-06	
J	Dams-O'Connor, K; Bellgowan, PSF; Corriveau, R; Pugh, MJ; Smith, DH; Schneider, JA; Whitaker, K; Zetterberg, H				Dams-O'Connor, Kristen; Bellgowan, Patrick S. F.; Corriveau, Roderick; Pugh, Mary Jo; Smith, Douglas H.; Schneider, Julie A.; Whitaker, Keith; Zetterberg, Henrik			Alzheimer's Disease-Related Dementias Summit 2019: National Research Priorities for the Investigation of Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease and Related Dementias	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; head trauma; traumatic brain injury	ASSOCIATION; SINGLE; CONSEQUENCES; INDIVIDUALS; KNOWLEDGE; DECLINE; TDP-43; ADULTS	Traumatic brain injury (TBI) is a risk factor for later-life dementia. Clinical and pre-clinical studies have elucidated multiple mechanisms through which TBI may influence or exacerbate multiple pathological processes underlying Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The National Institutes of Health hosts triennial ADRD Summits to inform a national research agenda, and the 2019 ADRD Summit was the first to highlight "TBI and AD/ADRD Risk" as an emerging topic in the field. A multidisciplinary committee of TBI researchers with relevant expertise reviewed extant literature, identified research gaps and opportunities, and proposed draft research recommendations at the 2019 ADRD Summit. These research recommendations, further refined after broad stakeholder input at the Summit, cover four overall areas: 1) Encourage crosstalk and interdisciplinary collaboration between TBI and dementia researchers; 2) Establish infrastructure to study TBI as a risk factor for AD/ADRD; 3) Promote basic and clinical research examining the development and progression of TBI AD/ADRD neuropathologies and associated clinical symptoms; and 4) Characterize the clinical phenotype of progressive dementia associated with TBI and develop non-invasive diagnostic approaches. These recommendations recognize a need to strengthen communication and build frameworks to connect the complexity of TBI with rapidly evolving AD/ADRD research. Recommendations acknowledge TBI as a clinically and pathologically heterogeneous disease whose associations with AD/ADRDs remain incompletely understood. The recommendations highlight the scientific advantage of investigating AD/ADRD in the context of a known TBI exposure, the study of which can directly inform on disease mechanisms and treatment targets for AD/ADRDs with shared common pathways.	[Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Bellgowan, Patrick S. F.; Corriveau, Roderick; Whitaker, Keith] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA USA; [Schneider, Julie A.] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL USA; [Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, Dept Rehabil & Human Performance, One Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	kristen.dams-oconnor@mountsinai.org			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Alzheimer's AssociationAlzheimer's Association; GHR Foundation; BiogenBiogen; Alzheimer's Drug Discovery Foundation; American Stroke Association, a division of the American Heart Association; CurePSP; John A. Hartford Foundation; WellMed Charitable Foundation; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); EIP Pharma; Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD) Coalition; NIH Office of Disease Prevention; Foundation for the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The conference was supported by NINDS, organized in collaboration with NIA, with assistance from the NIH Office of Disease Prevention, the Foundation for the National Institutes of Health with support from their contributors: Alzheimer's Association; GHR Foundation; Biogen; Accelerate Cure/Treatments for Alzheimer's Disease (ACT-AD) Coalition; Alzheimer's Drug Discovery Foundation; American Stroke Association, a division of the American Heart Association; CurePSP; EIP Pharma; the John A. Hartford Foundation; and the WellMed Charitable Foundation.	Alosco ML, 2021, ALZHEIMERS RES THER, V13, DOI 10.1186/s13195-021-00872-x; [Anonymous], 2021, Neurology, V96, P593, DOI 10.1212/WNL.0000000000011717; Anor CJ, 2017, NEURODEGENER DIS, V17, P127, DOI 10.1159/000455127; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bieniek KF, 2021, J NEUROPATH EXP NEUR, V80, P210, DOI 10.1093/jnen/nlab001; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brett B.L., 2021, Biol. Psychiatry, DOI 10.1016/j.biopsych.2021.05.025; Chu SF, 2016, ASIA-PAC J PUBLIC HE, V28, P519, DOI 10.1177/1010539516662956; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corriveau RA, 2017, NEUROLOGY, V89, P2381, DOI 10.1212/WNL.0000000000004717; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Grasset L, 2020, ALZHEIMERS DEMENT, V16, P853, DOI 10.1002/alz.12080; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Holtzman D.M., 2021, ADRD SUMMIT 2016 REP; Institute of Medicine, 2009, GULF WAR HLTH, V7; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katz DI, 2021, NEUROLOGY, V96, P848, DOI 10.1212/WNL.0000000000011850; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LoBue C, 2020, ARCH CLIN NEUROPSYCH, V35, P123, DOI 10.1093/arclin/acz074; Loignon A, 2020, J HEAD TRAUMA REHAB, V35, pE21, DOI 10.1097/HTR.0000000000000514; Marceaux JC, 2020, CLIN NEUROPSYCHOL, V34, P1175, DOI 10.1080/13854046.2019.1679889; McKee AC, 2020, SEMIN NEUROL, V40, P359, DOI 10.1055/s-0040-1713632; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Montine TJ, 2014, NEUROLOGY, V83, P851, DOI 10.1212/WNL.0000000000000733; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Postupna N, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.624696; Pugh MJ, 2021, J NEUROTRAUM, V38, P3222, DOI 10.1089/neu.2021.0059; Pujol-Calderon F, 2019, NEUROSCI LETT, V698, P58, DOI 10.1016/j.neulet.2018.12.042; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schneider J.A., ADRD SUMMIT 2019 REP; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; World Health Organization, 2020, DEM; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	66	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3186	3194		10.1089/neu.2021.0216			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700002	34714152				2022-02-06	
J	Daneshvar, DH; Baugh, CM; Lama, RD; Yutsis, M; Pea, RD; Goldman, S; Grant, GA; Cantu, RC; Sanders, LM; Zafonte, RD; Hainline, B; Sorcar, P				Daneshvar, Daniel H.; Baugh, Christine M.; Lama, Roberto D.; Yutsis, Maya; Pea, Roy D.; Goldman, Shelley; Grant, Gerald A.; Cantu, Robert C.; Sanders, Lee M.; Zafonte, Ross D.; Hainline, Brian; Sorcar, Piya			Participating in Two Video Concussion Education Programs Sequentially Improves Concussion-Reporting Intention	NEUROTRAUMA REPORTS			English	Article						concussion; education; prevention; reporting	FOOTBALL PLAYERS; COLLEGIATE; SPORT; EPIDEMIOLOGY	Undiagnosed concussions increase the risk of additional concussion and persistent symptoms from concussion. Because there are no reliable objective markers of concussion, self-reporting of subjective and non-visible symptoms are critical to ensuring proper concussion management. For this reason, educational interventions target concussion reporting, but the majority of studies have examined the efficacy of single educational interventions or compared interventions to one another. This randomized crossover study sought to identify whether there was benefit to administering multiple concussion education programs in tandem, back to back. The study randomized 313 male high school football players to first receive CrashCourse concussion education (CC) or Centers for Disease Control and Prevention video concussion education (CDC) followed by crossover with the other education. Athlete concussion-reporting intention, attitudes, subjective norms, perceived behavioral control, and enjoyment of education were assessed at baseline and after each intervention. There were statistically significant improvements across all measures, both after single intervention and crossover (all p < 0.001). Secondary analyses examining differences between education found that athletes reported higher enjoyment of concussion education immediately after participating in CC, as compared to CDC (p < 0.001). These findings demonstrate an additive benefit to implementing CC and CDC education in tandem, without decrement in enjoyment of concussion education after experiencing dual educations; in fact, enjoyment of concussion education improved after receiving education programs back to back. These educational programs appear to complement one another, and the results support the use of multi-modal concussion education to differentially target and maximize concussion reporting.	[Daneshvar, Daniel H.; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Daneshvar, Daniel H.; Zafonte, Ross D.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Daneshvar, Daniel H.; Zafonte, Ross D.] Spaulding Rehabil Hosp, Boston, MA USA; [Daneshvar, Daniel H.; Cantu, Robert C.] Boston Univ, Sch Med, Chron Traumat Encephalopathy Ctr, Boston, MA 02118 USA; [Baugh, Christine M.] Univ Colorado Denver, Ctr Bioeth & Humanities, Anschutz Med Campus, Aurora, CO USA; [Baugh, Christine M.] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO USA; [Lama, Roberto D.] Stanford Univ, Sch Engn, Stanford, CA 94305 USA; [Pea, Roy D.; Goldman, Shelley] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Yutsis, Maya] Stanford Sch Med, Dept Neurol, Palo Alto, CA USA; [Grant, Gerald A.] Stanford Sch Med, Dept Neurosurg, Palo Alto, CA USA; [Cantu, Robert C.] Stanford Sch Med, Dept Pediat, Palo Alto, CA USA; [Sanders, Lee M.] Stanford Sch Med, Stanford Ctr Innovat Global Hlth, Palo Alto, CA USA; [Zafonte, Ross D.] Emerson Hosp, Cantu Concuss Ctr, Concord, MA USA; [Hainline, Brian] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Sorcar, Piya] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Sorcar, Piya] NYU, Langone Med Ctr, New York, NY USA		Daneshvar, DH (corresponding author), Spaulding Rehabil Hosp, 300 First Ave, Charlestown, MA 02129 USA.	ddaneshvar@mgh.harvard.edu					AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Arakkal AT, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00241-6; Audrit H, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.07.007; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Baugh CM, 2019, J NEUROTRAUM, V36, P2065, DOI 10.1089/neu.2018.6161; Bookbinder HA, 2020, J ATHL TRAINING, V55, P843, DOI 10.4085/1062-6050-362-19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chao CM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01652; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Cover R, 2018, J ATHL TRAINING, V53, P646, DOI 10.4085/1062-6050-338-17; Daneshvar Daniel H, 2021, Inquiry, V58, p469580211022641, DOI 10.1177/00469580211022641; Daneshvar DH, 2021, J ATHL TRAINING, V56, P1197, DOI 10.4085/509-20; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; ENNETT ST, 1994, AM J PUBLIC HEALTH, V84, P1394, DOI 10.2105/AJPH.84.9.1394; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glanz K, 2008, HLTH BEHAV HLTH ED T, V4; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hickling A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8244-5; Kroshus E, 2020, BRIT J SPORT MED, V54, P1314, DOI 10.1136/bjsports-2020-102185; Kroshus E, 2019, HEALTH EDUC BEHAV, V46, P916, DOI 10.1177/1090198119859414; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Perski O, 2019, J MED INTERNET RES, V21, DOI 10.2196/16197; Register-Mihalik JK, 2021, RES SPORTS MED, V29, P1, DOI 10.1080/15438627.2020.1719493; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sabatino MJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.141.1_MeetingAbstract.203; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Sullivan L, 2020, J PUBLIC HEALTH MAN, V26, pS84, DOI 10.1097/PHH.0000000000001128; Takacs ZK, 2019, PSYCHOL BULL, V145, P653, DOI 10.1037/bul0000195; TeachAids, CRASHCOURSE FREE CON; The National Federation of State High School Associations, CONC SPORTS; The National Federation of State High School Associations, 2018, 3 REV ONL COURS INCL; Tibubos AN, 2019, J PSYCHOL, V153, P628, DOI 10.1080/00223980.2019.1586630	42	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					581	591		10.1089/neur.2021.0033			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XN2RY	WOS:000729358800001	35018360	gold, Green Published			2022-02-06	
J	De Simone, G; Sbardella, D; Oddone, F; Pesce, A; Coletta, M; Ascenzi, P				De Simone, Giovanna; Sbardella, Diego; Oddone, Francesco; Pesce, Alessandra; Coletta, Massimo; Ascenzi, Paolo			Structural and (Pseudo-)Enzymatic Properties of Neuroglobin: Its Possible Role in Neuroprotection	CELLS			English	Article						neuroglobin; structure; reactivity; (pseudo-)enzymatic properties; neuroprotection; retina	MOLECULAR-DYNAMICS SIMULATION; LIGAND-BINDING PROPERTIES; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; MURINE NEUROGLOBIN; ENDOGENOUS NEUROPROTECTANT; HEXACOORDINATE HEMOGLOBIN; TEMPERATURE-DEPENDENCE; NITROBINDINS STRUCTURE; PROTOGLOBIN STRUCTURE	Neuroglobin (Ngb), the third member of the globin family, was discovered in human and murine brains in 2000. This monomeric globin is structurally similar to myoglobin (Mb) and hemoglobin (Hb) alpha and beta subunits, but it hosts a bis-histidyl six-coordinated heme-Fe atom. Therefore, the heme-based reactivity of Ngb is modulated by the dissociation of the distal HisE7-heme-Fe bond, which reflects in turn the redox state of the cell. The high Ngb levels (~100-200 mu M) present in the retinal ganglion cell layer and in the optic nerve facilitate the O-2 buffer and delivery. In contrast, the very low levels of Ngb (~1 mu M) in most tissues and organs support (pseudo-)enzymatic properties including NO/O-2 metabolism, peroxynitrite and free radical scavenging, nitrite, hydroxylamine, hydrogen sulfide reduction, and the nitration of aromatic compounds. Here, structural and (pseudo-)enzymatic properties of Ngb, which are at the root of tissue and organ protection, are reviewed, envisaging a possible role in the protection from neuronal degeneration of the retina and the optic nerve.	[De Simone, Giovanna; Ascenzi, Paolo] Univ Roma Tre, Dipartimento Sci, Viale Marconi 446, I-00146 Rome, Italy; [Sbardella, Diego; Oddone, Francesco; Coletta, Massimo] IRCCS Fdn Bietti, I-00198 Rome, Italy; [Pesce, Alessandra] Univ Genoa, Dipartimento Fis, Via Dodecaneso 33, I-16100 Genoa, Italy; [Coletta, Massimo] Univ Roma Tor Vergata, Dipartmento Sci Clin & Med Traslaz, Via Montpellier 1, I-00133 Rome, Italy; [Ascenzi, Paolo] Accademia Nazl Lincei, Via Lungara 10, I-00165 Rome, Italy; [Ascenzi, Paolo] IRCSS Fdn Santa Lucia, Unita Neuroendocrinol Metab & Neurofarmacol, I-00179 Rome, Italy		Ascenzi, P (corresponding author), Univ Roma Tre, Dipartimento Sci, Viale Marconi 446, I-00146 Rome, Italy.; Coletta, M (corresponding author), IRCCS Fdn Bietti, I-00198 Rome, Italy.; Coletta, M (corresponding author), Univ Roma Tor Vergata, Dipartmento Sci Clin & Med Traslaz, Via Montpellier 1, I-00133 Rome, Italy.; Ascenzi, P (corresponding author), Accademia Nazl Lincei, Via Lungara 10, I-00165 Rome, Italy.; Ascenzi, P (corresponding author), IRCSS Fdn Santa Lucia, Unita Neuroendocrinol Metab & Neurofarmacol, I-00179 Rome, Italy.	giovanna.desimone@uniroma3.it; diego.sbardella@fondazionebietti.it; francesco.oddone@fondazionebietti.it; pesce@fisica.unige.it; coletta@med.uniroma2.it; ascenzi@uniroma3.it		De Simone, Giovanna/0000-0002-9358-9891			Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; Abraini JH, 2014, ANESTHESIOLOGY, V121, P1018, DOI 10.1097/ALN.0000000000000435; Alagurajan J, 2018, BIOCHEMISTRY-US, V57, P4824, DOI 10.1021/acs.biochem.8b00586; Andersen JF, 2010, TOXICON, V56, P1120, DOI 10.1016/j.toxicon.2009.11.002; Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Anselmi M, 2008, BIOPHYS J, V95, P4157, DOI 10.1529/biophysj.108.135855; Anselmi M, 2007, BIOPHYS J, V93, P434, DOI 10.1529/biophysj.106.099648; Anselmi M, 2011, J PHYS CHEM B, V115, P2436, DOI 10.1021/jp110833v; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Arroyo-Manez P, 2011, BBA-PROTEINS PROTEOM, V1814, P1054, DOI 10.1016/j.bbapap.2010.08.005; ASCENZI P, 1981, J BIOL CHEM, V256, P5383; Ascenzi P, 2016, MOL ASPECTS MED, V52, P1, DOI 10.1016/j.mam.2016.10.004; Ascenzi P, 2016, J PORPHYR PHTHALOCYA, V20, P134, DOI 10.1142/S1088424616300081; Ascenzi P, 2014, IUBMB LIFE, V66, P268, DOI 10.1002/iub.1267; Astudillo L, 2010, BIOPHYS J, V99, pL16, DOI 10.1016/j.bpj.2010.04.033; Athwal NS, 2016, BIOCHEMISTRY-US, V55, P5809, DOI 10.1021/acs.biochem.6b00775; Avella G, 2014, ACTA CRYSTALLOGR D, V70, P1640, DOI 10.1107/S1399004714007032; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bocahut A, 2013, J BIOL INORG CHEM, V18, P111, DOI 10.1007/s00775-012-0956-2; Bocahut A, 2011, J AM CHEM SOC, V133, P8753, DOI 10.1021/ja202587a; Bocahut A, 2009, J PHYS CHEM B, V113, P16257, DOI 10.1021/jp906854x; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bonding SH, 2008, INT J BIOL MACROMOL, V43, P295, DOI 10.1016/j.ijbiomac.2008.07.003; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Brittain T, 2008, IUBMB LIFE, V60, P135, DOI 10.1002/iub.16; Brunori M, 2006, FASEB J, V20, P2192, DOI 10.1096/fj.06-6643rev; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Bunn HFL, 1986, HEMOGLOBIN MOL GENET; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Champagne DE, 2005, PATHOPHYSIOL HAEMO T, V34, P221, DOI 10.1159/000092428; Chan ASY, 2012, INVEST OPHTH VIS SCI, V53, P704, DOI 10.1167/iovs.11-7408; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Cwerman-Thibault H, 2017, MOL THER-METH CLIN D, V5, P200, DOI 10.1016/j.omtm.2017.04.008; Danielsson J, 2008, J CHEM THEORY COMPUT, V4, P1083, DOI 10.1021/ct800066q; De Marinis E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.30; de Sanctis D, 2004, IUBMB LIFE, V56, P643, DOI 10.1080/15216540500059640; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; De Simone G, 2021, J INORG BIOCHEM, V224, DOI 10.1016/j.jinorgbio.2021.111579; De Simone G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041674; De Simone G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249395; De Simone G, 2020, ANTIOXID REDOX SIGN, V33, P229, DOI 10.1089/ars.2019.7874; De Simone Giovanna, 2017, BioMolecular Concepts, V8, P105, DOI 10.1515/bmc-2017-0013; De Simone G, 2016, IUBMB LIFE, V68, P423, DOI 10.1002/iub.1500; de Vidania S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.562581; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Dienel GA, 2019, PHYSIOL REV, V99, P949, DOI 10.1152/physrev.00062.2017; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Du WH, 2003, J AM CHEM SOC, V125, P8080, DOI 10.1021/ja034584r; Dzoljic E, 2015, FUNCT NEUROL, V30, P159; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Ezhevskaya M, 2011, J INORG BIOCHEM, V105, P1131, DOI 10.1016/j.jinorgbio.2011.05.020; Fabrizius A, 2016, NEUROSCIENCE, V337, P339, DOI 10.1016/j.neuroscience.2016.07.042; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fago A, 2004, IUBMB LIFE, V56, P689, DOI 10.1080/15216540500037299; Fago A, 2006, J INORG BIOCHEM, V100, P1339, DOI 10.1016/j.jinorgbio.2006.03.009; Fernandez VS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081986; Fiocchetti M, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108823; Fiocchetti M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6315034; Fiocchetti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189179; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; Gardner PR, 2015, J BIOL CHEM, V290, P27204, DOI 10.1074/jbc.M115.679621; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; GIACOMETTI GM, 1981, J MOL BIOL, V146, P363, DOI 10.1016/0022-2836(81)90393-4; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Giuffre A, 2008, BIOCHEM BIOPH RES CO, V367, P893, DOI 10.1016/j.bbrc.2008.01.021; Gorabi AM, 2021, FREE RADICAL BIO MED, V162, P471, DOI 10.1016/j.freeradbiomed.2020.11.002; Guimaraes BG, 2014, ACTA CRYSTALLOGR D, V70, P1005, DOI 10.1107/S1399004714000078; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hamdane D, 2005, J BIOL CHEM, V280, P36809, DOI 10.1074/jbc.M506253200; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hundahl C, 2006, FEBS J, V273, P1323, DOI 10.1111/j.1742-4658.2006.05158.x; Hundahl CA, 2012, BIOCHEM BIOPH RES CO, V425, P100, DOI 10.1016/j.bbrc.2012.07.061; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Jayaraman T, 2011, J BIOL CHEM, V286, P42679, DOI 10.1074/jbc.M111.271973; Jin KL, 2008, NEUROSCI LETT, V430, P135, DOI 10.1016/j.neulet.2007.10.031; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kamioka Y, 2013, BBA-PROTEINS PROTEOM, V1834, P1779, DOI 10.1016/j.bbapap.2013.02.021; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; Kelsen J, 2008, STROKE, V39, pE177, DOI 10.1161/STROKEAHA.108.526533; Keppner A, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101687; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2007, GENE, V398, P172, DOI 10.1016/j.gene.2007.02.044; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kiger L, 2004, IUBMB LIFE, V56, P709, DOI 10.1080/15216540500037711; Kimura H, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11060896; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Lechauve C, 2014, MOL THER, V22, P1096, DOI 10.1038/mt.2014.44; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lechauve C, 2013, J BIOL CHEM, V288, P6957, DOI 10.1074/jbc.M112.407601; Lechauve C, 2012, BBA-MOL CELL RES, V1823, P2261, DOI 10.1016/j.bbamcr.2012.09.009; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Li Y, 2016, J MOL NEUROSCI, V58, P28, DOI 10.1007/s12031-015-0645-z; Lilkova E., 2015, PYMOL MOL GRAPHICS S; Lima DC, 2011, INT J DEV NEUROSCI, V29, P891, DOI 10.1016/j.ijdevneu.2011.07.002; Lutz S, 2011, FARADAY DISCUSS, V150, P375, DOI 10.1039/c0fd00003e; Lutz S, 2009, J PHYS CHEM B, V113, P15334, DOI 10.1021/jp905673p; McBryde FD, 2017, ACTA PHYSIOL, V219, P274, DOI 10.1111/apha.12706; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Montfort WR, 2000, BBA-PROTEIN STRUCT M, V1482, P110, DOI 10.1016/S0167-4838(00)00165-5; Moschetti T, 2009, BIOCHEM BIOPH RES CO, V390, P121, DOI 10.1016/j.bbrc.2009.09.078; Moschetti T, 2009, BIOPHYS J, V97, P1700, DOI 10.1016/j.bpj.2009.05.059; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ20070372; Nienhaus K, 2004, J BIOL CHEM, V279, P22944, DOI 10.1074/jbc.M401561200; Nienhaus K, 2013, CHEM-EUR J, V19, P3558, DOI 10.1002/chem.201203558; Nienhaus K, 2010, CHEMPHYSCHEM, V11, P119, DOI 10.1002/cphc.200900637; Orlowski S, 2008, BIOSYSTEMS, V94, P263, DOI 10.1016/j.biosystems.2008.04.016; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Pesce A, 2004, IUBMB LIFE, V56, P657, DOI 10.1080/15216540500078830; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P79, DOI 10.1016/B978-0-12-407693-8.00003-0; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Rizzi M, 1996, J MOL BIOL, V258, P1, DOI 10.1006/jmbi.1996.0228; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; Roberts PA, 2016, J MATH BIOL, V73, P1, DOI 10.1007/s00285-015-0931-y; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Ruetz M, 2017, J BIOL CHEM, V292, P6512, DOI 10.1074/jbc.M116.770370; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Sen N, 2017, J MOL BIOL, V429, P543, DOI 10.1016/j.jmb.2016.12.015; Shi SY, 2011, INT J OPHTHALMOL-CHI, V4, P393, DOI 10.3980/j.issn.2222-3959.2011.04.14; Singh S, 2013, NITRIC OXIDE-BIOL CH, V32, P21, DOI 10.1016/j.niox.2013.03.008; Skommer J, 2012, INT J BIOL MACROMOL, V51, P284, DOI 10.1016/j.ijbiomac.2012.05.020; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; Stourac J, 2019, NUCLEIC ACIDS RES, V47, pW414, DOI 10.1093/nar/gkz378; Sturms R, 2011, BIOCHEMISTRY-US, V50, P10829, DOI 10.1021/bi201425f; Sugitani K, 2017, BIOCHEM BIOPH RES CO, V493, P1254, DOI 10.1016/j.bbrc.2017.09.127; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tang BL, 2020, J CELL PHYSIOL, V235, P7653, DOI 10.1002/jcp.29682; Tejero J, 2020, BIOCHEM BIOPH RES CO, V523, P567, DOI 10.1016/j.bbrc.2019.12.089; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Trashin S, 2016, J BIOL CHEM, V291, P18959, DOI 10.1074/jbc.M116.730176; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Tun SBB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55315-3; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101; Van Acker ZP, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080873; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vinck E, 2004, J AM CHEM SOC, V126, P4516, DOI 10.1021/ja0383322; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Wajcman H, 2009, CR BIOL, V332, P273, DOI 10.1016/j.crvi.2008.07.026; Walker FA, 2006, J BIOL INORG CHEM, V11, P391, DOI 10.1007/s00775-006-0095-8; Wei X, 2011, AM J PATHOL, V179, P2788, DOI 10.1016/j.ajpath.2011.08.015; Xu Y., 2018, INT J MOL SCI, V19, P2133, DOI [10.3390/ijms19072133, DOI 10.3390/IJMS19072133]; Yamashita T, 2014, CHEM PHARM BULL, V62, P613, DOI 10.1248/cpb.c13-00183; Yang YS, 2015, BIOMOL NMR ASSIGN, V9, P153, DOI 10.1007/s12104-014-9563-1; Yu ZL, 2014, NEUROSCIENCE, V270, P158, DOI 10.1016/j.neuroscience.2014.04.013; Yu ZY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1007-x; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015	174	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3366	10.3390/cells10123366			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XW9RE	WOS:000735946000001	34943874	Green Published			2022-02-06	
J	DeFinis, JH; Hou, SP				DeFinis, Jaclyn H.; Hou, Shaoping			Dual-Pseudorabies Viral Tracing for Spinal Tyrosine Hydroxylase Interneurons Involved in Segmental Micturition Reflex Circuitry in Spinal Cord Injured Rats	NEUROTRAUMA REPORTS			English	Article						bladder; external urethral sphincter; spinal cord transection; tyrosine hydroxylase; trans-synaptic tracing	CENTRAL-NERVOUS-SYSTEM; URINARY-BLADDER; NEURAL-CONTROL; NEURONS; VIRUS; PLASTICITY; DOPAMINE; BRAIN; RECEPTORS; PATHWAYS	Traumatic spinal cord injury (SCI) often leads to urinary dysfunction. Although an involuntary micturition reflex can be established to elicit voiding with time, complications arise in the form of bladder hyper-reflexia and detrusor-sphincter dyssynergia that cause incontinence and inefficient expulsion of urine. To date, the neuronal mechanisms that underlie regulation of micturition after SCI are not well understood. We recently observed an increase of a population of tyrosine hydroxylase (TH)(+) cells in the rat lumbosacral cord post-SCI, which contribute to the sustention of a low level of dopamine that modulates the recovered bladder reflex. To identify whether spinal TH+ cells are involved in the micturition reflex pathway post-SCI, two isoforms of the trans-synaptic retrograde tracer, pseudorabies virus encoding green fluorescent protein (GFP; PRV-152) or red fluorescent protein (RFP; PRV-614), were injected into the bladder detrusor or the external urethral sphincter (EUS), respectively, 3 weeks after a spinal cord transection at the 10th thoracic level (T10) in rats. Immunohistochemistry was performed to examine infected TH+ cells in the caudal cord at both 48 and 72 h post-injection. As a result, double-labeled TH+/GFP(+) and TH+/RFP+ cells could be found in the superficial dorsal horn, parasympathetic nuclei, and dorsal gray commissure (lamina X) at both time points. More importantly, a shared population of TH+ interneurons (TH+/GFP(+)/RFP+) exists between bladder and EUS circuitry. These results suggest that spinal TH+ interneurons may coordinate activity of the bladder and EUS that occurs during micturition reflexes post-SCI.	[DeFinis, Jaclyn H.; Hou, Shaoping] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Marion Murray Spinal Cord Res Ctr, 2900 Queen Lane, Philadelphia, PA 19129 USA		Hou, SP (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Marion Murray Spinal Cord Res Ctr, 2900 Queen Lane, Philadelphia, PA 19129 USA.	sh698@drexel.edu			NIHNINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099076, NIDDKF31DK123840-01]	The support of this project was provided by NIHNINDS R01NS099076 to S. Hou and NIDDKF31DK123840-01 to J.H. DeFinis.	Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blok BFM, 2002, UROLOGY, V59, P13, DOI 10.1016/S0090-4295(01)01633-8; Cameron AA, 2006, J NEUROSCI, V26, P2923, DOI 10.1523/JNEUROSCI.4390-05.2006; Card J.P., 1994, USE PSEUDORABIES VIR, P363; Chang HY, 2007, AM J PHYSIOL-RENAL, V292, pF1044, DOI 10.1152/ajprenal.00175.2006; de Groat W.C., 1993, NEUROPHYSIOLOGY MICT, P227; de Groat WC, 2015, COMPR PHYSIOL, V5, P327, DOI 10.1002/cphy.c130056; de Groat WC, 2012, EXP NEUROL, V235, P123, DOI 10.1016/j.expneurol.2011.05.003; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Gladwell SJ, 1999, EXP BRAIN RES, V128, P377, DOI 10.1007/s002210050857; Hou SP, 2016, EXP NEUROL, V285, P136, DOI 10.1016/j.expneurol.2015.12.001; Hou SP, 2014, COMPR PHYSIOL, V4, P1419, DOI 10.1002/cphy.c130045; Hou SP, 2013, J NEUROSCI, V 33, P17138, DOI 10.1523/JNEUROSCI.2851-13.2013; Im YJ, 2008, YONSEI MED J, V49, P479, DOI 10.3349/ymj.2008.49.3.479; MOUCHET P, 1986, BRAIN RES BULL, V16, P341, DOI 10.1016/0361-9230(86)90055-9; NADELHAFT I, 1995, J COMP NEUROL, V359, P443, DOI 10.1002/cne.903590307; Nadelhaft I, 1996, J COMP NEUROL, V375, P502; Nadelhaft I, 2001, BRAIN RES, V903, P33, DOI 10.1016/S0006-8993(01)02349-6; Qiao YA, 2021, J NEUROTRAUM, V38, P803, DOI 10.1089/neu.2020.7284; Shefchyk SJ, 2002, PROG BRAIN RES, V137, P71; Stafford SA, 2006, BRIT J PHARMACOL, V148, P510, DOI 10.1038/sj.bjp.0706763; VIZZARD MA, 1995, J COMP NEUROL, V355, P629, DOI 10.1002/cne.903550411; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Zinck NDT, 2006, PROG BRAIN RES, V152, P147, DOI 10.1016/S0079-6123(05)52010-7	25	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					660	668		10.1089/neur.2021.0045			9	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XT4YC	WOS:000733593900001	35018366	Green Published, gold			2022-02-06	
J	Degeneffe, CE				Degeneffe, Charles Edmund			Families of veterans with traumatic brain injury in Australia and the United States: Implications for rehabilitation counselors	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article; Early Access						family; international; military; traumatic brain injury; veteran	MILITARY VETERANS; SERVICE MEMBERS; NEEDS; IRAQ; QUALITY; LIFE	Starting with World War I, Australia and the United States have been allies in military operations. Since then, both countries have been challenged by meeting the needs of military personnel incurring traumatic brain injury (TBI), especially during recent operations in Iraq and Afghanistan. TBI impacts all members of the veteran's family. This paper articulates the shared responsibility both countries assume in meeting the support needs faced by families of military veterans with TBI and how TBI in the military is different than in the civilian population. The paper describes how both countries differently address the needs of family caregivers of veterans with TBI and outlines areas for rehabilitation counselor collaborations in research and training.	[Degeneffe, Charles Edmund] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, San Diego, CA 92182 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, San Diego, CA 92182 USA.	cdegenef@sdsu.edu					Australian Army, AUSTR ARM AFGH; Australian Society of Rehabilitation Counsellors Ltd, 2020, COMP REH COUNS; Australian War Memorial, 2021, IND SERV AUSTR ARM F; Australians Together, 2021, WHAT HIST OUR HIST I; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bellon M, 2015, BRAIN IMPAIR, V16, P131, DOI 10.1017/BrImp.2015.17; Brain Injury Australia, 2016, SPEAK ANN NAT LAUNCH; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Burke HS, 2009, J REHABIL, V75, P5; Bursnall S, 2018, REHABIL PSYCHOL, V63, P447, DOI 10.1037/rep0000225; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Cifu DX, 2010, AM J PHYS MED REHAB, V89, P688, DOI 10.1097/PHM.0b013e3181e722ad; Council for Accreditation of Counseling and Related Educational Programs, 2015, 2016 CACREP STAND; Cummins T.L., 2021, GLOBAL PSYCHIAT, V4, P1; Defence Families of Australia, 2020, ANN AG YEAR REV 2020; Defense Medical Surveillance System, 2021, DOD NUMB TRAUM BRAIN; Degeneffe C.E., 2019, J APPL REHABIL COUS, V50, P252; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DEGENEFFE CE, 2015, FAMILIES REHABILITAT, P213; Degeneffe CE, 2008, J REHABIL, V74, P10; Department of Defence, YOUR FAM; Department of Veterans' Affairs, PARTN SERV PENS; Department of Veterans' Affairs, 2020, COMP DEP MRCA; Department of Veterans' Affairs, SUPP FAM; Embassy of Australia, 2020, AUSTR US DEF REL; Friedman C, 2018, REHABIL RES POL EDUC, V32, P123, DOI 10.1891/2168-6653.32.2.123; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Health.mil, DOD WORLDW TBI NUMB; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ignatius D., 2021, WASH POST; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Lawrence-Wood E., 2019, IMPACT COMBAT REPORT; Lhamon D. P., 2018, BRIEFING REPORT BROK; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Matthews L.R., 2007, REHABILITATION ED, V21, P241; McLennan V, 2021, REHABIL RES POL EDUC, V35, P106, DOI 10.1891/RE-20-29; Moriarty H, 2018, J FAM NURS, V24, P184, DOI 10.1177/1074840718773470; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Office of the Historian, AUSTR NZ US SEC TREA; Parliament of Australia, 2020, SOC SEC WELF; Pozzato I, 2019, AUST NZ J PUBL HEAL, V43, P382, DOI 10.1111/1753-6405.12878; Rehabilitation Counselling Association of Australasia, ACCR MAN REH COUNS E; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Sim M., 2015, US AUSTR JOINT RES E; Summerall E. L., 2008, TRAUMATIC BRAIN INJU; United States Department of Veterans Affairs, 2021, VA CAR SUPP; United States Department of Veterans Affairs, 2020, VA BEN SPOUS DEP SUR; United States Department of Veterans Affairs, 2015, POL TBI SYST CAR; United States State Department, 2021, US REL AUSTR; Waszak DL, 2017, WORKPLACE HEALTH SAF, V65, P430, DOI 10.1177/2165079916682524; Whiteneck G. G., 2015, VA TRAUMATIC BRAIN I; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080	53	0	0	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.												10.1017/jrc.2021.5		DEC 2021	11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	XL9FR	WOS:000728445700001		Bronze			2022-02-06	
J	Deng, HS; Goldschmidt, E; Nwachuku, E; Yue, JHK; Angriman, F; Wei, ZS; Agarwal, N; Puccio, AM; Okonkwo, DO				Deng, Hansen; Goldschmidt, Ezequiel; Nwachuku, Enyinna; Yue, John K.; Angriman, Federico; Wei, Zhishuo; Agarwal, Nitin; Puccio, Ava M.; Okonkwo, David O.			Hydrocephalus and Cerebrospinal Fluid Analysis Following Severe Traumatic Brain Injury: Evaluation of a Prospective Cohort	NEUROLOGY INTERNATIONAL			English	Article						post-traumatic hydrocephalus; traumatic brain injury; ventriculoperitoneal shunt; decompressive hemicraniectomy; shunt failure; cerebrospinal fluid	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; POSTTRAUMATIC HYDROCEPHALUS; RISK-FACTORS; INTRACRANIAL HYPERTENSION; SHUNT FAILURE; HEMICRANIECTOMY; COMPLICATIONS; INFECTION; DIAGNOSIS	The development of hydrocephalus after severe traumatic brain injury (TBI) is an under-recognized healthcare phenomenon and can increase morbidity. The current study aims to characterize post-traumatic hydrocephalus (PTH) in a large cohort. Patients were prospectively enrolled age 16-80 years old with Glasgow Coma Scale (GCS) score & LE;8. Demographics, GCS, Injury Severity Score (ISS), surgery, and cerebrospinal fluid (CSF) were analyzed. Outcomes were shunt failure and Glasgow Outcome Scale (GOS) at 6 and 12-months. Statistical significance was assessed at p < 0.05. In 402 patients, mean age was 38.0 & PLUSMN; 16.7 years and 315 (78.4%) were male. Forty (10.0%) patients developed PTH, with predominant injuries being subdural hemorrhage (36.4%) and diffuse axonal injury (36.4%). Decompressive hemicraniectomy (DHC) was associated with hydrocephalus (OR 3.62, 95% CI (1.62-8.07), p < 0.01). Eighteen (4.5%) patients had shunt failure and proximal obstruction was most common. Differences in baseline CSF cell count were associated with increased shunt failure. PTH was not associated with worse outcomes at 6 (p = 0.55) or 12 (p = 0.47) months. Hydrocephalus is a frequent sequela in 10.0% of patients, particularly after DHC. Shunt placement and revision procedures are common after severe TBI, within the first 4 months of injury and necessitates early recognition by the clinician.	[Deng, Hansen; Nwachuku, Enyinna; Wei, Zhishuo; Agarwal, Nitin; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15213 USA; [Goldschmidt, Ezequiel] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Angriman, Federico] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Neurotrauma Clin Trials Ctr, Med Ctr, Pittsburgh, PA 15213 USA		Deng, HS (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15213 USA.	hdneurosurg@gmail.com; ezegold@gmail.com; nwachukuel@upmc.edu; john.yue@ucsf.edu; F.angriman@mail.utoronto.ca; chris.wei@pitt.edu; agarwaln@upmc.edu; puccioam@upmc.edu; okonkwodo@upmc.edu		Angriman, Federico/0000-0003-0971-386X	National Institutes of Health, National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Institute of Neurological Disorders and Stroke NIH/NINR [R00 NR13176]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS101036]	This work had funding support provided by the federally funded grants of National Institutes of Health, National Institute of Nursing Research, and National Institute of Neurological Disorders and Stroke NIH/NINR R00 NR13176 and NIH/NINDS K23 NS101036.	Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Anderson IA, 2019, J NEUROSURG, V130, P145, DOI 10.3171/2017.8.JNS17399; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Deng HS, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56060300; Deng HS, 2021, J NEUROTRAUM, V38, P291, DOI 10.1089/neu.2020.7028; Di GF, 2018, WORLD NEUROSURG, V116, pE406, DOI 10.1016/j.wneu.2018.04.216; Fulkerson DH, 2011, J NEUROSURG-PEDIATR, V7, P147, DOI 10.3171/2010.11.PEDS10244; Giordan E, 2019, J NEUROSURG, V131, P1024, DOI 10.3171/2018.5.JNS1875; Goldschmidt E, 2020, J CLIN NEUROSCI, V73, P85, DOI 10.1016/j.jocn.2020.01.027; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Khan Farid, 2015, Surg Neurol Int, V6, P25, DOI 10.4103/2152-7806.151388; Kowalski RG, 2019, J NEUROSURG, V130, P406, DOI 10.3171/2017.7.JNS17555; LUNDJOHANSEN M, 1994, NEUROSURGERY, V35, P839, DOI 10.1227/00006123-199411000-00006; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rammos S, 2008, J NEUROSURG, V109, P1001, DOI 10.3171/JNS.2008.109.12.1001; SHAPIRO K, 1985, J NEUROSURG, V63, P76, DOI 10.3171/jns.1985.63.1.0076; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Tribl G, 2000, BRAIN INJURY, V14, P345; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478	37	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2035-8385	2035-8377		NEUROL INT	Neurol. Int.	DEC	2021	13	4					527	534		10.3390/neurolint13040052			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XX5KX	WOS:000736335400001	34698266	Green Published, gold			2022-02-06	
J	Diaz, J; Rooney, A; Calvo, RY; Benham, DA; Carr, M; Badiee, J; Sise, CB; Sise, MJ; Bansal, V; Martin, MJ				Diaz, Joseph; Rooney, Alexandra; Calvo, Richard Y.; Benham, Derek A.; Carr, Matthew; Badiee, Jayraan; Sise, C. Beth; Sise, Michael J.; Bansal, Vishal; Martin, Matthew J.			Isolated intracranial hemorrhage in elderly patients with pre-injury anticoagulation: is full trauma team activation necessary?	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	16th Annual Academic Surgical Congress (ASC)	FEB 02-04, 2021	ELECTR NETWORK			Geriatric; Intracranial hemorrhage; Blunt trauma; Anticoagulation; Traumatic brain injury; Trauma team activation	MAJOR TRAUMA; WARFARIN; TRIAGE; RISK; AGE	Background: Traumatic intracranial hemorrhage (ICH) is a highly morbid injury, particularly among elderly patients on preinjury anticoagulants (AC). Many trauma centers initiate full trauma team activation (FTTA) for these high-risk patients. We sought to determine if FTTA was superior compared with those who were evaluated as a trauma consultation (CON). Methods: Patients aged >= 55 on preinjury AC who presented from January 2015 to December 2019 with blunt isolated head injury (non-head AIS <= 2) and confirmed ICH were identified. CON patients and FTTA patients were matched by age and head AIS. Cox proportional hazard model was used to assess patient and injury characteristics with mortality and survivor discharge disposition. Reasults: There were 45 CON patients and 45 FTTA patients. Mean age was 80 years in both groups. Fall was the most common mechanism (98% CON vs. 92% FTTA). Glasgow Coma Score (GCS) was lower in FTTA (14 vs. 15, p<0.01). CON had a significantly longer time from arrival to CT scan (1.3 vs. 0.4 hrs, p<0.01). Hospital days were similar (CON: 3.9 vs. FTTA: 3.7 days). However, CON had increased ventilator use (p=0.03). Lower admission GCS was the only factor associated with increased risk of death. Among survivors, only head AIS increased the risk of discharge to a level of care higher than that of preinjury (p=0.01). Conclusion: There was no difference in mortality or adverse discharge disposition between FTTA and CON, although FTTA was associated with a more rapid evaluation and diagnosis. Any alteration in GCS was strongly associated with mortality and should prompt evaluation by FTTA. (C) 2021 Elsevier Inc. All rights reserved.	[Diaz, Joseph; Rooney, Alexandra; Calvo, Richard Y.; Benham, Derek A.; Carr, Matthew; Badiee, Jayraan; Sise, C. Beth; Sise, Michael J.; Bansal, Vishal; Martin, Matthew J.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA USA		Martin, MJ (corresponding author), Scripps Mercy Hosp, Trauma Serv MER62, 4077 Fifth Ave, San Diego, CA 92103 USA.	traumadoc22@gmail.com					Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Carr BW, 2018, J TRAUMA ACUTE CARE, V85, P598, DOI 10.1097/TA.0000000000001986; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Davis JW, 2017, J TRAUMA ACUTE CARE, V83, P1173, DOI 10.1097/TA.0000000000001623; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; Mabry CD, 2015, J AM COLL SURGEONS, V220, P446, DOI 10.1016/j.jamcollsurg.2014.12.039; Madiraju SK, 2017, J SURG RES, V218, P261, DOI 10.1016/j.jss.2017.05.102; McCoy CE, 2013, WEST J EMERG MED, V14, P69, DOI 10.5811/westjem.2013.1.15981; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Phillips S, 1996, J TRAUMA, V40, P278, DOI 10.1097/00005373-199602000-00018; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Techar K, 2019, J SURG RES, V242, P4, DOI 10.1016/j.jss.2019.04.006; Warriner Z, 2020, CURR TRAUMA REP, V6, P125, DOI 10.1007/s40719-020-00206-6; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P915, DOI 10.1097/TA.0000000000001995	22	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2021	268						491	497		10.1016/j.jss.2021.07.021			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	WA4PM	WOS:000702868600013	34438190				2022-02-06	
J	Doltchinkova, V; Mouleshkova, N; Vitkova, V				Doltchinkova, Virjinia; Mouleshkova, Nevena; Vitkova, Victoria			Surface Properties of Synaptosomes in the Presence of L-Glutamic and Kainic Acids: In Vitro Alteration of the ATPase and Acetylcholinesterase Activities	MEMBRANES			English	Article						synaptosomes; L-glutamate; kainic acid; electrophoretic mobility; surface electrical charge; enzyme activity; bending elasticity	COLORIMETRIC DETERMINATION; ELASTIC-MODULUS; MEMBRANES; NEURONS; FLUCTUATIONS; NEUROBIOLOGY; MODEL	Morphologically and functionally identical to brain synapses, the nerve ending particles synaptosomes are biochemically derived membrane structures responsible for the transmission of neural information. Their surface and mechanical properties, measured in vitro, provide useful information about the functional activity of synapses in the brain in vivo. Glutamate and kainic acid are of particular interest because of their role in brain pathology (including causing seizure, migraine, ischemic stroke, aneurysmal subarachnoid hemorrhage, intracerebral hematoma, traumatic brain injury and stroke). The effects of the excitatory neurotransmitter L-glutamic acid and its agonist kainic acid are tested on Na+, K+-ATPase and Mg2+-ATPase activities in synaptic membranes prepared from the cerebral cortex of rat brain tissue. The surface parameters of synaptosome preparations from the cerebral cortex in the presence of L-glutamic and kainic acids are studied by microelectrophoresis for the first time. The studied neurotransmitters promote a significant increase in the electrophoretic mobility and surface electrical charge of synaptosomes at 1-4 h after isolation. The measured decrease in the bending modulus of model bimolecular membranes composed of monounsaturated lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine provides evidence for softer membranes in the presence of L-glutamate. Kainic acid does not affect membrane mechanical stability even at ten-fold higher concentrations. Both the L-glutamic and kainic acids reduce acetylcholinesterase activity and deviation from the normal functions of neurotransmission in synapses is presumed. The presented results regarding the modulation of the enzyme activity of synaptic membranes and surface properties of synaptosomes are expected by biochemical and biophysical studies to contribute to the elucidation of the molecular mechanisms of neurotransmitters/agonists' action on membranes.	[Doltchinkova, Virjinia; Mouleshkova, Nevena] Sofia Univ St Kliment Ohridski, Dept Biophys & Radiobiol, Fac Biol, 8 Dragan Tsankov Blvd, Sofia 1164, Bulgaria; [Vitkova, Victoria] Bulgarian Acad Sci, Georgi Nadjakov Inst Solid State Phys, 72 Tsarigradsko Chaussee Blvd, Sofia 1784, Bulgaria		Doltchinkova, V (corresponding author), Sofia Univ St Kliment Ohridski, Dept Biophys & Radiobiol, Fac Biol, 8 Dragan Tsankov Blvd, Sofia 1164, Bulgaria.	dolchinkova@biofac.uni-sofia.bg; veni40@mail.bg; victoria@issp.bas.bg					Achilonu I, 2012, BIOCHEMISTRY-US, V51, P995, DOI 10.1021/bi201541w; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Angelova PR, 2021, FREE RADICAL BIO MED, V173, P52, DOI 10.1016/j.freeradbiomed.2021.07.003; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Binotti B, 2021, ARCH BIOCHEM BIOPHYS, V709, DOI 10.1016/j.abb.2021.108966; Bivas I, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.012901; Bivas I, 2006, ADV PLANAR LIP BILAY, V5, P313, DOI 10.1016/S1554-4516(06)05011-3; BIVAS I, 1987, J PHYS-PARIS, V48, P855, DOI 10.1051/jphys:01987004805085500; BOSMANN HB, 1972, EXP CELL RES, V72, P436, DOI 10.1016/0014-4827(72)90012-2; Brown W.H., 2017, ORGANIC CHEM, V8th, P1312; Callenberg K.M., 2013, THESIS U PITTSBURGH; Crans RAJ, 2020, BRAIN RES, V1730, DOI 10.1016/j.brainres.2019.146640; de Lores Arnaiz Georgina Rodriguez, 2014, Int J Biomed Sci, V10, P85; Delgado AV, 2007, J COLLOID INTERF SCI, V309, P194, DOI 10.1016/j.jcis.2006.12.075; Dencheva E., 2017, 10 ANN SEM EC INT PA, P125; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Doltchinkova V, 2019, AIP CONF PROC, V2075, DOI 10.1063/1.5091387; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Erecinska M, 1996, BBA-BIOENERGETICS, V1277, P13, DOI 10.1016/S0005-2728(96)00103-X; EVANS EA, 1973, BIOPHYS J, V13, P926, DOI 10.1016/S0006-3495(73)86035-7; Evans Gareth J O, 2015, Cold Spring Harb Protoc, V2015, P421, DOI 10.1101/pdb.top074450; Faizi HA, 2019, SOFT MATTER, V15, P6006, DOI 10.1039/c9sm00772e; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; Fiske CH, 1925, J BIOL CHEM, V66, P375; Arvizu-Santamaria AG, 2017, SUPRAMOL CHEM, V29, P658, DOI 10.1080/10610278.2017.1332368; Genova J, 2005, J OPTOELECTRON ADV M, V7, P257; Genova J., 2004, BULG J PHYS, V31, P68; Genova J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022707; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hsu JP, 2002, ELECTROPHORESIS, V23, P2001, DOI 10.1002/1522-2683(200207)23:13<2001::AID-ELPS2001>3.0.CO;2-5; Hubel N, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005804; Institute of Medicine (US), 2011, GLUT REL BIOM DRUG D; Jebali Jamel, 2013, RGCI, V13, P425, DOI 10.5894/rgci430; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; Joseph C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101442; KIMELBERG HK, 1972, BIOCHIM BIOPHYS ACTA, V282, P277, DOI 10.1016/0005-2736(72)90334-3; Konev S.V., 1987, STRUCTURAL LABILITY; Kretschmer BD, 2002, AMINO ACIDS, V23, P1, DOI 10.1007/s007260200027; LAKSHMANAN J, 1974, BIOCHEM BIOPH RES CO, V58, P690, DOI 10.1016/S0006-291X(74)80473-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luisi P.L., 2000, GIANT VESICLES; Luo L, 2020, PRINCIPLES NEUROBIOL, V2nd, P69, DOI [10.1201/9781003053972, DOI 10.1201/9781003053972]; Ma YQ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01513; Maestu F, 2021, AGEING RES REV, V69, DOI 10.1016/j.arr.2021.101372; McKay MJ, 2021, ACS OMEGA, V6, P8488, DOI 10.1021/acsomega.1c00276; MCLAUGHLIN S, 1973, NATURE, V243, P234, DOI 10.1038/243234a0; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; MILNER ST, 1987, PHYS REV A, V36, P4371, DOI 10.1103/PhysRevA.36.4371; MIRONOV SL, 1985, J MEMBRANE BIOL, V86, P197, DOI 10.1007/BF01870598; Mitov M.D., 1992, ADV SUPRAMOLECULAR C, V2, P93; Pereda AE, 2015, CURR BIOL, V25, pR38, DOI 10.1016/j.cub.2014.11.029; Pinigin KV, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.042406; Pontes B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067708; Rezin GT, 2014, REV BRAS PSIQUIATR, V36, P138, DOI 10.1590/1516-4446-2012-0956; ROZHANETS V V, 1978, Biokhimiya, V43, P892; Sairazi N.S.M, 2015, EVID-BASED COMPL ALT, V12; SEAMAN GVF, 1960, J GEN PHYSIOL, V44, P251, DOI 10.1085/jgp.44.2.251; Slater C.R, 2009, ENCY NEUROSCI, P601, DOI [10.1016/B978-008045046-9.01287-0, DOI 10.1016/B978-008045046-9.01287-0]; STOYLOVA SS, 1986, STUD BIOPHYS, V113, P27; SZKUDLAREK J, 1986, NEUROSCI LETT, V65, P304, DOI 10.1016/0304-3940(86)90279-X; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Thang A., 2021, PHYSL ACETYLCHOLINES; Tzvetanova E, 2009, CELL BIOCHEM FUNCT, V27, P243, DOI 10.1002/cbf.1566; VIANELLO A, 1982, BIOCHIM BIOPHYS ACTA, V689, P89, DOI 10.1016/0005-2736(82)90192-4; Vitkova V, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012059; Vitkova V, 2011, ADV PLANAR LIP BILAY, V14, P257, DOI 10.1016/B978-0-12-387720-8.00009-1; Galassi VV, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11070478; Vukova T, 2005, MED SCI MONITOR, V11, pBR50; Wang YM, 2019, J AM CHEM SOC, V141, P17507, DOI 10.1021/jacs.9b09414; Whittaker V.P., 1984, HDB NEUROCHEMISTRY, V2, P327; Yoneda Juliana Sakamoto, 2020, Biophys Rev, V12, P49, DOI 10.1007/s12551-020-00616-5; Zou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073499	74	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0375		MEMBRANES-BASEL	Membranes	DEC	2021	11	12							987	10.3390/membranes11120987			20	Biochemistry & Molecular Biology; Chemistry, Physical; Engineering, Chemical; Materials Science, Multidisciplinary; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Engineering; Materials Science; Polymer Science	XW4DH	WOS:000735571400001	34940488	Green Published			2022-02-06	
J	Dressing, M; Wise, J; Katzenstein, J; Mularoni, PP				Dressing, Michael; Wise, Jillian; Katzenstein, Jennifer; Mularoni, P. Patrick			A Scale Measuring Academic-Related Anxiety Following Concussion	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						adolescent; pediatrics; sports medicine	ADOLESCENTS; RECOVERY; INJURY	Does academic-related anxiety contribute to an adolescent's recovery process and return to activity after experiencing a concussion? The authors created a novel measure of academic-related anxiety (Mularoni Measure of Academic Anxiety following Concussion [MMAAC]) and administered it to adolescents following concussion in outpatient pediatric sports medicine clinics. Two previously validated measures of anxiety were also administered, and results were compared with the MMAAC scores as well as the lengths of time for return to school and sports. Results show that higher MMAAC scores positively correlate with the length of time an adolescent needs to return to school. Study results indicate that the MMAAC reliably measures academic-related anxiety in adolescents suffering from concussions and can be helpful in predicting a basic timetable for return to school. The authors believe that this brief survey can be used by physicians in clinic to evaluate anxiety and assist with return to school expectations to provide comprehensive recovery support.	[Dressing, Michael] Joe DiMaggio Childrens Hosp, Dept Orthoped Surg & Sports Med, Hollywood, FL 33021 USA; [Wise, Jillian] Childrens Resource Grp CRG, Indianapolis, IN USA; [Katzenstein, Jennifer] Johns Hopkins All Childrens Hosp, Child Dev & Rehabil Ctr, St Petersburg, FL USA; [Mularoni, P. Patrick] Johns Hopkins All Childrens Hosp, Dept Sports Med, St Petersburg, FL USA		Dressing, M (corresponding author), Joe DiMaggio Childrens Hosp, Dept Orthoped Surg & Sports Med, Hollywood, FL 33021 USA.	mdressing@mhs.net					Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Baker JG, 2019, J HEAD TRAUMA REHAB, V34, P419, DOI 10.1097/HTR.0000000000000541; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DeMatteo C, 2020, CLIN PEDIATR, V59, P5, DOI 10.1177/0009922819879457; Driscoll R., 2007, WESTSIDE TEST ANXIET; Eslami AA, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.21096; Itriyeva Khalida, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2017-0070; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Meadus RJ, 2007, J PSYCHIATR MENT HLT, V14, P209, DOI 10.1111/j.1365-2850.2007.01067.x; Muris P, 1998, J BEHAV THER EXP PSY, V29, P327, DOI 10.1016/S0005-7916(98)00023-8; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5	15	0	0	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	DEC	2021	15	4					323	333		10.1123/jcsp.2019-0077			11	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	WY7KQ	WOS:000719457700003					2022-02-06	
J	Duan, KK; Mayer, AR; Shaff, NA; Chen, JY; Lin, DD; Calhoun, VD; Jensen, DM; Liu, JY				Duan, Kuaikuai; Mayer, Andrew R.; Shaff, Nicholas A.; Chen, Jiayu; Lin, Dongdong; Calhoun, Vince D.; Jensen, Dawn M.; Liu, Jingyu			DNA methylation under the major depression pathway predicts pediatric quality of life four-month post-pediatric mild traumatic brain injury	CLINICAL EPIGENETICS			English	Article						Pediatric mild traumatic brain injury; Depression; DNA methylation; Post-concussion symptom burden; Pediatric quality of life	NEUROTROPHIC FACTOR; GENETIC-FACTORS; EXPRESSION; BIOMARKERS; DIAGNOSIS; CHILDREN; RECOVERY; RISK	Background Major depression has been recognized as the most commonly diagnosed psychiatric complication of mild traumatic brain injury (mTBI). Moreover, major depression is associated with poor outcomes following mTBI; however, the underlying biological mechanisms of this are largely unknown. Recently, genomic and epigenetic factors have been increasingly implicated in the recovery following TBI. Results This study leveraged DNA methylation within the major depression pathway, along with demographic and behavior measures (features used in the clinical model) to predict post-concussive symptom burden and quality of life four-month post-injury in a cohort of 110 pediatric mTBI patients and 87 age-matched healthy controls. The results demonstrated that including DNA methylation markers in the major depression pathway improved the prediction accuracy for quality of life but not persistent post-concussive symptom burden. Specifically, the prediction accuracy (i.e., the correlation between the predicted value and observed value) of quality of life was improved from 0.59 (p = 1.20 x 10(-3)) (clinical model) to 0.71 (p = 3.89 x 10(-5)); the identified cytosine-phosphate-guanine sites were mainly in the open sea regions and the mapped genes were related to TBI in several molecular studies. Moreover, depression symptoms were a strong predictor (with large weights) for both post-concussive symptom burden and pediatric quality of life. Conclusion This study emphasized that both molecular and behavioral manifestations of depression symptoms played a prominent role in predicting the recovery process following pediatric mTBI, suggesting the urgent need to further study TBI-caused depression symptoms for better recovery outcome.	[Duan, Kuaikuai; Calhoun, Vince D.] Georgia Inst Technol, Dept Elect & Comp Engn, Atlanta, GA 30303 USA; [Duan, Kuaikuai; Chen, Jiayu; Lin, Dongdong; Calhoun, Vince D.; Liu, Jingyu] Emory Univ, Georgia State Univ, Triinst Ctr Translat Res Neuroimaging & Data Sci, Georgia Inst Technol, 55 Pk Pl NE,18th Floor, Atlanta, GA 30303 USA; [Mayer, Andrew R.; Shaff, Nicholas A.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM USA; [Calhoun, Vince D.; Liu, Jingyu] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Calhoun, Vince D.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Jensen, Dawn M.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA		Liu, JY (corresponding author), Emory Univ, Georgia State Univ, Triinst Ctr Translat Res Neuroimaging & Data Sci, Georgia Inst Technol, 55 Pk Pl NE,18th Floor, Atlanta, GA 30303 USA.; Liu, JY (corresponding author), Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA.	jliu75@gsu.edu		Liu, Jingyu/0000-0002-1724-7523	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS098494-01A1, 3R01NS098494-03S1A1, R01EB006841, R01MH118695]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)	This research was supported by grants from the National Institutes of Health to Andrew R. Mayer (Grant Numbers: 1R01NS098494-01A1 and 3R01NS098494-03S1A1) and to Vince Calhoun (R01EB006841), and the Grant R01MH118695 to Vince Calhoun from National Institute of Mental Health. The NIH/NIMH had no role in study review, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Blaze J, 2020, FRONT BEHAV NEUROSCI, P14; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Braun PR, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0376-y; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Chamberlain JA, 2018, AM J CLIN NUTR, V108, P611, DOI 10.1093/ajcn/nqy119; Chen JY, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00594; Chen JY, 2012, IEEE ENG MED BIO, P360, DOI 10.1109/EMBC.2012.6345943; Di Pietro V, 2018, FRONT NEUROL, P9; Di Pietro V, 2018, FRONT MOL NEUROSCI, P11; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Lee H, 2020, APPL SCI-BASEL, V10; LEVIN BE, 1994, RESTOR NEUROL NEUROS, V7, P5, DOI 10.3233/RNN-1994-7102; Li Y, 2018, THESIS U PITTSBURGH THESIS U PITTSBURGH; Lin DD, 2021, EPIGENETICS-US, V16, P876, DOI 10.1080/15592294.2020.1827718; Lin DD, 2018, SCHIZOPHRENIA BULL, V44, P443, DOI 10.1093/schbul/sbx068; Lipponen A, 2018, ACTA NEUROPATHOL COM, P6; Liu JY, 2008, IEEE SIGNAL PROC LET, V15, P413, DOI 10.1109/LSP.2008.922513; Liu JY, 2009, HUM BRAIN MAPP, V30, P241, DOI 10.1002/hbm.20508; Lubkin DT, 2017, SCI REP-UK, P7; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Maheras AL, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0208-17.2017; Mallah K, 2019, MOL CELL PROTEOMICS, V18, P1669, DOI 10.1074/mcp.RA119.001604; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; Mayer AR, 2019, HUM BRAIN MAPP, V40, P5370, DOI 10.1002/hbm.24778; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McFadyen CA, 2019, J NEUROTRAUM; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nielsen DA, 2019, BEHAV BRAIN RES, V356, P415, DOI 10.1016/j.bbr.2018.05.013; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Polimanti R, 2017, J NEUROTRAUM, V34, P781, DOI 10.1089/neu.2016.4550; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Song N., 2021, JUDE LIFETIME COHORT, V13, P53, DOI [10.1186/s13073-021-00875-1, DOI 10.1186/S13073-021-00875-1]; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Sugden K, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100014; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Yip PK, 2017, SCI REP-UK, P7; Zeiler FA, 2019, J NEUROTRAUM; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	65	0	0	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1868-7075	1868-7083		CLIN EPIGENETICS	Clin. Epigenetics	DEC	2021	13	1							140	10.1186/s13148-021-01128-z			17	Oncology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Genetics & Heredity	TG9UV	WOS:000671742100001	34247653	gold, Green Published			2022-02-06	
J	Sam, JE; Kandasamy, R; Wong, ASH; Ghani, ARI; Ang, SY; Idris, Z; Abdullah, JM				Ee Sam, Jo; Kandasamy, Regunath; Wong, Albert Sii Hieng; Ghani, Abdul Rahman Izaini; Ang, Song Yee; Idris, Zamzuri; Abdullah, Jafri Malin			Vacuum Drains versus Passive Drains versus No Drains in Decompressive CraniectomieseA Randomized Controlled Trial on Subgaleal Drain Complication	WORLD NEUROSURGERY			English	Article						Complications; Decompressive craniectomy; Functional outcome; Mortality; Postcraniectomy hydrocephalus; Subgaleal; Subgaleal hematoma	NEGATIVE-PRESSURE DRAINAGE; HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; SUCTION DRAINAGE; HYDROCEPHALUS; MANAGEMENT; HEMICRANIECTOMY; HYPOTENSION; HEMORRHAGE; CRANIOTOMY	OBJECTIVE: Subgaleal drains are generally deemed necessary for cranial surgeries including decompressive craniectomies (DCs) to avoid excessive postoperative subgaleal hematoma (SGH) formation. Many surgeries have moved away from routine prophylactic drainage but the role of subgaleal drainage in cranial surgeries has not been addressed. METHODS: This was a randomized controlled trial at 2 centers. A total of 78 patients requiring DC were random-ized in a 1:1:1 ratio into 3 groups: vacuum drains (VD), passive drains (PD), and no drains (ND). Complications studied were need for surgical revision, SGH amount, new remote hematomas, postcraniectomy hydrocephalus (PCH), functional outcomes, and mortality. RESULTS: Only 1 VD patient required surgical revision to evacuate SGH. There was no difference in SGH thickness and volume among the 3 drain types (P = 0.171 and P = 0.320, respectively). Rate of new remote hematoma and PCH was not significantly different (P = 0.647 and P = 0.083, respectively), but the ND group did not have any patient with PCH. In the subgroup analysis of 49 patients with traumatic brain injury, the SGH amount of the PD and ND group was significantly higher than that of the VD group. However, these higher amounts did not translate as a sig-n ificant risk factor for poor functional outcome or mortality. VD may have better functional outcome and mortality. CONCLUSIONS: In terms of complication rates, VD, PD, and ND may be used safely in DC. A higher amount of SGH was not associated with poorer outcomes. Further studies are needed to clarify the advantage of VD regarding functional outcome and mortality, and if ND reduces PCH rates.	[Ee Sam, Jo; Kandasamy, Regunath; Ghani, Abdul Rahman Izaini; Ang, Song Yee; Idris, Zamzuri] Univ Sains Malaysia, Sch Med Sci, Jalan Hosp USM, Dept Neurosci, Hlth Campus, Kota Baharu, Kelantan, Malaysia; [Ee Sam, Jo; Ghani, Abdul Rahman Izaini] Hosp Umum Sarawak, Jalan Hosp, Dept Neurosurg, Sarawak, Malaysia; [Abdullah, Jafri Malin] Univ Sains Malaysia, Dept Neurosci & Brain Behav Clust, Hosp Univ Sains, Hlth Campus, Kota Baharu, Kelantan, Malaysia		Sam, JE (corresponding author), Univ Sains Malaysia, Sch Med Sci, Jalan Hosp USM, Dept Neurosci, Hlth Campus, Kota Baharu, Kelantan, Malaysia.	joeesam@gmail.com	Idris, Zamzuri/AAB-6764-2022	Idris, Zamzuri/0000-0002-9470-0571			Alam BK, 2017, CUREUS, V9, DOI 10.7759/cureus.997; Alexander P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014390; Brown DA, 2017, HAND CLINIC, V140, P299, DOI 10.1016/B978-0-444-63600-3.00016-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Chen JH, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00107; Choi Su Yong, 2015, J Cerebrovasc Endovasc Neurosurg, V17, P194, DOI 10.7461/jcen.2015.17.3.194; Chung Ho-Jung, 2015, Brain Tumor Res Treat, V3, P132, DOI 10.14791/btrt.2015.3.2.132; CRUSE PJE, 1973, ARCH SURG-CHICAGO, V107, P206, DOI 10.1001/archsurg.1973.01350200078018; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gilsanz F J, 1984, Rev Esp Anestesiol Reanim, V31, P20; GOEL A, 1992, BRIT J NEUROSURG, V6, P357, DOI 10.3109/02688699209023795; Grobmyer Stephen R, 2002, Surg Infect (Larchmt), V3, P245, DOI 10.1089/109629602761624207; Hamou HA, 2020, ACTA NEUROCHIR, V162, P729, DOI 10.1007/s00701-019-04196-6; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Herbowski Leszek, 2019, J Neurosurg Sci, DOI 10.23736/S0390-5616.19.04737-4; Herbowski L, 2017, INT J BIOMETEOROL, V61, P181, DOI 10.1007/s00484-016-1202-3; Hernandez-Palazon J, 1998, BRIT J ANAESTH, V80, P599, DOI 10.1093/bja/80.5.599; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huang X, 2010, INT J MED SCI, V7, P385; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Hung PI, 2017, EUR SPINE J, V26, P733, DOI 10.1007/s00586-016-4672-4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kanayama M, 2010, CLIN ORTHOP RELAT R, V468, P2690, DOI 10.1007/s11999-010-1235-6; Karamchandani K, 2006, BRIT J ANAESTH, V96, P608, DOI 10.1093/bja/ael063; Kasner SE, 1999, STROKE, V30, P188, DOI 10.1161/01.STR.30.1.188; Kosins AM, 2013, PLAST RECONSTR SURG, V132, P443, DOI 10.1097/PRS.0b013e3182958945; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; LAURENSON VG, 1985, NEUROSURGERY, V17, P868, DOI 10.1097/00006123-198511000-00025; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Payne DH, 1996, J SPINAL DISORD, V9, P401; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Roth J, 2011, NEUROSURGERY, V68, pE271, DOI 10.1227/NEU.0b013e3181fe6165; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Sudmann E, 1973, J Oslo City Hosp, V23, P77; Van Roost D, 2003, NEUROSURGERY, V53, P1315, DOI 10.1227/01.NEU.0000093498.08913.9E; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809; Woo Peter Y M, 2019, Asian J Neurosurg, V14, P256, DOI 10.4103/ajns.AJNS_285_17; Yadav Monu, 2014, Case Rep Anesthesiol, V2014, P146870, DOI 10.1155/2014/146870; Zhang GM, 2009, SURG NEUROL, V72, P138, DOI 10.1016/j.surneu.2008.06.014	45	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2021	156						E381	E391		10.1016/j.wneu.2021.09.074			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XG7TZ	WOS:000724953500006	34563715				2022-02-06	
J	Egana-Huguet, J; Soria-Gomez, E; Grandes, P				Egana-Huguet, Jon; Soria-Gomez, Edgar; Grandes, Pedro			The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						endocannabinoid system; glial cells; epilepsy; neuroinflammation	CANNABINOID CB1 RECEPTOR; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; GYRUS GRANULE CELLS; N-PALMITOYLETHANOLAMINE; IN-VITRO; INFLAMMATORY MEDIATORS; ANTIEPILEPTIC DRUGS; THERAPEUTIC TARGET; STATUS EPILEPTICUS	Epilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The neuroprotective and therapeutic effect of (endo)cannabinoid compounds has been extensively investigated in several models of epilepsy. Therefore, the study of specific cell-type-dependent mechanisms underlying cannabinoid effects is crucial to understanding epileptic disorders. It is estimated that about 100 billion neurons and a roughly equal number of glial cells co-exist in the human brain. The glial population is in charge of neuronal viability, and therefore, their participation in brain pathophysiology is crucial. Furthermore, glial malfunctioning occurs in a wide range of neurological disorders. However, little is known about the impact of the endocannabinoid system (ECS) regulation over glial cells, even less in pathological conditions such as epilepsy. In this review, we aim to compile the existing knowledge on the role of the ECS in different cell types, with a particular emphasis on glial cells and their impact on epilepsy. Thus, we propose that glial cells could be a novel target for cannabinoid agents for treating the etiology of epilepsy and managing seizure-like disorders.	[Egana-Huguet, Jon; Soria-Gomez, Edgar; Grandes, Pedro] Univ Basque Country, UPV EHU, Dept Neurosci, Fac Med & Nursing, Leioa 48940, Spain; [Egana-Huguet, Jon; Soria-Gomez, Edgar; Grandes, Pedro] Achucarro Basque Ctr Neurosci, Sci Pk UPV EHU, Leioa 48940, Spain; [Soria-Gomez, Edgar] Basque Fdn Sci, Ikerbasque, Bilbao 48009, Spain; [Grandes, Pedro] Univ Victoria, Div Med Sci, Victoria, BC 3800, Canada		Soria-Gomez, E; Grandes, P (corresponding author), Univ Basque Country, UPV EHU, Dept Neurosci, Fac Med & Nursing, Leioa 48940, Spain.; Soria-Gomez, E; Grandes, P (corresponding author), Achucarro Basque Ctr Neurosci, Sci Pk UPV EHU, Leioa 48940, Spain.; Soria-Gomez, E (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48009, Spain.; Grandes, P (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC 3800, Canada.	jon.egana@ehu.eus; dgarjesus.soria@ehu.eus; pedro.grandes@ehu.eus	Soria-Gomez, Edgar/AAH-3567-2019; EGANA HUGUET, JON/ABF-9180-2021	Soria-Gomez, Edgar/0000-0002-1361-5915; EGANA HUGUET, JON/0000-0003-0683-9715	Basque GovernmentBasque Government [IT1230-19]; MINECO/FEDER, UESpanish Government [SAF2015-65034-R]; Ministry of Science and InnovationSpanish Government [PID2019-107548RBI00]; Red de Trastornos Adictivos,Instituto de Salud Carlos III; Instituto de Salud Carlos III (ISC-III)Instituto de Salud Carlos IIIEuropean Commission; European Regional Development Funds-European Union (ERDF-EU) [RD16/0017/0012]; Ikerbasque and MINECO [PGC2018-093990-A-I00]	This work was supported by the Basque Government (IT1230-19, to P.G.); MINECO/FEDER, UE (SAF2015-65034-R, to P.G.); Ministry of Science and Innovation (PID2019-107548RBI00, to P.G.); Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU, Investing in your future; RD16/0017/0012, to P.G.); J.E.-H. is a Postdoctoral Researcher contracted with funds of Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU, Investing in your future; RD16/0017/0012), and the Basque Government (IT1230-19). E.S.-G. is funded by Ikerbasque and MINECO (PGC2018-093990-A-I00; MICIU/AEI/FEDER, UE).	Adamsky A, 2018, CELL, V174, P59, DOI 10.1016/j.cell.2018.05.002; Aghaei I, 2015, EPILEPSY RES, V117, P23, DOI 10.1016/j.eplepsyres.2015.08.010; Alger BE, 2014, EPILEPSY CURR, V14, P272, DOI 10.5698/1535-7597-14.5.272; Allen NJ, 2018, SCIENCE, V362, P181, DOI 10.1126/science.aat0473; Ambrogini P, 2019, BBA-MOL BASIS DIS, V1865, P1098, DOI 10.1016/j.bbadis.2019.01.026; Amini E, 2015, MOL NEUROBIOL, V52, P492, DOI 10.1007/s12035-014-8876-5; Andres-Mach M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050900; Andres-Mach M, 2012, PROG NEURO-PSYCHOPH, V39, P301, DOI 10.1016/j.pnpbp.2012.07.001; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2017, NEUROPHARMACOLOGY, V124, P13, DOI 10.1016/j.neuropharm.2017.06.017; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Aronica E, 2018, HAND CLINIC, V145, P193, DOI 10.1016/B978-0-12-802395-2.00015-8; Askari VR, 2019, BIOCHEM PHARMACOL, V159, P154, DOI 10.1016/j.bcp.2018.12.001; Asth L, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2019.106832; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Bair RE, 2015, EXPERT OPIN PHARMACO, V16, P1911, DOI 10.1517/14656566.2015.1074181; Barker-Haliski M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022863; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Bates K, 2015, PRIMARY CARE, V42, P217, DOI 10.1016/j.pop.2015.01.006; Bauer J, 2017, EPILEPSIA, V58, P57, DOI 10.1111/epi.13784; Bedner P, 2016, J NEUROSCI RES, V94, P779, DOI 10.1002/jnr.23800; Begg M, 2003, J BIOL CHEM, V278, P46188, DOI 10.1074/jbc.M307258200; Beheshti I, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00107; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ern.11.51, 10.1586/ERN.11.51]; Bhuyan P, 2015, EXP NEUROL, V271, P329, DOI 10.1016/j.expneurol.2015.06.012; Blair R.E., 2015, CANNABINOIDS NEUROLO, P125, DOI [10.1016/b978-0-12-417041-4.00006-0, DOI 10.1016/B978-0-12-417041-4.00006-0]; Boison D, 2018, GLIA, V66, P1235, DOI 10.1002/glia.23247; Boison D, 2012, GLIA, V60, P1234, DOI 10.1002/glia.22285; Bonilla-Del Rio I, 2021, J COMP NEUROL, V529, P2332, DOI 10.1002/cne.25098; Bonilla-Del Rio I, 2019, ADDICT BIOL, V24, P182, DOI 10.1111/adb.12585; Borowicz-Reutt KK, 2020, PHARMACOL REP, V72, P1218, DOI 10.1007/s43440-020-00143-w; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Breuer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158779; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cao QJ, 2018, EXP THER MED, V16, P4784, DOI 10.3892/etm.2018.6788; Carlisle SJ, 2002, INT IMMUNOPHARMACOL, V2, P69, DOI 10.1016/S1567-5769(01)00147-3; Cattaneo S, 2021, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.608001; Chen ZG, 2004, BRAIN BEHAV IMMUN, V18, P175, DOI 10.1016/S0889-1591(03)00117-X; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Citraro R, 2016, EUR J PHARMACOL, V791, P523, DOI 10.1016/j.ejphar.2016.09.029; Citraro R, 2013, NEUROPHARMACOLOGY, V69, P115, DOI 10.1016/j.neuropharm.2012.11.017; Clark KC, 2016, GLIA, V64, P1190, DOI 10.1002/glia.22991; Coiret G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037320; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Coulter DA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022434; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Cully M, 2014, NATURE, V511, pS12, DOI 10.1038/511S12a; De Meij J, 2021, CANNABIS CANNABINOID, DOI 10.1089/can.2020.0170; de Vries EE, 2016, NEUROSCI BIOBEHAV R, V63, P177, DOI 10.1016/j.neubiorev.2016.02.007; Dell KL, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0590-1; Devinsky O, 2020, ACTA NEUROL SCAND, V142, P531, DOI 10.1111/ane.13305; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dey A, 2016, TRENDS PHARMACOL SCI, V37, P463, DOI 10.1016/j.tips.2016.03.001; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Di Sapia R, 2021, NEUROBIOL DIS, V158, DOI 10.1016/j.nbd.2021.105468; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Dulla CG, 2015, EPILEPSY CURR, V15, P349, DOI 10.5698/1535-7511-15.6.349; Eastman CL, 2020, NEUROPHARMACOLOGY, V172, DOI 10.1016/j.neuropharm.2019.107907; Egana-Huguet J, 2021, FRONT NEUROANAT, V15, DOI 10.3389/fnana.2021.645940; Eisenstein M, 2014, NATURE, V511, pS4, DOI 10.1038/511S4a; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Espejo-Porras F, 2018, AMYOTROPH LAT SCL FR, V19, P377, DOI 10.1080/21678421.2018.1425454; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Forthoffer N, 2020, REV NEUROL-FRANCE, V176, P448, DOI 10.1016/j.neurol.2020.04.012; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Friedman D, 2019, LANCET NEUROL, V18, P504, DOI 10.1016/S1474-4422(19)30032-8; Froger N, 2009, J NEUROCHEM, V111, P1383, DOI 10.1111/j.1471-4159.2009.06407.x; Gabrielli M, 2015, EMBO REP, V16, P213, DOI 10.15252/embr.201439668; Galiazzo G, 2018, HISTOCHEM CELL BIOL, V150, P187, DOI 10.1007/s00418-018-1684-7; Gaston TE, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0882-y; Goffin K, 2011, BRAIN, V134, P1033, DOI 10.1093/brain/awq385; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Guida F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00342-1; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Guo SY, 2016, AM J TRANSL RES, V8, P2631; Gupta R, 2005, ARCH DIS CHILD, V90, P379, DOI 10.1136/adc.2004.051375; Gutierrez-Rodriguez A, 2018, GLIA, V66, P1417, DOI 10.1002/glia.23314; Gutierrez-Rodriguez A, 2017, J COMP NEUROL, V525, P302, DOI 10.1002/cne.24066; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Hanamsagar R, 2017, CURR OPIN NEUROBIOL, V47, P146, DOI 10.1016/j.conb.2017.10.007; Hancock EC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001770.pub3; Hernangomez M, 2014, CURR PHARM DESIGN, V20, P4707; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hind WH, 2016, BRIT J PHARMACOL, V173, P815, DOI 10.1111/bph.13368; Hiragi T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7040026; Hohmann U, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01180; Holloman BL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147302; Hu SSJ, 2015, HANDB EXP PHARMACOL, V231, P59, DOI 10.1007/978-3-319-20825-1_3; Iannotti FA, 2014, ACS CHEM NEUROSCI, V5, P1131, DOI 10.1021/cn5000524; Ilyasov AA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00733; Serrano-Castro PJ, 2011, REV NEUROLOGIA, V53, P721, DOI 10.33588/rn.5312.2011151; Ji XY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168961; Jia Y, 2020, NEUROSCI LETT, V720, DOI 10.1016/j.neulet.2020.134779; Jiang GT, 2021, NEUROSCI BULL, V37, P1427, DOI 10.1007/s12264-021-00750-4; Jimenez-Blasco D, 2020, NATURE, V583, P603, DOI 10.1038/s41586-020-2470-y; Jordan CJ, 2019, NEUROSCI BIOBEHAV R, V98, P208, DOI 10.1016/j.neubiorev.2018.12.026; Kalafatakis I, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11071058; Kallendrusch S, 2013, GLIA, V61, P1822, DOI 10.1002/glia.22560; Kardos J, 2017, PROG NEUROBIOL, V153, P86, DOI 10.1016/j.pneurobio.2017.03.005; Karlocai MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027196; Kasatkina LA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115431; Katona I, 2015, HANDB EXP PHARMACOL, V231, P285, DOI 10.1007/978-3-319-20825-1_10; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kelly SB, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02238-4; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Khaspekov LG, 2017, BIOCHEMISTRY-MOSCOW+, V82, P380, DOI 10.1134/S0006297917030178; Kim SY, 2016, J NEUROSCI RES, V94, P794, DOI 10.1002/jnr.23758; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kolliker-Frers R, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/9999146; Komorowska-Muller JA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010019; Kozela E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081669; Kreitzer FR, 2009, PHARMACOL THERAPEUT, V122, P83, DOI 10.1016/j.pharmthera.2009.01.005; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kreutz S, 2009, GLIA, V57, P286, DOI 10.1002/glia.20756; Kuhn S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111424; Lentini C, 2021, CELL STEM CELL, V28, P2104, DOI 10.1016/j.stem.2021.09.002; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liu J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01005; Liu M, 2020, AM J PHYSIOL-CELL PH, V319, pC605, DOI 10.1152/ajpcell.00205.2020; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; Luszczki JJ, 2006, EUR J PHARMACOL, V547, P65, DOI 10.1016/j.ejphar.2006.07.037; Lutz B, 2008, NAT MED, V14, P721, DOI 10.1038/nm0708-721; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Malek N, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/130639; Mandolini GM, 2018, EPIDEMIOL PSYCH SCI, V27, P327, DOI 10.1017/S2045796018000239; Mao K, 2015, INT J CLIN EXP MED, V8, P8820; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McCoy KL, 1999, J PHARMACOL EXP THER, V289, P1620; Mecha M, 2015, BRAIN BEHAV IMMUN, V49, P233, DOI 10.1016/j.bbi.2015.06.002; Mecha M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.71; Mechoulam R, 2017, EPILEPSY BEHAV, V70, P278, DOI 10.1016/j.yebeh.2017.01.014; Meng XD, 2014, INT J CLIN EXP PATHO, V7, P2825; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Molina-Holgado F, 2002, J NEUROSCI RES, V67, P829, DOI 10.1002/jnr.10165; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2015, J NEUROSCI, V35, P3842, DOI 10.1523/JNEUROSCI.3167-14.2015; Morales P, 2021, ADV EXP MED BIOL, V1264, P47, DOI 10.1007/978-3-030-57369-0_4; Morano A, 2020, NEUROPSYCH DIS TREAT, V16, P381, DOI 10.2147/NDT.S203782; Mounsey RB, 2015, EXP NEUROL, V273, P36, DOI 10.1016/j.expneurol.2015.07.024; Musella A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07519-8; Naderi N, 2012, NEUROCHEM RES, V37, P279, DOI 10.1007/s11064-011-0607-y; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Nagib MM, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107504; Narain C, 2014, NATURE, V511, pS8, DOI 10.1038/511S8a; Navarrete C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062992; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0599; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; Pacher P, 2020, ANNU REV PHARMACOL, V60, P637, DOI 10.1146/annurev-pharmtox-010818-021441; Patel DC, 2019, NAT REV NEUROSCI, V20, P282, DOI 10.1038/s41583-019-0126-4; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Pearson-Smith JN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112365; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pellati F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1691428; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pertwee RG, 2015, HANDB EXP PHARMACOL, V231, P1, DOI 10.1007/978-3-319-20825-1_1; Perucca Emilio, 2017, J Epilepsy Res, V7, P61, DOI 10.14581/jer.17012; Petrosino S, 2017, BRIT J PHARMACOL, V174, P1349, DOI 10.1111/bph.13580; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Pietr M, 2009, FEBS LETT, V583, P2071, DOI 10.1016/j.febslet.2009.05.028; Presley CS, 2015, BIOORGAN MED CHEM, V23, P5390, DOI 10.1016/j.bmc.2015.07.057; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rao G, 2017, NEUROPSYCH DIS TREAT, V13, P585, DOI 10.2147/NDT.S114786; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Reusch N, 2022, GLIA, V70, P71, DOI 10.1002/glia.24089; Rodriguez-Cruces R, 2015, QUANT IMAGING MED SU, V5, P264, DOI 10.3978/j.issn.2223-4292.2015.02.06; Rodriguez-Iglesias N, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00024; Rosch R, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00556; Rosell-Valle C, 2021, BRAIN STRUCT FUNCT, V226, P1479, DOI 10.1007/s00429-021-02261-4; Rosenberg EC, 2017, EPILEPSY BEHAV, V70, P319, DOI 10.1016/j.yebeh.2016.11.006; Roy A, 2015, ELIFE, V4, DOI 10.7554/eLife.12703; Sadanandan N, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.596287; Sahu P, 2019, PSYCHOPHARMACOLOGY, V236, P1829, DOI 10.1007/s00213-019-5166-y; Saliba SW, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1362-7; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Sardinha VM, 2017, GLIA, V65, P1944, DOI 10.1002/glia.23205; Sarris J, 2013, CNS DRUGS, V27, P301, DOI 10.1007/s40263-013-0059-9; Savage N, 2014, NATURE, V507, pS8, DOI 10.1038/507S8a; Schartz ND, 2018, NEUROBIOL DIS, V109, P163, DOI 10.1016/j.nbd.2017.10.012; Shan W, 2021, CNS NEUROSCI THER, V27, P994, DOI 10.1111/cns.13690; Shapiro L, 2019, EPILEPSIA, V60, P2359, DOI 10.1111/epi.16388; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Silvestro S, 2019, MOLECULES, V24, DOI 10.3390/molecules24081459; Sledzinski P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010263; Sonego AB, 2018, BRAIN BEHAV IMMUN, V74, P241, DOI 10.1016/j.bbi.2018.09.014; Soria-Gomez E, 2021, NEURON, V109, P1513, DOI 10.1016/j.neuron.2021.03.007; Spittau B, 2013, GLIA, V61, P287, DOI 10.1002/glia.22435; Steinhauser C, 2016, NEUROSCIENCE, V323, P157, DOI 10.1016/j.neuroscience.2014.12.047; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; Sugaya Y, 2018, CELL MOL LIFE SCI, V75, P2793, DOI 10.1007/s00018-018-2834-8; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Sun J, 2013, BRAIN RES, V1491, P225, DOI 10.1016/j.brainres.2012.11.006; Szaflarski JP, 2014, EPILEPSY BEHAV, V41, P277, DOI 10.1016/j.yebeh.2014.08.135; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Talarico G, 2019, CURR NEUROPHARMACOL, V17, P176, DOI 10.2174/1570159X16666180702144644; Tanaka M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00087; Tang Yaliang, 2021, J Cell Signal, V2, P85, DOI 10.33696/signaling.2.038; Terrone G, 2017, CURR PHARM DESIGN, V23, P5569, DOI 10.2174/1381612823666170926113754; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Tian DS, 2017, J NEUROSCI, V37, P7878, DOI 10.1523/JNEUROSCI.0315-17.2017; Tomas-Roig J, 2016, CNS NEUROSCI THER, V22, P387, DOI 10.1111/cns.12506; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Tuduri E, 2017, INT J BIOCHEM CELL B, V88, P204, DOI 10.1016/j.biocel.2017.04.010; Valero J, 2016, ACS CHEM NEUROSCI, V7, P442, DOI 10.1021/acschemneuro.6b00009; van den Munckhof B, 2015, EPILEPSIA, V56, P1738, DOI 10.1111/epi.13128; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Verhoog QP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.591690; Verrotti A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092645; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vicente-Gutierrez C, 2019, NAT METAB, V1, P201, DOI 10.1038/s42255-018-0031-6; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; von Widdern JC, 2020, MOLECULES, V25, DOI 10.3390/molecules25030496; Waksman Y, 1999, J PHARMACOL EXP THER, V288, P1357; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; Warden A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27618; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Wong M, 2019, J NEURODEV DISORD, V11, DOI 10.1186/s11689-019-9289-6; Wu Q, 2018, EPILEPSY RES, V148, P8, DOI 10.1016/j.eplepsyres.2018.10.002; Youngerman BE, 2020, NEUROSURGERY, V86, pE366, DOI 10.1093/neuros/nyz556; Yu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132487; Yu Y, 2020, MOL NEUROBIOL, V57, P2830, DOI 10.1007/s12035-020-01923-4; Zhang HY, 2017, ADDICT BIOL, V22, P752, DOI 10.1111/adb.12367; Zhang HY, 2014, P NATL ACAD SCI USA, V111, pE5007, DOI 10.1073/pnas.1413210111; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhou JJ, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18161	248	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2021	22	24							13231	10.3390/ijms222413231			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	YA9TY	WOS:000738668500001	34948035	Green Published			2022-02-06	
J	Faulkner, JW; Snell, DL; Shepherd, D; Theadom, A				Faulkner, Josh W.; Snell, Deborah L.; Shepherd, Daniel; Theadom, Alice			Turning away from sound: The role of fear avoidance in noise sensitivity following mild traumatic brain injury	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Mild traumatic brain injury; Noise sensitivity; Fear avoidance; Injury outcomes	CHRONIC-FATIGUE-SYNDROME; MUSCULOSKELETAL PAIN; EARLY PREDICTORS; HEAD-INJURY; SYMPTOMS; MODEL; CONCUSSION; STATE; CONSEQUENCES; INDIVIDUALS	Background: Noise sensitivity (NS) following mild traumatic brain injury (mTBI) is common impacts functioning and outcomes. Recent research suggests psychological factors may have a significant role in the development of NS after mTBI. Psychological interventions have been advocated for to reduce this experience. To be effective, these interventions must aim to target the psychological processes that contribute to this relationship. Fear avoidance holds promise in this regard. The current study aimed to explore the role of fear avoidance in NS and examine its role in mediating the relationship between psychological distress and NS. Method: Adults (n = 234) diagnosed with mTBI were recruited from outpatient mTBI clinics throughout New Zealand. Participants completed self-report measures of pre-injury mental health status, as well as current postconcussion symptoms, psychological distress (anxiety, stress, depression, fear avoidance and post-traumatic stress symptoms) and functional status upon entry to an mTBI outpatient clinic (M = 8.9, SD = 9.2, post injury). Results: A pre-injury mental health diagnosis was associated with NS after mTBI, as were symptoms of anxiety, stress, depression, and post-traumatic stress. Regression analyses revealed that fear avoidance (8 = 0.45, p = .01), as well as stress (8 = 0.07, p = .01) and PTSD symptoms (8 = 0.02, p = .01), made a significant and unique contribution to NS. A series of mediation analyses found that fear avoidance had a significant indirect effect on the relationships between psychological distress and NS. Conclusions: Fear avoidance is related to NS following mTBI. Targeting fear avoidance behaviours and beliefs may represent a treatment target for reducing NS after mTBI.	[Faulkner, Josh W.] Massey Univ, POB 756, Wellington 6140, New Zealand; [Snell, Deborah L.] Univ Otago Christchurch, 2 Riccarton Ave, Christchurch 8011, New Zealand; [Shepherd, Daniel; Theadom, Alice] Auckland Univ Technol, Univ Technol, TBI Network, 90 Akoranga Dr, Auckland, New Zealand		Faulkner, JW (corresponding author), Massey Univ, Coll Humanities & Social Sci, Sch Psychol, POB 756, Wellington, New Zealand.	j.faulkner1@massey.ac.nz			Health Research Council of New Zealand Foxley Clinical Fellowship [20/041]; Health Research Council of New Zealand Clinical Practitioner Research Fellowship [18/046]	The study was funded by a Health Research Council of New Zealand Foxley Clinical Fellowship (20/041) and Clinical Practitioner Research Fellowship (18/046).	Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Band R, 2017, HEALTH PSYCHOL, V36, P264, DOI 10.1037/hea0000422; Belojevic G, 2003, Noise Health, V6, P77; Beutel ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155357; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Callahan ML, 2019, APPL NEUROPSYCH-ADUL, V26, P365, DOI 10.1080/23279095.2018.1433179; Callahan ML, 2018, APPL NEUROPSYCH-ADUL, V25, P126, DOI 10.1080/23279095.2016.1261867; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassetta BD, 2021, REHABIL PSYCHOL, V66, P160, DOI 10.1037/rep0000372; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faulkner JW, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.110141; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Fritz MS, 2012, MULTIVAR BEHAV RES, V47, P61, DOI 10.1080/00273171.2012.640596; Gil-Martinez A, 2017, PAIN MED, V18, P2214, DOI 10.1093/pm/pnx127; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes A., 2012, PROCESS VERSATILE CO; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Hoffman SN, 2019, J HEAD TRAUMA REHAB, V34, pE61, DOI 10.1097/HTR.0000000000000453; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corp. Released, 2020, IBM SPSS STAT WINDOW; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Job R.F. Soames, 1999, Noise Health, V1, P57; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleinstauber M, 2013, COGN BEHAV THERAPY, V42, P84, DOI 10.1080/16506073.2012.717301; Knudsen AK, 2011, BRIT J PSYCHIAT, V199, P430, DOI 10.1192/bjp.bp.110.082974; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; LEW HL, 2009, J REHABIL RES DEV, V46; Linton SJ, 2008, EUR J PAIN, V12, P722, DOI 10.1016/j.ejpain.2007.11.001; Lohnberg JA, 2007, J CLIN PSYCHOL MED S, V14, P113, DOI 10.1007/s10880-007-9062-y; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Mantua J, 2019, BRAIN INJURY, V33, P1467, DOI 10.1080/02699052.2019.1646434; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McGeary C, 2020, NEUROREHABILITATION, V47, P35, DOI 10.3233/NRE-203084; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rickards TA, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1748032; Shepherd D, 2021, J HEAD TRAUMA REHAB, V36, pE289, DOI 10.1097/HTR.0000000000000645; Shepherd D, 2020, QUAL LIFE RES, V29, P665, DOI 10.1007/s11136-019-02346-y; Shepherd D, 2019, BRAIN INJURY, V33, P1050, DOI 10.1080/02699052.2019.1606443; Shepherd D, 2015, INT J ENV RES PUB HE, V12, P5284, DOI 10.3390/ijerph120505284; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2020, DISABIL REHABIL, V42, P1942, DOI 10.1080/09638288.2018.1542461; Snell DL, 2020, BRAIN INJURY, V34, P610, DOI 10.1080/02699052.2020.1729417; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vieira Érica Brandão de Moraes, 2016, Rev. dor, V17, P125, DOI 10.5935/1806-0013.20160029; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WEINSTEIN ND, 1980, J SOUND VIB, V68, P241, DOI 10.1016/0022-460X(80)90468-X; Weiss Daniel S., 1997, P399; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wright B, 2014, NOISE HEALTH, V16, P166, DOI 10.4103/1463-1741.134917; Zale EL, 2015, CURR OPIN PSYCHOL, V5, P24, DOI 10.1016/j.copsyc.2015.03.014	79	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	DEC	2021	151								110664	10.1016/j.jpsychores.2021.110664			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	XR0YF	WOS:000731965000007	34749069				2022-02-06	
J	Faw, TD; Lakhani, B; Schmalbrock, P; Knopp, MV; Lohse, KR; Kramer, JLK; Liu, HW; Nguyen, HT; Phillips, EG; Bratasz, A; Fisher, LC; Deibert, RJ; Boyd, LA; McTigue, DM; Basso, DM				Faw, Timothy D.; Lakhani, Bimal; Schmalbrock, Petra; V. Knopp, Michael; Lohse, Keith R.; Kramer, John L. K.; Liu, Hanwen; Nguyen, Huyen T.; Phillips, Eileen G.; Bratasz, Anna; Fisher, Lesley C.; Deibert, Rochelle J.; Boyd, Lara A.; McTigue, Dana M.; Basso, D. Michele			Eccentric rehabilitation induces white matter plasticity and sensorimotor recovery in chronic spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Rehabilitation; Eccentric; White matter plasticity; Oligodendrogenesis	OLIGODENDROCYTE PRECURSOR CELLS; GEOMETRICALLY ACCURATE; ACTIVATION PATTERNS; RECEPTOR ACTIVATION; COMPRESSION TRAUMA; LOCOMOTOR RECOVERY; SLOPED SURFACES; MYELINATION; APOPTOSIS; BRAIN	Experience-dependent white matter plasticity offers new potential for rehabilitation-induced recovery after neurotrauma. This first-in-human translational experiment combined myelin water imaging in humans and genetic fate-mapping of oligodendrocyte lineage cells in mice to investigate whether downhill locomotor rehabilitation that emphasizes eccentric muscle actions promotes white matter plasticity and recovery in chronic, incomplete spinal cord injury (SCI). In humans, of 20 individuals with SCI that enrolled, four passed the imaging screen and had myelin water imaging before and after a 12-week (3 times/week) downhill locomotor treadmill training program (SCI + DH). One individual was excluded for imaging artifacts. Uninjured control participants (n = 7) had two myelin water imaging sessions within the same day. Changes in myelin water fraction (MWF), a histopathologically-validated myelin biomarker, were analyzed in a priori motor learning and non-motor learning brain regions and the cervical spinal cord using statistical approaches appropriate for small sample sizes. PDGFR alpha-CreERT2:mT/mG mice, that express green fluorescent protein on oligodendrocyte precursor cells and subsequent newly-differentiated oligodendrocytes upon tamoxifen-induced recombination, were either naive (n = 6) or received a moderate (75 kilodyne), contusive SCI at T9 and were randomized to downhill training (n = 6) or unexercised groups (n = 6). We initiated recombination 29 days post-injury, seven days prior to downhill training. Mice underwent two weeks of daily downhill training on the same 10% decline grade used in humans. Between-group comparison of functional (motor and sensory) and histological (oligodendrogenesis, oligodendroglial/axon interaction, paranodal structure) outcomes occurred post-training. In humans with SCI, downhill training increased MWF in brain motor learning regions (postcentral, precuneus) and mixed motor and sensory tracts of the ventral cervical spinal cord compared to control participants (P < 0.05). In mice with thoracic SCI, downhill training induced oligodendrogenesis in cervical dorsal and lateral white matter, increased axon-oligodendroglial interactions, and normalized paranodal structure in dorsal column sensory tracts (P < 0.05). Downhill training improved sensorimotor recovery in mice by normalizing hip and knee motor control and reducing hyperalgesia, both of which were associated with new oligodendrocytes in the cervical dorsal columns (P < 0.05). Our findings indicate that eccentric-focused, downhill rehabilitation promotes white matter plasticity	[Faw, Timothy D.; McTigue, Dana M.; Basso, D. Michele] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA; [Faw, Timothy D.; Phillips, Eileen G.; Fisher, Lesley C.; Deibert, Rochelle J.; McTigue, Dana M.; Basso, D. Michele] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Faw, Timothy D.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA; [Lakhani, Bimal] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Schmalbrock, Petra; V. Knopp, Michael; Nguyen, Huyen T.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Lohse, Keith R.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA; [Lohse, Keith R.] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84108 USA; [Kramer, John L. K.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Kramer, John L. K.; Liu, Hanwen] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada; [Liu, Hanwen] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Phillips, Eileen G.; Fisher, Lesley C.; Deibert, Rochelle J.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Bratasz, Anna] Ohio State Univ, Davis Heart & Lung Res Inst, Small Anim Imaging Shared Resources, Columbus, OH 43210 USA; [McTigue, Dana M.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Basso, DM (corresponding author), 106A Atwell Hall,453 W 10th Ave, Columbus, OH 43210 USA.	michele.basso@osumc.edu		Faw, Timothy/0000-0001-7794-0074	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA016058] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD082808] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31 NS096921, P30 NS104177, R01 NS074882] Funding Source: Medline		Akay T, 2014, P NATL ACAD SCI USA, V111, P16877, DOI 10.1073/pnas.1419045111; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Bacmeister CM, 2020, NAT NEUROSCI, V23, P819, DOI 10.1038/s41593-020-0637-3; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Birkl C, 2019, NEUROIMAGE, V199, P545, DOI 10.1016/j.neuroimage.2019.05.042; Bonizzato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05282-6; BORGES K, 1994, NEUROSCIENCE, V63, P135, DOI 10.1016/0306-4522(94)90012-4; Borich MR, 2014, J NEUROL PHYS THER, V38, P151, DOI 10.1097/NPT.0b013e3182a3d353; Buehner JJ, 2012, ARCH PHYS MED REHAB, V93, P1530, DOI 10.1016/j.apmr.2012.02.035; BURKE D, 1978, J PHYSIOL-LONDON, V277, P131, DOI 10.1113/jphysiol.1978.sp012265; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Chen HSM, 2017, NEUROIMAGE, V153, P122, DOI 10.1016/j.neuroimage.2017.03.065; CHUNG K, 1983, J COMP NEUROL, V214, P72, DOI 10.1002/cne.902140107; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; De Leener B, 2018, NEUROIMAGE, V165, P170, DOI 10.1016/j.neuroimage.2017.10.041; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Deoni SCL, 2015, NEUROIMAGE, V115, P147, DOI 10.1016/j.neuroimage.2015.04.058; DiGiovanna J, 2016, J NEUROSCI, V36, P10440, DOI 10.1523/JNEUROSCI.4343-15.2016; Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158; Duncan GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05473-1; Edgerton VR, 2009, EXERC SPORT SCI REV, V37, P171, DOI 10.1097/JES.0b013e3181b7b932; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Etxeberria A, 2016, J NEUROSCI, V36, P6937, DOI 10.1523/JNEUROSCI.0908-16.2016; Fang Y, 2004, BRAIN RES, V1023, P200, DOI 10.1016/j.brainres.2004.07.035; Fang Y, 2001, J NEUROPHYSIOL, V86, P1764, DOI 10.1152/jn.2001.86.4.1764; Faw T.D., 2020, ECCENTRIC FOCUSED RE; Faw TD, 2018, J NEUROTRAUM, V35, P2167, DOI 10.1089/neu.2017.5395; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Fields RD, 2015, NEURON, V86, P374, DOI 10.1016/j.neuron.2015.01.014; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Forrest GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094108; Freund P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051729; Gallo V, 2008, J PHYSIOL-LONDON, V586, P3767, DOI 10.1113/jphysiol.2008.158436; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GLEDHILL RF, 1973, NATURE, V244, P443, DOI 10.1038/244443a0; GOSLOW GE, 1973, J MORPHOL, V141, P1, DOI 10.1002/jmor.1051410102; Grillner S, 1988, Adv Neurol, V47, P425; GRILLNER S, 1984, ACTA PHYSIOL SCAND, V120, P393, DOI 10.1111/j.1748-1716.1984.tb07400.x; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hamilton N, 2009, J ANAT, V214, P208, DOI 10.1111/j.1469-7580.2008.01017.x; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Hansen CN, 2012, BRAIN BEHAV, V2, P541, DOI 10.1002/brb3.71; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; HARRISON BM, 1977, ANN NEUROL, V1, P542, DOI 10.1002/ana.410010606; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; Hoque M, 2019, NEUROREHABILITATION, V44, P587, DOI 10.3233/NRE-192701; Hoque Maruf M, 2018, Neurology (ECronicon), V10, P761; Hoque MM, 2018, NEUROSCIENCE, V391, P73, DOI 10.1016/j.neuroscience.2018.09.007; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; HULLIGER M, 1985, J PHYSIOL-LONDON, V362, P437, DOI 10.1113/jphysiol.1985.sp015687; Isakov A, 2016, J EXP BIOL, V219, P1760, DOI 10.1242/jeb.133652; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Kwon YH, 2011, NEUROREHABILITATION, V29, P253, DOI 10.3233/NRE-2011-0701; Lakhani B, 2017, NEUROIMAGE-CLIN, V14, P344, DOI 10.1016/j.nicl.2017.01.009; Lakhani B, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7526135; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Lay A.N, 2005, NEUROMUSCULAR COORDI; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Lin SC, 2002, J NEUROCYTOL, V31, P537, DOI 10.1023/A:1025799816285; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Liu HW, 2020, J NEUROIMAGING, V30, P50, DOI 10.1111/jon.12659; Liu HW, 2017, NEUROLOGY, V89, P602, DOI 10.1212/WNL.0000000000004197; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lohse KR, 2014, NEUROPSYCHOLOGIA, V59, P130, DOI 10.1016/j.neuropsychologia.2014.05.001; Malone M, 2013, GLIA, V61, P843, DOI 10.1002/glia.22476; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Morrison SA, 2018, ARCH PHYS MED REHAB, V99, P555, DOI 10.1016/j.apmr.2017.10.003; Mount CW, 2019, ELIFE, V8, DOI 10.7554/eLife.49291; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neely S.A., New oligodendrocytes exhibit more abundant andaccurate myelin regeneration than those that survive demyelination, DOI [10.1101/2020.05.22.110551, DOI 10.1101/2020.05.22.110551, 10.1101/20 20.05.22.110551]; Olsson CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00255; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Perrey S, 2018, EUR J SPORT SCI, V18, P75, DOI 10.1080/17461391.2017.1391334; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; Pukos N, 2019, GLIA, V67, P2178, DOI 10.1002/glia.23702; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rossignol S., 1988, NEURAL CONTROL RHYTH, P201; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 1998, J NEUROSCI, V18, P9303; Takeoka A, 2019, CELL REP, V27, P71, DOI 10.1016/j.celrep.2019.03.010; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Timoszyk WK, 2005, BRAIN RES, V1050, P180, DOI 10.1016/j.brainres.2005.05.041; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Warden P, 2001, EXP NEUROL, V168, P213, DOI 10.1006/exnr.2000.7622; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wilkinson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039140; Worthen-Chaudhari L, 2015, GAIT POSTURE, V41, P597, DOI 10.1016/j.gaitpost.2015.01.003; Xiao L, 2016, NAT NEUROSCI, V19, P1210, DOI 10.1038/nn.4351; Yamazaki Y, 2007, NEURON GLIA BIOL, V3, P325, DOI 10.1017/S1740925X08000070; Yao WX, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00086; Yiannakas MC, 2016, NEUROIMAGE-CLIN, V10, P71, DOI 10.1016/j.nicl.2015.11.001; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	136	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2021	346								113853	10.1016/j.expneurol.2021.113853			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WP7DW	WOS:000713288500006	34464653				2022-02-06	
J	Fishman, Y; Gross, I; Hashavya, S; Benifla, M; Tenenbaum, A; Rekhtman, D				Fishman, Yuri; Gross, Itai; Hashavya, Saar; Benifla, Menachem; Tenenbaum, Ariel; Rekhtman, David			Pediatricians as Case Managers Reduce the Exposure to Computerized Tomography in Children Experiencing Minor Head Trauma	PEDIATRIC EMERGENCY CARE			English	Article						head trauma; computerized tomography; case manager	EMERGENCY-DEPARTMENT VISITS; BRAIN-INJURY; RADIATION-EXPOSURE; SUBSEQUENT RISK; DECISION RULES; CT SCANS; EPIDEMIOLOGY; LEUKEMIA; CHALICE; CANCER	Background: Head trauma is one of the most common reasons for pediatric emergency medicine department (PED) visits. Computerized tomography (CT) scan is considered the criterion standard for the diagnosis of traumatic brain injury but was shown to increases the risk of malignancies. Methods: We retrospectively analyzed collected data of all children (ages 0-16 years) experiencing mild head trauma who were admitted to a single center, from January 1, 2010, to December 31, 2015. Comparison between patients treated by pediatricians/pediatric emergency medicine physicians (PEMP) with those treated by surgeons regarding CT rates and prognosis was done. Results: During the previously mentioned period, 4232 children presented to the PED after minor head trauma, the average age was 5.4 (+/- 4) years and 67.1% were male. Head CT was done in 7.7%, of which 30.7% had positive findings. Younger children tended to have higher percentage of positive findings on CT scan (60%, 43.8%, 26.6%, P = 0.003, for children up to 5 months, 5-24 months, and older than 24 months, respectively). Pediatricians ordered less CT scans when compared with surgeons (5.4% vs 8.5%, P < 0.001). Moreover, they had higher rates of positive findings on CT scan (52.5% vs 25.8%, P < 0.001). When all other characteristics were similar, if the case manager was a pediatrician, the patient's chances to undergo a CT scan were 4.3 times lower than if the case manager was a surgeon (odds ratio, 4.277; confidence interval, 2.274-7.104). No difference in readmissions or other complications were found between the 2 groups. Discussion: This study highlights that when the casemanager of children with minor head trauma is a pediatrician/PEMP, CT scan rates and thus exposure to radiation are diminished without a failure to detect clinically important traumatic brain injury. In conclusion, our findings suggest that when possible, all children experiencing minor head trauma should be treated by a pediatrician/PEMP in the PED.	[Fishman, Yuri] Hadassah & Hebrew Univ Hosp, Dept Gen Surg, Jerusalem, Israel; [Gross, Itai; Hashavya, Saar; Rekhtman, David] Hadassah Med Ctr, Dept Pediat Emergency Med, POB 12000, IL-91120 Jerusalem, Israel; [Benifla, Menachem] Rambam Med Ctr, Unit Pediat Neurosurg, Haifa, Israel; [Tenenbaum, Ariel] Hadassah Med Ctr, Dept Pediat, Jerusalem, Israel		Gross, I (corresponding author), Hadassah Med Ctr, Dept Pediat Emergency Med, POB 12000, IL-91120 Jerusalem, Israel.	itaigross@gmail.com					Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Corwin DJ., 2019, PEDIATR EMERG CARE, P1; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; de Gonzalez AB, 2016, BRIT J CANCER, V114, P388, DOI 10.1038/bjc.2015.415; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; IMA, 2006, ISR GUID PED HEAD TR; IMA, 2014, ISR GUID PED MIN HEA; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stylianos S, 2007, J TRAUMA, V63, pS96, DOI 10.1097/TA.0b013e31815acc42; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	24	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2021	37	12					E1642	E1645		10.1097/PEC.0000000000002143			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	XK6NI	WOS:000727579500172	32569250				2022-02-06	
J	Forodighasemabadi, A; Rasoanandrianina, H; El Mendili, MM; Guye, M; Callot, V				Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa; El Mendili, Mohamed Mounir; Guye, Maxime; Callot, Virginie			An optimized MP2RAGE sequence for studying both brain and cervical spinal cord in a single acquisition at 3T	MAGNETIC RESONANCE IMAGING			English	Article						T-1 mapping; Magnetization Prepared 2 Rapid Acquisition; Gradient Echo; Central Nervous System; Brain; Cervical Spinal Cord	IN-VIVO; T-1	Magnetization Prepared 2 Rapid Acquisition Gradient Echo (MP2RAGE) is a T-1 mapping technique that has been used broadly on brain and recently on cervical spinal cord (cSC). The growing interest for combined investigation of brain and SC in numerous pathologies of the central nervous system such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and traumatic injuries, now brings about the need for optimization with regards to this specific investigation. This implies large spatial coverage with high spatial resolution and short acquisition time, high CNR and low B-1(+) sensitivity, as well as high reproducibility and robust post-processing tools for T-1 quantification in different regions of brain and SC. In this work, a dedicated protocol (referred to as Pr-BSC) has been optimized for simultaneous brain and cSC T-1 MP2RAGE acquisition at 3T. After computer simulation optimization, the protocol was applied for in vivo validation experiments and compared to previously published state of the art protocols focusing on either the brain (Pr-B) or the cSC (Pr-SC). Reproducibility and in-ROI standard deviations were assessed on healthy volunteers in the perspective of future clinical use. The mean T-1 values, obtained by the Pr-BSC, in brain white, gray and deep gray matters were: (mean +/- in-ROI SD) 792 +/- 27 ms, 1339 +/- 139 ms and 1136 +/- 88 ms, respectively. In cSC, T-1 values for white matter corticospinal, posterior sensory, lateral sensory and rubro/reticulospinal tracts were 902 +/- 41 ms, 920 +/- 35 ms, 903 +/- 46 ms, 891 +/- 41 ms, respectively, and 954 +/- 32 ms for anterior and intermediate gray matter. The Pr-BSC protocol showed excellent agreement with previously proposed Pr-B on brain and Pr-SC on cSC, with very high inter-scan reproducibility (coefficients of variation of 0.52 +/- 0.36% and 1.12 +/- 0.62% on brain and cSC, respectively). This optimized protocol covering both brain and cSC with a sub-millimetric isotropic spatial resolution in one acquisition of less than 8 min, opens up great perspectives for clinical applications focusing on degenerative tissue such as encountered in MS and ALS.	[Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa; El Mendili, Mohamed Mounir; Guye, Maxime; Callot, Virginie] Aix Marseille Univ, CRMBM, CNRS, Marseille, France; [Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa; El Mendili, Mohamed Mounir; Guye, Maxime; Callot, Virginie] Hop Univ Timone, AP HM, CEMEREM, Marseille, France; [Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa] Univ Gustave Eiffel, Aix Marseille Univ, LBA, Marseille, France; [Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa; Callot, Virginie] iLab Spine Int Associated Lab, Marseille, France; [Forodighasemabadi, Arash; Rasoanandrianina, Henitsoa; Callot, Virginie] iLab Spine Int Associated Lab, Montreal, PQ, Canada		Callot, V (corresponding author), Aix Marseille Univ, Hop Univ Timone, CRMBM CEMEREM, 27 Bd Jean Moulin, F-13385 Marseille 05, France.	virginie.callot@univ-amu.fr			France Life Imaging Network [ANR-11-INBS-0006]; Institut Carnot Star; ARSEP Foundation (Fondation pour l'Aide a la Recherche sur la Sclerose en Plaques); CNRS (Centre National de la Recherche Scientifique)Centre National de la Recherche Scientifique (CNRS); European Union's Horizon 2020 Research and Innovation program under the Marie Skodowska-Curie grant [713750]; Regional Council of Provence-Alpes-Cote d'AzurRegion Provence-Alpes-Cote d'Azur; A*MIDEX - Investissements d'Avenir project by the French GovernmentFrench National Research Agency (ANR) [ANR-11-IDEX-0001-02]	This work was performed within a laboratory member of France Life Imaging Network (grant ANR-11-INBS-0006) and was supported by the Institut Carnot Star, the ARSEP Foundation (Fondation pour l'Aide a` la Recherche sur la Sclerose en Plaques) and the CNRS (Centre National de la Recherche Scientifique) . The project also received funding from the European Union's Horizon 2020 Research and Innovation program under the Marie Skodowska-Curie grant agreement No 713750, with the financial support of the Regional Council of Provence-Alpes-Cote d'Azur and A*MIDEX (n? ANR-11-IDEX-0001-02) , funded by the Investissements d'Avenir project by the French Government, managed by the French National Research Agency (ANR) .	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Azzarito M, 2021, HUM BRAIN MAPP, V42, P220, DOI 10.1002/hbm.25218; Battiston M, 2018, MAGN RESON MED, V79, P2142, DOI [10.1002/mrm.26852, 10.1002/mrm.26909]; Cheng HLM, 2012, J MAGN RESON IMAGING, V36, P805, DOI 10.1002/jmri.23718; Chung S, 2010, MAGN RESON MED, V64, P439, DOI 10.1002/mrm.22423; Cohen-Adad J, 2010, NEUROIMAGE, V50, P1074, DOI 10.1016/j.neuroimage.2009.12.122; De Leener B, 2018, NEUROIMAGE, V165, P170, DOI 10.1016/j.neuroimage.2017.10.041; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Demortiere S, 2020, AM J NEURORADIOL, V41, P1131, DOI 10.3174/ajnr.A6567; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Finsterbusch J, 2013, NEUROIMAGE, V79, P153, DOI 10.1016/j.neuroimage.2013.04.021; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Freund P, 2016, BRAIN, V139, P1855, DOI 10.1093/brain/aww076; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; GOWLAND P, 1993, MAGNET RESON MED, V30, P351, DOI 10.1002/mrm.1910300312; GOWLAND PA, 1991, MAGNET RESON MED, V18, P224, DOI 10.1002/mrm.1910180123; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Heule R, 2016, MAGN RESON MED, V75, P1413, DOI 10.1002/mrm.25668; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Islam H, 2019, MAGN RESON MED, V81, P825, DOI 10.1002/mrm.27388; Kober T, 2012, INVEST RADIOL, V47, P346, DOI 10.1097/RLI.0b013e31824600e9; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Massire A, 2016, NEUROIMAGE, V143, P58, DOI 10.1016/j.neuroimage.2016.08.055; Moraal B, 2008, EUR RADIOL, V18, P2311, DOI 10.1007/s00330-008-1009-7; Mussard E, 2020, MAGN RESON MED, V84, P1881, DOI 10.1002/mrm.28244; Nurnberger L, 2017, NEUROIMAGE-CLIN, V13, P405, DOI 10.1016/j.nicl.2016.12.025; O'Brien KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099676; Okubo G, 2016, J MAGN RESON IMAGING, V43, P55, DOI 10.1002/jmri.24960; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Paul F, 2016, ACTA NEUROL SCAND, V134, P24, DOI 10.1111/ane.12649; Rasoanandrianina H, 2019, NMR BIOMED, V32, P1; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Simioni S, 2014, J NEUROL, V261, P1606, DOI 10.1007/s00415-014-7398-4; Simon B, 2010, EUR RADIOL, V20, P1675, DOI 10.1007/s00330-009-1705-y; Smith SA, 2008, MAGN RESON MED, V60, P213, DOI 10.1002/mrm.21596; Steenwijk MD, 2016, MULT SCLER J, V22, P1279, DOI 10.1177/1352458515615953; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8	41	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	DEC	2021	84						18	26		10.1016/j.mri.2021.08.011			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	UW3WZ	WOS:000700091700003	34517015				2022-02-06	
J	Fossati, C; Torre, G; Vasta, S; Giombini, A; Quaranta, F; Papalia, R; Pigozzi, F				Fossati, Chiara; Torre, Guglielmo; Vasta, Sebastiano; Giombini, Arrigo; Quaranta, Federico; Papalia, Rocco; Pigozzi, Fabio			Physical Exercise and Mental Health: The Routes of a Reciprocal Relation	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mental health; sports participation; injury; depression; anxiety	SPORT PARTICIPATION; DEPRESSIVE SYMPTOMS; HIGH-SCHOOL; ALZHEIMERS-DISEASE; CAREGIVER BURDEN; OUTCOMES; ADOLESCENCE; PERFORMANCE; CONCUSSION; FATIGUE	Sport participation and exercise practice are considered to be beneficial for mental status, yielding an improved mood and better quality of life. On the other hand, good mental fitness is thought to lead to better physical status and sport performance. The key aim of this narrative review is to provide an unstructured overview on the topic with special considerations on the role of mental and physical health to summarize the evidence on their reciprocal influence. While very few papers describe the role of mental health measures in affecting physical performance, more evidence is available concerning the effect of exercise and sport in improving mental health outcomes. Furthermore, there is a consistent role of depressive and anxiety symptoms in influencing the risk of sport injury in either recreational or elite athletes. Moreover, the importance of investigating mental health issues in elite and retired athletes is highlighted. On the basis of the available literature, several biases were found to affect the provided evidence mainly because of the complexity of a proper study design in this field.	[Fossati, Chiara; Giombini, Arrigo; Quaranta, Federico; Pigozzi, Fabio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, I-00135 Rome, Italy; [Torre, Guglielmo; Vasta, Sebastiano; Papalia, Rocco] Campus Biomedico Univ Rome, Dept Orthopaed & Trauma Surg, I-00128 Rome, Italy		Torre, G (corresponding author), Campus Biomedico Univ Rome, Dept Orthopaed & Trauma Surg, I-00128 Rome, Italy.	chiara.fossati@uniroma4.it; g.torre@unicampus.it; s.vasta@unicampus.it; arrigo.giombini@uniroma4.it; federico.quaranta@uniroma4.it; r.papalia@unicampus.it; fabio.pigozzi@uniroma4.it		Pigozzi, Fabio/0000-0001-5808-9405; Papalia, Rocco/0000-0002-6069-4871			Akesdotter C, 2020, J SCI MED SPORT, V23, P329, DOI 10.1016/j.jsams.2019.10.022; Alam N, 2019, HEALTH SOC WORK, V44, P128, DOI 10.1093/hsw/hlz001; Aparicio VA, 2019, MENOPAUSE, V26, P1146, DOI 10.1097/GME.0000000000001384; Arnold R, 2012, J SPORT EXERCISE PSY, V34, P397, DOI 10.1123/jsep.34.3.397; Ashdown-Franks G, 2017, MENT HEALTH PHYS ACT, V12, P19, DOI 10.1016/j.mhpa.2016.12.001; Avitsland A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08936-7; Bou-Sospedra C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124316; Brokmeier LL, 2020, PSYCHIAT RES, V284, DOI 10.1016/j.psychres.2019.112675; Budini F, 2014, J ELECTROMYOGR KINES, V24, P412, DOI 10.1016/j.jelekin.2014.02.003; Chang C, 2020, BRIT J SPORT MED, V54, P216, DOI 10.1136/bjsports-2019-101583; Christofoletti G, 2011, CLINICS, V66, P613, DOI 10.1590/S1807-59322011000400015; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Deslandes AC, 2010, BRAZ J MED BIOL RES, V43, P585, DOI 10.1590/S0100-879X2010000600010; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; Dore I, 2019, J ADOLESCENT HEALTH, V64, P790, DOI 10.1016/j.jadohealth.2018.11.024; Duncan MJ, 2015, RES SPORTS MED, V23, P1, DOI 10.1080/15438627.2014.975811; Firth J, 2020, RES PSYCHOTHER-PSYCH, V23, P33, DOI 10.4081/ripppo.2020.433; Forbes D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub4; Fossati C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041115; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Gorczynski P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004412.pub2; Gu XL, 2019, J SPORT SCI, V37, P1927, DOI 10.1080/02640414.2019.1605652; Guddal MH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028555; Hutchison MG, 2018, INT J PSYCHOPHYSIOL, V132, P55, DOI 10.1016/j.ijpsycho.2017.11.006; Jewett R, 2014, J ADOLESCENT HEALTH, V55, P640, DOI 10.1016/j.jadohealth.2014.04.018; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Knappe F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203904; Landi F, 2004, ARCH GERONTOL GERIAT, P235; Li HM, 2017, AM J SPORT MED, V45, P2148, DOI 10.1177/0363546517702847; MacIntyre TE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01892; MacMahon C, 2014, J SPORT EXERCISE PSY, V36, P375, DOI 10.1123/jsep.2013-0249; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Maslow K, 2008, ALZHEIMERS DEMENT, V4, P110, DOI 10.1016/j.jalz.2008.02.005; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Meeusen R, 2013, EUR J SPORT SCI, V13, P1, DOI 10.1080/17461391.2012.730061; Mittal Vijay A, 2017, Curr Treat Options Psychiatry, V4, P152, DOI 10.1007/s40501-017-0112-2; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; Nazem TG, 2012, SPORTS HEALTH, V4, P302, DOI 10.1177/1941738112439685; Neville C, 2014, AUSTRALAS J AGEING, V33, P124, DOI 10.1111/ajag.12076; Noblet AJ, 2002, J APPL SPORT PSYCHOL, V14, P1, DOI 10.1080/10413200209339007; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; Peluso Marco Aurélio Monteiro, 2005, Clinics, V60, P61, DOI 10.1590/S1807-59322005000100012; Petterson H, 2017, J SPORT REHABIL, V26, P578, DOI 10.1123/jsr.2016-0047; Pozuelo-Carrascosa DP, 2017, NURS HEALTH SCI, V19, P316, DOI 10.1111/nhs.12347; Rethorst CD, 2013, J PSYCHIATR PRACT, V19, P204, DOI 10.1097/01.pra.0000430504.16952.3e; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rosendahl J, 2009, SCAND J MED SCI SPOR, V19, P731, DOI 10.1111/j.1600-0838.2008.00821.x; Sabiston CM, 2016, J SPORT EXERCISE PSY, V38, P105, DOI 10.1123/jsep.2015-0175; Sampaio A, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-020-01938-5; Schuch FB, 2016, J PSYCHIATR RES, V77, P42, DOI 10.1016/j.jpsychires.2016.02.023; Snedden TR, 2019, AM J HEALTH PROMOT, V33, P675, DOI 10.1177/0890117118817715; Souter G, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0175-7; Stella F, 2011, CLINICS, V66, P1353, DOI 10.1590/S1807-59322011000800008; Strohle A, 2007, PSYCHOL MED, V37, P1657, DOI 10.1017/S003329170700089X; Telenius EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126102; Thune-Boyle ICV, 2012, INT PSYCHOGERIATR, V24, P1046, DOI 10.1017/S1041610211002365; Trivedi MH, 2011, J CLIN PSYCHIAT, V72, P677, DOI 10.4088/JCP.10m06743; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; von Rosen P, 2021, PHYSIOTHER THEOR PR, V37, P748, DOI 10.1080/09593985.2019.1641869; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	60	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2021	18	23							12364	10.3390/ijerph182312364			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	XV6LZ	WOS:000735052600001	34886090	Green Published			2022-02-06	
J	Fox, CM; Wu, JG; Chen, L; Florczyk, DL				Fox, Christopher M.; Wu, Jonathan G.; Chen, Lucia; Florczyk, Dena L.			Injury Patterns in Collegiate Club Quidditch	SPORTS MEDICINE-OPEN			English	Article						Quidditch; Epidemiology; Club sports; Injury; Concussion; Surveillance; College; Club; Sports	ATHLETIC-ASSOCIATION; SURVEILLANCE SYSTEM; HIGH-SCHOOL; EPIDEMIOLOGY; SPORTS	Background The purpose of this study is to assess injury patterns in collegiate club quidditch athletes at a single university over three seasons. Injury data were gathered from athletic trainers that provided sideline medical coverage during competitions, the on-site athletic training center where athletes had daily access for evaluation and treatment for acute and chronic injuries, and a sports medicine physician at the on-campus student health center. Athlete exposures were estimated using available previous rosters, practice, and game schedules for the 2014-2017 quidditch seasons. Injuries were evaluated regarding the sex of the athlete, mechanism, body part injuries, and injury type. This is a retrospective descriptive epidemiology study. Results The overall injury incidence rate (IR) for collegiate club quidditch injuries was 4.55 per 1000 athlete exposures (AEs). Male athletes had an IR = 5.22 (95% CI 3.77, 7.23). Females had an IR = 3.77 (95% CI 2.49, 5.72). The most common mechanism of injury in males was collision with another athlete (36%; IR = 1.88; 95% CI 1.09, 3.24). The most common injuries were lower extremity injuries (foot, ankle, lower leg, knee, thigh, hip/groin) at 57%. The most common injury type in males was sprains at 39% (IR = 2.03; 95% CI 1.20, 3.42). The overall incidence rate for all quidditch athletes for concussions was 1.18 per 1000 AEs. Conclusions Quidditch is an increasingly popular mixed-gender collegiate club sport. This study helps identify areas for improvement in education, injury prevention, and care of athletes at the local and national levels. Concussion rates in quidditch are comparable to other contact sports and should encourage discussion to make rule changes to improve the safety of the sport.	[Fox, Christopher M.] Univ Missouri, Sch Med, Kansas City, MO 64110 USA; [Fox, Christopher M.] Univ Missouri, Truman Med Ctr, Kansas City, MO 64110 USA; [Wu, Jonathan G.] Harbor UCLA Med Ctr, Dept Internal Med, 1000 W Carson St, Torrance, CA 90502 USA; [Chen, Lucia] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Florczyk, Dena L.] Univ Calif Los Angeles, Arthur Ashe Student Hlth & Wellness Ctr, Dept Sports Med, Los Angeles, CA USA		Wu, JG (corresponding author), Harbor UCLA Med Ctr, Dept Internal Med, 1000 W Carson St, Torrance, CA 90502 USA.	wujonathan.g@gmail.com		Wu, Jonathan/0000-0002-3471-8147	University of California, Los Angeles Club Sports Athletic Training ProgramUniversity of California System	Special thanks to the University of California, Los Angeles Club Sports Athletic Training Program for their support throughout this study.	[Anonymous], 2021, SAFETY QUIDDITCH PRE; [Anonymous], 2021, HIST US QUIDDITCH US; [Anonymous], 2021, US QUIDDITCH RULEBOO, V13th; [Anonymous], 2021, TEAM RANKINGS PLAY U; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Brezinski T, 2021, ATHL TRAIN SPORTS HL, V13, P111; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P173; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kerr ZY, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3482; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Longworth T, 2021, BMJ OPEN SPORT EXERC, V7, DOI 10.1136/bmjsem-2020-000860; Pennington R, 2017, INT J SPORTS PHYS TH, V12, P833, DOI 10.26603/ijspt20170833; Roos KG, 2014, SPORTS MED, V44, P405, DOI 10.1007/s40279-013-0124-z; Rothman K.J., 2008, Modern epidemiology, V3rd	19	0	0	5	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	DEC	2021	7	1							44	10.1186/s40798-021-00336-4			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	TB7OU	WOS:000668135800001	34176026	Green Published, gold			2022-02-06	
J	Franke, LM; Perera, RA; Aygemang, AA; Marquardt, CA; Teich, C; Sponheim, SR; Duncan, CC; Walker, WC				Franke, Laura Manning; Perera, Robert A.; Aygemang, Amma A.; Marquardt, Craig A.; Teich, Collin; Sponheim, Scott R.; Duncan, Connie C.; Walker, William C.			Auditory evoked brain potentials as markers of chronic effects of mild traumatic brain injury in mid-life	CLINICAL NEUROPHYSIOLOGY			English	Article						Mild traumatic brain injury; Concussion; Chronic traumatic encephalopathy; Event-related potentials; Auditory processing; Military; Veteran	EVENT-RELATED POTENTIALS; ANTERIOR CINGULATE CORTEX; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HEARING-LOSS; P300; P50; N200; DYSFUNCTION; DEPRESSION	Objective: Auditory event-related potential (ERP) correlates of pre-dementia in late-life may also be sensitive to chronic effects of mild traumatic brain injury (mTBI) in mid-life. In addition to mTBI history, other clinical factors may also influence ERP measures of brain function. This study's objective was to evaluate the relationship between mTBI history, auditory ERP metrics, and common comorbidities. Methods: ERPs elicited during an auditory target detection task, psychological symptoms, and hearing sensitivity were collected in 152 combat-exposed veterans and service members, as part of a prospective observational cohort study. Participants, with an average age of 43.6 years, were grouped according to positive (n = 110) or negative (n = 42) mTBI history. Positive histories were subcategorized into repetitive mTBI (3 +) (n = 40) or non-repetitive (1-2) (n = 70). Results: Positive history of mTBI was associated with reduced N200 amplitude to targets and novel distractors. In participants with repetitive mTBI compared to non-repetitive and no mTBI, P50 was larger in response to nontargets and N100 was smaller in response to nontargets and targets. Changes in N200 were mediated by depression and anxiety symptoms and hearing loss, with no evidence of a supplementary direct mTBI pathway. Conclusions: Auditory brain function differed between the positive and negative mTBI groups, especially for repetitive injury, which implicated more basic, early auditory processing than did any mTBI exposure. Symptoms of internalizing psychopathology (depression and anxiety) and hearing loss are implicated in mTBI's diminished brain responses to behaviorally relevant and novel stimuli. Significance: A mid-life neurologic vulnerability conferred by mTBI, particularly repetitive mTBI, may be detectable using auditory brain potentials, and so auditory ERPs are a target for study of dementia risk in this population. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Franke, Laura Manning; Aygemang, Amma A.; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Perera, Robert A.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; [Franke, Laura Manning; Walker, William C.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Marquardt, Craig A.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55455 USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Teich, Collin; Sponheim, Scott R.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Duncan, Connie C.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Duncan, Connie C.] Uniformed Serv Univ Hlth Sci, Dept Med & Clin Psychol, Bethesda, MD 20814 USA		Franke, LM (corresponding author), Dept Phys Med & Rehabil, 1223 East Marshall St,Box 980677, Richmond, VA 23284 USA.	laura.manning@vcuhealth.org; robert.perera@vcuhealth.org; amma.a.agyemang@vcuhealth.org; marqu310@umn.edu; teich047@umn.edu; sponh001@umn.edu; conniecduncan@me.com; William.walker@vcu-health.org		Marquardt, Craig/0000-0003-2714-6168	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; U.S. Army Medical Research Acquisition Activity, Fort Detrick MD [21702-5014]	This material is based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.	Albers MW, 2006, CURR NEUROL NEUROSCI, V6, P379, DOI 10.1007/s11910-996-0018-7; Alexander GE, 2012, NEUROBIOL AGING, V33, P2723, DOI 10.1016/j.neurobiolaging.2012.01.014; Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennys K, 2007, J CLIN NEUROPHYSIOL, V24, P405, DOI 10.1097/WNP.0b013e31815068d5; Bennys K, 2011, J CLIN NEUROPHYSIOL, V28, P625, DOI 10.1097/WNP.0b013e31823cc2d3; Bollen K. A., 1989, STRUCTURAL EQUATIONS, DOI 10.1002/9781118619179; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Candrian G, 2018, ANN PHYS REHABIL MED, V61, P18, DOI 10.1016/j.rehab.2017.07.246; Cavanagh JF, 2019, NEUROPSYCHOLOGIA, V132, DOI 10.1016/j.neuropsychologia.2019.107125; Clark J G, 1981, ASHA, V23, P493; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Duncan CC, 2003, PSYCHOPHYSIOLOGY, V40, P45, DOI 10.1111/1469-8986.00006; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; ELMASSIOUI F, 1988, ELECTROEN CLIN NEURO, V70, P46; Gill J, 2018, BRAIN INJURY, V32, P1359, DOI 10.1080/02699052.2018.1471738; Gilmore CS, 2018, BEHAV BRAIN RES, V340, P174, DOI 10.1016/j.bbr.2016.12.002; Gimson A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019399; Golob EJ, 2009, NEUROLOGY, V73, P1649, DOI 10.1212/WNL.0b013e3181c1de77; Golob EJ, 2007, BRAIN, V130, P740, DOI 10.1093/brain/awl375; Golob EJ, 2002, CLIN NEUROPHYSIOL, V113, P151, DOI 10.1016/S1388-2457(01)00713-1; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Green DL, 2015, BRAIN RES, V1624, P390, DOI 10.1016/j.brainres.2015.07.054; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; GUTERMAN Y, 1992, INT J PSYCHOPHYSIOL, V12, P197, DOI 10.1016/0167-8760(92)90011-Y; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Irwin K, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00275; Katz R, 2010, AM J GERIAT PSYCHIAT, V18, P1017, DOI 10.1097/JGP.0b013e3181d695f2; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Knott V, 2009, NEUROIMAGE, V44, P992, DOI 10.1016/j.neuroimage.2008.10.002; Kohler S, 2011, AM J GERIAT PSYCHIAT, V19, P902, DOI 10.1097/JGP.0b013e31821f1b6a; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P61, DOI 10.1016/j.ijpsycho.2011.02.001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lindin M, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00079; Luck S.J., 2012, APA HDB RES METHODS, V1, P523; Martin BA, 1997, J ACOUST SOC AM, V101, P1585, DOI 10.1121/1.418146; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mohlman J, 2009, AGING MENT HEALTH, V13, P246, DOI 10.1080/13607860802428026; Neylan TC, 1999, BIOL PSYCHIAT, V46, P1656, DOI 10.1016/S0006-3223(99)00047-5; Oates PA, 2002, EAR HEARING, V23, P399, DOI 10.1097/00003446-200210000-00002; Papaliagkas VT, 2011, CLIN NEUROPHYSIOL, V122, P1322, DOI 10.1016/j.clinph.2010.12.036; Papaliagkas VT, 2009, CURR ALZHEIMER RES, V6, P279, DOI 10.2174/156720509788486626; Pizzagalli DA, 2003, PSYCHOPHYSIOLOGY, V40, P939, DOI 10.1111/1469-8986.00112; PODOSHIN L, 1990, J LARYNGOL OTOL, V104, P191, DOI 10.1017/S0022215100112241; Reza MF, 2007, NEUROPSYCHOL REHABIL, V17, P723, DOI 10.1080/09602010601082441; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Sevigny MC, 2003, BRAIN COGNITION, V53, P351, DOI 10.1016/S0278-2626(03)00141-6; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simard M, 2009, CURR PSYCHIAT REP, V11, P41, DOI 10.1007/s11920-009-0007-z; Skogen JC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0020-5; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411	58	0	0	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	DEC	2021	132	12					2979	2988		10.1016/j.clinph.2021.09.007			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WS2LP	WOS:000715019100005	34715422				2022-02-06	
J	Gaebe, K; Li, AY; Das, S				Gaebe, Karolina; Li, Alyssa Y.; Das, Sunit			Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease	CANCERS			English	Article						brain metastases; intracranial metastatic disease; biomarker; non-small cell lung cancer; breast cancer; melanoma	CIRCULATING TUMOR-CELLS; FIBRILLARY ACIDIC PROTEIN; SERUM NEUROFILAMENT LIGHT; TRAUMATIC BRAIN-INJURY; LUNG-CANCER PATIENTS; CEREBROSPINAL-FLUID; IMAGING BIOMARKER; DNA METHYLATION; BREAST-CANCER; LIQUID BIOPSY	Simple Summary The development of brain metastases, or intracranial metastatic disease (IMD), is a serious and life-altering complication for many patients with cancer. While there have been substantial advancements in the treatments available for IMD and in our understanding of its pathogenesis, conventional methods remain insufficient to detect IMD at an early stage. In this review, we discuss current research on biomarkers specific to IMD. In particular, we highlight biomarkers that can be easily accessed via the bloodstream or cerebrospinal fluid, including circulating tumor cells and DNA, as well as advanced imaging techniques. The continued development of these assays could enable clinicians to detect IMD prior to the development of IMD-associated symptoms and ultimately improve patient prognosis and survival. Nearly 30% of patients with cancer will develop intracranial metastatic disease (IMD), and more than half of these patients will die within a few months following their diagnosis. In light of the profound effect of IMD on survival and quality of life, there is significant interest in identifying biomarkers that could facilitate the early detection of IMD or identify patients with cancer who are at high IMD risk. In this review, we will highlight early efforts to identify biomarkers of IMD and consider avenues for future investigation.	[Gaebe, Karolina; Li, Alyssa Y.; Das, Sunit] Univ Toronto, Inst Med Sci, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 3K1, Canada; [Das, Sunit] Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada		Das, S (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, 1 Kings Coll Circle, Toronto, ON M5S 3K1, Canada.; Das, S (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	karolina.gaebe@mail.utoronto.ca; alyssa.li@mail.utoronto.ca; sunit.das@utoronto.ca	Das, Sunit/J-3903-2015	Das, Sunit/0000-0002-2146-4168			Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Alsidawi S, 2014, INT J MOL SCI, V15, P10508, DOI 10.3390/ijms150610508; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Barajas RF, 2009, AM J NEURORADIOL, V30, P367, DOI 10.3174/ajnr.A1362; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bhatia A, 2019, NEURO-ONCOLOGY, V21, P1578, DOI 10.1093/neuonc/noz141; Boral D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00196-1; Butler TM, 2017, CURR OPIN GENET DEV, V42, P14, DOI 10.1016/j.gde.2016.12.003; Cagney DN, 2017, NEURO-ONCOLOGY, V19, P1511, DOI 10.1093/neuonc/nox077; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Chen LJ, 2019, PATHOL RES PRACT, V215, P427, DOI 10.1016/j.prp.2018.11.011; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Choi H, 2016, TRANSL LUNG CANCER R, V5, P413, DOI 10.21037/tlcr.2016.07.08; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cui Y, 2008, RADIOLOGY, V248, P894, DOI 10.1148/radiol.2483071407; Dai J, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00261-0; Darlix A, 2021, INT J CANCER, V149, P1605, DOI 10.1002/ijc.33724; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Castro DG, 2021, ADV RADIAT ONCOL, V6, DOI 10.1016/j.adro.2021.100673; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Engelborghs Sebastiaan, 2017, Alzheimers Dement (Amst), V8, P111, DOI 10.1016/j.dadm.2017.04.007; Erickson AW, 2021, JAMA ONCOL, V7, P1220, DOI 10.1001/jamaoncol.2021.1600; Escudero L, 2021, CANCERS, V13, DOI 10.3390/cancers13091989; Eslami-S Z, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a037333; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Fan Y., 2019, ANN ONCOL, V30, pv602, DOI [10.1093/annonc/mdz260.001, DOI 10.1093/ANNONC/MDZ260.001]; Farjam R, 2014, NEURO-ONCOLOGY, V16, P131, DOI 10.1093/neuonc/not153; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Filipow S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00169; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gomez-Roca C, 2009, J THORAC ONCOL, V4, P1212, DOI 10.1097/JTO.0b013e3181b44321; Gorges K, 2019, CANCERS, V11, DOI 10.3390/cancers11111685; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Habbous Steven, 2021, Neurooncol Adv, V3, pvdaa178, DOI 10.1093/noajnl/vdaa178; Hanssen A, 2018, CANCERS, V10, DOI 10.3390/cancers10120527; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Hepner A, 2019, WORLD J ONCOL, V10, P169, DOI 10.14740/wjon1228; Hoefnagels FWA, 2009, J NEUROL, V256, P878, DOI 10.1007/s00415-009-5034-5; Hoon DSB, 2001, J INVEST DERMATOL, V117, P375, DOI 10.1046/j.0022-202x.2001.01417.x; Jakubovic R, 2014, CLIN ONCOL-UK, V26, P704, DOI 10.1016/j.clon.2014.06.010; Jiang WF, 2011, CELL BIOCHEM FUNCT, V29, P582, DOI 10.1002/cbf.1791; Kanwal R, 2015, METHODS MOL BIOL, V1238, P3, DOI 10.1007/978-1-4939-1804-1_1; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Khoja L, 2013, J INVEST DERMATOL, V133, P1582, DOI 10.1038/jid.2012.468; Kondrup M, 2020, BIOMED REP, V12, P204, DOI 10.3892/br.2020.1277; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Kruger S, 2011, NUKLEARMED-NUCL MED, V50, P101, DOI 10.3413/Nukmed-0338-10-07; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; LeBleu VS, 2020, TRENDS CANCER, V6, P767, DOI 10.1016/j.trecan.2020.03.007; Lee JH, 2020, CLIN CANCER RES, V26, P4064, DOI 10.1158/1078-0432.CCR-19-3926; Li Y, 2017, ONCOTARGET, V8, P35743, DOI 10.18632/oncotarget.16182; Lin XL, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e13061; Liu Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9815806; Lok E, 2014, MELANOMA RES, V24, P120, DOI 10.1097/CMR.0000000000000045; Loreth D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136993; Lowery FJ, 2017, BBA-REV CANCER, V1867, P49, DOI 10.1016/j.bbcan.2016.12.001; Lu YH, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7461727; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Marzese DM, 2014, HUM MOL GENET, V23, P226, DOI 10.1093/hmg/ddt420; Mills SJ, 2012, CANCER IMAGING, V12, P245, DOI 10.1102/1470-7330.2012.0012; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Nassiri F, 2020, NAT MED, V26, P1044, DOI 10.1038/s41591-020-0932-2; Nia ES, 2017, J NUCL MED TECHNOL, V45, P193, DOI 10.2967/jnmt.117.194571; Niranjan Ajay, 2019, Prog Neurol Surg, V34, P125, DOI 10.1159/000493057; Noerholm M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-22; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Pan WY, 2015, CLIN CHEM, V61, P514, DOI 10.1373/clinchem.2014.235457; Pang XW, 2012, MED ONCOL, V29, P2626, DOI 10.1007/s12032-012-0169-0; Peters S, 2016, CANCER TREAT REV, V45, P139, DOI 10.1016/j.ctrv.2016.03.009; Pierga JY, 2013, ANN ONCOL, V24, P2999, DOI 10.1093/annonc/mdt348; Pope Whitney B, 2018, Handb Clin Neurol, V149, P89, DOI 10.1016/B978-0-12-811161-1.00007-4; Qin Z, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0092-4; Saad AG, 2008, CANCER-AM CANCER SOC, V113, P2129, DOI 10.1002/cncr.23826; Salomon MP, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.245; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; Sato J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221538; Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; Scoccianti S, 2012, RADIOTHER ONCOL, V102, P168, DOI 10.1016/j.radonc.2011.08.041; Seton-Rogers S, 2020, NAT REV CANCER, V20, P481, DOI 10.1038/s41568-020-0293-7; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shankar GM, 2017, EXPERT REV MOL DIAGN, V17, P943, DOI 10.1080/14737159.2017.1374854; Siravegna G, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2017-000253; SORENSEN JB, 1988, J CLIN ONCOL, V6, P1474, DOI 10.1200/JCO.1988.6.9.1474; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Suh JH, 2020, NAT REV CLIN ONCOL, V17, P279, DOI 10.1038/s41571-019-0320-3; Taunk NK, 2018, NEURO-ONCOLOGY, V20, P567, DOI 10.1093/neuonc/nox159; Teplyuk NM, 2012, NEURO-ONCOLOGY, V14, P689, DOI 10.1093/neuonc/nos074; Thust SC, 2018, J MAGN RESON IMAGING, V48, P571, DOI 10.1002/jmri.26171; Tomaszewski MR, 2021, RADIOLOGY, V298, P505, DOI [10.1148/radiol.2021219005, 10.1148/radiol.2021202553]; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Turiello R, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001689; Unterrainerl M, 2017, J NUCL MED, V58, P584, DOI 10.2967/jnumed.116.180075; Visvanathan K, 2017, J CLIN ONCOL, V35, P751, DOI 10.1200/JCO.2015.66.2080; Vosoughi E, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4374-x; Wei CH, 2019, AGING-US, V11, P6734, DOI 10.18632/aging.102201; Weide B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081624; Winther-Larsen A, 2020, CANCERS, V12, DOI 10.3390/cancers12102852; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Yan WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep43464; Zakaria R, 2015, J NEURO-ONCOL, V121, P421, DOI 10.1007/s11060-014-1642-8; Zakaria R, 2014, CANCER IMAGING, V14, DOI 10.1186/1470-7330-14-8; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587; Zhao SJ, 2021, TRANSL LUNG CANCER R, V10, DOI 10.21037/tlcr-20-361; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	118	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6694		CANCERS	Cancers	DEC	2021	13	23							5973	10.3390/cancers13235973			17	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	YF7JS	WOS:000741978900001	34885083	Green Published			2022-02-06	
J	Gallagher, D; King, D; Hume, P; Clark, T; Pearce, A; Gissane, C				Gallagher, Dearbhla; King, Doug; Hume, Patria; Clark, Trevor; Pearce, Alan; Gissane, Conor			Annual Baseline King-Devick Oculomotor Function Testing Is Needed Due to Scores Varying by Age	SPORTS			English	Article						oculomotor function; internal consistency; test-retest reliability; individualised; baseline testing	REFERENCE VALUES; SPORTS-MEDICINE; SCREENING TOOL; RUGBY UNION; CONCUSSION; MANAGEMENT; AMERICAN; RELIABILITY; PERFORMANCE; STATEMENT	Objective: To document baseline King-Devick (K-D) oculomotor function scores for male and female participants aged between 4 and 20 years old. Methods: Utilising a cross section of schools, rugby clubs and gymnastic clubs, 1936 participants (1300 male, 636 female) completed the spiral-bound K-D test for the identification of disturbed oculomotor function. Results: This study identified that overall, the baseline scores of the K-D test became faster by 1.4 (0.3 to 4.5) s per year, when compared with the previous age group in the same number of reading card groups. When comparing normative values of the original K-D validation study with the same age groups of the current cohort, participants aged 6 to 11 years recorded a faster baseline time (range 3.5 to 8.6 s), while those in the 12 to 14 years. age group recorded slower baseline times (range -3.9 to -7.9 s). Discussion: In general, there were age group differences, but not sex differences, for K-D test times in the current cohort. Analysis of single card times, across all age groups, showed changes likely due to improved reading time. Conclusion: The results support the need for individualised annual pre-injury baseline testing of the K-D test.	[Gallagher, Dearbhla] Bucks New Univ, Human Performance Exercise & Wellbeing Ctr, Wycombe HP11 2JZ, Bucks, England; [King, Doug; Hume, Patria] Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand SPRINZ, Auckland 1142, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia; [King, Doug] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Dept Sport & Exercise Sci, Durham DH1 3LE, England; [Hume, Patria] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Stroke & Appl Neurosci NISAN, Auckland 1142, New Zealand; [Clark, Trevor] Int Coll Management, Sydney, NSW 2095, Australia; [Pearce, Alan] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic 3086, Australia; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, London TW1 4SX, England		King, D (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sports Performance Res Inst New Zealand SPRINZ, Auckland 1142, New Zealand.; King, D (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia.; King, D (corresponding author), Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Dept Sport & Exercise Sci, Durham DH1 3LE, England.	Dearbhla.Gallagher@bucks.ac.uk; dking@aut.ac.nz; phume@aut.ac.nz; tclark@icms.edu.au; Alan.Pearce@latrobe.edu.au; conor.gissane@btinternet.com	Hume, Patria/P-1084-2017	Hume, Patria/0000-0003-1847-8128			Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Anderson HD, 2017, BRAIN INJURY, V31, P1813, DOI 10.1080/02699052.2017.1346283; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J, 1998, STAT POWER ANAL BEHA; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kaplan GA, 2001, INT J EPIDEMIOL, V30, P256, DOI 10.1093/ije/30.2.256; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Konynenbelt B., 2016, OPTOM VIS PERFORM, V4, P221; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Lieberman S, 1983, J Am Optom Assoc, V54, P631; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Rabinowitz AR, 2012, J INT NEUROPSYCH SOC, V18, P139, DOI 10.1017/S1355617711001275; Raynowska J., 2015, ANN SPORTS MED RES, V2, P1051; Rist B., 2017, INT J EXERC SCI, V10, P619; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Silver D, 2018, J NEUROL SCI, V388, P40, DOI 10.1016/j.jns.2018.02.046; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	46	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4663		SPORTS	Sports	DEC	2021	9	12							166	10.3390/sports9120166			13	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XY6YN	WOS:000737115200001	34941804	Green Published, gold			2022-02-06	
J	Garcia-Vilana, S; Sanchez-Molina, D; Velazquez-Ameijide, J; Lluma, J				Garcia-Vilana, Silvia; Sanchez-Molina, David; Velazquez-Ameijide, Juan; Lluma, Jordi			Injury Metrics for Assessing the Risk of Acute Subdural Hematoma in Traumatic Events	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						bridging veins; TBI; injury metrics; damage metrics; biomechanics; strain rate dependent materials	STRAIN RESPONSES; BRAIN-INJURY; BIOMECHANICS; VALIDATION; PREDICTORS; COLLISIONS; FAILURE	Worldwide, the ocurrence of acute subdural hematomas (ASDHs) in road traffic crashes is a major public health problem. ASDHs are usually produced by loss of structural integrity of one of the cerebral bridging veins (CBVs) linking the parasagittal sinus to the brain. Therefore, to assess the risk of ASDH it is important to know the mechanical conditions to which the CBVs are subjected during a potentially traumatic event (such as a traffic accident or a fall from height). Recently, new studies on CBVs have been published allowing much more accurate prediction of the likelihood of mechanical failure of CBVs. These new data can be used to propose new damage metrics, which make more accurate predictions about the probability of occurrence of ASDH in road crashes. This would allow a better assessement of the effects of passive safety countermeasures and, consequently, to improve vehicle restraint systems. Currently, some widely used damage metrics are based on partially obsolete data and measurements of the mechanical behavior of CBVs that have not been confirmed by subsequent studies. This paper proposes a revision of some existing metrics and constructs a new metric based on more accurate recent data on the mechanical failure of human CBVs.	[Garcia-Vilana, Silvia; Sanchez-Molina, David; Velazquez-Ameijide, Juan; Lluma, Jordi] Univ Politecn Cataluna, Campus EEBE,Ave Eduard Maristany 16, Barcelona 08019, Spain		Sanchez-Molina, D (corresponding author), Univ Politecn Cataluna, Campus EEBE,Ave Eduard Maristany 16, Barcelona 08019, Spain.	silvia.garcia.vilana@upc.edu; david.sanchez-molina@upc.edu; juan.velazquez@upc.edu; jordi.lluma@upc.edu		Velazquez-Ameijide, Juan/0000-0001-6872-3609; Garcia-Vilana, Silvia/0000-0002-8659-1985; Lluma, Jordi/0000-0002-4982-206X	Fundacio La Marato de TV3 (Barcelona) [289/C/2017, 201704.30]	This research was funded by Fundacio La Marato de TV3 (Barcelona, No. Grant 289/C/2017, 201704.30). The research was developed within the studies of the research project "Age Effects on Traumatic Brain Injuries".	Arregui-Dalmases C, 2017, NEUROCIRUGIA, V28, P41, DOI 10.1016/j.neucir.2016.02.010; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Basu B, 2009, CERAM INT, V35, P237, DOI 10.1016/j.ceramint.2007.10.003; Bertalan Z, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034008; Costa JMC, 2020, J MECH BEHAV BIOMED, V111, DOI 10.1016/j.jmbbm.2020.103976; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dickey GJ, 2021, COMPUT METHOD BIOMEC, DOI 10.1080/10255842.2021.1948022; Doorly M.C., 2007, THESIS U COLL DUBL D; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8_1; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Garcia-Vilana S, 2021, BIOENGINEERING-BASEL, V8, DOI 10.3390/bioengineering8100145; Garcia-Vilana S, 2021, MED PHYS, V48, P5540, DOI 10.1002/mp.15082; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gnedenko B, 1943, ANN MATH, V44, P423, DOI 10.2307/1968974; Golman AJ, 2015, COMPUT METHOD BIOMEC, V18, P1044, DOI 10.1080/10255842.2013.869319; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hazay M, 2019, ACTA BIOENG BIOMECH, V21, P141, DOI 10.5277/ABB-01281-2018-02; Jones DA, 2016, TRAFFIC INJ PREV, V17, P109, DOI 10.1080/15389588.2016.1195495; Kim T, 2020, ACCIDENT ANAL PREV, V147, DOI 10.1016/j.aap.2020.105761; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levy Y, 2021, ANN BIOMED ENG, V49, P2914, DOI 10.1007/s10439-021-02855-3; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Migueis GFJ, 2019, CLIN BIOMECH, V63, P104, DOI 10.1016/j.clinbiomech.2019.02.010; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Ott KA, 2012, SAE INT J PASSEN CAR, V5, DOI 10.4271/2012-01-0569; Pasquesi SA, 2017, ANN BIOMED ENG, V45, P1877, DOI 10.1007/s10439-017-1833-5; Rowson B, 2020, ANN BIOMED ENG, V48, P2734, DOI 10.1007/s10439-020-02684-w; Sanchez-Molina D, 2016, COMPUT METH PROG BIO, V136, P55, DOI 10.1016/j.cmpb.2016.08.007; Sanchez-Molina D, 2015, J MECH BEHAV BIOMED, V51, P328, DOI 10.1016/j.jmbbm.2015.07.002; Sanchez-Molina D, 2012, TRAFFIC INJ PREV, V13, P278, DOI 10.1080/15389588.2011.650803; Sanchez-Molina D, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090831; Sanchez-Molina D, 2020, BIOMED ENG-APP BAS C, V32, DOI 10.4015/S1016237220500404; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tippett L.H.C, 1960, J TEXT I P, V51, P413, DOI [10.1080/19447016008664510, DOI 10.1080/19447016008664510]; Tippett L.H.C., 1954, INC STAT, V5, P147, DOI [10.2307/2986646, DOI 10.2307/2986646]; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang BZ, 2016, ACCIDENT ANAL PREV, V95, P236, DOI 10.1016/j.aap.2016.07.002; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732	51	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2021	18	24							13296	10.3390/ijerph182413296			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	YA7TU	WOS:000738531800001	34948905	Green Published			2022-02-06	
J	Gardner, AJ; Iverson, GL; Edwards, S; Tucker, R				Gardner, Andrew J.; Iverson, Grant L.; Edwards, Suzi; Tucker, Ross			A Case-Control Study of Tackle-Based Head Injury Assessment (HIA) Risk Factors in the National Rugby League	SPORTS MEDICINE-OPEN			English	Article						Tackle; Injury prevention; Head impact events; Head injury assessment; Concussion	VIDEO ANALYSIS; UNION; MATCH; IMPLEMENTATION; CONCUSSION; SCIENCE	Background The tackle is the in-game activity carrying the greatest risk for concussion in rugby. A recent evaluation of tackle characteristics in rugby union precipitated a rule modification to reduce head impact risk during tackles. This study aims to replicate the work conducted in rugby union by examining the association between tackle characteristics and head injury events in professional rugby league. Methods There were 446 tackles resulting in a head injury assessment (HIA) and 5,694 tackles that did not result in a head injury from two National Rugby League (NRL) seasons that were reviewed and coded. Tackle height, body position of players, and contact area on an opponent's body were evaluated, with the propensity of each situation to cause an HIA calculated as HIAs per 1000 events. Results The propensity for tacklers to sustain a head injury was 0.99 HIAs per 1000 tackles, 1.74-fold greater than for the ball carrier (0.57 HIAs per 1000 tackles). There was a 3.2-fold higher risk for an HIA when the tackler was upright compared to bent-at-the-waist. The greatest risk of a tackler HIA occurred when head contact was very low (knee, boot) or high (head and elbow). HIAs were most common following head-to-head impacts. The lowest propensity for tackler HIA was found when the tackler's head was in proximity with the ball carrier's torso. Conclusions The result of this study replicated the findings in professional rugby union. This has implications for the injury prevention initiatives implemented to reduce HIA risk because the majority of injuries are sustained by the tackler.	[Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Edwards, Suzi] Univ Sydney, Discipline Exercise & Sport Sci, Camperdown, NSW, Australia; [Edwards, Suzi] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Tucker, Ross] World Rugby Pty Ltd, Dublin, Ireland		Gardner, AJ (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia.	Andrew.Gardner@newcastle.edu.au		Gardner, Andrew/0000-0001-5031-5586	Priority Research Centre for Stroke and Brain Injury	This study was funded in part by the Priority Research Centre for Stroke and Brain Injury. Unrestricted philanthropic support was provided by ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Austin D, 2011, J STRENGTH COND RES, V25, P1659, DOI 10.1519/JSC.0b013e3181da781c; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Cross MJ, 2017, BRIT J SPORT MED; Donaldson A, 2017, INJURY PREV, V23, P273, DOI 10.1136/injuryprev-2015-041737; Donaldson A, 2013, BRIT J SPORT MED, V47, P473, DOI 10.1136/bjsports-2013-092323; Edwards S, 2021, INT J SPORTS SCI COA, V16, P944, DOI 10.1177/1747954121996946; Fitzpatrick AC, 2018, J SCI MED SPORT, V21, P160, DOI 10.1016/j.jsams.2017.08.012; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gabbett TJ, 2012, J SPORT SCI, V30, P1421, DOI 10.1080/02640414.2012.710760; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Den Hollander S, 2021, INT J SPORTS SCI COA, V16, P421, DOI 10.1177/1747954120976943; Hopkinson M, 2020, EUR J SPORT SCI, DOI 10.1080/17461391.2020.1853817; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; Ignacy T, J SPORT ENG TECHNOL, V2021; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; King DA, 2009, CLIN J SPORT MED, V19, P277, DOI 10.1097/JSM.0b013e3181a7c6b0; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Raftery M, 2021, BRIT J SPORT MED, V55, DOI 10.1136/bjsports-2019-101885; Redman KJ, J STRENGTH COND RES, V2021; Speranza MJA, 2018, INT J SPORT PHYSIOL, V13, P770, DOI 10.1123/ijspp.2017-0593; Speranza MJA, 2017, SCI MED FOOTBALL, V1, P265, DOI 10.1080/24733938.2017.1361041; Speranza MJA, 2018, INT J SPORT PHYSIOL, V13, P347, DOI 10.1123/ijspp.2016-0701; Tee JC, 2019, J SPORT SCI, V37, P1181, DOI 10.1080/02640414.2018.1547100; Tierney GJ, 2019, J SPORT SCI, V37, P262, DOI 10.1080/02640414.2018.1494952; Tierney GJ, 2018, J SCI MED SPORT, V21, P1210, DOI 10.1016/j.jsams.2018.05.010; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883	37	0	0	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	DEC	2021	7	1							84	10.1186/s40798-021-00377-9			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WZ3VN	WOS:000719898600001	34787721	Green Published, gold			2022-02-06	
J	Ghoubaira, J; Diab, M; Nassereldine, H; Tamim, H; Saadeh, S; Price, R; Moustafa, M; Al-Hajj, S				Ghoubaira, Joseph; Diab, Marwa; Nassereldine, Hasan; Tamim, Hani; Saadeh, Samer; Price, Raymond; Moustafa, Moustafa; Al-Hajj, Samar			Road traffic injury in Lebanon: A prospective study to assess injury characteristics and risk factors	HEALTH SCIENCE REPORTS			English	Article						middle eastern region' Lebanon; road traffic injury; traumatic brain injury	MOTORCYCLE HELMET USE; SEAT-BELT UTILIZATION; SAUDI-ARABIA; DEATHS; AGENDA	Background Road traffic injury (RTI) is a significant yet poorly characterized cause of morbidity and mortality in the Middle East. This hospital-based-study examined RTI in Lebanon and provided an understanding of their characteristics. Methods We collected prospective RTI data from three participating hospitals over 3 months using a designed tool based on Canadian CHIRPP and WHO tools. We performed logistic regression analysis to examine the relationship between contributing risk factors (age, sex) and injury types as well as the association of safety measures used (seatbelts or helmets) and body parts injured. Results A total of 153 patients were collected. Male preponderance with 72%, with mean age 32.6 (SD = 14.9) years. RTI was highest among passengers aged 15 to 29 (48%). Motorcyclists comprised the greatest injury proportion (38%), followed by vehicle-occupants (35%), and pedestrians (25%) (P = .04). Hip injuries represented the most affected body part (48.7%), followed by head/neck (38.2%). Only 31% (n = 47) of victims applied safety measures (seatbelts or helmets). Six drivers (7%) reported cell phone use at collision. The use of safety measures was associated with a substantial reduction in head/neck injuries (P = .03), spine injuries (P = .049), and lower risk of traumatic brain injury (TBI) (P = .02). Conclusions RTI is a major health problem in Lebanon. Safety measures, though poorly adhered to, were associated with less severe injuries, and should be further promoted via awareness campaigns and enforcement. Trauma registries are needed to assess the RTI burden and inform safety interventions and quality-of-care improvement programs.	[Ghoubaira, Joseph; Diab, Marwa; Nassereldine, Hasan; Al-Hajj, Samar] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Tamim, Hani] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut, Lebanon; [Saadeh, Samer] Lebanese Univ, ZHUMC Med Ctr, Emergency Dept, Beirut, Lebanon; [Price, Raymond] Univ Utah, Ctr Global Surg, Salt Lake City, UT USA; [Moustafa, Moustafa] Univ Virginia, Dept Surg, Richmond, VA USA		Al-Hajj, S (corresponding author), Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon.	sh137@aub.edu.lb		Ghoubaira, Joseph/0000-0003-4006-2743	Arab Council of the Social Sciences	This publication was made possible through the support of the Arab Council of the Social Sciences. The statements made and views expressed are solely the responsibility of the author.	Abu-Zidan FM, 2012, WORLD J SURG, V36, P255, DOI 10.1007/s00268-011-1386-y; Al-Hajj S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037973; Al-Hajj S, 2021, J PUBLIC HEALTH-UK, V43, pE24, DOI 10.1093/pubmed/fdaa043; Al-Hajj S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08523-w; Alghnam S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152706; Bendak S, 2005, ACCIDENT ANAL PREV, V37, P367, DOI 10.1016/j.aap.2004.10.007; Bendak S, 2013, INT J INJ CONTROL SA, V20, P342, DOI 10.1080/17457300.2012.745575; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Choueiri EM., 2007, ADV TRANSPORTATION S, V11, P75; Craft G, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121486; Crain J, 2016, HEALTH PROMOT CHRON, V36, P112, DOI 10.24095/hpcdp.36.6.02; Croisant Sharon A Petronella, 2013, Glob Adv Health Med, V2, P16, DOI 10.7453/gahmj.2013.045; Dunbar G, 2001, J EXP PSYCHOL-APPL, V7, P227, DOI 10.1037//1076-898X.7.3.227; El-Zein S., 2004, ROAD ACCIDENTS MEDNE, V22; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Ghandour L, 2016, INT J DRUG POLICY, V28, P10, DOI 10.1016/j.drugpo.2015.09.013; Grivna M, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-016-0113-2; Holder Y., 2002, WHO INJURY SURVEILAN; Hoye A, 2016, ACCIDENT ANAL PREV, V88, P175, DOI 10.1016/j.aap.2015.12.022; Hyder AA, 2014, B WORLD HEALTH ORGAN, V92, P423, DOI 10.2471/BLT.13.132613; Kobusingye OC, 2005, B WORLD HEALTH ORGAN, V83, P626; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; Margie P, WORLD REPORT ROAD TR; Mokdad AH, 2018, INT J PUBLIC HEALTH, V63, P187, DOI 10.1007/s00038-017-0987-0; Ha NT, 2018, TRAFFIC INJ PREV, V19, P75, DOI 10.1080/15389588.2017.1322203; Nishi A, 2018, B WORLD HEALTH ORGAN, V96, P514, DOI 10.2471/BLT.18.215509; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; OBERMEYER CM, 2015, DIFI FAM RES P, V2015, P1; Oluwadiya K S, 2004, West Afr J Med, V23, P42; Organization W.H, ROAD SAF E MED REG F; Petridou E, 1998, ACCIDENT ANAL PREV, V30, P87, DOI 10.1016/S0001-4575(97)00065-1; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; Thor Craig P, 2010, Ann Adv Automot Med, V54, P295; Toroyan T, 2013, INJURY PREV, V19, P150, DOI 10.1136/injuryprev-2013-040775; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Williams AF, 2006, INJURY PREV, V12, P4, DOI 10.1136/ip.2006.011783; Word Health Organization (WHO), ROAD SAF E MED REG F; Yadukul S., 2016, INDIAN J FORENSIC ME, V10, P6; YASA, 2009, MOT SAF; Zafar SN, 2018, INT J SURG, V52, P245, DOI 10.1016/j.ijsu.2018.02.034; Ziad Akl MA., 2019, OPEN PUBLIC HLTH J, V12, P127	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2398-8835		HEALTH SCI REP-US	Health Sci. Rep.	DEC	2021	4	4							e396	10.1002/hsr2.396			7	Public, Environmental & Occupational Health; Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health; General & Internal Medicine	XW2BK	WOS:000735431100060	34849405	Green Published, gold			2022-02-06	
J	Giacometti, LL; Huh, JW; Raghupathi, R				Giacometti, Laura L.; Huh, Jimmy W.; Raghupathi, Ramesh			Sex and estrous-phase dependent alterations in depression-like behavior following mild traumatic brain injury in adolescent rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						adolescence; donkey anti-mouse; elevated plus maze; estrous cycle; forced swim test; mild traumatic brain injury; mouse-anti-GFAP; RRID; AB_2298772; RRID; AB_2340785; RRID; AB_477010; RRID; RGD_10395233; sex differences	FORCED SWIMMING TEST; DOPAMINE-D-2 RECEPTOR-BINDING; REDUCES IMMOBILITY; PREFRONTAL CORTEX; AMINO-ACIDS; CYCLE; PROGESTERONE; ANXIETY; MODEL; INCREASES	Following mild traumatic brain injury (TBI), high school and collegiate-aged females tend to report more emotional symptoms than males. Adolescent male and female rats (35 days old) were subjected to mild TBI and evaluated for anxiety- and depression-like behaviors using the elevated plus maze and forced swim test (FST), respectively, and cellular alterations. Injured brains did not exhibit an overt lesion, atrophy of tissue or astrocytic reactivity underneath the impact site at 6-week post-injury, suggestive of the mild nature of trauma. Neither male nor female brain-injured rats exhibited anxiety-like behavior at 2 or 6 weeks, regardless of estrous phase at the time of behavior testing. Brain-injured male rats did not exhibit any alterations in immobility, swimming and climbing times in the FST compared to sham-injured rats at either 2- or 6-week post-injury. Brain-injured female rats did, however, exhibit an increase in immobility (in the absence of changes in swimming and climbing times) in the FST at 6 weeks post-injury only during the estrus phase of the estrous cycle, suggestive of a depression-like phenotype. Combined administration of the estrogen receptor antagonist, tamoxifen, and the progesterone receptor antagonist, mifepristone, during proestrus was able to prevent the depression-like phenotype observed during estrus. Taken together, these data suggest that female rats may be more vulnerable to exhibiting behavioral deficits following mild TBI and that estrous phase may play a role in depression-like behavior.	[Giacometti, Laura L.] Drexel Univ, Coll Med, Dept Pharmacol & Physiol, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Room 277,2900 Queen Lane, Philadelphia, PA 19129 USA; [Giacometti, Laura L.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Grad Sch Biomed Sci & Profess Studies, Philadelphia, PA 19129 USA		Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, Room 277,2900 Queen Lane, Philadelphia, PA 19129 USA.	rr79@drexel.edu			National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110898]; Commonwealth Universal Research Enhancement from the Pennsylvania Department of Health [SAP 410-007-9710, SAP 410-007-7079]	Work supported by grants from the National Institute of Neurologic Disorders and Stroke (R01 NS110898) and Commonwealth Universal Research Enhancement from the Pennsylvania Department of Health (SAP 410-007-9710 and ySAP 410-007-7079)	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Arias C, 2009, HORM BEHAV, V55, P257, DOI 10.1016/j.yhbeh.2008.10.016; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORSINI F, 1988, EUR J PHARMACOL, V148, P301, DOI 10.1016/0014-2999(88)90107-0; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Dazzi L, 2007, NEUROPSYCHOPHARMACOL, V32, P892, DOI 10.1038/sj.npp.1301150; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; ENDICOTT J, 1993, J AFFECT DISORDERS, V29, P193, DOI 10.1016/0165-0327(93)90033-G; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FERNANDEZRUIZ JJ, 1989, BRAIN RES, V476, P388, DOI 10.1016/0006-8993(89)91266-3; Frye CA, 2004, BEHAV NEUROSCI, V118, P306, DOI 10.1037/0735-7044.118.2.306; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Giacometti LL, 2020, NEUROSCI BIOBEHAV R, V113, P157, DOI 10.1016/j.neubiorev.2020.03.010; Hantsoo L, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0628-3; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hsiao CC, 2004, PSYCHIAT CLIN NEUROS, V58, P593, DOI 10.1111/j.1440-1819.2004.01308.x; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Klimke A, 1999, PSYCHIAT RES-NEUROIM, V90, P91, DOI 10.1016/S0925-4927(99)00009-8; Lefevre EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176156; Li Y, 2012, BEHAV BRAIN RES, V234, P238, DOI 10.1016/j.bbr.2012.06.034; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Martinez FG, 2006, BRAIN RES, V1108, P117, DOI 10.1016/j.brainres.2006.06.014; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Molina-Hernadez M, 2005, PHARMACOL BIOCHEM BE, V80, P401, DOI 10.1016/j.pbb.2004.11.017; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; MORISSETTE M, 1993, NEUROENDOCRINOLOGY, V58, P16, DOI 10.1159/000126507; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Omura J, 2018, PM&R, V10, P317, DOI 10.1016/j.pmrj.2017.07.080; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rodriguez-Landa JF, 2007, J PSYCHOPHARMACOL, V21, P76, DOI 10.1177/0269881106064203; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Sumner BEH, 1999, MOL BRAIN RES, V73, P119, DOI 10.1016/S0169-328X(99)00243-0; Tang YP, 1997, BEHAV BRAIN RES, V83, P189, DOI 10.1016/S0166-4328(97)86067-6; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; XIAO L, 1994, NEUROSCI LETT, V180, P155, DOI 10.1016/0304-3940(94)90510-X; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	64	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2022	100	2					490	505		10.1002/jnr.24989		DEC 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI0XA	WOS:000724109000001	34850450				2022-02-06	
J	Gidion, F; Carroll, J; Lubbe, N				Gidion, Fritjof; Carroll, Jolyon; Lubbe, Nils			Motorcyclist injuries: Analysis of German in-depth crash data to identify priorities for injury assessment and prevention	ACCIDENT ANALYSIS AND PREVENTION			English	Article						PTW; HBM; ATD; Brain injury; Thorax injury; Leg injury		Globally there are more than 350,000 PTW fatalities each year. Safety concepts to protect Powered Two-Wheeler (PTW) riders exist and are being developed further, but they need appropriate procedures and test tools (Anthropometric Test Devices (ATDs) for physical testing and Human Body Models (HBMs) for virtual testing) to direct and promote those developments. To aid further development of the tools, we aim to rank the frequency of specific injuries arising from the prevalent impact types, discuss how current ATDs and HBMs are equipped to assess these injuries, and suggest what further development should be prioritized. We analyzed a sample of injured riders from the German In-depth Accident Study (GIDAS) according to the Abbreviated Injury Scale (AIS) 2015 classification, using severity thresholds of at-least-moderate (AIS2+) and at least-serious (AIS3+). PTW rider injuries were ranked by frequency for all crashes and also for sub-samples of specific impact types (impact with passenger cars, ground, and roadside furniture). The most frequent AIS3+ injuries were: femur fracture (17%), rib cage fracture (13%), lung injury (9%), tibia fracture (7%), and cerebrum injury (7%). In all impacts together and as for impacts with the road surface, injuries to the thorax were most frequent. In impacts with cars and road furniture, thorax injuries were also frequent, but outranked by lower extremity injuries. Considering both AIS2+ and AIS3+ injuries, the priorities for PTW rider safety interventions are: fracture of the rib cage, femur fracture, tibia fracture, radius fracture, cerebrum injury, and cerebral concussion. The ATD currently used most frequently, the Hybrid III, is unlikely to provide adequate rib fracture injury assessments, but HBMs are promising in this area. Rib injury assessment may also reasonably predict other injuries that were correlated or in proximity to rib fractures: clavicle, lung, and upper abdomen organ injury. Lower extremity, upper extremity, and head injuries are likely addressable to some extent with current ATDs while HBMs hold the promise of more detailed and mechanism-specific injury assessments. Both ATDs and HBMs need more validation for use in the PTW environment.	[Gidion, Fritjof; Carroll, Jolyon; Lubbe, Nils] Autol Res, Wallentinsvagen 22, SE-44783 Vargarda, Sweden		Gidion, F (corresponding author), Autol Res, Wallentinsvagen 22, SE-44783 Vargarda, Sweden.	fritjof.gidion@autoliv.com; jolyon.carroll@autoliv.com; nils.lubbe@autoliv.com					Angamuthu S.K., 2018, 2018 IRCOBI C P; Aranda-Marco R., 2019, D 2 3 IMPROVED NUMER; Aranda-Marco R., 2020, 2020 IRCOBI C P; Association for the Advancement of Automotive Medicine, 2018, ABBREVIATED INJURY S, V6th; Bambach MR, 2014, ACCIDENT ANAL PREV, V62, P248, DOI 10.1016/j.aap.2013.10.009; Bjorklund M., 2020, 2020 IRCOBI C P; Chinn B., 2001, COST 327 MOTORCYCLE; Eggers A., 2011, EVALUATION THORACIC, P11; European Commission, 2013, EU PROJ MOSAFIM MOT; European Commission, 2018, TRAFF SAF BAS FACTS; European Committee for Standardization (CEN), 2012, ROAD RESTR SYST 8; European Parliament and Council of the European Union, 2002, OFFICIAL J EUROPEAN; European Parliament Council of the European Union, 2007, OFFICIAL J EUROPEAN; Fahlstedt M, 2021, ANN BIOMED ENG, V49, P1097, DOI 10.1007/s10439-020-02703-w; Forman J, 2019, TRAFFIC INJ PREV, V20, P607, DOI 10.1080/15389588.2019.1630825; Forman Jason L, 2012, Ann Adv Automot Med, V56, P109; Fredriksson R., 2015, 2015 IRCOBI C P; Govardhan R., 2018, 2018 IRCOBI ASIA C P; Haworth N, 2012, ACCIDENT ANAL PREV, V44, P12, DOI 10.1016/j.aap.2010.10.031; Haworth N., 1997, CASE CONTROL STUDY M; International Organization for Standardization,, 2005, 1323232005 ISO; International Organization for Standardization,, 2013, 123502013 ISOTR; Iraeus J, 2020, J MECH BEHAV BIOMED, V106, DOI 10.1016/j.jmbbm.2020.103742; Kent Richard, 2003, Stapp Car Crash J, V47, P267; Kuhn M., 2019, COMPACT ACCIDENT RES; Kullgren A, 2019, TRAFFIC INJ PREV, V20, pS7, DOI 10.1080/15389588.2019.1610171; Lebarbe M., 2014, P PERS ARM SYST S 20; Maier S., 2021, IRCOBI C P; Mellor A., 2005, P 19 INT TECHN C ENH; Meredith L, 2016, TRAFFIC INJ PREV, V17, P644, DOI 10.1080/15389588.2015.1136061; Mroz K., 2010, 2010 IRCOBI C P; National Center for Statistics and Analysis, 2020, 813060 DOT HS TRAFF; National Highway Traffic Safety Administration, 1986, FED REG, V51; Otte D., 2015, ACCIDENT CHARACTERIS, DOI [10.4271/2015-01-1466, DOI 10.4271/2015-01-1466]; Otte D., 1994, 1994 IRCOBI C P; Painter M.S., 2018, 2018 IRCOBI ASIA C P; Peldschus S., 2007, P 20 INT TECHN C ENH; Petitjean Audrey, 2002, Stapp Car Crash J, V46, P27; Pipkorn B., 2019, 2019 IRCOBI C P, P175; Pipkorn B, 2020, ACCIDENT ANAL PREV, V138, DOI 10.1016/j.aap.2020.105443; Ramet M., 1981, 1981 IRCOBI C P; Rizzi M, 2016, SAFE SYSTEM APPROACH; Statistisches Bundesamt (Destatis), 2020, VERK FACHS 8 REIH 7; Tadokoro H., 1985, SAE TECHNICAL PAPER; Thom HH, 1981, MOTORCYCLE ACCIDENT, V1; Thomas P., 2016, STUDY SERIOUS ROAD T, DOI [10.2832/29647, DOI 10.2832/29647]; Unger T., 2020, 2020 IRCOBI C P; van Ratingen M, 2016, CHIN J TRAUMATOL, V19, P63, DOI 10.1016/j.cjtee.2015.11.016; Whitaker J, 1980, TRRL LR913 MONOGRAPH; Whyte T., 2020, 2020 IRCOBI C P; Wisch M., 2019, D1 1 POWERED 2 WHEEL; Withnall C., 2003, P 18 INT TECHN C ENH; World Health Organization, 2018, GLOBAL STATUS REPORT	53	0	0	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	DEC	2021	163								106463	10.1016/j.aap.2021.106463			12	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	XB7IB	WOS:000721497900005	34768139				2022-02-06	
J	Gold, DM; Rizzo, JR; Lee, YSC; Childs, A; Hudson, TE; Martone, J; Matsuzawa, YK; Fraser, F; Ricker, JH; Dai, WW; Selesnick, I; Balcer, LJ; Galetta, SL; Rucker, JC				Gold, Doria M.; Rizzo, John-Ross; Lee, Yuen Shan Christine; Childs, Amanda; Hudson, Todd E.; Martone, John; Matsuzawa, Yuka K.; Fraser, Felicia; Ricker, Joseph H.; Dai, Weiwei; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.			King-Devick Test Performance and Cognitive Dysfunction after Concussion: A Pilot Eye Movement Study	BRAIN SCIENCES			English	Article						concussion; King-Devick; rapid automatized naming tasks; saccades; inter-saccadic interval; cognitive dysfunction	TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; RUGBY LEAGUE; SYMPTOMS; SACCADES; DEFICITS; VISION; SPORT	(1) Background: The King-Devick (KD) rapid number naming test is sensitive for concussion diagnosis, with increased test time from baseline as the outcome measure. Eye tracking during KD performance in concussed individuals shows an association between inter-saccadic interval (ISI) (the time between saccades) prolongation and prolonged testing time. This pilot study retrospectively assesses the relation between ISI prolongation during KD testing and cognitive performance in persistently-symptomatic individuals post-concussion. (2) Results: Fourteen participants (median age 34 years; 6 women) with prior neuropsychological assessment and KD testing with eye tracking were included. KD test times (72.6 +/- 20.7 s) and median ISI (379.1 +/- 199.1 msec) were prolonged compared to published normative values. Greater ISI prolongation was associated with lower scores for processing speed (WAIS-IV Coding, r = 0.72, p = 0.0017), attention/working memory (Trails Making A, r = -0.65, p = 0.006) (Digit Span Forward, r = 0.57, p = -0.017) (Digit Span Backward, r= -0.55, p = 0.021) (Digit Span Total, r = -0.74, p = 0.001), and executive function (Stroop Color Word Interference, r = -0.8, p = 0.0003). (3) Conclusions: This pilot study provides preliminary evidence suggesting that cognitive dysfunction may be associated with prolonged ISI and KD test times in concussion.	[Gold, Doria M.; Rizzo, John-Ross; Hudson, Todd E.; Martone, John; Dai, Weiwei; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA; [Rizzo, John-Ross; Lee, Yuen Shan Christine; Childs, Amanda; Hudson, Todd E.; Matsuzawa, Yuka K.; Ricker, Joseph H.] NYU, Dept Phys Med & Rehabil, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Rizzo, John-Ross] NYU, Dept Mech & Aerosp Engn, Tandon Sch Engn, Brooklyn, NY 11201 USA; [Rizzo, John-Ross] NYU, Dept Biomed Engn, Tandon Sch Engn, Brooklyn, NY 11201 USA; [Fraser, Felicia] MetroHlth Syst, Dept Phys Med & Rehabil, Cleveland, OH 44109 USA; [Dai, Weiwei; Selesnick, Ivan] NYU, Dept Elect & Comp Engn, Tandon Sch Engn, Brooklyn, NY 11201 USA; [Balcer, Laura J.] NYU, Grossman Sch Med, Dept Populat Hlth, 550 1St Ave, New York, NY 10016 USA; [Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA		Rucker, JC (corresponding author), NYU, Dept Neurol, Grossman Sch Med, New York, NY 10016 USA.; Rucker, JC (corresponding author), NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.	amanda.childs@nyulangone.org; ffraser@metrohealth.org			NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HDOO1097]; NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Empire Clinical Research Investigator Program (ECRIP)	This research was funded in part by 5K12HDOO1097 NICHD and NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program (JRR). Empire Clinical Research Investigator Program (ECRIP).	Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Akhand O, 2019, J NEURO-OPHTHALMOL, V39, P68, DOI 10.1097/WNO.0000000000000726; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Barton JJS, 2020, ANN NEUROL, V88, P1054, DOI 10.1002/ana.25876; Barton JJS, 2020, ANN NEUROL, V88, P453, DOI 10.1002/ana.25820; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Dai WW, 2017, J VISION, V17, DOI 10.1167/17.9.10; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fallon S, 2019, J NEUROL SCI, V402, P52, DOI 10.1016/j.jns.2019.04.036; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Matuseviciene G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018734; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rucker JC, 2020, ANN NEUROL, V88, P1053, DOI 10.1002/ana.25875; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Wetzel PA, 2018, INVEST OPHTH VIS SCI, V59, P4011, DOI 10.1167/iovs.18-23815; Yue JK, 2020, NEUROSURGERY, V87, P466, DOI 10.1093/neuros/nyaa022; Zee, 2015, NEUROLOGY EYE MOVEME	62	0	0	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2021	11	12							1571	10.3390/brainsci11121571			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XX4NF	WOS:000736273800001	34942873	Green Published			2022-02-06	
J	Graham, RF; van Rassel, CR; Burma, JS; Rutschmann, TD; Miutz, LN; Sutter, B; Schneider, K				Graham, Robert F.; van Rassel, Cody R.; Burma, Joel S.; Rutschmann, Trevor D.; Miutz, Lauren N.; Sutter, Bonnie; Schneider, Kathryn			Concurrent Validity of a Stationary Cycling Test and the Buffalo Concussion Treadmill Test in Adults With Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						exercise intolerance; rehabilitation; exercise testing; mild traumatic brain injuries	SPORT-RELATED CONCUSSION; EXERCISE; INJURY	Context: After concussion, a multifaceted assessment is recommended, including tests of physical exertion. The current criterion standard for exercise testing after concussion is the Buffalo Concussion Treadmill Test (BCTT); however, validated tests that use alternative exercise modalities are lacking. Objective: To evaluate the feasibility and concurrent validity of a universal cycling test of exertion compared with the BCTT in adults who sustained a sport-related concussion. Design: Crossover study. Setting: University sports medicine clinic. Patients or Other Participants: Twenty adults (age = 18-60 years) diagnosed with a sport-related concussion. Intervention(s): Participants completed the BCTT and a cycling test of exertion in random order, approximately 48 hours apart. Main Outcome Measure(s): The primary outcome of interest was maximum heart rate (HRmax; beats per minute [bpm]). Secondary outcomes of interest were the total number of symptoms endorsed on the Post-Concussion Symptom Scale, whether the participant reached volitional fatigue (yes or no), the symptom responsible for test cessation (Post-Concussion Symptom Scale), maximum rating of perceived exertion, symptom severity on a visual scale (0-10), and the time to test cessation. Results: Of the 20 participants, 19 (10 males, 9 females) completed both tests. One participant did not return for the second test and was excluded from the analysis. No adverse events were reported. The median HRmax for the BCTT (171 bpm; interquartile range = 139-184 bpm) was not different from the median HRmax for the cycle (173 bpm; interquartile range = 160-182 bpm; z = -0.63; P = .53). For both tests, the 3 most frequently reported symptoms responsible for test cessation were headache, dizziness, and pressure in the head. Of interest, most participants (64%) reported a different symptom responsible for cessation of each test. Conclusions: On the novel cycling test of exertion, participants achieved similar HRmax and test durations and, therefore, this test may be a suitable alternative to the BCTT. Future research to understand the physiological reason for the heterogeneity in symptoms responsible for test cessation is warranted.	[Graham, Robert F.; van Rassel, Cody R.; Burma, Joel S.; Rutschmann, Trevor D.; Miutz, Lauren N.; Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Burma, Joel S.; Schneider, Kathryn] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Rutschmann, Trevor D.] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Sutter, Bonnie; Schneider, Kathryn] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Schneider, Kathryn] Evidence Sport & Spinal Therapy, Calgary, AB, Canada		Graham, RF (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	robert.graham1@ucalgary.ca					[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2017, CSEP CERTIFIED PERSO; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Burma JS, 2020, CLIN J SPORT MED, V30, pe111, DOI [10. 1097/JSM.0000000000000845, DOI 10.1097/JSM.0000000000000845]; Caputo F, 2004, EUR J APPL PHYSIOL, V93, P87, DOI 10.1007/s00421-004-1169-3; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Cordingley DM, 2017, CAN J NEUROL SCI, V44, P684, DOI 10.1017/cjn.2017.209; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Egana M, 2010, EUR J APPL PHYSIOL, V110, P39, DOI 10.1007/s00421-010-1466-y; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Iannetta D, 2020, MED SCI SPORT EXER, V52, P466, DOI 10.1249/MSS.0000000000002147; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morissette MP, 2020, MED SCI SPORT EXER, V52, P820, DOI 10.1249/MSS.0000000000002198; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; White M, 2005, MED SCI SPORT EXERC, V37, P1645, DOI [10.1249/01.mss.0000181063.22533.ee, DOI 10.1249/01.MSS.0000181063.22533.EE]; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196	32	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2021	56	12					1292	1299		10.4085/1062-6050-0003.21			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XR2GR	WOS:000732055000005	34911073	gold			2022-02-06	
J	He, GL; Wang, ZZ; Yu, XT; Shen, TT; Luo, Z; Li, P; Luo, X; Tan, YL; Gao, P; Yang, XS				He, Gen-Lin; Wang, Ze-Ze; Yu, Xue-Ting; Shen, Ting-Ting; Luo, Zhen; Li, Ping; Luo, Xue; Tan, Yu-Long; Gao, Peng; Yang, Xue-Sen			The involvement of microglial CX3CR1 in heat acclimation-induced amelioration of adult hippocampal neurogenesis impairment in EMF-exposed mice	BRAIN RESEARCH BULLETIN			English	Article						EMF; Heat acclimation; Microglia; CX3CR1; Hippocampal neurogenesis	TRAUMATIC BRAIN-INJURY; RAT; ACTIVATION; NEUROPROTECTION; PROLIFERATION; BEHAVIOR; CELLS; GLIA; TIME	Microglial CX3C chemokine receptor 1 (CX3CR1) has been implicated in numerous cellular mechanisms, including signalling pathways that regulate brain homoeostasis and adult hippocampal neurogenesis. Specific environmental conditions can impair hippocampal neurogenesis-related cognition, learning and memory. However, the role of CX3CR1 in the neurogenic alterations resulting from the cross-tolerance protection conferred by heat acclimation (HA) against the effects of electromagnetic field (EMF) exposure is less well understood. Here, we investigated the role of microglial CX3CR1 signalling in adult hippocampal neurogenesis induced by HA in EMF-exposed mice. We found that EMF exposure significantly decreased the number of proliferating and differentiating cells in the dentate gyrus (DG) of the hippocampus, resulting in a reduced neurogenesis rate. Moreover, alterations in the phenotypes of activated microglia and decreased expression levels of CX3CR1, but not sirtuin 1 (SIRT1), were observed in the brains of EMF-exposed mice. Remarkably, HA treatment improved microglial phenotypes, restored the expression of CX3CR1, and ameliorated the decrease in the adult hippocampal neurogenesis rate following EMF exposure. Moreover, pharmacological inhibition of CX3CR1 and SIRT1 failed to restore CX3CR1 expression and ameliorate hippocampal neurogenesis impairment following HA plus EMF stimulation. These results indicate that microglial CX3CR1 is involved in the crosstolerance protective effect of HA on adult hippocampal neurogenesis upon EMF exposure.	[He, Gen-Lin; Wang, Ze-Ze; Yu, Xue-Ting; Shen, Ting-Ting; Luo, Zhen; Li, Ping; Luo, Xue; Tan, Yu-Long; Yang, Xue-Sen] Army Med Univ, Dept Trop Med, 30 Gaotanyan Cent St, Chongqing 400038, Peoples R China; [He, Gen-Lin; Wang, Ze-Ze; Yu, Xue-Ting; Shen, Ting-Ting; Luo, Zhen; Li, Ping; Luo, Xue; Tan, Yu-Long; Yang, Xue-Sen] Army Med Univ, Minist Educ China, Key Lab Extreme Environm Med, Chongqing, Peoples R China; [Gao, Peng] Army Med Univ, Minist Educ, Key Lab Med Protect Electromagnet Radiat, Chongqing, Peoples R China		Yang, XS (corresponding author), Army Med Univ, Dept Trop Med, 30 Gaotanyan Cent St, Chongqing 400038, Peoples R China.	xuesenyyy@163.com					Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Al-Onaizi M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186875; Ammari M, 2008, BIOMED PHARMACOTHER, V62, P273, DOI 10.1016/j.biopha.2008.03.002; Araki T, 2021, EUR J NEUROSCI, V54, P5880, DOI 10.1111/ejn.14969; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Armstrong LE, 2002, REV NEUROSCIENCE, V13, P271; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Biscaro B, 2012, NEURODEGENER DIS, V9, P187, DOI 10.1159/000330363; Brillaud E, 2007, TOXICOLOGY, V238, P23, DOI 10.1016/j.tox.2007.05.019; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.10179; Diaz-Aparicio I, 2020, J NEUROSCI, V40, P1453, DOI 10.1523/JNEUROSCI.0993-19.2019; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Elkabes S, 1996, J NEUROSCI, V16, P2508; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Gemma C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00229; Gudasheva TA, 2016, DRUG DES DEV THER, V10, P3545, DOI 10.2147/DDDT.S118768; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; He GL, 2020, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00591; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; Horowitz M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00548; Horowitz M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00256; Johansson Olle, 2009, Pathophysiology, V16, P157, DOI 10.1016/j.pathophys.2009.03.004; Kanikowska D, 2012, INT J BIOMETEOROL, V56, P107, DOI 10.1007/s00484-010-0401-6; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Koyama Y, 2018, NEUROSCIENCE, V385, P121, DOI 10.1016/j.neuroscience.2018.05.045; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; LAI H, 1994, BIOELECTROMAGNETICS, V15, P95, DOI 10.1002/bem.2250150202; Liu PZ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00052; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Matsuda T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7514; Matsuzaki K, 2009, PFLUG ARCH EUR J PHY, V458, P661, DOI 10.1007/s00424-009-0654-2; Mausset-Bonnefont AL, 2004, NEUROBIOL DIS, V17, P445, DOI 10.1016/j.nbd.2004.07.004; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morgan SC, 2004, J NEUROCHEM, V90, P89, DOI 10.1111/j.1471-4159.2004.02461.x; Occelli F, 2018, NEUROSCIENCE, V385, P11, DOI 10.1016/j.neuroscience.2018.06.002; Orendacova J, 2009, CELL MOL NEUROBIOL, V29, P981, DOI 10.1007/s10571-009-9385-3; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Racek A, 2018, PHYSIOL RES, V67, P495, DOI 10.33549/physiolres.933752; Reshef R, 2014, BRAIN BEHAV IMMUN, V41, P239, DOI 10.1016/j.bbi.2014.04.009; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sakhaie MH, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/9194261; Sellner S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0374-8; Shahin S, 2018, TOXICOL SCI, V161, P349, DOI 10.1093/toxsci/kfx221; Shahin S, 2015, TOXICOL SCI, V148, P380, DOI 10.1093/toxsci/kfv205; Sharma H S, 1992, Endocr Regul, V26, P133; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; Su LL, 2018, INT J RADIAT BIOL, V94, P295, DOI 10.1080/09553002.2018.1432913; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; Umschweif G, 2014, J CEREBR BLOOD F MET, V34, P1381, DOI 10.1038/jcbfm.2014.93; Valero J, 2016, ACS CHEM NEUROSCI, V7, P442, DOI 10.1021/acschemneuro.6b00009; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang JJ, 2021, MOL NEUROBIOL, V58, P1074, DOI 10.1007/s12035-020-02138-3; Wu MD, 2012, BRAIN BEHAV IMMUN, V26, P292, DOI 10.1016/j.bbi.2011.09.012; Yang JH, 2016, BRAIN RES BULL, V120, P25, DOI 10.1016/j.brainresbull.2015.10.012; Yang X.-S., 2012, BRAIN RES B, V88, P371; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Yi JF, 2017, CELL PHYSIOL BIOCHEM, V41, P101, DOI 10.1159/000455979; Zhang BF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21468-x; Zhang JQ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abb9888; Zhang JQ, 2017, BRAIN BEHAV IMMUN, V66, P111, DOI 10.1016/j.bbi.2017.07.012	64	0	0	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	DEC	2021	177						181	193		10.1016/j.brainresbull.2021.09.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM9UG	WOS:000711422800002	34555433	hybrid			2022-02-06	
J	Hennessy, MJ; Delle Baite, L; Marshman, LAG				Hennessy, Maria J.; Delle Baite, Lorryn; Marshman, Laurence A. G.			More than amnesia: prospective cohort study of an integrated novel assessment of the cognitive and behavioural features of PTA	BRAIN IMPAIRMENT			English	Article						Post-traumatic amnesia; traumatic brain injury; assessment	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA; HEAD-INJURY; AGITATED BEHAVIOR; ACUTE PERIOD; MEMORY; RECOVERY; SCALE; ORIENTATION; VALIDATION	Background and Objective: Post-traumatic amnesia (PTA) is an early significant stage of recovery from traumatic brain injury (TBI). Current prospective PTA scales do not assess the full range of PTA symptomatology. This study conducted a novel integrated assessment of cognition and behaviour during PTA. Method: Twenty-four moderate-to-severe TBI participants in PTA and 23 TBI controls emerged from PTA were matched for age, gender, and years of education. All completed PTA measures (Galveston Orientation and Amnesia Test: GOAT, Westmead Post-traumatic Amnesia Scale: WPTAS), a cognitive battery; and behaviour ratings scored by 2 independent raters (informant and staff). Results: Significantly poorer performance was found during PTA for attention, processing speed, delayed verbal free recall and recognition, and visual learning. A large effect size was found for category fluency only. Behaviour ratings were significantly higher during PTA. Five behaviours were rated as high frequency (>50%) by both raters: Inattention, Impulsivity, Sleep Disturbance, Daytime Arousal, and Self-Monitoring. Prospective PTA measures produced significantly different duration estimates from 2 days (GOAT vs. WPTAS 1(st) day) to 9 days (WPTAS 1(st) day vs. 3-day). The WPTAS correlated most highly with processing speed and language tasks; whilst the GOAT correlated most highly with language and executive control of verbal memory. Conclusion: New prospective measures are needed that integrate core cognitive and behavioural features are brief, easy to administer, and capable of measuring emergence. The term PTA is a misnomer that requires revision to better accommodate the clinical syndrome.	[Hennessy, Maria J.] James Cook Univ Singapore, Psychol, Singapore, Singapore; [Hennessy, Maria J.; Delle Baite, Lorryn] James Cook Univ, Psychol, Townsville, Qld, Australia; [Marshman, Laurence A. G.] James Cook Univ, Sch Med & Dent, Townsville, Qld, Australia; [Marshman, Laurence A. G.] Queensland Hlth, Townsville Hosp & Hlth Serv, Townsville Hosp, Neurosurg, Townsville, Qld, Australia		Hennessy, MJ (corresponding author), James Cook Univ Singapore, Psychol, Singapore, Singapore.; Hennessy, MJ (corresponding author), James Cook Univ, Psychol, Townsville, Qld, Australia.	mariahennessy67@gmail.com					Andriessen TMJC, 2009, BRAIN INJURY, V23, P345, DOI 10.1080/02699050902791414; Baddeley A.D., 1997, HUMAN MEMORY THEORY; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Colarusso R.P., 2003, MOTOR FREE VISUAL PE; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis D.C., 2000, CALIFORNIA VERBAL LE; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Hennessy MJ, 2020, J CLIN NEUROSCI, V81, P37, DOI 10.1016/j.jocn.2020.09.030; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Keelan RE, 2019, J INT NEUROPSYCH SOC, V25, P302, DOI 10.1017/S1355617718001157; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; McLellan J, 2017, J CLIN NEUROSCI, V44, P184, DOI 10.1016/j.jocn.2017.06.027; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Paradis M., 1987, ASSESSMENT BILINGUAL, DOI [10.3109/02699052.2010.506858, DOI 10.3109/02699052.2010.506858]; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roberts CM, 2018, J INT NEUROPSYCH SOC, V24, P1064, DOI 10.1017/S1355617718000565; Roberts CM, 2015, NEUROPSYCHOLOGY, V29, P522, DOI 10.1037/neu0000178; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith A., 1991, SYMBOL DIGIT MODALIT; Steel J, 2017, BRAIN INJURY, V31, P1320, DOI 10.1080/02699052.2017.1332385; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C., 1940, INJURIES BRAIN SPINA, P100; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tittle A, 2011, BRAIN INJURY, V25, P933, DOI 10.3109/02699052.2011.597042; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Walsh K. W., 1985, UNDERSTANDING BRAIN; Walterfang M., 2003, AUSTRALAS PSYCHIATRY, V11, P325, DOI [10.1046/j.1440-1665.2003.t01-1-00558.x, DOI 10.1046/J.1440-1665.2003.T01-1-00558.X]; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]	53	0	0	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2021	22	3					294	311	PII S1443964621000024	10.1017/BrImp.2021.2			18	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XE3FT	WOS:000723278500004					2022-02-06	
J	Hetzer, SM; Shalosky, EM; Torrens, JN; Evanson, NK				Hetzer, Shelby M.; Shalosky, Emily M.; Torrens, Jordyn N.; Evanson, Nathan K.			Chronic Histological Outcomes of Indirect Traumatic Optic Neuropathy in Adolescent Mice: Persistent Degeneration and Temporally Regulated Glial Responses	CELLS			English	Article						traumatic optic neuropathy; head trauma; adolescent head trauma; mice; chronic; gliosis; neurodegeneration	LONG-TERM DISABILITY; BRAIN-INJURY; WALLERIAN DEGENERATION; AXONAL INJURY; UNITED-STATES; MODEL; NERVE; NUCLEUS; BLAST; NEUROINFLAMMATION	Injury to the optic nerve, termed, traumatic optic neuropathy (TON) is a known comorbidity of traumatic brain injury (TBI) and is now known to cause chronic and progressive retinal thinning up to 35 years after injury. Although animal models of TBI have described the presence of optic nerve degeneration and research exploring acute mechanisms is underway, few studies in humans or animals have examined chronic TON pathophysiology outside the retina. We used a closed-head weight-drop model of TBI/TON in 6-week-old male C57BL/6 mice. Mice were euthanized 7-, 14-, 30-, 90-, and 150-days post-injury (DPI) to assess histological changes in the visual system of the brain spanning a total of 12 regions. We show chronic elevation of FluoroJade-C, indicative of neurodegeneration, throughout the time course. Intriguingly, FJ-C staining revealed a bimodal distribution of mice indicating the possibility of subpopulations that may be more or less susceptible to injury outcomes. Additionally, we show that microglia and astrocytes react to optic nerve damage in both temporally and regionally different ways. Despite these differences, astrogliosis and microglial changes were alleviated between 14-30 DPI in all regions examined, perhaps indicating a potentially critical period for intervention/recovery that may determine chronic outcomes.	[Hetzer, Shelby M.; Evanson, Nathan K.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA; [Shalosky, Emily M.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Torrens, Jordyn N.; Evanson, Nathan K.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA		Evanson, NK (corresponding author), Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH 45267 USA.; Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA.; Evanson, NK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45229 USA.	canslesy@mail.uc.edu; shalosem@mail.uc.edu; torrenjn@mail.uc.edu; Nathan.evanson@cchmc.org			National Institutes of Health [NIH]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD001097, NS007453]; Procter Award; Division of Pediatric Rehabilitation Medicine at Cincinnati Children's Hospital Medical Center	This work was supported by the National Institutes of Health [NIH grants HD001097 (NKE) and NS007453 (SMH)] and by a Procter Award and the Division of Pediatric Rehabilitation Medicine at Cincinnati Children's Hospital Medical Center (NKE). Funding entities played no role in the design, execution, analysis, or interpretation of results.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Boehme NA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90412-2; Cansler S.M., 2020, INDIRECT TRAUMATIC O, DOI [10.1101/2020.06.11.144766, DOI 10.1101/2020.06.11.144766]; Carroll S.L., 2017, REFERENCE MODULE NEU; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Chan JW, 2019, INVEST OPHTH VIS SCI, V60, P2005, DOI 10.1167/iovs.18-26094; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chen C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061171; Chen YJ, 2017, ONCOTARGET, V8, P86924, DOI 10.18632/oncotarget.21008; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; ERB DE, 1991, EXP BRAIN RES, V83, P253; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Finkelstein E., 2006, INCIDENCE EC BURDEN, pxiii; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Green DR, 2016, CELL DEATH DIFFER, V23, P915, DOI 10.1038/cdd.2015.172; Guilhaume-Correa F, 2020, J NEUROSCI RES, V98, P557, DOI 10.1002/jnr.24535; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hetzer SM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10050996; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Horn A.K.E., 2012, HUMAN NERVOUS SYSTEM, V3rd ed., P328; Huang X, 2021, NEURAL PLAST, V2021, DOI 10.1155/2021/5554824; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069938; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Keating CE, 2020, J NEUROTRAUM, V37, P1918, DOI 10.1089/neu.2019.6738; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kossmann T., 2007, NEUROL CLIN NEUROSCI, P1397; Kozicz T, 2011, J COMP NEUROL, V519, P1413, DOI 10.1002/cne.22580; Lee SY, 2021, J PHARMACOL SCI, V145, P223, DOI 10.1016/j.jphs.2020.12.007; Leung CKS, 2011, INVEST OPHTH VIS SCI, V52, P1539, DOI 10.1167/iovs.10-6012; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; McConnell HL, 2019, NEUROCHEM INT, V128, P70, DOI 10.1016/j.neuint.2019.04.005; Morin LP, 2014, J COMP NEUROL, V522, P3733, DOI 10.1002/cne.23635; Murray B., 2014, ENCY NEUROLOGICAL SC, V2nd, P333; Parhamifar L, 2014, ADV GENET, V88, P353, DOI 10.1016/B978-0-12-800148-6.00012-2; Patel VC, 2017, EXP NEUROL, V289, P85, DOI 10.1016/j.expneurol.2016.12.012; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder H, 2020, NEUROANATOMY OF THE MOUSE: AN INTRODUCTION, P305, DOI 10.1007/978-3-030-19898-5_13; Seger CA, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00104; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Steinman J, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116101; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; TURNER JE, 1977, ANAT REC, V187, P291, DOI 10.1002/ar.1091870303; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; VAUGHN JE, 1970, J COMP NEUROL, V140, P207, DOI 10.1002/cne.901400205; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Wylot B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010099; Yakushin SB, 2000, EXP BRAIN RES, V131, P433, DOI 10.1007/s002219900302; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yoo H., NEUROANATOMY PUPILLA; Yu-Wai-Man Patrick, 1800, Taiwan J Ophthalmol, V5, P3; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2; Zubricky R.D., 2021, NEUROANATOMY SUPERIO	73	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3343	10.3390/cells10123343			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XW9VO	WOS:000735957400001	34943851	Green Published			2022-02-06	
J	Homayounpour, M; Gomez, NG; Ingram, AC; Coats, B; Merryweather, AS				Homayounpour, Mohammad; Gomez, Nicholas G.; Ingram, Alexandra C.; Coats, Brittany; Merryweather, Andrew S.			Cervical Muscle Activation Characteristics and Head Kinematics in Males and Females Following Acoustic Warnings and Impulsive Head Forces	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head kinematics; Neck muscle; Directional acoustic warning; mTBI; Startle; Posture; Co-contraction	SEGMENT DYNAMIC STABILIZATION; CHOICE-REACTION TIME; NECK STRENGTH; GENDER-DIFFERENCES; SEX-DIFFERENCES; IMPACT FORCE; WHIPLASH; ACCELERATION; BIOMECHANICS; CONCUSSION	Sex, head and neck posture, and cervical muscle preparation are contributing factors in the severity of head and neck injuries. However, it is unknown how these factors modulate the head kinematics. In this study, twenty-four (16 male and 8 female) participants experienced 50 impulsive forces to their heads with and without an acoustic warning. Female participants demonstrated a 71 ms faster (p = 0.002) muscle activation onset compared to males after warning. The magnitude of muscle activation was not significant between sexes. Females exhibited 21% (p < 0.008) greater peak angular velocity in all force directions and 18% (p < 0.04) greater peak angular acceleration in sagittal plane compared to males. Females exhibited 15% (p = 0.03) greater peak linear acceleration compared to males only in sagittal flexion. Preparation attenuated head kinematics significantly (p < 0.03) in 11 out of 18 investigated head kinematics for both sexes. A warning eliciting a startle response 420 ms prior to the impact resulted in significant attenuation of all measured head kinematics in sagittal extension (p < 0.037). In conclusion, both sex and warning type were significant factors in head kinematics. These data provide insight into the complex relationship of muscle activation and sex, and may help identify innovative strategies to reduce head and neck injury risk in sports.	[Homayounpour, Mohammad; Gomez, Nicholas G.; Ingram, Alexandra C.; Coats, Brittany; Merryweather, Andrew S.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA		Merryweather, AS (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.	a.merryweather@utah.edu		Gomez, Nicholas/0000-0002-7206-7752; Merryweather, Andrew/0000-0002-9048-9473	National Science FoundationNational Science Foundation (NSF) [1622741]; National Institute of Occupational Safety and Health (NIOSH Education and Research Center)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [5T42OH008414-14, 2T42OH008414-13]	This research was funded in part by grants from the National Science Foundation (#1622741) and the National Institute of Occupational Safety and Health (NIOSH Education and Research Center Training Grant, 5T42OH008414-14, and the Targeted Research Training Grant, 2T42OH008414-13). The writers also acknowledge Karina Velarde for help in data collection.	Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; Aston JP, 2020, 2020 3RD IEEE INTERNATIONAL CONFERENCE ON SOFT ROBOTICS (ROBOSOFT), P607, DOI 10.1109/RoboSoft48309.2020.9116034; Avela J, 1998, EUR J APPL PHYSIOL O, V78, P403, DOI 10.1007/s004210050438; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouin JS, 2006, SPINE, V31, P146, DOI 10.1097/01.brs.0000195157.75056.df; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fanta O, 2013, NEUROENDOCRINOL LETT, V34, P708; FELLOWS SJ, 1989, EXP BRAIN RES, V77, P135; Gavkare AM, 2013, IND MED GAZ, V6, P214; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; He J, 1998, IEEE Trans Rehabil Eng, V6, P182, DOI 10.1109/86.681184; Homayounpour Mohammad, 2019, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V63, P802, DOI 10.1177/1071181319631320; Homayounpour M, 2021, J BIOMECH, V128, DOI 10.1016/j.jbiomech.2021.110732; Homayounpour M, 2021, ANN BIOMED ENG, V49, P2260, DOI 10.1007/s10439-021-02757-4; Jain Aditya, 2015, Int J Appl Basic Med Res, V5, P124, DOI 10.4103/2229-516X.157168; Kaur P., 2006, INT J DIAB DEV CTRIE, V26, P112, DOI DOI 10.4103/0973-3930.32170; Kofler M, 2001, BRAIN RES, V921, P206, DOI 10.1016/S0006-8993(01)03120-1; Kuo C, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0086; LAHTELA K, 1985, SCAND J PSYCHOL, V26, P357, DOI 10.1111/j.1467-9450.1985.tb01175.x; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Luttmer NG, 2020, IEEE INT CONF ROBOT, P9135, DOI 10.1109/ICRA40945.2020.9196600; Mang DWH, 2015, SPINE J, V15, P153, DOI 10.1016/j.spinee.2014.08.002; Mang DWH, 2012, J APPL PHYSIOL, V113, P532, DOI 10.1152/japplphysiol.00100.2012; Mansell J, 2005, J ATHL TRAINING, V40, P310; Bernety HM, 2020, AIP ADV, V10, DOI 10.1063/1.5138650; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mortensen JD, 2020, J BIOMECH, V100, DOI 10.1016/j.jbiomech.2019.109411; Mortensen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199912; NOUGIER V, 1989, INT J SPORT PSYCHOL, V20, P205; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Reynier KA, 2020, ANN BIOMED ENG, V48, P2751, DOI 10.1007/s10439-020-02609-7; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Spierer DK, 2010, J STRENGTH COND RES, V24, P957, DOI 10.1519/JSC.0b013e3181c7c536; Stearne D, 2005, FEMALE COLLEGIATE SO; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; Welford A., 1980, REACTION TIMES, P73; Zajdel R, 2007, COMPUT BIOL MED, V37, P1724, DOI 10.1016/j.compbiomed.2007.04.008	51	0	0	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2021	49	12			SI		3438	3451		10.1007/s10439-021-02890-0		DEC 2021	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	XO7FF	WOS:000724641200001	34853920				2022-02-06	
J	Homo, RL; Grigorian, A; Chen, J; Figueroa, C; Chin, T; Kuza, CM; Lekawa, M; Nahmias, J				Homo, Richelle L.; Grigorian, Areg; Chen, Jefferson; Figueroa, Cesar; Chin, Theresa; Kuza, Catherine M.; Lekawa, Michael; Nahmias, Jeffry			Regional, Racial, and Mortality Disparities Associated With Neurosurgeon Staffing at Level I Trauma Centers	AMERICAN SURGEON			English	Article							GUIDELINES; MANAGEMENT	Background: Traumatic brain injury (TBI) occurs in approximately 30% of trauma patients. Because neurosurgeons hold expertise in treating TBI, increased neurosurgical staffing may improve patient outcomes. We hypothesized that TBI patients treated at level I trauma centers (LITCs) with >= 3 neurosurgeons have a decreased risk of mortality vs. those treated at LITCs with <3 neurosurgeons. Methods: The Trauma Quality Improvement Program database (2010-2016) was queried for patients >= 18 years with TBI. Patient characteristics and mortality were compared between >= 3 and <3 neurosurgeon-staffed LITCs. A multivariable logistic regression analysis was used to identify risk factors associated with mortality. Results: Traumatic brain injury occurred in 243 438 patients with 5188 (2%) presenting to LITCs with <3 neurosurgeons and 238 250 (98%) to LITCs with >= 3 neurosurgeons. Median injury severity score (ISS) was similar between both groups (17, P = .09). There were more Black (37% vs. 12%, P < .001) and Hispanic (18% vs. 12%, P < .001) patients in the <3 neurosurgeon group. Nearly 60% of LITCs with <3 neurosurgeons are found in the South. Mortality was higher in the <3 vs. the >= 3 group (12% vs. 10%, P < .001). Patients treated in the <3 neurosurgeon group had a higher risk for mortality than those treated in the >= 3 neurosurgeon group (odds ratio (OR) 1.13, 95% confidence intervals (CI) 1.01-1.26, P = .028). Discussion: There exists a significant racial disparity in access to neurosurgeon staffing with additional disparities in outcomes based on staffing. Future efforts are needed to improve this chasm of care that exists for trauma patients of color.	[Homo, Richelle L.; Grigorian, Areg; Figueroa, Cesar; Chin, Theresa; Lekawa, Michael; Nahmias, Jeffry] Univ Calif Los Angeles, Dept Surg, Div Trauma Burns & Surg Crit Care, Los Angeles, CA USA; [Chen, Jefferson] Univ Calif Los Angeles, Dept Neurol Surg, Los Angeles, CA USA; [Kuza, Catherine M.] Univ Southern Calif, Dept Anesthesiol, Los Angeles, CA 90007 USA		Nahmias, J (corresponding author), Univ Calif Irvine, Med Ctr, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	jnahmias@hs.uci.edu					Adogwa O, 2016, SPINE, V41, P1677, DOI 10.1097/BRS.0000000000001616; Albert NG, 2010, HISPANIC POPULATION; American Association of Neurological Surgeons, 2012, ENS AD NEUR WORKF 21; American College of Surgeons, 2015, ACS TQIP BEST PRACT, P1; American College of Surgeons Health Policy Research Institute, 2010, SURG WORKF US PROF R, P103; American College of Surgeons Health Policy Research Institute, 2012, NEUR SUBSP SUPPL MAP; Babu MA, 2019, NEUROSURGERY, V84, P977, DOI 10.1093/neuros/nyy354; Bakhsheshian J, 2018, WORLD NEUROSURG, V119, pE284, DOI 10.1016/j.wneu.2018.07.134; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2017, LEAD CAUS DEATH AG G; Chen JW, 2019, NEUROSURGERY, V84, P985, DOI 10.1093/neuros/nyy415; De Vloo P, 2018, WORLD NEUROSURG, V114, pE546, DOI 10.1016/j.wneu.2018.03.032; Drewery, 2010, THE BLACK POPULATION; Faul M, 2015, WEST J EMERG MED, V16, P98, DOI 10.5811/westjem.2014.10.22837; Firempong AO, 2014, NEUROL RES, V36, P857, DOI 10.1179/1743132814Y.0000000343; Hanchate AD, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10816; Hutchinson, 2018, SURGERY, V36, P613, DOI [10.1016/j.mpsur.2018.09.007, DOI 10.1016/J.MPSUR.2018.09.007]; Rosman J, 2013, NEUROSURGERY, V73, P354, DOI 10.1227/01.neu.0000430762.08458.49; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	20	0	0	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	DEC	2021	87	12					1972	1979		10.1177/0003134820983187			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	XN9VA	WOS:000729843900015	33380167				2022-02-06	
J	Hosomi, S; Kitamura, T; Sobue, T; Nakagawa, Y; Ogura, H; Shimazu, T				Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka; Nakagawa, Yuko; Ogura, Hiroshi; Shimazu, Takeshi			Association of Pre-Hospital Helicopter Transport with Reduced Mortality in Traumatic Brain Injury in Japan: A Nationwide Retrospective Cohort Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						ground emergency medical services; helicopter; Japan Trauma Data Bank; mortality; traumatic brain injury	COST-EFFECTIVENESS; SCENE TRANSPORT; EPIDEMIOLOGY; SURVIVAL; CARE	Patients with traumatic brain injury (TBI) are severely injured patients who require timely, efficient, and specialized care. The effectiveness of helicopter emergency medical services (HEMS) for patients with TBI remains unclear. This study aimed to compare the mortality of patients with TBI transported by HEMS and ground ambulance using propensity score-matching analysis, and to analyze the effects of HEMS in various subpopulations. We conducted a retrospective analysis of the Japan Trauma Data Bank. The study period was from January 2004 to December 2018. The participants were divided into two groups: the helicopter group (patients transported by HEMS) and ground group (patients transported by ground ambulance). The principal outcome was death at hospital discharge. In total, 58,532 patients were eligible for analysis (ground group, n = 54,820 [93.7%]; helicopter group, n = 3712 [6.3%]). Helicopter transport decreased patient mortality at hospital discharge (adjusted odds ratio [OR], 0.83; 95% confidence interval [CI], 0.74-0.92). In propensity score-matched patients, the proportion of deaths at hospital discharge was lower in the helicopter (18.76%) than in the ground (21.21%) group (crude OR, 0.86; 95% CI, 0.77-0.96). The mortality rate in the helicopter group was significantly reduced in many subpopulations, especially in cases of severe TBI with a decreased level of consciousness or higher Injury Severity Score (ISS; Japan Coma Scale score 2 [adjusted OR, 0.60; 95% CI, 0.45-0.80] and ISS >= 50 [adjusted OR, 0.69; 95% CI, 0.48-0.99]). Although the study design was non-randomized, our findings in patients with TBI showed that HEMS conferred a mortality benefit over ground ambulance.	[Hosomi, Sanae; Nakagawa, Yuko; Ogura, Hiroshi; Shimazu, Takeshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan; [Hosomi, Sanae; Kitamura, Tetsuhisa; Sobue, Tomotaka] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Osaka, Japan		Hosomi, S (corresponding author), Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	s-hosomi@hp-emerg.med.osaka-u.ac.jp	Kitamura, Tetsuhisa/AAA-2555-2020	Kitamura, Tetsuhisa/0000-0003-0107-0580			Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; [Anonymous], 2020, EMERGENCY MED NETWOR; Association for the Advancement of Automotive Medicine, 2001, ABBREVIATED INJURY S; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Brown JB, 2016, J TRAUMA ACUTE CARE, V80, P702, DOI 10.1097/TA.0000000000000971; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Delgado MK, 2013, ANN EMERG MED, V62, P351, DOI 10.1016/j.annemergmed.2013.02.025; Enomoto Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237192; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Gallo V, 2011, J CLIN EPIDEMIOL, V64, P1350, DOI 10.1016/j.jclinepi.2011.07.010; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2013, CRIT CARE, V17, DOI 10.1186/cc12779; Gravesteijn BY, 2021, PREHOSP EMERG CARE, V25, P629, DOI 10.1080/10903127.2020.1817210; Guidelines Committee on the Management of Severe Head Injury., 2019, GUIDELINES MANAGEMEN, V4th; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Izawa J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l430; Japan Trauma Care and Research, 2019, JAP TRAUM DAT BANK A; JPTEC Council (eds), 2020, JAP PREH TRAUM EV CA, V2nd; Katayama Y, 2021, EUR J TRAUMA EMERG S, V47, P515, DOI 10.1007/s00068-019-01154-w; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McMonagle MP, 2007, ANZ J SURG, V77, P241, DOI 10.1111/j.1445-2197.2007.04026.x; Pakkanen T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0438-1; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Taylor C, 2012, INJURY, V43, P1843, DOI 10.1016/j.injury.2012.07.184; Thomas Stephen H, 2003, Curr Opin Anaesthesiol, V16, P153, DOI 10.1097/00001503-200304000-00008; Vercruysse GA, 2015, J TRAUMA ACUTE CARE, V78, P510, DOI 10.1097/TA.0000000000000553	32	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0181		DEC 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XH9EL	WOS:000725728800001	34779275	Green Accepted, hybrid			2022-02-06	
J	Houston, KE; McDaniel, CE; Greenspan, L; Tirandazi, P				Houston, Kevin E.; McDaniel, Catherine E.; Greenspan, Lynn; Tirandazi, Pooyan			Case Series: Periodic Accommodative Fluctuations after Concussion	OPTOMETRY AND VISION SCIENCE			English	Article							SPASM; MICROFLUCTUATIONS; EYES	SIGNIFICANCE This is the first report recording an accommodative disorder after concussion characterized by periodic moderately sized myopic refractive error fluctuations without measurable other features of spasm of the near reflex. PURPOSE Objectively document a class of accommodative dysfunction that may be related to concussion. CASE REPORTS Case 1 involved two sports-related concussions 2 months apart with symptoms of headache and variable blur. Refractive stability was measured 28 months after injury with a binocular open-field refractometer documenting fluctuations from -0.25 to -1.75 D occurring 10 times during 4.2 seconds of recording with no evident miosis or convergent strabismus. The symptoms resolved with 1% atropine x 3 weeks. Case 2 involved a concussive blast injury (improvised explosive device) 7 years prior with symptoms of headache behind the eyes and occasional variable blur and reduced tolerance of electronic displays and other visually intensive tasks. Refractive fluctuations from +0.50 to -2.00 D occurred seven times over 44 seconds of recording with no appreciable miosis or change of interpalpebral fissure. The signs and symptoms were unresponsive to seven occupational therapy sessions involving task modifications and accommodative vision therapy activities. CONCLUSIONS In patients complaining of blurry vision, a careful evaluation of the stability of accommodation is indicated.	[Houston, Kevin E.; Tirandazi, Pooyan] Massachusetts Eye & Ear, Boston, MA 02114 USA; [McDaniel, Catherine E.] Ohio State Univ, Coll Optometry, Columbus, OH 43210 USA; [Greenspan, Lynn] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA		Houston, KE (corresponding author), Massachusetts Eye & Ear, Boston, MA 02114 USA.	kevin_houston@meei.harvard.edu					Bharadwaj SR, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.8.18; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; COGAN DG, 1955, ARCH OPHTHALMOL-CHIC, V54, P752; COLLINS M, 1995, VISION RES, V35, P2491; Dreissen YEM, 2019, J NEUROL NEUROSUR PS, V90, P1244, DOI 10.1136/jnnp-2018-320071; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Goldstein JH, 1996, SURV OPHTHALMOL, V40, P269, DOI 10.1016/S0039-6257(96)82002-9; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Grassmann M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8146809; GRAY LS, 1993, VISION RES, V33, P2083, DOI 10.1016/0042-6989(93)90007-J; Kanda H, 2012, JPN J OPHTHALMOL, V56, P617, DOI 10.1007/s10384-012-0187-7; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; LEIBOWITZ HW, 1975, J OPT SOC AM, V65, P1121, DOI 10.1364/JOSA.65.001121; McMurray CJ, 2004, J CATARACT REFR SURG, V30, P2629, DOI 10.1016/j.jcrs.2004.05.049; Motlagh M, STATPEARLS PHYSL ACC; Ninomiya S, 2003, AM J OPHTHALMOL, V136, P1161, DOI 10.1016/S0002-9394(03)00585-3; Radhakrishnan H, 2007, OPHTHAL PHYSL OPT, V27, P342, DOI 10.1111/j.1475-1313.2007.00484.x; Roy S, 2021, J AAPOS, V25, DOI 10.1016/j.jaapos.2021.02.010; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Schultz KE, 2009, OPTOMETRY VISION SCI, V86, P677, DOI 10.1097/OPX.0b013e3181a7b3ce	20	0	0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	DEC	2021	98	12					1387	1393		10.1097/OPX.0000000000001810			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	XO1HK	WOS:000729944000009	34905525				2022-02-06	
J	Houston, MN; Bookbinder, HA; Roach, SP; Ross, JD; Aderman, MJ; Peck, KY; Malvasi, SR; Svoboda, SJ; Cameron, KL				Houston, Megan N.; Bookbinder, Haley A.; Roach, Sean P.; Ross, Jeremy D.; Aderman, Michael J.; Peck, Karen Y.; Malvasi, Steven R.; Svoboda, Steven J.; Cameron, Kenneth L.			Reference Values for the Headache Impact Test-6 Questionnaire	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Concussion; Health-related quality of life; Patient-reported out-comes; Rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SPORT-RELATED CONCUSSION; NATURAL-HISTORY; US MILITARY; EPIDEMIOLOGY; CARE; SYMPTOMS; HIT-6	Objective: To determine reference values for the Headache Impact Test-6 (HIT-6) in a young, physically active cohort and to examine the influence of sex, concussion history, headache history, and competitive sport level on HIT-6 scores. Design: Cross-sectional. Setting: United States Service Academy. Participants: United States Service Academy cadets (N=2678) completed an HIT-6 questionnaire as part of their annual concussion baseline assessment. Cadets with a recent concussion were excluded from baseline testing. Interventions: Not applicable. Main Outcome Measures: Reference values were calculated and stratified by sex, concussion history, headache history, and competitive sport level. Mann-Whitney U and Kruskal-Wallis tests were used to examine the effect of sex, concussion history, headache history, and competitive sport level on HIT-6 scores (P<.05). Results: Of the 3599 cadets baselined, 2687 cadets (23% female) agreed to participate in the study and completed the HIT-6. Female participants reported significantly worse HIT-6 scores compared with male participants both with (P<.001) and without (P<.001) a concussion history. In both sexes, participants with a headache history reported worse scores than those with no headache/concussion history and a concussion history (all P<.005). Female cadets who participated in intramural athletics reported worse HIT-6 scores at baseline than female intercollegiate athletes (P=.003). Conclusions: This is the first study to stratify HIT-6 data by sex, concussion history, headache history, and sport level in a collegiate population at risk for concussions. Sex and headache history appear to influence HIT-6 scores and should be given special consideration when interpreting health-related quality of life deficits due to headache. Archives of Physical Medicine and Rehabilitation 2021;102:2369-76 (c) 2021 The American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.	[Houston, Megan N.; Bookbinder, Haley A.; Ross, Jeremy D.; Aderman, Michael J.; Malvasi, Steven R.; Cameron, Kenneth L.] Keller Army Community Hosp, Dept Orthopaed Res, West Point, NY 10996 USA; [Roach, Sean P.] Orange Reg Med Ctr, Middletown, NY USA; [Peck, Karen Y.] US Mil Acad, West Point, NY 10996 USA; [Svoboda, Steven J.] Medstar Hlth, Washington, DC USA		Houston, MN (corresponding author), Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil			US Army Medical Research and Materiel Command, Ft. Detrick, MDU.S. Army Medical Research & Materiel Command (USAMRMC) [HU0001-15-2-0037 [2988]]	Presented as a poster to the National Athletic Trainers' Association, June 2018, New Orleans, LA. Supported in part by a research grant from the US Army Medical Research and Materiel Command, Ft. Detrick, MD (grant no. HU0001-15-2-0037 [2988]).	Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Bayliss M, 2002, HIT 6TM USERS GUIDE; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Caccese JB, 2021, SPORTS MED, V51, P1087, DOI 10.1007/s40279-020-01415-4; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cohen J., 2013, STAT POWER ANAL BEHA; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Delaruelle Z, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0922-7; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Houston MN, 2016, J ATHL TRAINING, V51, P442, DOI 10.4085/1062-6050-51.7.03; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Connor P J, 1990, Fam Med, V22, P307; Omorou YA, 2013, QUAL LIFE RES, V22, P2021, DOI 10.1007/s11136-013-0355-3; Piebes SK, 2011, J SPORT REHABIL, V20, P129, DOI 10.1123/jsr.20.1.129; Smelt AFH, 2014, CEPHALALGIA, V34, P29, DOI 10.1177/0333102413497599; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Weber ML, 2019, ANN BIOMED ENG, V47, P2136, DOI 10.1007/s10439-018-02151-7; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890	33	0	0	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2021	102	12					2369	2376		10.1016/j.apmr.2021.05.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XJ1SP	WOS:000726577100011	34175274				2022-02-06	
J	Hovareshti, P; Roeder, S; Holt, LS; Gao, P; Xiao, LM; Zalkin, C; Ou, V; Tolani, D; Klatt, BN; Whitney, SL				Hovareshti, Pedram; Roeder, Shamus; Holt, Lisa S.; Gao, Pan; Xiao, Lemin; Zalkin, Chad; Ou, Victoria; Tolani, Devendra; Klatt, Brooke N.; Whitney, Susan L.			VestAid: A Tablet-Based Technology for Objective Exercise Monitoring in Vestibular Rehabilitation	SENSORS			English	Article						vestibular rehabilitation; VORx1 exercises; dizziness; exercise monitoring; telemedicine	PERCEIVED EXERTION; VALIDATION; SCALE	(1) Background: Current vestibular rehabilitation therapy is an exercise-based approach aimed at promoting gaze stability, habituating symptoms, and improving balance and walking in patients with mild traumatic brain injury (mTBI). A major component of these exercises is the adaptation of the vestibulo-ocular reflex (VOR) and habituation training. Due to acute injury, the gain of the VOR is usually reduced, resulting in eye movement velocity that is less than head movement velocity. There is a higher chance for the success of the therapy program if the patient (a) understands the exercise procedure, (b) performs the exercises according to the prescribed regimen, (c) reports pre- and post-exercise symptoms and perceived difficulty, and (d) gets feedback on performance. (2) Methods: The development and laboratory evaluation of VestAid, an innovative, low-cost, tablet-based system that helps patients perform vestibulo-ocular reflex (VORx1) exercises correctly at home without therapist guidance, is presented. VestAid uses the tablet camera to automatically assess patient performance and compliance with exercise parameters. The system provides physical therapists (PTs) with near real-time, objective (head speed and gaze fixation compliance), and subjective (perceived difficulty and pre- and post- exercise symptoms) metrics through a web-based provider portal. The accuracy of the head-angle and eye-gaze compliance metrics was evaluated. The accuracy of estimated head angles calculated via VestAid's low-complexity algorithms was compared to the state-of-the-art deep-learning method on a public dataset. The accuracy of VestAid's metric evaluation during the VORx1 exercises was assessed in comparison to the output of an inertial measurement unit (IMU)-based system. (3) Results: There are low mean interpeak time errors (consistently below 0.1 s) across all speeds of the VORx1 exercise, as well as consistently matching numbers of identified peaks. The spatial comparison (after adjusting for the lag measured with the cross-correlation) between the VestAid and IMU-based systems also shows good matching, as shown by the low mean absolute head angle error, in which for all speeds, the mean is less than 10 degrees. (4) Conclusions: The accuracy of the system is sufficient to provide therapists with a good assessment of patient performance. While the VestAid system's head pose evaluation model may not be perfectly accurate as a result of the occluded facial features when the head moves further towards an extreme in pitch and yaw, the head speed measurements and associated compliance measures are sufficiently accurate for monitoring patients' VORx1 exercise compliance and general performance.	[Hovareshti, Pedram; Roeder, Shamus; Holt, Lisa S.; Gao, Pan; Xiao, Lemin; Zalkin, Chad; Ou, Victoria; Tolani, Devendra] NxtHlth Team, Intelligent Automat, Rockville, MD 20855 USA; [Klatt, Brooke N.; Whitney, Susan L.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA 15219 USA		Hovareshti, P (corresponding author), NxtHlth Team, Intelligent Automat, Rockville, MD 20855 USA.	phovareshti@i-a-i.com; sroeder@i-a-i.com; lholt@i-a-i.com; pgao@i-a-i.com; lxiao.fn@i-a-i.com; czalkin@i-a-i.com; vou@i-a-i.com; dtolani@i-a-i.com; bnk12@pitt.edu; whitney@pitt.edu		Whitney, Susan/0000-0003-4271-8718			Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Asteriadis S., P INT WORKSH AFF AW, P1, DOI [10.1145/1655260.1655261, DOI 10.1145/1655260.1655261]; Deterding A, 2011, P 15 INT AC MINDTREK; Fanelli G, 2013, INT J COMPUT VISION, V101, P437, DOI 10.1007/s11263-012-0549-0; George A., 2016, 2016 INT C SIGN PROC, P1, DOI DOI 10.1109/SPC0M.2016.7746701; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Hall Courtney D, 1800, J Neurol Phys Ther, DOI 10.1097/NPT.0000000000000382; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; Hamari J, 2014, P ANN HICSS, P3025, DOI 10.1109/HICSS.2014.377; Huang K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-69; Kermen A, 2015, 3DTV CONF; Liao SC, 2016, IEEE T PATTERN ANAL, V38, P211, DOI 10.1109/TPAMI.2015.2448075; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Haver T.C, 2018, PRAGMATIC INTRO SIGN; Ren SQ, 2014, PROC CVPR IEEE, P1685, DOI 10.1109/CVPR.2014.218; Rhudy M., 2014, INT J COMPUT SCI ENG, V5, P1, DOI [10.5121/ijcses.2014.5201, DOI 10.5121/IJCSES.2014.5201]; Robertson RJ, 2004, MED SCI SPORT EXER, V36, P102, DOI 10.1249/01.MSS.0000106169.35222.8B; Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A; Ruiz N, 2018, IEEE COMPUT SOC CONF, P2155, DOI 10.1109/CVPRW.2018.00281; Sailer M, 2017, COMPUT HUM BEHAV, V69, P371, DOI 10.1016/j.chb.2016.12.033; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; Tharwat A, 2018, APPL COMPUT INF, DOI [DOI 10.1016/J.ACI.2018.08.003, 10.1016/j.aci.2018.08.003]; Todd CJ, 2018, IEEE T NEUR SYS REH, V26, P1223, DOI 10.1109/TNSRE.2018.2834964; Whitney SL, 2011, NEUROREHABILITATION, V29, P157, DOI 10.3233/NRE-2011-0690; Wu Y, 2017, PROC CVPR IEEE, P5719, DOI 10.1109/CVPR.2017.606; Xiong XH, 2013, PROC CVPR IEEE, P532, DOI 10.1109/CVPR.2013.75	28	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	DEC	2021	21	24							8388	10.3390/s21248388			18	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	XZ2CE	WOS:000737465300001	34960480	gold, Green Published			2022-02-06	
J	Hubbard, WB; Spry, ML; Gooch, JL; Cloud, AL; Vekaria, HJ; Burden, S; Powell, DK; Berkowitz, BA; Geldenhuys, WJ; Harris, NG; Sullivan, PG				Hubbard, W. Brad; Spry, Malinda L.; Gooch, Jennifer L.; Cloud, Amber L.; Vekaria, Hemendra J.; Burden, Shawn; Powell, David K.; Berkowitz, Bruce A.; Geldenhuys, Werner J.; Harris, Neil G.; Sullivan, Patrick G.			Clinically relevant mitochondrial-targeted therapy improves chronic outcomes after traumatic brain injury	BRAIN			English	Article						controlled cortical impact; mitochondria; Seahorse; synapse; MRI	PPAR-GAMMA AGONIST; ACTIVATED RECEPTOR-GAMMA; MEMBRANE PROTEIN; OXIDATIVE DAMAGE; CYCLOSPORINE-A; ALPHA AGONIST; MITONEET; PIOGLITAZONE; REGISTRATION; DYSFUNCTION	Pioglitazone, an FDA-approved compound, has been shown to target the novel mitochondrial protein mitoNEET and produce short-term neuroprotection and functional benefits following traumatic brain injury. To expand on these findings, we now investigate the dose- and time-dependent effects of pioglitazone administration on mitochondrial function after experimental traumatic brain injury. We then hypothesize that optimal pioglitazone dosing will lead to ongoing neuroprotection and cognitive benefits that are dependent on pioglitazone-mitoNEET signalling pathways. We show that delayed intervention is significantly more effective than early intervention at improving acute mitochondrial bioenergetics in the brain after traumatic brain injury. In corroboration, we demonstrate that mitoNEET is more heavily expressed, especially near the cortical contusion, in the 18 h following traumatic brain injury. To explore whether these findings relate to ongoing pathological and behavioural outcomes, mice received controlled cortical impact followed by initiation of pioglitazone treatment at either 3 or 18 h post-injury. Mice with treatment initiation at 18 h post-injury exhibited significantly improved behaviour and tissue sparing compared to mice with pioglitazone initiated at 3h post-injury. Further using mitoNEET knockout mice, we show that this therapeutic effect is dependent on mitoNEET. Finally, we demonstrate that delayed pioglitazone treatment improves serial motor and cognitive performance in conjunction with attenuated brain atrophy after traumatic brain injury. This study illustrates that mitoNEET is the critical target for delayed pioglitazone intervention after traumatic brain injury, mitochondrial-targeting is highly time-dependent after injury and there is an extended therapeutic window to effectively treat mitochondrial dysfunction after brain injury.	[Hubbard, W. Brad; Spry, Malinda L.; Gooch, Jennifer L.; Vekaria, Hemendra J.; Burden, Shawn; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 475 Biomed & Biol Sci Res Bldg, Lexington, KY 40536 USA; [Hubbard, W. Brad; Powell, David K.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Hubbard, W. Brad] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Lexington VA Healthcare Syst, Lexington, KY 40502 USA; [Cloud, Amber L.] Univ Kentucky, Coll Med, Lexington, KY 40536 USA; [Berkowitz, Bruce A.] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Sch Med, Detroit, MI 48202 USA; [Geldenhuys, Werner J.] West Virginia Univ, Sch Pharm, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Harris, Neil G.] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Dept Neurosurg, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Harris, Neil G.] Univ Calif Los Angeles, Intellectual Dev & Disabil Res Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, 475 Biomed & Biol Sci Res Bldg, Lexington, KY 40536 USA.	patsullivan@uky.edu			BLR&D Department of Veterans Affairs MeritUS Department of Veterans Affairs [1I01BX003405]; Kentucky Spinal Cord and Head Injury Research Trust [15-14A]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS112693-01A1]; BLR&D Career Development Award from the Department of Veterans AffairsUS Department of Veterans Affairs [IK2 BX004618]; Kentucky Spinal Cord and Head Injury Research Trust fellowship; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY026584, AG058171]; NCI Cancer Center Support GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA177558]; MRISC [1 S10 OD023573-01]	This project was supported by BLR&D Department of Veterans Affairs Merit Award 1I01BX003405 (P.G.S.), by the Kentucky Spinal Cord and Head Injury Research Trust no. 15-14A (P.G.S.) and by NIH NINDS R01 NS112693-01A1 (P.G.S.). W.B.H. was supported by BLR&D Career Development Award Number IK2 BX004618 from the Department of Veterans Affairs and by a Kentucky Spinal Cord and Head Injury Research Trust fellowship. B.A.B. was supported by the National Institutes of Health [EY026584, AG058171]. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.; The authors would like to thank the Redox Metabolism-Shared Resource Facility (RM-SRF) at the University of Kentucky for their technical assistance with slot blotting and acknowledge the NCI Cancer Center Support Grant (no. P30 CA177558). The work was also supported, in part, by grant 1 S10 OD023573-01 (MRISC) used to purchase the 7T small animal scanner.	ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Blackburn JK, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113234; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chao HL, 2019, J NEUROSCI, V39, P1930, DOI 10.1523/JNEUROSCI.3415-17.2018; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Das M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49428-y; Deng YB, 2020, GENES DIS, V7, P253, DOI 10.1016/j.gendis.2019.05.002; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Geldenhuys WJ, 2019, COMMUN CHEM, V2, DOI 10.1038/s42004-019-0172-x; Geldenhuys WJ, 2017, ACS CHEM NEUROSCI, V8, P2759, DOI 10.1021/acschemneuro.7b00287; Geldenhuys WJ, 2016, BIOORG MED CHEM LETT, V26, P5350, DOI 10.1016/j.bmcl.2016.09.009; Golinelli-Cohen MP, 2016, J BIOL CHEM, V291, P7583, DOI 10.1074/jbc.M115.711218; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hall ED, 2015, BRAIN NEUROTRAUMA MO; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hubbard WB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45568-3; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, ACUTE NEURONAL INJUR, P63, DOI [10.1007/978-3-319-77495-4_4, DOI 10.1007/978-3-319-77495-4_4]; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2005, 11 ANN M ORG HUM BRA; Jonas E, 2004, J BIOENERG BIOMEMBR, V36, P357, DOI 10.1023/B:JOBB.0000041768.11006.90; Karlsson M, 2021, J NEUROTRAUM, V38, P1870, DOI 10.1089/neu.2020.7317; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kiaei M, 2008, PPAR RES, V2008, DOI 10.1155/2008/418765; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kusminski CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4962; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lamade AM, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113307; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Low YL, 2020, MOL PHARMACEUT, V17, P873, DOI 10.1021/acs.molpharmaceut.9b01131; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Martinez-Vicente M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00064; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Qi L, 2010, INT J CLIN EXP MED, V3, P283; Rabchevsky AG, 2017, NEURAL REGEN RES, V12, P1807, DOI 10.4103/1673-5374.219040; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Sedlackova L, 2019, BBA-MOL CELL RES, V1866, P575, DOI 10.1016/j.bbamcr.2018.12.012; Semple BD, 2011, EXP NEUROL, V229, P195, DOI 10.1016/j.expneurol.2011.02.002; Smith U, 2001, INT J CLIN PRACT, P13; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vekaria HJ, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104866; Vernay A, 2017, P NATL ACAD SCI USA, V114, P8277, DOI 10.1073/pnas.1706643114; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Yang TX, 2008, PPAR RES, V2008, DOI 10.1155/2008/943614; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yonutas HM, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113243; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	81	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2021	144		12				3788	3807		10.1093/brain/awab341			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YI0CK	WOS:000743525200027	34972207	hybrid, Green Published			2022-02-06	
J	Iihara, K; Saito, N; Suzuki, M; Date, I; Fujii, Y; Houkin, K; Inoue, T; Iwama, T; Kawamata, T; Kim, P; Kinouchi, H; Kishima, H; Kohmura, E; Kurisu, K; Maruyama, K; Matsumaru, Y; Mikuni, N; Miyamoto, S; Morita, A; Nakase, H; Narita, Y; Nishikawa, R; Nozaki, K; Ogasawara, K; Ohata, K; Sakai, N; Sakamoto, H; Shiokawa, Y; Takahashi, JC; Ueki, K; Wakabayashi, T; Yoshimoto, K; Arai, H; Tominaga, T				Iihara, Koji; Saito, Nobuhito; Suzuki, Michiyasu; Date, Isao; Fujii, Yukihiko; Houkin, Kiyohiro; Inoue, Tooru; Iwama, Toru; Kawamata, Takakazu; Kim, Phyo; Kinouchi, Hiroyuk, I; Kishima, Haruhiko; Kohmura, Eij, I; Kurisu, Kaoru; Maruyama, Keisuke; Matsumaru, Yuj, I; Mikuni, Nobuhiro; Miyamoto, Susumu; Morita, Akio; Nakase, Hiroyuk, I; Narita, Yoshitaka; Nishikawa, Ryo; Nozaki, Kazuhiko; Ogasawara, Kuniaki; Ohata, Kenji; Sakai, Nobuyuki; Sakamoto, Hiroaki; Shiokawa, Yoshiaki; Takahashi, Jun C.; Ueki, Keisuke; Wakabayashi, Toshihiko; Yoshimoto, Koji; Arai, Hajime; Tominaga, Teiji		Japan Neurosurgical Soc	The Japan Neurosurgical Database: Statistics Update 2018 and 2019	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						national database; neurosurgery; performance measure; quality of care; registry	BRAIN-TUMOR REGISTRY; DOUBLE-BLIND; BIG DATA; QUALITY; OUTCOMES; STROKE; MULTICENTER; ANEURYSMS; TRENDS	Each year, the Japan Neurosurgical Society (JNS) reports up-to-date statistics from the Japan Neurosurgical Database regarding case volume, patient demographics, and in-hospital outcomes of the overall cohort and neurosurgical subgroup according to the major classifications of main diagnosis. We hereby report patient demographics, in-hospital mortality, length of hospital stay, purpose of admission, number of medical management, direct surgery, endovascular treatment, and radiosurgery of the patients based on the major classifications and/or main diagnosis registered in 2018 and 2019 in the overall cohort (523283 and 571143 patients, respectively) and neurosurgical subgroup (177184 and 191595 patients, respectively). The patient demographics, disease severity, proportion of purpose of admission (e.g., operation, 33.9-33.5%) and emergent admission (68.4-67.8%), and in-hospital mortality (e.g., cerebrovascular diseases, 6.3-6.5%; brain tumor, 3.1-3%; and neurotrauma, 4.3%) in the overall cohort were comparable between 2018 and 2019. In total, 207783 and 225217 neurosurgical procedures were performed in the neurosurgical subgroup in 2018 and 2019, respectively, of which endovascular treatment comprised 19.1% and 20.3%, respectively. Neurosurgical management of chronic subdural hematoma (19.4-18.9%) and cerebral aneurysm (15.4-14.8%) was most common. Notably, the proportion of management of ischemic stroke/transient ischemic attack, including recombinant tissue plasminogen activator infusion and endovascular acute reperfusion therapy, increased from 7.5% in 2018 to 8.8% in 2019. The JNS statistical update represents a critical resource for the lay public, policy makers, media professionals, neurosurgeons, healthcare administrators, researchers, health advocates, and others seeking the best available data on neurosurgical practice.	[Iihara, Koji] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, 6-1 Kishibeshinmachi, Suita, Osaka 5648565, Japan; [Saito, Nobuhito] Univ Tokyo, Dept Neurosurg, Tokyo, Japan; [Suzuki, Michiyasu] Yamaguchi Univ, Dept Adv ThermoNeuroBiol, Grad Sch Med, Ube, Yamaguchi, Japan; [Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med, Okayama, Okayama, Japan; [Fujii, Yukihiko] Niigata Univ, Brain Res Inst, Dept Neurosurg, Niigata, Niigata, Japan; [Houkin, Kiyohiro] Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Sch Med, Fukuoka, Fukuoka, Japan; [Iwama, Toru] Gifu Univ, Dept Neurosurg, Sch Med, Gifu, Gifu, Japan; [Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Kim, Phyo] Utsunomiya Neurospine Ctr, Dept Neurol Surg, Utsunomiya, Tochigi, Japan; [Kinouchi, Hiroyuk, I] Univ Yamanashi, Dept Neurosurg, Interdisciplinary Grad Sch Med, Chuo, Yamanashi, Japan; [Kishima, Haruhiko] Osaka Univ, Dept Neurosurg, Grad Sch Med, Suita, Osaka, Japan; [Kohmura, Eij, I] Mutual Aid Assoc Publ Sch Teachers, Kinki Cent Hosp, Itami, Hyogo, Japan; [Kurisu, Kaoru] Chugoku Rosai Hosp, Dept Neurosurg, Kure, Hiroshima, Japan; [Maruyama, Keisuke] Kyorin Univ, Sch Med, Dept Neurosurg, Mitaka, Tokyo, Japan; [Matsumaru, Yuj, I] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Miyamoto, Susumu] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Kyoto, Japan; [Morita, Akio] Nippon Med Sch, Dept Neurol Surg, Tokyo, Japan; [Nakase, Hiroyuk, I] Nara Med Univ, Dept Neurosurg, Kashihara, Nara, Japan; [Narita, Yoshitaka] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo, Japan; [Nishikawa, Ryo] Saitama Med Univ, Dept Neurooncol Neurosurg, Int Med Ctr, Saitama, Japan; [Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga, Japan; [Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate, Japan; [Ohata, Kenji] Naniwa Ikuno Hosp, Osaka, Osaka, Japan; [Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Sakamoto, Hiroaki] Osaka City Gen Hosp, Dept Pediat Neurosurg, Osaka, Osaka, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Dept Neurosurg, Sch Med, Mitaka, Tokyo, Japan; [Takahashi, Jun C.] Kindai Univ, Dept Neurosurg, Fac Med, Osakasayama, Osaka, Japan; [Ueki, Keisuke] Dokkyo Med Univ, Dept Neurol Surg, Mibu, Tochigi, Japan; [Wakabayashi, Toshihiko] Nagoya Kyoritsu Hosp, Focused Ultrasound Therapy Ctr, Nagoya, Aichi, Japan; [Yoshimoto, Koji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurosurg, Kagoshima, Kagoshima, Japan; [Arai, Hajime] Juntendo Univ, Fac Med, Tokyo, Japan; [Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi, Japan		Iihara, K (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, 6-1 Kishibeshinmachi, Suita, Osaka 5648565, Japan.	kiihara@ncvc.go.jp			Practical Research Project for Life-Style related Diseases, Cardiovascular Diseases and Diabetes Mellitus [16hk0102037h0001, 17hk0102037h0002, 18hk0102037h0003]	Creation of the JND was supported by the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (16hk0102037h0001, 17hk0102037h0002, 18hk0102037h0003) . We also thank all the collaborators of the 1360 participating hospitals in the JND, Ms. Misa Takegami and Dr. Kunihiro Nishimura (National Cerebral and Cardio-vascular Center) for preparing the manuscript, and the secretarial assistance provided by Ms. Kei Watanabe of the JNS.	Anderson IA, 2019, J NEUROSURG, V130, P1491, DOI 10.3171/2017.12.JNS172759; Asher AL, 2014, SPINE, V39, pS106, DOI 10.1097/BRS.0000000000000579; Asher AL, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12311; Busl KM, 2019, JAMA NEUROL, V76, P612, DOI 10.1001/jamaneurol.2018.4407; Clark S, 2020, NEUROSURGERY, V87, pE313, DOI 10.1093/neuros/nyaa144; Feigin VL, 2021, JAMA NEUROL, V78, P165, DOI 10.1001/jamaneurol.2020.4152; Fiorella D, 2020, J NEUROINTERV SURG, V12, P869, DOI 10.1136/neurintsurg-2019-015535; Funakoshi Y, 2021, INT J CLIN ONCOL, V26, P1441, DOI 10.1007/s10147-021-01929-5; Hayakawa M, 2020, NEUROL MED-CHIR, V60, P191, DOI 10.2176/nmc.oa.2019-0267; Hiramatsu M, 2020, J NEUROSURG, V133, P166, DOI 10.3171/2019.4.JNS183458; Hosomi K, 2020, PAIN, V161, P351, DOI 10.1097/j.pain.0000000000001712; Hosomi K, 2013, PAIN, V154, P1065, DOI 10.1016/j.pain.2013.03.016; Iihara K, 2020, NEUROL MED-CHIR, V60, P165, DOI 10.2176/nmc.st.2019-0211; Iihara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096819; Ikawa F, 2020, J NEUROSURG, V134, P983, DOI 10.3171/2020.1.JNS192848; Kada A, 2019, INT J STROKE, DOI 10.1177/1747493019884526; Kawada Tomoyuki, 2016, Neurology, V86, P1650, DOI 10.1212/01.wnl.0000482984.98040.c0; Kuroda S, 2015, NEUROL MED-CHIR, V55, P194, DOI 10.2176/nmc.ra.2014-0305; McGirt MJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12297; Miyamoto S, 2014, STROKE, V45, P1415, DOI 10.1161/STROKEAHA.113.004386; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Narita Y, 2015, NEUROL MED-CHIR, V55, P286, DOI 10.2176/nmc.ra.2014-0348; Nishimura A, 2016, NEUROL MED-CHIR, V56, P655, DOI 10.2176/nmc.ra.2016-0174; Oi SZ, 2011, CHILD NERV SYST, V27, P1563, DOI 10.1007/s00381-011-1541-7; Oi S, 2009, J NEUROS-PEDIATR, V3, P412, DOI 10.3171/2009.1.PEDS08168; Oravec CS, 2018, NEUROSURGERY, V82, P728, DOI 10.1093/neuros/nyx328; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Oya S, 2021, NEUROL MED-CHIR, V61, P98, DOI 10.2176/nmc.oa.2020-0304; Parker SL, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15355; Pittman CA, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15382; Ramos RD, 2017, NEUROSURGERY, V81, P422, DOI 10.1093/neuros/nyx055; Ren N, 2021, CIRC J, V85, P201, DOI 10.1253/circj.CJ-20-0639; Reponen E, 2019, NEUROSURGERY, V85, P500, DOI 10.1093/neuros/nyy380; Sakai N, JAPANESE SURVEILLA 2, V59, P106; Schuhmann MU, 2001, J NEUROL NEUROSUR PS, V71, P182, DOI 10.1136/jnnp.71.2.182; Sedrakyan A, 2016, LANCET, V388, P1358, DOI 10.1016/S0140-6736(16)31402-7; Sherrod BA, 2016, J NEUROSURG-PEDIATR, V18, P350, DOI 10.3171/2016.2.PEDS15604; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Suehiro E, 2017, J NEUROTRAUM, V34, P2230, DOI 10.1089/neu.2016.4948; Takahashi JC, 2016, STROKE, V47, P37, DOI 10.1161/STROKEAHA.115.010819; Toi H, 2018, J NEUROSURG, V128, P222, DOI 10.3171/2016.9.JNS16623; Walicke P, 2017, NEUROSURGERY, V80, P505, DOI 10.1093/neuros/nyw133; Wilde HW, 2019, NEUROSURGERY, V85, pE485, DOI 10.1093/neuros/nyz020	43	0	0	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2021	61	12					675	710		10.2176/nmc.st.2021-0254			36	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XQ7GS	WOS:000731713400001	34732592	Green Published, gold			2022-02-06	
J	Ishii, R; Schwedt, TJ; Trivedi, M; Dumkrieger, G; Cortez, MM; Brennan, KC; Digre, K; Dodick, DW				Ishii, Ryotaro; Schwedt, Todd J.; Trivedi, Meesha; Dumkrieger, Gina; Cortez, Melissa M.; Brennan, K. C.; Digre, Kathleen; Dodick, David W.			Mild traumatic brain injury affects the features of migraine	JOURNAL OF HEADACHE AND PAIN			English	Article						Migraine; Mild traumatic brain injury (mTBI); Disability; Post-traumatic headache; Physical abuse; Psychiatric comorbidity; Depression; Anxiety; Chronic migraine; American registry for migraine research (ARMR)	POST-CONCUSSION SYMPTOMS; POSTTRAUMATIC HEADACHE; RISK-FACTORS; PAIN; PREVALENCE; PREDICTORS; ALLODYNIA; VALIDITY; VIOLENCE; ADULTS	Background Headache is one of the most common symptoms after concussion, and mild traumatic brain injury (mTBI) is a risk factor for chronic migraine (CM). However, there remains a paucity of data regarding the impact of mTBI on migraine-related symptoms and clinical course. Methods Of 2161 migraine patients who participated in the American Registry for Migraine Research between February 2016 and March 2020, 1098 completed questions assessing history of TBI (50.8%). Forty-four patients reported a history of moderate to severe TBI, 413 patients reported a history of mTBI. Patients' demographics, headache symptoms and triggers, history of physical abuse, allodynia symptoms (ASC-12), migraine disability (MIDAS), depression (PHQ-2), and anxiety (GAD-7) were compared between migraine groups with (n = 413) and without (n = 641) a history of mTBI. Either the chi-square-test or Fisher's exact test, as appropriate, was used for the analyses of categorical variables. The Mann-Whitney test was used for the analyses of continuous variables. Logistic regression models were used to compare variables of interest while adjusting for age, gender, and CM. Results A significantly higher proportion of patients with mTBI had CM (74.3% [307/413] vs. 65.8% [422/641], P = 0.004), had never been married or were divorced (36.6% [147/402] vs. 29.4% [187/636], P = 0.007), self-reported a history of physical abuse (24.3% [84/345] vs. 14.3% [70/491], P < 0.001), had mild to severe anxiety (50.5% [205/406] vs. 41.0% [258/630], P = 0.003), had headache-related vertigo (23.0% [95/413] vs. 15.9% [102/640], P = 0.009), and difficulty finding words (43.0% [174/405] vs. 32.9% [208/633], P < 0.001) in more than half their attacks, and headaches triggered by lack of sleep (39.4% [155/393] vs. 32.6% [198/607], P = 0.018) and reading (6.6% [26/393] vs. 3.0% [18/607], P = 0.016), compared to patients without mTBI. Patients with mTBI had significantly greater ASC-12 scores (median [interquartile range]; 5 [1-9] vs. 4 [1-7], P < 0.001), MIDAS scores (42 [18-85] vs. 34.5 [15-72], P = 0.034), and PHQ-2 scores (1 [0-2] vs. 1 [0-2], P = 0.012). Conclusion Patients with a history of mTBI are more likely to have a self-reported a history of physical abuse, vertigo, and allodynia during headache attacks, headaches triggered by lack of sleep and reading, greater headache burden and headache disability, and symptoms of anxiety and depression. This study suggests that a history of mTBI is associated with the phenotype, burden, clinical course, and associated comorbid diseases in patients with migraine, and highlights the importance of inquiring about a lifetime history of mTBI in patients being evaluated for migraine.	[Ishii, Ryotaro; Schwedt, Todd J.; Trivedi, Meesha; Dumkrieger, Gina; Dodick, David W.] Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA; [Ishii, Ryotaro] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Cortez, Melissa M.; Brennan, K. C.; Digre, Kathleen] Univ Utah, Dept Neurol, Salt Lake City, UT USA		Ishii, R (corresponding author), Mayo Clin Arizona, Dept Neurol, Phoenix, AZ 85054 USA.; Ishii, R (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	rishii@koto.kpu-m.ac.jp	Cortez, Melissa/AAC-3475-2021	Cortez, Melissa/0000-0001-5015-441X; Dumkrieger, Gina/0000-0001-9519-5370; ishii, ryotaro/0000-0002-6976-1081; Dodick, David/0000-0002-9486-6790; Trivedi, Meesha/0000-0002-0786-9417; Schwedt, Todd/0000-0002-7780-7086; Digre, Kathleen/0000-0003-2011-418X			Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashina S, 2012, J HEADACHE PAIN, V13, P615, DOI 10.1007/s10194-012-0479-9; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Baykan B, 2016, CLIN J PAIN, V32, P631, DOI 10.1097/AJP.0000000000000301; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Chan TLH, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-1080-2; Cole W. R., 2016, TRANSLATIONAL RES TR; Corrigan JD, 2018, INJURY PREV, V24, P396, DOI 10.1136/injuryprev-2017-042371; Cortez MM, 2021, CEPHALALGIA, V41, P1089, DOI 10.1177/03331024211010304; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Gil-Gouveia R, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0824-7; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Guglielmetti M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114024; Hanna JJ, 2020, CEPHALALGIA REP, V3, DOI [10.1177/2515816320942191, DOI 10.1177/2515816320942191]; Haque B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-82; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Labastida-Ramirez A, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01122-5; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Levy D, 2020, CEPHALALGIA, V40, P675, DOI 10.1177/0333102419896368; Lines CR, 2001, PAIN, V93, P185, DOI 10.1016/S0304-3959(01)00315-3; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lovati C, 2013, NEUROL SCI, V34, pS133, DOI 10.1007/s10072-013-1369-x; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Mares C, 2019, CAN J NEUROL SCI, V46, P14, DOI 10.1017/cjn.2018.361; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Metti A, 2020, NEUROLOGY, V94, pE1137, DOI 10.1212/WNL.0000000000008935; Minen MT, 2016, J NEUROL NEUROSUR PS, V87, P741, DOI 10.1136/jnnp-2015-312233; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Park SP, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0529-1; Pearl TA, 2020, HEADACHE, V60, P1910, DOI 10.1111/head.13911; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; Schwedt TJ, 2020, HEADACHE, V60, P337, DOI 10.1111/head.13688; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Spierings ELH, 2001, HEADACHE, V41, P554, DOI 10.1046/j.1526-4610.2001.041006554.x; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stewart WF, 2000, PAIN, V88, P41, DOI 10.1016/S0304-3959(00)00305-5; Swinson Richard P, 2006, Evid Based Med, V11, P184, DOI 10.1136/ebm.11.6.184; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Valera EM, 2021, J HEAD TRAUMA REHAB, V36, pE1, DOI 10.1097/HTR.0000000000000652; Varner C, 2021, CAN J EMERG MED, V23, P365, DOI 10.1007/s43678-020-00076-6; Viana M, 2018, CEPHALALGIA, V38, P2045, DOI 10.1177/0333102418761047; Vo P, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0907-6; Vuralli D, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0933-4; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	69	0	0	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2021	22	1							80	10.1186/s10194-021-01291-x			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU2AR	WOS:000680842500002	34294026	Green Published, gold			2022-02-06	
J	Jalayondeja, T; Urasyanandana, K				Jalayondeja, Tinapas; Urasyanandana, Karanarak			Correlations between optic nerve sheath diameters measured using computed tomography and elevated intracranial pressure levels	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Optic nerve sheath diameter; Intracranial pressure; Computed tomography		Background: Increased intracranial pressure (ICP) is commonly encountered in neurosurgery. Invasive external ventricular drainage is the gold standard ICP monitoring method. Higher ICPs enlarge the optic nerve sheath diameter (ONSD). Currently, few data describing correlations between ONSDs measured using computed tomography and ICPs. This manuscript describes a study that aimed to evaluate associations between the ICP and the ONSD measured using head CT, and to determine the ability of the ONSD to predict intracranial hypertension. Objectives: We aimed to study correlations between ONSDs and ICPs in patients who underwent ventricular shunting procedures, and to determine ONSD cutoff values that represent ICPs >15 mmHg and >20 mmHg, together with their sensitivities, specificities, negative predictive values (NPVs), and positive predictive values (PPVs). Methods: The patients' charts, operative notes, and brain computed tomography (CT) findings were reviewed retrospectively. The ONSDs were measured at 3 mm behind the globes on axial CT images from 102 patients who underwent ventricular shunting. Intraoperative ICP data were collected. Results: A total of 102 patients were enrolled, comprising 93 (91.2%) without and 9 (8.8%) with traumatic brain injuries. Their mean age was 56.95 years (SD 17.01 years). The most common diagnoses were spontaneous intracerebral hemorrhages (ICH) with or without hydrocephalus (30 [29.4%]) and aneurysmal subarachnoid hemorrhages (SAH) (19 [18.6%]). The mean preoperative ONSD was 4.875 mm (SD 0.96 mm). The ONSD correlated significantly with the ICP levels (p < 0.001). An ONSD cutoff value of 5.125 mm predicted an ICP >15 mmHg (sensitivity: 94.7%; specificity: 90.6%; PPV: 85.7%; NPV: 96.7%). An ONSD cutoff value of 5.35 mm corresponded with an ICP >20 mmHg (sensitivity: 94.7%; specificity: 84.3%; PPV: 58.1 %; NPV: 98.6%). The ONSD decreased significantly to within the normal range (4.17 mm [standard deviation (SD) 0.60 mm]; p < 0.001) at 27 days (SD 14.70 days) postoperatively. Conclusions: CT-determined ONSDs correlated strongly with invasive ICP measurements. An ONSD of 5.35 mm, which corresponded with an ICP >20 mmHg, could become a noninvasive, alternative indicator for ICP level.	[Jalayondeja, Tinapas; Urasyanandana, Karanarak] Phramongkutklao Hosp, Dept Surg, Neurosurg Unit, 315 Ratchawithi Rd, Bangkok 10400, Thailand		Urasyanandana, K (corresponding author), Phramongkutklao Hosp, Dept Surg, Neurosurg Unit, 315 Ratchawithi Rd, Bangkok 10400, Thailand.	virion3000@gmail.com					Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen LM, 2019, BRIT J OPHTHALMOL, V103, P437, DOI 10.1136/bjophthalmol-2018-312934; Gao YZ, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1202-5; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Haredy M, 2018, CHILD NERV SYST, V34, P939, DOI 10.1007/s00381-018-3728-7; Jenjitranant P, 2020, EUR J RADIOL, V125, DOI 10.1016/j.ejrad.2020.108875; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Lee HC, 2018, CLIN NEUROL NEUROSUR, V167, P31, DOI 10.1016/j.clineuro.2018.02.012; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Manouchehrifar M, 2018, AM J EMERG MED, V36, P2064, DOI 10.1016/j.ajem.2018.08.041; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Ussahgij W., 2020, Open Access Macedonian Journal of Medical Sciences, V8, P62, DOI 10.3889/oamjms.2020.3272; Wang JX, 2020, J NEUROSURG, V133, P514, DOI 10.3171/2019.4.JNS183297	18	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2021	26								101328	10.1016/j.inat.2021.101328			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WJ5UI	WOS:000709109700003		gold			2022-02-06	
J	Jansen, AE; McGrath, M; Samorezov, S; Johnston, J; Bartsch, A; Alberts, J				Jansen, A. Elizabeth; McGrath, Morgan; Samorezov, Sergey; Johnston, Joshua; Bartsch, Adam; Alberts, Jay			Characterizing Head Impact Exposure in Men and Women During Boxing and Mixed Martial Arts	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head impact; head impact power; peak linear acceleration; peak angular acceleration; boxing; mixed martial arts	INSTRUMENTED MOUTHGUARD; FOOTBALL; CONCUSSION; PLAYERS; SYSTEM; VALIDATION; KINEMATICS; FREQUENCY; MODEL	Background: The accumulation of subconcussive impacts has been implicated in permanent neurological impairment. A gap in understanding the relationship between head impacts and neurological function is the lack of precise characterization and quantification of forces that individuals experience during sports training and competition. Purpose: To characterize impact exposure during training and competition among male and female athletes participating in boxing and mixed martial arts (MMA) via an instrumented custom-fit Impact Monitoring Mouthguard (IMM). Study Design: Cross-sectional study; Level of evidence, 3. Methods: Twenty-three athletes (n = 4 women) were provided a custom-fit IMM. The IMM monitored impacts during sparring and competition. All training and competition sessions were videotaped. Video and IMM data were synchronized for post hoc data verification of true positives and substantiation of impact location. IMM data were collected from boxing and MMA athletes at a collaborating site. For each true-positive impact, peak linear acceleration and peak angular acceleration were calculated. Wilcoxon rank sum tests were used to evaluate potential differences in sport, activity type, and sex with respect to each outcome. Differences in impact location were assessed via Kruskal-Wallis tests. Results: IMM data were collected from 53 amateur training sessions and 6 competitions (session range, 5-20 minutes). A total of 896 head impacts (men, n = 786; women, n = 110) were identified using IMM data and video verification: 827 in practice and 69 during competition. MMA and boxers experienced a comparable number of impacts per practice session or competition. In general, MMA impacts produced significantly higher peak angular acceleration than did boxing impacts (P < .001) and were more varied in impact location on the head during competitions. In terms of sex, men experienced a greater number of impacts than women per practice session. However, there was no significant difference between men and women in terms of impact magnitude. Conclusion: Characteristic profiles of head impact exposure differed between boxing and MMA athletes; however, the impact magnitudes were not significantly different for male and female athletes.	[Jansen, A. Elizabeth; McGrath, Morgan; Samorezov, Sergey; Johnston, Joshua; Bartsch, Adam; Alberts, Jay] Cleveland Clin, Cleveland, OH 44195 USA; [Jansen, A. Elizabeth; McGrath, Morgan; Samorezov, Sergey; Johnston, Joshua; Alberts, Jay] Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave,C51, Cleveland, OH 44195 USA; [Alberts, Jay] Cleveland Clin, Neurol Inst, 9500 Euclid Ave,C51, Cleveland, OH 44195 USA; [Bartsch, Adam] Prevent Biometr, Edina, MN USA		Alberts, J (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave,C51, Cleveland, OH 44195 USA.; Alberts, J (corresponding author), Cleveland Clin, Neurol Inst, 9500 Euclid Ave,C51, Cleveland, OH 44195 USA.	albertj@ccf.org			Federal Aviation Administration [13-P-022]; US Department of Defense (DoD)United States Department of Defense [W81XWH-17-1-0019]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R43NS076102-01A1, R41HD079158-01A1, 2R44NS076102-02A1]; Cleveland Clinic	Funding for this study was received by A.B. from the Federal Aviation Administration (grant 13-P-022). S.S. owns stock in Prevent Biometrics and is an investor of the technology, owned by Cleveland Clinic and licensed by Prevent Biometrics. A.B. received grants from the US Department of Defense (DoD Cooperative Agreement W81XWH-17-1-0019) and the National Institutes of Health (NIH 1R43NS076102-01A1, NIH R41HD079158-01A1, NIH 2R44NS076102-02A1) during the conduct of the study in addition to personal fees from Prevent Biometrics and other support from Cleveland Clinic. In addition, A.B. has patents with royalties paid to Prevent Biometrics (US 9149227 B2, US 9289176 B2, US 9044198 B2, and US 9585619 B2) and patents pending (14/726,853, 15/432,107, 62/760,117, 62/760,512, and 19308-X-8US-P1). AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bartsch AJ, 2019, IEEE ENG MED BIO, P2068, DOI 10.1109/EMBC.2019.8856907; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Boutte AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221036; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Champagne AA, 2020, J CEREBR BLOOD F MET, V40, P1453, DOI 10.1177/0271678X19862861; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hedin DS, 2016, IEEE ENG MED BIO, P2007, DOI 10.1109/EMBC.2016.7591119; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Leeds DD, 2019, MIL MED, V184, P206, DOI 10.1093/milmed/usy415; Lightman K, 2016, IEEE SPECTRUM, V53, P48, DOI 10.1109/MSPEC.2016.7420400; Major BP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549624; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Paris AJ, 2010, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, 2010, P815; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	0	0	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2021	9	12							23259671211059815	10.1177/23259671211059815			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	XN4TR	WOS:000729499800001	34901294	Green Published			2022-02-06	
J	Jelinek, M; Jurajda, M; Duris, K				Jelinek, Matyas; Jurajda, Michal; Duris, Kamil			Oxidative Stress in the Brain: Basic Concepts and Treatment Strategies in Stroke	ANTIOXIDANTS			English	Article						oxidative stress; free radicals; ROS; RNS; brain; stroke; antioxidants; scavengers	FOCAL CEREBRAL-ISCHEMIA; MITOCHONDRIAL CYTOCHROME-C; VITAMIN-E; REPERFUSION INJURY; NADPH OXIDASE; FREE-RADICALS; NITRIC-OXIDE; RAT MODEL; ANTIOXIDANTS; INFARCTION	The production of free radicals is inevitably associated with metabolism and other enzymatic processes. Under physiological conditions, however, free radicals are effectively eliminated by numerous antioxidant mechanisms. Oxidative stress occurs due to an imbalance between the production and elimination of free radicals under pathological conditions. Oxidative stress is also associated with ageing. The brain is prone to oxidative damage because of its high metabolic activity and high vulnerability to ischemic damage. Oxidative stress, thus, plays a major role in the pathophysiology of both acute and chronic pathologies in the brain, such as stroke, traumatic brain injury or neurodegenerative diseases. The goal of this article is to summarize the basic concepts of oxidative stress and its significance in brain pathologies, as well as to discuss treatment strategies for dealing with oxidative stress in stroke.	[Jelinek, Matyas; Jurajda, Michal; Duris, Kamil] Masaryk Univ, Fac Med, Dept Pathophysiol, Brno 62500, Czech Republic; [Jelinek, Matyas] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno 62500, Czech Republic; [Duris, Kamil] Masaryk Univ, Univ Hosp Brno, Dept Neurosurg, Brno 62500, Czech Republic; [Duris, Kamil] Masaryk Univ, Fac Med, Brno 62500, Czech Republic		Duris, K (corresponding author), Masaryk Univ, Fac Med, Dept Pathophysiol, Brno 62500, Czech Republic.; Duris, K (corresponding author), Masaryk Univ, Univ Hosp Brno, Dept Neurosurg, Brno 62500, Czech Republic.; Duris, K (corresponding author), Masaryk Univ, Fac Med, Brno 62500, Czech Republic.	jelinek.matyas@mail.muni.cz; mjuraj@med.muni.cz; kduris@med.muni.cz					Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Alper BS, 2020, BMJ EVID-BASED MED, V25, P168, DOI 10.1136/bmjebm-2020-111386; Annapurna A, 2013, EUR REV MED PHARMACO, V17, P491; Aronowski J, 1996, NEUROPHARMACOLOGY, V35, P689, DOI 10.1016/S0028-3908(96)00046-9; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Baranoski JF, 2019, NEUROSURGERY, V85, pE174, DOI 10.1093/neuros/nyz031; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bjorklund G, 2017, NUTRITION, V33, P311, DOI 10.1016/j.nut.2016.07.018; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boshuizen MCS, 2018, STROKE, V49, P1563, DOI 10.1161/STROKEAHA.117.020465; Casas AI, 2019, J CLIN INVEST, V129, P1772, DOI 10.1172/JCI124283; Casas AI, 2017, P NATL ACAD SCI USA, V114, P12315, DOI 10.1073/pnas.1705034114; Chen S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00433; Cheng PF, 2018, BRIT J NUTR, V120, P1181, DOI 10.1017/S0007114518002647; Choi W, 2019, BIOORG CHEM, V86, P686, DOI 10.1016/j.bioorg.2019.02.049; Diener HC, 1998, CEREBROVASC DIS, V8, P172, DOI 10.1159/000015847; Dringen R, 2000, EUR J BIOCHEM, V267, P4903, DOI 10.1046/j.1432-1327.2000.01651.x; Duan JN, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/6631805; Duan XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1203285; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Fock EM, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13020144; Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]; Fujimura M, 2000, J NEUROSCI, V20, P2817; Genovese T, 2011, BRAIN RES, V1372, P92, DOI 10.1016/j.brainres.2010.11.088; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; He JL, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.641157; Herb M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar5926; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hishiki T, 2012, J MOL MED, V90, P245, DOI 10.1007/s00109-012-0875-2; Hou YY, 2018, GENES DIS, V5, P245, DOI 10.1016/j.gendis.2018.06.001; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Jelinek M, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8877116; Jeong HG, 2018, STROKE, V49, P3030, DOI 10.1161/STROKEAHA.118.022631; Kagan VE, 1998, ANN NY ACAD SCI, V854, P425, DOI 10.1111/j.1749-6632.1998.tb09921.x; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Kirkland RA, 2002, J NEUROSCI, V22, P6480; Klaunig JE, 2018, CURR PHARM DESIGN, V24, P4771, DOI 10.2174/1381612825666190215121712; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821; Lauridsen C, 2019, POULTRY SCI, V98, P4240, DOI 10.3382/ps/pey407; Lei JR, 2019, EXP THER MED, V17, P3215, DOI 10.3892/etm.2019.7324; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Loh HC, 2021, STROKE VASC NEUROL, V6, P109, DOI 10.1136/svn-2020-000519; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Lu HJ, 2015, CELL MOL NEUROBIOL, V35, P921, DOI 10.1007/s10571-015-0187-5; Luo JR, 2020, J CELL MOL MED, V24, P1760, DOI 10.1111/jcmm.14870; Lushchak VI, 2014, CHEM-BIOL INTERACT, V224, P164, DOI 10.1016/j.cbi.2014.10.016; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Margaritelis NV, 2018, ADV NUTR, V9, P813, DOI 10.1093/advances/nmy052; MARTZ D, 1989, STROKE, V20, P488, DOI 10.1161/01.STR.20.4.488; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mishima K, 2003, NEUROSCI LETT, V337, P56, DOI 10.1016/S0304-3940(02)01293-4; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Morelli MB, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121227; Murphy MP, 2014, FREE RADICAL BIO MED, V66, P20, DOI 10.1016/j.freeradbiomed.2013.04.010; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; O'Collins VE, 2012, J CEREBR BLOOD F MET, V32, P585, DOI 10.1038/jcbfm.2011.203; Ord ENJ, 2013, J CEREBR BLOOD F MET, V33, P1215, DOI 10.1038/jcbfm.2013.70; Orellana-Urzua S, 2021, CNS NEUROL DISORD-DR, V20, P3, DOI 10.2174/1871527319666200910153431; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Ozkul A, 2007, J CLIN NEUROSCI, V14, P1062, DOI 10.1016/j.jocn.2006.11.008; Palacio C., 2016, OXIDATIVE STRESS ANT, P493; Picon-Pages P, 2019, BBA-MOL BASIS DIS, V1865, P1949, DOI 10.1016/j.bbadis.2018.11.007; Pravalika K, 2019, LIFE SCI, V216, P49, DOI 10.1016/j.lfs.2018.11.014; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Ritz MF, 2008, BRAIN RES, V1239, P226, DOI 10.1016/j.brainres.2008.08.073; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Saeed SA, 2007, EXP BRAIN RES, V182, P1, DOI 10.1007/s00221-007-1050-9; Salatin S, 2015, CELL BIOL INT, V39, P881, DOI 10.1002/cbin.10459; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schluter T, 2008, CARDIOVASC RES, V80, P271, DOI 10.1093/cvr/cvn185; Sena E, 2007, STROKE, V38, P388, DOI 10.1161/01.STR.0000254462.75851.22; Shirley R, 2014, ANTIOXIDANTS-BASEL, V3, P472, DOI 10.3390/antiox3030472; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Song GN, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8857486; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Tadokoro K, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104743; Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411; Touyz RM, 2008, HYPERTENSION, V51, P172, DOI 10.1161/HYPERTENSIONAHA.107.103200; Tsutsumi Z, 2004, CLIN CHIM ACTA, V339, P117, DOI 10.1016/j.cccn.2003.09.019; Tu XK, 2014, INFLAMMATION, V37, P1544, DOI 10.1007/s10753-014-9881-6; Vergeade A, 2012, J CARDIOVASC PHARM, V60, P538, DOI 10.1097/FJC.0b013e318271223c; Dao VTV, 2020, FREE RADICAL BIO MED, V148, P60, DOI 10.1016/j.freeradbiomed.2019.12.038; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; WILLIAMS AJK, 1987, GUT, V28, P1157, DOI 10.1136/gut.28.9.1157; Xie YK, 2019, NEURAL REGEN RES, V14, P1734, DOI 10.4103/1673-5374.257529; Yang QW, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01036; Yang XY, 2007, AM J CHINESE MED, V35, P477, DOI 10.1142/S0192415X07004990; Zhang TT, 2014, NEUROSCI LETT, V579, P12, DOI 10.1016/j.neulet.2014.07.005; Zhang ZJ, 2012, BRAIN RES BULL, V87, P193, DOI 10.1016/j.brainresbull.2011.11.002; Zhou X, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0371-6	95	0	0	10	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	DEC	2021	10	12							1886	10.3390/antiox10121886			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	XW8CV	WOS:000735841100001	34942989	Green Published			2022-02-06	
J	Jensen, AR; Evans, LL; Meert, KL; VanBuren, JM; Richards, R; Alvey, JS; Holubkov, R; Pollack, MM; Burd, RS				Jensen, Aaron R.; Evans, Lauren L.; Meert, Kathleen L.; VanBuren, John M.; Richards, Rachel; Alvey, Jessica S.; Holubkov, Richard; Pollack, Murray M.; Burd, Randall S.		Eunice Kennedy Shriver Natl Inst C; Collaborative Pediat Critical Care; Assessment Hlth-Related Quality Li	Functional status impairment at six-month follow-up is independently associated with child physical abuse mechanism	CHILD ABUSE & NEGLECT			English	Article						Pediatrics; Injuries and wounds; Child abuse; Physical abuse; Outcomes assessment	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NONACCIDENTAL TRAUMA; STATUS SCALE; COGNITIVE SEQUELAE; MORTALITY; MORBIDITY; OUTCOMES; VICTIMS; INFANTS	Background: Children with abusive injuries have worse mortality, length-of-stay, complications, and healthcare costs compared to those sustaining an accidental injury. Long-term functional impairment is common in children with abusive head trauma but has not been examined in a cohort with heterogeneous body region injuries. Objective: To assess for an independent association between child physical abuse and functional impairment at discharge and six-month follow-up. Participants and setting: Seriously injured children (<15 years) treated at seven pediatric trauma centers. Methods: Functional status was compared between child physical abuse and accidental injury groups at discharge and six-month follow-up. Functional impairment was defined at discharge ("new domain morbidity") as a change from pre-injury >= 2 points in any of the six domains of the Functional Status Scale (FSS), and impairment at six-month follow-up as an abnormal total FSS score.	[Jensen, Aaron R.; Evans, Lauren L.] Univ Calif San Francisco, Div Pediat Surg, UCSF Benioff Childrens Hosp, San Francisco, CA 94611 USA; [Jensen, Aaron R.; Evans, Lauren L.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94611 USA; [Meert, Kathleen L.] Cent Michigan Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI 48201 USA; [VanBuren, John M.; Richards, Rachel; Alvey, Jessica S.; Holubkov, Richard] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84108 USA; [Pollack, Murray M.] George Washington Univ, Dept Pediat, Childrens Natl Hlth Syst, Sch Med & Hlth Sci, Washington, DC 20010 USA; [Burd, Randall S.] Childrens Natl Med Ctr, Div Trauma & Burn Surg, Washington, DC 20010 USA		Jensen, AR (corresponding author), UCSF Benioff Childrens Hosp Oakland, Pediat Gen Surg, 744 52nd St,4th Floor OPC, Oakland, CA 94609 USA.	Aaron.Jensen@UCSF.edu; Lauren.Evans@UCSF.edu; kmeert@dmc.org; john.vanburen@hsc.utah.edu; rachel.richards@hsc.utah.edu; jessica.alvey@hsc.utah.edu; richard.holubkov@hsc.utah.edu; MPollack@childrensnational.org; rburd@childrensnational.org			Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN); National Institutes of Health, Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HD049934, UG1HD050096, UG1HD083166, UG1HD049981, UG1HD083171, UG1HD083170, UG1HD063108, U10HD049983]	This work was supported by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN), National Institutes of Health, Department of Health and Human Services: U01HD049934, UG1HD050096, UG1HD083166, UG1HD049981, UG1HD083171, UG1HD083170, UG1HD063108, and U10HD049983.	Ahmed OZ, 2019, J TRAUMA ACUTE CARE, V86, P810, DOI 10.1097/TA.0000000000002120; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bonafide CP, 2013, PEDIATRICS, V131, pE1150, DOI 10.1542/peds.2012-2443; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Brown JB, 2018, J TRAUMA ACUTE CARE, V85, P668, DOI 10.1097/TA.0000000000001841; Burd R. S. J. A., 2021, J AM COLL SURGEONS; Burd RS, 2021, JAMA SURG, V156, DOI 10.1001/jamasurg.2021.2058; de Roulet A, 2019, J PEDIATR SURG, V54, P1405, DOI 10.1016/j.jpedsurg.2018.07.005; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P161, DOI 10.1097/TA.0b013e3182984831; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; DESWIET M, 1980, PEDIATRICS, V65, P1028; Durand MB, 2019, J TRAUMA NURS, V26, P239, DOI 10.1097/JTN.0000000000000461; Eismann EA, 2020, CHILD ABUSE NEGLECT, V108, DOI 10.1016/j.chiabu.2020.104643; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Heerman WJ, 2014, AM J PREV MED, V46, P449, DOI 10.1016/j.amepre.2014.01.005; Jones RE, 2019, PEDIATR SURG INT, V35, P869, DOI 10.1007/s00383-019-04491-4; Kim PT, 2017, J PEDIATR SURG, V52, P1827, DOI 10.1016/j.jpedsurg.2017.02.014; Livingston JK, 2019, PEDIATR SURG INT, V35, P779, DOI 10.1007/s00383-019-04482-5; Millar MM, 2021, TIMING INCENTI UNPUB; Nair AB, 2020, PEDIATR CRIT CARE ME, V21, P122, DOI 10.1097/PCC.0000000000002175; Nuno M, 2018, CHILD ABUSE NEGLECT, V85, P39, DOI 10.1016/j.chiabu.2018.08.011; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Oh DL, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1037-7; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Pontarelli EM, 2014, PEDIATR EMERG CARE, V30, P677, DOI 10.1097/PEC.0000000000000226; Puls HT., HOSP PEDIAT, DOI [10.1542/hpeds.2017-0109, DOI 10.1542/HPEDS.2017-0109]; Rabbia F, 2002, J HUM HYPERTENS, V16, P327, DOI 10.1038/sj.jhh.1001398; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Rosenfeld EH, 2020, J PEDIATR SURG, V55, P693, DOI 10.1016/j.jpedsurg.2019.03.024; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Shahi N, 2020, J PEDIATR SURG, V55, P335, DOI 10.1016/j.jpedsurg.2019.10.024; Stipanicic A, 2008, CHILD ABUSE NEGLECT, V32, P415, DOI 10.1016/j.chiabu.2007.07.008; Talvik I, 2007, ACTA PAEDIATR, V96, P1164, DOI 10.1111/j.1651-2227.2007.00362.x; Vadivelu S, 2015, WORLD NEUROSURG, V84, P1340, DOI 10.1016/j.wneu.2015.06.023; van Baar ME, 2011, BURNS, V37, P930, DOI 10.1016/j.burns.2011.05.004; Wilcox ME, 2019, CURR OPIN CRIT CARE, V25, P473, DOI 10.1097/MCC.0000000000000650; Zagory JA, 2018, J COMMUN HEALTH, V43, P986, DOI 10.1007/s10900-018-0515-z	44	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	DEC	2021	122								105333	10.1016/j.chiabu.2021.105333			9	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	WH5KG	WOS:000707715800030	34583299				2022-02-06	
J	Joubran, K; Bar-Haim, S; Shmuelof, L				Joubran, Katherin; Bar-Haim, Simona; Shmuelof, Lior			Dynamic balance recovery in chronic acquired brain injury participants following a perturbation training	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; chronic; falls; gait; rehabilitation; stroke	MONTREAL COGNITIVE ASSESSMENT; COMMUNITY-DWELLING PERSONS; MOBILITY SCALE; TASK-PERFORMANCE; CHRONIC STROKE; GLOBAL BURDEN; WALK TEST; INDIVIDUALS; FALLS; GAIT	Acquired brain injury (ABI) is defined as a damage to the brain that occurs after birth. Subjects post-ABI frequently suffer from dynamic balance impairments that persist years after the injury. This study aimed to investigate the effect of a perturbation method using mechatronic shoes that introduce unexpected balance perturbations on the recovery of dynamic balance and gait velocity in chronic ABI participants. In an intervention trial, 35 chronic ABI participants (stroke and traumatic brain injury) participated in 22 sessions of perturbation training, twice a week for 3 months. Dynamic balance was assessed pre- and post-training using Community Balance and Mobility Scale (CB&M). Gait velocity was also assessed in the stroke participants using the 10 Meter Walking Test (10MWT). Dynamic balance improved significantly post-training (P = 0.001). This improvement was greater than the improvement that was observed in a sub-group that was tested twice before training (P = 0.04). Sixteen participants (45.7%) out of 35 met or exceeded minimal detectable change (MDC) of the CB&M Scale. Self-paced velocity also improved significantly (P = 0.02) but only two participants (9.5%) out of 21 exceeded the MDC of 10MWT post-stroke. Our results suggest that unexpected balance perturbation training using mechatronic shoes leads to an improvement in dynamic balance and gait velocity in chronic ABI participants. The advantage of perturbation training using mechatronic shoes with respect to conventional balance training should be further examined.	[Joubran, Katherin; Shmuelof, Lior] Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Beer Sheva, Israel; [Joubran, Katherin; Shmuelof, Lior] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Bar-Haim, Simona] Ben Gurion Univ Negev, Recanati Sch Community Hlth Profess, Dept Phys Therapy, Beer Sheva, Israel		Joubran, K (corresponding author), POB 2819, IL-16503 Nazareth, Israel.	catrinju@gmail.com			Israel Science FoundationIsrael Science Foundation [607/16]	The Israel Insurance Association (R.A.), Association of Life Insurance Companies of Israel LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Israel Science Foundation grant 607/16 for L.S.	Bar-Haim S, 2013, DISABIL REHABIL-ASSI, V8, P417, DOI 10.3109/17483107.2012.754954; Bowden MG, 2008, NEUROREHAB NEURAL RE, V22, P672, DOI 10.1177/1545968308318837; Cassidy JM, 2017, TRANSL STROKE RES, V8, P33, DOI 10.1007/s12975-016-0467-5; Collen F M, 1990, Int Disabil Stud, V12, P6; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donkor ES, 2018, STROKE RES TREAT, V2018, DOI 10.1155/2018/3238165; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Gorelick PB, 2019, LANCET NEUROL, V18, P417, DOI 10.1016/S1474-4422(19)30030-4; Handelzalts S, 2019, NEUROREHAB NEURAL RE, V33, P213, DOI 10.1177/1545968319829453; Hayden ME, 2013, PM&R, V5, P319, DOI 10.1016/j.pmrj.2012.12.005; Hiengkaew V, 2012, ARCH PHYS MED REHAB, V93, P1201, DOI 10.1016/j.apmr.2012.01.014; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Hyndman D, 2006, DISABIL REHABIL, V28, P849, DOI 10.1080/09638280500534994; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Katan M, 2018, SEMIN NEUROL, V38, P208, DOI 10.1055/s-0038-1649503; Klima D, 2019, PERCEPT MOTOR SKILL, V126, P50, DOI 10.1177/0031512518809203; Knorr S, 2010, ARCH PHYS MED REHAB, V91, P890, DOI 10.1016/j.apmr.2010.02.010; Lewek MD, 2011, J NEUROL PHYS THER, V35, P116, DOI 10.1097/NPT.0b013e318227fe70; Llorens R, 2018, BRAIN INJURY, V32, P303, DOI 10.1080/02699052.2017.1418905; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Miller KJ, 2016, PHYS THER, V96, P1648, DOI 10.2522/ptj.20150423; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Peterson Michelle, 2015, Arch Phys Med Rehabil, V96, P379, DOI 10.1016/j.apmr.2013.06.012; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Scrivener K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-129; Tally Z, 2017, TOP STROKE REHABIL, V24, P539, DOI 10.1080/10749357.2017.1345445; Tefertiller C, 2019, ARCH PHYS MED REHAB, V100, P1409, DOI 10.1016/j.apmr.2019.03.015; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; van Swigchem R, 2013, NEUROREHAB NEURAL RE, V27, P230, DOI 10.1177/1545968312462070; Yates JS, 2002, J REHABIL RES DEV, V39, P385	36	0	0	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2021	44	4					350	357		10.1097/MRR.0000000000000485			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WR7OY	WOS:000714686900009	34739006	Green Submitted			2022-02-06	
J	Jung, H; Jeong, JG; Cheong, YS; Nam, TW; Kim, JH; Park, CH; Park, E; Jung, TD				Jung, Hyunwoo; Jeong, Jae-Gyeong; Cheong, Youn-Soo; Nam, Tae-Woo; Kim, Ju-Hyun; Park, Chan-Hee; Park, Eunhee; Jung, Tae-Du			The Effectiveness of Computer-Assisted Cognitive Rehabilitation and the Degree of Recovery in Patients with Traumatic Brain Injury and Stroke	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; stroke; computer-assisted cognitive rehabilitation; computerized neuropsychological test	ALZHEIMERS-DISEASE; HEAD-INJURY; IMPAIRMENT; PROTEIN; ADULTS; BETA; CARE	Objectives: To determine the effectiveness of computer-assisted cognitive rehabilitation and compare the patterns of cognitive function recovery occurring in both traumatic brain injury (TBI) and stroke. Methods: A total of 62 patients were finally enrolled, consisting of 30 with TBI and 32 with stroke. The patients received 30 sessions of computer-assisted cognitive rehabilitation (Comcog) five times per week. Each session lasted for 30 min. Before and immediately after cognitive rehabilitation, all patients were evaluated by computerized neuropsychological test (CNT), Mini-Mental State Examination (MMSE), and modified Barthel index (MBI). Results: We analyzed the differences between pre- and post-cognitive rehabilitation in each TBI and stroke group. Significant differences were observed in MMSE, MBI, and some CNT contents, including digit span forward, verbal learning, verbal learning delayed recall, visual span forward, visual span backward, visual learning, trail making test A and B, and intelligence quotient (IQ) in the TBI group (p < 0.05). In the stroke group, in addition to significant differences that appeared in the TBI group, additional significant differences in the digit span backward, visual learning delayed recall, auditory continuous performance test (CPT), visual CPT, and card sorting test. We compared the difference values at pre- and post-cognitive rehabilitation for cognitive recovery between the TBI and stroke groups. All contents, except the digital span forward, visual learning, word-color test, and MMSE, had greater mean values in the stroke group; and thus, statistically significant higher values were observed in the visual span forward and card sorting test (p < 0.05). Conclusion: Most evaluation results showed improvement and the evaluation between the TBI and stroke groups also showed significant differences in cognitive functions in addition to more CNT contents, which significantly change in the stroke group. The stroke group showed a high difference value in most CNT contents. Therefore, those with stroke in the focal brain region tend to have better cognitive function recovery after a computer-assisted cognitive rehabilitation than those with TBI, which could cause diffuse brain damage and post-injury inflammation.	[Jung, Hyunwoo; Jeong, Jae-Gyeong; Cheong, Youn-Soo; Nam, Tae-Woo; Kim, Ju-Hyun; Park, Chan-Hee] Kyungpook Natl Univ Hosp, Dept Rehabil Med, Daegu 41944, South Korea; [Park, Eunhee; Jung, Tae-Du] Kyungpook Natl Univ Chilgok Hosp, Dept Rehabil Med, Daegu 41404, South Korea; [Park, Eunhee; Jung, Tae-Du] Kyungpook Natl Univ, Sch Med, Dept Rehabil Med, Daegu 41944, South Korea		Park, E; Jung, TD (corresponding author), Kyungpook Natl Univ Chilgok Hosp, Dept Rehabil Med, Daegu 41404, South Korea.; Park, E; Jung, TD (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Rehabil Med, Daegu 41944, South Korea.	hwjung_87@naver.com; cloud90524@naver.com; yscheong@gmail.com; n0530@daum.ne; kjoohyun88@gmail.com; chany9090@gmail.com; ehmdpark@naver.com; teeed0522@hanmail.net		Jung, Tae-du/0000-0002-1636-8665; Jeong, Jae-Gyeong/0000-0001-7552-8174; Park, Eunhee/0000-0001-6553-2321			Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Barker-Collo S, 2006, NEUROPSYCHOL REV, V16, P53, DOI 10.1007/s11065-006-9007-5; BASSO A, 1990, CORTEX, V26, P501, DOI 10.1016/S0010-9452(13)80300-0; Boake C., 1991, COGNITIVE REHABILITA, P3; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Bracy O.L., 1983, COGN REHABIL, V1, P7; Castor N, 2018, BRAIN INJURY, V32, P1803, DOI 10.1080/02699052.2018.1508748; CAVANAUGH JC, 1985, HUM DEV, V28, P146, DOI 10.1159/000272958; Chen SHA, 1997, BRAIN INJURY, V11, P197; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; Gontkovsky ST, 2002, NEUROREHABILITATION, V17, P195; Halligan P.W., 2005, EFFECTIVENESS REHABI; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim Y.H., 2001, J KOREAN ACAD REHABI, V25, P209; Kim Y.H., 2003, J KOREAN ACAD REHABI, V27, P830; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Li K, 2013, OCCUP THER HEALTH CA, V27, P333, DOI 10.3109/07380577.2013.844877; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; Michel J A, 2006, Eura Medicophys, V42, P59; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Sansonetti D, 2013, AUST OCCUP THER J, V60, P334, DOI 10.1111/1440-1630.12069; Sigmundsdottir L, 2016, NEUROPSYCHOL REHABIL, V26, P673, DOI 10.1080/09602011.2016.1140657; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Taylor GH, 2013, TOP STROKE REHABIL, V20, P270, DOI 10.1310/tsr2003-270; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Wood R.L., 2018, COGNITIVE REHABILITA, V12; Ye MM, 2020, NEUROPSYCHOL REHABIL, DOI 10.1080/09602011.2020.1831555; Yoo C, 2015, J PHYS THER SCI, V27, P2487, DOI 10.1589/jpts.27.2487; Yu KH, 2013, STROKE, V44, P786, DOI 10.1161/STROKEAHA.112.668343; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007; 김연희, 2003, Annals of Rehabilitation Medicine, V27, P667	42	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	DEC	2021	10	24							5728	10.3390/jcm10245728			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YF9QZ	WOS:000742135400001	34945019	Green Published			2022-02-06	
J	Kahanov, L; Hadelsberg, UP; Kaye, A; Spektor, S; Valero, F; Cohen, J; Moscovici, S				Kahanov, Lea; Hadelsberg, Uri P.; Kaye, Andrew; Spektor, Sergey; Valero, Fidel; Cohen, Jose; Moscovici, Samuel			False lateralazing sign in skull base tumor a case series of five patients	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						False laterlazing sign; Skull base; Trigeminal neuralgia; Hemifacial spasm; Ipsilateral hemiparesis	LOCALIZING SIGNS; TRIGEMINAL NEURALGIA; HEMIFACIAL SPASM; COMPRESSION; MASS	Paradoxical neurological signs constitute a very important clinical entity for physicians to be aware of and they are of paramount importance to bear in mind in-order to avoid confusion when diagnosing lesions based on anatomic localization. Although false lateralizing syndromes have been widely described in the areas of traumatic brain injury and intracranial vascular-hemorrhagic lesions, this sort of manifestation has been overlooked in the instance of skull base neoplasms. Despite modern neuroimaging, knowledge of these disorders is essential, for correct clinical diagnosis. The authors hereby present five such cases of patients harboring cranial-based tumors whose impaired functions are appropriately categorized as a false localizing sign. All patients showed improvement of symptoms after surgical intervention. The purpose of this article is to describe the causality of this phenomenon, and to increase awareness to the entity of false lateralizing signs when clinically approaching a patient with a skull base tumor.	[Kahanov, Lea; Hadelsberg, Uri P.; Kaye, Andrew; Spektor, Sergey; Valero, Fidel; Cohen, Jose; Moscovici, Samuel] Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel		Hadelsberg, UP (corresponding author), Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel.	urih85@gmail.com					Campos-Benitez M, 2008, J NEUROSURG, V109, P416, DOI 10.3171/JNS/2008/109/9/0416; Carrasco R, 2009, J CLIN NEUROSCI, V16, P1628, DOI 10.1016/j.jocn.2009.02.015; da Silva Carlos Eduardo, 2015, Surg Neurol Int, V6, P113, DOI 10.4103/2152-7806.159489; GELMERS HJ, 1982, ACTA NEUROCHIR, V60, P81, DOI 10.1007/BF01401753; Groeneveld G., 1927, DTSCH Z NERVENHEILKD, V97, P32; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Liu MX, 2016, NEUROSURG REV, V39, P411, DOI 10.1007/s10143-016-0702-2; Matsuura N, 1996, J NEUROSURG, V84, P1067, DOI 10.3171/jns.1996.84.6.1067; McKenna C, 2009, BRAIN INJURY, V23, P597, DOI 10.1080/02699050902973921; MICHELUCCI R, 1989, J NEUROL NEUROSUR PS, V52, P1202, DOI 10.1136/jnnp.52.10.1202; Moon KS, 2007, J CLIN NEUROSCI, V14, P989, DOI 10.1016/j.jocn.2006.05.016; Panikkath R, 2013, CASE REP MED, V2013, DOI 10.1155/2013/296874; Rhoton AL, 2000, NEUROSURGERY, V47, pS131, DOI 10.1097/00006123-200009001-00015; Rhoton AL, 2008, NEUROSURG CLIN N AM, V19, P145, DOI 10.1016/j.nec.2008.02.005; Shimano H, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.06.026	15	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2021	26								101340	10.1016/j.inat.2021.101340			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	WJ6AL	WOS:000709125600002		gold			2022-02-06	
J	Kaitsuka, T; Matsushita, M; Matsushita, N				Kaitsuka, Taku; Matsushita, Masayuki; Matsushita, Nobuko			Regulation of Hypoxic Signaling and Oxidative Stress via the MicroRNA-SIRT2 Axis and Its Relationship with Aging-Related Diseases	CELLS			English	Article						sirtuins; SIRT2; hypoxia; HIF-1 alpha; oxidative stress; microRNA; Parkinson's disease; Alzheimer's disease	DOXORUBICIN-INDUCED CARDIOTOXICITY; ALPHA-SYNUCLEIN ACCUMULATION; INDUCIBLE FACTOR 1-ALPHA; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA; MAMMALIAN SIRTUINS; INDUCED APOPTOSIS; ISCHEMIC-STROKE; DOWN-REGULATION; EMERGING ROLES	The sirtuin family of nicotinamide adenine dinucleotide-dependent deacetylase and ADP-ribosyl transferases plays key roles in aging, metabolism, stress response, and aging-related diseases. SIRT2 is a unique sirtuin that is expressed in the cytosol and is abundant in neuronal cells. Various microRNAs were recently reported to regulate SIRT2 expression via its 3 & PRIME;-untranslated region (UTR), and single nucleotide polymorphisms in the miRNA-binding sites of SIRT2 3 & PRIME;-UTR were identified in patients with neurodegenerative diseases. The present review highlights recent studies into SIRT2-mediated regulation of the stress response, posttranscriptional regulation of SIRT2 by microRNAs, and the implications of the SIRT2-miRNA axis in aging-related diseases.	[Kaitsuka, Taku] Int Univ Hlth & Welf, Sch Pharm Fukuoka, Fukuoka, Fukuoka 8318501, Japan; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa 9030215, Japan; [Matsushita, Nobuko] Azabu Univ, Sch Life & Environm Sci, Lab Hyg & Publ Hlth, Dept Med Technol, Sagamihara, Kanagawa 2525201, Japan		Matsushita, N (corresponding author), Azabu Univ, Sch Life & Environm Sci, Lab Hyg & Publ Hlth, Dept Med Technol, Sagamihara, Kanagawa 2525201, Japan.	kaitsuka@iuhw.ac.jp; masayuki@med.u-ryukyu.ac.jp; matsushita@azabu-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [19K07053]	FundingThis research was supported in part by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant No. 19K07053 to NM).	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Ai T, 2016, J MED CHEM, V59, P2928, DOI 10.1021/acs.jmedchem.5b01376; Alarcon-Aris D, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102944; Bai M, 2020, CELL CYCLE, V19, P2018, DOI 10.1080/15384101.2020.1788251; Bai YW, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20191908; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Bertero T, 2017, INT REV CEL MOL BIO, V333, P91, DOI 10.1016/bs.ircmb.2017.03.006; Bianchi E, 2015, CELL DEATH DIFFER, V22, P1906, DOI 10.1038/cdd.2015.30; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Brock M, 2015, INT J BIOCHEM CELL B, V61, P129, DOI 10.1016/j.biocel.2015.02.002; Cha DJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01208; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen QH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94734-z; Chen XY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.668659; Chen XY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20327-5; Chen XJ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1498034; Chen XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116919; Chen XQ, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.614107; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Choi DC, 2014, J NEUROSCI, V34, P12725, DOI 10.1523/JNEUROSCI.0985-14.2014; Chopra V, 2012, CELL REP, V2, P1492, DOI 10.1016/j.celrep.2012.11.001; Ciesielska S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116022; Csak T, 2015, LIVER INT, V35, P532, DOI 10.1111/liv.12633; Deng JH, 2019, EUR REV MED PHARMACO, V23, P10699, DOI 10.26355/eurrev_201912_19770; Deng WJ, 2020, J CELL MOL MED, V24, P10987, DOI 10.1111/jcmm.15732; Di Fruscia P, 2015, CHEMMEDCHEM, V10, P69, DOI 10.1002/cmdc.201402431; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Du F, 2020, J CELL MOL MED, V24, P9985, DOI 10.1111/jcmm.15603; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; ElKhouly AM, 2020, NON-CODING RNA RES, V5, P11, DOI 10.1016/j.ncrna.2020.01.001; Emde A, 2014, EMBO J, V33, P1428, DOI 10.15252/embj.201488142; Farnsworth B, 2016, J ALZHEIMERS DIS, V53, P209, DOI 10.3233/JAD-160160; Fathi M, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111914; Feng M, 2021, NEUROSCI RES, V163, P52, DOI 10.1016/j.neures.2020.03.005; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Germana Z, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03713-9; Gillardon F, 2008, PROTEOM CLIN APPL, V2, P697, DOI 10.1002/prca.200780025; Greco S, 2014, ANTIOXID REDOX SIGN, V21, P1202, DOI 10.1089/ars.2013.5403; Gu R, 2020, INT J NEUROSCI, V130, P443, DOI 10.1080/00207454.2019.1692834; Guarente L, 2009, SCIENCE, V324, P1281, DOI 10.1126/science.1175679; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hu A, 2020, MOL CARCINOGEN, V59, P1280, DOI 10.1002/mc.23256; Huang X, 2014, ACTA BIOCH BIOPH SIN, V46, P220, DOI 10.1093/abbs/gmt141; Hubbi ME, 2013, J BIOL CHEM, V288, P20768, DOI 10.1074/jbc.M113.476903; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Joo HY, 2015, BIOCHEM BIOPH RES CO, V462, P294, DOI 10.1016/j.bbrc.2015.04.119; Ju C, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140300; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Kaitsuka T, 2020, BIOCHEM BIOPH RES CO, V529, P957, DOI 10.1016/j.bbrc.2020.06.159; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lee SD, 2016, CANCER LETT, V373, P138, DOI 10.1016/j.canlet.2016.01.031; Li B, 2020, CELL MOL IMMUNOL, V17, P976, DOI 10.1038/s41423-019-0257-6; Li SZ, 2016, AM J TRANSL RES, V8, P993; Li YY, 2021, LAB INVEST, V101, P104, DOI 10.1038/s41374-020-0450-3; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin JF, 2018, EUR REV MED PHARMACO, V22, P8415, DOI 10.26355/eurrev_201812_16540; Liu B, 2013, CELL PHYSIOL BIOCHEM, V32, P655, DOI 10.1159/000354469; Liu DW, 2019, MOL MED REP, V19, P5335, DOI 10.3892/mmr.2019.10197; Liu H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253522; Liu QQ, 2019, INT J MOL MED, V43, P839, DOI 10.3892/ijmm.2018.3996; Liu WJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1629-z; Liu YM, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00372; Long JK, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0085-2; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Macharia LW, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00125; McMillan KJ, 2017, MOL THER, V25, P2404, DOI 10.1016/j.ymthe.2017.08.017; Mori Y, 2020, J CLIN BIOCHEM NUTR, V67, P167, DOI 10.3164/jcbn.19-78; Nie H, 2014, NEUROREPORT, V25, P838, DOI 10.1097/WNR.0000000000000192; Oh H, 2015, OSTEOARTHR CARTILAGE, V23, P2288, DOI 10.1016/j.joca.2015.07.009; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pittenger ST, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35747-z; Qian B, 2021, DIABETOLOGIA, V64, P2037, DOI 10.1007/s00125-021-05489-1; Rack JGM, 2014, J MOL BIOL, V426, P1677, DOI 10.1016/j.jmb.2013.10.027; Radwan MO, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127458; Radwan MO, 2019, MOLECULES, V24, DOI 10.3390/molecules24183295; Ramakrishnan G, 2014, J BIOL CHEM, V289, P6054, DOI 10.1074/jbc.M113.537266; Ranadive N, 2021, BRAIN RES BULL, V171, P135, DOI 10.1016/j.brainresbull.2021.03.016; Roshdy E, 2021, EUR J MED CHEM, V224, DOI 10.1016/j.ejmech.2021.113709; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Seo KS, 2015, ONCOGENE, V34, P1354, DOI 10.1038/onc.2014.76; Shen YY, 2020, J MOL NEUROSCI, V70, P878, DOI 10.1007/s12031-020-01513-y; Silva DF, 2017, MOL NEUROBIOL, V54, P4021, DOI 10.1007/s12035-016-9951-x; Singh P, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/2643587; Song WJ, 2021, BRAIN RES BULL, V168, P8, DOI 10.1016/j.brainresbull.2020.10.020; Sun SF, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00381; Thangaraj MP, 2017, J BIOL CHEM, V292, P5166, DOI 10.1074/jbc.M117.775544; Titze-de-Almeida R, 2018, CURR GENE THER, V18, P143, DOI 10.2174/1566523218666180430121323; van Leeuwen IMM, 2013, MOL CANCER THER, V12, P471, DOI 10.1158/1535-7163.MCT-12-0904; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197182; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wang XJ, 2015, DRUG DES DEV THER, V9, P2553, DOI 10.2147/DDDT.S81539; Wang Y, 2020, AGING CELL, V19, DOI 10.1111/acel.13194; Wang Yan, 2018, Cell Physiol Biochem, V51, P2732, DOI 10.1159/000495963; Watts Michelle E, 2018, Noncoding RNA, V4, DOI 10.3390/ncrna4020010; Winkle M, 2021, NAT REV DRUG DISCOV, V20, P629, DOI 10.1038/s41573-021-00219-z; Wu DH, 2018, NEUROSCIENCE, V374, P61, DOI 10.1016/j.neuroscience.2018.01.040; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xu FR, 2021, NEUROCHEM RES, V46, P2192, DOI 10.1007/s11064-021-03356-4; Yang QJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00791; Yang SD, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12890; Yang WL, 2019, CELL MOL LIFE SCI, V76, P453, DOI 10.1007/s00018-018-2941-6; Yang XH, 2016, MOL MED REP, V13, P5241, DOI 10.3892/mmr.2016.5202; Yang XP, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.620615; Yang Z, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03372-2; Yao BW, 2020, J CELL MOL MED, V24, P8718, DOI 10.1111/jcmm.15503; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zaccagnini G, 2014, ANTIOXID REDOX SIGN, V21, P1177, DOI 10.1089/ars.2013.5206; Zhang DW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4165; Zhao LS, 2018, REDOX BIOL, V16, P189, DOI 10.1016/j.redox.2018.02.026; Zhao LS, 2018, REDOX BIOL, V15, P284, DOI 10.1016/j.redox.2017.12.013; Zhao YY, 2021, AGING CELL, V20, DOI 10.1111/acel.13391; Zhong JJ, 2017, ONCOTARGET, V8, P83523, DOI 10.18632/oncotarget.18315; Zhuang L, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00716-0	123	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	DEC	2021	10	12							3316	10.3390/cells10123316			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	XX5JF	WOS:000736331000001	34943825	Green Published			2022-02-06	
J	Karaliute, M; Saksvik, SB; Smevik, H; Follestad, T; Einarsen, C; Vik, A; Haberg, AK; Iverson, GL; Skandsen, T; Olsen, A				Karaliute, Migle; Saksvik, Simen B.; Smevik, Hanne; Follestad, Turid; Einarsen, Cathrine; Vik, Anne; Haberg, Asta K.; Iverson, Grant L.; Skandsen, Toril; Olsen, Alexander			Methodology Matters: Comparing Approaches for Defining Persistent Symptoms after Mild Traumatic Brain Injury	NEUROTRAUMA REPORTS			English	Article						concussion; outcome; post-concussion syndrome; prognosis; Rivermead Post Concussion Symptom Questionnaire; The British Columbia Post-Concussion Symptom Inventory	POST-CONCUSSION SYMPTOMS; GOOD-OLD-DAYS; POSTCONCUSSION SYNDROME; POPULATION; INTERVENTIONS; QUESTIONNAIRE; PREVALENCE; PREDICTORS; RECOVERY; FATIGUE	Some people experience persistent post-concussion symptoms (PPCS) after mild traumatic brain injury (mTBI). A meaningful clinical classification and scientific progress are hampered by a lack of consensus regarding the phenomenology, assessment, and operationalization of PPCS. Here we demonstrate and evaluate how the methodology used to assess and define persistent symptoms after mTBI influences PPCS as a binary outcome. We present empirical data from 15 classification methods reflecting procedures found in the literature and clinical practice. In total, 221 patients with mTBI, 73 patients with orthopedic injuries, and 77 community controls were included in the study. The prevalence rate of PPCS in the mTBI group varied between 10% and 47%, depending on the method used to assess and define unfavorable outcome. There was generally low positive agreement between the different methods; even the two methods yielding the most similar prevalence rates (89.2% overall proportion agreement) agreed on less than half (45.5% positive agreement) of the PPCS cases. Using a liberal but not uncommon threshold for symptom severity, there was a considerable misclassification rate of PPCS in both comparison groups. Our results highlight the importance for researchers to be aware of the limitations of using binary approaches for classification of PPCS. The poor agreement between methods should be considered when (1) interpreting the heterogeneity in the existing PPCS literature and (2) developing new improved methods. An empirically informed consensus regarding classification of PPCS should be a priority for the research community.	[Karaliute, Migle; Saksvik, Simen B.; Smevik, Hanne; Olsen, Alexander] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Einarsen, Cathrine; Vik, Anne; Haberg, Asta K.; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Karaliute, Migle] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Saksvik, Simen B.; Einarsen, Cathrine; Skandsen, Toril; Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp & Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGeneral Hosp Children Sports Concuss Program, Charlestown, MA USA; [Iverson, Grant L.] Red Sox Fdn & Massachusetts Gen Hosp Program, Home Base, Charlestown, MA USA		Olsen, A (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Social & Educ Sci, Dept Psychol, N-7491 Trondheim, Norway.	alexander.olsen@ntnu.no					Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Altman D.G., 1990, PRACTICAL STAT MED R; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Mayer AR, 2020, J NEUROTRAUM, V37, P1504, DOI 10.1089/neu.2019.6805; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Morris Sarah E, 2012, Dialogues Clin Neurosci, V14, P29; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Saksvik SB, 2020, J NEUROTRAUM, V37, P2528, DOI 10.1089/neu.2019.6898; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Skandsen T, 2021, ARCH PHYS MED REHAB, V102, P1102, DOI 10.1016/j.apmr.2020.10.106; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thompson C, 2016, BRAIN INJURY, V30, P770; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; World Health Organization, 1992, ICD 10 CLASS MENT BE; World Health Organization, 1993, ICD 10 CLASS MENT BE	52	0	0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2689-288X		NEUROTRAUMA REP	Neurotrauma Rep.	DEC 1	2021	2	1					603	617		10.1089/neur.2021.0028			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	YB2DV	WOS:000738830600001	35018362	gold, Green Published			2022-02-06	
J	Keshavarzi, Z; Amiresmaili, S; Shahrokhi, N; Bibak, B; Shakeri, F				Keshavarzi, Zakieh; Amiresmaili, Sedigheh; Shahrokhi, Nader; Bibak, Bahram; Shakeri, Farzane			Neuroprotective effects of auraptene following traumatic brain injury in male rats: The role of oxidative stress	BRAIN RESEARCH BULLETIN			English	Article						TBI; oxidative stress; auraptene; TNF-alpha; rats	CELLS; MODEL	Aim: Traumatic Brain Injury (TBI) is widely acknowledged as a significant risk factor for death and disability. Our goal in this experiment was to see if Auraptene (AUR) could help rats recover from TBI-induced disability by measuring of oxidative stress parameters. Material and methods: Adult male Wistar rats were randomly assigned to one of six groups: sham, TBI, Vehicle (DMSO), TBI+ AUR (4 mg/kg), TBI + AUR (8 mg/kg), TBI + AUR (25 mg/kg). The animals were anesthetized. After that, diffuse TBI was done by Marmarou model in male rats. Then, the brain tissues were harvested. Some of oxidative stress parameters, and TNF alpha levels were evaluated. Results: TBI-induced brain damage was significantly inhibited by AUR (25 mg/kg), as evidenced by decreased Malondialdehyde (MDA) and Nitric Oxide (NO) levels, oxidative stress inhibition and reduced levels of proinflammatory cytokine tumor necrosis factor (TNF-alpha) in the brain. Conclusion: This study showed that probably the AUR prevents complications of TBI through decreases in brain edema, modulating oxidative stress, and reductions in the levels of inflammatory cytokines.	[Keshavarzi, Zakieh; Bibak, Bahram; Shakeri, Farzane] North Khorasan Univ Med Sci, Nat Prod & Med Plants Res Ctr, Bojnurd, Iran; [Keshavarzi, Zakieh; Bibak, Bahram; Shakeri, Farzane] North Khorasan Univ Med Sci, Dept Physiol, Bojnurd, Iran; [Amiresmaili, Sedigheh] Bam Univ Med Sci, Dept Physiol, Bam, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Physiol Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran		Amiresmaili, S (corresponding author), Bam Univ Med Sci, Dept Physiol, Bam, Iran.	esmailisedigheh@yahoo.com					Abbasloo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31866; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Amiresmaili S, 2021, ECOTOX ENVIRON SAFE, V213, DOI 10.1016/j.ecoenv.2021.111987; Askari VR, 2021, PHARMACOL REP, V73, P154, DOI 10.1007/s43440-020-00083-5; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bastin A, 2021, J CELL PHYSIOL, V236, P2790, DOI 10.1002/jcp.30049; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Davis AM, 2006, MOL REPROD DEV, V73, P1034, DOI 10.1002/mrd.20520; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Gao XG, 2018, FOOD FUNCT, V9, P2684, DOI 10.1039/c8fo00107c; Genovese S, 2011, CURR DRUG TARGETS, V12, P381, DOI 10.2174/138945011794815248; Ghanbarabadi M, 2016, NEUROSCI LETT, V623, P13, DOI 10.1016/j.neulet.2016.04.047; Gromovaya V.F., 2008, PHARM CHEM J+, V42, P25; Jamialahmadi K, 2018, J PHARMACOPUNCT, V21, P177, DOI 10.3831/KPI.2018.21.021; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kuki W, 2008, NUTR CANCER, V60, P368, DOI 10.1080/01635580701745327; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Liu FY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1388-x; Liu Y, 2014, BEHAV BRAIN RES, V267, P178, DOI 10.1016/j.bbr.2014.02.040; Mahakizadeh S, 2018, J CONTEMP MED SCI, V4, P63, DOI 10.22317/jcms.06201802; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Murakami A, 2000, CARCINOGENESIS, V21, P1843, DOI 10.1093/carcin/21.10.1843; Okuyama S., 2014, EVID BASED COMPLEMEN, V2014, P1; Okuyama S, 2019, J NUTR SCI VITAMINOL, V65, P66, DOI 10.3177/jnsv.65.66; Okuyama S, 2015, MOLECULES, V20, P20230, DOI 10.3390/molecules201119691; Okuyama S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/408503; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Sekiguchi H, 2012, J MED FOOD, V15, P658, DOI 10.1089/jmf.2011.1844; Siddiqui M., 2021, LIAQUAT MED RES J, V3, P1, DOI [10.38106/lmrj.2021.36, DOI 10.38106/LMRJ.2021.36]; Valko T., 2004, DEMOGR RES, VS2, P305; Wadhwa N., 2012, INT J CURR SCI, V3, P29, DOI DOI 10.12691/JEPHH-7-1-1; Williams A.L., 2018, TRAUMATIC BRAIN INJU; Xu DP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010096; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Yucel A., 2012, J EXP INTEGR MED, V2, P1	37	0	0	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	DEC	2021	177						203	209		10.1016/j.brainresbull.2021.09.021			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WM9UG	WOS:000711422800004	34624461				2022-02-06	
J	Khaitin, A				Khaitin, Andrey			Calcium in Neuronal and Glial Response to Axotomy	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						axotomy; calcium; glia; neurotrauma	CILIARY NEUROTROPHIC FACTOR; CRAYFISH STRETCH-RECEPTOR; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE-C; NERVE INJURY; ULTRASTRUCTURAL-CHANGES; AXONAL REGENERATION; FACTOR PREVENTS; MOTOR-NEURONS	Neurotrauma assumes an instant or delayed disconnection of axons (axotomy), which affects not only neurons, but surrounding glia as well. Not only mechanically injured glia near the site of disconnection, especially transection, is subjected to the damage, but also glia that is remote from the lesion site. Glial cells, which surround the neuronal body, in turn, support neuron survival, so there is a mutual protection between neuron and glia. Calcium signaling is a central mediator of all post-axotomy events, both in neuron and glia, playing a critical role in their survival/regeneration or death/degeneration. The involvement of calcium in post-axotomy survival of the remote, mechanically intact glia is poorly studied. The purpose of this review is to sum up the calcium-involving mechanisms in responses of neurons and glial cells to axotomy to show their importance and to give some suggestions for future research of remote glia in this context.	[Khaitin, Andrey] Southern Fed Univ, Acad Biol & Biotechnol, Rostov Na Donu 344090, Russia		Khaitin, A (corresponding author), Southern Fed Univ, Acad Biol & Biotechnol, Rostov Na Donu 344090, Russia.	andrej.wojt@gmail.com		Khaitin, Andrey/0000-0003-0413-7656	Ministry of Science and Higher Education of the Russian Federation [0852-2020-0028]	FundingThis research was funded by the Ministry of Science and Higher Education of the Russian Federation, grant no. 0852-2020-0028.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Adelsberger H, 1996, PFLUG ARCH EUR J PHY, V432, P867, DOI 10.1007/s004240050210; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Bahr M., 2004, NEUROPROTECTION, V2; Ben-Yaakov K, 2009, RESULTS PROBL CELL D, V48, P327, DOI 10.1007/400_2009_14; Boudes M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00035; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chandross KJ, 1998, GLIA, V24, P21, DOI 10.1002/(SICI)1098-1136(199809)24:1<21::AID-GLIA3>3.0.CO;2-3; Cherkas PS, 2004, PAIN, V110, P290, DOI 10.1016/j.pain.2004.04.007; Dassesse D, 1998, BRAIN RES, V786, P181, DOI 10.1016/S0006-8993(97)01458-3; Demyanenko S, 2019, J MOL NEUROSCI, V68, P667, DOI 10.1007/s12031-019-01329-5; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Detrait E, 2000, J NEUROBIOL, V44, P382, DOI 10.1002/1097-4695(20000915)44:4<382::AID-NEU2>3.0.CO;2-Q; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Dong HX, 2003, J NEUROSCI, V23, P8682; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Eddleman CS, 2002, BIOL BULL-US, V203, P219, DOI 10.2307/1543406; Eddleman CS, 1998, J NEUROSCI, V18, P4029; Elziere L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097736; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fawcett JW, 2018, DEV NEUROBIOL, V78, P890, DOI 10.1002/dneu.22637; Fedorenko GM, 2008, J NEUROSCI RES, V86, P1409, DOI 10.1002/jnr.21587; Fedorenko GM, 2011, J NEUROSCI RES, V89, P341, DOI 10.1002/jnr.22560; Fedorenko GM, 2009, J INTEGR NEUROSCI, V8, P433, DOI 10.1142/S0219635209002290; Fedorenko G, 2015, J NEUROSCI RES, V93, P707, DOI 10.1002/jnr.23530; Fedorenko GM, 2009, CELL TISSUE RES, V337, P477, DOI 10.1007/s00441-009-0825-7; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Gemes G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-46; Gemes G, 2009, ANESTHESIOLOGY, V111, P393, DOI 10.1097/ALN.0b013e3181ae63b0; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Ghoumari AM, 2002, J NEUROSCI, V22, P3531; Giaume C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00088; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Gitler D, 2002, J NEUROBIOL, V52, P267, DOI 10.1002/neu.10084; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; Gobel J, 2018, BIOCHEM BIOPH RES CO, V500, P17, DOI 10.1016/j.bbrc.2017.06.191; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Grider MH, 2005, J NEUROSCI RES, V82, P404, DOI 10.1002/jnr.20635; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hanani M, 2012, BRAIN RES, V1487, P183, DOI 10.1016/j.brainres.2012.03.070; HARRISON BC, 1992, J NEUROCHEM, V58, P320, DOI 10.1111/j.1471-4159.1992.tb09313.x; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hilaire C, 2005, NEUROSCI LETT, V380, P330, DOI 10.1016/j.neulet.2005.01.068; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hogan Q, 2008, ANESTH ANALG, V107, P1045, DOI 10.1213/ane.0b013e31817bd1f0; Iwasaki Y, 1999, J NEUROL SCI, V169, P148, DOI 10.1016/S0022-510X(99)00238-5; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Karasawa M, 2019, J CLIN NEUROSCI, V60, P128, DOI 10.1016/j.jocn.2018.11.020; Kasseckert SA, 2013, NEUROSURGERY, V72, P468, DOI 10.1227/NEU.0b013e31827d0de7; Khaitin AM, 2015, INVERTEBR NEUROSCI, V15, DOI 10.1007/s10158-014-0176-2; Khaitin A, 2018, MOL CELL NEUROSCI, V88, P7, DOI 10.1016/j.mcn.2017.12.004; Kirsch M, 2003, MOL CELL NEUROSCI, V24, P130, DOI 10.1016/S1044-7431(03)00130-1; Kobeissy F.H., 2015, BRAIN NEUROTRAUMA; Kondratskyi A, 2015, BBA-BIOMEMBRANES, V1848, P2532, DOI 10.1016/j.bbamem.2014.10.030; Kucenas S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020511; KUWADA JY, 1981, J PHYSIOL-LONDON, V317, P463, DOI 10.1113/jphysiol.1981.sp013836; KUWADA JY, 1981, J PHYSIOL-LONDON, V317, P435, DOI 10.1113/jphysiol.1981.sp013835; Largo C, 1996, NEUROL RES, V18, P445; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lopez-Verrilli MA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00205; Lund LM, 1997, J NEUROBIOL, V33, P796, DOI 10.1002/(SICI)1097-4695(19971120)33:6<796::AID-NEU7>3.0.CO;2-4; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; Mattson MP, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P663; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; MEIRI H, 1983, BRAIN RES, V263, P1, DOI 10.1016/0006-8993(83)91195-2; Messner B, 2016, CELL MOL LIFE SCI, V73, P1699, DOI 10.1007/s00018-015-2094-9; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Michetti F, 2021, NEUROSCI BIOBEHAV R, V127, P446, DOI 10.1016/j.neubiorev.2021.04.035; Moser H, 1996, J EXP BIOL, V199, P1781; Muramoto A, 1998, ZOOL SCI, V15, P11, DOI 10.2108/zsj.15.11; Nadeau JR, 2014, GLIA, V62, P763, DOI 10.1002/glia.22640; Nakamura TY, 2006, J CELL BIOL, V172, P1081, DOI 10.1083/jcb.200508156; Namekata I, 2015, BIOL PHARM BULL, V38, P147, DOI 10.1248/bpb.b14-00525; Nejatbakhsh N, 2011, J NEUROSCI, V31, P15231, DOI 10.1523/JNEUROSCI.2516-11.2011; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Ogura H, 2007, NEUROREPORT, V18, P17, DOI 10.1097/WNR.0b013e328011e6e3; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Rigaud M, 2009, ANESTHESIOLOGY, V111, P381, DOI 10.1097/ALN.0b013e3181ae6212; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rodemer W, 2020, NEURAL REGEN RES, V15, P996, DOI 10.4103/1673-5374.270298; Rodriguez-Muela N, 2012, AUTOPHAGY, V8, P286, DOI 10.4161/auto.8.2.18982; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rose J, 2017, TOXICOLOGY, V391, P109, DOI 10.1016/j.tox.2017.06.011; Rudkovskii MV, 2020, MOL CELL NEUROSCI, V107, DOI 10.1016/j.mcn.2020.103534; Sakuragi S, 2017, BIOCHEM BIOPH RES CO, V486, P879, DOI 10.1016/j.bbrc.2017.03.096; SANCHEZVIVES MV, 1994, EUR J NEUROSCI, V6, P9, DOI 10.1111/j.1460-9568.1994.tb00243.x; SCHMALBRUCH H, 1995, BRAIN RES, V700, P254, DOI 10.1016/0006-8993(95)00982-V; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Siebert JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-148; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Spira ME, 2003, J COMP NEUROL, V457, P293, DOI 10.1002/cne.10569; Spray DC, 2019, GLIA, V67, P791, DOI 10.1002/glia.23554; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Swieck K, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0491-y; Tsantoulas C, 2012, J NEUROSCI, V32, P17502, DOI 10.1523/JNEUROSCI.3561-12.2012; Twiss JL, 2009, TRENDS CELL BIOL, V19, P236, DOI 10.1016/j.tcb.2009.02.007; van Adel BA, 2005, J NEUROBIOL, V63, P215, DOI 10.1002/neu.20117; Vanderluit JL, 2003, CELL DEATH DIFFER, V10, P969, DOI 10.1038/sj.cdd.4401258; Verkhratsky A, 2014, NEUROSCI BULL, V30, P125, DOI 10.1007/s12264-013-1343-x; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Watanabe M, 2002, PROG RETIN EYE RES, V21, P529, DOI 10.1016/S1350-9462(02)00037-X; Whiteside G, 1998, EUR J NEUROSCI, V10, P3400, DOI 10.1046/j.1460-9568.1998.00346.x; WILCOX BJ, 1995, J COMP NEUROL, V359, P573, DOI 10.1002/cne.903590405; Woods JJ, 2019, ACS CENTRAL SCI, V5, P153, DOI 10.1021/acscentsci.8b00773; Xu P, 2013, GLIA, V61, P1029, DOI 10.1002/glia.22491; YAMADA E, 1994, BRAIN RES, V639, P341, DOI 10.1016/0006-8993(94)91751-5; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Ziv NE, 1997, J NEUROSCI, V17, P3568; Zohar O, 2001, NEUROSCI RES, V41, P151, DOI 10.1016/S0168-0102(01)00273-5	119	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2021	22	24							13344	10.3390/ijms222413344			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	YA2GH	WOS:000738157700001	34948141	Green Published, gold			2022-02-06	
J	Kim, M; Kim, J; Moon, S; Choi, BY; Kim, S; Jeon, HS; Suh, SW; Kim, YM; Choi, YK				Kim, Minsu; Kim, Joohwan; Moon, Sunhong; Choi, Bo Young; Kim, Sueun; Jeon, Hui Su; Suh, Sang Won; Kim, Young-Myeong; Choi, Yoon Kyung			Korean Red Ginseng Improves Astrocytic Mitochondrial Function by Upregulating HO-1-Mediated AMPK alpha-PGC-1 alpha-ERR alpha Circuit after Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						Korean red ginseng; heme oxygenase-1; traumatic brain injury; AMPK alpha-PGC-1 alpha-ERR alpha circuit; astrocytic mitochondrial function	ENDOTHELIAL GROWTH-FACTOR; CARBON-MONOXIDE; HEME OXYGENASE-1; ENERGY-METABOLISM; VEGF; NEURONS; PGC-1-ALPHA/ERR-ALPHA; NEUROGENESIS; ANGIOGENESIS; BIOGENESIS	Heme oxygenase-1 (HO-1) exerts beneficial effects, including angiogenesis and energy metabolism via the peroxisome proliferator-activating receptor-gamma coactivator-1 alpha (PGC-1 alpha)-estrogen-related receptor alpha (ERR alpha) pathway in astrocytes. However, the role of Korean red ginseng extract (KRGE) in HO-1-mediated mitochondrial function in traumatic brain injury (TBI) is not well-elucidated. We found that HO-1 was upregulated in astrocytes located in peri-injured brain regions after a TBI, following exposure to KRGE. Experiments with pharmacological inhibitors and target-specific siRNAs revealed that HO-1 levels highly correlated with increased AMP-activated protein kinase alpha (AMPK alpha) activation, which led to the PGC-1 alpha-ERR alpha axis-induced increases in mitochondrial functions (detected based on expression of cytochrome c oxidase subunit 2 (MTCO2) and cytochrome c as well as O-2 consumption and ATP production). Knockdown of ERR alpha significantly reduced the p-AMPK alpha/AMPK alpha ratio and PGC-1 alpha expression, leading to AMPK alpha-PGC-1 alpha-ERR alpha circuit formation. Inactivation of HO by injecting the HO inhibitor Sn(IV) protoporphyrin IX dichloride diminished the expression of p-AMPK alpha, PGC-1 alpha, ERR alpha, MTCO2, and cytochrome c in the KRGE-administered peri-injured region of a brain subjected to TBI. These data suggest that KRGE enhanced astrocytic mitochondrial function via a HO-1-mediated AMPK alpha-PGC-1 alpha-ERR alpha circuit and consequent oxidative phosphorylation, O-2 consumption, and ATP production. This circuit may play an important role in repairing neurovascular function after TBI in the peri-injured region by stimulating astrocytic mitochondrial biogenesis.	[Kim, Minsu; Moon, Sunhong; Kim, Sueun; Jeon, Hui Su; Choi, Yoon Kyung] Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 05029, South Korea; [Kim, Joohwan; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea; [Choi, Bo Young; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon 24252, Gangwon Do, South Korea		Choi, YK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Bio Mol Informat Ctr, Seoul 05029, South Korea.	kjmmmmm6@konkuk.ac.kr; joohwank@hs.uci.edu; sunhong95047@konkuk.ac.kr; bychoi@hallym.ac.kr; rlatndms0325@konkuk.ac.kr; heeth313@konkuk.ac.kr; swsuh@hallym.ac.kr; ymkim@kangwon.ac.kr; ykchoi@konkuk.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2020R1A2C1004397]; Korean Society of Ginseng; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI20C0253]	This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2020R1A2C1004397) and a grant from the Korean Society of Ginseng (2019 & 2021). This research was also supported by a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI20C0253).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benvenisti-Zarom L, 2007, NEUROBIOL DIS, V26, P688, DOI 10.1016/j.nbd.2007.03.006; Bobela W, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0220-x; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chen-Roetling J, 2006, BIOCHEM BIOPH RES CO, V350, P233, DOI 10.1016/j.bbrc.2006.09.036; Choi YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202039; Choi YK, 2017, ANTIOXID REDOX SIGN, V27, P21, DOI 10.1089/ars.2016.6684; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Choi YK, 2016, BIOCHEM BIOPH RES CO, V479, P297, DOI 10.1016/j.bbrc.2016.09.063; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Huang QX, 2021, J AM CHEM SOC, V143, P1416, DOI 10.1021/jacs.0c10836; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Jeong KJ, 2014, J GINSENG RES, V38, P83, DOI 10.1016/j.jgr.2013.11.014; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim Y, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8050121; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101	27	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2021	22	23							13081	10.3390/ijms222313081			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	XV7SC	WOS:000735136100001	34884886	gold, Green Published			2022-02-06	
J	King, DJ; Seri, S; Catroppa, C; Anderson, VA; Wood, AG				King, Daniel J.; Seri, Stefano; Catroppa, Cathy; Anderson, Vicki A.; Wood, Amanda G.			Structural-covariance networks identify topology-based cortical-thickness changes in children with persistent executive function impairments after traumatic brain injury	NEUROIMAGE			English	Article						Traumatic brain injury; Development; Structural-covariance networks; Executive function; Child; Paediatric	HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; SOCIAL COMPETENCE; CONNECTIVITY; PERFORMANCE; HUBS; MRI; MODERATE; NEUROPATHOLOGY; CONVERGENCE	Paediatric traumatic brain injury (pTBI) results in inconsistent changes to regional morphometry of the brain across studies. Structural-covariance networks represent the degree to which the morphology (typically cortical-thickness) of cortical-regions co-varies with other regions, driven by both biological and developmental factors. Understanding how heterogeneous regional changes may influence wider cortical network organization may more appropriately capture prognostic information in terms of long term outcome following a pTBI. The current study aimed to investigate the relationships between cortical organisation as measured by structural-covariance, and long-term cognitive impairment following pTBI. T1-weighted magnetic resonance imaging (MRI) from n = 83 pTBI patients and 33 typically developing controls underwent 3D-tissue segmentation using Freesurfer to estimate cortical-thickness across 68 cortical ROIs. Structural-covariance between regions was estimated using Pearson's correlations between cortical-thickness measures across 68 regions-of-interest (ROIs), generating a group-level 68 x 68 adjacency matrix for patients and controls. We grouped a subset of patients who underwent executive function testing at 2-years post-injury using a neuropsychological impairment (NPI) rule, defining impaired-and non-impaired subgroups. Despite finding no significant reductions in regional cortical-thickness between the control and pTBI groups, we found specific reductions in graph-level strength of the structural covariance graph only between controls and the pTBI group with executive function (EF) impairment. Node-level differences in strength for this group were primarily found in frontal regions. We also investigated whether the top n nodes in terms of effect-size of cortical-thickness reductions were nodes that had significantly greater strength in the typically developing brain than n randomly selected regions. We found that acute cortical-thickness reductions post-pTBI are loaded onto regions typically high in structural covariance. This association was found in those patients with persistent EF impairment at 2-years post-injury, but not in those for whom these abilities were spared. This study posits that the topography of post-injury cortical-thickness reductions in regions that are central to the typical structural-covariance topology of the brain, can explain which patients have poor EF at follow-up.	[King, Daniel J.; Seri, Stefano; Wood, Amanda G.] Aston Univ, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England; [King, Daniel J.; Seri, Stefano; Wood, Amanda G.] Aston Univ, Aston Inst Hlth & Neurodev, Birmingham B4 7ET, W Midlands, England; [Seri, Stefano] Birmingham Womens & Childrens Hosp NHS Fdn Trust, Dept Clin Neurophysiol, Birmingham, W Midlands, England; [Catroppa, Cathy; Anderson, Vicki A.; Wood, Amanda G.] Murdoch Childrens Res Inst, Clin Sci, Brain & Mind Res, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Wood, Amanda G.] Deakin Univ, Fac Hlth, Sch Psychol, Melbourne Burwood Campus, Geelong, Vic, Australia		King, DJ (corresponding author), Aston Univ, Coll Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England.; King, DJ (corresponding author), Aston Univ, Aston Inst Hlth & Neurodev, Birmingham B4 7ET, W Midlands, England.	d.king6@aston.ac.uk	Griffiths-King, Daniel/ABE-6359-2021; Wood, Amanda/K-9595-2013	Griffiths-King, Daniel/0000-0001-5797-9203; Wood, Amanda/0000-0002-1537-6858	European Research Council (ERC) Consolidator Grant (ERC-CoG)European Research Council (ERC) [682734]; Aston University, School of Life and Health Sciences; Victoria Neurotrauma Initiative, Australia [CO6E1]	This work was supported by a European Research Council (ERC) Consolidator Grant (ERC-CoG) to AW [grant number 682734]. DK was supported by a studentship from Aston University, School of Life and Health Sciences. This work was supported by a grant from the Victoria Neurotrauma Initiative, Australia (No. CO6E1) to VAA.	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Batalle D, 2018, J CHILD PSYCHOL PSYC, V59, P350, DOI 10.1111/jcpp.12838; Batalle D, 2013, NEUROIMAGE, V83, P901, DOI 10.1016/j.neuroimage.2013.07.045; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Beauchamp MH, 2015, J INT NEUROPSYCH SOC, V21, P596, DOI 10.1017/S1355617715000636; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler, 2007, BRAIN INJURY MED PRI, P225; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Cauda F, 2019, BRAIN, V142, DOI 10.1093/brain/awz080; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Craddock C., 2013, FRONT NEUROINFORM, V7, DOI [DOI 10.3389/CONF.FNINF.2013.09.00041, 10.3389/conf.fninf.2013.09.00041]; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2017, CHILD NEUROPSYCHOL, V23, P554, DOI 10.1080/09297049.2016.1161015; Downing K., 2015, THESIS TEXAS WOMANS; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FORNITO A., 2016, FUNDAMENTALS BRAIN N; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gong GL, 2012, NEUROIMAGE, V59, P1239, DOI 10.1016/j.neuroimage.2011.08.017; Goulas A, 2017, BRAIN STRUCT FUNCT, V222, P1281, DOI 10.1007/s00429-016-1277-y; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hedges L.V., 2014, STAT METHODS METAANA; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hong SJ, 2017, BRAIN, V140, P2133, DOI 10.1093/brain/awx145; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Khundrakpam BS, 2017, NEUROIMAGE, V144, P227, DOI 10.1016/j.neuroimage.2016.08.041; Khundrakpam BS, 2016, NEUROIMAGE, V134, P192, DOI 10.1016/j.neuroimage.2016.03.062; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; King DJ, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101844; King DJ, 2020, DEV COGN NEUROS-NETH, V42, DOI 10.1016/j.dcn.2020.100762; Klapwijk ET, 2019, NEUROIMAGE, V189, P116, DOI 10.1016/j.neuroimage.2019.01.014; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Manly T., 1999, TEST EVERYDAY ATTENT; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morgan SE, 2018, BIOL PSYCHIAT-COGN N, V3, P754, DOI 10.1016/j.bpsc.2018.03.003; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; Oldham S, 2019, DEV COGN NEUROS-NETH, V36, DOI 10.1016/j.dcn.2018.12.005; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reid AT, 2016, NEUROIMAGE, V125, P311, DOI 10.1016/j.neuroimage.2015.10.057; Romero-Garcia R, 2018, NEUROIMAGE, V171, P256, DOI 10.1016/j.neuroimage.2017.12.060; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Santa-Cruz C, 2017, ESTUD PSICOL-MADRID, V38, P284, DOI 10.1080/02109395.2017.1311459; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; TEASDALE G, 1974, LANCET, V2, P81; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van der Kleij LA, 2020, J NEUROTRAUM, V37, P600, DOI 10.1089/neu.2019.6514; Vasa F, 2018, CEREB CORTEX, V28, P281, DOI 10.1093/cercor/bhx249; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wannan CMJ, 2019, AM J PSYCHIAT, V176, P552, DOI 10.1176/appi.ajp.2019.18040380; Watson, 2016, BRAINGR GRAPH THEOR; Wechsler D, 2003, WECHSLER INTELLIGENC; Wei YB, 2018, NETW NEUROSCI, V3, P124, DOI 10.1162/netn_a_00057; Whitaker KJ, 2016, P NATL ACAD SCI USA, V113, P9105, DOI 10.1073/pnas.1601745113; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yee Y, 2017, STRUCTURAL COVARIANC, DOI [10.1101/183004, DOI 10.1101/183004]; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	105	0	0	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	DEC 1	2021	244								118612	10.1016/j.neuroimage.2021.118612			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WD9MA	WOS:000705255300013	34563681	Green Published, gold, Green Accepted			2022-02-06	
J	Klyce, DW; West, SJ; Perrin, PB; Agtarap, SD; Finn, JA; Juengst, SB; Dams-O'Connor, K; Eagye, CB; Vargas, TA; Chung, JS; Bombardier, CH				Klyce, Daniel W.; West, Samuel J.; Perrin, Paul B.; Agtarap, Stephanie D.; Finn, Jacob A.; Juengst, Shannon B.; Dams-O'Connor, Kristen; Eagye, C. B.; Vargas, Tiffanie A.; Chung, Joyce S.; Bombardier, Charles H.			Network Analysis of Neurobehavioral and Post-Traumatic Stress Disorder Symptoms One Year after Traumatic Brain Injury: A Veterans Affairs Traumatic Brain Injury Model Systems Study	JOURNAL OF NEUROTRAUMA			English	Article						network analysis; post-traumatic stress disorder; traumatic brain injury; veterans	PERSISTENT POSTCONCUSSIVE SYMPTOMS; PROLONGED EXPOSURE THERAPY; ANXIETY SENSITIVITY; SERVICE MEMBERS; PAIN DIAGNOSES; WAR VETERANS; PTSD; IRAQ; AFGHANISTAN; PREVALENCE	Traumatic brain injury (TBI) is often experienced under stressful circumstances that can lead to symptoms of post-traumatic stress disorder (PTSD) and neurobehavioral symptoms of brain injury. There is considerable symptom overlap in the behavioral expression of these conditions. Psychometric network analysis is a useful approach to investigate the role of specific symptoms in connecting these two disorders and is well suited to explore their interrelatedness. This study applied network analysis to examine the associations among PTSD and TBI symptoms in a sample of Service Members and Veterans (SM/Vs) with a history of TBI one year after injury. Responses to the Neurobehavioral Symptom Inventory (NSI) and PTSD Checklist-Civilian version (PCL-C) were obtained from participants who completed comprehensive inpatient rehabilitation services across five Veterans Affairs polytrauma rehabilitation centers. Participants (N = 612) were 93.1% male with an average age of 36.98 years at injury. The analysis produced a stable network. Within the NSI symptom groups, the frustration symptom was an important bridge between the affective and cognitive TBI symptoms. The PCL-C nodes formed their own small cluster with hyperarousal yielding connections with the affective, cognitive, and somatic symptom groups. Consistent with this observation, the hyperarousal node had the second strongest bridge centrality in the network. Hyperarousal appears to play a key role in holding together this network of distress and thus represents a prime target for intervention among individuals with elevated symptoms of PTSD and a history of TBI. Network analysis offers an empirical approach to visualizing and quantifying the associations among symptoms. The identification of symptoms that are central to connecting multiple conditions can inform diagnostic precision and treatment selection.	[Klyce, Daniel W.] Virginia Commonwealth Univ Hlth Syst, Cent Virginia Vet Affairs Hlth Care Syst, Sheltering Arms Inst, Cent Virginia VA Hlth Care Syst, Richmond, VA USA; [West, Samuel J.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA; [West, Samuel J.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Cent Virginia Vet Affairs Hlth Care Syst, Box 2018, Richmond, VA 23284 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Agtarap, Stephanie D.; Eagye, C. B.] Craig Hosp, Dept Res, Englewood, CO USA; [Finn, Jacob A.] Univ Minnesota Twin Cities, Rehabil & Extended Care Patient Serv Line, Minneapolis VA Hlth Care Syst, Psychiat & Behav Sci, Minneapolis, MN USA; [Juengst, Shannon B.] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, Dept Rehabil & Human Performance, New York, NY USA; [Vargas, Tiffanie A.] Cent Virginia Vet Affairs Hlth Care Syst, Richmond, VA USA; [Chung, Joyce S.] Polytrauma Syst Care, VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Bombardier, Charles H.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Juengst, Shannon B.] TIRR Mem Herman, Brain Injury Res Ctr, Houston, TX USA		Klyce, DW (corresponding author), Cent Virginia VA Hlth Care Syst, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	daniel.klyce@va.gov		West, Samuel/0000-0002-6439-9159	DHA Contracting Office (CO-NCR) [HT0014-19-C-0004, HT0014]	This work was prepared under Contract HT0014-19-C-0004 with DHA Contracting Office (CO-NCR) HT0014 and, therefore, is defined as U.S. Government work under Title 17 U.S.C. x101. Per Title 17 U.S.C. x105, copyright protection is not available for any work of the U.S. Government. For more information, please contactdha.TBICOEinfo@mail.mil.UNCLASSIFIED	Aase DM, 2018, PSYCHIAT RES, V268, P460, DOI 10.1016/j.psychres.2018.08.019; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Medical Association, 2013, DIAGNOSTIC STAT MANU; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Armour C, 2017, J ANXIETY DISORD, V45, P49, DOI 10.1016/j.janxdis.2016.11.008; Armour C, 2016, CLIN PSYCHOL REV, V44, P60, DOI 10.1016/j.cpr.2015.12.003; Armstrong Michael, 2019, Phys Med Rehabil Clin N Am, V30, P13, DOI 10.1016/j.pmr.2018.08.013; Asmundson GJG, 2019, COGN BEHAV THERAPY, V48, P1, DOI 10.1080/16506073.2018.1522371; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bowe A, 2015, J DUAL DIAGN, V11, P22, DOI 10.1080/15504263.2014.989653; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Eftekhari A, 2013, JAMA PSYCHIAT, V70, P949, DOI 10.1001/jamapsychiatry.2013.36; Elliott H, 2020, CLIN PSYCHOL SCI, V8, P139, DOI 10.1177/2167702619865958; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fried EI, 2018, CLIN PSYCHOL SCI, V6, P335, DOI 10.1177/2167702617745092; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Jones PJ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01305; Jones PJ, 2017, networktools: Assorted Tools for Identifying Important Nodes in Networks. R Package Version 1.0.0.; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Kansagara D., 2013, COMPLICATIONS MILD T; Kim SH, 2020, NEUROPSYCHOLOGY, V34, P713, DOI 10.1037/neu0000678; Konnert C, 2015, INT PSYCHOGERIATR, V27, P297, DOI 10.1017/S1041610214001884; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lazarov A, 2020, PSYCHOL MED, V50, P2154, DOI 10.1017/S0033291719002034; Lehavot K, 2018, AM J PREV MED, V54, pE1, DOI 10.1016/j.amepre.2017.09.008; Lew HL, 2013, J REHABIL RES DEV, V50, pXI, DOI 10.1682/JRRD.2013.09.0212; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Marshall GN, 2010, J ABNORM PSYCHOL, V119, P143, DOI 10.1037/a0018009; McCrea M., 2008, MILD TRAUMATIC BRAIN; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Mitchell MA, 2014, J PSYCHIATR RES, V48, P25, DOI 10.1016/j.jpsychires.2013.10.013; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; O'Neil ME, 2017, J CLIN EXP NEUROPSYC, V39, P449, DOI 10.1080/13803395.2016.1232699; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Park SC, 2020, J AFFECT DISORDERS, V271, P19, DOI 10.1016/j.jad.2020.03.078; Petrakis IL, 2011, AM J ADDICTION, V20, P185, DOI 10.1111/j.1521-0391.2011.00126.x; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; REISS S, 1991, CLIN PSYCHOL REV, V11, P141, DOI 10.1016/0272-7358(91)90092-9; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Schoorl M, 2015, MINDFULNESS, V6, P1004, DOI 10.1007/s12671-014-0346-7; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Silva MA, 2021, REHABIL PSYCHOL, V66, P170, DOI 10.1037/rep0000367; Smits JAJ, 2008, BEHAV RES THER, V46, P1047, DOI 10.1016/j.brat.2008.06.010; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Weathers F.W., 1993, ANN M INT SOC TRAUM; Weintraub MJ, 2020, BIPOLAR DISORD, V22, P128, DOI 10.1111/bdi.12870; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	72	0	0	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2021	38	23					3332	3340		10.1089/neu.2021.0200			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XJ2CB	WOS:000726601700014	34652955				2022-02-06	
J	Kobayashi, K; Liu, CSP; Jonas, RA; Ishibashi, N				Kobayashi, Kei; Liu, Christopher; Jonas, Richard A.; Ishibashi, Nobuyuki			The Current Status of Neuroprotection in Congenital Heart Disease	CHILDREN-BASEL			English	Article						congenital heart disease; neuroprotection; brain; cardiac anomalies; neurological deficit	HYPOTHERMIC CIRCULATORY ARREST; CORRECTIVE CARDIAC-SURGERY; TRAUMATIC BRAIN-INJURY; TIGHT GLYCEMIC CONTROL; SCHOOL-AGED CHILDREN; CARDIOPULMONARY BYPASS; NEURODEVELOPMENTAL OUTCOMES; GREAT-ARTERIES; WORKING-MEMORY; INFLAMMATORY RESPONSE	Neurological deficits are a serious and common sequelae of congenital heart disease (CHD). While their underlying mechanisms have not been fully characterized, their manifestations are well-known and understood to persist through adulthood. Development of therapies to address or prevent these deficits are critical to attenuate future morbidity and improve quality of life. In this review, we aim to summarize the current status of neuroprotective therapy in CHD. Through an exploration of present research in the pre-operative, intra-operative, and post-operative phases of patient management, we will describe existing clinical and bench efforts as well as current endeavors underway within this research area.	[Kobayashi, Kei; Liu, Christopher; Jonas, Richard A.; Ishibashi, Nobuyuki] Childrens Natl Hosp, Sheikh Zayed Inst Pediat Surg Innovat, Ctr Neurosci Res, Washington, DC 20010 USA; [Kobayashi, Kei; Jonas, Richard A.; Ishibashi, Nobuyuki] Childrens Natl Hosp, Childrens Natl Heart Inst, Washington, DC 20010 USA; [Liu, Christopher] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23298 USA; [Jonas, Richard A.; Ishibashi, Nobuyuki] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA		Ishibashi, N (corresponding author), Childrens Natl Hosp, Sheikh Zayed Inst Pediat Surg Innovat, Ctr Neurosci Res, Washington, DC 20010 USA.; Ishibashi, N (corresponding author), Childrens Natl Hosp, Childrens Natl Heart Inst, Washington, DC 20010 USA.; Ishibashi, N (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.	keikobayashi0428@gmail.com; liucm3@vcu.edu; rjonas@childrensnational.org; nishibas@childrensnational.org	Kobayashi, Kei/ABC-7399-2020	Kobayashi, Kei/0000-0002-8815-9029			Adams JA, 2018, MED HYPOTHESES, V110, P144, DOI 10.1016/j.mehy.2017.12.008; Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Agus MSD, 2014, CIRCULATION, V129, P2297, DOI 10.1161/CIRCULATIONAHA.113.008124; Alkaitis Matthew S, 2012, Curr Heart Fail Rep, V9, P200, DOI 10.1007/s11897-012-0097-5; Ando M, 2005, ANN THORAC SURG, V80, P1672, DOI 10.1016/j.athoracsur.2005.04.035; Andropoulos DB, 2013, J THORAC CARDIOV SUR, V146, P124, DOI 10.1016/j.jtcvs.2012.09.046; Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Ares S., 2012, HDB GROWTH GROWTH MO; Atallah J, 2008, CIRCULATION, V118, P1410, DOI 10.1161/CIRCULATIONAHA.107.741579; Beca J, 2013, CIRCULATION, V127, P971, DOI 10.1161/CIRCULATIONAHA.112.001089; Bellinger DC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002302; Bellinger DC, 2011, CIRCULATION, V124, P1361, DOI 10.1161/CIRCULATIONAHA.111.026963; Bellinger DC, 2009, CARDIOL YOUNG, V19, P86, DOI 10.1017/S1047951108003454; Bellinger DC, 1997, J DEV BEHAV PEDIATR, V18, P75, DOI 10.1097/00004703-199704000-00001; Bellinger DC, 1999, CIRCULATION, V100, P526, DOI 10.1161/01.CIR.100.5.526; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Benavente-Fernandez I, 2020, PEDIATR RES, V87, P391, DOI 10.1038/s41390-019-0646-7; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Bettendorf M, 2000, LANCET, V356, P529, DOI 10.1016/S0140-6736(00)02576-9; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Boneva RS, 2001, CIRCULATION, V103, P2376; Bonthrone AF, 2021, INFANCY, V26, P184, DOI 10.1111/infa.12376; Bronicki RA, 2000, ANN THORAC SURG, V69, P1490, DOI 10.1016/S0003-4975(00)01082-1; Buller KM, 2009, J NEUROSCI RES, V87, P599, DOI 10.1002/jnr.21890; CALACIURA F, 1995, CLIN ENDOCRINOL, V43, P473, DOI 10.1111/j.1365-2265.1995.tb02620.x; Calderon J, 2020, J PEDIATR-US, V227, P191, DOI 10.1016/j.jpeds.2020.08.038; Calderon J, 2010, DEV MED CHILD NEUROL, V52, P1139, DOI 10.1111/j.1469-8749.2010.03735.x; Cassidy AR, 2015, J INT NEUROPSYCH SOC, V21, P34, DOI 10.1017/S1355617714001027; Cheatham SL, 2015, PEDIATR CARDIOL, V36, P685, DOI 10.1007/s00246-014-1065-5; Checchia PA, 2003, CRIT CARE MED, V31, P1742, DOI 10.1097/01.CCM.0000063443.32874.60; Checchia PA, 2013, J THORAC CARDIOV SUR, V146, P530, DOI 10.1016/j.jtcvs.2012.09.100; Chen CY, 2015, INFANT BEHAV DEV, V40, P12, DOI 10.1016/j.infbeh.2015.02.007; Chen Q, 2021, AGING-US, V13, P3031, DOI 10.18632/aging.202460; Cole AR, 2019, JACC-BASIC TRANSL SC, V4, P176, DOI 10.1016/j.jacbts.2018.11.006; Curvello V, 2019, NEUROCRIT CARE, V30, P467, DOI 10.1007/s12028-018-0638-1; de Greeff JW, 2018, J SCI MED SPORT, V21, P501, DOI 10.1016/j.jsams.2017.09.595; DeMaso DR, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2241; Diaz LK, 2016, J THORAC CARDIOV SUR, V152, P482, DOI 10.1016/j.jtcvs.2016.03.095; Dimmick S.J., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004220.pub2, DOI 10.1002/14651858.CD004220.PUB2]; Drabek T, 2014, RESUSCITATION, V85, P284, DOI 10.1016/j.resuscitation.2013.10.015; Dulfer K, 2014, J ADOLESCENT HEALTH, V55, P65, DOI 10.1016/j.jadohealth.2013.12.010; Dunbar-Masterson C, 2001, CIRCULATION, V104, pI138; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Filippi L, 2018, J MATERN-FETAL NEO M, V31, P973, DOI 10.1080/14767058.2017.1304536; Fischer HS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4317; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; Forbess JM, 2002, CIRCULATION, V106, pI95, DOI 10.1161/01.cir.0000032915.33237.72; Fourdain S, 2021, DEV NEUROREHABIL, V24, P56, DOI 10.1080/17518423.2020.1711541; Fudulu D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1971452; Fudulu DP, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00112; Gaynor JW, 2018, ANN THORAC SURG, V106, P151, DOI 10.1016/j.athoracsur.2018.02.060; Gaynor JW, 2015, PEDIATRICS, V135, P816, DOI 10.1542/peds.2014-3825; Gaynor JW, 2009, PEDIATRICS, V124, P241, DOI 10.1542/peds.2008-2281; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Goldberg CS, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1010; Goldstein EZ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.665409; Gong J, 2019, J INT MED RES, V47, P1677, DOI 10.1177/0300060518821272; Graham EM, 2019, J AM COLL CARDIOL, V74, P659, DOI 10.1016/j.jacc.2019.05.060; Graham EM, 2011, J THORAC CARDIOV SUR, V142, P1523, DOI 10.1016/j.jtcvs.2011.04.019; Grunewaldt KH, 2013, PEDIATRICS, V131, pE747, DOI 10.1542/peds.2012-1965; Guerra GG, 2011, PEDIATR ANESTH, V21, P932, DOI 10.1111/j.1460-9592.2011.03581.x; Gunes T, 2007, PEDIATR NEUROL, V36, P17, DOI 10.1016/j.pediatrneurol.2006.08.005; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hao ML, 2015, INFLAMMATION, V38, P1617, DOI 10.1007/s10753-015-0137-x; Hirst JJ, 2006, NEUROENDOCRINOLOGY, V84, P264, DOI 10.1159/000097990; Hovels-Gurich HH, 2007, ANN THORAC SURG, V83, P1425, DOI 10.1016/j.athoracsur.2006.10.069; Hoffman GM, 2013, J THORAC CARDIOV SUR, V146, P1153, DOI 10.1016/j.jtcvs.2012.12.060; Holm I, 2007, ARCH PEDIAT ADOL MED, V161, P945, DOI 10.1001/archpedi.161.10.945; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; James C, 2016, INTENS CARE MED, V42, P1744, DOI 10.1007/s00134-016-4420-6; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Jin XQ, 2015, NEUROPSYCH DIS TREAT, V11, P1395, DOI 10.2147/NDT.S82052; Juul SE, 2020, NEW ENGL J MED, V382, P233, DOI 10.1056/NEJMoa1907423; Kaandorp JJ, 2012, ARCH DIS CHILD-FETAL, V97, pF162, DOI 10.1136/archdischild-2011-300356; Kajimoto M, 2021, J THORAC CARDIOV SUR, V161, pE485, DOI 10.1016/j.jtcvs.2019.12.075; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Korotcova L, 2015, ANN THORAC SURG, V100, P1030, DOI 10.1016/j.athoracsur.2015.04.017; Landucci E, 2018, NEUROSCI LETT, V668, P103, DOI 10.1016/j.neulet.2018.01.023; Lawrence KM, 2019, J THORAC CARDIOV SUR, V157, P1982, DOI 10.1016/j.jtcvs.2018.12.093; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Licht DJ, 2004, J THORAC CARDIOV SUR, V128, P841, DOI 10.1016/j.jtcvs.2004.07.022; Limperopoulos C, 2002, J PEDIATR-US, V141, P51, DOI 10.1067/mpd.2002.125227; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; Liu G, 2020, J THORAC CARDIOV SUR, V160, pE55, DOI 10.1016/j.jtcvs.2020.03.057; Liu YQ, 2004, STROKE, V35, P1460, DOI 10.1161/01.STR.0000128029.50221.fa; Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; Mackes NK, 2020, P NATL ACAD SCI USA, V117, P641, DOI 10.1073/pnas.1911264116; Maeda Takuya, 2021, JTCVS Open, V5, P99, DOI 10.1016/j.xjon.2021.02.003; Maeda T, 2020, ANN THORAC SURG, V109, P1274, DOI 10.1016/j.athoracsur.2019.08.036; Mahle WT, 2001, CLIN PERINATOL, V28, P235, DOI 10.1016/S0095-5108(05)70077-4; Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Matei N, 2018, MED GAS RES, V8, P98, DOI 10.4103/2045-9912.239959; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Ming SP, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000023998; Mittnacht J, 2015, HORM RES PAEDIAT, V84, P130, DOI 10.1159/000381711; MOLLER JH, 1994, CIRCULATION, V89, P923, DOI 10.1161/01.CIR.89.2.923; Moons P, 2010, CIRCULATION, V122, P2264, DOI 10.1161/CIRCULATIONAHA.110.946343; Morton PD, 2017, CIRC RES, V120, P960, DOI 10.1161/CIRCRESAHA.116.309048; Nampijja Margaret, 2018, Wellcome Open Res, V3, P152, DOI 10.12688/wellcomeopenres.14702.1; Newburger JW, 2012, CIRCULATION, V125, P2081, DOI 10.1161/CIRCULATIONAHA.111.064113; NEWBURGER JW, 1993, NEW ENGL J MED, V329, P1057, DOI 10.1056/NEJM199310073291501; Nguyen PN, 2003, PEDIATR RES, V54, P840, DOI 10.1203/01.PDR.0000088066.47755.36; NICOLAIDES KH, 1987, LANCET, V1, P942; PALMER C, 1993, PEDIATR RES, V33, P405; Patra K, 2016, AM J PERINAT, V33, P738, DOI 10.1055/s-0036-1572532; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Plumpton K, 2005, INTENS CARE MED, V31, P581, DOI 10.1007/s00134-004-2549-1; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Ren CH, 2011, NEUROL RES, V33, P514, DOI 10.1179/016164111X13007856084241; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Robson VK, 2019, J PEDIATR-US, V204, P38, DOI 10.1016/j.jpeds.2018.08.069; Romanowicz J, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012711; Romero-Miguel D, 2021, EUR J NEUROL, V28, P1056, DOI 10.1111/ene.14642; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Sadhwani A, 2016, J PEDIATR-US, V174, P193, DOI 10.1016/j.jpeds.2016.03.048; Salameh A, 2015, BRAIN PATHOL, V25, P733, DOI 10.1111/bpa.12242; Sananes R, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-014589; Sanz JH, 2017, CONGENIT HEART DIS, V12, P202, DOI 10.1111/chd.12427; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schroeder VA, 2003, CIRCULATION, V107, P2823, DOI 10.1161/01.CIR.0000070955.55636.25; Schumacher M, 2020, BEST PRACT RES CL OB, V69, P50, DOI 10.1016/j.bpobgyn.2020.09.001; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; Sonneville R, 2012, J CLIN ENDOCR METAB, V97, P2113, DOI 10.1210/jc.2011-2971; Soshi T, 2021, CEREB CORTEX, V31, P4501, DOI 10.1093/cercor/bhab102; Spittle A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub4; Su F, 2016, ANESTH ANALG, V122, P1556, DOI 10.1213/ANE.0000000000000869; Sun LQ, 2015, CIRCULATION, V131, P1313, DOI 10.1161/CIRCULATIONAHA.114.013051; van Egmond-van Dam JC, 2021, DISABIL REHABIL, DOI 10.1080/09638288.2021.1924298; van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64; Wang P, 2016, SHOCK, V46, P312, DOI 10.1097/SHK.0000000000000585; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilckens KA, 2021, HIPPOCAMPUS, V31, P335, DOI 10.1002/hipo.23292; Wu H., 2012, CARDIOVASC ENG TECHN, V3, P292, DOI [10.1007/s13239-012-0096-4, DOI 10.1007/S13239-012-0096-4]; Yang Y, 1998, BRAIN RES, V804, P169, DOI 10.1016/S0006-8993(98)00410-7; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023; You WS, 2020, RADIOLOGY, V294, P141, DOI 10.1148/radiol.2019190751; Yu HJ, 2016, CARDIOVASC TOXICOL, V16, P325, DOI 10.1007/s12012-015-9342-y; Zhong HX, 2013, PEDIATR ANESTH, V23, P726, DOI 10.1111/pan.12181; Zuppa AF, 2019, BRIT J ANAESTH, V123, P839, DOI 10.1016/j.bja.2019.06.026; Zyblewski Sinai C, 2021, Ann Thorac Surg, DOI 10.1016/j.athoracsur.2021.04.006	148	0	0	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	DEC	2021	8	12							1116	10.3390/children8121116			19	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	XW4KG	WOS:000735589600001	34943311	Green Published			2022-02-06	
J	Kontos, AP; Eagle, SR; Mucha, A; Kochick, V; Reichard, J; Moldolvan, C; Holland, CL; Blaney, NA; Collins, MW				Kontos, Anthony P.; Eagle, Shawn R.; Mucha, Anne; Kochick, Victoria; Reichard, Jessica; Moldolvan, Claire; Holland, Cyndi L.; Blaney, Nicholas A.; Collins, Michael W.			A Randomized Controlled Trial of Precision Vestibular Rehabilitation in Adolescents following Concussion: Preliminary Findings	JOURNAL OF PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; MOTOR SCREENING VOMS; CERVICOVESTIBULAR REHABILITATION; DIZZINESS; SYMPTOMS; DEFICITS; THERAPY; STRESS; YOUTH; REST	Objective To compare the effectiveness of a 4-week precision vestibular rehabilitation intervention compared with a behavioral management control intervention for adolescents with vestibular symptoms/impairment within 21 days of a concussion. Study design This study used double-blind, randomized controlled trial design involving adolescent (12-18 years) patients with a diagnosed sport/recreation-related concussion with vestibular symptoms/impairment from a concussion-specialty clinic between October 2018 and February 2020. Eligible participants were randomized in a 1:1 to either a 4-week vestibular intervention group (VESTIB) or a behavioral management control group (CONTROL). CONTROLS (n = 25) were prescribed behavioral management strategies (eg, physical activity, sleep, hydration, nutrition, stress management) and instructed to perform stretching/physical activity (eg, walking, stationary cycle) 30 minutes/day. VESTIB (n = 25) were prescribed precision vestibular rehabilitation exercises and instructed to perform at-home exercises for 30 minutes/day. Primary outcomes were improvement in Vestibular/Ocular Motor Screening vestibular items (ie, horizontal/vertical vestibular-ocular reflex, visual motion sensitivity) at 4 weeks post-enrollment. Results We screened 310 and enrolled a total of 55 (18%) adolescent patients who were randomized to one of the interventions. Fifty of fifty-five (91 %) participants completed all aspects of the study protocol. Participants in VESTIB improved significantly across the intervention period in horizontal (mean difference-1.628; 95% CI [-3.20, -0.06]; P = .04) and vertical (mean difference-2.24; 95% CI [-4.01, -0.48]; P = .01) vestibular-ocular reflex, but not visual motion sensitivity (mean difference-2.03; 95% CI [-4.26, 0.19]) of the Vestibular/Ocular Motor Screening score compared with CONTROLS. Conclusions Overall, the vestibular intervention group experienced greater clinical improvements in vestibular symptoms/impairment than controls across the 4-week intervention.	[Kontos, Anthony P.; Eagle, Shawn R.; Mucha, Anne; Kochick, Victoria; Holland, Cyndi L.; Blaney, Nicholas A.; Collins, Michael W.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthoped Surg, Pittsburgh, PA 15203 USA; [Kontos, Anthony P.; Mucha, Anne; Kochick, Victoria; Reichard, Jessica; Moldolvan, Claire; Collins, Michael W.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA 15203 USA; [Reichard, Jessica; Moldolvan, Claire] UPMC Ctr Rehabil Serv, Pittsburgh, PA USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthoped Surg, 3850 S Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kochick, Victoria/0000-0002-1580-4971	Chuck Noll Foundation [0001]; University of PittsburghUniversity of Pittsburgh; National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Football League (NFL)	Funded by the Chuck Noll Foundation (0001). A.K. and M.C. receive royalties from APA Books and research support through the University of Pittsburgh, the National Institute of Health (NIH), and the National Football League (NFL). The other authors declare no conflicts of interest.	Alsalaheen B, 2020, PEDIATR PHYS THER, V32, P331, DOI 10.1097/PEP.0000000000000729; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Gillie BL, 2020, APPL NEUROPSYCH-CHIL, DOI 10.1080/21622965.2020.1799790; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2019, J HEAD TRAUMA REHAB, V34, P394, DOI 10.1097/HTR.0000000000000536; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Langevin P, 2019, BMC SPORTS SCI MED R, V11, DOI 10.1186/s13102-019-0139-3; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Ramsey KA, 2021, J INT NEUROPSYCH SOC, V27, P875, DOI 10.1017/S1355617720001320; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087	32	0	0	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2021	239						193	199		10.1016/j.jpeds.2021.08.032			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	WY4LX	WOS:000719251000035	34450120				2022-02-06	
J	Krainin, BM; Seehusen, CN; Smulligan, KL; Wingerson, MJ; Wilson, JC; Howell, DR				Krainin, Benjamin M.; Seehusen, Corrine N.; Smulligan, Katherine L.; Wingerson, Mathew J.; Wilson, Julie C.; Howell, David R.			Symptom and clinical recovery outcomes for pediatric concussion following early physical activity	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						mild traumatic brain injury; adolescent; exercise; rehabilitation; treatment; trauma	POSTCONCUSSIVE SYMPTOMS; PROGNOSTIC UTILITY; EXERCISE; CHILDREN; ADOLESCENTS	OBJECTIVE Recent research supports initiating physical activity as soon as 24 to 48 hours after concussion to reduce persistent postconcussive symptoms. However, this practice has not been widely adopted. The objective of this study was to evaluate the association of early physical activity with patient-reported and functional outcomes for pediatric patients following a concussion. METHODS A retrospective cohort of patients who presented to a pediatric sports medicine clinic (48% female, mean age14.3 +/- 2.6 years, and mean 9.8 +/- 5.7 days postconcussion) were evaluated. Patients were grouped based on whether they reported engaging in physical activity prior to presenting to the clinic. Patient- and parent-reported symptom frequency (Health and Behavior Inventory), 11 different clinical outcomes (including missed school, memory recall, and balance assessments), the presence of symptoms persisting beyond 28 days, and a subgroup analysis of those patients receiving exercise versus symptom-limiting activity prescriptions were examined. Outcomes were compared between physical activity groups using the Mann-Whitney U-test and the chi-square test. To adjust for the effect of potential confounders, a logistic binary regression model was constructed. RESULTS In total, 211 pediatric patients were included, 35 (17%) of whom reported early physical activity. A greater proportion of the no physical activity group reported a headache (85% vs 60%, p = 0.001). The no physical activity group also reported higher patient-reported (23.1 +/- 13.4 vs 15.0 +/- 13.4, p < 0.001) and parent-reported (19.4 +/- 12.7 vs 11.2 +/- 10.3, p = 0.001) symptom frequency at the initial visit. The early physical activity group had a lower proportion of patients with persistent symptoms (44% vs 22%, p = 0.02) and a shorter time to symptom resolution (15.6 +/- 12.4 days vs 27.2 +/- 24.2 days, p = 0.02). After adjusting for potential confounders, early physical activity was associated with 5.8 lower odds of experiencing persistent symptoms (adjusted OR 5.83, 95% CI 2.05-16.61; p = 0.001). CONCLUSIONS A significant association between early physical activity and decreased symptom burden was observed. A lower proportion of those patients who engaged in early physical activity experienced persistent symptoms 28 days postinjury. However, low rates of early physical activity prior to the initial clinic visit were also observed, indicating that this approach may not be well known by acute care or primary care providers, or is not widely adopted by patients and families.	[Krainin, Benjamin M.] Univ Colorado, Dept Family Med, Sch Med, Aurora, CO USA; [Krainin, Benjamin M.] Univ Colorado, Dept Emergency Med, Sch Med, Aurora, CO USA; [Seehusen, Corrine N.; Wingerson, Mathew J.; Wilson, Julie C.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Smulligan, Katherine L.; Wingerson, Mathew J.; Wilson, Julie C.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sch Med, Aurora, CO 80045 USA.	david.howell@.cuanschutz.edu			Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R43NS108823]; MINDSOURCE Brain Injury Network; Tai Foundation	Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant no. R03HD094560), the National Institute of Neurological Disorders and Stroke (grant nos. R01NS100952 and R43NS108823), MINDSOURCE Brain Injury Network, and the Tai Foundation.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lishchynsky JT, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00588; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; Patsimas T, 2020, J ATHL TRAINING, V55, P1020, DOI 10.4085/1062-6050-200-19; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; The Management of Concussion-mild Traumatic Brain Injury Working Group, VA DOD CLIN PRACT GU; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Van Deventer KA, 2021, J SPORT HEALTH SCI, V10, P131, DOI 10.1016/j.jshs.2020.08.005; Varner CE, 2021, ACAD EMERG MED, V28, P493, DOI 10.1111/acem.14215; Wilson Julie C, 2020, J Clin Transl Res, V5, P161; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	0	0	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2021	28	6					623	630		10.3171/2021.6.PEDS21264			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	XN9ER	WOS:000729800900001	34560641				2022-02-06	
J	Kreter, N; Rogers, CL; Fino, PC				Kreter, Nicholas; Rogers, Claire L.; Fino, Peter C.			Anticipatory and reactive responses to underfoot perturbations during gait in healthy adults and individuals with a recent mild traumatic brain injury	CLINICAL BIOMECHANICS			English	Article						Concussion; Balance; Locomotor control; Inertial measurement units; Proprioception	CONCUSSION; ADJUSTMENTS; STABILITY; RECOVERY; TASK; STEP	Background: Following mild traumatic brain injury, individuals often exhibit quantifiable gait deficits over flat surfaces, but little is known about how they control gait over complex surfaces. Such complex surfaces require precise neuromotor control to anticipate and react to small disturbances in walking surfaces, and mild traumatic brain injury-related balance deficits may adversely affect these gait adjustments. Methods: This study investigates anticipatory and reactive gait adjustments for expected and unexpected underfoot perturbations in healthy adults (n = 5) and individuals with mild traumatic brain injury (n = 5). Participants completed walking trials with random unexpected or expected underfoot perturbations from a mechanized shoe and inertial measurement units collected kinematic data from the feet and sternum. Linear mixed-effects models assessed the effects of segment, group, and their interaction on standardized difference of accelerations between perturbation and non-perturbation trials Findings: Both groups demonstrated similar gait strategies when perturbations were unexpected. During late swing phase before expected perturbations, persons with mild traumatic brain injury exhibited greater lateral acceleration of their perturbed foot and less lateral movement of their trunk compared with unperturbed gait. Control participants exhibited less lateral foot acceleration and no difference in mediolateral trunk acceleration compared with unperturbed gait during the same period. A significant group*segment interaction (p < 0.001) during this part of the gait cycle suggests the groups adopted different anticipatory strategies for the perturbation. Interpretation: Individuals with mild traumatic brain injury may be adopting cautious strategies for expected perturbations due to persistent neuromechanical deficits stemming from their injury.	[Kreter, Nicholas; Fino, Peter C.] Univ Utah, Dept Hlth & Kinesiol, 250 South 1850 East, Salt Lake City, UT 84112 USA; [Rogers, Claire L.] Univ Utah, Dept Biomed Engn, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA		Kreter, N (corresponding author), Univ Utah, Dept Hlth & Kinesiol, 250 South 1850 East, Salt Lake City, UT 84112 USA.	nick.kreter@utah.edu			University of Utah Vice President of Research; Medical Research Foundation of Oregon; Eunice Kennedy Shiver National Institute of Child Health & Human Development of the National Institutes of Health [K12HD073945]	Research reported in this publication was supported by the University of Utah Vice President of Research, the Medical Research Foundation of Oregon, and the Eunice Kennedy Shiver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number K12HD073945 (PCF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Utah, Medical Research Foundation of Oregon, or the National Institutes of Health.	Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Bruijn SM, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0816; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cain SM., 2017, 41 ANN M AM SOC BIOM; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Ellmers TJ, 2019, J EXP PSYCHOL HUMAN, V45, P697, DOI 10.1037/xhp0000615; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kim H, 2013, GAIT POSTURE, V38, P853, DOI 10.1016/j.gaitpost.2013.04.013; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Nnodim JO, 2013, GAIT POSTURE, V37, P61, DOI 10.1016/j.gaitpost.2012.06.002; Nordin AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41131-2; Pedley M., 2013, TILT SENSING USING 3; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reimann H., 2018, KINESIOL REV, V7, P18, DOI [10.1123/kr.2017, DOI 10.1123/KR.2017-0053]; Thies SB, 2005, GAIT POSTURE, V22, P26, DOI 10.1016/j.gaitpost.2004.06.004; Weerdesteyn V, 2004, HUM MOVEMENT SCI, V23, P351, DOI 10.1016/j.humov.2004.08.011; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009; Zhang YJ, 2020, J PHYSIOL-LONDON, V598, P1987, DOI 10.1113/JP278986	24	0	0	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2021	90								105496	10.1016/j.clinbiomech.2021.105496			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	WD3SO	WOS:000704865000008	34607181				2022-02-06	
J	Kunorozva, L; van Tonder, R; Starling, L; Brown, JC; Viviers, PL; Derman, EW				Kunorozva, Lovemore; van Tonder, Riaan; Starling, Lindsay; Brown, James C.; Viviers, Pierre L.; Derman, Elton W.			A five-year clinical audit of concussive injuries in South African collegiate male rugby players-a South African experience	SPORT SCIENCES FOR HEALTH			English	Article						Head injuries; concussion; Headache; Clinical assessment; audit; Male; Collegiate rugby; Sport Concussion Assessment Tool (SCAT)-3; SCAT5	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSION SYMPTOMS; RECOVERY; PREDICTORS; FOOTBALL; OUTCOMES; SEX	Background Sports-related concussion (SRC) is a common injury mostly in contact sports. Specifically, it is a public health concern for collegiate rugby athletes because at least one concussion is reported in every two games and concussion has been reported to increase the risk of developing neuro-degenerative disorders later in life. Aim To clinically audit concussions to examine commonly reported signs/symptoms in the Sports Concussion Assessment Tool (SCAT). Materials and methods Retrospective audit of a South African University health services medical electronic records database for all concussion International Classification of Diseases 10 (ICD10) diagnoses codes: S06.0, S06.00 and S06.01 in 367 rugby players (age 24.6 +/- 4.3, height 1.8 +/- 0.1 and weight; 90.7 +/- 14.4) for the period 2013-2018. Results SCAT data was obtained for 70% of the 434 concussions. Headache (57%), "pressure in head" (56%), feeling slowed down (55%) and fatigue/low energy (54%) were the most frequently reported concussion symptoms on the SCAT. A significant reduction in the serial SCAT symptom (p < 0.001) and severity (p < 0.001) scores was observed in a sub-set of the rugby players. The concussion incidence proportion was 7%; this was obtained from an annual estimate of the University rugby club's registered players and concussion count (n = 87) during the five-year period. Discussion and conclusions The initial SCAT sub-domain scores following a SRC in this collegiate cohort were consistent with other elite adult male sport cohorts in endorsing many symptoms and showing low-concentration scores. A unique feature of this study was the tracking of serial symptoms in a sub-set of this cohort. These players showed a clear reduction in symptom endorsement, but were still not symptom-free by their third SCAT. The collegiate student population should be educated regarding symptoms, including headache, which might be indicative of concussion following a head injury.	[Kunorozva, Lovemore; van Tonder, Riaan; Starling, Lindsay; Brown, James C.; Viviers, Pierre L.; Derman, Elton W.] Stellenbosch Univ, Fac Hlth Sci, Div Orthopaed, Inst Sport & Exercise Med, Cape Town, South Africa; [Kunorozva, Lovemore; van Tonder, Riaan; Starling, Lindsay; Brown, James C.; Viviers, Pierre L.; Derman, Elton W.] IOC Res Ctr, Pretoria, South Africa; [Viviers, Pierre L.] Stellenbosch Univ, Campus Hlth Serv, Cape Town, South Africa		Kunorozva, L (corresponding author), Stellenbosch Univ, Fac Hlth Sci, Div Orthopaed, Inst Sport & Exercise Med, Cape Town, South Africa.; Kunorozva, L (corresponding author), IOC Res Ctr, Pretoria, South Africa.	23484608@sun.ac.za		Brown, James/0000-0002-7778-7783			Aggarwal SS, 2020, BRAIN INJURY, V34, P811, DOI 10.1080/02699052.2020.1740942; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Barth JT., 1983, NEUROSURGERY, DOI [10.1097/00006123-198311000-00008, DOI 10.1097/00006123-198311000-00008]; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bruce JM, 2021, BRIT J SPORT MED, V55, P557, DOI 10.1136/bjsports-2020-102072; Bunt SC, 2021, CLIN J SPORT MED, V31, pE229, DOI 10.1097/JSM.0000000000000788; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corti SJ, 2019, J CHILD NEUROL, V34, P262, DOI 10.1177/0883073818825031; Covassin T., 2014, ATHL TRAIN SPORT HLT, DOI [10.3928/19425864-20140916-01, DOI 10.3928/19425864-20140916-01]; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller GW, 2019, BRIT J SPORT MED, V53, P1526, DOI 10.1136/bjsports-2017-098560; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P65, DOI 10.1007/0-387-32565-4_4; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Houck Z, 2019, BRAIN INJURY, V33, P480, DOI 10.1080/02699052.2019.1565897; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McGroarty NK, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120932306; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Petit Kyle M, 2020, Int J Exerc Sci, V13, P1143; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Posthumus M., 2016, S AFRICAN J SPORT ME, DOI [10.17159/2413-3108/2008/v20i3a633, DOI 10.17159/2413-3108/2008/V20I3A633]; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Zhang CQ, 2014, MEAS EVAL COUNS DEV, V47, P256, DOI 10.1177/0748175614538064	63	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1824-7490	1825-1234		SPORT SCI HLTH	Sport Sci. Health	DEC	2021	17	4					1007	1015		10.1007/s11332-021-00768-1			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	XD3MQ	WOS:000722615400021					2022-02-06	
J	Lapierre, N; Piquer, O; Celikovic, E; Routhier, F; Ruel, J; Lamontagne, ME				Lapierre, Nolwenn; Piquer, Olivier; Celikovic, Erik; Routhier, Francois; Ruel, Julie; Lamontagne, Marie-Eve			Accessibility of Online Resources for Associations Providing Services to People with Brain Injuries in Covid-19 Pandemic	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						accessibility; disability; digital resources; Covid-19		Background. Since the Covid-19 pandemic, many community-based services for people with traumatic brain injury (TBI) have been moved online, which may have hindered their accessibility. The study aims to assess the accessibility of online information and resources dedicated to people with TBI. Methods. The websites of 14 organizations offering information and resources to people with TBI in Quebec were evaluated. Two co-authors independently evaluated one page of each website and compared their results. Descriptive statistical analyses were performed. Results. The average accessibility score of the 14 websites evaluated was 54% with a standard deviation of 16%. Website design and writing were the most accessible aspects (72.3%). Only two out of the 14 websites (14%) presented multimedia content. This category presented the most barriers to accessibility with a score of 42%. Regarding images, they reached an accessibility score of 46%. Their main shortcoming was the absence of a caption. Conclusion. This study highlights accessibility issues specific to people with TBI to access online resources and identifies specific areas of improvement. The results of this study provide community organizations with avenues of improvement to make their online resources more accessible to people with TBI and may therefore lead to improved community practices.	[Lapierre, Nolwenn; Piquer, Olivier; Celikovic, Erik; Routhier, Francois; Lamontagne, Marie-Eve] Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ G1V 0A6, Canada; [Ruel, Julie] Inst Univ Deficience Intellectuelle & Trouble Spe, Chaire Interdisciplinaire Rech Litteratie CIRLI, Trois Rivieres, PQ G8Z 3T1, Canada		Lamontagne, ME (corresponding author), Univ Laval, Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ G1V 0A6, Canada.	nolwenn.lapierre.1@ulaval.ca; olivier.piquer.1@ulaval.ca; erik.celikovic.1@ulaval.ca; julie.ruel@uqo.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429			Alberola E., 2016, REALITES IND, P32, DOI [10.3917/rindu1.163.0032, DOI 10.3917/RINDU1.163.0032]; Antener G, 2014, LECT NOTES COMPUT SC, V8547, P157, DOI 10.1007/978-3-319-08596-8_24; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; FORTIN MF, 2015, FONDEMENTS ETAPES PR; Fougeyrollas P., 2015, DEV HUMAIN HANDICAP, P5; Gonthier C., PORTRAIT RESEAU QUEB; Gouvernement du Canada, 2012, SC PROGR EV INT COMP; Initiative (WAI) WWA, WEB CONTENT ACCESSIB; Jaspers MWM, 2004, INT J MED INFORM, V73, P781, DOI 10.1016/j.ijmedinf.2004.08.003; Kujala S, 2003, BEHAV INFORM TECHNOL, V22, P1, DOI 10.1080/0144929021000055530; Manivannan S, 2021, WORLD NEUROSURG, V153, pE419, DOI 10.1016/j.wneu.2021.06.140; Morrow Emily L, 1800, JMIR Rehabil Assist Technol, V8, pe26586, DOI 10.2196/26586; Office Quebecois de la Lague Francaise, BAN DEP LING POL CAR; Orozco A, 2016, LECT NOTES COMPUT SC, V9737, P91, DOI 10.1007/978-3-319-40250-5_9; Regroupement des Associations de Personnes Traumatisees Craniocerebrales du Quebec, 2021, CONNX TCC CONNEXION; Reseau Education Media, 2010, LITT NUM CAN INCL TR, P56; Ruel J., 2019, ELA ETUDES LINGUIST, V3, P285, DOI [10.3917/ela.195.0285, DOI 10.3917/ELA.195.0285]; Ruel J., 2018, GUIDE INFORM ACCESSI, P116; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Wang CC, 1998, HEALTH PROMOT INT, V13, P75, DOI 10.1093/heapro/13.1.75	22	0	0	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2021	18	23							12609	10.3390/ijerph182312609			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	XV5LG	WOS:000734983100001	34886333	Green Published			2022-02-06	
J	Le Bail, A; Jardine, CG; Cottenceau, V; Petit, L; Biais, M; Carrie, C				Le Bail, Antoine; Jardine, Cedric Gil; Cottenceau, Vincent; Petit, Laurent; Biais, Matthieu; Carrie, Cedric			Ability of neutrophil-to-lymphocyte ratio to predict secondary neurological impairment in patients with mild to moderate head injury. A retrospective study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Neutrophil-to-lymphocyte ratio; Traumatic brain injury; Cerebral contusion; Emergency medicine	TRAUMATIC BRAIN-INJURY; GREY ZONE; TALK; DIE; COHORT	Background: The main objective was to assess the performance of the neutrophil-lymphocyte ratio (NLR) for early prediction of delayed neurological impairment and cerebral contusion worsening in patients with mild-to-moderate traumatic brain injury (TBI). Methods: Over a 3-year period, every adult patient triaged to our level 1 trauma center with brain contusion and Glasgow Coma Scale (GCS) of 10 or greater were retrospectively included. The main study outcome was the occurrence of delayed clinical deterioration, defined as a GCS < 10 and/or a secondary need for mechanical ventilation, within 5 days after TBI. The performance of MR for prediction of delayed clinical deterioration was assessed by receiver operating characteristic (ROC) curve. Results: Overall, 115 patients were included and 16 (14%) presented a delayed clinical deterioration. Overall, the NLR at ED admission was higher in patients who developed a delayed clinical deterioration (18 [12-29] vs 8 [5-13]. p = 0.0003). The area under the ROC curves for NLR at ED admission in predicting delayed clinical deterioration was 0.79 [0.65-0.93] and NLR > 15 was found to be independently associated with the occurrence of delayed clinical deterioration (adjusted OR 10.1 [95%CI: 23-45.6]). Conclusion: The NLR at ED admission was independently associated with the occurrence of delayed clinical deterioration, although limited by a poor discriminative value by itself. Further studies are needed to test the predictive value of composite scoring systems including NLR for prevention of under-triage of patients with mild-to-moderate TBI.(C) 2021 Published by Elsevier Inc.	[Le Bail, Antoine; Jardine, Cedric Gil; Carrie, Cedric] CHU Pellegrin, Emergency Dept, F-33000 Bordeaux, France; [Cottenceau, Vincent; Petit, Laurent; Biais, Matthieu] CHU Pellegrin, Anesthesiol & Crit Care Dept, F-33000 Bordeaux, France; [Biais, Matthieu] Univ Bordeaux Segalen, F-33000 Bordeaux, France		Carrie, C (corresponding author), CHU Bordeaux, Anesthesiol & Crit Care Dept, Hop Pellegrin, Surg & Trauma Intens Care Unit, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	cedric.carrie@chu-bordeaux.fr					Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Alexiou GA, 2020, BIOMARK MED, V14, P1085, DOI 10.2217/bmm-2020-0150; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Cannesson M, 2015, CAN J ANESTH, V62, P1139, DOI 10.1007/s12630-015-0465-1; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Degos V, 2012, ANESTH ANALG, V114, P1026, DOI 10.1213/ANE.0b013e318249fe7a; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Sabouri E, 2020, WORLD NEUROSURG, V140, P142, DOI 10.1016/j.wneu.2020.04.185; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Siwicka-Gieroba D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091453; Soulaiman SE, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-0266-3; Trevisi G, 2018, WORLD NEUROSURG, V118, pE316, DOI 10.1016/j.wneu.2018.06.185; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhao JL, 2019, WORLD NEUROSURG, V124, pE411, DOI 10.1016/j.wneu.2018.12.107	23	0	0	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2021	50						46	50		10.1016/j.ajem.2021.06.030			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WE1SM	WOS:000705407400009	34273867				2022-02-06	
J	Leard-Schneider, L; Leveque, Y				Leard-Schneider, Laurene; Leveque, Yohana			PERCEPTION OF MUSIC AND SPEECH PROSODY AFTER SEVERE TRAUMATIC BRAIN INJURY	MUSIC PERCEPTION			English	Article						emotion perception; acquired amusia; intonation processing; auditory cognition; nonverbal information	EMOTION RECOGNITION; CONGENITAL AMUSIA; COGNITIVE DEFICITS; MONTREAL BATTERY; SENSITIVITY; DISORDERS; PATHWAYS; IDENTIFICATION; METAANALYSIS; EXPRESSIONS	THE PRESENT STUDY AIMED TO EXAMINE THE perception of music and prosody in patients who had undergone a severe traumatic brain injury (TBI). Our second objective was to describe the association between music and prosody impairments in clinical individual presentations. Thirty-six patients who were out of the acute phase underwent a set of music and prosody tests: two subtests of the Montreal Battery for Evaluation of Amusia evaluating respectively melody (scale) and rhythm perception, two subtests of theMontreal Evaluation of Communication on prosody understanding in sentences, and two other tests evaluating prosody understanding in vowels. Forty-two percent of the patients were impaired in the melodic test, 51% were impaired in the rhythmic test, and 71% were impaired in at least one of the four prosody tests. The amusic patients performed significantly worse than non-amusics on the four prosody tests. This descriptive study shows for the first time the high prevalence of music deficits after severe TBI. It also suggests associations between prosody and music impairments, as well as between linguistic and emotional prosody impairments. Causes of these impairments remain to be explored.	[Leard-Schneider, Laurene; Leveque, Yohana] Univ Claude Bernard Lyon 1, Lyon, France; [Leveque, Yohana] CNRS UMR 5020, Lyon, France; [Leveque, Yohana] INSERM U1028, Lyon, France		Leveque, Y (corresponding author), Hosp Vinatier, Lyon Neurosci Res Ctr CRNL, 95 Bd Pinel,Neurocampus, F-69500 Bron, France.	Yohana.leveque@inserm.fr			University of Lyon [ANR-10-LABX-0060]	This work was carried out within the framework of the LABEX CeLyA (ANR-10-LABX-0060) of the University of Lyon, and in association with the LURCO (Laboratoire Unadre o de Recherche Clinique en Orthophonie)	Alho K, 2014, HEARING RES, V307, P29, DOI 10.1016/j.heares.2013.08.001; Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Balzani C., 2014, PSYCHOMUSICOLOGY MUS, V24, P117, DOI 10.1037/pmu0000037; Belfi AM, 2017, NEUROPSYCHOLOGIA, V97, P29, DOI 10.1016/j.neuropsychologia.2017.01.030; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Belyk M, 2014, SOC COGN AFFECT NEUR, V9, P1395, DOI 10.1093/scan/nst124; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Besson M, 2002, TRENDS COGN SCI, V6, P405, DOI 10.1016/S1364-6613(02)01975-7; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bruck C, 2011, NEUROIMAGE, V58, P259, DOI 10.1016/j.neuroimage.2011.06.005; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Charpentier J, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9246-9; Charpentier J, 2018, COGN AFFECT BEHAV NE, V18, P748, DOI 10.3758/s13415-018-0602-8; CONFAVREUX C, 1992, ARCH NEUROL-CHICAGO, V49, P971, DOI 10.1001/archneur.1992.00530330095023; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; Fruhholz S, 2015, NEUROIMAGE, V109, P27, DOI 10.1016/j.neuroimage.2015.01.016; Fruhholz S, 2014, PROG NEUROBIOL, V123, P1, DOI 10.1016/j.pneurobio.2014.09.003; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Hausen M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00566; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Ilie G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0385-3; Joanette Y., 2004, PROTOCOLE MEC PROTOC, VOrtho ed; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Leung JH, 2017, BRAIN LANG, V166, P19, DOI 10.1016/j.bandl.2016.12.001; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lima CF, 2011, EMOTION, V11, P1021, DOI 10.1037/a0024521; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Lolli SL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01340; Magne C, 2016, BRAIN LANG, V153, P13, DOI 10.1016/j.bandl.2016.01.001; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; Mas-Herrero E, 2014, CURR BIOL, V24, P699, DOI 10.1016/j.cub.2014.01.068; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDonald C, 2008, MUSIC PERCEPT, V25, P345, DOI 10.1525/MP.2008.25.4.345; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; Merrill J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00076; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mitchell RLC, 2008, NEUROPSYCHOLOGIA, V46, P2880, DOI 10.1016/j.neuropsychologia.2008.05.024; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; NESPOULOUS J. L., 1992, MT; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2017, EUR J HUM GENET, V25, P625, DOI 10.1038/ejhg.2017.15; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Pfeifer J, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/tnhum.2015.00161, 10.3389/fnhum.2015.00161]; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pralus A, 2019, NEUROPSYCHOLOGIA, V134, DOI [10.1016/j.neuropsychologia.2010.107234, 10.1016/j.neuropsychologia.2019.107234]; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rigon A, 2019, J INT NEUROPSYCH SOC, V25, P285, DOI 10.1017/S1355617718001108; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Sammler D, 2018, BRAIN LANG, V183, P1, DOI 10.1016/j.bandl.2018.05.001; Sammler D, 2015, CURR BIOL, V25, P3079, DOI 10.1016/j.cub.2015.10.009; Sarkamo T, 2009, NEUROPSYCHOLOGIA, V47, P2642, DOI 10.1016/j.neuropsychologia.2009.05.015; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schuppert M, 2000, BRAIN, V123, P546, DOI 10.1093/brain/123.3.546; Sheppard SM, 2020, NEUROLOGY, V94, pE1013, DOI [10.1212/WNL.0000000000009052, 10.1212/WNL.0000000000008870]; Sihvonen AJ, 2019, NEUROSCI BIOBEHAV R, V107, P104, DOI 10.1016/j.neubiorev.2019.08.023; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stewart L, 2008, CURR OPIN NEUROBIOL, V18, P127, DOI 10.1016/j.conb.2008.07.008; Thompson WF, 2003, ANN NY ACAD SCI, V999, P530, DOI 10.1196/annals.1284.067; Thompson WF, 2004, EMOTION, V4, P46, DOI 10.1037/1528-3542.4.1.46; Thompson WF, 2012, P NATL ACAD SCI USA, V109, P19027, DOI 10.1073/pnas.1210344109; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VIGNAUD A., 2007, THESIS; Wambacq IJA, 2004, COGNITIVE BRAIN RES, V20, P427, DOI 10.1016/j.cogbrainres.2004.03.015; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wright Amy E, 2016, Perspect ASHA Spec Interest Groups, V1, P82, DOI 10.1044/persp1.SIG2.82; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zatorre RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001372; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	81	0	0	1	1	UNIV CALIFORNIA PRESS	OAKLAND	155 GRAND AVE, SUITE 400, OAKLAND, CA 94612-3758 USA	0730-7829			MUSIC PERCEPT	Music Percept.	DEC	2021	39	2					103	117		10.1525/MP.2021.39.2.103			15	Music; Psychology, Experimental	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Music; Psychology	XE5CS	WOS:000723406100001					2022-02-06	
J	Lee, BJ; Blueitt, D; Hannon, J; Goto, S; Garrison, C				Lee, Bobby Jean; Blueitt, Damond; Hannon, Joseph; Goto, Shiho; Garrison, Craig			Movement Patterns During a Jump-Landing Task in Athletes After Sport-Related Concussion and Healthy Control Individuals	JOURNAL OF ATHLETIC TRAINING			English	Article						participants; Key Words; mild traumatic brain injuries; lower extremity injuries; biomechanics	EXTREMITY MUSCULOSKELETAL INJURY; INTER-JOINT COORDINATION; DIVIDED-ATTENTION; HIGH-SCHOOL; RISK; EPIDEMIOLOGY; BIOMECHANICS; INCREASE; MOMENTS; GENDER	Context: A relationship between a history of sport-related concussion (SRC) and lower extremity injury has been well established in the literature. Objective: To determine if biomechanical differences existed during a double-limb jump landing between athletes who had been released to return to play after SRC and healthy matched control individuals. Design: Cross-sectional study. Setting: Health system-based outpatient sports medicine center. Patients or Other Participants: A total of 21 participants with SRC (age = 15.38 +/- 1.77 years, height = 169.23 +/- 8.59 cm, mass = 63.43 +/- 7.39 kg, time since release to return to sport after SRC = 16.33 +/- 12.7 days) were compared with 21 age-, sex-, and activity-matched healthy participants serving as controls (age = 15.36 +/- 1.73 years, height =169.92 +/- 11.1 cm, mass = 65.62 +/- 12.08 kg). Main Outcome Measure(s): Biomechanical performance during the double-limb jump landing was assessed using a motion-capture system and force plates. The average of 3 consecutive trials was used to calculate lower extremity joint kinetics and kinematics. The variables of interest were internal knee-extension moment, internal varus moment, and total sagittal-plane knee displacement for the dominant and nondom-inant limbs. Independent ttests were performed to examine the differences between SRC and control groups for the variables of interest. Results: No differences existed between groups for the descriptive data. The SRC group demonstrated greater internal knee-extension moments in the dominant (-0.028 +/- 0.009 Nm/kg, P= .003) and nondominant (-0.018 +/- 0.007, P= .02) limbs. The SRC group also exhibited greater internal varus moments in the dominant (0.012 +/- 0.004 Nm/kg, P= .005) and nondominant (0.010 +/- 0.003, P = .005) limbs. For sagittal-plane knee displacement, the SRC group displayed less knee-flexion displacement in the dominant (-12.56 +/- 4.67 degrees, P = .01) but not the nondominant (-8.30 +/- 4.91 degrees, P= .10) limb. Conclusions: Athletes who had been released for return to sport after SRC landed with greater knee valgus than healthy matched control participants.	[Lee, Bobby Jean; Hannon, Joseph; Goto, Shiho] Texas Hlth Sports Med, 800 5th Ave,Suite 150, Ft Worth, TX 76104 USA; [Blueitt, Damond] Orthoped Specialty Associates, Ft Worth, TX USA; [Garrison, Craig] Ben Hogan Sports Med, Ft Worth, TX USA		Lee, BJ (corresponding author), Texas Hlth Sports Med, 800 5th Ave,Suite 150, Ft Worth, TX 76104 USA.	bobbyjeanlee@texashealth.org					Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Goerger BM, 2015, BRIT J SPORT MED, V49, P188, DOI 10.1136/bjsports-2013-092982; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kernozek TW, 2005, MED SCI SPORT EXER, V37, P1003, DOI 10.1249/01.mss.0000171616.14640.2b; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McPherson AL, 2020, SPORTS MED, V50, P1203, DOI 10.1007/s40279-020-01262-3; Myer GD, 2015, BRIT J SPORT MED, V49, P118, DOI 10.1136/bjsports-2013-092536; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Podraza JT, 2010, KNEE, V17, P291, DOI 10.1016/j.knee.2010.02.013; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	35	0	0	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2021	56	12					1306	1312		10.4085/533-20			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XR2GR	WOS:000732055000007	34911071	gold			2022-02-06	
J	Leonard, BT; Kontos, AP; Marchetti, GF; Zhang, M; Eagle, SR; Reecher, HM; Bensinger, ES; Snyder, VC; Holland, CL; Sheehy, CK; Rossi, EA				Leonard, Bianca T.; Kontos, Anthony P.; Marchetti, Gregory F.; Zhang, Min; Eagle, Shawn R.; Reecher, Hope M.; Bensinger, Ethan S.; Snyder, Valerie C.; Holland, Cyndi L.; Sheehy, Christy K.; Rossi, Ethan A.			Fixational eye movements following concussion	JOURNAL OF VISION			English	Article						fixational eye movements; microsaccades; concussion; scanning laser ophthalmoscopy; eye motion measurement	VISUAL FIXATION; NEURAL ACTIVITY; MICROSACCADES; DYSFUNCTION; ACTIVATION; STRIATE; VISION; MOTION; CORTEX; FMRI	The purpose of this study was to evaluate fixational eye movements (FEMs) with high spatial and temporal resolution following concussion, where oculomotor symptoms and impairments are common. Concussion diagnosis was determined using current consensus guidelines. A retinal eye-tracking device, the tracking scanning laser ophthalmoscope (TSLO), was used to measure FEMs in adolescents and young adults following a concussion and in an unaffected control population. FEMs were quantified in two fixational paradigms: (1) when fixating on the center, or (2) when fixating on the corner of the TSLO imaging raster. Fixational saccade amplitude in recent concussion patients (<= 21 days) was significantly greater, on average, in the concussion group (mean = 1.03 degrees; SD = 0.36 degrees) compared with the controls (mean = 0.82 degrees; SD = 0.31 degrees), when fixating on the center of the imaging raster (t = 2.87, df = 82, p = 0.005). These fixational saccades followed the main sequence and therefore also had greater peak velocity (t = 2.86, df = 82, p = 0.006) and peak acceleration (t = 2.80, df = 82, p = 0.006). These metrics significantly differentiated concussed from controls (AUC = 0.67-0.68, minimum p = 0.005). No group differences were seen for the drift metrics in either task or for any of the FEMs metrics in the corner-of-raster fixation task. Fixational saccade amplitudes were significantly different in the concussion group, but only when fixating on the center of the raster. This task specificity suggests that task optimization may improve differentiation and warrants further study. FEMs measured in the acute-to-subacute period of concussion recovery may provide a quick (<3 minutes), objective, sensitive, and accurate ocular dysfunction assessment. Future work should assess the impact of age, mechanism of injury, and post-concussion recovery on FEM alterations following concussion.	[Leonard, Bianca T.; Zhang, Min; Reecher, Hope M.; Snyder, Valerie C.; Rossi, Ethan A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Kontos, Anthony P.; Eagle, Shawn R.; Holland, Cyndi L.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA USA; [Marchetti, Gregory F.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Bensinger, Ethan S.] Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA; [Sheehy, Christy K.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rossi, Ethan A.] Univ Pittsburgh, Dept Bioengn, Swanson Sch Engn, Pittsburgh, PA USA		Rossi, EA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	rossiea@pitt.edu			C. Light Technologies, Inc.; University of PittsburghUniversity of Pittsburgh; University of Pittsburgh Clinical and Translational Science Institute, through National Institutes of Health [UL1 TR001857, KL2 TR001856, TL1 TR001858]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 EY08098]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); National Football League through the University of Pittsburgh	The authors thank Emory N. Verstraete and Bharadwaj Chirravuri for their assistance with TSLO motion trace segmentation. Supported by a grant from C. Light Technologies, Inc., to EAR and by departmental startup funds from the University of Pittsburgh to EAR. This project was also supported by the University of Pittsburgh Clinical and Translational Science Institute, through grants from the National Institutes of Health (UL1 TR001857, KL2 TR001856, TL1 TR001858) . This work was also supported by a National Institutes of Health Core Grant (P30 EY08098) to the University of Pittsburgh Department of Ophthalmology and from an unrestricted grant to the University of Pittsburgh Department of Ophthalmology from Research to Prevent Blindness. CKS is the founder, CEO, and majority shareholder of C. Light Technologies, Inc., and is a co-inventor of patents on technologies associated with the TSLO device used in this study. ESB was a consultant for C. Light Technologies, Inc. APK receives funding for his research from the National Football League through the University of Pittsburgh and royalties from APA Books. No competing financial interests exist for any of the other authors.	Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Bijvank JAN, 2019, INVEST OPHTH VIS SCI, V60, P1372, DOI 10.1167/iovs.18-26096; Bolger C, 1999, J NEUROL NEUROSUR PS, V66, P528, DOI 10.1136/jnnp.66.4.528; Cochrane GD, 2020, CLIN EXP OPTOM, V103, P929, DOI 10.1111/cxo.13045; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; DEUBEL H, 1986, BIOL CYBERN, V54, P351, DOI 10.1007/BF00355540; Egana Jose Ignacio, 2013, Front Psychiatry, V4, P37, DOI 10.3389/fpsyt.2013.00037; Fried M, 2014, VISION RES, V101, P62, DOI 10.1016/j.visres.2014.05.004; Gao Y, 2017, RESTOR NEUROL NEUROS, V35, P365, DOI 10.3233/RNN-170749; Goffart L, 2012, J NEUROSCI, V32, P10627, DOI 10.1523/JNEUROSCI.0696-12.2012; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; Hafed ZM, 2012, J NEUROPHYSIOL, V107, P1904, DOI 10.1152/jn.01125.2011; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herrington TM, 2009, J NEUROSCI, V29, P5793, DOI 10.1523/JNEUROSCI.4412-08.2009; Hohl SS, 2011, J NEUROSCI, V31, P16561, DOI 10.1523/JNEUROSCI.3166-11.2011; Hunfalvay M, 2021, BRAIN INJURY, V35, P209, DOI 10.1080/02699052.2020.1865566; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kagan I, 2008, J VISION, V8, DOI 10.1167/8.14.19; Kapoula Z, 2014, AGE, V36, P535, DOI 10.1007/s11357-013-9582-3; Kellar D, 2018, NEUROIMAGE-CLIN, V18, P413, DOI 10.1016/j.nicl.2018.01.025; KELLY DH, 1990, J OPT SOC AM A, V7, P2237, DOI 10.1364/JOSAA.7.002237; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; Kontos AP, 2021, AM J SPORT MED, V49, P2211, DOI 10.1177/03635465211012359; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; McCamy MB, 2013, PEERJ, V1, DOI 10.7717/peerj.9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray NG, 2020, J NEUROTRAUM, V37, P340, DOI 10.1089/neu.2019.6595; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Poletti M, 2008, J VISION, V8, DOI 10.1167/8.14.4; Poletti M, 2016, VISION RES, V118, P83, DOI 10.1016/j.visres.2015.01.018; Ratnam K, 2017, J VISION, V17, DOI 10.1167/17.1.30; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Rucci M, 2008, NETWORK-COMP NEURAL, V19, P253, DOI 10.1080/09548980802520992; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Rucci M, 2015, ANNU REV VIS SCI, V1, P499, DOI 10.1146/annurev-vision-082114-035742; Rucci M, 2015, TRENDS NEUROSCI, V38, P195, DOI 10.1016/j.tins.2015.01.005; Shaikh AG, 2017, NEUROL SCI, V38, P1977, DOI 10.1007/s10072-017-3069-4; Sheehy CK, 2018, J NEURO-OPHTHALMOL, V38, P488, DOI 10.1097/WNO.0000000000000734; Sheehy CK, 2012, BIOMED OPT EXPRESS, V3, P2611, DOI 10.1364/BOE.3.002611; Shirama A, 2016, J AUTISM DEV DISORD, V46, P1613, DOI 10.1007/s10803-015-2688-y; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Zhang M, 2021, BIOMED OPT EXPRESS, V12, P2353, DOI 10.1364/BOE.418070	50	0	0	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	1534-7362			J VISION	J. Vision	DEC	2021	21	13					1	14		10.1167/jov.21.13.11			14	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	XW4HO	WOS:000735582600001	34940825	Green Published, gold			2022-02-06	
J	Lepard, J; Ammar, A; Shlobin, NA; Boyke, AE; Berger, C; Vital, A; Rolle, M; Corley, J; Barthelemy, EJ; Park, KB				Lepard, Jacob; Ammar, Adam; Shlobin, Nathan A.; Boyke, Andre E.; Berger, Connor; Vital, Anchelo; Rolle, Myron; Corley, Jacquelyn; Barthelemy, Ernest J.; Park, Kee B.			An Assessment of Global Neurotrauma Prevention and Care Delivery: The Provider Perspective	WORLD NEUROSURGERY			English	Article						Global neurosurgery; Neurotrauma; Prevention	BRAIN-INJURY; HELMET LAW; EPIDEMIOLOGY	-BACKGROUND: Neurotrauma is a leading cause of morbidity and mortality around the world. Assessment of injury prevention and prehospital care for neurotrauma patients is necessary to improve care systems. -METHODS: A 29-question electronic survey was devel-oped based on the Enhancing the Quality and Transparency Of health Research (EQUATOR) checklist to assess neuro-trauma policies and laws related to safety precautions. The survey was distributed to members of World Health Orga- -ization regions that were considered to be experienced medical authorities in neurosurgery and traumatic brain injury. -RESULTS: There were 82 (39%) responses representing 46 countries. Almost all respondents (95.2%) were within the neurosurgical field. Of respondents, 40.2% were from high-income countries (HICs), and 59.8% were from low-and middle-income countries (LMICs). Motor vehicle accidents were reported as the leading cause of neuro-trauma, followed by workplace injury and assault. Of re-spondents, 84.1% reported having a helmet law in their country. HICs (4.38 +/- 0.78) were ranked more likely than LMICs (2.88 +/- 1.34; P = 0.0001) to enforce helmet laws on a scale of 1-10. Effectiveness of helmet laws was rated as 3.94 +/- 0.95 out of 10. Measures regarding prehospital care varied between HICs and LMICs. Patients in HICs were more likely to use public emergency ambulance trans-portation (81.8% vs. 42.9%; P = 0.0004). All prehospital personnel having emergency training was also reported to be more likely in HICs than LMICs (60.6% vs. 8.7%; P = 0.0001). -CONCLUSIONS: When injuries occur, timely access to neurosurgical care is critical. A focus on prehospital com-ponents of the trauma system is paramount, and policy-makers can use the information presented here to implement and refine health care systems to ensure safe, timely, affordable, and equitable access to neurotrauma care.	[Lepard, Jacob] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Ammar, Adam; Berger, Connor; Vital, Anchelo; Rolle, Myron; Corley, Jacquelyn; Park, Kee B.] Harvard Univ, Program Global Surg & Social Change, Boston, MA 02115 USA; [Shlobin, Nathan A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Boyke, Andre E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA; [Barthelemy, Ernest J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA		Boyke, AE (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA.	andre.boyke@einsteinmed.org		Ammar, Adam/0000-0001-8467-2469; Shlobin, Nathan/0000-0003-2079-6125			Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Barthelemy EJ, 2019, WORLD NEUROSURG, V126, pE232, DOI 10.1016/j.wneu.2019.02.019; Bonnie R.J., 1999, REDUCING BURDEN INJU; Corley J, 2019, WORLD NEUROSURG, V132, P434, DOI 10.1016/j.wneu.2019.08.240; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dunne J, 2020, J NEUROSCI RURAL PRA, V11, P287, DOI 10.1055/s-0040-1709363; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Nathens AB, 2005, LANCET, V366, P1772; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; National Highway Traffic Safety Administration, 2008, MOT HELM US LAWS; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Popescu C, 2015, J Med Life, V8, P272; Reuvers R, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08544-5; Rosenthal AA, 2017, AM SURGEON, V83, pE438; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The World Bank, DAT COUNTR CLASS LOW; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Weiss H, 2010, PEDIATRICS, V126, P1149, DOI 10.1542/peds.2010-0902; World Health Organization, 2018, GLOBAL STATUS REPORT	24	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2021	156						E183	E191		10.1016/j.wneu.2021.09.025			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XG8VJ	WOS:000725025500036	34560295	Bronze			2022-02-06	
J	Li, FF; Lu, LY; Shang, SA; Chen, HY; Wang, P; Muthaiah, VP; Yin, XD; Chen, YC				Li, Fengfang; Lu, Liyan; Shang, Song'an; Chen, Huiyou; Wang, Peng; Muthaiah, Vijaya Prakash; Yin, Xindao; Chen, Yu-Chen			Altered static and dynamic functional network connectivity in post-traumatic headache	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache; Mild traumatic brain injury; Functional magnetic resonance imaging; Functional network connectivity	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; PAIN	Background Post-traumatic headache (PTH) is a very common symptom following mild traumatic brain injury (mTBI), yet much remains unknown about the underlying pathophysiological mechanisms of PTH. Neuroimaging studies suggest that aberrant functional network connectivity (FNC) may be an important factor in pain disorders. The present study aimed to investigate the functional characteristics of static FNC (sFNC) and dynamic FNC (dFNC) in mTBI patients with PTH. Methods With Institutional Review Board (IRB) approval, we prospectively recruited 50 mTBI patients with PTH, who were diagnosed with ICHD-3 beta diagnostic criteria and 39 mTBI without PTH who were well matched for age, gender and education. Resting-state functional magnetic resonance imaging (fMRI) scanning (3.0 T, Philips Medical Systems, Netherlands), Montreal Cognitive Assessment (MoCA) and headache symptom measurement (headache frequency and headache intensity) were performed. The resting-state fMRI sequence took 8 min and 10 s. Independent component analysis and sliding window method were applied to examine the FNC on the basis of nine resting-state networks, namely, default mode network (DMN), sensorimotor network (SMN), executive control network (ECN), auditory network (AuN), attention network (AN), salience network (SN), visual network (VN), and cerebellum network (CN). The differences in sFNC and dFNC were determined and correlated with clinical variables using Pearson rank correlation. Results For sFNC, compared with mTBI patients without PTH, mTB with PTH group showed four altered interactions, including decreased interactions in SN-SMN and VN-DMN pairs, increased sFNC in SN-ECN and SMN-DMN pairs. For dFNC, significant group differences were found in State 2, including increased connectivity alteration in the DMN with CN, DMN with SMN, and AuN with CN. Significant reduced connectivity changes in the DMN with VN was found in State 4. Furthermore, the number of transitions (r=0.394, p=0.005) between states was positively associated with headache frequency. Additionally, dwell time (r=-0.320, p=0.025) in State 1 was negatively correlated with MoCA score. Conclusions MTBI patients with PTH are characterized with altered sFNC and dFNC, which could provide new perspective to understand the neuropathological mechanism underlying the PTH to determine more appropriate management, and may be a useful imaging biomarker for identifying and predicting mTBI with PTH.	[Li, Fengfang; Lu, Liyan; Shang, Song'an; Chen, Huiyou; Wang, Peng; Yin, Xindao; Chen, Yu-Chen] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China; [Muthaiah, Vijaya Prakash] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Rehabil Sci, Buffalo, NY USA		Yin, XD; Chen, YC (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	y.163yy@163.com; chenyuchen1989@126.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82102012, 82102006]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20201118, BK20211008]	This work was funded by the Natural Science Foundation of China (No. 82102012, 82102006) and Natural Science Foundation of Jiangsu Province (No. BK20201118, BK20211008).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Diedrichsen J, 2019, NEURON, V102, P918, DOI 10.1016/j.neuron.2019.04.021; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Du YH, 2016, SCHIZOPHR RES, V170, P55, DOI 10.1016/j.schres.2015.11.021; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fiorenzato E, 2019, BRAIN, V142, P2860, DOI 10.1093/brain/awz192; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Hou WS, 2019, BRAIN CONNECT, V9, P475, DOI 10.1089/brain.2018.0629; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Li FF, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/2174371; Li FF, 2020, CNS NEUROSCI THER, V26, P1083, DOI 10.1111/cns.13430; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Lu LY, 2021, CLIN NEURORADIOL, DOI 10.1007/s00062-021-01082-6; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Malhi GS, 2019, BRIT J PSYCHIAT, V215, P545, DOI 10.1192/bjp.2019.10; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Rashid B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00897; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Skorobogatykh K, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1047-3; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Varndell W, 2017, J CLIN NURS, V26, P7, DOI 10.1111/jocn.13594; Vasa F, 2020, P NATL ACAD SCI USA, V117, P3248, DOI 10.1073/pnas.1906144117; Vereb D, 2020, PAIN, V161, P856, DOI 10.1097/j.pain.0000000000001770; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zou Y, 2021, QUANT IMAG MED SURG, V11, P2253, DOI 10.21037/qims-20-588	40	0	0	4	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC	2021	22	1							137	10.1186/s10194-021-01348-x			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WW7OC	WOS:000718100000001	34773973	Green Published, gold			2022-02-06	
